{
  "file_name": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
  "total_pages": 62,
  "pdf_type": "normal",
  "font_analysis": {
    "font_sizes_frequency": {
      "23.98040008544922": 4,
      "21.94206428527832": 1,
      "20.02363395690918": 2,
      "17.02608299255371": 1,
      "11.030982971191406": 1607,
      "9.951866149902344": 374,
      "14.028532981872559": 14,
      "12.94941520690918": 44,
      "11.99020004272461": 90,
      "7.074217319488525": 6,
      "8.992650032043457": 635,
      "5.755295753479004": 17,
      "6.354805946350098": 2,
      "14.987749099731445": 1
    },
    "heading_sizes": [
      23.98040008544922,
      20.02363395690918,
      14.028532981872559,
      12.94941520690918,
      11.99020004272461
    ]
  },
  "table_analysis": {
    "total_tables": 19,
    "tables_info": [
      {
        "bbox": [
          69.44236755371094,
          198.00790405273438,
          535.5504760742188,
          618.6722412109375
        ],
        "num_rows": 8,
        "num_cols": 2
      },
      {
        "bbox": [
          76.7583999633789,
          161.1072235107422,
          488.0915832519531,
          468.9308166503906
        ],
        "num_rows": 13,
        "num_cols": 4
      },
      {
        "bbox": [
          79.6368408203125,
          131.0200958251953,
          482.7152404785156,
          498.6583251953125
        ],
        "num_rows": 14,
        "num_cols": 4
      },
      {
        "bbox": [
          69.32242584228516,
          320.963623046875,
          530.5894775390625,
          412.0640869140625
        ],
        "num_rows": 6,
        "num_cols": 5
      },
      {
        "bbox": [
          75.1992416381836,
          103.28153991699219,
          535.027099609375,
          250.9601593017578
        ],
        "num_rows": 6,
        "num_cols": 4
      },
      {
        "bbox": [
          80.1165771484375,
          407.0455017089844,
          536.0652465820312,
          746.0350341796875
        ],
        "num_rows": 7,
        "num_cols": 3
      },
      {
        "bbox": [
          63.445613861083984,
          229.399658203125,
          347.4513854980469,
          526.9473876953125
        ],
        "num_rows": 4,
        "num_cols": 2
      },
      {
        "bbox": [
          63.08580780029297,
          322.2111511230469,
          470.86480712890625,
          711.61669921875
        ],
        "num_rows": 3,
        "num_cols": 3
      },
      {
        "bbox": [
          63.08580780029297,
          111.912109375,
          512.3389892578125,
          496.62054443359375
        ],
        "num_rows": 19,
        "num_cols": 4
      },
      {
        "bbox": [
          85.2737808227539,
          236.09640502929688,
          526.5341796875,
          636.9871826171875
        ],
        "num_rows": 5,
        "num_cols": 6
      },
      {
        "bbox": [
          71.24138641357422,
          437.7160339355469,
          463.9277648925781,
          612.8446655273438
        ],
        "num_rows": 7,
        "num_cols": 2
      },
      {
        "bbox": [
          75.31917572021484,
          553.509521484375,
          523.83251953125,
          650.6033935546875
        ],
        "num_rows": 8,
        "num_cols": 3
      },
      {
        "bbox": [
          63.08580780029297,
          246.28526306152344,
          507.6462097167969,
          728.0387573242188
        ],
        "num_rows": 4,
        "num_cols": 3
      },
      {
        "bbox": [
          63.08580780029297,
          162.736572265625,
          524.9752807617188,
          666.5671997070312
        ],
        "num_rows": 15,
        "num_cols": 3
      },
      {
        "bbox": [
          63.08580780029297,
          215.23919677734375,
          526.054443359375,
          675.056640625
        ],
        "num_rows": 4,
        "num_cols": 6
      },
      {
        "bbox": [
          113.57844543457031,
          598.9887084960938,
          296.0759582519531,
          700.3978881835938
        ],
        "num_rows": 5,
        "num_cols": 3
      },
      {
        "bbox": [
          232.07421875,
          394.132568359375,
          528.913330078125,
          601.2661743164062
        ],
        "num_rows": 10,
        "num_cols": 2
      },
      {
        "bbox": [
          72.44074249267578,
          346.39178466796875,
          527.3104858398438,
          721.70166015625
        ],
        "num_rows": 8,
        "num_cols": 3
      },
      {
        "bbox": [
          85.0339126586914,
          485.5893249511719,
          491.3747253417969,
          708.91650390625
        ],
        "num_rows": 6,
        "num_cols": 2
      }
    ]
  },
  "text_blocks": [
    {
      "text": "제네릭의약품의 국제공통기술문서",
      "font_size": 23.98040008544922,
      "font_name": "H2hdrM",
      "bbox": [
        112.85883331298828,
        253.56134033203125,
        492.6451721191406,
        277.5351257324219
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품질요약자료 작성 가이드라인",
      "font_size": 23.98040008544922,
      "font_name": "H2hdrM",
      "bbox": [
        130.84909057617188,
        291.9194030761719,
        466.6670837402344,
        315.8931884765625
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[민원인 안내서]",
      "font_size": 23.98040008544922,
      "font_name": "H2hdrM",
      "bbox": [
        213.12449645996094,
        333.27423095703125,
        384.5659484863281,
        357.2480163574219
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2015. 12.",
      "font_size": 21.94206428527832,
      "font_name": "H2hdrM",
      "bbox": [
        248.1455078125,
        484.73980712890625,
        346.7704772949219,
        506.67584228515625
      ],
      "page_num": 1,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의약품심사부 의약품규격과",
      "font_size": 20.02363395690918,
      "font_name": "H2hdrM",
      "bbox": [
        179.54269409179688,
        716.8942260742188,
        415.45452880859375,
        736.912353515625
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침·안내서 제‧개정 점검표",
      "font_size": 17.02608299255371,
      "font_name": "H2hdrM",
      "bbox": [
        186.25904846191406,
        110.29235076904297,
        410.0584716796875,
        127.31375122070312
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "명칭",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        83.95449829101562,
        150.65963745117188,
        529.3843994140625,
        165.3276824951172
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제네릭의약품의 국제공통기술문서 품질요약자료 작성 가이드라인 [민원인안내서]",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        83.95449829101562,
        150.65963745117188,
        529.3843994140625,
        165.3276824951172
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아래에 해당하는 사항에 체크하여 주시기 바랍니다.",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        167.7890625,
        179.068603515625,
        429.0168762207031,
        193.73663330078125
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등록대상",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        72.20086669921875,
        327.7061462402344,
        116.2166748046875,
        342.3741760253906
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여부",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        83.2348861694336,
        345.20703125,
        105.30292510986328,
        359.87506103515625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 이미 등록된 지침·안내서 중 동일·유사한 내용의",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        198.00790405273438,
        395.4665832519531,
        212.67593383789062
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침·안내서가 있습니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        151.238037109375,
        214.42996215820312,
        278.0503234863281,
        229.09799194335938
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        198.48736572265625,
        507.804443359375,
        228.61851501464844
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        198.48736572265625,
        507.804443359375,
        228.61851501464844
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        231.09173583984375,
        535.55029296875,
        245.75978088378906
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고려하시기 바랍니다. 그럼에도 불구하고 동 지침·안내서의 제정이 필요한",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        150.51841735839844,
        247.6336669921875,
        535.5506591796875,
        278.7237548828125
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우 그 사유를 아래에 기재해 주시기 바랍니다.",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        150.51841735839844,
        247.6336669921875,
        535.5506591796875,
        278.7237548828125
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(사유 :                                                                 )",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        280.5976257324219,
        526.6383666992188,
        295.2656555175781
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        297.2594299316406,
        436.1248779296875,
        311.9274597167969
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내용을 단순 편집 또는 나열한 것입니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        151.238037109375,
        313.8013610839844,
        355.40838623046875,
        328.4693908691406
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        297.8587646484375,
        507.804443359375,
        327.8700256347656
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        297.8587646484375,
        507.804443359375,
        327.8700256347656
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        330.34326171875,
        507.804443359375,
        360.4743957519531
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        330.34326171875,
        507.804443359375,
        360.4743957519531
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        330.34326171875,
        507.804443359375,
        360.4743957519531
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        362.3482971191406,
        443.0807800292969,
        377.0163269042969
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내용입니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        150.51841735839844,
        377.8114013671875,
        210.643798828125,
        392.47943115234375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        362.3482971191406,
        507.804443359375,
        392.47943115234375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        362.3482971191406,
        507.804443359375,
        392.47943115234375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 외국 규정을 번역하거나 설명하는 내용입니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        394.35333251953125,
        507.804443359375,
        424.48443603515625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        394.35333251953125,
        507.804443359375,
        424.48443603515625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        394.35333251953125,
        507.804443359375,
        424.48443603515625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 정보제공 등 직원 교육용 자료입니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        426.47821044921875,
        507.804443359375,
        456.4894714355469
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        426.47821044921875,
        507.804443359375,
        456.4894714355469
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        426.47821044921875,
        507.804443359375,
        456.4894714355469
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다.",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        458.4832458496094,
        530.2739868164062,
        489.5733337402344
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침·안내서 제·개정 절차를 적용하실 필요는 없습니다.",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        458.4832458496094,
        530.2739868164062,
        489.5733337402344
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침·안내서",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        65.48451232910156,
        514.2223510742188,
        126.81218719482422,
        528.890380859375
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구분",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        83.2348861694336,
        531.7232055664062,
        105.30292510986328,
        546.3912353515625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        491.56707763671875,
        448.0770263671875,
        506.235107421875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사무의 세부기준이나 절차를 제시하는 것입니까? (공무원용)",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        150.6383514404297,
        506.9103088378906,
        432.84918212890625,
        521.578369140625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예(☞지침)",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        491.56707763671875,
        529.4337768554688,
        521.578369140625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        491.56707763671875,
        529.4337768554688,
        521.578369140625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        523.5721435546875,
        451.9553527832031,
        538.2401733398438
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        150.6383514404297,
        538.9153442382812,
        451.9564514160156,
        569.0465087890625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식약처의 입장을 기술하는 것입니까? (민원인용)",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        150.6383514404297,
        538.9153442382812,
        451.9564514160156,
        569.0465087890625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 예(☞안내서)",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        531.2437744140625,
        535.5504760742188,
        561.3748779296875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        531.2437744140625,
        535.5504760742188,
        561.3748779296875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기타 확인",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        69.44236755371094,
        586.5033569335938,
        118.97551727294922,
        601.17138671875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사항",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        83.2348861694336,
        604.0042114257812,
        105.30292510986328,
        618.6722412109375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        571.040283203125,
        426.0497131347656,
        585.7083129882812
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "민원인을 구속하는 내용이 있습니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        150.6383514404297,
        586.3834838867188,
        337.0552978515625,
        601.051513671875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        571.040283203125,
        507.804443359375,
        601.051513671875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        571.040283203125,
        507.804443359375,
        601.051513671875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침·",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        603.0452880859375,
        531.6868286132812,
        617.7133178710938
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안내서 제·개정 절차를 진행하시기 바랍니다.",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        150.51841735839844,
        619.4673461914062,
        375.1716613769531,
        634.1353759765625
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상기 사항에 대하여 확인하였음.",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        216.0029296875,
        636.129150390625,
        381.7624816894531,
        650.7971801757812
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2017  년   5  월   25  일",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        222.71929931640625,
        671.969970703125,
        363.6429138183594,
        686.6380004882812
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "담당자",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        330.4209289550781,
        706.2525024414062,
        499.4093322753906,
        735.3048095703125
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확  인(부서장)",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        330.4209289550781,
        706.2525024414062,
        499.4093322753906,
        735.3048095703125
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "김 영 림",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        330.4209289550781,
        706.2525024414062,
        499.4093322753906,
        735.3048095703125
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- iii -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        282.5668640136719,
        788.5885009765625,
        312.2957458496094,
        798.5376586914062
      ],
      "page_num": 3,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이",
      "font_size": 14.028532981872559,
      "font_name": "T7",
      "bbox": [
        99.18624114990234,
        108.24170684814453,
        509.1110534667969,
        125.0713119506836
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안내서는",
      "font_size": 14.028532981872559,
      "font_name": "T7",
      "bbox": [
        99.18624114990234,
        108.24170684814453,
        509.1110534667969,
        125.0713119506836
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제네릭의약품의",
      "font_size": 14.028532981872559,
      "font_name": "T7",
      "bbox": [
        99.18624114990234,
        108.24170684814453,
        509.1110534667969,
        125.0713119506836
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "국제공통기술문서(CTD:",
      "font_size": 14.028532981872559,
      "font_name": "T7",
      "bbox": [
        99.18624114990234,
        108.24170684814453,
        509.1110534667969,
        125.0713119506836
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Common",
      "font_size": 14.028532981872559,
      "font_name": "T7",
      "bbox": [
        99.18624114990234,
        108.24170684814453,
        509.1110534667969,
        125.0713119506836
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Technical Document) 중 제2부의 품질평가자료요약 작성에 대한 식",
      "font_size": 14.028532981872559,
      "font_name": "T7",
      "bbox": [
        85.75352478027344,
        129.21878051757812,
        509.00506591796875,
        188.00253295898438
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품의약품안전처의 입장을 기술한 것으로, 대외적으로 법적 효력을",
      "font_size": 14.028532981872559,
      "font_name": "T7",
      "bbox": [
        85.75352478027344,
        129.21878051757812,
        509.00506591796875,
        188.00253295898438
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가지는 것이 아님",
      "font_size": 14.028532981872559,
      "font_name": "T7",
      "bbox": [
        85.75352478027344,
        129.21878051757812,
        509.00506591796875,
        188.00253295898438
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문",
      "font_size": 14.028532981872559,
      "font_name": "T7",
      "bbox": [
        98.46663665771484,
        192.15000915527344,
        509.00457763671875,
        208.9796142578125
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서",
      "font_size": 14.028532981872559,
      "font_name": "T7",
      "bbox": [
        85.75352478027344,
        213.12709045410156,
        509.12603759765625,
        313.864990234375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반드시 준수하셔야 하는 사항이 아님을 알려드립니다. 또한, 본 안내",
      "font_size": 14.028532981872559,
      "font_name": "T7",
      "bbox": [
        85.75352478027344,
        213.12709045410156,
        509.12603759765625,
        313.864990234375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서는 2015년 12월 31일 현재의 과학적·기술적 사실 및 유효한 법규",
      "font_size": 14.028532981872559,
      "font_name": "T7",
      "bbox": [
        85.75352478027344,
        213.12709045410156,
        509.12603759765625,
        313.864990234375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인",
      "font_size": 14.028532981872559,
      "font_name": "T7",
      "bbox": [
        85.75352478027344,
        213.12709045410156,
        509.12603759765625,
        313.864990234375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.",
      "font_size": 14.028532981872559,
      "font_name": "T7",
      "bbox": [
        85.75352478027344,
        213.12709045410156,
        509.12603759765625,
        313.864990234375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등(이",
      "font_size": 12.94941520690918,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        85.75352478027344,
        359.06219482421875,
        509.0041198730469,
        376.28118896484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한 사",
      "font_size": 12.94941520690918,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        109.86045837402344,
        378.6008605957031,
        509.0041198730469,
        395.8198547363281
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안에 대하여 식품의약품안전처의 입장을 기술하는 것",
      "font_size": 12.94941520690918,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        109.86045837402344,
        398.1394958496094,
        421.5715026855469,
        415.3584899902344
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평",
      "font_size": 11.99020004272461,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        62.48613357543945,
        671.5136108398438,
        538.1483154296875,
        684.1560668945312
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가원 의약품심사부 의약품규격과에 문의하시기 바랍니다.",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        81.79566955566406,
        689.0070190429688,
        389.64483642578125,
        703.3792724609375
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전화 : 043-719-2952",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        80.59632110595703,
        708.1860961914062,
        187.07461547851562,
        722.558349609375
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "팩스 : 043-719-2950",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        80.59632110595703,
        727.3651123046875,
        187.07461547851562,
        741.7373657226562
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- iv -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        282.4469299316406,
        788.5885009765625,
        312.2957458496094,
        798.5376586914062
      ],
      "page_num": 4,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목  차",
      "font_size": 23.98040008544922,
      "font_name": "H2hdrM",
      "bbox": [
        263.85699462890625,
        108.16023254394531,
        331.0205993652344,
        132.134033203125
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3. 품질평가자료요약 ……………………………………………………………………… 1",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        67.40347290039062,
        144.681884765625,
        519.8942260742188,
        159.066162109375
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서론 ……………………………………………………………………………………………… 1",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        67.40347290039062,
        168.89541625976562,
        522.4129028320312,
        183.2797088623047
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.S. 원료의약품 (제품명, 제조자) ……………………………………………………… 1",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        67.40347290039062,
        193.10894775390625,
        517.2556762695312,
        207.4932403564453
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.S.1. 일반정보(제품명, 제조자) ………………………………………………………… 1",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        217.20263671875,
        525.17138671875,
        231.5869140625
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.S.2. 제조(제품명, 제조자) ……………………………………………………………… 4",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        241.41616821289062,
        525.17138671875,
        255.8004608154297
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.S.3. 특성(제품명, 제조자) ……………………………………………………………… 4",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        265.62969970703125,
        525.17138671875,
        280.01397705078125
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.S.4. 원료의약품의 품질관리(제품명, 제조자) ………………………………………… 6",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        289.7233581542969,
        526.3707275390625,
        304.1076354980469
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.S.5. 표준품 또는 표준물질(제품명, 제조자) ………………………………………… 9",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        313.9369201660156,
        525.17138671875,
        328.3211975097656
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.S.6. 용기 및 포장 시스템(제품명, 제조자)",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        338.15045166015625,
        526.2507934570312,
        352.53472900390625
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "………………………………………… 10",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        338.15045166015625,
        526.2507934570312,
        352.53472900390625
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.S.7 안정성(제품명, 제조자) …………………………………………………………… 11",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        362.2441101074219,
        523.4923095703125,
        376.6283874511719
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P 완제의약품(제품명, 제형) ………………………………………………………… 12",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        67.40347290039062,
        386.4576416015625,
        518.6948852539062,
        400.8419189453125
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.P.1 완제의약품의 개요와 조성(제품명, 제형) ……………………………………… 12",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        410.67120361328125,
        524.3318481445312,
        425.05548095703125
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.2 개발경위(제품명, 제형) …………………………………………………………… 15",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        434.7648620605469,
        524.3318481445312,
        449.1491394042969
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.3 제조(제품명, 제형) ………………………………………………………………… 16",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        458.9783935546875,
        524.3318481445312,
        473.3626708984375
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.4 첨가제의 관리(제품명, 제형) …………………………………………………… 21",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        483.1919250488281,
        523.1325073242188,
        497.5762023925781
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.5 완제의약품의 관리(제품명, 제형) ………………………………………………… 23",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        507.2856140136719,
        525.5311889648438,
        521.669921875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.6 표준품 또는 표준물질(제품명, 제형) …………………………………………… 34",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        531.4991455078125,
        524.3318481445312,
        545.8834228515625
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.7 용기 및 포장(제품명, 제형) …………………………………………………… 35",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        555.7127075195312,
        526.130859375,
        570.0969848632812
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.8 안정성(제품명, 제형) ……………………………………………………………… 36",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        579.806396484375,
        524.3318481445312,
        594.190673828125
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.A 부록 …………………………………………………………………………………… 40",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        67.40347290039062,
        604.0198974609375,
        523.1325073242188,
        618.4041748046875
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.A.1 시설과 설비 ………………………………………………………………………… 40",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        628.2334594726562,
        527.3302001953125,
        642.6177368164062
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.A.2 외래성 물질에 대한 안전성 평가 ……………………………………………… 40",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.28028106689453,
        652.3271484375,
        526.0109252929688,
        666.71142578125
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.A.3 첨가제 ……………………………………………………………………………… 40",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        73.40022277832031,
        676.5406494140625,
        526.130859375,
        690.9249267578125
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.R. 지역별 정보 …………………………………………………………………………… 40",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        67.40347290039062,
        700.7542114257812,
        521.9331665039062,
        715.1384887695312
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Appendix. 속방성 및 서방성 제제의 개발경위 기재 예시 (FDA) ………………… 41",
      "font_size": 11.99020004272461,
      "font_name": "T9",
      "bbox": [
        67.40347290039062,
        724.847900390625,
        525.17138671875,
        739.232177734375
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제·개정 이력",
      "font_size": 20.02363395690918,
      "font_name": "MalgunGothicBold",
      "bbox": [
        240.22979736328125,
        126.25091552734375,
        354.6477966308594,
        152.8765869140625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연번",
      "font_size": 9.951866149902344,
      "font_name": "MalgunGothicBold",
      "bbox": [
        71.96099853515625,
        209.8504180908203,
        435.9632568359375,
        223.08352661132812
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제·개정번호",
      "font_size": 9.951866149902344,
      "font_name": "MalgunGothicBold",
      "bbox": [
        71.96099853515625,
        209.8504180908203,
        435.9632568359375,
        223.08352661132812
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "승인일자",
      "font_size": 9.951866149902344,
      "font_name": "MalgunGothicBold",
      "bbox": [
        71.96099853515625,
        209.8504180908203,
        435.9632568359375,
        223.08352661132812
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주요내용",
      "font_size": 9.951866149902344,
      "font_name": "MalgunGothicBold",
      "bbox": [
        71.96099853515625,
        209.8504180908203,
        435.9632568359375,
        223.08352661132812
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 9.951866149902344,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        79.27703094482422,
        248.32835388183594,
        425.88916015625,
        261.56146240234375
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "B1-2015-2-015",
      "font_size": 9.951866149902344,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        79.27703094482422,
        248.32835388183594,
        425.88916015625,
        261.56146240234375
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2015.12.31",
      "font_size": 9.951866149902344,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        79.27703094482422,
        248.32835388183594,
        425.88916015625,
        261.56146240234375
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제정",
      "font_size": 9.951866149902344,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        79.27703094482422,
        248.32835388183594,
        425.88916015625,
        261.56146240234375
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.951866149902344,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        79.27703094482422,
        290.0427551269531,
        256.5461120605469,
        303.27587890625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안내서-0206-01",
      "font_size": 9.951866149902344,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        79.27703094482422,
        290.0427551269531,
        256.5461120605469,
        303.27587890625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.951866149902344,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        79.27703094482422,
        290.0427551269531,
        256.5461120605469,
        303.27587890625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "「식약처 지침서등의 관리에 관한 규정」 개정에",
      "font_size": 9.951866149902344,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        307.7532043457031,
        273.9803161621094,
        527.6151733398438,
        287.21343994140625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "따른 등록번호 일괄 정비",
      "font_size": 9.951866149902344,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        358.4857177734375,
        290.0427551269531,
        476.88311767578125,
        303.27587890625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(규제개혁담당관실-3761호,2017.5.16)",
      "font_size": 9.951866149902344,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        332.2199401855469,
        305.9853515625,
        499.6841125488281,
        319.2184753417969
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- vi -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        282.4469299316406,
        788.5885009765625,
        312.2957458496094,
        798.5376586914062
      ],
      "page_num": 6,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "머 리 말",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        257.50042724609375,
        103.88416290283203,
        346.5685729980469,
        123.90228271484375
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "식품의약품안전처에서는 우수한 의약품을 공급하고 의약품 허가심사 체계를",
      "font_size": 12.94941520690918,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        155.02574157714844,
        542.5822143554688,
        167.9716033935547
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "선진화하고자 2009년부터 신약 허가 신청 시 자료를 국제공통기술문서(Common",
      "font_size": 12.94941520690918,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        178.4001922607422,
        542.4618530273438,
        191.34605407714844
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Technical Document, CTD)로 제출하도록 하였고, 제3부 품질평가자료에 대한",
      "font_size": 12.94941520690918,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        201.77464294433594,
        542.4612426757812,
        214.7205047607422
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가이드라인 및 해설서를 발간한 바 있습니다.",
      "font_size": 12.94941520690918,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        225.1490936279297,
        324.1285400390625,
        238.09495544433594
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또한 2015년 3월 「의약품의 품목허가․신고․심사 규정」이 개정되면서 2016년",
      "font_size": 12.94941520690918,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        263.5071716308594,
        542.5822143554688,
        276.4530334472656
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3월부터 제네릭의약품 및 자료제출의약품의 허가 신청 시 국제공통기술문서 적용이",
      "font_size": 12.94941520690918,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        286.8816223144531,
        542.4616088867188,
        299.8274841308594
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의무화되었습니다.",
      "font_size": 12.94941520690918,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        310.256103515625,
        159.21792602539062,
        323.20196533203125
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이에 국내 제약기업의 국제공통기술문서 자료 작성을 돕고자 2015년 6월",
      "font_size": 12.94941520690918,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        348.6141662597656,
        542.5822143554688,
        361.5600280761719
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "‘제네릭의약품의 국제공통기술문서 작성 해설서’를 발간한 바 있습니다. 이 가이드",
      "font_size": 12.94941520690918,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        371.9886169433594,
        538.1477661132812,
        384.9344787597656
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라인은 국제공통기술문서의 품질평가 자료 중 제2부 품질평가자료요약(Quality",
      "font_size": 12.94941520690918,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        395.3630676269531,
        542.5798950195312,
        408.3089294433594
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Overall Summary, QOS)에 대해 구체적인 작성요령과 상세한 예를 들어 설명하",
      "font_size": 12.94941520690918,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        418.737548828125,
        538.1472778320312,
        431.68341064453125
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고자 발간하게 되었으며, 미국 FDA의 질의응답식 품질심사(Question based",
      "font_size": 12.94941520690918,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        442.11199951171875,
        542.4631958007812,
        455.057861328125
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Review, QbR) 가이드라인의 예시를 참조하고 국내 심사 현황과 업계 의견을",
      "font_size": 12.94941520690918,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        465.4864501953125,
        542.4617919921875,
        478.43231201171875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반영하여 실제 문서 작성에 도움이 되도록 실용적이고 세부적인 내용으로 구성",
      "font_size": 12.94941520690918,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        488.86090087890625,
        538.1488647460938,
        501.8067626953125
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하였습니다.",
      "font_size": 12.94941520690918,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        512.2354125976562,
        125.99592590332031,
        525.1812133789062
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 가이드라인이 국제공통기술문서 작성 시 많이 활용되어 국내 제약 기업의",
      "font_size": 12.94941520690918,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        550.5934448242188,
        542.4622802734375,
        563.5392456054688
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "활발한 글로벌 시장 진출에 실질적인 도움이 되기를 기대합니다.",
      "font_size": 12.94941520690918,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        574.8070068359375,
        447.8326110839844,
        587.7528076171875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 1 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        283.2864685058594,
        788.5885009765625,
        311.57611083984375,
        798.5376586914062
      ],
      "page_num": 7,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3. 품질평가자료 요약 (Quality Overall Summary, QOS)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        108.98011779785156,
        383.0358581542969,
        120.9670181274414
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품질평가자료 요약은 제3부(품질평가자료)에 있는 자료의 범위와 구성에 따라 요약하는 것이다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        145.5242462158203,
        541.822998046875,
        156.55218505859375
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품질평가자료요약은 국제공통기술문서의 다른 부분에서 언급되지 않은 정보, 자료 또는 정의는",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        165.30262756347656,
        541.9432373046875,
        176.33056640625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함하지 않는다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        185.08102416992188,
        144.1182861328125,
        196.1089630126953
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품질평가자료 요약은 심사자에게 제3부의 개요를 제공할 수 있도록 각 부분의 정보를 충분히",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        214.92840576171875,
        541.8228149414062,
        225.9563446044922
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함해야 한다. 품질평가자료 요약은 자료 작성시 규정을 따르지 않는 경우 그 타당성을 설명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        234.706787109375,
        538.1487426757812,
        245.73472595214844
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 등의 방식으로 신청의약품의 주요사항을 명확히 하여야 한다. 품질평가자료 요약은, 다른",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        254.48516845703125,
        541.9423828125,
        265.51312255859375
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부분에 있는 관련 자료를 종합적으로 고려한 중요 사항에 대한 고찰을 포함한다.(다른 부분의",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        274.2635498046875,
        541.8228149414062,
        285.29150390625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료를 인용할 때는 인용한 부분의 목차명과 쪽수를 기재하여 서로 참조가 가능하도록 한다.)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        294.04193115234375,
        526.1166381835938,
        305.06988525390625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품질평가자료 요약은 표나 그림을 제외한 본문이 일반적으로 40쪽을 넘지 않아야 한다. 생물",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        323.7694396972656,
        538.1487426757812,
        334.7973937988281
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의약품과 좀더 복잡한 제조 공정을 이용하여 제조된 의약품은 표나 그림을 제외하고 일반적으로",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        343.5478515625,
        541.8238525390625,
        354.5758056640625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본문이 80쪽을 넘지 않아야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        363.32623291015625,
        223.18263244628906,
        374.35418701171875
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아래 본문 중 밑줄로 표시한 도표, 수치 등에 대해서는 제3부에 직접 기재 사항을 그대로",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        393.0537414550781,
        541.8215942382812,
        404.0816955566406
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이용할 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        412.8321228027344,
        138.3885955810547,
        423.8600769042969
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서론",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        474.58056640625,
        95.18448638916016,
        486.5674743652344
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서론에는 원료의약품의 일반명, 상품명 또는 상용명, 회사명, 제형, 함량(역가), 투여경로, 신청",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        501.1755676269531,
        538.2678833007812,
        512.2034912109375
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 적응증을 포함한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        61.88645935058594,
        520.9539794921875,
        184.80343627929688,
        531.98193359375
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.S. 원료의약품(제품명, 제조자)(Drug Substance)(name, manufacturer)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        575.75,
        472.2674865722656,
        587.7369384765625
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.S.1. 일반정보(제품명, 제조자)(General Information)(name, manufacturer)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        605.23779296875,
        495.0551452636719,
        617.2247314453125
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.S.1에서 얻은 정보를 포함한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        631.832763671875,
        238.77418518066406,
        642.8607177734375
      ],
      "page_num": 7,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 설",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        677.039306640625,
        107.58169555664062,
        689.0262451171875
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 3.2.S.1 일반정보에 설명된 원료의약품의 명칭, 구조 그리고 일반적인 특성에 대한 정보를",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        703.5144653320312,
        541.8224487304688,
        714.5424194335938
      ],
      "page_num": 7,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요약하여 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.87995910644531,
        723.2928466796875,
        170.5311737060547,
        734.32080078125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 신청품목의 주성분이 두 개 이상인 경우 [주성분 1] 및 [주성분 2] 등으로 구분하고 품질",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        743.0712280273438,
        538.14794921875,
        754.0991821289062
      ],
      "page_num": 7,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 2 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        283.2864685058594,
        788.5885009765625,
        311.57611083984375,
        798.5376586914062
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가자료 요약을 각각 작성한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.52015686035156,
        99.01507568359375,
        239.82666015625,
        110.04302215576172
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 동일한 주성분에 대해 제조원이 두 개 이상인 경우 품질평가자료 요약은 하나로 작성하되,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        118.79345703125,
        541.8226318359375,
        129.82139587402344
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조원 간 공통되지 않은 정보(예; 상이한 생산 공정)는 별도의 항에 작성한다. (예: (주성분,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.52015686035156,
        138.5718536376953,
        541.822998046875,
        149.59979248046875
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조원 1), (주성분, 제조원 2))",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.52015686035156,
        158.35023498535156,
        227.2389373779297,
        169.378173828125
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 원료의약품등록(DMF) 대상 성분이 아닌 경우 아래 표에 해당하는 자료를 제출한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        178.1286163330078,
        508.84051513671875,
        189.15655517578125
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공개 부분에 해당하는 자료",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        115.37747192382812,
        204.97927856445312,
        484.8968811035156,
        216.00721740722656
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비공개 부분에 해당하는 자료",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        115.37747192382812,
        204.97927856445312,
        484.8968811035156,
        216.00721740722656
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 구조결정에 관한 자료",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.91885375976562,
        223.31922912597656,
        194.53457641601562,
        234.34716796875
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 물리화학적 성질에 관한 자료",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.91885375976562,
        243.0976104736328,
        232.91342163085938,
        254.12554931640625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 유연물질에 관한 자료",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.91885375976562,
        262.8760070800781,
        194.53457641601562,
        273.9039611816406
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 안정성시험자료(결과표)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.91885375976562,
        282.6543884277344,
        202.7716522216797,
        293.6823425292969
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 제조공정에 관한 자료",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.91885375976562,
        302.4327697753906,
        194.53457641601562,
        313.4607238769531
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 용기 및 포장 시스템",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.91885375976562,
        322.2111511230469,
        189.01754760742188,
        333.2391052246094
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 시험방법, 시험성적서에 관한 자료",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.91885375976562,
        341.9895324707031,
        258.09979248046875,
        353.0174865722656
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 시험방법 밸리데이션 자료",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.91885375976562,
        361.7679138183594,
        216.482666015625,
        372.7958679199219
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 표준품에 관한 자료",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.91885375976562,
        381.54632568359375,
        183.50054931640625,
        392.57427978515625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 제조공정 및 공정관리에 관한 자료(상세)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        302.47607421875,
        302.4327697753906,
        520.9544677734375,
        313.4607238769531
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 비공개 부분에 해당하는 자료는 원료의약품 제조원으로부터 심사부서에 직접 제출 가능",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        407.3181457519531,
        518.2391357421875,
        418.3460998535156
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 성상, 해리상수(pKa), 결정다형, 용해도(pH에 따른 영향 포함), 흡습성, 융점 및 분배계수 등을",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        446.8749084472656,
        541.9426879882812,
        457.9028625488281
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함한 물리화학적 성질에 대해서 기재한다 (아래의 내용에 국한하지 않고 필요한 사항에 대해",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.52015686035156,
        466.6532897949219,
        541.8224487304688,
        477.6812438964844
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가하고 기재한다).",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.52015686035156,
        486.43170166015625,
        172.56968688964844,
        497.45965576171875
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 물리적 형태(모양, 색상, 물리적 상태)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        506.2100830078125,
        257.82183837890625,
        517.238037109375
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 해리상수(이온화되는 화합물인 경우)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        525.9884643554688,
        255.06332397460938,
        537.0164184570312
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 결정다형(결정형, 무정형, 수화물, 용매화물)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        545.766845703125,
        294.0366516113281,
        556.7947998046875
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 용해도 특성(물, 유기용매에 대한 용해도, pH에 따른 영향 포함)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        565.5452270507812,
        386.272216796875,
        576.5731811523438
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 흡습성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        585.3236083984375,
        107.58169555664062,
        596.3515625
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 융점, 끓는점(무정형 물질의 경우 유리전이온도)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        605.1019897460938,
        309.63372802734375,
        616.1299438476562
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 분배계수",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        624.88037109375,
        118.49543762207031,
        635.9083251953125
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위 사항은 모두 기재하는 것이 바람직하며, 특성을 수치화할 수 없는 경우 타당한 사유를 기재",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        664.4371337890625,
        538.2682495117188,
        675.465087890625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다 (예: 화학구조 중 이온화기가 없으므로 pKa가 없음).",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.92535400390625,
        684.2155151367188,
        348.9671325683594,
        695.2434692382812
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 용해도의 경우, 아래와 같이 기술한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        723.7723388671875,
        266.3592529296875,
        734.80029296875
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 경구용 제제는 생물약제학적분류체계(BCS) 용해도 등급을 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        743.5507202148438,
        418.19696044921875,
        754.5786743164062
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 3 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        283.2864685058594,
        788.5885009765625,
        311.57611083984375,
        798.5376586914062
      ],
      "page_num": 9,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 용해도는 시험조건과 해당 결과를 함께 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        99.01507568359375,
        334.0955505371094,
        110.04302215576172
      ],
      "page_num": 9,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 결정다형에 대한 pH-용해도 정보를 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        118.79345703125,
        313.6136474609375,
        129.82139587402344
      ],
      "page_num": 9,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 해당 원료의약품의 결정형에 대해서는 pH-용해도 정보를 기재해야 한다. 원료의약품의",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        138.5718536376953,
        541.8220825195312,
        149.59979248046875
      ],
      "page_num": 9,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결정형보다 안정한 결정형에 대해서는 특정 pH에서의 상대적 용해도를 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        81.67573547363281,
        158.35023498535156,
        498.8858947753906,
        169.378173828125
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예 시",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        203.5567626953125,
        107.58169555664062,
        215.5436553955078
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시 1)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        230.03189086914062,
        94.82987976074219,
        241.05982971191406
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한글명:",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        249.81027221679688,
        93.26586151123047,
        260.8382263183594
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "국제일반명칭(INN, International Nonproprietary Names for Pharmaceutical Substances):",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        269.5886535644531,
        528.750244140625,
        280.6166076660156
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공정서 수재품목은 그 수재명:",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        289.3670654296875,
        208.64332580566406,
        300.39501953125
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "화학명(IUPAC 명칭):",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        309.14544677734375,
        164.26698303222656,
        320.17340087890625
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CAS 번호:",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        328.923828125,
        110.5364990234375,
        339.9517822265625
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구조식:",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        348.70220947265625,
        93.26586151123047,
        359.73016357421875
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분자식:",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        368.4805908203125,
        93.26586151123047,
        379.508544921875
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분자량:",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        388.25897216796875,
        93.26586151123047,
        399.28692626953125
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예시 2)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        427.81573486328125,
        94.82987976074219,
        438.84368896484375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 성상: 주성분 A는 흰색의 결정형 가루로 pH 7.0인 물에 거의 녹지 않으며, 염화메틸렌에 잘",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        447.5941467285156,
        541.9426879882812,
        458.6221008300781
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "녹으며, 아세톤과 알코올에 조금 녹는다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        88.75189971923828,
        467.3725280761719,
        296.5555725097656,
        478.4004821777344
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". pKa: 5.5",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        487.1509094238281,
        111.27619934082031,
        498.1788635253906
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 결정다형: 결정형 I과 결정형 II의 2 가지 결정형이 있다. 결정형 I이 더 안정한 결정형으로",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        506.92926025390625,
        541.8220825195312,
        517.9572143554688
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "완제의약품 제조에 사용된다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        110.46013641357422,
        526.7077026367188,
        260.2156066894531,
        537.7356567382812
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 용해도: 각 pH에서의 용해도 결과는 아래와 같다 (온도 37 ℃).",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        546.486083984375,
        388.5726318359375,
        557.5140380859375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용매",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        154.7161407470703,
        573.2168579101562,
        455.394287109375,
        584.2448120117188
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결정형 I",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        154.7161407470703,
        573.2168579101562,
        455.394287109375,
        584.2448120117188
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결정형 II",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        154.7161407470703,
        573.2168579101562,
        455.394287109375,
        584.2448120117188
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1 N HCl, pH 1.2",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.841064453125,
        592.7554931640625,
        464.8389587402344,
        603.783447265625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.10 mg/mL",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.841064453125,
        592.7554931640625,
        464.8389587402344,
        603.783447265625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.40 mg/mL",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.841064453125,
        592.7554931640625,
        464.8389587402344,
        603.783447265625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.15 M 아세트산염 완충액, pH 3.0",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.841064453125,
        612.1742553710938,
        464.8389587402344,
        623.2022094726562
      ],
      "page_num": 9,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.09 mg/mL",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.841064453125,
        612.1742553710938,
        464.8389587402344,
        623.2022094726562
      ],
      "page_num": 9,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.40 mg/mL",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.841064453125,
        612.1742553710938,
        464.8389587402344,
        623.2022094726562
      ],
      "page_num": 9,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.15 M 아세트산염 완충액, pH 4.5",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.841064453125,
        631.5930786132812,
        468.0782775878906,
        642.6210327148438
      ],
      "page_num": 9,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.011 mg/mL",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.841064453125,
        631.5930786132812,
        468.0782775878906,
        642.6210327148438
      ],
      "page_num": 9,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.033 mg/mL",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.841064453125,
        631.5930786132812,
        468.0782775878906,
        642.6210327148438
      ],
      "page_num": 9,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.15 M 인산염 완충액, pH 6.8",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.841064453125,
        651.1317138671875,
        478.3822021484375,
        662.15966796875
      ],
      "page_num": 9,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(< 0.001 mg/mL)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.841064453125,
        651.1317138671875,
        478.3822021484375,
        662.15966796875
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(< 0.001 mg/mL)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.841064453125,
        651.1317138671875,
        478.3822021484375,
        662.15966796875
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위 결과에 따라 주성분 A는 생물학적분류체계 (Biopharmaceutical Classification System,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        677.9823608398438,
        541.8218994140625,
        689.0103149414062
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BCS)에 따라 낮은 용해도 성분에 해당한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        67.52340698242188,
        697.7607421875,
        293.3173522949219,
        708.7886962890625
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 흡습성: 일주일간 25℃/75 ± 5 %에서 흡습되는 양이 0.1 % 이하였다. 자세한 내용은 3.2.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        717.5391235351562,
        538.1332397460938,
        728.5670776367188
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "P.2.1.1 원료의약품을 참고한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        65.84431457519531,
        737.3175048828125,
        226.42088317871094,
        748.345458984375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 4 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        283.2864685058594,
        788.5885009765625,
        311.57611083984375,
        798.5376586914062
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 융점: 결정형 I 225 ℃, 결정형 II 201 ℃",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        99.01507568359375,
        276.0903625488281,
        110.04302215576172
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 분배계수: ClogP = 4.251",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        118.79345703125,
        196.67010498046875,
        129.82139587402344
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.S.2. 제조(제품명, 제조자)(Manufacture)(name, manufacturer)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        166.39736938476562,
        426.092529296875,
        178.38426208496094
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.S.2에서 얻은 다음 정보를 포함한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        192.87249755859375,
        266.23931884765625,
        203.9004364013672
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 제조자(제조원)에 대한 사항",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        212.65089416503906,
        214.68365478515625,
        223.6788330078125
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 적절한 품질의 원료의약품을 일정하게 제조하기 위해 제조공정(예. 출발물질, 중요공정 및",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        232.4292755126953,
        541.8224487304688,
        243.45721435546875
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재처리에 대한 사항 포함) 및 관리에 관한 간단한 설명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.59957122802734,
        252.20767211914062,
        353.4484558105469,
        263.2356262207031
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 3.2.S.2.2에 기재된 제조공정도(flow diagram)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        271.9860534667969,
        308.4349060058594,
        283.0140075683594
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 3.2.S.2.3에 설명된 원료의약품 제조에 사용된 출발물질과 생물유래 원료물질에 대한 설명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        291.7644348144531,
        532.5113525390625,
        302.7923889160156
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 중요 제조공정, 공정관리 및 허용기준과 그 타당성에 대한 고찰, 특히 3.2.S.2.4에 설명된",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        311.5428161621094,
        541.9423828125,
        322.5707702636719
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "중요 중간물질에 대한 설명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.87995910644531,
        331.3211975097656,
        211.32546997070312,
        342.3491516113281
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 3.2.S.2.5에 설명된 공정 밸리데이션 및/또는 평가에 대한 설명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        351.0995788574219,
        393.7466125488281,
        362.1275329589844
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 3.2.S.2.6에 설명된 개발과정에서의 제조방법에 관한 중대한 변경에 대한 간략한 요약 및",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        370.8779602050781,
        541.82275390625,
        381.9059143066406
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품의 일관성을 평가하기 위해 사용된 검토결과로부터 얻은 결론. 품질에 관한 자료 요약",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.43911743164062,
        390.6563415527344,
        538.2682495117188,
        401.6842956542969
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(QOS)은 제조공정 변경에 따른 뱃치를 사용한 (M4S 및 M4E의) 비임상시험 또는 임상시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.43911743164062,
        410.43475341796875,
        541.822509765625,
        421.46270751953125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과와 상호 참고가 가능하여야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.43911743164062,
        430.213134765625,
        263.6007080078125,
        441.2410888671875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해 설",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        475.4196472167969,
        107.58169555664062,
        487.40655517578125
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 3.2.S.2 제조에 설명된 원료의약품의 제조원, 제조공정 및 공정관리, 원료관리, 중요공정 및",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        501.894775390625,
        541.82275390625,
        512.9227294921875
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "중간체 관리, 공정 밸리데이션 및 평가, 제조공정개발 등의 내용을 요약하여 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.28028106689453,
        521.6731567382812,
        511.38641357421875,
        532.7011108398438
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 제조 및 시험에 관한 모든 사업소 또는 시설에 해당하는 제조원의 명칭, 주소, 책임부과범위",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        541.4515380859375,
        538.1480712890625,
        552.4794921875
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(수행업무) 및 수탁업소를 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.04041290283203,
        561.2299194335938,
        256.7372741699219,
        572.2578735351562
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 원료의약품 자료 중 비공개 부분을 제외한 내용을 요약 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        581.00830078125,
        409.65460205078125,
        592.0362548828125
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.S.3. 특성(제품명, 제조자)(Characterization)(name, manufacturer)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        628.6122436523438,
        448.7602233886719,
        640.5991821289062
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.S.3.1에 설명된 것과 같은 구조 및 이성체에 관한 요약자료를 기술하여야 한다. 원료의약",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        655.08740234375,
        538.2678833007812,
        666.1153564453125
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품이 광학활성체인 경우에는 임상시험에 사용된 의약품이 입체이성체 또는 입체이성체의 복합",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        674.8657836914062,
        538.2682495117188,
        685.8937377929688
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물인지를 나타내고 동시에 판매를 위한 최종 완제품에 사용되는 원료의약품의 입체이성체에",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        694.6441650390625,
        541.8220825195312,
        705.672119140625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관한 정보를 제공하여야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        714.4225463867188,
        208.19076538085938,
        725.4505004882812
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전체 품질에 대한 자료(QOS)는 합성, 제조 또는 분해 등의 과정에서 발생할 수 있는 잠재적",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        734.200927734375,
        538.2678833007812,
        745.2288818359375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 5 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        283.2864685058594,
        788.5885009765625,
        311.57611083984375,
        798.5376586914062
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이고 실제적인 불순물에 대한 자료를 요약하여야 한다. 또한 개별적인 불순물과 총 불순물에",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        99.01507568359375,
        541.8224487304688,
        110.04302215576172
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 허용기준 설정에 관한 근거자료를 요약해야 한다. 품질에 관한 전체 자료 요약은 임상시",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        118.79345703125,
        538.2682495117188,
        129.82139587402344
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "험에 사용한 뱃치와 제품 생산용 공정으로 제조된 특정 뱃치에서 불순물 함유정도를 요약하여",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        138.5718536376953,
        541.8224487304688,
        149.59979248046875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설명하고 제시된 불순물의 한계가 어떻게 정량화 되었는지 밝혀야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        158.35023498535156,
        422.51458740234375,
        169.378173828125
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그래프와 함께 3.2.S.3.2에서 제공되는 자료의 도표 요약은 필요한 경우 포함한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        178.1286163330078,
        479.36376953125,
        189.15655517578125
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 설",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        221.537109375,
        107.58169555664062,
        233.5240020751953
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 3.2.S.3.1 구조 및 기타 특성에 설명된 원료의약품의 구조와 물리적 특성, 불순물 등에 대",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        248.01223754882812,
        538.2682495117188,
        259.0401916503906
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여 요약하여 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.76002502441406,
        267.7906188964844,
        197.8763427734375,
        278.8185729980469
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 한 개 이상의 비대칭중심(chiral center)을 포함하는 키랄(chiral) 원료의약품의 경우 라세",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        287.5690002441406,
        538.14794921875,
        298.5969543457031
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미체인지 특정 광학이성질체(enantiomer)인지 기재한다. 원료의약품이 특정 광학이성체인",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        307.347412109375,
        541.9420166015625,
        318.3753662109375
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우, 광학이성체를 확인하고 정량하기 위한 시험이 포함되어야 한다. 비대칭성(chirality)에",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        327.12579345703125,
        541.8224487304688,
        338.15374755859375
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대해서는 광학이성체간의 상호 전환 가능성을 고려해야 한다. (예. 라세미화/에피머화; racemi",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        346.9041748046875,
        538.1006469726562,
        357.93212890625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "zation/epimerization).",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        366.68255615234375,
        187.44357299804688,
        377.71051025390625
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 잠재적 불순물을 확인하고 특징을 기술한다. 즉, 원료의약품에 존재할 수 있는 모든 불순물을",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        386.4609375,
        541.9423828125,
        397.4888916015625
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재한다. 유기유연물질인 경우 명칭, 구조 또는 HPLC 등 분석기기 상대유지시간(RRT)에 따라",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.16034698486328,
        406.23931884765625,
        541.8220825195312,
        417.26727294921875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불순물을 확인하고, 발생 기원에 따라 공정 불순물과 분해생성물로 구분한다. 또한 아래 예시의",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.16034698486328,
        426.0177001953125,
        541.8217163085938,
        437.045654296875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표와 같이 특정 유연물질, 구조, 기원 및 관리방법 (규격 또는 미지유연물질 등 구분)에 대해서도",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.16034698486328,
        445.7961120605469,
        541.9424438476562,
        456.8240661621094
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간략히 정리한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.16034698486328,
        465.5744934082031,
        156.13897705078125,
        476.6024475097656
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 공정서에 유연물질 시험방법이 있는 경우에도 다른 발생 가능한 불순물을 파악하는 것이",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        485.3528747558594,
        541.8224487304688,
        496.3808288574219
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필요하다. (예: 분해산물, 잔류용매, 무기불순물 등)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        505.1312255859375,
        323.30633544921875,
        516.1591796875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예 시",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        550.3377685546875,
        107.58169555664062,
        562.32470703125
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 유연물질 요약 예시",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        576.6930541992188,
        171.9864501953125,
        587.7210083007812
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유연물질명",
      "font_size": 11.030982971191406,
      "font_name": "T13",
      "bbox": [
        82.63521575927734,
        600.543701171875,
        508.88385009765625,
        613.7772216796875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화학명",
      "font_size": 11.030982971191406,
      "font_name": "T13",
      "bbox": [
        82.63521575927734,
        600.543701171875,
        508.88385009765625,
        613.7772216796875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구조",
      "font_size": 11.030982971191406,
      "font_name": "T13",
      "bbox": [
        82.63521575927734,
        600.543701171875,
        508.88385009765625,
        613.7772216796875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기원",
      "font_size": 11.030982971191406,
      "font_name": "T13",
      "bbox": [
        82.63521575927734,
        600.543701171875,
        508.88385009765625,
        613.7772216796875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관리방법",
      "font_size": 11.030982971191406,
      "font_name": "T13",
      "bbox": [
        82.63521575927734,
        600.543701171875,
        508.88385009765625,
        613.7772216796875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[특정 유연물질]",
      "font_size": 11.030982971191406,
      "font_name": "T13",
      "bbox": [
        183.74041748046875,
        620.0823364257812,
        263.0635070800781,
        633.3158569335938
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 구조 및 기타 특성에 대한 상세한 자료는 해당되는 경우 DMF 자료를 참고한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        685.8936767578125,
        480.3232421875,
        696.921630859375
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 6 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        283.2864685058594,
        788.5885009765625,
        311.57611083984375,
        798.5376586914062
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.S.4. 원료의약품의 품질관리(제품명, 제조자)(Control of Drug Substance) (name,",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        107.06221771240234,
        542.1422729492188,
        119.04911804199219
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "manufacturer)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        128.63864135742188,
        137.40896606445312,
        140.6255340576172
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준, 시험방법, 밸리데이션(validation)의 타당성에 관한 자료를 요약하여 설명한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        155.11376953125,
        482.3621826171875,
        166.14170837402344
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.S.4.1에서 얻은 기준이 제공되어야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        174.89215087890625,
        281.59100341796875,
        185.9200897216797
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.S.4.4의 뱃치 분석에 관한 도표요약은 필요시 그래프와 함께 제공되어야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        194.6705322265625,
        473.8468017578125,
        205.69847106933594
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 설",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        243.95262145996094,
        107.58169555664062,
        255.93951416015625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 3.2.S.4 원료의약품의 관리에 설명된 원료의약품의 기준, 시험방법 및 시험방법 밸리데이션에",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        270.3078918457031,
        541.9441528320312,
        281.3358459472656
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대하여 요약하여 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        72.92047882080078,
        290.0862731933594,
        205.1923828125,
        301.1142272949219
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 시험 기준과 뱃치 분석결과를 표로 작성한다. 특정 유연물질의 화학명을 별도 기재하고 시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        309.8646545410156,
        538.14794921875,
        320.8926086425781
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과와 허용 기준은 단위를 포함하여 수치로 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.16034698486328,
        329.6430358886719,
        343.9299011230469,
        340.6709899902344
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 원료의약품 기준과 관련하여, 식약처장이 인정한 공정서 수재품목은 공정서 각조의 요구사항을",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        349.4214172363281,
        541.9431762695312,
        360.4493713378906
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "충족시켜야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        72.92047882080078,
        369.1997985839844,
        154.4598846435547,
        380.2277526855469
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 선광도, 수분, 순도, 잔류용매, 결정다형 및 입자도 등 원료의약품의 특성을 고려하여 시험항목을",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        388.9781799316406,
        541.9440307617188,
        400.0061340332031
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설정하고 그 타당성을 제시한다. (완제의약품 제조와 품질에 영향을 미칠 수 있는 원료의약품의",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.16034698486328,
        408.7565612792969,
        541.9441528320312,
        419.7845153808594
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "중요한 특성에 대한 고찰이 포함되어야 함)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.16034698486328,
        428.53497314453125,
        278.0908508300781,
        439.56292724609375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 각 시험항목별로 시험방법을 적절하게 설정하고 밸리데이션을 실시한다. 시험방법의 중요",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        448.3133544921875,
        541.9426879882812,
        459.34130859375
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "파라미터와 시스템적합성 기준을 포함하여 표 또는 서술 형식으로 요약한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        468.09173583984375,
        465.90411376953125,
        479.11968994140625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 공정서에 따라 시험할 경우 공정서 방법이 적용될 수 있는지 특이성(예: 주피크가 생산 공정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        487.8701171875,
        541.8224487304688,
        498.8980712890625
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 분해생성물에서 발생하는 모든 공정 불순물과 분리할 수 있음)과 유연물질 시험방법의 특이성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.87995910644531,
        507.64849853515625,
        538.1488647460938,
        518.6764526367188
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(예: 주성분 피크를 포함하여 모든 공정 불순물 및 분해생성물을 서로 분리할 수 있는지 확인)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.87995910644531,
        527.4268798828125,
        541.8223876953125,
        538.454833984375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 자체적으로 검증하는 것이 바람직하다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.87995910644531,
        547.2052612304688,
        293.3173522949219,
        558.2332153320312
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 공정서 방법을 변경하여 사용하거나 자사 시험방법으로 대체하는 경우 밸리데이션이 필요하며,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        566.983642578125,
        541.822998046875,
        578.0115966796875
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자사 시험방법이 공정서에서 규정하는 시험방법보다 동등 이상인 경우에 그 방법을 적용할 수",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.04041290283203,
        586.7620239257812,
        541.82275390625,
        597.7899780273438
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.04041290283203,
        606.5404052734375,
        98.3302993774414,
        617.568359375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 시험방법 밸리데이션 요약자료를 DMF 등록번호로 대체하는 것은 불가하며, 원료의약품 제조",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        626.3187866210938,
        538.14794921875,
        637.3467407226562
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원의 밸리데이션 자료 제출은 가능하나, 해당 밸리데이션 자료가 자사 품질관리 시 적절히 적",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.87995910644531,
        646.09716796875,
        538.2682495117188,
        657.1251220703125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용될 수 있는지 판단할 수 있는 자료를 함께 제출하여야 한다. (시험법 이전자료 등)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.87995910644531,
        665.8756103515625,
        481.3806457519531,
        676.903564453125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 순도시험(유연물질)항목에는 원료의약품에 함유될 수 있고 규격을 설정하여 관리하는 유연",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        685.6539916992188,
        538.2682495117188,
        696.6819458007812
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질에 대하여 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.76002502441406,
        705.432373046875,
        206.96412658691406,
        716.4603271484375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 「의약품의 품목허가․신고 심사 규정」(식약처고시)의 심사자료 요건에 따라 유연물질을 설정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        725.2107543945312,
        538.14794921875,
        736.2387084960938
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 7 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        283.2864685058594,
        788.5885009765625,
        311.57611083984375,
        798.5376586914062
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하고, 근거 및 뱃치분석 결과를 간략히 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.87995910644531,
        99.01507568359375,
        311.3348388671875,
        110.04302215576172
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 공정서 각조에 순도시험 항목이 없는 경우에는 공개된 문헌을 참고하거나 원료의약품 제조",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        118.79345703125,
        538.2682495117188,
        129.82139587402344
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원과 협조하여 잠재적인 합성 공정 불순물 (예: 이성체, 부가생성물), 분해생성물, 금속 촉매 및",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        138.5718536376953,
        541.9426879882812,
        149.59979248046875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "잔류용매 등에 대해 설정하여 관리하는 것이 바람직하다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        158.35023498535156,
        355.9237365722656,
        169.378173828125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 대조약 상대유지시간(RRT)에 의해 확인된 불순물 기준을 안전성 입증(qualification)을 위해",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        178.1286163330078,
        541.9426879882812,
        189.15655517578125
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용하는 경우, 상대유지시간 비교, 자외부스펙트럼 및 대조의약품과의 질량분석을 통해 미확인",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.59957122802734,
        197.90699768066406,
        541.9427490234375,
        208.9349365234375
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특정 유연물질에 대한 안전성을 수용할 수 있다. 그러나 불순물을 확인(identification) 하기 위",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.59957122802734,
        217.68539428710938,
        538.2682495117188,
        228.7133331298828
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해서는 모든 노력을 기울여야 한다. 설정한 불순물 기준이 대조약보다 더 높다면 신청인은 이",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.59957122802734,
        237.46377563476562,
        541.82275390625,
        248.49171447753906
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불순물이 이 기준에서 안전하다는 것을 보여주는(qualification) 자료를 제공해야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.59957122802734,
        257.2421569824219,
        493.51611328125,
        268.2701110839844
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 대조약의 가속 또는 가혹시험 자료를 사용하여 원료의약품 불순물 기준을 설정하는 것은 바람",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        277.0205383300781,
        538.14794921875,
        288.0484924316406
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "직하지 않다. 사용기간(또는 그에 준한 기간) 이내이나, 제조일로부터 시일이 경과한 다양한 제",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.64009094238281,
        296.7989196777344,
        538.1483154296875,
        307.8268737792969
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품으로 시험하는 것이 바람직하다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.64009094238281,
        316.5773010253906,
        241.77255249023438,
        327.6052551269531
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 「의약품잔류용매기준지침」에 따라 모든 잔류용매는 품질기준에 적합한 수준으로 제거되어야",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        336.355712890625,
        541.82177734375,
        347.3836669921875
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하므로 잔류용매 제거에 대한 공정능력(process capability)을 고려하고, 해당 지침에 따라",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.04041290283203,
        356.13409423828125,
        541.822021484375,
        367.16204833984375
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "잔류용매 기준을 설정한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.04041290283203,
        375.9124755859375,
        207.35121154785156,
        386.9404296875
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 「의약품잔류용매기준지침」에 포함되지 않은 잔류용매는 안전성을 고려하여 기준을 설정한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        395.69085693359375,
        536.5728149414062,
        406.71881103515625
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 결정다형과 관련하여, 결정다형이 있고 결정다형 간 용해도 차이가 있는 등 품질에 영향을 미",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        415.46923828125,
        538.2682495117188,
        426.4971923828125
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치는 경우 기준을 설정한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.64009094238281,
        435.24761962890625,
        208.79043579101562,
        446.27557373046875
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 원료의약품의 입자도 기준은 입자도가 완제의약품의 성능 또는 제조에 중요한 경우 설정한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        455.0260009765625,
        541.9429321289062,
        466.053955078125
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예를 들면, 건식혼합 공정에서 원료의약품 및 부형제의 입자도는 혼합 공정에 영향을 미칠 수",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.28028106689453,
        474.80438232421875,
        541.8224487304688,
        485.83233642578125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있다. 용해도가 낮은 원료의약품의 경우 입자도는 완제의약품의 용출에 중요한 영향을 미칠 수",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.28028106689453,
        494.5827941894531,
        541.9426879882812,
        505.6107482910156
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있다. 용해도가 높은 원료의약품의 경우, 입자도는 완제의약품 성능에 중요한 영향을 주지 않을",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.28028106689453,
        514.3611450195312,
        541.9426879882812,
        525.3890991210938
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수도 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.28028106689453,
        534.1395263671875,
        124.11632537841797,
        545.16748046875
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 입자도의 기준, 허용범위 및 설정근거는 입자도가 완제의약품에 미치는 영향에 따라, 설정여부",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        553.9179077148438,
        541.9423828125,
        564.9458618164062
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 기준 범위 등을 결정한다. 기준은 입자도의 변경이 원료의약품의 제조 능력 또는 완제의약",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.52015686035156,
        573.6963500976562,
        538.14794921875,
        584.7243041992188
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품의 성능에 영향을 미치는지에 근거해야 한다. 일반적으로, 신청인은 물리적인 특성 또는 실험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.52015686035156,
        593.4747314453125,
        538.2682495117188,
        604.502685546875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 통해 입자도와 같은 원료의약품의 특성 변경이 제품에 어떻게 영향을 미치는지를 입증해야",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.52015686035156,
        613.2531127929688,
        541.8220825195312,
        624.2810668945312
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.52015686035156,
        633.031494140625,
        102.38115692138672,
        644.0594482421875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 입자도가 중요한 경우에는 입자도분포를 구체화하고, 그 외에 제제연구 등 자료를 근거로 하여",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        652.8098754882812,
        541.9426879882812,
        663.8378295898438
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "입자도 규격을 하나로 설정하는 것이 가능하다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.40022277832031,
        672.5882568359375,
        303.89886474609375,
        683.6162109375
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예 시",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        717.7947387695312,
        107.58169555664062,
        729.7816772460938
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원료의약품의 규격 설정 예시 1)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        744.2698974609375,
        221.1221923828125,
        755.2978515625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 8 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        283.2864685058594,
        788.5885009765625,
        311.57611083984375,
        798.5376586914062
      ],
      "page_num": 14,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "* RC1: [유연물질 화학명]",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        494.3430480957031,
        192.01593017578125,
        505.3710021972656
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RC2: [유연물질 화학명]",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        514.1213989257812,
        191.89599609375,
        525.1493530273438
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RC3: [유연물질 화학명]",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        533.8998413085938,
        191.89599609375,
        544.9277954101562
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "완제의약품의 제조와 품질에 영향을 미치는 중요한 요소에 대해 규격을 설정하였다. 각 시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        573.4566040039062,
        538.14794921875,
        584.4845581054688
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법은 USP 일반시험법을 참조하거나 자사 시험방법으로 설정하였으며, 결정형과 입자도에",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        593.2349853515625,
        541.9423828125,
        604.262939453125
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 규격도 포함하였다. 완제의약품의 제조공정에는 난용성 원료의약품의 습식 과립공정이 포",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        613.0133666992188,
        538.2682495117188,
        624.0413208007812
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "함되므로 입자도와 결정형은 완제의약품에 중요한 요소로 작용한다. 이러한 입자도와 결정형이",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        632.791748046875,
        541.9423828125,
        643.8197021484375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "완제의약품에 어떠한 영향을 미치는 지에 대해서는 2.3.P.2.2. 개발경위에서 확인할 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        652.5701293945312,
        535.9458618164062,
        663.5980834960938
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원료의약품의 규격 설정 예시 2)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        692.1268920898438,
        221.1221923828125,
        703.1548461914062
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험항목",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        96.66761016845703,
        104.64891052246094,
        523.2379760742188,
        115.67686462402344
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허용 기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        96.66761016845703,
        104.64891052246094,
        523.2379760742188,
        115.67686462402344
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험 방법",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        96.66761016845703,
        104.64891052246094,
        523.2379760742188,
        115.67686462402344
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험결과(제조번호)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        96.66761016845703,
        104.64891052246094,
        523.2379760742188,
        115.67686462402344
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성상",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        124.06770324707031,
        437.8826904296875,
        135.09564208984375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "흰색, 결정형 가루",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        124.06770324707031,
        437.8826904296875,
        135.09564208984375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "육안검사",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        124.06770324707031,
        437.8826904296875,
        135.09564208984375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적합",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        124.06770324707031,
        437.8826904296875,
        135.09564208984375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확인시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        143.60633850097656,
        120.77420806884766,
        154.63427734375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "A: IR",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        161.1072235107422,
        105.04071807861328,
        172.13516235351562
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "B: UV",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        178.72796630859375,
        110.46046447753906,
        189.7559051513672
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "A. IR: 표준품과 같음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        163.23153686523438,
        161.1072235107422,
        271.65277099609375,
        172.13516235351562
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "B. UV: 표준품과 같음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        163.23153686523438,
        178.72796630859375,
        277.1697998046875,
        189.7559051513672
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP <197M>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        324.7839660644531,
        161.1072235107422,
        396.0855712890625,
        172.13516235351562
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP <197U>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        324.7839660644531,
        178.72796630859375,
        394.765869140625,
        189.7559051513672
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        415.81463623046875,
        161.1072235107422,
        437.8826904296875,
        172.13516235351562
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        415.81463623046875,
        178.72796630859375,
        437.8826904296875,
        189.7559051513672
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함량",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        198.14674377441406,
        437.8826904296875,
        209.1746826171875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "98.0 ~ 102.0 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        198.14674377441406,
        437.8826904296875,
        209.1746826171875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        198.14674377441406,
        437.8826904296875,
        209.1746826171875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        198.14674377441406,
        437.8826904296875,
        209.1746826171875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중금속",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        217.68539428710938,
        437.8826904296875,
        228.7133331298828
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20 ppm 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        217.68539428710938,
        437.8826904296875,
        228.7133331298828
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP <231>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        217.68539428710938,
        437.8826904296875,
        228.7133331298828
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        217.68539428710938,
        437.8826904296875,
        228.7133331298828
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "잔류용매",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        254.72491455078125,
        120.77420806884766,
        265.75286865234375
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "메탄올: 3000 ppm 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        163.23153686523438,
        237.1041717529297,
        286.5243835449219,
        248.13211059570312
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "염화메틸렌: 600 ppm 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        163.23153686523438,
        254.72491455078125,
        301.996337890625,
        265.75286865234375
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "톨루엔: 890 ppm 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        163.23153686523438,
        272.22576904296875,
        280.0482177734375,
        283.25372314453125
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP <467>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        324.7839660644531,
        254.72491455078125,
        386.2509460449219,
        265.75286865234375
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "300 ppm",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        415.81463623046875,
        237.1041717529297,
        462.9256591796875,
        248.13211059570312
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "150 ppm",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        415.81463623046875,
        254.72491455078125,
        462.9256591796875,
        265.75286865234375
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "80 ppm",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        415.81463623046875,
        272.22576904296875,
        456.3292236328125,
        283.25372314453125
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "특정유연물질",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        293.8022155761719,
        142.84225463867188,
        304.8301696777344
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC1",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        311.4229431152344,
        104.07976531982422,
        322.4508972167969
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC2",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        328.923828125,
        104.07976531982422,
        339.9517822265625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC3",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        346.5445556640625,
        104.07976531982422,
        357.572509765625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미지유연물질",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        364.1653137207031,
        142.84225463867188,
        375.1932678222656
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 유연물질",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        381.6661682128906,
        137.32522583007812,
        392.6941223144531
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC1: 0.15 % 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        163.23153686523438,
        311.4229431152344,
        259.4194030761719,
        322.4508972167969
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC2: 0.25 % 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        163.23153686523438,
        328.923828125,
        259.4194030761719,
        339.9517822265625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC3: 0.25 % 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        163.23153686523438,
        346.5445556640625,
        259.4194030761719,
        357.572509765625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미지유연물질: 각 0.10 % 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        163.23153686523438,
        364.1653137207031,
        320.10650634765625,
        375.1932678222656
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 유연물질: 0.75 % 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        163.23153686523438,
        381.6661682128906,
        298.1584167480469,
        392.6941223144531
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법 #41",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        324.7839660644531,
        337.79412841796875,
        394.2030029296875,
        348.82208251953125
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC1: 0.05 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        415.81463623046875,
        311.4229431152344,
        484.5018005371094,
        322.4508972167969
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC2: 0.05 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        415.81463623046875,
        328.923828125,
        488.0915832519531,
        339.9517822265625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC3: 0.10 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        415.81463623046875,
        346.5445556640625,
        484.5018005371094,
        357.572509765625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        415.81463623046875,
        364.1653137207031,
        457.26861572265625,
        375.1932678222656
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.30 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        415.81463623046875,
        381.6661682128906,
        453.5585632324219,
        392.6941223144531
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결정형(XRD)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        403.24261474609375,
        464.7481384277344,
        414.27056884765625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2Ɵ 차이가 5 % 미만",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        403.24261474609375,
        464.7481384277344,
        414.27056884765625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법 #47",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        403.24261474609375,
        464.7481384277344,
        414.27056884765625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1 % 미만",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        403.24261474609375,
        464.7481384277344,
        414.27056884765625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "입자도",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.7583999633789,
        440.2821350097656,
        109.86045837402344,
        451.3100891113281
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "D90: 30 um 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        163.23153686523438,
        422.78125,
        255.22134399414062,
        433.8092041015625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "D50: 15 um 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        163.23153686523438,
        440.2821350097656,
        255.22134399414062,
        451.3100891113281
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "D10: 5 um 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        163.23153686523438,
        457.9028625488281,
        248.74517822265625,
        468.9308166503906
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법 #48",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        324.7839660644531,
        440.2821350097656,
        394.2030029296875,
        451.3100891113281
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20 um",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        415.81463623046875,
        422.78125,
        449.9725341796875,
        433.8092041015625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10 um",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        415.81463623046875,
        440.2821350097656,
        449.9725341796875,
        451.3100891113281
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.5 um",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        415.81463623046875,
        457.9028625488281,
        453.0904846191406,
        468.9308166503906
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험항목",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        90.91072845458984,
        717.5391235351562,
        533.0726318359375,
        728.5670776367188
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허용 기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        90.91072845458984,
        717.5391235351562,
        533.0726318359375,
        728.5670776367188
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험 방법",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        90.91072845458984,
        717.5391235351562,
        533.0726318359375,
        728.5670776367188
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험결과(제조번호)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        90.91072845458984,
        717.5391235351562,
        533.0726318359375,
        728.5670776367188
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성상",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        736.9578857421875,
        457.55169677734375,
        747.98583984375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "흰색의 결정형 가루",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        736.9578857421875,
        457.55169677734375,
        747.98583984375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "육안검사",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        736.9578857421875,
        457.55169677734375,
        747.98583984375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적합",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        736.9578857421875,
        457.55169677734375,
        747.98583984375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 9 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        283.2864685058594,
        788.5885009765625,
        311.57611083984375,
        798.5376586914062
      ],
      "page_num": 15,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위 규격은 원료의약품의 중요한 특성을 포함하나, 결정형 또는 입자도 등 고체 상태와 관련된",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        526.5878295898438,
        541.8224487304688,
        537.6157836914062
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물리적 성질에 대한 규격은 포함되어 있지 않다. 완제의약품 제조공정 중 구형 백당에 주성분이",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        546.3662109375,
        541.8233642578125,
        557.3941650390625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "완전히 녹는 공정이 있으므로 위 특성이 완제의약품 품질에 미치는 영향이 적을 것으로 판단하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        566.1445922851562,
        538.26904296875,
        577.1725463867188
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "였기 때문이다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        585.9229736328125,
        129.75326538085938,
        596.950927734375
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.S.5. 표준품 또는 표준물질(제품명, 제조자)(Reference Standards or Materials)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        633.406982421875,
        538.2317504882812,
        645.3939208984375
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(name, manufacturer)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        654.9833984375,
        183.22412109375,
        666.9703369140625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.S.5에서 얻은 정보(필요시 도표로 표시)를 포함한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        681.5784301757812,
        340.5989990234375,
        692.6063842773438
      ],
      "page_num": 15,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 설",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        726.784912109375,
        107.58169555664062,
        738.7718505859375
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확인시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        131.0200958251953,
        306.9133605957031,
        142.04803466796875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "A. IR: 표준품과 같은 스펙트럼",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        131.0200958251953,
        306.9133605957031,
        142.04803466796875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "B. 염화물 시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        149.07920837402344,
        148.64083862304688,
        226.07748413085938,
        159.6687774658203
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IR, USP <197K>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        321.9055480957031,
        131.0200958251953,
        411.3173522949219,
        142.04803466796875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Chloride, USP <191>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        321.9055480957031,
        148.64083862304688,
        432.1852111816406,
        159.6687774658203
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.6039123535156,
        131.0200958251953,
        457.55169677734375,
        142.04803466796875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.6039123535156,
        148.64083862304688,
        457.55169677734375,
        159.6687774658203
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중금속",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        176.81005859375,
        503.6070556640625,
        187.83799743652344
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20 ppm 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        176.81005859375,
        503.6070556640625,
        187.83799743652344
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "USP <231> 2법",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        176.81005859375,
        503.6070556640625,
        187.83799743652344
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20 ppm 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        176.81005859375,
        503.6070556640625,
        187.83799743652344
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수분",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        205.09913635253906,
        466.7514343261719,
        216.1270751953125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.5 % 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        205.09913635253906,
        466.7514343261719,
        216.1270751953125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP <921> 시험1a",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        205.09913635253906,
        466.7514343261719,
        216.1270751953125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.2 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        205.09913635253906,
        466.7514343261719,
        216.1270751953125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "선광도[α]D",
      "font_size": 7.074217319488525,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        242.13865661621094,
        134.84629821777344,
        253.925048828125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25 +66.4° ~ +68.0°",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        134.80694580078125,
        237.34390258789062,
        471.84185791015625,
        253.16659545898438
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법 #467",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        134.80694580078125,
        237.34390258789062,
        471.84185791015625,
        253.16659545898438
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "+67.10",
      "font_size": 7.074217319488525,
      "font_name": "Batang",
      "bbox": [
        134.80694580078125,
        237.34390258789062,
        471.84185791015625,
        253.16659545898438
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함량",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        270.427734375,
        473.34783935546875,
        281.4556884765625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "98.5~101.5 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        270.427734375,
        473.34783935546875,
        281.4556884765625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법 #125a",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        270.427734375,
        473.34783935546875,
        281.4556884765625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "99.8 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        270.427734375,
        473.34783935546875,
        281.4556884765625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "잔류용매",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        316.21771240234375,
        123.65264892578125,
        327.24566650390625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "메탄올 3000ppm 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        149.07920837402344,
        298.5969543457031,
        263.25732421875,
        309.6249084472656
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "톨루엔 890 ppm 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        149.07920837402344,
        316.21771240234375,
        262.17791748046875,
        327.24566650390625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "테트라히드로푸란 720 ppm 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        149.07920837402344,
        333.83843994140625,
        317.108154296875,
        344.86639404296875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP <467> 시험C",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        321.9055480957031,
        316.21771240234375,
        418.70947265625,
        327.24566650390625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "200 ppm",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.6039123535156,
        298.5969543457031,
        482.7152404785156,
        309.6249084472656
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "80 ppm",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.6039123535156,
        316.21771240234375,
        476.1184997558594,
        327.24566650390625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "300 ppm",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.6039123535156,
        333.83843994140625,
        482.7152404785156,
        344.86639404296875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        426.1375732421875,
        123.65264892578125,
        437.16552734375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질A: 0.5 % 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        149.07920837402344,
        364.52490234375,
        269.01422119140625,
        375.5528564453125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질B: 0.15 % 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        149.07920837402344,
        382.1456604003906,
        275.2508239746094,
        393.1736145019531
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질C: 0.15 % 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        149.07920837402344,
        399.7663879394531,
        275.2508239746094,
        410.7943420410156
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질D: 0.15 % 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        149.07920837402344,
        417.26727294921875,
        275.4903869628906,
        428.29522705078125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질E: 1.0 % 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        149.07920837402344,
        434.8880310058594,
        268.2945861816406,
        445.9159851074219
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질F: 0.50 % 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        149.07920837402344,
        452.5087585449219,
        274.5312194824219,
        463.5367126464844
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미지: 0.10 % 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        149.07920837402344,
        470.0096435546875,
        245.50692749023438,
        481.03759765625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총: 2.0 % 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        149.07920837402344,
        487.63037109375,
        227.87615966796875,
        498.6583251953125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법 #231a",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        321.9055480957031,
        426.1375732421875,
        403.80499267578125,
        437.16552734375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.20 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.6039123535156,
        364.52490234375,
        473.34783935546875,
        375.5528564453125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.10 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.6039123535156,
        382.1456604003906,
        473.34783935546875,
        393.1736145019531
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.09 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.6039123535156,
        399.7663879394531,
        473.34783935546875,
        410.7943420410156
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.11 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.6039123535156,
        417.26727294921875,
        473.34783935546875,
        428.29522705078125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.30 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.6039123535156,
        434.8880310058594,
        473.34783935546875,
        445.9159851074219
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.30 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.6039123535156,
        452.5087585449219,
        473.34783935546875,
        463.5367126464844
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.07 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.6039123535156,
        470.0096435546875,
        476.9376220703125,
        481.03759765625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.4 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.6039123535156,
        487.63037109375,
        466.7514343261719,
        498.6583251953125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 10 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 16,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 3.2.S.5 표준품 또는 표준물질에 설명된 원료의약품을 시험하는데 필요한 표준품 또는 표준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        99.01507568359375,
        538.2682495117188,
        110.04302215576172
      ],
      "page_num": 16,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질에 대하여 요약하여 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.16034698486328,
        118.79345703125,
        246.6898956298828,
        129.82139587402344
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 표준품에 대한 사항은 제2부에는 요약하여 기재하고 제3부에 시험성적서, 제조, 적합성 및 특성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        138.5718536376953,
        541.8231811523438,
        149.59979248046875
      ],
      "page_num": 16,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등에 대한 세부사항을 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.16034698486328,
        158.35023498535156,
        228.69964599609375,
        169.378173828125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 표준품은 필요 시 추가적인 재결정 등을 통하여 가능한 순도를 높이고, 원료의약품 시험성적",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        178.1286163330078,
        538.2678833007812,
        189.15655517578125
      ],
      "page_num": 16,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서에 전형적으로 보고되는 확인시험 이외에 NMR을 통한 구조 증명과 같이 추가적인 시험을",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.03716278076172,
        197.90699768066406,
        541.8224487304688,
        208.9349365234375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통하여 그 특징을 설명해야 한다. 표준품은 물리적인 수치가 일정해지거나 문헌상 순물질의",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.03716278076172,
        217.68539428710938,
        541.8224487304688,
        228.7133331298828
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "값에 이를 때까지 재결정하여 제조한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.03716278076172,
        237.46377563476562,
        276.5267639160156,
        248.49171447753906
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 아래 표와 같이 요약할 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        257.2421569824219,
        239.2266387939453,
        268.2701110839844
      ],
      "page_num": 16,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질명/IUPAC명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        192.85548400878906,
        290.2061462402344,
        341.69482421875,
        301.2341003417969
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기원",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        192.85548400878906,
        290.2061462402344,
        341.69482421875,
        301.2341003417969
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "근거자료위치",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        409.338134765625,
        281.3358154296875,
        475.4220275878906,
        292.36376953125
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(성적서 위치 포함)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        394.2263488769531,
        298.9565734863281,
        490.4957275390625,
        309.9845275878906
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원료의약품 A",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        99.78591918945312,
        316.5773010253906,
        341.95806884765625,
        327.6052551269531
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        99.78591918945312,
        316.5773010253906,
        341.95806884765625,
        327.6052551269531
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 1",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        106.02253723144531,
        335.0371398925781,
        341.69482421875,
        346.0650939941406
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "합성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        106.02253723144531,
        335.0371398925781,
        341.69482421875,
        346.0650939941406
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 2",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        106.02253723144531,
        353.4969787597656,
        345.6093444824219,
        364.5249328613281
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        106.02253723144531,
        353.4969787597656,
        345.6093444824219,
        364.5249328613281
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 표준품을 합성하는 경우 해당 제조방법에 대한 요약 기재가 필요할 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        378.4297180175781,
        465.90411376953125,
        389.4576721191406
      ],
      "page_num": 16,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예 시",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        423.63623046875,
        107.58169555664062,
        435.6231384277344
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시 1)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        450.11138916015625,
        94.82987976074219,
        461.13934326171875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 허가제출용 뱃치 제조에 사용된 원료의약품(제조번호 # 15531)의 시험에는 상용표준품이",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        469.8897705078125,
        541.8220825195312,
        480.917724609375
      ],
      "page_num": 16,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용되었는데 이 표준품은 USP 표준품(제조번호 # H)으로 성적서를 통해 그 품질을 확인",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.31917572021484,
        489.66815185546875,
        538.14794921875,
        500.69610595703125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하였다. 관련 보고서와 시험성적서는 3.2.S.5 표준품 또는 표준물질을 참고한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.31917572021484,
        509.446533203125,
        484.1342468261719,
        520.4744873046875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시 2)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        549.0032958984375,
        94.82987976074219,
        560.03125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 원료의약품의 1차 표준품(제조번호 # 3)은 주성분 제조업자로부터 구매하였다. 이 표준품은",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        568.7816772460938,
        541.9424438476562,
        579.8096313476562
      ],
      "page_num": 16,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "합성 공정을 통해 제조되었고, 자사에서 2 회의 추가 재결정을 통해 순도를 높여 순도 99.9",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.59957122802734,
        588.56005859375,
        541.823486328125,
        599.5880126953125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "%의 표준품을 얻었다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.59957122802734,
        608.3384399414062,
        185.04330444335938,
        619.3663940429688
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.S.6. 용기 및 포장(제품명, 제조자)(Container Closure System)(name, manufacturer)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        655.822509765625,
        536.5526733398438,
        667.8094482421875
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.S.6. 용기 및 포장에서 얻은 정보에 대한 간단한 설명과 고찰을 포함한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        682.41748046875,
        450.81927490234375,
        693.4454345703125
      ],
      "page_num": 16,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 설",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        727.6240234375,
        107.58169555664062,
        739.6109619140625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 11 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 3.2.S.6. 용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        99.01507568359375,
        533.214599609375,
        110.04302215576172
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예 시",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        144.2216033935547,
        107.58169555664062,
        156.20849609375
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예시 1)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        170.6967315673828,
        94.82987976074219,
        181.72467041015625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원료의약품은 투명한 Polyethylene Bag과 차광된 Polyethylene Bag으로 포장하고, fiber",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        190.47512817382812,
        538.3204345703125,
        201.50306701660156
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "board drum에 sealing하여 보관한다. 원료의약품 보관에 사용하는 용기 및 포장에 대한 추가",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.04041290283203,
        210.25350952148438,
        538.1484375,
        221.2814483642578
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적인 정보는 3.2.S.6. 용기 및 포장을 참고한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.04041290283203,
        230.03189086914062,
        306.5374755859375,
        241.05982971191406
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시 2)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        269.5886535644531,
        94.82987976074219,
        280.6166076660156
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원료의약품은 이중 포장되어 있다. Low density polyethylene으로 포장하고 sealing한 후",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        289.3670654296875,
        541.8224487304688,
        300.39501953125
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "aluminum laminated foil로 포장하고 sealing 한다. 이러한 이중 포장 후 fiberboard drum에",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.04041290283203,
        309.14544677734375,
        541.82275390625,
        320.17340087890625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보관한다. 원료의약품 보관에 사용하는 용기 및 포장에 대한 추가적인 정보는 3.2.S.6. 용기",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.04041290283203,
        328.923828125,
        541.943115234375,
        339.9517822265625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 포장을 참고한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.04041290283203,
        348.70220947265625,
        173.0498046875,
        359.73016357421875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.S.7 안정성(제품명, 제조자)(Stability)(name, manufacturer)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        396.18621826171875,
        410.021240234375,
        408.1731262207031
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.S.7.1에서 설명된 것과 같이 수행된 시험의 요약(조건, 뱃치, 시험방법)과 결과에",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        422.7971496582031,
        542.1422729492188,
        434.7840576171875
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 고찰 및 결론의 요약, 보관조건, 재시험일자 또는 유효기간에 대한 사항을 포함한다.",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        444.3735656738281,
        537.8124389648438,
        456.3604736328125
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.S.7.2에서 설명된 것과 같이 승인 후의 안정성 시험계획을 포함한다.",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        465.9499816894531,
        458.17559814453125,
        477.9368896484375
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.S.7.3에서 얻은 안정성 결과의 도표요약은 필요시 그래프와 함께 제공하여야 한다.",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        487.5263977050781,
        536.1333618164062,
        499.5133056640625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 설",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        539.549560546875,
        107.58169555664062,
        551.5364990234375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 3.2.S.7 안정성에 기재된 사항을 요약하고, 재시험일자 또는 유효기간에 대한 사항을 포함",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        570.9393310546875,
        538.14794921875,
        581.96728515625
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.87995910644531,
        590.7177124023438,
        99.04991149902344,
        601.7456665039062
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 재시험일자: 원료의약품이 기준을 만족하고 완제의약품의 제조에 사용하기에 적절한지를 보증",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        610.49609375,
        538.2682495117188,
        621.5240478515625
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하기 위해 시험해야 하는 일자.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.40022277832031,
        630.2744750976562,
        226.9936065673828,
        641.3024291992188
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 재시험기간: 원료의약품이 정해진 조건에서 저장되고 있는 경우 기준 내 적합할 것으로 예상됨에",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        650.0528564453125,
        541.8233642578125,
        661.080810546875
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라 완제의약품 제조에 사용될 수 있는 기간.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        72.92047882080078,
        669.8312377929688,
        291.30572509765625,
        680.8591918945312
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 사용기간: 정해진 조건에서 보관된다면, 원료의약품 뱃치가 그 날짜 이전에는 승인된 기준(Shelf",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        689.609619140625,
        541.9434204101562,
        700.6375732421875
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "life specification)에 적합할 것으로 예상되고 그 이후에는 사용해서는 안 되는 날짜",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        72.92047882080078,
        709.3880004882812,
        478.4203796386719,
        720.4159545898438
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 가혹시험 및 분해경로의 확인과 같은 정보가 중요한 경우, 이 항에 기재하지 않고 제3부에 상세",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        729.1664428710938,
        538.14794921875,
        740.1943969726562
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 12 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재 한다. 또한, 이러한 정보는 완제의약품의 설계, 성능 또는 제조에 영향을 미칠 수 있으므로",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.16034698486328,
        99.01507568359375,
        541.9426879882812,
        110.04302215576172
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.P.2. 개발경위에 기재할 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.16034698486328,
        118.79345703125,
        251.6072235107422,
        129.82139587402344
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 아래 표와 같이 요약 기재할 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        138.5718536376953,
        266.6917724609375,
        149.59979248046875
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험종류",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        163.98406982421875,
        355.6833190917969,
        183.762451171875
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험조건",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        163.98406982421875,
        355.6833190917969,
        183.762451171875
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용기형태/재질",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        163.98406982421875,
        355.6833190917969,
        183.762451171875
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조번호",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        163.98406982421875,
        355.6833190917969,
        183.762451171875
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(제조단위)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        303.79534912109375,
        181.6048126220703,
        356.16851806640625,
        192.63275146484375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험 주기",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        387.3900451660156,
        172.73451232910156,
        511.8822326660156,
        183.762451171875
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험 결과",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        387.3900451660156,
        172.73451232910156,
        511.8822326660156,
        183.762451171875
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예 시",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        271.402587890625,
        107.58169555664062,
        283.3894958496094
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P 완제의약품(제품명, 제형)(Drug Product)(name, dosage form)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        472.42291259765625,
        440.2448425292969,
        484.4098205566406
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.P.1 완제의약품의 개요와 조성(제품명, 제형)(Description and Composition of the",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        499.0338439941406,
        542.1422729492188,
        511.020751953125
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Drug Product)(name, dosage form)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        518.212890625,
        259.74267578125,
        530.1998291015625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.P.1에서 얻은 정보를 포함한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        542.4105224609375,
        242.8250274658203,
        553.4384765625
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.P.1에서 얻은 조성을 제공하여야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        562.1889038085938,
        277.63311767578125,
        573.2168579101562
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 설",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        612.31005859375,
        107.58169555664062,
        624.2969970703125
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 3.2.P.1 완제의약품의 개요와 조성에서 얻은 제형에 대한 정보(성상 등), 조성(성분, 용도,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        643.6998291015625,
        541.8226318359375,
        654.727783203125
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규격, 분량)을 요약하여 표 등으로 제공하고, 첨부용제 및 제제에 사용된 용기와 마개를 포",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        663.4782104492188,
        538.1483154296875,
        674.5061645507812
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "함한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        683.256591796875,
        110.32379913330078,
        694.2845458984375
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 필요시 대조약과의 조성 비교표를 기재할 수 있다(예 : 주사제).",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        703.0349731445312,
        399.5793762207031,
        714.0629272460938
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 조성 기재 시, 제조공정 중 제거되는 용매 및 공정보조제(processing aid)를 포함하여 완제의",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        722.8133544921875,
        538.2682495117188,
        733.84130859375
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "약품을 구성하는 성분, 분량, 규격 및 배합목적 등을 모두 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.52015686035156,
        742.5917358398438,
        405.6964416503906,
        753.6196899414062
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험종류",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        78.31755065917969,
        303.4627685546875,
        479.14031982421875,
        312.45294189453125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험조건",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        78.31755065917969,
        303.4627685546875,
        479.14031982421875,
        312.45294189453125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용기형태/재질",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        78.31755065917969,
        303.4627685546875,
        479.14031982421875,
        312.45294189453125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조번호",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        78.31755065917969,
        303.4627685546875,
        479.14031982421875,
        312.45294189453125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "측정시기 (개월)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        78.31755065917969,
        303.4627685546875,
        479.14031982421875,
        312.45294189453125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결과",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        78.31755065917969,
        303.4627685546875,
        479.14031982421875,
        312.45294189453125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "장기보존시험",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        69.32242584228516,
        335.3479309082031,
        202.26100158691406,
        344.3381042480469
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25℃/60% RH",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        69.32242584228516,
        335.3479309082031,
        202.26100158691406,
        344.3381042480469
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Polyethylene",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        219.84085083007812,
        320.963623046875,
        278.8453674316406,
        329.95379638671875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bag, Fiber",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        225.1179962158203,
        335.3479309082031,
        274.5279846191406,
        344.3381042480469
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "drum",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        237.47129821777344,
        349.7322082519531,
        259.2304992675781,
        358.7223815917969
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "001",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        301.996337890625,
        320.963623046875,
        318.1488952636719,
        329.95379638671875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "002",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        301.996337890625,
        335.3479309082031,
        318.1488952636719,
        344.3381042480469
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "003",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        301.996337890625,
        349.7322082519531,
        318.1488952636719,
        358.7223815917969
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0, 3, 6, 9, 12",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        342.05462646484375,
        335.3479309082031,
        402.70306396484375,
        344.3381042480469
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수분함량이 증가하는",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        429.2473449707031,
        320.963623046875,
        513.9185180664062,
        329.95379638671875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "양상이나, 기준 내 적합하여",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        412.5763854980469,
        335.3479309082031,
        530.5894775390625,
        344.3381042480469
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12 개월간 안정",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        437.76275634765625,
        349.7322082519531,
        502.40771484375,
        358.7223815917969
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가속시험",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        78.31755065917969,
        388.68963623046875,
        202.26100158691406,
        397.6798095703125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "40℃/75% RH",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        78.31755065917969,
        388.68963623046875,
        202.26100158691406,
        397.6798095703125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Polyethylene",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        219.84085083007812,
        374.30535888671875,
        278.8453674316406,
        383.2955322265625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bag, Fiber",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        225.1179962158203,
        388.68963623046875,
        274.5279846191406,
        397.6798095703125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "drum",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        237.47129821777344,
        403.07391357421875,
        259.2304992675781,
        412.0640869140625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "001",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        301.996337890625,
        374.30535888671875,
        318.1488952636719,
        383.2955322265625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "002",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        301.996337890625,
        388.68963623046875,
        318.1488952636719,
        397.6798095703125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "003",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        301.996337890625,
        403.07391357421875,
        318.1488952636719,
        412.0640869140625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0, 3, 6",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        357.2863464355469,
        388.68963623046875,
        387.5912780761719,
        397.6798095703125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수분함량이 증가하는",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        429.72711181640625,
        367.1131896972656,
        513.4387817382812,
        376.1033630371094
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "양상이나, 기준 내",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        432.84539794921875,
        381.49749755859375,
        510.4404296875,
        390.4876708984375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합하므로 가속조건에서 6",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        413.535888671875,
        395.88177490234375,
        529.7499389648438,
        404.8719482421875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개월간 안정",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        445.4385986328125,
        410.26605224609375,
        494.851806640625,
        419.2562255859375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 13 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 첨가제는 2.3.P.4 첨가제의 관리에 기재한다. 허가제출용 뱃치와 실생산 뱃치의 투입 원료량은",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        99.01507568359375,
        541.8224487304688,
        110.04302215576172
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.P.3 제조에 기재한다. 여러 공정 단계를 거치는 방출제어 등의 완제의약품은 중요 중간체",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.40022277832031,
        118.79345703125,
        538.2682495117188,
        129.82139587402344
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(예: tablet core 또는 bead) 별로 구분하여 아래 표와 같이 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.40022277832031,
        138.5718536376953,
        412.4400634765625,
        149.59979248046875
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성분",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        116.6967544555664,
        165.30262756347656,
        442.2003479003906,
        176.33056640625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        116.6967544555664,
        165.30262756347656,
        442.2003479003906,
        176.33056640625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "배합목적",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        116.6967544555664,
        165.30262756347656,
        442.2003479003906,
        176.33056640625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "질량/정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        116.6967544555664,
        165.30262756347656,
        442.2003479003906,
        176.33056640625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[원료의약품]",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        94.62871551513672,
        187.4783935546875,
        334.49871826171875,
        198.50633239746094
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        94.62871551513672,
        187.4783935546875,
        334.49871826171875,
        198.50633239746094
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[첨가제]",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        105.66273498535156,
        209.65415954589844,
        149.6788787841797,
        220.68209838867188
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[용매]",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.17974090576172,
        230.3108367919922,
        330.72076416015625,
        242.73800659179688
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용매*",
      "font_size": 7.074217319488525,
      "font_name": "Batang",
      "bbox": [
        111.17974090576172,
        230.3108367919922,
        330.72076416015625,
        242.73800659179688
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 량",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        113.93824768066406,
        253.88583374023438,
        141.40335083007812,
        264.9137878417969
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 제조 공정 중 제거됨",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        280.7364807128906,
        188.41754150390625,
        291.7644348144531
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 완제의약품 제조 과정에서 과량 투입 또는 과량 충전할 경우 그 근거를 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        320.2932434082031,
        468.56964111328125,
        331.3211975097656
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 사용되는 첨가제가 단일 성분이 아닐 경우(착색제, 착향제 등) 그 조성을 모두 기재한다. 단,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        340.0716247558594,
        541.8226318359375,
        351.0995788574219
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "신청인이 그 조성을 알 수 없을 경우에는 원료 제조원에서 직접 심사 부서에 제출할 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.23976135253906,
        359.85003662109375,
        529.6165771484375,
        370.87799072265625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 제조공정 중 사용되는 용매에 대한 정보도 간략히 기술한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        379.62841796875,
        382.1894836425781,
        390.6563720703125
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 제조 공정 중 사용되는 용매(결합용수, 코팅용매 등)에 대해서도 기술한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        399.40679931640625,
        436.0672607421875,
        410.43475341796875
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 첨가제 사용량의 적절성에 대해 추가로 기재할 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        419.1851806640625,
        356.55035400390625,
        430.213134765625
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 대조약의 첨가제 정보가 확인되는 경우(예: 주사제 등)는 이에 대해 추가 기술할 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        438.96356201171875,
        527.8175659179688,
        449.99151611328125
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예 시",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        484.1700744628906,
        107.58169555664062,
        496.156982421875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<속방성 제제>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        510.52532958984375,
        130.7891082763672,
        521.5532836914062
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성분명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        535.9375610351562,
        472.4239807128906,
        546.9655151367188
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        535.9375610351562,
        472.4239807128906,
        546.9655151367188
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "배합목적",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        535.9375610351562,
        472.4239807128906,
        546.9655151367188
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "질량/정(mg)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        535.9375610351562,
        472.4239807128906,
        546.9655151367188
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비고",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        535.9375610351562,
        472.4239807128906,
        546.9655151367188
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        555.4762573242188,
        372.4950866699219,
        566.5042114257812
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        555.4762573242188,
        372.4950866699219,
        566.5042114257812
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        555.4762573242188,
        372.4950866699219,
        566.5042114257812
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.00",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        555.4762573242188,
        372.4950866699219,
        566.5042114257812
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유당수화물",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        100.02578735351562,
        574.89501953125,
        379.0906066894531,
        585.9229736328125
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NF",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        100.02578735351562,
        574.89501953125,
        379.0906066894531,
        585.9229736328125
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부형제",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        100.02578735351562,
        574.89501953125,
        379.0906066894531,
        585.9229736328125
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "160.00",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        100.02578735351562,
        574.89501953125,
        379.0906066894531,
        585.9229736328125
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미결정셀룰로오스",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        83.59469604492188,
        600.5469970703125,
        375.85296630859375,
        611.574951171875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NF",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        83.59469604492188,
        600.5469970703125,
        375.85296630859375,
        611.574951171875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부형제",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        83.59469604492188,
        600.5469970703125,
        375.85296630859375,
        611.574951171875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "61.61",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        83.59469604492188,
        600.5469970703125,
        375.85296630859375,
        611.574951171875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "건조감량, 벌크밀도, 중합도",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        404.7806091308594,
        594.3848266601562,
        520.9946899414062,
        603.375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기재",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        452.3948059082031,
        608.7691040039062,
        470.38507080078125,
        617.75927734375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "포비돈",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        626.1989135742188,
        487.41552734375,
        637.2268676757812
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "NF",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        626.1989135742188,
        487.41552734375,
        637.2268676757812
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결합제",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        626.1989135742188,
        487.41552734375,
        637.2268676757812
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7.20",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        626.1989135742188,
        487.41552734375,
        637.2268676757812
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "K 값 기재",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        626.1989135742188,
        487.41552734375,
        637.2268676757812
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "크로스포비돈",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        94.50878143310547,
        645.6177368164062,
        486.69622802734375,
        656.6456909179688
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "NF",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        94.50878143310547,
        645.6177368164062,
        486.69622802734375,
        656.6456909179688
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붕해제",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        94.50878143310547,
        645.6177368164062,
        486.69622802734375,
        656.6456909179688
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7.20",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        94.50878143310547,
        645.6177368164062,
        486.69622802734375,
        656.6456909179688
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "type 기재",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        94.50878143310547,
        645.6177368164062,
        486.69622802734375,
        656.6456909179688
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스테아르산마그네슘",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.07768249511719,
        665.1563720703125,
        372.4950866699219,
        676.184326171875
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "NF",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.07768249511719,
        665.1563720703125,
        372.4950866699219,
        676.184326171875
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "활택제",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.07768249511719,
        665.1563720703125,
        372.4950866699219,
        676.184326171875
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.20",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.07768249511719,
        665.1563720703125,
        372.4950866699219,
        676.184326171875
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "FD&C Blue #2",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        87.55255126953125,
        684.5751342773438,
        372.4950866699219,
        695.6030883789062
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "별규",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        87.55255126953125,
        684.5751342773438,
        372.4950866699219,
        695.6030883789062
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "착색제",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        87.55255126953125,
        684.5751342773438,
        372.4950866699219,
        695.6030883789062
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.80",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        87.55255126953125,
        684.5751342773438,
        372.4950866699219,
        695.6030883789062
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정제수",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        702.5947265625,
        364.5424499511719,
        715.0218505859375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "USP",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        702.5947265625,
        364.5424499511719,
        715.0218505859375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결합용수*",
      "font_size": 7.074217319488525,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        702.5947265625,
        364.5424499511719,
        715.0218505859375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        111.05980682373047,
        702.5947265625,
        364.5424499511719,
        715.0218505859375
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "총 질량",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        108.30130004882812,
        723.5325927734375,
        146.80044555664062,
        734.560546875
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 14 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 20,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "* 제조 공정 중 제거됨.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        99.01507568359375,
        189.8137664794922,
        110.04302215576172
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "<서방성제제>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        138.5718536376953,
        130.7891082763672,
        149.59979248046875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1: 히프로멜로오스와 PEG 400의 혼합물",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        597.6701049804688,
        255.94094848632812,
        608.6980590820312
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2: 제조 공정 중 제거됨",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        617.448486328125,
        169.58807373046875,
        628.4764404296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "<대조약과의 특징 비교표 - 서방캡슐>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        657.0052490234375,
        253.122802734375,
        668.033203125
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성분",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        132.76803588867188,
        164.0551300048828,
        495.21160888671875,
        173.04530334472656
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규격",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        132.76803588867188,
        164.0551300048828,
        495.21160888671875,
        173.04530334472656
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배합목적",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        132.76803588867188,
        164.0551300048828,
        495.21160888671875,
        173.04530334472656
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "질량 (mg)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        132.76803588867188,
        164.0551300048828,
        495.21160888671875,
        173.04530334472656
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비고",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        132.76803588867188,
        164.0551300048828,
        495.21160888671875,
        173.04530334472656
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방출제어(Controlled Released, CR) 펠렛",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.67898559570312,
        181.55599975585938,
        248.74517822265625,
        190.54617309570312
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Core",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.67898559570312,
        198.93701171875,
        96.45387268066406,
        207.92718505859375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구형백당",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        123.77291870117188,
        216.43788146972656,
        513.2095336914062,
        225.4280548095703
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기제",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        123.77291870117188,
        216.43788146972656,
        513.2095336914062,
        225.4280548095703
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "142.5",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        123.77291870117188,
        216.43788146972656,
        513.2095336914062,
        225.4280548095703
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25-30 mesh",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        123.77291870117188,
        216.43788146972656,
        513.2095336914062,
        225.4280548095703
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        128.21051025390625,
        233.93875122070312,
        419.8537902832031,
        242.92892456054688
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "XXX",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        128.21051025390625,
        233.93875122070312,
        419.8537902832031,
        242.92892456054688
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "24.00",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        128.21051025390625,
        233.93875122070312,
        419.8537902832031,
        242.92892456054688
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Clear Coating 7321",
      "font_size": 5.755295753479004,
      "font_name": "Batang",
      "bbox": [
        99.66598510742188,
        250.1422576904297,
        419.8537902832031,
        260.3099365234375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결합제",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        99.66598510742188,
        250.1422576904297,
        419.8537902832031,
        260.3099365234375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "28.48",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        99.66598510742188,
        250.1422576904297,
        419.8537902832031,
        260.3099365234375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부틸레이티드히드록시아니솔",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        83.2348861694336,
        268.82061767578125,
        422.4926452636719,
        277.810791015625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항산화제/안정화제",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        83.2348861694336,
        268.82061767578125,
        422.4926452636719,
        277.810791015625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.0225",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        83.2348861694336,
        268.82061767578125,
        422.4926452636719,
        277.810791015625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정제수2",
      "font_size": 5.755295753479004,
      "font_name": "Batang",
      "bbox": [
        126.53142547607422,
        285.1440124511719,
        325.3836364746094,
        295.3116760253906
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용매",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        126.53142547607422,
        285.1440124511719,
        325.3836364746094,
        295.3116760253906
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방출제어막",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.67898559570312,
        303.7025146484375,
        120.65460968017578,
        312.69268798828125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에틸셀룰로오스",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        110.22026062011719,
        321.203369140625,
        517.874755859375,
        330.19354248046875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방출조절제",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        110.22026062011719,
        321.203369140625,
        517.874755859375,
        330.19354248046875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "18.00",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        110.22026062011719,
        321.203369140625,
        517.874755859375,
        330.19354248046875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "점도 20 mPa.s",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        110.22026062011719,
        321.203369140625,
        517.874755859375,
        330.19354248046875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시트르산트리에틸",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        105.78266906738281,
        338.7042541503906,
        419.8537902832031,
        347.6944274902344
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "코팅기제",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        105.78266906738281,
        338.7042541503906,
        419.8537902832031,
        347.6944274902344
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.000",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        105.78266906738281,
        338.7042541503906,
        419.8537902832031,
        347.6944274902344
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정제수2",
      "font_size": 5.755295753479004,
      "font_name": "Batang",
      "bbox": [
        126.53142547607422,
        354.90777587890625,
        325.3836364746094,
        365.075439453125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용매",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        126.53142547607422,
        354.90777587890625,
        325.3836364746094,
        365.075439453125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 질량 (방출제어 펠렛)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.67898559570312,
        373.58612060546875,
        419.8537902832031,
        382.5762939453125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "216.0",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.67898559570312,
        373.58612060546875,
        419.8537902832031,
        382.5762939453125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "속방(Immediate Release, IR) 펠렛",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.67898559570312,
        391.0870056152344,
        221.75982666015625,
        400.0771789550781
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Core",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.67898559570312,
        408.468017578125,
        96.45387268066406,
        417.45819091796875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구형백당",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        123.77291870117188,
        425.9688720703125,
        513.2095336914062,
        434.95904541015625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Base",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        123.77291870117188,
        425.9688720703125,
        513.2095336914062,
        434.95904541015625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "47.5",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        123.77291870117188,
        425.9688720703125,
        513.2095336914062,
        434.95904541015625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "18-20 mesh",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        123.77291870117188,
        425.9688720703125,
        513.2095336914062,
        434.95904541015625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약물층",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.67898559570312,
        443.4697570800781,
        102.66436004638672,
        452.4599304199219
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        128.21051025390625,
        460.85076904296875,
        414.4566955566406,
        469.8409423828125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "YYY",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        128.21051025390625,
        460.85076904296875,
        414.4566955566406,
        469.8409423828125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8.0",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        128.21051025390625,
        460.85076904296875,
        414.4566955566406,
        469.8409423828125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Clear Coating 7321",
      "font_size": 5.755295753479004,
      "font_name": "Batang",
      "bbox": [
        99.66598510742188,
        477.1741638183594,
        417.2149353027344,
        487.341796875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결합제",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        99.66598510742188,
        477.1741638183594,
        417.2149353027344,
        487.341796875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9.49",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        99.66598510742188,
        477.1741638183594,
        417.2149353027344,
        487.341796875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부틸레이티드히드록시아니솔",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        83.2348861694336,
        495.8525085449219,
        422.4926452636719,
        504.8426818847656
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항산화제/안정화제",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        83.2348861694336,
        495.8525085449219,
        422.4926452636719,
        504.8426818847656
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.0075",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        83.2348861694336,
        495.8525085449219,
        422.4926452636719,
        504.8426818847656
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정제수2",
      "font_size": 5.755295753479004,
      "font_name": "Batang",
      "bbox": [
        126.53142547607422,
        512.0560302734375,
        325.3836364746094,
        522.2236938476562
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용매",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        126.53142547607422,
        512.0560302734375,
        325.3836364746094,
        522.2236938476562
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 질량 (속방 펠렛)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.67898559570312,
        530.734375,
        417.2149353027344,
        539.7245483398438
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "65.0",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.67898559570312,
        530.734375,
        417.2149353027344,
        539.7245483398438
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경질젤라틴캡슐",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        110.22026062011719,
        548.2352905273438,
        502.8490905761719,
        557.2254638671875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상부/하부",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        110.22026062011719,
        548.2352905273438,
        502.8490905761719,
        557.2254638671875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Size #1",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        110.22026062011719,
        548.2352905273438,
        502.8490905761719,
        557.2254638671875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 충진물 질량",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        192.49566650390625,
        565.6162719726562,
        419.8537902832031,
        574.6064453125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "281.0",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        192.49566650390625,
        565.6162719726562,
        419.8537902832031,
        574.6064453125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "캡슐 총 질량",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        196.9332733154297,
        583.1171264648438,
        419.8537902832031,
        592.1072998046875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "380.0",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        196.9332733154297,
        583.1171264648438,
        419.8537902832031,
        592.1072998046875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대조약",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        167.18939208984375,
        683.927001953125,
        478.1808166503906,
        692.9171752929688
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "신청품목",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        167.18939208984375,
        683.927001953125,
        478.1808166503906,
        692.9171752929688
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검토의견",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        167.18939208984375,
        683.927001953125,
        478.1808166503906,
        692.9171752929688
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제형",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        701.4278564453125,
        455.8729248046875,
        710.4180297851562
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "캡슐",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        701.4278564453125,
        455.8729248046875,
        710.4180297851562
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "캡슐",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        701.4278564453125,
        455.8729248046875,
        710.4180297851562
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제제학적 동등성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        701.4278564453125,
        455.8729248046875,
        710.4180297851562
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제제설계",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.64171600341797,
        721.6857299804688,
        238.4307861328125,
        737.8680419921875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용출시험 결과 속방층(주성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.64171600341797,
        721.6857299804688,
        238.4307861328125,
        737.8680419921875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분 함량 25%) 및 서방층(주",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        123.05330657958984,
        736.0700073242188,
        238.4307861328125,
        745.0601806640625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주성분 25%를 함유하는 속방",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        248.62525939941406,
        721.6857299804688,
        381.1505126953125,
        730.6759033203125
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "펠렛 및 주성분 75%를 함유하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        248.62525939941406,
        728.8778686523438,
        514.2813110351562,
        745.0601806640625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생체 내 유사한 약물방출 설계",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        248.62525939941406,
        728.8778686523438,
        514.2813110351562,
        745.0601806640625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 15 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.P.2 개발경위(제품명, 제형)(Pharmaceutical Development)(name, dosage form)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        317.07269287109375,
        529.2366333007812,
        329.0596008300781
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.P.2.에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        341.27032470703125,
        379.69781494140625,
        352.29827880859375
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필요에 따라 임상시험에서 사용된 제형의 조성에 대한 도표 요약과 용출 프로파일을 제공하여야",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        361.0487060546875,
        541.8238525390625,
        372.07666015625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        380.82708740234375,
        80.9843521118164,
        391.85504150390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 설",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        431.068115234375,
        107.58169555664062,
        443.0550231933594
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 3.2.P.2. 개발경위에서 얻은 정보와 자료에 대한 고찰을 요약하여 기재하되, 개발계획을 수",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        462.4578857421875,
        538.1483154296875,
        473.48583984375
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "립한 초기 시점부터 실시한 연구내용부터 포함한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.52015686035156,
        482.23626708984375,
        334.9620361328125,
        493.26422119140625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 필요 시 대조약(제품명)에 대한 정보를 기재할 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        502.0146484375,
        353.7918701171875,
        513.0426025390625
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 제품의 개발, 생산에 영향을 미치는 원료의약품의 특징, 첨가제의 선정 사유 등에 대해",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        521.7930297851562,
        541.8231201171875,
        532.8209838867188
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.7195053100586,
        541.5714111328125,
        122.79704284667969,
        552.599365234375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 제조방법 개발과정에 대해 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        561.3497924804688,
        257.6039733886719,
        572.3777465820312
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 필요 시 대조약과의 이화학적동등성시험 결과, 생물학적동등성시험 결과 등에 대해 요약하여",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        581.128173828125,
        541.82373046875,
        592.1561279296875
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.28028106689453,
        600.9065551757812,
        119.43885803222656,
        611.9345092773438
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 필요 시, 대조약의 제제 또는 제법 특허를 회피한 경우 해당 정보를 기재할 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        620.6849975585938,
        502.51123046875,
        631.7129516601562
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 2.3.P.2.1. 완제의약품의 조성에는 제조방법 초기 연구 및 스케일업, 그 근거 등에 대해",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        640.46337890625,
        541.9423217773438,
        651.4913330078125
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.4796371459961,
        660.2417602539062,
        122.67710876464844,
        671.2697143554688
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 2.3.P.2.1.1. 원료의약품에는 완제의약품의 안정성, 제조, 또는 생물약제학적으로 영향을",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        680.0201416015625,
        541.9430541992188,
        691.048095703125
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미치는 원료의약품의 특성 또는 물리화학적 성질을 기재하고, 그 근거로 수행한 시험결과를",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.52015686035156,
        699.7985229492188,
        541.9420776367188,
        710.8264770507812
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요약한다 (예: 원료의약품 입자도와 완제의약품 용출패턴과의 관계 등).",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.52015686035156,
        719.576904296875,
        434.8413391113281,
        730.6048583984375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원료의약품의 안정성시험 결과는 완제의약품의 설계, 성능 및 제조에 영향을 줄 수 있으므로",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        739.3552856445312,
        541.82373046875,
        750.3832397460938
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성분 함량 75%)으로 설계",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        123.05330657958984,
        103.28153991699219,
        238.4307861328125,
        112.27172088623047
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "된 제형을 나타냄",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        123.05330657958984,
        117.66581726074219,
        194.89437866210938,
        126.65599822998047
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 서방 펠렛 혼합물로 구성하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        248.62525939941406,
        103.28153991699219,
        378.155029296875,
        112.27172088623047
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여 개발",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        248.62525939941406,
        117.66581726074219,
        280.0482177734375,
        126.65599822998047
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "캡슐",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        151.10928344726562,
        100.6225357055664,
        160.09945678710938
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "충진물",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.1992416381836,
        158.30142211914062,
        361.00433349609375,
        174.48373413085938
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "펠렛으로 충진",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.1992416381836,
        158.30142211914062,
        361.00433349609375,
        174.48373413085938
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "속방과 서방 펠렛으로 충진",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.1992416381836,
        158.30142211914062,
        361.00433349609375,
        174.48373413085938
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대조약 허가사항에 따르면 캡슐을",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        388.3495178222656,
        129.53285217285156,
        535.027099609375,
        138.5230255126953
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "삼키기 어려운 환자들이 캡슐을",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        388.3495178222656,
        143.91714477539062,
        535.027099609375,
        152.90731811523438
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "열어 스푼에 펠렛을 섞어 복용할",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        388.3495178222656,
        158.30142211914062,
        535.027099609375,
        167.29159545898438
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수 있도록 하는데, 동 제품에서도",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        388.3495178222656,
        172.68569946289062,
        535.027099609375,
        181.67587280273438
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가능하게 하고자 함",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        388.3495178222656,
        187.06997680664062,
        469.3056335449219,
        196.06015014648438
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "펠렛",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        213.201416015625,
        100.6225357055664,
        222.19158935546875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "크기의",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.1992416381836,
        227.58570861816406,
        105.18006134033203,
        236.5758819580078
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "타당성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.1992416381836,
        241.96998596191406,
        102.18461608886719,
        250.9601593017578
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대조약 허가사항에 따르면",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        123.05330657958984,
        213.201416015625,
        241.4262237548828,
        222.19158935546875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "음식물 영향이 거의 없음.",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        123.05330657958984,
        227.58570861816406,
        241.42591857910156,
        236.5758819580078
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "펠렛 크기 0.8 ~ 0.9 mm.",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        123.05330657958984,
        241.96998596191406,
        232.6615447998047,
        250.9601593017578
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.0 mm 미만의 펠렛으로 개발",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        248.62525939941406,
        227.58570861816406,
        375.9962158203125,
        236.5758819580078
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대조약 허가사항에 따르면 약물",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        388.3495178222656,
        198.817138671875,
        535.027099609375,
        207.80731201171875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "흡수에 미치는 음식물 영향이 거",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        388.3495178222656,
        213.201416015625,
        532.0316162109375,
        222.19158935546875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 없음.",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        388.3495178222656,
        227.58570861816406,
        422.5189208984375,
        236.5758819580078
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "동 제품도 대조약과 같이 음식물",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        388.3495178222656,
        241.96998596191406,
        532.0316162109375,
        250.9601593017578
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "과 상관없이 복용할 수 있도록 함.",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        388.3495178222656,
        256.354248046875,
        530.3405151367188,
        265.34442138671875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 16 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재한다 (예: 가혹시험에서 확인된 유연물질, 분해경로에 대한 정보 등).",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.64009094238281,
        99.01507568359375,
        435.70782470703125,
        110.04302215576172
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 2.3.P.2.1.2 첨가제에는 첨가제와 원료의약품 간 배합적합성에 대해 기재한다. 의약품 개발",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        118.79345703125,
        541.8220825195312,
        129.82139587402344
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과정에서 첨가제와 원료의약품의 배합적합성을 평가하여야 하나, 일부 기존 자료로 대체할",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.79729461669922,
        138.5718536376953,
        541.8228149414062,
        149.59979248046875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수도 있다. 제네릭의약품의 경우, 안정성 문제가 없는 것으로 알려진 첨가제의 종류, 분량이",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.79729461669922,
        158.35023498535156,
        541.8233032226562,
        169.378173828125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대조약과 동일하다면 배합적합성 평가 자료 대신 경험적 자료가 허용될 수 있지만 이런",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.79729461669922,
        178.1286163330078,
        541.8224487304688,
        189.15655517578125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우에도 원료의약품과의 배합적합성을 확인하는 것이 바람직하다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.79729461669922,
        197.90699768066406,
        417.23748779296875,
        208.9349365234375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "첨가제의 적합성은 통상적으로 원료의약품과 각 첨가제 간 상호작용을 평가하기 위해",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        217.68539428710938,
        541.82275390625,
        228.7133331298828
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“binary mixture\"를 가지고 시험하거나, 원료의약품과 모든 첨가제를 혼합한 것과 이",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        237.46377563476562,
        541.8224487304688,
        248.49171447753906
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혼합물에서 각 첨가제를 하나씩 제외한 것을 가지고 시험한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        257.2421569824219,
        402.84527587890625,
        268.2701110839844
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험 조건은 가속시험조건(40 ℃ / 75% RH), 장기보존조건(25 ℃ / 60% RH) 또는 완제",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        277.0205383300781,
        538.1487426757812,
        288.0484924316406
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의약품 제조공정을 반영한 조건(예: 수분 10∼20% 첨가 / 50 ℃ RH) 등을 고려할 수 있",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.55742645263672,
        296.7989196777344,
        538.2682495117188,
        307.8268737792969
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으며, 시험기간은 통상 4 주 이상 관찰하나 시험목적에 따라 과학적인 타당성을 가지고",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.55742645263672,
        316.5773010253906,
        541.8224487304688,
        327.6052551269531
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설정할 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.55742645263672,
        336.355712890625,
        158.65760803222656,
        347.3836669921875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험 항목은 일반적으로 함량 및 유연물질에 대해서는 반드시 설정하며, 원료의약품의",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        356.13409423828125,
        541.8238525390625,
        367.16204833984375
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "중요한 특성(예: 원료의약품의 결정형 등)이 변화할 가능성이 있는 경우 이를 포함한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        375.9124755859375,
        528.0574340820312,
        386.9404296875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 2.3.P.2.2 완제의약품에는 완제의약품의 특성, 이러한 특성을 확보하기 위한 방법, 개발과정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        395.69085693359375,
        541.8220825195312,
        406.71881103515625
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "중 수행된 시험 및 그 결과 등이 포함될 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.16034698486328,
        415.46923828125,
        332.656005859375,
        426.4971923828125
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 2.3.P.2.3 제조 공정 개발에는 3.2.P.3. 제조에 기술된 제조공정이 선택된 이유, 제조공정이",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        435.24761962890625,
        541.8220825195312,
        446.27557373046875
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "완제의약품 품질에 미치는 영향, 중요 공정 변수 등에 대한 내용이 포함된다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.28028106689453,
        455.0260009765625,
        464.37188720703125,
        466.053955078125
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 2.3.P.2.4 용기 및 포장에는 완제의약품의 용기 및 포장을 선정한 이유 등을 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        474.80438232421875,
        516.27685546875,
        485.83233642578125
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예 시",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        520.0109252929688,
        107.58169555664062,
        531.9978637695312
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 속방성 제제 및 서방성 제제의 개발경위 기재: Appendix 참조",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        546.486083984375,
        391.347900390625,
        557.5140380859375
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.P.3 제조(제품명, 제형)(Manufacturing)(name, dosage form)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        594.0899658203125,
        418.41668701171875,
        606.076904296875
      ],
      "page_num": 22,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.P.3에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        620.6849975585938,
        376.45953369140625,
        631.7129516601562
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "・제조자(제조원)에 대한 정보",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        640.46337890625,
        207.84735107421875,
        651.4913330078125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "・적절한 품질을 일정하게 제조하기 위한 제조공정 및 그 공정 관리에 대한 간단한 설명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        660.2417602539062,
        507.2051086425781,
        671.2697143554688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.P.3.3에 기재된 제조공정 도식",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        680.0201416015625,
        229.1954345703125,
        691.048095703125
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.P.3.5에 기재된 공정 밸리데이션 및 평가에 대한 간단한 설명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        699.7985229492188,
        388.58941650390625,
        710.8264770507812
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 17 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 23,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 설",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        104.66483306884766,
        107.58169555664062,
        116.6517333984375
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 제조원에 대한 정보, 제조공정, 제조장비, 공정관리방법 등을 요약 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        136.05459594726562,
        463.1452941894531,
        147.08253479003906
      ],
      "page_num": 23,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 제조원에 대한 정보는 각 단위공정에 대한 제조 및 품질관리 범위에 대한 내용을 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        155.83297729492188,
        541.8226318359375,
        166.8609161376953
      ],
      "page_num": 23,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(제조자, 제조의뢰자, 일부공정제조자 등)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.16034698486328,
        175.6113739013672,
        283.8421936035156,
        186.63931274414062
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 위수탁관계가 있는 경우 이를 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        195.38975524902344,
        271.75628662109375,
        206.41769409179688
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 허가신청용 뱃치와 실생산 뱃치 간에 뱃치사이즈, 제조장비, 작동원리 등이 다를 경우 그",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        215.1681365966797,
        541.8224487304688,
        226.19607543945312
      ],
      "page_num": 23,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "차이점을 비교표 또는 도식 등을 이용하여 요약 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.23976135253906,
        234.94651794433594,
        368.66375732421875,
        245.97445678710938
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 제조공정은 공정조건과 중요 공정변수를 포함한 도식으로 나타낸다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        254.72491455078125,
        416.99761962890625,
        265.75286865234375
      ],
      "page_num": 23,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 제조방법은 아래 서식으로 기재하거나, 서식의 항목을 포함한 다른 기술방식(예시 참조)을",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        274.5032958984375,
        541.8224487304688,
        285.53125
      ],
      "page_num": 23,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이용하여 기술하고, 뱃치에 관한 사항은 아래 예시를 참고하여 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.87995910644531,
        294.28167724609375,
        443.02349853515625,
        305.30963134765625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정 번호",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        60.56717300415039,
        319.7808837890625,
        496.8902587890625,
        329.7300109863281
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공정 명칭",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        60.56717300415039,
        319.7808837890625,
        496.8902587890625,
        329.7300109863281
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원료․시약․용매 등",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        60.56717300415039,
        319.7808837890625,
        496.8902587890625,
        329.7300109863281
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공정 과정",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        60.56717300415039,
        319.7808837890625,
        496.8902587890625,
        329.7300109863281
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비고",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        60.56717300415039,
        319.7808837890625,
        496.8902587890625,
        329.7300109863281
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        407.0455017089844,
        160.3526153564453,
        416.99462890625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원료칭량",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        407.0455017089844,
        160.3526153564453,
        416.99462890625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분 ○○",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        343.15533447265625,
        230.99432373046875,
        353.1044616699219
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결합제 ○○",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        359.097900390625,
        230.99432373046875,
        369.0470275878906
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부형제 ○○",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        375.0404968261719,
        230.99432373046875,
        384.9896240234375
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "활택제 ○○",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        391.1029357910156,
        230.99432373046875,
        401.05206298828125
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "붕해제 ○○",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        407.0455017089844,
        230.99432373046875,
        416.99462890625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제피제 ○○",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        422.98809814453125,
        230.99432373046875,
        432.9372253417969
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "착색제 ○○",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        439.050537109375,
        230.99432373046875,
        448.9996643066406
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유기용매 ○○",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        454.99310302734375,
        244.26437377929688,
        464.9422302246094
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정제수",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        470.9356994628906,
        209.36280822753906,
        480.88482666015625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분 제조원4)",
      "font_size": 6.354805946350098,
      "font_name": "Batang",
      "bbox": [
        451.3153991699219,
        381.7234191894531,
        522.4342651367188,
        393.0208435058594
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생동시",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        469.42559814453125,
        415.0767517089844,
        504.32666015625,
        425.02587890625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생산규모 △정",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        454.4337158203125,
        431.0193176269531,
        519.3185424804688,
        440.96844482421875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        502.34136962890625,
        163.66757202148438,
        520.2018432617188
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결합액의",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        502.34136962890625,
        163.66757202148438,
        520.2018432617188
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조제",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        130.3693389892578,
        518.283935546875,
        150.27854919433594,
        528.2330932617188
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분 ○○",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        494.3101501464844,
        230.99432373046875,
        504.25927734375
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결합제 ○○",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        510.2527160644531,
        230.99432373046875,
        520.2018432617188
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정제수",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        526.3151245117188,
        209.36280822753906,
        536.2642822265625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        568.62890625,
        150.27854919433594,
        578.5780639648438
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혼합",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        568.62890625,
        150.27854919433594,
        578.5780639648438
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부형제 ○○",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        552.6863403320312,
        230.99432373046875,
        562.635498046875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "활택제 ○○",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        568.62890625,
        230.99432373046875,
        578.5780639648438
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "붕해제 ○○",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        584.6913452148438,
        230.99432373046875,
        594.6405029296875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각 원료를 oo mesh체로 체과 후",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        273.2119140625,
        544.6550903320312,
        428.24420166015625,
        554.604248046875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Convection mixer",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        273.2119140625,
        560.717529296875,
        359.1427917480469,
        570.6666870117188
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Ribbon blender)에서 oo rpm으로",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        273.2119140625,
        576.6600952148438,
        437.95892333984375,
        586.6092529296875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "oo분간 혼합한다.",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        273.2119140625,
        592.6027221679688,
        352.757080078125,
        602.5518798828125
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중요공정",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        466.9069519042969,
        552.6863403320312,
        506.8448486328125,
        562.635498046875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(중요장비, 혼합속도",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        441.12091064453125,
        568.62890625,
        536.0652465820312,
        578.5780639648438
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        479.9798583984375,
        584.6913452148438,
        493.80682373046875,
        594.6405029296875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        619.09375,
        150.27854919433594,
        629.0429077148438
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제립",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        619.09375,
        150.27854919433594,
        629.0429077148438
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정2의 결합액",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        611.0625,
        246.9456787109375,
        621.0116577148438
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정3의 혼합물",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        627.1249389648438,
        246.9456787109375,
        637.0740966796875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        645.4649047851562,
        150.27854919433594,
        655.4140625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "건조",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        645.4649047851562,
        150.27854919433594,
        655.4140625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        663.9247436523438,
        150.27854919433594,
        673.8739013671875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정립",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        663.9247436523438,
        150.27854919433594,
        673.8739013671875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        682.3845825195312,
        150.27854919433594,
        692.333740234375
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "활택",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        682.3845825195312,
        150.27854919433594,
        692.333740234375
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        720.143310546875,
        246.9456787109375,
        730.0924682617188
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "타정",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        720.143310546875,
        246.9456787109375,
        730.0924682617188
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정7의 반제품",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        720.143310546875,
        246.9456787109375,
        730.0924682617188
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "타정기에서",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        273.2119140625,
        704.0808715820312,
        326.4194030761719,
        714.030029296875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본압: □~□mm,",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        273.2119140625,
        720.143310546875,
        346.5205078125,
        730.0924682617188
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예압: □~□mm,",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        273.2119140625,
        736.0858764648438,
        346.5205078125,
        746.0350341796875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중요공정",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        466.9069519042969,
        704.0808715820312,
        506.8448486328125,
        714.030029296875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(중요장비, 타정조건",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        441.12091064453125,
        720.143310546875,
        536.0652465820312,
        730.0924682617188
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        479.9798583984375,
        736.0858764648438,
        493.80682373046875,
        746.0350341796875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 18 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "* 최종제품이 동물유래성분을 함유하거나 제조과정 중 동물유래성분이 사용된 경우 「의약품의",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        349.5412902832031,
        541.8221435546875,
        360.5692443847656
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품목허가‧신고‧심사 규정」제14조(제조방법)에 따라 필요한 사항을 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        67.88320922851562,
        369.3196716308594,
        449.5,
        380.3476257324219
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예 시",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        414.52618408203125,
        107.58169555664062,
        426.5130920410156
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 제조자(제조원)에 대한 정보 : 회사명 및 주소 기재",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        440.8814697265625,
        332.3398742675781,
        451.909423828125
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "회사명 및 주소",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.96099853515625,
        464.9751281738281,
        488.6152038574219,
        476.0030822753906
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "담당업무",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.96099853515625,
        464.9751281738281,
        488.6152038574219,
        476.0030822753906
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "GMP 증명서",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.96099853515625,
        464.9751281738281,
        488.6152038574219,
        476.0030822753906
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비고",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.96099853515625,
        464.9751281738281,
        488.6152038574219,
        476.0030822753906
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "회사명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.445613861083984,
        481.6369323730469,
        96.42739868164062,
        492.6648864746094
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주소",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.445613861083984,
        499.2576599121094,
        85.39337921142578,
        510.2856140136719
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "완제의약품의 제조, 포장 및 시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        168.268798828125,
        481.6369323730469,
        347.4513854980469,
        492.6648864746094
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(출하, 안정성)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        168.268798828125,
        499.2576599121094,
        240.19137573242188,
        510.2856140136719
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "회사명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.445613861083984,
        515.91943359375,
        96.42739868164062,
        526.9473876953125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주소",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.445613861083984,
        533.4203491210938,
        85.39337921142578,
        544.4483032226562
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원료의약품 입자도 시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        168.268798828125,
        515.91943359375,
        289.1632995605469,
        526.9473876953125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조용수 미생물한도시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        168.268798828125,
        524.669921875,
        501.8077087402344,
        544.4483032226562
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품질 위수탁",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        168.268798828125,
        524.669921875,
        501.8077087402344,
        544.4483032226562
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 제조공정 요약",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        577.1725463867188,
        144.52133178710938,
        588.2005004882812
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 제조공정은 다음과 같다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        596.950927734375,
        198.59596252441406,
        607.9788818359375
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. <혼합> 유당수화물, 포비돈, 미결정셀룰로오스를 high shear mixer에서 혼합한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        616.7293090820312,
        510.1601257324219,
        627.7572631835938
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. <습식과립> 주성분을 별도로 정제수와 섞는다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        636.5076904296875,
        325.0074462890625,
        647.53564453125
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. <습식체과> 주성분 현탁액을 공정 1의 혼합물에 분사하고 impeller에서 빠른 속도로 혼합",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        656.2860717773438,
        540.3836059570312,
        667.3140258789062
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "후 분쇄한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        676.064453125,
        150.14222717285156,
        687.0924072265625
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. <습식체과> 분쇄를 계속하여 종말점에 다다른 후(약 5분 후) 균질한 혼합물을 얻는다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        695.8428344726562,
        526.7381591796875,
        706.8707885742188
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5. <습식체과> 습체를 6 mesh(3.3 mm) 체에 통과시켜 큰 덩어리를 제거하여 건조가 균일",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        715.6212158203125,
        536.5888061523438,
        726.649169921875
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하게 될 수 있도록 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        88.27215576171875,
        735.3995971679688,
        215.95925903320312,
        746.4275512695312
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "속도: □~□rpm으로",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        273.2119140625,
        101.85903930664062,
        368.6365051269531,
        111.80816650390625
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평균질량 △~△mg,",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        273.2119140625,
        117.9214859008789,
        366.1194152832031,
        127.87061309814453
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개별질량 △~△mg",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        273.2119140625,
        133.8640594482422,
        359.85198974609375,
        143.8131866455078
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경도     △~△kp,",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        273.2119140625,
        149.806640625,
        360.0728759765625,
        159.75576782226562
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마손도   △~△%,",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        273.2119140625,
        165.86907958984375,
        357.07452392578125,
        175.81820678710938
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "붕해도   △분 이내가 되도록",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        273.2119140625,
        181.81166076660156,
        408.01885986328125,
        191.7607879638672
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "타정한다.",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        273.2119140625,
        197.75424194335938,
        316.05694580078125,
        207.703369140625
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.1165771484375,
        229.399658203125,
        86.04656982421875,
        239.34878540039062
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "필름코팅액의",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        110.34020233154297,
        221.36842346191406,
        173.62168884277344,
        231.3175506591797
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조제",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        130.3693389892578,
        237.31100463867188,
        150.27854919433594,
        247.2601318359375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제피제 ○○",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        213.3372039794922,
        230.99432373046875,
        223.2863311767578
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "착색제 ○○",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        229.399658203125,
        230.99432373046875,
        239.34878540039062
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유기용매 ○○",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        245.34222412109375,
        240.9494171142578,
        255.29135131835938
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        77.11820220947266,
        271.8332824707031,
        160.3526153564453,
        281.78240966796875
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "필름코팅",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        77.11820220947266,
        271.8332824707031,
        160.3526153564453,
        281.78240966796875
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정8의 나정",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        263.80206298828125,
        236.8716278076172,
        273.7511901855469
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정9의 필름코팅액",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        176.0645751953125,
        279.74462890625,
        266.85491943359375,
        289.6937561035156
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        77.11820220947266,
        306.2356872558594,
        252.82298278808594,
        316.184814453125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "포장",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        77.11820220947266,
        306.2356872558594,
        252.82298278808594,
        316.184814453125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정10의 반제품",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        77.11820220947266,
        306.2356872558594,
        252.82298278808594,
        316.184814453125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "직접용기․",
      "font_size": 9.951866149902344,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.0674133300781,
        298.2044677734375,
        507.73614501953125,
        308.1535949707031
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "포장의 재질",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        459.4709777832031,
        314.14703369140625,
        514.4007568359375,
        324.0961608886719
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 19 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 25,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6. <건조> 과립물을 60±5°C (LOD 0.5 % 이하가 될 때까지) 온도에서 fluid bed dryer로",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        99.01507568359375,
        538.3446655273438,
        110.04302215576172
      ],
      "page_num": 25,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "건조한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        88.27215576171875,
        118.79345703125,
        135.51014709472656,
        129.82139587402344
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. <분쇄> 건조된 과립을 impact mill(날 장착)에서 12 mesh (1.1 mm) 체를 통과시킨다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        138.5718536376953,
        531.295654296875,
        149.59979248046875
      ],
      "page_num": 25,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "8. <최종혼합> 분쇄된 과립을 bin-blender에서 크로스포비돈을 넣어 5 분간 혼합하고,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        158.35023498535156,
        528.0304565429688,
        169.378173828125
      ],
      "page_num": 25,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스테아르산마그네슘을 넣어 2 분간 혼합한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        88.27215576171875,
        178.1286163330078,
        322.72869873046875,
        189.15655517578125
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9. <타정 및 포장> 혼합물을 타정 후 포장한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        197.90699768066406,
        313.97344970703125,
        208.9349365234375
      ],
      "page_num": 25,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 제조공정을 도식으로 표현하면 다음과 같다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        237.46377563476562,
        297.42242431640625,
        248.49171447753906
      ],
      "page_num": 25,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 허가제출용 뱃치에 관한 사항(요약)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        627.3976440429688,
        251.70513916015625,
        638.4255981445312
      ],
      "page_num": 25,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 제조량 및 목표량",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        647.176025390625,
        162.39166259765625,
        658.2039794921875
      ],
      "page_num": 25,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공정단계",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        88.39209747314453,
        672.5882568359375,
        517.0007934570312,
        683.6162109375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조번호 #9A",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        88.39209747314453,
        672.5882568359375,
        517.0007934570312,
        683.6162109375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목표량",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        88.39209747314453,
        672.5882568359375,
        517.0007934570312,
        683.6162109375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "최소 생산 수율 (limit)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        88.39209747314453,
        672.5882568359375,
        517.0007934570312,
        683.6162109375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혼합(건조 후)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        692.0070190429688,
        131.89007568359375,
        703.0349731445312
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "산출량",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.90910339355469,
        711.545654296875,
        471.5489807128906,
        722.5736083984375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "45.629kg(98%)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.90910339355469,
        711.545654296875,
        471.5489807128906,
        722.5736083984375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "46.56kg(100%)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.90910339355469,
        711.545654296875,
        471.5489807128906,
        722.5736083984375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "96%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.90910339355469,
        711.545654296875,
        471.5489807128906,
        722.5736083984375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "최종혼합",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        730.9644775390625,
        107.10161590576172,
        741.992431640625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 20 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 뱃치조성(실생산 뱃치와 비교)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        296.6790466308594,
        225.6792449951172,
        307.7070007324219
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성분명, 규격",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        322.2111511230469,
        284.3658752441406,
        341.98956298828125
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가제출용 뱃치",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        322.2111511230469,
        284.3658752441406,
        341.98956298828125
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(23만 정)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        201.85060119628906,
        339.7120361328125,
        250.7456512451172,
        350.739990234375
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실생산 뱃치",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        333.53924560546875,
        322.2111511230469,
        394.1064147949219,
        333.2391052246094
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(230만 정)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        333.53924560546875,
        330.96160888671875,
        510.28399658203125,
        350.739990234375
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "% (w/w)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        333.53924560546875,
        330.96160888671875,
        510.28399658203125,
        350.739990234375
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분, USP",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        359.25067138671875,
        488.1124267578125,
        370.27862548828125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.4 kg",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        359.25067138671875,
        488.1124267578125,
        370.27862548828125
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4.0 kg",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        359.25067138671875,
        488.1124267578125,
        370.27862548828125
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.83",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        359.25067138671875,
        488.1124267578125,
        370.27862548828125
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유당, NF",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        378.6694641113281,
        494.7074890136719,
        389.6974182128906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "32.00 kg",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        378.6694641113281,
        494.7074890136719,
        389.6974182128906
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "320.00 kg",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        378.6694641113281,
        494.7074890136719,
        389.6974182128906
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "66.67",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        378.6694641113281,
        494.7074890136719,
        389.6974182128906
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미결정셀룰로오스, NF",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        398.0882263183594,
        494.7074890136719,
        409.1161804199219
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "12.32 kg",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        398.0882263183594,
        494.7074890136719,
        409.1161804199219
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "123.20 kg",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        398.0882263183594,
        494.7074890136719,
        409.1161804199219
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "25.67",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        398.0882263183594,
        494.7074890136719,
        409.1161804199219
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포비돈, NF",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        417.62689208984375,
        488.1124267578125,
        428.65484619140625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.44 kg",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        417.62689208984375,
        488.1124267578125,
        428.65484619140625
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "14.40 kg",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        417.62689208984375,
        488.1124267578125,
        428.65484619140625
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.00",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        417.62689208984375,
        488.1124267578125,
        428.65484619140625
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "크로스포비돈, NF",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        437.045654296875,
        488.1124267578125,
        448.0736083984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.44 kg",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        437.045654296875,
        488.1124267578125,
        448.0736083984375
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "14.40 kg",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        437.045654296875,
        488.1124267578125,
        448.0736083984375
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.00",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        437.045654296875,
        488.1124267578125,
        448.0736083984375
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스테아르산마그네슘, NF",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        456.4644470214844,
        488.1124267578125,
        467.4924011230469
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.24 kg",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        456.4644470214844,
        488.1124267578125,
        467.4924011230469
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.4 kg",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        456.4644470214844,
        488.1124267578125,
        467.4924011230469
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.50",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        456.4644470214844,
        488.1124267578125,
        467.4924011230469
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "FD&C Blue #2",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        476.0030822753906,
        488.1124267578125,
        487.0310363769531
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.160 kg",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        476.0030822753906,
        488.1124267578125,
        487.0310363769531
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.60 kg",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        476.0030822753906,
        488.1124267578125,
        487.0310363769531
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.33",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        476.0030822753906,
        488.1124267578125,
        487.0310363769531
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정제수",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        495.421875,
        359.17626953125,
        506.4498291015625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9.6 L",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        495.421875,
        359.17626953125,
        506.4498291015625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "96 L",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        495.421875,
        359.17626953125,
        506.4498291015625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 질량",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        514.8406372070312,
        371.39495849609375,
        525.8685913085938
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "48 kg",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        514.8406372070312,
        371.39495849609375,
        525.8685913085938
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "480 kg",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        514.8406372070312,
        371.39495849609375,
        525.8685913085938
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 제조공정 중 품질검사 항목",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        560.03125,
        211.80487060546875,
        571.0592041015625
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "산출량",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.90910339355469,
        104.64891052246094,
        471.5489807128906,
        115.67686462402344
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "47.04kg(98%)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.90910339355469,
        104.64891052246094,
        471.5489807128906,
        115.67686462402344
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "48kg(100%)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.90910339355469,
        104.64891052246094,
        471.5489807128906,
        115.67686462402344
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "96%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.90910339355469,
        104.64891052246094,
        471.5489807128906,
        115.67686462402344
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "타정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        124.06770324707031,
        85.15384674072266,
        135.09564208984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "산출량",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.90910339355469,
        143.60633850097656,
        471.5489807128906,
        154.63427734375
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "46.70kg(97.3%)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.90910339355469,
        143.60633850097656,
        471.5489807128906,
        154.63427734375
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "48kg(100%)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.90910339355469,
        143.60633850097656,
        471.5489807128906,
        154.63427734375
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "96%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.90910339355469,
        143.60633850097656,
        471.5489807128906,
        154.63427734375
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정제 생산량",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        163.02511596679688,
        471.5489807128906,
        174.0530548095703
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "225,420",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        163.02511596679688,
        471.5489807128906,
        174.0530548095703
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "231,000",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        163.02511596679688,
        471.5489807128906,
        174.0530548095703
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "93%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        163.02511596679688,
        471.5489807128906,
        174.0530548095703
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "500정 병포장",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.91885375976562,
        182.44390869140625,
        346.7320861816406,
        193.4718475341797
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "198병",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.91885375976562,
        182.44390869140625,
        346.7320861816406,
        193.4718475341797
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "200병",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.91885375976562,
        182.44390869140625,
        346.7320861816406,
        193.4718475341797
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "100정 병포장",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.91885375976562,
        201.9825439453125,
        350.09027099609375,
        213.01048278808594
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "950병",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.91885375976562,
        201.9825439453125,
        350.09027099609375,
        213.01048278808594
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1010병",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.91885375976562,
        201.9825439453125,
        350.09027099609375,
        213.01048278808594
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "60정 병포장",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.15709686279297,
        221.4013214111328,
        346.7320861816406,
        232.42926025390625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "500병",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.15709686279297,
        221.4013214111328,
        346.7320861816406,
        232.42926025390625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "500병",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.15709686279297,
        221.4013214111328,
        346.7320861816406,
        232.42926025390625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "포장",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        99.42611694335938,
        240.82009887695312,
        471.5489807128906,
        251.84803771972656
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "224,000(96.9%)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        99.42611694335938,
        240.82009887695312,
        471.5489807128906,
        251.84803771972656
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "231,000",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        99.42611694335938,
        240.82009887695312,
        471.5489807128906,
        251.84803771972656
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "93%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        99.42611694335938,
        240.82009887695312,
        471.5489807128906,
        251.84803771972656
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 수율",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        91.15059661865234,
        260.3587646484375,
        471.5489807128906,
        271.38671875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "99%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        91.15059661865234,
        260.3587646484375,
        471.5489807128906,
        271.38671875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "100%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        91.15059661865234,
        260.3587646484375,
        471.5489807128906,
        271.38671875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "97%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        91.15059661865234,
        260.3587646484375,
        471.5489807128906,
        271.38671875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        76.63846588134766,
        585.5145263671875,
        520.7577514648438,
        601.6968383789062
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험항목",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        76.63846588134766,
        585.5145263671875,
        520.7577514648438,
        601.6968383789062
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        76.63846588134766,
        585.5145263671875,
        520.7577514648438,
        601.6968383789062
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분석방법 번호",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        76.63846588134766,
        585.5145263671875,
        520.7577514648438,
        601.6968383789062
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가제출용 뱃치 결과",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        76.63846588134766,
        585.5145263671875,
        520.7577514648438,
        601.6968383789062
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(제조번호 #9A)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        443.3996887207031,
        599.8988037109375,
        508.1965637207031,
        608.8889770507812
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혼합",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        624.591796875,
        443.89862060546875,
        633.5819702148438
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체에 남은 분율",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        624.591796875,
        443.89862060546875,
        633.5819702148438
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.0% 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        624.591796875,
        443.89862060546875,
        633.5819702148438
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "M-1231",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        624.591796875,
        443.89862060546875,
        633.5819702148438
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        624.591796875,
        443.89862060546875,
        633.5819702148438
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "습식체과",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        656.4769897460938,
        443.89862060546875,
        665.4671630859375
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체에 남은 분율",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        656.4769897460938,
        443.89862060546875,
        665.4671630859375
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.0% 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        656.4769897460938,
        443.89862060546875,
        665.4671630859375
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "M-1233",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        656.4769897460938,
        443.89862060546875,
        665.4671630859375
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        656.4769897460938,
        443.89862060546875,
        665.4671630859375
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "건조",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        688.2422485351562,
        154.35635375976562,
        704.424560546875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "건조감량",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        688.2422485351562,
        154.35635375976562,
        704.424560546875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체에 남은 분율",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        118.37584686279297,
        702.6265258789062,
        185.77932739257812,
        711.61669921875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.5% 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        688.2422485351562,
        273.8086853027344,
        697.232421875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.0% 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        688.2422485351562,
        443.89862060546875,
        711.61669921875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "M-1232",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        688.2422485351562,
        443.89862060546875,
        711.61669921875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.3%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        688.2422485351562,
        443.89862060546875,
        711.61669921875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1 % 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        422.89080810546875,
        702.6265258789062,
        470.86480712890625,
        711.61669921875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분쇄",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        733.79248046875,
        443.89862060546875,
        742.7826538085938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체에 남은 분율",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        733.79248046875,
        443.89862060546875,
        742.7826538085938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.0% 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        733.79248046875,
        443.89862060546875,
        742.7826538085938
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "M-1233",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        733.79248046875,
        443.89862060546875,
        742.7826538085938
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.2%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        733.79248046875,
        443.89862060546875,
        742.7826538085938
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 21 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 실생산 뱃치와 허가제출용 뱃치 간의 장비 및 작동원리 비교",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        366.68255615234375,
        382.1125793457031,
        377.71051025390625
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단위 공정명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        65.48451232910156,
        401.8041687011719,
        200.29110717773438,
        412.8321228027344
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "장비명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        65.48451232910156,
        401.8041687011719,
        200.29110717773438,
        412.8321228027344
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개발 뱃치",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        259.4194030761719,
        392.09478759765625,
        514.1609497070312,
        403.12274169921875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가제출용 뱃치",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        259.4194030761719,
        392.09478759765625,
        514.1609497070312,
        403.12274169921875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실생산 뱃치",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        259.4194030761719,
        392.09478759765625,
        514.1609497070312,
        403.12274169921875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2 kg, 1만정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        253.1827850341797,
        411.5135498046875,
        528.0737915039062,
        422.54150390625
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "48 kg, 23만정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        253.1827850341797,
        411.5135498046875,
        528.0737915039062,
        422.54150390625
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "480 kg, 230만정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        253.1827850341797,
        411.5135498046875,
        528.0737915039062,
        422.54150390625
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "습식과립",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.76002502441406,
        439.8026428222656,
        117.77583312988281,
        450.8305969238281
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "High Shear",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        153.7566680908203,
        430.9323425292969,
        217.51849365234375,
        441.9602966308594
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Granulator",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        155.91549682617188,
        439.8026428222656,
        512.3389892578125,
        459.5810241699219
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PMA 10",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        155.91549682617188,
        439.8026428222656,
        512.3389892578125,
        459.5810241699219
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PMA 300",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        155.91549682617188,
        439.8026428222656,
        512.3389892578125,
        459.5810241699219
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PMA 1800",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        155.91549682617188,
        439.8026428222656,
        512.3389892578125,
        459.5810241699219
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "습식체과",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.76002502441406,
        476.8421630859375,
        117.77583312988281,
        487.8701171875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Impact Mill",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        153.87660217285156,
        467.97186279296875,
        217.5188446044922,
        478.99981689453125
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(FitzSieve)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        155.31582641601562,
        476.8421630859375,
        503.46392822265625,
        496.62054443359375
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FS 75",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        155.31582641601562,
        476.8421630859375,
        503.46392822265625,
        496.62054443359375
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FS 200",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        155.31582641601562,
        476.8421630859375,
        503.46392822265625,
        496.62054443359375
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FS 200",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        155.31582641601562,
        476.8421630859375,
        503.46392822265625,
        496.62054443359375
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "건조",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        84.67411041259766,
        505.01141357421875,
        498.4264221191406,
        516.0393676757812
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Fluid Bed Dryer",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        84.67411041259766,
        505.01141357421875,
        498.4264221191406,
        516.0393676757812
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "STREA 1",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        84.67411041259766,
        505.01141357421875,
        498.4264221191406,
        516.0393676757812
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MP 4",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        84.67411041259766,
        505.01141357421875,
        498.4264221191406,
        516.0393676757812
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MP 6",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        84.67411041259766,
        505.01141357421875,
        498.4264221191406,
        516.0393676757812
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분쇄",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        84.67411041259766,
        524.550048828125,
        217.5188446044922,
        544.3284301757812
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Impact Mill",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        84.67411041259766,
        524.550048828125,
        217.5188446044922,
        544.3284301757812
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(FitzSieve)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        155.31582641601562,
        533.3004760742188,
        503.46392822265625,
        553.078857421875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FS 75",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        155.31582641601562,
        533.3004760742188,
        503.46392822265625,
        553.078857421875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FS 200",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        155.31582641601562,
        533.3004760742188,
        503.46392822265625,
        553.078857421875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FS 200",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        155.31582641601562,
        533.3004760742188,
        503.46392822265625,
        553.078857421875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "최종혼합",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.76002502441406,
        561.5895385742188,
        517.0107421875,
        572.6174926757812
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bin-Blender",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.76002502441406,
        561.5895385742188,
        517.0107421875,
        572.6174926757812
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Size 5 L",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.76002502441406,
        561.5895385742188,
        517.0107421875,
        572.6174926757812
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Size 100 L",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.76002502441406,
        561.5895385742188,
        517.0107421875,
        572.6174926757812
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Size 1000 L",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.76002502441406,
        561.5895385742188,
        517.0107421875,
        572.6174926757812
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "타정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        84.67411041259766,
        581.00830078125,
        495.9144287109375,
        592.0362548828125
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Tablet Press",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        84.67411041259766,
        581.00830078125,
        495.9144287109375,
        592.0362548828125
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Beta",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        84.67411041259766,
        581.00830078125,
        495.9144287109375,
        592.0362548828125
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Beta",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        84.67411041259766,
        581.00830078125,
        495.9144287109375,
        592.0362548828125
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Beta",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        84.67411041259766,
        581.00830078125,
        495.9144287109375,
        592.0362548828125
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.4 첨가제의 관리(제품명, 제형)(Control of Excipients)(name, dosage form)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        647.551513671875,
        516.1636962890625,
        659.5384521484375
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.P.4에 기재된 첨가제의 품질에 관한 간략한 요약을 포함하여야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        676.5439453125,
        425.99273681640625,
        687.5718994140625
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 설",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        726.6650390625,
        107.58169555664062,
        738.6519775390625
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최종혼합",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        133.48854064941406,
        99.0663070678711,
        142.4787139892578
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성상",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        118.37584686279297,
        111.912109375,
        136.3660888671875,
        120.90229034423828
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함량",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        118.37584686279297,
        126.29639434814453,
        136.3660888671875,
        135.2865753173828
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혼합균일성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        118.37584686279297,
        140.68067932128906,
        163.35147094726562,
        149.6708526611328
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "탭밀도",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        118.37584686279297,
        155.06495666503906,
        148.35667419433594,
        164.0551300048828
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정수율",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        118.37584686279297,
        169.44923400878906,
        154.35635375976562,
        178.4394073486328
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "흰색의 과립",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        119.104248046875,
        276.8099670410156,
        128.09442138671875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "90.0~110.0%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        133.48854064941406,
        284.625244140625,
        142.4787139892578
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 5.0% 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        147.87281799316406,
        296.5963439941406,
        156.8629913330078
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.65~0.85g/mL",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        162.25709533691406,
        293.4693298339844,
        171.2472686767578
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "96.0~100.5%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        176.64137268066406,
        284.625244140625,
        185.6315460205078
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "M-1234",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        334.97845458984375,
        119.104248046875,
        370.0810546875,
        128.09442138671875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "M-1235",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        334.97845458984375,
        133.48854064941406,
        370.0810546875,
        142.4787139892578
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "M-1236",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        334.97845458984375,
        162.25709533691406,
        370.0810546875,
        171.2472686767578
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        422.89080810546875,
        111.912109375,
        440.88104248046875,
        120.90229034423828
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "99.1%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        422.89080810546875,
        126.29639434814453,
        449.29571533203125,
        135.2865753173828
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 2.0%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        422.89080810546875,
        140.68067932128906,
        466.68597412109375,
        149.6708526611328
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.73g/mL",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        422.89080810546875,
        155.06495666503906,
        463.5368347167969,
        164.0551300048828
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "47.04kg(98%)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        422.89080810546875,
        169.44923400878906,
        482.53076171875,
        178.4394073486328
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "타정",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        263.186767578125,
        81.07605743408203,
        272.17694091796875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경도",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        118.37584686279297,
        191.26539611816406,
        136.3660888671875,
        200.2555694580078
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "두께",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        118.37584686279297,
        205.64967346191406,
        136.3660888671875,
        214.6398468017578
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "질량",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        118.37584686279297,
        220.03395080566406,
        136.3660888671875,
        229.0241241455078
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10정평균",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        118.37584686279297,
        234.41822814941406,
        168.02601623535156,
        243.4084014892578
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개개",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        118.37584686279297,
        248.80250549316406,
        136.3660888671875,
        257.79266357421875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마손도",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        118.37584686279297,
        263.186767578125,
        149.798828125,
        272.17694091796875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "붕해도",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        118.37584686279297,
        277.571044921875,
        149.798828125,
        286.56121826171875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정수율",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        118.37584686279297,
        291.9553527832031,
        158.7939453125,
        300.9455261230469
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8~12Kp(기준 10Kp)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        191.26539611816406,
        313.9027404785156,
        200.2555694580078
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3 . 5 ~ 3 . 9 m m ( 기 준",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        205.64967346191406,
        327.7794189453125,
        214.6398468017578
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.7mm)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        220.03395080566406,
        259.33172607421875,
        229.0241241455078
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2 2 8 ~ 2 5 2 m g ( 기 준",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        248.80250549316406,
        327.7791442871094,
        257.79266357421875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "240mg ± 5%)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        263.186767578125,
        288.9556884765625,
        272.17694091796875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2 2 2 ~ 2 5 8 m g ( 기 준",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        277.571044921875,
        327.7791442871094,
        286.56121826171875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "240mg ± 7.5%)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        291.9553527832031,
        296.99102783203125,
        300.9455261230469
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.0% 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        306.3396301269531,
        273.8086853027344,
        315.3298034667969
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5분 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        320.7239074707031,
        267.2122497558594,
        329.7140808105469
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "93~101%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        227.39675903320312,
        335.1081848144531,
        268.5545349121094,
        344.0983581542969
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "M-1238",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        334.97845458984375,
        205.64967346191406,
        370.0810546875,
        214.6398468017578
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "M-1239",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        334.97845458984375,
        220.03395080566406,
        370.0810546875,
        229.0241241455078
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "M-1240",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        334.97845458984375,
        234.41822814941406,
        370.0810546875,
        243.4084014892578
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "M-1241",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        334.97845458984375,
        277.571044921875,
        370.0810546875,
        286.56121826171875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP<701>",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        334.97845458984375,
        291.9553527832031,
        380.7789306640625,
        300.9455261230469
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9.96Kp",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        422.89080810546875,
        205.64967346191406,
        453.48248291015625,
        214.6398468017578
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.72mm",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        422.89080810546875,
        220.03395080566406,
        456.7637634277344,
        229.0241241455078
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "241.2mg",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        422.89080810546875,
        248.80250549316406,
        459.7978820800781,
        257.79266357421875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "235.5~243.9mg",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        422.89080810546875,
        263.186767578125,
        490.6214599609375,
        272.17694091796875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.6%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        422.89080810546875,
        277.571044921875,
        443.89862060546875,
        286.56121826171875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1분",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        422.89080810546875,
        291.9553527832031,
        437.1630554199219,
        300.9455261230469
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "225.420정(97.3%)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        422.89080810546875,
        306.3396301269531,
        499.8011169433594,
        315.3298034667969
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 22 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 첨가제의 용도, 규격 등에 대해 도표로 요약, 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        99.01507568359375,
        351.87286376953125,
        110.04302215576172
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 공정서 규격 첨가제인 경우에는 등급을 포함하여 아래 표와 같이 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        118.79345703125,
        455.37677001953125,
        129.82139587402344
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "명칭",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        122.6935043334961,
        145.6441192626953,
        503.7266540527344,
        156.67205810546875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "배합목적",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        122.6935043334961,
        145.6441192626953,
        503.7266540527344,
        156.67205810546875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등급",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        122.6935043334961,
        145.6441192626953,
        503.7266540527344,
        156.67205810546875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "로트 번호*",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        122.6935043334961,
        145.6441192626953,
        503.7266540527344,
        156.67205810546875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정서 규격 여부",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        122.6935043334961,
        145.6441192626953,
        503.7266540527344,
        156.67205810546875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 허가제출용 뱃치의 생산에 사용된 첨가제의 로트 번호",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        191.505126953125,
        308.2329406738281,
        200.49530029296875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공정서 규격 이외 추가로 설정된 항목이 있다면 아래 표와 같이 기재하고 이에 대한 근거",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.88483428955078,
        229.31268310546875,
        538.2686157226562,
        240.3406219482422
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료는 2.3.P.2.2 완제의약품에 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.88483428955078,
        249.091064453125,
        275.95404052734375,
        260.1190185546875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험 항목",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.66436004638672,
        275.94171142578125,
        448.9163818359375,
        286.96966552734375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허용 기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.66436004638672,
        275.94171142578125,
        448.9163818359375,
        286.96966552734375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분석방법",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.66436004638672,
        275.94171142578125,
        448.9163818359375,
        286.96966552734375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험결과",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.66436004638672,
        275.94171142578125,
        448.9163818359375,
        286.96966552734375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 공정서에 수재되지 않은 첨가제의 경우는 해당 첨가제에 대한 기준을 표로 요약하고 필요한",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        337.55438232421875,
        541.8217163085938,
        348.58233642578125
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우 시험방법 밸리데이션 및 사용 등급을 표시한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.87995910644531,
        357.332763671875,
        338.08038330078125,
        368.3607177734375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 동물유래성분 첨가제의 경우, 원산국, 전염성해면상뇌증(BSE/TSE) 증명서의 발행처를 기재",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        377.11114501953125,
        538.2682495117188,
        388.13909912109375
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.16034698486328,
        396.8895568847656,
        98.3302993774414,
        407.9175109863281
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 기 사용례가 없는 새로운 첨가제는 제조사, 특성, 품질관리, 안전성 입증자료 등을 포함한",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        416.6679382324219,
        541.8224487304688,
        427.6958923339844
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세부적인 사항들이 요구될 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.99989318847656,
        436.4463195800781,
        253.04644775390625,
        447.4742736816406
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예 시",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        481.65283203125,
        107.58169555664062,
        493.6397399902344
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.4. 첨가제의 관리 (서방성 제제 예시)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        508.12799072265625,
        274.85260009765625,
        519.1559448242188
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공정서에 수재된 첨가제들을 아래 표에 정리하였다. 첨가제들의 관리는 해당 공정서에 따른다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        527.9063720703125,
        535.6133422851562,
        538.934326171875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성분명",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        110.22026062011719,
        554.8280639648438,
        472.6609191894531,
        571.0103759765625
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "배합목적",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        110.22026062011719,
        554.8280639648438,
        472.6609191894531,
        571.0103759765625
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조원명",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        110.22026062011719,
        554.8280639648438,
        472.6609191894531,
        571.0103759765625
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등급",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        110.22026062011719,
        554.8280639648438,
        472.6609191894531,
        571.0103759765625
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        110.22026062011719,
        554.8280639648438,
        472.6609191894531,
        571.0103759765625
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "뱃치 제조에",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        110.22026062011719,
        554.8280639648438,
        472.6609191894531,
        571.0103759765625
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용된 제조번호",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        411.2571105957031,
        569.2123413085938,
        478.66058349609375,
        578.2025146484375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구형백당, 25-30 mesh*",
      "font_size": 5.755295753479004,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        585.4158935546875,
        387.19122314453125,
        595.58349609375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sugar Inc.",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        585.4158935546875,
        387.19122314453125,
        595.58349609375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NF",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        585.4158935546875,
        387.19122314453125,
        595.58349609375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시트르산트리에틸",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        604.09423828125,
        311.707275390625,
        620.2765502929688
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Plasticizer",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        604.09423828125,
        311.707275390625,
        620.2765502929688
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Inc.",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        278.48907470703125,
        611.286376953125,
        387.19122314453125,
        627.4686889648438
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NF",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        278.48907470703125,
        611.286376953125,
        387.19122314453125,
        627.4686889648438
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부틸레이티드히드록시아니솔",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        635.9793701171875,
        313.8661193847656,
        652.1616821289062
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Antioxidant",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        635.9793701171875,
        313.8661193847656,
        652.1616821289062
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Inc.",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        278.48907470703125,
        643.1715087890625,
        387.19122314453125,
        659.3538208007812
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NF",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        278.48907470703125,
        643.1715087890625,
        387.19122314453125,
        659.3538208007812
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에틸셀룰로오스",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        664.9876708984375,
        305.1123962402344,
        681.1699829101562
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Control",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        664.9876708984375,
        305.1123962402344,
        681.1699829101562
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Release Inc.",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        259.2994689941406,
        671.0023193359375,
        392.6672058105469,
        688.3621215820312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "별규**",
      "font_size": 5.755295753479004,
      "font_name": "Batang",
      "bbox": [
        259.2994689941406,
        671.0023193359375,
        392.6672058105469,
        688.3621215820312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정제수",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        693.9959716796875,
        390.0372619628906,
        702.9861450195312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "In-House",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        693.9959716796875,
        390.0372619628906,
        702.9861450195312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        693.9959716796875,
        390.0372619628906,
        702.9861450195312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 구형백당의 입자 크기는 25~30 mesh로, 완제의약품의 약물방출이 일정하고 재현성 있도록",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        718.73779296875,
        541.9423828125,
        729.7657470703125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서방펠렛이 일정한 표면적을 갖게 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        68.4828872680664,
        738.5161743164062,
        269.4775390625,
        749.5441284179688
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 23 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "** 에틸셀룰로오스는 완제의약품의 방출속도 조절에 중요한 기능을 한다. 개발 과정 중 에틸셀",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        99.01507568359375,
        538.2682495117188,
        110.04302215576172
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "룰로오스의 등급에 따라 점도가 다르며, 점도는 서방코팅층을 통한 방출속도에 유의하게",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.16034698486328,
        118.79345703125,
        541.8231201171875,
        129.82139587402344
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "영향을 미치는 것으로 나타났다(2.3.P.2.2 완제의약품 참조). 방출 양상이 일관성 있도록,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.16034698486328,
        138.5718536376953,
        541.9429321289062,
        149.59979248046875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "점도 관리를 포함한 규격을 설정하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.16034698486328,
        158.35023498535156,
        276.3138427734375,
        169.378173828125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정서 이외 기준",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        229.0758514404297,
        185.28785705566406,
        309.072021484375,
        195.2369842529297
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험항목",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        109.38072204589844,
        203.7476806640625,
        455.06781005859375,
        213.69680786132812
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        109.38072204589844,
        203.7476806640625,
        455.06781005859375,
        213.69680786132812
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험결과 (제조번호)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        109.38072204589844,
        203.7476806640625,
        455.06781005859375,
        213.69680786132812
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에톡시함량 (N-Type)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        222.20751953125,
        378.3953857421875,
        232.15664672851562
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "48.0 ~ 49.5 %",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        222.20751953125,
        378.3953857421875,
        232.15664672851562
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "48.8 %",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        222.20751953125,
        378.3953857421875,
        232.15664672851562
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "점도",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        240.66734313964844,
        398.3201599121094,
        250.61647033691406
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "18.0 ~ 22.0 mPa.s",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        240.66734313964844,
        398.3201599121094,
        250.61647033691406
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20.1 mPa.s",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        240.66734313964844,
        398.3201599121094,
        250.61647033691406
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.5 완제의약품의 관리(제품명, 제형)(Control of Drug Product)(name, dosage",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        299.21221923828125,
        542.26220703125,
        311.1991271972656
      ],
      "page_num": 29,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "form)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        318.3912353515625,
        88.4754867553711,
        330.3781433105469
      ],
      "page_num": 29,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준의 설정근거에 대한 간단한 요약, 시험방법과 밸리데이션 및 불순물의 특징에 대한 요약을",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        342.4690246582031,
        541.8224487304688,
        353.4969787597656
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제공하여야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        362.2474060058594,
        142.2265167236328,
        373.2753601074219
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.P.5.1에서 얻은 기준을 제공하여야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        382.0257873535156,
        281.83087158203125,
        393.0537414550781
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.P.5.4에서 제공된 뱃치 분석의 도표요약을 필요시 그래프와 함께 포함하여야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        401.8041687011719,
        496.1546630859375,
        412.8321228027344
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 설",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        452.0451965332031,
        107.58169555664062,
        464.0321044921875
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 제품의 규격 및 시험방법, 기준설정 근거 및 시험방법 밸리데이션에 대해 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        483.4349670410156,
        497.11419677734375,
        494.4629211425781
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 완제의약품의 기준 및 시험방법은 중요 특성을 포함하도록 하여 표로 작성한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        503.21337890625,
        477.44482421875,
        514.2413330078125
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 완제의약품에 적용하는 시험항목은 다음과 같다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        522.9917602539062,
        319.49041748046875,
        534.0197143554688
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 성상",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        542.7701416015625,
        98.22642517089844,
        553.798095703125
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 확인시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        562.5485229492188,
        120.29446411132812,
        573.5764770507812
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 함량시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        582.326904296875,
        120.29446411132812,
        593.3548583984375
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 분해 산물",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        602.1052856445312,
        125.69154357910156,
        613.1332397460938
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 제제학적시험(「의약품의 품목허가‧신고‧심사 규정」[별표13])",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        621.8836669921875,
        387.351806640625,
        632.91162109375
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 뱃치 결과는 다음을 고려하여 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        641.6620483398438,
        274.155029296875,
        652.6900024414062
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 모든 용량(strengths)에 대한 시험 결과를 표로 작성한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        661.4404296875,
        371.66217041015625,
        672.4683837890625
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 정량적인 시험 결과는 “기준에 적합” 또는 “적합”이 아닌 수치로 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        681.2188110351562,
        462.3330078125,
        692.2467651367188
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 순도시험(정량시험)의 경우, 정량한계 이상은 결과 값을 기재하고 정량한계 미만에서는",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        700.9971923828125,
        541.823486328125,
        712.025146484375
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“LOQ 미만”으로 기재하고, “불검출”인 경우 검출한계(LOD)를 함께 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        81.55580139160156,
        720.7755737304688,
        482.00238037109375,
        731.8035278320312
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 기준 및 시험방법 설정 근거는 다음과 같이 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        740.553955078125,
        345.516357421875,
        751.5819091796875
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 24 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 공정서에 수재되지 않은 시험방법은 중요 변수 및 시스템적합성시험 기준을 포함하여 표",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        99.01507568359375,
        541.8224487304688,
        110.04302215576172
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 서술 형태의 요약자료로 제출한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.67898559570312,
        118.79345703125,
        276.67364501953125,
        129.82139587402344
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 기준 설정근거로 대조약을 사용한 경우, 대조약 분석결과를 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        138.5718536376953,
        427.0721435546875,
        149.59979248046875
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 시험방법 밸리데이션을 수행한 경우 아래와 같이 요약표를 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        158.35023498535156,
        423.8338623046875,
        169.378173828125
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 유연물질은 원료의약품의 분해생성물, 용기/마개와 반응하여 생성된 유연물질로 분류할 수",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        462.9373779296875,
        541.8224487304688,
        473.96533203125
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있다. 2.3.S.3. 특성 또는 2.3.S.4. 원료의약품의 품질관리에서 확인된 유연물질은 구조 기재를",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.07930755615234,
        482.71575927734375,
        541.8219604492188,
        493.74371337890625
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생략할 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.07930755615234,
        502.494140625,
        152.18112182617188,
        513.5220947265625
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 일반적으로 유연물질이 완제의약품에서 발생한 분해생성물이 아니라면 완제의약품에서 관리",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        522.2725219726562,
        541.9423828125,
        533.3004760742188
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 규명할 필요는 없다. 신청자가 원료의약품의 합성 중간체 또는 공정 불순물을 완제",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.4796371459961,
        542.0509033203125,
        538.2686157226562,
        553.078857421875
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의약품에 규격 설정하는 경우(예: 크로마토그램에 검출되거나 마커로 사용 등), 원료의약품",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.4796371459961,
        561.8292846679688,
        541.8220825195312,
        572.8572387695312
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규격에 준하여 관리한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.4796371459961,
        581.607666015625,
        198.59596252441406,
        592.6356201171875
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "순도시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        103.983642578125,
        608.4583129882812,
        423.13037109375,
        628.2366943359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허용기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        103.983642578125,
        608.4583129882812,
        423.13037109375,
        628.2366943359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설정근거",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        103.983642578125,
        608.4583129882812,
        423.13037109375,
        628.2366943359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가제출용 의약품",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        103.983642578125,
        608.4583129882812,
        423.13037109375,
        628.2366943359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(제조번호)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        350.80987548828125,
        625.959228515625,
        402.1036376953125,
        636.9871826171875
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대조약",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        466.9069519042969,
        608.4583129882812,
        499.8887634277344,
        619.4862670898438
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(제조번호)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        457.19219970703125,
        625.959228515625,
        509.4454650878906,
        636.9871826171875
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[특정 분해생성물]",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.27703094482422,
        645.4978637695312,
        442.440185546875,
        656.5258178710938
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[허가제출용 뱃치의 결과]",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.27703094482422,
        645.4978637695312,
        442.440185546875,
        656.5258178710938
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기타 분해생성물",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        84.7940444946289,
        664.9166259765625,
        167.188720703125,
        675.944580078125
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 분해생성물",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        90.31105041503906,
        684.3353881835938,
        161.79196166992188,
        695.3633422851562
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 순도시험의 경우, 특정 유연물질에 대해 표준품을 이용하여 정량하거나, 유연물질의 상대반",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        730.9644775390625,
        538.14794921875,
        741.992431640625
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유연물질",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        311.83099365234375,
        186.7103729248047,
        347.8114929199219,
        195.70054626464844
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "A",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        155.31582641601562,
        204.21124267578125,
        506.76611328125,
        213.201416015625
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "B",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        155.31582641601562,
        204.21124267578125,
        506.76611328125,
        213.201416015625
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "C",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        155.31582641601562,
        204.21124267578125,
        506.76611328125,
        213.201416015625
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "D",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        155.31582641601562,
        204.21124267578125,
        506.76611328125,
        213.201416015625
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "E",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        155.31582641601562,
        204.21124267578125,
        506.76611328125,
        213.201416015625
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "F",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        155.31582641601562,
        204.21124267578125,
        506.76611328125,
        213.201416015625
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "특이성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        236.09640502929688,
        112.2591552734375,
        245.08657836914062
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 간에 방해가 없음 (첨부된 크로마토그램",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        122.9333724975586,
        221.71212768554688,
        539.5845947265625,
        230.70230102539062
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참고)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        122.9333724975586,
        236.09640502929688,
        144.3143768310547,
        245.08657836914062
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분 피크 순도(PDA) > 0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        122.9333724975586,
        250.4806671142578,
        254.1033172607422,
        259.4708251953125
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "직선성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        267.8616638183594,
        181.2412567138672,
        284.0439758300781
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05-2.5%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        267.8616638183594,
        181.2412567138672,
        284.0439758300781
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "r2=0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        142.72264099121094,
        281.0684814453125,
        174.46617126464844,
        291.2361145019531
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05-1.0%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        207.2476806640625,
        267.8616638183594,
        252.6025848388672,
        276.8518371582031
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "r2=0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        213.9640350341797,
        281.0684814453125,
        245.7084503173828,
        291.2361145019531
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05-1.0%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        275.7305603027344,
        267.8616638183594,
        321.0854797363281,
        276.8518371582031
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "r2=0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        282.5668640136719,
        281.0684814453125,
        314.19134521484375,
        291.2361145019531
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05-1.0%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        344.21343994140625,
        267.8616638183594,
        389.568359375,
        276.8518371582031
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "r2=0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        351.04974365234375,
        281.0684814453125,
        382.6742248535156,
        291.2361145019531
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05-1.0%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        412.6963195800781,
        267.8616638183594,
        458.0512390136719,
        276.8518371582031
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "r2=0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        419.5326232910156,
        281.0684814453125,
        451.2767639160156,
        291.2361145019531
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05-1.0%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        481.17919921875,
        267.8616638183594,
        526.5341796875,
        276.8518371582031
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "r2=0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        488.0155029296875,
        281.0684814453125,
        519.6399536132812,
        291.2361145019531
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정밀성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        306.93896484375,
        527.9730834960938,
        315.92913818359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 6.7 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        306.93896484375,
        527.9730834960938,
        315.92913818359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 4.5 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        306.93896484375,
        527.9730834960938,
        315.92913818359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 6.8 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        306.93896484375,
        527.9730834960938,
        315.92913818359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 5.2 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        306.93896484375,
        527.9730834960938,
        315.92913818359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 3.2 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        306.93896484375,
        527.9730834960938,
        315.92913818359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 4.5 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        306.93896484375,
        527.9730834960938,
        315.92913818359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실험실내",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.83618927001953,
        331.6319885253906,
        119.8121337890625,
        340.6221618652344
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정밀성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        338.8241271972656,
        527.9730834960938,
        355.0064392089844
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 8.2 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        338.8241271972656,
        527.9730834960938,
        355.0064392089844
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 9.2 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        338.8241271972656,
        527.9730834960938,
        355.0064392089844
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 10.4 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        338.8241271972656,
        527.9730834960938,
        355.0064392089844
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 9.6 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        338.8241271972656,
        527.9730834960938,
        355.0064392089844
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 8.2 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        338.8241271972656,
        527.9730834960938,
        355.0064392089844
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 9.8 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        338.8241271972656,
        527.9730834960938,
        355.0064392089844
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정확성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        363.39727783203125,
        526.174072265625,
        372.387451171875
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "95-104 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        363.39727783203125,
        526.174072265625,
        372.387451171875
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "80-97 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        363.39727783203125,
        526.174072265625,
        372.387451171875
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "88-105 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        363.39727783203125,
        526.174072265625,
        372.387451171875
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "92-112 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        363.39727783203125,
        526.174072265625,
        372.387451171875
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "80-101 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        363.39727783203125,
        526.174072265625,
        372.387451171875
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "82-115 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        363.39727783203125,
        526.174072265625,
        372.387451171875
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정량한계",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.83618927001953,
        388.09027099609375,
        519.3377685546875,
        397.0804443359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.83618927001953,
        388.09027099609375,
        519.3377685546875,
        397.0804443359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.83618927001953,
        388.09027099609375,
        519.3377685546875,
        397.0804443359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.83618927001953,
        388.09027099609375,
        519.3377685546875,
        397.0804443359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.83618927001953,
        388.09027099609375,
        519.3377685546875,
        397.0804443359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.83618927001953,
        388.09027099609375,
        519.3377685546875,
        397.0804443359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.83618927001953,
        388.09027099609375,
        519.3377685546875,
        397.0804443359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검출한계",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.83618927001953,
        419.9754333496094,
        519.3377685546875,
        428.9656066894531
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.02 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.83618927001953,
        419.9754333496094,
        519.3377685546875,
        428.9656066894531
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.02 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.83618927001953,
        419.9754333496094,
        519.3377685546875,
        428.9656066894531
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.02 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.83618927001953,
        419.9754333496094,
        519.3377685546875,
        428.9656066894531
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.02 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.83618927001953,
        419.9754333496094,
        519.3377685546875,
        428.9656066894531
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.02 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.83618927001953,
        419.9754333496094,
        519.3377685546875,
        428.9656066894531
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.02 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.83618927001953,
        419.9754333496094,
        519.3377685546875,
        428.9656066894531
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 25 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "응계수(RRF)를 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.40022277832031,
        99.01507568359375,
        200.15512084960938,
        110.04302215576172
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 분해생성물의 기준은 다음과 같이 설정할 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        138.5718536376953,
        329.08526611328125,
        149.59979248046875
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 공정서 규격(기타 유연물질의 설정 근거는 공정서 규격에 근거할 수 없다.)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        158.35023498535156,
        463.3906555175781,
        169.378173828125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 「의약품의 품목허가·신고·심사 규정」(식약처고시)에 따라 아래와 같이 기준을 설정한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        178.1286163330078,
        536.8126831054688,
        189.15655517578125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 보고수준(RT; reporting threshold), 구조규명 수준(IT; identification threshold), 안전성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        197.90699768066406,
        538.268310546875,
        208.9349365234375
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "입증 수준(QT; qualification threshold)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        85.63359069824219,
        217.68539428710938,
        285.2864685058594,
        228.7133331298828
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 기타 유연물질은 구조규명 수준과 동등 또는 그 이하로 설정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        237.46377563476562,
        396.7010803222656,
        248.49171447753906
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 특정 유연물질은 안전성입증 수준과 동등 또는 그 이하로 설정하거나 입증",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        257.2421569824219,
        464.5079345703125,
        268.2701110839844
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 불순물의 안전성은 아래와 같이 입증한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        296.7989196777344,
        290.58612060546875,
        307.8268737792969
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 독성시험자료: 반복투여독성시험자료, 유전독성시험자료(복귀돌연변이시험, 체외염색체이상",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        316.5773010253906,
        538.2701416015625,
        327.6052551269531
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험), 기타 필요한 독성시험자료",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        88.51203155517578,
        336.355712890625,
        251.864990234375,
        347.3836669921875
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 주요 대사산물 여부",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        356.13409423828125,
        188.17800903320312,
        367.16204833984375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 공정서 또는 기타 과학적 문헌",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        375.9124755859375,
        243.10824584960938,
        386.9404296875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4) 기허가 완제의약품에서 확인된 유연물질 수준(일반적으로 사용기간 만료 시점 또는 만료",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        395.69085693359375,
        541.8220825195312,
        406.71881103515625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시점 부근의 대조약 뱃치 분석결과 참조)인지 여부",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        89.47151184082031,
        415.46923828125,
        343.85333251953125,
        426.4971923828125
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 완제의약품의 가혹시험 결과 및 분석 방법을 피크 순도를 포함하여 요약, 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        455.0260009765625,
        497.11419677734375,
        466.053955078125
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가혹 조건",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        94.62871551513672,
        497.8902893066406,
        135.166748046875,
        506.8804626464844
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함량시험 방법",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        217.8019561767578,
        481.94769287109375,
        462.4693603515625,
        490.9378662109375
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "순도시험 방법",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        217.8019561767578,
        481.94769287109375,
        462.4693603515625,
        490.9378662109375
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "% 함량",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        169.8279571533203,
        499.3287048339844,
        275.127685546875,
        515.5110473632812
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "peak purity",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        169.8279571533203,
        499.3287048339844,
        275.127685546875,
        515.5110473632812
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "threshold",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        226.79708862304688,
        513.7130126953125,
        267.24072265625,
        522.7031860351562
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "peak purity",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        284.0060729980469,
        499.3287048339844,
        337.1340637207031,
        508.3188781738281
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "angle",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        297.5587463378906,
        513.7130126953125,
        320.61212158203125,
        522.7031860351562
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "확인된",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        357.64617919921875,
        499.3287048339844,
        384.63153076171875,
        508.3188781738281
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분해생성물",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        348.6510314941406,
        513.7130126953125,
        393.62664794921875,
        522.7031860351562
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "peak purity",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        408.1387939453125,
        499.3287048339844,
        461.2676696777344,
        508.3188781738281
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "threshold",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        413.0561218261719,
        513.7130126953125,
        453.4989013671875,
        522.7031860351562
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "peak purity",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        470.26513671875,
        499.3287048339844,
        523.3929443359375,
        508.3188781738281
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "angle",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        483.8177795410156,
        513.7130126953125,
        506.87030029296875,
        522.7031860351562
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미처리",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        101.3450698852539,
        531.2138671875,
        128.3304443359375,
        540.2040405273438
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조건 1 (고온)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        86.35319519042969,
        548.7147216796875,
        143.47482299804688,
        557.7048950195312
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "..",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        112.2591552734375,
        566.0957641601562,
        117.52393341064453,
        575.0859375
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 가혹시험은 주성분이 10 ~ 30 % 분해되는 것을 목표로 한다. 매우 안정한 주성분의 경우,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        590.9574584960938,
        541.822998046875,
        601.9854125976562
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "강제 분해시험(가혹 조건에서 실시) 결과 요약 및 타당성입증자료를 제출한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.59957122802734,
        610.73583984375,
        462.21307373046875,
        621.7637939453125
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 용출시험은 다음과 같은 양식으로 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        650.2926025390625,
        296.10308837890625,
        661.320556640625
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 26 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 32,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험조건",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        106.6222152709961,
        106.08734130859375,
        296.83880615234375,
        117.11529541015625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설정값",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        106.6222152709961,
        106.08734130859375,
        296.83880615234375,
        117.11529541015625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험액",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        112.13922119140625,
        125.50611877441406,
        145.12100219726562,
        136.5340576171875
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험액의 양",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        98.34669494628906,
        145.04476928710938,
        158.7939453125,
        156.0727081298828
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험액의 온도",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        92.8296890258789,
        164.4635467529297,
        164.31060791015625,
        175.49148559570312
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "장치",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        117.53630065917969,
        183.88232421875,
        139.60433959960938,
        194.91026306152344
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "회전수",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        112.13922119140625,
        203.4209747314453,
        145.12100219726562,
        214.44891357421875
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        117.53630065917969,
        222.83975219726562,
        139.60433959960938,
        233.86769104003906
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 공정서에 수재된 시험방법이 아닌 경우, 용출시험 분석 방법을 상세 기술하고, 용출규격설정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        249.69039916992188,
        541.8214111328125,
        260.7183532714844
      ],
      "page_num": 32,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "근거자료를 제출하며, 밸리데이션 요약 자료를 제출한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        269.46881103515625,
        357.98956298828125,
        280.49676513671875
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예 시",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        314.6753234863281,
        120.85090637207031,
        330.48211669921875
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 속방성 제제의 기준 및 시험방법 기재",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        341.03057861328125,
        265.17626953125,
        352.05853271484375
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 본 제품은 USP 의약품각조를 참고하여 작성한 자사 기준에 따른다. USP 의약품각조에서",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        680.1400146484375,
        541.8220825195312,
        691.16796875
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용하는 용출 용매와 다르게 사용한 경우 이를 작성한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.841064453125,
        699.9183959960938,
        366.26507568359375,
        710.9463500976562
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 개발단계에서 완제의약품이 수분에 민감성을 보이지 않았고, 건조 공정의 종료 시점 결정을",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        724.6113891601562,
        541.8224487304688,
        735.6393432617188
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위해 건조감량을 측정하므로 기준 및 시험방법에는 수분 시험은 포함하지 않는다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.00151824951172,
        744.3897705078125,
        486.32000732421875,
        755.417724609375
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험항목",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        71.24138641357422,
        376.2232360839844,
        398.3041076660156,
        385.2134094238281
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허용 기준",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        71.24138641357422,
        376.2232360839844,
        398.3041076660156,
        385.2134094238281
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험 방법",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        71.24138641357422,
        376.2232360839844,
        398.3041076660156,
        385.2134094238281
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "뱃치 결과",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        444.2392272949219,
        366.51385498046875,
        487.65277099609375,
        375.5040283203125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(제조번호 9A)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        434.8843078613281,
        385.9326477050781,
        494.0445251464844,
        394.9228210449219
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성상",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        403.4335021972656,
        338.9363098144531,
        419.6158142089844
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인되",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        403.4335021972656,
        338.9363098144531,
        419.6158142089844
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "어 있는 청색의 직사각형 정제",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        125.45201110839844,
        410.6256408691406,
        435.1241760253906,
        426.8079528808594
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "육안 검사",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        125.45201110839844,
        410.6256408691406,
        435.1241760253906,
        426.8079528808594
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        125.45201110839844,
        410.6256408691406,
        435.1241760253906,
        426.8079528808594
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "확인시험",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        71.24138641357422,
        437.7160339355469,
        110.21733093261719,
        446.7062072753906
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(HPLC)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        73.40022277832031,
        452.1003112792969,
        104.97537994384766,
        461.0904846191406
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함량시험법에 따라 시험할 때 표준품과 동일한 유",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        125.45201110839844,
        437.7160339355469,
        338.8163757324219,
        446.7062072753906
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지시간을 나타낸다.",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        125.45201110839844,
        444.9081726074219,
        435.1241760253906,
        461.0904846191406
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        125.45201110839844,
        444.9081726074219,
        435.1241760253906,
        461.0904846191406
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        125.45201110839844,
        444.9081726074219,
        435.1241760253906,
        461.0904846191406
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함량시험",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        71.24138641357422,
        472.1184387207031,
        443.538818359375,
        481.1086120605469
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표시량의 90.0 ~ 110.0%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        71.24138641357422,
        472.1184387207031,
        443.538818359375,
        481.1086120605469
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        71.24138641357422,
        472.1184387207031,
        443.538818359375,
        481.1086120605469
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "98.8%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        71.24138641357422,
        472.1184387207031,
        443.538818359375,
        481.1086120605469
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함량균일성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        66.6838607788086,
        501.7261047363281,
        114.6549301147461,
        510.7162780761719
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        508.918212890625,
        367.60943603515625,
        525.1005249023438
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP<905>에 따라 시험할 때 적합",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        508.918212890625,
        367.60943603515625,
        525.1005249023438
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        508.918212890625,
        367.60943603515625,
        525.1005249023438
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평균: 99.1%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        417.1339111328125,
        489.49945068359375,
        469.0849914550781,
        498.4896240234375
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD: 0.8%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        417.1339111328125,
        508.918212890625,
        463.9277648925781,
        517.9083862304688
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "범위: 98.2-100.1%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        417.1339111328125,
        528.3370361328125,
        498.7095031738281,
        537.3272094726562
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "순도시험",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        71.24138641357422,
        574.84619140625,
        107.22188568115234,
        583.8363647460938
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC2: 0.5% 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        125.45201110839844,
        545.718017578125,
        194.17477416992188,
        554.7081909179688
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC3: 0.5% 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        125.45201110839844,
        565.1367797851562,
        194.17477416992188,
        574.126953125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개개유연물질: 각각 0.2% 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        125.45201110839844,
        584.5555419921875,
        252.94290161132812,
        593.5457153320312
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총유연물질: 1.5%이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        125.45201110839844,
        603.8544921875,
        216.96240234375,
        612.8446655273438
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Method #41",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        349.1307678222656,
        574.84619140625,
        401.9831848144531,
        583.8363647460938
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.2%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        417.1339111328125,
        545.718017578125,
        438.2613830566406,
        554.7081909179688
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.2%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        417.1339111328125,
        565.1367797851562,
        438.2613830566406,
        574.126953125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        417.1339111328125,
        584.5555419921875,
        438.2613830566406,
        593.5457153320312
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.65%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        417.1339111328125,
        603.8544921875,
        443.538818359375,
        612.8446655273438
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용출시험",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        71.24138641357422,
        631.0647583007812,
        399.2953186035156,
        640.054931640625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표시량의 80% (Q) 이상 / 30 분, USP<711>",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        71.24138641357422,
        631.0647583007812,
        399.2953186035156,
        640.054931640625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP(HPLC)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        71.24138641357422,
        631.0647583007812,
        399.2953186035156,
        640.054931640625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평균: 88%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        417.1339111328125,
        621.3553466796875,
        461.04962158203125,
        630.3455200195312
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "범위: 85-90%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        417.1339111328125,
        640.7741088867188,
        477.3613586425781,
        649.7642822265625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 27 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 33,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 기준 및 시험방법 설정 요약",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        99.01507568359375,
        221.399658203125,
        110.04302215576172
      ],
      "page_num": 33,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 성상: 정제의 색상, 형태, 일반적 외형에 대해 육안 시험한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        118.79345703125,
        384.3479919433594,
        129.82139587402344
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 확인시험: USP 의약품각조의 함량시험법에 따라 시험한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        138.5718536376953,
        373.1943664550781,
        149.59979248046875
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 함량시험: USP 의약품각조에 따라 기준은 90.0 - 110.0%로 설정하고, 의약품각조의 시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        158.35023498535156,
        538.2682495117188,
        169.378173828125
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "법을 사용하였다. 위약에 의한 간섭효과는 없었다. 시험검체와 위약, 대조약의 크로마토그램은",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.36132049560547,
        178.1286163330078,
        541.944580078125,
        189.15655517578125
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다. 가혹시험은 유연물질 항 다음에 기재",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.36132049560547,
        197.90699768066406,
        538.2686767578125,
        208.9349365234375
      ],
      "page_num": 33,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되어 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.36132049560547,
        217.68539428710938,
        123.03691101074219,
        228.7133331298828
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 함량균일성 시험: USP 일반시험법 <905> 함량균일성시험의 허용기준을 적용하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        237.46377563476562,
        501.7916259765625,
        248.49171447753906
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 순도(분해산물): 주성분에서 2개의 주요 분해산물이 확인되었다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        257.2421569824219,
        394.80963134765625,
        268.2701110839844
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유연물질명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        287.6888732910156,
        417.0140075683594,
        298.7168273925781
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화학명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        287.6888732910156,
        417.0140075683594,
        298.7168273925781
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화학 구조",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        287.6888732910156,
        417.0140075683594,
        298.7168273925781
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설정 기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        287.6888732910156,
        417.0140075683594,
        298.7168273925781
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC2",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        307.107666015625,
        420.73199462890625,
        318.1356201171875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[화학명]",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        307.107666015625,
        420.73199462890625,
        318.1356201171875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[화학구조]",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        307.107666015625,
        420.73199462890625,
        318.1356201171875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.5% 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        307.107666015625,
        420.73199462890625,
        318.1356201171875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC3",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        326.52642822265625,
        420.73199462890625,
        337.55438232421875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[화학명]",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        326.52642822265625,
        420.73199462890625,
        337.55438232421875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[화학구조]",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        326.52642822265625,
        420.73199462890625,
        337.55438232421875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.5% 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        326.52642822265625,
        420.73199462890625,
        337.55438232421875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 품목에 대한 USP 의약품각조의 기준은 다음과 같다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        351.93865966796875,
        357.03009033203125,
        362.96661376953125
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유연물질명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        391.2557067871094,
        285.3250427246094,
        402.2836608886719
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설정 기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        391.2557067871094,
        285.3250427246094,
        402.2836608886719
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "판정기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        391.2557067871094,
        285.3250427246094,
        402.2836608886719
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험 결과",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        381.0334777832031,
        382.3854064941406,
        430.566650390625,
        393.4133605957031
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(제조번호 #9A)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        381.0334777832031,
        400.0061340332031,
        460.39178466796875,
        411.0340881347656
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC2",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        419.4249267578125,
        410.4943542480469,
        430.452880859375
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.5% 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        419.4249267578125,
        410.4943542480469,
        430.452880859375
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP 기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        419.4249267578125,
        410.4943542480469,
        430.452880859375
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.2%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        419.4249267578125,
        410.4943542480469,
        430.452880859375
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC3",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        438.96356201171875,
        406.7843322753906,
        449.99151611328125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.5% 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        438.96356201171875,
        406.7843322753906,
        449.99151611328125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP 기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        438.96356201171875,
        406.7843322753906,
        449.99151611328125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.2%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        438.96356201171875,
        406.7843322753906,
        449.99151611328125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미지 유연물질",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        458.3823547363281,
        406.7843322753906,
        469.4103088378906
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.2% 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        458.3823547363281,
        406.7843322753906,
        469.4103088378906
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ICH Q3B 구조규명 수준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        458.3823547363281,
        406.7843322753906,
        469.4103088378906
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        458.3823547363281,
        406.7843322753906,
        469.4103088378906
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 유연물질",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        477.8011169433594,
        413.3804626464844,
        488.8290710449219
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.5% 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        477.8011169433594,
        413.3804626464844,
        488.8290710449219
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP 기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        477.8011169433594,
        413.3804626464844,
        488.8290710449219
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.65%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        477.8011169433594,
        413.3804626464844,
        488.8290710449219
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 시험방법은, 공정 불순물 검출이 가능한 자사 시험방법(#41)이며, 정확성, 정밀성,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        503.21337890625,
        541.8226318359375,
        514.2413330078125
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "직선성, 특이성 및 시스템적합성이 검증된 방법이다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        67.52340698242188,
        522.9917602539062,
        332.20355224609375,
        534.0197143554688
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질명",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.31917572021484,
        553.509521484375,
        445.19580078125,
        569.6918334960938
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허용기준",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.31917572021484,
        553.509521484375,
        445.19580078125,
        569.6918334960938
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "직선성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.31917572021484,
        553.509521484375,
        445.19580078125,
        569.6918334960938
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정밀성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.31917572021484,
        553.509521484375,
        445.19580078125,
        569.6918334960938
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정확성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.31917572021484,
        553.509521484375,
        445.19580078125,
        569.6918334960938
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검출한계",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        75.31917572021484,
        553.509521484375,
        445.19580078125,
        569.6918334960938
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(LOD)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        411.2571105957031,
        567.893798828125,
        437.0754089355469,
        576.8839721679688
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정량한계",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        469.3056640625,
        553.509521484375,
        508.2816162109375,
        562.4996948242188
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(LOQ)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        474.3429260253906,
        567.893798828125,
        500.1612243652344,
        576.8839721679688
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC2",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        88.87183380126953,
        594.9841918945312,
        182.54107666015625,
        603.974365234375
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.5% 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        88.87183380126953,
        594.9841918945312,
        182.54107666015625,
        603.974365234375
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "r2=0.996",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        203.76956176757812,
        584.2171630859375,
        240.91104125976562,
        594.3848266601562
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD=1.5%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        199.931640625,
        604.6935424804688,
        244.80711364746094,
        613.6837158203125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평균 0.13%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        265.17626953125,
        585.3946533203125,
        314.12896728515625,
        594.3848266601562
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 6.45%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        265.05633544921875,
        604.6935424804688,
        314.2489013671875,
        613.6837158203125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "92-110%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        338.3366394042969,
        585.3946533203125,
        378.4150085449219,
        594.3848266601562
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD=2.8%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        335.93792724609375,
        604.6935424804688,
        380.81341552734375,
        613.6837158203125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.025%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        408.378662109375,
        594.9841918945312,
        503.1465148925781,
        603.974365234375
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.075%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        408.378662109375,
        594.9841918945312,
        503.1465148925781,
        603.974365234375
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC3",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        88.87183380126953,
        631.90380859375,
        182.54107666015625,
        640.8939819335938
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.5% 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        88.87183380126953,
        631.90380859375,
        182.54107666015625,
        640.8939819335938
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "r2=0.996",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        203.76956176757812,
        621.0169677734375,
        240.91104125976562,
        631.1846313476562
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD=1.5%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        199.931640625,
        641.6132202148438,
        244.80711364746094,
        650.6033935546875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평균 0.14%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        265.17626953125,
        622.1944580078125,
        314.12896728515625,
        631.1846313476562
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 5.7%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        267.8148498535156,
        641.6132202148438,
        311.6100158691406,
        650.6033935546875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "91-110%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        338.3366394042969,
        622.1944580078125,
        378.4150085449219,
        631.1846313476562
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD=2.9%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        335.93792724609375,
        641.6132202148438,
        380.81341552734375,
        650.6033935546875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.035%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        408.378662109375,
        630.5142211914062,
        523.83251953125,
        641.5421752929688
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        408.378662109375,
        630.5142211914062,
        523.83251953125,
        641.5421752929688
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함량 시험방법과 유연물질 시험방법이 특이적이고 안정적임을 증명하기 위해 가혹시험을",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        684.6950073242188,
        541.8220825195312,
        695.7229614257812
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실시하였다. 산, 염기, 산화제, 열, 빛 조건에 노출시킨 후, HPLC(PDA, Peak purity analysi",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        67.52340698242188,
        704.473388671875,
        538.2208862304688,
        715.5013427734375
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "s)로 분석하였다. 분해산물 피크들은 관련 피크들에서 완전히 분리되었다. 주성분 피크의 피크",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        67.52340698242188,
        724.2517700195312,
        541.8228149414062,
        735.2797241210938
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "순도는 > 0.99로 관찰되었다. Peak purity angle은 peak purity threshold보다 작고, 간섭은",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        67.52340698242188,
        744.0301513671875,
        541.8232421875,
        755.05810546875
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 28 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 34,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "없었다. 주성분 피크나 유연물질 RC2와 RC3 피크에 대한 분해산물 피크의 간섭은 없었다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        67.52340698242188,
        99.01507568359375,
        541.8226318359375,
        110.04302215576172
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자세한 내용은 3.2.P.5.3 시험방법 밸리데이션을 참고한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        67.52340698242188,
        118.79345703125,
        364.2261962890625,
        129.82139587402344
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가혹 조건",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        122.09382629394531,
        149.31124877929688,
        484.8971862792969,
        158.30142211914062
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함량 시험",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        122.09382629394531,
        149.31124877929688,
        484.8971862792969,
        158.30142211914062
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 시험",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        122.09382629394531,
        149.31124877929688,
        484.8971862792969,
        158.30142211914062
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "% 함량",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        242.98831176757812,
        166.69224548339844,
        515.7205200195312,
        175.6824188232422
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피크순도",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        242.98831176757812,
        166.69224548339844,
        515.7205200195312,
        175.6824188232422
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관찰된 분해산물",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        242.98831176757812,
        166.69224548339844,
        515.7205200195312,
        175.6824188232422
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피크 순도",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        242.98831176757812,
        166.69224548339844,
        515.7205200195312,
        175.6824188232422
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미처리",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        184.19313049316406,
        507.6462097167969,
        193.1833038330078
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "99%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        184.19313049316406,
        507.6462097167969,
        193.1833038330078
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        184.19313049316406,
        507.6462097167969,
        193.1833038330078
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NA",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        184.19313049316406,
        507.6462097167969,
        193.1833038330078
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        184.19313049316406,
        507.6462097167969,
        193.1833038330078
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1 N HCl, 70 ℃, 14 시간",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        201.69400024414062,
        507.6462097167969,
        210.68417358398438
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "97%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        201.69400024414062,
        507.6462097167969,
        210.68417358398438
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        201.69400024414062,
        507.6462097167969,
        210.68417358398438
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC2: 2%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        201.69400024414062,
        507.6462097167969,
        210.68417358398438
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        201.69400024414062,
        507.6462097167969,
        210.68417358398438
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1 N NaOH, 70 ℃, 30 분",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        219.0749969482422,
        507.6462097167969,
        228.06517028808594
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "98%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        219.0749969482422,
        507.6462097167969,
        228.06517028808594
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        219.0749969482422,
        507.6462097167969,
        228.06517028808594
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC2: 1%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        219.0749969482422,
        507.6462097167969,
        228.06517028808594
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        219.0749969482422,
        507.6462097167969,
        228.06517028808594
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3% H2O2, 60 ℃, 2 시간",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        246.28526306152344,
        348.372802734375,
        255.89596557617188
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "97%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        246.28526306152344,
        348.372802734375,
        255.89596557617188
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        246.28526306152344,
        348.372802734375,
        255.89596557617188
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC2: 1%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        396.7449645996094,
        236.5758819580078,
        435.0234375,
        245.56605529785156
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC3: 1%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        396.7449645996094,
        255.99464416503906,
        435.0234375,
        264.98480224609375
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        483.2181091308594,
        246.28526306152344,
        507.6462097167969,
        255.2754364013672
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정제수, 60 ℃, 13 시간",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        273.3756408691406,
        507.6462097167969,
        282.3658142089844
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "99%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        273.3756408691406,
        507.6462097167969,
        282.3658142089844
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        273.3756408691406,
        507.6462097167969,
        282.3658142089844
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NA",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        273.3756408691406,
        507.6462097167969,
        282.3658142089844
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        273.3756408691406,
        507.6462097167969,
        282.3658142089844
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "습도(90% RH), 25 ℃, 7 일",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        290.87652587890625,
        507.6462097167969,
        299.86669921875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "99%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        290.87652587890625,
        507.6462097167969,
        299.86669921875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        290.87652587890625,
        507.6462097167969,
        299.86669921875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NA",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        290.87652587890625,
        507.6462097167969,
        299.86669921875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        290.87652587890625,
        507.6462097167969,
        299.86669921875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "광안정성 408 일",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        317.9669189453125,
        348.372802734375,
        326.95709228515625
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "55%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        317.9669189453125,
        348.372802734375,
        326.95709228515625
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        317.9669189453125,
        348.372802734375,
        326.95709228515625
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC2: 25%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        393.9864807128906,
        308.37738037109375,
        437.66229248046875,
        317.3675537109375
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC3: 20%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        393.9864807128906,
        327.6763000488281,
        437.66229248046875,
        336.6664733886719
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        483.2181091308594,
        317.9669189453125,
        507.6462097167969,
        326.95709228515625
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "UV (단파장/ 장파장), 7 일",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        354.8865661621094,
        348.372802734375,
        363.8767395019531
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "27%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        354.8865661621094,
        348.372802734375,
        363.8767395019531
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        354.8865661621094,
        348.372802734375,
        363.8767395019531
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC2: 35%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        393.9864807128906,
        345.17718505859375,
        437.66229248046875,
        354.1673583984375
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC3: 30%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        393.9864807128906,
        364.595947265625,
        437.66229248046875,
        373.58612060546875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        483.2181091308594,
        354.8865661621094,
        507.6462097167969,
        363.8767395019531
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "건열, 105 ℃, 14 시간",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        381.9769592285156,
        507.6462097167969,
        390.9671325683594
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "97%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        381.9769592285156,
        507.6462097167969,
        390.9671325683594
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        381.9769592285156,
        507.6462097167969,
        390.9671325683594
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NA",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        381.9769592285156,
        507.6462097167969,
        390.9671325683594
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        70.16197204589844,
        381.9769592285156,
        507.6462097167969,
        390.9671325683594
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 용출: 용출시험법은 USP 의약품각조의 시험방법을 따랐으며, 시험 조건과 기준은 다음과",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        430.09326171875,
        541.9423828125,
        441.1212158203125
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "같다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        72.20086669921875,
        449.87164306640625,
        97.49075317382812,
        460.89959716796875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용출시험 조건",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        114.53792572021484,
        480.318359375,
        296.359375,
        491.3463134765625
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "값",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        114.53792572021484,
        480.318359375,
        296.359375,
        491.3463134765625
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용출액",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        133.72752380371094,
        499.8570251464844,
        328.3817138671875,
        510.8849792480469
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "pH 4.5 완충액",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        133.72752380371094,
        499.8570251464844,
        328.3817138671875,
        510.8849792480469
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용량",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        139.24453735351562,
        519.2758178710938,
        311.56256103515625,
        530.3037719726562
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "900 mL",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        139.24453735351562,
        519.2758178710938,
        311.56256103515625,
        530.3037719726562
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "온도",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        139.24453735351562,
        538.694580078125,
        305.7143249511719,
        549.7225341796875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "37 ℃",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        139.24453735351562,
        538.694580078125,
        305.7143249511719,
        549.7225341796875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험법",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        133.72752380371094,
        558.2332153320312,
        323.06646728515625,
        569.2611694335938
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2 법(패들법)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        133.72752380371094,
        558.2332153320312,
        323.06646728515625,
        569.2611694335938
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "회전 속도",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        125.45201110839844,
        577.6519775390625,
        310.3686828613281,
        588.679931640625
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "50 rpm",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        125.45201110839844,
        577.6519775390625,
        310.3686828613281,
        588.679931640625
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        139.24453735351562,
        597.07080078125,
        346.3722839355469,
        608.0987548828125
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "80% (Q) 이상 / 30분",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        139.24453735351562,
        597.07080078125,
        346.3722839355469,
        608.0987548828125
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 서방성 제제의 기준 및 시험방법 기재",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        642.2614135742188,
        270.5730285644531,
        653.2893676757812
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험항목",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        68.36294555664062,
        677.4540405273438,
        397.8243713378906,
        686.4442138671875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허용 기준",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        68.36294555664062,
        677.4540405273438,
        397.8243713378906,
        686.4442138671875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험 방법",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        68.36294555664062,
        677.4540405273438,
        397.8243713378906,
        686.4442138671875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험 결과",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        473.5033874511719,
        667.74462890625,
        516.9168701171875,
        676.7348022460938
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(제조번호 P034)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        459.1111755371094,
        687.1634521484375,
        528.34619140625,
        696.1536254882812
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성상",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        719.048583984375,
        81.07605743408203,
        728.0387573242188
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상부 불투명한 청녹색과 하부 불투명한 노",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        704.664306640625,
        300.3172302246094,
        713.6544799804688
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "란색의 경질 1호 캡슐. 상‧하부 각각 흰색으로",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        719.048583984375,
        303.3132629394531,
        728.0387573242188
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "“MK”와 “32”가 각인되어 있다.",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        733.432861328125,
        244.89520263671875,
        742.4230346679688
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "육안 검사",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        310.51171875,
        719.048583984375,
        472.9036865234375,
        728.0387573242188
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        310.51171875,
        719.048583984375,
        472.9036865234375,
        728.0387573242188
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 29 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 35,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 기준 및 시험방법 설정 요약",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        453.82733154296875,
        216.0029296875,
        464.85528564453125
      ],
      "page_num": 35,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 성상: 캡슐의 낱알표시, 색상과 형태에 대해 육안으로 검사한다. 이 때 캡슐 표면의 색상",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        473.605712890625,
        541.82275390625,
        484.6336669921875
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불균일, 연질화, 뜯김이나 깨짐 등에 대해서도 관찰한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.841064453125,
        493.38409423828125,
        359.18890380859375,
        504.41204833984375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 확인시험: 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        513.1624755859375,
        477.80462646484375,
        524.1904296875
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HPLC: 주성분 피크의 유지시간은 표준품과 같다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        532.9408569335938,
        324.64764404296875,
        543.9688110351562
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "UV: 표준품과 같은 파장에서 흡수극대를 나타낸다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        552.71923828125,
        332.92315673828125,
        563.7471923828125
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 함량시험: 함량 기준은 95.0 - 105.0%이며, 분석 조건은 다음 표와 같다. 이 시험과 관련",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        572.4976196289062,
        538.2682495117188,
        583.5255737304688
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다. 대조약의 함량",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.48126220703125,
        592.2760009765625,
        538.2682495117188,
        603.303955078125
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "균일성과 용출 시험에서도 HPLC 법이 사용되었다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.48126220703125,
        612.0543823242188,
        330.404541015625,
        623.0823364257812
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "캡슐 내부에는 흰색 또는 미황색의 구형의",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        101.84310913085938,
        303.31268310546875,
        110.83329010009766
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "펠렛이 충진되어 있다.",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        116.2273941040039,
        212.392822265625,
        125.21757507324219
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "확인시험",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        153.9861297607422,
        99.0663070678711,
        162.97630310058594
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. HPLC: 크로마토그램의 주피크의 유지시",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        130.85142517089844,
        300.3172302246094,
        139.8415985107422
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "간은 표준품의 피크와 같다.",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        138.04356384277344,
        472.9036865234375,
        154.2258758544922
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사 시험방법 #125b (HPLC)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        138.04356384277344,
        472.9036865234375,
        154.2258758544922
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        138.04356384277344,
        472.9036865234375,
        154.2258758544922
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. UV: 표준품과 같은 파장에서 흡수극대",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        162.736572265625,
        300.3172302246094,
        171.72674560546875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "를 나타낸다.",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        177.120849609375,
        171.9747314453125,
        186.11102294921875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사 시험방법 #125b (HPLC,",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        310.51171875,
        162.736572265625,
        447.7144470214844,
        171.72674560546875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PDA 검출기)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        310.51171875,
        169.9287109375,
        472.9036865234375,
        186.11102294921875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        310.51171875,
        169.9287109375,
        472.9036865234375,
        186.11102294921875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용출시험",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        233.33941650390625,
        99.0663070678711,
        242.32958984375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시간",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        194.62171936035156,
        137.80532836914062,
        203.6118927001953
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "30 분",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        213.92063903808594,
        144.04193115234375,
        222.9108123779297
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4 시간",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        233.33941650390625,
        147.63998413085938,
        242.32958984375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8 시간",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        252.75819396972656,
        147.63998413085938,
        261.74835205078125
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12 시간",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        272.0570983886719,
        153.03704833984375,
        281.0472717285156
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용출율 %",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        209.0467071533203,
        194.62171936035156,
        251.1406707763672,
        203.6118927001953
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25-35%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        209.0467071533203,
        213.92063903808594,
        243.84765625,
        222.9108123779297
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "40-60%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        209.0467071533203,
        233.33941650390625,
        243.84765625,
        242.32958984375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "65-85%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        209.0467071533203,
        252.75819396972656,
        243.84765625,
        261.74835205078125
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "85% 이상",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        209.0467071533203,
        272.0570983886719,
        249.94454956054688,
        281.0472717285156
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용출시험조건: 900 mL, 0.05 M",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        310.51171875,
        209.24574279785156,
        447.7141418457031,
        218.2359161376953
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인산염완충액(pH 6.8), 37 ℃",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        310.51171875,
        223.63002014160156,
        432.485595703125,
        232.6201934814453
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용출시험법 제1법(회전검체통법),",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        310.51171875,
        243.04879760742188,
        447.7138366699219,
        252.03897094726562
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "100 rpm",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        310.51171875,
        257.4330749511719,
        347.14349365234375,
        266.4232482910156
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "30 분: 27-31%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        454.9134521484375,
        204.33111572265625,
        521.3764038085938,
        213.3212890625
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4 시간: 48-53%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        454.9134521484375,
        223.63002014160156,
        524.9752807617188,
        232.6201934814453
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8 시간: 73-78%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        454.9134521484375,
        243.04879760742188,
        524.9752807617188,
        252.03897094726562
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12 시간: 90-94%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        454.9134521484375,
        262.4675598144531,
        530.3715209960938,
        271.4577331542969
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함량균일성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        289.5579528808594,
        112.61573028564453,
        298.5481262207031
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        289.5579528808594,
        511.0625305175781,
        312.9324035644531
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP<905>",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        289.5579528808594,
        511.0625305175781,
        312.9324035644531
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사 시험방법 #125c (HPLC)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        289.5579528808594,
        511.0625305175781,
        312.9324035644531
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "99.1-101.3%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        289.5579528808594,
        511.0625305175781,
        312.9324035644531
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD = 0.8%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        454.9134521484375,
        303.9422302246094,
        508.9031066894531,
        312.9324035644531
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함량",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        321.443115234375,
        486.7154235839844,
        330.43328857421875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "95.0-105.0%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        321.443115234375,
        486.7154235839844,
        330.43328857421875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사 시험방법 #125b (HPLC)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        321.443115234375,
        486.7154235839844,
        330.43328857421875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "101.2%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        321.443115234375,
        486.7154235839844,
        330.43328857421875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "순도시험",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        367.9523010253906,
        99.0663070678711,
        376.9424743652344
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "불순물 A: 1.5% 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        338.8241271972656,
        208.9267578125,
        347.8143005371094
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 E: 1.0% 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        358.2428894042969,
        217.32220458984375,
        367.2330627441406
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미지 유연물질: 0.2% 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        377.66168212890625,
        229.31570434570312,
        386.65185546875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 유연물질: 2.5% 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        119.8150634765625,
        396.9605712890625,
        220.32058715820312,
        405.95074462890625
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사 시험방법 #231b (HPLC)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        310.51171875,
        367.9523010253906,
        436.4754638671875,
        376.9424743652344
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.8%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        454.9134521484375,
        338.8241271972656,
        476.0409240722656,
        347.8143005371094
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.4%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        454.9134521484375,
        358.2428894042969,
        476.0409240722656,
        367.2330627441406
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.07%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        454.9134521484375,
        377.66168212890625,
        481.318359375,
        386.65185546875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.5%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        454.9134521484375,
        396.9605712890625,
        476.0409240722656,
        405.95074462890625
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수분",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        414.4614562988281,
        476.0409240722656,
        423.4516296386719
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.5% 이하",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        414.4614562988281,
        476.0409240722656,
        423.4516296386719
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "칼피셔법 (USP<921> 1a법)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        414.4614562988281,
        476.0409240722656,
        423.4516296386719
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.9%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        414.4614562988281,
        476.0409240722656,
        423.4516296386719
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이동상",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        654.439208984375,
        90.07118225097656,
        663.4293823242188
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아세토니트릴:완충액 = 30:70",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        145.9608917236328,
        637.5376586914062,
        268.8556213378906,
        646.52783203125
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "완충액: 물 1000 mL에 KH2PO4 6.8g을 녹이고 트리에틸아민으로 pH를 7.4 ± 0.05로",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        145.9608917236328,
        656.9564208984375,
        521.9541625976562,
        666.5671997070312
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조절한 액",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        145.9608917236328,
        671.3407592773438,
        186.37899780273438,
        680.3309326171875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "칼럼",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        688.7217407226562,
        304.56597900390625,
        698.3324584960938
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Symtrex C8, 5 ㎛, 150mm X 4.6mm",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        688.7217407226562,
        304.56597900390625,
        698.3324584960938
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유량",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        706.2225952148438,
        189.49728393554688,
        715.2127685546875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.5 mL/분",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        706.2225952148438,
        189.49728393554688,
        715.2127685546875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "온도",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        723.7235107421875,
        166.96188354492188,
        732.7136840820312
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "40°C",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        723.7235107421875,
        166.96188354492188,
        732.7136840820312
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검출기",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        740.744873046875,
        237.9467010498047,
        749.7350463867188
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "272 nm UV detector",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        740.744873046875,
        237.9467010498047,
        749.7350463867188
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 30 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 36,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HPLC 분석법에 대해 정확성, 정밀성, 특이성과 직선성을 평가하기 위한 밸리데이션을 실시",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        237.70350646972656,
        538.267822265625,
        248.7314453125
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하였다. 특이성과 안정성을 검증하기 위해 제품은 여러 가지 가혹 조건에서 PDA 검출기가",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        257.4819030761719,
        541.9422607421875,
        268.5098571777344
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "장착된 HPLC 기기로 분석이 진행되었다. 모든 분해산물 피크는 주성분 피크로부터 분리되",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        277.2602844238281,
        538.2674560546875,
        288.2882385253906
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "었고, 피크 순도는 > 0.99로 계산되어 주성분 피크가 완전히 분리됨을 확인하였다. 분석방법",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        297.0386657714844,
        541.8219604492188,
        308.0666198730469
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "밸리데이션과 가혹시험에 대해 아래에 요약되어 있다. 자세한 사항은 3.2.P.5.3 시험방법 밸",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        316.8170471191406,
        538.2682495117188,
        327.8450012207031
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "리데이션을 참고한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        336.5954284667969,
        166.5733184814453,
        347.6233825683594
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특이성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        382.0257873535156,
        101.58460998535156,
        393.0537414550781
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        167.90899658203125,
        362.0076599121094,
        478.3768005371094,
        373.0356140136719
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "간에 방해가 없음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        167.90899658203125,
        379.62841796875,
        255.82135009765625,
        390.6563720703125
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피크 순도(PDA)>0.99",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        167.90899658203125,
        402.1637878417969,
        278.70556640625,
        413.1917419433594
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "직선성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        420.183349609375,
        286.2618103027344,
        432.6105041503906
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10 - 150%, r2 = 0.99",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        420.183349609375,
        286.2618103027344,
        432.6105041503906
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정밀성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        441.1212158203125,
        227.96173095703125,
        452.149169921875
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 0.18%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        441.1212158203125,
        227.96173095703125,
        452.149169921875
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실험실내 정밀성*",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        460.53997802734375,
        221.3656005859375,
        471.56793212890625
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSD 0.5%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        460.53997802734375,
        221.3656005859375,
        471.56793212890625
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정확성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        479.9587707519531,
        411.4969787597656,
        490.9867248535156
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "98 - 101%, 표시량의 50%, 100%, 150% 포함",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        479.9587707519531,
        411.4969787597656,
        490.9867248535156
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 2명의 시험자가 서로 다른 기구로 시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        505.3709716796875,
        266.4955749511719,
        516.39892578125
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가혹 조건",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        178.46327209472656,
        550.5615844726562,
        467.5063171386719,
        561.5895385742188
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "% 함량",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        178.46327209472656,
        550.5615844726562,
        467.5063171386719,
        561.5895385742188
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피크 순도",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        178.46327209472656,
        550.5615844726562,
        467.5063171386719,
        561.5895385742188
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미처리",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        570.1002807617188,
        457.6493225097656,
        581.1282348632812
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "99%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        570.1002807617188,
        457.6493225097656,
        581.1282348632812
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        570.1002807617188,
        457.6493225097656,
        581.1282348632812
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1 N HCl, 70 ℃, 14 시간",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        589.51904296875,
        457.6493225097656,
        600.5469970703125
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "85%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        589.51904296875,
        457.6493225097656,
        600.5469970703125
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        589.51904296875,
        457.6493225097656,
        600.5469970703125
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1 N NaOH, 70 ℃, 30 분",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        608.9378051757812,
        457.6493225097656,
        619.9657592773438
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "30%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        608.9378051757812,
        457.6493225097656,
        619.9657592773438
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        608.9378051757812,
        457.6493225097656,
        619.9657592773438
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3% H2O2, 60 ℃, 2 시간",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        628.4764404296875,
        457.6493225097656,
        640.2628784179688
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        628.4764404296875,
        457.6493225097656,
        640.2628784179688
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        628.4764404296875,
        457.6493225097656,
        640.2628784179688
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "습도(90% RH), 25 ℃, 7 일",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        647.8952026367188,
        457.6493225097656,
        658.9231567382812
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "95%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        647.8952026367188,
        457.6493225097656,
        658.9231567382812
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        647.8952026367188,
        457.6493225097656,
        658.9231567382812
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "UV (단파장/ 장파장), 7일",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        667.3140258789062,
        457.6493225097656,
        678.3419799804688
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "98%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        667.3140258789062,
        457.6493225097656,
        678.3419799804688
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        667.3140258789062,
        457.6493225097656,
        678.3419799804688
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "건열, 105 ℃, 14 시간",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        686.8526611328125,
        457.6493225097656,
        697.880615234375
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "70%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        686.8526611328125,
        457.6493225097656,
        697.880615234375
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.78429412841797,
        686.8526611328125,
        457.6493225097656,
        697.880615234375
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 함량균일성 시험: USP 일반시험법 <905>에 따라 시험한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        732.0432739257812,
        375.380126953125,
        743.0712280273438
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주입량",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        104.719970703125,
        170.06784057617188,
        113.71015167236328
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20 ㎕",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        104.719970703125,
        170.06784057617188,
        113.71015167236328
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석 시간",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        122.2208480834961,
        170.06784057617188,
        131.21102905273438
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "15 분",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        122.2208480834961,
        170.06784057617188,
        131.21102905273438
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유지 시간",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        139.6018524169922,
        178.22341918945312,
        148.59202575683594
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약 8 분",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        139.6018524169922,
        178.22341918945312,
        148.59202575683594
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표준액 및 시험액",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        157.10272216796875,
        398.172119140625,
        166.0928955078125
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분 0.1 mg/mL을 포함하는 표준액과 시험액을 조제한다.",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        157.10272216796875,
        398.172119140625,
        166.0928955078125
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시스템 적합성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        181.79574584960938,
        518.958740234375,
        197.97805786132812
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분 피크로 계산한 칼럼 효율은 이론단수 5000 이상, 대칭계수는 2.0 이하이다. 표준",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        181.79574584960938,
        518.958740234375,
        197.97805786132812
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "액을 5 번 주입했을 때 피크면적의 상대표준편차는 1.0% 이하이다.",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        145.9608917236328,
        196.18002319335938,
        434.16180419921875,
        205.17019653320312
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 31 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 37,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 순도(분해산물): 주성분의 기지 분해산물에 대해 아래 표에 요약하였다. 유연물질 B, C, D,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        99.01507568359375,
        541.943359375,
        110.04302215576172
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "F (2.3.S.4 원료의약품 품질관리 참고)는 완제의약품에서는 관찰되지 않았으므로, 원료의약품",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.36132049560547,
        118.79345703125,
        538.2687377929688,
        129.82139587402344
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서 관리한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.36132049560547,
        138.5718536376953,
        143.9055938720703,
        149.59979248046875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "명칭",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.78916931152344,
        163.98406982421875,
        375.5164794921875,
        175.0120086669922
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화학구조",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.78916931152344,
        163.98406982421875,
        375.5164794921875,
        175.0120086669922
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기원",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.78916931152344,
        163.98406982421875,
        375.5164794921875,
        175.0120086669922
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 A",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        194.7904052734375,
        230.15525817871094,
        205.81834411621094
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[화학 구조]",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        194.7904052734375,
        230.15525817871094,
        205.81834411621094
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에스터기 가수분해 산물",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        264.216796875,
        183.40284729003906,
        385.2312316894531,
        194.4307861328125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분 활성 대사산물",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        264.216796875,
        206.05809020996094,
        374.1968688964844,
        217.08602905273438
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 E",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        225.47686767578125,
        374.1968688964844,
        236.5048065185547
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[화학 구조]",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        225.47686767578125,
        374.1968688964844,
        236.5048065185547
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "산화에 의한 분해산물",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        225.47686767578125,
        374.1968688964844,
        236.5048065185547
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "최종 제품의 분해산물 기준에 대한 근거는 다음 표에 제시하였다. 제시된 기준은 「의약품의",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        270.66748046875,
        541.82373046875,
        281.6954345703125
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품목허가‧신고‧심사 규정」(식약처고시)에 근거하여 설정하였다. 제조번호 P034 시험결과 유연",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        67.28353118896484,
        290.44586181640625,
        538.2686767578125,
        301.47381591796875
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질은 기준에 적합하였다. 추가적인 내용은 3.2.P.5.6 기준 설정근거를 참고한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        67.28353118896484,
        310.2242431640625,
        473.60693359375,
        321.252197265625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.59632110595703,
        344.5068054199219,
        233.70993041992188,
        364.2851867675781
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조번호 P034",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.59632110595703,
        344.5068054199219,
        233.70993041992188,
        364.2851867675781
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험 결과",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        167.18939208984375,
        362.0076599121094,
        216.7225341796875,
        373.0356140136719
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대조약",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        262.0579833984375,
        335.75634765625,
        298.71417236328125,
        346.7843017578125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(제조번호",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        254.50205993652344,
        353.3771057128906,
        306.3900146484375,
        364.4050598144531
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "#22242)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        256.660888671875,
        370.8779602050781,
        300.51837158203125,
        381.9059143066406
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        347.4516906738281,
        353.2572326660156,
        470.86480712890625,
        364.2851867675781
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "판정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        347.4516906738281,
        353.2572326660156,
        470.86480712890625,
        364.2851867675781
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 A",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.27703094482422,
        390.2967529296875,
        501.08843994140625,
        401.32470703125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.80%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.27703094482422,
        390.2967529296875,
        501.08843994140625,
        401.32470703125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.5%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.27703094482422,
        390.2967529296875,
        501.08843994140625,
        401.32470703125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.5% 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.27703094482422,
        390.2967529296875,
        501.08843994140625,
        401.32470703125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대사산물에 해당",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.27703094482422,
        390.2967529296875,
        501.08843994140625,
        401.32470703125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 E",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        409.71551513671875,
        514.7606811523438,
        420.74346923828125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.40%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        409.71551513671875,
        514.7606811523438,
        420.74346923828125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.0%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        409.71551513671875,
        514.7606811523438,
        420.74346923828125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.0% 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        409.71551513671875,
        514.7606811523438,
        420.74346923828125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대조약과 동등한 수준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        409.71551513671875,
        514.7606811523438,
        420.74346923828125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미지",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        97.02741241455078,
        429.2541809082031,
        122.76986694335938,
        440.2821350097656
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.11332702636719,
        436.6053771972656,
        509.0328369140625,
        457.7829895019531
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "≤0.07%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.11332702636719,
        436.6053771972656,
        509.0328369140625,
        457.7829895019531
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "≤0.05%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.11332702636719,
        436.6053771972656,
        509.0328369140625,
        457.7829895019531
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.20% 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.11332702636719,
        436.6053771972656,
        509.0328369140625,
        457.7829895019531
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구조규명 수준(IT)2)",
      "font_size": 7.074217319488525,
      "font_name": "Batang",
      "bbox": [
        86.11332702636719,
        436.6053771972656,
        509.0328369140625,
        457.7829895019531
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 유연물질1)",
      "font_size": 7.074217319488525,
      "font_name": "Batang",
      "bbox": [
        74.4796371459961,
        464.77459716796875,
        501.08843994140625,
        477.3216552734375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.5%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.4796371459961,
        464.77459716796875,
        501.08843994140625,
        477.3216552734375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.7%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.4796371459961,
        464.77459716796875,
        501.08843994140625,
        477.3216552734375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.5% 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.4796371459961,
        464.77459716796875,
        501.08843994140625,
        477.3216552734375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대조약보다 낮음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.4796371459961,
        464.77459716796875,
        501.08843994140625,
        477.3216552734375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 유연물질 B, C, D, F는 제품 유연물질 계산에서는 제외한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.63846588134766,
        491.7059326171875,
        400.08673095703125,
        502.73388671875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 동 품목의 일일최대복용량은 64 mg이므로 미지 유연물질의 기준은 구조규명 수준(IT)인",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.63846588134766,
        511.48431396484375,
        541.9426879882812,
        522.5122680664062
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.2% 이하로 설정하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        92.5898208618164,
        531.2626953125,
        219.10484313964844,
        542.2906494140625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질(분해산물)은 다음 HPLC 조건으로 시험한다. 자세한 사항은 3.2.P.5.2 시험방법과",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        570.8194580078125,
        538.5845336914062,
        581.847412109375
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.P.5.4 뱃치 분석을 참고한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        67.52340698242188,
        590.5978393554688,
        235.9884033203125,
        601.6257934570312
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이동상",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        616.0811157226562,
        482.3664855957031,
        632.263427734375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이동상 A: K2HPO4 3.2 g 과 KH2PO4 0.85 g을 물에 녹여 1000 mL로 한다.",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        616.0811157226562,
        482.3664855957031,
        632.263427734375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이동상 B: 아세토니트릴",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        158.7939453125,
        630.4653930664062,
        258.1001281738281,
        639.45556640625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "컬럼",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        647.8463745117188,
        338.26800537109375,
        656.8365478515625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Symtrex C18, 5 μm, 250 mm × 4.6 mm",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        647.8463745117188,
        338.26800537109375,
        656.8365478515625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유속",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        665.3472900390625,
        202.33035278320312,
        674.3374633789062
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.5 mL/분",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        665.3472900390625,
        202.33035278320312,
        674.3374633789062
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "농도구배",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        698.9105834960938,
        123.77291870117188,
        707.9007568359375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시간 (분)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        165.2704315185547,
        685.6051635742188,
        405.1014709472656,
        694.5953369140625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.0",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        165.2704315185547,
        685.6051635742188,
        405.1014709472656,
        694.5953369140625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "30.0",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        165.2704315185547,
        685.6051635742188,
        405.1014709472656,
        694.5953369140625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "37.0",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        165.2704315185547,
        685.6051635742188,
        405.1014709472656,
        694.5953369140625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이동상 A (%)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        165.2704315185547,
        698.43115234375,
        397.0661315917969,
        707.4213256835938
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "80",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        165.2704315185547,
        698.43115234375,
        397.0661315917969,
        707.4213256835938
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        165.2704315185547,
        698.43115234375,
        397.0661315917969,
        707.4213256835938
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        165.2704315185547,
        698.43115234375,
        397.0661315917969,
        707.4213256835938
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이동상 B (%)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        165.2704315185547,
        711.257080078125,
        397.0661315917969,
        720.2472534179688
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        165.2704315185547,
        711.257080078125,
        397.0661315917969,
        720.2472534179688
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "80",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        165.2704315185547,
        711.257080078125,
        397.0661315917969,
        720.2472534179688
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "80",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        165.2704315185547,
        711.257080078125,
        397.0661315917969,
        720.2472534179688
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "온도",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        732.4739379882812,
        183.02081298828125,
        741.464111328125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "40 ℃",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        732.4739379882812,
        183.02081298828125,
        741.464111328125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 32 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 38,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "* 유연물질 B, C, D, F는 완제의약품에서 유연물질에서는 제외한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        362.0076599121094,
        413.27960205078125,
        373.0356140136719
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유연물질 분석법에 대하여 정확성, 정밀성, 특이성과 직선성에 대한 밸리데이션을 실시하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        401.5644226074219,
        541.9429321289062,
        412.5923767089844
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특이성과 안정성을 검증하기 위해 여러 가지 가혹 조건에서 PDA 검출기가 장착된 HPLC",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        67.28353118896484,
        421.34283447265625,
        541.8230590820312,
        432.37078857421875
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기기로 분석이 진행되었다. 모든 분해산물 피크는 주성분 피크로부터 분리되었고, 피크 순도는",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        67.28353118896484,
        441.1212158203125,
        541.8233032226562,
        452.149169921875
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "> 0.99로 계산되어 주성분 피크가 균일함을 확인하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        67.28353118896484,
        460.89959716796875,
        346.83563232421875,
        471.92755126953125
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 A는 열, 염기 및 산 조건에서 생성되는 1차 분해산물이다. 예상한 바와 같이 유연",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        480.677978515625,
        538.1487426757812,
        491.7059326171875
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질 B, C, D, F는 가혹시험 조건에서 변화가 없었으므로 이 유연물질들이 제품의 분해산물이",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        67.52340698242188,
        500.45635986328125,
        541.8238525390625,
        511.48431396484375
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아님을 확인하였다. 분석법 밸리데이션과 가혹시험에 관련해서 아래 표에 요약하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        67.52340698242188,
        520.2347412109375,
        493.15631103515625,
        531.2626953125
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        309.3123474121094,
        565.4963989257812,
        345.2928466796875,
        574.486572265625
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "A",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        154.11647033691406,
        581.81982421875,
        507.99591064453125,
        591.9874267578125
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "B1",
      "font_size": 5.755295753479004,
      "font_name": "Batang",
      "bbox": [
        154.11647033691406,
        581.81982421875,
        507.99591064453125,
        591.9874267578125
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "C1",
      "font_size": 5.755295753479004,
      "font_name": "Batang",
      "bbox": [
        154.11647033691406,
        581.81982421875,
        507.99591064453125,
        591.9874267578125
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "D1",
      "font_size": 5.755295753479004,
      "font_name": "Batang",
      "bbox": [
        154.11647033691406,
        581.81982421875,
        507.99591064453125,
        591.9874267578125
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "E",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        154.11647033691406,
        581.81982421875,
        507.99591064453125,
        591.9874267578125
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "F1",
      "font_size": 5.755295753479004,
      "font_name": "Batang",
      "bbox": [
        154.11647033691406,
        581.81982421875,
        507.99591064453125,
        591.9874267578125
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "특이성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        614.7625732421875,
        90.07118225097656,
        623.7527465820312
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질간에 방해가 없음(아래의 크로마토그램을",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        123.65298461914062,
        600.3782958984375,
        533.9470825195312,
        609.3684692382812
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "참고)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        123.65298461914062,
        614.7625732421875,
        144.67417907714844,
        623.7527465820312
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분 피크 순도(PDA)>0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        123.65298461914062,
        629.1468505859375,
        245.82659912109375,
        638.1370239257812
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "직선성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        656.3571166992188,
        90.07118225097656,
        665.3472900390625
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05-2.5%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        134.80694580078125,
        646.647705078125,
        180.16188049316406,
        655.6378784179688
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "r2=0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        141.6432342529297,
        664.8890380859375,
        173.2677001953125,
        675.056640625
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05-1.0%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        206.28819274902344,
        646.647705078125,
        251.64312744140625,
        655.6378784179688
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "r2=0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        213.12449645996094,
        664.8890380859375,
        244.74896240234375,
        675.056640625
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05-1.0%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        273.9315490722656,
        646.647705078125,
        319.2864685058594,
        655.6378784179688
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "r2=0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        280.767822265625,
        664.8890380859375,
        312.3923034667969,
        675.056640625
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05-1.0%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        344.69317626953125,
        646.647705078125,
        390.1668701171875,
        655.6378784179688
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "r2=0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        351.52947998046875,
        664.8890380859375,
        383.2738952636719,
        675.056640625
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05-1.0%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        414.13555908203125,
        646.647705078125,
        459.610107421875,
        655.6378784179688
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "r2=0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        420.9718322753906,
        664.8890380859375,
        452.7162780761719,
        675.056640625
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05-1.0%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        480.699462890625,
        646.647705078125,
        526.054443359375,
        655.6378784179688
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "r2=0.99",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        487.41583251953125,
        664.8890380859375,
        519.1602172851562,
        675.056640625
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정밀성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        683.447509765625,
        525.214599609375,
        692.4376831054688
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RSD 6.7%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        683.447509765625,
        525.214599609375,
        692.4376831054688
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RSD 4.5%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        683.447509765625,
        525.214599609375,
        692.4376831054688
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RSD 6.8%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        683.447509765625,
        525.214599609375,
        692.4376831054688
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RSD 5.2%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        683.447509765625,
        525.214599609375,
        692.4376831054688
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RSD 3.2%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        683.447509765625,
        525.214599609375,
        692.4376831054688
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RSD 4.5%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        683.447509765625,
        525.214599609375,
        692.4376831054688
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험실",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        700.9483642578125,
        116.4539566040039,
        709.9385375976562
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        700.9483642578125,
        116.4539566040039,
        709.9385375976562
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정밀성2",
      "font_size": 5.755295753479004,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        708.1405029296875,
        525.214599609375,
        724.3228149414062
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RSD 8.2%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        708.1405029296875,
        525.214599609375,
        724.3228149414062
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RSD 9.2%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        708.1405029296875,
        525.214599609375,
        724.3228149414062
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RSD 10.4%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        708.1405029296875,
        525.214599609375,
        724.3228149414062
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RSD 9.6%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        708.1405029296875,
        525.214599609375,
        724.3228149414062
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RSD 8.2%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        708.1405029296875,
        525.214599609375,
        724.3228149414062
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RSD 9.8%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        708.1405029296875,
        525.214599609375,
        724.3228149414062
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정확성3",
      "font_size": 5.755295753479004,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        731.6560668945312,
        523.4164428710938,
        741.8236694335938
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "95-104%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        731.6560668945312,
        523.4164428710938,
        741.8236694335938
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "80-97%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        731.6560668945312,
        523.4164428710938,
        741.8236694335938
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "88-105%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        731.6560668945312,
        523.4164428710938,
        741.8236694335938
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "92-112%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        731.6560668945312,
        523.4164428710938,
        741.8236694335938
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "80-101%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        731.6560668945312,
        523.4164428710938,
        741.8236694335938
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "82-115%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        731.6560668945312,
        523.4164428710938,
        741.8236694335938
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검출기",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        104.719970703125,
        239.54246520996094,
        113.71015167236328
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "UV (파장 272 nm)",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        104.719970703125,
        239.54246520996094,
        113.71015167236328
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주입량",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        122.2208480834961,
        183.02081298828125,
        131.21102905273438
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10 ㎕",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        122.2208480834961,
        183.02081298828125,
        131.21102905273438
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분석시간",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        139.6018524169922,
        183.02081298828125,
        148.59202575683594
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "37 분",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        139.6018524169922,
        183.02081298828125,
        148.59202575683594
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상대유지시간",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        215.23919677734375,
        141.76315307617188,
        224.2293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 E: 0.49",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        158.7939453125,
        157.10272216796875,
        231.43588256835938,
        166.0928955078125
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 A: 0.70",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        158.7939453125,
        176.52149963378906,
        232.0355682373047,
        185.5116729736328
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 B: 0.89*",
      "font_size": 5.755295753479004,
      "font_name": "Batang",
      "bbox": [
        158.7939453125,
        194.64291381835938,
        234.71278381347656,
        204.8105926513672
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분: 1.00",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        158.7939453125,
        215.23919677734375,
        212.00611877441406,
        224.2293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 C: 1.44*",
      "font_size": 5.755295753479004,
      "font_name": "Batang",
      "bbox": [
        158.7939453125,
        233.48046875,
        234.71278381347656,
        243.6481475830078
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 D: 1.66*",
      "font_size": 5.755295753479004,
      "font_name": "Batang",
      "bbox": [
        158.7939453125,
        252.7793731689453,
        234.95265197753906,
        262.9470520019531
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 F: 2.55*",
      "font_size": 5.755295753479004,
      "font_name": "Batang",
      "bbox": [
        158.7939453125,
        272.19818115234375,
        234.1131134033203,
        282.3658142089844
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "샘플 조제",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        300.4660339355469,
        128.21051025390625,
        309.4562072753906
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표준품: 0.01 mg/mL, 유연물질 B 0.01 mg/mL",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        158.7939453125,
        290.87652587890625,
        357.1542053222656,
        299.86669921875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검액: 약 2 mg/mL",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        158.7939453125,
        310.1754150390625,
        240.10694885253906,
        319.16558837890625
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시스템적합성",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        327.6763000488281,
        291.0822448730469,
        336.6664733886719
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "칼럼 효율: 이론단수 5000 이상",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        327.6763000488281,
        291.0822448730469,
        336.6664733886719
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 33 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1 유연물질 B, C, D, F는 제품 유연물질 계산에 포함되지 않으나, 원료의약품 HPLC(분해산물)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        155.03311157226562,
        538.2298583984375,
        167.58013916015625
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험의 분석방법 밸리데이션을 위해 기재함. (2.3.S.4 원료의약품의 품질관리 참조)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        71.841064453125,
        176.33058166503906,
        484.13916015625,
        187.3585205078125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2 2명의 시험자가 서로 다른 기구로 시험함",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        194.58987426757812,
        281.6070556640625,
        207.13690185546875
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가혹 조건",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        126.05168151855469,
        241.3865509033203,
        465.7071533203125,
        251.33567810058594
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "% 함량",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        126.05168151855469,
        241.3865509033203,
        465.7071533203125,
        251.33567810058594
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피크 순도",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        126.05168151855469,
        241.3865509033203,
        465.7071533203125,
        251.33567810058594
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관찰된 분해산물",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        126.05168151855469,
        241.3865509033203,
        465.7071533203125,
        251.33567810058594
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미처리",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        259.84637451171875,
        435.8572998046875,
        269.7955017089844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "99%",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        259.84637451171875,
        435.8572998046875,
        269.7955017089844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        259.84637451171875,
        435.8572998046875,
        269.7955017089844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NA",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        259.84637451171875,
        435.8572998046875,
        269.7955017089844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1 N HCl, 70 ℃, 14 시간",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        278.30621337890625,
        468.5013122558594,
        288.2553405761719
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "85%",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        278.30621337890625,
        468.5013122558594,
        288.2553405761719
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        278.30621337890625,
        468.5013122558594,
        288.2553405761719
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 A(12%)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        278.30621337890625,
        468.5013122558594,
        288.2553405761719
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1 N NaOH, 70 ℃, 30 분",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        296.7660217285156,
        468.5013122558594,
        306.71514892578125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "30%",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        296.7660217285156,
        468.5013122558594,
        306.71514892578125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        296.7660217285156,
        468.5013122558594,
        306.71514892578125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 A(65%)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        296.7660217285156,
        468.5013122558594,
        306.71514892578125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3% H2O2, 60 ℃, 2 시간",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        325.6544494628906,
        348.3446044921875,
        336.2930603027344
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20%",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        325.6544494628906,
        348.3446044921875,
        336.2930603027344
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        325.6544494628906,
        348.3446044921875,
        336.2930603027344
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 E(50%)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        388.4694519042969,
        315.2258605957031,
        468.14044189453125,
        325.17498779296875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미지 유연물질(15%)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        381.873046875,
        336.20294189453125,
        474.73681640625,
        346.1520690917969
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "습도(90% RH), 25 ℃, 7 일",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        354.6627502441406,
        465.5020446777344,
        364.61187744140625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "95%",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        354.6627502441406,
        465.5020446777344,
        364.61187744140625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        354.6627502441406,
        465.5020446777344,
        364.61187744140625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 A(3%)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        354.6627502441406,
        465.5020446777344,
        364.61187744140625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "UV (단파장/ 장파장), 7 일",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        373.1225891113281,
        435.8572998046875,
        383.07171630859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "98%",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        373.1225891113281,
        435.8572998046875,
        383.07171630859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        373.1225891113281,
        435.8572998046875,
        383.07171630859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NA",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        373.1225891113281,
        435.8572998046875,
        383.07171630859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "건열, 105 ℃, 14 시간",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        391.5823974609375,
        468.5013122558594,
        401.5315246582031
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "70%",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        391.5823974609375,
        468.5013122558594,
        401.5315246582031
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">0.99",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        391.5823974609375,
        468.5013122558594,
        401.5315246582031
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 A(23%)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        68.60282135009766,
        391.5823974609375,
        468.5013122558594,
        401.5315246582031
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 용출: 「경구용의약품의 용출규격 설정 가이드라인」에 따라 예비시험 및 본시험을 수행하여",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        435.72711181640625,
        541.822509765625,
        446.75506591796875
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용출시험 조건을 설정하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        70.76165008544922,
        455.5054931640625,
        215.38685607910156,
        466.533447265625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용출 기준은 4 개의 시점에 대해 설정하였으며, 평균 용출률의 ± 10% 범위로 설정하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        727.128662109375,
        541.8226318359375,
        738.1566162109375
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "LOQ",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        104.719970703125,
        516.5792236328125,
        113.71015167236328
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.05%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        104.719970703125,
        516.5792236328125,
        113.71015167236328
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.05%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        104.719970703125,
        516.5792236328125,
        113.71015167236328
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.05%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        104.719970703125,
        516.5792236328125,
        113.71015167236328
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.05%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        104.719970703125,
        516.5792236328125,
        113.71015167236328
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.05%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        104.719970703125,
        516.5792236328125,
        113.71015167236328
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.05%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        104.719970703125,
        516.5792236328125,
        113.71015167236328
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "LOD",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        122.2208480834961,
        516.5792236328125,
        131.21102905273438
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.02%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        122.2208480834961,
        516.5792236328125,
        131.21102905273438
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.02%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        122.2208480834961,
        516.5792236328125,
        131.21102905273438
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.02%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        122.2208480834961,
        516.5792236328125,
        131.21102905273438
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.02%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        122.2208480834961,
        516.5792236328125,
        131.21102905273438
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.02%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        122.2208480834961,
        516.5792236328125,
        131.21102905273438
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.02%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        63.08580780029297,
        122.2208480834961,
        516.5792236328125,
        131.21102905273438
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험조건",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.54442596435547,
        482.35614013671875,
        292.7610168457031,
        493.38409423828125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설정값",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.54442596435547,
        482.35614013671875,
        292.7610168457031,
        493.38409423828125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험액",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        108.06143188476562,
        501.7749328613281,
        287.9259033203125,
        512.8028564453125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인산염완충액(pH 6.8)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        108.06143188476562,
        501.7749328613281,
        287.9259033203125,
        512.8028564453125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험액의 양",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        94.26890563964844,
        521.1937255859375,
        218.61216735839844,
        532.2216796875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "900 mL",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        94.26890563964844,
        521.1937255859375,
        218.61216735839844,
        532.2216796875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험액의 온도",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        88.87183380126953,
        540.7323608398438,
        206.64801025390625,
        551.7603149414062
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "37 ℃",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        88.87183380126953,
        540.7323608398438,
        206.64801025390625,
        551.7603149414062
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "장치",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        113.57844543457031,
        560.151123046875,
        243.10791015625,
        571.1790771484375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "회전검체통법",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        113.57844543457031,
        560.151123046875,
        243.10791015625,
        571.1790771484375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "회전수",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        108.06143188476562,
        579.5698852539062,
        222.69619750976562,
        590.5978393554688
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "100 rpm",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        108.06143188476562,
        579.5698852539062,
        222.69619750976562,
        590.5978393554688
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        113.57844543457031,
        644.1793212890625,
        135.52621459960938,
        655.207275390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시간",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        183.6204833984375,
        598.9887084960938,
        205.5682373046875,
        610.0166625976562
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "30 분",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        183.6204833984375,
        621.6439208984375,
        213.24441528320312,
        632.671875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4 시간",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        183.6204833984375,
        644.1793212890625,
        217.6820068359375,
        655.207275390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8 시간",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        183.6204833984375,
        666.7146606445312,
        217.6820068359375,
        677.7426147460938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12 시간",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        183.6204833984375,
        689.3699340820312,
        224.15817260742188,
        700.3978881835938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용출률 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        244.54745483398438,
        598.9887084960938,
        296.0759582519531,
        610.0166625976562
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25-35%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        244.54745483398438,
        621.6439208984375,
        286.9695739746094,
        632.671875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "40-60%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        244.54745483398438,
        644.1793212890625,
        286.9695739746094,
        655.207275390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "65-85%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        244.54745483398438,
        666.7146606445312,
        286.9695739746094,
        677.7426147460938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "85% 이상",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        244.54745483398438,
        689.3699340820312,
        294.56036376953125,
        700.3978881835938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 34 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 40,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4 시간, 8 시간 시점의 기준은 개발 뱃치의 용출 평균 값보다 엄격한 기준을 적용하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        67.52340698242188,
        99.01507568359375,
        521.1011962890625,
        110.04302215576172
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시점",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        95.46826171875,
        124.49835968017578,
        430.8065185546875,
        133.48854064941406
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조번호 P034 시험 결과",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        95.46826171875,
        124.49835968017578,
        430.8065185546875,
        133.48854064941406
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설정 기준",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        95.46826171875,
        124.49835968017578,
        430.8065185546875,
        133.48854064941406
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "근거",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        95.46826171875,
        124.49835968017578,
        430.8065185546875,
        133.48854064941406
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "30분",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        94.62871551513672,
        141.99923706054688,
        529.7499389648438,
        158.18154907226562
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "27-31%, 평균 29%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        94.62871551513672,
        141.99923706054688,
        529.7499389648438,
        158.18154907226562
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25-35%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        94.62871551513672,
        141.99923706054688,
        529.7499389648438,
        158.18154907226562
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25% 가량의 주성분 속방이 필요하며, 이보다 더",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        94.62871551513672,
        141.99923706054688,
        529.7499389648438,
        158.18154907226562
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "많은 주성분이 속방될 수 있으므로 기준 설정",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        316.7483215332031,
        156.38351440429688,
        505.5260009765625,
        165.37368774414062
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4 시간",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        90.5509262084961,
        173.7645263671875,
        405.39947509765625,
        182.75469970703125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "48-53%, 평균 51%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        90.5509262084961,
        173.7645263671875,
        405.39947509765625,
        182.75469970703125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "40-60%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        90.5509262084961,
        173.7645263671875,
        405.39947509765625,
        182.75469970703125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평균 용출율의 ±10%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        90.5509262084961,
        173.7645263671875,
        405.39947509765625,
        182.75469970703125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8 시간",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        90.5509262084961,
        191.26539611816406,
        405.39947509765625,
        200.2555694580078
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "73-78%, 평균 75%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        90.5509262084961,
        191.26539611816406,
        405.39947509765625,
        200.2555694580078
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "65-85%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        90.5509262084961,
        191.26539611816406,
        405.39947509765625,
        200.2555694580078
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평균 용출율의 ±10%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        90.5509262084961,
        191.26539611816406,
        405.39947509765625,
        200.2555694580078
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12 시간",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        208.76626586914062,
        379.7142028808594,
        217.75643920898438
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "90-94%, 평균 92%",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        208.76626586914062,
        379.7142028808594,
        217.75643920898438
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "85% 이상",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        208.76626586914062,
        379.7142028808594,
        217.75643920898438
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용출 완료 시점",
      "font_size": 8.992650032043457,
      "font_name": "Batang",
      "bbox": [
        87.79241943359375,
        208.76626586914062,
        379.7142028808594,
        217.75643920898438
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 수분: 주성분이 가수분해될 수 있으므로 완제의약품의 수분함량 조절이 필요하다. 수분 기",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        251.84805297851562,
        538.2682495117188,
        262.8760070800781
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "준(3.5% 이하)은 각 성분의 수분기준 상한(2.8%), 시험 결과(2.9%)와 안정성시험 결과(3.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        81.07605743408203,
        271.6264343261719,
        538.2527465820312,
        282.6543884277344
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0%)에 근거하여 결정되었다. 수분 시험은 칼피셔법(USP<921> method 1a)에 따른다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        81.07605743408203,
        291.4048156738281,
        510.546875,
        302.4327697753906
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 무균 제제",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        330.96160888671875,
        122.33369445800781,
        341.98956298828125
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 미생물관련 기준 및 시험방법, 결과 요약",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        350.739990234375,
        277.28973388671875,
        361.7679443359375
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험 항목",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        118.85558319091797,
        376.1522216796875,
        469.5071105957031,
        387.18017578125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험법",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        118.85558319091797,
        376.1522216796875,
        469.5071105957031,
        387.18017578125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허용기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        118.85558319091797,
        376.1522216796875,
        469.5071105957031,
        387.18017578125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험결과(제조번호)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        118.85558319091797,
        376.1522216796875,
        469.5071105957031,
        387.18017578125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "엔도톡신 (해당하는 경우)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.91722869873047,
        395.69085693359375,
        422.36749267578125,
        406.71881103515625
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "무균",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        132.52816772460938,
        415.109619140625,
        422.36749267578125,
        426.1375732421875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.6 표준품 또는 표준물질(제품명, 제형)(Reference Standards or Materials)(name,",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        468.3473815917969,
        542.1422729492188,
        480.33428955078125
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "dosage form)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        487.5263977050781,
        132.37168884277344,
        499.5133056640625
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.P.6에서 얻은 정보(필요시 도표로 표시)를 포함한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        511.72406005859375,
        340.8388671875,
        522.7520141601562
      ],
      "page_num": 40,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 설",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        561.84521484375,
        107.58169555664062,
        573.8321533203125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 3.2.P.6 표준품 및 표준물질에 설명된 완제의약품 시험에 필요한 표준품 또는 표준물질에",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        593.2349853515625,
        541.9423828125,
        604.262939453125
      ],
      "page_num": 40,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 정보를 요약하여 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        613.0133666992188,
        236.6153564453125,
        624.0413208007812
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 원료의약품과 동일한 표준품을 사용하는 경우, 2.3.S.5 표준품 또는 표준물질을 참고한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        632.791748046875,
        527.6976318359375,
        643.8197021484375
      ],
      "page_num": 40,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 표준품은 로트 번호와 시험성적서 발행처 및 주소 등 품질을 입증할 수 있는 정보를 기재",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        652.5701293945312,
        538.2682495117188,
        663.5980834960938
      ],
      "page_num": 40,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다. 단, 공정서 표준품에 대하여 정보가 제공되는 경우 그 품질을 알 수 있는 정보를",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.76002502441406,
        672.3485107421875,
        541.942626953125,
        683.37646484375
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.76002502441406,
        692.1268920898438,
        121.83756256103516,
        703.1548461914062
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 순도시험에서 표준품을 사용하는 경우, 해당 표준품에 대한 내용도 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        711.9052734375,
        464.13201904296875,
        722.9332275390625
      ],
      "page_num": 40,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 35 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 41,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.P.7 용기 및 포장(제품명, 제형)(Container Closure System)(name, dosage form)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        107.18208312988281,
        533.1944580078125,
        119.16898345947266
      ],
      "page_num": 41,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.P.7에 있는 정보의 간단한 설명과 고찰을 포함한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        128.6227264404297,
        338.08038330078125,
        139.65066528320312
      ],
      "page_num": 41,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 설",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        178.74388122558594,
        107.58169555664062,
        190.73077392578125
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 3.2.P.7 용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        210.25350952148438,
        530.336181640625,
        221.2814483642578
      ],
      "page_num": 41,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 용기 및 포장에 대해 요약하여 표로 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        230.03189086914062,
        310.708251953125,
        241.05982971191406
      ],
      "page_num": 41,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분류",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        87.6724853515625,
        256.7626953125,
        461.1497497558594,
        267.7906494140625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "포장 형태",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        87.6724853515625,
        256.7626953125,
        461.1497497558594,
        267.7906494140625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조원",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        87.6724853515625,
        256.7626953125,
        461.1497497558594,
        267.7906494140625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "병포장",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        82.15547180175781,
        276.30133056640625,
        380.8751220703125,
        287.32928466796875
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "60 mL 흰색 원형 HDPE 병 (60, 100 정)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        82.15547180175781,
        276.30133056640625,
        380.8751220703125,
        287.32928466796875
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 사용된 용기 및 포장의 안전성 입증을 위해 공정서 수재 시험방법 등으로 시험할 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        303.1519775390625,
        541.822998046875,
        314.179931640625
      ],
      "page_num": 41,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또한 동일한 포장 형태를 사용하는 기허가 의약품을 근거로 갈음할 수 있으며 시험성적서를",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.52015686035156,
        322.93035888671875,
        541.8214111328125,
        333.95831298828125
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제출한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.52015686035156,
        342.7087707519531,
        120.27840423583984,
        353.7367248535156
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예 시",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        387.915283203125,
        107.58169555664062,
        399.9021911621094
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 포장 용기에 대해 다음과 같이 기재할 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        414.2705383300781,
        312.5341796875,
        425.2984924316406
      ],
      "page_num": 41,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- XXX 정 2 mg은 HDPE (흰색, 원형) 병포장으로 시판될 것이다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        439.08343505859375,
        406.92303466796875,
        450.11138916015625
      ],
      "page_num": 41,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 60 mL (60, 100 정) 28mm 지름, Al induction 씰로 된 PP CRC",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        463.89630126953125,
        418.4688720703125,
        474.92425537109375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 325 mL (500 정) 45mm 지름, Al induction 씰로 된 PP CRC",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        488.5893249511719,
        403.23712158203125,
        499.6172790527344
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 용기 시스템에 대한 요약은 다음과 같다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        513.4022216796875,
        286.38836669921875,
        524.43017578125
      ],
      "page_num": 41,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분류",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.42449188232422,
        543.8489379882812,
        515.2404174804688,
        554.8768920898438
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설명",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.42449188232422,
        543.8489379882812,
        515.2404174804688,
        554.8768920898438
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조원",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.42449188232422,
        543.8489379882812,
        515.2404174804688,
        554.8768920898438
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "병포장",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        96.90747833251953,
        563.2677001953125,
        523.2328491210938,
        574.295654296875
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "60 mL, 흰색 원형 HDPE 병 (60, 100정)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        96.90747833251953,
        563.2677001953125,
        523.2328491210938,
        574.295654296875
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bottle.Co",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        96.90747833251953,
        563.2677001953125,
        523.2328491210938,
        574.295654296875
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "병포장",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        96.90747833251953,
        582.6865234375,
        523.2328491210938,
        593.7144775390625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "325 mL, 흰색 원형 HDPE 병 (500 정)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        96.90747833251953,
        582.6865234375,
        523.2328491210938,
        593.7144775390625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bottle.Co",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        96.90747833251953,
        582.6865234375,
        523.2328491210938,
        593.7144775390625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "뚜껑 (60 mL 용)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        69.80216979980469,
        602.2251586914062,
        453.0714416503906,
        622.0035400390625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "28 mm CR cap white HDPE Outer Shell clear PP",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        69.80216979980469,
        602.2251586914062,
        453.0714416503906,
        622.0035400390625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CRC",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        302.83587646484375,
        610.9755859375,
        523.2328491210938,
        630.7539672851562
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bottle.Co",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        302.83587646484375,
        610.9755859375,
        523.2328491210938,
        630.7539672851562
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "뚜껑 (325 mL 용)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        66.56392669677734,
        639.2646484375,
        523.2328491210938,
        650.2926025390625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "45 mm PP white CT Fine Ribbed Closures",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        66.56392669677734,
        639.2646484375,
        523.2328491210938,
        650.2926025390625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bottle.Co",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        66.56392669677734,
        639.2646484375,
        523.2328491210938,
        650.2926025390625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Closure liner",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.55742645263672,
        658.6834716796875,
        519.5424194335938,
        669.71142578125
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PE faced Al inner seal",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.55742645263672,
        658.6834716796875,
        519.5424194335938,
        669.71142578125
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Pulp.inc",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.55742645263672,
        658.6834716796875,
        519.5424194335938,
        669.71142578125
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Heat seal",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        110.70000457763672,
        678.1022338867188,
        518.7702026367188,
        689.1301879882812
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "S Liner",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        110.70000457763672,
        678.1022338867188,
        518.7702026367188,
        689.1301879882812
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 사용된 용기 포장은 USP <661> 플라스틱용기시험법과 USP <671> 용기성능시험법에",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        703.5144653320312,
        541.8209838867188,
        714.5424194335938
      ],
      "page_num": 41,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적합하다. 자세한 사항은 3.2.P.2.4. 용기 및 포장을 참조한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.15872192382812,
        723.2928466796875,
        396.96844482421875,
        734.32080078125
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 36 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.P.8 안정성(제품명, 제형)(Stability)(name, dosage form)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        107.06221771240234,
        395.50909423828125,
        119.04911804199219
      ],
      "page_num": 42,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수행된 시험(조건, 뱃치, 시험방법)의 요약 그리고, 안정성시험 및 데이터 해석에 대한 결과 및",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        133.537353515625,
        541.8224487304688,
        144.56529235839844
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결론의 간략한 고찰을 포함하여야 한다. 보관조건, 유효기간, 필요시 사용시 보관조건 및 사용",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        153.31573486328125,
        538.2682495117188,
        164.3436737060547
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시 유효기간에 관한 결론을 제시하여야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        173.0941162109375,
        285.069091796875,
        184.12205505371094
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.P.8.3에 기재된 안정성시험 결과가 필요시 그래프와 함께 요약표를 포함하여야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        192.87249755859375,
        507.188720703125,
        203.9004364013672
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.P.8.2에 기재된 승인 후의 안정성시험 계획을 제공하여야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        212.65089416503906,
        397.20831298828125,
        223.6788330078125
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 설",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        262.89190673828125,
        107.58169555664062,
        274.8788146972656
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 안정성시험에 적용된 기준 및 시험방법을 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        294.28167724609375,
        334.60223388671875,
        305.30963134765625
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 완제의약품의 기준 및 시험방법과 안정성시험의 기준 및 시험방법이 상이할 경우, 이를",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        314.06005859375,
        541.82275390625,
        325.0880126953125
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "명시하고 타당한 근거를 제시한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.03878784179688,
        333.83843994140625,
        251.48728942871094,
        344.86639404296875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 용기 및 포장 형태에 대해 명확히 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        353.6168212890625,
        296.10308837890625,
        364.644775390625
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 안정성시험(장기보존시험, 가속시험) 기준 및 결과를 표로 나타낸다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        373.3952331542969,
        417.47735595703125,
        384.4231872558594
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 보관 검체를 재시험하는 경우, 해당 사항을 표시한다 (예: 용출기준 변경이 있는 경우).",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        393.1736145019531,
        514.505126953125,
        404.2015686035156
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 필요한 경우, 쓸 때 조제하는 제제 또는 완제의약품 복용 시와 동일한 조건과 같은 특수",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        412.9519958496094,
        541.82275390625,
        423.9799499511719
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구를 실시하고, 안정성시험 결과 및 시험방법을 기재한다. 사이클링 연구 수행 결과(동결",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        432.7303771972656,
        538.2682495117188,
        443.7583312988281
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-해동, 가열-냉각 연구)가 있는 경우 이를 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        452.5087585449219,
        340.23919677734375,
        463.5367126464844
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 안정성시험 결과를 바탕으로 보관조건 및 사용기한 설정에 대해 기술한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        472.2871398925781,
        449.979736328125,
        483.3150939941406
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 시판 후 안정성시험 계획서와 이행서약을 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        492.0655212402344,
        338.17303466796875,
        503.0934753417969
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 안정성시험 계획서는 다음 사항에 대해 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        511.84393310546875,
        324.88751220703125,
        522.8718872070312
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 검체 보존조건",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        531.622314453125,
        155.195556640625,
        542.6502685546875
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 안정성시험용 검체 정보 (제조번호, 포장형태 등)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        551.4006958007812,
        331.58184814453125,
        562.4286499023438
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 시험주기",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        571.1790771484375,
        127.73043823242188,
        582.20703125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4) 시험항목과 시험 일정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        590.9574584960938,
        193.69500732421875,
        601.9854125976562
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 안정성시험 이행서약은 다음 사항에 대해 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        610.73583984375,
        335.9215087890625,
        621.7637939453125
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 안정성시험을 실시할 제조단위",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        630.5142211914062,
        237.7108154296875,
        641.5421752929688
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 연 단위로 안정성 계획에 추가될 제조단위",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        650.2926025390625,
        298.03814697265625,
        661.320556640625
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 연간보고서의 안정성시험 결과 및 시판된 완제의약품의 변화 및 이상이 발견될 경우",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        670.0709838867188,
        541.8231201171875,
        681.0989379882812
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관리방법 등에 관한 자료.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        85.75352478027344,
        689.849365234375,
        218.14537048339844,
        700.8773193359375
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 37 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예 시",
      "font_size": 11.99020004272461,
      "font_name": "HYmprL",
      "bbox": [
        77.59794616699219,
        104.66483306884766,
        107.58169555664062,
        116.6517333984375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 비무균제제(정제)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        131.1399688720703,
        158.03590393066406,
        142.16790771484375
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 안정성시험 항목",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        150.91835021972656,
        156.8746337890625,
        161.9462890625
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 기준 및 시험방법에 설정된 모든 시험 항목을 설정하였다. 단, 경시 변화가 없을 것으로",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        376.8714294433594,
        541.8224487304688,
        387.8993835449219
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예상되는 확인시험과 함량균일성시험은 제외하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        77.47801208496094,
        396.6498107910156,
        339.03985595703125,
        407.6777648925781
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 안정성시험결과 요약",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        446.27557373046875,
        178.94302368164062,
        457.30352783203125
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 60 정, 500 정 병포장에 대해 가속시험(40 ℃, 75% RH)을 0, 3, 6 개월에 실시하였고,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        466.053955078125,
        541.822998046875,
        477.0819091796875
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "장기보존시험(25 ℃, 60% RH)을 0, 3, 6, 9, 12 개월에 실시하였다. (100 정 포장은 브래",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        77.2381362915039,
        485.83233642578125,
        538.2682495117188,
        496.86029052734375
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "켓팅 방법으로 갈음하며, 3.2.P.8. 안정성을 참조한다.) 안정성시험 결과는 다음 표와 같다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        77.2381362915039,
        505.6107177734375,
        541.822998046875,
        516.638671875
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상세 사항은 3.2.P.8.1 안정성 요약과 결론과 3.2.P.8.3 안정성 자료를 참고한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        77.2381362915039,
        525.3890991210938,
        486.08013916015625,
        536.4170532226562
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가속시험 결과 모든 시험항목에 대해 기준에 적합하였다. 가속시험 결과와 장기보존시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        545.16748046875,
        541.9420166015625,
        556.1954345703125
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과를 비교했을 때, 가속시험에서만 유연물질 증가 경향이 있었다. 허가 신청한 사용기간",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.55742645263672,
        564.9458618164062,
        538.2679443359375,
        575.9738159179688
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(제조일로부터 24 개월)은 타당하며, 추후 장기보존시험을 계속하여 신청한 사용기간에 대해",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.55742645263672,
        584.7242431640625,
        541.8225708007812,
        595.752197265625
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "입증할 계획이다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        78.55742645263672,
        604.5026245117188,
        161.77590942382812,
        615.5305786132812
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 안정성시험 계획",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        644.0594482421875,
        156.8746337890625,
        655.08740234375
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험항목",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        103.50390625,
        177.40940856933594,
        506.365234375,
        188.43734741210938
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        103.50390625,
        177.40940856933594,
        506.365234375,
        188.43734741210938
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        103.50390625,
        177.40940856933594,
        506.365234375,
        188.43734741210938
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성상",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        77.11820220947266,
        196.82818603515625,
        435.7238464355469,
        216.60655212402344
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        77.11820220947266,
        196.82818603515625,
        435.7238464355469,
        216.60655212402344
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "되어 있는 청색의 직사각형 정제",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        184.22015380859375,
        214.4489288330078,
        349.13079833984375,
        225.47686767578125
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "육안",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        445.9183349609375,
        205.57861328125,
        467.9863586425781,
        216.60655212402344
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함량시험(HPLC)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        77.11820220947266,
        233.86770629882812,
        468.4894714355469,
        244.89564514160156
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표시량의 90.0 ~ 110.0 %",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        77.11820220947266,
        233.86770629882812,
        468.4894714355469,
        244.89564514160156
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        77.11820220947266,
        233.86770629882812,
        468.4894714355469,
        244.89564514160156
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질(HPLC)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        77.11820220947266,
        287.20941162109375,
        159.8345489501953,
        298.23736572265625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC2: 0.5% 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        184.22015380859375,
        253.28646850585938,
        268.2942810058594,
        264.3144226074219
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RC3: 0.5% 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        184.22015380859375,
        275.94171142578125,
        268.2942810058594,
        286.96966552734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개개유연물질: 각각 0.2% 이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        184.22015380859375,
        298.4770812988281,
        340.0157165527344,
        309.5050354003906
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 유연물질: 1.5%이하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        184.22015380859375,
        321.0124816894531,
        301.5162658691406,
        332.0404357910156
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        445.9183349609375,
        287.20941162109375,
        489.93414306640625,
        298.23736572265625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용출 (HPLC)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        77.11820220947266,
        340.5511169433594,
        468.4894714355469,
        351.5790710449219
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표시량의 80% (Q) 이상 / 30 분, USP<711>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        77.11820220947266,
        340.5511169433594,
        468.4894714355469,
        351.5790710449219
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        77.11820220947266,
        340.5511169433594,
        468.4894714355469,
        351.5790710449219
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조번호",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        83.71463012695312,
        669.4716796875,
        515.6002197265625,
        680.4996337890625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보존조건",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        83.71463012695312,
        669.4716796875,
        515.6002197265625,
        680.4996337890625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험일정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        83.71463012695312,
        669.4716796875,
        515.6002197265625,
        680.4996337890625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용기/포장",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        83.71463012695312,
        669.4716796875,
        515.6002197265625,
        680.4996337890625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "포장재질",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        83.71463012695312,
        669.4716796875,
        515.6002197265625,
        680.4996337890625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Lot #9A",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        83.59469604492188,
        688.8904418945312,
        212.04507446289062,
        708.0694580078125
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "40 ± 2℃",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        83.59469604492188,
        688.8904418945312,
        212.04507446289062,
        708.0694580078125
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "75 ± 5% RH",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        151.59783935546875,
        719.69677734375,
        221.9320831298828,
        730.7247314453125
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0, 3, 6 개월",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        708.3092041015625,
        436.683349609375,
        719.337158203125
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "60 정 병포장",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        708.3092041015625,
        436.683349609375,
        719.337158203125
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Lot #10A",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        708.3092041015625,
        436.683349609375,
        719.337158203125
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Lot #11A",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        727.8478393554688,
        131.17855834960938,
        738.8757934570312
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 38 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 안정성 시험 결과 요약",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        296.6790466308594,
        189.85711669921875,
        307.7070007324219
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 허가 후 안정성시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        641.7819213867188,
        173.4256591796875,
        652.8098754882812
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 3 개 뱃치의 최소, 최대 포장 단위에 대해 장기보존시험을 실시하였으며, 0, 3, 6, 9, 12",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        661.560302734375,
        541.8230590820312,
        672.5882568359375
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개월 동안 시험하였다. 향후 연간 모니터링할 예정이다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        77.11820220947266,
        681.3386840820312,
        358.22943115234375,
        692.3666381835938
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 매년 1 개 이상 제조단위를 가지고 장기보존시험을 수행할 것이다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        701.1170654296875,
        415.67828369140625,
        712.14501953125
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 사용기간은 3 개 이상 제조단위의 장기보존시험 결과에 따라 연장될 수 있을 것이다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        720.8954467773438,
        509.107666015625,
        731.9234008789062
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 허가 후 안정성시험에서 부적합이 될 경우, 해당 뱃치를 회수할 것이다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        740.673828125,
        439.78521728515625,
        751.7017822265625
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Lot #9A",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        83.59469604492188,
        104.64891052246094,
        212.04507446289062,
        123.82795715332031
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25 ± 2℃",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        83.59469604492188,
        104.64891052246094,
        212.04507446289062,
        123.82795715332031
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "60 ± 5% RH",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        151.59783935546875,
        135.4552459716797,
        221.9320831298828,
        146.48318481445312
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0, 3, 6, 9, 12 개월",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        124.06770324707031,
        436.683349609375,
        135.09564208984375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "60 정 병포장",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        124.06770324707031,
        436.683349609375,
        135.09564208984375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Lot #10A",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        124.06770324707031,
        436.683349609375,
        135.09564208984375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Lot #11A",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        143.60633850097656,
        131.17855834960938,
        154.63427734375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Lot #9A",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        83.59469604492188,
        163.02511596679688,
        212.04507446289062,
        182.2041473388672
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "40 ± 2℃",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        83.59469604492188,
        163.02511596679688,
        212.04507446289062,
        182.2041473388672
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "75 ± 5% RH",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        151.59783935546875,
        193.83145141601562,
        221.9320831298828,
        204.85939025878906
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0, 3, 6 개월",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        182.44390869140625,
        439.9212646484375,
        193.4718475341797
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "500 정 병포장",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        182.44390869140625,
        439.9212646484375,
        193.4718475341797
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Lot #10A",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        182.44390869140625,
        439.9212646484375,
        193.4718475341797
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Lot #11A",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        201.9825439453125,
        131.17855834960938,
        213.01048278808594
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Lot #9A",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        83.59469604492188,
        221.4013214111328,
        212.04507446289062,
        240.58035278320312
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25 ± 2℃",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        83.59469604492188,
        221.4013214111328,
        212.04507446289062,
        240.58035278320312
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "60 ± 5% RH",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        151.59783935546875,
        252.20767211914062,
        221.9320831298828,
        263.2356262207031
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0, 3, 6, 9, 12 개월",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        240.82009887695312,
        439.9212646484375,
        251.84803771972656
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "500 정 병포장",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        240.82009887695312,
        439.9212646484375,
        251.84803771972656
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Lot #10A",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        240.82009887695312,
        439.9212646484375,
        251.84803771972656
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Lot #11A",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.23651123046875,
        260.3587646484375,
        131.17855834960938,
        271.38671875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가속시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        281.12762451171875,
        320.7727355957031,
        492.9322204589844,
        331.8006896972656
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "장기보존시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        281.12762451171875,
        320.7727355957031,
        492.9322204589844,
        331.8006896972656
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함량 (90-110%)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.03878784179688,
        357.45263671875,
        160.79421997070312,
        368.4805908203125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상 없음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        278.48907470703125,
        346.1849670410156,
        327.9019775390625,
        357.2129211425781
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "98-102.1% 범위 내에 있음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        232.553955078125,
        368.7203369140625,
        373.83740234375,
        379.748291015625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상 없음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.1241760253906,
        337.31463623046875,
        484.6573486328125,
        348.34259033203125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "98.7-101.5% 범위 내에",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        398.1842041015625,
        359.9698791503906,
        525.2714233398438,
        370.9978332519531
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        448.91668701171875,
        377.47076416015625,
        470.9847412109375,
        388.49871826171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 RC 2 (0.5% 이하)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.03878784179688,
        405.4002380371094,
        219.6824951171875,
        416.4281921386719
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상 없음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        278.48907470703125,
        394.132568359375,
        327.9019775390625,
        405.1605224609375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1-0.2% 범위 내에 있음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        237.47129821777344,
        416.7878112792969,
        368.7998046875,
        427.8157653808594
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상 없음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.1241760253906,
        394.132568359375,
        484.6573486328125,
        405.1605224609375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1-0.2% 범위 내에 있음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        394.2263488769531,
        416.7878112792969,
        525.5548095703125,
        427.8157653808594
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유연물질 RC 3 (0.5% 이하)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.03878784179688,
        444.597412109375,
        219.6824951171875,
        455.6253662109375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상 없음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        278.48907470703125,
        433.3297119140625,
        327.9019775390625,
        444.357666015625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1-0.2% 범위 내에 있음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        237.47129821777344,
        455.9849548339844,
        368.7998046875,
        467.0129089355469
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상 없음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.1241760253906,
        433.3297119140625,
        484.6573486328125,
        444.357666015625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1-0.2% 범위 내에 있음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        394.2263488769531,
        455.9849548339844,
        525.5548095703125,
        467.0129089355469
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개개 유연물질 (0.2% 이하)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.03878784179688,
        483.9144287109375,
        214.4053497314453,
        494.9423828125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상 없음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        278.48907470703125,
        472.5268859863281,
        327.9019775390625,
        483.5548400878906
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05-0.1% 범위 내에 있음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        234.23304748535156,
        495.18212890625,
        372.1582946777344,
        506.2100830078125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상 없음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.1241760253906,
        472.5268859863281,
        484.6573486328125,
        483.5548400878906
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05-0.1% 범위 내에 있음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        390.98809814453125,
        495.18212890625,
        528.913330078125,
        506.2100830078125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 유연물질 (1.0% 이하)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.03878784179688,
        523.111572265625,
        203.371337890625,
        534.1395263671875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "증가 경향 보임(0.7%)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        247.665771484375,
        511.72406005859375,
        358.68798828125,
        522.7520141601562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.5 - 0.8% 범위 내에 있음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        232.07421875,
        534.3792724609375,
        374.317138671875,
        545.4072265625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상 없음 (<0.3%)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        411.9767150878906,
        511.72406005859375,
        507.7654113769531,
        522.7520141601562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "< 0.3% 범위 내에 있음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        399.6234130859375,
        534.3792724609375,
        520.1580810546875,
        545.4072265625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용출",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.03878784179688,
        551.0410766601562,
        532.6312866210938,
        562.0690307617188
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합 (93-98%), S1만 적용",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.03878784179688,
        551.0410766601562,
        532.6312866210938,
        562.0690307617188
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합 (95-100%), S1만 적용",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.03878784179688,
        551.0410766601562,
        532.6312866210938,
        562.0690307617188
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수분(0.5% 이하)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.03878784179688,
        578.8507080078125,
        159.47512817382812,
        589.878662109375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상 없음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        278.48907470703125,
        567.5830078125,
        327.9019775390625,
        578.6109619140625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.1-5.5% 범위 내에 있음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        237.47129821777344,
        590.2382202148438,
        368.7998046875,
        601.2661743164062
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상 없음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        435.1241760253906,
        567.5830078125,
        484.6573486328125,
        578.6109619140625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.1-5.5% 범위 내에 있음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        394.2263488769531,
        590.2382202148438,
        525.5548095703125,
        601.2661743164062
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성상",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.03878784179688,
        606.7801513671875,
        470.9847412109375,
        617.80810546875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.03878784179688,
        606.7801513671875,
        470.9847412109375,
        617.80810546875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        76.03878784179688,
        606.7801513671875,
        470.9847412109375,
        617.80810546875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 39 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 무균제제",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        99.01507568359375,
        116.81635284423828,
        110.04302215576172
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 무균제제의 경우 안정성시험 조건‧시험항목 등에 대해 비무균제제와 다르지 않으나, 시험항목",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        118.79345703125,
        541.9436645507812,
        129.82139587402344
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "중 미생물관련 특성에 대하여 별도로 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        73.04041290283203,
        138.5718536376953,
        307.37701416015625,
        149.59979248046875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.8.1 안정성 요약 및 결론",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        158.35023498535156,
        218.16143798828125,
        169.378173828125
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 무균시험 등과 관련된 안정성시험에 대해 요약하여 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        178.1286163330078,
        394.5428161621094,
        189.15655517578125
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.P.8.2 허가 후 안정성시험 계획과 이행서약",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        217.68539428710938,
        300.6767272949219,
        228.7133331298828
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 허가 후 수행할 안정성시험 항목 중 무균시험 등 다음 사항을 포함하여 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        237.46377563476562,
        495.1951904296875,
        248.49171447753906
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험항목",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        262.8760070800781,
        348.5307922363281,
        273.9039611816406
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        262.8760070800781,
        348.5307922363281,
        273.9039611816406
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허용기준",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        262.8760070800781,
        348.5307922363281,
        273.9039611816406
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "엔도톡신",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        282.2947692871094,
        308.1893615722656,
        293.3227233886719
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "무균",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        299.91552734375,
        419.7289123535156,
        312.86138916015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 안정성시험 시점",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        327.24566650390625,
        162.39199829101562,
        338.27362060546875
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        362.3672790527344,
        96.06759643554688,
        373.3952331542969
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시점 (개월)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        182.90087890625,
        352.65789794921875,
        240.67111206054688,
        363.68585205078125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        182.90087890625,
        372.07666015625,
        430.30303955078125,
        383.1046142578125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        182.90087890625,
        372.07666015625,
        430.30303955078125,
        383.1046142578125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        182.90087890625,
        372.07666015625,
        430.30303955078125,
        383.1046142578125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        182.90087890625,
        372.07666015625,
        430.30303955078125,
        383.1046142578125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        182.90087890625,
        372.07666015625,
        430.30303955078125,
        383.1046142578125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "15",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        182.90087890625,
        372.07666015625,
        430.30303955078125,
        383.1046142578125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "18",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        182.90087890625,
        372.07666015625,
        430.30303955078125,
        383.1046142578125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "24",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        182.90087890625,
        372.07666015625,
        430.30303955078125,
        383.1046142578125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "36",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        182.90087890625,
        372.07666015625,
        430.30303955078125,
        383.1046142578125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "엔도톡신",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        391.61529541015625,
        425.2585754394531,
        402.64324951171875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        391.61529541015625,
        425.2585754394531,
        402.64324951171875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        391.61529541015625,
        425.2585754394531,
        402.64324951171875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        391.61529541015625,
        425.2585754394531,
        402.64324951171875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        391.61529541015625,
        425.2585754394531,
        402.64324951171875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "무균",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        406.23931884765625,
        453.910400390625,
        422.0620422363281
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        406.23931884765625,
        453.910400390625,
        422.0620422363281
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        406.23931884765625,
        453.910400390625,
        422.0620422363281
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.8.3 안정성자료",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        456.2247009277344,
        168.74786376953125,
        467.2526550292969
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안정성자료에서는 용기/마개 완전성, 무균, 엔도톡신 등을 포함해 시험 결과를 요약 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        476.0030822753906,
        537.7721557617188,
        487.0310363769531
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 40 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 46,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.A 부록(Appendices)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        107.06221771240234,
        196.24972534179688,
        119.04911804199219
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.A.1 시설과 설비(Facilities and Equipment)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        128.63864135742188,
        323.3082275390625,
        140.6255340576172
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.A.1에 기재된 시설에 관한 내용의 요약이 포함되어야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        155.11376953125,
        377.4190673828125,
        166.14170837402344
      ],
      "page_num": 46,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.A.2 외래성 물질에 대한 안전성 평가(Adventitious Agents Safety Evaluation)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        209.5502166748047,
        519.1620483398438,
        221.537109375
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생산 시 내인성 및 외래성 물질을 관리하기 위하여 실행된 방법에 대한 고찰이 포함되어야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        236.0253448486328,
        538.1319580078125,
        247.05328369140625
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.A.2의 바이러스 제거 감소인수(reduction factor)에 대한 도표로 된 요약을 제공한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        255.80374145507812,
        510.18707275390625,
        266.8316955566406
      ],
      "page_num": 46,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.A.3 첨가제(Excipients)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        310.24017333984375,
        208.53041076660156,
        322.2270812988281
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.R. 지역별 정보(Regional Information)",
      "font_size": 11.99020004272461,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        366.3388366699219,
        291.6453857421875,
        378.32574462890625
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필요에 따라 3.2.R에 기재된 지역별 요구 사항에 대하여 간략하게 기재한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        392.9338684082031,
        443.863037109375,
        403.9618225097656
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 41 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 47,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Appendix. 속방성 및 서방성 제제의 개발경위 기재 예시 (FDA)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        56.609317779541016,
        99.01507568359375,
        382.55389404296875,
        110.04302215576172
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "<속방성 제제>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        127.13109588623047,
        128.98233032226562,
        201.43081665039062,
        140.01026916503906
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.2.1 완제의약품 조성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        151.75743103027344,
        204.1290283203125,
        162.78536987304688
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.2.1.1 원료의약품",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        171.53582763671875,
        191.89532470703125,
        182.5637664794922
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "완제의약품 개발에 영향을 미칠 것으로 판단되는 원료의약품에 대한 성질을 간단하게",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        191.314208984375,
        536.78515625,
        202.34214782714844
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재하였으며, 원료의약품에 대한 기본적인 정보를 포함한 기타 구체적인 사항은 3.2.S",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        211.09259033203125,
        536.7855224609375,
        222.1205291748047
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원료의약품을 참고한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        230.8709716796875,
        199.55543518066406,
        241.89891052246094
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "완제의약품 개발에 영향을 줄 것으로 판단되는 항목은 용해도, pH에 따른 용해도, 입자도,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        250.64935302734375,
        536.7857666015625,
        261.67730712890625
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결정다형, 안정성 등이 있을 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        270.427734375,
        263.36083984375,
        281.4556884765625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "▪ 용해도 및 pH에 따른 용해도",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        290.2061462402344,
        248.14517211914062,
        301.2341003417969
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.S.1에 요약된 사항을 참고한다. 원료의약품은 생물학약제학적 분류체계(BCS)에",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        309.9845275878906,
        536.7855224609375,
        321.0124816894531
      ],
      "page_num": 47,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라 낮은 용해성 약물로 분류된다. pH에 따라 용해도는 달라지며, pH가 낮을 때",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        97.38722229003906,
        329.7629089355469,
        536.7855224609375,
        340.7908630371094
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용해도가 높다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        97.38722229003906,
        349.5412902832031,
        172.8099365234375,
        360.5692443847656
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "▪ 입자도",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        369.3196716308594,
        134.56707763671875,
        380.3476257324219
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원료의약품의 용해도가 낮으므로 제제에서의 입자도가 중요하다. 아래 그림은 입자",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        389.0980529785156,
        533.1107177734375,
        400.1260070800781
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "도가 용출에 중요한 영향을 미침을 보여준다. 원료의약품이 적절한 입자도(30 um)를",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        97.38722229003906,
        408.8764343261719,
        536.7855224609375,
        419.9043884277344
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가질 때 대조약과 유사한 용출 양상을 보임을 알 수 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        97.38722229003906,
        428.6548156738281,
        391.81121826171875,
        439.6827697753906
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<원료의약품 입자도(D90)에 따른 용출양상 (USP apparatus 2, 50 rpm, pH 4.5)>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        89.83131408691406,
        637.7063598632812,
        507.86370849609375,
        649.4927368164062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "▪ 결정형",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        677.2631225585938,
        134.56707763671875,
        688.2910766601562
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.S.1 일반정보에 결정형에 대해 상세히 기술하였다. 결정형 II 형은 I 형보다 불안",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        697.04150390625,
        533.1110229492188,
        708.0694580078125
      ],
      "page_num": 47,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정하므로, 결정형 I 형을 유지하는 것이 품질 유지에 중요하다. I 형은 안정하고 과립",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        97.38722229003906,
        716.8198852539062,
        533.1110229492188,
        727.8478393554688
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물에서의 용해도가 낮으며, 외부 압력에 대한 영향을 적게 받아 제조공정에 미치는",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        97.38722229003906,
        736.5982666015625,
        536.78515625,
        747.626220703125
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 42 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 48,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "영향이 적을 것으로 판단된다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        97.38722229003906,
        154.51441955566406,
        248.96865844726562,
        165.5423583984375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "▪ 안정성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        174.29281616210938,
        134.56707763671875,
        185.3207550048828
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "√ 문헌연구: 이 약은 가혹조건(열, 빛, 습도)에 대한 문헌 보고서가 있으며, 빛에 대한",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        194.07119750976562,
        536.78515625,
        205.09913635253906
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조건이 안정성에 영향을 미친다고 알려진 바 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        97.38722229003906,
        213.84957885742188,
        353.3121337890625,
        224.8775177001953
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "√ 자체 안정성 연구: 결정형 I 및 II에 대해서 평가가 이루어졌으며, 가속 시험에서 II",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        233.62796020507812,
        536.7858276367188,
        244.65589904785156
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형은 I 형 대비 빨리 분해되고 불순물도 많이 검출되었다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        97.38722229003906,
        253.40634155273438,
        389.89227294921875,
        264.4342956542969
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.2.1.2 첨가제",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        292.963134765625,
        169.94757080078125,
        303.9910888671875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대조약에서 유당수화물, 스테아르산마그네슘, 미결정셀룰로오스를 사용하는 것으로 파악",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        312.74151611328125,
        533.1110229492188,
        323.76947021484375
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되므로, 위 첨가제는 원료의약품과 배합 가능하다고 판단된다. 또한 배합적합성시험 결과,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        332.5198974609375,
        536.6654663085938,
        343.5478515625
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원료의약품의 분해는 관찰되지 않았으며 상호작용은 없는 것으로 판단된다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        352.29827880859375,
        459.33465576171875,
        363.32623291015625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.2.2 완제의약품",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        391.85504150390625,
        182.18093872070312,
        402.88299560546875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "▪ 대조약(RLD)의 정보 검토",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        411.6334228515625,
        220.32058715820312,
        422.661376953125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "√ 완제의약품 개발 시 속방성 제제의 특성을 같이 고려하여 용출, 함량, 붕해, 안정성,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        431.41180419921875,
        536.7857666015625,
        442.43975830078125
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "순도 및 정제로서의 특성이 중요할 것으로 판단되었으며,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        451.1902160644531,
        375.380126953125,
        462.2181701660156
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "√ 특히 USP 각조에 따르면 대조약은 pH 4.5 완충액에서 30 분 안에 즉시 용출된다고",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        470.9685974121094,
        536.6648559570312,
        481.9965515136719
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기술되어 있으므로 생동성을 보증하는데 빠른 용출이 중요할 것으로 판단된다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        490.7469787597656,
        485.2406005859375,
        501.7749328613281
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "▪ 목표 제품 설계 방법",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        530.3037719726562,
        195.01431274414062,
        541.3317260742188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조공정개발 시 최종 완제의약품의 품질 보증을 위해 다음 특성을 규정하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        550.0821533203125,
        496.27459716796875,
        561.110107421875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "√ 완제의약품에서의 원료의약품 입자도",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        589.638916015625,
        295.7593994140625,
        600.6668701171875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "√ 완제의약품에서의 원료의약품 결정다형",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        609.4172973632812,
        306.79339599609375,
        620.4452514648438
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "√ 완제의약품에서의 붕해도",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        629.1956787109375,
        235.3121337890625,
        640.2236328125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "√ 완제의약품에서의 용출",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        648.9740600585938,
        224.39837646484375,
        660.0020141601562
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "√ 완제의약품의 경도",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        668.75244140625,
        202.33001708984375,
        679.7803955078125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 43 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 49,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "▪ 첨가제",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        298.4770812988281,
        127.2071304321289,
        309.5050354003906
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "첨가제 종류 및 등급 선정은 기사용례와  대조약 분석을 바탕으로 하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        318.2554931640625,
        468.6895751953125,
        329.283447265625
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 공정에 사용되는 방식인 습식과립법을 기준으로 각 첨가제에 대해 추천되는 등급",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        338.03387451171875,
        533.1110229492188,
        349.06182861328125
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(입자도 포함)을 사용하였으며, 유당수화물은 ... , 미결정셀룰로오스는 평균입도 ... ,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        357.812255859375,
        536.7857666015625,
        368.8402099609375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수분함량 ... 인 것을, 스테아르산마그네슘은 입도 ... 을 사용하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        377.59063720703125,
        434.26824951171875,
        388.61859130859375
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "▪ 제제 조성 최적화",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        417.14739990234375,
        178.46295166015625,
        428.17535400390625
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제제 조성을 최적화하기 위해, 각 제제 조성에 대한 함량균일성시험 및 30 분간의",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        436.92578125,
        536.7854614257812,
        447.9537353515625
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용출시험을 수행하였다. 모든 제제 조성에 대해서 용출시험이 적합하였고 함량균일성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        456.70416259765625,
        533.1109008789062,
        467.73211669921875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험 결과(RSD)는 2.0 % 미만이었다. 붕해제 함량은 용출에 영향을 미치는 중요 인자",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        476.4825744628906,
        533.1107177734375,
        487.5105285644531
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "였으며, 연구 결과 붕해제 함량은 2.5 % 이상이어야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        496.2609558105469,
        382.2164306640625,
        507.2889099121094
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.2.4 용기 및 포장",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        535.9375610351562,
        193.09500122070312,
        546.9655151367188
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "광안정성시험 결과를 참조하여 차광이 되는 1차 포장 용기를 선택하였으며, 이 용기는",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        555.7159423828125,
        536.78515625,
        566.743896484375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미국약전 <661> “Containers-plastics\"에 따른 용기이다. 이 용기를 다시 차광성이 있는",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        575.494384765625,
        536.78515625,
        586.5223388671875
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2차 포장 용기를 사용하여 포장하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        595.2727661132812,
        275.47430419921875,
        606.3007202148438
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 44 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 50,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "<서방성 제제>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        127.13109588623047,
        115.3172607421875,
        201.43081665039062,
        126.34520721435547
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.2 개발경위",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        155.233642578125,
        155.9151611328125,
        166.26158142089844
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.2.1 완제의약품 조성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        175.01202392578125,
        209.6463623046875,
        186.0399627685547
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.2.1.1 원료의약품",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        194.7904052734375,
        197.41265869140625,
        205.81834411621094
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분 ... 의 용량 용해도(dose solubility volume)는 0.68 mL이다 (2.3.S.1 일반정보",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        214.56878662109375,
        536.7855224609375,
        225.5967254638672
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참조). 주성분 ... 는 BCS 분류에 따라 “높은 용해도”를 가지므로, 물리적 특성(결정다형,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        234.34718322753906,
        533.0946655273438,
        245.3751220703125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "입자도)이 최종 제형의 생물약제학적 특성에 미치는 영향은 미미할 것이다. 그리고, 구형",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        254.12554931640625,
        533.1107177734375,
        265.15350341796875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "백당 주성분 층이 형성되기 위해 주성분 ... 가 물에 완전히 용해되므로 입자도 및 결정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        273.9039611816406,
        533.1114501953125,
        284.9319152832031
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다형과 같은 모든 고체 상태 특성들은 제조가능성 및 개발 상황과는 관계가 없을 것이다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        293.6823425292969,
        536.7857666015625,
        304.7102966308594
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "화학적 안정성 면에서 주성분 ... 는 산화에 매우 취약하다. 이는 제제에 항산화제를 추가",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        313.4607238769531,
        533.1114501953125,
        324.4886779785156
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함으로써 해결하였다 (2.3.P.2.2 완제의약품 참조).",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        333.2391052246094,
        336.5216064453125,
        344.2670593261719
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.2.1.2 첨가제",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        372.7958679199219,
        175.46490478515625,
        383.8238220214844
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "초기 제제 조성 단계에 주성분 ... 와 첨가제들 간 배합 부적합성에 대해 알기 위해",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        392.5742492675781,
        536.6655883789062,
        403.6022033691406
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다수의 첨가제들에 대하여 배합적합성시험을 수행하였다. 주성분 ... 와 첨가제들로",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        412.3526306152344,
        536.7841186523438,
        423.3805847167969
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이루어진 구형 백당의 수분 코팅이 이루어지는 제조공정과 유사하게 하기 위하여 물을",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        432.13104248046875,
        536.7858276367188,
        443.15899658203125
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10 % 추가하여 주성분-첨가제 혼합물 200 mg을 밀폐된 바이알에 넣고 50 ℃에 3 주간",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        451.909423828125,
        536.6656494140625,
        462.9373779296875
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방치하였다. 다양한 폴리머, 충진제, 희석제, 가소제들에 대한 3 주간의 예비 배합적합성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        471.68780517578125,
        536.7865600585938,
        482.71575927734375
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험 결과, 유당이 배합 부적합성을 보였다. 이는 주성분 ... 의 구조 중 1차 아민과",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        491.4661865234375,
        536.7854614257812,
        502.494140625
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유당의 glycosidic hydroxyl 간의 반응(Maillard 반응)에 의한 것이었다. 따라서 최종",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        511.24456787109375,
        536.7858276367188,
        522.2725219726562
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제제에서 선택된 모든 첨가제들을 포함하여 일반적으로 사용되는 첨가제들과 주성분",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        531.02294921875,
        536.7854614257812,
        542.0509033203125
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "... 는 배합적합성이 있는 것으로 결론지었다 (2.3.P.1 완제의약품의 개요와 조성 참조).",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        550.8013305664062,
        536.7860717773438,
        561.8292846679688
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그러나 유당 또는 glycosidic hydroxyl 또는 알데히드기를 갖는 다른 첨가제들은",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        570.5797119140625,
        536.7847900390625,
        581.607666015625
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Maillard 반응 가능하므로 사용을 피해야 한다. 상세한 사항은 3.2.P.2.1.2 첨가제를",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        590.3580932617188,
        536.7855224609375,
        601.3860473632812
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참조한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        610.136474609375,
        134.07093811035156,
        621.1644287109375
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "첨가제/등급",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        135.52655029296875,
        645.8574829101562,
        347.05279541015625,
        656.8854370117188
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분 ...  함량(%)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        135.52655029296875,
        645.8574829101562,
        347.05279541015625,
        656.8854370117188
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "최종 제제에",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        374.67694091796875,
        636.9871826171875,
        438.7982482910156,
        648.01513671875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용여부(Y/N)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        368.68017578125,
        654.60791015625,
        441.2010803222656,
        665.6358642578125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "첨가제 없음(대조군)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        114.17811584472656,
        674.0266723632812,
        415.3039245605469,
        685.0546264648438
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "91",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        114.17811584472656,
        674.0266723632812,
        415.3039245605469,
        685.0546264648438
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "N/A",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        114.17811584472656,
        674.0266723632812,
        415.3039245605469,
        685.0546264648438
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구형 백당",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        140.32394409179688,
        693.5653076171875,
        408.74688720703125,
        704.59326171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "90",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        140.32394409179688,
        693.5653076171875,
        408.74688720703125,
        704.59326171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Y",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        140.32394409179688,
        693.5653076171875,
        408.74688720703125,
        704.59326171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에틸셀룰로오스",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        126.53142547607422,
        712.984130859375,
        408.74688720703125,
        724.0120849609375
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "92",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        126.53142547607422,
        712.984130859375,
        408.74688720703125,
        724.0120849609375
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Y",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        126.53142547607422,
        712.984130859375,
        408.74688720703125,
        724.0120849609375
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미결정셀룰로오스",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        121.01441192626953,
        732.2830200195312,
        409.25848388671875,
        743.3109741210938
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "90",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        121.01441192626953,
        732.2830200195312,
        409.25848388671875,
        743.3109741210938
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "N",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        121.01441192626953,
        732.2830200195312,
        409.25848388671875,
        743.3109741210938
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 45 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 51,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.P.2.2 완제의약품",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        363.9255676269531,
        176.66357421875,
        374.9535217285156
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대조약과 유사하게 하기 위하여 대조약의 특성에 근거하여 제네릭의약품이 다음 네 가지",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        383.7039489746094,
        536.78515625,
        394.7319030761719
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특성들을 갖도록 할 필요가 있다. 추가 정보는 3.2.P.2.2.1 제제 개발을 참조한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.43911743164062,
        403.4823303222656,
        493.1293640136719,
        414.5102844238281
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 대조약과 약제학적으로 동일하도록 캡슐제형으로 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        423.2607116699219,
        368.66375732421875,
        434.2886657714844
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 캡슐은 코팅 펠렛으로 충진한다. 이는 대조약의 분석 및 허가사항에 근거한 것으로,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        443.03912353515625,
        536.6654663085938,
        454.06707763671875
      ],
      "page_num": 51,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "캡슐을 삼키는데 어려움이 있는 환자들을 위하여 캡슐을 열고 스푼에 펠렛을 섞어서",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        90.67086029052734,
        462.8175048828125,
        536.6658935546875,
        473.845458984375
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "복용할 수 있도록 하는 것이다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        90.67086029052734,
        482.59588623046875,
        249.32846069335938,
        493.62384033203125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 코팅 펠렛의 크기는 1.0 mm 이하로 한다. 이는 대조약이 1.0 mm 이하 크기의 코팅",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        502.374267578125,
        536.6652221679688,
        513.4022216796875
      ],
      "page_num": 51,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "펠렛을 함유하고 있다는 것에 따른 것이다. 이러한 펠렛 크기는 유문 괄약근(pyloric",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        91.2705307006836,
        522.1526489257812,
        536.6673583984375,
        533.1806030273438
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "sphincter)을 통과할 수 있을 만큼 작아서 식전 및 식후 상태 모두에서 비슷한 위 체류",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        91.2705307006836,
        541.9310302734375,
        536.785888671875,
        552.958984375
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간을 나타내도록 한다. 식후 및 식전 생물학적동등성시험이 모두 요구되므로, 식전 및",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        91.2705307006836,
        561.7094116210938,
        536.7855224609375,
        572.7373657226562
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "식후 상태에서 생물학적으로 동등한 서방성 제제를 성공적으로 개발하기 위하여 제품",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        91.2705307006836,
        581.48779296875,
        536.78515625,
        592.5157470703125
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설계 시 1.0 mm 이하의 코팅 펠렛을 사용해야 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        91.2705307006836,
        601.2661743164062,
        357.389892578125,
        612.2941284179688
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 아래 그림에 묘사한 대로, 용출시험 결과 대조약이 속방층(주성분 ... 함량 25%)과 서",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        621.0445556640625,
        533.1110229492188,
        632.072509765625
      ],
      "page_num": 51,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방층(주성분 함량 75%)으로 이루어졌음을 나타냈다. 따라서, 대조약과 생물학적으로",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.18949127197266,
        640.8229370117188,
        536.7847900390625,
        651.8508911132812
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동등한 제네릭의약품을 설계할 때 유사하게 하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.18949127197266,
        660.601318359375,
        354.63140869140625,
        671.6292724609375
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유당",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        153.9965362548828,
        189.51617431640625,
        409.25848388671875,
        200.5441131591797
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        153.9965362548828,
        189.51617431640625,
        409.25848388671875,
        200.5441131591797
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "N",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        153.9965362548828,
        189.51617431640625,
        409.25848388671875,
        200.5441131591797
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "히프로멜로오스",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        126.53142547607422,
        208.93495178222656,
        408.74688720703125,
        219.962890625
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "91",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        126.53142547607422,
        208.93495178222656,
        408.74688720703125,
        219.962890625
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Y",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        126.53142547607422,
        208.93495178222656,
        408.74688720703125,
        219.962890625
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시트르산트리에틸",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        121.01441192626953,
        228.35372924804688,
        408.74688720703125,
        239.3816680908203
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "92",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        121.01441192626953,
        228.35372924804688,
        408.74688720703125,
        239.3816680908203
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Y",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        121.01441192626953,
        228.35372924804688,
        408.74688720703125,
        239.3816680908203
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "디에틸프탈레이트",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        121.01441192626953,
        247.89236450195312,
        409.25848388671875,
        258.9203186035156
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "92",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        121.01441192626953,
        247.89236450195312,
        409.25848388671875,
        258.9203186035156
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "N",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        121.01441192626953,
        247.89236450195312,
        409.25848388671875,
        258.9203186035156
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부틸레이티드히드록시아니솔",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.54930114746094,
        267.3111572265625,
        408.74688720703125,
        278.339111328125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "98",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.54930114746094,
        267.3111572265625,
        408.74688720703125,
        278.339111328125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Y",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        93.54930114746094,
        267.3111572265625,
        408.74688720703125,
        278.339111328125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아스코르브산",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        132.04843139648438,
        286.72991943359375,
        409.25848388671875,
        297.75787353515625
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "95",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        132.04843139648438,
        286.72991943359375,
        409.25848388671875,
        297.75787353515625
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "N",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        132.04843139648438,
        286.72991943359375,
        409.25848388671875,
        297.75787353515625
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "폴리에틸렌글리콜",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        121.01441192626953,
        306.2685852050781,
        408.74688720703125,
        317.2965393066406
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "92",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        121.01441192626953,
        306.2685852050781,
        408.74688720703125,
        317.2965393066406
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Y",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        121.01441192626953,
        306.2685852050781,
        408.74688720703125,
        317.2965393066406
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 46 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "<대조약 용출 양상 (USP Apparatus 1, 100 rpm, 37 ℃)>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        148.11972045898438,
        378.0700988769531,
        449.5759582519531,
        389.0980529785156
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대조약이 속방 및 서방 펠렛으로 구성되었다는 점에 근거하여 제네릭의약품도 속방 및",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        417.62689208984375,
        536.7855224609375,
        428.65484619140625
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서방 펠렛으로 구성하여 비슷한 용출 양상을 갖도록 설계하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.43911743164062,
        437.4052734375,
        402.84527587890625,
        448.4332275390625
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서방 펠렛들은 속도를 조절하는 막(에틸셀룰로오스(소수성 폴리머, 기허가례에 근거하여",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        457.18365478515625,
        536.78515625,
        468.21160888671875
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "선정) 및 시트르산트리에틸(가소제)로 구성)을 코팅하여 약물 방출을 조절하였다. 이러한",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.43911743164062,
        476.9620361328125,
        536.78515625,
        487.989990234375
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시스템에서 수용성 주성분 ... 의 소수성 막 통과가 감소함으로써 약물방출이 약화되고,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.43911743164062,
        496.74041748046875,
        536.6654663085938,
        507.76837158203125
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이는 pH 비의존적으로 이루어진다. 제형 설계와 관련한 상세 정보는 3.2.P.2.2.1 제제",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.43911743164062,
        516.518798828125,
        536.7855224609375,
        527.5467529296875
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개발을 참조한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.43911743164062,
        536.2971801757812,
        162.0157928466797,
        547.3251342773438
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개발 과정 중, 폴리머의 점도 및 속도 조절 막의 두께가 완제의약품의 용출 양상을 변경할",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        556.0755615234375,
        536.7860107421875,
        567.103515625
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있는 요인인 것으로 확인되었다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.43911743164062,
        575.8539428710938,
        250.6477508544922,
        586.8818969726562
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품 개발 중 두 가지 펠렛 제제 형태들이 평가되었다. 첫 번째 형태(I 형)는 캡슐에 두",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        615.4107055664062,
        536.7855224609375,
        626.4386596679688
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가지 펠렛(속방 펠렛 및 서방 펠렛) 혼합물이 충진된 형태이고, 두 번째 형태(II 형)는",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.43911743164062,
        635.1891479492188,
        536.7855224609375,
        646.2171020507812
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "속방층 및 서방층으로 이루어진 한 가지 다층 펠렛이다. 결국은 속방 및 서방 펠렛 혼합",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.43911743164062,
        654.967529296875,
        533.1110229492188,
        665.9954833984375
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물인 I 형으로 결정되었다. 이 결정은 속방 및 서방 펠렛을 각각 개발하는 것이 훨씬 쉽다는",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.43911743164062,
        674.7459106445312,
        536.7857666015625,
        685.7738647460938
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사실과 기허가 사항에 근거한 것이다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.43911743164062,
        694.5242919921875,
        260.12261962890625,
        705.55224609375
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 47 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 53,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제형설계와 관련한 상세한 정보는 3.2.P.2.2.1 제제 개발을 참조한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        262.3965148925781,
        431.3897705078125,
        273.4244689941406
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "첨가제 선정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        301.95330810546875,
        136.00628662109375,
        312.98126220703125
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분 ... 가 구형 백당에 부착할 수 있도록 돕는 결합제로 Clear coating 732(히프로",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        321.731689453125,
        533.1107177734375,
        332.7596435546875
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "멜로오스와 폴리에틸렌글리콜로 구성)를, 속도 조절막의 구성성분으로 에틸셀룰로오스",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        341.51007080078125,
        533.1123657226562,
        352.53802490234375
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(소수성 폴리머)와 시트르산트리에틸(가소제)를 선택하였다. 이는 기허가 유사 품목에서",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        361.2884521484375,
        536.7861938476562,
        372.31640625
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이들 첨가제들을 사용했던 경험과 주성분 ... 와 이 첨가제들의 배합적합성(2.3.P.2.1.2",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        381.06683349609375,
        536.7842407226562,
        392.09478759765625
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "첨가제 참조)에 근거한 것이다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        400.84521484375,
        238.29444885253906,
        411.8731689453125
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에틸셀룰로오스: 주성분 ... 의 방출을 약화시키는 소수성 폴리머인 에틸셀룰로오스는 다른",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        440.4019775390625,
        536.78564453125,
        451.429931640625
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "점도를 갖는 여러 등급의 제품이 상용화 되어있다. 이 첨가제는 제품 활성과 관련된 주요",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        460.1803894042969,
        536.6656494140625,
        471.2083435058594
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기능을 발휘하므로 어떤 점도가 제품 활성에 효과가 있는지 결정하기 위하여 소규모 실",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        479.9587707519531,
        533.1110229492188,
        490.9867248535156
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "험실 시험에서 여러 등급의 에틸셀룰로오스들을 평가하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        499.7371520996094,
        386.4141845703125,
        510.7651062011719
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<에틸셀룰로오스 점도에 따른 주성분 ...  코팅펠렛의 용출 양상>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        133.3677215576172,
        712.62451171875,
        464.328369140625,
        723.6524658203125
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 48 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 54,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위 결과는 에틸셀룰로오스의 점도가 제품의 활성에 유의한 영향을 미친다는 것을 나타",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        103.33035278320312,
        533.1107177734375,
        114.35830688476562
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "낸다. 따라서, 개발 및 제조 중 첨가제 점도 등급을 엄격히 관리하였다. 기허가 품목에",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        123.10874938964844,
        536.78515625,
        134.13668823242188
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이미 사용되는 에틸셀룰로오스의 등급인 20 mPa.S 점도를 갖는 것을 사용하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        142.8871307373047,
        497.9537353515625,
        153.91506958007812
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구형 백당 : 제품 개발 중, 25 ~ 30 mesh의 입자 분포를 갖는 구형 백당을 선택하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        182.44390869140625,
        536.7857666015625,
        193.4718475341797
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구형 백당의 입자 분포를 제한하는 것은 코팅 표면을 일정하게 하기 위함이다. 일정한",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        202.2222900390625,
        536.78515625,
        213.25022888183594
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표면의 구형 백당은 적용되는 코팅 수준에 따라 두께가 일정한 막으로 된 서방형 펠렛",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        222.00067138671875,
        536.7855224609375,
        233.0286102294922
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조를 가능하게 한다. 이는 일정하고 재현성 있는 약물 용출 양상을 보장하는 중요한",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        241.779052734375,
        536.78515625,
        252.80699157714844
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요소이다. 추가적으로, 입자 크기를 25 ~ 30 mesh로 제한하는 것은 코팅 펠렛이 1.0",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        261.55743408203125,
        536.7860107421875,
        272.58538818359375
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "mm 이하가 되도록 하고, 이는 주성분 ... 흡수에 대한 음식물의 영향을 최소화하는 중요한",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        281.3358154296875,
        536.7860107421875,
        292.36376953125
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요소이다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        301.1142272949219,
        130.80540466308594,
        312.1421813964844
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "첨가제 선택과 관련한 추가 상세 정보는 3.2.P.2.1.2 첨가제를 참조한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        340.6709899902344,
        447.82086181640625,
        351.6989440917969
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "최종 제제의 최적화",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        380.2277526855469,
        174.38516235351562,
        391.2557067871094
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개발 초기 단계에 2.3.P.1 완제의약품의 개요와 조성에 기재된 최종 제제와 정성적으로",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        400.0061340332031,
        536.78515625,
        411.0340881347656
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비슷한 여러 가지 실험실 규모의 연구 제제에 대한 시험을 가속 시험조건(40 ℃/75%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        419.7845153808594,
        536.7862548828125,
        430.8124694824219
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RH, 4 주)에서 실시하였다. 이 시험들은 주성분 ... 가 산화되어 Impurity E 및 가수분해",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        439.5628967285156,
        533.1107177734375,
        450.5908508300781
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "되어 Impurity A(활성 대사체)로 분해되기 쉽다는 것을 나타냈다. 산화가 주된 분해경로",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        459.34130859375,
        533.1107177734375,
        470.3692626953125
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "였으므로 다른 항산화제들을 함유하는 실험실 제제들을 가속 조건(40 ℃/75% RH, 4",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        479.11968994140625,
        536.6660766601562,
        490.14764404296875
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주)에서 시험하였다. 아래 표에 기재한 대로, 아스코르브산과 부틸레이티드히드록시아니",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        498.8980712890625,
        533.1097412109375,
        509.926025390625
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "솔이 항산화 효과를 나타냈으나, 부틸레이티드히드록시아니솔의 효과가 훨씬 우수했으므로",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        518.6764526367188,
        536.7869873046875,
        529.7044067382812
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최종 제제에 선택되었다. 부틸레이티드히드록시아니솔 0.03 mg을 사용하여 제품의 안정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        538.454833984375,
        533.1107177734375,
        549.4827880859375
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성을 갖도록 한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        558.2332153320312,
        172.09033203125,
        569.2611694335938
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가수분해산물인 Impurity A는 활성 대사체로, 안전성 문제에 영향이 없으므로 제품",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        578.0115966796875,
        536.664794921875,
        589.03955078125
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안정성 시험들에서 기록하지 않았다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        597.7899780273438,
        269.4775390625,
        608.8179321289062
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 49 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주성분 함량",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        334.25885009765625,
        110.36973571777344,
        389.1890869140625,
        120.31886291503906
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(%)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        353.6883239746094,
        126.31231689453125,
        369.7934265136719,
        136.26144409179688
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Impurity A",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        409.338134765625,
        110.36973571777344,
        461.6436462402344,
        120.31886291503906
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(%)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        427.4483337402344,
        126.31231689453125,
        443.5534362792969,
        136.26144409179688
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Impurity E",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        474.9425964355469,
        110.36973571777344,
        526.4865112304688,
        120.31886291503906
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(%)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        492.6929626464844,
        126.31231689453125,
        508.6785888671875,
        136.26144409179688
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "속방 펠렛* (항산화제 무첨가)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        126.89122772216797,
        143.543701171875,
        506.65850830078125,
        154.7212677001953
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "80",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        126.89122772216797,
        143.543701171875,
        506.65850830078125,
        154.7212677001953
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        126.89122772216797,
        143.543701171875,
        506.65850830078125,
        154.7212677001953
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "17",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        126.89122772216797,
        143.543701171875,
        506.65850830078125,
        154.7212677001953
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "속방 펠렛* (+아스코르브산 5.0 mg)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        110.70000457763672,
        162.0035400390625,
        506.65850830078125,
        173.18109130859375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "87",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        110.70000457763672,
        162.0035400390625,
        506.65850830078125,
        173.18109130859375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        110.70000457763672,
        162.0035400390625,
        506.65850830078125,
        173.18109130859375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        110.70000457763672,
        162.0035400390625,
        506.65850830078125,
        173.18109130859375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "속방 펠렛* (+아스코르브산 10.0 mg)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        107.70162963867188,
        180.46336364746094,
        506.65850830078125,
        191.6409149169922
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "89",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        107.70162963867188,
        180.46336364746094,
        506.65850830078125,
        191.6409149169922
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        107.70162963867188,
        180.46336364746094,
        506.65850830078125,
        191.6409149169922
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        107.70162963867188,
        180.46336364746094,
        506.65850830078125,
        191.6409149169922
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "속방 펠렛* (+아스코르브산 20.0 mg)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        107.70162963867188,
        198.92318725585938,
        503.6602478027344,
        210.10073852539062
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "94",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        107.70162963867188,
        198.92318725585938,
        503.6602478027344,
        210.10073852539062
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        107.70162963867188,
        198.92318725585938,
        503.6602478027344,
        210.10073852539062
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        107.70162963867188,
        198.92318725585938,
        503.6602478027344,
        210.10073852539062
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "속방 펠렛 (+부틸레이티드히드록시아니솔 0.01 mg)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        218.6114501953125,
        503.6602478027344,
        228.56057739257812
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "96",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        218.6114501953125,
        503.6602478027344,
        228.56057739257812
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        218.6114501953125,
        503.6602478027344,
        228.56057739257812
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        218.6114501953125,
        503.6602478027344,
        228.56057739257812
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "속방 펠렛 (+부틸레이티드히드록시아니솔 0.03 mg)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        237.07127380371094,
        503.6602478027344,
        247.02040100097656
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "97",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        237.07127380371094,
        503.6602478027344,
        247.02040100097656
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        237.07127380371094,
        503.6602478027344,
        247.02040100097656
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        237.07127380371094,
        503.6602478027344,
        247.02040100097656
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "속방 펠렛 (+부틸레이티드히드록시아니솔 0.06 mg)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        255.53109741210938,
        503.6602478027344,
        265.480224609375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "97",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        255.53109741210938,
        503.6602478027344,
        265.480224609375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        255.53109741210938,
        503.6602478027344,
        265.480224609375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        74.35969543457031,
        255.53109741210938,
        503.6602478027344,
        265.480224609375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 괄호에 기재된 것을 제외하고 2.3.P.1 완제의약품의 개요와 조성에 기재된 제제와 정성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        281.4556884765625,
        533.1110229492188,
        292.483642578125
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적으로 유사함",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        301.23406982421875,
        136.00595092773438,
        312.26202392578125
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품의 생물학적 동등성/생체이용률 최적화",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        340.7908630371094,
        293.9603576660156,
        351.8188171386719
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용출에 미치는 방출 조절막 두께의 효과를 연구하기 위한 일련의 시험들을 수행하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        360.5692443847656,
        536.7857666015625,
        371.5971984863281
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다양한 pH에서 주성분 ... 의 용해도가 유사하고 방출 조절막이 확산으로 제어된다는",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        380.3476257324219,
        536.664306640625,
        391.3755798339844
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사실에 따라 연구용 제제에서 용출이 pH 비의존적이라는 것을 알아냈다. 이는 pH에",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        400.1260070800781,
        536.7855224609375,
        411.1539611816406
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따른 대조약의 관찰된 용출 양상과 일치하였다. 따라서 서방 코팅(6%, 11%, 16%)의",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        419.9043884277344,
        536.7855224609375,
        430.9323425292969
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세 가지 연구용 제제를 설계하여 pH 6.8에서 대조약 용출 양상과 비교하였다. 이 시험",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        439.6827697753906,
        536.7855224609375,
        450.7107238769531
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과, 최종 생물학적동등성시험용 제제로 11% 서방코팅한 제제를 선택하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        459.4611511230469,
        481.76251220703125,
        470.4891052246094
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<용출시험결과(USP Apparatus 1, 100rpm, 37℃, pH 6.8)>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        144.6416015625,
        687.6917114257812,
        452.9342346191406,
        698.7196655273438
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.2.3 제조공정개발",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        727.24853515625,
        187.69760131835938,
        738.2764892578125
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 50 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 56,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "코팅 공정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        103.33035278320312,
        124.9722671508789,
        114.35830688476562
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "완제의약품을 제조하기 위하여, bottom spray coating(Wurster coating) 공정을 속방",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        123.10874938964844,
        536.7855224609375,
        134.13668823242188
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "펠렛에서 구형백당-주성분 층화 공정 및 서방 펠렛에서 기능성 서방 코팅 공정에 채택하",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        142.8871307373047,
        533.1107177734375,
        153.91506958007812
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "였다. 이 공정을 선택한 사유는 크게 두 가지가 있다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        162.66551208496094,
        351.0333251953125,
        173.69345092773438
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. Wuster 공정은 매우 일정한 코팅을 가능하게 한다. 공정 설계 관점에서, 이는 함량",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        182.44390869140625,
        533.1107177734375,
        193.4718475341797
      ],
      "page_num": 56,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "균일성(구형 백당에 일정량의 주성분 코팅) 및 재현성 있는 약물방출(일정한 서방 코",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        101.94474792480469,
        202.2222900390625,
        533.1110229492188,
        213.25022888183594
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "팅층)을 보장하는데 매우 중요하다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        101.94474792480469,
        222.00067138671875,
        279.6719970703125,
        233.0286102294922
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. Wurster 코팅 공정 구현 및 유사한 기능성 서방 코팅 기전에 대한 제조 관련 사전",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        241.779052734375,
        536.7855224609375,
        252.80699157714844
      ],
      "page_num": 56,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지식",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        102.06468200683594,
        261.55743408203125,
        124.13272094726562,
        272.58538818359375
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "캡슐 충진공정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        301.1142272949219,
        152.43704223632812,
        312.1421813964844
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다른 제품의 충진 공정에 이용한 사전 지식에 기초하여 dosing disk와 질량 분급을",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        320.8926086425781,
        536.6644287109375,
        331.9205627441406
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이용한 캡슐 충진 공정을 선택하였다. 하나의 캡슐에 충진된 두 가지 펠렛으로 제형을",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        340.6709899902344,
        536.6644287109375,
        351.6989440917969
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설계한 사실이 캡슐 충진 공정의 활용을 필요하게 한다. 제조공정과 관련한 추가 상세",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        360.4493713378906,
        536.664794921875,
        371.4773254394531
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정보는 3.2.P.2.3 제조공정 개발을 참조한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        380.2277526855469,
        310.97503662109375,
        391.2557067871094
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "완제의약품 품질과 관련된 제조공정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        419.7845153808594,
        262.2975158691406,
        430.8124694824219
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "완제의약품 품질 특성들과 관련 있는 공정 단계들에 대한 매트릭스를 구성하였다. 약물",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        439.5628967285156,
        536.78515625,
        450.5908508300781
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품질에 높은 영향력을 갖는 공정단계가 확인된다. 공정단계가 성공적으로 진행되었음을",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        459.34130859375,
        536.7847900390625,
        470.3692626953125
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보장하기 위하여 이들 위치에서 공정 시험/관리(In-process tests/controls)가 시행된다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        479.11968994140625,
        529.376708984375,
        490.14764404296875
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원료",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        226.5572052001953,
        505.8504638671875,
        485.7364196777344,
        516.87841796875
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약물 층화",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        226.5572052001953,
        505.8504638671875,
        485.7364196777344,
        516.87841796875
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서방 코팅",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        226.5572052001953,
        505.8504638671875,
        485.7364196777344,
        516.87841796875
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "캡슐충진",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        226.5572052001953,
        505.8504638671875,
        485.7364196777344,
        516.87841796875
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "순도",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        101.3450698852539,
        525.3890991210938,
        248.625244140625,
        536.4170532226562
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "높음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        101.3450698852539,
        525.3890991210938,
        248.625244140625,
        536.4170532226562
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함량/함량균일성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        101.3450698852539,
        544.8079223632812,
        474.7024230957031,
        555.8358764648438
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "높음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        101.3450698852539,
        544.8079223632812,
        474.7024230957031,
        555.8358764648438
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "높음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        101.3450698852539,
        544.8079223632812,
        474.7024230957031,
        555.8358764648438
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용출",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        101.3450698852539,
        564.2266845703125,
        474.7024230957031,
        575.254638671875
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "높음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        101.3450698852539,
        564.2266845703125,
        474.7024230957031,
        575.254638671875
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "높음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        101.3450698852539,
        564.2266845703125,
        474.7024230957031,
        575.254638671875
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "높음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        101.3450698852539,
        564.2266845703125,
        474.7024230957031,
        575.254638671875
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안정성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        101.3450698852539,
        583.7653198242188,
        399.383544921875,
        594.7932739257812
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "높음",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        101.3450698852539,
        583.7653198242188,
        399.383544921875,
        594.7932739257812
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "요약하면, 대조약과 유사한 용출 양상을 구현하도록 속방 및 서방 펠렛을 혼합하여",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        610.615966796875,
        536.7850341796875,
        621.6439208984375
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "캡슐화하는 것으로 제품이 설계되었다. 적절한 약물 방출 프로파일에 근거하여 중요",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        630.3943481445312,
        536.7850952148438,
        641.4223022460938
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공정단계들로 1) 약물 층화(속방 펠렛 제조), 2) 서방코팅(서방 펠렛 제조), 3) 캡슐충진",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        650.1727294921875,
        533.1117553710938,
        661.20068359375
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(속방 및 서방 펠렛 충진)을 확인하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        669.9511108398438,
        286.86810302734375,
        680.9790649414062
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중요공정변수",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        709.5078735351562,
        146.91970825195312,
        720.5358276367188
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약물층화 공정: 약물층화 공정은 완제품의 함량균일성 뿐만 아니라 코팅 효율성에 직접",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        729.2862548828125,
        533.1110229492188,
        740.314208984375
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 51 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 57,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적으로 영향을 미치므로 제조공정 중 중요단계로 확인되었다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        103.33035278320312,
        397.3282470703125,
        114.35830688476562
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약물층화 공정에 대한 중요공정변수 및 최적 세팅은 동일한 크기 분포 및 다공성을 갖는",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        123.10874938964844,
        536.785888671875,
        134.13668823242188
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구형 백당에 약물을 코팅하는 유사한 제품에서의 사전 지식에 근거하여 확인하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        142.8871307373047,
        536.7857666015625,
        153.91506958007812
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그리고, 7” Wurster에서 확인된 중요공정변수에 대하여 실험실 규모 시험(3 kg 뱃치)을",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        162.66551208496094,
        536.7855224609375,
        173.69345092773438
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수행하였다. 약물층화 공정에 대한 중요공정변수는 약물층화액의 분무속도, Bed 온도,",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        182.44390869140625,
        536.7857666015625,
        193.4718475341797
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "약물미립화 압력, 그리고 유동층 기체 부피인 것으로 확인되었다. 가장 중요하게 이",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        202.2222900390625,
        536.6652221679688,
        213.25022888183594
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험들은 분무 방울 크기를 20 μm로 하는 것이 구형 백당에 약물을 입히는 공정에",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        222.00067138671875,
        536.7854614257812,
        233.0286102294922
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "중요하고 분무 속도와 약물미립화 기압 공정변수들을 통해 달성되는 것으로 확립되었다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        241.779052734375,
        530.0963134765625,
        252.80699157714844
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "요약하면, 최적화된 공정에서, 함량 98~101 %를 나타내는 펠렛으로 코팅 효율성이",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        261.55743408203125,
        536.78515625,
        272.58538818359375
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "98.0 %였다. 실험실 규모 뱃치 시험의 자세한 결과는 3.2.P.2.3 제조공정 개발을 참조한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        281.3358154296875,
        531.5355224609375,
        292.36376953125
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<최적화된 약물 층화 공정변수 세팅(7” Wurster (89 mm partition))>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        119.69512939453125,
        320.8926086425781,
        478.00091552734375,
        331.9205627441406
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 약물층화 공정에서, 주성분 ... , clear coating 732(결합제), 그리고 부틸레이티드히드록",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        655.6867065429688,
        533.1100463867188,
        666.7146606445312
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시아니솔(안정화제)을 10% w/ 부틸레이티드히드록시아니솔 수용액 상태로 분무한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        675.465087890625,
        496.27459716796875,
        686.4930419921875
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서방코팅 공정 : 제네릭의약품의 기능에 따라, 기능성 코팅 공정이 완제의약품 제조공정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        715.0218505859375,
        533.1107177734375,
        726.0498046875
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서 중요 단계로 확인되었다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        734.8002319335938,
        238.05458068847656,
        745.8281860351562
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정변수",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        94.62871551513672,
        345.5527038574219,
        401.30206298828125,
        355.5018310546875
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설정값",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        94.62871551513672,
        345.5527038574219,
        401.30206298828125,
        355.5018310546875
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사유",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        94.62871551513672,
        345.5527038574219,
        401.30206298828125,
        355.5018310546875
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유동화 기체 부피",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        74.59957122802734,
        387.986328125,
        154.59573364257812,
        397.9354553222656
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "80 ~ 100",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        184.1002197265625,
        379.9551086425781,
        239.70680236816406,
        389.90423583984375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "m3/시간",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        189.73716735839844,
        394.66925048828125,
        225.71717834472656,
        405.8468322753906
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구형 백당의 적절한 유동화 상태를 위한 범위",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        258.6997985839844,
        364.0125427246094,
        468.46612548828125,
        373.961669921875
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(동일한 크기 분포 및 다공성을 갖는 구형 백당에 약물을",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        258.6997985839844,
        379.9551086425781,
        527.3104858398438,
        389.90423583984375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "코팅하는 유사한 제품에서의 사전 지식 및 실험실 규모에",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        258.6997985839844,
        395.897705078125,
        523.8756103515625,
        405.8468322753906
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서의 확증시험에 근거함)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        258.6997985839844,
        411.96014404296875,
        372.3126525878906,
        421.9092712402344
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bed 온도",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        92.8296890258789,
        454.3937683105469,
        235.79220581054688,
        464.3428955078125
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "35 ~ 45 ℃",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        92.8296890258789,
        454.3937683105469,
        235.79220581054688,
        464.3428955078125
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "35 ℃보다 낮아지면 용매의 증발이 너무 적게 일어나서",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        258.6997985839844,
        430.41998291015625,
        527.3099975585938,
        440.3691101074219
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "core가 응집되어 수율이 낮아질 수 있고, 45 ℃보다 높",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        258.6997985839844,
        446.362548828125,
        523.8760375976562,
        456.3116760253906
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아지면 증발을 증가시켜 약물/결합제가 펠렛 중심에 부착",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        258.6997985839844,
        462.30511474609375,
        523.8760375976562,
        472.2542419433594
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하기 어려워져 코팅효율성 및 함량균일성이 떨어짐",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        258.6997985839844,
        478.3675842285156,
        493.53204345703125,
        488.31671142578125
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분무속도*",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        92.11007690429688,
        520.8011474609375,
        245.1471405029297,
        530.7503051757812
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "15 ~ 20 mL/분",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        92.11007690429688,
        520.8011474609375,
        245.1471405029297,
        530.7503051757812
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "낮은 분무속도는 방울 크기를 감소시키고 증발을 높여서",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        258.6997985839844,
        496.827392578125,
        527.3104858398438,
        506.7765197753906
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약물/결합제가 펠렛 중심에 부착하기 어려워짐에 따라 코",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        258.6997985839844,
        512.7699584960938,
        523.8760375976562,
        522.7191162109375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "팅효율성 및 함량균일성이 떨어짐. 빠른 분무속도는 방울",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        258.6997985839844,
        528.7125244140625,
        527.3104858398438,
        538.6616821289062
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "크기를 증가시켜서 제품이 응집되어 수율이 낮아짐",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        258.6997985839844,
        544.7749633789062,
        493.53204345703125,
        554.72412109375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약물미세화 기압",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        77.11820220947266,
        591.6437377929688,
        225.4149627685547,
        601.5928955078125
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.0 bar",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        77.11820220947266,
        591.6437377929688,
        225.4149627685547,
        601.5928955078125
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "최적 분무속도에서 약물미세화 기압을 1.0 bar로 하면",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        258.6997985839844,
        567.669921875,
        527.3104858398438,
        577.6190795898438
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20 μm 크기의 방울이 만들어진다. 약물미세화 기압이",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        258.6997985839844,
        583.7323608398438,
        527.3104858398438,
        593.6815185546875
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.5 bar를 초과하면 과도한 펠렛 속성을 갖게 되므로 이",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        258.6997985839844,
        599.6749877929688,
        523.8760375976562,
        609.6241455078125
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "를 피해야 함",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        258.6997985839844,
        615.6175537109375,
        318.54736328125,
        625.5667114257812
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주입 기체 온도",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        638.6323852539062,
        483.72607421875,
        648.58154296875
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "45 ~ 55 ℃",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        638.6323852539062,
        483.72607421875,
        648.58154296875
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Wurster의 건조/습도 기록지를 이용하여 계산됨.",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        79.6368408203125,
        638.6323852539062,
        483.72607421875,
        648.58154296875
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 52 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 58,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서방코팅 공정에 대한 중요공정변수들은 통계적 실험설계(DOE)를 이용하여 확인하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        103.33035278320312,
        536.7857666015625,
        114.35830688476562
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통계적 실험설계의 1차 목적은 공정변수의 영향을 결정하여 코팅효율성을 최대화하는",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        123.10874938964844,
        536.7857055664062,
        134.13668823242188
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "것이었고, 2차 목적은 최적화된 공정을 통해 완전히 바로잡힌, 즉 사용기간 동안 일관성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        142.8871307373047,
        536.7855834960938,
        153.91506958007812
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는 방출 프로파일을 유지하는 제품을 만들어내는 것이었다. 실험설계는 몇 가지 공정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        162.66551208496094,
        533.1107177734375,
        173.69345092773438
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "변수를 극도로 하여 시험하는 것으로 설정되었고, 이 공정변수의 극도값은 다른 제품에",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        182.44390869140625,
        533.111083984375,
        193.4718475341797
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서의 Wurster 코팅 공정 및 문헌 등을 통해 얻어진 사전 지식에 기초하여 선택되었다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        202.2222900390625,
        523.0201416015625,
        213.25022888183594
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실험설계 시험의 결과는 아래에 요약하였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        222.00067138671875,
        314.93292236328125,
        233.0286102294922
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<DOE CR Process Variables Studied>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        196.09371948242188,
        261.43756103515625,
        401.6018371582031,
        272.46551513671875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정변수",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        142.72264099121094,
        284.5722961425781,
        443.9993591308594,
        295.6002502441406
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "최소",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        142.72264099121094,
        284.5722961425781,
        443.9993591308594,
        295.6002502441406
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "최대",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        142.72264099121094,
        284.5722961425781,
        443.9993591308594,
        295.6002502441406
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bed 온도",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        140.80369567871094,
        303.9910583496094,
        445.07879638671875,
        315.0190124511719
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "40℃",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        140.80369567871094,
        303.9910583496094,
        445.07879638671875,
        315.0190124511719
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "70℃",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        140.80369567871094,
        303.9910583496094,
        445.07879638671875,
        315.0190124511719
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약물미세화 기압",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        123.53305053710938,
        323.40985107421875,
        447.529052734375,
        334.43780517578125
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1 bar",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        123.53305053710938,
        323.40985107421875,
        447.529052734375,
        334.43780517578125
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5 bar",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        123.53305053710938,
        323.40985107421875,
        447.529052734375,
        334.43780517578125
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유동화 기체 부피",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        120.77454376220703,
        341.4294128417969,
        465.3478088378906,
        353.9764404296875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "70 m3/시간",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        120.77454376220703,
        341.4294128417969,
        465.3478088378906,
        353.9764404296875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "150 m3/시간",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        120.77454376220703,
        341.4294128417969,
        465.3478088378906,
        353.9764404296875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분무 속도",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        139.96414184570312,
        362.3672790527344,
        458.0317687988281,
        373.3952331542969
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10 mL/분",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        139.96414184570312,
        362.3672790527344,
        458.0317687988281,
        373.3952331542969
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "70 mL/분",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        139.96414184570312,
        362.3672790527344,
        458.0317687988281,
        373.3952331542969
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서방 코팅액 농도",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        120.77454376220703,
        381.7860412597656,
        444.2038269042969,
        392.8139953613281
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        120.77454376220703,
        381.7860412597656,
        444.2038269042969,
        392.8139953613281
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "30%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        120.77454376220703,
        381.7860412597656,
        444.2038269042969,
        392.8139953613281
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방울 크기",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        139.96414184570312,
        401.32470703125,
        449.8527526855469,
        412.3526611328125
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5 μm",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        139.96414184570312,
        401.32470703125,
        449.8527526855469,
        412.3526611328125
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "70 μm",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        139.96414184570312,
        401.32470703125,
        449.8527526855469,
        412.3526611328125
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<DOE Response Variables Obtained>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        198.7322998046875,
        447.8338623046875,
        398.9635314941406,
        458.86181640625
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정변수 결과 범위는 코팅 두께 및 코팅 막 완전성 변경에 따라 서방 코팅된 완제의",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        639.624267578125,
        533.1107177734375,
        650.6522216796875
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "약품의 약물방출 프로파일에 대한 예측되는 영향을 나타냈다. 모든 공정변수들은 코팅",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        659.4026489257812,
        536.7855224609375,
        670.4306030273438
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "효율성에 어느 정도의 효과를 가지는 것으로 보였는데, 최대의 효과는 분무속도 및 약",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        679.1810302734375,
        533.1110229492188,
        690.208984375
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물미세화 압력을 공정에서 변경했을 때 관찰되었다. Curing과 관련하여 관찰된 용출 프",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        698.9594116210938,
        533.1110229492188,
        709.9873657226562
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "로파일 유사성 인자(f2 > 50)는 실험설계에서 조사된 코팅 조건들의 범위 하에서 서방",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        718.73779296875,
        533.1110229492188,
        730.5242309570312
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "코팅이 완전히 연합된다는 것을 나타냈고 추가 curing 단계의 필요성이 없어졌다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        738.5161743164062,
        501.67169189453125,
        749.5441284179688
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최소치",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        365.92169189453125,
        470.9685974121094,
        497.7302551269531,
        481.9965515136719
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "최대치",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        365.92169189453125,
        470.9685974121094,
        497.7302551269531,
        481.9965515136719
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "코팅 효율성",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        177.02406311035156,
        490.3873596191406,
        497.3338623046875,
        501.4153137207031
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "75.8%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        177.02406311035156,
        490.3873596191406,
        497.3338623046875,
        501.4153137207031
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "99.2%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        177.02406311035156,
        490.3873596191406,
        497.3338623046875,
        501.4153137207031
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약물방출 (1시간)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        164.07107543945312,
        509.80615234375,
        492.4176940917969,
        520.8341064453125
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        164.07107543945312,
        509.80615234375,
        492.4176940917969,
        520.8341064453125
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        164.07107543945312,
        509.80615234375,
        492.4176940917969,
        520.8341064453125
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약물방출 (4시간)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        164.07107543945312,
        529.3447875976562,
        492.4176940917969,
        540.3727416992188
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        164.07107543945312,
        529.3447875976562,
        492.4176940917969,
        540.3727416992188
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "64%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        164.07107543945312,
        529.3447875976562,
        492.4176940917969,
        540.3727416992188
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약물방출 (8시간)",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        164.07107543945312,
        548.7635498046875,
        492.4176940917969,
        559.79150390625
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "55%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        164.07107543945312,
        548.7635498046875,
        492.4176940917969,
        559.79150390625
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "88%",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        164.07107543945312,
        548.7635498046875,
        492.4176940917969,
        559.79150390625
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약물방출 f2값",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        172.94627380371094,
        568.182373046875,
        241.66900634765625,
        579.96875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "즉시 조제된 것 vs. 60℃에 18시간 보관한 것",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        90.43099212646484,
        577.0526733398438,
        492.6699523925781,
        596.8310546875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "53.1",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        90.43099212646484,
        577.0526733398438,
        492.6699523925781,
        596.8310546875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "97.9",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        90.43099212646484,
        577.0526733398438,
        492.6699523925781,
        596.8310546875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 53 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 59,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험설계 시험의 결과들은 최적 조건을 이용한 3kg 실험실 규모의 서방코팅 뱃치의",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        103.21049499511719,
        536.78515625,
        114.23844146728516
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조를 위해 이용될 수 있는 공정변수를 선택하기 위해 이용되어, 유사성 인자 >50 (즉",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        122.98887634277344,
        533.1110229492188,
        134.01681518554688
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시 조제된 것 vs. 60℃에 18시간 보관한 것), 1시간/4시간/8시간의 약물방출이 각각",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        142.7672576904297,
        536.78515625,
        153.79519653320312
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "<10% / 35% / 65%이고, 코팅 효율성이 95%를 초과하는 완제의약품을 제조하게 하였",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        162.545654296875,
        533.1110229492188,
        173.57359313964844
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 실험설계 시험의 결과를 통해 분무 방울 크기 30 μm가 서방 막의 최적 코팅을 위",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        182.32403564453125,
        533.1110229492188,
        193.3519744873047
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해 절대적으로 중요하다는 것을 알게 되었고, 이는 분무 속도와 약물미세화 기압 공정",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        202.1024169921875,
        533.1110229492188,
        213.13035583496094
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "변수들을 적절히 조합하였기 때문이다. 최적화된 공정 세팅은 아래 표와 같다. 서방 막",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        221.88079833984375,
        533.1110229492188,
        232.9087371826172
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 완전성은 전자현미경 스캐닝을 통해 추가적으로 평가 및 확인되었다. 최적화된 뱃치",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        241.65919494628906,
        533.1107177734375,
        252.6871337890625
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 코팅 공정 효율성은 99.0%였다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        261.43756103515625,
        264.800048828125,
        272.46551513671875
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실험설계 구성, 실험실 규모의 결과, 최적 공정변수 선택사유, 그리고 최적화된 3kg 규",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        281.2159729003906,
        533.1110229492188,
        292.2439270019531
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모 뱃치에서의 결과들에 대한 상세한 내용은 3.2.P.2.3항을 참조한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        86.47313690185547,
        300.9943542480469,
        438.10614013671875,
        312.0223083496094
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<최적화된 서방 공정 세팅(7” Wurster (89 mm partition))>",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        144.4017333984375,
        340.5511169433594,
        453.17510986328125,
        351.5790710449219
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "캡슐충진: 속방 및 서방 펠렛들은 자동캡슐 충진기에서 두 개의 독립된 feeder를 이용하여",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        713.2238159179688,
        536.6661376953125,
        724.2517700195312
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경질 젤라틴 캡슐에 충진된다. 캡슐충진 공정변수들은 기기 제조사의 권장사항과 유사 제",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        733.002197265625,
        533.1110229492188,
        744.0301513671875
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정변수",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        100.26565551757812,
        367.4887390136719,
        411.13714599609375,
        377.4378662109375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설정값",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        100.26565551757812,
        367.4887390136719,
        411.13714599609375,
        377.4378662109375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사유",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        100.26565551757812,
        367.4887390136719,
        411.13714599609375,
        377.4378662109375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유동화 기체 부피",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.3564453125,
        392.6315002441406,
        259.5393371582031,
        403.9289245605469
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "90~110 m3/시간",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        80.3564453125,
        392.6315002441406,
        259.5393371582031,
        403.9289245605469
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "최적 범위보다 낮거나 높은 경우에는 유동화 패턴이 나",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        272.85211181640625,
        385.9485778808594,
        529.6329345703125,
        395.897705078125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "빠져서 낮은 코팅 효율성을 초래할 수 있음",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        272.85211181640625,
        401.8911437988281,
        472.663818359375,
        411.84027099609375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bed 온도",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        98.46663665771484,
        439.6498718261719,
        243.58798217773438,
        449.5989990234375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "37~43 ℃",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        98.46663665771484,
        439.6498718261719,
        243.58798217773438,
        449.5989990234375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "낮은 온도는 증발이 감소하여 펠렛 응집을 초래할 수",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        272.85211181640625,
        423.5874328613281,
        532.8279418945312,
        433.53656005859375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있고, 높은 온도는 펠렛을 경화시킬 수 있고 서방 막의",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        272.85211181640625,
        439.6498718261719,
        532.9474487304688,
        449.5989990234375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부착력이 떨어져서 약물방출을 빠르게 할 수 있음",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        272.85211181640625,
        455.59246826171875,
        502.6475830078125,
        465.5415954589844
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분무속도",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        100.26565551757812,
        493.2313232421875,
        252.82298278808594,
        503.1804504394531
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25~30 mL/분",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        100.26565551757812,
        493.2313232421875,
        252.82298278808594,
        503.1804504394531
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분무속도가 낮은 경우 방울 크기를 감소시키고 증발을",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        272.85211181640625,
        477.28875732421875,
        532.9474487304688,
        487.2378845214844
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "높여서 낮은 코팅 효율성 및 빠른 약물방출을 초래할",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        272.85211181640625,
        493.2313232421875,
        532.8275146484375,
        503.1804504394531
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수 있음",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        272.85211181640625,
        509.1739196777344,
        311.06817626953125,
        519.123046875
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약물미세화 기압",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        82.7551498413086,
        559.6387329101562,
        238.12808227539062,
        569.587890625
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.5 bar",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        82.7551498413086,
        559.6387329101562,
        238.12808227539062,
        569.587890625
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "최적 분무속도(25~30 mL/분)에서 약물미세화 기압은",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        272.85211181640625,
        535.6649169921875,
        532.9474487304688,
        545.6140747070312
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적절한 서방코팅을 보장하기 위해 중요한 방울 크기를",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        272.85211181640625,
        551.6074829101562,
        532.9474487304688,
        561.556640625
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "30μm로 만든다. 3.0 bar를 초과한 약물미세화 기압은",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        272.85211181640625,
        567.669921875,
        532.9474487304688,
        577.6190795898438
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "과도한 펠렛 속성을 갖게 하므로 이를 피해야 함",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        272.85211181640625,
        583.612548828125,
        497.61029052734375,
        593.5617065429688
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "코팅액 농도",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        92.8296890258789,
        634.077392578125,
        244.36709594726562,
        644.0265502929688
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "15 % w/v",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        92.8296890258789,
        634.077392578125,
        244.36709594726562,
        644.0265502929688
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "농도가 낮으면 낮은 점도의 코팅 현탁을 형성하여 분무",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        272.85211181640625,
        610.1035766601562,
        529.6324462890625,
        620.052734375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "속도에 영향을 미칠 수 있고, 농도가 높으면 너무 점도",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        272.85211181640625,
        626.046142578125,
        529.5130004882812,
        635.9953002929688
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가 높은 현탁을 형성하여 최대 기압을 사용하지 않으면",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        272.85211181640625,
        641.9887084960938,
        532.9474487304688,
        651.9378662109375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분무하기 어려움",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        272.85211181640625,
        658.0511474609375,
        347.69158935546875,
        668.0003051757812
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주입 기체 온도",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        676.510986328125,
        497.87841796875,
        686.4601440429688
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "55 ~ 62 ℃",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        676.510986328125,
        497.87841796875,
        686.4601440429688
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Wurster의 건조/습도 기록지를 이용하여 계산됨.",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        85.2737808227539,
        676.510986328125,
        497.87841796875,
        686.4601440429688
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 54 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 60,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품을 충진할 때 자동캡슐충진기 작동 조건을 참고하였다. 공정 검사는 속방 및 서방 펠렛",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        103.21049499511719,
        536.6656494140625,
        114.23844146728516
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모두의 100% 질량확인 기능이 있는 캡슐 충진 기계에서 수행될 것이다. 캡슐충진공정 공",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        122.98887634277344,
        533.1110229492188,
        134.01681518554688
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정관리 요약은 2.3.P.3 제조를 참조한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        142.7672576904297,
        281.11126708984375,
        153.79519653320312
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "스케일업",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        182.32403564453125,
        124.97193145751953,
        193.3519744873047
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Wurster에서 스케일업이 서방캡슐 제품을 포함한 다른 제품들에서 성공적으로 이루어",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        202.1024169921875,
        533.1107177734375,
        213.13035583496094
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "졌다. 추가적으로, 실험실 규모 뱃치들에서의 실험설계에 근거하여 구형 백당에 부착하는",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        221.88079833984375,
        536.78515625,
        232.9087371826172
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주성분 ...  및 서방층의 코팅과 관련한 중요공정변수들에 대한 허용범위가 결정되었다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        241.65919494628906,
        536.7857666015625,
        252.6871337890625
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이러한 공정 지식은 실험실 규모에서부터 허가용 뱃치 생산에서 파일럿 규모까지 스케일",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        261.43756103515625,
        533.1107177734375,
        272.46551513671875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "업 하는데 성공적으로 이용되었다. 성공적으로 스케일업하는데 이용되었던 공정변수의",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        281.2159729003906,
        536.7847900390625,
        292.2439270019531
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "변경사항들은 다음과 같다. 추가 정보는 3.2.P.3.3 제조공정 및 공정관리를 참조한다.",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        80.95612335205078,
        300.9943542480469,
        512.7057495117188,
        312.0223083496094
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실험실 규모",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        198.49241638183594,
        327.9319763183594,
        332.81964111328125,
        337.881103515625
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가용 뱃치",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        198.49241638183594,
        327.9319763183594,
        332.81964111328125,
        337.881103515625
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기기:",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        346.39178466796875,
        95.78485107421875,
        356.3409118652344
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Partitions: 번호/지름",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        362.3343811035156,
        170.5475616455078,
        372.28350830078125
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분무 Gun의 번호",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        378.3968200683594,
        151.237548828125,
        388.345947265625
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7” Wurster",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        198.85223388671875,
        346.39178466796875,
        253.23985290527344,
        356.3409118652344
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1/89 mm",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        204.24929809570312,
        362.3343811035156,
        247.68922424316406,
        372.28350830078125
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        223.0791015625,
        378.3968200683594,
        229.00909423828125,
        388.345947265625
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "18” Wurster",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        275.2508239746094,
        346.39178466796875,
        335.5152893066406,
        356.3409118652344
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1/219 mm",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        280.64788818359375,
        362.3343811035156,
        330.0845642089844,
        372.28350830078125
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        302.35614013671875,
        378.3968200683594,
        308.2861328125,
        388.345947265625
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "뱃치크기1",
      "font_size": 6.354805946350098,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        404.76800537109375,
        237.2780303955078,
        422.74835205078125
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3 kg",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        404.76800537109375,
        237.2780303955078,
        422.74835205078125
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(10,700 단위)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        193.4551544189453,
        420.8304443359375,
        258.6142883300781,
        430.7795715332031
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "40 kg",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        291.2021789550781,
        396.8566589355469,
        319.67340087890625,
        406.8057861328125
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(142,000",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        284.1260070800781,
        412.7992248535156,
        329.8984069824219,
        422.74835205078125
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "단위)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        293.4809265136719,
        428.7417907714844,
        317.2624816894531,
        438.69091796875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분 층",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        275.7305603027344,
        447.2016296386719,
        320.7061767578125,
        457.1507568359375
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정변수",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        186.25904846191406,
        465.6614685058594,
        446.99774169921875,
        475.610595703125
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사유",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        186.25904846191406,
        465.6614685058594,
        446.99774169921875,
        475.610595703125
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유동화 기체 부피",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        484.12127685546875,
        152.43690490722656,
        494.0704040527344
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(m3/시간)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        498.8354187011719,
        116.0115737915039,
        510.1328430175781
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "80~100",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        191.416259765625,
        492.1524963378906,
        314.04315185546875,
        502.10162353515625
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "480~600",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        191.416259765625,
        492.1524963378906,
        314.04315185546875,
        502.10162353515625
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분포-플레이트 면적 비율2에 근거하",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        350.210205078125,
        482.8928527832031,
        523.9955444335938,
        494.0704040527344
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여 선형 스케일업",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        350.210205078125,
        500.1837158203125,
        430.08642578125,
        510.1328430175781
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주입 기체 온도(℃)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        518.6434936523438,
        430.0869140625,
        528.5926513671875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "45~55",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        518.6434936523438,
        430.0869140625,
        528.5926513671875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "45~55",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        518.6434936523438,
        430.0869140625,
        528.5926513671875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "스케일 독립 변수",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        518.6434936523438,
        430.0869140625,
        528.5926513671875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bed 온도(℃)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        537.1033325195312,
        430.0869140625,
        547.052490234375
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "35~45",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        537.1033325195312,
        430.0869140625,
        547.052490234375
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "35~45",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        537.1033325195312,
        430.0869140625,
        547.052490234375
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "스케일 독립 변수",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        537.1033325195312,
        430.0869140625,
        547.052490234375
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분무 속도(mL/분)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        555.5631713867188,
        527.3104858398438,
        573.4237060546875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "15~20",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        555.5631713867188,
        527.3104858398438,
        573.4237060546875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "90~120",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        555.5631713867188,
        527.3104858398438,
        573.4237060546875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분포-플레이트 면적 비율에 근거하여",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        555.5631713867188,
        527.3104858398438,
        573.4237060546875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "선형 스케일업",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        350.210205078125,
        571.5057373046875,
        415.09454345703125,
        581.4548950195312
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약물미세화 기압(bar)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        605.9081420898438,
        285.6187744140625,
        615.8572998046875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.0",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        605.9081420898438,
        285.6187744140625,
        615.8572998046875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.0",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        605.9081420898438,
        285.6187744140625,
        615.8572998046875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "높은 분무 속도에 따라, 분무 방울 크",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        350.210205078125,
        589.965576171875,
        523.8760375976562,
        599.9147338867188
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기 중앙값을 20μm로 유지하기 위해",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        350.210205078125,
        605.9081420898438,
        527.3104858398438,
        615.8572998046875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "노즐의 기압이 증가되었음3",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        350.210205078125,
        620.6223754882812,
        477.17816162109375,
        631.9197387695312
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "코팅효율",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        640.430419921875,
        368.93408203125,
        650.3795776367188
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "98%",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        640.430419921875,
        368.93408203125,
        650.3795776367188
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "98%",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        640.430419921875,
        368.93408203125,
        650.3795776367188
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "N/A",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        640.430419921875,
        368.93408203125,
        650.3795776367188
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서방 층",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        280.767822265625,
        658.8902587890625,
        315.6689453125,
        668.8394165039062
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정변수",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        186.25904846191406,
        677.35009765625,
        446.99774169921875,
        687.2992553710938
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사유",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        186.25904846191406,
        677.35009765625,
        446.99774169921875,
        687.2992553710938
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유동화 기체 부피",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        695.8099365234375,
        152.43690490722656,
        705.7590942382812
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(m3/시간)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        710.4042358398438,
        116.0115737915039,
        721.70166015625
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "90~110",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        191.416259765625,
        694.461669921875,
        523.9955444335938,
        713.67041015625
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "540~660",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        191.416259765625,
        694.461669921875,
        523.9955444335938,
        713.67041015625
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분포-플레이트 면적 비율2에 근거하",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        191.416259765625,
        694.461669921875,
        523.9955444335938,
        713.67041015625
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여 선형 스케일업",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        350.210205078125,
        711.7525024414062,
        430.08642578125,
        721.70166015625
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주입 기체 온도(℃)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        730.2122802734375,
        430.0869140625,
        740.1614379882812
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "55~62",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        730.2122802734375,
        430.0869140625,
        740.1614379882812
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "55~62",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        730.2122802734375,
        430.0869140625,
        740.1614379882812
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스케일 독립 변수",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        730.2122802734375,
        430.0869140625,
        740.1614379882812
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 55 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 61,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1 뱃치크기는 사전 경험 뿐 아니라 기기 제조원의 권장사항에 따른다.",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        229.48977661132812,
        386.0989990234375,
        240.66734313964844
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2 스케일업 동안 동일한 기체 속도를 유지한다.",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        247.4701385498047,
        281.1558837890625,
        258.647705078125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3 실험실 규모 시험 결과 노즐압이 증가하면 원하는 펠렛 특징이 나오지 않을 수 있다.",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        265.4504699707031,
        469.3823547363281,
        276.6280517578125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.P.2.4 용기 및 포장",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        304.3506774902344,
        193.09500122070312,
        315.3786315917969
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분 ... 의 가수분해 가능성 때문에 용기 및 포장은 완제의약품을 수분으로부터 보호",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        64.52503204345703,
        324.1290588378906,
        533.1110229492188,
        335.1570129394531
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해야 한다. 신청한 용기 및 포장은 기밀용기에 해당하는 USP <671> 요건을 충족한다",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.43911743164062,
        343.9074401855469,
        533.1107177734375,
        354.9353942871094
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(3.2.P.2.4 용기 및 포장 참조).",
      "font_size": 11.030982971191406,
      "font_name": "Batang",
      "bbox": [
        75.43911743164062,
        363.6858215332031,
        232.05821228027344,
        374.7137756347656
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bed 온도(℃)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        110.36973571777344,
        430.0869140625,
        120.31886291503906
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "37~43",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        110.36973571777344,
        430.0869140625,
        120.31886291503906
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "37~43",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        110.36973571777344,
        430.0869140625,
        120.31886291503906
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스케일 독립 변수",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        110.36973571777344,
        430.0869140625,
        120.31886291503906
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분무 속도(mL/분)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        136.86077880859375,
        314.04315185546875,
        146.80990600585938
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25~30",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        136.86077880859375,
        314.04315185546875,
        146.80990600585938
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "150~180",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        136.86077880859375,
        314.04315185546875,
        146.80990600585938
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분포-플레이트 면적 비율에 근거하여",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        350.210205078125,
        128.82955932617188,
        527.3104858398438,
        138.7786865234375
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "선형 스케일업",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        350.210205078125,
        144.7721405029297,
        415.09454345703125,
        154.7212677001953
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약물미세화 기압(bar)",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        179.29441833496094,
        285.6187744140625,
        189.24354553222656
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.5",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        179.29441833496094,
        285.6187744140625,
        189.24354553222656
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.5",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        179.29441833496094,
        285.6187744140625,
        189.24354553222656
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "높은 분무 속도에 따라, 분무 방울 크",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        350.210205078125,
        163.23196411132812,
        523.8760375976562,
        173.18109130859375
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기 중앙값을 30μm로 유지하기 위해",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        350.210205078125,
        179.29441833496094,
        527.3104858398438,
        189.24354553222656
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "노즐의 기압이 증가되었음3",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        350.210205078125,
        193.88868713378906,
        477.17816162109375,
        205.1861114501953
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "코팅효율",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        213.69680786132812,
        368.93408203125,
        223.64593505859375
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "99%",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        213.69680786132812,
        368.93408203125,
        223.64593505859375
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "99%",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        213.69680786132812,
        368.93408203125,
        223.64593505859375
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "N/A",
      "font_size": 9.951866149902344,
      "font_name": "Batang",
      "bbox": [
        72.44074249267578,
        213.69680786132812,
        368.93408203125,
        223.64593505859375
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 56 -",
      "font_size": 9.951866149902344,
      "font_name": "Gulim",
      "bbox": [
        280.40802001953125,
        788.5885009765625,
        314.4545593261719,
        798.5376586914062
      ],
      "page_num": 62,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“국제공통기술문서 품질요약자료 작성 가이드라인” [민원인안내서]",
      "font_size": 14.987749099731445,
      "font_name": "Batang",
      "bbox": [
        74.11982727050781,
        434.60906982421875,
        525.5103149414062,
        449.5926818847656
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.0339126586914,
        487.40985107421875,
        169.948486328125,
        501.06365966796875
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.0339126586914,
        487.40985107421875,
        169.948486328125,
        501.06365966796875
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.0339126586914,
        487.40985107421875,
        169.948486328125,
        501.06365966796875
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.0339126586914,
        513.42138671875,
        169.948486328125,
        527.0752563476562
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.0339126586914,
        513.42138671875,
        169.948486328125,
        527.0752563476562
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.0339126586914,
        513.42138671875,
        169.948486328125,
        527.0752563476562
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "편 집 위 원 장",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.0339126586914,
        539.4329833984375,
        169.948486328125,
        553.0868530273438
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "편",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.0339126586914,
        565.3246459960938,
        169.94790649414062,
        578.978515625
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "집",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.0339126586914,
        565.3246459960938,
        169.94790649414062,
        578.978515625
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.0339126586914,
        565.3246459960938,
        169.94790649414062,
        578.978515625
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.0339126586914,
        565.3246459960938,
        169.94790649414062,
        578.978515625
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "도 움 주 신  분",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.0339126586914,
        617.3477783203125,
        169.94790649414062,
        631.0016479492188
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.0339126586914,
        695.2626342773438,
        169.94790649414062,
        708.91650390625
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.0339126586914,
        695.2626342773438,
        169.94790649414062,
        708.91650390625
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "처",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.0339126586914,
        695.2626342773438,
        169.94790649414062,
        708.91650390625
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2015 년 12 월",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        192.6156005859375,
        485.5893249511719,
        289.7629699707031,
        501.1114196777344
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "손 여 원",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        192.6156005859375,
        513.42138671875,
        251.02447509765625,
        527.0752563476562
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 선 희",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        192.6156005859375,
        539.4329833984375,
        244.42752075195312,
        553.0868530273438
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "김은정, 양성준, 이경신, 김선미, 윤나영, 강나루,",
      "font_size": 12.94941520690918,
      "font_name": "T9",
      "bbox": [
        192.6156005859375,
        563.504150390625,
        478.2748718261719,
        579.0262451171875
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유지혜, 김지예, 서재욱, 지정은, 정혜선",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        192.6156005859375,
        589.5157470703125,
        426.24896240234375,
        605.037841796875
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전평가원 의약품심사조정과,",
      "font_size": 12.94941520690918,
      "font_name": "T9",
      "bbox": [
        192.6156005859375,
        615.5272827148438,
        436.17767333984375,
        631.0493774414062
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "순환계약품과, 종양약품과, 소화계약품과,",
      "font_size": 12.94941520690918,
      "font_name": "T9",
      "bbox": [
        192.6156005859375,
        641.4190063476562,
        436.0577392578125,
        656.9411010742188
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약효동등성과",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        192.6156005859375,
        669.2510986328125,
        270.4539489746094,
        682.9049682617188
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전평가원 의약품심사부 의약품규격과",
      "font_size": 12.94941520690918,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        192.6156005859375,
        695.2626342773438,
        491.3747253417969,
        708.91650390625
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    }
  ],
  "markdown_content": "<!-- PAGE_1 -->\n# 제네릭의약품의 국제공통기술문서\n\n<!-- PAGE_1 -->\n# 품질요약자료 작성 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n- 2015. 12.\n<!-- PAGE_1 -->\n## 의약품심사부 의약품규격과\n\n지침·안내서 제‧개정 점검표\n\n명칭\n\n제네릭의약품의 국제공통기술문서 품질요약자료 작성 가이드라인 [민원인안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n**[표 시작]**\n\n| 0.1 N HCl, 70 ℃, 14 시간 | 97% | >0.99 | RC2: 2% | >0.99 | Core | 100정 병포장 | 950병 | 1010병 | 함량 | 98.0 ~ 102.0 % | USP | 적합 | Lot #11A | 서의 Wurster 코팅 공정 및 문헌 등을 통해 얻어진 사전 지식에 기초하여 선택되었다. | 해 절대적으로 중요하다는 것을 알게 되었고, 이는 분무 속도와 약물미세화 기압 공정 | 균일성(구형 백당에 일정량의 주성분 코팅) 및 재현성 있는 약물방출(일정한 서방 코 | 속방 펠렛* (+아스코르브산 20.0 mg) | 94 | 2 | 8 | □ 이미 등록된 지침·안내서 중 동일·유사한 내용의 | 대조약 허가사항에 따르면 약물 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 예 시 | 수분 | 0.5 % 이하 | USP <921> 시험1a | 0.2 % | 시험항목 | 기준 | 시험결과 (제조번호) | 회전수 | 공개 부분에 해당하는 자료 | 비공개 부분에 해당하는 자료 | 두께 | A | B | C | D | E | F | 3 . 5 ~ 3 . 9 m m ( 기 준 | 주성분 활성 대사산물 | M-1238 | 9.96Kp | 육안 | 30 분: 27-31% |\n| 연번 | 제·개정번호 | 승인일자 | 주요내용 | 12 시간 | 90-94%, 평균 92% | 85% 이상 | 용출 완료 시점 | [첨가제] | 히프로멜로오스 | 91 | Y | 용출시험조건: 900 mL, 0.05 M |\n| 코팅효율 | 99% | 99% | N/A | 2.3.S.1. 일반정보(제품명, 제조자) ………………………………………………………… 1 | 펠렛 | 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 | 반드시 준수하셔야 하는 사항이 아님을 알려드립니다. 또한, 본 안내 | 서는 2015년 12월 31일 현재의 과학적·기술적 사실 및 유효한 법규 | 를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. | 상대유지시간 | 조건이 안정성에 영향을 미친다고 알려진 바 있다. | 30 분 | 대조약 허가사항에 따르면 | 구형백당 | 기제 | 142.5 | 25-30 mesh | 지침·안내서가 있습니까? | 주성분: 1.00 | 제피제 ○○ | 되어 있는 청색의 직사각형 정제 | 25-35% | 흡수에 미치는 음식물 영향이 거 |\n| 0.1 N NaOH, 70 ℃, 30 분 | 98% | >0.99 | RC2: 1% | >0.99 | 되어 있다. | 속방 펠렛 (+부틸레이티드히드록시아니솔 0.01 mg) | 96 | 2 | 2 | 중금속 | 20 ppm 이하 | USP <231> | 적합 | 해 설 | 60정 병포장 | 500병 | 500병 | Lot #9A | 25 ± 2℃ | 입증 수준(QT; qualification threshold) | 변수들을 적절히 조합하였기 때문이다. 최적화된 공정 세팅은 아래 표와 같다. 서방 막 | 팅층)을 보장하는데 매우 중요하다. | 필름코팅액의 | 질량 | 3.7mm) | M-1239 | 3.72mm |\n| 유연물질 E | [화학 구조] | 산화에 의한 분해산물 | . 구조결정에 관한 자료 | 기준 | 인산염완충액(pH 6.8), 37 ℃ | 4 시간: 48-53% |\n| 적인 정보는 3.2.S.6. 용기 및 포장을 참고한다. | 크기의 | 9 | 원료의약품을 참고한다. | [용매] | 용매* | 시트르산트리에틸 | 92 | Y | 음식물 영향이 거의 없음. | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로 | 착색제 ○○ | 1.0 mm 미만의 펠렛으로 개발 | 의 없음. |\n| 차이점을 비교표 또는 도식 등을 이용하여 요약 기재한다. | 속방 펠렛 (+부틸레이티드히드록시아니솔 0.03 mg) | 97 | 2 | 1 | 함량시험(HPLC) | 표시량의 90.0 ~ 110.0 % | USP | 값에 이를 때까지 재결정하여 제조한다. | 특이성 | 참조). 주성분 ... 는 BCS 분류에 따라 “높은 용해도”를 가지므로, 물리적 특성(결정다형, | 10정평균 | 4 시간 | 참고) | 주성분 | XXX | 24.00 | 조제 | 25 +66.4° ~ +68.0° | 시험방법 #467 | +67.10 | 유연물질 C: 1.44* | 메탄올: 3000 ppm 이하 | 40-60% | M-1240 | RC2: 1% | 300 ppm |\n| 2.3.S.2. 제조(제품명, 제조자) ……………………………………………………………… 4 | 타당성 | 선광도[α]D | 0, 3, 6, 9, 12 개월 | 500 정 병포장 | Lot #10A | 중요하고 분무 속도와 약물미립화 기압 공정변수들을 통해 달성되는 것으로 확립되었다. | 의 완전성은 전자현미경 스캐닝을 통해 추가적으로 평가 및 확인되었다. 최적화된 뱃치 | 포장 | 224,000(96.9%) | 231,000 | 93% | 펠렛 크기 0.8 ~ 0.9 mm. | 가혹 조건 | % 함량 | 피크 순도 | 관찰된 분해산물 | 동 제품도 대조약과 같이 음식물 |\n| 3% H2O2, 60 ℃, 2 시간 | 97% | >0.99 | . 물리화학적 성질에 관한 자료 | 해 설 | 유기용매 ○○ | 용출시험법 제1법(회전검체통법), | 8 시간: 73-78% | >0.99 |\n| 재처리에 대한 사항 포함) 및 관리에 관한 간단한 설명 | 1 | B1-2015-2-015 | 2015.12.31 | 제정 | Clear Coating 7321 | 결합제 | 28.48 | 개개 | 디에틸프탈레이트 | 92 | N | 주성분 피크 순도(PDA) > 0.99 | 60 ± 5% RH | 2 2 8 ~ 2 5 2 m g ( 기 준 | 241.2mg |\n| 속방 펠렛 (+부틸레이티드히드록시아니솔 0.06 mg) | 97 | 2 | 1 | 불순물이 이 기준에서 안전하다는 것을 보여주는(qualification) 자료를 제공해야 한다. | 잔류용매 | 혼합물에서 각 첨가제를 하나씩 제외한 것을 가지고 시험한다. | 입자도)이 최종 제형의 생물약제학적 특성에 미치는 영향은 미미할 것이다. 그리고, 구형 | 분류 | 포장 형태 | 제조원 | 형은 I 형 대비 빨리 분해되고 불순물도 많이 검출되었다. | 총 량 | 8 시간 | 유연물질 D: 1.66* | 염화메틸렌: 600 ppm 이하 | RC2: 0.5% 이하 | 65-85% | 100 rpm | USP <467> | 과 상관없이 복용할 수 있도록 함. | RC3: 1% | 150 ppm |\n| Lot #11A | 이러한 공정 지식은 실험실 규모에서부터 허가용 뱃치 생산에서 파일럿 규모까지 스케일 | 의 코팅 공정 효율성은 99.0%였다. | 총 수율 | 99% | 100% | 97% | 지식 | <DOE CR Process Variables Studied> | 12 시간: 90-94% |\n| 2.3.S.3. 특성(제품명, 제조자) ……………………………………………………………… 4 | 시험항목 | 시험방법 | 허용기준 | . 유연물질에 관한 자료 | 해 설 | 부틸레이티드히드록시아니솔 | 98 | Y | 마손도 | 공정8의 나정 | 240mg ± 5%) | 235.5~243.9mg |\n| 하여 요약하여 기재한다. | 근거자료를 제출하며, 밸리데이션 요약 자료를 제출한다. | 10 | 필름코팅 | 예 시 | 함량 | 98.5~101.5 % | 시험방법 #125a | 99.8 % | 결정다형, 안정성 등이 있을 수 있다. | 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0225 | 직선성 | 0.05-2.5% | 12 시간 | 유연물질 F: 2.55* | 톨루엔: 890 ppm 이하 | 0.05-1.0% | 85% 이상 | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% | 80 ppm | 0.05-1.0% |\n| 정제수, 60 ℃, 13 시간 | 99% | >0.99 | NA | >0.99 | 병포장 | 60 mL 흰색 원형 HDPE 병 (60, 100 정) | 백당 주성분 층이 형성되기 위해 주성분 ... 가 물에 완전히 용해되므로 입자도 및 결정 | 시험 항목 | 허용 기준 | 분석방법 | 시험결과 | RC3: 0.5% 이하 | 「식약처 지침서등의 관리에 관한 규정」 개정에 |\n| 엔도톡신 | 98.0 %였다. 실험실 규모 뱃치 시험의 자세한 결과는 3.2.P.2.3 제조공정 개발을 참조한다. | 붕해도 | (사유 :                                                                 ) | r2=0.99 | 공정9의 필름코팅액 | r2=0.99 | 2 2 2 ~ 2 5 8 m g ( 기 준 | r2=0.99 | M-1241 | r2=0.99 | 근거자료위치 | r2=0.99 | 0.6% | r2=0.99 |\n| . 안정성시험자료(결과표) | 유연물질(HPLC) | 정제수2 | 용매 | 아스코르브산 | 95 | N | 공정변수 | 최소 | 최대 | 자사기준 |\n| 습도(90% RH), 25 ℃, 7 일 | 99% | >0.99 | NA | >0.99 | 대하여 요약하여 기재한다. | 2.3.S.4. 원료의약품의 품질관리(제품명, 제조자) ………………………………………… 6 | 유연물질명 | 화학명 | 화학 구조 | 설정 기준 | 2 | 안내서-0206-01 | - | 0%)에 근거하여 결정되었다. 수분 시험은 칼피셔법(USP<921> method 1a)에 따른다. | 공정수율 | 표준품: 0.01 mg/mL, 유연물질 B 0.01 mg/mL | 물질명/IUPAC명 | 기원 | 240mg ± 7.5%) | USP<701> | 따른 등록번호 일괄 정비 | 1분 |\n| 이용하여 기술하고, 뱃치에 관한 사항은 아래 예시를 참고하여 기재한다. | 특정유연물질 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 |\n| 무균 | . 제조공정에 관한 자료 | 요소이다. | 변경사항들은 다음과 같다. 추가 정보는 3.2.P.3.3 제조공정 및 공정관리를 참조한다. | 모 뱃치에서의 결과들에 대한 상세한 내용은 3.2.P.2.3항을 참조한다. | 샘플 조제 | 메탄올 3000ppm 이하 | 개개유연물질: 각각 0.2% 이하 | . 제조공정 및 공정관리에 관한 자료(상세) | (성적서 위치 포함) | 200 ppm | □ 예 | ■ 아니오 | 직접용기․ |\n| RC2 | [화학명] | [화학구조] | 0.5% 이하 | 방출제어막 | 11 | 포장 | 공정10의 반제품 | 시험종류 | 시험조건 | 용기형태/재질 | 제조번호 | 측정시기 (개월) | 결과 | 정밀성 | RSD 6.7 % | RSD 4.5 % | RSD 6.8 % | RSD 5.2 % | RSD 3.2 % | RSD 4.5 % | 폴리에틸렌글리콜 | 92 | Y | Bed 온도 | 40℃ | 70℃ | 1.0% 이하 | (규제개혁담당관실-3761호,2017.5.16) | 225.420정(97.3%) | RSD = 0.8% |\n| RC1 | 검액: 약 2 mg/mL | RC1: 0.15 % 이하 | RC2: 25% | RC1: 0.05 % |\n| 2.3.S.5. 표준품 또는 표준물질(제품명, 제조자) ………………………………………… 9 | 품으로 시험하는 것이 바람직하다. | 예 시 | 잔류용매 | 화학적 안정성 면에서 주성분 ... 는 산화에 매우 취약하다. 이는 제제에 항산화제를 추가 | 원료의약품 A | USP | 톨루엔 890 ppm 이하 | 내용을 단순 편집 또는 나열한 것입니까? | USP <467> 시험C | 유연물질 E(50%) | 80 ppm | 포장의 재질 |\n| 광안정성 408 일 | 55% | >0.99 | . 용기 및 포장 시스템 | 에틸셀룰로오스 | 방출조절제 | 18.00 | 점도 20 mPa.s | <최적화된 약물 층화 공정변수 세팅(7” Wurster (89 mm partition))> | 총 유연물질: 1.5%이하 | Polyethylene | 5분 이하 | 가속시험 | 장기보존시험 | 001 | 실생산 뱃치 | 수분함량이 증가하는 | >0.99 |\n| RC3 | [화학명] | [화학구조] | 0.5% 이하 | 약물미세화 기압 | 1 bar | 5 bar |\n| 등록대상 | 결과와 허용 기준은 단위를 포함하여 수치로 기재한다. | 중요 중간물질에 대한 설명 | RC2 | 실험실내 | 시스템적합성 | 칼럼 효율: 이론단수 5000 이상 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? | □ 예 | ■ 아니오 | RC2: 0.25 % 이하 | 실험실 규모 | 허가용 뱃치 | (230만 정) | % (w/w) | RC3: 20% | RC2: 0.05 % |\n| 명시하고 타당한 근거를 제시한다. | 설정할 수 있다. | 함으로써 해결하였다 (2.3.P.2.2 완제의약품 참조). | 시험), 기타 필요한 독성시험자료 | 유연물질 1 | 합성 | 테트라히드로푸란 720 ppm 이하 | Bag, Fiber | 93~101% | 대조약 | 002 | 0, 3, 6, 9, 12 | 미지 유연물질(15%) | 양상이나, 기준 내 적합하여 | 이상 없음 | 300 ppm |\n| 2.3.S.6. 용기 및 포장 시스템(제품명, 제조자) | ………………………………………… 10 | . 시험방법, 시험성적서에 관한 자료 | 용출 (HPLC) | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP | 멜로오스와 폴리에틸렌글리콜로 구성)를, 속도 조절막의 구성성분으로 에틸셀룰로오스 | 정밀성 | RSD 8.2 % | RSD 9.2 % | RSD 10.4 % | RSD 9.6 % | RSD 8.2 % | RSD 9.8 % | 시트르산트리에틸 | 코팅기제 | 3.000 | 불순물 A: 1.5% 이하 | 유동화 기체 부피 | 70 m3/시간 | 150 m3/시간 | <최적화된 서방 공정 세팅(7” Wurster (89 mm partition))> | (23만 정) | 시험방법 #41 | 0.8% |\n| 기기: | 제출한다. | 해야 한다. 신청한 용기 및 포장은 기밀용기에 해당하는 USP <671> 요건을 충족한다 | RC3 | 유연물질명 | 제조번호 P034 | 여부 | 공정변수 | 설정값 | 사유 | RC3: 0.25 % 이하 | 주성분 ○○ | 7” Wurster | 18” Wurster | 이상 없음 | RC2: 35% | RC3: 0.10 % |\n| 및 포장을 참고한다. | 원료의약품의 분해는 관찰되지 않았으며 상호작용은 없는 것으로 판단된다. | 용해도가 높다. | drum | 003 | 12 개월간 안정 |\n| UV (단파장/ 장파장), 7 일 | 27% | >0.99 | 경우 시험방법 밸리데이션 및 사용 등급을 표시한다. | 함량 (90-110%) | 유연물질 2 | USP | 정제수2 | 용매 | 시점 (개월) | (제조번호 | 기준 | 판정 | >0.99 |\n| Partitions: 번호/지름 | 2.3.S.7 안정성(제품명, 제조자) …………………………………………………………… 11 | 시험 | 신청인이 그 조성을 알 수 없을 경우에는 원료 제조원에서 직접 심사 부서에 제출할 수 있다. | . 시험방법 밸리데이션 자료 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등(이 | 유연물질 E: 1.0% 이하 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | 분무 속도 | 10 mL/분 | 70 mL/분 | 시험 결과 | 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 | 결합제 ○○ | 1/89 mm | 1/219 mm | 98.7-101.5% 범위 내에 | 0.4% | □ 예 | ■ 아니오 |\n| zation/epimerization). | (3.2.P.2.4 용기 및 포장 참조). | 미지유연물질 | 정확성 | 95-104 % | 80-97 % | 88-105 % | 92-112 % | 80-101 % | 82-115 % | 공정변수 | 설정값 | 사유 | 유연물질A: 0.5 % 이하 | 미지유연물질: 각 0.10 % 이하 | 구형 백당의 적절한 유동화 상태를 위한 범위 | RC3: 30% | 0.05 % | 수분함량이 증가하는 | 0.20 % | 뱃치 결과 |\n| 충족시켜야 한다. | 0 | 3 | 6 | 9 | 12 | 15 | 18 | 24 | 36 | 98-102.1% 범위 내에 있음 | #22242) | 자사 시험방법 #231b (HPLC) |\n| 시험항목 | 허용 기준 | 시험 방법 | 잔류용매 기준을 설정한다. | 총 질량 (방출제어 펠렛) | 216.0 | 중요한 특성(예: 원료의약품의 결정형 등)이 변화할 가능성이 있는 경우 이를 포함한다. | 시험 항목 | 시험법 | 허용기준 | 시험결과(제조번호) | 부형제 ○○ | Polyethylene | 001 | 있음 |\n| 건열, 105 ℃, 14 시간 | 97% | >0.99 | NA | >0.99 | 분무 Gun의 번호 | . 표준품에 관한 자료 | 총 유연물질 | 정보는 3.2.P.2.3 제조공정 개발을 참조한다. | 수분함량 ... 인 것을, 스테아르산마그네슘은 입도 ... 을 사용하였다. | 하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한 사 | 미지 유연물질: 0.2% 이하 | 서방 코팅액 농도 | 10% | 30% | <대조약 용출 양상 (USP Apparatus 1, 100 rpm, 37 ℃)> | 유연물질B: 0.15 % 이하 | 내용입니까? | 총 유연물질: 0.75 % 이하 | 간에 방해가 없음 | 80 ~ 100 | 1 | (동일한 크기 분포 및 다공성을 갖는 구형 백당에 약물을 | 1 | 시험 결과 | 0.30 % | 양상이나, 기준 내 | 0.10 % | 주성분 제조원4) | 0.07% |\n| 최적 범위보다 낮거나 높은 경우에는 유동화 패턴이 나 | (제조번호 9A) |\n| 유연물질명 | 설정 기준 | 판정기준 | 엔도톡신 | O | O | O | O | 유동화 기체 부피 | 속방(Immediate Release, IR) 펠렛 | 예 시 | 가속시험 | 40℃/75% RH | 유연물질 A | 0.80% | 1.5% | 1.5% 이하 | 대사산물에 해당 | 정량한계 | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 활택제 ○○ | Bag, Fiber | 개발 뱃치 | 허가제출용 뱃치 | 실생산 뱃치 | 002 | 0, 3, 6 |\n| 한다. | 예상되는 확인시험과 함량균일성시험은 제외하였다. | 엔도톡신 (해당하는 경우) | 유동화 기체 부피 | 90~110 m3/시간 | 총 유연물질: 2.5% 이하 | □ 외국 규정을 번역하거나 설명하는 내용입니까? | □ 예 | ■ 아니오 | m3/시간 | 코팅하는 유사한 제품에서의 사전 지식 및 실험실 규모에 | 이상 없음 | 40 kg | 적합하므로 가속조건에서 6 | 이상 없음 | 1.5% |\n| 첨가제 참조)에 근거한 것이다. | 안에 대하여 식품의약품안전처의 입장을 기술하는 것 | 방울 크기 | 5 μm | 70 μm | 유연물질C: 0.15 % 이하 | 피크 순도(PDA)>0.99 | 빠져서 낮은 코팅 효율성을 초래할 수 있음 | (제조번호 #9A) | 0.09 % |\n| 뱃치크기1 | 3 kg | 무균 | O | O | 특성들을 갖도록 할 필요가 있다. 추가 정보는 3.2.P.2.2.1 제제 개발을 참조한다. | 유연물질 RC 2 (0.5% 이하) | 결정형(XRD) | 2Ɵ 차이가 5 % 미만 | 시험방법 #47 | 1 % 미만 | 1 | 원료칭량 | 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인되 | 붕해제 ○○ | drum | 003 |\n| 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형) ……………………………………… 12 | Core | 유연물질 E | 0.40% | 1.0% | 1.0% 이하 | 대조약과 동등한 수준 | 어 있는 청색의 직사각형 정제 | 육안 검사 | 적합 | 2 kg, 1만정 | 48 kg, 23만정 | 480 kg, 230만정 | 서의 확증시험에 근거함) | 개월간 안정 |\n| 중 수행된 시험 및 그 결과 등이 포함될 수 있다. | 예 시 | 시점 부근의 대조약 뱃치 분석결과 참조)인지 여부 | 무균 | 유연물질D: 0.15 % 이하 | 0.1-0.2% 범위 내에 있음 | (142,000 | 0.1-0.2% 범위 내에 있음 | 0.11 % | 생동시 |\n| RC2 | 0.5% 이하 | USP 기준 | 0.2% | 검출한계 | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | (10,700 단위) |\n| 예 시 | 유연물질 | 구형백당 | Base | 47.5 | 18-20 mesh | □ 정보제공 등 직원 교육용 자료입니까? | □ 예 | ■ 아니오 | D90: 30 um 이하 | 제피제 ○○ | 낮은 온도는 증발이 감소하여 펠렛 응집을 초래할 수 | 시험방법 #231a | 20 um |\n| 중요한 특성에 대한 고찰이 포함되어야 함) | 결과와 상호 참고가 가능하여야 한다. | 해 설 | 미지 | 가질 때 대조약과 유사한 용출 양상을 보임을 알 수 있다. | High Shear | 35 ℃보다 낮아지면 용매의 증발이 너무 적게 일어나서 | 단위) | 생산규모 △정 |\n| 2.3.P.2 개발경위(제품명, 제형) …………………………………………………………… 15 | 치는 경우 기준을 설정한다. | 세부적인 사항들이 요구될 수 있다. | “국제공통기술문서 품질요약자료 작성 가이드라인” [민원인안내서] | 서방 펠렛으로 구성하여 비슷한 용출 양상을 갖도록 설계하였다. | 유연물질 | ≤0.07% | ≤0.05% | 0.20% 이하 | 구조규명 수준(IT)2) | 유연물질E: 1.0 % 이하 | 이상 없음 | 이상 없음 | 0.30 % |\n| 확인시험 | 습식과립 | RC3 | 0.5% 이하 | USP 기준 | 0.2% | 입자도 | RH, 4 주)에서 실시하였다. 이 시험들은 주성분 ... 가 산화되어 Impurity E 및 가수분해 | Bed 온도 | 37~43 ℃ | 함량시험법에 따라 시험할 때 표준품과 동일한 유 | Granulator | PMA 10 | PMA 300 | PMA 1800 | D50: 15 um 이하 | 착색제 ○○ | 있고, 높은 온도는 펠렛을 경화시킬 수 있고 서방 막의 | 시험방법 #48 | 10 um |\n| 약물층 | 유연물질 RC 3 (0.5% 이하) | 지시간을 나타낸다. | USP | 적합 | core가 응집되어 수율이 낮아질 수 있고, 45 ℃보다 높 | 주성분 층 |\n| 같다. | (HPLC) | 해 설 | 순도 및 정제로서의 특성이 중요할 것으로 판단되었으며, | <DOE Response Variables Obtained> |\n| 용출시험 조건을 설정하였다. | 완제의약품 품질에 미치는 영향, 중요 공정 변수 등에 대한 내용이 포함된다. | -해동, 가열-냉각 연구)가 있는 경우 이를 기재한다. | 용출시험을 수행하였다. 모든 제제 조성에 대해서 용출시험이 적합하였고 함량균일성 | Bed 온도 | 35 ~ 45 ℃ | 유연물질F: 0.50 % 이하 | 유기용매 ○○ | 0.1-0.2% 범위 내에 있음 | 부착력이 떨어져서 약물방출을 빠르게 할 수 있음 | 0.1-0.2% 범위 내에 있음 | 0.30 % |\n| 2.3.P.3 제조(제품명, 제형) ………………………………………………………………… 16 | 미지 유연물질 | 0.2% 이하 | ICH Q3B 구조규명 수준 | 0.1% | 되어 Impurity A(활성 대사체)로 분해되기 쉽다는 것을 나타냈다. 산화가 주된 분해경로 | 결과, 최종 생물학적동등성시험용 제제로 11% 서방코팅한 제제를 선택하였다. | 주성분 | YYY | 8.0 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다. | 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다. | D10: 5 um 이하 | 아지면 증발을 증가시켜 약물/결합제가 펠렛 중심에 부착 | 2.5 um |\n| 회사명 및 주소 | 담당업무 | GMP 증명서 | 비고 | 간략히 정리한다. | 총 유연물질1) | 1.5% | 3.7% | 2.5% 이하 | 대조약보다 낮음 | 녹으며, 아세톤과 알코올에 조금 녹는다. | 공정변수 | 사유 |\n| 함량시험 | 표시량의 90.0 ~ 110.0% | USP | 98.8% | 파라미터와 시스템적합성 기준을 포함하여 표 또는 서술 형식으로 요약한다. | 미지: 0.10 % 이하 | Impact Mill | 정제수 | 최소치 | 최대치 | 0.07 % |\n| 습식체과 | 해 설 | 시험 결과(RSD)는 2.0 % 미만이었다. 붕해제 함량은 용출에 영향을 미치는 중요 인자 | Clear Coating 7321 | 결합제 | 9.49 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 분무속도가 낮은 경우 방울 크기를 감소시키고 증발을 | 이상 없음 | 이상 없음 |\n| 립한 초기 시점부터 실시한 연구내용부터 포함한다. | 총 유연물질 | 1.5% 이하 | USP 기준 | 0.65% | 예 시 | 기능을 발휘하므로 어떤 점도가 제품 활성에 효과가 있는지 결정하기 위하여 소규모 실 | 보장하기 위하여 이들 위치에서 공정 시험/관리(In-process tests/controls)가 시행된다. | 시험조건 | 설정값 | 용출시험 조건 | 값 | 완제의약품의 제조, 포장 및 시험 | 함량시험 방법 | 순도시험 방법 | 하기 어려워져 코팅효율성 및 함량균일성이 떨어짐 |\n| 유동화 기체 부피 | 2.3.P.4 첨가제의 관리(제품명, 제형) …………………………………………………… 21 | 평가하고 기재한다). | 개개 유연물질 (0.2% 이하) | 예 시 | 발 | 행 | 일 | 복용할 수 있도록 하는 것이다. | 2015 년 12 월 | 분포-플레이트 면적 비율2에 근거하 |\n| 1) 유연물질 B, C, D, F는 제품 유연물질 계산에서는 제외한다. | 기술되어 있으므로 생동성을 보증하는데 빠른 용출이 중요할 것으로 판단된다. | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 총: 2.0 % 이하 | 코팅 효율성 | 75.8% | 99.2% | 80~100 | 480~600 | 평균: 99.1% | 1.4 % | □ 예(☞지침) | ■ 아니오 |\n| 불균일, 연질화, 뜯김이나 깨짐 등에 대해서도 관찰한다. | 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0075 | 였으며, 연구 결과 붕해제 함량은 2.5 % 이상이어야 한다. | 분무속도 | 25~30 mL/분 | 주성분 ○○ | 0.05-0.1% 범위 내에 있음 | 낮은 분무속도는 방울 크기를 감소시키고 증발을 높여서 | 높여서 낮은 코팅 효율성 및 빠른 약물방출을 초래할 | 0.05-0.1% 범위 내에 있음 |\n| (m3/시간) | 생략할 수 있다. | 2 | 결합액의 | 험실 시험에서 여러 등급의 에틸셀룰로오스들을 평가하였다. | 주)에서 시험하였다. 아래 표에 기재한 대로, 아스코르브산과 부틸레이티드히드록시아니 | 가혹 조건 | 시험액 | 인산염완충액(pH 6.8) | 용출액 | pH 4.5 완충액 | (출하, 안정성) | % 함량 | peak purity | peak purity | 여 선형 스케일업 | 확인된 | peak purity | peak purity |\n| 2.3.P.5 완제의약품의 관리(제품명, 제형) ………………………………………………… 23 | 필요하다. (예: 분해산물, 잔류용매, 무기불순물 등) | 건조 | Fluid Bed Dryer | STREA 1 | MP 4 | MP 6 | 사무의 세부기준이나 절차를 제시하는 것입니까? (공무원용) | 원료 | 약물 층화 | 서방 코팅 | 캡슐충진 |\n| 하였다. 관련 보고서와 시험성적서는 3.2.S.5 표준품 또는 표준물질을 참고한다. | 시험 | USP<905>에 따라 시험할 때 적합 | USP | 정제수2 | 용매 | 약물방출 (1시간) | 2% | 25% | 결합제 ○○ | 증가 경향 보임(0.7%) | 수 있음 | 이상 없음 (<0.3%) | RSD: 0.8% |\n| 발 | 행 | 인 | 원료의약품 입자도 시험 | 손 여 원 | threshold | 약물/결합제가 펠렛 중심에 부착하기 어려워짐에 따라 코 | angle | 분해생성물 | threshold | angle |\n| 주입 기체 온도(℃) | 45~55 | 45~55 | 스케일 독립 변수 | 중간체 관리, 공정 밸리데이션 및 평가, 제조공정개발 등의 내용을 요약하여 기재한다. | 예 시 | 분무속도* | 15 ~ 20 mL/분 | 시험액의 양 | 900 mL | 조제 | 용량 | 900 mL |\n| 총 유연물질 (1.0% 이하) | 상세 사항은 3.2.P.8.1 안정성 요약과 결론과 3.2.P.8.3 안정성 자료를 참고한다. | 분쇄 | Impact Mill | 순도 | 높음 | 완제의약품 제조에 사용된다. | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 제조용수 미생물한도시험 | 품질 위수탁 | 정제수 |\n| 2.3.P.6 표준품 또는 표준물질(제품명, 제형) …………………………………………… 34 | 총 질량 (속방 펠렛) | 65.0 | 구분 | 0.2% 이하로 설정하였다. | 미처리 | 약물방출 (4시간) | 25% | 64% | 팅효율성 및 함량균일성이 떨어짐. 빠른 분무속도는 방울 | 범위: 98.2-100.1% | ■ 예(☞안내서) | □ 아니오 |\n| Bed 온도(℃) | 35~45 | 35~45 | 스케일 독립 변수 | 수도 있다. | 개발을 참조한다. | 성분명 | 규격 | 배합목적 | 질량/정(mg) | 비고 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 0.5 - 0.8% 범위 내에 있음 | 최적 분무속도(25~30 mL/분)에서 약물미세화 기압은 | < 0.3% 범위 내에 있음 |\n| 기재한다. | 해 설 | 최종 제제에 선택되었다. 부틸레이티드히드록시아니솔 0.03 mg을 사용하여 제품의 안정 | 편 집 위 원 장 | 시험액의 온도 | 37 ℃ | 온도 | 37 ℃ | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까? (민원인용) | 이 선 희 |\n| 등을 자체적으로 검증하는 것이 바람직하다. | 함량/함량균일성 | 높음 | 높음 | 분류 | 설명 | 제조원 | RC2: 0.5% 이하 | 크기를 증가시켜서 제품이 응집되어 수율이 낮아짐 | 각 원료를 oo mesh체로 체과 후 | 0.2% |\n| 용출 | 적합 (93-98%), S1만 적용 | 적합 (95-100%), S1만 적용 | 예 시 | 조건 1 (고온) | 경질젤라틴캡슐 | 상부/하부 | Size #1 | 약물방출 (8시간) | 55% | 88% | 가혹 조건 | % 함량 | 피크 순도 | 적절한 서방코팅을 보장하기 위해 중요한 방울 크기를 |\n| 분무 속도(mL/분) | 15~20 | 90~120 | 분포-플레이트 면적 비율에 근거하여 | 2.3.P.7 용기 및 포장(제품명, 제형) …………………………………………………… 35 | 유연물질명 | 허용기준 | 직선성 | 정밀성 | 정확성 | 검출한계 | 성분명 | 배합목적 | 제조원명 | 등급 | 규격 | 뱃치 제조에 | 주성분 | USP | 주성분 | 2.00 | 부형제 ○○ | 중요공정 | 정량한계 |\n| (수행업무) 및 수탁업소를 기재한다. | 최종혼합 | Bin-Blender | Size 5 L | Size 100 L | Size 1000 L | 해 설 | 성을 갖도록 한다. | 약물미세화 기압 | 1.5 bar | 장치 | 회전검체통법 | 시험법 | 2 법(패들법) | Convection mixer |\n| 편 | 집 | 위 | 원 | 병포장 | 60 mL, 흰색 원형 HDPE 병 (60, 100정) | Bottle.Co | 용출 | 높음 | 높음 | 높음 | .. | RC3: 0.5% 이하 | 총 충진물 질량 | 281.0 | 김은정, 양성준, 이경신, 김선미, 윤나영, 강나루, | 유연물질 | 0.2% |\n| 3 | 혼합 | 미처리 | 99% | >0.99 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | 약물방출 f2값 | 활택제 ○○ | 최적 분무속도에서 약물미세화 기압을 1.0 bar로 하면 | 30μm로 만든다. 3.0 bar를 초과한 약물미세화 기압은 | 이상 없음 | 선형 스케일업 | 사용된 제조번호 | (LOD) | 이상 없음 | □ 예 | ■ 아니오 | (LOQ) |\n| 순도시험 | 수 있는 요인인 것으로 확인되었다. | 즉시 조제된 것 vs. 60℃에 18시간 보관한 것 | 53.1 | 97.9 | 유당수화물 | NF | 부형제 | 160.00 | 용매 | 결정형 I | 결정형 II | (Ribbon blender)에서 oo rpm으로 | Method #41 |\n| 2.3.P.8 안정성(제품명, 제형) ……………………………………………………………… 36 | 규격에 준하여 관리한다. | 수분(0.5% 이하) | 타정 | Tablet Press | Beta | Beta | Beta | 회전수 | 100 rpm | 회전 속도 | 50 rpm | A | B1 | C1 | D1 | E | F1 |\n| 기타 확인 | 공정 | 시험항목 | 기준 | 분석방법 번호 | 허가제출용 뱃치 결과 | 병포장 | 325 mL, 흰색 원형 HDPE 병 (500 정) | Bottle.Co | 안정성 | 높음 | 개개유연물질: 각각 0.2% 이하 | 민원인을 구속하는 내용이 있습니까? | 붕해제 ○○ | 캡슐 총 질량 | 380.0 | r2=0.996 | 20 μm 크기의 방울이 만들어진다. 약물미세화 기압이 | 평균 0.13% | 과도한 펠렛 속성을 갖게 하므로 이를 피해야 함 | 92-110% | 0.1% | 등) |\n| 한다. | 약물미세화 기압 | 1.0 bar | 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유지혜, 김지예, 서재욱, 지정은, 정혜선 | 5.1-5.5% 범위 내에 있음 | 높은 분무 속도에 따라, 분무 방울 크 | 5.1-5.5% 범위 내에 있음 |\n| 0.1 N HCl, pH 1.2 | 0.10 mg/mL | 0.40 mg/mL | 2차 포장 용기를 사용하여 포장하였다. | RC2 | 0.5% 이하 | 기준 | 80% (Q) 이상 / 30분 | oo분간 혼합한다. | 건조감량, 벌크밀도, 중합도 | 0.025% | 0.075% |\n| 기재한다. | 안정성 시험들에서 기록하지 않았다. | 유연물질명 | 화학명 | 구조 | 기원 | 관리방법 | 미결정셀룰로오스 | NF | 부형제 | 61.61 | 설계 시 1.0 mm 이하의 코팅 펠렛을 사용해야 한다. | 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질간에 방해가 없음(아래의 크로마토그램을 | 시간 | 용출률 % | 2.5 bar를 초과하면 과도한 펠렛 속성을 갖게 되므로 이 | (제조번호 #9A) |\n| 약물미세화 기압(bar) | 1.0 | 2.0 | 있다. | 성상 | 적합 | 적합 | 입증할 계획이다. | 사항 | 총유연물질: 1.5%이하 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | RSD=1.5% | RSD 6.45% | RSD=2.8% | 기 중앙값을 20μm로 유지하기 위해 | 0.65% |\n**기재**\n\n**[표 끝]**\n\n고려하시기 바랍니다. 그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n지침·안내서\n\n안내서 제·개정 절차를 진행하시기 바랍니다.\n\n상기 사항에 대하여 확인하였음.\n\n2017  년   5  월   25  일\n\n담당자\n\n확  인(부서장)\n\n김 영 림\n\n- - iii -\n<!-- PAGE_3 -->\n### 이\n\n<!-- PAGE_3 -->\n### 안내서는\n\n<!-- PAGE_3 -->\n### 제네릭의약품의\n\n<!-- PAGE_3 -->\n### 국제공통기술문서(CTD:\n\n<!-- PAGE_3 -->\n### Common\n\n<!-- PAGE_3 -->\n### Technical Document) 중 제2부의 품질평가자료요약 작성에 대한 식\n\n<!-- PAGE_3 -->\n### 품의약품안전처의 입장을 기술한 것으로, 대외적으로 법적 효력을\n\n<!-- PAGE_3 -->\n### 가지는 것이 아님\n\n<!-- PAGE_3 -->\n### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_3 -->\n##### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n##### 가원 의약품심사부 의약품규격과에 문의하시기 바랍니다.\n\n<!-- PAGE_3 -->\n##### 전화 : 043-719-2952\n\n<!-- PAGE_3 -->\n##### 팩스 : 043-719-2950\n\n- - iv -\n<!-- PAGE_4 -->\n# 목  차\n\n<!-- PAGE_4 -->\n##### 2.3. 품질평가자료요약 ……………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 서론 ……………………………………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.S. 원료의약품 (제품명, 제조자) ……………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.P 완제의약품(제품명, 제형) ………………………………………………………… 12\n\n<!-- PAGE_4 -->\n##### 2.3.A 부록 …………………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.1 시설과 설비 ………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가 ……………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.3 첨가제 ……………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.R. 지역별 정보 …………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### Appendix. 속방성 및 서방성 제제의 개발경위 기재 예시 (FDA) ………………… 41\n\n<!-- PAGE_5 -->\n## 제·개정 이력\n\n- - vi -\n머 리 말\n\n<!-- PAGE_6 -->\n#### 식품의약품안전처에서는 우수한 의약품을 공급하고 의약품 허가심사 체계를\n\n<!-- PAGE_6 -->\n#### 선진화하고자 2009년부터 신약 허가 신청 시 자료를 국제공통기술문서(Common\n\n<!-- PAGE_6 -->\n#### Technical Document, CTD)로 제출하도록 하였고, 제3부 품질평가자료에 대한\n\n<!-- PAGE_6 -->\n#### 가이드라인 및 해설서를 발간한 바 있습니다.\n\n<!-- PAGE_6 -->\n#### 또한 2015년 3월 「의약품의 품목허가․신고․심사 규정」이 개정되면서 2016년\n\n<!-- PAGE_6 -->\n#### 3월부터 제네릭의약품 및 자료제출의약품의 허가 신청 시 국제공통기술문서 적용이\n\n<!-- PAGE_6 -->\n#### 의무화되었습니다.\n\n<!-- PAGE_6 -->\n#### 이에 국내 제약기업의 국제공통기술문서 자료 작성을 돕고자 2015년 6월\n\n<!-- PAGE_6 -->\n#### ‘제네릭의약품의 국제공통기술문서 작성 해설서’를 발간한 바 있습니다. 이 가이드\n\n<!-- PAGE_6 -->\n#### 라인은 국제공통기술문서의 품질평가 자료 중 제2부 품질평가자료요약(Quality\n\n<!-- PAGE_6 -->\n#### Overall Summary, QOS)에 대해 구체적인 작성요령과 상세한 예를 들어 설명하\n\n<!-- PAGE_6 -->\n#### 고자 발간하게 되었으며, 미국 FDA의 질의응답식 품질심사(Question based\n\n<!-- PAGE_6 -->\n#### Review, QbR) 가이드라인의 예시를 참조하고 국내 심사 현황과 업계 의견을\n\n<!-- PAGE_6 -->\n#### 반영하여 실제 문서 작성에 도움이 되도록 실용적이고 세부적인 내용으로 구성\n\n<!-- PAGE_6 -->\n#### 하였습니다.\n\n<!-- PAGE_6 -->\n#### 본 가이드라인이 국제공통기술문서 작성 시 많이 활용되어 국내 제약 기업의\n\n<!-- PAGE_6 -->\n#### 활발한 글로벌 시장 진출에 실질적인 도움이 되기를 기대합니다.\n\n- - 1 -\n<!-- PAGE_7 -->\n##### 2.3. 품질평가자료 요약 (Quality Overall Summary, QOS)\n\n품질평가자료 요약은 제3부(품질평가자료)에 있는 자료의 범위와 구성에 따라 요약하는 것이다.\n\n품질평가자료요약은 국제공통기술문서의 다른 부분에서 언급되지 않은 정보, 자료 또는 정의는\n\n포함하지 않는다.\n\n품질평가자료 요약은 심사자에게 제3부의 개요를 제공할 수 있도록 각 부분의 정보를 충분히\n\n포함해야 한다. 품질평가자료 요약은 자료 작성시 규정을 따르지 않는 경우 그 타당성을 설명\n\n하는 등의 방식으로 신청의약품의 주요사항을 명확히 하여야 한다. 품질평가자료 요약은, 다른\n\n부분에 있는 관련 자료를 종합적으로 고려한 중요 사항에 대한 고찰을 포함한다.(다른 부분의\n\n자료를 인용할 때는 인용한 부분의 목차명과 쪽수를 기재하여 서로 참조가 가능하도록 한다.)\n\n품질평가자료 요약은 표나 그림을 제외한 본문이 일반적으로 40쪽을 넘지 않아야 한다. 생물\n\n의약품과 좀더 복잡한 제조 공정을 이용하여 제조된 의약품은 표나 그림을 제외하고 일반적으로\n\n본문이 80쪽을 넘지 않아야 한다.\n\n아래 본문 중 밑줄로 표시한 도표, 수치 등에 대해서는 제3부에 직접 기재 사항을 그대로\n\n이용할 수 있다.\n\n서론\n\n서론에는 원료의약품의 일반명, 상품명 또는 상용명, 회사명, 제형, 함량(역가), 투여경로, 신청\n\n하는 적응증을 포함한다.\n\n<!-- PAGE_7 -->\n##### 2.3.S. 원료의약품(제품명, 제조자)(Drug Substance)(name, manufacturer)\n\n<!-- PAGE_7 -->\n##### 2.3.S.1. 일반정보(제품명, 제조자)(General Information)(name, manufacturer)\n\n- 3.2.S.1에서 얻은 정보를 포함한다.\n<!-- PAGE_7 -->\n##### 해 설\n\n- ○ 3.2.S.1 일반정보에 설명된 원료의약품의 명칭, 구조 그리고 일반적인 특성에 대한 정보를\n요약하여 기재한다.\n\n- ○ 신청품목의 주성분이 두 개 이상인 경우 [주성분 1] 및 [주성분 2] 등으로 구분하고 품질\n- - 2 -\n평가자료 요약을 각각 작성한다.\n\n- ○ 동일한 주성분에 대해 제조원이 두 개 이상인 경우 품질평가자료 요약은 하나로 작성하되,\n제조원 간 공통되지 않은 정보(예; 상이한 생산 공정)는 별도의 항에 작성한다. (예: (주성분,\n\n제조원 1), (주성분, 제조원 2))\n\n- ○ 원료의약품등록(DMF) 대상 성분이 아닌 경우 아래 표에 해당하는 자료를 제출한다.\n* 비공개 부분에 해당하는 자료는 원료의약품 제조원으로부터 심사부서에 직접 제출 가능\n\n- ○ 성상, 해리상수(pKa), 결정다형, 용해도(pH에 따른 영향 포함), 흡습성, 융점 및 분배계수 등을\n포함한 물리화학적 성질에 대해서 기재한다 (아래의 내용에 국한하지 않고 필요한 사항에 대해\n\n- - 물리적 형태(모양, 색상, 물리적 상태)\n- - 해리상수(이온화되는 화합물인 경우)\n- - 결정다형(결정형, 무정형, 수화물, 용매화물)\n- - 용해도 특성(물, 유기용매에 대한 용해도, pH에 따른 영향 포함)\n- - 흡습성\n- - 융점, 끓는점(무정형 물질의 경우 유리전이온도)\n- - 분배계수\n위 사항은 모두 기재하는 것이 바람직하며, 특성을 수치화할 수 없는 경우 타당한 사유를 기재\n\n한다 (예: 화학구조 중 이온화기가 없으므로 pKa가 없음).\n\n- ○ 용해도의 경우, 아래와 같이 기술한다.\n- - 경구용 제제는 생물약제학적분류체계(BCS) 용해도 등급을 기재한다.\n- - 3 -\n- - 용해도는 시험조건과 해당 결과를 함께 기재한다.\n- - 결정다형에 대한 pH-용해도 정보를 기재한다.\n- - 해당 원료의약품의 결정형에 대해서는 pH-용해도 정보를 기재해야 한다. 원료의약품의\n결정형보다 안정한 결정형에 대해서는 특정 pH에서의 상대적 용해도를 기재한다.\n\n예시 1)\n\n한글명:\n\n국제일반명칭(INN, International Nonproprietary Names for Pharmaceutical Substances):\n\n공정서 수재품목은 그 수재명:\n\n화학명(IUPAC 명칭):\n\nCAS 번호:\n\n구조식:\n\n분자식:\n\n분자량:\n\n예시 2)\n\n. 성상: 주성분 A는 흰색의 결정형 가루로 pH 7.0인 물에 거의 녹지 않으며, 염화메틸렌에 잘\n\n. pKa: 5.5\n\n. 결정다형: 결정형 I과 결정형 II의 2 가지 결정형이 있다. 결정형 I이 더 안정한 결정형으로\n\n. 용해도: 각 pH에서의 용해도 결과는 아래와 같다 (온도 37 ℃).\n\n- 0.15 M 아세트산염 완충액, pH 3.0\n- 0.09 mg/mL\n- 0.40 mg/mL\n- 0.15 M 아세트산염 완충액, pH 4.5\n- 0.011 mg/mL\n- 0.033 mg/mL\n- 0.15 M 인산염 완충액, pH 6.8\n(< 0.001 mg/mL)\n\n(< 0.001 mg/mL)\n\n위 결과에 따라 주성분 A는 생물학적분류체계 (Biopharmaceutical Classification System,\n\nBCS)에 따라 낮은 용해도 성분에 해당한다.\n\n. 흡습성: 일주일간 25℃/75 ± 5 %에서 흡습되는 양이 0.1 % 이하였다. 자세한 내용은 3.2.\n\nP.2.1.1 원료의약품을 참고한다.\n\n- - 4 -\n. 융점: 결정형 I 225 ℃, 결정형 II 201 ℃\n\n. 분배계수: ClogP = 4.251\n\n<!-- PAGE_10 -->\n##### 2.3.S.2. 제조(제품명, 제조자)(Manufacture)(name, manufacturer)\n\n- 3.2.S.2에서 얻은 다음 정보를 포함한다.\n- - 제조자(제조원)에 대한 사항\n- - 적절한 품질의 원료의약품을 일정하게 제조하기 위해 제조공정(예. 출발물질, 중요공정 및\n- - 3.2.S.2.2에 기재된 제조공정도(flow diagram)\n- - 3.2.S.2.3에 설명된 원료의약품 제조에 사용된 출발물질과 생물유래 원료물질에 대한 설명\n- - 중요 제조공정, 공정관리 및 허용기준과 그 타당성에 대한 고찰, 특히 3.2.S.2.4에 설명된\n- - 3.2.S.2.5에 설명된 공정 밸리데이션 및/또는 평가에 대한 설명\n- - 3.2.S.2.6에 설명된 개발과정에서의 제조방법에 관한 중대한 변경에 대한 간략한 요약 및\n제품의 일관성을 평가하기 위해 사용된 검토결과로부터 얻은 결론. 품질에 관한 자료 요약\n\n(QOS)은 제조공정 변경에 따른 뱃치를 사용한 (M4S 및 M4E의) 비임상시험 또는 임상시험\n\n- ○ 3.2.S.2 제조에 설명된 원료의약품의 제조원, 제조공정 및 공정관리, 원료관리, 중요공정 및\n- ○ 제조 및 시험에 관한 모든 사업소 또는 시설에 해당하는 제조원의 명칭, 주소, 책임부과범위\n- ○ 원료의약품 자료 중 비공개 부분을 제외한 내용을 요약 기재한다.\n<!-- PAGE_10 -->\n##### 2.3.S.3. 특성(제품명, 제조자)(Characterization)(name, manufacturer)\n\n- 3.2.S.3.1에 설명된 것과 같은 구조 및 이성체에 관한 요약자료를 기술하여야 한다. 원료의약\n품이 광학활성체인 경우에는 임상시험에 사용된 의약품이 입체이성체 또는 입체이성체의 복합\n\n물인지를 나타내고 동시에 판매를 위한 최종 완제품에 사용되는 원료의약품의 입체이성체에\n\n관한 정보를 제공하여야 한다.\n\n전체 품질에 대한 자료(QOS)는 합성, 제조 또는 분해 등의 과정에서 발생할 수 있는 잠재적\n\n- - 5 -\n이고 실제적인 불순물에 대한 자료를 요약하여야 한다. 또한 개별적인 불순물과 총 불순물에\n\n대한 허용기준 설정에 관한 근거자료를 요약해야 한다. 품질에 관한 전체 자료 요약은 임상시\n\n험에 사용한 뱃치와 제품 생산용 공정으로 제조된 특정 뱃치에서 불순물 함유정도를 요약하여\n\n설명하고 제시된 불순물의 한계가 어떻게 정량화 되었는지 밝혀야 한다.\n\n그래프와 함께 3.2.S.3.2에서 제공되는 자료의 도표 요약은 필요한 경우 포함한다.\n\n- ○ 3.2.S.3.1 구조 및 기타 특성에 설명된 원료의약품의 구조와 물리적 특성, 불순물 등에 대\n- ○ 한 개 이상의 비대칭중심(chiral center)을 포함하는 키랄(chiral) 원료의약품의 경우 라세\n미체인지 특정 광학이성질체(enantiomer)인지 기재한다. 원료의약품이 특정 광학이성체인\n\n경우, 광학이성체를 확인하고 정량하기 위한 시험이 포함되어야 한다. 비대칭성(chirality)에\n\n대해서는 광학이성체간의 상호 전환 가능성을 고려해야 한다. (예. 라세미화/에피머화; racemi\n\n- ○ 잠재적 불순물을 확인하고 특징을 기술한다. 즉, 원료의약품에 존재할 수 있는 모든 불순물을\n기재한다. 유기유연물질인 경우 명칭, 구조 또는 HPLC 등 분석기기 상대유지시간(RRT)에 따라\n\n불순물을 확인하고, 발생 기원에 따라 공정 불순물과 분해생성물로 구분한다. 또한 아래 예시의\n\n표와 같이 특정 유연물질, 구조, 기원 및 관리방법 (규격 또는 미지유연물질 등 구분)에 대해서도\n\n- ○ 공정서에 유연물질 시험방법이 있는 경우에도 다른 발생 가능한 불순물을 파악하는 것이\n- ○ 유연물질 요약 예시\n[특정 유연물질]\n\n- ○ 구조 및 기타 특성에 대한 상세한 자료는 해당되는 경우 DMF 자료를 참고한다.\n- - 6 -\n<!-- PAGE_12 -->\n##### 2.3.S.4. 원료의약품의 품질관리(제품명, 제조자)(Control of Drug Substance) (name,\n\n<!-- PAGE_12 -->\n##### manufacturer)\n\n기준, 시험방법, 밸리데이션(validation)의 타당성에 관한 자료를 요약하여 설명한다.\n\n- 3.2.S.4.1에서 얻은 기준이 제공되어야 한다.\n- 3.2.S.4.4의 뱃치 분석에 관한 도표요약은 필요시 그래프와 함께 제공되어야 한다.\n- ○ 3.2.S.4 원료의약품의 관리에 설명된 원료의약품의 기준, 시험방법 및 시험방법 밸리데이션에\n- ○ 시험 기준과 뱃치 분석결과를 표로 작성한다. 특정 유연물질의 화학명을 별도 기재하고 시험\n- ○ 원료의약품 기준과 관련하여, 식약처장이 인정한 공정서 수재품목은 공정서 각조의 요구사항을\n- ○ 선광도, 수분, 순도, 잔류용매, 결정다형 및 입자도 등 원료의약품의 특성을 고려하여 시험항목을\n설정하고 그 타당성을 제시한다. (완제의약품 제조와 품질에 영향을 미칠 수 있는 원료의약품의\n\n- ○ 각 시험항목별로 시험방법을 적절하게 설정하고 밸리데이션을 실시한다. 시험방법의 중요\n- ○ 공정서에 따라 시험할 경우 공정서 방법이 적용될 수 있는지 특이성(예: 주피크가 생산 공정\n및 분해생성물에서 발생하는 모든 공정 불순물과 분리할 수 있음)과 유연물질 시험방법의 특이성\n\n(예: 주성분 피크를 포함하여 모든 공정 불순물 및 분해생성물을 서로 분리할 수 있는지 확인)\n\n- ○ 공정서 방법을 변경하여 사용하거나 자사 시험방법으로 대체하는 경우 밸리데이션이 필요하며,\n자사 시험방법이 공정서에서 규정하는 시험방법보다 동등 이상인 경우에 그 방법을 적용할 수\n\n- ○ 시험방법 밸리데이션 요약자료를 DMF 등록번호로 대체하는 것은 불가하며, 원료의약품 제조\n원의 밸리데이션 자료 제출은 가능하나, 해당 밸리데이션 자료가 자사 품질관리 시 적절히 적\n\n용될 수 있는지 판단할 수 있는 자료를 함께 제출하여야 한다. (시험법 이전자료 등)\n\n- ○ 순도시험(유연물질)항목에는 원료의약품에 함유될 수 있고 규격을 설정하여 관리하는 유연\n물질에 대하여 기재한다.\n\n- ○ 「의약품의 품목허가․신고 심사 규정」(식약처고시)의 심사자료 요건에 따라 유연물질을 설정\n- - 7 -\n하고, 근거 및 뱃치분석 결과를 간략히 기재한다.\n\n- ○ 공정서 각조에 순도시험 항목이 없는 경우에는 공개된 문헌을 참고하거나 원료의약품 제조\n원과 협조하여 잠재적인 합성 공정 불순물 (예: 이성체, 부가생성물), 분해생성물, 금속 촉매 및\n\n잔류용매 등에 대해 설정하여 관리하는 것이 바람직하다.\n\n- ○ 대조약 상대유지시간(RRT)에 의해 확인된 불순물 기준을 안전성 입증(qualification)을 위해\n사용하는 경우, 상대유지시간 비교, 자외부스펙트럼 및 대조의약품과의 질량분석을 통해 미확인\n\n특정 유연물질에 대한 안전성을 수용할 수 있다. 그러나 불순물을 확인(identification) 하기 위\n\n해서는 모든 노력을 기울여야 한다. 설정한 불순물 기준이 대조약보다 더 높다면 신청인은 이\n\n- ○ 대조약의 가속 또는 가혹시험 자료를 사용하여 원료의약품 불순물 기준을 설정하는 것은 바람\n직하지 않다. 사용기간(또는 그에 준한 기간) 이내이나, 제조일로부터 시일이 경과한 다양한 제\n\n- ○ 「의약품잔류용매기준지침」에 따라 모든 잔류용매는 품질기준에 적합한 수준으로 제거되어야\n하므로 잔류용매 제거에 대한 공정능력(process capability)을 고려하고, 해당 지침에 따라\n\n- ○ 「의약품잔류용매기준지침」에 포함되지 않은 잔류용매는 안전성을 고려하여 기준을 설정한다.\n- ○ 결정다형과 관련하여, 결정다형이 있고 결정다형 간 용해도 차이가 있는 등 품질에 영향을 미\n- ○ 원료의약품의 입자도 기준은 입자도가 완제의약품의 성능 또는 제조에 중요한 경우 설정한다.\n예를 들면, 건식혼합 공정에서 원료의약품 및 부형제의 입자도는 혼합 공정에 영향을 미칠 수\n\n있다. 용해도가 낮은 원료의약품의 경우 입자도는 완제의약품의 용출에 중요한 영향을 미칠 수\n\n있다. 용해도가 높은 원료의약품의 경우, 입자도는 완제의약품 성능에 중요한 영향을 주지 않을\n\n- ○ 입자도의 기준, 허용범위 및 설정근거는 입자도가 완제의약품에 미치는 영향에 따라, 설정여부\n및 기준 범위 등을 결정한다. 기준은 입자도의 변경이 원료의약품의 제조 능력 또는 완제의약\n\n품의 성능에 영향을 미치는지에 근거해야 한다. 일반적으로, 신청인은 물리적인 특성 또는 실험\n\n을 통해 입자도와 같은 원료의약품의 특성 변경이 제품에 어떻게 영향을 미치는지를 입증해야\n\n한다.\n\n- ○ 입자도가 중요한 경우에는 입자도분포를 구체화하고, 그 외에 제제연구 등 자료를 근거로 하여\n입자도 규격을 하나로 설정하는 것이 가능하다.\n\n<!-- PAGE_13 -->\n##### 예 시\n\n원료의약품의 규격 설정 예시 1)\n\n- - 8 -\n* RC1: [유연물질 화학명]\n\nRC2: [유연물질 화학명]\n\nRC3: [유연물질 화학명]\n\n완제의약품의 제조와 품질에 영향을 미치는 중요한 요소에 대해 규격을 설정하였다. 각 시험\n\n방법은 USP 일반시험법을 참조하거나 자사 시험방법으로 설정하였으며, 결정형과 입자도에\n\n대한 규격도 포함하였다. 완제의약품의 제조공정에는 난용성 원료의약품의 습식 과립공정이 포\n\n함되므로 입자도와 결정형은 완제의약품에 중요한 요소로 작용한다. 이러한 입자도와 결정형이\n\n완제의약품에 어떠한 영향을 미치는 지에 대해서는 2.3.P.2.2. 개발경위에서 확인할 수 있다.\n\n원료의약품의 규격 설정 예시 2)\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색, 결정형 가루\n\n육안검사\n\n적합\n\n확인시험\n\n**[표 시작]**\n\n| A: IR | A. IR: 표준품과 같음 | 0.65~0.85g/mL | USP <197M> | M-1236 | 적합 |\n| --- | --- | --- | --- | --- | --- |\n| 정제 생산량 | 225,420 | 231,000 | 93% | 였다. 이 공정을 선택한 사유는 크게 두 가지가 있다. | Lot #9A | 40 ± 2℃ | 시험액의 온도 | 명칭 | 화학구조 | 기원 | 성분 | 규격 | 배합목적 | 질량/정 | 2. UV: 표준품과 같은 파장에서 흡수극대 | 마손도   △~△%, | 자사 시험방법 #125b (HPLC, |\n| 공정수율 | PDA 검출기) | 적합 | 47.04kg(98%) |\n| 4 시간 | 48-53%, 평균 51% | 40-60% | 평균 용출율의 ±10% | 를 나타낸다. | 유연물질 A: 0.70 | 96.0~100.5% |\n| B: UV | 해 설 | 0, 3, 6 개월 | 500 정 병포장 | Lot #10A | 스테아르산마그네슘을 넣어 2 분간 혼합한다. | B. UV: 표준품과 같음 | 붕해도   △분 이내가 되도록 | (제조단위) | USP <197U> | 적합 |\n| [원료의약품] | 주성분 | 장치 | 공정서 이외 기준 | 에스터기 가수분해 산물 | 유연물질 | 가능하게 하고자 함 |\n| 8 시간 | 73-78%, 평균 75% | 65-85% | 평균 용출율의 ±10% | 경도 | 유당 | 10 | N | 8~12Kp(기준 10Kp) |\n| 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인 | 시간 | 액을 5 번 주입했을 때 피크면적의 상대표준편차는 1.0% 이하이다. | 75 ± 5% RH | 유연물질 B: 0.89* | 용출율 % | 노즐의 기압이 증가되었음3 |\n| 경우에도 원료의약품과의 배합적합성을 확인하는 것이 바람직하다. | 타정한다. |\n\n**[표 끝]**\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색의 결정형 가루\n\n육안검사\n\n적합\n\n- - 9 -\n위 규격은 원료의약품의 중요한 특성을 포함하나, 결정형 또는 입자도 등 고체 상태와 관련된\n\n물리적 성질에 대한 규격은 포함되어 있지 않다. 완제의약품 제조공정 중 구형 백당에 주성분이\n\n완전히 녹는 공정이 있으므로 위 특성이 완제의약품 품질에 미치는 영향이 적을 것으로 판단하\n\n였기 때문이다.\n\n<!-- PAGE_15 -->\n##### 2.3.S.5. 표준품 또는 표준물질(제품명, 제조자)(Reference Standards or Materials)\n\n<!-- PAGE_15 -->\n##### (name, manufacturer)\n\n- 3.2.S.5에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n<!-- PAGE_15 -->\n##### 해 설\n\n**[표 시작]**\n\n| 확인시험 | A. IR: 표준품과 같은 스펙트럼 | IR, USP <197K> | 적합 |\n| --- | --- | --- | --- |\n| 60 ± 5% RH | 90.0~110.0% | 개별질량 △~△mg | M-1235 |\n| 분석시간 | 37 분 | 혼합균일성 | 간은 표준품의 피크와 같다. | 자사 시험방법 #125b (HPLC) | 적합 | RSD 2.0% |\n| Lot #11A | 정관리 요약은 2.3.P.3 제조를 참조한다. | 산출량 | 46.70kg(97.3%) | 48kg(100%) | 96% | 시험액의 양 | 선형 스케일업 |\n| 캡슐 | B. 염화물 시험 | RSD 5.0% 이하 | 경도     △~△kp, | Chloride, USP <191> | 적합 |\n| 영향이 적을 것으로 판단된다. | 탭밀도 | 유연물질 E: 0.49 | 0.73g/mL |\n\n**[표 끝]**\n\n중금속\n\n20 ppm 이하\n\nUSP <231> 2법\n\n20 ppm 이하\n\n- - 10 -\n- ○ 3.2.S.5 표준품 또는 표준물질에 설명된 원료의약품을 시험하는데 필요한 표준품 또는 표준\n물질에 대하여 요약하여 기재한다.\n\n- ○ 표준품에 대한 사항은 제2부에는 요약하여 기재하고 제3부에 시험성적서, 제조, 적합성 및 특성\n등에 대한 세부사항을 기재한다.\n\n- - 표준품은 필요 시 추가적인 재결정 등을 통하여 가능한 순도를 높이고, 원료의약품 시험성적\n서에 전형적으로 보고되는 확인시험 이외에 NMR을 통한 구조 증명과 같이 추가적인 시험을\n\n통하여 그 특징을 설명해야 한다. 표준품은 물리적인 수치가 일정해지거나 문헌상 순물질의\n\n- ○ 아래 표와 같이 요약할 수 있다.\n- - 표준품을 합성하는 경우 해당 제조방법에 대한 요약 기재가 필요할 수 있다.\n예시 1)\n\n- - 허가제출용 뱃치 제조에 사용된 원료의약품(제조번호 # 15531)의 시험에는 상용표준품이\n사용되었는데 이 표준품은 USP 표준품(제조번호 # H)으로 성적서를 통해 그 품질을 확인\n\n예시 2)\n\n- - 원료의약품의 1차 표준품(제조번호 # 3)은 주성분 제조업자로부터 구매하였다. 이 표준품은\n합성 공정을 통해 제조되었고, 자사에서 2 회의 추가 재결정을 통해 순도를 높여 순도 99.9\n\n%의 표준품을 얻었다.\n\n<!-- PAGE_16 -->\n##### 2.3.S.6. 용기 및 포장(제품명, 제조자)(Container Closure System)(name, manufacturer)\n\n- 3.2.S.6. 용기 및 포장에서 얻은 정보에 대한 간단한 설명과 고찰을 포함한다.\n<!-- PAGE_16 -->\n##### 해 설\n\n- - 11 -\n- ○ 3.2.S.6. 용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n<!-- PAGE_17 -->\n##### 예 시\n\n예시 1)\n\n원료의약품은 투명한 Polyethylene Bag과 차광된 Polyethylene Bag으로 포장하고, fiber\n\nboard drum에 sealing하여 보관한다. 원료의약품 보관에 사용하는 용기 및 포장에 대한 추가\n\n예시 2)\n\n원료의약품은 이중 포장되어 있다. Low density polyethylene으로 포장하고 sealing한 후\n\naluminum laminated foil로 포장하고 sealing 한다. 이러한 이중 포장 후 fiberboard drum에\n\n보관한다. 원료의약품 보관에 사용하는 용기 및 포장에 대한 추가적인 정보는 3.2.S.6. 용기\n\n<!-- PAGE_17 -->\n##### 2.3.S.7 안정성(제품명, 제조자)(Stability)(name, manufacturer)\n\n<!-- PAGE_17 -->\n##### 3.2.S.7.1에서 설명된 것과 같이 수행된 시험의 요약(조건, 뱃치, 시험방법)과 결과에\n\n<!-- PAGE_17 -->\n##### 대한 고찰 및 결론의 요약, 보관조건, 재시험일자 또는 유효기간에 대한 사항을 포함한다.\n\n<!-- PAGE_17 -->\n##### 3.2.S.7.2에서 설명된 것과 같이 승인 후의 안정성 시험계획을 포함한다.\n\n<!-- PAGE_17 -->\n##### 3.2.S.7.3에서 얻은 안정성 결과의 도표요약은 필요시 그래프와 함께 제공하여야 한다.\n\n- ○ 3.2.S.7 안정성에 기재된 사항을 요약하고, 재시험일자 또는 유효기간에 대한 사항을 포함\n- ○ 재시험일자: 원료의약품이 기준을 만족하고 완제의약품의 제조에 사용하기에 적절한지를 보증\n하기 위해 시험해야 하는 일자.\n\n- ○ 재시험기간: 원료의약품이 정해진 조건에서 저장되고 있는 경우 기준 내 적합할 것으로 예상됨에\n따라 완제의약품 제조에 사용될 수 있는 기간.\n\n- ○ 사용기간: 정해진 조건에서 보관된다면, 원료의약품 뱃치가 그 날짜 이전에는 승인된 기준(Shelf\nlife specification)에 적합할 것으로 예상되고 그 이후에는 사용해서는 안 되는 날짜\n\n- ○ 가혹시험 및 분해경로의 확인과 같은 정보가 중요한 경우, 이 항에 기재하지 않고 제3부에 상세\n- - 12 -\n기재 한다. 또한, 이러한 정보는 완제의약품의 설계, 성능 또는 제조에 영향을 미칠 수 있으므로\n\n- 2.3.P.2. 개발경위에 기재할 수 있다.\n- ○ 아래 표와 같이 요약 기재할 수 있다.\n시험종류\n\n시험조건\n\n용기형태/재질\n\n제조번호\n\n시험 주기\n\n시험 결과\n\n<!-- PAGE_18 -->\n##### 2.3.P 완제의약품(제품명, 제형)(Drug Product)(name, dosage form)\n\n<!-- PAGE_18 -->\n##### 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형)(Description and Composition of the\n\n<!-- PAGE_18 -->\n##### Drug Product)(name, dosage form)\n\n- 3.2.P.1에서 얻은 정보를 포함한다.\n- 3.2.P.1에서 얻은 조성을 제공하여야 한다.\n<!-- PAGE_18 -->\n##### 해 설\n\n- ○ 3.2.P.1 완제의약품의 개요와 조성에서 얻은 제형에 대한 정보(성상 등), 조성(성분, 용도,\n규격, 분량)을 요약하여 표 등으로 제공하고, 첨부용제 및 제제에 사용된 용기와 마개를 포\n\n함한다.\n\n- ○ 필요시 대조약과의 조성 비교표를 기재할 수 있다(예 : 주사제).\n- ○ 조성 기재 시, 제조공정 중 제거되는 용매 및 공정보조제(processing aid)를 포함하여 완제의\n약품을 구성하는 성분, 분량, 규격 및 배합목적 등을 모두 기재한다.\n\n**[표 시작]**\n\n| 장기보존시험 | 25℃/60% RH |\n| --- | --- |\n\n**[표 끝]**\n\n- - 13 -\n- ○ 첨가제는 2.3.P.4 첨가제의 관리에 기재한다. 허가제출용 뱃치와 실생산 뱃치의 투입 원료량은\n- 2.3.P.3 제조에 기재한다. 여러 공정 단계를 거치는 방출제어 등의 완제의약품은 중요 중간체\n(예: tablet core 또는 bead) 별로 구분하여 아래 표와 같이 기재한다.\n\n* 제조 공정 중 제거됨\n\n- ○ 완제의약품 제조 과정에서 과량 투입 또는 과량 충전할 경우 그 근거를 기재한다.\n- ○ 사용되는 첨가제가 단일 성분이 아닐 경우(착색제, 착향제 등) 그 조성을 모두 기재한다. 단,\n- ○ 제조공정 중 사용되는 용매에 대한 정보도 간략히 기술한다.\n- ○ 제조 공정 중 사용되는 용매(결합용수, 코팅용매 등)에 대해서도 기술한다.\n- ○ 첨가제 사용량의 적절성에 대해 추가로 기재할 수 있다.\n- ○ 대조약의 첨가제 정보가 확인되는 경우(예: 주사제 등)는 이에 대해 추가 기술할 수 있다.\n<속방성 제제>\n\n포비돈\n\nNF\n\n결합제\n\n- 7.20\nK 값 기재\n\n크로스포비돈\n\nNF\n\n붕해제\n\n- 7.20\ntype 기재\n\n스테아르산마그네슘\n\nNF\n\n활택제\n\n- 1.20\nFD&C Blue #2\n\n별규\n\n착색제\n\n- 0.80\n정제수\n\nUSP\n\n결합용수*\n\n- -\n총 질량\n\n- - 14 -\n* 제조 공정 중 제거됨.\n\n<서방성제제>\n\n1: 히프로멜로오스와 PEG 400의 혼합물\n\n2: 제조 공정 중 제거됨\n\n<대조약과의 특징 비교표 - 서방캡슐>\n\n성분\n\n규격\n\n배합목적\n\n질량 (mg)\n\n비고\n\n방출제어(Controlled Released, CR) 펠렛\n\n대조약\n\n신청품목\n\n검토의견\n\n제형\n\n캡슐\n\n캡슐\n\n제제학적 동등성\n\n제제설계\n\n용출시험 결과 속방층(주성\n\n분 함량 25%) 및 서방층(주\n\n주성분 25%를 함유하는 속방\n\n펠렛 및 주성분 75%를 함유하\n\n생체 내 유사한 약물방출 설계\n\n- - 15 -\n<!-- PAGE_21 -->\n##### 2.3.P.2 개발경위(제품명, 제형)(Pharmaceutical Development)(name, dosage form)\n\n- 3.2.P.2.에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n필요에 따라 임상시험에서 사용된 제형의 조성에 대한 도표 요약과 용출 프로파일을 제공하여야\n\n한다.\n\n- ○ 3.2.P.2. 개발경위에서 얻은 정보와 자료에 대한 고찰을 요약하여 기재하되, 개발계획을 수\n- ○ 필요 시 대조약(제품명)에 대한 정보를 기재할 수 있다.\n- ○ 제품의 개발, 생산에 영향을 미치는 원료의약품의 특징, 첨가제의 선정 사유 등에 대해\n- ○ 제조방법 개발과정에 대해 기재한다.\n- ○ 필요 시 대조약과의 이화학적동등성시험 결과, 생물학적동등성시험 결과 등에 대해 요약하여\n- ○ 필요 시, 대조약의 제제 또는 제법 특허를 회피한 경우 해당 정보를 기재할 수 있다.\n- ○ 2.3.P.2.1. 완제의약품의 조성에는 제조방법 초기 연구 및 스케일업, 그 근거 등에 대해\n기재한다.\n\n- ○ 2.3.P.2.1.1. 원료의약품에는 완제의약품의 안정성, 제조, 또는 생물약제학적으로 영향을\n미치는 원료의약품의 특성 또는 물리화학적 성질을 기재하고, 그 근거로 수행한 시험결과를\n\n요약한다 (예: 원료의약품 입자도와 완제의약품 용출패턴과의 관계 등).\n\n원료의약품의 안정성시험 결과는 완제의약품의 설계, 성능 및 제조에 영향을 줄 수 있으므로\n\n**[표 시작]**\n\n| 해 설 | 예 시 | Lot #9A | 25 ± 2℃ | 적으로 영향을 미치므로 제조공정 중 중요단계로 확인되었다. | 검출기 | UV (파장 272 nm) | 산출량 | 47.04kg(98%) | 48kg(100%) | 96% | 시험조건 | 설정값 | 성분 함량 75%)으로 설계 | 는 서방 펠렛 혼합물로 구성하 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 성상 | 주성분 함량 | Impurity A | 적합 | Impurity E |\n| 펠렛이 충진되어 있다. | <서방성 제제> |\n| 또는 서술 형태의 요약자료로 제출한다. | 주입량 | 10 ㎕ | 건조한다. | 된 제형을 나타냄 | 흰색의 과립 | 여 개발 | 평균질량 △~△mg, | M-1234 |\n| 0, 3, 6, 9, 12 개월 | 60 정 병포장 | Lot #10A | 모두의 100% 질량확인 기능이 있는 캡슐 충진 기계에서 수행될 것이다. 캡슐충진공정 공 | 제조를 위해 이용될 수 있는 공정변수를 선택하기 위해 이용되어, 유사성 인자 >50 (즉 | 시점 | 제조번호 P034 시험 결과 | 설정 기준 | 근거 | 시험액 | 함량 | (%) | 99.1% | (%) | (%) |\n| 1. HPLC: 크로마토그램의 주피크의 유지시 | <속방성 제제> | 분포-플레이트 면적 비율에 근거하여 | 대조약 허가사항에 따르면 캡슐을 |\n| 30분 | 27-31%, 평균 29% | 25-35% | 25% 가량의 주성분 속방이 필요하며, 이보다 더 |\n| 이미 사용되는 에틸셀룰로오스의 등급인 20 mPa.S 점도를 갖는 것을 사용하였다. | 펠렛에서 구형백당-주성분 층화 공정 및 서방 펠렛에서 기능성 서방 코팅 공정에 채택하 | 명칭 | 배합목적 | 등급 | 로트 번호* | 공정서 규격 여부 | 속방 펠렛* (항산화제 무첨가) | 80 | 2 | 17 | 삼키기 어려운 환자들이 캡슐을 |\n| 가혹 조건 | 함량 시험 | 유연물질 시험 |\n**많은 주성분이 속방될 수 있으므로 기준 설정**\n| 충진물 | 펠렛으로 충진 | 속방과 서방 펠렛으로 충진 | 속방 펠렛* (+아스코르브산 5.0 mg) | 87 | 2 | 10 | 열어 스푼에 펠렛을 섞어 복용할 |\n| 있는 방출 프로파일을 유지하는 제품을 만들어내는 것이었다. 실험설계는 몇 가지 공정 | <10% / 35% / 65%이고, 코팅 효율성이 95%를 초과하는 완제의약품을 제조하게 하였 | % 함량 | 피크순도 | 관찰된 분해산물 | 피크 순도 | 높은 분무 속도에 따라, 분무 방울 크 |\n| 시험항목 | 기준 | 시험방법 | 수 있도록 하는데, 동 제품에서도 |\n| 500정 병포장 | 198병 | 200병 | 변수를 극도로 하여 시험하는 것으로 설정되었고, 이 공정변수의 극도값은 다른 제품에 | 다. 실험설계 시험의 결과를 통해 분무 방울 크기 30 μm가 서방 막의 최적 코팅을 위 | 속방 펠렛* (+아스코르브산 10.0 mg) | 89 | 2 | 10 | 기 중앙값을 30μm로 유지하기 위해 |\n\n**[표 끝]**\n\n- - 16 -\n기재한다 (예: 가혹시험에서 확인된 유연물질, 분해경로에 대한 정보 등).\n\n- ○ 2.3.P.2.1.2 첨가제에는 첨가제와 원료의약품 간 배합적합성에 대해 기재한다. 의약품 개발\n과정에서 첨가제와 원료의약품의 배합적합성을 평가하여야 하나, 일부 기존 자료로 대체할\n\n수도 있다. 제네릭의약품의 경우, 안정성 문제가 없는 것으로 알려진 첨가제의 종류, 분량이\n\n대조약과 동일하다면 배합적합성 평가 자료 대신 경험적 자료가 허용될 수 있지만 이런\n\n첨가제의 적합성은 통상적으로 원료의약품과 각 첨가제 간 상호작용을 평가하기 위해\n\n“binary mixture\"를 가지고 시험하거나, 원료의약품과 모든 첨가제를 혼합한 것과 이\n\n시험 조건은 가속시험조건(40 ℃ / 75% RH), 장기보존조건(25 ℃ / 60% RH) 또는 완제\n\n의약품 제조공정을 반영한 조건(예: 수분 10∼20% 첨가 / 50 ℃ RH) 등을 고려할 수 있\n\n으며, 시험기간은 통상 4 주 이상 관찰하나 시험목적에 따라 과학적인 타당성을 가지고\n\n시험 항목은 일반적으로 함량 및 유연물질에 대해서는 반드시 설정하며, 원료의약품의\n\n- ○ 2.3.P.2.2 완제의약품에는 완제의약품의 특성, 이러한 특성을 확보하기 위한 방법, 개발과정\n- ○ 2.3.P.2.3 제조 공정 개발에는 3.2.P.3. 제조에 기술된 제조공정이 선택된 이유, 제조공정이\n- ○ 2.3.P.2.4 용기 및 포장에는 완제의약품의 용기 및 포장을 선정한 이유 등을 기재한다.\n- - 속방성 제제 및 서방성 제제의 개발경위 기재: Appendix 참조\n<!-- PAGE_22 -->\n##### 2.3.P.3 제조(제품명, 제형)(Manufacturing)(name, dosage form)\n\n- 3.2.P.3에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n・제조자(제조원)에 대한 정보\n\n・적절한 품질을 일정하게 제조하기 위한 제조공정 및 그 공정 관리에 대한 간단한 설명\n\n- 3.2.P.3.3에 기재된 제조공정 도식\n- 3.2.P.3.5에 기재된 공정 밸리데이션 및 평가에 대한 간단한 설명\n- - 17 -\n- ○ 제조원에 대한 정보, 제조공정, 제조장비, 공정관리방법 등을 요약 기재한다.\n- ○ 제조원에 대한 정보는 각 단위공정에 대한 제조 및 품질관리 범위에 대한 내용을 기재한다.\n(제조자, 제조의뢰자, 일부공정제조자 등)\n\n. 위수탁관계가 있는 경우 이를 기재한다.\n\n- ○ 허가신청용 뱃치와 실생산 뱃치 간에 뱃치사이즈, 제조장비, 작동원리 등이 다를 경우 그\n- ○ 제조공정은 공정조건과 중요 공정변수를 포함한 도식으로 나타낸다.\n- ○ 제조방법은 아래 서식으로 기재하거나, 서식의 항목을 포함한 다른 기술방식(예시 참조)을\n공정 번호\n\n공정 명칭\n\n원료․시약․용매 등\n\n공정 과정\n\n비고\n\n**[표 시작]**\n\n**(중요장비, 혼합속도**\n| 참조한다. | 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 순도시험 | 허용기준 | 설정근거 | 허가제출용 의약품 | 공정2의 결합액 | 농도가 낮으면 낮은 점도의 코팅 현탁을 형성하여 분무 | Inc. | NF | CRC | Bottle.Co | 대조약 |\n| 도 움 주 신  분 | 이동상 | 이동상 A: K2HPO4 3.2 g 과 KH2PO4 0.85 g을 물에 녹여 1000 mL로 한다. | 참고) | 식품의약품안전평가원 의약품심사조정과, | 를 피해야 함 |\n| 4 | 제립 | 30 분 | r2=0.996 | 25-35% | 평균 0.14% | 91-110% | 노즐의 기압이 증가되었음3 | 평균: 88% |\n| 공정3의 혼합물 | 속도에 영향을 미칠 수 있고, 농도가 높으면 너무 점도 | (제조번호) | (제조번호) |\n| RC3 | 0.5% 이하 | 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 | 주성분 피크 순도(PDA)>0.99 | 이동상 B: 아세토니트릴 | 0.035% | 0.1% |\n| 코팅액 농도 | 15 % w/v | 최종 제제에 |\n| <원료의약품 입자도(D90)에 따른 용출양상 (USP apparatus 2, 50 rpm, pH 4.5)> | 아세토니트릴:완충액 = 30:70 | 순환계약품과, 종양약품과, 소화계약품과, | RSD=1.5% | RSD 5.7% | 가 높은 현탁을 형성하여 최대 기압을 사용하지 않으면 | RSD=2.9% | 범위: 85-90% |\n| 5 | 건조 | 기준 | 0.05-2.5% | 첨가제/등급 | 주성분 ...  함량(%) | 4 시간 | 0.05-1.0% | 40-60% | 0.05-1.0% | Inc. | NF | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% |\n| 공정단계들로 1) 약물 층화(속방 펠렛 제조), 2) 서방코팅(서방 펠렛 제조), 3) 캡슐충진 | 컬럼 | Symtrex C18, 5 μm, 250 mm × 4.6 mm | 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 |\n| 완충액: 물 1000 mL에 KH2PO4 6.8g을 녹이고 트리에틸아민으로 pH를 7.4 ± 0.05로 | 사용여부(Y/N) |\n| 동등한 제네릭의약품을 설계할 때 유사하게 하였다. | 분무하기 어려움 | 서방 층 |\n| 6 | 정립 | 기타 분해생성물 | 유속 | 1.5 mL/분 | UV (단파장/ 장파장), 7일 | 98% | >0.99 | r2=0.99 | 8 시간 | r2=0.99 | 65-85% | r2=0.99 | r2=0.99 | r2=0.99 | r2=0.99 |\n| (속방 및 서방 펠렛 충진)을 확인하였다. | 제조번호 | 보존조건 | 시험일정 | 용기/포장 | 포장재질 | 조절한 액 | 약효동등성과 | Release Inc. | 별규** | 시험 결과 |\n| 주입 기체 온도 | 55 ~ 62 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨. | 후 분쇄한다. | 공정단계 | 제조번호 #9A | 목표량 | 최소 생산 수율 (limit) | 첨가제 없음(대조군) | 91 | N/A | 공정변수 | 사유 |\n| 7 | 활택 | 효율성에 어느 정도의 효과를 가지는 것으로 보였는데, 최대의 효과는 분무속도 및 약 | Heat seal | S Liner |\n| 총 분해생성물 | 건열, 105 ℃, 14 시간 | 70% | >0.99 | 시간 (분) | 0.0 | 30.0 | 37.0 | (제조번호 P034) |\n| Lot #9A | 40 ± 2℃ | 관리방법 등에 관한 자료. | <용출시험결과(USP Apparatus 1, 100rpm, 37℃, pH 6.8)> | 12 시간 | 0.5% 이하 | 1.0% 이하 | M-1232 | 0.3% | 85% 이상 |\n| 발 | 행 | 처 | 구형 백당 | 90 | Y | 90~110 | 540~660 | 분포-플레이트 면적 비율2에 근거하 | 식품의약품안전평가원 의약품심사부 의약품규격과 |\n| 물미세화 압력을 공정에서 변경했을 때 관찰되었다. Curing과 관련하여 관찰된 용출 프 | 농도구배 | 이동상 A (%) | 80 | 20 | 20 |\n| 체에 남은 분율 | 상부 불투명한 청녹색과 하부 불투명한 노 | 타정기에서 | 0.1 % 이하 | 중요공정 |\n| 0, 3, 6 개월 | 60 정 병포장 | Lot #10A | 산출량 | 45.629kg(98%) | 46.56kg(100%) | 96% | 이동상 B (%) | 20 | 80 | 80 | 여 선형 스케일업 |\n| 정하므로, 결정형 I 형을 유지하는 것이 품질 유지에 중요하다. I 형은 안정하고 과립 | 에틸셀룰로오스 | 92 | Y | <에틸셀룰로오스 점도에 따른 주성분 ...  코팅펠렛의 용출 양상> |\n| 8 | 타정 | 공정7의 반제품 | “LOQ 미만”으로 기재하고, “불검출”인 경우 검출한계(LOD)를 함께 기재한다. | 로파일 유사성 인자(f2 > 50)는 실험설계에서 조사된 코팅 조건들의 범위 하에서 서방 | 란색의 경질 1호 캡슐. 상‧하부 각각 흰색으로 | 75 ± 5% RH | 본압: □~□mm, | 육안 검사 | 적합 | (중요장비, 타정조건 |\n| Lot #11A | 온도 | 40 ℃ | 미결정셀룰로오스 | 90 | N |\n| 경질 젤라틴 캡슐에 충진된다. 캡슐충진 공정변수들은 기기 제조사의 권장사항과 유사 제 | 에서 중요 단계로 확인되었다. | “MK”와 “32”가 각인되어 있다. | 예압: □~□mm, | 등) |\n\n**[표 끝]**\n\n- - 18 -\n* 최종제품이 동물유래성분을 함유하거나 제조과정 중 동물유래성분이 사용된 경우 「의약품의\n\n품목허가‧신고‧심사 규정」제14조(제조방법)에 따라 필요한 사항을 기재한다.\n\n- ○ 제조자(제조원)에 대한 정보 : 회사명 및 주소 기재\n**[표 시작]**\n\n**2 스케일업 동안 동일한 기체 속도를 유지한다.**\n**자료는 2.3.P.2.2 완제의약품에 기재한다.**\n**▪ 용해도 및 pH에 따른 용해도**\n**2.3.P.2.1.2 첨가제**\n| ▪ 첨가제 | 첨가제 선정 | 적으로 유사함 | 캡슐 충진공정 |\n**2.3.P.2.4 용기 및 포장**\n**제품의 생물학적 동등성/생체이용률 최적화**\n**2.3.P.2.2 완제의약품**\n**▪ 입자도**\n**2.3.P.2.1.2 첨가제**\n| 최종 제제의 최적화 | 특이성 |\n**2.3.P.2.2 완제의약품**\n| 단위 공정명 | 장비명 |\n**▪ 대조약(RLD)의 정보 검토**\n**▪ 제제 조성 최적화**\n| 완제의약품 품질과 관련된 제조공정 | 직선성 | 10 - 150%, r2 = 0.99 |\n| 정밀성 | RSD 0.18% |\n| > 0.99로 계산되어 주성분 피크가 균일함을 확인하였다. | 실험실내 정밀성* | RSD 0.5% |\n**회사명**\n| 주소 | 함량균일성 |\n**회사명**\n\n**[표 끝]**\n\n주소\n\n- ○ 제조공정 요약\n- - 제조공정은 다음과 같다.\n- 1. <혼합> 유당수화물, 포비돈, 미결정셀룰로오스를 high shear mixer에서 혼합한다.\n- 2. <습식과립> 주성분을 별도로 정제수와 섞는다.\n- 3. <습식체과> 주성분 현탁액을 공정 1의 혼합물에 분사하고 impeller에서 빠른 속도로 혼합\n- 4. <습식체과> 분쇄를 계속하여 종말점에 다다른 후(약 5분 후) 균질한 혼합물을 얻는다.\n- 5. <습식체과> 습체를 6 mesh(3.3 mm) 체에 통과시켜 큰 덩어리를 제거하여 건조가 균일\n하게 될 수 있도록 한다.\n\n속도: □~□rpm으로\n\n- - 19 -\n- 6. <건조> 과립물을 60±5°C (LOD 0.5 % 이하가 될 때까지) 온도에서 fluid bed dryer로\n- 7. <분쇄> 건조된 과립을 impact mill(날 장착)에서 12 mesh (1.1 mm) 체를 통과시킨다.\n- 8. <최종혼합> 분쇄된 과립을 bin-blender에서 크로스포비돈을 넣어 5 분간 혼합하고,\n- 9. <타정 및 포장> 혼합물을 타정 후 포장한다.\n- - 제조공정을 도식으로 표현하면 다음과 같다.\n- ○ 허가제출용 뱃치에 관한 사항(요약)\n- - 제조량 및 목표량\n혼합(건조 후)\n\n최종혼합\n\n- - 20 -\n- - 뱃치조성(실생산 뱃치와 비교)\n**[표 시작]**\n\n| 성분명, 규격 | 허가제출용 뱃치 |\n| --- | --- |\n| 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 |\n**첨가제 선택과 관련한 추가 상세 정보는 3.2.P.2.1.2 첨가제를 참조한다.**\n| 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 | 유연물질 A(3%) |\n**순도시험**\n| UV (단파장/ 장파장), 7 일 | 98% | >0.99 | NA |\n| 건열, 105 ℃, 14 시간 | 70% | >0.99 | 유연물질 A(23%) |\n**1. 대조약과 약제학적으로 동일하도록 캡슐제형으로 한다.**\n| 정확성 | 98 - 101%, 표시량의 50%, 100%, 150% 포함 |\n| 정제수 | 9.6 L | 96 L |\n| 총 질량 | 48 kg | 480 kg |\n**직선성, 특이성 및 시스템적합성이 검증된 방법이다.**\n**▪ 목표 제품 설계 방법**\n**2.3.P.2.4 용기 및 포장**\n| 구형백당, 25-30 mesh* | Sugar Inc. | NF |\n| √ 완제의약품에서의 원료의약품 입자도 | 3.2.P.5.4 뱃치 분석을 참고한다. |\n| 뚜껑 (60 mL 용) | 28 mm CR cap white HDPE Outer Shell clear PP |\n| 시트르산트리에틸 | Plasticizer |\n| √ 완제의약품에서의 원료의약품 결정다형 | 균일성과 용출 시험에서도 HPLC 법이 사용되었다. | 강제 분해시험(가혹 조건에서 실시) 결과 요약 및 타당성입증자료를 제출한다. |\n| 특이성 | 대한 정보를 요약하여 기재한다. |\n| 혼합 | 체에 남은 분율 | 1.0% 이하 | M-1231 | 0.1% |\n| √ 완제의약품에서의 붕해도 | 용출시험 | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP(HPLC) |\n| 부틸레이티드히드록시아니솔 | Antioxidant |\n| 코팅효율 | 98% | 98% | N/A |\n| [특정 분해생성물] | [허가제출용 뱃치의 결과] |\n**√ 완제의약품에서의 용출**\n| 습식체과 | 체에 남은 분율 | 1.0% 이하 | M-1233 | 0.1% | 이동상 | 직선성 |\n| 에틸셀룰로오스 | Control |\n**√ 완제의약품의 경도**\n| ▪ 결정형 | 시험항목 | 허용 기준 | 시험 방법 |\n**개월 동안 시험하였다. 향후 연간 모니터링할 예정이다.**\n| 건조 | 건조감량 | 칼럼 | Symtrex C8, 5 ㎛, 150mm X 4.6mm | 기재한다. |\n| 정제수 | In-House | USP | 유동화 기체 부피 | 사실과 기허가 사항에 근거한 것이다. |\n| 실험실 | 내 | 사용하는 용출 용매와 다르게 사용한 경우 이를 작성한다. |\n\n**[표 끝]**\n\n주성분, USP\n\n- 0.4 kg\n- 4.0 kg\n- 0.83\n유당, NF\n\n- 32.00 kg\n- 320.00 kg\n- 66.67\n미결정셀룰로오스, NF\n\n- 12.32 kg\n- 123.20 kg\n- 25.67\n포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n크로스포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n스테아르산마그네슘, NF\n\n- 0.24 kg\n- 2.4 kg\n- 0.50\nFD&C Blue #2\n\n- 0.160 kg\n- 1.60 kg\n- 0.33\n- - 제조공정 중 품질검사 항목\n타정\n\n분쇄\n\n체에 남은 분율\n\n- 1.0% 이하\nM-1233\n\n- 0.2%\n- - 21 -\n- - 실생산 뱃치와 허가제출용 뱃치 간의 장비 및 작동원리 비교\n<!-- PAGE_27 -->\n##### 2.3.P.4 첨가제의 관리(제품명, 제형)(Control of Excipients)(name, dosage form)\n\n- 3.2.P.4에 기재된 첨가제의 품질에 관한 간략한 요약을 포함하여야 한다.\n<!-- PAGE_27 -->\n##### 해 설\n\n**[표 시작]**\n\n| 분석 시간 | 15 분 | 자세한 내용은 3.2.P.5.3 시험방법 밸리데이션을 참고한다. |\n| --- | --- | --- |\n| 최종혼합 | 분무 속도(mL/분) | 25~30 | 150~180 |\n| 유지 시간 | 약 8 분 | 에서 관리한다. | 중 미생물관련 특성에 대하여 별도로 기재한다. |\n**2.3.P.2.1 완제의약품 조성**\n| 확인시험 | 표준액 및 시험액 | 주성분 0.1 mg/mL을 포함하는 표준액과 시험액을 조제한다. | 2.3.P.2 개발경위 |\n**점도 관리를 포함한 규격을 설정하였다.**\n**2.3.P.2.1.1 원료의약품**\n| ▪ 안정성 | 2.3.P.2.1 완제의약품 조성 | 시험의 분석방법 밸리데이션을 위해 기재함. (2.3.S.4 원료의약품의 품질관리 참조) |\n| 스케일업 | 약물미세화 기압(bar) | 1.5 | 2.5 |\n| 미처리 | 99% | >0.99 | NA | >0.99 |\n| 2.3.P.2.1.1 원료의약품 | 유연물질 A | [화학 구조] |\n| 에톡시함량 (N-Type) | 48.0 ~ 49.5 % | 48.8 % | 실험설계 시험의 결과는 아래에 요약하였다. |\n**1 뱃치크기는 사전 경험 뿐 아니라 기기 제조원의 권장사항에 따른다.**\n**용출시험**\n| 점도 | 18.0 ~ 22.0 mPa.s | 20.1 mPa.s |\n| 제형설계와 관련한 상세한 정보는 3.2.P.2.2.1 제제 개발을 참조한다. | 미처리 | 99% | >0.99 | NA |\n| 타정 | 3 실험실 규모 시험 결과 노즐압이 증가하면 원하는 펠렛 특징이 나오지 않을 수 있다. |\n| 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유연물질 A(12%) |\n| 함량균일성 | 시험 | USP<905> | 자사 시험방법 #125c (HPLC) | 99.1-101.3% |\n| 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 유연물질 A(65%) |\n**물질은 기준에 적합하였다. 추가적인 내용은 3.2.P.5.6 기준 설정근거를 참고한다.**\n| 함량 | 95.0-105.0% | 자사 시험방법 #125b (HPLC) | 101.2% | 첨가제 종류 및 등급 선정은 기사용례와  대조약 분석을 바탕으로 하였다. |\n| 수분 | 3.5% 이하 | 칼피셔법 (USP<921> 1a법) | 2.9% |\n\n**[표 끝]**\n\n- - 22 -\n- ○ 첨가제의 용도, 규격 등에 대해 도표로 요약, 기재한다.\n- ○ 공정서 규격 첨가제인 경우에는 등급을 포함하여 아래 표와 같이 기재한다.\n* 허가제출용 뱃치의 생산에 사용된 첨가제의 로트 번호\n\n공정서 규격 이외 추가로 설정된 항목이 있다면 아래 표와 같이 기재하고 이에 대한 근거\n\n- ○ 공정서에 수재되지 않은 첨가제의 경우는 해당 첨가제에 대한 기준을 표로 요약하고 필요한\n- ○ 동물유래성분 첨가제의 경우, 원산국, 전염성해면상뇌증(BSE/TSE) 증명서의 발행처를 기재\n- ○ 기 사용례가 없는 새로운 첨가제는 제조사, 특성, 품질관리, 안전성 입증자료 등을 포함한\n- 2.3.P.4. 첨가제의 관리 (서방성 제제 예시)\n공정서에 수재된 첨가제들을 아래 표에 정리하였다. 첨가제들의 관리는 해당 공정서에 따른다.\n\n* 구형백당의 입자 크기는 25~30 mesh로, 완제의약품의 약물방출이 일정하고 재현성 있도록\n\n서방펠렛이 일정한 표면적을 갖게 한다.\n\n- - 23 -\n** 에틸셀룰로오스는 완제의약품의 방출속도 조절에 중요한 기능을 한다. 개발 과정 중 에틸셀\n\n룰로오스의 등급에 따라 점도가 다르며, 점도는 서방코팅층을 통한 방출속도에 유의하게\n\n영향을 미치는 것으로 나타났다(2.3.P.2.2 완제의약품 참조). 방출 양상이 일관성 있도록,\n\n<!-- PAGE_29 -->\n##### 2.3.P.5 완제의약품의 관리(제품명, 제형)(Control of Drug Product)(name, dosage\n\n<!-- PAGE_29 -->\n##### form)\n\n기준의 설정근거에 대한 간단한 요약, 시험방법과 밸리데이션 및 불순물의 특징에 대한 요약을\n\n제공하여야 한다.\n\n- 3.2.P.5.1에서 얻은 기준을 제공하여야 한다.\n- 3.2.P.5.4에서 제공된 뱃치 분석의 도표요약을 필요시 그래프와 함께 포함하여야 한다.\n- ○ 제품의 규격 및 시험방법, 기준설정 근거 및 시험방법 밸리데이션에 대해 기재한다.\n- ○ 완제의약품의 기준 및 시험방법은 중요 특성을 포함하도록 하여 표로 작성한다.\n- - 완제의약품에 적용하는 시험항목은 다음과 같다.\n. 성상\n\n. 확인시험\n\n. 함량시험\n\n. 분해 산물\n\n. 제제학적시험(「의약품의 품목허가‧신고‧심사 규정」[별표13])\n\n- ○ 뱃치 결과는 다음을 고려하여 기재한다.\n- - 모든 용량(strengths)에 대한 시험 결과를 표로 작성한다.\n- - 정량적인 시험 결과는 “기준에 적합” 또는 “적합”이 아닌 수치로 기재한다.\n- - 순도시험(정량시험)의 경우, 정량한계 이상은 결과 값을 기재하고 정량한계 미만에서는\n- ○ 기준 및 시험방법 설정 근거는 다음과 같이 기재한다.\n- - 24 -\n- - 공정서에 수재되지 않은 시험방법은 중요 변수 및 시스템적합성시험 기준을 포함하여 표\n- - 기준 설정근거로 대조약을 사용한 경우, 대조약 분석결과를 기재한다.\n- - 시험방법 밸리데이션을 수행한 경우 아래와 같이 요약표를 기재한다.\n- - 유연물질은 원료의약품의 분해생성물, 용기/마개와 반응하여 생성된 유연물질로 분류할 수\n있다. 2.3.S.3. 특성 또는 2.3.S.4. 원료의약품의 품질관리에서 확인된 유연물질은 구조 기재를\n\n- - 일반적으로 유연물질이 완제의약품에서 발생한 분해생성물이 아니라면 완제의약품에서 관리\n또는 규명할 필요는 없다. 신청자가 원료의약품의 합성 중간체 또는 공정 불순물을 완제\n\n의약품에 규격 설정하는 경우(예: 크로마토그램에 검출되거나 마커로 사용 등), 원료의약품\n\n- ○ 순도시험의 경우, 특정 유연물질에 대해 표준품을 이용하여 정량하거나, 유연물질의 상대반\n주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 간에 방해가 없음 (첨부된 크로마토그램\n\n- - 25 -\n응계수(RRF)를 기재한다.\n\n- ○ 분해생성물의 기준은 다음과 같이 설정할 수 있다.\n1) 공정서 규격(기타 유연물질의 설정 근거는 공정서 규격에 근거할 수 없다.)\n\n2) 「의약품의 품목허가·신고·심사 규정」(식약처고시)에 따라 아래와 같이 기준을 설정한다.\n\n- - 보고수준(RT; reporting threshold), 구조규명 수준(IT; identification threshold), 안전성\n- - 기타 유연물질은 구조규명 수준과 동등 또는 그 이하로 설정\n- - 특정 유연물질은 안전성입증 수준과 동등 또는 그 이하로 설정하거나 입증\n- ○ 불순물의 안전성은 아래와 같이 입증한다.\n1) 독성시험자료: 반복투여독성시험자료, 유전독성시험자료(복귀돌연변이시험, 체외염색체이상\n\n2) 주요 대사산물 여부\n\n3) 공정서 또는 기타 과학적 문헌\n\n4) 기허가 완제의약품에서 확인된 유연물질 수준(일반적으로 사용기간 만료 시점 또는 만료\n\n- ○ 완제의약품의 가혹시험 결과 및 분석 방법을 피크 순도를 포함하여 요약, 기재한다.\n- - 가혹시험은 주성분이 10 ~ 30 % 분해되는 것을 목표로 한다. 매우 안정한 주성분의 경우,\n- ○ 용출시험은 다음과 같은 양식으로 기재한다.\n- - 26 -\n- - 공정서에 수재된 시험방법이 아닌 경우, 용출시험 분석 방법을 상세 기술하고, 용출규격설정\n1) 속방성 제제의 기준 및 시험방법 기재\n\n. 본 제품은 USP 의약품각조를 참고하여 작성한 자사 기준에 따른다. USP 의약품각조에서\n\n. 개발단계에서 완제의약품이 수분에 민감성을 보이지 않았고, 건조 공정의 종료 시점 결정을\n\n위해 건조감량을 측정하므로 기준 및 시험방법에는 수분 시험은 포함하지 않는다.\n\n- - 27 -\n- ○ 기준 및 시험방법 설정 요약\n. 성상: 정제의 색상, 형태, 일반적 외형에 대해 육안 시험한다.\n\n. 확인시험: USP 의약품각조의 함량시험법에 따라 시험한다.\n\n. 함량시험: USP 의약품각조에 따라 기준은 90.0 - 110.0%로 설정하고, 의약품각조의 시험\n\n법을 사용하였다. 위약에 의한 간섭효과는 없었다. 시험검체와 위약, 대조약의 크로마토그램은\n\n- 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다. 가혹시험은 유연물질 항 다음에 기재\n. 함량균일성 시험: USP 일반시험법 <905> 함량균일성시험의 허용기준을 적용하였다.\n\n. 순도(분해산물): 주성분에서 2개의 주요 분해산물이 확인되었다.\n\n이 품목에 대한 USP 의약품각조의 기준은 다음과 같다.\n\n유연물질 시험방법은, 공정 불순물 검출이 가능한 자사 시험방법(#41)이며, 정확성, 정밀성,\n\n함량 시험방법과 유연물질 시험방법이 특이적이고 안정적임을 증명하기 위해 가혹시험을\n\n실시하였다. 산, 염기, 산화제, 열, 빛 조건에 노출시킨 후, HPLC(PDA, Peak purity analysi\n\ns)로 분석하였다. 분해산물 피크들은 관련 피크들에서 완전히 분리되었다. 주성분 피크의 피크\n\n순도는 > 0.99로 관찰되었다. Peak purity angle은 peak purity threshold보다 작고, 간섭은\n\n- - 28 -\n없었다. 주성분 피크나 유연물질 RC2와 RC3 피크에 대한 분해산물 피크의 간섭은 없었다.\n\n. 용출: 용출시험법은 USP 의약품각조의 시험방법을 따랐으며, 시험 조건과 기준은 다음과\n\n2) 서방성 제제의 기준 및 시험방법 기재\n\n**[표 시작]**\n\n**아님을 확인하였다. 분석법 밸리데이션과 가혹시험에 관련해서 아래 표에 요약하였다.**\n**제조공정개발 시 최종 완제의약품의 품질 보증을 위해 다음 특성을 규정하였다.**\n**시아니솔(안정화제)을 10% w/ 부틸레이티드히드록시아니솔 수용액 상태로 분무한다.**\n| 유량 | 1.5 mL/분 |\n| 중요공정변수 | (m3/시간) |\n**성상**\n\n**[표 끝]**\n\n- - 29 -\n- ○ 기준 및 시험방법 설정 요약\n. 성상: 캡슐의 낱알표시, 색상과 형태에 대해 육안으로 검사한다. 이 때 캡슐 표면의 색상\n\n. 확인시험: 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.\n\nHPLC: 주성분 피크의 유지시간은 표준품과 같다.\n\nUV: 표준품과 같은 파장에서 흡수극대를 나타낸다.\n\n. 함량시험: 함량 기준은 95.0 - 105.0%이며, 분석 조건은 다음 표와 같다. 이 시험과 관련\n\n하여 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다. 대조약의 함량\n\n캡슐 내부에는 흰색 또는 미황색의 구형의\n\n온도\n\n40°C\n\n검출기\n\n272 nm UV detector\n\n- - 30 -\nHPLC 분석법에 대해 정확성, 정밀성, 특이성과 직선성을 평가하기 위한 밸리데이션을 실시\n\n하였다. 특이성과 안정성을 검증하기 위해 제품은 여러 가지 가혹 조건에서 PDA 검출기가\n\n장착된 HPLC 기기로 분석이 진행되었다. 모든 분해산물 피크는 주성분 피크로부터 분리되\n\n었고, 피크 순도는 > 0.99로 계산되어 주성분 피크가 완전히 분리됨을 확인하였다. 분석방법\n\n밸리데이션과 가혹시험에 대해 아래에 요약되어 있다. 자세한 사항은 3.2.P.5.3 시험방법 밸\n\n리데이션을 참고한다.\n\n* 2명의 시험자가 서로 다른 기구로 시험\n\n. 함량균일성 시험: USP 일반시험법 <905>에 따라 시험한다.\n\n주입량\n\n20 ㎕\n\n**[표 시작]**\n\n| 시스템 적합성 | 주성분 피크로 계산한 칼럼 효율은 이론단수 5000 이상, 대칭계수는 2.0 이하이다. 표준 |\n| --- | --- |\n| 뚜껑 (325 mL 용) | 45 mm PP white CT Fine Ribbed Closures | Bottle.Co |\n\n**[표 끝]**\n\n- - 31 -\n. 순도(분해산물): 주성분의 기지 분해산물에 대해 아래 표에 요약하였다. 유연물질 B, C, D,\n\nF (2.3.S.4 원료의약품 품질관리 참고)는 완제의약품에서는 관찰되지 않았으므로, 원료의약품\n\n최종 제품의 분해산물 기준에 대한 근거는 다음 표에 제시하였다. 제시된 기준은 「의약품의\n\n품목허가‧신고‧심사 규정」(식약처고시)에 근거하여 설정하였다. 제조번호 P034 시험결과 유연\n\n2) 동 품목의 일일최대복용량은 64 mg이므로 미지 유연물질의 기준은 구조규명 수준(IT)인\n\n유연물질(분해산물)은 다음 HPLC 조건으로 시험한다. 자세한 사항은 3.2.P.5.2 시험방법과\n\n- - 32 -\n* 유연물질 B, C, D, F는 완제의약품에서 유연물질에서는 제외한다.\n\n유연물질 분석법에 대하여 정확성, 정밀성, 특이성과 직선성에 대한 밸리데이션을 실시하였다.\n\n특이성과 안정성을 검증하기 위해 여러 가지 가혹 조건에서 PDA 검출기가 장착된 HPLC\n\n기기로 분석이 진행되었다. 모든 분해산물 피크는 주성분 피크로부터 분리되었고, 피크 순도는\n\n유연물질 A는 열, 염기 및 산 조건에서 생성되는 1차 분해산물이다. 예상한 바와 같이 유연\n\n물질 B, C, D, F는 가혹시험 조건에서 변화가 없었으므로 이 유연물질들이 제품의 분해산물이\n\n정밀성\n\nRSD 6.7%\n\nRSD 4.5%\n\nRSD 6.8%\n\nRSD 5.2%\n\nRSD 3.2%\n\nRSD 4.5%\n\n정밀성2\n\nRSD 8.2%\n\nRSD 9.2%\n\nRSD 10.4%\n\nRSD 9.6%\n\nRSD 8.2%\n\nRSD 9.8%\n\n정확성3\n\n95-104%\n\n80-97%\n\n88-105%\n\n92-112%\n\n80-101%\n\n82-115%\n\n- - 33 -\n1 유연물질 B, C, D, F는 제품 유연물질 계산에 포함되지 않으나, 원료의약품 HPLC(분해산물)\n\n2 2명의 시험자가 서로 다른 기구로 시험함\n\n. 용출: 「경구용의약품의 용출규격 설정 가이드라인」에 따라 예비시험 및 본시험을 수행하여\n\n용출 기준은 4 개의 시점에 대해 설정하였으며, 평균 용출률의 ± 10% 범위로 설정하였다.\n\nLOQ\n\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\nLOD\n\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- - 34 -\n4 시간, 8 시간 시점의 기준은 개발 뱃치의 용출 평균 값보다 엄격한 기준을 적용하였다.\n\n. 수분: 주성분이 가수분해될 수 있으므로 완제의약품의 수분함량 조절이 필요하다. 수분 기\n\n준(3.5% 이하)은 각 성분의 수분기준 상한(2.8%), 시험 결과(2.9%)와 안정성시험 결과(3.\n\n3) 무균 제제\n\n. 미생물관련 기준 및 시험방법, 결과 요약\n\n<!-- PAGE_40 -->\n##### 2.3.P.6 표준품 또는 표준물질(제품명, 제형)(Reference Standards or Materials)(name,\n\n<!-- PAGE_40 -->\n##### dosage form)\n\n- 3.2.P.6에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n- ○ 3.2.P.6 표준품 및 표준물질에 설명된 완제의약품 시험에 필요한 표준품 또는 표준물질에\n- ○ 원료의약품과 동일한 표준품을 사용하는 경우, 2.3.S.5 표준품 또는 표준물질을 참고한다.\n- ○ 표준품은 로트 번호와 시험성적서 발행처 및 주소 등 품질을 입증할 수 있는 정보를 기재\n한다. 단, 공정서 표준품에 대하여 정보가 제공되는 경우 그 품질을 알 수 있는 정보를\n\n- ○ 순도시험에서 표준품을 사용하는 경우, 해당 표준품에 대한 내용도 기재한다.\n- - 35 -\n<!-- PAGE_41 -->\n##### 2.3.P.7 용기 및 포장(제품명, 제형)(Container Closure System)(name, dosage form)\n\n- 3.2.P.7에 있는 정보의 간단한 설명과 고찰을 포함한다.\n- ○ 3.2.P.7 용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n- ○ 용기 및 포장에 대해 요약하여 표로 기재한다.\n- ○ 사용된 용기 및 포장의 안전성 입증을 위해 공정서 수재 시험방법 등으로 시험할 수 있다.\n또한 동일한 포장 형태를 사용하는 기허가 의약품을 근거로 갈음할 수 있으며 시험성적서를\n\n- ○ 포장 용기에 대해 다음과 같이 기재할 수 있다.\n- - XXX 정 2 mg은 HDPE (흰색, 원형) 병포장으로 시판될 것이다.\n. 60 mL (60, 100 정) 28mm 지름, Al induction 씰로 된 PP CRC\n\n. 325 mL (500 정) 45mm 지름, Al induction 씰로 된 PP CRC\n\n- - 용기 시스템에 대한 요약은 다음과 같다.\n**[표 시작]**\n\n| Closure liner | PE faced Al inner seal | Pulp.inc |\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 사용된 용기 포장은 USP <661> 플라스틱용기시험법과 USP <671> 용기성능시험법에\n적합하다. 자세한 사항은 3.2.P.2.4. 용기 및 포장을 참조한다.\n\n- - 36 -\n<!-- PAGE_42 -->\n##### 2.3.P.8 안정성(제품명, 제형)(Stability)(name, dosage form)\n\n수행된 시험(조건, 뱃치, 시험방법)의 요약 그리고, 안정성시험 및 데이터 해석에 대한 결과 및\n\n결론의 간략한 고찰을 포함하여야 한다. 보관조건, 유효기간, 필요시 사용시 보관조건 및 사용\n\n시 유효기간에 관한 결론을 제시하여야 한다.\n\n- 3.2.P.8.3에 기재된 안정성시험 결과가 필요시 그래프와 함께 요약표를 포함하여야 한다.\n- 3.2.P.8.2에 기재된 승인 후의 안정성시험 계획을 제공하여야 한다.\n- ○ 안정성시험에 적용된 기준 및 시험방법을 기재한다.\n- - 완제의약품의 기준 및 시험방법과 안정성시험의 기준 및 시험방법이 상이할 경우, 이를\n- ○ 용기 및 포장 형태에 대해 명확히 기재한다.\n- ○ 안정성시험(장기보존시험, 가속시험) 기준 및 결과를 표로 나타낸다.\n- ○ 보관 검체를 재시험하는 경우, 해당 사항을 표시한다 (예: 용출기준 변경이 있는 경우).\n- ○ 필요한 경우, 쓸 때 조제하는 제제 또는 완제의약품 복용 시와 동일한 조건과 같은 특수\n연구를 실시하고, 안정성시험 결과 및 시험방법을 기재한다. 사이클링 연구 수행 결과(동결\n\n- ○ 안정성시험 결과를 바탕으로 보관조건 및 사용기한 설정에 대해 기술한다.\n- ○ 시판 후 안정성시험 계획서와 이행서약을 기재한다.\n- - 안정성시험 계획서는 다음 사항에 대해 기재한다.\n1) 검체 보존조건\n\n2) 안정성시험용 검체 정보 (제조번호, 포장형태 등)\n\n3) 시험주기\n\n4) 시험항목과 시험 일정\n\n- - 안정성시험 이행서약은 다음 사항에 대해 기재한다.\n1) 안정성시험을 실시할 제조단위\n\n2) 연 단위로 안정성 계획에 추가될 제조단위\n\n3) 연간보고서의 안정성시험 결과 및 시판된 완제의약품의 변화 및 이상이 발견될 경우\n\n- - 37 -\n1) 비무균제제(정제)\n\n- - 안정성시험 항목\n. 기준 및 시험방법에 설정된 모든 시험 항목을 설정하였다. 단, 경시 변화가 없을 것으로\n\n- - 안정성시험결과 요약\n. 60 정, 500 정 병포장에 대해 가속시험(40 ℃, 75% RH)을 0, 3, 6 개월에 실시하였고,\n\n장기보존시험(25 ℃, 60% RH)을 0, 3, 6, 9, 12 개월에 실시하였다. (100 정 포장은 브래\n\n켓팅 방법으로 갈음하며, 3.2.P.8. 안정성을 참조한다.) 안정성시험 결과는 다음 표와 같다.\n\n가속시험 결과 모든 시험항목에 대해 기준에 적합하였다. 가속시험 결과와 장기보존시험\n\n결과를 비교했을 때, 가속시험에서만 유연물질 증가 경향이 있었다. 허가 신청한 사용기간\n\n(제조일로부터 24 개월)은 타당하며, 추후 장기보존시험을 계속하여 신청한 사용기간에 대해\n\n- - 안정성시험 계획\n- - 38 -\n- - 안정성 시험 결과 요약\n- - 허가 후 안정성시험\n. 3 개 뱃치의 최소, 최대 포장 단위에 대해 장기보존시험을 실시하였으며, 0, 3, 6, 9, 12\n\n. 매년 1 개 이상 제조단위를 가지고 장기보존시험을 수행할 것이다.\n\n. 사용기간은 3 개 이상 제조단위의 장기보존시험 결과에 따라 연장될 수 있을 것이다.\n\n. 허가 후 안정성시험에서 부적합이 될 경우, 해당 뱃치를 회수할 것이다.\n\n- - 39 -\n2) 무균제제\n\n- ○ 무균제제의 경우 안정성시험 조건‧시험항목 등에 대해 비무균제제와 다르지 않으나, 시험항목\n- 2.3.P.8.1 안정성 요약 및 결론\n- - 무균시험 등과 관련된 안정성시험에 대해 요약하여 기재한다.\n- 2.3.P.8.2 허가 후 안정성시험 계획과 이행서약\n- - 허가 후 수행할 안정성시험 항목 중 무균시험 등 다음 사항을 포함하여 기재한다.\n- - 안정성시험 시점\n- 2.3.P.8.3 안정성자료\n안정성자료에서는 용기/마개 완전성, 무균, 엔도톡신 등을 포함해 시험 결과를 요약 기재한다.\n\n- - 40 -\n<!-- PAGE_46 -->\n##### 2.3.A 부록(Appendices)\n\n<!-- PAGE_46 -->\n##### 2.3.A.1 시설과 설비(Facilities and Equipment)\n\n- 3.2.A.1에 기재된 시설에 관한 내용의 요약이 포함되어야 한다.\n<!-- PAGE_46 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가(Adventitious Agents Safety Evaluation)\n\n생산 시 내인성 및 외래성 물질을 관리하기 위하여 실행된 방법에 대한 고찰이 포함되어야 한다.\n\n- 3.2.A.2의 바이러스 제거 감소인수(reduction factor)에 대한 도표로 된 요약을 제공한다.\n<!-- PAGE_46 -->\n##### 2.3.A.3 첨가제(Excipients)\n\n<!-- PAGE_46 -->\n##### 2.3.R. 지역별 정보(Regional Information)\n\n필요에 따라 3.2.R에 기재된 지역별 요구 사항에 대하여 간략하게 기재한다.\n\n- - 41 -\nAppendix. 속방성 및 서방성 제제의 개발경위 기재 예시 (FDA)\n\n완제의약품 개발에 영향을 미칠 것으로 판단되는 원료의약품에 대한 성질을 간단하게\n\n기재하였으며, 원료의약품에 대한 기본적인 정보를 포함한 기타 구체적인 사항은 3.2.S\n\n완제의약품 개발에 영향을 줄 것으로 판단되는 항목은 용해도, pH에 따른 용해도, 입자도,\n\n- 2.3.S.1에 요약된 사항을 참고한다. 원료의약품은 생물학약제학적 분류체계(BCS)에\n따라 낮은 용해성 약물로 분류된다. pH에 따라 용해도는 달라지며, pH가 낮을 때\n\n원료의약품의 용해도가 낮으므로 제제에서의 입자도가 중요하다. 아래 그림은 입자\n\n도가 용출에 중요한 영향을 미침을 보여준다. 원료의약품이 적절한 입자도(30 um)를\n\n- 2.3.S.1 일반정보에 결정형에 대해 상세히 기술하였다. 결정형 II 형은 I 형보다 불안\n물에서의 용해도가 낮으며, 외부 압력에 대한 영향을 적게 받아 제조공정에 미치는\n\n- - 42 -\n√ 문헌연구: 이 약은 가혹조건(열, 빛, 습도)에 대한 문헌 보고서가 있으며, 빛에 대한\n\n√ 자체 안정성 연구: 결정형 I 및 II에 대해서 평가가 이루어졌으며, 가속 시험에서 II\n\n대조약에서 유당수화물, 스테아르산마그네슘, 미결정셀룰로오스를 사용하는 것으로 파악\n\n되므로, 위 첨가제는 원료의약품과 배합 가능하다고 판단된다. 또한 배합적합성시험 결과,\n\n√ 완제의약품 개발 시 속방성 제제의 특성을 같이 고려하여 용출, 함량, 붕해, 안정성,\n\n√ 특히 USP 각조에 따르면 대조약은 pH 4.5 완충액에서 30 분 안에 즉시 용출된다고\n\n- - 43 -\n본 공정에 사용되는 방식인 습식과립법을 기준으로 각 첨가제에 대해 추천되는 등급\n\n(입자도 포함)을 사용하였으며, 유당수화물은 ... , 미결정셀룰로오스는 평균입도 ... ,\n\n제제 조성을 최적화하기 위해, 각 제제 조성에 대한 함량균일성시험 및 30 분간의\n\n광안정성시험 결과를 참조하여 차광이 되는 1차 포장 용기를 선택하였으며, 이 용기는\n\n미국약전 <661> “Containers-plastics\"에 따른 용기이다. 이 용기를 다시 차광성이 있는\n\n- - 44 -\n주성분 ... 의 용량 용해도(dose solubility volume)는 0.68 mL이다 (2.3.S.1 일반정보\n\n다형과 같은 모든 고체 상태 특성들은 제조가능성 및 개발 상황과는 관계가 없을 것이다.\n\n초기 제제 조성 단계에 주성분 ... 와 첨가제들 간 배합 부적합성에 대해 알기 위해\n\n다수의 첨가제들에 대하여 배합적합성시험을 수행하였다. 주성분 ... 와 첨가제들로\n\n이루어진 구형 백당의 수분 코팅이 이루어지는 제조공정과 유사하게 하기 위하여 물을\n\n10 % 추가하여 주성분-첨가제 혼합물 200 mg을 밀폐된 바이알에 넣고 50 ℃에 3 주간\n\n방치하였다. 다양한 폴리머, 충진제, 희석제, 가소제들에 대한 3 주간의 예비 배합적합성\n\n시험 결과, 유당이 배합 부적합성을 보였다. 이는 주성분 ... 의 구조 중 1차 아민과\n\n유당의 glycosidic hydroxyl 간의 반응(Maillard 반응)에 의한 것이었다. 따라서 최종\n\n제제에서 선택된 모든 첨가제들을 포함하여 일반적으로 사용되는 첨가제들과 주성분\n\n... 는 배합적합성이 있는 것으로 결론지었다 (2.3.P.1 완제의약품의 개요와 조성 참조).\n\n그러나 유당 또는 glycosidic hydroxyl 또는 알데히드기를 갖는 다른 첨가제들은\n\nMaillard 반응 가능하므로 사용을 피해야 한다. 상세한 사항은 3.2.P.2.1.2 첨가제를\n\n- - 45 -\n대조약과 유사하게 하기 위하여 대조약의 특성에 근거하여 제네릭의약품이 다음 네 가지\n\n- 2. 캡슐은 코팅 펠렛으로 충진한다. 이는 대조약의 분석 및 허가사항에 근거한 것으로,\n캡슐을 삼키는데 어려움이 있는 환자들을 위하여 캡슐을 열고 스푼에 펠렛을 섞어서\n\n- 3. 코팅 펠렛의 크기는 1.0 mm 이하로 한다. 이는 대조약이 1.0 mm 이하 크기의 코팅\n펠렛을 함유하고 있다는 것에 따른 것이다. 이러한 펠렛 크기는 유문 괄약근(pyloric\n\nsphincter)을 통과할 수 있을 만큼 작아서 식전 및 식후 상태 모두에서 비슷한 위 체류\n\n시간을 나타내도록 한다. 식후 및 식전 생물학적동등성시험이 모두 요구되므로, 식전 및\n\n식후 상태에서 생물학적으로 동등한 서방성 제제를 성공적으로 개발하기 위하여 제품\n\n- 4. 아래 그림에 묘사한 대로, 용출시험 결과 대조약이 속방층(주성분 ... 함량 25%)과 서\n방층(주성분 함량 75%)으로 이루어졌음을 나타냈다. 따라서, 대조약과 생물학적으로\n\n- - 46 -\n대조약이 속방 및 서방 펠렛으로 구성되었다는 점에 근거하여 제네릭의약품도 속방 및\n\n서방 펠렛들은 속도를 조절하는 막(에틸셀룰로오스(소수성 폴리머, 기허가례에 근거하여\n\n선정) 및 시트르산트리에틸(가소제)로 구성)을 코팅하여 약물 방출을 조절하였다. 이러한\n\n시스템에서 수용성 주성분 ... 의 소수성 막 통과가 감소함으로써 약물방출이 약화되고,\n\n이는 pH 비의존적으로 이루어진다. 제형 설계와 관련한 상세 정보는 3.2.P.2.2.1 제제\n\n개발 과정 중, 폴리머의 점도 및 속도 조절 막의 두께가 완제의약품의 용출 양상을 변경할\n\n제품 개발 중 두 가지 펠렛 제제 형태들이 평가되었다. 첫 번째 형태(I 형)는 캡슐에 두\n\n가지 펠렛(속방 펠렛 및 서방 펠렛) 혼합물이 충진된 형태이고, 두 번째 형태(II 형)는\n\n속방층 및 서방층으로 이루어진 한 가지 다층 펠렛이다. 결국은 속방 및 서방 펠렛 혼합\n\n물인 I 형으로 결정되었다. 이 결정은 속방 및 서방 펠렛을 각각 개발하는 것이 훨씬 쉽다는\n\n- - 47 -\n주성분 ... 가 구형 백당에 부착할 수 있도록 돕는 결합제로 Clear coating 732(히프로\n\n(소수성 폴리머)와 시트르산트리에틸(가소제)를 선택하였다. 이는 기허가 유사 품목에서\n\n이들 첨가제들을 사용했던 경험과 주성분 ... 와 이 첨가제들의 배합적합성(2.3.P.2.1.2\n\n에틸셀룰로오스: 주성분 ... 의 방출을 약화시키는 소수성 폴리머인 에틸셀룰로오스는 다른\n\n점도를 갖는 여러 등급의 제품이 상용화 되어있다. 이 첨가제는 제품 활성과 관련된 주요\n\n- - 48 -\n위 결과는 에틸셀룰로오스의 점도가 제품의 활성에 유의한 영향을 미친다는 것을 나타\n\n낸다. 따라서, 개발 및 제조 중 첨가제 점도 등급을 엄격히 관리하였다. 기허가 품목에\n\n구형 백당 : 제품 개발 중, 25 ~ 30 mesh의 입자 분포를 갖는 구형 백당을 선택하였다.\n\n구형 백당의 입자 분포를 제한하는 것은 코팅 표면을 일정하게 하기 위함이다. 일정한\n\n표면의 구형 백당은 적용되는 코팅 수준에 따라 두께가 일정한 막으로 된 서방형 펠렛\n\n제조를 가능하게 한다. 이는 일정하고 재현성 있는 약물 용출 양상을 보장하는 중요한\n\n요소이다. 추가적으로, 입자 크기를 25 ~ 30 mesh로 제한하는 것은 코팅 펠렛이 1.0\n\nmm 이하가 되도록 하고, 이는 주성분 ... 흡수에 대한 음식물의 영향을 최소화하는 중요한\n\n개발 초기 단계에 2.3.P.1 완제의약품의 개요와 조성에 기재된 최종 제제와 정성적으로\n\n비슷한 여러 가지 실험실 규모의 연구 제제에 대한 시험을 가속 시험조건(40 ℃/75%\n\n였으므로 다른 항산화제들을 함유하는 실험실 제제들을 가속 조건(40 ℃/75% RH, 4\n\n솔이 항산화 효과를 나타냈으나, 부틸레이티드히드록시아니솔의 효과가 훨씬 우수했으므로\n\n가수분해산물인 Impurity A는 활성 대사체로, 안전성 문제에 영향이 없으므로 제품\n\n- - 49 -\n* 괄호에 기재된 것을 제외하고 2.3.P.1 완제의약품의 개요와 조성에 기재된 제제와 정성\n\n용출에 미치는 방출 조절막 두께의 효과를 연구하기 위한 일련의 시험들을 수행하였다.\n\n다양한 pH에서 주성분 ... 의 용해도가 유사하고 방출 조절막이 확산으로 제어된다는\n\n사실에 따라 연구용 제제에서 용출이 pH 비의존적이라는 것을 알아냈다. 이는 pH에\n\n따른 대조약의 관찰된 용출 양상과 일치하였다. 따라서 서방 코팅(6%, 11%, 16%)의\n\n세 가지 연구용 제제를 설계하여 pH 6.8에서 대조약 용출 양상과 비교하였다. 이 시험\n\n- 2.3.P.2.3 제조공정개발\n- - 50 -\n코팅 공정\n\n완제의약품을 제조하기 위하여, bottom spray coating(Wurster coating) 공정을 속방\n\n- 1. Wuster 공정은 매우 일정한 코팅을 가능하게 한다. 공정 설계 관점에서, 이는 함량\n- 2. Wurster 코팅 공정 구현 및 유사한 기능성 서방 코팅 기전에 대한 제조 관련 사전\n다른 제품의 충진 공정에 이용한 사전 지식에 기초하여 dosing disk와 질량 분급을\n\n이용한 캡슐 충진 공정을 선택하였다. 하나의 캡슐에 충진된 두 가지 펠렛으로 제형을\n\n설계한 사실이 캡슐 충진 공정의 활용을 필요하게 한다. 제조공정과 관련한 추가 상세\n\n완제의약품 품질 특성들과 관련 있는 공정 단계들에 대한 매트릭스를 구성하였다. 약물\n\n품질에 높은 영향력을 갖는 공정단계가 확인된다. 공정단계가 성공적으로 진행되었음을\n\n요약하면, 대조약과 유사한 용출 양상을 구현하도록 속방 및 서방 펠렛을 혼합하여\n\n캡슐화하는 것으로 제품이 설계되었다. 적절한 약물 방출 프로파일에 근거하여 중요\n\n약물층화 공정: 약물층화 공정은 완제품의 함량균일성 뿐만 아니라 코팅 효율성에 직접\n\n- - 51 -\n약물층화 공정에 대한 중요공정변수 및 최적 세팅은 동일한 크기 분포 및 다공성을 갖는\n\n구형 백당에 약물을 코팅하는 유사한 제품에서의 사전 지식에 근거하여 확인하였다.\n\n그리고, 7” Wurster에서 확인된 중요공정변수에 대하여 실험실 규모 시험(3 kg 뱃치)을\n\n수행하였다. 약물층화 공정에 대한 중요공정변수는 약물층화액의 분무속도, Bed 온도,\n\n약물미립화 압력, 그리고 유동층 기체 부피인 것으로 확인되었다. 가장 중요하게 이\n\n시험들은 분무 방울 크기를 20 μm로 하는 것이 구형 백당에 약물을 입히는 공정에\n\n요약하면, 최적화된 공정에서, 함량 98~101 %를 나타내는 펠렛으로 코팅 효율성이\n\n* 약물층화 공정에서, 주성분 ... , clear coating 732(결합제), 그리고 부틸레이티드히드록\n\n서방코팅 공정 : 제네릭의약품의 기능에 따라, 기능성 코팅 공정이 완제의약품 제조공정\n\n**[표 시작]**\n\n| 주입 기체 온도 | 45 ~ 55 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨. |\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 52 -\n서방코팅 공정에 대한 중요공정변수들은 통계적 실험설계(DOE)를 이용하여 확인하였다.\n\n통계적 실험설계의 1차 목적은 공정변수의 영향을 결정하여 코팅효율성을 최대화하는\n\n것이었고, 2차 목적은 최적화된 공정을 통해 완전히 바로잡힌, 즉 사용기간 동안 일관성\n\n공정변수 결과 범위는 코팅 두께 및 코팅 막 완전성 변경에 따라 서방 코팅된 완제의\n\n약품의 약물방출 프로파일에 대한 예측되는 영향을 나타냈다. 모든 공정변수들은 코팅\n\n코팅이 완전히 연합된다는 것을 나타냈고 추가 curing 단계의 필요성이 없어졌다.\n\n- - 53 -\n실험설계 시험의 결과들은 최적 조건을 이용한 3kg 실험실 규모의 서방코팅 뱃치의\n\n시 조제된 것 vs. 60℃에 18시간 보관한 것), 1시간/4시간/8시간의 약물방출이 각각\n\n실험설계 구성, 실험실 규모의 결과, 최적 공정변수 선택사유, 그리고 최적화된 3kg 규\n\n캡슐충진: 속방 및 서방 펠렛들은 자동캡슐 충진기에서 두 개의 독립된 feeder를 이용하여\n\n- - 54 -\n품을 충진할 때 자동캡슐충진기 작동 조건을 참고하였다. 공정 검사는 속방 및 서방 펠렛\n\nWurster에서 스케일업이 서방캡슐 제품을 포함한 다른 제품들에서 성공적으로 이루어\n\n졌다. 추가적으로, 실험실 규모 뱃치들에서의 실험설계에 근거하여 구형 백당에 부착하는\n\n주성분 ...  및 서방층의 코팅과 관련한 중요공정변수들에 대한 허용범위가 결정되었다.\n\n업 하는데 성공적으로 이용되었다. 성공적으로 스케일업하는데 이용되었던 공정변수의\n\n주입 기체 온도(℃)\n\n55~62\n\n55~62\n\n스케일 독립 변수\n\n- - 55 -\n주성분 ... 의 가수분해 가능성 때문에 용기 및 포장은 완제의약품을 수분으로부터 보호\n\nBed 온도(℃)\n\n37~43\n\n37~43\n\n스케일 독립 변수\n\n- - 56 -",
  "chunks": [
    {
      "chunk_id": "chunk_001",
      "text": "<!-- PAGE_1 -->\n# 제네릭의약품의 국제공통기술문서\n\n<!-- PAGE_1 -->\n# 품질요약자료 작성 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n- 2015. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 0,
        "window_size": 3,
        "char_count": 108,
        "word_count": 21,
        "page_number": 1,
        "window_text": "<!-- PAGE_1 -->\n# 제네릭의약품의 국제공통기술문서\n\n<!-- PAGE_1 -->\n# 품질요약자료 작성 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n- 2015.  12.\n <!-- PAGE_1 -->\n## 의약품심사부 의약품규격과\n\n지침·안내서 제‧개정 점검표\n\n명칭\n\n제네릭의약품의 국제공통기술문서 품질요약자료 작성 가이드라인 [민원인안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 0.1 N HCl, 70 ℃, 14 시간 | 97% | >0.99 | RC2: 2% | >0.99 | Core | 100정 병포장 | 950병 | 1010병 | 함량 | 98.0 ~ 102.0 % | USP | 적합 | Lot #11A | 서의 Wurster 코팅 공정 및 문헌 등을 통해 얻어진 사전 지식에 기초하여 선택되었다. ",
        "original_sentence": "<!-- PAGE_1 -->\n# 제네릭의약품의 국제공통기술문서\n\n<!-- PAGE_1 -->\n# 품질요약자료 작성 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n- 2015. "
      }
    },
    {
      "chunk_id": "chunk_002",
      "text": "12.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 1,
        "window_size": 3,
        "char_count": 4,
        "word_count": 1,
        "page_number": 1,
        "window_text": "<!-- PAGE_1 -->\n# 제네릭의약품의 국제공통기술문서\n\n<!-- PAGE_1 -->\n# 품질요약자료 작성 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n- 2015.  12.\n <!-- PAGE_1 -->\n## 의약품심사부 의약품규격과\n\n지침·안내서 제‧개정 점검표\n\n명칭\n\n제네릭의약품의 국제공통기술문서 품질요약자료 작성 가이드라인 [민원인안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 0.1 N HCl, 70 ℃, 14 시간 | 97% | >0.99 | RC2: 2% | >0.99 | Core | 100정 병포장 | 950병 | 1010병 | 함량 | 98.0 ~ 102.0 % | USP | 적합 | Lot #11A | 서의 Wurster 코팅 공정 및 문헌 등을 통해 얻어진 사전 지식에 기초하여 선택되었다.  | 해 절대적으로 중요하다는 것을 알게 되었고, 이는 분무 속도와 약물미세화 기압 공정 | 균일성(구형 백당에 일정량의 주성분 코팅) 및 재현성 있는 약물방출(일정한 서방 코 | 속방 펠렛* (+아스코르브산 20.0 mg) | 94 | 2 | 8 | □ 이미 등록된 지침·안내서 중 동일·유사한 내용의 | 대조약 허가사항에 따르면 약물 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 예 시 | 수분 | 0.5 % 이하 | USP <921> 시험1a | 0.2 % | 시험항목 | 기준 | 시험결과 (제조번호) | 회전수 | 공개 부분에 해당하는 자료 | 비공개 부분에 해당하는 자료 | 두께 | A | B | C | D | E | F | 3 . ",
        "original_sentence": "12.\n"
      }
    },
    {
      "chunk_id": "chunk_003",
      "text": "<!-- PAGE_1 -->\n## 의약품심사부 의약품규격과\n\n지침·안내서 제‧개정 점검표\n\n명칭\n\n제네릭의약품의 국제공통기술문서 품질요약자료 작성 가이드라인 [민원인안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 2,
        "window_size": 3,
        "char_count": 127,
        "word_count": 22,
        "page_number": 1,
        "window_text": "<!-- PAGE_1 -->\n# 제네릭의약품의 국제공통기술문서\n\n<!-- PAGE_1 -->\n# 품질요약자료 작성 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n- 2015.  12.\n <!-- PAGE_1 -->\n## 의약품심사부 의약품규격과\n\n지침·안내서 제‧개정 점검표\n\n명칭\n\n제네릭의약품의 국제공통기술문서 품질요약자료 작성 가이드라인 [민원인안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 0.1 N HCl, 70 ℃, 14 시간 | 97% | >0.99 | RC2: 2% | >0.99 | Core | 100정 병포장 | 950병 | 1010병 | 함량 | 98.0 ~ 102.0 % | USP | 적합 | Lot #11A | 서의 Wurster 코팅 공정 및 문헌 등을 통해 얻어진 사전 지식에 기초하여 선택되었다.  | 해 절대적으로 중요하다는 것을 알게 되었고, 이는 분무 속도와 약물미세화 기압 공정 | 균일성(구형 백당에 일정량의 주성분 코팅) 및 재현성 있는 약물방출(일정한 서방 코 | 속방 펠렛* (+아스코르브산 20.0 mg) | 94 | 2 | 8 | □ 이미 등록된 지침·안내서 중 동일·유사한 내용의 | 대조약 허가사항에 따르면 약물 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 예 시 | 수분 | 0.5 % 이하 | USP <921> 시험1a | 0.2 % | 시험항목 | 기준 | 시험결과 (제조번호) | 회전수 | 공개 부분에 해당하는 자료 | 비공개 부분에 해당하는 자료 | 두께 | A | B | C | D | E | F | 3 .  5 ~ 3 . ",
        "original_sentence": "<!-- PAGE_1 -->\n## 의약품심사부 의약품규격과\n\n지침·안내서 제‧개정 점검표\n\n명칭\n\n제네릭의약품의 국제공통기술문서 품질요약자료 작성 가이드라인 [민원인안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_004",
      "text": "**[표 시작]**\n\n| 0.1 N HCl, 70 ℃, 14 시간 | 97% | >0.99 | RC2: 2% | >0.99 | Core | 100정 병포장 | 950병 | 1010병 | 함량 | 98.0 ~ 102.0 % | USP | 적합 | Lot #11A | 서의 Wurster 코팅 공정 및 문헌 등을 통해 얻어진 사전 지식에 기초하여 선택되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 3,
        "window_size": 3,
        "char_count": 199,
        "word_count": 56,
        "page_number": 5,
        "window_text": "<!-- PAGE_1 -->\n# 제네릭의약품의 국제공통기술문서\n\n<!-- PAGE_1 -->\n# 품질요약자료 작성 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n- 2015.  12.\n <!-- PAGE_1 -->\n## 의약품심사부 의약품규격과\n\n지침·안내서 제‧개정 점검표\n\n명칭\n\n제네릭의약품의 국제공통기술문서 품질요약자료 작성 가이드라인 [민원인안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 0.1 N HCl, 70 ℃, 14 시간 | 97% | >0.99 | RC2: 2% | >0.99 | Core | 100정 병포장 | 950병 | 1010병 | 함량 | 98.0 ~ 102.0 % | USP | 적합 | Lot #11A | 서의 Wurster 코팅 공정 및 문헌 등을 통해 얻어진 사전 지식에 기초하여 선택되었다.  | 해 절대적으로 중요하다는 것을 알게 되었고, 이는 분무 속도와 약물미세화 기압 공정 | 균일성(구형 백당에 일정량의 주성분 코팅) 및 재현성 있는 약물방출(일정한 서방 코 | 속방 펠렛* (+아스코르브산 20.0 mg) | 94 | 2 | 8 | □ 이미 등록된 지침·안내서 중 동일·유사한 내용의 | 대조약 허가사항에 따르면 약물 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 예 시 | 수분 | 0.5 % 이하 | USP <921> 시험1a | 0.2 % | 시험항목 | 기준 | 시험결과 (제조번호) | 회전수 | 공개 부분에 해당하는 자료 | 비공개 부분에 해당하는 자료 | 두께 | A | B | C | D | E | F | 3 .  5 ~ 3 .  9 m m ( 기 준 | 주성분 활성 대사산물 | M-1238 | 9.96Kp | 육안 | 30 분: 27-31% |\n| 연번 | 제·개정번호 | 승인일자 | 주요내용 | 12 시간 | 90-94%, 평균 92% | 85% 이상 | 용출 완료 시점 | [첨가제] | 히프로멜로오스 | 91 | Y | 용출시험조건: 900 mL, 0.05 M |\n| 코팅효율 | 99% | 99% | N/A | 2.3.S.1. ",
        "original_sentence": "**[표 시작]**\n\n| 0.1 N HCl, 70 ℃, 14 시간 | 97% | >0.99 | RC2: 2% | >0.99 | Core | 100정 병포장 | 950병 | 1010병 | 함량 | 98.0 ~ 102.0 % | USP | 적합 | Lot #11A | 서의 Wurster 코팅 공정 및 문헌 등을 통해 얻어진 사전 지식에 기초하여 선택되었다. "
      }
    },
    {
      "chunk_id": "chunk_005",
      "text": "| 해 절대적으로 중요하다는 것을 알게 되었고, 이는 분무 속도와 약물미세화 기압 공정 | 균일성(구형 백당에 일정량의 주성분 코팅) 및 재현성 있는 약물방출(일정한 서방 코 | 속방 펠렛* (+아스코르브산 20.0 mg) | 94 | 2 | 8 | □ 이미 등록된 지침·안내서 중 동일·유사한 내용의 | 대조약 허가사항에 따르면 약물 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 예 시 | 수분 | 0.5 % 이하 | USP <921> 시험1a | 0.2 % | 시험항목 | 기준 | 시험결과 (제조번호) | 회전수 | 공개 부분에 해당하는 자료 | 비공개 부분에 해당하는 자료 | 두께 | A | B | C | D | E | F | 3 . ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 4,
        "window_size": 3,
        "char_count": 505,
        "word_count": 160,
        "page_number": 3,
        "window_text": "12.\n <!-- PAGE_1 -->\n## 의약품심사부 의약품규격과\n\n지침·안내서 제‧개정 점검표\n\n명칭\n\n제네릭의약품의 국제공통기술문서 품질요약자료 작성 가이드라인 [민원인안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 0.1 N HCl, 70 ℃, 14 시간 | 97% | >0.99 | RC2: 2% | >0.99 | Core | 100정 병포장 | 950병 | 1010병 | 함량 | 98.0 ~ 102.0 % | USP | 적합 | Lot #11A | 서의 Wurster 코팅 공정 및 문헌 등을 통해 얻어진 사전 지식에 기초하여 선택되었다.  | 해 절대적으로 중요하다는 것을 알게 되었고, 이는 분무 속도와 약물미세화 기압 공정 | 균일성(구형 백당에 일정량의 주성분 코팅) 및 재현성 있는 약물방출(일정한 서방 코 | 속방 펠렛* (+아스코르브산 20.0 mg) | 94 | 2 | 8 | □ 이미 등록된 지침·안내서 중 동일·유사한 내용의 | 대조약 허가사항에 따르면 약물 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 예 시 | 수분 | 0.5 % 이하 | USP <921> 시험1a | 0.2 % | 시험항목 | 기준 | 시험결과 (제조번호) | 회전수 | 공개 부분에 해당하는 자료 | 비공개 부분에 해당하는 자료 | 두께 | A | B | C | D | E | F | 3 .  5 ~ 3 .  9 m m ( 기 준 | 주성분 활성 대사산물 | M-1238 | 9.96Kp | 육안 | 30 분: 27-31% |\n| 연번 | 제·개정번호 | 승인일자 | 주요내용 | 12 시간 | 90-94%, 평균 92% | 85% 이상 | 용출 완료 시점 | [첨가제] | 히프로멜로오스 | 91 | Y | 용출시험조건: 900 mL, 0.05 M |\n| 코팅효율 | 99% | 99% | N/A | 2.3.S.1.  일반정보(제품명, 제조자) ………………………………………………………… 1 | 펠렛 | 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 | 반드시 준수하셔야 하는 사항이 아님을 알려드립니다. ",
        "original_sentence": "| 해 절대적으로 중요하다는 것을 알게 되었고, 이는 분무 속도와 약물미세화 기압 공정 | 균일성(구형 백당에 일정량의 주성분 코팅) 및 재현성 있는 약물방출(일정한 서방 코 | 속방 펠렛* (+아스코르브산 20.0 mg) | 94 | 2 | 8 | □ 이미 등록된 지침·안내서 중 동일·유사한 내용의 | 대조약 허가사항에 따르면 약물 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 예 시 | 수분 | 0.5 % 이하 | USP <921> 시험1a | 0.2 % | 시험항목 | 기준 | 시험결과 (제조번호) | 회전수 | 공개 부분에 해당하는 자료 | 비공개 부분에 해당하는 자료 | 두께 | A | B | C | D | E | F | 3 . "
      }
    },
    {
      "chunk_id": "chunk_006",
      "text": "5 ~ 3 . ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 5,
        "window_size": 3,
        "char_count": 8,
        "word_count": 4,
        "page_number": 23,
        "window_text": "<!-- PAGE_1 -->\n## 의약품심사부 의약품규격과\n\n지침·안내서 제‧개정 점검표\n\n명칭\n\n제네릭의약품의 국제공통기술문서 품질요약자료 작성 가이드라인 [민원인안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 0.1 N HCl, 70 ℃, 14 시간 | 97% | >0.99 | RC2: 2% | >0.99 | Core | 100정 병포장 | 950병 | 1010병 | 함량 | 98.0 ~ 102.0 % | USP | 적합 | Lot #11A | 서의 Wurster 코팅 공정 및 문헌 등을 통해 얻어진 사전 지식에 기초하여 선택되었다.  | 해 절대적으로 중요하다는 것을 알게 되었고, 이는 분무 속도와 약물미세화 기압 공정 | 균일성(구형 백당에 일정량의 주성분 코팅) 및 재현성 있는 약물방출(일정한 서방 코 | 속방 펠렛* (+아스코르브산 20.0 mg) | 94 | 2 | 8 | □ 이미 등록된 지침·안내서 중 동일·유사한 내용의 | 대조약 허가사항에 따르면 약물 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 예 시 | 수분 | 0.5 % 이하 | USP <921> 시험1a | 0.2 % | 시험항목 | 기준 | 시험결과 (제조번호) | 회전수 | 공개 부분에 해당하는 자료 | 비공개 부분에 해당하는 자료 | 두께 | A | B | C | D | E | F | 3 .  5 ~ 3 .  9 m m ( 기 준 | 주성분 활성 대사산물 | M-1238 | 9.96Kp | 육안 | 30 분: 27-31% |\n| 연번 | 제·개정번호 | 승인일자 | 주요내용 | 12 시간 | 90-94%, 평균 92% | 85% 이상 | 용출 완료 시점 | [첨가제] | 히프로멜로오스 | 91 | Y | 용출시험조건: 900 mL, 0.05 M |\n| 코팅효율 | 99% | 99% | N/A | 2.3.S.1.  일반정보(제품명, 제조자) ………………………………………………………… 1 | 펠렛 | 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 | 반드시 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안내 | 서는 2015년 12월 31일 현재의 과학적·기술적 사실 및 유효한 법규 | 를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. ",
        "original_sentence": "5 ~ 3 . "
      }
    },
    {
      "chunk_id": "chunk_007",
      "text": "9 m m ( 기 준 | 주성분 활성 대사산물 | M-1238 | 9.96Kp | 육안 | 30 분: 27-31% |\n| 연번 | 제·개정번호 | 승인일자 | 주요내용 | 12 시간 | 90-94%, 평균 92% | 85% 이상 | 용출 완료 시점 | [첨가제] | 히프로멜로오스 | 91 | Y | 용출시험조건: 900 mL, 0.05 M |\n| 코팅효율 | 99% | 99% | N/A | 2.3.S.1. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 6,
        "window_size": 3,
        "char_count": 229,
        "word_count": 68,
        "page_number": 5,
        "window_text": "**[표 시작]**\n\n| 0.1 N HCl, 70 ℃, 14 시간 | 97% | >0.99 | RC2: 2% | >0.99 | Core | 100정 병포장 | 950병 | 1010병 | 함량 | 98.0 ~ 102.0 % | USP | 적합 | Lot #11A | 서의 Wurster 코팅 공정 및 문헌 등을 통해 얻어진 사전 지식에 기초하여 선택되었다.  | 해 절대적으로 중요하다는 것을 알게 되었고, 이는 분무 속도와 약물미세화 기압 공정 | 균일성(구형 백당에 일정량의 주성분 코팅) 및 재현성 있는 약물방출(일정한 서방 코 | 속방 펠렛* (+아스코르브산 20.0 mg) | 94 | 2 | 8 | □ 이미 등록된 지침·안내서 중 동일·유사한 내용의 | 대조약 허가사항에 따르면 약물 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 예 시 | 수분 | 0.5 % 이하 | USP <921> 시험1a | 0.2 % | 시험항목 | 기준 | 시험결과 (제조번호) | 회전수 | 공개 부분에 해당하는 자료 | 비공개 부분에 해당하는 자료 | 두께 | A | B | C | D | E | F | 3 .  5 ~ 3 .  9 m m ( 기 준 | 주성분 활성 대사산물 | M-1238 | 9.96Kp | 육안 | 30 분: 27-31% |\n| 연번 | 제·개정번호 | 승인일자 | 주요내용 | 12 시간 | 90-94%, 평균 92% | 85% 이상 | 용출 완료 시점 | [첨가제] | 히프로멜로오스 | 91 | Y | 용출시험조건: 900 mL, 0.05 M |\n| 코팅효율 | 99% | 99% | N/A | 2.3.S.1.  일반정보(제품명, 제조자) ………………………………………………………… 1 | 펠렛 | 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 | 반드시 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안내 | 서는 2015년 12월 31일 현재의 과학적·기술적 사실 및 유효한 법규 | 를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 상대유지시간 | 조건이 안정성에 영향을 미친다고 알려진 바 있다. ",
        "original_sentence": "9 m m ( 기 준 | 주성분 활성 대사산물 | M-1238 | 9.96Kp | 육안 | 30 분: 27-31% |\n| 연번 | 제·개정번호 | 승인일자 | 주요내용 | 12 시간 | 90-94%, 평균 92% | 85% 이상 | 용출 완료 시점 | [첨가제] | 히프로멜로오스 | 91 | Y | 용출시험조건: 900 mL, 0.05 M |\n| 코팅효율 | 99% | 99% | N/A | 2.3.S.1. "
      }
    },
    {
      "chunk_id": "chunk_008",
      "text": "일반정보(제품명, 제조자) ………………………………………………………… 1 | 펠렛 | 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 | 반드시 준수하셔야 하는 사항이 아님을 알려드립니다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 7,
        "window_size": 3,
        "char_count": 115,
        "word_count": 21,
        "page_number": 5,
        "window_text": "| 해 절대적으로 중요하다는 것을 알게 되었고, 이는 분무 속도와 약물미세화 기압 공정 | 균일성(구형 백당에 일정량의 주성분 코팅) 및 재현성 있는 약물방출(일정한 서방 코 | 속방 펠렛* (+아스코르브산 20.0 mg) | 94 | 2 | 8 | □ 이미 등록된 지침·안내서 중 동일·유사한 내용의 | 대조약 허가사항에 따르면 약물 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 예 시 | 수분 | 0.5 % 이하 | USP <921> 시험1a | 0.2 % | 시험항목 | 기준 | 시험결과 (제조번호) | 회전수 | 공개 부분에 해당하는 자료 | 비공개 부분에 해당하는 자료 | 두께 | A | B | C | D | E | F | 3 .  5 ~ 3 .  9 m m ( 기 준 | 주성분 활성 대사산물 | M-1238 | 9.96Kp | 육안 | 30 분: 27-31% |\n| 연번 | 제·개정번호 | 승인일자 | 주요내용 | 12 시간 | 90-94%, 평균 92% | 85% 이상 | 용출 완료 시점 | [첨가제] | 히프로멜로오스 | 91 | Y | 용출시험조건: 900 mL, 0.05 M |\n| 코팅효율 | 99% | 99% | N/A | 2.3.S.1.  일반정보(제품명, 제조자) ………………………………………………………… 1 | 펠렛 | 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 | 반드시 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안내 | 서는 2015년 12월 31일 현재의 과학적·기술적 사실 및 유효한 법규 | 를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 상대유지시간 | 조건이 안정성에 영향을 미친다고 알려진 바 있다.  | 30 분 | 대조약 허가사항에 따르면 | 구형백당 | 기제 | 142.5 | 25-30 mesh | 지침·안내서가 있습니까? ",
        "original_sentence": "일반정보(제품명, 제조자) ………………………………………………………… 1 | 펠렛 | 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 | 반드시 준수하셔야 하는 사항이 아님을 알려드립니다. "
      }
    },
    {
      "chunk_id": "chunk_009",
      "text": "또한, 본 안내 | 서는 2015년 12월 31일 현재의 과학적·기술적 사실 및 유효한 법규 | 를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 8,
        "window_size": 3,
        "char_count": 124,
        "word_count": 34,
        "page_number": 5,
        "window_text": "5 ~ 3 .  9 m m ( 기 준 | 주성분 활성 대사산물 | M-1238 | 9.96Kp | 육안 | 30 분: 27-31% |\n| 연번 | 제·개정번호 | 승인일자 | 주요내용 | 12 시간 | 90-94%, 평균 92% | 85% 이상 | 용출 완료 시점 | [첨가제] | 히프로멜로오스 | 91 | Y | 용출시험조건: 900 mL, 0.05 M |\n| 코팅효율 | 99% | 99% | N/A | 2.3.S.1.  일반정보(제품명, 제조자) ………………………………………………………… 1 | 펠렛 | 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 | 반드시 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안내 | 서는 2015년 12월 31일 현재의 과학적·기술적 사실 및 유효한 법규 | 를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 상대유지시간 | 조건이 안정성에 영향을 미친다고 알려진 바 있다.  | 30 분 | 대조약 허가사항에 따르면 | 구형백당 | 기제 | 142.5 | 25-30 mesh | 지침·안내서가 있습니까?  | 주성분: 1.00 | 제피제 ○○ | 되어 있는 청색의 직사각형 정제 | 25-35% | 흡수에 미치는 음식물 영향이 거 |\n| 0.1 N NaOH, 70 ℃, 30 분 | 98% | >0.99 | RC2: 1% | >0.99 | 되어 있다. ",
        "original_sentence": "또한, 본 안내 | 서는 2015년 12월 31일 현재의 과학적·기술적 사실 및 유효한 법규 | 를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. "
      }
    },
    {
      "chunk_id": "chunk_010",
      "text": "| 상대유지시간 | 조건이 안정성에 영향을 미친다고 알려진 바 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 9,
        "window_size": 3,
        "char_count": 39,
        "word_count": 10,
        "page_number": 3,
        "window_text": "9 m m ( 기 준 | 주성분 활성 대사산물 | M-1238 | 9.96Kp | 육안 | 30 분: 27-31% |\n| 연번 | 제·개정번호 | 승인일자 | 주요내용 | 12 시간 | 90-94%, 평균 92% | 85% 이상 | 용출 완료 시점 | [첨가제] | 히프로멜로오스 | 91 | Y | 용출시험조건: 900 mL, 0.05 M |\n| 코팅효율 | 99% | 99% | N/A | 2.3.S.1.  일반정보(제품명, 제조자) ………………………………………………………… 1 | 펠렛 | 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 | 반드시 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안내 | 서는 2015년 12월 31일 현재의 과학적·기술적 사실 및 유효한 법규 | 를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 상대유지시간 | 조건이 안정성에 영향을 미친다고 알려진 바 있다.  | 30 분 | 대조약 허가사항에 따르면 | 구형백당 | 기제 | 142.5 | 25-30 mesh | 지침·안내서가 있습니까?  | 주성분: 1.00 | 제피제 ○○ | 되어 있는 청색의 직사각형 정제 | 25-35% | 흡수에 미치는 음식물 영향이 거 |\n| 0.1 N NaOH, 70 ℃, 30 분 | 98% | >0.99 | RC2: 1% | >0.99 | 되어 있다.  | 속방 펠렛 (+부틸레이티드히드록시아니솔 0.01 mg) | 96 | 2 | 2 | 중금속 | 20 ppm 이하 | USP <231> | 적합 | 해 설 | 60정 병포장 | 500병 | 500병 | Lot #9A | 25 ± 2℃ | 입증 수준(QT; qualification threshold) | 변수들을 적절히 조합하였기 때문이다. ",
        "original_sentence": "| 상대유지시간 | 조건이 안정성에 영향을 미친다고 알려진 바 있다. "
      }
    },
    {
      "chunk_id": "chunk_011",
      "text": "| 30 분 | 대조약 허가사항에 따르면 | 구형백당 | 기제 | 142.5 | 25-30 mesh | 지침·안내서가 있습니까? ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 10,
        "window_size": 3,
        "char_count": 72,
        "word_count": 19,
        "page_number": 2,
        "window_text": "일반정보(제품명, 제조자) ………………………………………………………… 1 | 펠렛 | 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 | 반드시 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안내 | 서는 2015년 12월 31일 현재의 과학적·기술적 사실 및 유효한 법규 | 를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 상대유지시간 | 조건이 안정성에 영향을 미친다고 알려진 바 있다.  | 30 분 | 대조약 허가사항에 따르면 | 구형백당 | 기제 | 142.5 | 25-30 mesh | 지침·안내서가 있습니까?  | 주성분: 1.00 | 제피제 ○○ | 되어 있는 청색의 직사각형 정제 | 25-35% | 흡수에 미치는 음식물 영향이 거 |\n| 0.1 N NaOH, 70 ℃, 30 분 | 98% | >0.99 | RC2: 1% | >0.99 | 되어 있다.  | 속방 펠렛 (+부틸레이티드히드록시아니솔 0.01 mg) | 96 | 2 | 2 | 중금속 | 20 ppm 이하 | USP <231> | 적합 | 해 설 | 60정 병포장 | 500병 | 500병 | Lot #9A | 25 ± 2℃ | 입증 수준(QT; qualification threshold) | 변수들을 적절히 조합하였기 때문이다.  최적화된 공정 세팅은 아래 표와 같다. ",
        "original_sentence": "| 30 분 | 대조약 허가사항에 따르면 | 구형백당 | 기제 | 142.5 | 25-30 mesh | 지침·안내서가 있습니까? "
      }
    },
    {
      "chunk_id": "chunk_012",
      "text": "| 주성분: 1.00 | 제피제 ○○ | 되어 있는 청색의 직사각형 정제 | 25-35% | 흡수에 미치는 음식물 영향이 거 |\n| 0.1 N NaOH, 70 ℃, 30 분 | 98% | >0.99 | RC2: 1% | >0.99 | 되어 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 11,
        "window_size": 3,
        "char_count": 138,
        "word_count": 41,
        "page_number": 5,
        "window_text": "또한, 본 안내 | 서는 2015년 12월 31일 현재의 과학적·기술적 사실 및 유효한 법규 | 를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 상대유지시간 | 조건이 안정성에 영향을 미친다고 알려진 바 있다.  | 30 분 | 대조약 허가사항에 따르면 | 구형백당 | 기제 | 142.5 | 25-30 mesh | 지침·안내서가 있습니까?  | 주성분: 1.00 | 제피제 ○○ | 되어 있는 청색의 직사각형 정제 | 25-35% | 흡수에 미치는 음식물 영향이 거 |\n| 0.1 N NaOH, 70 ℃, 30 분 | 98% | >0.99 | RC2: 1% | >0.99 | 되어 있다.  | 속방 펠렛 (+부틸레이티드히드록시아니솔 0.01 mg) | 96 | 2 | 2 | 중금속 | 20 ppm 이하 | USP <231> | 적합 | 해 설 | 60정 병포장 | 500병 | 500병 | Lot #9A | 25 ± 2℃ | 입증 수준(QT; qualification threshold) | 변수들을 적절히 조합하였기 때문이다.  최적화된 공정 세팅은 아래 표와 같다.  서방 막 | 팅층)을 보장하는데 매우 중요하다. ",
        "original_sentence": "| 주성분: 1.00 | 제피제 ○○ | 되어 있는 청색의 직사각형 정제 | 25-35% | 흡수에 미치는 음식물 영향이 거 |\n| 0.1 N NaOH, 70 ℃, 30 분 | 98% | >0.99 | RC2: 1% | >0.99 | 되어 있다. "
      }
    },
    {
      "chunk_id": "chunk_013",
      "text": "| 속방 펠렛 (+부틸레이티드히드록시아니솔 0.01 mg) | 96 | 2 | 2 | 중금속 | 20 ppm 이하 | USP <231> | 적합 | 해 설 | 60정 병포장 | 500병 | 500병 | Lot #9A | 25 ± 2℃ | 입증 수준(QT; qualification threshold) | 변수들을 적절히 조합하였기 때문이다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 12,
        "window_size": 3,
        "char_count": 191,
        "word_count": 50,
        "page_number": 3,
        "window_text": "| 상대유지시간 | 조건이 안정성에 영향을 미친다고 알려진 바 있다.  | 30 분 | 대조약 허가사항에 따르면 | 구형백당 | 기제 | 142.5 | 25-30 mesh | 지침·안내서가 있습니까?  | 주성분: 1.00 | 제피제 ○○ | 되어 있는 청색의 직사각형 정제 | 25-35% | 흡수에 미치는 음식물 영향이 거 |\n| 0.1 N NaOH, 70 ℃, 30 분 | 98% | >0.99 | RC2: 1% | >0.99 | 되어 있다.  | 속방 펠렛 (+부틸레이티드히드록시아니솔 0.01 mg) | 96 | 2 | 2 | 중금속 | 20 ppm 이하 | USP <231> | 적합 | 해 설 | 60정 병포장 | 500병 | 500병 | Lot #9A | 25 ± 2℃ | 입증 수준(QT; qualification threshold) | 변수들을 적절히 조합하였기 때문이다.  최적화된 공정 세팅은 아래 표와 같다.  서방 막 | 팅층)을 보장하는데 매우 중요하다.  | 필름코팅액의 | 질량 | 3.7mm) | M-1239 | 3.72mm |\n| 유연물질 E | [화학 구조] | 산화에 의한 분해산물 | . ",
        "original_sentence": "| 속방 펠렛 (+부틸레이티드히드록시아니솔 0.01 mg) | 96 | 2 | 2 | 중금속 | 20 ppm 이하 | USP <231> | 적합 | 해 설 | 60정 병포장 | 500병 | 500병 | Lot #9A | 25 ± 2℃ | 입증 수준(QT; qualification threshold) | 변수들을 적절히 조합하였기 때문이다. "
      }
    },
    {
      "chunk_id": "chunk_014",
      "text": "최적화된 공정 세팅은 아래 표와 같다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 13,
        "window_size": 3,
        "char_count": 22,
        "word_count": 6,
        "page_number": 26,
        "window_text": "| 30 분 | 대조약 허가사항에 따르면 | 구형백당 | 기제 | 142.5 | 25-30 mesh | 지침·안내서가 있습니까?  | 주성분: 1.00 | 제피제 ○○ | 되어 있는 청색의 직사각형 정제 | 25-35% | 흡수에 미치는 음식물 영향이 거 |\n| 0.1 N NaOH, 70 ℃, 30 분 | 98% | >0.99 | RC2: 1% | >0.99 | 되어 있다.  | 속방 펠렛 (+부틸레이티드히드록시아니솔 0.01 mg) | 96 | 2 | 2 | 중금속 | 20 ppm 이하 | USP <231> | 적합 | 해 설 | 60정 병포장 | 500병 | 500병 | Lot #9A | 25 ± 2℃ | 입증 수준(QT; qualification threshold) | 변수들을 적절히 조합하였기 때문이다.  최적화된 공정 세팅은 아래 표와 같다.  서방 막 | 팅층)을 보장하는데 매우 중요하다.  | 필름코팅액의 | 질량 | 3.7mm) | M-1239 | 3.72mm |\n| 유연물질 E | [화학 구조] | 산화에 의한 분해산물 | .  구조결정에 관한 자료 | 기준 | 인산염완충액(pH 6.8), 37 ℃ | 4 시간: 48-53% |\n| 적인 정보는 3.2.S.6. ",
        "original_sentence": "최적화된 공정 세팅은 아래 표와 같다. "
      }
    },
    {
      "chunk_id": "chunk_015",
      "text": "서방 막 | 팅층)을 보장하는데 매우 중요하다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 14,
        "window_size": 3,
        "char_count": 27,
        "word_count": 7,
        "page_number": 56,
        "window_text": "| 주성분: 1.00 | 제피제 ○○ | 되어 있는 청색의 직사각형 정제 | 25-35% | 흡수에 미치는 음식물 영향이 거 |\n| 0.1 N NaOH, 70 ℃, 30 분 | 98% | >0.99 | RC2: 1% | >0.99 | 되어 있다.  | 속방 펠렛 (+부틸레이티드히드록시아니솔 0.01 mg) | 96 | 2 | 2 | 중금속 | 20 ppm 이하 | USP <231> | 적합 | 해 설 | 60정 병포장 | 500병 | 500병 | Lot #9A | 25 ± 2℃ | 입증 수준(QT; qualification threshold) | 변수들을 적절히 조합하였기 때문이다.  최적화된 공정 세팅은 아래 표와 같다.  서방 막 | 팅층)을 보장하는데 매우 중요하다.  | 필름코팅액의 | 질량 | 3.7mm) | M-1239 | 3.72mm |\n| 유연물질 E | [화학 구조] | 산화에 의한 분해산물 | .  구조결정에 관한 자료 | 기준 | 인산염완충액(pH 6.8), 37 ℃ | 4 시간: 48-53% |\n| 적인 정보는 3.2.S.6.  용기 및 포장을 참고한다. ",
        "original_sentence": "서방 막 | 팅층)을 보장하는데 매우 중요하다. "
      }
    },
    {
      "chunk_id": "chunk_016",
      "text": "| 필름코팅액의 | 질량 | 3.7mm) | M-1239 | 3.72mm |\n| 유연물질 E | [화학 구조] | 산화에 의한 분해산물 | . ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 15,
        "window_size": 3,
        "char_count": 80,
        "word_count": 23,
        "page_number": 5,
        "window_text": "| 속방 펠렛 (+부틸레이티드히드록시아니솔 0.01 mg) | 96 | 2 | 2 | 중금속 | 20 ppm 이하 | USP <231> | 적합 | 해 설 | 60정 병포장 | 500병 | 500병 | Lot #9A | 25 ± 2℃ | 입증 수준(QT; qualification threshold) | 변수들을 적절히 조합하였기 때문이다.  최적화된 공정 세팅은 아래 표와 같다.  서방 막 | 팅층)을 보장하는데 매우 중요하다.  | 필름코팅액의 | 질량 | 3.7mm) | M-1239 | 3.72mm |\n| 유연물질 E | [화학 구조] | 산화에 의한 분해산물 | .  구조결정에 관한 자료 | 기준 | 인산염완충액(pH 6.8), 37 ℃ | 4 시간: 48-53% |\n| 적인 정보는 3.2.S.6.  용기 및 포장을 참고한다.  | 크기의 | 9 | 원료의약품을 참고한다. ",
        "original_sentence": "| 필름코팅액의 | 질량 | 3.7mm) | M-1239 | 3.72mm |\n| 유연물질 E | [화학 구조] | 산화에 의한 분해산물 | . "
      }
    },
    {
      "chunk_id": "chunk_017",
      "text": "구조결정에 관한 자료 | 기준 | 인산염완충액(pH 6.8), 37 ℃ | 4 시간: 48-53% |\n| 적인 정보는 3.2.S.6. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 16,
        "window_size": 3,
        "char_count": 75,
        "word_count": 19,
        "page_number": 11,
        "window_text": "최적화된 공정 세팅은 아래 표와 같다.  서방 막 | 팅층)을 보장하는데 매우 중요하다.  | 필름코팅액의 | 질량 | 3.7mm) | M-1239 | 3.72mm |\n| 유연물질 E | [화학 구조] | 산화에 의한 분해산물 | .  구조결정에 관한 자료 | 기준 | 인산염완충액(pH 6.8), 37 ℃ | 4 시간: 48-53% |\n| 적인 정보는 3.2.S.6.  용기 및 포장을 참고한다.  | 크기의 | 9 | 원료의약품을 참고한다.  | [용매] | 용매* | 시트르산트리에틸 | 92 | Y | 음식물 영향이 거의 없음. ",
        "original_sentence": "구조결정에 관한 자료 | 기준 | 인산염완충액(pH 6.8), 37 ℃ | 4 시간: 48-53% |\n| 적인 정보는 3.2.S.6. "
      }
    },
    {
      "chunk_id": "chunk_018",
      "text": "용기 및 포장을 참고한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 17,
        "window_size": 3,
        "char_count": 15,
        "word_count": 4,
        "page_number": 13,
        "window_text": "서방 막 | 팅층)을 보장하는데 매우 중요하다.  | 필름코팅액의 | 질량 | 3.7mm) | M-1239 | 3.72mm |\n| 유연물질 E | [화학 구조] | 산화에 의한 분해산물 | .  구조결정에 관한 자료 | 기준 | 인산염완충액(pH 6.8), 37 ℃ | 4 시간: 48-53% |\n| 적인 정보는 3.2.S.6.  용기 및 포장을 참고한다.  | 크기의 | 9 | 원료의약품을 참고한다.  | [용매] | 용매* | 시트르산트리에틸 | 92 | Y | 음식물 영향이 거의 없음.  | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로 | 착색제 ○○ | 1.0 mm 미만의 펠렛으로 개발 | 의 없음. ",
        "original_sentence": "용기 및 포장을 참고한다. "
      }
    },
    {
      "chunk_id": "chunk_019",
      "text": "| 크기의 | 9 | 원료의약품을 참고한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 18,
        "window_size": 3,
        "char_count": 25,
        "word_count": 7,
        "page_number": 13,
        "window_text": "| 필름코팅액의 | 질량 | 3.7mm) | M-1239 | 3.72mm |\n| 유연물질 E | [화학 구조] | 산화에 의한 분해산물 | .  구조결정에 관한 자료 | 기준 | 인산염완충액(pH 6.8), 37 ℃ | 4 시간: 48-53% |\n| 적인 정보는 3.2.S.6.  용기 및 포장을 참고한다.  | 크기의 | 9 | 원료의약품을 참고한다.  | [용매] | 용매* | 시트르산트리에틸 | 92 | Y | 음식물 영향이 거의 없음.  | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로 | 착색제 ○○ | 1.0 mm 미만의 펠렛으로 개발 | 의 없음.  |\n| 차이점을 비교표 또는 도식 등을 이용하여 요약 기재한다. ",
        "original_sentence": "| 크기의 | 9 | 원료의약품을 참고한다. "
      }
    },
    {
      "chunk_id": "chunk_020",
      "text": "| [용매] | 용매* | 시트르산트리에틸 | 92 | Y | 음식물 영향이 거의 없음. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 19,
        "window_size": 3,
        "char_count": 50,
        "word_count": 15,
        "page_number": 3,
        "window_text": "구조결정에 관한 자료 | 기준 | 인산염완충액(pH 6.8), 37 ℃ | 4 시간: 48-53% |\n| 적인 정보는 3.2.S.6.  용기 및 포장을 참고한다.  | 크기의 | 9 | 원료의약품을 참고한다.  | [용매] | 용매* | 시트르산트리에틸 | 92 | Y | 음식물 영향이 거의 없음.  | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로 | 착색제 ○○ | 1.0 mm 미만의 펠렛으로 개발 | 의 없음.  |\n| 차이점을 비교표 또는 도식 등을 이용하여 요약 기재한다.  | 속방 펠렛 (+부틸레이티드히드록시아니솔 0.03 mg) | 97 | 2 | 1 | 함량시험(HPLC) | 표시량의 90.0 ~ 110.0 % | USP | 값에 이를 때까지 재결정하여 제조한다. ",
        "original_sentence": "| [용매] | 용매* | 시트르산트리에틸 | 92 | Y | 음식물 영향이 거의 없음. "
      }
    },
    {
      "chunk_id": "chunk_021",
      "text": "| ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로 | 착색제 ○○ | 1.0 mm 미만의 펠렛으로 개발 | 의 없음. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 20,
        "window_size": 3,
        "char_count": 84,
        "word_count": 23,
        "page_number": 2,
        "window_text": "용기 및 포장을 참고한다.  | 크기의 | 9 | 원료의약품을 참고한다.  | [용매] | 용매* | 시트르산트리에틸 | 92 | Y | 음식물 영향이 거의 없음.  | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로 | 착색제 ○○ | 1.0 mm 미만의 펠렛으로 개발 | 의 없음.  |\n| 차이점을 비교표 또는 도식 등을 이용하여 요약 기재한다.  | 속방 펠렛 (+부틸레이티드히드록시아니솔 0.03 mg) | 97 | 2 | 1 | 함량시험(HPLC) | 표시량의 90.0 ~ 110.0 % | USP | 값에 이를 때까지 재결정하여 제조한다.  | 특이성 | 참조). ",
        "original_sentence": "| ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로 | 착색제 ○○ | 1.0 mm 미만의 펠렛으로 개발 | 의 없음. "
      }
    },
    {
      "chunk_id": "chunk_022",
      "text": "|\n| 차이점을 비교표 또는 도식 등을 이용하여 요약 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 21,
        "window_size": 3,
        "char_count": 36,
        "word_count": 10,
        "page_number": 3,
        "window_text": "| 크기의 | 9 | 원료의약품을 참고한다.  | [용매] | 용매* | 시트르산트리에틸 | 92 | Y | 음식물 영향이 거의 없음.  | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로 | 착색제 ○○ | 1.0 mm 미만의 펠렛으로 개발 | 의 없음.  |\n| 차이점을 비교표 또는 도식 등을 이용하여 요약 기재한다.  | 속방 펠렛 (+부틸레이티드히드록시아니솔 0.03 mg) | 97 | 2 | 1 | 함량시험(HPLC) | 표시량의 90.0 ~ 110.0 % | USP | 값에 이를 때까지 재결정하여 제조한다.  | 특이성 | 참조).  주성분 ... 는 BCS 분류에 따라 “높은 용해도”를 가지므로, 물리적 특성(결정다형, | 10정평균 | 4 시간 | 참고) | 주성분 | XXX | 24.00 | 조제 | 25 +66.4° ~ +68.0° | 시험방법 #467 | +67.10 | 유연물질 C: 1.44* | 메탄올: 3000 ppm 이하 | 40-60% | M-1240 | RC2: 1% | 300 ppm |\n| 2.3.S.2. ",
        "original_sentence": "|\n| 차이점을 비교표 또는 도식 등을 이용하여 요약 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_023",
      "text": "| 속방 펠렛 (+부틸레이티드히드록시아니솔 0.03 mg) | 97 | 2 | 1 | 함량시험(HPLC) | 표시량의 90.0 ~ 110.0 % | USP | 값에 이를 때까지 재결정하여 제조한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 22,
        "window_size": 3,
        "char_count": 111,
        "word_count": 28,
        "page_number": 3,
        "window_text": "| [용매] | 용매* | 시트르산트리에틸 | 92 | Y | 음식물 영향이 거의 없음.  | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로 | 착색제 ○○ | 1.0 mm 미만의 펠렛으로 개발 | 의 없음.  |\n| 차이점을 비교표 또는 도식 등을 이용하여 요약 기재한다.  | 속방 펠렛 (+부틸레이티드히드록시아니솔 0.03 mg) | 97 | 2 | 1 | 함량시험(HPLC) | 표시량의 90.0 ~ 110.0 % | USP | 값에 이를 때까지 재결정하여 제조한다.  | 특이성 | 참조).  주성분 ... 는 BCS 분류에 따라 “높은 용해도”를 가지므로, 물리적 특성(결정다형, | 10정평균 | 4 시간 | 참고) | 주성분 | XXX | 24.00 | 조제 | 25 +66.4° ~ +68.0° | 시험방법 #467 | +67.10 | 유연물질 C: 1.44* | 메탄올: 3000 ppm 이하 | 40-60% | M-1240 | RC2: 1% | 300 ppm |\n| 2.3.S.2.  제조(제품명, 제조자) ……………………………………………………………… 4 | 타당성 | 선광도[α]D | 0, 3, 6, 9, 12 개월 | 500 정 병포장 | Lot #10A | 중요하고 분무 속도와 약물미립화 기압 공정변수들을 통해 달성되는 것으로 확립되었다. ",
        "original_sentence": "| 속방 펠렛 (+부틸레이티드히드록시아니솔 0.03 mg) | 97 | 2 | 1 | 함량시험(HPLC) | 표시량의 90.0 ~ 110.0 % | USP | 값에 이를 때까지 재결정하여 제조한다. "
      }
    },
    {
      "chunk_id": "chunk_024",
      "text": "| 특이성 | 참조). ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 23,
        "window_size": 3,
        "char_count": 13,
        "word_count": 4,
        "page_number": 3,
        "window_text": "| ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로 | 착색제 ○○ | 1.0 mm 미만의 펠렛으로 개발 | 의 없음.  |\n| 차이점을 비교표 또는 도식 등을 이용하여 요약 기재한다.  | 속방 펠렛 (+부틸레이티드히드록시아니솔 0.03 mg) | 97 | 2 | 1 | 함량시험(HPLC) | 표시량의 90.0 ~ 110.0 % | USP | 값에 이를 때까지 재결정하여 제조한다.  | 특이성 | 참조).  주성분 ... 는 BCS 분류에 따라 “높은 용해도”를 가지므로, 물리적 특성(결정다형, | 10정평균 | 4 시간 | 참고) | 주성분 | XXX | 24.00 | 조제 | 25 +66.4° ~ +68.0° | 시험방법 #467 | +67.10 | 유연물질 C: 1.44* | 메탄올: 3000 ppm 이하 | 40-60% | M-1240 | RC2: 1% | 300 ppm |\n| 2.3.S.2.  제조(제품명, 제조자) ……………………………………………………………… 4 | 타당성 | 선광도[α]D | 0, 3, 6, 9, 12 개월 | 500 정 병포장 | Lot #10A | 중요하고 분무 속도와 약물미립화 기압 공정변수들을 통해 달성되는 것으로 확립되었다.  | 의 완전성은 전자현미경 스캐닝을 통해 추가적으로 평가 및 확인되었다. ",
        "original_sentence": "| 특이성 | 참조). "
      }
    },
    {
      "chunk_id": "chunk_025",
      "text": "주성분 ... 는 BCS 분류에 따라 “높은 용해도”를 가지므로, 물리적 특성(결정다형, | 10정평균 | 4 시간 | 참고) | 주성분 | XXX | 24.00 | 조제 | 25 +66.4° ~ +68.0° | 시험방법 #467 | +67.10 | 유연물질 C: 1.44* | 메탄올: 3000 ppm 이하 | 40-60% | M-1240 | RC2: 1% | 300 ppm |\n| 2.3.S.2. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 24,
        "window_size": 3,
        "char_count": 224,
        "word_count": 58,
        "page_number": 19,
        "window_text": "|\n| 차이점을 비교표 또는 도식 등을 이용하여 요약 기재한다.  | 속방 펠렛 (+부틸레이티드히드록시아니솔 0.03 mg) | 97 | 2 | 1 | 함량시험(HPLC) | 표시량의 90.0 ~ 110.0 % | USP | 값에 이를 때까지 재결정하여 제조한다.  | 특이성 | 참조).  주성분 ... 는 BCS 분류에 따라 “높은 용해도”를 가지므로, 물리적 특성(결정다형, | 10정평균 | 4 시간 | 참고) | 주성분 | XXX | 24.00 | 조제 | 25 +66.4° ~ +68.0° | 시험방법 #467 | +67.10 | 유연물질 C: 1.44* | 메탄올: 3000 ppm 이하 | 40-60% | M-1240 | RC2: 1% | 300 ppm |\n| 2.3.S.2.  제조(제품명, 제조자) ……………………………………………………………… 4 | 타당성 | 선광도[α]D | 0, 3, 6, 9, 12 개월 | 500 정 병포장 | Lot #10A | 중요하고 분무 속도와 약물미립화 기압 공정변수들을 통해 달성되는 것으로 확립되었다.  | 의 완전성은 전자현미경 스캐닝을 통해 추가적으로 평가 및 확인되었다.  최적화된 뱃치 | 포장 | 224,000(96.9%) | 231,000 | 93% | 펠렛 크기 0.8 ~ 0.9 mm. ",
        "original_sentence": "주성분 ... 는 BCS 분류에 따라 “높은 용해도”를 가지므로, 물리적 특성(결정다형, | 10정평균 | 4 시간 | 참고) | 주성분 | XXX | 24.00 | 조제 | 25 +66.4° ~ +68.0° | 시험방법 #467 | +67.10 | 유연물질 C: 1.44* | 메탄올: 3000 ppm 이하 | 40-60% | M-1240 | RC2: 1% | 300 ppm |\n| 2.3.S.2. "
      }
    },
    {
      "chunk_id": "chunk_026",
      "text": "제조(제품명, 제조자) ……………………………………………………………… 4 | 타당성 | 선광도[α]D | 0, 3, 6, 9, 12 개월 | 500 정 병포장 | Lot #10A | 중요하고 분무 속도와 약물미립화 기압 공정변수들을 통해 달성되는 것으로 확립되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 25,
        "window_size": 3,
        "char_count": 148,
        "word_count": 33,
        "page_number": 21,
        "window_text": "| 속방 펠렛 (+부틸레이티드히드록시아니솔 0.03 mg) | 97 | 2 | 1 | 함량시험(HPLC) | 표시량의 90.0 ~ 110.0 % | USP | 값에 이를 때까지 재결정하여 제조한다.  | 특이성 | 참조).  주성분 ... 는 BCS 분류에 따라 “높은 용해도”를 가지므로, 물리적 특성(결정다형, | 10정평균 | 4 시간 | 참고) | 주성분 | XXX | 24.00 | 조제 | 25 +66.4° ~ +68.0° | 시험방법 #467 | +67.10 | 유연물질 C: 1.44* | 메탄올: 3000 ppm 이하 | 40-60% | M-1240 | RC2: 1% | 300 ppm |\n| 2.3.S.2.  제조(제품명, 제조자) ……………………………………………………………… 4 | 타당성 | 선광도[α]D | 0, 3, 6, 9, 12 개월 | 500 정 병포장 | Lot #10A | 중요하고 분무 속도와 약물미립화 기압 공정변수들을 통해 달성되는 것으로 확립되었다.  | 의 완전성은 전자현미경 스캐닝을 통해 추가적으로 평가 및 확인되었다.  최적화된 뱃치 | 포장 | 224,000(96.9%) | 231,000 | 93% | 펠렛 크기 0.8 ~ 0.9 mm.  | 가혹 조건 | % 함량 | 피크 순도 | 관찰된 분해산물 | 동 제품도 대조약과 같이 음식물 |\n| 3% H2O2, 60 ℃, 2 시간 | 97% | >0.99 | . ",
        "original_sentence": "제조(제품명, 제조자) ……………………………………………………………… 4 | 타당성 | 선광도[α]D | 0, 3, 6, 9, 12 개월 | 500 정 병포장 | Lot #10A | 중요하고 분무 속도와 약물미립화 기압 공정변수들을 통해 달성되는 것으로 확립되었다. "
      }
    },
    {
      "chunk_id": "chunk_027",
      "text": "| 의 완전성은 전자현미경 스캐닝을 통해 추가적으로 평가 및 확인되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 26,
        "window_size": 3,
        "char_count": 41,
        "word_count": 10,
        "page_number": 62,
        "window_text": "| 특이성 | 참조).  주성분 ... 는 BCS 분류에 따라 “높은 용해도”를 가지므로, 물리적 특성(결정다형, | 10정평균 | 4 시간 | 참고) | 주성분 | XXX | 24.00 | 조제 | 25 +66.4° ~ +68.0° | 시험방법 #467 | +67.10 | 유연물질 C: 1.44* | 메탄올: 3000 ppm 이하 | 40-60% | M-1240 | RC2: 1% | 300 ppm |\n| 2.3.S.2.  제조(제품명, 제조자) ……………………………………………………………… 4 | 타당성 | 선광도[α]D | 0, 3, 6, 9, 12 개월 | 500 정 병포장 | Lot #10A | 중요하고 분무 속도와 약물미립화 기압 공정변수들을 통해 달성되는 것으로 확립되었다.  | 의 완전성은 전자현미경 스캐닝을 통해 추가적으로 평가 및 확인되었다.  최적화된 뱃치 | 포장 | 224,000(96.9%) | 231,000 | 93% | 펠렛 크기 0.8 ~ 0.9 mm.  | 가혹 조건 | % 함량 | 피크 순도 | 관찰된 분해산물 | 동 제품도 대조약과 같이 음식물 |\n| 3% H2O2, 60 ℃, 2 시간 | 97% | >0.99 | .  물리화학적 성질에 관한 자료 | 해 설 | 유기용매 ○○ | 용출시험법 제1법(회전검체통법), | 8 시간: 73-78% | >0.99 |\n| 재처리에 대한 사항 포함) 및 관리에 관한 간단한 설명 | 1 | B1-2015-2-015 | 2015.12.31 | 제정 | Clear Coating 7321 | 결합제 | 28.48 | 개개 | 디에틸프탈레이트 | 92 | N | 주성분 피크 순도(PDA) > 0.99 | 60 ± 5% RH | 2 2 8 ~ 2 5 2 m g ( 기 준 | 241.2mg |\n| 속방 펠렛 (+부틸레이티드히드록시아니솔 0.06 mg) | 97 | 2 | 1 | 불순물이 이 기준에서 안전하다는 것을 보여주는(qualification) 자료를 제공해야 한다. ",
        "original_sentence": "| 의 완전성은 전자현미경 스캐닝을 통해 추가적으로 평가 및 확인되었다. "
      }
    },
    {
      "chunk_id": "chunk_028",
      "text": "최적화된 뱃치 | 포장 | 224,000(96.9%) | 231,000 | 93% | 펠렛 크기 0.8 ~ 0.9 mm. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 27,
        "window_size": 3,
        "char_count": 68,
        "word_count": 17,
        "page_number": 5,
        "window_text": "주성분 ... 는 BCS 분류에 따라 “높은 용해도”를 가지므로, 물리적 특성(결정다형, | 10정평균 | 4 시간 | 참고) | 주성분 | XXX | 24.00 | 조제 | 25 +66.4° ~ +68.0° | 시험방법 #467 | +67.10 | 유연물질 C: 1.44* | 메탄올: 3000 ppm 이하 | 40-60% | M-1240 | RC2: 1% | 300 ppm |\n| 2.3.S.2.  제조(제품명, 제조자) ……………………………………………………………… 4 | 타당성 | 선광도[α]D | 0, 3, 6, 9, 12 개월 | 500 정 병포장 | Lot #10A | 중요하고 분무 속도와 약물미립화 기압 공정변수들을 통해 달성되는 것으로 확립되었다.  | 의 완전성은 전자현미경 스캐닝을 통해 추가적으로 평가 및 확인되었다.  최적화된 뱃치 | 포장 | 224,000(96.9%) | 231,000 | 93% | 펠렛 크기 0.8 ~ 0.9 mm.  | 가혹 조건 | % 함량 | 피크 순도 | 관찰된 분해산물 | 동 제품도 대조약과 같이 음식물 |\n| 3% H2O2, 60 ℃, 2 시간 | 97% | >0.99 | .  물리화학적 성질에 관한 자료 | 해 설 | 유기용매 ○○ | 용출시험법 제1법(회전검체통법), | 8 시간: 73-78% | >0.99 |\n| 재처리에 대한 사항 포함) 및 관리에 관한 간단한 설명 | 1 | B1-2015-2-015 | 2015.12.31 | 제정 | Clear Coating 7321 | 결합제 | 28.48 | 개개 | 디에틸프탈레이트 | 92 | N | 주성분 피크 순도(PDA) > 0.99 | 60 ± 5% RH | 2 2 8 ~ 2 5 2 m g ( 기 준 | 241.2mg |\n| 속방 펠렛 (+부틸레이티드히드록시아니솔 0.06 mg) | 97 | 2 | 1 | 불순물이 이 기준에서 안전하다는 것을 보여주는(qualification) 자료를 제공해야 한다.  | 잔류용매 | 혼합물에서 각 첨가제를 하나씩 제외한 것을 가지고 시험한다. ",
        "original_sentence": "최적화된 뱃치 | 포장 | 224,000(96.9%) | 231,000 | 93% | 펠렛 크기 0.8 ~ 0.9 mm. "
      }
    },
    {
      "chunk_id": "chunk_029",
      "text": "| 가혹 조건 | % 함량 | 피크 순도 | 관찰된 분해산물 | 동 제품도 대조약과 같이 음식물 |\n| 3% H2O2, 60 ℃, 2 시간 | 97% | >0.99 | . ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 28,
        "window_size": 3,
        "char_count": 96,
        "word_count": 32,
        "page_number": 3,
        "window_text": "제조(제품명, 제조자) ……………………………………………………………… 4 | 타당성 | 선광도[α]D | 0, 3, 6, 9, 12 개월 | 500 정 병포장 | Lot #10A | 중요하고 분무 속도와 약물미립화 기압 공정변수들을 통해 달성되는 것으로 확립되었다.  | 의 완전성은 전자현미경 스캐닝을 통해 추가적으로 평가 및 확인되었다.  최적화된 뱃치 | 포장 | 224,000(96.9%) | 231,000 | 93% | 펠렛 크기 0.8 ~ 0.9 mm.  | 가혹 조건 | % 함량 | 피크 순도 | 관찰된 분해산물 | 동 제품도 대조약과 같이 음식물 |\n| 3% H2O2, 60 ℃, 2 시간 | 97% | >0.99 | .  물리화학적 성질에 관한 자료 | 해 설 | 유기용매 ○○ | 용출시험법 제1법(회전검체통법), | 8 시간: 73-78% | >0.99 |\n| 재처리에 대한 사항 포함) 및 관리에 관한 간단한 설명 | 1 | B1-2015-2-015 | 2015.12.31 | 제정 | Clear Coating 7321 | 결합제 | 28.48 | 개개 | 디에틸프탈레이트 | 92 | N | 주성분 피크 순도(PDA) > 0.99 | 60 ± 5% RH | 2 2 8 ~ 2 5 2 m g ( 기 준 | 241.2mg |\n| 속방 펠렛 (+부틸레이티드히드록시아니솔 0.06 mg) | 97 | 2 | 1 | 불순물이 이 기준에서 안전하다는 것을 보여주는(qualification) 자료를 제공해야 한다.  | 잔류용매 | 혼합물에서 각 첨가제를 하나씩 제외한 것을 가지고 시험한다.  | 입자도)이 최종 제형의 생물약제학적 특성에 미치는 영향은 미미할 것이다. ",
        "original_sentence": "| 가혹 조건 | % 함량 | 피크 순도 | 관찰된 분해산물 | 동 제품도 대조약과 같이 음식물 |\n| 3% H2O2, 60 ℃, 2 시간 | 97% | >0.99 | . "
      }
    },
    {
      "chunk_id": "chunk_030",
      "text": "물리화학적 성질에 관한 자료 | 해 설 | 유기용매 ○○ | 용출시험법 제1법(회전검체통법), | 8 시간: 73-78% | >0.99 |\n| 재처리에 대한 사항 포함) 및 관리에 관한 간단한 설명 | 1 | B1-2015-2-015 | 2015.12.31 | 제정 | Clear Coating 7321 | 결합제 | 28.48 | 개개 | 디에틸프탈레이트 | 92 | N | 주성분 피크 순도(PDA) > 0.99 | 60 ± 5% RH | 2 2 8 ~ 2 5 2 m g ( 기 준 | 241.2mg |\n| 속방 펠렛 (+부틸레이티드히드록시아니솔 0.06 mg) | 97 | 2 | 1 | 불순물이 이 기준에서 안전하다는 것을 보여주는(qualification) 자료를 제공해야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 29,
        "window_size": 3,
        "char_count": 386,
        "word_count": 103,
        "page_number": 5,
        "window_text": "| 의 완전성은 전자현미경 스캐닝을 통해 추가적으로 평가 및 확인되었다.  최적화된 뱃치 | 포장 | 224,000(96.9%) | 231,000 | 93% | 펠렛 크기 0.8 ~ 0.9 mm.  | 가혹 조건 | % 함량 | 피크 순도 | 관찰된 분해산물 | 동 제품도 대조약과 같이 음식물 |\n| 3% H2O2, 60 ℃, 2 시간 | 97% | >0.99 | .  물리화학적 성질에 관한 자료 | 해 설 | 유기용매 ○○ | 용출시험법 제1법(회전검체통법), | 8 시간: 73-78% | >0.99 |\n| 재처리에 대한 사항 포함) 및 관리에 관한 간단한 설명 | 1 | B1-2015-2-015 | 2015.12.31 | 제정 | Clear Coating 7321 | 결합제 | 28.48 | 개개 | 디에틸프탈레이트 | 92 | N | 주성분 피크 순도(PDA) > 0.99 | 60 ± 5% RH | 2 2 8 ~ 2 5 2 m g ( 기 준 | 241.2mg |\n| 속방 펠렛 (+부틸레이티드히드록시아니솔 0.06 mg) | 97 | 2 | 1 | 불순물이 이 기준에서 안전하다는 것을 보여주는(qualification) 자료를 제공해야 한다.  | 잔류용매 | 혼합물에서 각 첨가제를 하나씩 제외한 것을 가지고 시험한다.  | 입자도)이 최종 제형의 생물약제학적 특성에 미치는 영향은 미미할 것이다.  그리고, 구형 | 분류 | 포장 형태 | 제조원 | 형은 I 형 대비 빨리 분해되고 불순물도 많이 검출되었다. ",
        "original_sentence": "물리화학적 성질에 관한 자료 | 해 설 | 유기용매 ○○ | 용출시험법 제1법(회전검체통법), | 8 시간: 73-78% | >0.99 |\n| 재처리에 대한 사항 포함) 및 관리에 관한 간단한 설명 | 1 | B1-2015-2-015 | 2015.12.31 | 제정 | Clear Coating 7321 | 결합제 | 28.48 | 개개 | 디에틸프탈레이트 | 92 | N | 주성분 피크 순도(PDA) > 0.99 | 60 ± 5% RH | 2 2 8 ~ 2 5 2 m g ( 기 준 | 241.2mg |\n| 속방 펠렛 (+부틸레이티드히드록시아니솔 0.06 mg) | 97 | 2 | 1 | 불순물이 이 기준에서 안전하다는 것을 보여주는(qualification) 자료를 제공해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_031",
      "text": "| 잔류용매 | 혼합물에서 각 첨가제를 하나씩 제외한 것을 가지고 시험한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 30,
        "window_size": 3,
        "char_count": 43,
        "word_count": 11,
        "page_number": 9,
        "window_text": "최적화된 뱃치 | 포장 | 224,000(96.9%) | 231,000 | 93% | 펠렛 크기 0.8 ~ 0.9 mm.  | 가혹 조건 | % 함량 | 피크 순도 | 관찰된 분해산물 | 동 제품도 대조약과 같이 음식물 |\n| 3% H2O2, 60 ℃, 2 시간 | 97% | >0.99 | .  물리화학적 성질에 관한 자료 | 해 설 | 유기용매 ○○ | 용출시험법 제1법(회전검체통법), | 8 시간: 73-78% | >0.99 |\n| 재처리에 대한 사항 포함) 및 관리에 관한 간단한 설명 | 1 | B1-2015-2-015 | 2015.12.31 | 제정 | Clear Coating 7321 | 결합제 | 28.48 | 개개 | 디에틸프탈레이트 | 92 | N | 주성분 피크 순도(PDA) > 0.99 | 60 ± 5% RH | 2 2 8 ~ 2 5 2 m g ( 기 준 | 241.2mg |\n| 속방 펠렛 (+부틸레이티드히드록시아니솔 0.06 mg) | 97 | 2 | 1 | 불순물이 이 기준에서 안전하다는 것을 보여주는(qualification) 자료를 제공해야 한다.  | 잔류용매 | 혼합물에서 각 첨가제를 하나씩 제외한 것을 가지고 시험한다.  | 입자도)이 최종 제형의 생물약제학적 특성에 미치는 영향은 미미할 것이다.  그리고, 구형 | 분류 | 포장 형태 | 제조원 | 형은 I 형 대비 빨리 분해되고 불순물도 많이 검출되었다.  | 총 량 | 8 시간 | 유연물질 D: 1.66* | 염화메틸렌: 600 ppm 이하 | RC2: 0.5% 이하 | 65-85% | 100 rpm | USP <467> | 과 상관없이 복용할 수 있도록 함. ",
        "original_sentence": "| 잔류용매 | 혼합물에서 각 첨가제를 하나씩 제외한 것을 가지고 시험한다. "
      }
    },
    {
      "chunk_id": "chunk_032",
      "text": "| 입자도)이 최종 제형의 생물약제학적 특성에 미치는 영향은 미미할 것이다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 31,
        "window_size": 3,
        "char_count": 43,
        "word_count": 10,
        "page_number": 3,
        "window_text": "| 가혹 조건 | % 함량 | 피크 순도 | 관찰된 분해산물 | 동 제품도 대조약과 같이 음식물 |\n| 3% H2O2, 60 ℃, 2 시간 | 97% | >0.99 | .  물리화학적 성질에 관한 자료 | 해 설 | 유기용매 ○○ | 용출시험법 제1법(회전검체통법), | 8 시간: 73-78% | >0.99 |\n| 재처리에 대한 사항 포함) 및 관리에 관한 간단한 설명 | 1 | B1-2015-2-015 | 2015.12.31 | 제정 | Clear Coating 7321 | 결합제 | 28.48 | 개개 | 디에틸프탈레이트 | 92 | N | 주성분 피크 순도(PDA) > 0.99 | 60 ± 5% RH | 2 2 8 ~ 2 5 2 m g ( 기 준 | 241.2mg |\n| 속방 펠렛 (+부틸레이티드히드록시아니솔 0.06 mg) | 97 | 2 | 1 | 불순물이 이 기준에서 안전하다는 것을 보여주는(qualification) 자료를 제공해야 한다.  | 잔류용매 | 혼합물에서 각 첨가제를 하나씩 제외한 것을 가지고 시험한다.  | 입자도)이 최종 제형의 생물약제학적 특성에 미치는 영향은 미미할 것이다.  그리고, 구형 | 분류 | 포장 형태 | 제조원 | 형은 I 형 대비 빨리 분해되고 불순물도 많이 검출되었다.  | 총 량 | 8 시간 | 유연물질 D: 1.66* | 염화메틸렌: 600 ppm 이하 | RC2: 0.5% 이하 | 65-85% | 100 rpm | USP <467> | 과 상관없이 복용할 수 있도록 함.  | RC3: 1% | 150 ppm |\n| Lot #11A | 이러한 공정 지식은 실험실 규모에서부터 허가용 뱃치 생산에서 파일럿 규모까지 스케일 | 의 코팅 공정 효율성은 99.0%였다. ",
        "original_sentence": "| 입자도)이 최종 제형의 생물약제학적 특성에 미치는 영향은 미미할 것이다. "
      }
    },
    {
      "chunk_id": "chunk_033",
      "text": "그리고, 구형 | 분류 | 포장 형태 | 제조원 | 형은 I 형 대비 빨리 분해되고 불순물도 많이 검출되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 32,
        "window_size": 3,
        "char_count": 62,
        "word_count": 19,
        "page_number": 24,
        "window_text": "물리화학적 성질에 관한 자료 | 해 설 | 유기용매 ○○ | 용출시험법 제1법(회전검체통법), | 8 시간: 73-78% | >0.99 |\n| 재처리에 대한 사항 포함) 및 관리에 관한 간단한 설명 | 1 | B1-2015-2-015 | 2015.12.31 | 제정 | Clear Coating 7321 | 결합제 | 28.48 | 개개 | 디에틸프탈레이트 | 92 | N | 주성분 피크 순도(PDA) > 0.99 | 60 ± 5% RH | 2 2 8 ~ 2 5 2 m g ( 기 준 | 241.2mg |\n| 속방 펠렛 (+부틸레이티드히드록시아니솔 0.06 mg) | 97 | 2 | 1 | 불순물이 이 기준에서 안전하다는 것을 보여주는(qualification) 자료를 제공해야 한다.  | 잔류용매 | 혼합물에서 각 첨가제를 하나씩 제외한 것을 가지고 시험한다.  | 입자도)이 최종 제형의 생물약제학적 특성에 미치는 영향은 미미할 것이다.  그리고, 구형 | 분류 | 포장 형태 | 제조원 | 형은 I 형 대비 빨리 분해되고 불순물도 많이 검출되었다.  | 총 량 | 8 시간 | 유연물질 D: 1.66* | 염화메틸렌: 600 ppm 이하 | RC2: 0.5% 이하 | 65-85% | 100 rpm | USP <467> | 과 상관없이 복용할 수 있도록 함.  | RC3: 1% | 150 ppm |\n| Lot #11A | 이러한 공정 지식은 실험실 규모에서부터 허가용 뱃치 생산에서 파일럿 규모까지 스케일 | 의 코팅 공정 효율성은 99.0%였다.  | 총 수율 | 99% | 100% | 97% | 지식 | <DOE CR Process Variables Studied> | 12 시간: 90-94% |\n| 2.3.S.3. ",
        "original_sentence": "그리고, 구형 | 분류 | 포장 형태 | 제조원 | 형은 I 형 대비 빨리 분해되고 불순물도 많이 검출되었다. "
      }
    },
    {
      "chunk_id": "chunk_034",
      "text": "| 총 량 | 8 시간 | 유연물질 D: 1.66* | 염화메틸렌: 600 ppm 이하 | RC2: 0.5% 이하 | 65-85% | 100 rpm | USP <467> | 과 상관없이 복용할 수 있도록 함. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 33,
        "window_size": 3,
        "char_count": 117,
        "word_count": 34,
        "page_number": 3,
        "window_text": "| 잔류용매 | 혼합물에서 각 첨가제를 하나씩 제외한 것을 가지고 시험한다.  | 입자도)이 최종 제형의 생물약제학적 특성에 미치는 영향은 미미할 것이다.  그리고, 구형 | 분류 | 포장 형태 | 제조원 | 형은 I 형 대비 빨리 분해되고 불순물도 많이 검출되었다.  | 총 량 | 8 시간 | 유연물질 D: 1.66* | 염화메틸렌: 600 ppm 이하 | RC2: 0.5% 이하 | 65-85% | 100 rpm | USP <467> | 과 상관없이 복용할 수 있도록 함.  | RC3: 1% | 150 ppm |\n| Lot #11A | 이러한 공정 지식은 실험실 규모에서부터 허가용 뱃치 생산에서 파일럿 규모까지 스케일 | 의 코팅 공정 효율성은 99.0%였다.  | 총 수율 | 99% | 100% | 97% | 지식 | <DOE CR Process Variables Studied> | 12 시간: 90-94% |\n| 2.3.S.3.  특성(제품명, 제조자) ……………………………………………………………… 4 | 시험항목 | 시험방법 | 허용기준 | . ",
        "original_sentence": "| 총 량 | 8 시간 | 유연물질 D: 1.66* | 염화메틸렌: 600 ppm 이하 | RC2: 0.5% 이하 | 65-85% | 100 rpm | USP <467> | 과 상관없이 복용할 수 있도록 함. "
      }
    },
    {
      "chunk_id": "chunk_035",
      "text": "| RC3: 1% | 150 ppm |\n| Lot #11A | 이러한 공정 지식은 실험실 규모에서부터 허가용 뱃치 생산에서 파일럿 규모까지 스케일 | 의 코팅 공정 효율성은 99.0%였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 34,
        "window_size": 3,
        "char_count": 106,
        "word_count": 28,
        "page_number": 3,
        "window_text": "| 입자도)이 최종 제형의 생물약제학적 특성에 미치는 영향은 미미할 것이다.  그리고, 구형 | 분류 | 포장 형태 | 제조원 | 형은 I 형 대비 빨리 분해되고 불순물도 많이 검출되었다.  | 총 량 | 8 시간 | 유연물질 D: 1.66* | 염화메틸렌: 600 ppm 이하 | RC2: 0.5% 이하 | 65-85% | 100 rpm | USP <467> | 과 상관없이 복용할 수 있도록 함.  | RC3: 1% | 150 ppm |\n| Lot #11A | 이러한 공정 지식은 실험실 규모에서부터 허가용 뱃치 생산에서 파일럿 규모까지 스케일 | 의 코팅 공정 효율성은 99.0%였다.  | 총 수율 | 99% | 100% | 97% | 지식 | <DOE CR Process Variables Studied> | 12 시간: 90-94% |\n| 2.3.S.3.  특성(제품명, 제조자) ……………………………………………………………… 4 | 시험항목 | 시험방법 | 허용기준 | .  유연물질에 관한 자료 | 해 설 | 부틸레이티드히드록시아니솔 | 98 | Y | 마손도 | 공정8의 나정 | 240mg ± 5%) | 235.5~243.9mg |\n| 하여 요약하여 기재한다. ",
        "original_sentence": "| RC3: 1% | 150 ppm |\n| Lot #11A | 이러한 공정 지식은 실험실 규모에서부터 허가용 뱃치 생산에서 파일럿 규모까지 스케일 | 의 코팅 공정 효율성은 99.0%였다. "
      }
    },
    {
      "chunk_id": "chunk_036",
      "text": "| 총 수율 | 99% | 100% | 97% | 지식 | <DOE CR Process Variables Studied> | 12 시간: 90-94% |\n| 2.3.S.3. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 35,
        "window_size": 3,
        "char_count": 97,
        "word_count": 24,
        "page_number": 5,
        "window_text": "그리고, 구형 | 분류 | 포장 형태 | 제조원 | 형은 I 형 대비 빨리 분해되고 불순물도 많이 검출되었다.  | 총 량 | 8 시간 | 유연물질 D: 1.66* | 염화메틸렌: 600 ppm 이하 | RC2: 0.5% 이하 | 65-85% | 100 rpm | USP <467> | 과 상관없이 복용할 수 있도록 함.  | RC3: 1% | 150 ppm |\n| Lot #11A | 이러한 공정 지식은 실험실 규모에서부터 허가용 뱃치 생산에서 파일럿 규모까지 스케일 | 의 코팅 공정 효율성은 99.0%였다.  | 총 수율 | 99% | 100% | 97% | 지식 | <DOE CR Process Variables Studied> | 12 시간: 90-94% |\n| 2.3.S.3.  특성(제품명, 제조자) ……………………………………………………………… 4 | 시험항목 | 시험방법 | 허용기준 | .  유연물질에 관한 자료 | 해 설 | 부틸레이티드히드록시아니솔 | 98 | Y | 마손도 | 공정8의 나정 | 240mg ± 5%) | 235.5~243.9mg |\n| 하여 요약하여 기재한다.  | 근거자료를 제출하며, 밸리데이션 요약 자료를 제출한다. ",
        "original_sentence": "| 총 수율 | 99% | 100% | 97% | 지식 | <DOE CR Process Variables Studied> | 12 시간: 90-94% |\n| 2.3.S.3. "
      }
    },
    {
      "chunk_id": "chunk_037",
      "text": "특성(제품명, 제조자) ……………………………………………………………… 4 | 시험항목 | 시험방법 | 허용기준 | . ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 36,
        "window_size": 3,
        "char_count": 65,
        "word_count": 12,
        "page_number": 14,
        "window_text": "| 총 량 | 8 시간 | 유연물질 D: 1.66* | 염화메틸렌: 600 ppm 이하 | RC2: 0.5% 이하 | 65-85% | 100 rpm | USP <467> | 과 상관없이 복용할 수 있도록 함.  | RC3: 1% | 150 ppm |\n| Lot #11A | 이러한 공정 지식은 실험실 규모에서부터 허가용 뱃치 생산에서 파일럿 규모까지 스케일 | 의 코팅 공정 효율성은 99.0%였다.  | 총 수율 | 99% | 100% | 97% | 지식 | <DOE CR Process Variables Studied> | 12 시간: 90-94% |\n| 2.3.S.3.  특성(제품명, 제조자) ……………………………………………………………… 4 | 시험항목 | 시험방법 | 허용기준 | .  유연물질에 관한 자료 | 해 설 | 부틸레이티드히드록시아니솔 | 98 | Y | 마손도 | 공정8의 나정 | 240mg ± 5%) | 235.5~243.9mg |\n| 하여 요약하여 기재한다.  | 근거자료를 제출하며, 밸리데이션 요약 자료를 제출한다.  | 10 | 필름코팅 | 예 시 | 함량 | 98.5~101.5 % | 시험방법 #125a | 99.8 % | 결정다형, 안정성 등이 있을 수 있다. ",
        "original_sentence": "특성(제품명, 제조자) ……………………………………………………………… 4 | 시험항목 | 시험방법 | 허용기준 | . "
      }
    },
    {
      "chunk_id": "chunk_038",
      "text": "유연물질에 관한 자료 | 해 설 | 부틸레이티드히드록시아니솔 | 98 | Y | 마손도 | 공정8의 나정 | 240mg ± 5%) | 235.5~243.9mg |\n| 하여 요약하여 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 37,
        "window_size": 3,
        "char_count": 107,
        "word_count": 28,
        "page_number": 3,
        "window_text": "| RC3: 1% | 150 ppm |\n| Lot #11A | 이러한 공정 지식은 실험실 규모에서부터 허가용 뱃치 생산에서 파일럿 규모까지 스케일 | 의 코팅 공정 효율성은 99.0%였다.  | 총 수율 | 99% | 100% | 97% | 지식 | <DOE CR Process Variables Studied> | 12 시간: 90-94% |\n| 2.3.S.3.  특성(제품명, 제조자) ……………………………………………………………… 4 | 시험항목 | 시험방법 | 허용기준 | .  유연물질에 관한 자료 | 해 설 | 부틸레이티드히드록시아니솔 | 98 | Y | 마손도 | 공정8의 나정 | 240mg ± 5%) | 235.5~243.9mg |\n| 하여 요약하여 기재한다.  | 근거자료를 제출하며, 밸리데이션 요약 자료를 제출한다.  | 10 | 필름코팅 | 예 시 | 함량 | 98.5~101.5 % | 시험방법 #125a | 99.8 % | 결정다형, 안정성 등이 있을 수 있다.  | 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0225 | 직선성 | 0.05-2.5% | 12 시간 | 유연물질 F: 2.55* | 톨루엔: 890 ppm 이하 | 0.05-1.0% | 85% 이상 | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% | 80 ppm | 0.05-1.0% |\n| 정제수, 60 ℃, 13 시간 | 99% | >0.99 | NA | >0.99 | 병포장 | 60 mL 흰색 원형 HDPE 병 (60, 100 정) | 백당 주성분 층이 형성되기 위해 주성분 ... 가 물에 완전히 용해되므로 입자도 및 결정 | 시험 항목 | 허용 기준 | 분석방법 | 시험결과 | RC3: 0.5% 이하 | 「식약처 지침서등의 관리에 관한 규정」 개정에 |\n| 엔도톡신 | 98.0 %였다. ",
        "original_sentence": "유연물질에 관한 자료 | 해 설 | 부틸레이티드히드록시아니솔 | 98 | Y | 마손도 | 공정8의 나정 | 240mg ± 5%) | 235.5~243.9mg |\n| 하여 요약하여 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_039",
      "text": "| 근거자료를 제출하며, 밸리데이션 요약 자료를 제출한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 38,
        "window_size": 3,
        "char_count": 33,
        "word_count": 7,
        "page_number": 3,
        "window_text": "| 총 수율 | 99% | 100% | 97% | 지식 | <DOE CR Process Variables Studied> | 12 시간: 90-94% |\n| 2.3.S.3.  특성(제품명, 제조자) ……………………………………………………………… 4 | 시험항목 | 시험방법 | 허용기준 | .  유연물질에 관한 자료 | 해 설 | 부틸레이티드히드록시아니솔 | 98 | Y | 마손도 | 공정8의 나정 | 240mg ± 5%) | 235.5~243.9mg |\n| 하여 요약하여 기재한다.  | 근거자료를 제출하며, 밸리데이션 요약 자료를 제출한다.  | 10 | 필름코팅 | 예 시 | 함량 | 98.5~101.5 % | 시험방법 #125a | 99.8 % | 결정다형, 안정성 등이 있을 수 있다.  | 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0225 | 직선성 | 0.05-2.5% | 12 시간 | 유연물질 F: 2.55* | 톨루엔: 890 ppm 이하 | 0.05-1.0% | 85% 이상 | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% | 80 ppm | 0.05-1.0% |\n| 정제수, 60 ℃, 13 시간 | 99% | >0.99 | NA | >0.99 | 병포장 | 60 mL 흰색 원형 HDPE 병 (60, 100 정) | 백당 주성분 층이 형성되기 위해 주성분 ... 가 물에 완전히 용해되므로 입자도 및 결정 | 시험 항목 | 허용 기준 | 분석방법 | 시험결과 | RC3: 0.5% 이하 | 「식약처 지침서등의 관리에 관한 규정」 개정에 |\n| 엔도톡신 | 98.0 %였다.  실험실 규모 뱃치 시험의 자세한 결과는 3.2.P.2.3 제조공정 개발을 참조한다. ",
        "original_sentence": "| 근거자료를 제출하며, 밸리데이션 요약 자료를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_040",
      "text": "| 10 | 필름코팅 | 예 시 | 함량 | 98.5~101.5 % | 시험방법 #125a | 99.8 % | 결정다형, 안정성 등이 있을 수 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 39,
        "window_size": 3,
        "char_count": 84,
        "word_count": 25,
        "page_number": 5,
        "window_text": "특성(제품명, 제조자) ……………………………………………………………… 4 | 시험항목 | 시험방법 | 허용기준 | .  유연물질에 관한 자료 | 해 설 | 부틸레이티드히드록시아니솔 | 98 | Y | 마손도 | 공정8의 나정 | 240mg ± 5%) | 235.5~243.9mg |\n| 하여 요약하여 기재한다.  | 근거자료를 제출하며, 밸리데이션 요약 자료를 제출한다.  | 10 | 필름코팅 | 예 시 | 함량 | 98.5~101.5 % | 시험방법 #125a | 99.8 % | 결정다형, 안정성 등이 있을 수 있다.  | 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0225 | 직선성 | 0.05-2.5% | 12 시간 | 유연물질 F: 2.55* | 톨루엔: 890 ppm 이하 | 0.05-1.0% | 85% 이상 | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% | 80 ppm | 0.05-1.0% |\n| 정제수, 60 ℃, 13 시간 | 99% | >0.99 | NA | >0.99 | 병포장 | 60 mL 흰색 원형 HDPE 병 (60, 100 정) | 백당 주성분 층이 형성되기 위해 주성분 ... 가 물에 완전히 용해되므로 입자도 및 결정 | 시험 항목 | 허용 기준 | 분석방법 | 시험결과 | RC3: 0.5% 이하 | 「식약처 지침서등의 관리에 관한 규정」 개정에 |\n| 엔도톡신 | 98.0 %였다.  실험실 규모 뱃치 시험의 자세한 결과는 3.2.P.2.3 제조공정 개발을 참조한다.  | 붕해도 | (사유 :                                                                 ) | r2=0.99 | 공정9의 필름코팅액 | r2=0.99 | 2 2 2 ~ 2 5 8 m g ( 기 준 | r2=0.99 | M-1241 | r2=0.99 | 근거자료위치 | r2=0.99 | 0.6% | r2=0.99 |\n| . ",
        "original_sentence": "| 10 | 필름코팅 | 예 시 | 함량 | 98.5~101.5 % | 시험방법 #125a | 99.8 % | 결정다형, 안정성 등이 있을 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_041",
      "text": "| 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0225 | 직선성 | 0.05-2.5% | 12 시간 | 유연물질 F: 2.55* | 톨루엔: 890 ppm 이하 | 0.05-1.0% | 85% 이상 | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% | 80 ppm | 0.05-1.0% |\n| 정제수, 60 ℃, 13 시간 | 99% | >0.99 | NA | >0.99 | 병포장 | 60 mL 흰색 원형 HDPE 병 (60, 100 정) | 백당 주성분 층이 형성되기 위해 주성분 ... 가 물에 완전히 용해되므로 입자도 및 결정 | 시험 항목 | 허용 기준 | 분석방법 | 시험결과 | RC3: 0.5% 이하 | 「식약처 지침서등의 관리에 관한 규정」 개정에 |\n| 엔도톡신 | 98.0 %였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 40,
        "window_size": 3,
        "char_count": 408,
        "word_count": 107,
        "page_number": 3,
        "window_text": "유연물질에 관한 자료 | 해 설 | 부틸레이티드히드록시아니솔 | 98 | Y | 마손도 | 공정8의 나정 | 240mg ± 5%) | 235.5~243.9mg |\n| 하여 요약하여 기재한다.  | 근거자료를 제출하며, 밸리데이션 요약 자료를 제출한다.  | 10 | 필름코팅 | 예 시 | 함량 | 98.5~101.5 % | 시험방법 #125a | 99.8 % | 결정다형, 안정성 등이 있을 수 있다.  | 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0225 | 직선성 | 0.05-2.5% | 12 시간 | 유연물질 F: 2.55* | 톨루엔: 890 ppm 이하 | 0.05-1.0% | 85% 이상 | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% | 80 ppm | 0.05-1.0% |\n| 정제수, 60 ℃, 13 시간 | 99% | >0.99 | NA | >0.99 | 병포장 | 60 mL 흰색 원형 HDPE 병 (60, 100 정) | 백당 주성분 층이 형성되기 위해 주성분 ... 가 물에 완전히 용해되므로 입자도 및 결정 | 시험 항목 | 허용 기준 | 분석방법 | 시험결과 | RC3: 0.5% 이하 | 「식약처 지침서등의 관리에 관한 규정」 개정에 |\n| 엔도톡신 | 98.0 %였다.  실험실 규모 뱃치 시험의 자세한 결과는 3.2.P.2.3 제조공정 개발을 참조한다.  | 붕해도 | (사유 :                                                                 ) | r2=0.99 | 공정9의 필름코팅액 | r2=0.99 | 2 2 2 ~ 2 5 8 m g ( 기 준 | r2=0.99 | M-1241 | r2=0.99 | 근거자료위치 | r2=0.99 | 0.6% | r2=0.99 |\n| .  안정성시험자료(결과표) | 유연물질(HPLC) | 정제수2 | 용매 | 아스코르브산 | 95 | N | 공정변수 | 최소 | 최대 | 자사기준 |\n| 습도(90% RH), 25 ℃, 7 일 | 99% | >0.99 | NA | >0.99 | 대하여 요약하여 기재한다. ",
        "original_sentence": "| 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0225 | 직선성 | 0.05-2.5% | 12 시간 | 유연물질 F: 2.55* | 톨루엔: 890 ppm 이하 | 0.05-1.0% | 85% 이상 | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% | 80 ppm | 0.05-1.0% |\n| 정제수, 60 ℃, 13 시간 | 99% | >0.99 | NA | >0.99 | 병포장 | 60 mL 흰색 원형 HDPE 병 (60, 100 정) | 백당 주성분 층이 형성되기 위해 주성분 ... 가 물에 완전히 용해되므로 입자도 및 결정 | 시험 항목 | 허용 기준 | 분석방법 | 시험결과 | RC3: 0.5% 이하 | 「식약처 지침서등의 관리에 관한 규정」 개정에 |\n| 엔도톡신 | 98.0 %였다. "
      }
    },
    {
      "chunk_id": "chunk_042",
      "text": "실험실 규모 뱃치 시험의 자세한 결과는 3.2.P.2.3 제조공정 개발을 참조한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 41,
        "window_size": 3,
        "char_count": 47,
        "word_count": 10,
        "page_number": 5,
        "window_text": "| 근거자료를 제출하며, 밸리데이션 요약 자료를 제출한다.  | 10 | 필름코팅 | 예 시 | 함량 | 98.5~101.5 % | 시험방법 #125a | 99.8 % | 결정다형, 안정성 등이 있을 수 있다.  | 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0225 | 직선성 | 0.05-2.5% | 12 시간 | 유연물질 F: 2.55* | 톨루엔: 890 ppm 이하 | 0.05-1.0% | 85% 이상 | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% | 80 ppm | 0.05-1.0% |\n| 정제수, 60 ℃, 13 시간 | 99% | >0.99 | NA | >0.99 | 병포장 | 60 mL 흰색 원형 HDPE 병 (60, 100 정) | 백당 주성분 층이 형성되기 위해 주성분 ... 가 물에 완전히 용해되므로 입자도 및 결정 | 시험 항목 | 허용 기준 | 분석방법 | 시험결과 | RC3: 0.5% 이하 | 「식약처 지침서등의 관리에 관한 규정」 개정에 |\n| 엔도톡신 | 98.0 %였다.  실험실 규모 뱃치 시험의 자세한 결과는 3.2.P.2.3 제조공정 개발을 참조한다.  | 붕해도 | (사유 :                                                                 ) | r2=0.99 | 공정9의 필름코팅액 | r2=0.99 | 2 2 2 ~ 2 5 8 m g ( 기 준 | r2=0.99 | M-1241 | r2=0.99 | 근거자료위치 | r2=0.99 | 0.6% | r2=0.99 |\n| .  안정성시험자료(결과표) | 유연물질(HPLC) | 정제수2 | 용매 | 아스코르브산 | 95 | N | 공정변수 | 최소 | 최대 | 자사기준 |\n| 습도(90% RH), 25 ℃, 7 일 | 99% | >0.99 | NA | >0.99 | 대하여 요약하여 기재한다.  | 2.3.S.4. ",
        "original_sentence": "실험실 규모 뱃치 시험의 자세한 결과는 3.2.P.2.3 제조공정 개발을 참조한다. "
      }
    },
    {
      "chunk_id": "chunk_043",
      "text": "| 붕해도 | (사유 :                                                                 ) | r2=0.99 | 공정9의 필름코팅액 | r2=0.99 | 2 2 2 ~ 2 5 8 m g ( 기 준 | r2=0.99 | M-1241 | r2=0.99 | 근거자료위치 | r2=0.99 | 0.6% | r2=0.99 |\n| . ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 42,
        "window_size": 3,
        "char_count": 210,
        "word_count": 43,
        "page_number": 27,
        "window_text": "| 10 | 필름코팅 | 예 시 | 함량 | 98.5~101.5 % | 시험방법 #125a | 99.8 % | 결정다형, 안정성 등이 있을 수 있다.  | 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0225 | 직선성 | 0.05-2.5% | 12 시간 | 유연물질 F: 2.55* | 톨루엔: 890 ppm 이하 | 0.05-1.0% | 85% 이상 | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% | 80 ppm | 0.05-1.0% |\n| 정제수, 60 ℃, 13 시간 | 99% | >0.99 | NA | >0.99 | 병포장 | 60 mL 흰색 원형 HDPE 병 (60, 100 정) | 백당 주성분 층이 형성되기 위해 주성분 ... 가 물에 완전히 용해되므로 입자도 및 결정 | 시험 항목 | 허용 기준 | 분석방법 | 시험결과 | RC3: 0.5% 이하 | 「식약처 지침서등의 관리에 관한 규정」 개정에 |\n| 엔도톡신 | 98.0 %였다.  실험실 규모 뱃치 시험의 자세한 결과는 3.2.P.2.3 제조공정 개발을 참조한다.  | 붕해도 | (사유 :                                                                 ) | r2=0.99 | 공정9의 필름코팅액 | r2=0.99 | 2 2 2 ~ 2 5 8 m g ( 기 준 | r2=0.99 | M-1241 | r2=0.99 | 근거자료위치 | r2=0.99 | 0.6% | r2=0.99 |\n| .  안정성시험자료(결과표) | 유연물질(HPLC) | 정제수2 | 용매 | 아스코르브산 | 95 | N | 공정변수 | 최소 | 최대 | 자사기준 |\n| 습도(90% RH), 25 ℃, 7 일 | 99% | >0.99 | NA | >0.99 | 대하여 요약하여 기재한다.  | 2.3.S.4.  원료의약품의 품질관리(제품명, 제조자) ………………………………………… 6 | 유연물질명 | 화학명 | 화학 구조 | 설정 기준 | 2 | 안내서-0206-01 | - | 0%)에 근거하여 결정되었다. ",
        "original_sentence": "| 붕해도 | (사유 :                                                                 ) | r2=0.99 | 공정9의 필름코팅액 | r2=0.99 | 2 2 2 ~ 2 5 8 m g ( 기 준 | r2=0.99 | M-1241 | r2=0.99 | 근거자료위치 | r2=0.99 | 0.6% | r2=0.99 |\n| . "
      }
    },
    {
      "chunk_id": "chunk_044",
      "text": "안정성시험자료(결과표) | 유연물질(HPLC) | 정제수2 | 용매 | 아스코르브산 | 95 | N | 공정변수 | 최소 | 최대 | 자사기준 |\n| 습도(90% RH), 25 ℃, 7 일 | 99% | >0.99 | NA | >0.99 | 대하여 요약하여 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 43,
        "window_size": 3,
        "char_count": 150,
        "word_count": 41,
        "page_number": 5,
        "window_text": "| 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0225 | 직선성 | 0.05-2.5% | 12 시간 | 유연물질 F: 2.55* | 톨루엔: 890 ppm 이하 | 0.05-1.0% | 85% 이상 | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% | 80 ppm | 0.05-1.0% |\n| 정제수, 60 ℃, 13 시간 | 99% | >0.99 | NA | >0.99 | 병포장 | 60 mL 흰색 원형 HDPE 병 (60, 100 정) | 백당 주성분 층이 형성되기 위해 주성분 ... 가 물에 완전히 용해되므로 입자도 및 결정 | 시험 항목 | 허용 기준 | 분석방법 | 시험결과 | RC3: 0.5% 이하 | 「식약처 지침서등의 관리에 관한 규정」 개정에 |\n| 엔도톡신 | 98.0 %였다.  실험실 규모 뱃치 시험의 자세한 결과는 3.2.P.2.3 제조공정 개발을 참조한다.  | 붕해도 | (사유 :                                                                 ) | r2=0.99 | 공정9의 필름코팅액 | r2=0.99 | 2 2 2 ~ 2 5 8 m g ( 기 준 | r2=0.99 | M-1241 | r2=0.99 | 근거자료위치 | r2=0.99 | 0.6% | r2=0.99 |\n| .  안정성시험자료(결과표) | 유연물질(HPLC) | 정제수2 | 용매 | 아스코르브산 | 95 | N | 공정변수 | 최소 | 최대 | 자사기준 |\n| 습도(90% RH), 25 ℃, 7 일 | 99% | >0.99 | NA | >0.99 | 대하여 요약하여 기재한다.  | 2.3.S.4.  원료의약품의 품질관리(제품명, 제조자) ………………………………………… 6 | 유연물질명 | 화학명 | 화학 구조 | 설정 기준 | 2 | 안내서-0206-01 | - | 0%)에 근거하여 결정되었다.  수분 시험은 칼피셔법(USP<921> method 1a)에 따른다. ",
        "original_sentence": "안정성시험자료(결과표) | 유연물질(HPLC) | 정제수2 | 용매 | 아스코르브산 | 95 | N | 공정변수 | 최소 | 최대 | 자사기준 |\n| 습도(90% RH), 25 ℃, 7 일 | 99% | >0.99 | NA | >0.99 | 대하여 요약하여 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_045",
      "text": "| 2.3.S.4. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 44,
        "window_size": 3,
        "char_count": 11,
        "word_count": 2,
        "page_number": 5,
        "window_text": "실험실 규모 뱃치 시험의 자세한 결과는 3.2.P.2.3 제조공정 개발을 참조한다.  | 붕해도 | (사유 :                                                                 ) | r2=0.99 | 공정9의 필름코팅액 | r2=0.99 | 2 2 2 ~ 2 5 8 m g ( 기 준 | r2=0.99 | M-1241 | r2=0.99 | 근거자료위치 | r2=0.99 | 0.6% | r2=0.99 |\n| .  안정성시험자료(결과표) | 유연물질(HPLC) | 정제수2 | 용매 | 아스코르브산 | 95 | N | 공정변수 | 최소 | 최대 | 자사기준 |\n| 습도(90% RH), 25 ℃, 7 일 | 99% | >0.99 | NA | >0.99 | 대하여 요약하여 기재한다.  | 2.3.S.4.  원료의약품의 품질관리(제품명, 제조자) ………………………………………… 6 | 유연물질명 | 화학명 | 화학 구조 | 설정 기준 | 2 | 안내서-0206-01 | - | 0%)에 근거하여 결정되었다.  수분 시험은 칼피셔법(USP<921> method 1a)에 따른다.  | 공정수율 | 표준품: 0.01 mg/mL, 유연물질 B 0.01 mg/mL | 물질명/IUPAC명 | 기원 | 240mg ± 7.5%) | USP<701> | 따른 등록번호 일괄 정비 | 1분 |\n| 이용하여 기술하고, 뱃치에 관한 사항은 아래 예시를 참고하여 기재한다. ",
        "original_sentence": "| 2.3.S.4. "
      }
    },
    {
      "chunk_id": "chunk_046",
      "text": "원료의약품의 품질관리(제품명, 제조자) ………………………………………… 6 | 유연물질명 | 화학명 | 화학 구조 | 설정 기준 | 2 | 안내서-0206-01 | - | 0%)에 근거하여 결정되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 45,
        "window_size": 3,
        "char_count": 112,
        "word_count": 25,
        "page_number": 11,
        "window_text": "| 붕해도 | (사유 :                                                                 ) | r2=0.99 | 공정9의 필름코팅액 | r2=0.99 | 2 2 2 ~ 2 5 8 m g ( 기 준 | r2=0.99 | M-1241 | r2=0.99 | 근거자료위치 | r2=0.99 | 0.6% | r2=0.99 |\n| .  안정성시험자료(결과표) | 유연물질(HPLC) | 정제수2 | 용매 | 아스코르브산 | 95 | N | 공정변수 | 최소 | 최대 | 자사기준 |\n| 습도(90% RH), 25 ℃, 7 일 | 99% | >0.99 | NA | >0.99 | 대하여 요약하여 기재한다.  | 2.3.S.4.  원료의약품의 품질관리(제품명, 제조자) ………………………………………… 6 | 유연물질명 | 화학명 | 화학 구조 | 설정 기준 | 2 | 안내서-0206-01 | - | 0%)에 근거하여 결정되었다.  수분 시험은 칼피셔법(USP<921> method 1a)에 따른다.  | 공정수율 | 표준품: 0.01 mg/mL, 유연물질 B 0.01 mg/mL | 물질명/IUPAC명 | 기원 | 240mg ± 7.5%) | USP<701> | 따른 등록번호 일괄 정비 | 1분 |\n| 이용하여 기술하고, 뱃치에 관한 사항은 아래 예시를 참고하여 기재한다.  | 특정유연물질 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 |\n| 무균 | . ",
        "original_sentence": "원료의약품의 품질관리(제품명, 제조자) ………………………………………… 6 | 유연물질명 | 화학명 | 화학 구조 | 설정 기준 | 2 | 안내서-0206-01 | - | 0%)에 근거하여 결정되었다. "
      }
    },
    {
      "chunk_id": "chunk_047",
      "text": "수분 시험은 칼피셔법(USP<921> method 1a)에 따른다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 46,
        "window_size": 3,
        "char_count": 38,
        "word_count": 6,
        "page_number": 5,
        "window_text": "안정성시험자료(결과표) | 유연물질(HPLC) | 정제수2 | 용매 | 아스코르브산 | 95 | N | 공정변수 | 최소 | 최대 | 자사기준 |\n| 습도(90% RH), 25 ℃, 7 일 | 99% | >0.99 | NA | >0.99 | 대하여 요약하여 기재한다.  | 2.3.S.4.  원료의약품의 품질관리(제품명, 제조자) ………………………………………… 6 | 유연물질명 | 화학명 | 화학 구조 | 설정 기준 | 2 | 안내서-0206-01 | - | 0%)에 근거하여 결정되었다.  수분 시험은 칼피셔법(USP<921> method 1a)에 따른다.  | 공정수율 | 표준품: 0.01 mg/mL, 유연물질 B 0.01 mg/mL | 물질명/IUPAC명 | 기원 | 240mg ± 7.5%) | USP<701> | 따른 등록번호 일괄 정비 | 1분 |\n| 이용하여 기술하고, 뱃치에 관한 사항은 아래 예시를 참고하여 기재한다.  | 특정유연물질 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 |\n| 무균 | .  제조공정에 관한 자료 | 요소이다. ",
        "original_sentence": "수분 시험은 칼피셔법(USP<921> method 1a)에 따른다. "
      }
    },
    {
      "chunk_id": "chunk_048",
      "text": "| 공정수율 | 표준품: 0.01 mg/mL, 유연물질 B 0.01 mg/mL | 물질명/IUPAC명 | 기원 | 240mg ± 7.5%) | USP<701> | 따른 등록번호 일괄 정비 | 1분 |\n| 이용하여 기술하고, 뱃치에 관한 사항은 아래 예시를 참고하여 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 47,
        "window_size": 3,
        "char_count": 154,
        "word_count": 38,
        "page_number": 5,
        "window_text": "| 2.3.S.4.  원료의약품의 품질관리(제품명, 제조자) ………………………………………… 6 | 유연물질명 | 화학명 | 화학 구조 | 설정 기준 | 2 | 안내서-0206-01 | - | 0%)에 근거하여 결정되었다.  수분 시험은 칼피셔법(USP<921> method 1a)에 따른다.  | 공정수율 | 표준품: 0.01 mg/mL, 유연물질 B 0.01 mg/mL | 물질명/IUPAC명 | 기원 | 240mg ± 7.5%) | USP<701> | 따른 등록번호 일괄 정비 | 1분 |\n| 이용하여 기술하고, 뱃치에 관한 사항은 아래 예시를 참고하여 기재한다.  | 특정유연물질 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 |\n| 무균 | .  제조공정에 관한 자료 | 요소이다.  | 변경사항들은 다음과 같다. ",
        "original_sentence": "| 공정수율 | 표준품: 0.01 mg/mL, 유연물질 B 0.01 mg/mL | 물질명/IUPAC명 | 기원 | 240mg ± 7.5%) | USP<701> | 따른 등록번호 일괄 정비 | 1분 |\n| 이용하여 기술하고, 뱃치에 관한 사항은 아래 예시를 참고하여 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_049",
      "text": "| 특정유연물질 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 |\n| 무균 | . ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 48,
        "window_size": 3,
        "char_count": 58,
        "word_count": 12,
        "page_number": 2,
        "window_text": "원료의약품의 품질관리(제품명, 제조자) ………………………………………… 6 | 유연물질명 | 화학명 | 화학 구조 | 설정 기준 | 2 | 안내서-0206-01 | - | 0%)에 근거하여 결정되었다.  수분 시험은 칼피셔법(USP<921> method 1a)에 따른다.  | 공정수율 | 표준품: 0.01 mg/mL, 유연물질 B 0.01 mg/mL | 물질명/IUPAC명 | 기원 | 240mg ± 7.5%) | USP<701> | 따른 등록번호 일괄 정비 | 1분 |\n| 이용하여 기술하고, 뱃치에 관한 사항은 아래 예시를 참고하여 기재한다.  | 특정유연물질 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 |\n| 무균 | .  제조공정에 관한 자료 | 요소이다.  | 변경사항들은 다음과 같다.  추가 정보는 3.2.P.3.3 제조공정 및 공정관리를 참조한다. ",
        "original_sentence": "| 특정유연물질 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 |\n| 무균 | . "
      }
    },
    {
      "chunk_id": "chunk_050",
      "text": "제조공정에 관한 자료 | 요소이다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 49,
        "window_size": 3,
        "char_count": 20,
        "word_count": 5,
        "page_number": 3,
        "window_text": "수분 시험은 칼피셔법(USP<921> method 1a)에 따른다.  | 공정수율 | 표준품: 0.01 mg/mL, 유연물질 B 0.01 mg/mL | 물질명/IUPAC명 | 기원 | 240mg ± 7.5%) | USP<701> | 따른 등록번호 일괄 정비 | 1분 |\n| 이용하여 기술하고, 뱃치에 관한 사항은 아래 예시를 참고하여 기재한다.  | 특정유연물질 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 |\n| 무균 | .  제조공정에 관한 자료 | 요소이다.  | 변경사항들은 다음과 같다.  추가 정보는 3.2.P.3.3 제조공정 및 공정관리를 참조한다.  | 모 뱃치에서의 결과들에 대한 상세한 내용은 3.2.P.2.3항을 참조한다. ",
        "original_sentence": "제조공정에 관한 자료 | 요소이다. "
      }
    },
    {
      "chunk_id": "chunk_051",
      "text": "| 변경사항들은 다음과 같다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 50,
        "window_size": 3,
        "char_count": 17,
        "word_count": 4,
        "page_number": 2,
        "window_text": "| 공정수율 | 표준품: 0.01 mg/mL, 유연물질 B 0.01 mg/mL | 물질명/IUPAC명 | 기원 | 240mg ± 7.5%) | USP<701> | 따른 등록번호 일괄 정비 | 1분 |\n| 이용하여 기술하고, 뱃치에 관한 사항은 아래 예시를 참고하여 기재한다.  | 특정유연물질 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 |\n| 무균 | .  제조공정에 관한 자료 | 요소이다.  | 변경사항들은 다음과 같다.  추가 정보는 3.2.P.3.3 제조공정 및 공정관리를 참조한다.  | 모 뱃치에서의 결과들에 대한 상세한 내용은 3.2.P.2.3항을 참조한다.  | 샘플 조제 | 메탄올 3000ppm 이하 | 개개유연물질: 각각 0.2% 이하 | . ",
        "original_sentence": "| 변경사항들은 다음과 같다. "
      }
    },
    {
      "chunk_id": "chunk_052",
      "text": "추가 정보는 3.2.P.3.3 제조공정 및 공정관리를 참조한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 51,
        "window_size": 3,
        "char_count": 36,
        "word_count": 7,
        "page_number": 5,
        "window_text": "| 특정유연물질 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 |\n| 무균 | .  제조공정에 관한 자료 | 요소이다.  | 변경사항들은 다음과 같다.  추가 정보는 3.2.P.3.3 제조공정 및 공정관리를 참조한다.  | 모 뱃치에서의 결과들에 대한 상세한 내용은 3.2.P.2.3항을 참조한다.  | 샘플 조제 | 메탄올 3000ppm 이하 | 개개유연물질: 각각 0.2% 이하 | .  제조공정 및 공정관리에 관한 자료(상세) | (성적서 위치 포함) | 200 ppm | □ 예 | ■ 아니오 | 직접용기․ |\n| RC2 | [화학명] | [화학구조] | 0.5% 이하 | 방출제어막 | 11 | 포장 | 공정10의 반제품 | 시험종류 | 시험조건 | 용기형태/재질 | 제조번호 | 측정시기 (개월) | 결과 | 정밀성 | RSD 6.7 % | RSD 4.5 % | RSD 6.8 % | RSD 5.2 % | RSD 3.2 % | RSD 4.5 % | 폴리에틸렌글리콜 | 92 | Y | Bed 온도 | 40℃ | 70℃ | 1.0% 이하 | (규제개혁담당관실-3761호,2017.5.16) | 225.420정(97.3%) | RSD = 0.8% |\n| RC1 | 검액: 약 2 mg/mL | RC1: 0.15 % 이하 | RC2: 25% | RC1: 0.05 % |\n| 2.3.S.5. ",
        "original_sentence": "추가 정보는 3.2.P.3.3 제조공정 및 공정관리를 참조한다. "
      }
    },
    {
      "chunk_id": "chunk_053",
      "text": "| 모 뱃치에서의 결과들에 대한 상세한 내용은 3.2.P.2.3항을 참조한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 52,
        "window_size": 3,
        "char_count": 44,
        "word_count": 9,
        "page_number": 5,
        "window_text": "제조공정에 관한 자료 | 요소이다.  | 변경사항들은 다음과 같다.  추가 정보는 3.2.P.3.3 제조공정 및 공정관리를 참조한다.  | 모 뱃치에서의 결과들에 대한 상세한 내용은 3.2.P.2.3항을 참조한다.  | 샘플 조제 | 메탄올 3000ppm 이하 | 개개유연물질: 각각 0.2% 이하 | .  제조공정 및 공정관리에 관한 자료(상세) | (성적서 위치 포함) | 200 ppm | □ 예 | ■ 아니오 | 직접용기․ |\n| RC2 | [화학명] | [화학구조] | 0.5% 이하 | 방출제어막 | 11 | 포장 | 공정10의 반제품 | 시험종류 | 시험조건 | 용기형태/재질 | 제조번호 | 측정시기 (개월) | 결과 | 정밀성 | RSD 6.7 % | RSD 4.5 % | RSD 6.8 % | RSD 5.2 % | RSD 3.2 % | RSD 4.5 % | 폴리에틸렌글리콜 | 92 | Y | Bed 온도 | 40℃ | 70℃ | 1.0% 이하 | (규제개혁담당관실-3761호,2017.5.16) | 225.420정(97.3%) | RSD = 0.8% |\n| RC1 | 검액: 약 2 mg/mL | RC1: 0.15 % 이하 | RC2: 25% | RC1: 0.05 % |\n| 2.3.S.5.  표준품 또는 표준물질(제품명, 제조자) ………………………………………… 9 | 품으로 시험하는 것이 바람직하다. ",
        "original_sentence": "| 모 뱃치에서의 결과들에 대한 상세한 내용은 3.2.P.2.3항을 참조한다. "
      }
    },
    {
      "chunk_id": "chunk_054",
      "text": "| 샘플 조제 | 메탄올 3000ppm 이하 | 개개유연물질: 각각 0.2% 이하 | . ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 53,
        "window_size": 3,
        "char_count": 50,
        "word_count": 14,
        "page_number": 3,
        "window_text": "| 변경사항들은 다음과 같다.  추가 정보는 3.2.P.3.3 제조공정 및 공정관리를 참조한다.  | 모 뱃치에서의 결과들에 대한 상세한 내용은 3.2.P.2.3항을 참조한다.  | 샘플 조제 | 메탄올 3000ppm 이하 | 개개유연물질: 각각 0.2% 이하 | .  제조공정 및 공정관리에 관한 자료(상세) | (성적서 위치 포함) | 200 ppm | □ 예 | ■ 아니오 | 직접용기․ |\n| RC2 | [화학명] | [화학구조] | 0.5% 이하 | 방출제어막 | 11 | 포장 | 공정10의 반제품 | 시험종류 | 시험조건 | 용기형태/재질 | 제조번호 | 측정시기 (개월) | 결과 | 정밀성 | RSD 6.7 % | RSD 4.5 % | RSD 6.8 % | RSD 5.2 % | RSD 3.2 % | RSD 4.5 % | 폴리에틸렌글리콜 | 92 | Y | Bed 온도 | 40℃ | 70℃ | 1.0% 이하 | (규제개혁담당관실-3761호,2017.5.16) | 225.420정(97.3%) | RSD = 0.8% |\n| RC1 | 검액: 약 2 mg/mL | RC1: 0.15 % 이하 | RC2: 25% | RC1: 0.05 % |\n| 2.3.S.5.  표준품 또는 표준물질(제품명, 제조자) ………………………………………… 9 | 품으로 시험하는 것이 바람직하다.  | 예 시 | 잔류용매 | 화학적 안정성 면에서 주성분 ... 는 산화에 매우 취약하다. ",
        "original_sentence": "| 샘플 조제 | 메탄올 3000ppm 이하 | 개개유연물질: 각각 0.2% 이하 | . "
      }
    },
    {
      "chunk_id": "chunk_055",
      "text": "제조공정 및 공정관리에 관한 자료(상세) | (성적서 위치 포함) | 200 ppm | □ 예 | ■ 아니오 | 직접용기․ |\n| RC2 | [화학명] | [화학구조] | 0.5% 이하 | 방출제어막 | 11 | 포장 | 공정10의 반제품 | 시험종류 | 시험조건 | 용기형태/재질 | 제조번호 | 측정시기 (개월) | 결과 | 정밀성 | RSD 6.7 % | RSD 4.5 % | RSD 6.8 % | RSD 5.2 % | RSD 3.2 % | RSD 4.5 % | 폴리에틸렌글리콜 | 92 | Y | Bed 온도 | 40℃ | 70℃ | 1.0% 이하 | (규제개혁담당관실-3761호,2017.5.16) | 225.420정(97.3%) | RSD = 0.8% |\n| RC1 | 검액: 약 2 mg/mL | RC1: 0.15 % 이하 | RC2: 25% | RC1: 0.05 % |\n| 2.3.S.5. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 54,
        "window_size": 3,
        "char_count": 450,
        "word_count": 125,
        "page_number": 5,
        "window_text": "추가 정보는 3.2.P.3.3 제조공정 및 공정관리를 참조한다.  | 모 뱃치에서의 결과들에 대한 상세한 내용은 3.2.P.2.3항을 참조한다.  | 샘플 조제 | 메탄올 3000ppm 이하 | 개개유연물질: 각각 0.2% 이하 | .  제조공정 및 공정관리에 관한 자료(상세) | (성적서 위치 포함) | 200 ppm | □ 예 | ■ 아니오 | 직접용기․ |\n| RC2 | [화학명] | [화학구조] | 0.5% 이하 | 방출제어막 | 11 | 포장 | 공정10의 반제품 | 시험종류 | 시험조건 | 용기형태/재질 | 제조번호 | 측정시기 (개월) | 결과 | 정밀성 | RSD 6.7 % | RSD 4.5 % | RSD 6.8 % | RSD 5.2 % | RSD 3.2 % | RSD 4.5 % | 폴리에틸렌글리콜 | 92 | Y | Bed 온도 | 40℃ | 70℃ | 1.0% 이하 | (규제개혁담당관실-3761호,2017.5.16) | 225.420정(97.3%) | RSD = 0.8% |\n| RC1 | 검액: 약 2 mg/mL | RC1: 0.15 % 이하 | RC2: 25% | RC1: 0.05 % |\n| 2.3.S.5.  표준품 또는 표준물질(제품명, 제조자) ………………………………………… 9 | 품으로 시험하는 것이 바람직하다.  | 예 시 | 잔류용매 | 화학적 안정성 면에서 주성분 ... 는 산화에 매우 취약하다.  이는 제제에 항산화제를 추가 | 원료의약품 A | USP | 톨루엔 890 ppm 이하 | 내용을 단순 편집 또는 나열한 것입니까? ",
        "original_sentence": "제조공정 및 공정관리에 관한 자료(상세) | (성적서 위치 포함) | 200 ppm | □ 예 | ■ 아니오 | 직접용기․ |\n| RC2 | [화학명] | [화학구조] | 0.5% 이하 | 방출제어막 | 11 | 포장 | 공정10의 반제품 | 시험종류 | 시험조건 | 용기형태/재질 | 제조번호 | 측정시기 (개월) | 결과 | 정밀성 | RSD 6.7 % | RSD 4.5 % | RSD 6.8 % | RSD 5.2 % | RSD 3.2 % | RSD 4.5 % | 폴리에틸렌글리콜 | 92 | Y | Bed 온도 | 40℃ | 70℃ | 1.0% 이하 | (규제개혁담당관실-3761호,2017.5.16) | 225.420정(97.3%) | RSD = 0.8% |\n| RC1 | 검액: 약 2 mg/mL | RC1: 0.15 % 이하 | RC2: 25% | RC1: 0.05 % |\n| 2.3.S.5. "
      }
    },
    {
      "chunk_id": "chunk_056",
      "text": "표준품 또는 표준물질(제품명, 제조자) ………………………………………… 9 | 품으로 시험하는 것이 바람직하다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 55,
        "window_size": 3,
        "char_count": 62,
        "word_count": 11,
        "page_number": 24,
        "window_text": "| 모 뱃치에서의 결과들에 대한 상세한 내용은 3.2.P.2.3항을 참조한다.  | 샘플 조제 | 메탄올 3000ppm 이하 | 개개유연물질: 각각 0.2% 이하 | .  제조공정 및 공정관리에 관한 자료(상세) | (성적서 위치 포함) | 200 ppm | □ 예 | ■ 아니오 | 직접용기․ |\n| RC2 | [화학명] | [화학구조] | 0.5% 이하 | 방출제어막 | 11 | 포장 | 공정10의 반제품 | 시험종류 | 시험조건 | 용기형태/재질 | 제조번호 | 측정시기 (개월) | 결과 | 정밀성 | RSD 6.7 % | RSD 4.5 % | RSD 6.8 % | RSD 5.2 % | RSD 3.2 % | RSD 4.5 % | 폴리에틸렌글리콜 | 92 | Y | Bed 온도 | 40℃ | 70℃ | 1.0% 이하 | (규제개혁담당관실-3761호,2017.5.16) | 225.420정(97.3%) | RSD = 0.8% |\n| RC1 | 검액: 약 2 mg/mL | RC1: 0.15 % 이하 | RC2: 25% | RC1: 0.05 % |\n| 2.3.S.5.  표준품 또는 표준물질(제품명, 제조자) ………………………………………… 9 | 품으로 시험하는 것이 바람직하다.  | 예 시 | 잔류용매 | 화학적 안정성 면에서 주성분 ... 는 산화에 매우 취약하다.  이는 제제에 항산화제를 추가 | 원료의약품 A | USP | 톨루엔 890 ppm 이하 | 내용을 단순 편집 또는 나열한 것입니까?  | USP <467> 시험C | 유연물질 E(50%) | 80 ppm | 포장의 재질 |\n| 광안정성 408 일 | 55% | >0.99 | . ",
        "original_sentence": "표준품 또는 표준물질(제품명, 제조자) ………………………………………… 9 | 품으로 시험하는 것이 바람직하다. "
      }
    },
    {
      "chunk_id": "chunk_057",
      "text": "| 예 시 | 잔류용매 | 화학적 안정성 면에서 주성분 ... 는 산화에 매우 취약하다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 56,
        "window_size": 3,
        "char_count": 50,
        "word_count": 15,
        "page_number": 9,
        "window_text": "| 샘플 조제 | 메탄올 3000ppm 이하 | 개개유연물질: 각각 0.2% 이하 | .  제조공정 및 공정관리에 관한 자료(상세) | (성적서 위치 포함) | 200 ppm | □ 예 | ■ 아니오 | 직접용기․ |\n| RC2 | [화학명] | [화학구조] | 0.5% 이하 | 방출제어막 | 11 | 포장 | 공정10의 반제품 | 시험종류 | 시험조건 | 용기형태/재질 | 제조번호 | 측정시기 (개월) | 결과 | 정밀성 | RSD 6.7 % | RSD 4.5 % | RSD 6.8 % | RSD 5.2 % | RSD 3.2 % | RSD 4.5 % | 폴리에틸렌글리콜 | 92 | Y | Bed 온도 | 40℃ | 70℃ | 1.0% 이하 | (규제개혁담당관실-3761호,2017.5.16) | 225.420정(97.3%) | RSD = 0.8% |\n| RC1 | 검액: 약 2 mg/mL | RC1: 0.15 % 이하 | RC2: 25% | RC1: 0.05 % |\n| 2.3.S.5.  표준품 또는 표준물질(제품명, 제조자) ………………………………………… 9 | 품으로 시험하는 것이 바람직하다.  | 예 시 | 잔류용매 | 화학적 안정성 면에서 주성분 ... 는 산화에 매우 취약하다.  이는 제제에 항산화제를 추가 | 원료의약품 A | USP | 톨루엔 890 ppm 이하 | 내용을 단순 편집 또는 나열한 것입니까?  | USP <467> 시험C | 유연물질 E(50%) | 80 ppm | 포장의 재질 |\n| 광안정성 408 일 | 55% | >0.99 | .  용기 및 포장 시스템 | 에틸셀룰로오스 | 방출조절제 | 18.00 | 점도 20 mPa.s | <최적화된 약물 층화 공정변수 세팅(7” Wurster (89 mm partition))> | 총 유연물질: 1.5%이하 | Polyethylene | 5분 이하 | 가속시험 | 장기보존시험 | 001 | 실생산 뱃치 | 수분함량이 증가하는 | >0.99 |\n| RC3 | [화학명] | [화학구조] | 0.5% 이하 | 약물미세화 기압 | 1 bar | 5 bar |\n| 등록대상 | 결과와 허용 기준은 단위를 포함하여 수치로 기재한다. ",
        "original_sentence": "| 예 시 | 잔류용매 | 화학적 안정성 면에서 주성분 ... 는 산화에 매우 취약하다. "
      }
    },
    {
      "chunk_id": "chunk_058",
      "text": "이는 제제에 항산화제를 추가 | 원료의약품 A | USP | 톨루엔 890 ppm 이하 | 내용을 단순 편집 또는 나열한 것입니까? ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 57,
        "window_size": 3,
        "char_count": 74,
        "word_count": 21,
        "page_number": 3,
        "window_text": "제조공정 및 공정관리에 관한 자료(상세) | (성적서 위치 포함) | 200 ppm | □ 예 | ■ 아니오 | 직접용기․ |\n| RC2 | [화학명] | [화학구조] | 0.5% 이하 | 방출제어막 | 11 | 포장 | 공정10의 반제품 | 시험종류 | 시험조건 | 용기형태/재질 | 제조번호 | 측정시기 (개월) | 결과 | 정밀성 | RSD 6.7 % | RSD 4.5 % | RSD 6.8 % | RSD 5.2 % | RSD 3.2 % | RSD 4.5 % | 폴리에틸렌글리콜 | 92 | Y | Bed 온도 | 40℃ | 70℃ | 1.0% 이하 | (규제개혁담당관실-3761호,2017.5.16) | 225.420정(97.3%) | RSD = 0.8% |\n| RC1 | 검액: 약 2 mg/mL | RC1: 0.15 % 이하 | RC2: 25% | RC1: 0.05 % |\n| 2.3.S.5.  표준품 또는 표준물질(제품명, 제조자) ………………………………………… 9 | 품으로 시험하는 것이 바람직하다.  | 예 시 | 잔류용매 | 화학적 안정성 면에서 주성분 ... 는 산화에 매우 취약하다.  이는 제제에 항산화제를 추가 | 원료의약품 A | USP | 톨루엔 890 ppm 이하 | 내용을 단순 편집 또는 나열한 것입니까?  | USP <467> 시험C | 유연물질 E(50%) | 80 ppm | 포장의 재질 |\n| 광안정성 408 일 | 55% | >0.99 | .  용기 및 포장 시스템 | 에틸셀룰로오스 | 방출조절제 | 18.00 | 점도 20 mPa.s | <최적화된 약물 층화 공정변수 세팅(7” Wurster (89 mm partition))> | 총 유연물질: 1.5%이하 | Polyethylene | 5분 이하 | 가속시험 | 장기보존시험 | 001 | 실생산 뱃치 | 수분함량이 증가하는 | >0.99 |\n| RC3 | [화학명] | [화학구조] | 0.5% 이하 | 약물미세화 기압 | 1 bar | 5 bar |\n| 등록대상 | 결과와 허용 기준은 단위를 포함하여 수치로 기재한다.  | 중요 중간물질에 대한 설명 | RC2 | 실험실내 | 시스템적합성 | 칼럼 효율: 이론단수 5000 이상 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? ",
        "original_sentence": "이는 제제에 항산화제를 추가 | 원료의약품 A | USP | 톨루엔 890 ppm 이하 | 내용을 단순 편집 또는 나열한 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_059",
      "text": "| USP <467> 시험C | 유연물질 E(50%) | 80 ppm | 포장의 재질 |\n| 광안정성 408 일 | 55% | >0.99 | . ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 58,
        "window_size": 3,
        "char_count": 81,
        "word_count": 24,
        "page_number": 14,
        "window_text": "표준품 또는 표준물질(제품명, 제조자) ………………………………………… 9 | 품으로 시험하는 것이 바람직하다.  | 예 시 | 잔류용매 | 화학적 안정성 면에서 주성분 ... 는 산화에 매우 취약하다.  이는 제제에 항산화제를 추가 | 원료의약품 A | USP | 톨루엔 890 ppm 이하 | 내용을 단순 편집 또는 나열한 것입니까?  | USP <467> 시험C | 유연물질 E(50%) | 80 ppm | 포장의 재질 |\n| 광안정성 408 일 | 55% | >0.99 | .  용기 및 포장 시스템 | 에틸셀룰로오스 | 방출조절제 | 18.00 | 점도 20 mPa.s | <최적화된 약물 층화 공정변수 세팅(7” Wurster (89 mm partition))> | 총 유연물질: 1.5%이하 | Polyethylene | 5분 이하 | 가속시험 | 장기보존시험 | 001 | 실생산 뱃치 | 수분함량이 증가하는 | >0.99 |\n| RC3 | [화학명] | [화학구조] | 0.5% 이하 | 약물미세화 기압 | 1 bar | 5 bar |\n| 등록대상 | 결과와 허용 기준은 단위를 포함하여 수치로 기재한다.  | 중요 중간물질에 대한 설명 | RC2 | 실험실내 | 시스템적합성 | 칼럼 효율: 이론단수 5000 이상 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | RC2: 0.25 % 이하 | 실험실 규모 | 허가용 뱃치 | (230만 정) | % (w/w) | RC3: 20% | RC2: 0.05 % |\n| 명시하고 타당한 근거를 제시한다. ",
        "original_sentence": "| USP <467> 시험C | 유연물질 E(50%) | 80 ppm | 포장의 재질 |\n| 광안정성 408 일 | 55% | >0.99 | . "
      }
    },
    {
      "chunk_id": "chunk_060",
      "text": "용기 및 포장 시스템 | 에틸셀룰로오스 | 방출조절제 | 18.00 | 점도 20 mPa.s | <최적화된 약물 층화 공정변수 세팅(7” Wurster (89 mm partition))> | 총 유연물질: 1.5%이하 | Polyethylene | 5분 이하 | 가속시험 | 장기보존시험 | 001 | 실생산 뱃치 | 수분함량이 증가하는 | >0.99 |\n| RC3 | [화학명] | [화학구조] | 0.5% 이하 | 약물미세화 기압 | 1 bar | 5 bar |\n| 등록대상 | 결과와 허용 기준은 단위를 포함하여 수치로 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 59,
        "window_size": 3,
        "char_count": 300,
        "word_count": 77,
        "page_number": 5,
        "window_text": "| 예 시 | 잔류용매 | 화학적 안정성 면에서 주성분 ... 는 산화에 매우 취약하다.  이는 제제에 항산화제를 추가 | 원료의약품 A | USP | 톨루엔 890 ppm 이하 | 내용을 단순 편집 또는 나열한 것입니까?  | USP <467> 시험C | 유연물질 E(50%) | 80 ppm | 포장의 재질 |\n| 광안정성 408 일 | 55% | >0.99 | .  용기 및 포장 시스템 | 에틸셀룰로오스 | 방출조절제 | 18.00 | 점도 20 mPa.s | <최적화된 약물 층화 공정변수 세팅(7” Wurster (89 mm partition))> | 총 유연물질: 1.5%이하 | Polyethylene | 5분 이하 | 가속시험 | 장기보존시험 | 001 | 실생산 뱃치 | 수분함량이 증가하는 | >0.99 |\n| RC3 | [화학명] | [화학구조] | 0.5% 이하 | 약물미세화 기압 | 1 bar | 5 bar |\n| 등록대상 | 결과와 허용 기준은 단위를 포함하여 수치로 기재한다.  | 중요 중간물질에 대한 설명 | RC2 | 실험실내 | 시스템적합성 | 칼럼 효율: 이론단수 5000 이상 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | RC2: 0.25 % 이하 | 실험실 규모 | 허가용 뱃치 | (230만 정) | % (w/w) | RC3: 20% | RC2: 0.05 % |\n| 명시하고 타당한 근거를 제시한다.  | 설정할 수 있다. ",
        "original_sentence": "용기 및 포장 시스템 | 에틸셀룰로오스 | 방출조절제 | 18.00 | 점도 20 mPa.s | <최적화된 약물 층화 공정변수 세팅(7” Wurster (89 mm partition))> | 총 유연물질: 1.5%이하 | Polyethylene | 5분 이하 | 가속시험 | 장기보존시험 | 001 | 실생산 뱃치 | 수분함량이 증가하는 | >0.99 |\n| RC3 | [화학명] | [화학구조] | 0.5% 이하 | 약물미세화 기압 | 1 bar | 5 bar |\n| 등록대상 | 결과와 허용 기준은 단위를 포함하여 수치로 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_061",
      "text": "| 중요 중간물질에 대한 설명 | RC2 | 실험실내 | 시스템적합성 | 칼럼 효율: 이론단수 5000 이상 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 60,
        "window_size": 3,
        "char_count": 94,
        "word_count": 25,
        "page_number": 3,
        "window_text": "이는 제제에 항산화제를 추가 | 원료의약품 A | USP | 톨루엔 890 ppm 이하 | 내용을 단순 편집 또는 나열한 것입니까?  | USP <467> 시험C | 유연물질 E(50%) | 80 ppm | 포장의 재질 |\n| 광안정성 408 일 | 55% | >0.99 | .  용기 및 포장 시스템 | 에틸셀룰로오스 | 방출조절제 | 18.00 | 점도 20 mPa.s | <최적화된 약물 층화 공정변수 세팅(7” Wurster (89 mm partition))> | 총 유연물질: 1.5%이하 | Polyethylene | 5분 이하 | 가속시험 | 장기보존시험 | 001 | 실생산 뱃치 | 수분함량이 증가하는 | >0.99 |\n| RC3 | [화학명] | [화학구조] | 0.5% 이하 | 약물미세화 기압 | 1 bar | 5 bar |\n| 등록대상 | 결과와 허용 기준은 단위를 포함하여 수치로 기재한다.  | 중요 중간물질에 대한 설명 | RC2 | 실험실내 | 시스템적합성 | 칼럼 효율: 이론단수 5000 이상 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | RC2: 0.25 % 이하 | 실험실 규모 | 허가용 뱃치 | (230만 정) | % (w/w) | RC3: 20% | RC2: 0.05 % |\n| 명시하고 타당한 근거를 제시한다.  | 설정할 수 있다.  | 함으로써 해결하였다 (2.3.P.2.2 완제의약품 참조). ",
        "original_sentence": "| 중요 중간물질에 대한 설명 | RC2 | 실험실내 | 시스템적합성 | 칼럼 효율: 이론단수 5000 이상 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_062",
      "text": "| □ 예 | ■ 아니오 | RC2: 0.25 % 이하 | 실험실 규모 | 허가용 뱃치 | (230만 정) | % (w/w) | RC3: 20% | RC2: 0.05 % |\n| 명시하고 타당한 근거를 제시한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 61,
        "window_size": 3,
        "char_count": 118,
        "word_count": 36,
        "page_number": 2,
        "window_text": "| USP <467> 시험C | 유연물질 E(50%) | 80 ppm | 포장의 재질 |\n| 광안정성 408 일 | 55% | >0.99 | .  용기 및 포장 시스템 | 에틸셀룰로오스 | 방출조절제 | 18.00 | 점도 20 mPa.s | <최적화된 약물 층화 공정변수 세팅(7” Wurster (89 mm partition))> | 총 유연물질: 1.5%이하 | Polyethylene | 5분 이하 | 가속시험 | 장기보존시험 | 001 | 실생산 뱃치 | 수분함량이 증가하는 | >0.99 |\n| RC3 | [화학명] | [화학구조] | 0.5% 이하 | 약물미세화 기압 | 1 bar | 5 bar |\n| 등록대상 | 결과와 허용 기준은 단위를 포함하여 수치로 기재한다.  | 중요 중간물질에 대한 설명 | RC2 | 실험실내 | 시스템적합성 | 칼럼 효율: 이론단수 5000 이상 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | RC2: 0.25 % 이하 | 실험실 규모 | 허가용 뱃치 | (230만 정) | % (w/w) | RC3: 20% | RC2: 0.05 % |\n| 명시하고 타당한 근거를 제시한다.  | 설정할 수 있다.  | 함으로써 해결하였다 (2.3.P.2.2 완제의약품 참조).  | 시험), 기타 필요한 독성시험자료 | 유연물질 1 | 합성 | 테트라히드로푸란 720 ppm 이하 | Bag, Fiber | 93~101% | 대조약 | 002 | 0, 3, 6, 9, 12 | 미지 유연물질(15%) | 양상이나, 기준 내 적합하여 | 이상 없음 | 300 ppm |\n| 2.3.S.6. ",
        "original_sentence": "| □ 예 | ■ 아니오 | RC2: 0.25 % 이하 | 실험실 규모 | 허가용 뱃치 | (230만 정) | % (w/w) | RC3: 20% | RC2: 0.05 % |\n| 명시하고 타당한 근거를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_063",
      "text": "| 설정할 수 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 62,
        "window_size": 3,
        "char_count": 12,
        "word_count": 4,
        "page_number": 12,
        "window_text": "용기 및 포장 시스템 | 에틸셀룰로오스 | 방출조절제 | 18.00 | 점도 20 mPa.s | <최적화된 약물 층화 공정변수 세팅(7” Wurster (89 mm partition))> | 총 유연물질: 1.5%이하 | Polyethylene | 5분 이하 | 가속시험 | 장기보존시험 | 001 | 실생산 뱃치 | 수분함량이 증가하는 | >0.99 |\n| RC3 | [화학명] | [화학구조] | 0.5% 이하 | 약물미세화 기압 | 1 bar | 5 bar |\n| 등록대상 | 결과와 허용 기준은 단위를 포함하여 수치로 기재한다.  | 중요 중간물질에 대한 설명 | RC2 | 실험실내 | 시스템적합성 | 칼럼 효율: 이론단수 5000 이상 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | RC2: 0.25 % 이하 | 실험실 규모 | 허가용 뱃치 | (230만 정) | % (w/w) | RC3: 20% | RC2: 0.05 % |\n| 명시하고 타당한 근거를 제시한다.  | 설정할 수 있다.  | 함으로써 해결하였다 (2.3.P.2.2 완제의약품 참조).  | 시험), 기타 필요한 독성시험자료 | 유연물질 1 | 합성 | 테트라히드로푸란 720 ppm 이하 | Bag, Fiber | 93~101% | 대조약 | 002 | 0, 3, 6, 9, 12 | 미지 유연물질(15%) | 양상이나, 기준 내 적합하여 | 이상 없음 | 300 ppm |\n| 2.3.S.6.  용기 및 포장 시스템(제품명, 제조자) | ………………………………………… 10 | . ",
        "original_sentence": "| 설정할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_064",
      "text": "| 함으로써 해결하였다 (2.3.P.2.2 완제의약품 참조). ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 63,
        "window_size": 3,
        "char_count": 35,
        "word_count": 6,
        "page_number": 5,
        "window_text": "| 중요 중간물질에 대한 설명 | RC2 | 실험실내 | 시스템적합성 | 칼럼 효율: 이론단수 5000 이상 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | RC2: 0.25 % 이하 | 실험실 규모 | 허가용 뱃치 | (230만 정) | % (w/w) | RC3: 20% | RC2: 0.05 % |\n| 명시하고 타당한 근거를 제시한다.  | 설정할 수 있다.  | 함으로써 해결하였다 (2.3.P.2.2 완제의약품 참조).  | 시험), 기타 필요한 독성시험자료 | 유연물질 1 | 합성 | 테트라히드로푸란 720 ppm 이하 | Bag, Fiber | 93~101% | 대조약 | 002 | 0, 3, 6, 9, 12 | 미지 유연물질(15%) | 양상이나, 기준 내 적합하여 | 이상 없음 | 300 ppm |\n| 2.3.S.6.  용기 및 포장 시스템(제품명, 제조자) | ………………………………………… 10 | .  시험방법, 시험성적서에 관한 자료 | 용출 (HPLC) | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP | 멜로오스와 폴리에틸렌글리콜로 구성)를, 속도 조절막의 구성성분으로 에틸셀룰로오스 | 정밀성 | RSD 8.2 % | RSD 9.2 % | RSD 10.4 % | RSD 9.6 % | RSD 8.2 % | RSD 9.8 % | 시트르산트리에틸 | 코팅기제 | 3.000 | 불순물 A: 1.5% 이하 | 유동화 기체 부피 | 70 m3/시간 | 150 m3/시간 | <최적화된 서방 공정 세팅(7” Wurster (89 mm partition))> | (23만 정) | 시험방법 #41 | 0.8% |\n| 기기: | 제출한다. ",
        "original_sentence": "| 함으로써 해결하였다 (2.3.P.2.2 완제의약품 참조). "
      }
    },
    {
      "chunk_id": "chunk_065",
      "text": "| 시험), 기타 필요한 독성시험자료 | 유연물질 1 | 합성 | 테트라히드로푸란 720 ppm 이하 | Bag, Fiber | 93~101% | 대조약 | 002 | 0, 3, 6, 9, 12 | 미지 유연물질(15%) | 양상이나, 기준 내 적합하여 | 이상 없음 | 300 ppm |\n| 2.3.S.6. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 64,
        "window_size": 3,
        "char_count": 173,
        "word_count": 47,
        "page_number": 5,
        "window_text": "| □ 예 | ■ 아니오 | RC2: 0.25 % 이하 | 실험실 규모 | 허가용 뱃치 | (230만 정) | % (w/w) | RC3: 20% | RC2: 0.05 % |\n| 명시하고 타당한 근거를 제시한다.  | 설정할 수 있다.  | 함으로써 해결하였다 (2.3.P.2.2 완제의약품 참조).  | 시험), 기타 필요한 독성시험자료 | 유연물질 1 | 합성 | 테트라히드로푸란 720 ppm 이하 | Bag, Fiber | 93~101% | 대조약 | 002 | 0, 3, 6, 9, 12 | 미지 유연물질(15%) | 양상이나, 기준 내 적합하여 | 이상 없음 | 300 ppm |\n| 2.3.S.6.  용기 및 포장 시스템(제품명, 제조자) | ………………………………………… 10 | .  시험방법, 시험성적서에 관한 자료 | 용출 (HPLC) | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP | 멜로오스와 폴리에틸렌글리콜로 구성)를, 속도 조절막의 구성성분으로 에틸셀룰로오스 | 정밀성 | RSD 8.2 % | RSD 9.2 % | RSD 10.4 % | RSD 9.6 % | RSD 8.2 % | RSD 9.8 % | 시트르산트리에틸 | 코팅기제 | 3.000 | 불순물 A: 1.5% 이하 | 유동화 기체 부피 | 70 m3/시간 | 150 m3/시간 | <최적화된 서방 공정 세팅(7” Wurster (89 mm partition))> | (23만 정) | 시험방법 #41 | 0.8% |\n| 기기: | 제출한다.  | 해야 한다. ",
        "original_sentence": "| 시험), 기타 필요한 독성시험자료 | 유연물질 1 | 합성 | 테트라히드로푸란 720 ppm 이하 | Bag, Fiber | 93~101% | 대조약 | 002 | 0, 3, 6, 9, 12 | 미지 유연물질(15%) | 양상이나, 기준 내 적합하여 | 이상 없음 | 300 ppm |\n| 2.3.S.6. "
      }
    },
    {
      "chunk_id": "chunk_066",
      "text": "용기 및 포장 시스템(제품명, 제조자) | ………………………………………… 10 | . ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 65,
        "window_size": 3,
        "char_count": 48,
        "word_count": 10,
        "page_number": 4,
        "window_text": "| 설정할 수 있다.  | 함으로써 해결하였다 (2.3.P.2.2 완제의약품 참조).  | 시험), 기타 필요한 독성시험자료 | 유연물질 1 | 합성 | 테트라히드로푸란 720 ppm 이하 | Bag, Fiber | 93~101% | 대조약 | 002 | 0, 3, 6, 9, 12 | 미지 유연물질(15%) | 양상이나, 기준 내 적합하여 | 이상 없음 | 300 ppm |\n| 2.3.S.6.  용기 및 포장 시스템(제품명, 제조자) | ………………………………………… 10 | .  시험방법, 시험성적서에 관한 자료 | 용출 (HPLC) | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP | 멜로오스와 폴리에틸렌글리콜로 구성)를, 속도 조절막의 구성성분으로 에틸셀룰로오스 | 정밀성 | RSD 8.2 % | RSD 9.2 % | RSD 10.4 % | RSD 9.6 % | RSD 8.2 % | RSD 9.8 % | 시트르산트리에틸 | 코팅기제 | 3.000 | 불순물 A: 1.5% 이하 | 유동화 기체 부피 | 70 m3/시간 | 150 m3/시간 | <최적화된 서방 공정 세팅(7” Wurster (89 mm partition))> | (23만 정) | 시험방법 #41 | 0.8% |\n| 기기: | 제출한다.  | 해야 한다.  신청한 용기 및 포장은 기밀용기에 해당하는 USP <671> 요건을 충족한다 | RC3 | 유연물질명 | 제조번호 P034 | 여부 | 공정변수 | 설정값 | 사유 | RC3: 0.25 % 이하 | 주성분 ○○ | 7” Wurster | 18” Wurster | 이상 없음 | RC2: 35% | RC3: 0.10 % |\n| 및 포장을 참고한다. ",
        "original_sentence": "용기 및 포장 시스템(제품명, 제조자) | ………………………………………… 10 | . "
      }
    },
    {
      "chunk_id": "chunk_067",
      "text": "시험방법, 시험성적서에 관한 자료 | 용출 (HPLC) | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP | 멜로오스와 폴리에틸렌글리콜로 구성)를, 속도 조절막의 구성성분으로 에틸셀룰로오스 | 정밀성 | RSD 8.2 % | RSD 9.2 % | RSD 10.4 % | RSD 9.6 % | RSD 8.2 % | RSD 9.8 % | 시트르산트리에틸 | 코팅기제 | 3.000 | 불순물 A: 1.5% 이하 | 유동화 기체 부피 | 70 m3/시간 | 150 m3/시간 | <최적화된 서방 공정 세팅(7” Wurster (89 mm partition))> | (23만 정) | 시험방법 #41 | 0.8% |\n| 기기: | 제출한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 66,
        "window_size": 3,
        "char_count": 368,
        "word_count": 95,
        "page_number": 3,
        "window_text": "| 함으로써 해결하였다 (2.3.P.2.2 완제의약품 참조).  | 시험), 기타 필요한 독성시험자료 | 유연물질 1 | 합성 | 테트라히드로푸란 720 ppm 이하 | Bag, Fiber | 93~101% | 대조약 | 002 | 0, 3, 6, 9, 12 | 미지 유연물질(15%) | 양상이나, 기준 내 적합하여 | 이상 없음 | 300 ppm |\n| 2.3.S.6.  용기 및 포장 시스템(제품명, 제조자) | ………………………………………… 10 | .  시험방법, 시험성적서에 관한 자료 | 용출 (HPLC) | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP | 멜로오스와 폴리에틸렌글리콜로 구성)를, 속도 조절막의 구성성분으로 에틸셀룰로오스 | 정밀성 | RSD 8.2 % | RSD 9.2 % | RSD 10.4 % | RSD 9.6 % | RSD 8.2 % | RSD 9.8 % | 시트르산트리에틸 | 코팅기제 | 3.000 | 불순물 A: 1.5% 이하 | 유동화 기체 부피 | 70 m3/시간 | 150 m3/시간 | <최적화된 서방 공정 세팅(7” Wurster (89 mm partition))> | (23만 정) | 시험방법 #41 | 0.8% |\n| 기기: | 제출한다.  | 해야 한다.  신청한 용기 및 포장은 기밀용기에 해당하는 USP <671> 요건을 충족한다 | RC3 | 유연물질명 | 제조번호 P034 | 여부 | 공정변수 | 설정값 | 사유 | RC3: 0.25 % 이하 | 주성분 ○○ | 7” Wurster | 18” Wurster | 이상 없음 | RC2: 35% | RC3: 0.10 % |\n| 및 포장을 참고한다.  | 원료의약품의 분해는 관찰되지 않았으며 상호작용은 없는 것으로 판단된다. ",
        "original_sentence": "시험방법, 시험성적서에 관한 자료 | 용출 (HPLC) | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP | 멜로오스와 폴리에틸렌글리콜로 구성)를, 속도 조절막의 구성성분으로 에틸셀룰로오스 | 정밀성 | RSD 8.2 % | RSD 9.2 % | RSD 10.4 % | RSD 9.6 % | RSD 8.2 % | RSD 9.8 % | 시트르산트리에틸 | 코팅기제 | 3.000 | 불순물 A: 1.5% 이하 | 유동화 기체 부피 | 70 m3/시간 | 150 m3/시간 | <최적화된 서방 공정 세팅(7” Wurster (89 mm partition))> | (23만 정) | 시험방법 #41 | 0.8% |\n| 기기: | 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_068",
      "text": "| 해야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 67,
        "window_size": 3,
        "char_count": 9,
        "word_count": 3,
        "page_number": 13,
        "window_text": "| 시험), 기타 필요한 독성시험자료 | 유연물질 1 | 합성 | 테트라히드로푸란 720 ppm 이하 | Bag, Fiber | 93~101% | 대조약 | 002 | 0, 3, 6, 9, 12 | 미지 유연물질(15%) | 양상이나, 기준 내 적합하여 | 이상 없음 | 300 ppm |\n| 2.3.S.6.  용기 및 포장 시스템(제품명, 제조자) | ………………………………………… 10 | .  시험방법, 시험성적서에 관한 자료 | 용출 (HPLC) | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP | 멜로오스와 폴리에틸렌글리콜로 구성)를, 속도 조절막의 구성성분으로 에틸셀룰로오스 | 정밀성 | RSD 8.2 % | RSD 9.2 % | RSD 10.4 % | RSD 9.6 % | RSD 8.2 % | RSD 9.8 % | 시트르산트리에틸 | 코팅기제 | 3.000 | 불순물 A: 1.5% 이하 | 유동화 기체 부피 | 70 m3/시간 | 150 m3/시간 | <최적화된 서방 공정 세팅(7” Wurster (89 mm partition))> | (23만 정) | 시험방법 #41 | 0.8% |\n| 기기: | 제출한다.  | 해야 한다.  신청한 용기 및 포장은 기밀용기에 해당하는 USP <671> 요건을 충족한다 | RC3 | 유연물질명 | 제조번호 P034 | 여부 | 공정변수 | 설정값 | 사유 | RC3: 0.25 % 이하 | 주성분 ○○ | 7” Wurster | 18” Wurster | 이상 없음 | RC2: 35% | RC3: 0.10 % |\n| 및 포장을 참고한다.  | 원료의약품의 분해는 관찰되지 않았으며 상호작용은 없는 것으로 판단된다.  | 용해도가 높다. ",
        "original_sentence": "| 해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_069",
      "text": "신청한 용기 및 포장은 기밀용기에 해당하는 USP <671> 요건을 충족한다 | RC3 | 유연물질명 | 제조번호 P034 | 여부 | 공정변수 | 설정값 | 사유 | RC3: 0.25 % 이하 | 주성분 ○○ | 7” Wurster | 18” Wurster | 이상 없음 | RC2: 35% | RC3: 0.10 % |\n| 및 포장을 참고한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 68,
        "window_size": 3,
        "char_count": 194,
        "word_count": 54,
        "page_number": 5,
        "window_text": "용기 및 포장 시스템(제품명, 제조자) | ………………………………………… 10 | .  시험방법, 시험성적서에 관한 자료 | 용출 (HPLC) | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP | 멜로오스와 폴리에틸렌글리콜로 구성)를, 속도 조절막의 구성성분으로 에틸셀룰로오스 | 정밀성 | RSD 8.2 % | RSD 9.2 % | RSD 10.4 % | RSD 9.6 % | RSD 8.2 % | RSD 9.8 % | 시트르산트리에틸 | 코팅기제 | 3.000 | 불순물 A: 1.5% 이하 | 유동화 기체 부피 | 70 m3/시간 | 150 m3/시간 | <최적화된 서방 공정 세팅(7” Wurster (89 mm partition))> | (23만 정) | 시험방법 #41 | 0.8% |\n| 기기: | 제출한다.  | 해야 한다.  신청한 용기 및 포장은 기밀용기에 해당하는 USP <671> 요건을 충족한다 | RC3 | 유연물질명 | 제조번호 P034 | 여부 | 공정변수 | 설정값 | 사유 | RC3: 0.25 % 이하 | 주성분 ○○ | 7” Wurster | 18” Wurster | 이상 없음 | RC2: 35% | RC3: 0.10 % |\n| 및 포장을 참고한다.  | 원료의약품의 분해는 관찰되지 않았으며 상호작용은 없는 것으로 판단된다.  | 용해도가 높다.  | drum | 003 | 12 개월간 안정 |\n| UV (단파장/ 장파장), 7 일 | 27% | >0.99 | 경우 시험방법 밸리데이션 및 사용 등급을 표시한다. ",
        "original_sentence": "신청한 용기 및 포장은 기밀용기에 해당하는 USP <671> 요건을 충족한다 | RC3 | 유연물질명 | 제조번호 P034 | 여부 | 공정변수 | 설정값 | 사유 | RC3: 0.25 % 이하 | 주성분 ○○ | 7” Wurster | 18” Wurster | 이상 없음 | RC2: 35% | RC3: 0.10 % |\n| 및 포장을 참고한다. "
      }
    },
    {
      "chunk_id": "chunk_070",
      "text": "| 원료의약품의 분해는 관찰되지 않았으며 상호작용은 없는 것으로 판단된다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 69,
        "window_size": 3,
        "char_count": 42,
        "word_count": 9,
        "page_number": 48,
        "window_text": "시험방법, 시험성적서에 관한 자료 | 용출 (HPLC) | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP | 멜로오스와 폴리에틸렌글리콜로 구성)를, 속도 조절막의 구성성분으로 에틸셀룰로오스 | 정밀성 | RSD 8.2 % | RSD 9.2 % | RSD 10.4 % | RSD 9.6 % | RSD 8.2 % | RSD 9.8 % | 시트르산트리에틸 | 코팅기제 | 3.000 | 불순물 A: 1.5% 이하 | 유동화 기체 부피 | 70 m3/시간 | 150 m3/시간 | <최적화된 서방 공정 세팅(7” Wurster (89 mm partition))> | (23만 정) | 시험방법 #41 | 0.8% |\n| 기기: | 제출한다.  | 해야 한다.  신청한 용기 및 포장은 기밀용기에 해당하는 USP <671> 요건을 충족한다 | RC3 | 유연물질명 | 제조번호 P034 | 여부 | 공정변수 | 설정값 | 사유 | RC3: 0.25 % 이하 | 주성분 ○○ | 7” Wurster | 18” Wurster | 이상 없음 | RC2: 35% | RC3: 0.10 % |\n| 및 포장을 참고한다.  | 원료의약품의 분해는 관찰되지 않았으며 상호작용은 없는 것으로 판단된다.  | 용해도가 높다.  | drum | 003 | 12 개월간 안정 |\n| UV (단파장/ 장파장), 7 일 | 27% | >0.99 | 경우 시험방법 밸리데이션 및 사용 등급을 표시한다.  | 함량 (90-110%) | 유연물질 2 | USP | 정제수2 | 용매 | 시점 (개월) | (제조번호 | 기준 | 판정 | >0.99 |\n| Partitions: 번호/지름 | 2.3.S.7 안정성(제품명, 제조자) …………………………………………………………… 11 | 시험 | 신청인이 그 조성을 알 수 없을 경우에는 원료 제조원에서 직접 심사 부서에 제출할 수 있다. ",
        "original_sentence": "| 원료의약품의 분해는 관찰되지 않았으며 상호작용은 없는 것으로 판단된다. "
      }
    },
    {
      "chunk_id": "chunk_071",
      "text": "| 용해도가 높다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 70,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 47,
        "window_text": "| 해야 한다.  신청한 용기 및 포장은 기밀용기에 해당하는 USP <671> 요건을 충족한다 | RC3 | 유연물질명 | 제조번호 P034 | 여부 | 공정변수 | 설정값 | 사유 | RC3: 0.25 % 이하 | 주성분 ○○ | 7” Wurster | 18” Wurster | 이상 없음 | RC2: 35% | RC3: 0.10 % |\n| 및 포장을 참고한다.  | 원료의약품의 분해는 관찰되지 않았으며 상호작용은 없는 것으로 판단된다.  | 용해도가 높다.  | drum | 003 | 12 개월간 안정 |\n| UV (단파장/ 장파장), 7 일 | 27% | >0.99 | 경우 시험방법 밸리데이션 및 사용 등급을 표시한다.  | 함량 (90-110%) | 유연물질 2 | USP | 정제수2 | 용매 | 시점 (개월) | (제조번호 | 기준 | 판정 | >0.99 |\n| Partitions: 번호/지름 | 2.3.S.7 안정성(제품명, 제조자) …………………………………………………………… 11 | 시험 | 신청인이 그 조성을 알 수 없을 경우에는 원료 제조원에서 직접 심사 부서에 제출할 수 있다.  | . ",
        "original_sentence": "| 용해도가 높다. "
      }
    },
    {
      "chunk_id": "chunk_072",
      "text": "| drum | 003 | 12 개월간 안정 |\n| UV (단파장/ 장파장), 7 일 | 27% | >0.99 | 경우 시험방법 밸리데이션 및 사용 등급을 표시한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 71,
        "window_size": 3,
        "char_count": 93,
        "word_count": 27,
        "page_number": 5,
        "window_text": "신청한 용기 및 포장은 기밀용기에 해당하는 USP <671> 요건을 충족한다 | RC3 | 유연물질명 | 제조번호 P034 | 여부 | 공정변수 | 설정값 | 사유 | RC3: 0.25 % 이하 | 주성분 ○○ | 7” Wurster | 18” Wurster | 이상 없음 | RC2: 35% | RC3: 0.10 % |\n| 및 포장을 참고한다.  | 원료의약품의 분해는 관찰되지 않았으며 상호작용은 없는 것으로 판단된다.  | 용해도가 높다.  | drum | 003 | 12 개월간 안정 |\n| UV (단파장/ 장파장), 7 일 | 27% | >0.99 | 경우 시험방법 밸리데이션 및 사용 등급을 표시한다.  | 함량 (90-110%) | 유연물질 2 | USP | 정제수2 | 용매 | 시점 (개월) | (제조번호 | 기준 | 판정 | >0.99 |\n| Partitions: 번호/지름 | 2.3.S.7 안정성(제품명, 제조자) …………………………………………………………… 11 | 시험 | 신청인이 그 조성을 알 수 없을 경우에는 원료 제조원에서 직접 심사 부서에 제출할 수 있다.  | .  시험방법 밸리데이션 자료 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등(이 | 유연물질 E: 1.0% 이하 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | 분무 속도 | 10 mL/분 | 70 mL/분 | 시험 결과 | 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 | 결합제 ○○ | 1/89 mm | 1/219 mm | 98.7-101.5% 범위 내에 | 0.4% | □ 예 | ■ 아니오 |\n| zation/epimerization). ",
        "original_sentence": "| drum | 003 | 12 개월간 안정 |\n| UV (단파장/ 장파장), 7 일 | 27% | >0.99 | 경우 시험방법 밸리데이션 및 사용 등급을 표시한다. "
      }
    },
    {
      "chunk_id": "chunk_073",
      "text": "| 함량 (90-110%) | 유연물질 2 | USP | 정제수2 | 용매 | 시점 (개월) | (제조번호 | 기준 | 판정 | >0.99 |\n| Partitions: 번호/지름 | 2.3.S.7 안정성(제품명, 제조자) …………………………………………………………… 11 | 시험 | 신청인이 그 조성을 알 수 없을 경우에는 원료 제조원에서 직접 심사 부서에 제출할 수 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 72,
        "window_size": 3,
        "char_count": 210,
        "word_count": 51,
        "page_number": 5,
        "window_text": "| 원료의약품의 분해는 관찰되지 않았으며 상호작용은 없는 것으로 판단된다.  | 용해도가 높다.  | drum | 003 | 12 개월간 안정 |\n| UV (단파장/ 장파장), 7 일 | 27% | >0.99 | 경우 시험방법 밸리데이션 및 사용 등급을 표시한다.  | 함량 (90-110%) | 유연물질 2 | USP | 정제수2 | 용매 | 시점 (개월) | (제조번호 | 기준 | 판정 | >0.99 |\n| Partitions: 번호/지름 | 2.3.S.7 안정성(제품명, 제조자) …………………………………………………………… 11 | 시험 | 신청인이 그 조성을 알 수 없을 경우에는 원료 제조원에서 직접 심사 부서에 제출할 수 있다.  | .  시험방법 밸리데이션 자료 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등(이 | 유연물질 E: 1.0% 이하 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | 분무 속도 | 10 mL/분 | 70 mL/분 | 시험 결과 | 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 | 결합제 ○○ | 1/89 mm | 1/219 mm | 98.7-101.5% 범위 내에 | 0.4% | □ 예 | ■ 아니오 |\n| zation/epimerization).  | (3.2.P.2.4 용기 및 포장 참조). ",
        "original_sentence": "| 함량 (90-110%) | 유연물질 2 | USP | 정제수2 | 용매 | 시점 (개월) | (제조번호 | 기준 | 판정 | >0.99 |\n| Partitions: 번호/지름 | 2.3.S.7 안정성(제품명, 제조자) …………………………………………………………… 11 | 시험 | 신청인이 그 조성을 알 수 없을 경우에는 원료 제조원에서 직접 심사 부서에 제출할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_074",
      "text": "| . ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 73,
        "window_size": 3,
        "char_count": 4,
        "word_count": 2,
        "page_number": 1,
        "window_text": "| 용해도가 높다.  | drum | 003 | 12 개월간 안정 |\n| UV (단파장/ 장파장), 7 일 | 27% | >0.99 | 경우 시험방법 밸리데이션 및 사용 등급을 표시한다.  | 함량 (90-110%) | 유연물질 2 | USP | 정제수2 | 용매 | 시점 (개월) | (제조번호 | 기준 | 판정 | >0.99 |\n| Partitions: 번호/지름 | 2.3.S.7 안정성(제품명, 제조자) …………………………………………………………… 11 | 시험 | 신청인이 그 조성을 알 수 없을 경우에는 원료 제조원에서 직접 심사 부서에 제출할 수 있다.  | .  시험방법 밸리데이션 자료 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등(이 | 유연물질 E: 1.0% 이하 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | 분무 속도 | 10 mL/분 | 70 mL/분 | 시험 결과 | 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 | 결합제 ○○ | 1/89 mm | 1/219 mm | 98.7-101.5% 범위 내에 | 0.4% | □ 예 | ■ 아니오 |\n| zation/epimerization).  | (3.2.P.2.4 용기 및 포장 참조).  | 미지유연물질 | 정확성 | 95-104 % | 80-97 % | 88-105 % | 92-112 % | 80-101 % | 82-115 % | 공정변수 | 설정값 | 사유 | 유연물질A: 0.5 % 이하 | 미지유연물질: 각 0.10 % 이하 | 구형 백당의 적절한 유동화 상태를 위한 범위 | RC3: 30% | 0.05 % | 수분함량이 증가하는 | 0.20 % | 뱃치 결과 |\n| 충족시켜야 한다. ",
        "original_sentence": "| . "
      }
    },
    {
      "chunk_id": "chunk_075",
      "text": "시험방법 밸리데이션 자료 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등(이 | 유연물질 E: 1.0% 이하 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | 분무 속도 | 10 mL/분 | 70 mL/분 | 시험 결과 | 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 | 결합제 ○○ | 1/89 mm | 1/219 mm | 98.7-101.5% 범위 내에 | 0.4% | □ 예 | ■ 아니오 |\n| zation/epimerization). ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 74,
        "window_size": 3,
        "char_count": 276,
        "word_count": 71,
        "page_number": 3,
        "window_text": "| drum | 003 | 12 개월간 안정 |\n| UV (단파장/ 장파장), 7 일 | 27% | >0.99 | 경우 시험방법 밸리데이션 및 사용 등급을 표시한다.  | 함량 (90-110%) | 유연물질 2 | USP | 정제수2 | 용매 | 시점 (개월) | (제조번호 | 기준 | 판정 | >0.99 |\n| Partitions: 번호/지름 | 2.3.S.7 안정성(제품명, 제조자) …………………………………………………………… 11 | 시험 | 신청인이 그 조성을 알 수 없을 경우에는 원료 제조원에서 직접 심사 부서에 제출할 수 있다.  | .  시험방법 밸리데이션 자료 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등(이 | 유연물질 E: 1.0% 이하 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | 분무 속도 | 10 mL/분 | 70 mL/분 | 시험 결과 | 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 | 결합제 ○○ | 1/89 mm | 1/219 mm | 98.7-101.5% 범위 내에 | 0.4% | □ 예 | ■ 아니오 |\n| zation/epimerization).  | (3.2.P.2.4 용기 및 포장 참조).  | 미지유연물질 | 정확성 | 95-104 % | 80-97 % | 88-105 % | 92-112 % | 80-101 % | 82-115 % | 공정변수 | 설정값 | 사유 | 유연물질A: 0.5 % 이하 | 미지유연물질: 각 0.10 % 이하 | 구형 백당의 적절한 유동화 상태를 위한 범위 | RC3: 30% | 0.05 % | 수분함량이 증가하는 | 0.20 % | 뱃치 결과 |\n| 충족시켜야 한다.  | 0 | 3 | 6 | 9 | 12 | 15 | 18 | 24 | 36 | 98-102.1% 범위 내에 있음 | #22242) | 자사 시험방법 #231b (HPLC) |\n| 시험항목 | 허용 기준 | 시험 방법 | 잔류용매 기준을 설정한다. ",
        "original_sentence": "시험방법 밸리데이션 자료 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등(이 | 유연물질 E: 1.0% 이하 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | 분무 속도 | 10 mL/분 | 70 mL/분 | 시험 결과 | 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 | 결합제 ○○ | 1/89 mm | 1/219 mm | 98.7-101.5% 범위 내에 | 0.4% | □ 예 | ■ 아니오 |\n| zation/epimerization). "
      }
    },
    {
      "chunk_id": "chunk_076",
      "text": "| (3.2.P.2.4 용기 및 포장 참조). ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 75,
        "window_size": 3,
        "char_count": 26,
        "word_count": 6,
        "page_number": 5,
        "window_text": "| 함량 (90-110%) | 유연물질 2 | USP | 정제수2 | 용매 | 시점 (개월) | (제조번호 | 기준 | 판정 | >0.99 |\n| Partitions: 번호/지름 | 2.3.S.7 안정성(제품명, 제조자) …………………………………………………………… 11 | 시험 | 신청인이 그 조성을 알 수 없을 경우에는 원료 제조원에서 직접 심사 부서에 제출할 수 있다.  | .  시험방법 밸리데이션 자료 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등(이 | 유연물질 E: 1.0% 이하 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | 분무 속도 | 10 mL/분 | 70 mL/분 | 시험 결과 | 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 | 결합제 ○○ | 1/89 mm | 1/219 mm | 98.7-101.5% 범위 내에 | 0.4% | □ 예 | ■ 아니오 |\n| zation/epimerization).  | (3.2.P.2.4 용기 및 포장 참조).  | 미지유연물질 | 정확성 | 95-104 % | 80-97 % | 88-105 % | 92-112 % | 80-101 % | 82-115 % | 공정변수 | 설정값 | 사유 | 유연물질A: 0.5 % 이하 | 미지유연물질: 각 0.10 % 이하 | 구형 백당의 적절한 유동화 상태를 위한 범위 | RC3: 30% | 0.05 % | 수분함량이 증가하는 | 0.20 % | 뱃치 결과 |\n| 충족시켜야 한다.  | 0 | 3 | 6 | 9 | 12 | 15 | 18 | 24 | 36 | 98-102.1% 범위 내에 있음 | #22242) | 자사 시험방법 #231b (HPLC) |\n| 시험항목 | 허용 기준 | 시험 방법 | 잔류용매 기준을 설정한다.  | 총 질량 (방출제어 펠렛) | 216.0 | 중요한 특성(예: 원료의약품의 결정형 등)이 변화할 가능성이 있는 경우 이를 포함한다. ",
        "original_sentence": "| (3.2.P.2.4 용기 및 포장 참조). "
      }
    },
    {
      "chunk_id": "chunk_077",
      "text": "| 미지유연물질 | 정확성 | 95-104 % | 80-97 % | 88-105 % | 92-112 % | 80-101 % | 82-115 % | 공정변수 | 설정값 | 사유 | 유연물질A: 0.5 % 이하 | 미지유연물질: 각 0.10 % 이하 | 구형 백당의 적절한 유동화 상태를 위한 범위 | RC3: 30% | 0.05 % | 수분함량이 증가하는 | 0.20 % | 뱃치 결과 |\n| 충족시켜야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 76,
        "window_size": 3,
        "char_count": 229,
        "word_count": 66,
        "page_number": 5,
        "window_text": "| .  시험방법 밸리데이션 자료 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등(이 | 유연물질 E: 1.0% 이하 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | 분무 속도 | 10 mL/분 | 70 mL/분 | 시험 결과 | 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 | 결합제 ○○ | 1/89 mm | 1/219 mm | 98.7-101.5% 범위 내에 | 0.4% | □ 예 | ■ 아니오 |\n| zation/epimerization).  | (3.2.P.2.4 용기 및 포장 참조).  | 미지유연물질 | 정확성 | 95-104 % | 80-97 % | 88-105 % | 92-112 % | 80-101 % | 82-115 % | 공정변수 | 설정값 | 사유 | 유연물질A: 0.5 % 이하 | 미지유연물질: 각 0.10 % 이하 | 구형 백당의 적절한 유동화 상태를 위한 범위 | RC3: 30% | 0.05 % | 수분함량이 증가하는 | 0.20 % | 뱃치 결과 |\n| 충족시켜야 한다.  | 0 | 3 | 6 | 9 | 12 | 15 | 18 | 24 | 36 | 98-102.1% 범위 내에 있음 | #22242) | 자사 시험방법 #231b (HPLC) |\n| 시험항목 | 허용 기준 | 시험 방법 | 잔류용매 기준을 설정한다.  | 총 질량 (방출제어 펠렛) | 216.0 | 중요한 특성(예: 원료의약품의 결정형 등)이 변화할 가능성이 있는 경우 이를 포함한다.  | 시험 항목 | 시험법 | 허용기준 | 시험결과(제조번호) | 부형제 ○○ | Polyethylene | 001 | 있음 |\n| 건열, 105 ℃, 14 시간 | 97% | >0.99 | NA | >0.99 | 분무 Gun의 번호 | . ",
        "original_sentence": "| 미지유연물질 | 정확성 | 95-104 % | 80-97 % | 88-105 % | 92-112 % | 80-101 % | 82-115 % | 공정변수 | 설정값 | 사유 | 유연물질A: 0.5 % 이하 | 미지유연물질: 각 0.10 % 이하 | 구형 백당의 적절한 유동화 상태를 위한 범위 | RC3: 30% | 0.05 % | 수분함량이 증가하는 | 0.20 % | 뱃치 결과 |\n| 충족시켜야 한다. "
      }
    },
    {
      "chunk_id": "chunk_078",
      "text": "| 0 | 3 | 6 | 9 | 12 | 15 | 18 | 24 | 36 | 98-102.1% 범위 내에 있음 | #22242) | 자사 시험방법 #231b (HPLC) |\n| 시험항목 | 허용 기준 | 시험 방법 | 잔류용매 기준을 설정한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 77,
        "window_size": 3,
        "char_count": 137,
        "word_count": 43,
        "page_number": 5,
        "window_text": "시험방법 밸리데이션 자료 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등(이 | 유연물질 E: 1.0% 이하 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | 분무 속도 | 10 mL/분 | 70 mL/분 | 시험 결과 | 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 | 결합제 ○○ | 1/89 mm | 1/219 mm | 98.7-101.5% 범위 내에 | 0.4% | □ 예 | ■ 아니오 |\n| zation/epimerization).  | (3.2.P.2.4 용기 및 포장 참조).  | 미지유연물질 | 정확성 | 95-104 % | 80-97 % | 88-105 % | 92-112 % | 80-101 % | 82-115 % | 공정변수 | 설정값 | 사유 | 유연물질A: 0.5 % 이하 | 미지유연물질: 각 0.10 % 이하 | 구형 백당의 적절한 유동화 상태를 위한 범위 | RC3: 30% | 0.05 % | 수분함량이 증가하는 | 0.20 % | 뱃치 결과 |\n| 충족시켜야 한다.  | 0 | 3 | 6 | 9 | 12 | 15 | 18 | 24 | 36 | 98-102.1% 범위 내에 있음 | #22242) | 자사 시험방법 #231b (HPLC) |\n| 시험항목 | 허용 기준 | 시험 방법 | 잔류용매 기준을 설정한다.  | 총 질량 (방출제어 펠렛) | 216.0 | 중요한 특성(예: 원료의약품의 결정형 등)이 변화할 가능성이 있는 경우 이를 포함한다.  | 시험 항목 | 시험법 | 허용기준 | 시험결과(제조번호) | 부형제 ○○ | Polyethylene | 001 | 있음 |\n| 건열, 105 ℃, 14 시간 | 97% | >0.99 | NA | >0.99 | 분무 Gun의 번호 | .  표준품에 관한 자료 | 총 유연물질 | 정보는 3.2.P.2.3 제조공정 개발을 참조한다. ",
        "original_sentence": "| 0 | 3 | 6 | 9 | 12 | 15 | 18 | 24 | 36 | 98-102.1% 범위 내에 있음 | #22242) | 자사 시험방법 #231b (HPLC) |\n| 시험항목 | 허용 기준 | 시험 방법 | 잔류용매 기준을 설정한다. "
      }
    },
    {
      "chunk_id": "chunk_079",
      "text": "| 총 질량 (방출제어 펠렛) | 216.0 | 중요한 특성(예: 원료의약품의 결정형 등)이 변화할 가능성이 있는 경우 이를 포함한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 78,
        "window_size": 3,
        "char_count": 76,
        "word_count": 19,
        "page_number": 5,
        "window_text": "| (3.2.P.2.4 용기 및 포장 참조).  | 미지유연물질 | 정확성 | 95-104 % | 80-97 % | 88-105 % | 92-112 % | 80-101 % | 82-115 % | 공정변수 | 설정값 | 사유 | 유연물질A: 0.5 % 이하 | 미지유연물질: 각 0.10 % 이하 | 구형 백당의 적절한 유동화 상태를 위한 범위 | RC3: 30% | 0.05 % | 수분함량이 증가하는 | 0.20 % | 뱃치 결과 |\n| 충족시켜야 한다.  | 0 | 3 | 6 | 9 | 12 | 15 | 18 | 24 | 36 | 98-102.1% 범위 내에 있음 | #22242) | 자사 시험방법 #231b (HPLC) |\n| 시험항목 | 허용 기준 | 시험 방법 | 잔류용매 기준을 설정한다.  | 총 질량 (방출제어 펠렛) | 216.0 | 중요한 특성(예: 원료의약품의 결정형 등)이 변화할 가능성이 있는 경우 이를 포함한다.  | 시험 항목 | 시험법 | 허용기준 | 시험결과(제조번호) | 부형제 ○○ | Polyethylene | 001 | 있음 |\n| 건열, 105 ℃, 14 시간 | 97% | >0.99 | NA | >0.99 | 분무 Gun의 번호 | .  표준품에 관한 자료 | 총 유연물질 | 정보는 3.2.P.2.3 제조공정 개발을 참조한다.  | 수분함량 ... 인 것을, 스테아르산마그네슘은 입도 ... 을 사용하였다. ",
        "original_sentence": "| 총 질량 (방출제어 펠렛) | 216.0 | 중요한 특성(예: 원료의약품의 결정형 등)이 변화할 가능성이 있는 경우 이를 포함한다. "
      }
    },
    {
      "chunk_id": "chunk_080",
      "text": "| 시험 항목 | 시험법 | 허용기준 | 시험결과(제조번호) | 부형제 ○○ | Polyethylene | 001 | 있음 |\n| 건열, 105 ℃, 14 시간 | 97% | >0.99 | NA | >0.99 | 분무 Gun의 번호 | . ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 79,
        "window_size": 3,
        "char_count": 134,
        "word_count": 39,
        "page_number": 14,
        "window_text": "| 미지유연물질 | 정확성 | 95-104 % | 80-97 % | 88-105 % | 92-112 % | 80-101 % | 82-115 % | 공정변수 | 설정값 | 사유 | 유연물질A: 0.5 % 이하 | 미지유연물질: 각 0.10 % 이하 | 구형 백당의 적절한 유동화 상태를 위한 범위 | RC3: 30% | 0.05 % | 수분함량이 증가하는 | 0.20 % | 뱃치 결과 |\n| 충족시켜야 한다.  | 0 | 3 | 6 | 9 | 12 | 15 | 18 | 24 | 36 | 98-102.1% 범위 내에 있음 | #22242) | 자사 시험방법 #231b (HPLC) |\n| 시험항목 | 허용 기준 | 시험 방법 | 잔류용매 기준을 설정한다.  | 총 질량 (방출제어 펠렛) | 216.0 | 중요한 특성(예: 원료의약품의 결정형 등)이 변화할 가능성이 있는 경우 이를 포함한다.  | 시험 항목 | 시험법 | 허용기준 | 시험결과(제조번호) | 부형제 ○○ | Polyethylene | 001 | 있음 |\n| 건열, 105 ℃, 14 시간 | 97% | >0.99 | NA | >0.99 | 분무 Gun의 번호 | .  표준품에 관한 자료 | 총 유연물질 | 정보는 3.2.P.2.3 제조공정 개발을 참조한다.  | 수분함량 ... 인 것을, 스테아르산마그네슘은 입도 ... 을 사용하였다.  | 하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한 사 | 미지 유연물질: 0.2% 이하 | 서방 코팅액 농도 | 10% | 30% | <대조약 용출 양상 (USP Apparatus 1, 100 rpm, 37 ℃)> | 유연물질B: 0.15 % 이하 | 내용입니까? ",
        "original_sentence": "| 시험 항목 | 시험법 | 허용기준 | 시험결과(제조번호) | 부형제 ○○ | Polyethylene | 001 | 있음 |\n| 건열, 105 ℃, 14 시간 | 97% | >0.99 | NA | >0.99 | 분무 Gun의 번호 | . "
      }
    },
    {
      "chunk_id": "chunk_081",
      "text": "표준품에 관한 자료 | 총 유연물질 | 정보는 3.2.P.2.3 제조공정 개발을 참조한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 80,
        "window_size": 3,
        "char_count": 51,
        "word_count": 12,
        "page_number": 5,
        "window_text": "| 0 | 3 | 6 | 9 | 12 | 15 | 18 | 24 | 36 | 98-102.1% 범위 내에 있음 | #22242) | 자사 시험방법 #231b (HPLC) |\n| 시험항목 | 허용 기준 | 시험 방법 | 잔류용매 기준을 설정한다.  | 총 질량 (방출제어 펠렛) | 216.0 | 중요한 특성(예: 원료의약품의 결정형 등)이 변화할 가능성이 있는 경우 이를 포함한다.  | 시험 항목 | 시험법 | 허용기준 | 시험결과(제조번호) | 부형제 ○○ | Polyethylene | 001 | 있음 |\n| 건열, 105 ℃, 14 시간 | 97% | >0.99 | NA | >0.99 | 분무 Gun의 번호 | .  표준품에 관한 자료 | 총 유연물질 | 정보는 3.2.P.2.3 제조공정 개발을 참조한다.  | 수분함량 ... 인 것을, 스테아르산마그네슘은 입도 ... 을 사용하였다.  | 하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한 사 | 미지 유연물질: 0.2% 이하 | 서방 코팅액 농도 | 10% | 30% | <대조약 용출 양상 (USP Apparatus 1, 100 rpm, 37 ℃)> | 유연물질B: 0.15 % 이하 | 내용입니까?  | 총 유연물질: 0.75 % 이하 | 간에 방해가 없음 | 80 ~ 100 | 1 | (동일한 크기 분포 및 다공성을 갖는 구형 백당에 약물을 | 1 | 시험 결과 | 0.30 % | 양상이나, 기준 내 | 0.10 % | 주성분 제조원4) | 0.07% |\n| 최적 범위보다 낮거나 높은 경우에는 유동화 패턴이 나 | (제조번호 9A) |\n| 유연물질명 | 설정 기준 | 판정기준 | 엔도톡신 | O | O | O | O | 유동화 기체 부피 | 속방(Immediate Release, IR) 펠렛 | 예 시 | 가속시험 | 40℃/75% RH | 유연물질 A | 0.80% | 1.5% | 1.5% 이하 | 대사산물에 해당 | 정량한계 | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 활택제 ○○ | Bag, Fiber | 개발 뱃치 | 허가제출용 뱃치 | 실생산 뱃치 | 002 | 0, 3, 6 |\n| 한다. ",
        "original_sentence": "표준품에 관한 자료 | 총 유연물질 | 정보는 3.2.P.2.3 제조공정 개발을 참조한다. "
      }
    },
    {
      "chunk_id": "chunk_082",
      "text": "| 수분함량 ... 인 것을, 스테아르산마그네슘은 입도 ... 을 사용하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 81,
        "window_size": 3,
        "char_count": 44,
        "word_count": 10,
        "page_number": 14,
        "window_text": "| 총 질량 (방출제어 펠렛) | 216.0 | 중요한 특성(예: 원료의약품의 결정형 등)이 변화할 가능성이 있는 경우 이를 포함한다.  | 시험 항목 | 시험법 | 허용기준 | 시험결과(제조번호) | 부형제 ○○ | Polyethylene | 001 | 있음 |\n| 건열, 105 ℃, 14 시간 | 97% | >0.99 | NA | >0.99 | 분무 Gun의 번호 | .  표준품에 관한 자료 | 총 유연물질 | 정보는 3.2.P.2.3 제조공정 개발을 참조한다.  | 수분함량 ... 인 것을, 스테아르산마그네슘은 입도 ... 을 사용하였다.  | 하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한 사 | 미지 유연물질: 0.2% 이하 | 서방 코팅액 농도 | 10% | 30% | <대조약 용출 양상 (USP Apparatus 1, 100 rpm, 37 ℃)> | 유연물질B: 0.15 % 이하 | 내용입니까?  | 총 유연물질: 0.75 % 이하 | 간에 방해가 없음 | 80 ~ 100 | 1 | (동일한 크기 분포 및 다공성을 갖는 구형 백당에 약물을 | 1 | 시험 결과 | 0.30 % | 양상이나, 기준 내 | 0.10 % | 주성분 제조원4) | 0.07% |\n| 최적 범위보다 낮거나 높은 경우에는 유동화 패턴이 나 | (제조번호 9A) |\n| 유연물질명 | 설정 기준 | 판정기준 | 엔도톡신 | O | O | O | O | 유동화 기체 부피 | 속방(Immediate Release, IR) 펠렛 | 예 시 | 가속시험 | 40℃/75% RH | 유연물질 A | 0.80% | 1.5% | 1.5% 이하 | 대사산물에 해당 | 정량한계 | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 활택제 ○○ | Bag, Fiber | 개발 뱃치 | 허가제출용 뱃치 | 실생산 뱃치 | 002 | 0, 3, 6 |\n| 한다.  | 예상되는 확인시험과 함량균일성시험은 제외하였다. ",
        "original_sentence": "| 수분함량 ... 인 것을, 스테아르산마그네슘은 입도 ... 을 사용하였다. "
      }
    },
    {
      "chunk_id": "chunk_083",
      "text": "| 하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한 사 | 미지 유연물질: 0.2% 이하 | 서방 코팅액 농도 | 10% | 30% | <대조약 용출 양상 (USP Apparatus 1, 100 rpm, 37 ℃)> | 유연물질B: 0.15 % 이하 | 내용입니까? ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 82,
        "window_size": 3,
        "char_count": 158,
        "word_count": 41,
        "page_number": 3,
        "window_text": "| 시험 항목 | 시험법 | 허용기준 | 시험결과(제조번호) | 부형제 ○○ | Polyethylene | 001 | 있음 |\n| 건열, 105 ℃, 14 시간 | 97% | >0.99 | NA | >0.99 | 분무 Gun의 번호 | .  표준품에 관한 자료 | 총 유연물질 | 정보는 3.2.P.2.3 제조공정 개발을 참조한다.  | 수분함량 ... 인 것을, 스테아르산마그네슘은 입도 ... 을 사용하였다.  | 하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한 사 | 미지 유연물질: 0.2% 이하 | 서방 코팅액 농도 | 10% | 30% | <대조약 용출 양상 (USP Apparatus 1, 100 rpm, 37 ℃)> | 유연물질B: 0.15 % 이하 | 내용입니까?  | 총 유연물질: 0.75 % 이하 | 간에 방해가 없음 | 80 ~ 100 | 1 | (동일한 크기 분포 및 다공성을 갖는 구형 백당에 약물을 | 1 | 시험 결과 | 0.30 % | 양상이나, 기준 내 | 0.10 % | 주성분 제조원4) | 0.07% |\n| 최적 범위보다 낮거나 높은 경우에는 유동화 패턴이 나 | (제조번호 9A) |\n| 유연물질명 | 설정 기준 | 판정기준 | 엔도톡신 | O | O | O | O | 유동화 기체 부피 | 속방(Immediate Release, IR) 펠렛 | 예 시 | 가속시험 | 40℃/75% RH | 유연물질 A | 0.80% | 1.5% | 1.5% 이하 | 대사산물에 해당 | 정량한계 | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 활택제 ○○ | Bag, Fiber | 개발 뱃치 | 허가제출용 뱃치 | 실생산 뱃치 | 002 | 0, 3, 6 |\n| 한다.  | 예상되는 확인시험과 함량균일성시험은 제외하였다.  | 엔도톡신 (해당하는 경우) | 유동화 기체 부피 | 90~110 m3/시간 | 총 유연물질: 2.5% 이하 | □ 외국 규정을 번역하거나 설명하는 내용입니까? ",
        "original_sentence": "| 하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한 사 | 미지 유연물질: 0.2% 이하 | 서방 코팅액 농도 | 10% | 30% | <대조약 용출 양상 (USP Apparatus 1, 100 rpm, 37 ℃)> | 유연물질B: 0.15 % 이하 | 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_084",
      "text": "| 총 유연물질: 0.75 % 이하 | 간에 방해가 없음 | 80 ~ 100 | 1 | (동일한 크기 분포 및 다공성을 갖는 구형 백당에 약물을 | 1 | 시험 결과 | 0.30 % | 양상이나, 기준 내 | 0.10 % | 주성분 제조원4) | 0.07% |\n| 최적 범위보다 낮거나 높은 경우에는 유동화 패턴이 나 | (제조번호 9A) |\n| 유연물질명 | 설정 기준 | 판정기준 | 엔도톡신 | O | O | O | O | 유동화 기체 부피 | 속방(Immediate Release, IR) 펠렛 | 예 시 | 가속시험 | 40℃/75% RH | 유연물질 A | 0.80% | 1.5% | 1.5% 이하 | 대사산물에 해당 | 정량한계 | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 활택제 ○○ | Bag, Fiber | 개발 뱃치 | 허가제출용 뱃치 | 실생산 뱃치 | 002 | 0, 3, 6 |\n| 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 83,
        "window_size": 3,
        "char_count": 487,
        "word_count": 151,
        "page_number": 3,
        "window_text": "표준품에 관한 자료 | 총 유연물질 | 정보는 3.2.P.2.3 제조공정 개발을 참조한다.  | 수분함량 ... 인 것을, 스테아르산마그네슘은 입도 ... 을 사용하였다.  | 하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한 사 | 미지 유연물질: 0.2% 이하 | 서방 코팅액 농도 | 10% | 30% | <대조약 용출 양상 (USP Apparatus 1, 100 rpm, 37 ℃)> | 유연물질B: 0.15 % 이하 | 내용입니까?  | 총 유연물질: 0.75 % 이하 | 간에 방해가 없음 | 80 ~ 100 | 1 | (동일한 크기 분포 및 다공성을 갖는 구형 백당에 약물을 | 1 | 시험 결과 | 0.30 % | 양상이나, 기준 내 | 0.10 % | 주성분 제조원4) | 0.07% |\n| 최적 범위보다 낮거나 높은 경우에는 유동화 패턴이 나 | (제조번호 9A) |\n| 유연물질명 | 설정 기준 | 판정기준 | 엔도톡신 | O | O | O | O | 유동화 기체 부피 | 속방(Immediate Release, IR) 펠렛 | 예 시 | 가속시험 | 40℃/75% RH | 유연물질 A | 0.80% | 1.5% | 1.5% 이하 | 대사산물에 해당 | 정량한계 | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 활택제 ○○ | Bag, Fiber | 개발 뱃치 | 허가제출용 뱃치 | 실생산 뱃치 | 002 | 0, 3, 6 |\n| 한다.  | 예상되는 확인시험과 함량균일성시험은 제외하였다.  | 엔도톡신 (해당하는 경우) | 유동화 기체 부피 | 90~110 m3/시간 | 총 유연물질: 2.5% 이하 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | m3/시간 | 코팅하는 유사한 제품에서의 사전 지식 및 실험실 규모에 | 이상 없음 | 40 kg | 적합하므로 가속조건에서 6 | 이상 없음 | 1.5% |\n| 첨가제 참조)에 근거한 것이다. ",
        "original_sentence": "| 총 유연물질: 0.75 % 이하 | 간에 방해가 없음 | 80 ~ 100 | 1 | (동일한 크기 분포 및 다공성을 갖는 구형 백당에 약물을 | 1 | 시험 결과 | 0.30 % | 양상이나, 기준 내 | 0.10 % | 주성분 제조원4) | 0.07% |\n| 최적 범위보다 낮거나 높은 경우에는 유동화 패턴이 나 | (제조번호 9A) |\n| 유연물질명 | 설정 기준 | 판정기준 | 엔도톡신 | O | O | O | O | 유동화 기체 부피 | 속방(Immediate Release, IR) 펠렛 | 예 시 | 가속시험 | 40℃/75% RH | 유연물질 A | 0.80% | 1.5% | 1.5% 이하 | 대사산물에 해당 | 정량한계 | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 활택제 ○○ | Bag, Fiber | 개발 뱃치 | 허가제출용 뱃치 | 실생산 뱃치 | 002 | 0, 3, 6 |\n| 한다. "
      }
    },
    {
      "chunk_id": "chunk_085",
      "text": "| 예상되는 확인시험과 함량균일성시험은 제외하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 84,
        "window_size": 3,
        "char_count": 29,
        "word_count": 5,
        "page_number": 14,
        "window_text": "| 수분함량 ... 인 것을, 스테아르산마그네슘은 입도 ... 을 사용하였다.  | 하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한 사 | 미지 유연물질: 0.2% 이하 | 서방 코팅액 농도 | 10% | 30% | <대조약 용출 양상 (USP Apparatus 1, 100 rpm, 37 ℃)> | 유연물질B: 0.15 % 이하 | 내용입니까?  | 총 유연물질: 0.75 % 이하 | 간에 방해가 없음 | 80 ~ 100 | 1 | (동일한 크기 분포 및 다공성을 갖는 구형 백당에 약물을 | 1 | 시험 결과 | 0.30 % | 양상이나, 기준 내 | 0.10 % | 주성분 제조원4) | 0.07% |\n| 최적 범위보다 낮거나 높은 경우에는 유동화 패턴이 나 | (제조번호 9A) |\n| 유연물질명 | 설정 기준 | 판정기준 | 엔도톡신 | O | O | O | O | 유동화 기체 부피 | 속방(Immediate Release, IR) 펠렛 | 예 시 | 가속시험 | 40℃/75% RH | 유연물질 A | 0.80% | 1.5% | 1.5% 이하 | 대사산물에 해당 | 정량한계 | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 활택제 ○○ | Bag, Fiber | 개발 뱃치 | 허가제출용 뱃치 | 실생산 뱃치 | 002 | 0, 3, 6 |\n| 한다.  | 예상되는 확인시험과 함량균일성시험은 제외하였다.  | 엔도톡신 (해당하는 경우) | 유동화 기체 부피 | 90~110 m3/시간 | 총 유연물질: 2.5% 이하 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | m3/시간 | 코팅하는 유사한 제품에서의 사전 지식 및 실험실 규모에 | 이상 없음 | 40 kg | 적합하므로 가속조건에서 6 | 이상 없음 | 1.5% |\n| 첨가제 참조)에 근거한 것이다.  | 안에 대하여 식품의약품안전처의 입장을 기술하는 것 | 방울 크기 | 5 μm | 70 μm | 유연물질C: 0.15 % 이하 | 피크 순도(PDA)>0.99 | 빠져서 낮은 코팅 효율성을 초래할 수 있음 | (제조번호 #9A) | 0.09 % |\n| 뱃치크기1 | 3 kg | 무균 | O | O | 특성들을 갖도록 할 필요가 있다. ",
        "original_sentence": "| 예상되는 확인시험과 함량균일성시험은 제외하였다. "
      }
    },
    {
      "chunk_id": "chunk_086",
      "text": "| 엔도톡신 (해당하는 경우) | 유동화 기체 부피 | 90~110 m3/시간 | 총 유연물질: 2.5% 이하 | □ 외국 규정을 번역하거나 설명하는 내용입니까? ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 85,
        "window_size": 3,
        "char_count": 91,
        "word_count": 23,
        "page_number": 5,
        "window_text": "| 하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한 사 | 미지 유연물질: 0.2% 이하 | 서방 코팅액 농도 | 10% | 30% | <대조약 용출 양상 (USP Apparatus 1, 100 rpm, 37 ℃)> | 유연물질B: 0.15 % 이하 | 내용입니까?  | 총 유연물질: 0.75 % 이하 | 간에 방해가 없음 | 80 ~ 100 | 1 | (동일한 크기 분포 및 다공성을 갖는 구형 백당에 약물을 | 1 | 시험 결과 | 0.30 % | 양상이나, 기준 내 | 0.10 % | 주성분 제조원4) | 0.07% |\n| 최적 범위보다 낮거나 높은 경우에는 유동화 패턴이 나 | (제조번호 9A) |\n| 유연물질명 | 설정 기준 | 판정기준 | 엔도톡신 | O | O | O | O | 유동화 기체 부피 | 속방(Immediate Release, IR) 펠렛 | 예 시 | 가속시험 | 40℃/75% RH | 유연물질 A | 0.80% | 1.5% | 1.5% 이하 | 대사산물에 해당 | 정량한계 | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 활택제 ○○ | Bag, Fiber | 개발 뱃치 | 허가제출용 뱃치 | 실생산 뱃치 | 002 | 0, 3, 6 |\n| 한다.  | 예상되는 확인시험과 함량균일성시험은 제외하였다.  | 엔도톡신 (해당하는 경우) | 유동화 기체 부피 | 90~110 m3/시간 | 총 유연물질: 2.5% 이하 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | m3/시간 | 코팅하는 유사한 제품에서의 사전 지식 및 실험실 규모에 | 이상 없음 | 40 kg | 적합하므로 가속조건에서 6 | 이상 없음 | 1.5% |\n| 첨가제 참조)에 근거한 것이다.  | 안에 대하여 식품의약품안전처의 입장을 기술하는 것 | 방울 크기 | 5 μm | 70 μm | 유연물질C: 0.15 % 이하 | 피크 순도(PDA)>0.99 | 빠져서 낮은 코팅 효율성을 초래할 수 있음 | (제조번호 #9A) | 0.09 % |\n| 뱃치크기1 | 3 kg | 무균 | O | O | 특성들을 갖도록 할 필요가 있다.  추가 정보는 3.2.P.2.2.1 제제 개발을 참조한다. ",
        "original_sentence": "| 엔도톡신 (해당하는 경우) | 유동화 기체 부피 | 90~110 m3/시간 | 총 유연물질: 2.5% 이하 | □ 외국 규정을 번역하거나 설명하는 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_087",
      "text": "| □ 예 | ■ 아니오 | m3/시간 | 코팅하는 유사한 제품에서의 사전 지식 및 실험실 규모에 | 이상 없음 | 40 kg | 적합하므로 가속조건에서 6 | 이상 없음 | 1.5% |\n| 첨가제 참조)에 근거한 것이다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 86,
        "window_size": 3,
        "char_count": 125,
        "word_count": 38,
        "page_number": 2,
        "window_text": "| 총 유연물질: 0.75 % 이하 | 간에 방해가 없음 | 80 ~ 100 | 1 | (동일한 크기 분포 및 다공성을 갖는 구형 백당에 약물을 | 1 | 시험 결과 | 0.30 % | 양상이나, 기준 내 | 0.10 % | 주성분 제조원4) | 0.07% |\n| 최적 범위보다 낮거나 높은 경우에는 유동화 패턴이 나 | (제조번호 9A) |\n| 유연물질명 | 설정 기준 | 판정기준 | 엔도톡신 | O | O | O | O | 유동화 기체 부피 | 속방(Immediate Release, IR) 펠렛 | 예 시 | 가속시험 | 40℃/75% RH | 유연물질 A | 0.80% | 1.5% | 1.5% 이하 | 대사산물에 해당 | 정량한계 | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % | 활택제 ○○ | Bag, Fiber | 개발 뱃치 | 허가제출용 뱃치 | 실생산 뱃치 | 002 | 0, 3, 6 |\n| 한다.  | 예상되는 확인시험과 함량균일성시험은 제외하였다.  | 엔도톡신 (해당하는 경우) | 유동화 기체 부피 | 90~110 m3/시간 | 총 유연물질: 2.5% 이하 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | m3/시간 | 코팅하는 유사한 제품에서의 사전 지식 및 실험실 규모에 | 이상 없음 | 40 kg | 적합하므로 가속조건에서 6 | 이상 없음 | 1.5% |\n| 첨가제 참조)에 근거한 것이다.  | 안에 대하여 식품의약품안전처의 입장을 기술하는 것 | 방울 크기 | 5 μm | 70 μm | 유연물질C: 0.15 % 이하 | 피크 순도(PDA)>0.99 | 빠져서 낮은 코팅 효율성을 초래할 수 있음 | (제조번호 #9A) | 0.09 % |\n| 뱃치크기1 | 3 kg | 무균 | O | O | 특성들을 갖도록 할 필요가 있다.  추가 정보는 3.2.P.2.2.1 제제 개발을 참조한다.  | 유연물질 RC 2 (0.5% 이하) | 결정형(XRD) | 2Ɵ 차이가 5 % 미만 | 시험방법 #47 | 1 % 미만 | 1 | 원료칭량 | 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인되 | 붕해제 ○○ | drum | 003 |\n| 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형) ……………………………………… 12 | Core | 유연물질 E | 0.40% | 1.0% | 1.0% 이하 | 대조약과 동등한 수준 | 어 있는 청색의 직사각형 정제 | 육안 검사 | 적합 | 2 kg, 1만정 | 48 kg, 23만정 | 480 kg, 230만정 | 서의 확증시험에 근거함) | 개월간 안정 |\n| 중 수행된 시험 및 그 결과 등이 포함될 수 있다. ",
        "original_sentence": "| □ 예 | ■ 아니오 | m3/시간 | 코팅하는 유사한 제품에서의 사전 지식 및 실험실 규모에 | 이상 없음 | 40 kg | 적합하므로 가속조건에서 6 | 이상 없음 | 1.5% |\n| 첨가제 참조)에 근거한 것이다. "
      }
    },
    {
      "chunk_id": "chunk_088",
      "text": "| 안에 대하여 식품의약품안전처의 입장을 기술하는 것 | 방울 크기 | 5 μm | 70 μm | 유연물질C: 0.15 % 이하 | 피크 순도(PDA)>0.99 | 빠져서 낮은 코팅 효율성을 초래할 수 있음 | (제조번호 #9A) | 0.09 % |\n| 뱃치크기1 | 3 kg | 무균 | O | O | 특성들을 갖도록 할 필요가 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 87,
        "window_size": 3,
        "char_count": 189,
        "word_count": 56,
        "page_number": 3,
        "window_text": "| 예상되는 확인시험과 함량균일성시험은 제외하였다.  | 엔도톡신 (해당하는 경우) | 유동화 기체 부피 | 90~110 m3/시간 | 총 유연물질: 2.5% 이하 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | m3/시간 | 코팅하는 유사한 제품에서의 사전 지식 및 실험실 규모에 | 이상 없음 | 40 kg | 적합하므로 가속조건에서 6 | 이상 없음 | 1.5% |\n| 첨가제 참조)에 근거한 것이다.  | 안에 대하여 식품의약품안전처의 입장을 기술하는 것 | 방울 크기 | 5 μm | 70 μm | 유연물질C: 0.15 % 이하 | 피크 순도(PDA)>0.99 | 빠져서 낮은 코팅 효율성을 초래할 수 있음 | (제조번호 #9A) | 0.09 % |\n| 뱃치크기1 | 3 kg | 무균 | O | O | 특성들을 갖도록 할 필요가 있다.  추가 정보는 3.2.P.2.2.1 제제 개발을 참조한다.  | 유연물질 RC 2 (0.5% 이하) | 결정형(XRD) | 2Ɵ 차이가 5 % 미만 | 시험방법 #47 | 1 % 미만 | 1 | 원료칭량 | 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인되 | 붕해제 ○○ | drum | 003 |\n| 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형) ……………………………………… 12 | Core | 유연물질 E | 0.40% | 1.0% | 1.0% 이하 | 대조약과 동등한 수준 | 어 있는 청색의 직사각형 정제 | 육안 검사 | 적합 | 2 kg, 1만정 | 48 kg, 23만정 | 480 kg, 230만정 | 서의 확증시험에 근거함) | 개월간 안정 |\n| 중 수행된 시험 및 그 결과 등이 포함될 수 있다.  | 예 시 | 시점 부근의 대조약 뱃치 분석결과 참조)인지 여부 | 무균 | 유연물질D: 0.15 % 이하 | 0.1-0.2% 범위 내에 있음 | (142,000 | 0.1-0.2% 범위 내에 있음 | 0.11 % | 생동시 |\n| RC2 | 0.5% 이하 | USP 기준 | 0.2% | 검출한계 | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | (10,700 단위) |\n| 예 시 | 유연물질 | 구형백당 | Base | 47.5 | 18-20 mesh | □ 정보제공 등 직원 교육용 자료입니까? ",
        "original_sentence": "| 안에 대하여 식품의약품안전처의 입장을 기술하는 것 | 방울 크기 | 5 μm | 70 μm | 유연물질C: 0.15 % 이하 | 피크 순도(PDA)>0.99 | 빠져서 낮은 코팅 효율성을 초래할 수 있음 | (제조번호 #9A) | 0.09 % |\n| 뱃치크기1 | 3 kg | 무균 | O | O | 특성들을 갖도록 할 필요가 있다. "
      }
    },
    {
      "chunk_id": "chunk_089",
      "text": "추가 정보는 3.2.P.2.2.1 제제 개발을 참조한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 88,
        "window_size": 3,
        "char_count": 32,
        "word_count": 6,
        "page_number": 5,
        "window_text": "| 엔도톡신 (해당하는 경우) | 유동화 기체 부피 | 90~110 m3/시간 | 총 유연물질: 2.5% 이하 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | m3/시간 | 코팅하는 유사한 제품에서의 사전 지식 및 실험실 규모에 | 이상 없음 | 40 kg | 적합하므로 가속조건에서 6 | 이상 없음 | 1.5% |\n| 첨가제 참조)에 근거한 것이다.  | 안에 대하여 식품의약품안전처의 입장을 기술하는 것 | 방울 크기 | 5 μm | 70 μm | 유연물질C: 0.15 % 이하 | 피크 순도(PDA)>0.99 | 빠져서 낮은 코팅 효율성을 초래할 수 있음 | (제조번호 #9A) | 0.09 % |\n| 뱃치크기1 | 3 kg | 무균 | O | O | 특성들을 갖도록 할 필요가 있다.  추가 정보는 3.2.P.2.2.1 제제 개발을 참조한다.  | 유연물질 RC 2 (0.5% 이하) | 결정형(XRD) | 2Ɵ 차이가 5 % 미만 | 시험방법 #47 | 1 % 미만 | 1 | 원료칭량 | 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인되 | 붕해제 ○○ | drum | 003 |\n| 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형) ……………………………………… 12 | Core | 유연물질 E | 0.40% | 1.0% | 1.0% 이하 | 대조약과 동등한 수준 | 어 있는 청색의 직사각형 정제 | 육안 검사 | 적합 | 2 kg, 1만정 | 48 kg, 23만정 | 480 kg, 230만정 | 서의 확증시험에 근거함) | 개월간 안정 |\n| 중 수행된 시험 및 그 결과 등이 포함될 수 있다.  | 예 시 | 시점 부근의 대조약 뱃치 분석결과 참조)인지 여부 | 무균 | 유연물질D: 0.15 % 이하 | 0.1-0.2% 범위 내에 있음 | (142,000 | 0.1-0.2% 범위 내에 있음 | 0.11 % | 생동시 |\n| RC2 | 0.5% 이하 | USP 기준 | 0.2% | 검출한계 | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | (10,700 단위) |\n| 예 시 | 유연물질 | 구형백당 | Base | 47.5 | 18-20 mesh | □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 | D90: 30 um 이하 | 제피제 ○○ | 낮은 온도는 증발이 감소하여 펠렛 응집을 초래할 수 | 시험방법 #231a | 20 um |\n| 중요한 특성에 대한 고찰이 포함되어야 함) | 결과와 상호 참고가 가능하여야 한다. ",
        "original_sentence": "추가 정보는 3.2.P.2.2.1 제제 개발을 참조한다. "
      }
    },
    {
      "chunk_id": "chunk_090",
      "text": "| 유연물질 RC 2 (0.5% 이하) | 결정형(XRD) | 2Ɵ 차이가 5 % 미만 | 시험방법 #47 | 1 % 미만 | 1 | 원료칭량 | 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인되 | 붕해제 ○○ | drum | 003 |\n| 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형) ……………………………………… 12 | Core | 유연물질 E | 0.40% | 1.0% | 1.0% 이하 | 대조약과 동등한 수준 | 어 있는 청색의 직사각형 정제 | 육안 검사 | 적합 | 2 kg, 1만정 | 48 kg, 23만정 | 480 kg, 230만정 | 서의 확증시험에 근거함) | 개월간 안정 |\n| 중 수행된 시험 및 그 결과 등이 포함될 수 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 89,
        "window_size": 3,
        "char_count": 382,
        "word_count": 108,
        "page_number": 3,
        "window_text": "| □ 예 | ■ 아니오 | m3/시간 | 코팅하는 유사한 제품에서의 사전 지식 및 실험실 규모에 | 이상 없음 | 40 kg | 적합하므로 가속조건에서 6 | 이상 없음 | 1.5% |\n| 첨가제 참조)에 근거한 것이다.  | 안에 대하여 식품의약품안전처의 입장을 기술하는 것 | 방울 크기 | 5 μm | 70 μm | 유연물질C: 0.15 % 이하 | 피크 순도(PDA)>0.99 | 빠져서 낮은 코팅 효율성을 초래할 수 있음 | (제조번호 #9A) | 0.09 % |\n| 뱃치크기1 | 3 kg | 무균 | O | O | 특성들을 갖도록 할 필요가 있다.  추가 정보는 3.2.P.2.2.1 제제 개발을 참조한다.  | 유연물질 RC 2 (0.5% 이하) | 결정형(XRD) | 2Ɵ 차이가 5 % 미만 | 시험방법 #47 | 1 % 미만 | 1 | 원료칭량 | 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인되 | 붕해제 ○○ | drum | 003 |\n| 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형) ……………………………………… 12 | Core | 유연물질 E | 0.40% | 1.0% | 1.0% 이하 | 대조약과 동등한 수준 | 어 있는 청색의 직사각형 정제 | 육안 검사 | 적합 | 2 kg, 1만정 | 48 kg, 23만정 | 480 kg, 230만정 | 서의 확증시험에 근거함) | 개월간 안정 |\n| 중 수행된 시험 및 그 결과 등이 포함될 수 있다.  | 예 시 | 시점 부근의 대조약 뱃치 분석결과 참조)인지 여부 | 무균 | 유연물질D: 0.15 % 이하 | 0.1-0.2% 범위 내에 있음 | (142,000 | 0.1-0.2% 범위 내에 있음 | 0.11 % | 생동시 |\n| RC2 | 0.5% 이하 | USP 기준 | 0.2% | 검출한계 | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | (10,700 단위) |\n| 예 시 | 유연물질 | 구형백당 | Base | 47.5 | 18-20 mesh | □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 | D90: 30 um 이하 | 제피제 ○○ | 낮은 온도는 증발이 감소하여 펠렛 응집을 초래할 수 | 시험방법 #231a | 20 um |\n| 중요한 특성에 대한 고찰이 포함되어야 함) | 결과와 상호 참고가 가능하여야 한다.  | 해 설 | 미지 | 가질 때 대조약과 유사한 용출 양상을 보임을 알 수 있다. ",
        "original_sentence": "| 유연물질 RC 2 (0.5% 이하) | 결정형(XRD) | 2Ɵ 차이가 5 % 미만 | 시험방법 #47 | 1 % 미만 | 1 | 원료칭량 | 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인되 | 붕해제 ○○ | drum | 003 |\n| 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형) ……………………………………… 12 | Core | 유연물질 E | 0.40% | 1.0% | 1.0% 이하 | 대조약과 동등한 수준 | 어 있는 청색의 직사각형 정제 | 육안 검사 | 적합 | 2 kg, 1만정 | 48 kg, 23만정 | 480 kg, 230만정 | 서의 확증시험에 근거함) | 개월간 안정 |\n| 중 수행된 시험 및 그 결과 등이 포함될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_091",
      "text": "| 예 시 | 시점 부근의 대조약 뱃치 분석결과 참조)인지 여부 | 무균 | 유연물질D: 0.15 % 이하 | 0.1-0.2% 범위 내에 있음 | (142,000 | 0.1-0.2% 범위 내에 있음 | 0.11 % | 생동시 |\n| RC2 | 0.5% 이하 | USP 기준 | 0.2% | 검출한계 | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | (10,700 단위) |\n| 예 시 | 유연물질 | 구형백당 | Base | 47.5 | 18-20 mesh | □ 정보제공 등 직원 교육용 자료입니까? ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 90,
        "window_size": 3,
        "char_count": 309,
        "word_count": 91,
        "page_number": 2,
        "window_text": "| 안에 대하여 식품의약품안전처의 입장을 기술하는 것 | 방울 크기 | 5 μm | 70 μm | 유연물질C: 0.15 % 이하 | 피크 순도(PDA)>0.99 | 빠져서 낮은 코팅 효율성을 초래할 수 있음 | (제조번호 #9A) | 0.09 % |\n| 뱃치크기1 | 3 kg | 무균 | O | O | 특성들을 갖도록 할 필요가 있다.  추가 정보는 3.2.P.2.2.1 제제 개발을 참조한다.  | 유연물질 RC 2 (0.5% 이하) | 결정형(XRD) | 2Ɵ 차이가 5 % 미만 | 시험방법 #47 | 1 % 미만 | 1 | 원료칭량 | 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인되 | 붕해제 ○○ | drum | 003 |\n| 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형) ……………………………………… 12 | Core | 유연물질 E | 0.40% | 1.0% | 1.0% 이하 | 대조약과 동등한 수준 | 어 있는 청색의 직사각형 정제 | 육안 검사 | 적합 | 2 kg, 1만정 | 48 kg, 23만정 | 480 kg, 230만정 | 서의 확증시험에 근거함) | 개월간 안정 |\n| 중 수행된 시험 및 그 결과 등이 포함될 수 있다.  | 예 시 | 시점 부근의 대조약 뱃치 분석결과 참조)인지 여부 | 무균 | 유연물질D: 0.15 % 이하 | 0.1-0.2% 범위 내에 있음 | (142,000 | 0.1-0.2% 범위 내에 있음 | 0.11 % | 생동시 |\n| RC2 | 0.5% 이하 | USP 기준 | 0.2% | 검출한계 | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | (10,700 단위) |\n| 예 시 | 유연물질 | 구형백당 | Base | 47.5 | 18-20 mesh | □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 | D90: 30 um 이하 | 제피제 ○○ | 낮은 온도는 증발이 감소하여 펠렛 응집을 초래할 수 | 시험방법 #231a | 20 um |\n| 중요한 특성에 대한 고찰이 포함되어야 함) | 결과와 상호 참고가 가능하여야 한다.  | 해 설 | 미지 | 가질 때 대조약과 유사한 용출 양상을 보임을 알 수 있다.  | High Shear | 35 ℃보다 낮아지면 용매의 증발이 너무 적게 일어나서 | 단위) | 생산규모 △정 |\n| 2.3.P.2 개발경위(제품명, 제형) …………………………………………………………… 15 | 치는 경우 기준을 설정한다. ",
        "original_sentence": "| 예 시 | 시점 부근의 대조약 뱃치 분석결과 참조)인지 여부 | 무균 | 유연물질D: 0.15 % 이하 | 0.1-0.2% 범위 내에 있음 | (142,000 | 0.1-0.2% 범위 내에 있음 | 0.11 % | 생동시 |\n| RC2 | 0.5% 이하 | USP 기준 | 0.2% | 검출한계 | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | (10,700 단위) |\n| 예 시 | 유연물질 | 구형백당 | Base | 47.5 | 18-20 mesh | □ 정보제공 등 직원 교육용 자료입니까? "
      }
    },
    {
      "chunk_id": "chunk_092",
      "text": "| □ 예 | ■ 아니오 | D90: 30 um 이하 | 제피제 ○○ | 낮은 온도는 증발이 감소하여 펠렛 응집을 초래할 수 | 시험방법 #231a | 20 um |\n| 중요한 특성에 대한 고찰이 포함되어야 함) | 결과와 상호 참고가 가능하여야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 91,
        "window_size": 3,
        "char_count": 142,
        "word_count": 43,
        "page_number": 2,
        "window_text": "추가 정보는 3.2.P.2.2.1 제제 개발을 참조한다.  | 유연물질 RC 2 (0.5% 이하) | 결정형(XRD) | 2Ɵ 차이가 5 % 미만 | 시험방법 #47 | 1 % 미만 | 1 | 원료칭량 | 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인되 | 붕해제 ○○ | drum | 003 |\n| 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형) ……………………………………… 12 | Core | 유연물질 E | 0.40% | 1.0% | 1.0% 이하 | 대조약과 동등한 수준 | 어 있는 청색의 직사각형 정제 | 육안 검사 | 적합 | 2 kg, 1만정 | 48 kg, 23만정 | 480 kg, 230만정 | 서의 확증시험에 근거함) | 개월간 안정 |\n| 중 수행된 시험 및 그 결과 등이 포함될 수 있다.  | 예 시 | 시점 부근의 대조약 뱃치 분석결과 참조)인지 여부 | 무균 | 유연물질D: 0.15 % 이하 | 0.1-0.2% 범위 내에 있음 | (142,000 | 0.1-0.2% 범위 내에 있음 | 0.11 % | 생동시 |\n| RC2 | 0.5% 이하 | USP 기준 | 0.2% | 검출한계 | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | (10,700 단위) |\n| 예 시 | 유연물질 | 구형백당 | Base | 47.5 | 18-20 mesh | □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 | D90: 30 um 이하 | 제피제 ○○ | 낮은 온도는 증발이 감소하여 펠렛 응집을 초래할 수 | 시험방법 #231a | 20 um |\n| 중요한 특성에 대한 고찰이 포함되어야 함) | 결과와 상호 참고가 가능하여야 한다.  | 해 설 | 미지 | 가질 때 대조약과 유사한 용출 양상을 보임을 알 수 있다.  | High Shear | 35 ℃보다 낮아지면 용매의 증발이 너무 적게 일어나서 | 단위) | 생산규모 △정 |\n| 2.3.P.2 개발경위(제품명, 제형) …………………………………………………………… 15 | 치는 경우 기준을 설정한다.  | 세부적인 사항들이 요구될 수 있다. ",
        "original_sentence": "| □ 예 | ■ 아니오 | D90: 30 um 이하 | 제피제 ○○ | 낮은 온도는 증발이 감소하여 펠렛 응집을 초래할 수 | 시험방법 #231a | 20 um |\n| 중요한 특성에 대한 고찰이 포함되어야 함) | 결과와 상호 참고가 가능하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_093",
      "text": "| 해 설 | 미지 | 가질 때 대조약과 유사한 용출 양상을 보임을 알 수 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 92,
        "window_size": 3,
        "char_count": 46,
        "word_count": 16,
        "page_number": 7,
        "window_text": "| 유연물질 RC 2 (0.5% 이하) | 결정형(XRD) | 2Ɵ 차이가 5 % 미만 | 시험방법 #47 | 1 % 미만 | 1 | 원료칭량 | 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인되 | 붕해제 ○○ | drum | 003 |\n| 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형) ……………………………………… 12 | Core | 유연물질 E | 0.40% | 1.0% | 1.0% 이하 | 대조약과 동등한 수준 | 어 있는 청색의 직사각형 정제 | 육안 검사 | 적합 | 2 kg, 1만정 | 48 kg, 23만정 | 480 kg, 230만정 | 서의 확증시험에 근거함) | 개월간 안정 |\n| 중 수행된 시험 및 그 결과 등이 포함될 수 있다.  | 예 시 | 시점 부근의 대조약 뱃치 분석결과 참조)인지 여부 | 무균 | 유연물질D: 0.15 % 이하 | 0.1-0.2% 범위 내에 있음 | (142,000 | 0.1-0.2% 범위 내에 있음 | 0.11 % | 생동시 |\n| RC2 | 0.5% 이하 | USP 기준 | 0.2% | 검출한계 | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | (10,700 단위) |\n| 예 시 | 유연물질 | 구형백당 | Base | 47.5 | 18-20 mesh | □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 | D90: 30 um 이하 | 제피제 ○○ | 낮은 온도는 증발이 감소하여 펠렛 응집을 초래할 수 | 시험방법 #231a | 20 um |\n| 중요한 특성에 대한 고찰이 포함되어야 함) | 결과와 상호 참고가 가능하여야 한다.  | 해 설 | 미지 | 가질 때 대조약과 유사한 용출 양상을 보임을 알 수 있다.  | High Shear | 35 ℃보다 낮아지면 용매의 증발이 너무 적게 일어나서 | 단위) | 생산규모 △정 |\n| 2.3.P.2 개발경위(제품명, 제형) …………………………………………………………… 15 | 치는 경우 기준을 설정한다.  | 세부적인 사항들이 요구될 수 있다.  | “국제공통기술문서 품질요약자료 작성 가이드라인” [민원인안내서] | 서방 펠렛으로 구성하여 비슷한 용출 양상을 갖도록 설계하였다. ",
        "original_sentence": "| 해 설 | 미지 | 가질 때 대조약과 유사한 용출 양상을 보임을 알 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_094",
      "text": "| High Shear | 35 ℃보다 낮아지면 용매의 증발이 너무 적게 일어나서 | 단위) | 생산규모 △정 |\n| 2.3.P.2 개발경위(제품명, 제형) …………………………………………………………… 15 | 치는 경우 기준을 설정한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 93,
        "window_size": 3,
        "char_count": 133,
        "word_count": 29,
        "page_number": 3,
        "window_text": "| 예 시 | 시점 부근의 대조약 뱃치 분석결과 참조)인지 여부 | 무균 | 유연물질D: 0.15 % 이하 | 0.1-0.2% 범위 내에 있음 | (142,000 | 0.1-0.2% 범위 내에 있음 | 0.11 % | 생동시 |\n| RC2 | 0.5% 이하 | USP 기준 | 0.2% | 검출한계 | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | (10,700 단위) |\n| 예 시 | 유연물질 | 구형백당 | Base | 47.5 | 18-20 mesh | □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 | D90: 30 um 이하 | 제피제 ○○ | 낮은 온도는 증발이 감소하여 펠렛 응집을 초래할 수 | 시험방법 #231a | 20 um |\n| 중요한 특성에 대한 고찰이 포함되어야 함) | 결과와 상호 참고가 가능하여야 한다.  | 해 설 | 미지 | 가질 때 대조약과 유사한 용출 양상을 보임을 알 수 있다.  | High Shear | 35 ℃보다 낮아지면 용매의 증발이 너무 적게 일어나서 | 단위) | 생산규모 △정 |\n| 2.3.P.2 개발경위(제품명, 제형) …………………………………………………………… 15 | 치는 경우 기준을 설정한다.  | 세부적인 사항들이 요구될 수 있다.  | “국제공통기술문서 품질요약자료 작성 가이드라인” [민원인안내서] | 서방 펠렛으로 구성하여 비슷한 용출 양상을 갖도록 설계하였다.  | 유연물질 | ≤0.07% | ≤0.05% | 0.20% 이하 | 구조규명 수준(IT)2) | 유연물질E: 1.0 % 이하 | 이상 없음 | 이상 없음 | 0.30 % |\n| 확인시험 | 습식과립 | RC3 | 0.5% 이하 | USP 기준 | 0.2% | 입자도 | RH, 4 주)에서 실시하였다. ",
        "original_sentence": "| High Shear | 35 ℃보다 낮아지면 용매의 증발이 너무 적게 일어나서 | 단위) | 생산규모 △정 |\n| 2.3.P.2 개발경위(제품명, 제형) …………………………………………………………… 15 | 치는 경우 기준을 설정한다. "
      }
    },
    {
      "chunk_id": "chunk_095",
      "text": "| 세부적인 사항들이 요구될 수 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 94,
        "window_size": 3,
        "char_count": 22,
        "word_count": 6,
        "page_number": 2,
        "window_text": "| □ 예 | ■ 아니오 | D90: 30 um 이하 | 제피제 ○○ | 낮은 온도는 증발이 감소하여 펠렛 응집을 초래할 수 | 시험방법 #231a | 20 um |\n| 중요한 특성에 대한 고찰이 포함되어야 함) | 결과와 상호 참고가 가능하여야 한다.  | 해 설 | 미지 | 가질 때 대조약과 유사한 용출 양상을 보임을 알 수 있다.  | High Shear | 35 ℃보다 낮아지면 용매의 증발이 너무 적게 일어나서 | 단위) | 생산규모 △정 |\n| 2.3.P.2 개발경위(제품명, 제형) …………………………………………………………… 15 | 치는 경우 기준을 설정한다.  | 세부적인 사항들이 요구될 수 있다.  | “국제공통기술문서 품질요약자료 작성 가이드라인” [민원인안내서] | 서방 펠렛으로 구성하여 비슷한 용출 양상을 갖도록 설계하였다.  | 유연물질 | ≤0.07% | ≤0.05% | 0.20% 이하 | 구조규명 수준(IT)2) | 유연물질E: 1.0 % 이하 | 이상 없음 | 이상 없음 | 0.30 % |\n| 확인시험 | 습식과립 | RC3 | 0.5% 이하 | USP 기준 | 0.2% | 입자도 | RH, 4 주)에서 실시하였다.  이 시험들은 주성분 ... 가 산화되어 Impurity E 및 가수분해 | Bed 온도 | 37~43 ℃ | 함량시험법에 따라 시험할 때 표준품과 동일한 유 | Granulator | PMA 10 | PMA 300 | PMA 1800 | D50: 15 um 이하 | 착색제 ○○ | 있고, 높은 온도는 펠렛을 경화시킬 수 있고 서방 막의 | 시험방법 #48 | 10 um |\n| 약물층 | 유연물질 RC 3 (0.5% 이하) | 지시간을 나타낸다. ",
        "original_sentence": "| 세부적인 사항들이 요구될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_096",
      "text": "| “국제공통기술문서 품질요약자료 작성 가이드라인” [민원인안내서] | 서방 펠렛으로 구성하여 비슷한 용출 양상을 갖도록 설계하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 95,
        "window_size": 3,
        "char_count": 75,
        "word_count": 15,
        "page_number": 1,
        "window_text": "| 해 설 | 미지 | 가질 때 대조약과 유사한 용출 양상을 보임을 알 수 있다.  | High Shear | 35 ℃보다 낮아지면 용매의 증발이 너무 적게 일어나서 | 단위) | 생산규모 △정 |\n| 2.3.P.2 개발경위(제품명, 제형) …………………………………………………………… 15 | 치는 경우 기준을 설정한다.  | 세부적인 사항들이 요구될 수 있다.  | “국제공통기술문서 품질요약자료 작성 가이드라인” [민원인안내서] | 서방 펠렛으로 구성하여 비슷한 용출 양상을 갖도록 설계하였다.  | 유연물질 | ≤0.07% | ≤0.05% | 0.20% 이하 | 구조규명 수준(IT)2) | 유연물질E: 1.0 % 이하 | 이상 없음 | 이상 없음 | 0.30 % |\n| 확인시험 | 습식과립 | RC3 | 0.5% 이하 | USP 기준 | 0.2% | 입자도 | RH, 4 주)에서 실시하였다.  이 시험들은 주성분 ... 가 산화되어 Impurity E 및 가수분해 | Bed 온도 | 37~43 ℃ | 함량시험법에 따라 시험할 때 표준품과 동일한 유 | Granulator | PMA 10 | PMA 300 | PMA 1800 | D50: 15 um 이하 | 착색제 ○○ | 있고, 높은 온도는 펠렛을 경화시킬 수 있고 서방 막의 | 시험방법 #48 | 10 um |\n| 약물층 | 유연물질 RC 3 (0.5% 이하) | 지시간을 나타낸다.  | USP | 적합 | core가 응집되어 수율이 낮아질 수 있고, 45 ℃보다 높 | 주성분 층 |\n| 같다. ",
        "original_sentence": "| “국제공통기술문서 품질요약자료 작성 가이드라인” [민원인안내서] | 서방 펠렛으로 구성하여 비슷한 용출 양상을 갖도록 설계하였다. "
      }
    },
    {
      "chunk_id": "chunk_097",
      "text": "| 유연물질 | ≤0.07% | ≤0.05% | 0.20% 이하 | 구조규명 수준(IT)2) | 유연물질E: 1.0 % 이하 | 이상 없음 | 이상 없음 | 0.30 % |\n| 확인시험 | 습식과립 | RC3 | 0.5% 이하 | USP 기준 | 0.2% | 입자도 | RH, 4 주)에서 실시하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 96,
        "window_size": 3,
        "char_count": 169,
        "word_count": 48,
        "page_number": 3,
        "window_text": "| High Shear | 35 ℃보다 낮아지면 용매의 증발이 너무 적게 일어나서 | 단위) | 생산규모 △정 |\n| 2.3.P.2 개발경위(제품명, 제형) …………………………………………………………… 15 | 치는 경우 기준을 설정한다.  | 세부적인 사항들이 요구될 수 있다.  | “국제공통기술문서 품질요약자료 작성 가이드라인” [민원인안내서] | 서방 펠렛으로 구성하여 비슷한 용출 양상을 갖도록 설계하였다.  | 유연물질 | ≤0.07% | ≤0.05% | 0.20% 이하 | 구조규명 수준(IT)2) | 유연물질E: 1.0 % 이하 | 이상 없음 | 이상 없음 | 0.30 % |\n| 확인시험 | 습식과립 | RC3 | 0.5% 이하 | USP 기준 | 0.2% | 입자도 | RH, 4 주)에서 실시하였다.  이 시험들은 주성분 ... 가 산화되어 Impurity E 및 가수분해 | Bed 온도 | 37~43 ℃ | 함량시험법에 따라 시험할 때 표준품과 동일한 유 | Granulator | PMA 10 | PMA 300 | PMA 1800 | D50: 15 um 이하 | 착색제 ○○ | 있고, 높은 온도는 펠렛을 경화시킬 수 있고 서방 막의 | 시험방법 #48 | 10 um |\n| 약물층 | 유연물질 RC 3 (0.5% 이하) | 지시간을 나타낸다.  | USP | 적합 | core가 응집되어 수율이 낮아질 수 있고, 45 ℃보다 높 | 주성분 층 |\n| 같다.  | (HPLC) | 해 설 | 순도 및 정제로서의 특성이 중요할 것으로 판단되었으며, | <DOE Response Variables Obtained> |\n| 용출시험 조건을 설정하였다. ",
        "original_sentence": "| 유연물질 | ≤0.07% | ≤0.05% | 0.20% 이하 | 구조규명 수준(IT)2) | 유연물질E: 1.0 % 이하 | 이상 없음 | 이상 없음 | 0.30 % |\n| 확인시험 | 습식과립 | RC3 | 0.5% 이하 | USP 기준 | 0.2% | 입자도 | RH, 4 주)에서 실시하였다. "
      }
    },
    {
      "chunk_id": "chunk_098",
      "text": "이 시험들은 주성분 ... 가 산화되어 Impurity E 및 가수분해 | Bed 온도 | 37~43 ℃ | 함량시험법에 따라 시험할 때 표준품과 동일한 유 | Granulator | PMA 10 | PMA 300 | PMA 1800 | D50: 15 um 이하 | 착색제 ○○ | 있고, 높은 온도는 펠렛을 경화시킬 수 있고 서방 막의 | 시험방법 #48 | 10 um |\n| 약물층 | 유연물질 RC 3 (0.5% 이하) | 지시간을 나타낸다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 97,
        "window_size": 3,
        "char_count": 251,
        "word_count": 71,
        "page_number": 3,
        "window_text": "| 세부적인 사항들이 요구될 수 있다.  | “국제공통기술문서 품질요약자료 작성 가이드라인” [민원인안내서] | 서방 펠렛으로 구성하여 비슷한 용출 양상을 갖도록 설계하였다.  | 유연물질 | ≤0.07% | ≤0.05% | 0.20% 이하 | 구조규명 수준(IT)2) | 유연물질E: 1.0 % 이하 | 이상 없음 | 이상 없음 | 0.30 % |\n| 확인시험 | 습식과립 | RC3 | 0.5% 이하 | USP 기준 | 0.2% | 입자도 | RH, 4 주)에서 실시하였다.  이 시험들은 주성분 ... 가 산화되어 Impurity E 및 가수분해 | Bed 온도 | 37~43 ℃ | 함량시험법에 따라 시험할 때 표준품과 동일한 유 | Granulator | PMA 10 | PMA 300 | PMA 1800 | D50: 15 um 이하 | 착색제 ○○ | 있고, 높은 온도는 펠렛을 경화시킬 수 있고 서방 막의 | 시험방법 #48 | 10 um |\n| 약물층 | 유연물질 RC 3 (0.5% 이하) | 지시간을 나타낸다.  | USP | 적합 | core가 응집되어 수율이 낮아질 수 있고, 45 ℃보다 높 | 주성분 층 |\n| 같다.  | (HPLC) | 해 설 | 순도 및 정제로서의 특성이 중요할 것으로 판단되었으며, | <DOE Response Variables Obtained> |\n| 용출시험 조건을 설정하였다.  | 완제의약품 품질에 미치는 영향, 중요 공정 변수 등에 대한 내용이 포함된다. ",
        "original_sentence": "이 시험들은 주성분 ... 가 산화되어 Impurity E 및 가수분해 | Bed 온도 | 37~43 ℃ | 함량시험법에 따라 시험할 때 표준품과 동일한 유 | Granulator | PMA 10 | PMA 300 | PMA 1800 | D50: 15 um 이하 | 착색제 ○○ | 있고, 높은 온도는 펠렛을 경화시킬 수 있고 서방 막의 | 시험방법 #48 | 10 um |\n| 약물층 | 유연물질 RC 3 (0.5% 이하) | 지시간을 나타낸다. "
      }
    },
    {
      "chunk_id": "chunk_099",
      "text": "| USP | 적합 | core가 응집되어 수율이 낮아질 수 있고, 45 ℃보다 높 | 주성분 층 |\n| 같다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 98,
        "window_size": 3,
        "char_count": 63,
        "word_count": 20,
        "page_number": 3,
        "window_text": "| “국제공통기술문서 품질요약자료 작성 가이드라인” [민원인안내서] | 서방 펠렛으로 구성하여 비슷한 용출 양상을 갖도록 설계하였다.  | 유연물질 | ≤0.07% | ≤0.05% | 0.20% 이하 | 구조규명 수준(IT)2) | 유연물질E: 1.0 % 이하 | 이상 없음 | 이상 없음 | 0.30 % |\n| 확인시험 | 습식과립 | RC3 | 0.5% 이하 | USP 기준 | 0.2% | 입자도 | RH, 4 주)에서 실시하였다.  이 시험들은 주성분 ... 가 산화되어 Impurity E 및 가수분해 | Bed 온도 | 37~43 ℃ | 함량시험법에 따라 시험할 때 표준품과 동일한 유 | Granulator | PMA 10 | PMA 300 | PMA 1800 | D50: 15 um 이하 | 착색제 ○○ | 있고, 높은 온도는 펠렛을 경화시킬 수 있고 서방 막의 | 시험방법 #48 | 10 um |\n| 약물층 | 유연물질 RC 3 (0.5% 이하) | 지시간을 나타낸다.  | USP | 적합 | core가 응집되어 수율이 낮아질 수 있고, 45 ℃보다 높 | 주성분 층 |\n| 같다.  | (HPLC) | 해 설 | 순도 및 정제로서의 특성이 중요할 것으로 판단되었으며, | <DOE Response Variables Obtained> |\n| 용출시험 조건을 설정하였다.  | 완제의약품 품질에 미치는 영향, 중요 공정 변수 등에 대한 내용이 포함된다.  | -해동, 가열-냉각 연구)가 있는 경우 이를 기재한다. ",
        "original_sentence": "| USP | 적합 | core가 응집되어 수율이 낮아질 수 있고, 45 ℃보다 높 | 주성분 층 |\n| 같다. "
      }
    },
    {
      "chunk_id": "chunk_100",
      "text": "| (HPLC) | 해 설 | 순도 및 정제로서의 특성이 중요할 것으로 판단되었으며, | <DOE Response Variables Obtained> |\n| 용출시험 조건을 설정하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 99,
        "window_size": 3,
        "char_count": 104,
        "word_count": 23,
        "page_number": 3,
        "window_text": "| 유연물질 | ≤0.07% | ≤0.05% | 0.20% 이하 | 구조규명 수준(IT)2) | 유연물질E: 1.0 % 이하 | 이상 없음 | 이상 없음 | 0.30 % |\n| 확인시험 | 습식과립 | RC3 | 0.5% 이하 | USP 기준 | 0.2% | 입자도 | RH, 4 주)에서 실시하였다.  이 시험들은 주성분 ... 가 산화되어 Impurity E 및 가수분해 | Bed 온도 | 37~43 ℃ | 함량시험법에 따라 시험할 때 표준품과 동일한 유 | Granulator | PMA 10 | PMA 300 | PMA 1800 | D50: 15 um 이하 | 착색제 ○○ | 있고, 높은 온도는 펠렛을 경화시킬 수 있고 서방 막의 | 시험방법 #48 | 10 um |\n| 약물층 | 유연물질 RC 3 (0.5% 이하) | 지시간을 나타낸다.  | USP | 적합 | core가 응집되어 수율이 낮아질 수 있고, 45 ℃보다 높 | 주성분 층 |\n| 같다.  | (HPLC) | 해 설 | 순도 및 정제로서의 특성이 중요할 것으로 판단되었으며, | <DOE Response Variables Obtained> |\n| 용출시험 조건을 설정하였다.  | 완제의약품 품질에 미치는 영향, 중요 공정 변수 등에 대한 내용이 포함된다.  | -해동, 가열-냉각 연구)가 있는 경우 이를 기재한다.  | 용출시험을 수행하였다. ",
        "original_sentence": "| (HPLC) | 해 설 | 순도 및 정제로서의 특성이 중요할 것으로 판단되었으며, | <DOE Response Variables Obtained> |\n| 용출시험 조건을 설정하였다. "
      }
    },
    {
      "chunk_id": "chunk_101",
      "text": "| 완제의약품 품질에 미치는 영향, 중요 공정 변수 등에 대한 내용이 포함된다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 100,
        "window_size": 3,
        "char_count": 45,
        "word_count": 12,
        "page_number": 3,
        "window_text": "이 시험들은 주성분 ... 가 산화되어 Impurity E 및 가수분해 | Bed 온도 | 37~43 ℃ | 함량시험법에 따라 시험할 때 표준품과 동일한 유 | Granulator | PMA 10 | PMA 300 | PMA 1800 | D50: 15 um 이하 | 착색제 ○○ | 있고, 높은 온도는 펠렛을 경화시킬 수 있고 서방 막의 | 시험방법 #48 | 10 um |\n| 약물층 | 유연물질 RC 3 (0.5% 이하) | 지시간을 나타낸다.  | USP | 적합 | core가 응집되어 수율이 낮아질 수 있고, 45 ℃보다 높 | 주성분 층 |\n| 같다.  | (HPLC) | 해 설 | 순도 및 정제로서의 특성이 중요할 것으로 판단되었으며, | <DOE Response Variables Obtained> |\n| 용출시험 조건을 설정하였다.  | 완제의약품 품질에 미치는 영향, 중요 공정 변수 등에 대한 내용이 포함된다.  | -해동, 가열-냉각 연구)가 있는 경우 이를 기재한다.  | 용출시험을 수행하였다.  모든 제제 조성에 대해서 용출시험이 적합하였고 함량균일성 | Bed 온도 | 35 ~ 45 ℃ | 유연물질F: 0.50 % 이하 | 유기용매 ○○ | 0.1-0.2% 범위 내에 있음 | 부착력이 떨어져서 약물방출을 빠르게 할 수 있음 | 0.1-0.2% 범위 내에 있음 | 0.30 % |\n| 2.3.P.3 제조(제품명, 제형) ………………………………………………………………… 16 | 미지 유연물질 | 0.2% 이하 | ICH Q3B 구조규명 수준 | 0.1% | 되어 Impurity A(활성 대사체)로 분해되기 쉽다는 것을 나타냈다. ",
        "original_sentence": "| 완제의약품 품질에 미치는 영향, 중요 공정 변수 등에 대한 내용이 포함된다. "
      }
    },
    {
      "chunk_id": "chunk_102",
      "text": "| -해동, 가열-냉각 연구)가 있는 경우 이를 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 101,
        "window_size": 3,
        "char_count": 33,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| USP | 적합 | core가 응집되어 수율이 낮아질 수 있고, 45 ℃보다 높 | 주성분 층 |\n| 같다.  | (HPLC) | 해 설 | 순도 및 정제로서의 특성이 중요할 것으로 판단되었으며, | <DOE Response Variables Obtained> |\n| 용출시험 조건을 설정하였다.  | 완제의약품 품질에 미치는 영향, 중요 공정 변수 등에 대한 내용이 포함된다.  | -해동, 가열-냉각 연구)가 있는 경우 이를 기재한다.  | 용출시험을 수행하였다.  모든 제제 조성에 대해서 용출시험이 적합하였고 함량균일성 | Bed 온도 | 35 ~ 45 ℃ | 유연물질F: 0.50 % 이하 | 유기용매 ○○ | 0.1-0.2% 범위 내에 있음 | 부착력이 떨어져서 약물방출을 빠르게 할 수 있음 | 0.1-0.2% 범위 내에 있음 | 0.30 % |\n| 2.3.P.3 제조(제품명, 제형) ………………………………………………………………… 16 | 미지 유연물질 | 0.2% 이하 | ICH Q3B 구조규명 수준 | 0.1% | 되어 Impurity A(활성 대사체)로 분해되기 쉽다는 것을 나타냈다.  산화가 주된 분해경로 | 결과, 최종 생물학적동등성시험용 제제로 11% 서방코팅한 제제를 선택하였다. ",
        "original_sentence": "| -해동, 가열-냉각 연구)가 있는 경우 이를 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_103",
      "text": "| 용출시험을 수행하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 102,
        "window_size": 3,
        "char_count": 15,
        "word_count": 3,
        "page_number": 32,
        "window_text": "| (HPLC) | 해 설 | 순도 및 정제로서의 특성이 중요할 것으로 판단되었으며, | <DOE Response Variables Obtained> |\n| 용출시험 조건을 설정하였다.  | 완제의약품 품질에 미치는 영향, 중요 공정 변수 등에 대한 내용이 포함된다.  | -해동, 가열-냉각 연구)가 있는 경우 이를 기재한다.  | 용출시험을 수행하였다.  모든 제제 조성에 대해서 용출시험이 적합하였고 함량균일성 | Bed 온도 | 35 ~ 45 ℃ | 유연물질F: 0.50 % 이하 | 유기용매 ○○ | 0.1-0.2% 범위 내에 있음 | 부착력이 떨어져서 약물방출을 빠르게 할 수 있음 | 0.1-0.2% 범위 내에 있음 | 0.30 % |\n| 2.3.P.3 제조(제품명, 제형) ………………………………………………………………… 16 | 미지 유연물질 | 0.2% 이하 | ICH Q3B 구조규명 수준 | 0.1% | 되어 Impurity A(활성 대사체)로 분해되기 쉽다는 것을 나타냈다.  산화가 주된 분해경로 | 결과, 최종 생물학적동등성시험용 제제로 11% 서방코팅한 제제를 선택하였다.  | 주성분 | YYY | 8.0 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다. ",
        "original_sentence": "| 용출시험을 수행하였다. "
      }
    },
    {
      "chunk_id": "chunk_104",
      "text": "모든 제제 조성에 대해서 용출시험이 적합하였고 함량균일성 | Bed 온도 | 35 ~ 45 ℃ | 유연물질F: 0.50 % 이하 | 유기용매 ○○ | 0.1-0.2% 범위 내에 있음 | 부착력이 떨어져서 약물방출을 빠르게 할 수 있음 | 0.1-0.2% 범위 내에 있음 | 0.30 % |\n| 2.3.P.3 제조(제품명, 제형) ………………………………………………………………… 16 | 미지 유연물질 | 0.2% 이하 | ICH Q3B 구조규명 수준 | 0.1% | 되어 Impurity A(활성 대사체)로 분해되기 쉽다는 것을 나타냈다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 103,
        "window_size": 3,
        "char_count": 301,
        "word_count": 73,
        "page_number": 3,
        "window_text": "| 완제의약품 품질에 미치는 영향, 중요 공정 변수 등에 대한 내용이 포함된다.  | -해동, 가열-냉각 연구)가 있는 경우 이를 기재한다.  | 용출시험을 수행하였다.  모든 제제 조성에 대해서 용출시험이 적합하였고 함량균일성 | Bed 온도 | 35 ~ 45 ℃ | 유연물질F: 0.50 % 이하 | 유기용매 ○○ | 0.1-0.2% 범위 내에 있음 | 부착력이 떨어져서 약물방출을 빠르게 할 수 있음 | 0.1-0.2% 범위 내에 있음 | 0.30 % |\n| 2.3.P.3 제조(제품명, 제형) ………………………………………………………………… 16 | 미지 유연물질 | 0.2% 이하 | ICH Q3B 구조규명 수준 | 0.1% | 되어 Impurity A(활성 대사체)로 분해되기 쉽다는 것을 나타냈다.  산화가 주된 분해경로 | 결과, 최종 생물학적동등성시험용 제제로 11% 서방코팅한 제제를 선택하였다.  | 주성분 | YYY | 8.0 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다.  | 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다. ",
        "original_sentence": "모든 제제 조성에 대해서 용출시험이 적합하였고 함량균일성 | Bed 온도 | 35 ~ 45 ℃ | 유연물질F: 0.50 % 이하 | 유기용매 ○○ | 0.1-0.2% 범위 내에 있음 | 부착력이 떨어져서 약물방출을 빠르게 할 수 있음 | 0.1-0.2% 범위 내에 있음 | 0.30 % |\n| 2.3.P.3 제조(제품명, 제형) ………………………………………………………………… 16 | 미지 유연물질 | 0.2% 이하 | ICH Q3B 구조규명 수준 | 0.1% | 되어 Impurity A(활성 대사체)로 분해되기 쉽다는 것을 나타냈다. "
      }
    },
    {
      "chunk_id": "chunk_105",
      "text": "산화가 주된 분해경로 | 결과, 최종 생물학적동등성시험용 제제로 11% 서방코팅한 제제를 선택하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 104,
        "window_size": 3,
        "char_count": 57,
        "word_count": 12,
        "page_number": 5,
        "window_text": "| -해동, 가열-냉각 연구)가 있는 경우 이를 기재한다.  | 용출시험을 수행하였다.  모든 제제 조성에 대해서 용출시험이 적합하였고 함량균일성 | Bed 온도 | 35 ~ 45 ℃ | 유연물질F: 0.50 % 이하 | 유기용매 ○○ | 0.1-0.2% 범위 내에 있음 | 부착력이 떨어져서 약물방출을 빠르게 할 수 있음 | 0.1-0.2% 범위 내에 있음 | 0.30 % |\n| 2.3.P.3 제조(제품명, 제형) ………………………………………………………………… 16 | 미지 유연물질 | 0.2% 이하 | ICH Q3B 구조규명 수준 | 0.1% | 되어 Impurity A(활성 대사체)로 분해되기 쉽다는 것을 나타냈다.  산화가 주된 분해경로 | 결과, 최종 생물학적동등성시험용 제제로 11% 서방코팅한 제제를 선택하였다.  | 주성분 | YYY | 8.0 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다.  | 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다.  | D10: 5 um 이하 | 아지면 증발을 증가시켜 약물/결합제가 펠렛 중심에 부착 | 2.5 um |\n| 회사명 및 주소 | 담당업무 | GMP 증명서 | 비고 | 간략히 정리한다. ",
        "original_sentence": "산화가 주된 분해경로 | 결과, 최종 생물학적동등성시험용 제제로 11% 서방코팅한 제제를 선택하였다. "
      }
    },
    {
      "chunk_id": "chunk_106",
      "text": "| 주성분 | YYY | 8.0 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 105,
        "window_size": 3,
        "char_count": 72,
        "word_count": 20,
        "page_number": 2,
        "window_text": "| 용출시험을 수행하였다.  모든 제제 조성에 대해서 용출시험이 적합하였고 함량균일성 | Bed 온도 | 35 ~ 45 ℃ | 유연물질F: 0.50 % 이하 | 유기용매 ○○ | 0.1-0.2% 범위 내에 있음 | 부착력이 떨어져서 약물방출을 빠르게 할 수 있음 | 0.1-0.2% 범위 내에 있음 | 0.30 % |\n| 2.3.P.3 제조(제품명, 제형) ………………………………………………………………… 16 | 미지 유연물질 | 0.2% 이하 | ICH Q3B 구조규명 수준 | 0.1% | 되어 Impurity A(활성 대사체)로 분해되기 쉽다는 것을 나타냈다.  산화가 주된 분해경로 | 결과, 최종 생물학적동등성시험용 제제로 11% 서방코팅한 제제를 선택하였다.  | 주성분 | YYY | 8.0 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다.  | 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다.  | D10: 5 um 이하 | 아지면 증발을 증가시켜 약물/결합제가 펠렛 중심에 부착 | 2.5 um |\n| 회사명 및 주소 | 담당업무 | GMP 증명서 | 비고 | 간략히 정리한다.  | 총 유연물질1) | 1.5% | 3.7% | 2.5% 이하 | 대조약보다 낮음 | 녹으며, 아세톤과 알코올에 조금 녹는다. ",
        "original_sentence": "| 주성분 | YYY | 8.0 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다. "
      }
    },
    {
      "chunk_id": "chunk_107",
      "text": "| 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 106,
        "window_size": 3,
        "char_count": 33,
        "word_count": 7,
        "page_number": 2,
        "window_text": "모든 제제 조성에 대해서 용출시험이 적합하였고 함량균일성 | Bed 온도 | 35 ~ 45 ℃ | 유연물질F: 0.50 % 이하 | 유기용매 ○○ | 0.1-0.2% 범위 내에 있음 | 부착력이 떨어져서 약물방출을 빠르게 할 수 있음 | 0.1-0.2% 범위 내에 있음 | 0.30 % |\n| 2.3.P.3 제조(제품명, 제형) ………………………………………………………………… 16 | 미지 유연물질 | 0.2% 이하 | ICH Q3B 구조규명 수준 | 0.1% | 되어 Impurity A(활성 대사체)로 분해되기 쉽다는 것을 나타냈다.  산화가 주된 분해경로 | 결과, 최종 생물학적동등성시험용 제제로 11% 서방코팅한 제제를 선택하였다.  | 주성분 | YYY | 8.0 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다.  | 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다.  | D10: 5 um 이하 | 아지면 증발을 증가시켜 약물/결합제가 펠렛 중심에 부착 | 2.5 um |\n| 회사명 및 주소 | 담당업무 | GMP 증명서 | 비고 | 간략히 정리한다.  | 총 유연물질1) | 1.5% | 3.7% | 2.5% 이하 | 대조약보다 낮음 | 녹으며, 아세톤과 알코올에 조금 녹는다.  | 공정변수 | 사유 |\n| 함량시험 | 표시량의 90.0 ~ 110.0% | USP | 98.8% | 파라미터와 시스템적합성 기준을 포함하여 표 또는 서술 형식으로 요약한다. ",
        "original_sentence": "| 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다. "
      }
    },
    {
      "chunk_id": "chunk_108",
      "text": "| D10: 5 um 이하 | 아지면 증발을 증가시켜 약물/결합제가 펠렛 중심에 부착 | 2.5 um |\n| 회사명 및 주소 | 담당업무 | GMP 증명서 | 비고 | 간략히 정리한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 107,
        "window_size": 3,
        "char_count": 104,
        "word_count": 31,
        "page_number": 3,
        "window_text": "산화가 주된 분해경로 | 결과, 최종 생물학적동등성시험용 제제로 11% 서방코팅한 제제를 선택하였다.  | 주성분 | YYY | 8.0 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다.  | 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다.  | D10: 5 um 이하 | 아지면 증발을 증가시켜 약물/결합제가 펠렛 중심에 부착 | 2.5 um |\n| 회사명 및 주소 | 담당업무 | GMP 증명서 | 비고 | 간략히 정리한다.  | 총 유연물질1) | 1.5% | 3.7% | 2.5% 이하 | 대조약보다 낮음 | 녹으며, 아세톤과 알코올에 조금 녹는다.  | 공정변수 | 사유 |\n| 함량시험 | 표시량의 90.0 ~ 110.0% | USP | 98.8% | 파라미터와 시스템적합성 기준을 포함하여 표 또는 서술 형식으로 요약한다.  | 미지: 0.10 % 이하 | Impact Mill | 정제수 | 최소치 | 최대치 | 0.07 % |\n| 습식체과 | 해 설 | 시험 결과(RSD)는 2.0 % 미만이었다. ",
        "original_sentence": "| D10: 5 um 이하 | 아지면 증발을 증가시켜 약물/결합제가 펠렛 중심에 부착 | 2.5 um |\n| 회사명 및 주소 | 담당업무 | GMP 증명서 | 비고 | 간략히 정리한다. "
      }
    },
    {
      "chunk_id": "chunk_109",
      "text": "| 총 유연물질1) | 1.5% | 3.7% | 2.5% 이하 | 대조약보다 낮음 | 녹으며, 아세톤과 알코올에 조금 녹는다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 108,
        "window_size": 3,
        "char_count": 71,
        "word_count": 19,
        "page_number": 3,
        "window_text": "| 주성분 | YYY | 8.0 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다.  | 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다.  | D10: 5 um 이하 | 아지면 증발을 증가시켜 약물/결합제가 펠렛 중심에 부착 | 2.5 um |\n| 회사명 및 주소 | 담당업무 | GMP 증명서 | 비고 | 간략히 정리한다.  | 총 유연물질1) | 1.5% | 3.7% | 2.5% 이하 | 대조약보다 낮음 | 녹으며, 아세톤과 알코올에 조금 녹는다.  | 공정변수 | 사유 |\n| 함량시험 | 표시량의 90.0 ~ 110.0% | USP | 98.8% | 파라미터와 시스템적합성 기준을 포함하여 표 또는 서술 형식으로 요약한다.  | 미지: 0.10 % 이하 | Impact Mill | 정제수 | 최소치 | 최대치 | 0.07 % |\n| 습식체과 | 해 설 | 시험 결과(RSD)는 2.0 % 미만이었다.  붕해제 함량은 용출에 영향을 미치는 중요 인자 | Clear Coating 7321 | 결합제 | 9.49 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 분무속도가 낮은 경우 방울 크기를 감소시키고 증발을 | 이상 없음 | 이상 없음 |\n| 립한 초기 시점부터 실시한 연구내용부터 포함한다. ",
        "original_sentence": "| 총 유연물질1) | 1.5% | 3.7% | 2.5% 이하 | 대조약보다 낮음 | 녹으며, 아세톤과 알코올에 조금 녹는다. "
      }
    },
    {
      "chunk_id": "chunk_110",
      "text": "| 공정변수 | 사유 |\n| 함량시험 | 표시량의 90.0 ~ 110.0% | USP | 98.8% | 파라미터와 시스템적합성 기준을 포함하여 표 또는 서술 형식으로 요약한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 109,
        "window_size": 3,
        "char_count": 99,
        "word_count": 26,
        "page_number": 5,
        "window_text": "| 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다.  | D10: 5 um 이하 | 아지면 증발을 증가시켜 약물/결합제가 펠렛 중심에 부착 | 2.5 um |\n| 회사명 및 주소 | 담당업무 | GMP 증명서 | 비고 | 간략히 정리한다.  | 총 유연물질1) | 1.5% | 3.7% | 2.5% 이하 | 대조약보다 낮음 | 녹으며, 아세톤과 알코올에 조금 녹는다.  | 공정변수 | 사유 |\n| 함량시험 | 표시량의 90.0 ~ 110.0% | USP | 98.8% | 파라미터와 시스템적합성 기준을 포함하여 표 또는 서술 형식으로 요약한다.  | 미지: 0.10 % 이하 | Impact Mill | 정제수 | 최소치 | 최대치 | 0.07 % |\n| 습식체과 | 해 설 | 시험 결과(RSD)는 2.0 % 미만이었다.  붕해제 함량은 용출에 영향을 미치는 중요 인자 | Clear Coating 7321 | 결합제 | 9.49 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 분무속도가 낮은 경우 방울 크기를 감소시키고 증발을 | 이상 없음 | 이상 없음 |\n| 립한 초기 시점부터 실시한 연구내용부터 포함한다.  | 총 유연물질 | 1.5% 이하 | USP 기준 | 0.65% | 예 시 | 기능을 발휘하므로 어떤 점도가 제품 활성에 효과가 있는지 결정하기 위하여 소규모 실 | 보장하기 위하여 이들 위치에서 공정 시험/관리(In-process tests/controls)가 시행된다. ",
        "original_sentence": "| 공정변수 | 사유 |\n| 함량시험 | 표시량의 90.0 ~ 110.0% | USP | 98.8% | 파라미터와 시스템적합성 기준을 포함하여 표 또는 서술 형식으로 요약한다. "
      }
    },
    {
      "chunk_id": "chunk_111",
      "text": "| 미지: 0.10 % 이하 | Impact Mill | 정제수 | 최소치 | 최대치 | 0.07 % |\n| 습식체과 | 해 설 | 시험 결과(RSD)는 2.0 % 미만이었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 110,
        "window_size": 3,
        "char_count": 99,
        "word_count": 29,
        "page_number": 3,
        "window_text": "| D10: 5 um 이하 | 아지면 증발을 증가시켜 약물/결합제가 펠렛 중심에 부착 | 2.5 um |\n| 회사명 및 주소 | 담당업무 | GMP 증명서 | 비고 | 간략히 정리한다.  | 총 유연물질1) | 1.5% | 3.7% | 2.5% 이하 | 대조약보다 낮음 | 녹으며, 아세톤과 알코올에 조금 녹는다.  | 공정변수 | 사유 |\n| 함량시험 | 표시량의 90.0 ~ 110.0% | USP | 98.8% | 파라미터와 시스템적합성 기준을 포함하여 표 또는 서술 형식으로 요약한다.  | 미지: 0.10 % 이하 | Impact Mill | 정제수 | 최소치 | 최대치 | 0.07 % |\n| 습식체과 | 해 설 | 시험 결과(RSD)는 2.0 % 미만이었다.  붕해제 함량은 용출에 영향을 미치는 중요 인자 | Clear Coating 7321 | 결합제 | 9.49 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 분무속도가 낮은 경우 방울 크기를 감소시키고 증발을 | 이상 없음 | 이상 없음 |\n| 립한 초기 시점부터 실시한 연구내용부터 포함한다.  | 총 유연물질 | 1.5% 이하 | USP 기준 | 0.65% | 예 시 | 기능을 발휘하므로 어떤 점도가 제품 활성에 효과가 있는지 결정하기 위하여 소규모 실 | 보장하기 위하여 이들 위치에서 공정 시험/관리(In-process tests/controls)가 시행된다.  | 시험조건 | 설정값 | 용출시험 조건 | 값 | 완제의약품의 제조, 포장 및 시험 | 함량시험 방법 | 순도시험 방법 | 하기 어려워져 코팅효율성 및 함량균일성이 떨어짐 |\n| 유동화 기체 부피 | 2.3.P.4 첨가제의 관리(제품명, 제형) …………………………………………………… 21 | 평가하고 기재한다). ",
        "original_sentence": "| 미지: 0.10 % 이하 | Impact Mill | 정제수 | 최소치 | 최대치 | 0.07 % |\n| 습식체과 | 해 설 | 시험 결과(RSD)는 2.0 % 미만이었다. "
      }
    },
    {
      "chunk_id": "chunk_112",
      "text": "붕해제 함량은 용출에 영향을 미치는 중요 인자 | Clear Coating 7321 | 결합제 | 9.49 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 분무속도가 낮은 경우 방울 크기를 감소시키고 증발을 | 이상 없음 | 이상 없음 |\n| 립한 초기 시점부터 실시한 연구내용부터 포함한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 111,
        "window_size": 3,
        "char_count": 179,
        "word_count": 48,
        "page_number": 5,
        "window_text": "| 총 유연물질1) | 1.5% | 3.7% | 2.5% 이하 | 대조약보다 낮음 | 녹으며, 아세톤과 알코올에 조금 녹는다.  | 공정변수 | 사유 |\n| 함량시험 | 표시량의 90.0 ~ 110.0% | USP | 98.8% | 파라미터와 시스템적합성 기준을 포함하여 표 또는 서술 형식으로 요약한다.  | 미지: 0.10 % 이하 | Impact Mill | 정제수 | 최소치 | 최대치 | 0.07 % |\n| 습식체과 | 해 설 | 시험 결과(RSD)는 2.0 % 미만이었다.  붕해제 함량은 용출에 영향을 미치는 중요 인자 | Clear Coating 7321 | 결합제 | 9.49 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 분무속도가 낮은 경우 방울 크기를 감소시키고 증발을 | 이상 없음 | 이상 없음 |\n| 립한 초기 시점부터 실시한 연구내용부터 포함한다.  | 총 유연물질 | 1.5% 이하 | USP 기준 | 0.65% | 예 시 | 기능을 발휘하므로 어떤 점도가 제품 활성에 효과가 있는지 결정하기 위하여 소규모 실 | 보장하기 위하여 이들 위치에서 공정 시험/관리(In-process tests/controls)가 시행된다.  | 시험조건 | 설정값 | 용출시험 조건 | 값 | 완제의약품의 제조, 포장 및 시험 | 함량시험 방법 | 순도시험 방법 | 하기 어려워져 코팅효율성 및 함량균일성이 떨어짐 |\n| 유동화 기체 부피 | 2.3.P.4 첨가제의 관리(제품명, 제형) …………………………………………………… 21 | 평가하고 기재한다).  | 개개 유연물질 (0.2% 이하) | 예 시 | 발 | 행 | 일 | 복용할 수 있도록 하는 것이다. ",
        "original_sentence": "붕해제 함량은 용출에 영향을 미치는 중요 인자 | Clear Coating 7321 | 결합제 | 9.49 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 분무속도가 낮은 경우 방울 크기를 감소시키고 증발을 | 이상 없음 | 이상 없음 |\n| 립한 초기 시점부터 실시한 연구내용부터 포함한다. "
      }
    },
    {
      "chunk_id": "chunk_113",
      "text": "| 총 유연물질 | 1.5% 이하 | USP 기준 | 0.65% | 예 시 | 기능을 발휘하므로 어떤 점도가 제품 활성에 효과가 있는지 결정하기 위하여 소규모 실 | 보장하기 위하여 이들 위치에서 공정 시험/관리(In-process tests/controls)가 시행된다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 112,
        "window_size": 3,
        "char_count": 153,
        "word_count": 36,
        "page_number": 3,
        "window_text": "| 공정변수 | 사유 |\n| 함량시험 | 표시량의 90.0 ~ 110.0% | USP | 98.8% | 파라미터와 시스템적합성 기준을 포함하여 표 또는 서술 형식으로 요약한다.  | 미지: 0.10 % 이하 | Impact Mill | 정제수 | 최소치 | 최대치 | 0.07 % |\n| 습식체과 | 해 설 | 시험 결과(RSD)는 2.0 % 미만이었다.  붕해제 함량은 용출에 영향을 미치는 중요 인자 | Clear Coating 7321 | 결합제 | 9.49 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 분무속도가 낮은 경우 방울 크기를 감소시키고 증발을 | 이상 없음 | 이상 없음 |\n| 립한 초기 시점부터 실시한 연구내용부터 포함한다.  | 총 유연물질 | 1.5% 이하 | USP 기준 | 0.65% | 예 시 | 기능을 발휘하므로 어떤 점도가 제품 활성에 효과가 있는지 결정하기 위하여 소규모 실 | 보장하기 위하여 이들 위치에서 공정 시험/관리(In-process tests/controls)가 시행된다.  | 시험조건 | 설정값 | 용출시험 조건 | 값 | 완제의약품의 제조, 포장 및 시험 | 함량시험 방법 | 순도시험 방법 | 하기 어려워져 코팅효율성 및 함량균일성이 떨어짐 |\n| 유동화 기체 부피 | 2.3.P.4 첨가제의 관리(제품명, 제형) …………………………………………………… 21 | 평가하고 기재한다).  | 개개 유연물질 (0.2% 이하) | 예 시 | 발 | 행 | 일 | 복용할 수 있도록 하는 것이다.  | 2015 년 12 월 | 분포-플레이트 면적 비율2에 근거하 |\n| 1) 유연물질 B, C, D, F는 제품 유연물질 계산에서는 제외한다. ",
        "original_sentence": "| 총 유연물질 | 1.5% 이하 | USP 기준 | 0.65% | 예 시 | 기능을 발휘하므로 어떤 점도가 제품 활성에 효과가 있는지 결정하기 위하여 소규모 실 | 보장하기 위하여 이들 위치에서 공정 시험/관리(In-process tests/controls)가 시행된다. "
      }
    },
    {
      "chunk_id": "chunk_114",
      "text": "| 시험조건 | 설정값 | 용출시험 조건 | 값 | 완제의약품의 제조, 포장 및 시험 | 함량시험 방법 | 순도시험 방법 | 하기 어려워져 코팅효율성 및 함량균일성이 떨어짐 |\n| 유동화 기체 부피 | 2.3.P.4 첨가제의 관리(제품명, 제형) …………………………………………………… 21 | 평가하고 기재한다). ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 113,
        "window_size": 3,
        "char_count": 176,
        "word_count": 43,
        "page_number": 18,
        "window_text": "| 미지: 0.10 % 이하 | Impact Mill | 정제수 | 최소치 | 최대치 | 0.07 % |\n| 습식체과 | 해 설 | 시험 결과(RSD)는 2.0 % 미만이었다.  붕해제 함량은 용출에 영향을 미치는 중요 인자 | Clear Coating 7321 | 결합제 | 9.49 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 분무속도가 낮은 경우 방울 크기를 감소시키고 증발을 | 이상 없음 | 이상 없음 |\n| 립한 초기 시점부터 실시한 연구내용부터 포함한다.  | 총 유연물질 | 1.5% 이하 | USP 기준 | 0.65% | 예 시 | 기능을 발휘하므로 어떤 점도가 제품 활성에 효과가 있는지 결정하기 위하여 소규모 실 | 보장하기 위하여 이들 위치에서 공정 시험/관리(In-process tests/controls)가 시행된다.  | 시험조건 | 설정값 | 용출시험 조건 | 값 | 완제의약품의 제조, 포장 및 시험 | 함량시험 방법 | 순도시험 방법 | 하기 어려워져 코팅효율성 및 함량균일성이 떨어짐 |\n| 유동화 기체 부피 | 2.3.P.4 첨가제의 관리(제품명, 제형) …………………………………………………… 21 | 평가하고 기재한다).  | 개개 유연물질 (0.2% 이하) | 예 시 | 발 | 행 | 일 | 복용할 수 있도록 하는 것이다.  | 2015 년 12 월 | 분포-플레이트 면적 비율2에 근거하 |\n| 1) 유연물질 B, C, D, F는 제품 유연물질 계산에서는 제외한다.  | 기술되어 있으므로 생동성을 보증하는데 빠른 용출이 중요할 것으로 판단된다. ",
        "original_sentence": "| 시험조건 | 설정값 | 용출시험 조건 | 값 | 완제의약품의 제조, 포장 및 시험 | 함량시험 방법 | 순도시험 방법 | 하기 어려워져 코팅효율성 및 함량균일성이 떨어짐 |\n| 유동화 기체 부피 | 2.3.P.4 첨가제의 관리(제품명, 제형) …………………………………………………… 21 | 평가하고 기재한다). "
      }
    },
    {
      "chunk_id": "chunk_115",
      "text": "| 개개 유연물질 (0.2% 이하) | 예 시 | 발 | 행 | 일 | 복용할 수 있도록 하는 것이다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 114,
        "window_size": 3,
        "char_count": 58,
        "word_count": 20,
        "page_number": 3,
        "window_text": "붕해제 함량은 용출에 영향을 미치는 중요 인자 | Clear Coating 7321 | 결합제 | 9.49 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 분무속도가 낮은 경우 방울 크기를 감소시키고 증발을 | 이상 없음 | 이상 없음 |\n| 립한 초기 시점부터 실시한 연구내용부터 포함한다.  | 총 유연물질 | 1.5% 이하 | USP 기준 | 0.65% | 예 시 | 기능을 발휘하므로 어떤 점도가 제품 활성에 효과가 있는지 결정하기 위하여 소규모 실 | 보장하기 위하여 이들 위치에서 공정 시험/관리(In-process tests/controls)가 시행된다.  | 시험조건 | 설정값 | 용출시험 조건 | 값 | 완제의약품의 제조, 포장 및 시험 | 함량시험 방법 | 순도시험 방법 | 하기 어려워져 코팅효율성 및 함량균일성이 떨어짐 |\n| 유동화 기체 부피 | 2.3.P.4 첨가제의 관리(제품명, 제형) …………………………………………………… 21 | 평가하고 기재한다).  | 개개 유연물질 (0.2% 이하) | 예 시 | 발 | 행 | 일 | 복용할 수 있도록 하는 것이다.  | 2015 년 12 월 | 분포-플레이트 면적 비율2에 근거하 |\n| 1) 유연물질 B, C, D, F는 제품 유연물질 계산에서는 제외한다.  | 기술되어 있으므로 생동성을 보증하는데 빠른 용출이 중요할 것으로 판단된다.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 총: 2.0 % 이하 | 코팅 효율성 | 75.8% | 99.2% | 80~100 | 480~600 | 평균: 99.1% | 1.4 % | □ 예(☞지침) | ■ 아니오 |\n| 불균일, 연질화, 뜯김이나 깨짐 등에 대해서도 관찰한다. ",
        "original_sentence": "| 개개 유연물질 (0.2% 이하) | 예 시 | 발 | 행 | 일 | 복용할 수 있도록 하는 것이다. "
      }
    },
    {
      "chunk_id": "chunk_116",
      "text": "| 2015 년 12 월 | 분포-플레이트 면적 비율2에 근거하 |\n| 1) 유연물질 B, C, D, F는 제품 유연물질 계산에서는 제외한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 115,
        "window_size": 3,
        "char_count": 80,
        "word_count": 22,
        "page_number": 3,
        "window_text": "| 총 유연물질 | 1.5% 이하 | USP 기준 | 0.65% | 예 시 | 기능을 발휘하므로 어떤 점도가 제품 활성에 효과가 있는지 결정하기 위하여 소규모 실 | 보장하기 위하여 이들 위치에서 공정 시험/관리(In-process tests/controls)가 시행된다.  | 시험조건 | 설정값 | 용출시험 조건 | 값 | 완제의약품의 제조, 포장 및 시험 | 함량시험 방법 | 순도시험 방법 | 하기 어려워져 코팅효율성 및 함량균일성이 떨어짐 |\n| 유동화 기체 부피 | 2.3.P.4 첨가제의 관리(제품명, 제형) …………………………………………………… 21 | 평가하고 기재한다).  | 개개 유연물질 (0.2% 이하) | 예 시 | 발 | 행 | 일 | 복용할 수 있도록 하는 것이다.  | 2015 년 12 월 | 분포-플레이트 면적 비율2에 근거하 |\n| 1) 유연물질 B, C, D, F는 제품 유연물질 계산에서는 제외한다.  | 기술되어 있으므로 생동성을 보증하는데 빠른 용출이 중요할 것으로 판단된다.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 총: 2.0 % 이하 | 코팅 효율성 | 75.8% | 99.2% | 80~100 | 480~600 | 평균: 99.1% | 1.4 % | □ 예(☞지침) | ■ 아니오 |\n| 불균일, 연질화, 뜯김이나 깨짐 등에 대해서도 관찰한다.  | 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0075 | 였으며, 연구 결과 붕해제 함량은 2.5 % 이상이어야 한다. ",
        "original_sentence": "| 2015 년 12 월 | 분포-플레이트 면적 비율2에 근거하 |\n| 1) 유연물질 B, C, D, F는 제품 유연물질 계산에서는 제외한다. "
      }
    },
    {
      "chunk_id": "chunk_117",
      "text": "| 기술되어 있으므로 생동성을 보증하는데 빠른 용출이 중요할 것으로 판단된다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 116,
        "window_size": 3,
        "char_count": 44,
        "word_count": 10,
        "page_number": 3,
        "window_text": "| 시험조건 | 설정값 | 용출시험 조건 | 값 | 완제의약품의 제조, 포장 및 시험 | 함량시험 방법 | 순도시험 방법 | 하기 어려워져 코팅효율성 및 함량균일성이 떨어짐 |\n| 유동화 기체 부피 | 2.3.P.4 첨가제의 관리(제품명, 제형) …………………………………………………… 21 | 평가하고 기재한다).  | 개개 유연물질 (0.2% 이하) | 예 시 | 발 | 행 | 일 | 복용할 수 있도록 하는 것이다.  | 2015 년 12 월 | 분포-플레이트 면적 비율2에 근거하 |\n| 1) 유연물질 B, C, D, F는 제품 유연물질 계산에서는 제외한다.  | 기술되어 있으므로 생동성을 보증하는데 빠른 용출이 중요할 것으로 판단된다.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 총: 2.0 % 이하 | 코팅 효율성 | 75.8% | 99.2% | 80~100 | 480~600 | 평균: 99.1% | 1.4 % | □ 예(☞지침) | ■ 아니오 |\n| 불균일, 연질화, 뜯김이나 깨짐 등에 대해서도 관찰한다.  | 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0075 | 였으며, 연구 결과 붕해제 함량은 2.5 % 이상이어야 한다.  | 분무속도 | 25~30 mL/분 | 주성분 ○○ | 0.05-0.1% 범위 내에 있음 | 낮은 분무속도는 방울 크기를 감소시키고 증발을 높여서 | 높여서 낮은 코팅 효율성 및 빠른 약물방출을 초래할 | 0.05-0.1% 범위 내에 있음 |\n| (m3/시간) | 생략할 수 있다. ",
        "original_sentence": "| 기술되어 있으므로 생동성을 보증하는데 빠른 용출이 중요할 것으로 판단된다. "
      }
    },
    {
      "chunk_id": "chunk_118",
      "text": "| □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 총: 2.0 % 이하 | 코팅 효율성 | 75.8% | 99.2% | 80~100 | 480~600 | 평균: 99.1% | 1.4 % | □ 예(☞지침) | ■ 아니오 |\n| 불균일, 연질화, 뜯김이나 깨짐 등에 대해서도 관찰한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 117,
        "window_size": 3,
        "char_count": 170,
        "word_count": 46,
        "page_number": 2,
        "window_text": "| 개개 유연물질 (0.2% 이하) | 예 시 | 발 | 행 | 일 | 복용할 수 있도록 하는 것이다.  | 2015 년 12 월 | 분포-플레이트 면적 비율2에 근거하 |\n| 1) 유연물질 B, C, D, F는 제품 유연물질 계산에서는 제외한다.  | 기술되어 있으므로 생동성을 보증하는데 빠른 용출이 중요할 것으로 판단된다.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 총: 2.0 % 이하 | 코팅 효율성 | 75.8% | 99.2% | 80~100 | 480~600 | 평균: 99.1% | 1.4 % | □ 예(☞지침) | ■ 아니오 |\n| 불균일, 연질화, 뜯김이나 깨짐 등에 대해서도 관찰한다.  | 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0075 | 였으며, 연구 결과 붕해제 함량은 2.5 % 이상이어야 한다.  | 분무속도 | 25~30 mL/분 | 주성분 ○○ | 0.05-0.1% 범위 내에 있음 | 낮은 분무속도는 방울 크기를 감소시키고 증발을 높여서 | 높여서 낮은 코팅 효율성 및 빠른 약물방출을 초래할 | 0.05-0.1% 범위 내에 있음 |\n| (m3/시간) | 생략할 수 있다.  | 2 | 결합액의 | 험실 시험에서 여러 등급의 에틸셀룰로오스들을 평가하였다. ",
        "original_sentence": "| □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 총: 2.0 % 이하 | 코팅 효율성 | 75.8% | 99.2% | 80~100 | 480~600 | 평균: 99.1% | 1.4 % | □ 예(☞지침) | ■ 아니오 |\n| 불균일, 연질화, 뜯김이나 깨짐 등에 대해서도 관찰한다. "
      }
    },
    {
      "chunk_id": "chunk_119",
      "text": "| 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0075 | 였으며, 연구 결과 붕해제 함량은 2.5 % 이상이어야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 118,
        "window_size": 3,
        "char_count": 74,
        "word_count": 16,
        "page_number": 3,
        "window_text": "| 2015 년 12 월 | 분포-플레이트 면적 비율2에 근거하 |\n| 1) 유연물질 B, C, D, F는 제품 유연물질 계산에서는 제외한다.  | 기술되어 있으므로 생동성을 보증하는데 빠른 용출이 중요할 것으로 판단된다.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 총: 2.0 % 이하 | 코팅 효율성 | 75.8% | 99.2% | 80~100 | 480~600 | 평균: 99.1% | 1.4 % | □ 예(☞지침) | ■ 아니오 |\n| 불균일, 연질화, 뜯김이나 깨짐 등에 대해서도 관찰한다.  | 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0075 | 였으며, 연구 결과 붕해제 함량은 2.5 % 이상이어야 한다.  | 분무속도 | 25~30 mL/분 | 주성분 ○○ | 0.05-0.1% 범위 내에 있음 | 낮은 분무속도는 방울 크기를 감소시키고 증발을 높여서 | 높여서 낮은 코팅 효율성 및 빠른 약물방출을 초래할 | 0.05-0.1% 범위 내에 있음 |\n| (m3/시간) | 생략할 수 있다.  | 2 | 결합액의 | 험실 시험에서 여러 등급의 에틸셀룰로오스들을 평가하였다.  | 주)에서 시험하였다. ",
        "original_sentence": "| 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0075 | 였으며, 연구 결과 붕해제 함량은 2.5 % 이상이어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_120",
      "text": "| 분무속도 | 25~30 mL/분 | 주성분 ○○ | 0.05-0.1% 범위 내에 있음 | 낮은 분무속도는 방울 크기를 감소시키고 증발을 높여서 | 높여서 낮은 코팅 효율성 및 빠른 약물방출을 초래할 | 0.05-0.1% 범위 내에 있음 |\n| (m3/시간) | 생략할 수 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 119,
        "window_size": 3,
        "char_count": 158,
        "word_count": 42,
        "page_number": 5,
        "window_text": "| 기술되어 있으므로 생동성을 보증하는데 빠른 용출이 중요할 것으로 판단된다.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 총: 2.0 % 이하 | 코팅 효율성 | 75.8% | 99.2% | 80~100 | 480~600 | 평균: 99.1% | 1.4 % | □ 예(☞지침) | ■ 아니오 |\n| 불균일, 연질화, 뜯김이나 깨짐 등에 대해서도 관찰한다.  | 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0075 | 였으며, 연구 결과 붕해제 함량은 2.5 % 이상이어야 한다.  | 분무속도 | 25~30 mL/분 | 주성분 ○○ | 0.05-0.1% 범위 내에 있음 | 낮은 분무속도는 방울 크기를 감소시키고 증발을 높여서 | 높여서 낮은 코팅 효율성 및 빠른 약물방출을 초래할 | 0.05-0.1% 범위 내에 있음 |\n| (m3/시간) | 생략할 수 있다.  | 2 | 결합액의 | 험실 시험에서 여러 등급의 에틸셀룰로오스들을 평가하였다.  | 주)에서 시험하였다.  아래 표에 기재한 대로, 아스코르브산과 부틸레이티드히드록시아니 | 가혹 조건 | 시험액 | 인산염완충액(pH 6.8) | 용출액 | pH 4.5 완충액 | (출하, 안정성) | % 함량 | peak purity | peak purity | 여 선형 스케일업 | 확인된 | peak purity | peak purity |\n| 2.3.P.5 완제의약품의 관리(제품명, 제형) ………………………………………………… 23 | 필요하다. ",
        "original_sentence": "| 분무속도 | 25~30 mL/분 | 주성분 ○○ | 0.05-0.1% 범위 내에 있음 | 낮은 분무속도는 방울 크기를 감소시키고 증발을 높여서 | 높여서 낮은 코팅 효율성 및 빠른 약물방출을 초래할 | 0.05-0.1% 범위 내에 있음 |\n| (m3/시간) | 생략할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_121",
      "text": "| 2 | 결합액의 | 험실 시험에서 여러 등급의 에틸셀룰로오스들을 평가하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 120,
        "window_size": 3,
        "char_count": 45,
        "word_count": 11,
        "page_number": 5,
        "window_text": "| □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 총: 2.0 % 이하 | 코팅 효율성 | 75.8% | 99.2% | 80~100 | 480~600 | 평균: 99.1% | 1.4 % | □ 예(☞지침) | ■ 아니오 |\n| 불균일, 연질화, 뜯김이나 깨짐 등에 대해서도 관찰한다.  | 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0075 | 였으며, 연구 결과 붕해제 함량은 2.5 % 이상이어야 한다.  | 분무속도 | 25~30 mL/분 | 주성분 ○○ | 0.05-0.1% 범위 내에 있음 | 낮은 분무속도는 방울 크기를 감소시키고 증발을 높여서 | 높여서 낮은 코팅 효율성 및 빠른 약물방출을 초래할 | 0.05-0.1% 범위 내에 있음 |\n| (m3/시간) | 생략할 수 있다.  | 2 | 결합액의 | 험실 시험에서 여러 등급의 에틸셀룰로오스들을 평가하였다.  | 주)에서 시험하였다.  아래 표에 기재한 대로, 아스코르브산과 부틸레이티드히드록시아니 | 가혹 조건 | 시험액 | 인산염완충액(pH 6.8) | 용출액 | pH 4.5 완충액 | (출하, 안정성) | % 함량 | peak purity | peak purity | 여 선형 스케일업 | 확인된 | peak purity | peak purity |\n| 2.3.P.5 완제의약품의 관리(제품명, 제형) ………………………………………………… 23 | 필요하다.  (예: 분해산물, 잔류용매, 무기불순물 등) | 건조 | Fluid Bed Dryer | STREA 1 | MP 4 | MP 6 | 사무의 세부기준이나 절차를 제시하는 것입니까? ",
        "original_sentence": "| 2 | 결합액의 | 험실 시험에서 여러 등급의 에틸셀룰로오스들을 평가하였다. "
      }
    },
    {
      "chunk_id": "chunk_122",
      "text": "| 주)에서 시험하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 121,
        "window_size": 3,
        "char_count": 14,
        "word_count": 3,
        "page_number": 32,
        "window_text": "| 부틸레이티드히드록시아니솔 | 항산화제/안정화제 | 0.0075 | 였으며, 연구 결과 붕해제 함량은 2.5 % 이상이어야 한다.  | 분무속도 | 25~30 mL/분 | 주성분 ○○ | 0.05-0.1% 범위 내에 있음 | 낮은 분무속도는 방울 크기를 감소시키고 증발을 높여서 | 높여서 낮은 코팅 효율성 및 빠른 약물방출을 초래할 | 0.05-0.1% 범위 내에 있음 |\n| (m3/시간) | 생략할 수 있다.  | 2 | 결합액의 | 험실 시험에서 여러 등급의 에틸셀룰로오스들을 평가하였다.  | 주)에서 시험하였다.  아래 표에 기재한 대로, 아스코르브산과 부틸레이티드히드록시아니 | 가혹 조건 | 시험액 | 인산염완충액(pH 6.8) | 용출액 | pH 4.5 완충액 | (출하, 안정성) | % 함량 | peak purity | peak purity | 여 선형 스케일업 | 확인된 | peak purity | peak purity |\n| 2.3.P.5 완제의약품의 관리(제품명, 제형) ………………………………………………… 23 | 필요하다.  (예: 분해산물, 잔류용매, 무기불순물 등) | 건조 | Fluid Bed Dryer | STREA 1 | MP 4 | MP 6 | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 원료 | 약물 층화 | 서방 코팅 | 캡슐충진 |\n| 하였다. ",
        "original_sentence": "| 주)에서 시험하였다. "
      }
    },
    {
      "chunk_id": "chunk_123",
      "text": "아래 표에 기재한 대로, 아스코르브산과 부틸레이티드히드록시아니 | 가혹 조건 | 시험액 | 인산염완충액(pH 6.8) | 용출액 | pH 4.5 완충액 | (출하, 안정성) | % 함량 | peak purity | peak purity | 여 선형 스케일업 | 확인된 | peak purity | peak purity |\n| 2.3.P.5 완제의약품의 관리(제품명, 제형) ………………………………………………… 23 | 필요하다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 122,
        "window_size": 3,
        "char_count": 240,
        "word_count": 54,
        "page_number": 3,
        "window_text": "| 분무속도 | 25~30 mL/분 | 주성분 ○○ | 0.05-0.1% 범위 내에 있음 | 낮은 분무속도는 방울 크기를 감소시키고 증발을 높여서 | 높여서 낮은 코팅 효율성 및 빠른 약물방출을 초래할 | 0.05-0.1% 범위 내에 있음 |\n| (m3/시간) | 생략할 수 있다.  | 2 | 결합액의 | 험실 시험에서 여러 등급의 에틸셀룰로오스들을 평가하였다.  | 주)에서 시험하였다.  아래 표에 기재한 대로, 아스코르브산과 부틸레이티드히드록시아니 | 가혹 조건 | 시험액 | 인산염완충액(pH 6.8) | 용출액 | pH 4.5 완충액 | (출하, 안정성) | % 함량 | peak purity | peak purity | 여 선형 스케일업 | 확인된 | peak purity | peak purity |\n| 2.3.P.5 완제의약품의 관리(제품명, 제형) ………………………………………………… 23 | 필요하다.  (예: 분해산물, 잔류용매, 무기불순물 등) | 건조 | Fluid Bed Dryer | STREA 1 | MP 4 | MP 6 | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 원료 | 약물 층화 | 서방 코팅 | 캡슐충진 |\n| 하였다.  관련 보고서와 시험성적서는 3.2.S.5 표준품 또는 표준물질을 참고한다. ",
        "original_sentence": "아래 표에 기재한 대로, 아스코르브산과 부틸레이티드히드록시아니 | 가혹 조건 | 시험액 | 인산염완충액(pH 6.8) | 용출액 | pH 4.5 완충액 | (출하, 안정성) | % 함량 | peak purity | peak purity | 여 선형 스케일업 | 확인된 | peak purity | peak purity |\n| 2.3.P.5 완제의약품의 관리(제품명, 제형) ………………………………………………… 23 | 필요하다. "
      }
    },
    {
      "chunk_id": "chunk_124",
      "text": "(예: 분해산물, 잔류용매, 무기불순물 등) | 건조 | Fluid Bed Dryer | STREA 1 | MP 4 | MP 6 | 사무의 세부기준이나 절차를 제시하는 것입니까? ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 123,
        "window_size": 3,
        "char_count": 100,
        "word_count": 26,
        "page_number": 9,
        "window_text": "| 2 | 결합액의 | 험실 시험에서 여러 등급의 에틸셀룰로오스들을 평가하였다.  | 주)에서 시험하였다.  아래 표에 기재한 대로, 아스코르브산과 부틸레이티드히드록시아니 | 가혹 조건 | 시험액 | 인산염완충액(pH 6.8) | 용출액 | pH 4.5 완충액 | (출하, 안정성) | % 함량 | peak purity | peak purity | 여 선형 스케일업 | 확인된 | peak purity | peak purity |\n| 2.3.P.5 완제의약품의 관리(제품명, 제형) ………………………………………………… 23 | 필요하다.  (예: 분해산물, 잔류용매, 무기불순물 등) | 건조 | Fluid Bed Dryer | STREA 1 | MP 4 | MP 6 | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 원료 | 약물 층화 | 서방 코팅 | 캡슐충진 |\n| 하였다.  관련 보고서와 시험성적서는 3.2.S.5 표준품 또는 표준물질을 참고한다.  | 시험 | USP<905>에 따라 시험할 때 적합 | USP | 정제수2 | 용매 | 약물방출 (1시간) | 2% | 25% | 결합제 ○○ | 증가 경향 보임(0.7%) | 수 있음 | 이상 없음 (<0.3%) | RSD: 0.8% |\n| 발 | 행 | 인 | 원료의약품 입자도 시험 | 손 여 원 | threshold | 약물/결합제가 펠렛 중심에 부착하기 어려워짐에 따라 코 | angle | 분해생성물 | threshold | angle |\n| 주입 기체 온도(℃) | 45~55 | 45~55 | 스케일 독립 변수 | 중간체 관리, 공정 밸리데이션 및 평가, 제조공정개발 등의 내용을 요약하여 기재한다. ",
        "original_sentence": "(예: 분해산물, 잔류용매, 무기불순물 등) | 건조 | Fluid Bed Dryer | STREA 1 | MP 4 | MP 6 | 사무의 세부기준이나 절차를 제시하는 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_125",
      "text": "(공무원용) | 원료 | 약물 층화 | 서방 코팅 | 캡슐충진 |\n| 하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 124,
        "window_size": 3,
        "char_count": 44,
        "word_count": 14,
        "page_number": 20,
        "window_text": "| 주)에서 시험하였다.  아래 표에 기재한 대로, 아스코르브산과 부틸레이티드히드록시아니 | 가혹 조건 | 시험액 | 인산염완충액(pH 6.8) | 용출액 | pH 4.5 완충액 | (출하, 안정성) | % 함량 | peak purity | peak purity | 여 선형 스케일업 | 확인된 | peak purity | peak purity |\n| 2.3.P.5 완제의약품의 관리(제품명, 제형) ………………………………………………… 23 | 필요하다.  (예: 분해산물, 잔류용매, 무기불순물 등) | 건조 | Fluid Bed Dryer | STREA 1 | MP 4 | MP 6 | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 원료 | 약물 층화 | 서방 코팅 | 캡슐충진 |\n| 하였다.  관련 보고서와 시험성적서는 3.2.S.5 표준품 또는 표준물질을 참고한다.  | 시험 | USP<905>에 따라 시험할 때 적합 | USP | 정제수2 | 용매 | 약물방출 (1시간) | 2% | 25% | 결합제 ○○ | 증가 경향 보임(0.7%) | 수 있음 | 이상 없음 (<0.3%) | RSD: 0.8% |\n| 발 | 행 | 인 | 원료의약품 입자도 시험 | 손 여 원 | threshold | 약물/결합제가 펠렛 중심에 부착하기 어려워짐에 따라 코 | angle | 분해생성물 | threshold | angle |\n| 주입 기체 온도(℃) | 45~55 | 45~55 | 스케일 독립 변수 | 중간체 관리, 공정 밸리데이션 및 평가, 제조공정개발 등의 내용을 요약하여 기재한다.  | 예 시 | 분무속도* | 15 ~ 20 mL/분 | 시험액의 양 | 900 mL | 조제 | 용량 | 900 mL |\n| 총 유연물질 (1.0% 이하) | 상세 사항은 3.2.P.8.1 안정성 요약과 결론과 3.2.P.8.3 안정성 자료를 참고한다. ",
        "original_sentence": "(공무원용) | 원료 | 약물 층화 | 서방 코팅 | 캡슐충진 |\n| 하였다. "
      }
    },
    {
      "chunk_id": "chunk_126",
      "text": "관련 보고서와 시험성적서는 3.2.S.5 표준품 또는 표준물질을 참고한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 125,
        "window_size": 3,
        "char_count": 42,
        "word_count": 8,
        "page_number": 5,
        "window_text": "아래 표에 기재한 대로, 아스코르브산과 부틸레이티드히드록시아니 | 가혹 조건 | 시험액 | 인산염완충액(pH 6.8) | 용출액 | pH 4.5 완충액 | (출하, 안정성) | % 함량 | peak purity | peak purity | 여 선형 스케일업 | 확인된 | peak purity | peak purity |\n| 2.3.P.5 완제의약품의 관리(제품명, 제형) ………………………………………………… 23 | 필요하다.  (예: 분해산물, 잔류용매, 무기불순물 등) | 건조 | Fluid Bed Dryer | STREA 1 | MP 4 | MP 6 | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 원료 | 약물 층화 | 서방 코팅 | 캡슐충진 |\n| 하였다.  관련 보고서와 시험성적서는 3.2.S.5 표준품 또는 표준물질을 참고한다.  | 시험 | USP<905>에 따라 시험할 때 적합 | USP | 정제수2 | 용매 | 약물방출 (1시간) | 2% | 25% | 결합제 ○○ | 증가 경향 보임(0.7%) | 수 있음 | 이상 없음 (<0.3%) | RSD: 0.8% |\n| 발 | 행 | 인 | 원료의약품 입자도 시험 | 손 여 원 | threshold | 약물/결합제가 펠렛 중심에 부착하기 어려워짐에 따라 코 | angle | 분해생성물 | threshold | angle |\n| 주입 기체 온도(℃) | 45~55 | 45~55 | 스케일 독립 변수 | 중간체 관리, 공정 밸리데이션 및 평가, 제조공정개발 등의 내용을 요약하여 기재한다.  | 예 시 | 분무속도* | 15 ~ 20 mL/분 | 시험액의 양 | 900 mL | 조제 | 용량 | 900 mL |\n| 총 유연물질 (1.0% 이하) | 상세 사항은 3.2.P.8.1 안정성 요약과 결론과 3.2.P.8.3 안정성 자료를 참고한다.  | 분쇄 | Impact Mill | 순도 | 높음 | 완제의약품 제조에 사용된다. ",
        "original_sentence": "관련 보고서와 시험성적서는 3.2.S.5 표준품 또는 표준물질을 참고한다. "
      }
    },
    {
      "chunk_id": "chunk_127",
      "text": "| 시험 | USP<905>에 따라 시험할 때 적합 | USP | 정제수2 | 용매 | 약물방출 (1시간) | 2% | 25% | 결합제 ○○ | 증가 경향 보임(0.7%) | 수 있음 | 이상 없음 (<0.3%) | RSD: 0.8% |\n| 발 | 행 | 인 | 원료의약품 입자도 시험 | 손 여 원 | threshold | 약물/결합제가 펠렛 중심에 부착하기 어려워짐에 따라 코 | angle | 분해생성물 | threshold | angle |\n| 주입 기체 온도(℃) | 45~55 | 45~55 | 스케일 독립 변수 | 중간체 관리, 공정 밸리데이션 및 평가, 제조공정개발 등의 내용을 요약하여 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 126,
        "window_size": 3,
        "char_count": 344,
        "word_count": 96,
        "page_number": 5,
        "window_text": "(예: 분해산물, 잔류용매, 무기불순물 등) | 건조 | Fluid Bed Dryer | STREA 1 | MP 4 | MP 6 | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 원료 | 약물 층화 | 서방 코팅 | 캡슐충진 |\n| 하였다.  관련 보고서와 시험성적서는 3.2.S.5 표준품 또는 표준물질을 참고한다.  | 시험 | USP<905>에 따라 시험할 때 적합 | USP | 정제수2 | 용매 | 약물방출 (1시간) | 2% | 25% | 결합제 ○○ | 증가 경향 보임(0.7%) | 수 있음 | 이상 없음 (<0.3%) | RSD: 0.8% |\n| 발 | 행 | 인 | 원료의약품 입자도 시험 | 손 여 원 | threshold | 약물/결합제가 펠렛 중심에 부착하기 어려워짐에 따라 코 | angle | 분해생성물 | threshold | angle |\n| 주입 기체 온도(℃) | 45~55 | 45~55 | 스케일 독립 변수 | 중간체 관리, 공정 밸리데이션 및 평가, 제조공정개발 등의 내용을 요약하여 기재한다.  | 예 시 | 분무속도* | 15 ~ 20 mL/분 | 시험액의 양 | 900 mL | 조제 | 용량 | 900 mL |\n| 총 유연물질 (1.0% 이하) | 상세 사항은 3.2.P.8.1 안정성 요약과 결론과 3.2.P.8.3 안정성 자료를 참고한다.  | 분쇄 | Impact Mill | 순도 | 높음 | 완제의약품 제조에 사용된다.  | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 제조용수 미생물한도시험 | 품질 위수탁 | 정제수 |\n| 2.3.P.6 표준품 또는 표준물질(제품명, 제형) …………………………………………… 34 | 총 질량 (속방 펠렛) | 65.0 | 구분 | 0.2% 이하로 설정하였다. ",
        "original_sentence": "| 시험 | USP<905>에 따라 시험할 때 적합 | USP | 정제수2 | 용매 | 약물방출 (1시간) | 2% | 25% | 결합제 ○○ | 증가 경향 보임(0.7%) | 수 있음 | 이상 없음 (<0.3%) | RSD: 0.8% |\n| 발 | 행 | 인 | 원료의약품 입자도 시험 | 손 여 원 | threshold | 약물/결합제가 펠렛 중심에 부착하기 어려워짐에 따라 코 | angle | 분해생성물 | threshold | angle |\n| 주입 기체 온도(℃) | 45~55 | 45~55 | 스케일 독립 변수 | 중간체 관리, 공정 밸리데이션 및 평가, 제조공정개발 등의 내용을 요약하여 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_128",
      "text": "| 예 시 | 분무속도* | 15 ~ 20 mL/분 | 시험액의 양 | 900 mL | 조제 | 용량 | 900 mL |\n| 총 유연물질 (1.0% 이하) | 상세 사항은 3.2.P.8.1 안정성 요약과 결론과 3.2.P.8.3 안정성 자료를 참고한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 127,
        "window_size": 3,
        "char_count": 142,
        "word_count": 40,
        "page_number": 5,
        "window_text": "(공무원용) | 원료 | 약물 층화 | 서방 코팅 | 캡슐충진 |\n| 하였다.  관련 보고서와 시험성적서는 3.2.S.5 표준품 또는 표준물질을 참고한다.  | 시험 | USP<905>에 따라 시험할 때 적합 | USP | 정제수2 | 용매 | 약물방출 (1시간) | 2% | 25% | 결합제 ○○ | 증가 경향 보임(0.7%) | 수 있음 | 이상 없음 (<0.3%) | RSD: 0.8% |\n| 발 | 행 | 인 | 원료의약품 입자도 시험 | 손 여 원 | threshold | 약물/결합제가 펠렛 중심에 부착하기 어려워짐에 따라 코 | angle | 분해생성물 | threshold | angle |\n| 주입 기체 온도(℃) | 45~55 | 45~55 | 스케일 독립 변수 | 중간체 관리, 공정 밸리데이션 및 평가, 제조공정개발 등의 내용을 요약하여 기재한다.  | 예 시 | 분무속도* | 15 ~ 20 mL/분 | 시험액의 양 | 900 mL | 조제 | 용량 | 900 mL |\n| 총 유연물질 (1.0% 이하) | 상세 사항은 3.2.P.8.1 안정성 요약과 결론과 3.2.P.8.3 안정성 자료를 참고한다.  | 분쇄 | Impact Mill | 순도 | 높음 | 완제의약품 제조에 사용된다.  | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 제조용수 미생물한도시험 | 품질 위수탁 | 정제수 |\n| 2.3.P.6 표준품 또는 표준물질(제품명, 제형) …………………………………………… 34 | 총 질량 (속방 펠렛) | 65.0 | 구분 | 0.2% 이하로 설정하였다.  | 미처리 | 약물방출 (4시간) | 25% | 64% | 팅효율성 및 함량균일성이 떨어짐. ",
        "original_sentence": "| 예 시 | 분무속도* | 15 ~ 20 mL/분 | 시험액의 양 | 900 mL | 조제 | 용량 | 900 mL |\n| 총 유연물질 (1.0% 이하) | 상세 사항은 3.2.P.8.1 안정성 요약과 결론과 3.2.P.8.3 안정성 자료를 참고한다. "
      }
    },
    {
      "chunk_id": "chunk_129",
      "text": "| 분쇄 | Impact Mill | 순도 | 높음 | 완제의약품 제조에 사용된다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 128,
        "window_size": 3,
        "char_count": 47,
        "word_count": 13,
        "page_number": 9,
        "window_text": "관련 보고서와 시험성적서는 3.2.S.5 표준품 또는 표준물질을 참고한다.  | 시험 | USP<905>에 따라 시험할 때 적합 | USP | 정제수2 | 용매 | 약물방출 (1시간) | 2% | 25% | 결합제 ○○ | 증가 경향 보임(0.7%) | 수 있음 | 이상 없음 (<0.3%) | RSD: 0.8% |\n| 발 | 행 | 인 | 원료의약품 입자도 시험 | 손 여 원 | threshold | 약물/결합제가 펠렛 중심에 부착하기 어려워짐에 따라 코 | angle | 분해생성물 | threshold | angle |\n| 주입 기체 온도(℃) | 45~55 | 45~55 | 스케일 독립 변수 | 중간체 관리, 공정 밸리데이션 및 평가, 제조공정개발 등의 내용을 요약하여 기재한다.  | 예 시 | 분무속도* | 15 ~ 20 mL/분 | 시험액의 양 | 900 mL | 조제 | 용량 | 900 mL |\n| 총 유연물질 (1.0% 이하) | 상세 사항은 3.2.P.8.1 안정성 요약과 결론과 3.2.P.8.3 안정성 자료를 참고한다.  | 분쇄 | Impact Mill | 순도 | 높음 | 완제의약품 제조에 사용된다.  | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 제조용수 미생물한도시험 | 품질 위수탁 | 정제수 |\n| 2.3.P.6 표준품 또는 표준물질(제품명, 제형) …………………………………………… 34 | 총 질량 (속방 펠렛) | 65.0 | 구분 | 0.2% 이하로 설정하였다.  | 미처리 | 약물방출 (4시간) | 25% | 64% | 팅효율성 및 함량균일성이 떨어짐.  빠른 분무속도는 방울 | 범위: 98.2-100.1% | ■ 예(☞안내서) | □ 아니오 |\n| Bed 온도(℃) | 35~45 | 35~45 | 스케일 독립 변수 | 수도 있다. ",
        "original_sentence": "| 분쇄 | Impact Mill | 순도 | 높음 | 완제의약품 제조에 사용된다. "
      }
    },
    {
      "chunk_id": "chunk_130",
      "text": "| □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 제조용수 미생물한도시험 | 품질 위수탁 | 정제수 |\n| 2.3.P.6 표준품 또는 표준물질(제품명, 제형) …………………………………………… 34 | 총 질량 (속방 펠렛) | 65.0 | 구분 | 0.2% 이하로 설정하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 129,
        "window_size": 3,
        "char_count": 169,
        "word_count": 40,
        "page_number": 2,
        "window_text": "| 시험 | USP<905>에 따라 시험할 때 적합 | USP | 정제수2 | 용매 | 약물방출 (1시간) | 2% | 25% | 결합제 ○○ | 증가 경향 보임(0.7%) | 수 있음 | 이상 없음 (<0.3%) | RSD: 0.8% |\n| 발 | 행 | 인 | 원료의약품 입자도 시험 | 손 여 원 | threshold | 약물/결합제가 펠렛 중심에 부착하기 어려워짐에 따라 코 | angle | 분해생성물 | threshold | angle |\n| 주입 기체 온도(℃) | 45~55 | 45~55 | 스케일 독립 변수 | 중간체 관리, 공정 밸리데이션 및 평가, 제조공정개발 등의 내용을 요약하여 기재한다.  | 예 시 | 분무속도* | 15 ~ 20 mL/분 | 시험액의 양 | 900 mL | 조제 | 용량 | 900 mL |\n| 총 유연물질 (1.0% 이하) | 상세 사항은 3.2.P.8.1 안정성 요약과 결론과 3.2.P.8.3 안정성 자료를 참고한다.  | 분쇄 | Impact Mill | 순도 | 높음 | 완제의약품 제조에 사용된다.  | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 제조용수 미생물한도시험 | 품질 위수탁 | 정제수 |\n| 2.3.P.6 표준품 또는 표준물질(제품명, 제형) …………………………………………… 34 | 총 질량 (속방 펠렛) | 65.0 | 구분 | 0.2% 이하로 설정하였다.  | 미처리 | 약물방출 (4시간) | 25% | 64% | 팅효율성 및 함량균일성이 떨어짐.  빠른 분무속도는 방울 | 범위: 98.2-100.1% | ■ 예(☞안내서) | □ 아니오 |\n| Bed 온도(℃) | 35~45 | 35~45 | 스케일 독립 변수 | 수도 있다.  | 개발을 참조한다. ",
        "original_sentence": "| □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 제조용수 미생물한도시험 | 품질 위수탁 | 정제수 |\n| 2.3.P.6 표준품 또는 표준물질(제품명, 제형) …………………………………………… 34 | 총 질량 (속방 펠렛) | 65.0 | 구분 | 0.2% 이하로 설정하였다. "
      }
    },
    {
      "chunk_id": "chunk_131",
      "text": "| 미처리 | 약물방출 (4시간) | 25% | 64% | 팅효율성 및 함량균일성이 떨어짐. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 130,
        "window_size": 3,
        "char_count": 52,
        "word_count": 14,
        "page_number": 3,
        "window_text": "| 예 시 | 분무속도* | 15 ~ 20 mL/분 | 시험액의 양 | 900 mL | 조제 | 용량 | 900 mL |\n| 총 유연물질 (1.0% 이하) | 상세 사항은 3.2.P.8.1 안정성 요약과 결론과 3.2.P.8.3 안정성 자료를 참고한다.  | 분쇄 | Impact Mill | 순도 | 높음 | 완제의약품 제조에 사용된다.  | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 제조용수 미생물한도시험 | 품질 위수탁 | 정제수 |\n| 2.3.P.6 표준품 또는 표준물질(제품명, 제형) …………………………………………… 34 | 총 질량 (속방 펠렛) | 65.0 | 구분 | 0.2% 이하로 설정하였다.  | 미처리 | 약물방출 (4시간) | 25% | 64% | 팅효율성 및 함량균일성이 떨어짐.  빠른 분무속도는 방울 | 범위: 98.2-100.1% | ■ 예(☞안내서) | □ 아니오 |\n| Bed 온도(℃) | 35~45 | 35~45 | 스케일 독립 변수 | 수도 있다.  | 개발을 참조한다.  | 성분명 | 규격 | 배합목적 | 질량/정(mg) | 비고 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 0.5 - 0.8% 범위 내에 있음 | 최적 분무속도(25~30 mL/분)에서 약물미세화 기압은 | < 0.3% 범위 내에 있음 |\n| 기재한다. ",
        "original_sentence": "| 미처리 | 약물방출 (4시간) | 25% | 64% | 팅효율성 및 함량균일성이 떨어짐. "
      }
    },
    {
      "chunk_id": "chunk_132",
      "text": "빠른 분무속도는 방울 | 범위: 98.2-100.1% | ■ 예(☞안내서) | □ 아니오 |\n| Bed 온도(℃) | 35~45 | 35~45 | 스케일 독립 변수 | 수도 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 131,
        "window_size": 3,
        "char_count": 101,
        "word_count": 27,
        "page_number": 2,
        "window_text": "| 분쇄 | Impact Mill | 순도 | 높음 | 완제의약품 제조에 사용된다.  | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 제조용수 미생물한도시험 | 품질 위수탁 | 정제수 |\n| 2.3.P.6 표준품 또는 표준물질(제품명, 제형) …………………………………………… 34 | 총 질량 (속방 펠렛) | 65.0 | 구분 | 0.2% 이하로 설정하였다.  | 미처리 | 약물방출 (4시간) | 25% | 64% | 팅효율성 및 함량균일성이 떨어짐.  빠른 분무속도는 방울 | 범위: 98.2-100.1% | ■ 예(☞안내서) | □ 아니오 |\n| Bed 온도(℃) | 35~45 | 35~45 | 스케일 독립 변수 | 수도 있다.  | 개발을 참조한다.  | 성분명 | 규격 | 배합목적 | 질량/정(mg) | 비고 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 0.5 - 0.8% 범위 내에 있음 | 최적 분무속도(25~30 mL/분)에서 약물미세화 기압은 | < 0.3% 범위 내에 있음 |\n| 기재한다.  | 해 설 | 최종 제제에 선택되었다. ",
        "original_sentence": "빠른 분무속도는 방울 | 범위: 98.2-100.1% | ■ 예(☞안내서) | □ 아니오 |\n| Bed 온도(℃) | 35~45 | 35~45 | 스케일 독립 변수 | 수도 있다. "
      }
    },
    {
      "chunk_id": "chunk_133",
      "text": "| 개발을 참조한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 132,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 13,
        "window_text": "| □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 제조용수 미생물한도시험 | 품질 위수탁 | 정제수 |\n| 2.3.P.6 표준품 또는 표준물질(제품명, 제형) …………………………………………… 34 | 총 질량 (속방 펠렛) | 65.0 | 구분 | 0.2% 이하로 설정하였다.  | 미처리 | 약물방출 (4시간) | 25% | 64% | 팅효율성 및 함량균일성이 떨어짐.  빠른 분무속도는 방울 | 범위: 98.2-100.1% | ■ 예(☞안내서) | □ 아니오 |\n| Bed 온도(℃) | 35~45 | 35~45 | 스케일 독립 변수 | 수도 있다.  | 개발을 참조한다.  | 성분명 | 규격 | 배합목적 | 질량/정(mg) | 비고 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 0.5 - 0.8% 범위 내에 있음 | 최적 분무속도(25~30 mL/분)에서 약물미세화 기압은 | < 0.3% 범위 내에 있음 |\n| 기재한다.  | 해 설 | 최종 제제에 선택되었다.  부틸레이티드히드록시아니솔 0.03 mg을 사용하여 제품의 안정 | 편 집 위 원 장 | 시험액의 온도 | 37 ℃ | 온도 | 37 ℃ | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까? ",
        "original_sentence": "| 개발을 참조한다. "
      }
    },
    {
      "chunk_id": "chunk_134",
      "text": "| 성분명 | 규격 | 배합목적 | 질량/정(mg) | 비고 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 0.5 - 0.8% 범위 내에 있음 | 최적 분무속도(25~30 mL/분)에서 약물미세화 기압은 | < 0.3% 범위 내에 있음 |\n| 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 133,
        "window_size": 3,
        "char_count": 158,
        "word_count": 43,
        "page_number": 19,
        "window_text": "| 미처리 | 약물방출 (4시간) | 25% | 64% | 팅효율성 및 함량균일성이 떨어짐.  빠른 분무속도는 방울 | 범위: 98.2-100.1% | ■ 예(☞안내서) | □ 아니오 |\n| Bed 온도(℃) | 35~45 | 35~45 | 스케일 독립 변수 | 수도 있다.  | 개발을 참조한다.  | 성분명 | 규격 | 배합목적 | 질량/정(mg) | 비고 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 0.5 - 0.8% 범위 내에 있음 | 최적 분무속도(25~30 mL/분)에서 약물미세화 기압은 | < 0.3% 범위 내에 있음 |\n| 기재한다.  | 해 설 | 최종 제제에 선택되었다.  부틸레이티드히드록시아니솔 0.03 mg을 사용하여 제품의 안정 | 편 집 위 원 장 | 시험액의 온도 | 37 ℃ | 온도 | 37 ℃ | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까?  (민원인용) | 이 선 희 |\n| 등을 자체적으로 검증하는 것이 바람직하다. ",
        "original_sentence": "| 성분명 | 규격 | 배합목적 | 질량/정(mg) | 비고 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 0.5 - 0.8% 범위 내에 있음 | 최적 분무속도(25~30 mL/분)에서 약물미세화 기압은 | < 0.3% 범위 내에 있음 |\n| 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_135",
      "text": "| 해 설 | 최종 제제에 선택되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 134,
        "window_size": 3,
        "char_count": 22,
        "word_count": 7,
        "page_number": 7,
        "window_text": "빠른 분무속도는 방울 | 범위: 98.2-100.1% | ■ 예(☞안내서) | □ 아니오 |\n| Bed 온도(℃) | 35~45 | 35~45 | 스케일 독립 변수 | 수도 있다.  | 개발을 참조한다.  | 성분명 | 규격 | 배합목적 | 질량/정(mg) | 비고 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 0.5 - 0.8% 범위 내에 있음 | 최적 분무속도(25~30 mL/분)에서 약물미세화 기압은 | < 0.3% 범위 내에 있음 |\n| 기재한다.  | 해 설 | 최종 제제에 선택되었다.  부틸레이티드히드록시아니솔 0.03 mg을 사용하여 제품의 안정 | 편 집 위 원 장 | 시험액의 온도 | 37 ℃ | 온도 | 37 ℃ | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까?  (민원인용) | 이 선 희 |\n| 등을 자체적으로 검증하는 것이 바람직하다.  | 함량/함량균일성 | 높음 | 높음 | 분류 | 설명 | 제조원 | RC2: 0.5% 이하 | 크기를 증가시켜서 제품이 응집되어 수율이 낮아짐 | 각 원료를 oo mesh체로 체과 후 | 0.2% |\n| 용출 | 적합 (93-98%), S1만 적용 | 적합 (95-100%), S1만 적용 | 예 시 | 조건 1 (고온) | 경질젤라틴캡슐 | 상부/하부 | Size #1 | 약물방출 (8시간) | 55% | 88% | 가혹 조건 | % 함량 | 피크 순도 | 적절한 서방코팅을 보장하기 위해 중요한 방울 크기를 |\n| 분무 속도(mL/분) | 15~20 | 90~120 | 분포-플레이트 면적 비율에 근거하여 | 2.3.P.7 용기 및 포장(제품명, 제형) …………………………………………………… 35 | 유연물질명 | 허용기준 | 직선성 | 정밀성 | 정확성 | 검출한계 | 성분명 | 배합목적 | 제조원명 | 등급 | 규격 | 뱃치 제조에 | 주성분 | USP | 주성분 | 2.00 | 부형제 ○○ | 중요공정 | 정량한계 |\n| (수행업무) 및 수탁업소를 기재한다. ",
        "original_sentence": "| 해 설 | 최종 제제에 선택되었다. "
      }
    },
    {
      "chunk_id": "chunk_136",
      "text": "부틸레이티드히드록시아니솔 0.03 mg을 사용하여 제품의 안정 | 편 집 위 원 장 | 시험액의 온도 | 37 ℃ | 온도 | 37 ℃ | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까? ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 135,
        "window_size": 3,
        "char_count": 135,
        "word_count": 39,
        "page_number": 3,
        "window_text": "| 개발을 참조한다.  | 성분명 | 규격 | 배합목적 | 질량/정(mg) | 비고 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 0.5 - 0.8% 범위 내에 있음 | 최적 분무속도(25~30 mL/분)에서 약물미세화 기압은 | < 0.3% 범위 내에 있음 |\n| 기재한다.  | 해 설 | 최종 제제에 선택되었다.  부틸레이티드히드록시아니솔 0.03 mg을 사용하여 제품의 안정 | 편 집 위 원 장 | 시험액의 온도 | 37 ℃ | 온도 | 37 ℃ | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까?  (민원인용) | 이 선 희 |\n| 등을 자체적으로 검증하는 것이 바람직하다.  | 함량/함량균일성 | 높음 | 높음 | 분류 | 설명 | 제조원 | RC2: 0.5% 이하 | 크기를 증가시켜서 제품이 응집되어 수율이 낮아짐 | 각 원료를 oo mesh체로 체과 후 | 0.2% |\n| 용출 | 적합 (93-98%), S1만 적용 | 적합 (95-100%), S1만 적용 | 예 시 | 조건 1 (고온) | 경질젤라틴캡슐 | 상부/하부 | Size #1 | 약물방출 (8시간) | 55% | 88% | 가혹 조건 | % 함량 | 피크 순도 | 적절한 서방코팅을 보장하기 위해 중요한 방울 크기를 |\n| 분무 속도(mL/분) | 15~20 | 90~120 | 분포-플레이트 면적 비율에 근거하여 | 2.3.P.7 용기 및 포장(제품명, 제형) …………………………………………………… 35 | 유연물질명 | 허용기준 | 직선성 | 정밀성 | 정확성 | 검출한계 | 성분명 | 배합목적 | 제조원명 | 등급 | 규격 | 뱃치 제조에 | 주성분 | USP | 주성분 | 2.00 | 부형제 ○○ | 중요공정 | 정량한계 |\n| (수행업무) 및 수탁업소를 기재한다.  | 최종혼합 | Bin-Blender | Size 5 L | Size 100 L | Size 1000 L | 해 설 | 성을 갖도록 한다. ",
        "original_sentence": "부틸레이티드히드록시아니솔 0.03 mg을 사용하여 제품의 안정 | 편 집 위 원 장 | 시험액의 온도 | 37 ℃ | 온도 | 37 ℃ | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_137",
      "text": "(민원인용) | 이 선 희 |\n| 등을 자체적으로 검증하는 것이 바람직하다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 136,
        "window_size": 3,
        "char_count": 43,
        "word_count": 12,
        "page_number": 3,
        "window_text": "| 성분명 | 규격 | 배합목적 | 질량/정(mg) | 비고 | (FitzSieve) | FS 75 | FS 200 | FS 200 | 0.5 - 0.8% 범위 내에 있음 | 최적 분무속도(25~30 mL/분)에서 약물미세화 기압은 | < 0.3% 범위 내에 있음 |\n| 기재한다.  | 해 설 | 최종 제제에 선택되었다.  부틸레이티드히드록시아니솔 0.03 mg을 사용하여 제품의 안정 | 편 집 위 원 장 | 시험액의 온도 | 37 ℃ | 온도 | 37 ℃ | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까?  (민원인용) | 이 선 희 |\n| 등을 자체적으로 검증하는 것이 바람직하다.  | 함량/함량균일성 | 높음 | 높음 | 분류 | 설명 | 제조원 | RC2: 0.5% 이하 | 크기를 증가시켜서 제품이 응집되어 수율이 낮아짐 | 각 원료를 oo mesh체로 체과 후 | 0.2% |\n| 용출 | 적합 (93-98%), S1만 적용 | 적합 (95-100%), S1만 적용 | 예 시 | 조건 1 (고온) | 경질젤라틴캡슐 | 상부/하부 | Size #1 | 약물방출 (8시간) | 55% | 88% | 가혹 조건 | % 함량 | 피크 순도 | 적절한 서방코팅을 보장하기 위해 중요한 방울 크기를 |\n| 분무 속도(mL/분) | 15~20 | 90~120 | 분포-플레이트 면적 비율에 근거하여 | 2.3.P.7 용기 및 포장(제품명, 제형) …………………………………………………… 35 | 유연물질명 | 허용기준 | 직선성 | 정밀성 | 정확성 | 검출한계 | 성분명 | 배합목적 | 제조원명 | 등급 | 규격 | 뱃치 제조에 | 주성분 | USP | 주성분 | 2.00 | 부형제 ○○ | 중요공정 | 정량한계 |\n| (수행업무) 및 수탁업소를 기재한다.  | 최종혼합 | Bin-Blender | Size 5 L | Size 100 L | Size 1000 L | 해 설 | 성을 갖도록 한다.  | 약물미세화 기압 | 1.5 bar | 장치 | 회전검체통법 | 시험법 | 2 법(패들법) | Convection mixer |\n| 편 | 집 | 위 | 원 | 병포장 | 60 mL, 흰색 원형 HDPE 병 (60, 100정) | Bottle.Co | 용출 | 높음 | 높음 | 높음 | .. | RC3: 0.5% 이하 | 총 충진물 질량 | 281.0 | 김은정, 양성준, 이경신, 김선미, 윤나영, 강나루, | 유연물질 | 0.2% |\n| 3 | 혼합 | 미처리 | 99% | >0.99 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | 약물방출 f2값 | 활택제 ○○ | 최적 분무속도에서 약물미세화 기압을 1.0 bar로 하면 | 30μm로 만든다. ",
        "original_sentence": "(민원인용) | 이 선 희 |\n| 등을 자체적으로 검증하는 것이 바람직하다. "
      }
    },
    {
      "chunk_id": "chunk_138",
      "text": "| 함량/함량균일성 | 높음 | 높음 | 분류 | 설명 | 제조원 | RC2: 0.5% 이하 | 크기를 증가시켜서 제품이 응집되어 수율이 낮아짐 | 각 원료를 oo mesh체로 체과 후 | 0.2% |\n| 용출 | 적합 (93-98%), S1만 적용 | 적합 (95-100%), S1만 적용 | 예 시 | 조건 1 (고온) | 경질젤라틴캡슐 | 상부/하부 | Size #1 | 약물방출 (8시간) | 55% | 88% | 가혹 조건 | % 함량 | 피크 순도 | 적절한 서방코팅을 보장하기 위해 중요한 방울 크기를 |\n| 분무 속도(mL/분) | 15~20 | 90~120 | 분포-플레이트 면적 비율에 근거하여 | 2.3.P.7 용기 및 포장(제품명, 제형) …………………………………………………… 35 | 유연물질명 | 허용기준 | 직선성 | 정밀성 | 정확성 | 검출한계 | 성분명 | 배합목적 | 제조원명 | 등급 | 규격 | 뱃치 제조에 | 주성분 | USP | 주성분 | 2.00 | 부형제 ○○ | 중요공정 | 정량한계 |\n| (수행업무) 및 수탁업소를 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 137,
        "window_size": 3,
        "char_count": 546,
        "word_count": 150,
        "page_number": 3,
        "window_text": "| 해 설 | 최종 제제에 선택되었다.  부틸레이티드히드록시아니솔 0.03 mg을 사용하여 제품의 안정 | 편 집 위 원 장 | 시험액의 온도 | 37 ℃ | 온도 | 37 ℃ | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까?  (민원인용) | 이 선 희 |\n| 등을 자체적으로 검증하는 것이 바람직하다.  | 함량/함량균일성 | 높음 | 높음 | 분류 | 설명 | 제조원 | RC2: 0.5% 이하 | 크기를 증가시켜서 제품이 응집되어 수율이 낮아짐 | 각 원료를 oo mesh체로 체과 후 | 0.2% |\n| 용출 | 적합 (93-98%), S1만 적용 | 적합 (95-100%), S1만 적용 | 예 시 | 조건 1 (고온) | 경질젤라틴캡슐 | 상부/하부 | Size #1 | 약물방출 (8시간) | 55% | 88% | 가혹 조건 | % 함량 | 피크 순도 | 적절한 서방코팅을 보장하기 위해 중요한 방울 크기를 |\n| 분무 속도(mL/분) | 15~20 | 90~120 | 분포-플레이트 면적 비율에 근거하여 | 2.3.P.7 용기 및 포장(제품명, 제형) …………………………………………………… 35 | 유연물질명 | 허용기준 | 직선성 | 정밀성 | 정확성 | 검출한계 | 성분명 | 배합목적 | 제조원명 | 등급 | 규격 | 뱃치 제조에 | 주성분 | USP | 주성분 | 2.00 | 부형제 ○○ | 중요공정 | 정량한계 |\n| (수행업무) 및 수탁업소를 기재한다.  | 최종혼합 | Bin-Blender | Size 5 L | Size 100 L | Size 1000 L | 해 설 | 성을 갖도록 한다.  | 약물미세화 기압 | 1.5 bar | 장치 | 회전검체통법 | 시험법 | 2 법(패들법) | Convection mixer |\n| 편 | 집 | 위 | 원 | 병포장 | 60 mL, 흰색 원형 HDPE 병 (60, 100정) | Bottle.Co | 용출 | 높음 | 높음 | 높음 | .. | RC3: 0.5% 이하 | 총 충진물 질량 | 281.0 | 김은정, 양성준, 이경신, 김선미, 윤나영, 강나루, | 유연물질 | 0.2% |\n| 3 | 혼합 | 미처리 | 99% | >0.99 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | 약물방출 f2값 | 활택제 ○○ | 최적 분무속도에서 약물미세화 기압을 1.0 bar로 하면 | 30μm로 만든다.  3.0 bar를 초과한 약물미세화 기압은 | 이상 없음 | 선형 스케일업 | 사용된 제조번호 | (LOD) | 이상 없음 | □ 예 | ■ 아니오 | (LOQ) |\n| 순도시험 | 수 있는 요인인 것으로 확인되었다. ",
        "original_sentence": "| 함량/함량균일성 | 높음 | 높음 | 분류 | 설명 | 제조원 | RC2: 0.5% 이하 | 크기를 증가시켜서 제품이 응집되어 수율이 낮아짐 | 각 원료를 oo mesh체로 체과 후 | 0.2% |\n| 용출 | 적합 (93-98%), S1만 적용 | 적합 (95-100%), S1만 적용 | 예 시 | 조건 1 (고온) | 경질젤라틴캡슐 | 상부/하부 | Size #1 | 약물방출 (8시간) | 55% | 88% | 가혹 조건 | % 함량 | 피크 순도 | 적절한 서방코팅을 보장하기 위해 중요한 방울 크기를 |\n| 분무 속도(mL/분) | 15~20 | 90~120 | 분포-플레이트 면적 비율에 근거하여 | 2.3.P.7 용기 및 포장(제품명, 제형) …………………………………………………… 35 | 유연물질명 | 허용기준 | 직선성 | 정밀성 | 정확성 | 검출한계 | 성분명 | 배합목적 | 제조원명 | 등급 | 규격 | 뱃치 제조에 | 주성분 | USP | 주성분 | 2.00 | 부형제 ○○ | 중요공정 | 정량한계 |\n| (수행업무) 및 수탁업소를 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_139",
      "text": "| 최종혼합 | Bin-Blender | Size 5 L | Size 100 L | Size 1000 L | 해 설 | 성을 갖도록 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 138,
        "window_size": 3,
        "char_count": 78,
        "word_count": 23,
        "page_number": 5,
        "window_text": "부틸레이티드히드록시아니솔 0.03 mg을 사용하여 제품의 안정 | 편 집 위 원 장 | 시험액의 온도 | 37 ℃ | 온도 | 37 ℃ | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까?  (민원인용) | 이 선 희 |\n| 등을 자체적으로 검증하는 것이 바람직하다.  | 함량/함량균일성 | 높음 | 높음 | 분류 | 설명 | 제조원 | RC2: 0.5% 이하 | 크기를 증가시켜서 제품이 응집되어 수율이 낮아짐 | 각 원료를 oo mesh체로 체과 후 | 0.2% |\n| 용출 | 적합 (93-98%), S1만 적용 | 적합 (95-100%), S1만 적용 | 예 시 | 조건 1 (고온) | 경질젤라틴캡슐 | 상부/하부 | Size #1 | 약물방출 (8시간) | 55% | 88% | 가혹 조건 | % 함량 | 피크 순도 | 적절한 서방코팅을 보장하기 위해 중요한 방울 크기를 |\n| 분무 속도(mL/분) | 15~20 | 90~120 | 분포-플레이트 면적 비율에 근거하여 | 2.3.P.7 용기 및 포장(제품명, 제형) …………………………………………………… 35 | 유연물질명 | 허용기준 | 직선성 | 정밀성 | 정확성 | 검출한계 | 성분명 | 배합목적 | 제조원명 | 등급 | 규격 | 뱃치 제조에 | 주성분 | USP | 주성분 | 2.00 | 부형제 ○○ | 중요공정 | 정량한계 |\n| (수행업무) 및 수탁업소를 기재한다.  | 최종혼합 | Bin-Blender | Size 5 L | Size 100 L | Size 1000 L | 해 설 | 성을 갖도록 한다.  | 약물미세화 기압 | 1.5 bar | 장치 | 회전검체통법 | 시험법 | 2 법(패들법) | Convection mixer |\n| 편 | 집 | 위 | 원 | 병포장 | 60 mL, 흰색 원형 HDPE 병 (60, 100정) | Bottle.Co | 용출 | 높음 | 높음 | 높음 | .. | RC3: 0.5% 이하 | 총 충진물 질량 | 281.0 | 김은정, 양성준, 이경신, 김선미, 윤나영, 강나루, | 유연물질 | 0.2% |\n| 3 | 혼합 | 미처리 | 99% | >0.99 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | 약물방출 f2값 | 활택제 ○○ | 최적 분무속도에서 약물미세화 기압을 1.0 bar로 하면 | 30μm로 만든다.  3.0 bar를 초과한 약물미세화 기압은 | 이상 없음 | 선형 스케일업 | 사용된 제조번호 | (LOD) | 이상 없음 | □ 예 | ■ 아니오 | (LOQ) |\n| 순도시험 | 수 있는 요인인 것으로 확인되었다.  | 즉시 조제된 것 vs. ",
        "original_sentence": "| 최종혼합 | Bin-Blender | Size 5 L | Size 100 L | Size 1000 L | 해 설 | 성을 갖도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_140",
      "text": "| 약물미세화 기압 | 1.5 bar | 장치 | 회전검체통법 | 시험법 | 2 법(패들법) | Convection mixer |\n| 편 | 집 | 위 | 원 | 병포장 | 60 mL, 흰색 원형 HDPE 병 (60, 100정) | Bottle.Co | 용출 | 높음 | 높음 | 높음 | .. | RC3: 0.5% 이하 | 총 충진물 질량 | 281.0 | 김은정, 양성준, 이경신, 김선미, 윤나영, 강나루, | 유연물질 | 0.2% |\n| 3 | 혼합 | 미처리 | 99% | >0.99 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | 약물방출 f2값 | 활택제 ○○ | 최적 분무속도에서 약물미세화 기압을 1.0 bar로 하면 | 30μm로 만든다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 139,
        "window_size": 3,
        "char_count": 376,
        "word_count": 107,
        "page_number": 5,
        "window_text": "(민원인용) | 이 선 희 |\n| 등을 자체적으로 검증하는 것이 바람직하다.  | 함량/함량균일성 | 높음 | 높음 | 분류 | 설명 | 제조원 | RC2: 0.5% 이하 | 크기를 증가시켜서 제품이 응집되어 수율이 낮아짐 | 각 원료를 oo mesh체로 체과 후 | 0.2% |\n| 용출 | 적합 (93-98%), S1만 적용 | 적합 (95-100%), S1만 적용 | 예 시 | 조건 1 (고온) | 경질젤라틴캡슐 | 상부/하부 | Size #1 | 약물방출 (8시간) | 55% | 88% | 가혹 조건 | % 함량 | 피크 순도 | 적절한 서방코팅을 보장하기 위해 중요한 방울 크기를 |\n| 분무 속도(mL/분) | 15~20 | 90~120 | 분포-플레이트 면적 비율에 근거하여 | 2.3.P.7 용기 및 포장(제품명, 제형) …………………………………………………… 35 | 유연물질명 | 허용기준 | 직선성 | 정밀성 | 정확성 | 검출한계 | 성분명 | 배합목적 | 제조원명 | 등급 | 규격 | 뱃치 제조에 | 주성분 | USP | 주성분 | 2.00 | 부형제 ○○ | 중요공정 | 정량한계 |\n| (수행업무) 및 수탁업소를 기재한다.  | 최종혼합 | Bin-Blender | Size 5 L | Size 100 L | Size 1000 L | 해 설 | 성을 갖도록 한다.  | 약물미세화 기압 | 1.5 bar | 장치 | 회전검체통법 | 시험법 | 2 법(패들법) | Convection mixer |\n| 편 | 집 | 위 | 원 | 병포장 | 60 mL, 흰색 원형 HDPE 병 (60, 100정) | Bottle.Co | 용출 | 높음 | 높음 | 높음 | .. | RC3: 0.5% 이하 | 총 충진물 질량 | 281.0 | 김은정, 양성준, 이경신, 김선미, 윤나영, 강나루, | 유연물질 | 0.2% |\n| 3 | 혼합 | 미처리 | 99% | >0.99 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | 약물방출 f2값 | 활택제 ○○ | 최적 분무속도에서 약물미세화 기압을 1.0 bar로 하면 | 30μm로 만든다.  3.0 bar를 초과한 약물미세화 기압은 | 이상 없음 | 선형 스케일업 | 사용된 제조번호 | (LOD) | 이상 없음 | □ 예 | ■ 아니오 | (LOQ) |\n| 순도시험 | 수 있는 요인인 것으로 확인되었다.  | 즉시 조제된 것 vs.  60℃에 18시간 보관한 것 | 53.1 | 97.9 | 유당수화물 | NF | 부형제 | 160.00 | 용매 | 결정형 I | 결정형 II | (Ribbon blender)에서 oo rpm으로 | Method #41 |\n| 2.3.P.8 안정성(제품명, 제형) ……………………………………………………………… 36 | 규격에 준하여 관리한다. ",
        "original_sentence": "| 약물미세화 기압 | 1.5 bar | 장치 | 회전검체통법 | 시험법 | 2 법(패들법) | Convection mixer |\n| 편 | 집 | 위 | 원 | 병포장 | 60 mL, 흰색 원형 HDPE 병 (60, 100정) | Bottle.Co | 용출 | 높음 | 높음 | 높음 | .. | RC3: 0.5% 이하 | 총 충진물 질량 | 281.0 | 김은정, 양성준, 이경신, 김선미, 윤나영, 강나루, | 유연물질 | 0.2% |\n| 3 | 혼합 | 미처리 | 99% | >0.99 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | 약물방출 f2값 | 활택제 ○○ | 최적 분무속도에서 약물미세화 기압을 1.0 bar로 하면 | 30μm로 만든다. "
      }
    },
    {
      "chunk_id": "chunk_141",
      "text": "3.0 bar를 초과한 약물미세화 기압은 | 이상 없음 | 선형 스케일업 | 사용된 제조번호 | (LOD) | 이상 없음 | □ 예 | ■ 아니오 | (LOQ) |\n| 순도시험 | 수 있는 요인인 것으로 확인되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 140,
        "window_size": 3,
        "char_count": 121,
        "word_count": 36,
        "page_number": 3,
        "window_text": "| 함량/함량균일성 | 높음 | 높음 | 분류 | 설명 | 제조원 | RC2: 0.5% 이하 | 크기를 증가시켜서 제품이 응집되어 수율이 낮아짐 | 각 원료를 oo mesh체로 체과 후 | 0.2% |\n| 용출 | 적합 (93-98%), S1만 적용 | 적합 (95-100%), S1만 적용 | 예 시 | 조건 1 (고온) | 경질젤라틴캡슐 | 상부/하부 | Size #1 | 약물방출 (8시간) | 55% | 88% | 가혹 조건 | % 함량 | 피크 순도 | 적절한 서방코팅을 보장하기 위해 중요한 방울 크기를 |\n| 분무 속도(mL/분) | 15~20 | 90~120 | 분포-플레이트 면적 비율에 근거하여 | 2.3.P.7 용기 및 포장(제품명, 제형) …………………………………………………… 35 | 유연물질명 | 허용기준 | 직선성 | 정밀성 | 정확성 | 검출한계 | 성분명 | 배합목적 | 제조원명 | 등급 | 규격 | 뱃치 제조에 | 주성분 | USP | 주성분 | 2.00 | 부형제 ○○ | 중요공정 | 정량한계 |\n| (수행업무) 및 수탁업소를 기재한다.  | 최종혼합 | Bin-Blender | Size 5 L | Size 100 L | Size 1000 L | 해 설 | 성을 갖도록 한다.  | 약물미세화 기압 | 1.5 bar | 장치 | 회전검체통법 | 시험법 | 2 법(패들법) | Convection mixer |\n| 편 | 집 | 위 | 원 | 병포장 | 60 mL, 흰색 원형 HDPE 병 (60, 100정) | Bottle.Co | 용출 | 높음 | 높음 | 높음 | .. | RC3: 0.5% 이하 | 총 충진물 질량 | 281.0 | 김은정, 양성준, 이경신, 김선미, 윤나영, 강나루, | 유연물질 | 0.2% |\n| 3 | 혼합 | 미처리 | 99% | >0.99 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | 약물방출 f2값 | 활택제 ○○ | 최적 분무속도에서 약물미세화 기압을 1.0 bar로 하면 | 30μm로 만든다.  3.0 bar를 초과한 약물미세화 기압은 | 이상 없음 | 선형 스케일업 | 사용된 제조번호 | (LOD) | 이상 없음 | □ 예 | ■ 아니오 | (LOQ) |\n| 순도시험 | 수 있는 요인인 것으로 확인되었다.  | 즉시 조제된 것 vs.  60℃에 18시간 보관한 것 | 53.1 | 97.9 | 유당수화물 | NF | 부형제 | 160.00 | 용매 | 결정형 I | 결정형 II | (Ribbon blender)에서 oo rpm으로 | Method #41 |\n| 2.3.P.8 안정성(제품명, 제형) ……………………………………………………………… 36 | 규격에 준하여 관리한다.  | 수분(0.5% 이하) | 타정 | Tablet Press | Beta | Beta | Beta | 회전수 | 100 rpm | 회전 속도 | 50 rpm | A | B1 | C1 | D1 | E | F1 |\n| 기타 확인 | 공정 | 시험항목 | 기준 | 분석방법 번호 | 허가제출용 뱃치 결과 | 병포장 | 325 mL, 흰색 원형 HDPE 병 (500 정) | Bottle.Co | 안정성 | 높음 | 개개유연물질: 각각 0.2% 이하 | 민원인을 구속하는 내용이 있습니까? ",
        "original_sentence": "3.0 bar를 초과한 약물미세화 기압은 | 이상 없음 | 선형 스케일업 | 사용된 제조번호 | (LOD) | 이상 없음 | □ 예 | ■ 아니오 | (LOQ) |\n| 순도시험 | 수 있는 요인인 것으로 확인되었다. "
      }
    },
    {
      "chunk_id": "chunk_142",
      "text": "| 즉시 조제된 것 vs. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 141,
        "window_size": 3,
        "char_count": 15,
        "word_count": 5,
        "page_number": 23,
        "window_text": "| 최종혼합 | Bin-Blender | Size 5 L | Size 100 L | Size 1000 L | 해 설 | 성을 갖도록 한다.  | 약물미세화 기압 | 1.5 bar | 장치 | 회전검체통법 | 시험법 | 2 법(패들법) | Convection mixer |\n| 편 | 집 | 위 | 원 | 병포장 | 60 mL, 흰색 원형 HDPE 병 (60, 100정) | Bottle.Co | 용출 | 높음 | 높음 | 높음 | .. | RC3: 0.5% 이하 | 총 충진물 질량 | 281.0 | 김은정, 양성준, 이경신, 김선미, 윤나영, 강나루, | 유연물질 | 0.2% |\n| 3 | 혼합 | 미처리 | 99% | >0.99 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | 약물방출 f2값 | 활택제 ○○ | 최적 분무속도에서 약물미세화 기압을 1.0 bar로 하면 | 30μm로 만든다.  3.0 bar를 초과한 약물미세화 기압은 | 이상 없음 | 선형 스케일업 | 사용된 제조번호 | (LOD) | 이상 없음 | □ 예 | ■ 아니오 | (LOQ) |\n| 순도시험 | 수 있는 요인인 것으로 확인되었다.  | 즉시 조제된 것 vs.  60℃에 18시간 보관한 것 | 53.1 | 97.9 | 유당수화물 | NF | 부형제 | 160.00 | 용매 | 결정형 I | 결정형 II | (Ribbon blender)에서 oo rpm으로 | Method #41 |\n| 2.3.P.8 안정성(제품명, 제형) ……………………………………………………………… 36 | 규격에 준하여 관리한다.  | 수분(0.5% 이하) | 타정 | Tablet Press | Beta | Beta | Beta | 회전수 | 100 rpm | 회전 속도 | 50 rpm | A | B1 | C1 | D1 | E | F1 |\n| 기타 확인 | 공정 | 시험항목 | 기준 | 분석방법 번호 | 허가제출용 뱃치 결과 | 병포장 | 325 mL, 흰색 원형 HDPE 병 (500 정) | Bottle.Co | 안정성 | 높음 | 개개유연물질: 각각 0.2% 이하 | 민원인을 구속하는 내용이 있습니까?  | 붕해제 ○○ | 캡슐 총 질량 | 380.0 | r2=0.996 | 20 μm 크기의 방울이 만들어진다. ",
        "original_sentence": "| 즉시 조제된 것 vs. "
      }
    },
    {
      "chunk_id": "chunk_143",
      "text": "60℃에 18시간 보관한 것 | 53.1 | 97.9 | 유당수화물 | NF | 부형제 | 160.00 | 용매 | 결정형 I | 결정형 II | (Ribbon blender)에서 oo rpm으로 | Method #41 |\n| 2.3.P.8 안정성(제품명, 제형) ……………………………………………………………… 36 | 규격에 준하여 관리한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 142,
        "window_size": 3,
        "char_count": 192,
        "word_count": 43,
        "page_number": 5,
        "window_text": "| 약물미세화 기압 | 1.5 bar | 장치 | 회전검체통법 | 시험법 | 2 법(패들법) | Convection mixer |\n| 편 | 집 | 위 | 원 | 병포장 | 60 mL, 흰색 원형 HDPE 병 (60, 100정) | Bottle.Co | 용출 | 높음 | 높음 | 높음 | .. | RC3: 0.5% 이하 | 총 충진물 질량 | 281.0 | 김은정, 양성준, 이경신, 김선미, 윤나영, 강나루, | 유연물질 | 0.2% |\n| 3 | 혼합 | 미처리 | 99% | >0.99 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | 약물방출 f2값 | 활택제 ○○ | 최적 분무속도에서 약물미세화 기압을 1.0 bar로 하면 | 30μm로 만든다.  3.0 bar를 초과한 약물미세화 기압은 | 이상 없음 | 선형 스케일업 | 사용된 제조번호 | (LOD) | 이상 없음 | □ 예 | ■ 아니오 | (LOQ) |\n| 순도시험 | 수 있는 요인인 것으로 확인되었다.  | 즉시 조제된 것 vs.  60℃에 18시간 보관한 것 | 53.1 | 97.9 | 유당수화물 | NF | 부형제 | 160.00 | 용매 | 결정형 I | 결정형 II | (Ribbon blender)에서 oo rpm으로 | Method #41 |\n| 2.3.P.8 안정성(제품명, 제형) ……………………………………………………………… 36 | 규격에 준하여 관리한다.  | 수분(0.5% 이하) | 타정 | Tablet Press | Beta | Beta | Beta | 회전수 | 100 rpm | 회전 속도 | 50 rpm | A | B1 | C1 | D1 | E | F1 |\n| 기타 확인 | 공정 | 시험항목 | 기준 | 분석방법 번호 | 허가제출용 뱃치 결과 | 병포장 | 325 mL, 흰색 원형 HDPE 병 (500 정) | Bottle.Co | 안정성 | 높음 | 개개유연물질: 각각 0.2% 이하 | 민원인을 구속하는 내용이 있습니까?  | 붕해제 ○○ | 캡슐 총 질량 | 380.0 | r2=0.996 | 20 μm 크기의 방울이 만들어진다.  약물미세화 기압이 | 평균 0.13% | 과도한 펠렛 속성을 갖게 하므로 이를 피해야 함 | 92-110% | 0.1% | 등) |\n| 한다. ",
        "original_sentence": "60℃에 18시간 보관한 것 | 53.1 | 97.9 | 유당수화물 | NF | 부형제 | 160.00 | 용매 | 결정형 I | 결정형 II | (Ribbon blender)에서 oo rpm으로 | Method #41 |\n| 2.3.P.8 안정성(제품명, 제형) ……………………………………………………………… 36 | 규격에 준하여 관리한다. "
      }
    },
    {
      "chunk_id": "chunk_144",
      "text": "| 수분(0.5% 이하) | 타정 | Tablet Press | Beta | Beta | Beta | 회전수 | 100 rpm | 회전 속도 | 50 rpm | A | B1 | C1 | D1 | E | F1 |\n| 기타 확인 | 공정 | 시험항목 | 기준 | 분석방법 번호 | 허가제출용 뱃치 결과 | 병포장 | 325 mL, 흰색 원형 HDPE 병 (500 정) | Bottle.Co | 안정성 | 높음 | 개개유연물질: 각각 0.2% 이하 | 민원인을 구속하는 내용이 있습니까? ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 143,
        "window_size": 3,
        "char_count": 270,
        "word_count": 81,
        "page_number": 3,
        "window_text": "3.0 bar를 초과한 약물미세화 기압은 | 이상 없음 | 선형 스케일업 | 사용된 제조번호 | (LOD) | 이상 없음 | □ 예 | ■ 아니오 | (LOQ) |\n| 순도시험 | 수 있는 요인인 것으로 확인되었다.  | 즉시 조제된 것 vs.  60℃에 18시간 보관한 것 | 53.1 | 97.9 | 유당수화물 | NF | 부형제 | 160.00 | 용매 | 결정형 I | 결정형 II | (Ribbon blender)에서 oo rpm으로 | Method #41 |\n| 2.3.P.8 안정성(제품명, 제형) ……………………………………………………………… 36 | 규격에 준하여 관리한다.  | 수분(0.5% 이하) | 타정 | Tablet Press | Beta | Beta | Beta | 회전수 | 100 rpm | 회전 속도 | 50 rpm | A | B1 | C1 | D1 | E | F1 |\n| 기타 확인 | 공정 | 시험항목 | 기준 | 분석방법 번호 | 허가제출용 뱃치 결과 | 병포장 | 325 mL, 흰색 원형 HDPE 병 (500 정) | Bottle.Co | 안정성 | 높음 | 개개유연물질: 각각 0.2% 이하 | 민원인을 구속하는 내용이 있습니까?  | 붕해제 ○○ | 캡슐 총 질량 | 380.0 | r2=0.996 | 20 μm 크기의 방울이 만들어진다.  약물미세화 기압이 | 평균 0.13% | 과도한 펠렛 속성을 갖게 하므로 이를 피해야 함 | 92-110% | 0.1% | 등) |\n| 한다.  | 약물미세화 기압 | 1.0 bar | 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유지혜, 김지예, 서재욱, 지정은, 정혜선 | 5.1-5.5% 범위 내에 있음 | 높은 분무 속도에 따라, 분무 방울 크 | 5.1-5.5% 범위 내에 있음 |\n| 0.1 N HCl, pH 1.2 | 0.10 mg/mL | 0.40 mg/mL | 2차 포장 용기를 사용하여 포장하였다. ",
        "original_sentence": "| 수분(0.5% 이하) | 타정 | Tablet Press | Beta | Beta | Beta | 회전수 | 100 rpm | 회전 속도 | 50 rpm | A | B1 | C1 | D1 | E | F1 |\n| 기타 확인 | 공정 | 시험항목 | 기준 | 분석방법 번호 | 허가제출용 뱃치 결과 | 병포장 | 325 mL, 흰색 원형 HDPE 병 (500 정) | Bottle.Co | 안정성 | 높음 | 개개유연물질: 각각 0.2% 이하 | 민원인을 구속하는 내용이 있습니까? "
      }
    },
    {
      "chunk_id": "chunk_145",
      "text": "| 붕해제 ○○ | 캡슐 총 질량 | 380.0 | r2=0.996 | 20 μm 크기의 방울이 만들어진다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 144,
        "window_size": 3,
        "char_count": 61,
        "word_count": 17,
        "page_number": 5,
        "window_text": "| 즉시 조제된 것 vs.  60℃에 18시간 보관한 것 | 53.1 | 97.9 | 유당수화물 | NF | 부형제 | 160.00 | 용매 | 결정형 I | 결정형 II | (Ribbon blender)에서 oo rpm으로 | Method #41 |\n| 2.3.P.8 안정성(제품명, 제형) ……………………………………………………………… 36 | 규격에 준하여 관리한다.  | 수분(0.5% 이하) | 타정 | Tablet Press | Beta | Beta | Beta | 회전수 | 100 rpm | 회전 속도 | 50 rpm | A | B1 | C1 | D1 | E | F1 |\n| 기타 확인 | 공정 | 시험항목 | 기준 | 분석방법 번호 | 허가제출용 뱃치 결과 | 병포장 | 325 mL, 흰색 원형 HDPE 병 (500 정) | Bottle.Co | 안정성 | 높음 | 개개유연물질: 각각 0.2% 이하 | 민원인을 구속하는 내용이 있습니까?  | 붕해제 ○○ | 캡슐 총 질량 | 380.0 | r2=0.996 | 20 μm 크기의 방울이 만들어진다.  약물미세화 기압이 | 평균 0.13% | 과도한 펠렛 속성을 갖게 하므로 이를 피해야 함 | 92-110% | 0.1% | 등) |\n| 한다.  | 약물미세화 기압 | 1.0 bar | 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유지혜, 김지예, 서재욱, 지정은, 정혜선 | 5.1-5.5% 범위 내에 있음 | 높은 분무 속도에 따라, 분무 방울 크 | 5.1-5.5% 범위 내에 있음 |\n| 0.1 N HCl, pH 1.2 | 0.10 mg/mL | 0.40 mg/mL | 2차 포장 용기를 사용하여 포장하였다.  | RC2 | 0.5% 이하 | 기준 | 80% (Q) 이상 / 30분 | oo분간 혼합한다. ",
        "original_sentence": "| 붕해제 ○○ | 캡슐 총 질량 | 380.0 | r2=0.996 | 20 μm 크기의 방울이 만들어진다. "
      }
    },
    {
      "chunk_id": "chunk_146",
      "text": "약물미세화 기압이 | 평균 0.13% | 과도한 펠렛 속성을 갖게 하므로 이를 피해야 함 | 92-110% | 0.1% | 등) |\n| 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 145,
        "window_size": 3,
        "char_count": 80,
        "word_count": 23,
        "page_number": 3,
        "window_text": "60℃에 18시간 보관한 것 | 53.1 | 97.9 | 유당수화물 | NF | 부형제 | 160.00 | 용매 | 결정형 I | 결정형 II | (Ribbon blender)에서 oo rpm으로 | Method #41 |\n| 2.3.P.8 안정성(제품명, 제형) ……………………………………………………………… 36 | 규격에 준하여 관리한다.  | 수분(0.5% 이하) | 타정 | Tablet Press | Beta | Beta | Beta | 회전수 | 100 rpm | 회전 속도 | 50 rpm | A | B1 | C1 | D1 | E | F1 |\n| 기타 확인 | 공정 | 시험항목 | 기준 | 분석방법 번호 | 허가제출용 뱃치 결과 | 병포장 | 325 mL, 흰색 원형 HDPE 병 (500 정) | Bottle.Co | 안정성 | 높음 | 개개유연물질: 각각 0.2% 이하 | 민원인을 구속하는 내용이 있습니까?  | 붕해제 ○○ | 캡슐 총 질량 | 380.0 | r2=0.996 | 20 μm 크기의 방울이 만들어진다.  약물미세화 기압이 | 평균 0.13% | 과도한 펠렛 속성을 갖게 하므로 이를 피해야 함 | 92-110% | 0.1% | 등) |\n| 한다.  | 약물미세화 기압 | 1.0 bar | 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유지혜, 김지예, 서재욱, 지정은, 정혜선 | 5.1-5.5% 범위 내에 있음 | 높은 분무 속도에 따라, 분무 방울 크 | 5.1-5.5% 범위 내에 있음 |\n| 0.1 N HCl, pH 1.2 | 0.10 mg/mL | 0.40 mg/mL | 2차 포장 용기를 사용하여 포장하였다.  | RC2 | 0.5% 이하 | 기준 | 80% (Q) 이상 / 30분 | oo분간 혼합한다.  | 건조감량, 벌크밀도, 중합도 | 0.025% | 0.075% |\n| 기재한다. ",
        "original_sentence": "약물미세화 기압이 | 평균 0.13% | 과도한 펠렛 속성을 갖게 하므로 이를 피해야 함 | 92-110% | 0.1% | 등) |\n| 한다. "
      }
    },
    {
      "chunk_id": "chunk_147",
      "text": "| 약물미세화 기압 | 1.0 bar | 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유지혜, 김지예, 서재욱, 지정은, 정혜선 | 5.1-5.5% 범위 내에 있음 | 높은 분무 속도에 따라, 분무 방울 크 | 5.1-5.5% 범위 내에 있음 |\n| 0.1 N HCl, pH 1.2 | 0.10 mg/mL | 0.40 mg/mL | 2차 포장 용기를 사용하여 포장하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 146,
        "window_size": 3,
        "char_count": 222,
        "word_count": 61,
        "page_number": 5,
        "window_text": "| 수분(0.5% 이하) | 타정 | Tablet Press | Beta | Beta | Beta | 회전수 | 100 rpm | 회전 속도 | 50 rpm | A | B1 | C1 | D1 | E | F1 |\n| 기타 확인 | 공정 | 시험항목 | 기준 | 분석방법 번호 | 허가제출용 뱃치 결과 | 병포장 | 325 mL, 흰색 원형 HDPE 병 (500 정) | Bottle.Co | 안정성 | 높음 | 개개유연물질: 각각 0.2% 이하 | 민원인을 구속하는 내용이 있습니까?  | 붕해제 ○○ | 캡슐 총 질량 | 380.0 | r2=0.996 | 20 μm 크기의 방울이 만들어진다.  약물미세화 기압이 | 평균 0.13% | 과도한 펠렛 속성을 갖게 하므로 이를 피해야 함 | 92-110% | 0.1% | 등) |\n| 한다.  | 약물미세화 기압 | 1.0 bar | 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유지혜, 김지예, 서재욱, 지정은, 정혜선 | 5.1-5.5% 범위 내에 있음 | 높은 분무 속도에 따라, 분무 방울 크 | 5.1-5.5% 범위 내에 있음 |\n| 0.1 N HCl, pH 1.2 | 0.10 mg/mL | 0.40 mg/mL | 2차 포장 용기를 사용하여 포장하였다.  | RC2 | 0.5% 이하 | 기준 | 80% (Q) 이상 / 30분 | oo분간 혼합한다.  | 건조감량, 벌크밀도, 중합도 | 0.025% | 0.075% |\n| 기재한다.  | 안정성 시험들에서 기록하지 않았다. ",
        "original_sentence": "| 약물미세화 기압 | 1.0 bar | 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유지혜, 김지예, 서재욱, 지정은, 정혜선 | 5.1-5.5% 범위 내에 있음 | 높은 분무 속도에 따라, 분무 방울 크 | 5.1-5.5% 범위 내에 있음 |\n| 0.1 N HCl, pH 1.2 | 0.10 mg/mL | 0.40 mg/mL | 2차 포장 용기를 사용하여 포장하였다. "
      }
    },
    {
      "chunk_id": "chunk_148",
      "text": "| RC2 | 0.5% 이하 | 기준 | 80% (Q) 이상 / 30분 | oo분간 혼합한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 147,
        "window_size": 3,
        "char_count": 53,
        "word_count": 16,
        "page_number": 3,
        "window_text": "| 붕해제 ○○ | 캡슐 총 질량 | 380.0 | r2=0.996 | 20 μm 크기의 방울이 만들어진다.  약물미세화 기압이 | 평균 0.13% | 과도한 펠렛 속성을 갖게 하므로 이를 피해야 함 | 92-110% | 0.1% | 등) |\n| 한다.  | 약물미세화 기압 | 1.0 bar | 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유지혜, 김지예, 서재욱, 지정은, 정혜선 | 5.1-5.5% 범위 내에 있음 | 높은 분무 속도에 따라, 분무 방울 크 | 5.1-5.5% 범위 내에 있음 |\n| 0.1 N HCl, pH 1.2 | 0.10 mg/mL | 0.40 mg/mL | 2차 포장 용기를 사용하여 포장하였다.  | RC2 | 0.5% 이하 | 기준 | 80% (Q) 이상 / 30분 | oo분간 혼합한다.  | 건조감량, 벌크밀도, 중합도 | 0.025% | 0.075% |\n| 기재한다.  | 안정성 시험들에서 기록하지 않았다.  | 유연물질명 | 화학명 | 구조 | 기원 | 관리방법 | 미결정셀룰로오스 | NF | 부형제 | 61.61 | 설계 시 1.0 mm 이하의 코팅 펠렛을 사용해야 한다. ",
        "original_sentence": "| RC2 | 0.5% 이하 | 기준 | 80% (Q) 이상 / 30분 | oo분간 혼합한다. "
      }
    },
    {
      "chunk_id": "chunk_149",
      "text": "| 건조감량, 벌크밀도, 중합도 | 0.025% | 0.075% |\n| 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 148,
        "window_size": 3,
        "char_count": 46,
        "word_count": 11,
        "page_number": 5,
        "window_text": "약물미세화 기압이 | 평균 0.13% | 과도한 펠렛 속성을 갖게 하므로 이를 피해야 함 | 92-110% | 0.1% | 등) |\n| 한다.  | 약물미세화 기압 | 1.0 bar | 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유지혜, 김지예, 서재욱, 지정은, 정혜선 | 5.1-5.5% 범위 내에 있음 | 높은 분무 속도에 따라, 분무 방울 크 | 5.1-5.5% 범위 내에 있음 |\n| 0.1 N HCl, pH 1.2 | 0.10 mg/mL | 0.40 mg/mL | 2차 포장 용기를 사용하여 포장하였다.  | RC2 | 0.5% 이하 | 기준 | 80% (Q) 이상 / 30분 | oo분간 혼합한다.  | 건조감량, 벌크밀도, 중합도 | 0.025% | 0.075% |\n| 기재한다.  | 안정성 시험들에서 기록하지 않았다.  | 유연물질명 | 화학명 | 구조 | 기원 | 관리방법 | 미결정셀룰로오스 | NF | 부형제 | 61.61 | 설계 시 1.0 mm 이하의 코팅 펠렛을 사용해야 한다.  | 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질간에 방해가 없음(아래의 크로마토그램을 | 시간 | 용출률 % | 2.5 bar를 초과하면 과도한 펠렛 속성을 갖게 되므로 이 | (제조번호 #9A) |\n| 약물미세화 기압(bar) | 1.0 | 2.0 | 있다. ",
        "original_sentence": "| 건조감량, 벌크밀도, 중합도 | 0.025% | 0.075% |\n| 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_150",
      "text": "| 안정성 시험들에서 기록하지 않았다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 149,
        "window_size": 3,
        "char_count": 22,
        "word_count": 5,
        "page_number": 32,
        "window_text": "| 약물미세화 기압 | 1.0 bar | 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유지혜, 김지예, 서재욱, 지정은, 정혜선 | 5.1-5.5% 범위 내에 있음 | 높은 분무 속도에 따라, 분무 방울 크 | 5.1-5.5% 범위 내에 있음 |\n| 0.1 N HCl, pH 1.2 | 0.10 mg/mL | 0.40 mg/mL | 2차 포장 용기를 사용하여 포장하였다.  | RC2 | 0.5% 이하 | 기준 | 80% (Q) 이상 / 30분 | oo분간 혼합한다.  | 건조감량, 벌크밀도, 중합도 | 0.025% | 0.075% |\n| 기재한다.  | 안정성 시험들에서 기록하지 않았다.  | 유연물질명 | 화학명 | 구조 | 기원 | 관리방법 | 미결정셀룰로오스 | NF | 부형제 | 61.61 | 설계 시 1.0 mm 이하의 코팅 펠렛을 사용해야 한다.  | 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질간에 방해가 없음(아래의 크로마토그램을 | 시간 | 용출률 % | 2.5 bar를 초과하면 과도한 펠렛 속성을 갖게 되므로 이 | (제조번호 #9A) |\n| 약물미세화 기압(bar) | 1.0 | 2.0 | 있다.  | 성상 | 적합 | 적합 | 입증할 계획이다. ",
        "original_sentence": "| 안정성 시험들에서 기록하지 않았다. "
      }
    },
    {
      "chunk_id": "chunk_151",
      "text": "| 유연물질명 | 화학명 | 구조 | 기원 | 관리방법 | 미결정셀룰로오스 | NF | 부형제 | 61.61 | 설계 시 1.0 mm 이하의 코팅 펠렛을 사용해야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 150,
        "window_size": 3,
        "char_count": 95,
        "word_count": 28,
        "page_number": 11,
        "window_text": "| RC2 | 0.5% 이하 | 기준 | 80% (Q) 이상 / 30분 | oo분간 혼합한다.  | 건조감량, 벌크밀도, 중합도 | 0.025% | 0.075% |\n| 기재한다.  | 안정성 시험들에서 기록하지 않았다.  | 유연물질명 | 화학명 | 구조 | 기원 | 관리방법 | 미결정셀룰로오스 | NF | 부형제 | 61.61 | 설계 시 1.0 mm 이하의 코팅 펠렛을 사용해야 한다.  | 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질간에 방해가 없음(아래의 크로마토그램을 | 시간 | 용출률 % | 2.5 bar를 초과하면 과도한 펠렛 속성을 갖게 되므로 이 | (제조번호 #9A) |\n| 약물미세화 기압(bar) | 1.0 | 2.0 | 있다.  | 성상 | 적합 | 적합 | 입증할 계획이다.  | 사항 | 총유연물질: 1.5%이하 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | RSD=1.5% | RSD 6.45% | RSD=2.8% | 기 중앙값을 20μm로 유지하기 위해 | 0.65% |\n**기재**\n\n**[표 끝]**\n\n고려하시기 바랍니다. ",
        "original_sentence": "| 유연물질명 | 화학명 | 구조 | 기원 | 관리방법 | 미결정셀룰로오스 | NF | 부형제 | 61.61 | 설계 시 1.0 mm 이하의 코팅 펠렛을 사용해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_152",
      "text": "| 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질간에 방해가 없음(아래의 크로마토그램을 | 시간 | 용출률 % | 2.5 bar를 초과하면 과도한 펠렛 속성을 갖게 되므로 이 | (제조번호 #9A) |\n| 약물미세화 기압(bar) | 1.0 | 2.0 | 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 151,
        "window_size": 3,
        "char_count": 152,
        "word_count": 39,
        "page_number": 15,
        "window_text": "| 건조감량, 벌크밀도, 중합도 | 0.025% | 0.075% |\n| 기재한다.  | 안정성 시험들에서 기록하지 않았다.  | 유연물질명 | 화학명 | 구조 | 기원 | 관리방법 | 미결정셀룰로오스 | NF | 부형제 | 61.61 | 설계 시 1.0 mm 이하의 코팅 펠렛을 사용해야 한다.  | 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질간에 방해가 없음(아래의 크로마토그램을 | 시간 | 용출률 % | 2.5 bar를 초과하면 과도한 펠렛 속성을 갖게 되므로 이 | (제조번호 #9A) |\n| 약물미세화 기압(bar) | 1.0 | 2.0 | 있다.  | 성상 | 적합 | 적합 | 입증할 계획이다.  | 사항 | 총유연물질: 1.5%이하 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | RSD=1.5% | RSD 6.45% | RSD=2.8% | 기 중앙값을 20μm로 유지하기 위해 | 0.65% |\n**기재**\n\n**[표 끝]**\n\n고려하시기 바랍니다.  그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n",
        "original_sentence": "| 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질간에 방해가 없음(아래의 크로마토그램을 | 시간 | 용출률 % | 2.5 bar를 초과하면 과도한 펠렛 속성을 갖게 되므로 이 | (제조번호 #9A) |\n| 약물미세화 기압(bar) | 1.0 | 2.0 | 있다. "
      }
    },
    {
      "chunk_id": "chunk_153",
      "text": "| 성상 | 적합 | 적합 | 입증할 계획이다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 152,
        "window_size": 3,
        "char_count": 27,
        "word_count": 9,
        "page_number": 3,
        "window_text": "| 안정성 시험들에서 기록하지 않았다.  | 유연물질명 | 화학명 | 구조 | 기원 | 관리방법 | 미결정셀룰로오스 | NF | 부형제 | 61.61 | 설계 시 1.0 mm 이하의 코팅 펠렛을 사용해야 한다.  | 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질간에 방해가 없음(아래의 크로마토그램을 | 시간 | 용출률 % | 2.5 bar를 초과하면 과도한 펠렛 속성을 갖게 되므로 이 | (제조번호 #9A) |\n| 약물미세화 기압(bar) | 1.0 | 2.0 | 있다.  | 성상 | 적합 | 적합 | 입증할 계획이다.  | 사항 | 총유연물질: 1.5%이하 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | RSD=1.5% | RSD 6.45% | RSD=2.8% | 기 중앙값을 20μm로 유지하기 위해 | 0.65% |\n**기재**\n\n**[표 끝]**\n\n고려하시기 바랍니다.  그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침·안내서\n\n안내서 제·개정 절차를 진행하시기 바랍니다.\n\n",
        "original_sentence": "| 성상 | 적합 | 적합 | 입증할 계획이다. "
      }
    },
    {
      "chunk_id": "chunk_154",
      "text": "| 사항 | 총유연물질: 1.5%이하 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | RSD=1.5% | RSD 6.45% | RSD=2.8% | 기 중앙값을 20μm로 유지하기 위해 | 0.65% |\n**기재**\n\n**[표 끝]**\n\n고려하시기 바랍니다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 153,
        "window_size": 3,
        "char_count": 165,
        "word_count": 38,
        "page_number": 2,
        "window_text": "| 유연물질명 | 화학명 | 구조 | 기원 | 관리방법 | 미결정셀룰로오스 | NF | 부형제 | 61.61 | 설계 시 1.0 mm 이하의 코팅 펠렛을 사용해야 한다.  | 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질간에 방해가 없음(아래의 크로마토그램을 | 시간 | 용출률 % | 2.5 bar를 초과하면 과도한 펠렛 속성을 갖게 되므로 이 | (제조번호 #9A) |\n| 약물미세화 기압(bar) | 1.0 | 2.0 | 있다.  | 성상 | 적합 | 적합 | 입증할 계획이다.  | 사항 | 총유연물질: 1.5%이하 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | RSD=1.5% | RSD 6.45% | RSD=2.8% | 기 중앙값을 20μm로 유지하기 위해 | 0.65% |\n**기재**\n\n**[표 끝]**\n\n고려하시기 바랍니다.  그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침·안내서\n\n안내서 제·개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n",
        "original_sentence": "| 사항 | 총유연물질: 1.5%이하 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | RSD=1.5% | RSD 6.45% | RSD=2.8% | 기 중앙값을 20μm로 유지하기 위해 | 0.65% |\n**기재**\n\n**[표 끝]**\n\n고려하시기 바랍니다. "
      }
    },
    {
      "chunk_id": "chunk_155",
      "text": "그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 154,
        "window_size": 3,
        "char_count": 57,
        "word_count": 13,
        "page_number": 2,
        "window_text": "| 주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질간에 방해가 없음(아래의 크로마토그램을 | 시간 | 용출률 % | 2.5 bar를 초과하면 과도한 펠렛 속성을 갖게 되므로 이 | (제조번호 #9A) |\n| 약물미세화 기압(bar) | 1.0 | 2.0 | 있다.  | 성상 | 적합 | 적합 | 입증할 계획이다.  | 사항 | 총유연물질: 1.5%이하 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | RSD=1.5% | RSD 6.45% | RSD=2.8% | 기 중앙값을 20μm로 유지하기 위해 | 0.65% |\n**기재**\n\n**[표 끝]**\n\n고려하시기 바랍니다.  그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침·안내서\n\n안내서 제·개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n 2017  년   5  월   25  일\n\n담당자\n\n확  인(부서장)\n\n김 영 림\n\n- - iii -\n<!-- PAGE_3 -->\n### 이\n\n<!-- PAGE_3 -->\n### 안내서는\n\n<!-- PAGE_3 -->\n### 제네릭의약품의\n\n<!-- PAGE_3 -->\n### 국제공통기술문서(CTD:\n\n<!-- PAGE_3 -->\n### Common\n\n<!-- PAGE_3 -->\n### Technical Document) 중 제2부의 품질평가자료요약 작성에 대한 식\n\n<!-- PAGE_3 -->\n### 품의약품안전처의 입장을 기술한 것으로, 대외적으로 법적 효력을\n\n<!-- PAGE_3 -->\n### 가지는 것이 아님\n\n<!-- PAGE_3 -->\n### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_3 -->\n##### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n##### 가원 의약품심사부 의약품규격과에 문의하시기 바랍니다.\n\n",
        "original_sentence": "그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_156",
      "text": "지침·안내서\n\n안내서 제·개정 절차를 진행하시기 바랍니다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 155,
        "window_size": 3,
        "char_count": 34,
        "word_count": 6,
        "page_number": 2,
        "window_text": "| 성상 | 적합 | 적합 | 입증할 계획이다.  | 사항 | 총유연물질: 1.5%이하 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | RSD=1.5% | RSD 6.45% | RSD=2.8% | 기 중앙값을 20μm로 유지하기 위해 | 0.65% |\n**기재**\n\n**[표 끝]**\n\n고려하시기 바랍니다.  그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침·안내서\n\n안내서 제·개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n 2017  년   5  월   25  일\n\n담당자\n\n확  인(부서장)\n\n김 영 림\n\n- - iii -\n<!-- PAGE_3 -->\n### 이\n\n<!-- PAGE_3 -->\n### 안내서는\n\n<!-- PAGE_3 -->\n### 제네릭의약품의\n\n<!-- PAGE_3 -->\n### 국제공통기술문서(CTD:\n\n<!-- PAGE_3 -->\n### Common\n\n<!-- PAGE_3 -->\n### Technical Document) 중 제2부의 품질평가자료요약 작성에 대한 식\n\n<!-- PAGE_3 -->\n### 품의약품안전처의 입장을 기술한 것으로, 대외적으로 법적 효력을\n\n<!-- PAGE_3 -->\n### 가지는 것이 아님\n\n<!-- PAGE_3 -->\n### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_3 -->\n##### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n##### 가원 의약품심사부 의약품규격과에 문의하시기 바랍니다.\n\n <!-- PAGE_3 -->\n##### 전화 : 043-719-2952\n\n<!-- PAGE_3 -->\n##### 팩스 : 043-719-2950\n\n- - iv -\n<!-- PAGE_4 -->\n# 목  차\n\n<!-- PAGE_4 -->\n##### 2.3. ",
        "original_sentence": "지침·안내서\n\n안내서 제·개정 절차를 진행하시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_157",
      "text": "상기 사항에 대하여 확인하였음.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 156,
        "window_size": 3,
        "char_count": 19,
        "word_count": 4,
        "page_number": 2,
        "window_text": "| 사항 | 총유연물질: 1.5%이하 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | RSD=1.5% | RSD 6.45% | RSD=2.8% | 기 중앙값을 20μm로 유지하기 위해 | 0.65% |\n**기재**\n\n**[표 끝]**\n\n고려하시기 바랍니다.  그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침·안내서\n\n안내서 제·개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n 2017  년   5  월   25  일\n\n담당자\n\n확  인(부서장)\n\n김 영 림\n\n- - iii -\n<!-- PAGE_3 -->\n### 이\n\n<!-- PAGE_3 -->\n### 안내서는\n\n<!-- PAGE_3 -->\n### 제네릭의약품의\n\n<!-- PAGE_3 -->\n### 국제공통기술문서(CTD:\n\n<!-- PAGE_3 -->\n### Common\n\n<!-- PAGE_3 -->\n### Technical Document) 중 제2부의 품질평가자료요약 작성에 대한 식\n\n<!-- PAGE_3 -->\n### 품의약품안전처의 입장을 기술한 것으로, 대외적으로 법적 효력을\n\n<!-- PAGE_3 -->\n### 가지는 것이 아님\n\n<!-- PAGE_3 -->\n### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_3 -->\n##### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n##### 가원 의약품심사부 의약품규격과에 문의하시기 바랍니다.\n\n <!-- PAGE_3 -->\n##### 전화 : 043-719-2952\n\n<!-- PAGE_3 -->\n##### 팩스 : 043-719-2950\n\n- - iv -\n<!-- PAGE_4 -->\n# 목  차\n\n<!-- PAGE_4 -->\n##### 2.3.  품질평가자료요약 ……………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 서론 ……………………………………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.S. ",
        "original_sentence": "상기 사항에 대하여 확인하였음.\n\n"
      }
    },
    {
      "chunk_id": "chunk_158",
      "text": "2017  년   5  월   25  일\n\n담당자\n\n확  인(부서장)\n\n김 영 림\n\n- - iii -\n<!-- PAGE_3 -->\n### 이\n\n<!-- PAGE_3 -->\n### 안내서는\n\n<!-- PAGE_3 -->\n### 제네릭의약품의\n\n<!-- PAGE_3 -->\n### 국제공통기술문서(CTD:\n\n<!-- PAGE_3 -->\n### Common\n\n<!-- PAGE_3 -->\n### Technical Document) 중 제2부의 품질평가자료요약 작성에 대한 식\n\n<!-- PAGE_3 -->\n### 품의약품안전처의 입장을 기술한 것으로, 대외적으로 법적 효력을\n\n<!-- PAGE_3 -->\n### 가지는 것이 아님\n\n<!-- PAGE_3 -->\n### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_3 -->\n##### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n##### 가원 의약품심사부 의약품규격과에 문의하시기 바랍니다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 157,
        "window_size": 3,
        "char_count": 530,
        "word_count": 107,
        "page_number": 3,
        "window_text": "그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침·안내서\n\n안내서 제·개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n 2017  년   5  월   25  일\n\n담당자\n\n확  인(부서장)\n\n김 영 림\n\n- - iii -\n<!-- PAGE_3 -->\n### 이\n\n<!-- PAGE_3 -->\n### 안내서는\n\n<!-- PAGE_3 -->\n### 제네릭의약품의\n\n<!-- PAGE_3 -->\n### 국제공통기술문서(CTD:\n\n<!-- PAGE_3 -->\n### Common\n\n<!-- PAGE_3 -->\n### Technical Document) 중 제2부의 품질평가자료요약 작성에 대한 식\n\n<!-- PAGE_3 -->\n### 품의약품안전처의 입장을 기술한 것으로, 대외적으로 법적 효력을\n\n<!-- PAGE_3 -->\n### 가지는 것이 아님\n\n<!-- PAGE_3 -->\n### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_3 -->\n##### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n##### 가원 의약품심사부 의약품규격과에 문의하시기 바랍니다.\n\n <!-- PAGE_3 -->\n##### 전화 : 043-719-2952\n\n<!-- PAGE_3 -->\n##### 팩스 : 043-719-2950\n\n- - iv -\n<!-- PAGE_4 -->\n# 목  차\n\n<!-- PAGE_4 -->\n##### 2.3.  품질평가자료요약 ……………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 서론 ……………………………………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.S.  원료의약품 (제품명, 제조자) ……………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.P 완제의약품(제품명, 제형) ………………………………………………………… 12\n\n<!-- PAGE_4 -->\n##### 2.3.A 부록 …………………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.1 시설과 설비 ………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가 ……………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.3 첨가제 ……………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.R. ",
        "original_sentence": "2017  년   5  월   25  일\n\n담당자\n\n확  인(부서장)\n\n김 영 림\n\n- - iii -\n<!-- PAGE_3 -->\n### 이\n\n<!-- PAGE_3 -->\n### 안내서는\n\n<!-- PAGE_3 -->\n### 제네릭의약품의\n\n<!-- PAGE_3 -->\n### 국제공통기술문서(CTD:\n\n<!-- PAGE_3 -->\n### Common\n\n<!-- PAGE_3 -->\n### Technical Document) 중 제2부의 품질평가자료요약 작성에 대한 식\n\n<!-- PAGE_3 -->\n### 품의약품안전처의 입장을 기술한 것으로, 대외적으로 법적 효력을\n\n<!-- PAGE_3 -->\n### 가지는 것이 아님\n\n<!-- PAGE_3 -->\n### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_3 -->\n##### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n##### 가원 의약품심사부 의약품규격과에 문의하시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_159",
      "text": "<!-- PAGE_3 -->\n##### 전화 : 043-719-2952\n\n<!-- PAGE_3 -->\n##### 팩스 : 043-719-2950\n\n- - iv -\n<!-- PAGE_4 -->\n# 목  차\n\n<!-- PAGE_4 -->\n##### 2.3. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 158,
        "window_size": 3,
        "char_count": 142,
        "word_count": 29,
        "page_number": 3,
        "window_text": "지침·안내서\n\n안내서 제·개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n 2017  년   5  월   25  일\n\n담당자\n\n확  인(부서장)\n\n김 영 림\n\n- - iii -\n<!-- PAGE_3 -->\n### 이\n\n<!-- PAGE_3 -->\n### 안내서는\n\n<!-- PAGE_3 -->\n### 제네릭의약품의\n\n<!-- PAGE_3 -->\n### 국제공통기술문서(CTD:\n\n<!-- PAGE_3 -->\n### Common\n\n<!-- PAGE_3 -->\n### Technical Document) 중 제2부의 품질평가자료요약 작성에 대한 식\n\n<!-- PAGE_3 -->\n### 품의약품안전처의 입장을 기술한 것으로, 대외적으로 법적 효력을\n\n<!-- PAGE_3 -->\n### 가지는 것이 아님\n\n<!-- PAGE_3 -->\n### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_3 -->\n##### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n##### 가원 의약품심사부 의약품규격과에 문의하시기 바랍니다.\n\n <!-- PAGE_3 -->\n##### 전화 : 043-719-2952\n\n<!-- PAGE_3 -->\n##### 팩스 : 043-719-2950\n\n- - iv -\n<!-- PAGE_4 -->\n# 목  차\n\n<!-- PAGE_4 -->\n##### 2.3.  품질평가자료요약 ……………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 서론 ……………………………………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.S.  원료의약품 (제품명, 제조자) ……………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.P 완제의약품(제품명, 제형) ………………………………………………………… 12\n\n<!-- PAGE_4 -->\n##### 2.3.A 부록 …………………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.1 시설과 설비 ………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가 ……………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.3 첨가제 ……………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.R.  지역별 정보 …………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### Appendix. ",
        "original_sentence": "<!-- PAGE_3 -->\n##### 전화 : 043-719-2952\n\n<!-- PAGE_3 -->\n##### 팩스 : 043-719-2950\n\n- - iv -\n<!-- PAGE_4 -->\n# 목  차\n\n<!-- PAGE_4 -->\n##### 2.3. "
      }
    },
    {
      "chunk_id": "chunk_160",
      "text": "품질평가자료요약 ……………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 서론 ……………………………………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.S. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 159,
        "window_size": 3,
        "char_count": 134,
        "word_count": 15,
        "page_number": 4,
        "window_text": "상기 사항에 대하여 확인하였음.\n\n 2017  년   5  월   25  일\n\n담당자\n\n확  인(부서장)\n\n김 영 림\n\n- - iii -\n<!-- PAGE_3 -->\n### 이\n\n<!-- PAGE_3 -->\n### 안내서는\n\n<!-- PAGE_3 -->\n### 제네릭의약품의\n\n<!-- PAGE_3 -->\n### 국제공통기술문서(CTD:\n\n<!-- PAGE_3 -->\n### Common\n\n<!-- PAGE_3 -->\n### Technical Document) 중 제2부의 품질평가자료요약 작성에 대한 식\n\n<!-- PAGE_3 -->\n### 품의약품안전처의 입장을 기술한 것으로, 대외적으로 법적 효력을\n\n<!-- PAGE_3 -->\n### 가지는 것이 아님\n\n<!-- PAGE_3 -->\n### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_3 -->\n##### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n##### 가원 의약품심사부 의약품규격과에 문의하시기 바랍니다.\n\n <!-- PAGE_3 -->\n##### 전화 : 043-719-2952\n\n<!-- PAGE_3 -->\n##### 팩스 : 043-719-2950\n\n- - iv -\n<!-- PAGE_4 -->\n# 목  차\n\n<!-- PAGE_4 -->\n##### 2.3.  품질평가자료요약 ……………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 서론 ……………………………………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.S.  원료의약품 (제품명, 제조자) ……………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.P 완제의약품(제품명, 제형) ………………………………………………………… 12\n\n<!-- PAGE_4 -->\n##### 2.3.A 부록 …………………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.1 시설과 설비 ………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가 ……………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.3 첨가제 ……………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.R.  지역별 정보 …………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### Appendix.  속방성 및 서방성 제제의 개발경위 기재 예시 (FDA) ………………… 41\n\n<!-- PAGE_5 -->\n## 제·개정 이력\n\n- - vi -\n머 리 말\n\n<!-- PAGE_6 -->\n#### 식품의약품안전처에서는 우수한 의약품을 공급하고 의약품 허가심사 체계를\n\n<!-- PAGE_6 -->\n#### 선진화하고자 2009년부터 신약 허가 신청 시 자료를 국제공통기술문서(Common\n\n<!-- PAGE_6 -->\n#### Technical Document, CTD)로 제출하도록 하였고, 제3부 품질평가자료에 대한\n\n<!-- PAGE_6 -->\n#### 가이드라인 및 해설서를 발간한 바 있습니다.\n\n",
        "original_sentence": "품질평가자료요약 ……………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 서론 ……………………………………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.S. "
      }
    },
    {
      "chunk_id": "chunk_161",
      "text": "원료의약품 (제품명, 제조자) ……………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.P 완제의약품(제품명, 제형) ………………………………………………………… 12\n\n<!-- PAGE_4 -->\n##### 2.3.A 부록 …………………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.1 시설과 설비 ………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가 ……………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.3 첨가제 ……………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.R. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 160,
        "window_size": 3,
        "char_count": 419,
        "word_count": 56,
        "page_number": 4,
        "window_text": "2017  년   5  월   25  일\n\n담당자\n\n확  인(부서장)\n\n김 영 림\n\n- - iii -\n<!-- PAGE_3 -->\n### 이\n\n<!-- PAGE_3 -->\n### 안내서는\n\n<!-- PAGE_3 -->\n### 제네릭의약품의\n\n<!-- PAGE_3 -->\n### 국제공통기술문서(CTD:\n\n<!-- PAGE_3 -->\n### Common\n\n<!-- PAGE_3 -->\n### Technical Document) 중 제2부의 품질평가자료요약 작성에 대한 식\n\n<!-- PAGE_3 -->\n### 품의약품안전처의 입장을 기술한 것으로, 대외적으로 법적 효력을\n\n<!-- PAGE_3 -->\n### 가지는 것이 아님\n\n<!-- PAGE_3 -->\n### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_3 -->\n##### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n##### 가원 의약품심사부 의약품규격과에 문의하시기 바랍니다.\n\n <!-- PAGE_3 -->\n##### 전화 : 043-719-2952\n\n<!-- PAGE_3 -->\n##### 팩스 : 043-719-2950\n\n- - iv -\n<!-- PAGE_4 -->\n# 목  차\n\n<!-- PAGE_4 -->\n##### 2.3.  품질평가자료요약 ……………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 서론 ……………………………………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.S.  원료의약품 (제품명, 제조자) ……………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.P 완제의약품(제품명, 제형) ………………………………………………………… 12\n\n<!-- PAGE_4 -->\n##### 2.3.A 부록 …………………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.1 시설과 설비 ………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가 ……………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.3 첨가제 ……………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.R.  지역별 정보 …………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### Appendix.  속방성 및 서방성 제제의 개발경위 기재 예시 (FDA) ………………… 41\n\n<!-- PAGE_5 -->\n## 제·개정 이력\n\n- - vi -\n머 리 말\n\n<!-- PAGE_6 -->\n#### 식품의약품안전처에서는 우수한 의약품을 공급하고 의약품 허가심사 체계를\n\n<!-- PAGE_6 -->\n#### 선진화하고자 2009년부터 신약 허가 신청 시 자료를 국제공통기술문서(Common\n\n<!-- PAGE_6 -->\n#### Technical Document, CTD)로 제출하도록 하였고, 제3부 품질평가자료에 대한\n\n<!-- PAGE_6 -->\n#### 가이드라인 및 해설서를 발간한 바 있습니다.\n\n <!-- PAGE_6 -->\n#### 또한 2015년 3월 「의약품의 품목허가․신고․심사 규정」이 개정되면서 2016년\n\n<!-- PAGE_6 -->\n#### 3월부터 제네릭의약품 및 자료제출의약품의 허가 신청 시 국제공통기술문서 적용이\n\n<!-- PAGE_6 -->\n#### 의무화되었습니다.\n\n",
        "original_sentence": "원료의약품 (제품명, 제조자) ……………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.P 완제의약품(제품명, 제형) ………………………………………………………… 12\n\n<!-- PAGE_4 -->\n##### 2.3.A 부록 …………………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.1 시설과 설비 ………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가 ……………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.3 첨가제 ……………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.R. "
      }
    },
    {
      "chunk_id": "chunk_162",
      "text": "지역별 정보 …………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### Appendix. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 161,
        "window_size": 3,
        "char_count": 73,
        "word_count": 9,
        "page_number": 4,
        "window_text": "<!-- PAGE_3 -->\n##### 전화 : 043-719-2952\n\n<!-- PAGE_3 -->\n##### 팩스 : 043-719-2950\n\n- - iv -\n<!-- PAGE_4 -->\n# 목  차\n\n<!-- PAGE_4 -->\n##### 2.3.  품질평가자료요약 ……………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 서론 ……………………………………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.S.  원료의약품 (제품명, 제조자) ……………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.P 완제의약품(제품명, 제형) ………………………………………………………… 12\n\n<!-- PAGE_4 -->\n##### 2.3.A 부록 …………………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.1 시설과 설비 ………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가 ……………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.3 첨가제 ……………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.R.  지역별 정보 …………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### Appendix.  속방성 및 서방성 제제의 개발경위 기재 예시 (FDA) ………………… 41\n\n<!-- PAGE_5 -->\n## 제·개정 이력\n\n- - vi -\n머 리 말\n\n<!-- PAGE_6 -->\n#### 식품의약품안전처에서는 우수한 의약품을 공급하고 의약품 허가심사 체계를\n\n<!-- PAGE_6 -->\n#### 선진화하고자 2009년부터 신약 허가 신청 시 자료를 국제공통기술문서(Common\n\n<!-- PAGE_6 -->\n#### Technical Document, CTD)로 제출하도록 하였고, 제3부 품질평가자료에 대한\n\n<!-- PAGE_6 -->\n#### 가이드라인 및 해설서를 발간한 바 있습니다.\n\n <!-- PAGE_6 -->\n#### 또한 2015년 3월 「의약품의 품목허가․신고․심사 규정」이 개정되면서 2016년\n\n<!-- PAGE_6 -->\n#### 3월부터 제네릭의약품 및 자료제출의약품의 허가 신청 시 국제공통기술문서 적용이\n\n<!-- PAGE_6 -->\n#### 의무화되었습니다.\n\n <!-- PAGE_6 -->\n#### 이에 국내 제약기업의 국제공통기술문서 자료 작성을 돕고자 2015년 6월\n\n<!-- PAGE_6 -->\n#### ‘제네릭의약품의 국제공통기술문서 작성 해설서’를 발간한 바 있습니다. ",
        "original_sentence": "지역별 정보 …………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### Appendix. "
      }
    },
    {
      "chunk_id": "chunk_163",
      "text": "속방성 및 서방성 제제의 개발경위 기재 예시 (FDA) ………………… 41\n\n<!-- PAGE_5 -->\n## 제·개정 이력\n\n- - vi -\n머 리 말\n\n<!-- PAGE_6 -->\n#### 식품의약품안전처에서는 우수한 의약품을 공급하고 의약품 허가심사 체계를\n\n<!-- PAGE_6 -->\n#### 선진화하고자 2009년부터 신약 허가 신청 시 자료를 국제공통기술문서(Common\n\n<!-- PAGE_6 -->\n#### Technical Document, CTD)로 제출하도록 하였고, 제3부 품질평가자료에 대한\n\n<!-- PAGE_6 -->\n#### 가이드라인 및 해설서를 발간한 바 있습니다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 162,
        "window_size": 3,
        "char_count": 337,
        "word_count": 68,
        "page_number": 5,
        "window_text": "품질평가자료요약 ……………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 서론 ……………………………………………………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.S.  원료의약품 (제품명, 제조자) ……………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.P 완제의약품(제품명, 제형) ………………………………………………………… 12\n\n<!-- PAGE_4 -->\n##### 2.3.A 부록 …………………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.1 시설과 설비 ………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가 ……………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.3 첨가제 ……………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.R.  지역별 정보 …………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### Appendix.  속방성 및 서방성 제제의 개발경위 기재 예시 (FDA) ………………… 41\n\n<!-- PAGE_5 -->\n## 제·개정 이력\n\n- - vi -\n머 리 말\n\n<!-- PAGE_6 -->\n#### 식품의약품안전처에서는 우수한 의약품을 공급하고 의약품 허가심사 체계를\n\n<!-- PAGE_6 -->\n#### 선진화하고자 2009년부터 신약 허가 신청 시 자료를 국제공통기술문서(Common\n\n<!-- PAGE_6 -->\n#### Technical Document, CTD)로 제출하도록 하였고, 제3부 품질평가자료에 대한\n\n<!-- PAGE_6 -->\n#### 가이드라인 및 해설서를 발간한 바 있습니다.\n\n <!-- PAGE_6 -->\n#### 또한 2015년 3월 「의약품의 품목허가․신고․심사 규정」이 개정되면서 2016년\n\n<!-- PAGE_6 -->\n#### 3월부터 제네릭의약품 및 자료제출의약품의 허가 신청 시 국제공통기술문서 적용이\n\n<!-- PAGE_6 -->\n#### 의무화되었습니다.\n\n <!-- PAGE_6 -->\n#### 이에 국내 제약기업의 국제공통기술문서 자료 작성을 돕고자 2015년 6월\n\n<!-- PAGE_6 -->\n#### ‘제네릭의약품의 국제공통기술문서 작성 해설서’를 발간한 바 있습니다.  이 가이드\n\n<!-- PAGE_6 -->\n#### 라인은 국제공통기술문서의 품질평가 자료 중 제2부 품질평가자료요약(Quality\n\n<!-- PAGE_6 -->\n#### Overall Summary, QOS)에 대해 구체적인 작성요령과 상세한 예를 들어 설명하\n\n<!-- PAGE_6 -->\n#### 고자 발간하게 되었으며, 미국 FDA의 질의응답식 품질심사(Question based\n\n<!-- PAGE_6 -->\n#### Review, QbR) 가이드라인의 예시를 참조하고 국내 심사 현황과 업계 의견을\n\n<!-- PAGE_6 -->\n#### 반영하여 실제 문서 작성에 도움이 되도록 실용적이고 세부적인 내용으로 구성\n\n<!-- PAGE_6 -->\n#### 하였습니다.\n\n",
        "original_sentence": "속방성 및 서방성 제제의 개발경위 기재 예시 (FDA) ………………… 41\n\n<!-- PAGE_5 -->\n## 제·개정 이력\n\n- - vi -\n머 리 말\n\n<!-- PAGE_6 -->\n#### 식품의약품안전처에서는 우수한 의약품을 공급하고 의약품 허가심사 체계를\n\n<!-- PAGE_6 -->\n#### 선진화하고자 2009년부터 신약 허가 신청 시 자료를 국제공통기술문서(Common\n\n<!-- PAGE_6 -->\n#### Technical Document, CTD)로 제출하도록 하였고, 제3부 품질평가자료에 대한\n\n<!-- PAGE_6 -->\n#### 가이드라인 및 해설서를 발간한 바 있습니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_164",
      "text": "<!-- PAGE_6 -->\n#### 또한 2015년 3월 「의약품의 품목허가․신고․심사 규정」이 개정되면서 2016년\n\n<!-- PAGE_6 -->\n#### 3월부터 제네릭의약품 및 자료제출의약품의 허가 신청 시 국제공통기술문서 적용이\n\n<!-- PAGE_6 -->\n#### 의무화되었습니다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 163,
        "window_size": 3,
        "char_count": 166,
        "word_count": 30,
        "page_number": 6,
        "window_text": "원료의약품 (제품명, 제조자) ……………………………………………………… 1\n\n<!-- PAGE_4 -->\n##### 2.3.P 완제의약품(제품명, 제형) ………………………………………………………… 12\n\n<!-- PAGE_4 -->\n##### 2.3.A 부록 …………………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.1 시설과 설비 ………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가 ……………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.A.3 첨가제 ……………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### 2.3.R.  지역별 정보 …………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### Appendix.  속방성 및 서방성 제제의 개발경위 기재 예시 (FDA) ………………… 41\n\n<!-- PAGE_5 -->\n## 제·개정 이력\n\n- - vi -\n머 리 말\n\n<!-- PAGE_6 -->\n#### 식품의약품안전처에서는 우수한 의약품을 공급하고 의약품 허가심사 체계를\n\n<!-- PAGE_6 -->\n#### 선진화하고자 2009년부터 신약 허가 신청 시 자료를 국제공통기술문서(Common\n\n<!-- PAGE_6 -->\n#### Technical Document, CTD)로 제출하도록 하였고, 제3부 품질평가자료에 대한\n\n<!-- PAGE_6 -->\n#### 가이드라인 및 해설서를 발간한 바 있습니다.\n\n <!-- PAGE_6 -->\n#### 또한 2015년 3월 「의약품의 품목허가․신고․심사 규정」이 개정되면서 2016년\n\n<!-- PAGE_6 -->\n#### 3월부터 제네릭의약품 및 자료제출의약품의 허가 신청 시 국제공통기술문서 적용이\n\n<!-- PAGE_6 -->\n#### 의무화되었습니다.\n\n <!-- PAGE_6 -->\n#### 이에 국내 제약기업의 국제공통기술문서 자료 작성을 돕고자 2015년 6월\n\n<!-- PAGE_6 -->\n#### ‘제네릭의약품의 국제공통기술문서 작성 해설서’를 발간한 바 있습니다.  이 가이드\n\n<!-- PAGE_6 -->\n#### 라인은 국제공통기술문서의 품질평가 자료 중 제2부 품질평가자료요약(Quality\n\n<!-- PAGE_6 -->\n#### Overall Summary, QOS)에 대해 구체적인 작성요령과 상세한 예를 들어 설명하\n\n<!-- PAGE_6 -->\n#### 고자 발간하게 되었으며, 미국 FDA의 질의응답식 품질심사(Question based\n\n<!-- PAGE_6 -->\n#### Review, QbR) 가이드라인의 예시를 참조하고 국내 심사 현황과 업계 의견을\n\n<!-- PAGE_6 -->\n#### 반영하여 실제 문서 작성에 도움이 되도록 실용적이고 세부적인 내용으로 구성\n\n<!-- PAGE_6 -->\n#### 하였습니다.\n\n <!-- PAGE_6 -->\n#### 본 가이드라인이 국제공통기술문서 작성 시 많이 활용되어 국내 제약 기업의\n\n<!-- PAGE_6 -->\n#### 활발한 글로벌 시장 진출에 실질적인 도움이 되기를 기대합니다.\n\n",
        "original_sentence": "<!-- PAGE_6 -->\n#### 또한 2015년 3월 「의약품의 품목허가․신고․심사 규정」이 개정되면서 2016년\n\n<!-- PAGE_6 -->\n#### 3월부터 제네릭의약품 및 자료제출의약품의 허가 신청 시 국제공통기술문서 적용이\n\n<!-- PAGE_6 -->\n#### 의무화되었습니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_165",
      "text": "<!-- PAGE_6 -->\n#### 이에 국내 제약기업의 국제공통기술문서 자료 작성을 돕고자 2015년 6월\n\n<!-- PAGE_6 -->\n#### ‘제네릭의약품의 국제공통기술문서 작성 해설서’를 발간한 바 있습니다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 164,
        "window_size": 3,
        "char_count": 123,
        "word_count": 24,
        "page_number": 6,
        "window_text": "지역별 정보 …………………………………………………………………………… 40\n\n<!-- PAGE_4 -->\n##### Appendix.  속방성 및 서방성 제제의 개발경위 기재 예시 (FDA) ………………… 41\n\n<!-- PAGE_5 -->\n## 제·개정 이력\n\n- - vi -\n머 리 말\n\n<!-- PAGE_6 -->\n#### 식품의약품안전처에서는 우수한 의약품을 공급하고 의약품 허가심사 체계를\n\n<!-- PAGE_6 -->\n#### 선진화하고자 2009년부터 신약 허가 신청 시 자료를 국제공통기술문서(Common\n\n<!-- PAGE_6 -->\n#### Technical Document, CTD)로 제출하도록 하였고, 제3부 품질평가자료에 대한\n\n<!-- PAGE_6 -->\n#### 가이드라인 및 해설서를 발간한 바 있습니다.\n\n <!-- PAGE_6 -->\n#### 또한 2015년 3월 「의약품의 품목허가․신고․심사 규정」이 개정되면서 2016년\n\n<!-- PAGE_6 -->\n#### 3월부터 제네릭의약품 및 자료제출의약품의 허가 신청 시 국제공통기술문서 적용이\n\n<!-- PAGE_6 -->\n#### 의무화되었습니다.\n\n <!-- PAGE_6 -->\n#### 이에 국내 제약기업의 국제공통기술문서 자료 작성을 돕고자 2015년 6월\n\n<!-- PAGE_6 -->\n#### ‘제네릭의약품의 국제공통기술문서 작성 해설서’를 발간한 바 있습니다.  이 가이드\n\n<!-- PAGE_6 -->\n#### 라인은 국제공통기술문서의 품질평가 자료 중 제2부 품질평가자료요약(Quality\n\n<!-- PAGE_6 -->\n#### Overall Summary, QOS)에 대해 구체적인 작성요령과 상세한 예를 들어 설명하\n\n<!-- PAGE_6 -->\n#### 고자 발간하게 되었으며, 미국 FDA의 질의응답식 품질심사(Question based\n\n<!-- PAGE_6 -->\n#### Review, QbR) 가이드라인의 예시를 참조하고 국내 심사 현황과 업계 의견을\n\n<!-- PAGE_6 -->\n#### 반영하여 실제 문서 작성에 도움이 되도록 실용적이고 세부적인 내용으로 구성\n\n<!-- PAGE_6 -->\n#### 하였습니다.\n\n <!-- PAGE_6 -->\n#### 본 가이드라인이 국제공통기술문서 작성 시 많이 활용되어 국내 제약 기업의\n\n<!-- PAGE_6 -->\n#### 활발한 글로벌 시장 진출에 실질적인 도움이 되기를 기대합니다.\n\n - - 1 -\n<!-- PAGE_7 -->\n##### 2.3. ",
        "original_sentence": "<!-- PAGE_6 -->\n#### 이에 국내 제약기업의 국제공통기술문서 자료 작성을 돕고자 2015년 6월\n\n<!-- PAGE_6 -->\n#### ‘제네릭의약품의 국제공통기술문서 작성 해설서’를 발간한 바 있습니다. "
      }
    },
    {
      "chunk_id": "chunk_166",
      "text": "이 가이드\n\n<!-- PAGE_6 -->\n#### 라인은 국제공통기술문서의 품질평가 자료 중 제2부 품질평가자료요약(Quality\n\n<!-- PAGE_6 -->\n#### Overall Summary, QOS)에 대해 구체적인 작성요령과 상세한 예를 들어 설명하\n\n<!-- PAGE_6 -->\n#### 고자 발간하게 되었으며, 미국 FDA의 질의응답식 품질심사(Question based\n\n<!-- PAGE_6 -->\n#### Review, QbR) 가이드라인의 예시를 참조하고 국내 심사 현황과 업계 의견을\n\n<!-- PAGE_6 -->\n#### 반영하여 실제 문서 작성에 도움이 되도록 실용적이고 세부적인 내용으로 구성\n\n<!-- PAGE_6 -->\n#### 하였습니다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 165,
        "window_size": 3,
        "char_count": 378,
        "word_count": 72,
        "page_number": 6,
        "window_text": "속방성 및 서방성 제제의 개발경위 기재 예시 (FDA) ………………… 41\n\n<!-- PAGE_5 -->\n## 제·개정 이력\n\n- - vi -\n머 리 말\n\n<!-- PAGE_6 -->\n#### 식품의약품안전처에서는 우수한 의약품을 공급하고 의약품 허가심사 체계를\n\n<!-- PAGE_6 -->\n#### 선진화하고자 2009년부터 신약 허가 신청 시 자료를 국제공통기술문서(Common\n\n<!-- PAGE_6 -->\n#### Technical Document, CTD)로 제출하도록 하였고, 제3부 품질평가자료에 대한\n\n<!-- PAGE_6 -->\n#### 가이드라인 및 해설서를 발간한 바 있습니다.\n\n <!-- PAGE_6 -->\n#### 또한 2015년 3월 「의약품의 품목허가․신고․심사 규정」이 개정되면서 2016년\n\n<!-- PAGE_6 -->\n#### 3월부터 제네릭의약품 및 자료제출의약품의 허가 신청 시 국제공통기술문서 적용이\n\n<!-- PAGE_6 -->\n#### 의무화되었습니다.\n\n <!-- PAGE_6 -->\n#### 이에 국내 제약기업의 국제공통기술문서 자료 작성을 돕고자 2015년 6월\n\n<!-- PAGE_6 -->\n#### ‘제네릭의약품의 국제공통기술문서 작성 해설서’를 발간한 바 있습니다.  이 가이드\n\n<!-- PAGE_6 -->\n#### 라인은 국제공통기술문서의 품질평가 자료 중 제2부 품질평가자료요약(Quality\n\n<!-- PAGE_6 -->\n#### Overall Summary, QOS)에 대해 구체적인 작성요령과 상세한 예를 들어 설명하\n\n<!-- PAGE_6 -->\n#### 고자 발간하게 되었으며, 미국 FDA의 질의응답식 품질심사(Question based\n\n<!-- PAGE_6 -->\n#### Review, QbR) 가이드라인의 예시를 참조하고 국내 심사 현황과 업계 의견을\n\n<!-- PAGE_6 -->\n#### 반영하여 실제 문서 작성에 도움이 되도록 실용적이고 세부적인 내용으로 구성\n\n<!-- PAGE_6 -->\n#### 하였습니다.\n\n <!-- PAGE_6 -->\n#### 본 가이드라인이 국제공통기술문서 작성 시 많이 활용되어 국내 제약 기업의\n\n<!-- PAGE_6 -->\n#### 활발한 글로벌 시장 진출에 실질적인 도움이 되기를 기대합니다.\n\n - - 1 -\n<!-- PAGE_7 -->\n##### 2.3.  품질평가자료 요약 (Quality Overall Summary, QOS)\n\n품질평가자료 요약은 제3부(품질평가자료)에 있는 자료의 범위와 구성에 따라 요약하는 것이다.\n\n",
        "original_sentence": "이 가이드\n\n<!-- PAGE_6 -->\n#### 라인은 국제공통기술문서의 품질평가 자료 중 제2부 품질평가자료요약(Quality\n\n<!-- PAGE_6 -->\n#### Overall Summary, QOS)에 대해 구체적인 작성요령과 상세한 예를 들어 설명하\n\n<!-- PAGE_6 -->\n#### 고자 발간하게 되었으며, 미국 FDA의 질의응답식 품질심사(Question based\n\n<!-- PAGE_6 -->\n#### Review, QbR) 가이드라인의 예시를 참조하고 국내 심사 현황과 업계 의견을\n\n<!-- PAGE_6 -->\n#### 반영하여 실제 문서 작성에 도움이 되도록 실용적이고 세부적인 내용으로 구성\n\n<!-- PAGE_6 -->\n#### 하였습니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_167",
      "text": "<!-- PAGE_6 -->\n#### 본 가이드라인이 국제공통기술문서 작성 시 많이 활용되어 국내 제약 기업의\n\n<!-- PAGE_6 -->\n#### 활발한 글로벌 시장 진출에 실질적인 도움이 되기를 기대합니다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 166,
        "window_size": 3,
        "char_count": 120,
        "word_count": 26,
        "page_number": 6,
        "window_text": "<!-- PAGE_6 -->\n#### 또한 2015년 3월 「의약품의 품목허가․신고․심사 규정」이 개정되면서 2016년\n\n<!-- PAGE_6 -->\n#### 3월부터 제네릭의약품 및 자료제출의약품의 허가 신청 시 국제공통기술문서 적용이\n\n<!-- PAGE_6 -->\n#### 의무화되었습니다.\n\n <!-- PAGE_6 -->\n#### 이에 국내 제약기업의 국제공통기술문서 자료 작성을 돕고자 2015년 6월\n\n<!-- PAGE_6 -->\n#### ‘제네릭의약품의 국제공통기술문서 작성 해설서’를 발간한 바 있습니다.  이 가이드\n\n<!-- PAGE_6 -->\n#### 라인은 국제공통기술문서의 품질평가 자료 중 제2부 품질평가자료요약(Quality\n\n<!-- PAGE_6 -->\n#### Overall Summary, QOS)에 대해 구체적인 작성요령과 상세한 예를 들어 설명하\n\n<!-- PAGE_6 -->\n#### 고자 발간하게 되었으며, 미국 FDA의 질의응답식 품질심사(Question based\n\n<!-- PAGE_6 -->\n#### Review, QbR) 가이드라인의 예시를 참조하고 국내 심사 현황과 업계 의견을\n\n<!-- PAGE_6 -->\n#### 반영하여 실제 문서 작성에 도움이 되도록 실용적이고 세부적인 내용으로 구성\n\n<!-- PAGE_6 -->\n#### 하였습니다.\n\n <!-- PAGE_6 -->\n#### 본 가이드라인이 국제공통기술문서 작성 시 많이 활용되어 국내 제약 기업의\n\n<!-- PAGE_6 -->\n#### 활발한 글로벌 시장 진출에 실질적인 도움이 되기를 기대합니다.\n\n - - 1 -\n<!-- PAGE_7 -->\n##### 2.3.  품질평가자료 요약 (Quality Overall Summary, QOS)\n\n품질평가자료 요약은 제3부(품질평가자료)에 있는 자료의 범위와 구성에 따라 요약하는 것이다.\n\n 품질평가자료요약은 국제공통기술문서의 다른 부분에서 언급되지 않은 정보, 자료 또는 정의는\n\n포함하지 않는다.\n\n",
        "original_sentence": "<!-- PAGE_6 -->\n#### 본 가이드라인이 국제공통기술문서 작성 시 많이 활용되어 국내 제약 기업의\n\n<!-- PAGE_6 -->\n#### 활발한 글로벌 시장 진출에 실질적인 도움이 되기를 기대합니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_168",
      "text": "- - 1 -\n<!-- PAGE_7 -->\n##### 2.3. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 167,
        "window_size": 3,
        "char_count": 35,
        "word_count": 9,
        "page_number": 7,
        "window_text": "<!-- PAGE_6 -->\n#### 이에 국내 제약기업의 국제공통기술문서 자료 작성을 돕고자 2015년 6월\n\n<!-- PAGE_6 -->\n#### ‘제네릭의약품의 국제공통기술문서 작성 해설서’를 발간한 바 있습니다.  이 가이드\n\n<!-- PAGE_6 -->\n#### 라인은 국제공통기술문서의 품질평가 자료 중 제2부 품질평가자료요약(Quality\n\n<!-- PAGE_6 -->\n#### Overall Summary, QOS)에 대해 구체적인 작성요령과 상세한 예를 들어 설명하\n\n<!-- PAGE_6 -->\n#### 고자 발간하게 되었으며, 미국 FDA의 질의응답식 품질심사(Question based\n\n<!-- PAGE_6 -->\n#### Review, QbR) 가이드라인의 예시를 참조하고 국내 심사 현황과 업계 의견을\n\n<!-- PAGE_6 -->\n#### 반영하여 실제 문서 작성에 도움이 되도록 실용적이고 세부적인 내용으로 구성\n\n<!-- PAGE_6 -->\n#### 하였습니다.\n\n <!-- PAGE_6 -->\n#### 본 가이드라인이 국제공통기술문서 작성 시 많이 활용되어 국내 제약 기업의\n\n<!-- PAGE_6 -->\n#### 활발한 글로벌 시장 진출에 실질적인 도움이 되기를 기대합니다.\n\n - - 1 -\n<!-- PAGE_7 -->\n##### 2.3.  품질평가자료 요약 (Quality Overall Summary, QOS)\n\n품질평가자료 요약은 제3부(품질평가자료)에 있는 자료의 범위와 구성에 따라 요약하는 것이다.\n\n 품질평가자료요약은 국제공통기술문서의 다른 부분에서 언급되지 않은 정보, 자료 또는 정의는\n\n포함하지 않는다.\n\n 품질평가자료 요약은 심사자에게 제3부의 개요를 제공할 수 있도록 각 부분의 정보를 충분히\n\n포함해야 한다. ",
        "original_sentence": "- - 1 -\n<!-- PAGE_7 -->\n##### 2.3. "
      }
    },
    {
      "chunk_id": "chunk_169",
      "text": "품질평가자료 요약 (Quality Overall Summary, QOS)\n\n품질평가자료 요약은 제3부(품질평가자료)에 있는 자료의 범위와 구성에 따라 요약하는 것이다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 168,
        "window_size": 3,
        "char_count": 95,
        "word_count": 16,
        "page_number": 45,
        "window_text": "이 가이드\n\n<!-- PAGE_6 -->\n#### 라인은 국제공통기술문서의 품질평가 자료 중 제2부 품질평가자료요약(Quality\n\n<!-- PAGE_6 -->\n#### Overall Summary, QOS)에 대해 구체적인 작성요령과 상세한 예를 들어 설명하\n\n<!-- PAGE_6 -->\n#### 고자 발간하게 되었으며, 미국 FDA의 질의응답식 품질심사(Question based\n\n<!-- PAGE_6 -->\n#### Review, QbR) 가이드라인의 예시를 참조하고 국내 심사 현황과 업계 의견을\n\n<!-- PAGE_6 -->\n#### 반영하여 실제 문서 작성에 도움이 되도록 실용적이고 세부적인 내용으로 구성\n\n<!-- PAGE_6 -->\n#### 하였습니다.\n\n <!-- PAGE_6 -->\n#### 본 가이드라인이 국제공통기술문서 작성 시 많이 활용되어 국내 제약 기업의\n\n<!-- PAGE_6 -->\n#### 활발한 글로벌 시장 진출에 실질적인 도움이 되기를 기대합니다.\n\n - - 1 -\n<!-- PAGE_7 -->\n##### 2.3.  품질평가자료 요약 (Quality Overall Summary, QOS)\n\n품질평가자료 요약은 제3부(품질평가자료)에 있는 자료의 범위와 구성에 따라 요약하는 것이다.\n\n 품질평가자료요약은 국제공통기술문서의 다른 부분에서 언급되지 않은 정보, 자료 또는 정의는\n\n포함하지 않는다.\n\n 품질평가자료 요약은 심사자에게 제3부의 개요를 제공할 수 있도록 각 부분의 정보를 충분히\n\n포함해야 한다.  품질평가자료 요약은 자료 작성시 규정을 따르지 않는 경우 그 타당성을 설명\n\n하는 등의 방식으로 신청의약품의 주요사항을 명확히 하여야 한다. ",
        "original_sentence": "품질평가자료 요약 (Quality Overall Summary, QOS)\n\n품질평가자료 요약은 제3부(품질평가자료)에 있는 자료의 범위와 구성에 따라 요약하는 것이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_170",
      "text": "품질평가자료요약은 국제공통기술문서의 다른 부분에서 언급되지 않은 정보, 자료 또는 정의는\n\n포함하지 않는다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 169,
        "window_size": 3,
        "char_count": 62,
        "word_count": 12,
        "page_number": 7,
        "window_text": "<!-- PAGE_6 -->\n#### 본 가이드라인이 국제공통기술문서 작성 시 많이 활용되어 국내 제약 기업의\n\n<!-- PAGE_6 -->\n#### 활발한 글로벌 시장 진출에 실질적인 도움이 되기를 기대합니다.\n\n - - 1 -\n<!-- PAGE_7 -->\n##### 2.3.  품질평가자료 요약 (Quality Overall Summary, QOS)\n\n품질평가자료 요약은 제3부(품질평가자료)에 있는 자료의 범위와 구성에 따라 요약하는 것이다.\n\n 품질평가자료요약은 국제공통기술문서의 다른 부분에서 언급되지 않은 정보, 자료 또는 정의는\n\n포함하지 않는다.\n\n 품질평가자료 요약은 심사자에게 제3부의 개요를 제공할 수 있도록 각 부분의 정보를 충분히\n\n포함해야 한다.  품질평가자료 요약은 자료 작성시 규정을 따르지 않는 경우 그 타당성을 설명\n\n하는 등의 방식으로 신청의약품의 주요사항을 명확히 하여야 한다.  품질평가자료 요약은, 다른\n\n부분에 있는 관련 자료를 종합적으로 고려한 중요 사항에 대한 고찰을 포함한다.",
        "original_sentence": "품질평가자료요약은 국제공통기술문서의 다른 부분에서 언급되지 않은 정보, 자료 또는 정의는\n\n포함하지 않는다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_171",
      "text": "품질평가자료 요약은 심사자에게 제3부의 개요를 제공할 수 있도록 각 부분의 정보를 충분히\n\n포함해야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 170,
        "window_size": 3,
        "char_count": 60,
        "word_count": 14,
        "page_number": 7,
        "window_text": "- - 1 -\n<!-- PAGE_7 -->\n##### 2.3.  품질평가자료 요약 (Quality Overall Summary, QOS)\n\n품질평가자료 요약은 제3부(품질평가자료)에 있는 자료의 범위와 구성에 따라 요약하는 것이다.\n\n 품질평가자료요약은 국제공통기술문서의 다른 부분에서 언급되지 않은 정보, 자료 또는 정의는\n\n포함하지 않는다.\n\n 품질평가자료 요약은 심사자에게 제3부의 개요를 제공할 수 있도록 각 부분의 정보를 충분히\n\n포함해야 한다.  품질평가자료 요약은 자료 작성시 규정을 따르지 않는 경우 그 타당성을 설명\n\n하는 등의 방식으로 신청의약품의 주요사항을 명확히 하여야 한다.  품질평가자료 요약은, 다른\n\n부분에 있는 관련 자료를 종합적으로 고려한 중요 사항에 대한 고찰을 포함한다. (다른 부분의\n\n자료를 인용할 때는 인용한 부분의 목차명과 쪽수를 기재하여 서로 참조가 가능하도록 한다.)\n\n",
        "original_sentence": "품질평가자료 요약은 심사자에게 제3부의 개요를 제공할 수 있도록 각 부분의 정보를 충분히\n\n포함해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_172",
      "text": "품질평가자료 요약은 자료 작성시 규정을 따르지 않는 경우 그 타당성을 설명\n\n하는 등의 방식으로 신청의약품의 주요사항을 명확히 하여야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 171,
        "window_size": 3,
        "char_count": 79,
        "word_count": 19,
        "page_number": 21,
        "window_text": "품질평가자료 요약 (Quality Overall Summary, QOS)\n\n품질평가자료 요약은 제3부(품질평가자료)에 있는 자료의 범위와 구성에 따라 요약하는 것이다.\n\n 품질평가자료요약은 국제공통기술문서의 다른 부분에서 언급되지 않은 정보, 자료 또는 정의는\n\n포함하지 않는다.\n\n 품질평가자료 요약은 심사자에게 제3부의 개요를 제공할 수 있도록 각 부분의 정보를 충분히\n\n포함해야 한다.  품질평가자료 요약은 자료 작성시 규정을 따르지 않는 경우 그 타당성을 설명\n\n하는 등의 방식으로 신청의약품의 주요사항을 명확히 하여야 한다.  품질평가자료 요약은, 다른\n\n부분에 있는 관련 자료를 종합적으로 고려한 중요 사항에 대한 고찰을 포함한다. (다른 부분의\n\n자료를 인용할 때는 인용한 부분의 목차명과 쪽수를 기재하여 서로 참조가 가능하도록 한다.)\n\n 품질평가자료 요약은 표나 그림을 제외한 본문이 일반적으로 40쪽을 넘지 않아야 한다. ",
        "original_sentence": "품질평가자료 요약은 자료 작성시 규정을 따르지 않는 경우 그 타당성을 설명\n\n하는 등의 방식으로 신청의약품의 주요사항을 명확히 하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_173",
      "text": "품질평가자료 요약은, 다른\n\n부분에 있는 관련 자료를 종합적으로 고려한 중요 사항에 대한 고찰을 포함한다.",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 172,
        "window_size": 3,
        "char_count": 59,
        "word_count": 14,
        "page_number": 2,
        "window_text": "품질평가자료요약은 국제공통기술문서의 다른 부분에서 언급되지 않은 정보, 자료 또는 정의는\n\n포함하지 않는다.\n\n 품질평가자료 요약은 심사자에게 제3부의 개요를 제공할 수 있도록 각 부분의 정보를 충분히\n\n포함해야 한다.  품질평가자료 요약은 자료 작성시 규정을 따르지 않는 경우 그 타당성을 설명\n\n하는 등의 방식으로 신청의약품의 주요사항을 명확히 하여야 한다.  품질평가자료 요약은, 다른\n\n부분에 있는 관련 자료를 종합적으로 고려한 중요 사항에 대한 고찰을 포함한다. (다른 부분의\n\n자료를 인용할 때는 인용한 부분의 목차명과 쪽수를 기재하여 서로 참조가 가능하도록 한다.)\n\n 품질평가자료 요약은 표나 그림을 제외한 본문이 일반적으로 40쪽을 넘지 않아야 한다.  생물\n\n의약품과 좀더 복잡한 제조 공정을 이용하여 제조된 의약품은 표나 그림을 제외하고 일반적으로\n\n본문이 80쪽을 넘지 않아야 한다.\n\n",
        "original_sentence": "품질평가자료 요약은, 다른\n\n부분에 있는 관련 자료를 종합적으로 고려한 중요 사항에 대한 고찰을 포함한다."
      }
    },
    {
      "chunk_id": "chunk_174",
      "text": "(다른 부분의\n\n자료를 인용할 때는 인용한 부분의 목차명과 쪽수를 기재하여 서로 참조가 가능하도록 한다.)\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 173,
        "window_size": 3,
        "char_count": 61,
        "word_count": 14,
        "page_number": 19,
        "window_text": "품질평가자료 요약은 심사자에게 제3부의 개요를 제공할 수 있도록 각 부분의 정보를 충분히\n\n포함해야 한다.  품질평가자료 요약은 자료 작성시 규정을 따르지 않는 경우 그 타당성을 설명\n\n하는 등의 방식으로 신청의약품의 주요사항을 명확히 하여야 한다.  품질평가자료 요약은, 다른\n\n부분에 있는 관련 자료를 종합적으로 고려한 중요 사항에 대한 고찰을 포함한다. (다른 부분의\n\n자료를 인용할 때는 인용한 부분의 목차명과 쪽수를 기재하여 서로 참조가 가능하도록 한다.)\n\n 품질평가자료 요약은 표나 그림을 제외한 본문이 일반적으로 40쪽을 넘지 않아야 한다.  생물\n\n의약품과 좀더 복잡한 제조 공정을 이용하여 제조된 의약품은 표나 그림을 제외하고 일반적으로\n\n본문이 80쪽을 넘지 않아야 한다.\n\n 아래 본문 중 밑줄로 표시한 도표, 수치 등에 대해서는 제3부에 직접 기재 사항을 그대로\n\n이용할 수 있다.\n\n",
        "original_sentence": "(다른 부분의\n\n자료를 인용할 때는 인용한 부분의 목차명과 쪽수를 기재하여 서로 참조가 가능하도록 한다.)\n\n"
      }
    },
    {
      "chunk_id": "chunk_175",
      "text": "품질평가자료 요약은 표나 그림을 제외한 본문이 일반적으로 40쪽을 넘지 않아야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 174,
        "window_size": 3,
        "char_count": 48,
        "word_count": 11,
        "page_number": 3,
        "window_text": "품질평가자료 요약은 자료 작성시 규정을 따르지 않는 경우 그 타당성을 설명\n\n하는 등의 방식으로 신청의약품의 주요사항을 명확히 하여야 한다.  품질평가자료 요약은, 다른\n\n부분에 있는 관련 자료를 종합적으로 고려한 중요 사항에 대한 고찰을 포함한다. (다른 부분의\n\n자료를 인용할 때는 인용한 부분의 목차명과 쪽수를 기재하여 서로 참조가 가능하도록 한다.)\n\n 품질평가자료 요약은 표나 그림을 제외한 본문이 일반적으로 40쪽을 넘지 않아야 한다.  생물\n\n의약품과 좀더 복잡한 제조 공정을 이용하여 제조된 의약품은 표나 그림을 제외하고 일반적으로\n\n본문이 80쪽을 넘지 않아야 한다.\n\n 아래 본문 중 밑줄로 표시한 도표, 수치 등에 대해서는 제3부에 직접 기재 사항을 그대로\n\n이용할 수 있다.\n\n 서론\n\n서론에는 원료의약품의 일반명, 상품명 또는 상용명, 회사명, 제형, 함량(역가), 투여경로, 신청\n\n하는 적응증을 포함한다.\n\n",
        "original_sentence": "품질평가자료 요약은 표나 그림을 제외한 본문이 일반적으로 40쪽을 넘지 않아야 한다. "
      }
    },
    {
      "chunk_id": "chunk_176",
      "text": "생물\n\n의약품과 좀더 복잡한 제조 공정을 이용하여 제조된 의약품은 표나 그림을 제외하고 일반적으로\n\n본문이 80쪽을 넘지 않아야 한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 175,
        "window_size": 3,
        "char_count": 77,
        "word_count": 18,
        "page_number": 3,
        "window_text": "품질평가자료 요약은, 다른\n\n부분에 있는 관련 자료를 종합적으로 고려한 중요 사항에 대한 고찰을 포함한다. (다른 부분의\n\n자료를 인용할 때는 인용한 부분의 목차명과 쪽수를 기재하여 서로 참조가 가능하도록 한다.)\n\n 품질평가자료 요약은 표나 그림을 제외한 본문이 일반적으로 40쪽을 넘지 않아야 한다.  생물\n\n의약품과 좀더 복잡한 제조 공정을 이용하여 제조된 의약품은 표나 그림을 제외하고 일반적으로\n\n본문이 80쪽을 넘지 않아야 한다.\n\n 아래 본문 중 밑줄로 표시한 도표, 수치 등에 대해서는 제3부에 직접 기재 사항을 그대로\n\n이용할 수 있다.\n\n 서론\n\n서론에는 원료의약품의 일반명, 상품명 또는 상용명, 회사명, 제형, 함량(역가), 투여경로, 신청\n\n하는 적응증을 포함한다.\n\n <!-- PAGE_7 -->\n##### 2.3.S. ",
        "original_sentence": "생물\n\n의약품과 좀더 복잡한 제조 공정을 이용하여 제조된 의약품은 표나 그림을 제외하고 일반적으로\n\n본문이 80쪽을 넘지 않아야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_177",
      "text": "아래 본문 중 밑줄로 표시한 도표, 수치 등에 대해서는 제3부에 직접 기재 사항을 그대로\n\n이용할 수 있다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 176,
        "window_size": 3,
        "char_count": 62,
        "word_count": 17,
        "page_number": 7,
        "window_text": "(다른 부분의\n\n자료를 인용할 때는 인용한 부분의 목차명과 쪽수를 기재하여 서로 참조가 가능하도록 한다.)\n\n 품질평가자료 요약은 표나 그림을 제외한 본문이 일반적으로 40쪽을 넘지 않아야 한다.  생물\n\n의약품과 좀더 복잡한 제조 공정을 이용하여 제조된 의약품은 표나 그림을 제외하고 일반적으로\n\n본문이 80쪽을 넘지 않아야 한다.\n\n 아래 본문 중 밑줄로 표시한 도표, 수치 등에 대해서는 제3부에 직접 기재 사항을 그대로\n\n이용할 수 있다.\n\n 서론\n\n서론에는 원료의약품의 일반명, 상품명 또는 상용명, 회사명, 제형, 함량(역가), 투여경로, 신청\n\n하는 적응증을 포함한다.\n\n <!-- PAGE_7 -->\n##### 2.3.S.  원료의약품(제품명, 제조자)(Drug Substance)(name, manufacturer)\n\n<!-- PAGE_7 -->\n##### 2.3.S.1. ",
        "original_sentence": "아래 본문 중 밑줄로 표시한 도표, 수치 등에 대해서는 제3부에 직접 기재 사항을 그대로\n\n이용할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_178",
      "text": "서론\n\n서론에는 원료의약품의 일반명, 상품명 또는 상용명, 회사명, 제형, 함량(역가), 투여경로, 신청\n\n하는 적응증을 포함한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 177,
        "window_size": 3,
        "char_count": 75,
        "word_count": 15,
        "page_number": 7,
        "window_text": "품질평가자료 요약은 표나 그림을 제외한 본문이 일반적으로 40쪽을 넘지 않아야 한다.  생물\n\n의약품과 좀더 복잡한 제조 공정을 이용하여 제조된 의약품은 표나 그림을 제외하고 일반적으로\n\n본문이 80쪽을 넘지 않아야 한다.\n\n 아래 본문 중 밑줄로 표시한 도표, 수치 등에 대해서는 제3부에 직접 기재 사항을 그대로\n\n이용할 수 있다.\n\n 서론\n\n서론에는 원료의약품의 일반명, 상품명 또는 상용명, 회사명, 제형, 함량(역가), 투여경로, 신청\n\n하는 적응증을 포함한다.\n\n <!-- PAGE_7 -->\n##### 2.3.S.  원료의약품(제품명, 제조자)(Drug Substance)(name, manufacturer)\n\n<!-- PAGE_7 -->\n##### 2.3.S.1.  일반정보(제품명, 제조자)(General Information)(name, manufacturer)\n\n- 3.2.S.1에서 얻은 정보를 포함한다.\n",
        "original_sentence": "서론\n\n서론에는 원료의약품의 일반명, 상품명 또는 상용명, 회사명, 제형, 함량(역가), 투여경로, 신청\n\n하는 적응증을 포함한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_179",
      "text": "<!-- PAGE_7 -->\n##### 2.3.S. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 178,
        "window_size": 3,
        "char_count": 29,
        "word_count": 5,
        "page_number": 7,
        "window_text": "생물\n\n의약품과 좀더 복잡한 제조 공정을 이용하여 제조된 의약품은 표나 그림을 제외하고 일반적으로\n\n본문이 80쪽을 넘지 않아야 한다.\n\n 아래 본문 중 밑줄로 표시한 도표, 수치 등에 대해서는 제3부에 직접 기재 사항을 그대로\n\n이용할 수 있다.\n\n 서론\n\n서론에는 원료의약품의 일반명, 상품명 또는 상용명, 회사명, 제형, 함량(역가), 투여경로, 신청\n\n하는 적응증을 포함한다.\n\n <!-- PAGE_7 -->\n##### 2.3.S.  원료의약품(제품명, 제조자)(Drug Substance)(name, manufacturer)\n\n<!-- PAGE_7 -->\n##### 2.3.S.1.  일반정보(제품명, 제조자)(General Information)(name, manufacturer)\n\n- 3.2.S.1에서 얻은 정보를 포함한다.\n <!-- PAGE_7 -->\n##### 해 설\n\n- ○ 3.2.S.1 일반정보에 설명된 원료의약품의 명칭, 구조 그리고 일반적인 특성에 대한 정보를\n요약하여 기재한다.\n\n",
        "original_sentence": "<!-- PAGE_7 -->\n##### 2.3.S. "
      }
    },
    {
      "chunk_id": "chunk_180",
      "text": "원료의약품(제품명, 제조자)(Drug Substance)(name, manufacturer)\n\n<!-- PAGE_7 -->\n##### 2.3.S.1. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 179,
        "window_size": 3,
        "char_count": 84,
        "word_count": 9,
        "page_number": 7,
        "window_text": "아래 본문 중 밑줄로 표시한 도표, 수치 등에 대해서는 제3부에 직접 기재 사항을 그대로\n\n이용할 수 있다.\n\n 서론\n\n서론에는 원료의약품의 일반명, 상품명 또는 상용명, 회사명, 제형, 함량(역가), 투여경로, 신청\n\n하는 적응증을 포함한다.\n\n <!-- PAGE_7 -->\n##### 2.3.S.  원료의약품(제품명, 제조자)(Drug Substance)(name, manufacturer)\n\n<!-- PAGE_7 -->\n##### 2.3.S.1.  일반정보(제품명, 제조자)(General Information)(name, manufacturer)\n\n- 3.2.S.1에서 얻은 정보를 포함한다.\n <!-- PAGE_7 -->\n##### 해 설\n\n- ○ 3.2.S.1 일반정보에 설명된 원료의약품의 명칭, 구조 그리고 일반적인 특성에 대한 정보를\n요약하여 기재한다.\n\n - ○ 신청품목의 주성분이 두 개 이상인 경우 [주성분 1] 및 [주성분 2] 등으로 구분하고 품질\n- - 2 -\n평가자료 요약을 각각 작성한다.\n\n",
        "original_sentence": "원료의약품(제품명, 제조자)(Drug Substance)(name, manufacturer)\n\n<!-- PAGE_7 -->\n##### 2.3.S.1. "
      }
    },
    {
      "chunk_id": "chunk_181",
      "text": "일반정보(제품명, 제조자)(General Information)(name, manufacturer)\n\n- 3.2.S.1에서 얻은 정보를 포함한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 180,
        "window_size": 3,
        "char_count": 82,
        "word_count": 9,
        "page_number": 7,
        "window_text": "서론\n\n서론에는 원료의약품의 일반명, 상품명 또는 상용명, 회사명, 제형, 함량(역가), 투여경로, 신청\n\n하는 적응증을 포함한다.\n\n <!-- PAGE_7 -->\n##### 2.3.S.  원료의약품(제품명, 제조자)(Drug Substance)(name, manufacturer)\n\n<!-- PAGE_7 -->\n##### 2.3.S.1.  일반정보(제품명, 제조자)(General Information)(name, manufacturer)\n\n- 3.2.S.1에서 얻은 정보를 포함한다.\n <!-- PAGE_7 -->\n##### 해 설\n\n- ○ 3.2.S.1 일반정보에 설명된 원료의약품의 명칭, 구조 그리고 일반적인 특성에 대한 정보를\n요약하여 기재한다.\n\n - ○ 신청품목의 주성분이 두 개 이상인 경우 [주성분 1] 및 [주성분 2] 등으로 구분하고 품질\n- - 2 -\n평가자료 요약을 각각 작성한다.\n\n - ○ 동일한 주성분에 대해 제조원이 두 개 이상인 경우 품질평가자료 요약은 하나로 작성하되,\n제조원 간 공통되지 않은 정보(예; 상이한 생산 공정)는 별도의 항에 작성한다. ",
        "original_sentence": "일반정보(제품명, 제조자)(General Information)(name, manufacturer)\n\n- 3.2.S.1에서 얻은 정보를 포함한다.\n"
      }
    },
    {
      "chunk_id": "chunk_182",
      "text": "<!-- PAGE_7 -->\n##### 해 설\n\n- ○ 3.2.S.1 일반정보에 설명된 원료의약품의 명칭, 구조 그리고 일반적인 특성에 대한 정보를\n요약하여 기재한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 181,
        "window_size": 3,
        "char_count": 95,
        "word_count": 21,
        "page_number": 7,
        "window_text": "<!-- PAGE_7 -->\n##### 2.3.S.  원료의약품(제품명, 제조자)(Drug Substance)(name, manufacturer)\n\n<!-- PAGE_7 -->\n##### 2.3.S.1.  일반정보(제품명, 제조자)(General Information)(name, manufacturer)\n\n- 3.2.S.1에서 얻은 정보를 포함한다.\n <!-- PAGE_7 -->\n##### 해 설\n\n- ○ 3.2.S.1 일반정보에 설명된 원료의약품의 명칭, 구조 그리고 일반적인 특성에 대한 정보를\n요약하여 기재한다.\n\n - ○ 신청품목의 주성분이 두 개 이상인 경우 [주성분 1] 및 [주성분 2] 등으로 구분하고 품질\n- - 2 -\n평가자료 요약을 각각 작성한다.\n\n - ○ 동일한 주성분에 대해 제조원이 두 개 이상인 경우 품질평가자료 요약은 하나로 작성하되,\n제조원 간 공통되지 않은 정보(예; 상이한 생산 공정)는 별도의 항에 작성한다.  (예: (주성분,\n\n제조원 1), (주성분, 제조원 2))\n\n- ○ 원료의약품등록(DMF) 대상 성분이 아닌 경우 아래 표에 해당하는 자료를 제출한다.\n",
        "original_sentence": "<!-- PAGE_7 -->\n##### 해 설\n\n- ○ 3.2.S.1 일반정보에 설명된 원료의약품의 명칭, 구조 그리고 일반적인 특성에 대한 정보를\n요약하여 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_183",
      "text": "- ○ 신청품목의 주성분이 두 개 이상인 경우 [주성분 1] 및 [주성분 2] 등으로 구분하고 품질\n- - 2 -\n평가자료 요약을 각각 작성한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 182,
        "window_size": 3,
        "char_count": 83,
        "word_count": 24,
        "page_number": 2,
        "window_text": "원료의약품(제품명, 제조자)(Drug Substance)(name, manufacturer)\n\n<!-- PAGE_7 -->\n##### 2.3.S.1.  일반정보(제품명, 제조자)(General Information)(name, manufacturer)\n\n- 3.2.S.1에서 얻은 정보를 포함한다.\n <!-- PAGE_7 -->\n##### 해 설\n\n- ○ 3.2.S.1 일반정보에 설명된 원료의약품의 명칭, 구조 그리고 일반적인 특성에 대한 정보를\n요약하여 기재한다.\n\n - ○ 신청품목의 주성분이 두 개 이상인 경우 [주성분 1] 및 [주성분 2] 등으로 구분하고 품질\n- - 2 -\n평가자료 요약을 각각 작성한다.\n\n - ○ 동일한 주성분에 대해 제조원이 두 개 이상인 경우 품질평가자료 요약은 하나로 작성하되,\n제조원 간 공통되지 않은 정보(예; 상이한 생산 공정)는 별도의 항에 작성한다.  (예: (주성분,\n\n제조원 1), (주성분, 제조원 2))\n\n- ○ 원료의약품등록(DMF) 대상 성분이 아닌 경우 아래 표에 해당하는 자료를 제출한다.\n * 비공개 부분에 해당하는 자료는 원료의약품 제조원으로부터 심사부서에 직접 제출 가능\n\n- ○ 성상, 해리상수(pKa), 결정다형, 용해도(pH에 따른 영향 포함), 흡습성, 융점 및 분배계수 등을\n포함한 물리화학적 성질에 대해서 기재한다 (아래의 내용에 국한하지 않고 필요한 사항에 대해\n\n- - 물리적 형태(모양, 색상, 물리적 상태)\n- - 해리상수(이온화되는 화합물인 경우)\n- - 결정다형(결정형, 무정형, 수화물, 용매화물)\n- - 용해도 특성(물, 유기용매에 대한 용해도, pH에 따른 영향 포함)\n- - 흡습성\n- - 융점, 끓는점(무정형 물질의 경우 유리전이온도)\n- - 분배계수\n위 사항은 모두 기재하는 것이 바람직하며, 특성을 수치화할 수 없는 경우 타당한 사유를 기재\n\n한다 (예: 화학구조 중 이온화기가 없으므로 pKa가 없음).\n\n",
        "original_sentence": "- ○ 신청품목의 주성분이 두 개 이상인 경우 [주성분 1] 및 [주성분 2] 등으로 구분하고 품질\n- - 2 -\n평가자료 요약을 각각 작성한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_184",
      "text": "- ○ 동일한 주성분에 대해 제조원이 두 개 이상인 경우 품질평가자료 요약은 하나로 작성하되,\n제조원 간 공통되지 않은 정보(예; 상이한 생산 공정)는 별도의 항에 작성한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 183,
        "window_size": 3,
        "char_count": 98,
        "word_count": 25,
        "page_number": 3,
        "window_text": "일반정보(제품명, 제조자)(General Information)(name, manufacturer)\n\n- 3.2.S.1에서 얻은 정보를 포함한다.\n <!-- PAGE_7 -->\n##### 해 설\n\n- ○ 3.2.S.1 일반정보에 설명된 원료의약품의 명칭, 구조 그리고 일반적인 특성에 대한 정보를\n요약하여 기재한다.\n\n - ○ 신청품목의 주성분이 두 개 이상인 경우 [주성분 1] 및 [주성분 2] 등으로 구분하고 품질\n- - 2 -\n평가자료 요약을 각각 작성한다.\n\n - ○ 동일한 주성분에 대해 제조원이 두 개 이상인 경우 품질평가자료 요약은 하나로 작성하되,\n제조원 간 공통되지 않은 정보(예; 상이한 생산 공정)는 별도의 항에 작성한다.  (예: (주성분,\n\n제조원 1), (주성분, 제조원 2))\n\n- ○ 원료의약품등록(DMF) 대상 성분이 아닌 경우 아래 표에 해당하는 자료를 제출한다.\n * 비공개 부분에 해당하는 자료는 원료의약품 제조원으로부터 심사부서에 직접 제출 가능\n\n- ○ 성상, 해리상수(pKa), 결정다형, 용해도(pH에 따른 영향 포함), 흡습성, 융점 및 분배계수 등을\n포함한 물리화학적 성질에 대해서 기재한다 (아래의 내용에 국한하지 않고 필요한 사항에 대해\n\n- - 물리적 형태(모양, 색상, 물리적 상태)\n- - 해리상수(이온화되는 화합물인 경우)\n- - 결정다형(결정형, 무정형, 수화물, 용매화물)\n- - 용해도 특성(물, 유기용매에 대한 용해도, pH에 따른 영향 포함)\n- - 흡습성\n- - 융점, 끓는점(무정형 물질의 경우 유리전이온도)\n- - 분배계수\n위 사항은 모두 기재하는 것이 바람직하며, 특성을 수치화할 수 없는 경우 타당한 사유를 기재\n\n한다 (예: 화학구조 중 이온화기가 없으므로 pKa가 없음).\n\n - ○ 용해도의 경우, 아래와 같이 기술한다.\n",
        "original_sentence": "- ○ 동일한 주성분에 대해 제조원이 두 개 이상인 경우 품질평가자료 요약은 하나로 작성하되,\n제조원 간 공통되지 않은 정보(예; 상이한 생산 공정)는 별도의 항에 작성한다. "
      }
    },
    {
      "chunk_id": "chunk_185",
      "text": "(예: (주성분,\n\n제조원 1), (주성분, 제조원 2))\n\n- ○ 원료의약품등록(DMF) 대상 성분이 아닌 경우 아래 표에 해당하는 자료를 제출한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 184,
        "window_size": 3,
        "char_count": 85,
        "word_count": 19,
        "page_number": 5,
        "window_text": "<!-- PAGE_7 -->\n##### 해 설\n\n- ○ 3.2.S.1 일반정보에 설명된 원료의약품의 명칭, 구조 그리고 일반적인 특성에 대한 정보를\n요약하여 기재한다.\n\n - ○ 신청품목의 주성분이 두 개 이상인 경우 [주성분 1] 및 [주성분 2] 등으로 구분하고 품질\n- - 2 -\n평가자료 요약을 각각 작성한다.\n\n - ○ 동일한 주성분에 대해 제조원이 두 개 이상인 경우 품질평가자료 요약은 하나로 작성하되,\n제조원 간 공통되지 않은 정보(예; 상이한 생산 공정)는 별도의 항에 작성한다.  (예: (주성분,\n\n제조원 1), (주성분, 제조원 2))\n\n- ○ 원료의약품등록(DMF) 대상 성분이 아닌 경우 아래 표에 해당하는 자료를 제출한다.\n * 비공개 부분에 해당하는 자료는 원료의약품 제조원으로부터 심사부서에 직접 제출 가능\n\n- ○ 성상, 해리상수(pKa), 결정다형, 용해도(pH에 따른 영향 포함), 흡습성, 융점 및 분배계수 등을\n포함한 물리화학적 성질에 대해서 기재한다 (아래의 내용에 국한하지 않고 필요한 사항에 대해\n\n- - 물리적 형태(모양, 색상, 물리적 상태)\n- - 해리상수(이온화되는 화합물인 경우)\n- - 결정다형(결정형, 무정형, 수화물, 용매화물)\n- - 용해도 특성(물, 유기용매에 대한 용해도, pH에 따른 영향 포함)\n- - 흡습성\n- - 융점, 끓는점(무정형 물질의 경우 유리전이온도)\n- - 분배계수\n위 사항은 모두 기재하는 것이 바람직하며, 특성을 수치화할 수 없는 경우 타당한 사유를 기재\n\n한다 (예: 화학구조 중 이온화기가 없으므로 pKa가 없음).\n\n - ○ 용해도의 경우, 아래와 같이 기술한다.\n - - 경구용 제제는 생물약제학적분류체계(BCS) 용해도 등급을 기재한다.\n",
        "original_sentence": "(예: (주성분,\n\n제조원 1), (주성분, 제조원 2))\n\n- ○ 원료의약품등록(DMF) 대상 성분이 아닌 경우 아래 표에 해당하는 자료를 제출한다.\n"
      }
    },
    {
      "chunk_id": "chunk_186",
      "text": "* 비공개 부분에 해당하는 자료는 원료의약품 제조원으로부터 심사부서에 직접 제출 가능\n\n- ○ 성상, 해리상수(pKa), 결정다형, 용해도(pH에 따른 영향 포함), 흡습성, 융점 및 분배계수 등을\n포함한 물리화학적 성질에 대해서 기재한다 (아래의 내용에 국한하지 않고 필요한 사항에 대해\n\n- - 물리적 형태(모양, 색상, 물리적 상태)\n- - 해리상수(이온화되는 화합물인 경우)\n- - 결정다형(결정형, 무정형, 수화물, 용매화물)\n- - 용해도 특성(물, 유기용매에 대한 용해도, pH에 따른 영향 포함)\n- - 흡습성\n- - 융점, 끓는점(무정형 물질의 경우 유리전이온도)\n- - 분배계수\n위 사항은 모두 기재하는 것이 바람직하며, 특성을 수치화할 수 없는 경우 타당한 사유를 기재\n\n한다 (예: 화학구조 중 이온화기가 없으므로 pKa가 없음).\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 185,
        "window_size": 3,
        "char_count": 423,
        "word_count": 101,
        "page_number": 5,
        "window_text": "- ○ 신청품목의 주성분이 두 개 이상인 경우 [주성분 1] 및 [주성분 2] 등으로 구분하고 품질\n- - 2 -\n평가자료 요약을 각각 작성한다.\n\n - ○ 동일한 주성분에 대해 제조원이 두 개 이상인 경우 품질평가자료 요약은 하나로 작성하되,\n제조원 간 공통되지 않은 정보(예; 상이한 생산 공정)는 별도의 항에 작성한다.  (예: (주성분,\n\n제조원 1), (주성분, 제조원 2))\n\n- ○ 원료의약품등록(DMF) 대상 성분이 아닌 경우 아래 표에 해당하는 자료를 제출한다.\n * 비공개 부분에 해당하는 자료는 원료의약품 제조원으로부터 심사부서에 직접 제출 가능\n\n- ○ 성상, 해리상수(pKa), 결정다형, 용해도(pH에 따른 영향 포함), 흡습성, 융점 및 분배계수 등을\n포함한 물리화학적 성질에 대해서 기재한다 (아래의 내용에 국한하지 않고 필요한 사항에 대해\n\n- - 물리적 형태(모양, 색상, 물리적 상태)\n- - 해리상수(이온화되는 화합물인 경우)\n- - 결정다형(결정형, 무정형, 수화물, 용매화물)\n- - 용해도 특성(물, 유기용매에 대한 용해도, pH에 따른 영향 포함)\n- - 흡습성\n- - 융점, 끓는점(무정형 물질의 경우 유리전이온도)\n- - 분배계수\n위 사항은 모두 기재하는 것이 바람직하며, 특성을 수치화할 수 없는 경우 타당한 사유를 기재\n\n한다 (예: 화학구조 중 이온화기가 없으므로 pKa가 없음).\n\n - ○ 용해도의 경우, 아래와 같이 기술한다.\n - - 경구용 제제는 생물약제학적분류체계(BCS) 용해도 등급을 기재한다.\n - - 3 -\n- - 용해도는 시험조건과 해당 결과를 함께 기재한다.\n",
        "original_sentence": "* 비공개 부분에 해당하는 자료는 원료의약품 제조원으로부터 심사부서에 직접 제출 가능\n\n- ○ 성상, 해리상수(pKa), 결정다형, 용해도(pH에 따른 영향 포함), 흡습성, 융점 및 분배계수 등을\n포함한 물리화학적 성질에 대해서 기재한다 (아래의 내용에 국한하지 않고 필요한 사항에 대해\n\n- - 물리적 형태(모양, 색상, 물리적 상태)\n- - 해리상수(이온화되는 화합물인 경우)\n- - 결정다형(결정형, 무정형, 수화물, 용매화물)\n- - 용해도 특성(물, 유기용매에 대한 용해도, pH에 따른 영향 포함)\n- - 흡습성\n- - 융점, 끓는점(무정형 물질의 경우 유리전이온도)\n- - 분배계수\n위 사항은 모두 기재하는 것이 바람직하며, 특성을 수치화할 수 없는 경우 타당한 사유를 기재\n\n한다 (예: 화학구조 중 이온화기가 없으므로 pKa가 없음).\n\n"
      }
    },
    {
      "chunk_id": "chunk_187",
      "text": "- ○ 용해도의 경우, 아래와 같이 기술한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 186,
        "window_size": 3,
        "char_count": 26,
        "word_count": 7,
        "page_number": 3,
        "window_text": "- ○ 동일한 주성분에 대해 제조원이 두 개 이상인 경우 품질평가자료 요약은 하나로 작성하되,\n제조원 간 공통되지 않은 정보(예; 상이한 생산 공정)는 별도의 항에 작성한다.  (예: (주성분,\n\n제조원 1), (주성분, 제조원 2))\n\n- ○ 원료의약품등록(DMF) 대상 성분이 아닌 경우 아래 표에 해당하는 자료를 제출한다.\n * 비공개 부분에 해당하는 자료는 원료의약품 제조원으로부터 심사부서에 직접 제출 가능\n\n- ○ 성상, 해리상수(pKa), 결정다형, 용해도(pH에 따른 영향 포함), 흡습성, 융점 및 분배계수 등을\n포함한 물리화학적 성질에 대해서 기재한다 (아래의 내용에 국한하지 않고 필요한 사항에 대해\n\n- - 물리적 형태(모양, 색상, 물리적 상태)\n- - 해리상수(이온화되는 화합물인 경우)\n- - 결정다형(결정형, 무정형, 수화물, 용매화물)\n- - 용해도 특성(물, 유기용매에 대한 용해도, pH에 따른 영향 포함)\n- - 흡습성\n- - 융점, 끓는점(무정형 물질의 경우 유리전이온도)\n- - 분배계수\n위 사항은 모두 기재하는 것이 바람직하며, 특성을 수치화할 수 없는 경우 타당한 사유를 기재\n\n한다 (예: 화학구조 중 이온화기가 없으므로 pKa가 없음).\n\n - ○ 용해도의 경우, 아래와 같이 기술한다.\n - - 경구용 제제는 생물약제학적분류체계(BCS) 용해도 등급을 기재한다.\n - - 3 -\n- - 용해도는 시험조건과 해당 결과를 함께 기재한다.\n - - 결정다형에 대한 pH-용해도 정보를 기재한다.\n",
        "original_sentence": "- ○ 용해도의 경우, 아래와 같이 기술한다.\n"
      }
    },
    {
      "chunk_id": "chunk_188",
      "text": "- - 경구용 제제는 생물약제학적분류체계(BCS) 용해도 등급을 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 187,
        "window_size": 3,
        "char_count": 42,
        "word_count": 8,
        "page_number": 5,
        "window_text": "(예: (주성분,\n\n제조원 1), (주성분, 제조원 2))\n\n- ○ 원료의약품등록(DMF) 대상 성분이 아닌 경우 아래 표에 해당하는 자료를 제출한다.\n * 비공개 부분에 해당하는 자료는 원료의약품 제조원으로부터 심사부서에 직접 제출 가능\n\n- ○ 성상, 해리상수(pKa), 결정다형, 용해도(pH에 따른 영향 포함), 흡습성, 융점 및 분배계수 등을\n포함한 물리화학적 성질에 대해서 기재한다 (아래의 내용에 국한하지 않고 필요한 사항에 대해\n\n- - 물리적 형태(모양, 색상, 물리적 상태)\n- - 해리상수(이온화되는 화합물인 경우)\n- - 결정다형(결정형, 무정형, 수화물, 용매화물)\n- - 용해도 특성(물, 유기용매에 대한 용해도, pH에 따른 영향 포함)\n- - 흡습성\n- - 융점, 끓는점(무정형 물질의 경우 유리전이온도)\n- - 분배계수\n위 사항은 모두 기재하는 것이 바람직하며, 특성을 수치화할 수 없는 경우 타당한 사유를 기재\n\n한다 (예: 화학구조 중 이온화기가 없으므로 pKa가 없음).\n\n - ○ 용해도의 경우, 아래와 같이 기술한다.\n - - 경구용 제제는 생물약제학적분류체계(BCS) 용해도 등급을 기재한다.\n - - 3 -\n- - 용해도는 시험조건과 해당 결과를 함께 기재한다.\n - - 결정다형에 대한 pH-용해도 정보를 기재한다.\n - - 해당 원료의약품의 결정형에 대해서는 pH-용해도 정보를 기재해야 한다. ",
        "original_sentence": "- - 경구용 제제는 생물약제학적분류체계(BCS) 용해도 등급을 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_189",
      "text": "- - 3 -\n- - 용해도는 시험조건과 해당 결과를 함께 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 188,
        "window_size": 3,
        "char_count": 39,
        "word_count": 12,
        "page_number": 5,
        "window_text": "* 비공개 부분에 해당하는 자료는 원료의약품 제조원으로부터 심사부서에 직접 제출 가능\n\n- ○ 성상, 해리상수(pKa), 결정다형, 용해도(pH에 따른 영향 포함), 흡습성, 융점 및 분배계수 등을\n포함한 물리화학적 성질에 대해서 기재한다 (아래의 내용에 국한하지 않고 필요한 사항에 대해\n\n- - 물리적 형태(모양, 색상, 물리적 상태)\n- - 해리상수(이온화되는 화합물인 경우)\n- - 결정다형(결정형, 무정형, 수화물, 용매화물)\n- - 용해도 특성(물, 유기용매에 대한 용해도, pH에 따른 영향 포함)\n- - 흡습성\n- - 융점, 끓는점(무정형 물질의 경우 유리전이온도)\n- - 분배계수\n위 사항은 모두 기재하는 것이 바람직하며, 특성을 수치화할 수 없는 경우 타당한 사유를 기재\n\n한다 (예: 화학구조 중 이온화기가 없으므로 pKa가 없음).\n\n - ○ 용해도의 경우, 아래와 같이 기술한다.\n - - 경구용 제제는 생물약제학적분류체계(BCS) 용해도 등급을 기재한다.\n - - 3 -\n- - 용해도는 시험조건과 해당 결과를 함께 기재한다.\n - - 결정다형에 대한 pH-용해도 정보를 기재한다.\n - - 해당 원료의약품의 결정형에 대해서는 pH-용해도 정보를 기재해야 한다.  원료의약품의\n결정형보다 안정한 결정형에 대해서는 특정 pH에서의 상대적 용해도를 기재한다.\n\n",
        "original_sentence": "- - 3 -\n- - 용해도는 시험조건과 해당 결과를 함께 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_190",
      "text": "- - 결정다형에 대한 pH-용해도 정보를 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 189,
        "window_size": 3,
        "char_count": 30,
        "word_count": 7,
        "page_number": 5,
        "window_text": "- ○ 용해도의 경우, 아래와 같이 기술한다.\n - - 경구용 제제는 생물약제학적분류체계(BCS) 용해도 등급을 기재한다.\n - - 3 -\n- - 용해도는 시험조건과 해당 결과를 함께 기재한다.\n - - 결정다형에 대한 pH-용해도 정보를 기재한다.\n - - 해당 원료의약품의 결정형에 대해서는 pH-용해도 정보를 기재해야 한다.  원료의약품의\n결정형보다 안정한 결정형에 대해서는 특정 pH에서의 상대적 용해도를 기재한다.\n\n 예시 1)\n\n한글명:\n\n국제일반명칭(INN, International Nonproprietary Names for Pharmaceutical Substances):\n\n공정서 수재품목은 그 수재명:\n\n화학명(IUPAC 명칭):\n\nCAS 번호:\n\n구조식:\n\n분자식:\n\n분자량:\n\n예시 2)\n\n. ",
        "original_sentence": "- - 결정다형에 대한 pH-용해도 정보를 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_191",
      "text": "- - 해당 원료의약품의 결정형에 대해서는 pH-용해도 정보를 기재해야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 190,
        "window_size": 3,
        "char_count": 44,
        "word_count": 10,
        "page_number": 5,
        "window_text": "- - 경구용 제제는 생물약제학적분류체계(BCS) 용해도 등급을 기재한다.\n - - 3 -\n- - 용해도는 시험조건과 해당 결과를 함께 기재한다.\n - - 결정다형에 대한 pH-용해도 정보를 기재한다.\n - - 해당 원료의약품의 결정형에 대해서는 pH-용해도 정보를 기재해야 한다.  원료의약품의\n결정형보다 안정한 결정형에 대해서는 특정 pH에서의 상대적 용해도를 기재한다.\n\n 예시 1)\n\n한글명:\n\n국제일반명칭(INN, International Nonproprietary Names for Pharmaceutical Substances):\n\n공정서 수재품목은 그 수재명:\n\n화학명(IUPAC 명칭):\n\nCAS 번호:\n\n구조식:\n\n분자식:\n\n분자량:\n\n예시 2)\n\n.  성상: 주성분 A는 흰색의 결정형 가루로 pH 7.0인 물에 거의 녹지 않으며, 염화메틸렌에 잘\n\n. ",
        "original_sentence": "- - 해당 원료의약품의 결정형에 대해서는 pH-용해도 정보를 기재해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_192",
      "text": "원료의약품의\n결정형보다 안정한 결정형에 대해서는 특정 pH에서의 상대적 용해도를 기재한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 191,
        "window_size": 3,
        "char_count": 52,
        "word_count": 10,
        "page_number": 9,
        "window_text": "- - 3 -\n- - 용해도는 시험조건과 해당 결과를 함께 기재한다.\n - - 결정다형에 대한 pH-용해도 정보를 기재한다.\n - - 해당 원료의약품의 결정형에 대해서는 pH-용해도 정보를 기재해야 한다.  원료의약품의\n결정형보다 안정한 결정형에 대해서는 특정 pH에서의 상대적 용해도를 기재한다.\n\n 예시 1)\n\n한글명:\n\n국제일반명칭(INN, International Nonproprietary Names for Pharmaceutical Substances):\n\n공정서 수재품목은 그 수재명:\n\n화학명(IUPAC 명칭):\n\nCAS 번호:\n\n구조식:\n\n분자식:\n\n분자량:\n\n예시 2)\n\n.  성상: 주성분 A는 흰색의 결정형 가루로 pH 7.0인 물에 거의 녹지 않으며, 염화메틸렌에 잘\n\n.  pKa: 5.5\n\n. ",
        "original_sentence": "원료의약품의\n결정형보다 안정한 결정형에 대해서는 특정 pH에서의 상대적 용해도를 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_193",
      "text": "예시 1)\n\n한글명:\n\n국제일반명칭(INN, International Nonproprietary Names for Pharmaceutical Substances):\n\n공정서 수재품목은 그 수재명:\n\n화학명(IUPAC 명칭):\n\nCAS 번호:\n\n구조식:\n\n분자식:\n\n분자량:\n\n예시 2)\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 192,
        "window_size": 3,
        "char_count": 163,
        "word_count": 24,
        "page_number": 2,
        "window_text": "- - 결정다형에 대한 pH-용해도 정보를 기재한다.\n - - 해당 원료의약품의 결정형에 대해서는 pH-용해도 정보를 기재해야 한다.  원료의약품의\n결정형보다 안정한 결정형에 대해서는 특정 pH에서의 상대적 용해도를 기재한다.\n\n 예시 1)\n\n한글명:\n\n국제일반명칭(INN, International Nonproprietary Names for Pharmaceutical Substances):\n\n공정서 수재품목은 그 수재명:\n\n화학명(IUPAC 명칭):\n\nCAS 번호:\n\n구조식:\n\n분자식:\n\n분자량:\n\n예시 2)\n\n.  성상: 주성분 A는 흰색의 결정형 가루로 pH 7.0인 물에 거의 녹지 않으며, 염화메틸렌에 잘\n\n.  pKa: 5.5\n\n.  결정다형: 결정형 I과 결정형 II의 2 가지 결정형이 있다. ",
        "original_sentence": "예시 1)\n\n한글명:\n\n국제일반명칭(INN, International Nonproprietary Names for Pharmaceutical Substances):\n\n공정서 수재품목은 그 수재명:\n\n화학명(IUPAC 명칭):\n\nCAS 번호:\n\n구조식:\n\n분자식:\n\n분자량:\n\n예시 2)\n\n. "
      }
    },
    {
      "chunk_id": "chunk_194",
      "text": "성상: 주성분 A는 흰색의 결정형 가루로 pH 7.0인 물에 거의 녹지 않으며, 염화메틸렌에 잘\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 193,
        "window_size": 3,
        "char_count": 57,
        "word_count": 15,
        "page_number": 9,
        "window_text": "- - 해당 원료의약품의 결정형에 대해서는 pH-용해도 정보를 기재해야 한다.  원료의약품의\n결정형보다 안정한 결정형에 대해서는 특정 pH에서의 상대적 용해도를 기재한다.\n\n 예시 1)\n\n한글명:\n\n국제일반명칭(INN, International Nonproprietary Names for Pharmaceutical Substances):\n\n공정서 수재품목은 그 수재명:\n\n화학명(IUPAC 명칭):\n\nCAS 번호:\n\n구조식:\n\n분자식:\n\n분자량:\n\n예시 2)\n\n.  성상: 주성분 A는 흰색의 결정형 가루로 pH 7.0인 물에 거의 녹지 않으며, 염화메틸렌에 잘\n\n.  pKa: 5.5\n\n.  결정다형: 결정형 I과 결정형 II의 2 가지 결정형이 있다.  결정형 I이 더 안정한 결정형으로\n\n. ",
        "original_sentence": "성상: 주성분 A는 흰색의 결정형 가루로 pH 7.0인 물에 거의 녹지 않으며, 염화메틸렌에 잘\n\n. "
      }
    },
    {
      "chunk_id": "chunk_195",
      "text": "pKa: 5.5\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 194,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 23,
        "window_text": "원료의약품의\n결정형보다 안정한 결정형에 대해서는 특정 pH에서의 상대적 용해도를 기재한다.\n\n 예시 1)\n\n한글명:\n\n국제일반명칭(INN, International Nonproprietary Names for Pharmaceutical Substances):\n\n공정서 수재품목은 그 수재명:\n\n화학명(IUPAC 명칭):\n\nCAS 번호:\n\n구조식:\n\n분자식:\n\n분자량:\n\n예시 2)\n\n.  성상: 주성분 A는 흰색의 결정형 가루로 pH 7.0인 물에 거의 녹지 않으며, 염화메틸렌에 잘\n\n.  pKa: 5.5\n\n.  결정다형: 결정형 I과 결정형 II의 2 가지 결정형이 있다.  결정형 I이 더 안정한 결정형으로\n\n.  용해도: 각 pH에서의 용해도 결과는 아래와 같다 (온도 37 ℃).\n\n",
        "original_sentence": "pKa: 5.5\n\n. "
      }
    },
    {
      "chunk_id": "chunk_196",
      "text": "결정다형: 결정형 I과 결정형 II의 2 가지 결정형이 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 195,
        "window_size": 3,
        "char_count": 35,
        "word_count": 9,
        "page_number": 3,
        "window_text": "예시 1)\n\n한글명:\n\n국제일반명칭(INN, International Nonproprietary Names for Pharmaceutical Substances):\n\n공정서 수재품목은 그 수재명:\n\n화학명(IUPAC 명칭):\n\nCAS 번호:\n\n구조식:\n\n분자식:\n\n분자량:\n\n예시 2)\n\n.  성상: 주성분 A는 흰색의 결정형 가루로 pH 7.0인 물에 거의 녹지 않으며, 염화메틸렌에 잘\n\n.  pKa: 5.5\n\n.  결정다형: 결정형 I과 결정형 II의 2 가지 결정형이 있다.  결정형 I이 더 안정한 결정형으로\n\n.  용해도: 각 pH에서의 용해도 결과는 아래와 같다 (온도 37 ℃).\n\n - 0.15 M 아세트산염 완충액, pH 3.0\n- 0.09 mg/mL\n- 0.40 mg/mL\n- 0.15 M 아세트산염 완충액, pH 4.5\n- 0.011 mg/mL\n- 0.033 mg/mL\n- 0.15 M 인산염 완충액, pH 6.8\n(< 0.001 mg/mL)\n\n(< 0.001 mg/mL)\n\n위 결과에 따라 주성분 A는 생물학적분류체계 (Biopharmaceutical Classification System,\n\nBCS)에 따라 낮은 용해도 성분에 해당한다.\n\n",
        "original_sentence": "결정다형: 결정형 I과 결정형 II의 2 가지 결정형이 있다. "
      }
    },
    {
      "chunk_id": "chunk_197",
      "text": "결정형 I이 더 안정한 결정형으로\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 196,
        "window_size": 3,
        "char_count": 22,
        "word_count": 6,
        "page_number": 3,
        "window_text": "성상: 주성분 A는 흰색의 결정형 가루로 pH 7.0인 물에 거의 녹지 않으며, 염화메틸렌에 잘\n\n.  pKa: 5.5\n\n.  결정다형: 결정형 I과 결정형 II의 2 가지 결정형이 있다.  결정형 I이 더 안정한 결정형으로\n\n.  용해도: 각 pH에서의 용해도 결과는 아래와 같다 (온도 37 ℃).\n\n - 0.15 M 아세트산염 완충액, pH 3.0\n- 0.09 mg/mL\n- 0.40 mg/mL\n- 0.15 M 아세트산염 완충액, pH 4.5\n- 0.011 mg/mL\n- 0.033 mg/mL\n- 0.15 M 인산염 완충액, pH 6.8\n(< 0.001 mg/mL)\n\n(< 0.001 mg/mL)\n\n위 결과에 따라 주성분 A는 생물학적분류체계 (Biopharmaceutical Classification System,\n\nBCS)에 따라 낮은 용해도 성분에 해당한다.\n\n . ",
        "original_sentence": "결정형 I이 더 안정한 결정형으로\n\n. "
      }
    },
    {
      "chunk_id": "chunk_198",
      "text": "용해도: 각 pH에서의 용해도 결과는 아래와 같다 (온도 37 ℃).\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 197,
        "window_size": 3,
        "char_count": 40,
        "word_count": 10,
        "page_number": 9,
        "window_text": "pKa: 5.5\n\n.  결정다형: 결정형 I과 결정형 II의 2 가지 결정형이 있다.  결정형 I이 더 안정한 결정형으로\n\n.  용해도: 각 pH에서의 용해도 결과는 아래와 같다 (온도 37 ℃).\n\n - 0.15 M 아세트산염 완충액, pH 3.0\n- 0.09 mg/mL\n- 0.40 mg/mL\n- 0.15 M 아세트산염 완충액, pH 4.5\n- 0.011 mg/mL\n- 0.033 mg/mL\n- 0.15 M 인산염 완충액, pH 6.8\n(< 0.001 mg/mL)\n\n(< 0.001 mg/mL)\n\n위 결과에 따라 주성분 A는 생물학적분류체계 (Biopharmaceutical Classification System,\n\nBCS)에 따라 낮은 용해도 성분에 해당한다.\n\n .  흡습성: 일주일간 25℃/75 ± 5 %에서 흡습되는 양이 0.1 % 이하였다. ",
        "original_sentence": "용해도: 각 pH에서의 용해도 결과는 아래와 같다 (온도 37 ℃).\n\n"
      }
    },
    {
      "chunk_id": "chunk_199",
      "text": "- 0.15 M 아세트산염 완충액, pH 3.0\n- 0.09 mg/mL\n- 0.40 mg/mL\n- 0.15 M 아세트산염 완충액, pH 4.5\n- 0.011 mg/mL\n- 0.033 mg/mL\n- 0.15 M 인산염 완충액, pH 6.8\n(< 0.001 mg/mL)\n\n(< 0.001 mg/mL)\n\n위 결과에 따라 주성분 A는 생물학적분류체계 (Biopharmaceutical Classification System,\n\nBCS)에 따라 낮은 용해도 성분에 해당한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 198,
        "window_size": 3,
        "char_count": 262,
        "word_count": 54,
        "page_number": 5,
        "window_text": "결정다형: 결정형 I과 결정형 II의 2 가지 결정형이 있다.  결정형 I이 더 안정한 결정형으로\n\n.  용해도: 각 pH에서의 용해도 결과는 아래와 같다 (온도 37 ℃).\n\n - 0.15 M 아세트산염 완충액, pH 3.0\n- 0.09 mg/mL\n- 0.40 mg/mL\n- 0.15 M 아세트산염 완충액, pH 4.5\n- 0.011 mg/mL\n- 0.033 mg/mL\n- 0.15 M 인산염 완충액, pH 6.8\n(< 0.001 mg/mL)\n\n(< 0.001 mg/mL)\n\n위 결과에 따라 주성분 A는 생물학적분류체계 (Biopharmaceutical Classification System,\n\nBCS)에 따라 낮은 용해도 성분에 해당한다.\n\n .  흡습성: 일주일간 25℃/75 ± 5 %에서 흡습되는 양이 0.1 % 이하였다.  자세한 내용은 3.2.\n\n",
        "original_sentence": "- 0.15 M 아세트산염 완충액, pH 3.0\n- 0.09 mg/mL\n- 0.40 mg/mL\n- 0.15 M 아세트산염 완충액, pH 4.5\n- 0.011 mg/mL\n- 0.033 mg/mL\n- 0.15 M 인산염 완충액, pH 6.8\n(< 0.001 mg/mL)\n\n(< 0.001 mg/mL)\n\n위 결과에 따라 주성분 A는 생물학적분류체계 (Biopharmaceutical Classification System,\n\nBCS)에 따라 낮은 용해도 성분에 해당한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_200",
      "text": ". ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 199,
        "window_size": 3,
        "char_count": 2,
        "word_count": 1,
        "page_number": 1,
        "window_text": "결정형 I이 더 안정한 결정형으로\n\n.  용해도: 각 pH에서의 용해도 결과는 아래와 같다 (온도 37 ℃).\n\n - 0.15 M 아세트산염 완충액, pH 3.0\n- 0.09 mg/mL\n- 0.40 mg/mL\n- 0.15 M 아세트산염 완충액, pH 4.5\n- 0.011 mg/mL\n- 0.033 mg/mL\n- 0.15 M 인산염 완충액, pH 6.8\n(< 0.001 mg/mL)\n\n(< 0.001 mg/mL)\n\n위 결과에 따라 주성분 A는 생물학적분류체계 (Biopharmaceutical Classification System,\n\nBCS)에 따라 낮은 용해도 성분에 해당한다.\n\n .  흡습성: 일주일간 25℃/75 ± 5 %에서 흡습되는 양이 0.1 % 이하였다.  자세한 내용은 3.2.\n\n P.2.1.1 원료의약품을 참고한다.\n\n",
        "original_sentence": ". "
      }
    },
    {
      "chunk_id": "chunk_201",
      "text": "흡습성: 일주일간 25℃/75 ± 5 %에서 흡습되는 양이 0.1 % 이하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 200,
        "window_size": 3,
        "char_count": 45,
        "word_count": 11,
        "page_number": 3,
        "window_text": "용해도: 각 pH에서의 용해도 결과는 아래와 같다 (온도 37 ℃).\n\n - 0.15 M 아세트산염 완충액, pH 3.0\n- 0.09 mg/mL\n- 0.40 mg/mL\n- 0.15 M 아세트산염 완충액, pH 4.5\n- 0.011 mg/mL\n- 0.033 mg/mL\n- 0.15 M 인산염 완충액, pH 6.8\n(< 0.001 mg/mL)\n\n(< 0.001 mg/mL)\n\n위 결과에 따라 주성분 A는 생물학적분류체계 (Biopharmaceutical Classification System,\n\nBCS)에 따라 낮은 용해도 성분에 해당한다.\n\n .  흡습성: 일주일간 25℃/75 ± 5 %에서 흡습되는 양이 0.1 % 이하였다.  자세한 내용은 3.2.\n\n P.2.1.1 원료의약품을 참고한다.\n\n - - 4 -\n. ",
        "original_sentence": "흡습성: 일주일간 25℃/75 ± 5 %에서 흡습되는 양이 0.1 % 이하였다. "
      }
    },
    {
      "chunk_id": "chunk_202",
      "text": "자세한 내용은 3.2.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 201,
        "window_size": 3,
        "char_count": 14,
        "word_count": 3,
        "page_number": 5,
        "window_text": "- 0.15 M 아세트산염 완충액, pH 3.0\n- 0.09 mg/mL\n- 0.40 mg/mL\n- 0.15 M 아세트산염 완충액, pH 4.5\n- 0.011 mg/mL\n- 0.033 mg/mL\n- 0.15 M 인산염 완충액, pH 6.8\n(< 0.001 mg/mL)\n\n(< 0.001 mg/mL)\n\n위 결과에 따라 주성분 A는 생물학적분류체계 (Biopharmaceutical Classification System,\n\nBCS)에 따라 낮은 용해도 성분에 해당한다.\n\n .  흡습성: 일주일간 25℃/75 ± 5 %에서 흡습되는 양이 0.1 % 이하였다.  자세한 내용은 3.2.\n\n P.2.1.1 원료의약품을 참고한다.\n\n - - 4 -\n.  융점: 결정형 I 225 ℃, 결정형 II 201 ℃\n\n. ",
        "original_sentence": "자세한 내용은 3.2.\n\n"
      }
    },
    {
      "chunk_id": "chunk_203",
      "text": "P.2.1.1 원료의약품을 참고한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 202,
        "window_size": 3,
        "char_count": 22,
        "word_count": 3,
        "page_number": 9,
        "window_text": ".  흡습성: 일주일간 25℃/75 ± 5 %에서 흡습되는 양이 0.1 % 이하였다.  자세한 내용은 3.2.\n\n P.2.1.1 원료의약품을 참고한다.\n\n - - 4 -\n.  융점: 결정형 I 225 ℃, 결정형 II 201 ℃\n\n.  분배계수: ClogP = 4.251\n\n<!-- PAGE_10 -->\n##### 2.3.S.2. ",
        "original_sentence": "P.2.1.1 원료의약품을 참고한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_204",
      "text": "- - 4 -\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 203,
        "window_size": 3,
        "char_count": 10,
        "word_count": 5,
        "page_number": 5,
        "window_text": "흡습성: 일주일간 25℃/75 ± 5 %에서 흡습되는 양이 0.1 % 이하였다.  자세한 내용은 3.2.\n\n P.2.1.1 원료의약품을 참고한다.\n\n - - 4 -\n.  융점: 결정형 I 225 ℃, 결정형 II 201 ℃\n\n.  분배계수: ClogP = 4.251\n\n<!-- PAGE_10 -->\n##### 2.3.S.2.  제조(제품명, 제조자)(Manufacture)(name, manufacturer)\n\n- 3.2.S.2에서 얻은 다음 정보를 포함한다.\n",
        "original_sentence": "- - 4 -\n. "
      }
    },
    {
      "chunk_id": "chunk_205",
      "text": "융점: 결정형 I 225 ℃, 결정형 II 201 ℃\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 204,
        "window_size": 3,
        "char_count": 33,
        "word_count": 10,
        "page_number": 5,
        "window_text": "자세한 내용은 3.2.\n\n P.2.1.1 원료의약품을 참고한다.\n\n - - 4 -\n.  융점: 결정형 I 225 ℃, 결정형 II 201 ℃\n\n.  분배계수: ClogP = 4.251\n\n<!-- PAGE_10 -->\n##### 2.3.S.2.  제조(제품명, 제조자)(Manufacture)(name, manufacturer)\n\n- 3.2.S.2에서 얻은 다음 정보를 포함한다.\n - - 제조자(제조원)에 대한 사항\n- - 적절한 품질의 원료의약품을 일정하게 제조하기 위해 제조공정(예. ",
        "original_sentence": "융점: 결정형 I 225 ℃, 결정형 II 201 ℃\n\n. "
      }
    },
    {
      "chunk_id": "chunk_206",
      "text": "분배계수: ClogP = 4.251\n\n<!-- PAGE_10 -->\n##### 2.3.S.2. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 205,
        "window_size": 3,
        "char_count": 53,
        "word_count": 9,
        "page_number": 10,
        "window_text": "P.2.1.1 원료의약품을 참고한다.\n\n - - 4 -\n.  융점: 결정형 I 225 ℃, 결정형 II 201 ℃\n\n.  분배계수: ClogP = 4.251\n\n<!-- PAGE_10 -->\n##### 2.3.S.2.  제조(제품명, 제조자)(Manufacture)(name, manufacturer)\n\n- 3.2.S.2에서 얻은 다음 정보를 포함한다.\n - - 제조자(제조원)에 대한 사항\n- - 적절한 품질의 원료의약품을 일정하게 제조하기 위해 제조공정(예.  출발물질, 중요공정 및\n- - 3.2.S.2.2에 기재된 제조공정도(flow diagram)\n- - 3.2.S.2.3에 설명된 원료의약품 제조에 사용된 출발물질과 생물유래 원료물질에 대한 설명\n- - 중요 제조공정, 공정관리 및 허용기준과 그 타당성에 대한 고찰, 특히 3.2.S.2.4에 설명된\n- - 3.2.S.2.5에 설명된 공정 밸리데이션 및/또는 평가에 대한 설명\n- - 3.2.S.2.6에 설명된 개발과정에서의 제조방법에 관한 중대한 변경에 대한 간략한 요약 및\n제품의 일관성을 평가하기 위해 사용된 검토결과로부터 얻은 결론. ",
        "original_sentence": "분배계수: ClogP = 4.251\n\n<!-- PAGE_10 -->\n##### 2.3.S.2. "
      }
    },
    {
      "chunk_id": "chunk_207",
      "text": "제조(제품명, 제조자)(Manufacture)(name, manufacturer)\n\n- 3.2.S.2에서 얻은 다음 정보를 포함한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 206,
        "window_size": 3,
        "char_count": 75,
        "word_count": 9,
        "page_number": 5,
        "window_text": "- - 4 -\n.  융점: 결정형 I 225 ℃, 결정형 II 201 ℃\n\n.  분배계수: ClogP = 4.251\n\n<!-- PAGE_10 -->\n##### 2.3.S.2.  제조(제품명, 제조자)(Manufacture)(name, manufacturer)\n\n- 3.2.S.2에서 얻은 다음 정보를 포함한다.\n - - 제조자(제조원)에 대한 사항\n- - 적절한 품질의 원료의약품을 일정하게 제조하기 위해 제조공정(예.  출발물질, 중요공정 및\n- - 3.2.S.2.2에 기재된 제조공정도(flow diagram)\n- - 3.2.S.2.3에 설명된 원료의약품 제조에 사용된 출발물질과 생물유래 원료물질에 대한 설명\n- - 중요 제조공정, 공정관리 및 허용기준과 그 타당성에 대한 고찰, 특히 3.2.S.2.4에 설명된\n- - 3.2.S.2.5에 설명된 공정 밸리데이션 및/또는 평가에 대한 설명\n- - 3.2.S.2.6에 설명된 개발과정에서의 제조방법에 관한 중대한 변경에 대한 간략한 요약 및\n제품의 일관성을 평가하기 위해 사용된 검토결과로부터 얻은 결론.  품질에 관한 자료 요약\n\n(QOS)은 제조공정 변경에 따른 뱃치를 사용한 (M4S 및 M4E의) 비임상시험 또는 임상시험\n\n- ○ 3.2.S.2 제조에 설명된 원료의약품의 제조원, 제조공정 및 공정관리, 원료관리, 중요공정 및\n- ○ 제조 및 시험에 관한 모든 사업소 또는 시설에 해당하는 제조원의 명칭, 주소, 책임부과범위\n- ○ 원료의약품 자료 중 비공개 부분을 제외한 내용을 요약 기재한다.\n",
        "original_sentence": "제조(제품명, 제조자)(Manufacture)(name, manufacturer)\n\n- 3.2.S.2에서 얻은 다음 정보를 포함한다.\n"
      }
    },
    {
      "chunk_id": "chunk_208",
      "text": "- - 제조자(제조원)에 대한 사항\n- - 적절한 품질의 원료의약품을 일정하게 제조하기 위해 제조공정(예. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 207,
        "window_size": 3,
        "char_count": 60,
        "word_count": 14,
        "page_number": 2,
        "window_text": "융점: 결정형 I 225 ℃, 결정형 II 201 ℃\n\n.  분배계수: ClogP = 4.251\n\n<!-- PAGE_10 -->\n##### 2.3.S.2.  제조(제품명, 제조자)(Manufacture)(name, manufacturer)\n\n- 3.2.S.2에서 얻은 다음 정보를 포함한다.\n - - 제조자(제조원)에 대한 사항\n- - 적절한 품질의 원료의약품을 일정하게 제조하기 위해 제조공정(예.  출발물질, 중요공정 및\n- - 3.2.S.2.2에 기재된 제조공정도(flow diagram)\n- - 3.2.S.2.3에 설명된 원료의약품 제조에 사용된 출발물질과 생물유래 원료물질에 대한 설명\n- - 중요 제조공정, 공정관리 및 허용기준과 그 타당성에 대한 고찰, 특히 3.2.S.2.4에 설명된\n- - 3.2.S.2.5에 설명된 공정 밸리데이션 및/또는 평가에 대한 설명\n- - 3.2.S.2.6에 설명된 개발과정에서의 제조방법에 관한 중대한 변경에 대한 간략한 요약 및\n제품의 일관성을 평가하기 위해 사용된 검토결과로부터 얻은 결론.  품질에 관한 자료 요약\n\n(QOS)은 제조공정 변경에 따른 뱃치를 사용한 (M4S 및 M4E의) 비임상시험 또는 임상시험\n\n- ○ 3.2.S.2 제조에 설명된 원료의약품의 제조원, 제조공정 및 공정관리, 원료관리, 중요공정 및\n- ○ 제조 및 시험에 관한 모든 사업소 또는 시설에 해당하는 제조원의 명칭, 주소, 책임부과범위\n- ○ 원료의약품 자료 중 비공개 부분을 제외한 내용을 요약 기재한다.\n <!-- PAGE_10 -->\n##### 2.3.S.3. ",
        "original_sentence": "- - 제조자(제조원)에 대한 사항\n- - 적절한 품질의 원료의약품을 일정하게 제조하기 위해 제조공정(예. "
      }
    },
    {
      "chunk_id": "chunk_209",
      "text": "출발물질, 중요공정 및\n- - 3.2.S.2.2에 기재된 제조공정도(flow diagram)\n- - 3.2.S.2.3에 설명된 원료의약품 제조에 사용된 출발물질과 생물유래 원료물질에 대한 설명\n- - 중요 제조공정, 공정관리 및 허용기준과 그 타당성에 대한 고찰, 특히 3.2.S.2.4에 설명된\n- - 3.2.S.2.5에 설명된 공정 밸리데이션 및/또는 평가에 대한 설명\n- - 3.2.S.2.6에 설명된 개발과정에서의 제조방법에 관한 중대한 변경에 대한 간략한 요약 및\n제품의 일관성을 평가하기 위해 사용된 검토결과로부터 얻은 결론. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 208,
        "window_size": 3,
        "char_count": 301,
        "word_count": 66,
        "page_number": 5,
        "window_text": "분배계수: ClogP = 4.251\n\n<!-- PAGE_10 -->\n##### 2.3.S.2.  제조(제품명, 제조자)(Manufacture)(name, manufacturer)\n\n- 3.2.S.2에서 얻은 다음 정보를 포함한다.\n - - 제조자(제조원)에 대한 사항\n- - 적절한 품질의 원료의약품을 일정하게 제조하기 위해 제조공정(예.  출발물질, 중요공정 및\n- - 3.2.S.2.2에 기재된 제조공정도(flow diagram)\n- - 3.2.S.2.3에 설명된 원료의약품 제조에 사용된 출발물질과 생물유래 원료물질에 대한 설명\n- - 중요 제조공정, 공정관리 및 허용기준과 그 타당성에 대한 고찰, 특히 3.2.S.2.4에 설명된\n- - 3.2.S.2.5에 설명된 공정 밸리데이션 및/또는 평가에 대한 설명\n- - 3.2.S.2.6에 설명된 개발과정에서의 제조방법에 관한 중대한 변경에 대한 간략한 요약 및\n제품의 일관성을 평가하기 위해 사용된 검토결과로부터 얻은 결론.  품질에 관한 자료 요약\n\n(QOS)은 제조공정 변경에 따른 뱃치를 사용한 (M4S 및 M4E의) 비임상시험 또는 임상시험\n\n- ○ 3.2.S.2 제조에 설명된 원료의약품의 제조원, 제조공정 및 공정관리, 원료관리, 중요공정 및\n- ○ 제조 및 시험에 관한 모든 사업소 또는 시설에 해당하는 제조원의 명칭, 주소, 책임부과범위\n- ○ 원료의약품 자료 중 비공개 부분을 제외한 내용을 요약 기재한다.\n <!-- PAGE_10 -->\n##### 2.3.S.3.  특성(제품명, 제조자)(Characterization)(name, manufacturer)\n\n- 3.2.S.3.1에 설명된 것과 같은 구조 및 이성체에 관한 요약자료를 기술하여야 한다. ",
        "original_sentence": "출발물질, 중요공정 및\n- - 3.2.S.2.2에 기재된 제조공정도(flow diagram)\n- - 3.2.S.2.3에 설명된 원료의약품 제조에 사용된 출발물질과 생물유래 원료물질에 대한 설명\n- - 중요 제조공정, 공정관리 및 허용기준과 그 타당성에 대한 고찰, 특히 3.2.S.2.4에 설명된\n- - 3.2.S.2.5에 설명된 공정 밸리데이션 및/또는 평가에 대한 설명\n- - 3.2.S.2.6에 설명된 개발과정에서의 제조방법에 관한 중대한 변경에 대한 간략한 요약 및\n제품의 일관성을 평가하기 위해 사용된 검토결과로부터 얻은 결론. "
      }
    },
    {
      "chunk_id": "chunk_210",
      "text": "품질에 관한 자료 요약\n\n(QOS)은 제조공정 변경에 따른 뱃치를 사용한 (M4S 및 M4E의) 비임상시험 또는 임상시험\n\n- ○ 3.2.S.2 제조에 설명된 원료의약품의 제조원, 제조공정 및 공정관리, 원료관리, 중요공정 및\n- ○ 제조 및 시험에 관한 모든 사업소 또는 시설에 해당하는 제조원의 명칭, 주소, 책임부과범위\n- ○ 원료의약품 자료 중 비공개 부분을 제외한 내용을 요약 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 209,
        "window_size": 3,
        "char_count": 222,
        "word_count": 55,
        "page_number": 23,
        "window_text": "제조(제품명, 제조자)(Manufacture)(name, manufacturer)\n\n- 3.2.S.2에서 얻은 다음 정보를 포함한다.\n - - 제조자(제조원)에 대한 사항\n- - 적절한 품질의 원료의약품을 일정하게 제조하기 위해 제조공정(예.  출발물질, 중요공정 및\n- - 3.2.S.2.2에 기재된 제조공정도(flow diagram)\n- - 3.2.S.2.3에 설명된 원료의약품 제조에 사용된 출발물질과 생물유래 원료물질에 대한 설명\n- - 중요 제조공정, 공정관리 및 허용기준과 그 타당성에 대한 고찰, 특히 3.2.S.2.4에 설명된\n- - 3.2.S.2.5에 설명된 공정 밸리데이션 및/또는 평가에 대한 설명\n- - 3.2.S.2.6에 설명된 개발과정에서의 제조방법에 관한 중대한 변경에 대한 간략한 요약 및\n제품의 일관성을 평가하기 위해 사용된 검토결과로부터 얻은 결론.  품질에 관한 자료 요약\n\n(QOS)은 제조공정 변경에 따른 뱃치를 사용한 (M4S 및 M4E의) 비임상시험 또는 임상시험\n\n- ○ 3.2.S.2 제조에 설명된 원료의약품의 제조원, 제조공정 및 공정관리, 원료관리, 중요공정 및\n- ○ 제조 및 시험에 관한 모든 사업소 또는 시설에 해당하는 제조원의 명칭, 주소, 책임부과범위\n- ○ 원료의약품 자료 중 비공개 부분을 제외한 내용을 요약 기재한다.\n <!-- PAGE_10 -->\n##### 2.3.S.3.  특성(제품명, 제조자)(Characterization)(name, manufacturer)\n\n- 3.2.S.3.1에 설명된 것과 같은 구조 및 이성체에 관한 요약자료를 기술하여야 한다.  원료의약\n품이 광학활성체인 경우에는 임상시험에 사용된 의약품이 입체이성체 또는 입체이성체의 복합\n\n물인지를 나타내고 동시에 판매를 위한 최종 완제품에 사용되는 원료의약품의 입체이성체에\n\n관한 정보를 제공하여야 한다.\n\n",
        "original_sentence": "품질에 관한 자료 요약\n\n(QOS)은 제조공정 변경에 따른 뱃치를 사용한 (M4S 및 M4E의) 비임상시험 또는 임상시험\n\n- ○ 3.2.S.2 제조에 설명된 원료의약품의 제조원, 제조공정 및 공정관리, 원료관리, 중요공정 및\n- ○ 제조 및 시험에 관한 모든 사업소 또는 시설에 해당하는 제조원의 명칭, 주소, 책임부과범위\n- ○ 원료의약품 자료 중 비공개 부분을 제외한 내용을 요약 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_211",
      "text": "<!-- PAGE_10 -->\n##### 2.3.S.3. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 210,
        "window_size": 3,
        "char_count": 32,
        "word_count": 5,
        "page_number": 10,
        "window_text": "- - 제조자(제조원)에 대한 사항\n- - 적절한 품질의 원료의약품을 일정하게 제조하기 위해 제조공정(예.  출발물질, 중요공정 및\n- - 3.2.S.2.2에 기재된 제조공정도(flow diagram)\n- - 3.2.S.2.3에 설명된 원료의약품 제조에 사용된 출발물질과 생물유래 원료물질에 대한 설명\n- - 중요 제조공정, 공정관리 및 허용기준과 그 타당성에 대한 고찰, 특히 3.2.S.2.4에 설명된\n- - 3.2.S.2.5에 설명된 공정 밸리데이션 및/또는 평가에 대한 설명\n- - 3.2.S.2.6에 설명된 개발과정에서의 제조방법에 관한 중대한 변경에 대한 간략한 요약 및\n제품의 일관성을 평가하기 위해 사용된 검토결과로부터 얻은 결론.  품질에 관한 자료 요약\n\n(QOS)은 제조공정 변경에 따른 뱃치를 사용한 (M4S 및 M4E의) 비임상시험 또는 임상시험\n\n- ○ 3.2.S.2 제조에 설명된 원료의약품의 제조원, 제조공정 및 공정관리, 원료관리, 중요공정 및\n- ○ 제조 및 시험에 관한 모든 사업소 또는 시설에 해당하는 제조원의 명칭, 주소, 책임부과범위\n- ○ 원료의약품 자료 중 비공개 부분을 제외한 내용을 요약 기재한다.\n <!-- PAGE_10 -->\n##### 2.3.S.3.  특성(제품명, 제조자)(Characterization)(name, manufacturer)\n\n- 3.2.S.3.1에 설명된 것과 같은 구조 및 이성체에 관한 요약자료를 기술하여야 한다.  원료의약\n품이 광학활성체인 경우에는 임상시험에 사용된 의약품이 입체이성체 또는 입체이성체의 복합\n\n물인지를 나타내고 동시에 판매를 위한 최종 완제품에 사용되는 원료의약품의 입체이성체에\n\n관한 정보를 제공하여야 한다.\n\n 전체 품질에 대한 자료(QOS)는 합성, 제조 또는 분해 등의 과정에서 발생할 수 있는 잠재적\n\n- - 5 -\n이고 실제적인 불순물에 대한 자료를 요약하여야 한다. ",
        "original_sentence": "<!-- PAGE_10 -->\n##### 2.3.S.3. "
      }
    },
    {
      "chunk_id": "chunk_212",
      "text": "특성(제품명, 제조자)(Characterization)(name, manufacturer)\n\n- 3.2.S.3.1에 설명된 것과 같은 구조 및 이성체에 관한 요약자료를 기술하여야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 211,
        "window_size": 3,
        "char_count": 104,
        "word_count": 15,
        "page_number": 10,
        "window_text": "출발물질, 중요공정 및\n- - 3.2.S.2.2에 기재된 제조공정도(flow diagram)\n- - 3.2.S.2.3에 설명된 원료의약품 제조에 사용된 출발물질과 생물유래 원료물질에 대한 설명\n- - 중요 제조공정, 공정관리 및 허용기준과 그 타당성에 대한 고찰, 특히 3.2.S.2.4에 설명된\n- - 3.2.S.2.5에 설명된 공정 밸리데이션 및/또는 평가에 대한 설명\n- - 3.2.S.2.6에 설명된 개발과정에서의 제조방법에 관한 중대한 변경에 대한 간략한 요약 및\n제품의 일관성을 평가하기 위해 사용된 검토결과로부터 얻은 결론.  품질에 관한 자료 요약\n\n(QOS)은 제조공정 변경에 따른 뱃치를 사용한 (M4S 및 M4E의) 비임상시험 또는 임상시험\n\n- ○ 3.2.S.2 제조에 설명된 원료의약품의 제조원, 제조공정 및 공정관리, 원료관리, 중요공정 및\n- ○ 제조 및 시험에 관한 모든 사업소 또는 시설에 해당하는 제조원의 명칭, 주소, 책임부과범위\n- ○ 원료의약품 자료 중 비공개 부분을 제외한 내용을 요약 기재한다.\n <!-- PAGE_10 -->\n##### 2.3.S.3.  특성(제품명, 제조자)(Characterization)(name, manufacturer)\n\n- 3.2.S.3.1에 설명된 것과 같은 구조 및 이성체에 관한 요약자료를 기술하여야 한다.  원료의약\n품이 광학활성체인 경우에는 임상시험에 사용된 의약품이 입체이성체 또는 입체이성체의 복합\n\n물인지를 나타내고 동시에 판매를 위한 최종 완제품에 사용되는 원료의약품의 입체이성체에\n\n관한 정보를 제공하여야 한다.\n\n 전체 품질에 대한 자료(QOS)는 합성, 제조 또는 분해 등의 과정에서 발생할 수 있는 잠재적\n\n- - 5 -\n이고 실제적인 불순물에 대한 자료를 요약하여야 한다.  또한 개별적인 불순물과 총 불순물에\n\n대한 허용기준 설정에 관한 근거자료를 요약해야 한다. ",
        "original_sentence": "특성(제품명, 제조자)(Characterization)(name, manufacturer)\n\n- 3.2.S.3.1에 설명된 것과 같은 구조 및 이성체에 관한 요약자료를 기술하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_213",
      "text": "원료의약\n품이 광학활성체인 경우에는 임상시험에 사용된 의약품이 입체이성체 또는 입체이성체의 복합\n\n물인지를 나타내고 동시에 판매를 위한 최종 완제품에 사용되는 원료의약품의 입체이성체에\n\n관한 정보를 제공하여야 한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 212,
        "window_size": 3,
        "char_count": 122,
        "word_count": 25,
        "page_number": 3,
        "window_text": "품질에 관한 자료 요약\n\n(QOS)은 제조공정 변경에 따른 뱃치를 사용한 (M4S 및 M4E의) 비임상시험 또는 임상시험\n\n- ○ 3.2.S.2 제조에 설명된 원료의약품의 제조원, 제조공정 및 공정관리, 원료관리, 중요공정 및\n- ○ 제조 및 시험에 관한 모든 사업소 또는 시설에 해당하는 제조원의 명칭, 주소, 책임부과범위\n- ○ 원료의약품 자료 중 비공개 부분을 제외한 내용을 요약 기재한다.\n <!-- PAGE_10 -->\n##### 2.3.S.3.  특성(제품명, 제조자)(Characterization)(name, manufacturer)\n\n- 3.2.S.3.1에 설명된 것과 같은 구조 및 이성체에 관한 요약자료를 기술하여야 한다.  원료의약\n품이 광학활성체인 경우에는 임상시험에 사용된 의약품이 입체이성체 또는 입체이성체의 복합\n\n물인지를 나타내고 동시에 판매를 위한 최종 완제품에 사용되는 원료의약품의 입체이성체에\n\n관한 정보를 제공하여야 한다.\n\n 전체 품질에 대한 자료(QOS)는 합성, 제조 또는 분해 등의 과정에서 발생할 수 있는 잠재적\n\n- - 5 -\n이고 실제적인 불순물에 대한 자료를 요약하여야 한다.  또한 개별적인 불순물과 총 불순물에\n\n대한 허용기준 설정에 관한 근거자료를 요약해야 한다.  품질에 관한 전체 자료 요약은 임상시\n\n험에 사용한 뱃치와 제품 생산용 공정으로 제조된 특정 뱃치에서 불순물 함유정도를 요약하여\n\n설명하고 제시된 불순물의 한계가 어떻게 정량화 되었는지 밝혀야 한다.\n\n",
        "original_sentence": "원료의약\n품이 광학활성체인 경우에는 임상시험에 사용된 의약품이 입체이성체 또는 입체이성체의 복합\n\n물인지를 나타내고 동시에 판매를 위한 최종 완제품에 사용되는 원료의약품의 입체이성체에\n\n관한 정보를 제공하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_214",
      "text": "전체 품질에 대한 자료(QOS)는 합성, 제조 또는 분해 등의 과정에서 발생할 수 있는 잠재적\n\n- - 5 -\n이고 실제적인 불순물에 대한 자료를 요약하여야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 213,
        "window_size": 3,
        "char_count": 92,
        "word_count": 25,
        "page_number": 10,
        "window_text": "<!-- PAGE_10 -->\n##### 2.3.S.3.  특성(제품명, 제조자)(Characterization)(name, manufacturer)\n\n- 3.2.S.3.1에 설명된 것과 같은 구조 및 이성체에 관한 요약자료를 기술하여야 한다.  원료의약\n품이 광학활성체인 경우에는 임상시험에 사용된 의약품이 입체이성체 또는 입체이성체의 복합\n\n물인지를 나타내고 동시에 판매를 위한 최종 완제품에 사용되는 원료의약품의 입체이성체에\n\n관한 정보를 제공하여야 한다.\n\n 전체 품질에 대한 자료(QOS)는 합성, 제조 또는 분해 등의 과정에서 발생할 수 있는 잠재적\n\n- - 5 -\n이고 실제적인 불순물에 대한 자료를 요약하여야 한다.  또한 개별적인 불순물과 총 불순물에\n\n대한 허용기준 설정에 관한 근거자료를 요약해야 한다.  품질에 관한 전체 자료 요약은 임상시\n\n험에 사용한 뱃치와 제품 생산용 공정으로 제조된 특정 뱃치에서 불순물 함유정도를 요약하여\n\n설명하고 제시된 불순물의 한계가 어떻게 정량화 되었는지 밝혀야 한다.\n\n 그래프와 함께 3.2.S.3.2에서 제공되는 자료의 도표 요약은 필요한 경우 포함한다.\n\n",
        "original_sentence": "전체 품질에 대한 자료(QOS)는 합성, 제조 또는 분해 등의 과정에서 발생할 수 있는 잠재적\n\n- - 5 -\n이고 실제적인 불순물에 대한 자료를 요약하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_215",
      "text": "또한 개별적인 불순물과 총 불순물에\n\n대한 허용기준 설정에 관한 근거자료를 요약해야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 214,
        "window_size": 3,
        "char_count": 51,
        "word_count": 12,
        "page_number": 13,
        "window_text": "특성(제품명, 제조자)(Characterization)(name, manufacturer)\n\n- 3.2.S.3.1에 설명된 것과 같은 구조 및 이성체에 관한 요약자료를 기술하여야 한다.  원료의약\n품이 광학활성체인 경우에는 임상시험에 사용된 의약품이 입체이성체 또는 입체이성체의 복합\n\n물인지를 나타내고 동시에 판매를 위한 최종 완제품에 사용되는 원료의약품의 입체이성체에\n\n관한 정보를 제공하여야 한다.\n\n 전체 품질에 대한 자료(QOS)는 합성, 제조 또는 분해 등의 과정에서 발생할 수 있는 잠재적\n\n- - 5 -\n이고 실제적인 불순물에 대한 자료를 요약하여야 한다.  또한 개별적인 불순물과 총 불순물에\n\n대한 허용기준 설정에 관한 근거자료를 요약해야 한다.  품질에 관한 전체 자료 요약은 임상시\n\n험에 사용한 뱃치와 제품 생산용 공정으로 제조된 특정 뱃치에서 불순물 함유정도를 요약하여\n\n설명하고 제시된 불순물의 한계가 어떻게 정량화 되었는지 밝혀야 한다.\n\n 그래프와 함께 3.2.S.3.2에서 제공되는 자료의 도표 요약은 필요한 경우 포함한다.\n\n - ○ 3.2.S.3.1 구조 및 기타 특성에 설명된 원료의약품의 구조와 물리적 특성, 불순물 등에 대\n- ○ 한 개 이상의 비대칭중심(chiral center)을 포함하는 키랄(chiral) 원료의약품의 경우 라세\n미체인지 특정 광학이성질체(enantiomer)인지 기재한다. ",
        "original_sentence": "또한 개별적인 불순물과 총 불순물에\n\n대한 허용기준 설정에 관한 근거자료를 요약해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_216",
      "text": "품질에 관한 전체 자료 요약은 임상시\n\n험에 사용한 뱃치와 제품 생산용 공정으로 제조된 특정 뱃치에서 불순물 함유정도를 요약하여\n\n설명하고 제시된 불순물의 한계가 어떻게 정량화 되었는지 밝혀야 한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 215,
        "window_size": 3,
        "char_count": 113,
        "word_count": 27,
        "page_number": 26,
        "window_text": "원료의약\n품이 광학활성체인 경우에는 임상시험에 사용된 의약품이 입체이성체 또는 입체이성체의 복합\n\n물인지를 나타내고 동시에 판매를 위한 최종 완제품에 사용되는 원료의약품의 입체이성체에\n\n관한 정보를 제공하여야 한다.\n\n 전체 품질에 대한 자료(QOS)는 합성, 제조 또는 분해 등의 과정에서 발생할 수 있는 잠재적\n\n- - 5 -\n이고 실제적인 불순물에 대한 자료를 요약하여야 한다.  또한 개별적인 불순물과 총 불순물에\n\n대한 허용기준 설정에 관한 근거자료를 요약해야 한다.  품질에 관한 전체 자료 요약은 임상시\n\n험에 사용한 뱃치와 제품 생산용 공정으로 제조된 특정 뱃치에서 불순물 함유정도를 요약하여\n\n설명하고 제시된 불순물의 한계가 어떻게 정량화 되었는지 밝혀야 한다.\n\n 그래프와 함께 3.2.S.3.2에서 제공되는 자료의 도표 요약은 필요한 경우 포함한다.\n\n - ○ 3.2.S.3.1 구조 및 기타 특성에 설명된 원료의약품의 구조와 물리적 특성, 불순물 등에 대\n- ○ 한 개 이상의 비대칭중심(chiral center)을 포함하는 키랄(chiral) 원료의약품의 경우 라세\n미체인지 특정 광학이성질체(enantiomer)인지 기재한다.  원료의약품이 특정 광학이성체인\n\n경우, 광학이성체를 확인하고 정량하기 위한 시험이 포함되어야 한다. ",
        "original_sentence": "품질에 관한 전체 자료 요약은 임상시\n\n험에 사용한 뱃치와 제품 생산용 공정으로 제조된 특정 뱃치에서 불순물 함유정도를 요약하여\n\n설명하고 제시된 불순물의 한계가 어떻게 정량화 되었는지 밝혀야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_217",
      "text": "그래프와 함께 3.2.S.3.2에서 제공되는 자료의 도표 요약은 필요한 경우 포함한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 216,
        "window_size": 3,
        "char_count": 50,
        "word_count": 10,
        "page_number": 11,
        "window_text": "전체 품질에 대한 자료(QOS)는 합성, 제조 또는 분해 등의 과정에서 발생할 수 있는 잠재적\n\n- - 5 -\n이고 실제적인 불순물에 대한 자료를 요약하여야 한다.  또한 개별적인 불순물과 총 불순물에\n\n대한 허용기준 설정에 관한 근거자료를 요약해야 한다.  품질에 관한 전체 자료 요약은 임상시\n\n험에 사용한 뱃치와 제품 생산용 공정으로 제조된 특정 뱃치에서 불순물 함유정도를 요약하여\n\n설명하고 제시된 불순물의 한계가 어떻게 정량화 되었는지 밝혀야 한다.\n\n 그래프와 함께 3.2.S.3.2에서 제공되는 자료의 도표 요약은 필요한 경우 포함한다.\n\n - ○ 3.2.S.3.1 구조 및 기타 특성에 설명된 원료의약품의 구조와 물리적 특성, 불순물 등에 대\n- ○ 한 개 이상의 비대칭중심(chiral center)을 포함하는 키랄(chiral) 원료의약품의 경우 라세\n미체인지 특정 광학이성질체(enantiomer)인지 기재한다.  원료의약품이 특정 광학이성체인\n\n경우, 광학이성체를 확인하고 정량하기 위한 시험이 포함되어야 한다.  비대칭성(chirality)에\n\n대해서는 광학이성체간의 상호 전환 가능성을 고려해야 한다. ",
        "original_sentence": "그래프와 함께 3.2.S.3.2에서 제공되는 자료의 도표 요약은 필요한 경우 포함한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_218",
      "text": "- ○ 3.2.S.3.1 구조 및 기타 특성에 설명된 원료의약품의 구조와 물리적 특성, 불순물 등에 대\n- ○ 한 개 이상의 비대칭중심(chiral center)을 포함하는 키랄(chiral) 원료의약품의 경우 라세\n미체인지 특정 광학이성질체(enantiomer)인지 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 217,
        "window_size": 3,
        "char_count": 156,
        "word_count": 31,
        "page_number": 5,
        "window_text": "또한 개별적인 불순물과 총 불순물에\n\n대한 허용기준 설정에 관한 근거자료를 요약해야 한다.  품질에 관한 전체 자료 요약은 임상시\n\n험에 사용한 뱃치와 제품 생산용 공정으로 제조된 특정 뱃치에서 불순물 함유정도를 요약하여\n\n설명하고 제시된 불순물의 한계가 어떻게 정량화 되었는지 밝혀야 한다.\n\n 그래프와 함께 3.2.S.3.2에서 제공되는 자료의 도표 요약은 필요한 경우 포함한다.\n\n - ○ 3.2.S.3.1 구조 및 기타 특성에 설명된 원료의약품의 구조와 물리적 특성, 불순물 등에 대\n- ○ 한 개 이상의 비대칭중심(chiral center)을 포함하는 키랄(chiral) 원료의약품의 경우 라세\n미체인지 특정 광학이성질체(enantiomer)인지 기재한다.  원료의약품이 특정 광학이성체인\n\n경우, 광학이성체를 확인하고 정량하기 위한 시험이 포함되어야 한다.  비대칭성(chirality)에\n\n대해서는 광학이성체간의 상호 전환 가능성을 고려해야 한다.  (예. ",
        "original_sentence": "- ○ 3.2.S.3.1 구조 및 기타 특성에 설명된 원료의약품의 구조와 물리적 특성, 불순물 등에 대\n- ○ 한 개 이상의 비대칭중심(chiral center)을 포함하는 키랄(chiral) 원료의약품의 경우 라세\n미체인지 특정 광학이성질체(enantiomer)인지 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_219",
      "text": "원료의약품이 특정 광학이성체인\n\n경우, 광학이성체를 확인하고 정량하기 위한 시험이 포함되어야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 218,
        "window_size": 3,
        "char_count": 56,
        "word_count": 11,
        "page_number": 3,
        "window_text": "품질에 관한 전체 자료 요약은 임상시\n\n험에 사용한 뱃치와 제품 생산용 공정으로 제조된 특정 뱃치에서 불순물 함유정도를 요약하여\n\n설명하고 제시된 불순물의 한계가 어떻게 정량화 되었는지 밝혀야 한다.\n\n 그래프와 함께 3.2.S.3.2에서 제공되는 자료의 도표 요약은 필요한 경우 포함한다.\n\n - ○ 3.2.S.3.1 구조 및 기타 특성에 설명된 원료의약품의 구조와 물리적 특성, 불순물 등에 대\n- ○ 한 개 이상의 비대칭중심(chiral center)을 포함하는 키랄(chiral) 원료의약품의 경우 라세\n미체인지 특정 광학이성질체(enantiomer)인지 기재한다.  원료의약품이 특정 광학이성체인\n\n경우, 광학이성체를 확인하고 정량하기 위한 시험이 포함되어야 한다.  비대칭성(chirality)에\n\n대해서는 광학이성체간의 상호 전환 가능성을 고려해야 한다.  (예.  라세미화/에피머화; racemi\n\n- ○ 잠재적 불순물을 확인하고 특징을 기술한다. ",
        "original_sentence": "원료의약품이 특정 광학이성체인\n\n경우, 광학이성체를 확인하고 정량하기 위한 시험이 포함되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_220",
      "text": "비대칭성(chirality)에\n\n대해서는 광학이성체간의 상호 전환 가능성을 고려해야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 219,
        "window_size": 3,
        "char_count": 51,
        "word_count": 8,
        "page_number": 3,
        "window_text": "그래프와 함께 3.2.S.3.2에서 제공되는 자료의 도표 요약은 필요한 경우 포함한다.\n\n - ○ 3.2.S.3.1 구조 및 기타 특성에 설명된 원료의약품의 구조와 물리적 특성, 불순물 등에 대\n- ○ 한 개 이상의 비대칭중심(chiral center)을 포함하는 키랄(chiral) 원료의약품의 경우 라세\n미체인지 특정 광학이성질체(enantiomer)인지 기재한다.  원료의약품이 특정 광학이성체인\n\n경우, 광학이성체를 확인하고 정량하기 위한 시험이 포함되어야 한다.  비대칭성(chirality)에\n\n대해서는 광학이성체간의 상호 전환 가능성을 고려해야 한다.  (예.  라세미화/에피머화; racemi\n\n- ○ 잠재적 불순물을 확인하고 특징을 기술한다.  즉, 원료의약품에 존재할 수 있는 모든 불순물을\n기재한다. ",
        "original_sentence": "비대칭성(chirality)에\n\n대해서는 광학이성체간의 상호 전환 가능성을 고려해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_221",
      "text": "(예. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 220,
        "window_size": 3,
        "char_count": 4,
        "word_count": 1,
        "page_number": 10,
        "window_text": "- ○ 3.2.S.3.1 구조 및 기타 특성에 설명된 원료의약품의 구조와 물리적 특성, 불순물 등에 대\n- ○ 한 개 이상의 비대칭중심(chiral center)을 포함하는 키랄(chiral) 원료의약품의 경우 라세\n미체인지 특정 광학이성질체(enantiomer)인지 기재한다.  원료의약품이 특정 광학이성체인\n\n경우, 광학이성체를 확인하고 정량하기 위한 시험이 포함되어야 한다.  비대칭성(chirality)에\n\n대해서는 광학이성체간의 상호 전환 가능성을 고려해야 한다.  (예.  라세미화/에피머화; racemi\n\n- ○ 잠재적 불순물을 확인하고 특징을 기술한다.  즉, 원료의약품에 존재할 수 있는 모든 불순물을\n기재한다.  유기유연물질인 경우 명칭, 구조 또는 HPLC 등 분석기기 상대유지시간(RRT)에 따라\n\n불순물을 확인하고, 발생 기원에 따라 공정 불순물과 분해생성물로 구분한다. ",
        "original_sentence": "(예. "
      }
    },
    {
      "chunk_id": "chunk_222",
      "text": "라세미화/에피머화; racemi\n\n- ○ 잠재적 불순물을 확인하고 특징을 기술한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 221,
        "window_size": 3,
        "char_count": 47,
        "word_count": 9,
        "page_number": 5,
        "window_text": "원료의약품이 특정 광학이성체인\n\n경우, 광학이성체를 확인하고 정량하기 위한 시험이 포함되어야 한다.  비대칭성(chirality)에\n\n대해서는 광학이성체간의 상호 전환 가능성을 고려해야 한다.  (예.  라세미화/에피머화; racemi\n\n- ○ 잠재적 불순물을 확인하고 특징을 기술한다.  즉, 원료의약품에 존재할 수 있는 모든 불순물을\n기재한다.  유기유연물질인 경우 명칭, 구조 또는 HPLC 등 분석기기 상대유지시간(RRT)에 따라\n\n불순물을 확인하고, 발생 기원에 따라 공정 불순물과 분해생성물로 구분한다.  또한 아래 예시의\n\n표와 같이 특정 유연물질, 구조, 기원 및 관리방법 (규격 또는 미지유연물질 등 구분)에 대해서도\n\n- ○ 공정서에 유연물질 시험방법이 있는 경우에도 다른 발생 가능한 불순물을 파악하는 것이\n- ○ 유연물질 요약 예시\n[특정 유연물질]\n\n- ○ 구조 및 기타 특성에 대한 상세한 자료는 해당되는 경우 DMF 자료를 참고한다.\n",
        "original_sentence": "라세미화/에피머화; racemi\n\n- ○ 잠재적 불순물을 확인하고 특징을 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_223",
      "text": "즉, 원료의약품에 존재할 수 있는 모든 불순물을\n기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 222,
        "window_size": 3,
        "char_count": 33,
        "word_count": 8,
        "page_number": 13,
        "window_text": "비대칭성(chirality)에\n\n대해서는 광학이성체간의 상호 전환 가능성을 고려해야 한다.  (예.  라세미화/에피머화; racemi\n\n- ○ 잠재적 불순물을 확인하고 특징을 기술한다.  즉, 원료의약품에 존재할 수 있는 모든 불순물을\n기재한다.  유기유연물질인 경우 명칭, 구조 또는 HPLC 등 분석기기 상대유지시간(RRT)에 따라\n\n불순물을 확인하고, 발생 기원에 따라 공정 불순물과 분해생성물로 구분한다.  또한 아래 예시의\n\n표와 같이 특정 유연물질, 구조, 기원 및 관리방법 (규격 또는 미지유연물질 등 구분)에 대해서도\n\n- ○ 공정서에 유연물질 시험방법이 있는 경우에도 다른 발생 가능한 불순물을 파악하는 것이\n- ○ 유연물질 요약 예시\n[특정 유연물질]\n\n- ○ 구조 및 기타 특성에 대한 상세한 자료는 해당되는 경우 DMF 자료를 참고한다.\n - - 6 -\n<!-- PAGE_12 -->\n##### 2.3.S.4. ",
        "original_sentence": "즉, 원료의약품에 존재할 수 있는 모든 불순물을\n기재한다. "
      }
    },
    {
      "chunk_id": "chunk_224",
      "text": "유기유연물질인 경우 명칭, 구조 또는 HPLC 등 분석기기 상대유지시간(RRT)에 따라\n\n불순물을 확인하고, 발생 기원에 따라 공정 불순물과 분해생성물로 구분한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 223,
        "window_size": 3,
        "char_count": 92,
        "word_count": 19,
        "page_number": 2,
        "window_text": "(예.  라세미화/에피머화; racemi\n\n- ○ 잠재적 불순물을 확인하고 특징을 기술한다.  즉, 원료의약품에 존재할 수 있는 모든 불순물을\n기재한다.  유기유연물질인 경우 명칭, 구조 또는 HPLC 등 분석기기 상대유지시간(RRT)에 따라\n\n불순물을 확인하고, 발생 기원에 따라 공정 불순물과 분해생성물로 구분한다.  또한 아래 예시의\n\n표와 같이 특정 유연물질, 구조, 기원 및 관리방법 (규격 또는 미지유연물질 등 구분)에 대해서도\n\n- ○ 공정서에 유연물질 시험방법이 있는 경우에도 다른 발생 가능한 불순물을 파악하는 것이\n- ○ 유연물질 요약 예시\n[특정 유연물질]\n\n- ○ 구조 및 기타 특성에 대한 상세한 자료는 해당되는 경우 DMF 자료를 참고한다.\n - - 6 -\n<!-- PAGE_12 -->\n##### 2.3.S.4.  원료의약품의 품질관리(제품명, 제조자)(Control of Drug Substance) (name,\n\n<!-- PAGE_12 -->\n##### manufacturer)\n\n기준, 시험방법, 밸리데이션(validation)의 타당성에 관한 자료를 요약하여 설명한다.\n\n",
        "original_sentence": "유기유연물질인 경우 명칭, 구조 또는 HPLC 등 분석기기 상대유지시간(RRT)에 따라\n\n불순물을 확인하고, 발생 기원에 따라 공정 불순물과 분해생성물로 구분한다. "
      }
    },
    {
      "chunk_id": "chunk_225",
      "text": "또한 아래 예시의\n\n표와 같이 특정 유연물질, 구조, 기원 및 관리방법 (규격 또는 미지유연물질 등 구분)에 대해서도\n\n- ○ 공정서에 유연물질 시험방법이 있는 경우에도 다른 발생 가능한 불순물을 파악하는 것이\n- ○ 유연물질 요약 예시\n[특정 유연물질]\n\n- ○ 구조 및 기타 특성에 대한 상세한 자료는 해당되는 경우 DMF 자료를 참고한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 224,
        "window_size": 3,
        "char_count": 193,
        "word_count": 51,
        "page_number": 3,
        "window_text": "라세미화/에피머화; racemi\n\n- ○ 잠재적 불순물을 확인하고 특징을 기술한다.  즉, 원료의약품에 존재할 수 있는 모든 불순물을\n기재한다.  유기유연물질인 경우 명칭, 구조 또는 HPLC 등 분석기기 상대유지시간(RRT)에 따라\n\n불순물을 확인하고, 발생 기원에 따라 공정 불순물과 분해생성물로 구분한다.  또한 아래 예시의\n\n표와 같이 특정 유연물질, 구조, 기원 및 관리방법 (규격 또는 미지유연물질 등 구분)에 대해서도\n\n- ○ 공정서에 유연물질 시험방법이 있는 경우에도 다른 발생 가능한 불순물을 파악하는 것이\n- ○ 유연물질 요약 예시\n[특정 유연물질]\n\n- ○ 구조 및 기타 특성에 대한 상세한 자료는 해당되는 경우 DMF 자료를 참고한다.\n - - 6 -\n<!-- PAGE_12 -->\n##### 2.3.S.4.  원료의약품의 품질관리(제품명, 제조자)(Control of Drug Substance) (name,\n\n<!-- PAGE_12 -->\n##### manufacturer)\n\n기준, 시험방법, 밸리데이션(validation)의 타당성에 관한 자료를 요약하여 설명한다.\n\n - 3.2.S.4.1에서 얻은 기준이 제공되어야 한다.\n",
        "original_sentence": "또한 아래 예시의\n\n표와 같이 특정 유연물질, 구조, 기원 및 관리방법 (규격 또는 미지유연물질 등 구분)에 대해서도\n\n- ○ 공정서에 유연물질 시험방법이 있는 경우에도 다른 발생 가능한 불순물을 파악하는 것이\n- ○ 유연물질 요약 예시\n[특정 유연물질]\n\n- ○ 구조 및 기타 특성에 대한 상세한 자료는 해당되는 경우 DMF 자료를 참고한다.\n"
      }
    },
    {
      "chunk_id": "chunk_226",
      "text": "- - 6 -\n<!-- PAGE_12 -->\n##### 2.3.S.4. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 225,
        "window_size": 3,
        "char_count": 40,
        "word_count": 9,
        "page_number": 12,
        "window_text": "즉, 원료의약품에 존재할 수 있는 모든 불순물을\n기재한다.  유기유연물질인 경우 명칭, 구조 또는 HPLC 등 분석기기 상대유지시간(RRT)에 따라\n\n불순물을 확인하고, 발생 기원에 따라 공정 불순물과 분해생성물로 구분한다.  또한 아래 예시의\n\n표와 같이 특정 유연물질, 구조, 기원 및 관리방법 (규격 또는 미지유연물질 등 구분)에 대해서도\n\n- ○ 공정서에 유연물질 시험방법이 있는 경우에도 다른 발생 가능한 불순물을 파악하는 것이\n- ○ 유연물질 요약 예시\n[특정 유연물질]\n\n- ○ 구조 및 기타 특성에 대한 상세한 자료는 해당되는 경우 DMF 자료를 참고한다.\n - - 6 -\n<!-- PAGE_12 -->\n##### 2.3.S.4.  원료의약품의 품질관리(제품명, 제조자)(Control of Drug Substance) (name,\n\n<!-- PAGE_12 -->\n##### manufacturer)\n\n기준, 시험방법, 밸리데이션(validation)의 타당성에 관한 자료를 요약하여 설명한다.\n\n - 3.2.S.4.1에서 얻은 기준이 제공되어야 한다.\n - 3.2.S.4.4의 뱃치 분석에 관한 도표요약은 필요시 그래프와 함께 제공되어야 한다.\n",
        "original_sentence": "- - 6 -\n<!-- PAGE_12 -->\n##### 2.3.S.4. "
      }
    },
    {
      "chunk_id": "chunk_227",
      "text": "원료의약품의 품질관리(제품명, 제조자)(Control of Drug Substance) (name,\n\n<!-- PAGE_12 -->\n##### manufacturer)\n\n기준, 시험방법, 밸리데이션(validation)의 타당성에 관한 자료를 요약하여 설명한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 226,
        "window_size": 3,
        "char_count": 148,
        "word_count": 20,
        "page_number": 12,
        "window_text": "유기유연물질인 경우 명칭, 구조 또는 HPLC 등 분석기기 상대유지시간(RRT)에 따라\n\n불순물을 확인하고, 발생 기원에 따라 공정 불순물과 분해생성물로 구분한다.  또한 아래 예시의\n\n표와 같이 특정 유연물질, 구조, 기원 및 관리방법 (규격 또는 미지유연물질 등 구분)에 대해서도\n\n- ○ 공정서에 유연물질 시험방법이 있는 경우에도 다른 발생 가능한 불순물을 파악하는 것이\n- ○ 유연물질 요약 예시\n[특정 유연물질]\n\n- ○ 구조 및 기타 특성에 대한 상세한 자료는 해당되는 경우 DMF 자료를 참고한다.\n - - 6 -\n<!-- PAGE_12 -->\n##### 2.3.S.4.  원료의약품의 품질관리(제품명, 제조자)(Control of Drug Substance) (name,\n\n<!-- PAGE_12 -->\n##### manufacturer)\n\n기준, 시험방법, 밸리데이션(validation)의 타당성에 관한 자료를 요약하여 설명한다.\n\n - 3.2.S.4.1에서 얻은 기준이 제공되어야 한다.\n - 3.2.S.4.4의 뱃치 분석에 관한 도표요약은 필요시 그래프와 함께 제공되어야 한다.\n - ○ 3.2.S.4 원료의약품의 관리에 설명된 원료의약품의 기준, 시험방법 및 시험방법 밸리데이션에\n- ○ 시험 기준과 뱃치 분석결과를 표로 작성한다. ",
        "original_sentence": "원료의약품의 품질관리(제품명, 제조자)(Control of Drug Substance) (name,\n\n<!-- PAGE_12 -->\n##### manufacturer)\n\n기준, 시험방법, 밸리데이션(validation)의 타당성에 관한 자료를 요약하여 설명한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_228",
      "text": "- 3.2.S.4.1에서 얻은 기준이 제공되어야 한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 227,
        "window_size": 3,
        "char_count": 31,
        "word_count": 6,
        "page_number": 3,
        "window_text": "또한 아래 예시의\n\n표와 같이 특정 유연물질, 구조, 기원 및 관리방법 (규격 또는 미지유연물질 등 구분)에 대해서도\n\n- ○ 공정서에 유연물질 시험방법이 있는 경우에도 다른 발생 가능한 불순물을 파악하는 것이\n- ○ 유연물질 요약 예시\n[특정 유연물질]\n\n- ○ 구조 및 기타 특성에 대한 상세한 자료는 해당되는 경우 DMF 자료를 참고한다.\n - - 6 -\n<!-- PAGE_12 -->\n##### 2.3.S.4.  원료의약품의 품질관리(제품명, 제조자)(Control of Drug Substance) (name,\n\n<!-- PAGE_12 -->\n##### manufacturer)\n\n기준, 시험방법, 밸리데이션(validation)의 타당성에 관한 자료를 요약하여 설명한다.\n\n - 3.2.S.4.1에서 얻은 기준이 제공되어야 한다.\n - 3.2.S.4.4의 뱃치 분석에 관한 도표요약은 필요시 그래프와 함께 제공되어야 한다.\n - ○ 3.2.S.4 원료의약품의 관리에 설명된 원료의약품의 기준, 시험방법 및 시험방법 밸리데이션에\n- ○ 시험 기준과 뱃치 분석결과를 표로 작성한다.  특정 유연물질의 화학명을 별도 기재하고 시험\n- ○ 원료의약품 기준과 관련하여, 식약처장이 인정한 공정서 수재품목은 공정서 각조의 요구사항을\n- ○ 선광도, 수분, 순도, 잔류용매, 결정다형 및 입자도 등 원료의약품의 특성을 고려하여 시험항목을\n설정하고 그 타당성을 제시한다. ",
        "original_sentence": "- 3.2.S.4.1에서 얻은 기준이 제공되어야 한다.\n"
      }
    },
    {
      "chunk_id": "chunk_229",
      "text": "- 3.2.S.4.4의 뱃치 분석에 관한 도표요약은 필요시 그래프와 함께 제공되어야 한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 228,
        "window_size": 3,
        "char_count": 51,
        "word_count": 11,
        "page_number": 5,
        "window_text": "- - 6 -\n<!-- PAGE_12 -->\n##### 2.3.S.4.  원료의약품의 품질관리(제품명, 제조자)(Control of Drug Substance) (name,\n\n<!-- PAGE_12 -->\n##### manufacturer)\n\n기준, 시험방법, 밸리데이션(validation)의 타당성에 관한 자료를 요약하여 설명한다.\n\n - 3.2.S.4.1에서 얻은 기준이 제공되어야 한다.\n - 3.2.S.4.4의 뱃치 분석에 관한 도표요약은 필요시 그래프와 함께 제공되어야 한다.\n - ○ 3.2.S.4 원료의약품의 관리에 설명된 원료의약품의 기준, 시험방법 및 시험방법 밸리데이션에\n- ○ 시험 기준과 뱃치 분석결과를 표로 작성한다.  특정 유연물질의 화학명을 별도 기재하고 시험\n- ○ 원료의약품 기준과 관련하여, 식약처장이 인정한 공정서 수재품목은 공정서 각조의 요구사항을\n- ○ 선광도, 수분, 순도, 잔류용매, 결정다형 및 입자도 등 원료의약품의 특성을 고려하여 시험항목을\n설정하고 그 타당성을 제시한다.  (완제의약품 제조와 품질에 영향을 미칠 수 있는 원료의약품의\n\n- ○ 각 시험항목별로 시험방법을 적절하게 설정하고 밸리데이션을 실시한다. ",
        "original_sentence": "- 3.2.S.4.4의 뱃치 분석에 관한 도표요약은 필요시 그래프와 함께 제공되어야 한다.\n"
      }
    },
    {
      "chunk_id": "chunk_230",
      "text": "- ○ 3.2.S.4 원료의약품의 관리에 설명된 원료의약품의 기준, 시험방법 및 시험방법 밸리데이션에\n- ○ 시험 기준과 뱃치 분석결과를 표로 작성한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 229,
        "window_size": 3,
        "char_count": 86,
        "word_count": 20,
        "page_number": 5,
        "window_text": "원료의약품의 품질관리(제품명, 제조자)(Control of Drug Substance) (name,\n\n<!-- PAGE_12 -->\n##### manufacturer)\n\n기준, 시험방법, 밸리데이션(validation)의 타당성에 관한 자료를 요약하여 설명한다.\n\n - 3.2.S.4.1에서 얻은 기준이 제공되어야 한다.\n - 3.2.S.4.4의 뱃치 분석에 관한 도표요약은 필요시 그래프와 함께 제공되어야 한다.\n - ○ 3.2.S.4 원료의약품의 관리에 설명된 원료의약품의 기준, 시험방법 및 시험방법 밸리데이션에\n- ○ 시험 기준과 뱃치 분석결과를 표로 작성한다.  특정 유연물질의 화학명을 별도 기재하고 시험\n- ○ 원료의약품 기준과 관련하여, 식약처장이 인정한 공정서 수재품목은 공정서 각조의 요구사항을\n- ○ 선광도, 수분, 순도, 잔류용매, 결정다형 및 입자도 등 원료의약품의 특성을 고려하여 시험항목을\n설정하고 그 타당성을 제시한다.  (완제의약품 제조와 품질에 영향을 미칠 수 있는 원료의약품의\n\n- ○ 각 시험항목별로 시험방법을 적절하게 설정하고 밸리데이션을 실시한다.  시험방법의 중요\n- ○ 공정서에 따라 시험할 경우 공정서 방법이 적용될 수 있는지 특이성(예: 주피크가 생산 공정\n및 분해생성물에서 발생하는 모든 공정 불순물과 분리할 수 있음)과 유연물질 시험방법의 특이성\n\n(예: 주성분 피크를 포함하여 모든 공정 불순물 및 분해생성물을 서로 분리할 수 있는지 확인)\n\n- ○ 공정서 방법을 변경하여 사용하거나 자사 시험방법으로 대체하는 경우 밸리데이션이 필요하며,\n자사 시험방법이 공정서에서 규정하는 시험방법보다 동등 이상인 경우에 그 방법을 적용할 수\n\n- ○ 시험방법 밸리데이션 요약자료를 DMF 등록번호로 대체하는 것은 불가하며, 원료의약품 제조\n원의 밸리데이션 자료 제출은 가능하나, 해당 밸리데이션 자료가 자사 품질관리 시 적절히 적\n\n용될 수 있는지 판단할 수 있는 자료를 함께 제출하여야 한다. ",
        "original_sentence": "- ○ 3.2.S.4 원료의약품의 관리에 설명된 원료의약품의 기준, 시험방법 및 시험방법 밸리데이션에\n- ○ 시험 기준과 뱃치 분석결과를 표로 작성한다. "
      }
    },
    {
      "chunk_id": "chunk_231",
      "text": "특정 유연물질의 화학명을 별도 기재하고 시험\n- ○ 원료의약품 기준과 관련하여, 식약처장이 인정한 공정서 수재품목은 공정서 각조의 요구사항을\n- ○ 선광도, 수분, 순도, 잔류용매, 결정다형 및 입자도 등 원료의약품의 특성을 고려하여 시험항목을\n설정하고 그 타당성을 제시한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 230,
        "window_size": 3,
        "char_count": 155,
        "word_count": 36,
        "page_number": 3,
        "window_text": "- 3.2.S.4.1에서 얻은 기준이 제공되어야 한다.\n - 3.2.S.4.4의 뱃치 분석에 관한 도표요약은 필요시 그래프와 함께 제공되어야 한다.\n - ○ 3.2.S.4 원료의약품의 관리에 설명된 원료의약품의 기준, 시험방법 및 시험방법 밸리데이션에\n- ○ 시험 기준과 뱃치 분석결과를 표로 작성한다.  특정 유연물질의 화학명을 별도 기재하고 시험\n- ○ 원료의약품 기준과 관련하여, 식약처장이 인정한 공정서 수재품목은 공정서 각조의 요구사항을\n- ○ 선광도, 수분, 순도, 잔류용매, 결정다형 및 입자도 등 원료의약품의 특성을 고려하여 시험항목을\n설정하고 그 타당성을 제시한다.  (완제의약품 제조와 품질에 영향을 미칠 수 있는 원료의약품의\n\n- ○ 각 시험항목별로 시험방법을 적절하게 설정하고 밸리데이션을 실시한다.  시험방법의 중요\n- ○ 공정서에 따라 시험할 경우 공정서 방법이 적용될 수 있는지 특이성(예: 주피크가 생산 공정\n및 분해생성물에서 발생하는 모든 공정 불순물과 분리할 수 있음)과 유연물질 시험방법의 특이성\n\n(예: 주성분 피크를 포함하여 모든 공정 불순물 및 분해생성물을 서로 분리할 수 있는지 확인)\n\n- ○ 공정서 방법을 변경하여 사용하거나 자사 시험방법으로 대체하는 경우 밸리데이션이 필요하며,\n자사 시험방법이 공정서에서 규정하는 시험방법보다 동등 이상인 경우에 그 방법을 적용할 수\n\n- ○ 시험방법 밸리데이션 요약자료를 DMF 등록번호로 대체하는 것은 불가하며, 원료의약품 제조\n원의 밸리데이션 자료 제출은 가능하나, 해당 밸리데이션 자료가 자사 품질관리 시 적절히 적\n\n용될 수 있는지 판단할 수 있는 자료를 함께 제출하여야 한다.  (시험법 이전자료 등)\n\n- ○ 순도시험(유연물질)항목에는 원료의약품에 함유될 수 있고 규격을 설정하여 관리하는 유연\n물질에 대하여 기재한다.\n\n",
        "original_sentence": "특정 유연물질의 화학명을 별도 기재하고 시험\n- ○ 원료의약품 기준과 관련하여, 식약처장이 인정한 공정서 수재품목은 공정서 각조의 요구사항을\n- ○ 선광도, 수분, 순도, 잔류용매, 결정다형 및 입자도 등 원료의약품의 특성을 고려하여 시험항목을\n설정하고 그 타당성을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_232",
      "text": "(완제의약품 제조와 품질에 영향을 미칠 수 있는 원료의약품의\n\n- ○ 각 시험항목별로 시험방법을 적절하게 설정하고 밸리데이션을 실시한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 231,
        "window_size": 3,
        "char_count": 77,
        "word_count": 17,
        "page_number": 5,
        "window_text": "- 3.2.S.4.4의 뱃치 분석에 관한 도표요약은 필요시 그래프와 함께 제공되어야 한다.\n - ○ 3.2.S.4 원료의약품의 관리에 설명된 원료의약품의 기준, 시험방법 및 시험방법 밸리데이션에\n- ○ 시험 기준과 뱃치 분석결과를 표로 작성한다.  특정 유연물질의 화학명을 별도 기재하고 시험\n- ○ 원료의약품 기준과 관련하여, 식약처장이 인정한 공정서 수재품목은 공정서 각조의 요구사항을\n- ○ 선광도, 수분, 순도, 잔류용매, 결정다형 및 입자도 등 원료의약품의 특성을 고려하여 시험항목을\n설정하고 그 타당성을 제시한다.  (완제의약품 제조와 품질에 영향을 미칠 수 있는 원료의약품의\n\n- ○ 각 시험항목별로 시험방법을 적절하게 설정하고 밸리데이션을 실시한다.  시험방법의 중요\n- ○ 공정서에 따라 시험할 경우 공정서 방법이 적용될 수 있는지 특이성(예: 주피크가 생산 공정\n및 분해생성물에서 발생하는 모든 공정 불순물과 분리할 수 있음)과 유연물질 시험방법의 특이성\n\n(예: 주성분 피크를 포함하여 모든 공정 불순물 및 분해생성물을 서로 분리할 수 있는지 확인)\n\n- ○ 공정서 방법을 변경하여 사용하거나 자사 시험방법으로 대체하는 경우 밸리데이션이 필요하며,\n자사 시험방법이 공정서에서 규정하는 시험방법보다 동등 이상인 경우에 그 방법을 적용할 수\n\n- ○ 시험방법 밸리데이션 요약자료를 DMF 등록번호로 대체하는 것은 불가하며, 원료의약품 제조\n원의 밸리데이션 자료 제출은 가능하나, 해당 밸리데이션 자료가 자사 품질관리 시 적절히 적\n\n용될 수 있는지 판단할 수 있는 자료를 함께 제출하여야 한다.  (시험법 이전자료 등)\n\n- ○ 순도시험(유연물질)항목에는 원료의약품에 함유될 수 있고 규격을 설정하여 관리하는 유연\n물질에 대하여 기재한다.\n\n - ○ 「의약품의 품목허가․신고 심사 규정」(식약처고시)의 심사자료 요건에 따라 유연물질을 설정\n- - 7 -\n하고, 근거 및 뱃치분석 결과를 간략히 기재한다.\n\n",
        "original_sentence": "(완제의약품 제조와 품질에 영향을 미칠 수 있는 원료의약품의\n\n- ○ 각 시험항목별로 시험방법을 적절하게 설정하고 밸리데이션을 실시한다. "
      }
    },
    {
      "chunk_id": "chunk_233",
      "text": "시험방법의 중요\n- ○ 공정서에 따라 시험할 경우 공정서 방법이 적용될 수 있는지 특이성(예: 주피크가 생산 공정\n및 분해생성물에서 발생하는 모든 공정 불순물과 분리할 수 있음)과 유연물질 시험방법의 특이성\n\n(예: 주성분 피크를 포함하여 모든 공정 불순물 및 분해생성물을 서로 분리할 수 있는지 확인)\n\n- ○ 공정서 방법을 변경하여 사용하거나 자사 시험방법으로 대체하는 경우 밸리데이션이 필요하며,\n자사 시험방법이 공정서에서 규정하는 시험방법보다 동등 이상인 경우에 그 방법을 적용할 수\n\n- ○ 시험방법 밸리데이션 요약자료를 DMF 등록번호로 대체하는 것은 불가하며, 원료의약품 제조\n원의 밸리데이션 자료 제출은 가능하나, 해당 밸리데이션 자료가 자사 품질관리 시 적절히 적\n\n용될 수 있는지 판단할 수 있는 자료를 함께 제출하여야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 232,
        "window_size": 3,
        "char_count": 417,
        "word_count": 102,
        "page_number": 3,
        "window_text": "- ○ 3.2.S.4 원료의약품의 관리에 설명된 원료의약품의 기준, 시험방법 및 시험방법 밸리데이션에\n- ○ 시험 기준과 뱃치 분석결과를 표로 작성한다.  특정 유연물질의 화학명을 별도 기재하고 시험\n- ○ 원료의약품 기준과 관련하여, 식약처장이 인정한 공정서 수재품목은 공정서 각조의 요구사항을\n- ○ 선광도, 수분, 순도, 잔류용매, 결정다형 및 입자도 등 원료의약품의 특성을 고려하여 시험항목을\n설정하고 그 타당성을 제시한다.  (완제의약품 제조와 품질에 영향을 미칠 수 있는 원료의약품의\n\n- ○ 각 시험항목별로 시험방법을 적절하게 설정하고 밸리데이션을 실시한다.  시험방법의 중요\n- ○ 공정서에 따라 시험할 경우 공정서 방법이 적용될 수 있는지 특이성(예: 주피크가 생산 공정\n및 분해생성물에서 발생하는 모든 공정 불순물과 분리할 수 있음)과 유연물질 시험방법의 특이성\n\n(예: 주성분 피크를 포함하여 모든 공정 불순물 및 분해생성물을 서로 분리할 수 있는지 확인)\n\n- ○ 공정서 방법을 변경하여 사용하거나 자사 시험방법으로 대체하는 경우 밸리데이션이 필요하며,\n자사 시험방법이 공정서에서 규정하는 시험방법보다 동등 이상인 경우에 그 방법을 적용할 수\n\n- ○ 시험방법 밸리데이션 요약자료를 DMF 등록번호로 대체하는 것은 불가하며, 원료의약품 제조\n원의 밸리데이션 자료 제출은 가능하나, 해당 밸리데이션 자료가 자사 품질관리 시 적절히 적\n\n용될 수 있는지 판단할 수 있는 자료를 함께 제출하여야 한다.  (시험법 이전자료 등)\n\n- ○ 순도시험(유연물질)항목에는 원료의약품에 함유될 수 있고 규격을 설정하여 관리하는 유연\n물질에 대하여 기재한다.\n\n - ○ 「의약품의 품목허가․신고 심사 규정」(식약처고시)의 심사자료 요건에 따라 유연물질을 설정\n- - 7 -\n하고, 근거 및 뱃치분석 결과를 간략히 기재한다.\n\n - ○ 공정서 각조에 순도시험 항목이 없는 경우에는 공개된 문헌을 참고하거나 원료의약품 제조\n원과 협조하여 잠재적인 합성 공정 불순물 (예: 이성체, 부가생성물), 분해생성물, 금속 촉매 및\n\n잔류용매 등에 대해 설정하여 관리하는 것이 바람직하다.\n\n",
        "original_sentence": "시험방법의 중요\n- ○ 공정서에 따라 시험할 경우 공정서 방법이 적용될 수 있는지 특이성(예: 주피크가 생산 공정\n및 분해생성물에서 발생하는 모든 공정 불순물과 분리할 수 있음)과 유연물질 시험방법의 특이성\n\n(예: 주성분 피크를 포함하여 모든 공정 불순물 및 분해생성물을 서로 분리할 수 있는지 확인)\n\n- ○ 공정서 방법을 변경하여 사용하거나 자사 시험방법으로 대체하는 경우 밸리데이션이 필요하며,\n자사 시험방법이 공정서에서 규정하는 시험방법보다 동등 이상인 경우에 그 방법을 적용할 수\n\n- ○ 시험방법 밸리데이션 요약자료를 DMF 등록번호로 대체하는 것은 불가하며, 원료의약품 제조\n원의 밸리데이션 자료 제출은 가능하나, 해당 밸리데이션 자료가 자사 품질관리 시 적절히 적\n\n용될 수 있는지 판단할 수 있는 자료를 함께 제출하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_234",
      "text": "(시험법 이전자료 등)\n\n- ○ 순도시험(유연물질)항목에는 원료의약품에 함유될 수 있고 규격을 설정하여 관리하는 유연\n물질에 대하여 기재한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 233,
        "window_size": 3,
        "char_count": 81,
        "word_count": 17,
        "page_number": 3,
        "window_text": "특정 유연물질의 화학명을 별도 기재하고 시험\n- ○ 원료의약품 기준과 관련하여, 식약처장이 인정한 공정서 수재품목은 공정서 각조의 요구사항을\n- ○ 선광도, 수분, 순도, 잔류용매, 결정다형 및 입자도 등 원료의약품의 특성을 고려하여 시험항목을\n설정하고 그 타당성을 제시한다.  (완제의약품 제조와 품질에 영향을 미칠 수 있는 원료의약품의\n\n- ○ 각 시험항목별로 시험방법을 적절하게 설정하고 밸리데이션을 실시한다.  시험방법의 중요\n- ○ 공정서에 따라 시험할 경우 공정서 방법이 적용될 수 있는지 특이성(예: 주피크가 생산 공정\n및 분해생성물에서 발생하는 모든 공정 불순물과 분리할 수 있음)과 유연물질 시험방법의 특이성\n\n(예: 주성분 피크를 포함하여 모든 공정 불순물 및 분해생성물을 서로 분리할 수 있는지 확인)\n\n- ○ 공정서 방법을 변경하여 사용하거나 자사 시험방법으로 대체하는 경우 밸리데이션이 필요하며,\n자사 시험방법이 공정서에서 규정하는 시험방법보다 동등 이상인 경우에 그 방법을 적용할 수\n\n- ○ 시험방법 밸리데이션 요약자료를 DMF 등록번호로 대체하는 것은 불가하며, 원료의약품 제조\n원의 밸리데이션 자료 제출은 가능하나, 해당 밸리데이션 자료가 자사 품질관리 시 적절히 적\n\n용될 수 있는지 판단할 수 있는 자료를 함께 제출하여야 한다.  (시험법 이전자료 등)\n\n- ○ 순도시험(유연물질)항목에는 원료의약품에 함유될 수 있고 규격을 설정하여 관리하는 유연\n물질에 대하여 기재한다.\n\n - ○ 「의약품의 품목허가․신고 심사 규정」(식약처고시)의 심사자료 요건에 따라 유연물질을 설정\n- - 7 -\n하고, 근거 및 뱃치분석 결과를 간략히 기재한다.\n\n - ○ 공정서 각조에 순도시험 항목이 없는 경우에는 공개된 문헌을 참고하거나 원료의약품 제조\n원과 협조하여 잠재적인 합성 공정 불순물 (예: 이성체, 부가생성물), 분해생성물, 금속 촉매 및\n\n잔류용매 등에 대해 설정하여 관리하는 것이 바람직하다.\n\n - ○ 대조약 상대유지시간(RRT)에 의해 확인된 불순물 기준을 안전성 입증(qualification)을 위해\n사용하는 경우, 상대유지시간 비교, 자외부스펙트럼 및 대조의약품과의 질량분석을 통해 미확인\n\n특정 유연물질에 대한 안전성을 수용할 수 있다. ",
        "original_sentence": "(시험법 이전자료 등)\n\n- ○ 순도시험(유연물질)항목에는 원료의약품에 함유될 수 있고 규격을 설정하여 관리하는 유연\n물질에 대하여 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_235",
      "text": "- ○ 「의약품의 품목허가․신고 심사 규정」(식약처고시)의 심사자료 요건에 따라 유연물질을 설정\n- - 7 -\n하고, 근거 및 뱃치분석 결과를 간략히 기재한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 234,
        "window_size": 3,
        "char_count": 91,
        "word_count": 22,
        "page_number": 5,
        "window_text": "(완제의약품 제조와 품질에 영향을 미칠 수 있는 원료의약품의\n\n- ○ 각 시험항목별로 시험방법을 적절하게 설정하고 밸리데이션을 실시한다.  시험방법의 중요\n- ○ 공정서에 따라 시험할 경우 공정서 방법이 적용될 수 있는지 특이성(예: 주피크가 생산 공정\n및 분해생성물에서 발생하는 모든 공정 불순물과 분리할 수 있음)과 유연물질 시험방법의 특이성\n\n(예: 주성분 피크를 포함하여 모든 공정 불순물 및 분해생성물을 서로 분리할 수 있는지 확인)\n\n- ○ 공정서 방법을 변경하여 사용하거나 자사 시험방법으로 대체하는 경우 밸리데이션이 필요하며,\n자사 시험방법이 공정서에서 규정하는 시험방법보다 동등 이상인 경우에 그 방법을 적용할 수\n\n- ○ 시험방법 밸리데이션 요약자료를 DMF 등록번호로 대체하는 것은 불가하며, 원료의약품 제조\n원의 밸리데이션 자료 제출은 가능하나, 해당 밸리데이션 자료가 자사 품질관리 시 적절히 적\n\n용될 수 있는지 판단할 수 있는 자료를 함께 제출하여야 한다.  (시험법 이전자료 등)\n\n- ○ 순도시험(유연물질)항목에는 원료의약품에 함유될 수 있고 규격을 설정하여 관리하는 유연\n물질에 대하여 기재한다.\n\n - ○ 「의약품의 품목허가․신고 심사 규정」(식약처고시)의 심사자료 요건에 따라 유연물질을 설정\n- - 7 -\n하고, 근거 및 뱃치분석 결과를 간략히 기재한다.\n\n - ○ 공정서 각조에 순도시험 항목이 없는 경우에는 공개된 문헌을 참고하거나 원료의약품 제조\n원과 협조하여 잠재적인 합성 공정 불순물 (예: 이성체, 부가생성물), 분해생성물, 금속 촉매 및\n\n잔류용매 등에 대해 설정하여 관리하는 것이 바람직하다.\n\n - ○ 대조약 상대유지시간(RRT)에 의해 확인된 불순물 기준을 안전성 입증(qualification)을 위해\n사용하는 경우, 상대유지시간 비교, 자외부스펙트럼 및 대조의약품과의 질량분석을 통해 미확인\n\n특정 유연물질에 대한 안전성을 수용할 수 있다.  그러나 불순물을 확인(identification) 하기 위\n\n해서는 모든 노력을 기울여야 한다. ",
        "original_sentence": "- ○ 「의약품의 품목허가․신고 심사 규정」(식약처고시)의 심사자료 요건에 따라 유연물질을 설정\n- - 7 -\n하고, 근거 및 뱃치분석 결과를 간략히 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_236",
      "text": "- ○ 공정서 각조에 순도시험 항목이 없는 경우에는 공개된 문헌을 참고하거나 원료의약품 제조\n원과 협조하여 잠재적인 합성 공정 불순물 (예: 이성체, 부가생성물), 분해생성물, 금속 촉매 및\n\n잔류용매 등에 대해 설정하여 관리하는 것이 바람직하다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 235,
        "window_size": 3,
        "char_count": 140,
        "word_count": 33,
        "page_number": 3,
        "window_text": "시험방법의 중요\n- ○ 공정서에 따라 시험할 경우 공정서 방법이 적용될 수 있는지 특이성(예: 주피크가 생산 공정\n및 분해생성물에서 발생하는 모든 공정 불순물과 분리할 수 있음)과 유연물질 시험방법의 특이성\n\n(예: 주성분 피크를 포함하여 모든 공정 불순물 및 분해생성물을 서로 분리할 수 있는지 확인)\n\n- ○ 공정서 방법을 변경하여 사용하거나 자사 시험방법으로 대체하는 경우 밸리데이션이 필요하며,\n자사 시험방법이 공정서에서 규정하는 시험방법보다 동등 이상인 경우에 그 방법을 적용할 수\n\n- ○ 시험방법 밸리데이션 요약자료를 DMF 등록번호로 대체하는 것은 불가하며, 원료의약품 제조\n원의 밸리데이션 자료 제출은 가능하나, 해당 밸리데이션 자료가 자사 품질관리 시 적절히 적\n\n용될 수 있는지 판단할 수 있는 자료를 함께 제출하여야 한다.  (시험법 이전자료 등)\n\n- ○ 순도시험(유연물질)항목에는 원료의약품에 함유될 수 있고 규격을 설정하여 관리하는 유연\n물질에 대하여 기재한다.\n\n - ○ 「의약품의 품목허가․신고 심사 규정」(식약처고시)의 심사자료 요건에 따라 유연물질을 설정\n- - 7 -\n하고, 근거 및 뱃치분석 결과를 간략히 기재한다.\n\n - ○ 공정서 각조에 순도시험 항목이 없는 경우에는 공개된 문헌을 참고하거나 원료의약품 제조\n원과 협조하여 잠재적인 합성 공정 불순물 (예: 이성체, 부가생성물), 분해생성물, 금속 촉매 및\n\n잔류용매 등에 대해 설정하여 관리하는 것이 바람직하다.\n\n - ○ 대조약 상대유지시간(RRT)에 의해 확인된 불순물 기준을 안전성 입증(qualification)을 위해\n사용하는 경우, 상대유지시간 비교, 자외부스펙트럼 및 대조의약품과의 질량분석을 통해 미확인\n\n특정 유연물질에 대한 안전성을 수용할 수 있다.  그러나 불순물을 확인(identification) 하기 위\n\n해서는 모든 노력을 기울여야 한다.  설정한 불순물 기준이 대조약보다 더 높다면 신청인은 이\n\n- ○ 대조약의 가속 또는 가혹시험 자료를 사용하여 원료의약품 불순물 기준을 설정하는 것은 바람\n직하지 않다. ",
        "original_sentence": "- ○ 공정서 각조에 순도시험 항목이 없는 경우에는 공개된 문헌을 참고하거나 원료의약품 제조\n원과 협조하여 잠재적인 합성 공정 불순물 (예: 이성체, 부가생성물), 분해생성물, 금속 촉매 및\n\n잔류용매 등에 대해 설정하여 관리하는 것이 바람직하다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_237",
      "text": "- ○ 대조약 상대유지시간(RRT)에 의해 확인된 불순물 기준을 안전성 입증(qualification)을 위해\n사용하는 경우, 상대유지시간 비교, 자외부스펙트럼 및 대조의약품과의 질량분석을 통해 미확인\n\n특정 유연물질에 대한 안전성을 수용할 수 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 236,
        "window_size": 3,
        "char_count": 141,
        "word_count": 28,
        "page_number": 5,
        "window_text": "(시험법 이전자료 등)\n\n- ○ 순도시험(유연물질)항목에는 원료의약품에 함유될 수 있고 규격을 설정하여 관리하는 유연\n물질에 대하여 기재한다.\n\n - ○ 「의약품의 품목허가․신고 심사 규정」(식약처고시)의 심사자료 요건에 따라 유연물질을 설정\n- - 7 -\n하고, 근거 및 뱃치분석 결과를 간략히 기재한다.\n\n - ○ 공정서 각조에 순도시험 항목이 없는 경우에는 공개된 문헌을 참고하거나 원료의약품 제조\n원과 협조하여 잠재적인 합성 공정 불순물 (예: 이성체, 부가생성물), 분해생성물, 금속 촉매 및\n\n잔류용매 등에 대해 설정하여 관리하는 것이 바람직하다.\n\n - ○ 대조약 상대유지시간(RRT)에 의해 확인된 불순물 기준을 안전성 입증(qualification)을 위해\n사용하는 경우, 상대유지시간 비교, 자외부스펙트럼 및 대조의약품과의 질량분석을 통해 미확인\n\n특정 유연물질에 대한 안전성을 수용할 수 있다.  그러나 불순물을 확인(identification) 하기 위\n\n해서는 모든 노력을 기울여야 한다.  설정한 불순물 기준이 대조약보다 더 높다면 신청인은 이\n\n- ○ 대조약의 가속 또는 가혹시험 자료를 사용하여 원료의약품 불순물 기준을 설정하는 것은 바람\n직하지 않다.  사용기간(또는 그에 준한 기간) 이내이나, 제조일로부터 시일이 경과한 다양한 제\n\n- ○ 「의약품잔류용매기준지침」에 따라 모든 잔류용매는 품질기준에 적합한 수준으로 제거되어야\n하므로 잔류용매 제거에 대한 공정능력(process capability)을 고려하고, 해당 지침에 따라\n\n- ○ 「의약품잔류용매기준지침」에 포함되지 않은 잔류용매는 안전성을 고려하여 기준을 설정한다.\n",
        "original_sentence": "- ○ 대조약 상대유지시간(RRT)에 의해 확인된 불순물 기준을 안전성 입증(qualification)을 위해\n사용하는 경우, 상대유지시간 비교, 자외부스펙트럼 및 대조의약품과의 질량분석을 통해 미확인\n\n특정 유연물질에 대한 안전성을 수용할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_238",
      "text": "그러나 불순물을 확인(identification) 하기 위\n\n해서는 모든 노력을 기울여야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 237,
        "window_size": 3,
        "char_count": 54,
        "word_count": 10,
        "page_number": 62,
        "window_text": "- ○ 「의약품의 품목허가․신고 심사 규정」(식약처고시)의 심사자료 요건에 따라 유연물질을 설정\n- - 7 -\n하고, 근거 및 뱃치분석 결과를 간략히 기재한다.\n\n - ○ 공정서 각조에 순도시험 항목이 없는 경우에는 공개된 문헌을 참고하거나 원료의약품 제조\n원과 협조하여 잠재적인 합성 공정 불순물 (예: 이성체, 부가생성물), 분해생성물, 금속 촉매 및\n\n잔류용매 등에 대해 설정하여 관리하는 것이 바람직하다.\n\n - ○ 대조약 상대유지시간(RRT)에 의해 확인된 불순물 기준을 안전성 입증(qualification)을 위해\n사용하는 경우, 상대유지시간 비교, 자외부스펙트럼 및 대조의약품과의 질량분석을 통해 미확인\n\n특정 유연물질에 대한 안전성을 수용할 수 있다.  그러나 불순물을 확인(identification) 하기 위\n\n해서는 모든 노력을 기울여야 한다.  설정한 불순물 기준이 대조약보다 더 높다면 신청인은 이\n\n- ○ 대조약의 가속 또는 가혹시험 자료를 사용하여 원료의약품 불순물 기준을 설정하는 것은 바람\n직하지 않다.  사용기간(또는 그에 준한 기간) 이내이나, 제조일로부터 시일이 경과한 다양한 제\n\n- ○ 「의약품잔류용매기준지침」에 따라 모든 잔류용매는 품질기준에 적합한 수준으로 제거되어야\n하므로 잔류용매 제거에 대한 공정능력(process capability)을 고려하고, 해당 지침에 따라\n\n- ○ 「의약품잔류용매기준지침」에 포함되지 않은 잔류용매는 안전성을 고려하여 기준을 설정한다.\n - ○ 결정다형과 관련하여, 결정다형이 있고 결정다형 간 용해도 차이가 있는 등 품질에 영향을 미\n- ○ 원료의약품의 입자도 기준은 입자도가 완제의약품의 성능 또는 제조에 중요한 경우 설정한다.\n",
        "original_sentence": "그러나 불순물을 확인(identification) 하기 위\n\n해서는 모든 노력을 기울여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_239",
      "text": "설정한 불순물 기준이 대조약보다 더 높다면 신청인은 이\n\n- ○ 대조약의 가속 또는 가혹시험 자료를 사용하여 원료의약품 불순물 기준을 설정하는 것은 바람\n직하지 않다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 238,
        "window_size": 3,
        "char_count": 94,
        "word_count": 24,
        "page_number": 3,
        "window_text": "- ○ 공정서 각조에 순도시험 항목이 없는 경우에는 공개된 문헌을 참고하거나 원료의약품 제조\n원과 협조하여 잠재적인 합성 공정 불순물 (예: 이성체, 부가생성물), 분해생성물, 금속 촉매 및\n\n잔류용매 등에 대해 설정하여 관리하는 것이 바람직하다.\n\n - ○ 대조약 상대유지시간(RRT)에 의해 확인된 불순물 기준을 안전성 입증(qualification)을 위해\n사용하는 경우, 상대유지시간 비교, 자외부스펙트럼 및 대조의약품과의 질량분석을 통해 미확인\n\n특정 유연물질에 대한 안전성을 수용할 수 있다.  그러나 불순물을 확인(identification) 하기 위\n\n해서는 모든 노력을 기울여야 한다.  설정한 불순물 기준이 대조약보다 더 높다면 신청인은 이\n\n- ○ 대조약의 가속 또는 가혹시험 자료를 사용하여 원료의약품 불순물 기준을 설정하는 것은 바람\n직하지 않다.  사용기간(또는 그에 준한 기간) 이내이나, 제조일로부터 시일이 경과한 다양한 제\n\n- ○ 「의약품잔류용매기준지침」에 따라 모든 잔류용매는 품질기준에 적합한 수준으로 제거되어야\n하므로 잔류용매 제거에 대한 공정능력(process capability)을 고려하고, 해당 지침에 따라\n\n- ○ 「의약품잔류용매기준지침」에 포함되지 않은 잔류용매는 안전성을 고려하여 기준을 설정한다.\n - ○ 결정다형과 관련하여, 결정다형이 있고 결정다형 간 용해도 차이가 있는 등 품질에 영향을 미\n- ○ 원료의약품의 입자도 기준은 입자도가 완제의약품의 성능 또는 제조에 중요한 경우 설정한다.\n 예를 들면, 건식혼합 공정에서 원료의약품 및 부형제의 입자도는 혼합 공정에 영향을 미칠 수\n\n있다. ",
        "original_sentence": "설정한 불순물 기준이 대조약보다 더 높다면 신청인은 이\n\n- ○ 대조약의 가속 또는 가혹시험 자료를 사용하여 원료의약품 불순물 기준을 설정하는 것은 바람\n직하지 않다. "
      }
    },
    {
      "chunk_id": "chunk_240",
      "text": "사용기간(또는 그에 준한 기간) 이내이나, 제조일로부터 시일이 경과한 다양한 제\n\n- ○ 「의약품잔류용매기준지침」에 따라 모든 잔류용매는 품질기준에 적합한 수준으로 제거되어야\n하므로 잔류용매 제거에 대한 공정능력(process capability)을 고려하고, 해당 지침에 따라\n\n- ○ 「의약품잔류용매기준지침」에 포함되지 않은 잔류용매는 안전성을 고려하여 기준을 설정한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 239,
        "window_size": 3,
        "char_count": 210,
        "word_count": 40,
        "page_number": 3,
        "window_text": "- ○ 대조약 상대유지시간(RRT)에 의해 확인된 불순물 기준을 안전성 입증(qualification)을 위해\n사용하는 경우, 상대유지시간 비교, 자외부스펙트럼 및 대조의약품과의 질량분석을 통해 미확인\n\n특정 유연물질에 대한 안전성을 수용할 수 있다.  그러나 불순물을 확인(identification) 하기 위\n\n해서는 모든 노력을 기울여야 한다.  설정한 불순물 기준이 대조약보다 더 높다면 신청인은 이\n\n- ○ 대조약의 가속 또는 가혹시험 자료를 사용하여 원료의약품 불순물 기준을 설정하는 것은 바람\n직하지 않다.  사용기간(또는 그에 준한 기간) 이내이나, 제조일로부터 시일이 경과한 다양한 제\n\n- ○ 「의약품잔류용매기준지침」에 따라 모든 잔류용매는 품질기준에 적합한 수준으로 제거되어야\n하므로 잔류용매 제거에 대한 공정능력(process capability)을 고려하고, 해당 지침에 따라\n\n- ○ 「의약품잔류용매기준지침」에 포함되지 않은 잔류용매는 안전성을 고려하여 기준을 설정한다.\n - ○ 결정다형과 관련하여, 결정다형이 있고 결정다형 간 용해도 차이가 있는 등 품질에 영향을 미\n- ○ 원료의약품의 입자도 기준은 입자도가 완제의약품의 성능 또는 제조에 중요한 경우 설정한다.\n 예를 들면, 건식혼합 공정에서 원료의약품 및 부형제의 입자도는 혼합 공정에 영향을 미칠 수\n\n있다.  용해도가 낮은 원료의약품의 경우 입자도는 완제의약품의 용출에 중요한 영향을 미칠 수\n\n있다. ",
        "original_sentence": "사용기간(또는 그에 준한 기간) 이내이나, 제조일로부터 시일이 경과한 다양한 제\n\n- ○ 「의약품잔류용매기준지침」에 따라 모든 잔류용매는 품질기준에 적합한 수준으로 제거되어야\n하므로 잔류용매 제거에 대한 공정능력(process capability)을 고려하고, 해당 지침에 따라\n\n- ○ 「의약품잔류용매기준지침」에 포함되지 않은 잔류용매는 안전성을 고려하여 기준을 설정한다.\n"
      }
    },
    {
      "chunk_id": "chunk_241",
      "text": "- ○ 결정다형과 관련하여, 결정다형이 있고 결정다형 간 용해도 차이가 있는 등 품질에 영향을 미\n- ○ 원료의약품의 입자도 기준은 입자도가 완제의약품의 성능 또는 제조에 중요한 경우 설정한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 240,
        "window_size": 3,
        "char_count": 109,
        "word_count": 28,
        "page_number": 3,
        "window_text": "그러나 불순물을 확인(identification) 하기 위\n\n해서는 모든 노력을 기울여야 한다.  설정한 불순물 기준이 대조약보다 더 높다면 신청인은 이\n\n- ○ 대조약의 가속 또는 가혹시험 자료를 사용하여 원료의약품 불순물 기준을 설정하는 것은 바람\n직하지 않다.  사용기간(또는 그에 준한 기간) 이내이나, 제조일로부터 시일이 경과한 다양한 제\n\n- ○ 「의약품잔류용매기준지침」에 따라 모든 잔류용매는 품질기준에 적합한 수준으로 제거되어야\n하므로 잔류용매 제거에 대한 공정능력(process capability)을 고려하고, 해당 지침에 따라\n\n- ○ 「의약품잔류용매기준지침」에 포함되지 않은 잔류용매는 안전성을 고려하여 기준을 설정한다.\n - ○ 결정다형과 관련하여, 결정다형이 있고 결정다형 간 용해도 차이가 있는 등 품질에 영향을 미\n- ○ 원료의약품의 입자도 기준은 입자도가 완제의약품의 성능 또는 제조에 중요한 경우 설정한다.\n 예를 들면, 건식혼합 공정에서 원료의약품 및 부형제의 입자도는 혼합 공정에 영향을 미칠 수\n\n있다.  용해도가 낮은 원료의약품의 경우 입자도는 완제의약품의 용출에 중요한 영향을 미칠 수\n\n있다.  용해도가 높은 원료의약품의 경우, 입자도는 완제의약품 성능에 중요한 영향을 주지 않을\n\n- ○ 입자도의 기준, 허용범위 및 설정근거는 입자도가 완제의약품에 미치는 영향에 따라, 설정여부\n및 기준 범위 등을 결정한다. ",
        "original_sentence": "- ○ 결정다형과 관련하여, 결정다형이 있고 결정다형 간 용해도 차이가 있는 등 품질에 영향을 미\n- ○ 원료의약품의 입자도 기준은 입자도가 완제의약품의 성능 또는 제조에 중요한 경우 설정한다.\n"
      }
    },
    {
      "chunk_id": "chunk_242",
      "text": "예를 들면, 건식혼합 공정에서 원료의약품 및 부형제의 입자도는 혼합 공정에 영향을 미칠 수\n\n있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 241,
        "window_size": 3,
        "char_count": 56,
        "word_count": 14,
        "page_number": 13,
        "window_text": "설정한 불순물 기준이 대조약보다 더 높다면 신청인은 이\n\n- ○ 대조약의 가속 또는 가혹시험 자료를 사용하여 원료의약품 불순물 기준을 설정하는 것은 바람\n직하지 않다.  사용기간(또는 그에 준한 기간) 이내이나, 제조일로부터 시일이 경과한 다양한 제\n\n- ○ 「의약품잔류용매기준지침」에 따라 모든 잔류용매는 품질기준에 적합한 수준으로 제거되어야\n하므로 잔류용매 제거에 대한 공정능력(process capability)을 고려하고, 해당 지침에 따라\n\n- ○ 「의약품잔류용매기준지침」에 포함되지 않은 잔류용매는 안전성을 고려하여 기준을 설정한다.\n - ○ 결정다형과 관련하여, 결정다형이 있고 결정다형 간 용해도 차이가 있는 등 품질에 영향을 미\n- ○ 원료의약품의 입자도 기준은 입자도가 완제의약품의 성능 또는 제조에 중요한 경우 설정한다.\n 예를 들면, 건식혼합 공정에서 원료의약품 및 부형제의 입자도는 혼합 공정에 영향을 미칠 수\n\n있다.  용해도가 낮은 원료의약품의 경우 입자도는 완제의약품의 용출에 중요한 영향을 미칠 수\n\n있다.  용해도가 높은 원료의약품의 경우, 입자도는 완제의약품 성능에 중요한 영향을 주지 않을\n\n- ○ 입자도의 기준, 허용범위 및 설정근거는 입자도가 완제의약품에 미치는 영향에 따라, 설정여부\n및 기준 범위 등을 결정한다.  기준은 입자도의 변경이 원료의약품의 제조 능력 또는 완제의약\n\n품의 성능에 영향을 미치는지에 근거해야 한다. ",
        "original_sentence": "예를 들면, 건식혼합 공정에서 원료의약품 및 부형제의 입자도는 혼합 공정에 영향을 미칠 수\n\n있다. "
      }
    },
    {
      "chunk_id": "chunk_243",
      "text": "용해도가 낮은 원료의약품의 경우 입자도는 완제의약품의 용출에 중요한 영향을 미칠 수\n\n있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 242,
        "window_size": 3,
        "char_count": 52,
        "word_count": 12,
        "page_number": 14,
        "window_text": "사용기간(또는 그에 준한 기간) 이내이나, 제조일로부터 시일이 경과한 다양한 제\n\n- ○ 「의약품잔류용매기준지침」에 따라 모든 잔류용매는 품질기준에 적합한 수준으로 제거되어야\n하므로 잔류용매 제거에 대한 공정능력(process capability)을 고려하고, 해당 지침에 따라\n\n- ○ 「의약품잔류용매기준지침」에 포함되지 않은 잔류용매는 안전성을 고려하여 기준을 설정한다.\n - ○ 결정다형과 관련하여, 결정다형이 있고 결정다형 간 용해도 차이가 있는 등 품질에 영향을 미\n- ○ 원료의약품의 입자도 기준은 입자도가 완제의약품의 성능 또는 제조에 중요한 경우 설정한다.\n 예를 들면, 건식혼합 공정에서 원료의약품 및 부형제의 입자도는 혼합 공정에 영향을 미칠 수\n\n있다.  용해도가 낮은 원료의약품의 경우 입자도는 완제의약품의 용출에 중요한 영향을 미칠 수\n\n있다.  용해도가 높은 원료의약품의 경우, 입자도는 완제의약품 성능에 중요한 영향을 주지 않을\n\n- ○ 입자도의 기준, 허용범위 및 설정근거는 입자도가 완제의약품에 미치는 영향에 따라, 설정여부\n및 기준 범위 등을 결정한다.  기준은 입자도의 변경이 원료의약품의 제조 능력 또는 완제의약\n\n품의 성능에 영향을 미치는지에 근거해야 한다.  일반적으로, 신청인은 물리적인 특성 또는 실험\n\n을 통해 입자도와 같은 원료의약품의 특성 변경이 제품에 어떻게 영향을 미치는지를 입증해야\n\n한다.\n\n",
        "original_sentence": "용해도가 낮은 원료의약품의 경우 입자도는 완제의약품의 용출에 중요한 영향을 미칠 수\n\n있다. "
      }
    },
    {
      "chunk_id": "chunk_244",
      "text": "용해도가 높은 원료의약품의 경우, 입자도는 완제의약품 성능에 중요한 영향을 주지 않을\n\n- ○ 입자도의 기준, 허용범위 및 설정근거는 입자도가 완제의약품에 미치는 영향에 따라, 설정여부\n및 기준 범위 등을 결정한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 243,
        "window_size": 3,
        "char_count": 121,
        "word_count": 29,
        "page_number": 5,
        "window_text": "- ○ 결정다형과 관련하여, 결정다형이 있고 결정다형 간 용해도 차이가 있는 등 품질에 영향을 미\n- ○ 원료의약품의 입자도 기준은 입자도가 완제의약품의 성능 또는 제조에 중요한 경우 설정한다.\n 예를 들면, 건식혼합 공정에서 원료의약품 및 부형제의 입자도는 혼합 공정에 영향을 미칠 수\n\n있다.  용해도가 낮은 원료의약품의 경우 입자도는 완제의약품의 용출에 중요한 영향을 미칠 수\n\n있다.  용해도가 높은 원료의약품의 경우, 입자도는 완제의약품 성능에 중요한 영향을 주지 않을\n\n- ○ 입자도의 기준, 허용범위 및 설정근거는 입자도가 완제의약품에 미치는 영향에 따라, 설정여부\n및 기준 범위 등을 결정한다.  기준은 입자도의 변경이 원료의약품의 제조 능력 또는 완제의약\n\n품의 성능에 영향을 미치는지에 근거해야 한다.  일반적으로, 신청인은 물리적인 특성 또는 실험\n\n을 통해 입자도와 같은 원료의약품의 특성 변경이 제품에 어떻게 영향을 미치는지를 입증해야\n\n한다.\n\n - ○ 입자도가 중요한 경우에는 입자도분포를 구체화하고, 그 외에 제제연구 등 자료를 근거로 하여\n입자도 규격을 하나로 설정하는 것이 가능하다.\n\n",
        "original_sentence": "용해도가 높은 원료의약품의 경우, 입자도는 완제의약품 성능에 중요한 영향을 주지 않을\n\n- ○ 입자도의 기준, 허용범위 및 설정근거는 입자도가 완제의약품에 미치는 영향에 따라, 설정여부\n및 기준 범위 등을 결정한다. "
      }
    },
    {
      "chunk_id": "chunk_245",
      "text": "기준은 입자도의 변경이 원료의약품의 제조 능력 또는 완제의약\n\n품의 성능에 영향을 미치는지에 근거해야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 244,
        "window_size": 3,
        "char_count": 61,
        "word_count": 14,
        "page_number": 3,
        "window_text": "예를 들면, 건식혼합 공정에서 원료의약품 및 부형제의 입자도는 혼합 공정에 영향을 미칠 수\n\n있다.  용해도가 낮은 원료의약품의 경우 입자도는 완제의약품의 용출에 중요한 영향을 미칠 수\n\n있다.  용해도가 높은 원료의약품의 경우, 입자도는 완제의약품 성능에 중요한 영향을 주지 않을\n\n- ○ 입자도의 기준, 허용범위 및 설정근거는 입자도가 완제의약품에 미치는 영향에 따라, 설정여부\n및 기준 범위 등을 결정한다.  기준은 입자도의 변경이 원료의약품의 제조 능력 또는 완제의약\n\n품의 성능에 영향을 미치는지에 근거해야 한다.  일반적으로, 신청인은 물리적인 특성 또는 실험\n\n을 통해 입자도와 같은 원료의약품의 특성 변경이 제품에 어떻게 영향을 미치는지를 입증해야\n\n한다.\n\n - ○ 입자도가 중요한 경우에는 입자도분포를 구체화하고, 그 외에 제제연구 등 자료를 근거로 하여\n입자도 규격을 하나로 설정하는 것이 가능하다.\n\n <!-- PAGE_13 -->\n##### 예 시\n\n원료의약품의 규격 설정 예시 1)\n\n- - 8 -\n* RC1: [유연물질 화학명]\n\nRC2: [유연물질 화학명]\n\nRC3: [유연물질 화학명]\n\n완제의약품의 제조와 품질에 영향을 미치는 중요한 요소에 대해 규격을 설정하였다. ",
        "original_sentence": "기준은 입자도의 변경이 원료의약품의 제조 능력 또는 완제의약\n\n품의 성능에 영향을 미치는지에 근거해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_246",
      "text": "일반적으로, 신청인은 물리적인 특성 또는 실험\n\n을 통해 입자도와 같은 원료의약품의 특성 변경이 제품에 어떻게 영향을 미치는지를 입증해야\n\n한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 245,
        "window_size": 3,
        "char_count": 83,
        "word_count": 19,
        "page_number": 14,
        "window_text": "용해도가 낮은 원료의약품의 경우 입자도는 완제의약품의 용출에 중요한 영향을 미칠 수\n\n있다.  용해도가 높은 원료의약품의 경우, 입자도는 완제의약품 성능에 중요한 영향을 주지 않을\n\n- ○ 입자도의 기준, 허용범위 및 설정근거는 입자도가 완제의약품에 미치는 영향에 따라, 설정여부\n및 기준 범위 등을 결정한다.  기준은 입자도의 변경이 원료의약품의 제조 능력 또는 완제의약\n\n품의 성능에 영향을 미치는지에 근거해야 한다.  일반적으로, 신청인은 물리적인 특성 또는 실험\n\n을 통해 입자도와 같은 원료의약품의 특성 변경이 제품에 어떻게 영향을 미치는지를 입증해야\n\n한다.\n\n - ○ 입자도가 중요한 경우에는 입자도분포를 구체화하고, 그 외에 제제연구 등 자료를 근거로 하여\n입자도 규격을 하나로 설정하는 것이 가능하다.\n\n <!-- PAGE_13 -->\n##### 예 시\n\n원료의약품의 규격 설정 예시 1)\n\n- - 8 -\n* RC1: [유연물질 화학명]\n\nRC2: [유연물질 화학명]\n\nRC3: [유연물질 화학명]\n\n완제의약품의 제조와 품질에 영향을 미치는 중요한 요소에 대해 규격을 설정하였다.  각 시험\n\n방법은 USP 일반시험법을 참조하거나 자사 시험방법으로 설정하였으며, 결정형과 입자도에\n\n대한 규격도 포함하였다. ",
        "original_sentence": "일반적으로, 신청인은 물리적인 특성 또는 실험\n\n을 통해 입자도와 같은 원료의약품의 특성 변경이 제품에 어떻게 영향을 미치는지를 입증해야\n\n한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_247",
      "text": "- ○ 입자도가 중요한 경우에는 입자도분포를 구체화하고, 그 외에 제제연구 등 자료를 근거로 하여\n입자도 규격을 하나로 설정하는 것이 가능하다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 246,
        "window_size": 3,
        "char_count": 82,
        "word_count": 20,
        "page_number": 5,
        "window_text": "용해도가 높은 원료의약품의 경우, 입자도는 완제의약품 성능에 중요한 영향을 주지 않을\n\n- ○ 입자도의 기준, 허용범위 및 설정근거는 입자도가 완제의약품에 미치는 영향에 따라, 설정여부\n및 기준 범위 등을 결정한다.  기준은 입자도의 변경이 원료의약품의 제조 능력 또는 완제의약\n\n품의 성능에 영향을 미치는지에 근거해야 한다.  일반적으로, 신청인은 물리적인 특성 또는 실험\n\n을 통해 입자도와 같은 원료의약품의 특성 변경이 제품에 어떻게 영향을 미치는지를 입증해야\n\n한다.\n\n - ○ 입자도가 중요한 경우에는 입자도분포를 구체화하고, 그 외에 제제연구 등 자료를 근거로 하여\n입자도 규격을 하나로 설정하는 것이 가능하다.\n\n <!-- PAGE_13 -->\n##### 예 시\n\n원료의약품의 규격 설정 예시 1)\n\n- - 8 -\n* RC1: [유연물질 화학명]\n\nRC2: [유연물질 화학명]\n\nRC3: [유연물질 화학명]\n\n완제의약품의 제조와 품질에 영향을 미치는 중요한 요소에 대해 규격을 설정하였다.  각 시험\n\n방법은 USP 일반시험법을 참조하거나 자사 시험방법으로 설정하였으며, 결정형과 입자도에\n\n대한 규격도 포함하였다.  완제의약품의 제조공정에는 난용성 원료의약품의 습식 과립공정이 포\n\n함되므로 입자도와 결정형은 완제의약품에 중요한 요소로 작용한다. ",
        "original_sentence": "- ○ 입자도가 중요한 경우에는 입자도분포를 구체화하고, 그 외에 제제연구 등 자료를 근거로 하여\n입자도 규격을 하나로 설정하는 것이 가능하다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_248",
      "text": "<!-- PAGE_13 -->\n##### 예 시\n\n원료의약품의 규격 설정 예시 1)\n\n- - 8 -\n* RC1: [유연물질 화학명]\n\nRC2: [유연물질 화학명]\n\nRC3: [유연물질 화학명]\n\n완제의약품의 제조와 품질에 영향을 미치는 중요한 요소에 대해 규격을 설정하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 247,
        "window_size": 3,
        "char_count": 154,
        "word_count": 35,
        "page_number": 13,
        "window_text": "기준은 입자도의 변경이 원료의약품의 제조 능력 또는 완제의약\n\n품의 성능에 영향을 미치는지에 근거해야 한다.  일반적으로, 신청인은 물리적인 특성 또는 실험\n\n을 통해 입자도와 같은 원료의약품의 특성 변경이 제품에 어떻게 영향을 미치는지를 입증해야\n\n한다.\n\n - ○ 입자도가 중요한 경우에는 입자도분포를 구체화하고, 그 외에 제제연구 등 자료를 근거로 하여\n입자도 규격을 하나로 설정하는 것이 가능하다.\n\n <!-- PAGE_13 -->\n##### 예 시\n\n원료의약품의 규격 설정 예시 1)\n\n- - 8 -\n* RC1: [유연물질 화학명]\n\nRC2: [유연물질 화학명]\n\nRC3: [유연물질 화학명]\n\n완제의약품의 제조와 품질에 영향을 미치는 중요한 요소에 대해 규격을 설정하였다.  각 시험\n\n방법은 USP 일반시험법을 참조하거나 자사 시험방법으로 설정하였으며, 결정형과 입자도에\n\n대한 규격도 포함하였다.  완제의약품의 제조공정에는 난용성 원료의약품의 습식 과립공정이 포\n\n함되므로 입자도와 결정형은 완제의약품에 중요한 요소로 작용한다.  이러한 입자도와 결정형이\n\n완제의약품에 어떠한 영향을 미치는 지에 대해서는 2.3.P.2.2. ",
        "original_sentence": "<!-- PAGE_13 -->\n##### 예 시\n\n원료의약품의 규격 설정 예시 1)\n\n- - 8 -\n* RC1: [유연물질 화학명]\n\nRC2: [유연물질 화학명]\n\nRC3: [유연물질 화학명]\n\n완제의약품의 제조와 품질에 영향을 미치는 중요한 요소에 대해 규격을 설정하였다. "
      }
    },
    {
      "chunk_id": "chunk_249",
      "text": "각 시험\n\n방법은 USP 일반시험법을 참조하거나 자사 시험방법으로 설정하였으며, 결정형과 입자도에\n\n대한 규격도 포함하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 248,
        "window_size": 3,
        "char_count": 70,
        "word_count": 14,
        "page_number": 14,
        "window_text": "일반적으로, 신청인은 물리적인 특성 또는 실험\n\n을 통해 입자도와 같은 원료의약품의 특성 변경이 제품에 어떻게 영향을 미치는지를 입증해야\n\n한다.\n\n - ○ 입자도가 중요한 경우에는 입자도분포를 구체화하고, 그 외에 제제연구 등 자료를 근거로 하여\n입자도 규격을 하나로 설정하는 것이 가능하다.\n\n <!-- PAGE_13 -->\n##### 예 시\n\n원료의약품의 규격 설정 예시 1)\n\n- - 8 -\n* RC1: [유연물질 화학명]\n\nRC2: [유연물질 화학명]\n\nRC3: [유연물질 화학명]\n\n완제의약품의 제조와 품질에 영향을 미치는 중요한 요소에 대해 규격을 설정하였다.  각 시험\n\n방법은 USP 일반시험법을 참조하거나 자사 시험방법으로 설정하였으며, 결정형과 입자도에\n\n대한 규격도 포함하였다.  완제의약품의 제조공정에는 난용성 원료의약품의 습식 과립공정이 포\n\n함되므로 입자도와 결정형은 완제의약품에 중요한 요소로 작용한다.  이러한 입자도와 결정형이\n\n완제의약품에 어떠한 영향을 미치는 지에 대해서는 2.3.P.2.2.  개발경위에서 확인할 수 있다.\n\n",
        "original_sentence": "각 시험\n\n방법은 USP 일반시험법을 참조하거나 자사 시험방법으로 설정하였으며, 결정형과 입자도에\n\n대한 규격도 포함하였다. "
      }
    },
    {
      "chunk_id": "chunk_250",
      "text": "완제의약품의 제조공정에는 난용성 원료의약품의 습식 과립공정이 포\n\n함되므로 입자도와 결정형은 완제의약품에 중요한 요소로 작용한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 249,
        "window_size": 3,
        "char_count": 73,
        "word_count": 14,
        "page_number": 3,
        "window_text": "- ○ 입자도가 중요한 경우에는 입자도분포를 구체화하고, 그 외에 제제연구 등 자료를 근거로 하여\n입자도 규격을 하나로 설정하는 것이 가능하다.\n\n <!-- PAGE_13 -->\n##### 예 시\n\n원료의약품의 규격 설정 예시 1)\n\n- - 8 -\n* RC1: [유연물질 화학명]\n\nRC2: [유연물질 화학명]\n\nRC3: [유연물질 화학명]\n\n완제의약품의 제조와 품질에 영향을 미치는 중요한 요소에 대해 규격을 설정하였다.  각 시험\n\n방법은 USP 일반시험법을 참조하거나 자사 시험방법으로 설정하였으며, 결정형과 입자도에\n\n대한 규격도 포함하였다.  완제의약품의 제조공정에는 난용성 원료의약품의 습식 과립공정이 포\n\n함되므로 입자도와 결정형은 완제의약품에 중요한 요소로 작용한다.  이러한 입자도와 결정형이\n\n완제의약품에 어떠한 영향을 미치는 지에 대해서는 2.3.P.2.2.  개발경위에서 확인할 수 있다.\n\n 원료의약품의 규격 설정 예시 2)\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색, 결정형 가루\n\n육안검사\n\n적합\n\n확인시험\n\n**[표 시작]**\n\n| A: IR | A. IR: 표준품과 같음 | 0.65~0.85g/mL | USP <197M> | M-1236 | 적합 |\n| --- | --- | --- | --- | --- | --- |\n| 정제 생산량 | 225,420 | 231,000 | 93% | 였다. ",
        "original_sentence": "완제의약품의 제조공정에는 난용성 원료의약품의 습식 과립공정이 포\n\n함되므로 입자도와 결정형은 완제의약품에 중요한 요소로 작용한다. "
      }
    },
    {
      "chunk_id": "chunk_251",
      "text": "이러한 입자도와 결정형이\n\n완제의약품에 어떠한 영향을 미치는 지에 대해서는 2.3.P.2.2. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 250,
        "window_size": 3,
        "char_count": 53,
        "word_count": 10,
        "page_number": 3,
        "window_text": "<!-- PAGE_13 -->\n##### 예 시\n\n원료의약품의 규격 설정 예시 1)\n\n- - 8 -\n* RC1: [유연물질 화학명]\n\nRC2: [유연물질 화학명]\n\nRC3: [유연물질 화학명]\n\n완제의약품의 제조와 품질에 영향을 미치는 중요한 요소에 대해 규격을 설정하였다.  각 시험\n\n방법은 USP 일반시험법을 참조하거나 자사 시험방법으로 설정하였으며, 결정형과 입자도에\n\n대한 규격도 포함하였다.  완제의약품의 제조공정에는 난용성 원료의약품의 습식 과립공정이 포\n\n함되므로 입자도와 결정형은 완제의약품에 중요한 요소로 작용한다.  이러한 입자도와 결정형이\n\n완제의약품에 어떠한 영향을 미치는 지에 대해서는 2.3.P.2.2.  개발경위에서 확인할 수 있다.\n\n 원료의약품의 규격 설정 예시 2)\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색, 결정형 가루\n\n육안검사\n\n적합\n\n확인시험\n\n**[표 시작]**\n\n| A: IR | A. IR: 표준품과 같음 | 0.65~0.85g/mL | USP <197M> | M-1236 | 적합 |\n| --- | --- | --- | --- | --- | --- |\n| 정제 생산량 | 225,420 | 231,000 | 93% | 였다.  이 공정을 선택한 사유는 크게 두 가지가 있다. ",
        "original_sentence": "이러한 입자도와 결정형이\n\n완제의약품에 어떠한 영향을 미치는 지에 대해서는 2.3.P.2.2. "
      }
    },
    {
      "chunk_id": "chunk_252",
      "text": "개발경위에서 확인할 수 있다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 251,
        "window_size": 3,
        "char_count": 18,
        "word_count": 4,
        "page_number": 12,
        "window_text": "각 시험\n\n방법은 USP 일반시험법을 참조하거나 자사 시험방법으로 설정하였으며, 결정형과 입자도에\n\n대한 규격도 포함하였다.  완제의약품의 제조공정에는 난용성 원료의약품의 습식 과립공정이 포\n\n함되므로 입자도와 결정형은 완제의약품에 중요한 요소로 작용한다.  이러한 입자도와 결정형이\n\n완제의약품에 어떠한 영향을 미치는 지에 대해서는 2.3.P.2.2.  개발경위에서 확인할 수 있다.\n\n 원료의약품의 규격 설정 예시 2)\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색, 결정형 가루\n\n육안검사\n\n적합\n\n확인시험\n\n**[표 시작]**\n\n| A: IR | A. IR: 표준품과 같음 | 0.65~0.85g/mL | USP <197M> | M-1236 | 적합 |\n| --- | --- | --- | --- | --- | --- |\n| 정제 생산량 | 225,420 | 231,000 | 93% | 였다.  이 공정을 선택한 사유는 크게 두 가지가 있다.  | Lot #9A | 40 ± 2℃ | 시험액의 온도 | 명칭 | 화학구조 | 기원 | 성분 | 규격 | 배합목적 | 질량/정 | 2. ",
        "original_sentence": "개발경위에서 확인할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_253",
      "text": "원료의약품의 규격 설정 예시 2)\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색, 결정형 가루\n\n육안검사\n\n적합\n\n확인시험\n\n**[표 시작]**\n\n| A: IR | A. IR: 표준품과 같음 | 0.65~0.85g/mL | USP <197M> | M-1236 | 적합 |\n| --- | --- | --- | --- | --- | --- |\n| 정제 생산량 | 225,420 | 231,000 | 93% | 였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 252,
        "window_size": 3,
        "char_count": 245,
        "word_count": 62,
        "page_number": 5,
        "window_text": "완제의약품의 제조공정에는 난용성 원료의약품의 습식 과립공정이 포\n\n함되므로 입자도와 결정형은 완제의약품에 중요한 요소로 작용한다.  이러한 입자도와 결정형이\n\n완제의약품에 어떠한 영향을 미치는 지에 대해서는 2.3.P.2.2.  개발경위에서 확인할 수 있다.\n\n 원료의약품의 규격 설정 예시 2)\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색, 결정형 가루\n\n육안검사\n\n적합\n\n확인시험\n\n**[표 시작]**\n\n| A: IR | A. IR: 표준품과 같음 | 0.65~0.85g/mL | USP <197M> | M-1236 | 적합 |\n| --- | --- | --- | --- | --- | --- |\n| 정제 생산량 | 225,420 | 231,000 | 93% | 였다.  이 공정을 선택한 사유는 크게 두 가지가 있다.  | Lot #9A | 40 ± 2℃ | 시험액의 온도 | 명칭 | 화학구조 | 기원 | 성분 | 규격 | 배합목적 | 질량/정 | 2.  UV: 표준품과 같은 파장에서 흡수극대 | 마손도   △~△%, | 자사 시험방법 #125b (HPLC, |\n| 공정수율 | PDA 검출기) | 적합 | 47.04kg(98%) |\n| 4 시간 | 48-53%, 평균 51% | 40-60% | 평균 용출율의 ±10% | 를 나타낸다. ",
        "original_sentence": "원료의약품의 규격 설정 예시 2)\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색, 결정형 가루\n\n육안검사\n\n적합\n\n확인시험\n\n**[표 시작]**\n\n| A: IR | A. IR: 표준품과 같음 | 0.65~0.85g/mL | USP <197M> | M-1236 | 적합 |\n| --- | --- | --- | --- | --- | --- |\n| 정제 생산량 | 225,420 | 231,000 | 93% | 였다. "
      }
    },
    {
      "chunk_id": "chunk_254",
      "text": "이 공정을 선택한 사유는 크게 두 가지가 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 253,
        "window_size": 3,
        "char_count": 27,
        "word_count": 8,
        "page_number": 3,
        "window_text": "이러한 입자도와 결정형이\n\n완제의약품에 어떠한 영향을 미치는 지에 대해서는 2.3.P.2.2.  개발경위에서 확인할 수 있다.\n\n 원료의약품의 규격 설정 예시 2)\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색, 결정형 가루\n\n육안검사\n\n적합\n\n확인시험\n\n**[표 시작]**\n\n| A: IR | A. IR: 표준품과 같음 | 0.65~0.85g/mL | USP <197M> | M-1236 | 적합 |\n| --- | --- | --- | --- | --- | --- |\n| 정제 생산량 | 225,420 | 231,000 | 93% | 였다.  이 공정을 선택한 사유는 크게 두 가지가 있다.  | Lot #9A | 40 ± 2℃ | 시험액의 온도 | 명칭 | 화학구조 | 기원 | 성분 | 규격 | 배합목적 | 질량/정 | 2.  UV: 표준품과 같은 파장에서 흡수극대 | 마손도   △~△%, | 자사 시험방법 #125b (HPLC, |\n| 공정수율 | PDA 검출기) | 적합 | 47.04kg(98%) |\n| 4 시간 | 48-53%, 평균 51% | 40-60% | 평균 용출율의 ±10% | 를 나타낸다.  | 유연물질 A: 0.70 | 96.0~100.5% |\n| B: UV | 해 설 | 0, 3, 6 개월 | 500 정 병포장 | Lot #10A | 스테아르산마그네슘을 넣어 2 분간 혼합한다. ",
        "original_sentence": "이 공정을 선택한 사유는 크게 두 가지가 있다. "
      }
    },
    {
      "chunk_id": "chunk_255",
      "text": "| Lot #9A | 40 ± 2℃ | 시험액의 온도 | 명칭 | 화학구조 | 기원 | 성분 | 규격 | 배합목적 | 질량/정 | 2. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 254,
        "window_size": 3,
        "char_count": 76,
        "word_count": 26,
        "page_number": 2,
        "window_text": "개발경위에서 확인할 수 있다.\n\n 원료의약품의 규격 설정 예시 2)\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색, 결정형 가루\n\n육안검사\n\n적합\n\n확인시험\n\n**[표 시작]**\n\n| A: IR | A. IR: 표준품과 같음 | 0.65~0.85g/mL | USP <197M> | M-1236 | 적합 |\n| --- | --- | --- | --- | --- | --- |\n| 정제 생산량 | 225,420 | 231,000 | 93% | 였다.  이 공정을 선택한 사유는 크게 두 가지가 있다.  | Lot #9A | 40 ± 2℃ | 시험액의 온도 | 명칭 | 화학구조 | 기원 | 성분 | 규격 | 배합목적 | 질량/정 | 2.  UV: 표준품과 같은 파장에서 흡수극대 | 마손도   △~△%, | 자사 시험방법 #125b (HPLC, |\n| 공정수율 | PDA 검출기) | 적합 | 47.04kg(98%) |\n| 4 시간 | 48-53%, 평균 51% | 40-60% | 평균 용출율의 ±10% | 를 나타낸다.  | 유연물질 A: 0.70 | 96.0~100.5% |\n| B: UV | 해 설 | 0, 3, 6 개월 | 500 정 병포장 | Lot #10A | 스테아르산마그네슘을 넣어 2 분간 혼합한다.  | B. UV: 표준품과 같음 | 붕해도   △분 이내가 되도록 | (제조단위) | USP <197U> | 적합 |\n| [원료의약품] | 주성분 | 장치 | 공정서 이외 기준 | 에스터기 가수분해 산물 | 유연물질 | 가능하게 하고자 함 |\n| 8 시간 | 73-78%, 평균 75% | 65-85% | 평균 용출율의 ±10% | 경도 | 유당 | 10 | N | 8~12Kp(기준 10Kp) |\n| 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인 | 시간 | 액을 5 번 주입했을 때 피크면적의 상대표준편차는 1.0% 이하이다. ",
        "original_sentence": "| Lot #9A | 40 ± 2℃ | 시험액의 온도 | 명칭 | 화학구조 | 기원 | 성분 | 규격 | 배합목적 | 질량/정 | 2. "
      }
    },
    {
      "chunk_id": "chunk_256",
      "text": "UV: 표준품과 같은 파장에서 흡수극대 | 마손도   △~△%, | 자사 시험방법 #125b (HPLC, |\n| 공정수율 | PDA 검출기) | 적합 | 47.04kg(98%) |\n| 4 시간 | 48-53%, 평균 51% | 40-60% | 평균 용출율의 ±10% | 를 나타낸다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 255,
        "window_size": 3,
        "char_count": 159,
        "word_count": 40,
        "page_number": 5,
        "window_text": "원료의약품의 규격 설정 예시 2)\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색, 결정형 가루\n\n육안검사\n\n적합\n\n확인시험\n\n**[표 시작]**\n\n| A: IR | A. IR: 표준품과 같음 | 0.65~0.85g/mL | USP <197M> | M-1236 | 적합 |\n| --- | --- | --- | --- | --- | --- |\n| 정제 생산량 | 225,420 | 231,000 | 93% | 였다.  이 공정을 선택한 사유는 크게 두 가지가 있다.  | Lot #9A | 40 ± 2℃ | 시험액의 온도 | 명칭 | 화학구조 | 기원 | 성분 | 규격 | 배합목적 | 질량/정 | 2.  UV: 표준품과 같은 파장에서 흡수극대 | 마손도   △~△%, | 자사 시험방법 #125b (HPLC, |\n| 공정수율 | PDA 검출기) | 적합 | 47.04kg(98%) |\n| 4 시간 | 48-53%, 평균 51% | 40-60% | 평균 용출율의 ±10% | 를 나타낸다.  | 유연물질 A: 0.70 | 96.0~100.5% |\n| B: UV | 해 설 | 0, 3, 6 개월 | 500 정 병포장 | Lot #10A | 스테아르산마그네슘을 넣어 2 분간 혼합한다.  | B. UV: 표준품과 같음 | 붕해도   △분 이내가 되도록 | (제조단위) | USP <197U> | 적합 |\n| [원료의약품] | 주성분 | 장치 | 공정서 이외 기준 | 에스터기 가수분해 산물 | 유연물질 | 가능하게 하고자 함 |\n| 8 시간 | 73-78%, 평균 75% | 65-85% | 평균 용출율의 ±10% | 경도 | 유당 | 10 | N | 8~12Kp(기준 10Kp) |\n| 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인 | 시간 | 액을 5 번 주입했을 때 피크면적의 상대표준편차는 1.0% 이하이다.  | 75 ± 5% RH | 유연물질 B: 0.89* | 용출율 % | 노즐의 기압이 증가되었음3 |\n| 경우에도 원료의약품과의 배합적합성을 확인하는 것이 바람직하다. ",
        "original_sentence": "UV: 표준품과 같은 파장에서 흡수극대 | 마손도   △~△%, | 자사 시험방법 #125b (HPLC, |\n| 공정수율 | PDA 검출기) | 적합 | 47.04kg(98%) |\n| 4 시간 | 48-53%, 평균 51% | 40-60% | 평균 용출율의 ±10% | 를 나타낸다. "
      }
    },
    {
      "chunk_id": "chunk_257",
      "text": "| 유연물질 A: 0.70 | 96.0~100.5% |\n| B: UV | 해 설 | 0, 3, 6 개월 | 500 정 병포장 | Lot #10A | 스테아르산마그네슘을 넣어 2 분간 혼합한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 256,
        "window_size": 3,
        "char_count": 108,
        "word_count": 31,
        "page_number": 5,
        "window_text": "이 공정을 선택한 사유는 크게 두 가지가 있다.  | Lot #9A | 40 ± 2℃ | 시험액의 온도 | 명칭 | 화학구조 | 기원 | 성분 | 규격 | 배합목적 | 질량/정 | 2.  UV: 표준품과 같은 파장에서 흡수극대 | 마손도   △~△%, | 자사 시험방법 #125b (HPLC, |\n| 공정수율 | PDA 검출기) | 적합 | 47.04kg(98%) |\n| 4 시간 | 48-53%, 평균 51% | 40-60% | 평균 용출율의 ±10% | 를 나타낸다.  | 유연물질 A: 0.70 | 96.0~100.5% |\n| B: UV | 해 설 | 0, 3, 6 개월 | 500 정 병포장 | Lot #10A | 스테아르산마그네슘을 넣어 2 분간 혼합한다.  | B. UV: 표준품과 같음 | 붕해도   △분 이내가 되도록 | (제조단위) | USP <197U> | 적합 |\n| [원료의약품] | 주성분 | 장치 | 공정서 이외 기준 | 에스터기 가수분해 산물 | 유연물질 | 가능하게 하고자 함 |\n| 8 시간 | 73-78%, 평균 75% | 65-85% | 평균 용출율의 ±10% | 경도 | 유당 | 10 | N | 8~12Kp(기준 10Kp) |\n| 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인 | 시간 | 액을 5 번 주입했을 때 피크면적의 상대표준편차는 1.0% 이하이다.  | 75 ± 5% RH | 유연물질 B: 0.89* | 용출율 % | 노즐의 기압이 증가되었음3 |\n| 경우에도 원료의약품과의 배합적합성을 확인하는 것이 바람직하다.  | 타정한다. ",
        "original_sentence": "| 유연물질 A: 0.70 | 96.0~100.5% |\n| B: UV | 해 설 | 0, 3, 6 개월 | 500 정 병포장 | Lot #10A | 스테아르산마그네슘을 넣어 2 분간 혼합한다. "
      }
    },
    {
      "chunk_id": "chunk_258",
      "text": "| B. UV: 표준품과 같음 | 붕해도   △분 이내가 되도록 | (제조단위) | USP <197U> | 적합 |\n| [원료의약품] | 주성분 | 장치 | 공정서 이외 기준 | 에스터기 가수분해 산물 | 유연물질 | 가능하게 하고자 함 |\n| 8 시간 | 73-78%, 평균 75% | 65-85% | 평균 용출율의 ±10% | 경도 | 유당 | 10 | N | 8~12Kp(기준 10Kp) |\n| 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인 | 시간 | 액을 5 번 주입했을 때 피크면적의 상대표준편차는 1.0% 이하이다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 257,
        "window_size": 3,
        "char_count": 306,
        "word_count": 85,
        "page_number": 3,
        "window_text": "| Lot #9A | 40 ± 2℃ | 시험액의 온도 | 명칭 | 화학구조 | 기원 | 성분 | 규격 | 배합목적 | 질량/정 | 2.  UV: 표준품과 같은 파장에서 흡수극대 | 마손도   △~△%, | 자사 시험방법 #125b (HPLC, |\n| 공정수율 | PDA 검출기) | 적합 | 47.04kg(98%) |\n| 4 시간 | 48-53%, 평균 51% | 40-60% | 평균 용출율의 ±10% | 를 나타낸다.  | 유연물질 A: 0.70 | 96.0~100.5% |\n| B: UV | 해 설 | 0, 3, 6 개월 | 500 정 병포장 | Lot #10A | 스테아르산마그네슘을 넣어 2 분간 혼합한다.  | B. UV: 표준품과 같음 | 붕해도   △분 이내가 되도록 | (제조단위) | USP <197U> | 적합 |\n| [원료의약품] | 주성분 | 장치 | 공정서 이외 기준 | 에스터기 가수분해 산물 | 유연물질 | 가능하게 하고자 함 |\n| 8 시간 | 73-78%, 평균 75% | 65-85% | 평균 용출율의 ±10% | 경도 | 유당 | 10 | N | 8~12Kp(기준 10Kp) |\n| 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인 | 시간 | 액을 5 번 주입했을 때 피크면적의 상대표준편차는 1.0% 이하이다.  | 75 ± 5% RH | 유연물질 B: 0.89* | 용출율 % | 노즐의 기압이 증가되었음3 |\n| 경우에도 원료의약품과의 배합적합성을 확인하는 것이 바람직하다.  | 타정한다.  |\n\n**[표 끝]**\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색의 결정형 가루\n\n육안검사\n\n적합\n\n- - 9 -\n위 규격은 원료의약품의 중요한 특성을 포함하나, 결정형 또는 입자도 등 고체 상태와 관련된\n\n물리적 성질에 대한 규격은 포함되어 있지 않다. ",
        "original_sentence": "| B. UV: 표준품과 같음 | 붕해도   △분 이내가 되도록 | (제조단위) | USP <197U> | 적합 |\n| [원료의약품] | 주성분 | 장치 | 공정서 이외 기준 | 에스터기 가수분해 산물 | 유연물질 | 가능하게 하고자 함 |\n| 8 시간 | 73-78%, 평균 75% | 65-85% | 평균 용출율의 ±10% | 경도 | 유당 | 10 | N | 8~12Kp(기준 10Kp) |\n| 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인 | 시간 | 액을 5 번 주입했을 때 피크면적의 상대표준편차는 1.0% 이하이다. "
      }
    },
    {
      "chunk_id": "chunk_259",
      "text": "| 75 ± 5% RH | 유연물질 B: 0.89* | 용출율 % | 노즐의 기압이 증가되었음3 |\n| 경우에도 원료의약품과의 배합적합성을 확인하는 것이 바람직하다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 258,
        "window_size": 3,
        "char_count": 93,
        "word_count": 24,
        "page_number": 3,
        "window_text": "UV: 표준품과 같은 파장에서 흡수극대 | 마손도   △~△%, | 자사 시험방법 #125b (HPLC, |\n| 공정수율 | PDA 검출기) | 적합 | 47.04kg(98%) |\n| 4 시간 | 48-53%, 평균 51% | 40-60% | 평균 용출율의 ±10% | 를 나타낸다.  | 유연물질 A: 0.70 | 96.0~100.5% |\n| B: UV | 해 설 | 0, 3, 6 개월 | 500 정 병포장 | Lot #10A | 스테아르산마그네슘을 넣어 2 분간 혼합한다.  | B. UV: 표준품과 같음 | 붕해도   △분 이내가 되도록 | (제조단위) | USP <197U> | 적합 |\n| [원료의약품] | 주성분 | 장치 | 공정서 이외 기준 | 에스터기 가수분해 산물 | 유연물질 | 가능하게 하고자 함 |\n| 8 시간 | 73-78%, 평균 75% | 65-85% | 평균 용출율의 ±10% | 경도 | 유당 | 10 | N | 8~12Kp(기준 10Kp) |\n| 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인 | 시간 | 액을 5 번 주입했을 때 피크면적의 상대표준편차는 1.0% 이하이다.  | 75 ± 5% RH | 유연물질 B: 0.89* | 용출율 % | 노즐의 기압이 증가되었음3 |\n| 경우에도 원료의약품과의 배합적합성을 확인하는 것이 바람직하다.  | 타정한다.  |\n\n**[표 끝]**\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색의 결정형 가루\n\n육안검사\n\n적합\n\n- - 9 -\n위 규격은 원료의약품의 중요한 특성을 포함하나, 결정형 또는 입자도 등 고체 상태와 관련된\n\n물리적 성질에 대한 규격은 포함되어 있지 않다.  완제의약품 제조공정 중 구형 백당에 주성분이\n\n완전히 녹는 공정이 있으므로 위 특성이 완제의약품 품질에 미치는 영향이 적을 것으로 판단하\n\n였기 때문이다.\n\n",
        "original_sentence": "| 75 ± 5% RH | 유연물질 B: 0.89* | 용출율 % | 노즐의 기압이 증가되었음3 |\n| 경우에도 원료의약품과의 배합적합성을 확인하는 것이 바람직하다. "
      }
    },
    {
      "chunk_id": "chunk_260",
      "text": "| 타정한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 259,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 13,
        "window_text": "| 유연물질 A: 0.70 | 96.0~100.5% |\n| B: UV | 해 설 | 0, 3, 6 개월 | 500 정 병포장 | Lot #10A | 스테아르산마그네슘을 넣어 2 분간 혼합한다.  | B. UV: 표준품과 같음 | 붕해도   △분 이내가 되도록 | (제조단위) | USP <197U> | 적합 |\n| [원료의약품] | 주성분 | 장치 | 공정서 이외 기준 | 에스터기 가수분해 산물 | 유연물질 | 가능하게 하고자 함 |\n| 8 시간 | 73-78%, 평균 75% | 65-85% | 평균 용출율의 ±10% | 경도 | 유당 | 10 | N | 8~12Kp(기준 10Kp) |\n| 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인 | 시간 | 액을 5 번 주입했을 때 피크면적의 상대표준편차는 1.0% 이하이다.  | 75 ± 5% RH | 유연물질 B: 0.89* | 용출율 % | 노즐의 기압이 증가되었음3 |\n| 경우에도 원료의약품과의 배합적합성을 확인하는 것이 바람직하다.  | 타정한다.  |\n\n**[표 끝]**\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색의 결정형 가루\n\n육안검사\n\n적합\n\n- - 9 -\n위 규격은 원료의약품의 중요한 특성을 포함하나, 결정형 또는 입자도 등 고체 상태와 관련된\n\n물리적 성질에 대한 규격은 포함되어 있지 않다.  완제의약품 제조공정 중 구형 백당에 주성분이\n\n완전히 녹는 공정이 있으므로 위 특성이 완제의약품 품질에 미치는 영향이 적을 것으로 판단하\n\n였기 때문이다.\n\n <!-- PAGE_15 -->\n##### 2.3.S.5. ",
        "original_sentence": "| 타정한다. "
      }
    },
    {
      "chunk_id": "chunk_261",
      "text": "|\n\n**[표 끝]**\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색의 결정형 가루\n\n육안검사\n\n적합\n\n- - 9 -\n위 규격은 원료의약품의 중요한 특성을 포함하나, 결정형 또는 입자도 등 고체 상태와 관련된\n\n물리적 성질에 대한 규격은 포함되어 있지 않다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 260,
        "window_size": 3,
        "char_count": 159,
        "word_count": 39,
        "page_number": 14,
        "window_text": "| B. UV: 표준품과 같음 | 붕해도   △분 이내가 되도록 | (제조단위) | USP <197U> | 적합 |\n| [원료의약품] | 주성분 | 장치 | 공정서 이외 기준 | 에스터기 가수분해 산물 | 유연물질 | 가능하게 하고자 함 |\n| 8 시간 | 73-78%, 평균 75% | 65-85% | 평균 용출율의 ±10% | 경도 | 유당 | 10 | N | 8~12Kp(기준 10Kp) |\n| 성상 | 한쪽에는 “ABCD\", 다른 쪽에는 \"DEF2\"가 각인 | 시간 | 액을 5 번 주입했을 때 피크면적의 상대표준편차는 1.0% 이하이다.  | 75 ± 5% RH | 유연물질 B: 0.89* | 용출율 % | 노즐의 기압이 증가되었음3 |\n| 경우에도 원료의약품과의 배합적합성을 확인하는 것이 바람직하다.  | 타정한다.  |\n\n**[표 끝]**\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색의 결정형 가루\n\n육안검사\n\n적합\n\n- - 9 -\n위 규격은 원료의약품의 중요한 특성을 포함하나, 결정형 또는 입자도 등 고체 상태와 관련된\n\n물리적 성질에 대한 규격은 포함되어 있지 않다.  완제의약품 제조공정 중 구형 백당에 주성분이\n\n완전히 녹는 공정이 있으므로 위 특성이 완제의약품 품질에 미치는 영향이 적을 것으로 판단하\n\n였기 때문이다.\n\n <!-- PAGE_15 -->\n##### 2.3.S.5.  표준품 또는 표준물질(제품명, 제조자)(Reference Standards or Materials)\n\n<!-- PAGE_15 -->\n##### (name, manufacturer)\n\n- 3.2.S.5에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n",
        "original_sentence": "|\n\n**[표 끝]**\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색의 결정형 가루\n\n육안검사\n\n적합\n\n- - 9 -\n위 규격은 원료의약품의 중요한 특성을 포함하나, 결정형 또는 입자도 등 고체 상태와 관련된\n\n물리적 성질에 대한 규격은 포함되어 있지 않다. "
      }
    },
    {
      "chunk_id": "chunk_262",
      "text": "완제의약품 제조공정 중 구형 백당에 주성분이\n\n완전히 녹는 공정이 있으므로 위 특성이 완제의약품 품질에 미치는 영향이 적을 것으로 판단하\n\n였기 때문이다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 261,
        "window_size": 3,
        "char_count": 88,
        "word_count": 21,
        "page_number": 3,
        "window_text": "| 75 ± 5% RH | 유연물질 B: 0.89* | 용출율 % | 노즐의 기압이 증가되었음3 |\n| 경우에도 원료의약품과의 배합적합성을 확인하는 것이 바람직하다.  | 타정한다.  |\n\n**[표 끝]**\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색의 결정형 가루\n\n육안검사\n\n적합\n\n- - 9 -\n위 규격은 원료의약품의 중요한 특성을 포함하나, 결정형 또는 입자도 등 고체 상태와 관련된\n\n물리적 성질에 대한 규격은 포함되어 있지 않다.  완제의약품 제조공정 중 구형 백당에 주성분이\n\n완전히 녹는 공정이 있으므로 위 특성이 완제의약품 품질에 미치는 영향이 적을 것으로 판단하\n\n였기 때문이다.\n\n <!-- PAGE_15 -->\n##### 2.3.S.5.  표준품 또는 표준물질(제품명, 제조자)(Reference Standards or Materials)\n\n<!-- PAGE_15 -->\n##### (name, manufacturer)\n\n- 3.2.S.5에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n <!-- PAGE_15 -->\n##### 해 설\n\n**[표 시작]**\n\n| 확인시험 | A. IR: 표준품과 같은 스펙트럼 | IR, USP <197K> | 적합 |\n| --- | --- | --- | --- |\n| 60 ± 5% RH | 90.0~110.0% | 개별질량 △~△mg | M-1235 |\n| 분석시간 | 37 분 | 혼합균일성 | 간은 표준품의 피크와 같다. ",
        "original_sentence": "완제의약품 제조공정 중 구형 백당에 주성분이\n\n완전히 녹는 공정이 있으므로 위 특성이 완제의약품 품질에 미치는 영향이 적을 것으로 판단하\n\n였기 때문이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_263",
      "text": "<!-- PAGE_15 -->\n##### 2.3.S.5. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 262,
        "window_size": 3,
        "char_count": 32,
        "word_count": 5,
        "page_number": 15,
        "window_text": "| 타정한다.  |\n\n**[표 끝]**\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색의 결정형 가루\n\n육안검사\n\n적합\n\n- - 9 -\n위 규격은 원료의약품의 중요한 특성을 포함하나, 결정형 또는 입자도 등 고체 상태와 관련된\n\n물리적 성질에 대한 규격은 포함되어 있지 않다.  완제의약품 제조공정 중 구형 백당에 주성분이\n\n완전히 녹는 공정이 있으므로 위 특성이 완제의약품 품질에 미치는 영향이 적을 것으로 판단하\n\n였기 때문이다.\n\n <!-- PAGE_15 -->\n##### 2.3.S.5.  표준품 또는 표준물질(제품명, 제조자)(Reference Standards or Materials)\n\n<!-- PAGE_15 -->\n##### (name, manufacturer)\n\n- 3.2.S.5에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n <!-- PAGE_15 -->\n##### 해 설\n\n**[표 시작]**\n\n| 확인시험 | A. IR: 표준품과 같은 스펙트럼 | IR, USP <197K> | 적합 |\n| --- | --- | --- | --- |\n| 60 ± 5% RH | 90.0~110.0% | 개별질량 △~△mg | M-1235 |\n| 분석시간 | 37 분 | 혼합균일성 | 간은 표준품의 피크와 같다.  | 자사 시험방법 #125b (HPLC) | 적합 | RSD 2.0% |\n| Lot #11A | 정관리 요약은 2.3.P.3 제조를 참조한다. ",
        "original_sentence": "<!-- PAGE_15 -->\n##### 2.3.S.5. "
      }
    },
    {
      "chunk_id": "chunk_264",
      "text": "표준품 또는 표준물질(제품명, 제조자)(Reference Standards or Materials)\n\n<!-- PAGE_15 -->\n##### (name, manufacturer)\n\n- 3.2.S.5에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 263,
        "window_size": 3,
        "char_count": 139,
        "word_count": 20,
        "page_number": 15,
        "window_text": "|\n\n**[표 끝]**\n\n시험항목\n\n허용 기준\n\n시험 방법\n\n시험결과(제조번호)\n\n성상\n\n흰색의 결정형 가루\n\n육안검사\n\n적합\n\n- - 9 -\n위 규격은 원료의약품의 중요한 특성을 포함하나, 결정형 또는 입자도 등 고체 상태와 관련된\n\n물리적 성질에 대한 규격은 포함되어 있지 않다.  완제의약품 제조공정 중 구형 백당에 주성분이\n\n완전히 녹는 공정이 있으므로 위 특성이 완제의약품 품질에 미치는 영향이 적을 것으로 판단하\n\n였기 때문이다.\n\n <!-- PAGE_15 -->\n##### 2.3.S.5.  표준품 또는 표준물질(제품명, 제조자)(Reference Standards or Materials)\n\n<!-- PAGE_15 -->\n##### (name, manufacturer)\n\n- 3.2.S.5에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n <!-- PAGE_15 -->\n##### 해 설\n\n**[표 시작]**\n\n| 확인시험 | A. IR: 표준품과 같은 스펙트럼 | IR, USP <197K> | 적합 |\n| --- | --- | --- | --- |\n| 60 ± 5% RH | 90.0~110.0% | 개별질량 △~△mg | M-1235 |\n| 분석시간 | 37 분 | 혼합균일성 | 간은 표준품의 피크와 같다.  | 자사 시험방법 #125b (HPLC) | 적합 | RSD 2.0% |\n| Lot #11A | 정관리 요약은 2.3.P.3 제조를 참조한다.  | 산출량 | 46.70kg(97.3%) | 48kg(100%) | 96% | 시험액의 양 | 선형 스케일업 |\n| 캡슐 | B. ",
        "original_sentence": "표준품 또는 표준물질(제품명, 제조자)(Reference Standards or Materials)\n\n<!-- PAGE_15 -->\n##### (name, manufacturer)\n\n- 3.2.S.5에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n"
      }
    },
    {
      "chunk_id": "chunk_265",
      "text": "<!-- PAGE_15 -->\n##### 해 설\n\n**[표 시작]**\n\n| 확인시험 | A. IR: 표준품과 같은 스펙트럼 | IR, USP <197K> | 적합 |\n| --- | --- | --- | --- |\n| 60 ± 5% RH | 90.0~110.0% | 개별질량 △~△mg | M-1235 |\n| 분석시간 | 37 분 | 혼합균일성 | 간은 표준품의 피크와 같다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 264,
        "window_size": 3,
        "char_count": 210,
        "word_count": 57,
        "page_number": 15,
        "window_text": "완제의약품 제조공정 중 구형 백당에 주성분이\n\n완전히 녹는 공정이 있으므로 위 특성이 완제의약품 품질에 미치는 영향이 적을 것으로 판단하\n\n였기 때문이다.\n\n <!-- PAGE_15 -->\n##### 2.3.S.5.  표준품 또는 표준물질(제품명, 제조자)(Reference Standards or Materials)\n\n<!-- PAGE_15 -->\n##### (name, manufacturer)\n\n- 3.2.S.5에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n <!-- PAGE_15 -->\n##### 해 설\n\n**[표 시작]**\n\n| 확인시험 | A. IR: 표준품과 같은 스펙트럼 | IR, USP <197K> | 적합 |\n| --- | --- | --- | --- |\n| 60 ± 5% RH | 90.0~110.0% | 개별질량 △~△mg | M-1235 |\n| 분석시간 | 37 분 | 혼합균일성 | 간은 표준품의 피크와 같다.  | 자사 시험방법 #125b (HPLC) | 적합 | RSD 2.0% |\n| Lot #11A | 정관리 요약은 2.3.P.3 제조를 참조한다.  | 산출량 | 46.70kg(97.3%) | 48kg(100%) | 96% | 시험액의 양 | 선형 스케일업 |\n| 캡슐 | B.  염화물 시험 | RSD 5.0% 이하 | 경도     △~△kp, | Chloride, USP <191> | 적합 |\n| 영향이 적을 것으로 판단된다. ",
        "original_sentence": "<!-- PAGE_15 -->\n##### 해 설\n\n**[표 시작]**\n\n| 확인시험 | A. IR: 표준품과 같은 스펙트럼 | IR, USP <197K> | 적합 |\n| --- | --- | --- | --- |\n| 60 ± 5% RH | 90.0~110.0% | 개별질량 △~△mg | M-1235 |\n| 분석시간 | 37 분 | 혼합균일성 | 간은 표준품의 피크와 같다. "
      }
    },
    {
      "chunk_id": "chunk_266",
      "text": "| 자사 시험방법 #125b (HPLC) | 적합 | RSD 2.0% |\n| Lot #11A | 정관리 요약은 2.3.P.3 제조를 참조한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 265,
        "window_size": 3,
        "char_count": 80,
        "word_count": 20,
        "page_number": 5,
        "window_text": "<!-- PAGE_15 -->\n##### 2.3.S.5.  표준품 또는 표준물질(제품명, 제조자)(Reference Standards or Materials)\n\n<!-- PAGE_15 -->\n##### (name, manufacturer)\n\n- 3.2.S.5에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n <!-- PAGE_15 -->\n##### 해 설\n\n**[표 시작]**\n\n| 확인시험 | A. IR: 표준품과 같은 스펙트럼 | IR, USP <197K> | 적합 |\n| --- | --- | --- | --- |\n| 60 ± 5% RH | 90.0~110.0% | 개별질량 △~△mg | M-1235 |\n| 분석시간 | 37 분 | 혼합균일성 | 간은 표준품의 피크와 같다.  | 자사 시험방법 #125b (HPLC) | 적합 | RSD 2.0% |\n| Lot #11A | 정관리 요약은 2.3.P.3 제조를 참조한다.  | 산출량 | 46.70kg(97.3%) | 48kg(100%) | 96% | 시험액의 양 | 선형 스케일업 |\n| 캡슐 | B.  염화물 시험 | RSD 5.0% 이하 | 경도     △~△kp, | Chloride, USP <191> | 적합 |\n| 영향이 적을 것으로 판단된다.  | 탭밀도 | 유연물질 E: 0.49 | 0.73g/mL |\n\n**[표 끝]**\n\n중금속\n\n20 ppm 이하\n\nUSP <231> 2법\n\n20 ppm 이하\n\n- - 10 -\n- ○ 3.2.S.5 표준품 또는 표준물질에 설명된 원료의약품을 시험하는데 필요한 표준품 또는 표준\n물질에 대하여 요약하여 기재한다.\n\n",
        "original_sentence": "| 자사 시험방법 #125b (HPLC) | 적합 | RSD 2.0% |\n| Lot #11A | 정관리 요약은 2.3.P.3 제조를 참조한다. "
      }
    },
    {
      "chunk_id": "chunk_267",
      "text": "| 산출량 | 46.70kg(97.3%) | 48kg(100%) | 96% | 시험액의 양 | 선형 스케일업 |\n| 캡슐 | B. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 266,
        "window_size": 3,
        "char_count": 73,
        "word_count": 19,
        "page_number": 5,
        "window_text": "표준품 또는 표준물질(제품명, 제조자)(Reference Standards or Materials)\n\n<!-- PAGE_15 -->\n##### (name, manufacturer)\n\n- 3.2.S.5에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n <!-- PAGE_15 -->\n##### 해 설\n\n**[표 시작]**\n\n| 확인시험 | A. IR: 표준품과 같은 스펙트럼 | IR, USP <197K> | 적합 |\n| --- | --- | --- | --- |\n| 60 ± 5% RH | 90.0~110.0% | 개별질량 △~△mg | M-1235 |\n| 분석시간 | 37 분 | 혼합균일성 | 간은 표준품의 피크와 같다.  | 자사 시험방법 #125b (HPLC) | 적합 | RSD 2.0% |\n| Lot #11A | 정관리 요약은 2.3.P.3 제조를 참조한다.  | 산출량 | 46.70kg(97.3%) | 48kg(100%) | 96% | 시험액의 양 | 선형 스케일업 |\n| 캡슐 | B.  염화물 시험 | RSD 5.0% 이하 | 경도     △~△kp, | Chloride, USP <191> | 적합 |\n| 영향이 적을 것으로 판단된다.  | 탭밀도 | 유연물질 E: 0.49 | 0.73g/mL |\n\n**[표 끝]**\n\n중금속\n\n20 ppm 이하\n\nUSP <231> 2법\n\n20 ppm 이하\n\n- - 10 -\n- ○ 3.2.S.5 표준품 또는 표준물질에 설명된 원료의약품을 시험하는데 필요한 표준품 또는 표준\n물질에 대하여 요약하여 기재한다.\n\n - ○ 표준품에 대한 사항은 제2부에는 요약하여 기재하고 제3부에 시험성적서, 제조, 적합성 및 특성\n등에 대한 세부사항을 기재한다.\n\n",
        "original_sentence": "| 산출량 | 46.70kg(97.3%) | 48kg(100%) | 96% | 시험액의 양 | 선형 스케일업 |\n| 캡슐 | B. "
      }
    },
    {
      "chunk_id": "chunk_268",
      "text": "염화물 시험 | RSD 5.0% 이하 | 경도     △~△kp, | Chloride, USP <191> | 적합 |\n| 영향이 적을 것으로 판단된다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 267,
        "window_size": 3,
        "char_count": 85,
        "word_count": 21,
        "page_number": 3,
        "window_text": "<!-- PAGE_15 -->\n##### 해 설\n\n**[표 시작]**\n\n| 확인시험 | A. IR: 표준품과 같은 스펙트럼 | IR, USP <197K> | 적합 |\n| --- | --- | --- | --- |\n| 60 ± 5% RH | 90.0~110.0% | 개별질량 △~△mg | M-1235 |\n| 분석시간 | 37 분 | 혼합균일성 | 간은 표준품의 피크와 같다.  | 자사 시험방법 #125b (HPLC) | 적합 | RSD 2.0% |\n| Lot #11A | 정관리 요약은 2.3.P.3 제조를 참조한다.  | 산출량 | 46.70kg(97.3%) | 48kg(100%) | 96% | 시험액의 양 | 선형 스케일업 |\n| 캡슐 | B.  염화물 시험 | RSD 5.0% 이하 | 경도     △~△kp, | Chloride, USP <191> | 적합 |\n| 영향이 적을 것으로 판단된다.  | 탭밀도 | 유연물질 E: 0.49 | 0.73g/mL |\n\n**[표 끝]**\n\n중금속\n\n20 ppm 이하\n\nUSP <231> 2법\n\n20 ppm 이하\n\n- - 10 -\n- ○ 3.2.S.5 표준품 또는 표준물질에 설명된 원료의약품을 시험하는데 필요한 표준품 또는 표준\n물질에 대하여 요약하여 기재한다.\n\n - ○ 표준품에 대한 사항은 제2부에는 요약하여 기재하고 제3부에 시험성적서, 제조, 적합성 및 특성\n등에 대한 세부사항을 기재한다.\n\n - - 표준품은 필요 시 추가적인 재결정 등을 통하여 가능한 순도를 높이고, 원료의약품 시험성적\n서에 전형적으로 보고되는 확인시험 이외에 NMR을 통한 구조 증명과 같이 추가적인 시험을\n\n통하여 그 특징을 설명해야 한다. ",
        "original_sentence": "염화물 시험 | RSD 5.0% 이하 | 경도     △~△kp, | Chloride, USP <191> | 적합 |\n| 영향이 적을 것으로 판단된다. "
      }
    },
    {
      "chunk_id": "chunk_269",
      "text": "| 탭밀도 | 유연물질 E: 0.49 | 0.73g/mL |\n\n**[표 끝]**\n\n중금속\n\n20 ppm 이하\n\nUSP <231> 2법\n\n20 ppm 이하\n\n- - 10 -\n- ○ 3.2.S.5 표준품 또는 표준물질에 설명된 원료의약품을 시험하는데 필요한 표준품 또는 표준\n물질에 대하여 요약하여 기재한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 268,
        "window_size": 3,
        "char_count": 172,
        "word_count": 42,
        "page_number": 14,
        "window_text": "| 자사 시험방법 #125b (HPLC) | 적합 | RSD 2.0% |\n| Lot #11A | 정관리 요약은 2.3.P.3 제조를 참조한다.  | 산출량 | 46.70kg(97.3%) | 48kg(100%) | 96% | 시험액의 양 | 선형 스케일업 |\n| 캡슐 | B.  염화물 시험 | RSD 5.0% 이하 | 경도     △~△kp, | Chloride, USP <191> | 적합 |\n| 영향이 적을 것으로 판단된다.  | 탭밀도 | 유연물질 E: 0.49 | 0.73g/mL |\n\n**[표 끝]**\n\n중금속\n\n20 ppm 이하\n\nUSP <231> 2법\n\n20 ppm 이하\n\n- - 10 -\n- ○ 3.2.S.5 표준품 또는 표준물질에 설명된 원료의약품을 시험하는데 필요한 표준품 또는 표준\n물질에 대하여 요약하여 기재한다.\n\n - ○ 표준품에 대한 사항은 제2부에는 요약하여 기재하고 제3부에 시험성적서, 제조, 적합성 및 특성\n등에 대한 세부사항을 기재한다.\n\n - - 표준품은 필요 시 추가적인 재결정 등을 통하여 가능한 순도를 높이고, 원료의약품 시험성적\n서에 전형적으로 보고되는 확인시험 이외에 NMR을 통한 구조 증명과 같이 추가적인 시험을\n\n통하여 그 특징을 설명해야 한다.  표준품은 물리적인 수치가 일정해지거나 문헌상 순물질의\n\n- ○ 아래 표와 같이 요약할 수 있다.\n",
        "original_sentence": "| 탭밀도 | 유연물질 E: 0.49 | 0.73g/mL |\n\n**[표 끝]**\n\n중금속\n\n20 ppm 이하\n\nUSP <231> 2법\n\n20 ppm 이하\n\n- - 10 -\n- ○ 3.2.S.5 표준품 또는 표준물질에 설명된 원료의약품을 시험하는데 필요한 표준품 또는 표준\n물질에 대하여 요약하여 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_270",
      "text": "- ○ 표준품에 대한 사항은 제2부에는 요약하여 기재하고 제3부에 시험성적서, 제조, 적합성 및 특성\n등에 대한 세부사항을 기재한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 269,
        "window_size": 3,
        "char_count": 76,
        "word_count": 18,
        "page_number": 2,
        "window_text": "| 산출량 | 46.70kg(97.3%) | 48kg(100%) | 96% | 시험액의 양 | 선형 스케일업 |\n| 캡슐 | B.  염화물 시험 | RSD 5.0% 이하 | 경도     △~△kp, | Chloride, USP <191> | 적합 |\n| 영향이 적을 것으로 판단된다.  | 탭밀도 | 유연물질 E: 0.49 | 0.73g/mL |\n\n**[표 끝]**\n\n중금속\n\n20 ppm 이하\n\nUSP <231> 2법\n\n20 ppm 이하\n\n- - 10 -\n- ○ 3.2.S.5 표준품 또는 표준물질에 설명된 원료의약품을 시험하는데 필요한 표준품 또는 표준\n물질에 대하여 요약하여 기재한다.\n\n - ○ 표준품에 대한 사항은 제2부에는 요약하여 기재하고 제3부에 시험성적서, 제조, 적합성 및 특성\n등에 대한 세부사항을 기재한다.\n\n - - 표준품은 필요 시 추가적인 재결정 등을 통하여 가능한 순도를 높이고, 원료의약품 시험성적\n서에 전형적으로 보고되는 확인시험 이외에 NMR을 통한 구조 증명과 같이 추가적인 시험을\n\n통하여 그 특징을 설명해야 한다.  표준품은 물리적인 수치가 일정해지거나 문헌상 순물질의\n\n- ○ 아래 표와 같이 요약할 수 있다.\n - - 표준품을 합성하는 경우 해당 제조방법에 대한 요약 기재가 필요할 수 있다.\n",
        "original_sentence": "- ○ 표준품에 대한 사항은 제2부에는 요약하여 기재하고 제3부에 시험성적서, 제조, 적합성 및 특성\n등에 대한 세부사항을 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_271",
      "text": "- - 표준품은 필요 시 추가적인 재결정 등을 통하여 가능한 순도를 높이고, 원료의약품 시험성적\n서에 전형적으로 보고되는 확인시험 이외에 NMR을 통한 구조 증명과 같이 추가적인 시험을\n\n통하여 그 특징을 설명해야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 270,
        "window_size": 3,
        "char_count": 124,
        "word_count": 31,
        "page_number": 3,
        "window_text": "염화물 시험 | RSD 5.0% 이하 | 경도     △~△kp, | Chloride, USP <191> | 적합 |\n| 영향이 적을 것으로 판단된다.  | 탭밀도 | 유연물질 E: 0.49 | 0.73g/mL |\n\n**[표 끝]**\n\n중금속\n\n20 ppm 이하\n\nUSP <231> 2법\n\n20 ppm 이하\n\n- - 10 -\n- ○ 3.2.S.5 표준품 또는 표준물질에 설명된 원료의약품을 시험하는데 필요한 표준품 또는 표준\n물질에 대하여 요약하여 기재한다.\n\n - ○ 표준품에 대한 사항은 제2부에는 요약하여 기재하고 제3부에 시험성적서, 제조, 적합성 및 특성\n등에 대한 세부사항을 기재한다.\n\n - - 표준품은 필요 시 추가적인 재결정 등을 통하여 가능한 순도를 높이고, 원료의약품 시험성적\n서에 전형적으로 보고되는 확인시험 이외에 NMR을 통한 구조 증명과 같이 추가적인 시험을\n\n통하여 그 특징을 설명해야 한다.  표준품은 물리적인 수치가 일정해지거나 문헌상 순물질의\n\n- ○ 아래 표와 같이 요약할 수 있다.\n - - 표준품을 합성하는 경우 해당 제조방법에 대한 요약 기재가 필요할 수 있다.\n 예시 1)\n\n- - 허가제출용 뱃치 제조에 사용된 원료의약품(제조번호 # 15531)의 시험에는 상용표준품이\n사용되었는데 이 표준품은 USP 표준품(제조번호 # H)으로 성적서를 통해 그 품질을 확인\n\n예시 2)\n\n- - 원료의약품의 1차 표준품(제조번호 # 3)은 주성분 제조업자로부터 구매하였다. ",
        "original_sentence": "- - 표준품은 필요 시 추가적인 재결정 등을 통하여 가능한 순도를 높이고, 원료의약품 시험성적\n서에 전형적으로 보고되는 확인시험 이외에 NMR을 통한 구조 증명과 같이 추가적인 시험을\n\n통하여 그 특징을 설명해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_272",
      "text": "표준품은 물리적인 수치가 일정해지거나 문헌상 순물질의\n\n- ○ 아래 표와 같이 요약할 수 있다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 271,
        "window_size": 3,
        "char_count": 54,
        "word_count": 14,
        "page_number": 3,
        "window_text": "| 탭밀도 | 유연물질 E: 0.49 | 0.73g/mL |\n\n**[표 끝]**\n\n중금속\n\n20 ppm 이하\n\nUSP <231> 2법\n\n20 ppm 이하\n\n- - 10 -\n- ○ 3.2.S.5 표준품 또는 표준물질에 설명된 원료의약품을 시험하는데 필요한 표준품 또는 표준\n물질에 대하여 요약하여 기재한다.\n\n - ○ 표준품에 대한 사항은 제2부에는 요약하여 기재하고 제3부에 시험성적서, 제조, 적합성 및 특성\n등에 대한 세부사항을 기재한다.\n\n - - 표준품은 필요 시 추가적인 재결정 등을 통하여 가능한 순도를 높이고, 원료의약품 시험성적\n서에 전형적으로 보고되는 확인시험 이외에 NMR을 통한 구조 증명과 같이 추가적인 시험을\n\n통하여 그 특징을 설명해야 한다.  표준품은 물리적인 수치가 일정해지거나 문헌상 순물질의\n\n- ○ 아래 표와 같이 요약할 수 있다.\n - - 표준품을 합성하는 경우 해당 제조방법에 대한 요약 기재가 필요할 수 있다.\n 예시 1)\n\n- - 허가제출용 뱃치 제조에 사용된 원료의약품(제조번호 # 15531)의 시험에는 상용표준품이\n사용되었는데 이 표준품은 USP 표준품(제조번호 # H)으로 성적서를 통해 그 품질을 확인\n\n예시 2)\n\n- - 원료의약품의 1차 표준품(제조번호 # 3)은 주성분 제조업자로부터 구매하였다.  이 표준품은\n합성 공정을 통해 제조되었고, 자사에서 2 회의 추가 재결정을 통해 순도를 높여 순도 99.9\n\n%의 표준품을 얻었다.\n\n",
        "original_sentence": "표준품은 물리적인 수치가 일정해지거나 문헌상 순물질의\n\n- ○ 아래 표와 같이 요약할 수 있다.\n"
      }
    },
    {
      "chunk_id": "chunk_273",
      "text": "- - 표준품을 합성하는 경우 해당 제조방법에 대한 요약 기재가 필요할 수 있다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 272,
        "window_size": 3,
        "char_count": 46,
        "word_count": 13,
        "page_number": 5,
        "window_text": "- ○ 표준품에 대한 사항은 제2부에는 요약하여 기재하고 제3부에 시험성적서, 제조, 적합성 및 특성\n등에 대한 세부사항을 기재한다.\n\n - - 표준품은 필요 시 추가적인 재결정 등을 통하여 가능한 순도를 높이고, 원료의약품 시험성적\n서에 전형적으로 보고되는 확인시험 이외에 NMR을 통한 구조 증명과 같이 추가적인 시험을\n\n통하여 그 특징을 설명해야 한다.  표준품은 물리적인 수치가 일정해지거나 문헌상 순물질의\n\n- ○ 아래 표와 같이 요약할 수 있다.\n - - 표준품을 합성하는 경우 해당 제조방법에 대한 요약 기재가 필요할 수 있다.\n 예시 1)\n\n- - 허가제출용 뱃치 제조에 사용된 원료의약품(제조번호 # 15531)의 시험에는 상용표준품이\n사용되었는데 이 표준품은 USP 표준품(제조번호 # H)으로 성적서를 통해 그 품질을 확인\n\n예시 2)\n\n- - 원료의약품의 1차 표준품(제조번호 # 3)은 주성분 제조업자로부터 구매하였다.  이 표준품은\n합성 공정을 통해 제조되었고, 자사에서 2 회의 추가 재결정을 통해 순도를 높여 순도 99.9\n\n%의 표준품을 얻었다.\n\n <!-- PAGE_16 -->\n##### 2.3.S.6. ",
        "original_sentence": "- - 표준품을 합성하는 경우 해당 제조방법에 대한 요약 기재가 필요할 수 있다.\n"
      }
    },
    {
      "chunk_id": "chunk_274",
      "text": "예시 1)\n\n- - 허가제출용 뱃치 제조에 사용된 원료의약품(제조번호 # 15531)의 시험에는 상용표준품이\n사용되었는데 이 표준품은 USP 표준품(제조번호 # H)으로 성적서를 통해 그 품질을 확인\n\n예시 2)\n\n- - 원료의약품의 1차 표준품(제조번호 # 3)은 주성분 제조업자로부터 구매하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 273,
        "window_size": 3,
        "char_count": 168,
        "word_count": 37,
        "page_number": 5,
        "window_text": "- - 표준품은 필요 시 추가적인 재결정 등을 통하여 가능한 순도를 높이고, 원료의약품 시험성적\n서에 전형적으로 보고되는 확인시험 이외에 NMR을 통한 구조 증명과 같이 추가적인 시험을\n\n통하여 그 특징을 설명해야 한다.  표준품은 물리적인 수치가 일정해지거나 문헌상 순물질의\n\n- ○ 아래 표와 같이 요약할 수 있다.\n - - 표준품을 합성하는 경우 해당 제조방법에 대한 요약 기재가 필요할 수 있다.\n 예시 1)\n\n- - 허가제출용 뱃치 제조에 사용된 원료의약품(제조번호 # 15531)의 시험에는 상용표준품이\n사용되었는데 이 표준품은 USP 표준품(제조번호 # H)으로 성적서를 통해 그 품질을 확인\n\n예시 2)\n\n- - 원료의약품의 1차 표준품(제조번호 # 3)은 주성분 제조업자로부터 구매하였다.  이 표준품은\n합성 공정을 통해 제조되었고, 자사에서 2 회의 추가 재결정을 통해 순도를 높여 순도 99.9\n\n%의 표준품을 얻었다.\n\n <!-- PAGE_16 -->\n##### 2.3.S.6.  용기 및 포장(제품명, 제조자)(Container Closure System)(name, manufacturer)\n\n- 3.2.S.6. ",
        "original_sentence": "예시 1)\n\n- - 허가제출용 뱃치 제조에 사용된 원료의약품(제조번호 # 15531)의 시험에는 상용표준품이\n사용되었는데 이 표준품은 USP 표준품(제조번호 # H)으로 성적서를 통해 그 품질을 확인\n\n예시 2)\n\n- - 원료의약품의 1차 표준품(제조번호 # 3)은 주성분 제조업자로부터 구매하였다. "
      }
    },
    {
      "chunk_id": "chunk_275",
      "text": "이 표준품은\n합성 공정을 통해 제조되었고, 자사에서 2 회의 추가 재결정을 통해 순도를 높여 순도 99.9\n\n%의 표준품을 얻었다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 274,
        "window_size": 3,
        "char_count": 75,
        "word_count": 19,
        "page_number": 3,
        "window_text": "표준품은 물리적인 수치가 일정해지거나 문헌상 순물질의\n\n- ○ 아래 표와 같이 요약할 수 있다.\n - - 표준품을 합성하는 경우 해당 제조방법에 대한 요약 기재가 필요할 수 있다.\n 예시 1)\n\n- - 허가제출용 뱃치 제조에 사용된 원료의약품(제조번호 # 15531)의 시험에는 상용표준품이\n사용되었는데 이 표준품은 USP 표준품(제조번호 # H)으로 성적서를 통해 그 품질을 확인\n\n예시 2)\n\n- - 원료의약품의 1차 표준품(제조번호 # 3)은 주성분 제조업자로부터 구매하였다.  이 표준품은\n합성 공정을 통해 제조되었고, 자사에서 2 회의 추가 재결정을 통해 순도를 높여 순도 99.9\n\n%의 표준품을 얻었다.\n\n <!-- PAGE_16 -->\n##### 2.3.S.6.  용기 및 포장(제품명, 제조자)(Container Closure System)(name, manufacturer)\n\n- 3.2.S.6.  용기 및 포장에서 얻은 정보에 대한 간단한 설명과 고찰을 포함한다.\n",
        "original_sentence": "이 표준품은\n합성 공정을 통해 제조되었고, 자사에서 2 회의 추가 재결정을 통해 순도를 높여 순도 99.9\n\n%의 표준품을 얻었다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_276",
      "text": "<!-- PAGE_16 -->\n##### 2.3.S.6. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 275,
        "window_size": 3,
        "char_count": 32,
        "word_count": 5,
        "page_number": 16,
        "window_text": "- - 표준품을 합성하는 경우 해당 제조방법에 대한 요약 기재가 필요할 수 있다.\n 예시 1)\n\n- - 허가제출용 뱃치 제조에 사용된 원료의약품(제조번호 # 15531)의 시험에는 상용표준품이\n사용되었는데 이 표준품은 USP 표준품(제조번호 # H)으로 성적서를 통해 그 품질을 확인\n\n예시 2)\n\n- - 원료의약품의 1차 표준품(제조번호 # 3)은 주성분 제조업자로부터 구매하였다.  이 표준품은\n합성 공정을 통해 제조되었고, 자사에서 2 회의 추가 재결정을 통해 순도를 높여 순도 99.9\n\n%의 표준품을 얻었다.\n\n <!-- PAGE_16 -->\n##### 2.3.S.6.  용기 및 포장(제품명, 제조자)(Container Closure System)(name, manufacturer)\n\n- 3.2.S.6.  용기 및 포장에서 얻은 정보에 대한 간단한 설명과 고찰을 포함한다.\n <!-- PAGE_16 -->\n##### 해 설\n\n- - 11 -\n- ○ 3.2.S.6. ",
        "original_sentence": "<!-- PAGE_16 -->\n##### 2.3.S.6. "
      }
    },
    {
      "chunk_id": "chunk_277",
      "text": "용기 및 포장(제품명, 제조자)(Container Closure System)(name, manufacturer)\n\n- 3.2.S.6. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 276,
        "window_size": 3,
        "char_count": 76,
        "word_count": 9,
        "page_number": 16,
        "window_text": "예시 1)\n\n- - 허가제출용 뱃치 제조에 사용된 원료의약품(제조번호 # 15531)의 시험에는 상용표준품이\n사용되었는데 이 표준품은 USP 표준품(제조번호 # H)으로 성적서를 통해 그 품질을 확인\n\n예시 2)\n\n- - 원료의약품의 1차 표준품(제조번호 # 3)은 주성분 제조업자로부터 구매하였다.  이 표준품은\n합성 공정을 통해 제조되었고, 자사에서 2 회의 추가 재결정을 통해 순도를 높여 순도 99.9\n\n%의 표준품을 얻었다.\n\n <!-- PAGE_16 -->\n##### 2.3.S.6.  용기 및 포장(제품명, 제조자)(Container Closure System)(name, manufacturer)\n\n- 3.2.S.6.  용기 및 포장에서 얻은 정보에 대한 간단한 설명과 고찰을 포함한다.\n <!-- PAGE_16 -->\n##### 해 설\n\n- - 11 -\n- ○ 3.2.S.6.  용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n",
        "original_sentence": "용기 및 포장(제품명, 제조자)(Container Closure System)(name, manufacturer)\n\n- 3.2.S.6. "
      }
    },
    {
      "chunk_id": "chunk_278",
      "text": "용기 및 포장에서 얻은 정보에 대한 간단한 설명과 고찰을 포함한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 277,
        "window_size": 3,
        "char_count": 38,
        "word_count": 10,
        "page_number": 13,
        "window_text": "이 표준품은\n합성 공정을 통해 제조되었고, 자사에서 2 회의 추가 재결정을 통해 순도를 높여 순도 99.9\n\n%의 표준품을 얻었다.\n\n <!-- PAGE_16 -->\n##### 2.3.S.6.  용기 및 포장(제품명, 제조자)(Container Closure System)(name, manufacturer)\n\n- 3.2.S.6.  용기 및 포장에서 얻은 정보에 대한 간단한 설명과 고찰을 포함한다.\n <!-- PAGE_16 -->\n##### 해 설\n\n- - 11 -\n- ○ 3.2.S.6.  용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n <!-- PAGE_17 -->\n##### 예 시\n\n예시 1)\n\n원료의약품은 투명한 Polyethylene Bag과 차광된 Polyethylene Bag으로 포장하고, fiber\n\nboard drum에 sealing하여 보관한다. ",
        "original_sentence": "용기 및 포장에서 얻은 정보에 대한 간단한 설명과 고찰을 포함한다.\n"
      }
    },
    {
      "chunk_id": "chunk_279",
      "text": "<!-- PAGE_16 -->\n##### 해 설\n\n- - 11 -\n- ○ 3.2.S.6. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 278,
        "window_size": 3,
        "char_count": 50,
        "word_count": 13,
        "page_number": 16,
        "window_text": "<!-- PAGE_16 -->\n##### 2.3.S.6.  용기 및 포장(제품명, 제조자)(Container Closure System)(name, manufacturer)\n\n- 3.2.S.6.  용기 및 포장에서 얻은 정보에 대한 간단한 설명과 고찰을 포함한다.\n <!-- PAGE_16 -->\n##### 해 설\n\n- - 11 -\n- ○ 3.2.S.6.  용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n <!-- PAGE_17 -->\n##### 예 시\n\n예시 1)\n\n원료의약품은 투명한 Polyethylene Bag과 차광된 Polyethylene Bag으로 포장하고, fiber\n\nboard drum에 sealing하여 보관한다.  원료의약품 보관에 사용하는 용기 및 포장에 대한 추가\n\n예시 2)\n\n원료의약품은 이중 포장되어 있다. ",
        "original_sentence": "<!-- PAGE_16 -->\n##### 해 설\n\n- - 11 -\n- ○ 3.2.S.6. "
      }
    },
    {
      "chunk_id": "chunk_280",
      "text": "용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 279,
        "window_size": 3,
        "char_count": 45,
        "word_count": 12,
        "page_number": 3,
        "window_text": "용기 및 포장(제품명, 제조자)(Container Closure System)(name, manufacturer)\n\n- 3.2.S.6.  용기 및 포장에서 얻은 정보에 대한 간단한 설명과 고찰을 포함한다.\n <!-- PAGE_16 -->\n##### 해 설\n\n- - 11 -\n- ○ 3.2.S.6.  용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n <!-- PAGE_17 -->\n##### 예 시\n\n예시 1)\n\n원료의약품은 투명한 Polyethylene Bag과 차광된 Polyethylene Bag으로 포장하고, fiber\n\nboard drum에 sealing하여 보관한다.  원료의약품 보관에 사용하는 용기 및 포장에 대한 추가\n\n예시 2)\n\n원료의약품은 이중 포장되어 있다.  Low density polyethylene으로 포장하고 sealing한 후\n\naluminum laminated foil로 포장하고 sealing 한다. ",
        "original_sentence": "용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_281",
      "text": "<!-- PAGE_17 -->\n##### 예 시\n\n예시 1)\n\n원료의약품은 투명한 Polyethylene Bag과 차광된 Polyethylene Bag으로 포장하고, fiber\n\nboard drum에 sealing하여 보관한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 280,
        "window_size": 3,
        "char_count": 128,
        "word_count": 21,
        "page_number": 17,
        "window_text": "용기 및 포장에서 얻은 정보에 대한 간단한 설명과 고찰을 포함한다.\n <!-- PAGE_16 -->\n##### 해 설\n\n- - 11 -\n- ○ 3.2.S.6.  용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n <!-- PAGE_17 -->\n##### 예 시\n\n예시 1)\n\n원료의약품은 투명한 Polyethylene Bag과 차광된 Polyethylene Bag으로 포장하고, fiber\n\nboard drum에 sealing하여 보관한다.  원료의약품 보관에 사용하는 용기 및 포장에 대한 추가\n\n예시 2)\n\n원료의약품은 이중 포장되어 있다.  Low density polyethylene으로 포장하고 sealing한 후\n\naluminum laminated foil로 포장하고 sealing 한다.  이러한 이중 포장 후 fiberboard drum에\n\n보관한다. ",
        "original_sentence": "<!-- PAGE_17 -->\n##### 예 시\n\n예시 1)\n\n원료의약품은 투명한 Polyethylene Bag과 차광된 Polyethylene Bag으로 포장하고, fiber\n\nboard drum에 sealing하여 보관한다. "
      }
    },
    {
      "chunk_id": "chunk_282",
      "text": "원료의약품 보관에 사용하는 용기 및 포장에 대한 추가\n\n예시 2)\n\n원료의약품은 이중 포장되어 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 281,
        "window_size": 3,
        "char_count": 57,
        "word_count": 14,
        "page_number": 3,
        "window_text": "<!-- PAGE_16 -->\n##### 해 설\n\n- - 11 -\n- ○ 3.2.S.6.  용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n <!-- PAGE_17 -->\n##### 예 시\n\n예시 1)\n\n원료의약품은 투명한 Polyethylene Bag과 차광된 Polyethylene Bag으로 포장하고, fiber\n\nboard drum에 sealing하여 보관한다.  원료의약품 보관에 사용하는 용기 및 포장에 대한 추가\n\n예시 2)\n\n원료의약품은 이중 포장되어 있다.  Low density polyethylene으로 포장하고 sealing한 후\n\naluminum laminated foil로 포장하고 sealing 한다.  이러한 이중 포장 후 fiberboard drum에\n\n보관한다.  원료의약품 보관에 사용하는 용기 및 포장에 대한 추가적인 정보는 3.2.S.6. ",
        "original_sentence": "원료의약품 보관에 사용하는 용기 및 포장에 대한 추가\n\n예시 2)\n\n원료의약품은 이중 포장되어 있다. "
      }
    },
    {
      "chunk_id": "chunk_283",
      "text": "Low density polyethylene으로 포장하고 sealing한 후\n\naluminum laminated foil로 포장하고 sealing 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 282,
        "window_size": 3,
        "char_count": 86,
        "word_count": 12,
        "page_number": 24,
        "window_text": "용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n <!-- PAGE_17 -->\n##### 예 시\n\n예시 1)\n\n원료의약품은 투명한 Polyethylene Bag과 차광된 Polyethylene Bag으로 포장하고, fiber\n\nboard drum에 sealing하여 보관한다.  원료의약품 보관에 사용하는 용기 및 포장에 대한 추가\n\n예시 2)\n\n원료의약품은 이중 포장되어 있다.  Low density polyethylene으로 포장하고 sealing한 후\n\naluminum laminated foil로 포장하고 sealing 한다.  이러한 이중 포장 후 fiberboard drum에\n\n보관한다.  원료의약품 보관에 사용하는 용기 및 포장에 대한 추가적인 정보는 3.2.S.6.  용기\n\n<!-- PAGE_17 -->\n##### 2.3.S.7 안정성(제품명, 제조자)(Stability)(name, manufacturer)\n\n<!-- PAGE_17 -->\n##### 3.2.S.7.1에서 설명된 것과 같이 수행된 시험의 요약(조건, 뱃치, 시험방법)과 결과에\n\n<!-- PAGE_17 -->\n##### 대한 고찰 및 결론의 요약, 보관조건, 재시험일자 또는 유효기간에 대한 사항을 포함한다.\n\n",
        "original_sentence": "Low density polyethylene으로 포장하고 sealing한 후\n\naluminum laminated foil로 포장하고 sealing 한다. "
      }
    },
    {
      "chunk_id": "chunk_284",
      "text": "이러한 이중 포장 후 fiberboard drum에\n\n보관한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 283,
        "window_size": 3,
        "char_count": 36,
        "word_count": 7,
        "page_number": 3,
        "window_text": "<!-- PAGE_17 -->\n##### 예 시\n\n예시 1)\n\n원료의약품은 투명한 Polyethylene Bag과 차광된 Polyethylene Bag으로 포장하고, fiber\n\nboard drum에 sealing하여 보관한다.  원료의약품 보관에 사용하는 용기 및 포장에 대한 추가\n\n예시 2)\n\n원료의약품은 이중 포장되어 있다.  Low density polyethylene으로 포장하고 sealing한 후\n\naluminum laminated foil로 포장하고 sealing 한다.  이러한 이중 포장 후 fiberboard drum에\n\n보관한다.  원료의약품 보관에 사용하는 용기 및 포장에 대한 추가적인 정보는 3.2.S.6.  용기\n\n<!-- PAGE_17 -->\n##### 2.3.S.7 안정성(제품명, 제조자)(Stability)(name, manufacturer)\n\n<!-- PAGE_17 -->\n##### 3.2.S.7.1에서 설명된 것과 같이 수행된 시험의 요약(조건, 뱃치, 시험방법)과 결과에\n\n<!-- PAGE_17 -->\n##### 대한 고찰 및 결론의 요약, 보관조건, 재시험일자 또는 유효기간에 대한 사항을 포함한다.\n\n <!-- PAGE_17 -->\n##### 3.2.S.7.2에서 설명된 것과 같이 승인 후의 안정성 시험계획을 포함한다.\n\n",
        "original_sentence": "이러한 이중 포장 후 fiberboard drum에\n\n보관한다. "
      }
    },
    {
      "chunk_id": "chunk_285",
      "text": "원료의약품 보관에 사용하는 용기 및 포장에 대한 추가적인 정보는 3.2.S.6. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 284,
        "window_size": 3,
        "char_count": 45,
        "word_count": 10,
        "page_number": 5,
        "window_text": "원료의약품 보관에 사용하는 용기 및 포장에 대한 추가\n\n예시 2)\n\n원료의약품은 이중 포장되어 있다.  Low density polyethylene으로 포장하고 sealing한 후\n\naluminum laminated foil로 포장하고 sealing 한다.  이러한 이중 포장 후 fiberboard drum에\n\n보관한다.  원료의약품 보관에 사용하는 용기 및 포장에 대한 추가적인 정보는 3.2.S.6.  용기\n\n<!-- PAGE_17 -->\n##### 2.3.S.7 안정성(제품명, 제조자)(Stability)(name, manufacturer)\n\n<!-- PAGE_17 -->\n##### 3.2.S.7.1에서 설명된 것과 같이 수행된 시험의 요약(조건, 뱃치, 시험방법)과 결과에\n\n<!-- PAGE_17 -->\n##### 대한 고찰 및 결론의 요약, 보관조건, 재시험일자 또는 유효기간에 대한 사항을 포함한다.\n\n <!-- PAGE_17 -->\n##### 3.2.S.7.2에서 설명된 것과 같이 승인 후의 안정성 시험계획을 포함한다.\n\n <!-- PAGE_17 -->\n##### 3.2.S.7.3에서 얻은 안정성 결과의 도표요약은 필요시 그래프와 함께 제공하여야 한다.\n\n",
        "original_sentence": "원료의약품 보관에 사용하는 용기 및 포장에 대한 추가적인 정보는 3.2.S.6. "
      }
    },
    {
      "chunk_id": "chunk_286",
      "text": "용기\n\n<!-- PAGE_17 -->\n##### 2.3.S.7 안정성(제품명, 제조자)(Stability)(name, manufacturer)\n\n<!-- PAGE_17 -->\n##### 3.2.S.7.1에서 설명된 것과 같이 수행된 시험의 요약(조건, 뱃치, 시험방법)과 결과에\n\n<!-- PAGE_17 -->\n##### 대한 고찰 및 결론의 요약, 보관조건, 재시험일자 또는 유효기간에 대한 사항을 포함한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 285,
        "window_size": 3,
        "char_count": 231,
        "word_count": 39,
        "page_number": 17,
        "window_text": "Low density polyethylene으로 포장하고 sealing한 후\n\naluminum laminated foil로 포장하고 sealing 한다.  이러한 이중 포장 후 fiberboard drum에\n\n보관한다.  원료의약품 보관에 사용하는 용기 및 포장에 대한 추가적인 정보는 3.2.S.6.  용기\n\n<!-- PAGE_17 -->\n##### 2.3.S.7 안정성(제품명, 제조자)(Stability)(name, manufacturer)\n\n<!-- PAGE_17 -->\n##### 3.2.S.7.1에서 설명된 것과 같이 수행된 시험의 요약(조건, 뱃치, 시험방법)과 결과에\n\n<!-- PAGE_17 -->\n##### 대한 고찰 및 결론의 요약, 보관조건, 재시험일자 또는 유효기간에 대한 사항을 포함한다.\n\n <!-- PAGE_17 -->\n##### 3.2.S.7.2에서 설명된 것과 같이 승인 후의 안정성 시험계획을 포함한다.\n\n <!-- PAGE_17 -->\n##### 3.2.S.7.3에서 얻은 안정성 결과의 도표요약은 필요시 그래프와 함께 제공하여야 한다.\n\n - ○ 3.2.S.7 안정성에 기재된 사항을 요약하고, 재시험일자 또는 유효기간에 대한 사항을 포함\n- ○ 재시험일자: 원료의약품이 기준을 만족하고 완제의약품의 제조에 사용하기에 적절한지를 보증\n하기 위해 시험해야 하는 일자.\n\n",
        "original_sentence": "용기\n\n<!-- PAGE_17 -->\n##### 2.3.S.7 안정성(제품명, 제조자)(Stability)(name, manufacturer)\n\n<!-- PAGE_17 -->\n##### 3.2.S.7.1에서 설명된 것과 같이 수행된 시험의 요약(조건, 뱃치, 시험방법)과 결과에\n\n<!-- PAGE_17 -->\n##### 대한 고찰 및 결론의 요약, 보관조건, 재시험일자 또는 유효기간에 대한 사항을 포함한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_287",
      "text": "<!-- PAGE_17 -->\n##### 3.2.S.7.2에서 설명된 것과 같이 승인 후의 안정성 시험계획을 포함한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 286,
        "window_size": 3,
        "char_count": 68,
        "word_count": 13,
        "page_number": 17,
        "window_text": "이러한 이중 포장 후 fiberboard drum에\n\n보관한다.  원료의약품 보관에 사용하는 용기 및 포장에 대한 추가적인 정보는 3.2.S.6.  용기\n\n<!-- PAGE_17 -->\n##### 2.3.S.7 안정성(제품명, 제조자)(Stability)(name, manufacturer)\n\n<!-- PAGE_17 -->\n##### 3.2.S.7.1에서 설명된 것과 같이 수행된 시험의 요약(조건, 뱃치, 시험방법)과 결과에\n\n<!-- PAGE_17 -->\n##### 대한 고찰 및 결론의 요약, 보관조건, 재시험일자 또는 유효기간에 대한 사항을 포함한다.\n\n <!-- PAGE_17 -->\n##### 3.2.S.7.2에서 설명된 것과 같이 승인 후의 안정성 시험계획을 포함한다.\n\n <!-- PAGE_17 -->\n##### 3.2.S.7.3에서 얻은 안정성 결과의 도표요약은 필요시 그래프와 함께 제공하여야 한다.\n\n - ○ 3.2.S.7 안정성에 기재된 사항을 요약하고, 재시험일자 또는 유효기간에 대한 사항을 포함\n- ○ 재시험일자: 원료의약품이 기준을 만족하고 완제의약품의 제조에 사용하기에 적절한지를 보증\n하기 위해 시험해야 하는 일자.\n\n - ○ 재시험기간: 원료의약품이 정해진 조건에서 저장되고 있는 경우 기준 내 적합할 것으로 예상됨에\n따라 완제의약품 제조에 사용될 수 있는 기간.\n\n",
        "original_sentence": "<!-- PAGE_17 -->\n##### 3.2.S.7.2에서 설명된 것과 같이 승인 후의 안정성 시험계획을 포함한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_288",
      "text": "<!-- PAGE_17 -->\n##### 3.2.S.7.3에서 얻은 안정성 결과의 도표요약은 필요시 그래프와 함께 제공하여야 한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 287,
        "window_size": 3,
        "char_count": 75,
        "word_count": 14,
        "page_number": 17,
        "window_text": "원료의약품 보관에 사용하는 용기 및 포장에 대한 추가적인 정보는 3.2.S.6.  용기\n\n<!-- PAGE_17 -->\n##### 2.3.S.7 안정성(제품명, 제조자)(Stability)(name, manufacturer)\n\n<!-- PAGE_17 -->\n##### 3.2.S.7.1에서 설명된 것과 같이 수행된 시험의 요약(조건, 뱃치, 시험방법)과 결과에\n\n<!-- PAGE_17 -->\n##### 대한 고찰 및 결론의 요약, 보관조건, 재시험일자 또는 유효기간에 대한 사항을 포함한다.\n\n <!-- PAGE_17 -->\n##### 3.2.S.7.2에서 설명된 것과 같이 승인 후의 안정성 시험계획을 포함한다.\n\n <!-- PAGE_17 -->\n##### 3.2.S.7.3에서 얻은 안정성 결과의 도표요약은 필요시 그래프와 함께 제공하여야 한다.\n\n - ○ 3.2.S.7 안정성에 기재된 사항을 요약하고, 재시험일자 또는 유효기간에 대한 사항을 포함\n- ○ 재시험일자: 원료의약품이 기준을 만족하고 완제의약품의 제조에 사용하기에 적절한지를 보증\n하기 위해 시험해야 하는 일자.\n\n - ○ 재시험기간: 원료의약품이 정해진 조건에서 저장되고 있는 경우 기준 내 적합할 것으로 예상됨에\n따라 완제의약품 제조에 사용될 수 있는 기간.\n\n - ○ 사용기간: 정해진 조건에서 보관된다면, 원료의약품 뱃치가 그 날짜 이전에는 승인된 기준(Shelf\nlife specification)에 적합할 것으로 예상되고 그 이후에는 사용해서는 안 되는 날짜\n\n- ○ 가혹시험 및 분해경로의 확인과 같은 정보가 중요한 경우, 이 항에 기재하지 않고 제3부에 상세\n- - 12 -\n기재 한다. ",
        "original_sentence": "<!-- PAGE_17 -->\n##### 3.2.S.7.3에서 얻은 안정성 결과의 도표요약은 필요시 그래프와 함께 제공하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_289",
      "text": "- ○ 3.2.S.7 안정성에 기재된 사항을 요약하고, 재시험일자 또는 유효기간에 대한 사항을 포함\n- ○ 재시험일자: 원료의약품이 기준을 만족하고 완제의약품의 제조에 사용하기에 적절한지를 보증\n하기 위해 시험해야 하는 일자.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 288,
        "window_size": 3,
        "char_count": 128,
        "word_count": 29,
        "page_number": 2,
        "window_text": "용기\n\n<!-- PAGE_17 -->\n##### 2.3.S.7 안정성(제품명, 제조자)(Stability)(name, manufacturer)\n\n<!-- PAGE_17 -->\n##### 3.2.S.7.1에서 설명된 것과 같이 수행된 시험의 요약(조건, 뱃치, 시험방법)과 결과에\n\n<!-- PAGE_17 -->\n##### 대한 고찰 및 결론의 요약, 보관조건, 재시험일자 또는 유효기간에 대한 사항을 포함한다.\n\n <!-- PAGE_17 -->\n##### 3.2.S.7.2에서 설명된 것과 같이 승인 후의 안정성 시험계획을 포함한다.\n\n <!-- PAGE_17 -->\n##### 3.2.S.7.3에서 얻은 안정성 결과의 도표요약은 필요시 그래프와 함께 제공하여야 한다.\n\n - ○ 3.2.S.7 안정성에 기재된 사항을 요약하고, 재시험일자 또는 유효기간에 대한 사항을 포함\n- ○ 재시험일자: 원료의약품이 기준을 만족하고 완제의약품의 제조에 사용하기에 적절한지를 보증\n하기 위해 시험해야 하는 일자.\n\n - ○ 재시험기간: 원료의약품이 정해진 조건에서 저장되고 있는 경우 기준 내 적합할 것으로 예상됨에\n따라 완제의약품 제조에 사용될 수 있는 기간.\n\n - ○ 사용기간: 정해진 조건에서 보관된다면, 원료의약품 뱃치가 그 날짜 이전에는 승인된 기준(Shelf\nlife specification)에 적합할 것으로 예상되고 그 이후에는 사용해서는 안 되는 날짜\n\n- ○ 가혹시험 및 분해경로의 확인과 같은 정보가 중요한 경우, 이 항에 기재하지 않고 제3부에 상세\n- - 12 -\n기재 한다.  또한, 이러한 정보는 완제의약품의 설계, 성능 또는 제조에 영향을 미칠 수 있으므로\n\n- 2.3.P.2. ",
        "original_sentence": "- ○ 3.2.S.7 안정성에 기재된 사항을 요약하고, 재시험일자 또는 유효기간에 대한 사항을 포함\n- ○ 재시험일자: 원료의약품이 기준을 만족하고 완제의약품의 제조에 사용하기에 적절한지를 보증\n하기 위해 시험해야 하는 일자.\n\n"
      }
    },
    {
      "chunk_id": "chunk_290",
      "text": "- ○ 재시험기간: 원료의약품이 정해진 조건에서 저장되고 있는 경우 기준 내 적합할 것으로 예상됨에\n따라 완제의약품 제조에 사용될 수 있는 기간.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 289,
        "window_size": 3,
        "char_count": 83,
        "word_count": 21,
        "page_number": 3,
        "window_text": "<!-- PAGE_17 -->\n##### 3.2.S.7.2에서 설명된 것과 같이 승인 후의 안정성 시험계획을 포함한다.\n\n <!-- PAGE_17 -->\n##### 3.2.S.7.3에서 얻은 안정성 결과의 도표요약은 필요시 그래프와 함께 제공하여야 한다.\n\n - ○ 3.2.S.7 안정성에 기재된 사항을 요약하고, 재시험일자 또는 유효기간에 대한 사항을 포함\n- ○ 재시험일자: 원료의약품이 기준을 만족하고 완제의약품의 제조에 사용하기에 적절한지를 보증\n하기 위해 시험해야 하는 일자.\n\n - ○ 재시험기간: 원료의약품이 정해진 조건에서 저장되고 있는 경우 기준 내 적합할 것으로 예상됨에\n따라 완제의약품 제조에 사용될 수 있는 기간.\n\n - ○ 사용기간: 정해진 조건에서 보관된다면, 원료의약품 뱃치가 그 날짜 이전에는 승인된 기준(Shelf\nlife specification)에 적합할 것으로 예상되고 그 이후에는 사용해서는 안 되는 날짜\n\n- ○ 가혹시험 및 분해경로의 확인과 같은 정보가 중요한 경우, 이 항에 기재하지 않고 제3부에 상세\n- - 12 -\n기재 한다.  또한, 이러한 정보는 완제의약품의 설계, 성능 또는 제조에 영향을 미칠 수 있으므로\n\n- 2.3.P.2.  개발경위에 기재할 수 있다.\n",
        "original_sentence": "- ○ 재시험기간: 원료의약품이 정해진 조건에서 저장되고 있는 경우 기준 내 적합할 것으로 예상됨에\n따라 완제의약품 제조에 사용될 수 있는 기간.\n\n"
      }
    },
    {
      "chunk_id": "chunk_291",
      "text": "- ○ 사용기간: 정해진 조건에서 보관된다면, 원료의약품 뱃치가 그 날짜 이전에는 승인된 기준(Shelf\nlife specification)에 적합할 것으로 예상되고 그 이후에는 사용해서는 안 되는 날짜\n\n- ○ 가혹시험 및 분해경로의 확인과 같은 정보가 중요한 경우, 이 항에 기재하지 않고 제3부에 상세\n- - 12 -\n기재 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 290,
        "window_size": 3,
        "char_count": 188,
        "word_count": 46,
        "page_number": 3,
        "window_text": "<!-- PAGE_17 -->\n##### 3.2.S.7.3에서 얻은 안정성 결과의 도표요약은 필요시 그래프와 함께 제공하여야 한다.\n\n - ○ 3.2.S.7 안정성에 기재된 사항을 요약하고, 재시험일자 또는 유효기간에 대한 사항을 포함\n- ○ 재시험일자: 원료의약품이 기준을 만족하고 완제의약품의 제조에 사용하기에 적절한지를 보증\n하기 위해 시험해야 하는 일자.\n\n - ○ 재시험기간: 원료의약품이 정해진 조건에서 저장되고 있는 경우 기준 내 적합할 것으로 예상됨에\n따라 완제의약품 제조에 사용될 수 있는 기간.\n\n - ○ 사용기간: 정해진 조건에서 보관된다면, 원료의약품 뱃치가 그 날짜 이전에는 승인된 기준(Shelf\nlife specification)에 적합할 것으로 예상되고 그 이후에는 사용해서는 안 되는 날짜\n\n- ○ 가혹시험 및 분해경로의 확인과 같은 정보가 중요한 경우, 이 항에 기재하지 않고 제3부에 상세\n- - 12 -\n기재 한다.  또한, 이러한 정보는 완제의약품의 설계, 성능 또는 제조에 영향을 미칠 수 있으므로\n\n- 2.3.P.2.  개발경위에 기재할 수 있다.\n - ○ 아래 표와 같이 요약 기재할 수 있다.\n",
        "original_sentence": "- ○ 사용기간: 정해진 조건에서 보관된다면, 원료의약품 뱃치가 그 날짜 이전에는 승인된 기준(Shelf\nlife specification)에 적합할 것으로 예상되고 그 이후에는 사용해서는 안 되는 날짜\n\n- ○ 가혹시험 및 분해경로의 확인과 같은 정보가 중요한 경우, 이 항에 기재하지 않고 제3부에 상세\n- - 12 -\n기재 한다. "
      }
    },
    {
      "chunk_id": "chunk_292",
      "text": "또한, 이러한 정보는 완제의약품의 설계, 성능 또는 제조에 영향을 미칠 수 있으므로\n\n- 2.3.P.2. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 291,
        "window_size": 3,
        "char_count": 59,
        "word_count": 14,
        "page_number": 3,
        "window_text": "- ○ 3.2.S.7 안정성에 기재된 사항을 요약하고, 재시험일자 또는 유효기간에 대한 사항을 포함\n- ○ 재시험일자: 원료의약품이 기준을 만족하고 완제의약품의 제조에 사용하기에 적절한지를 보증\n하기 위해 시험해야 하는 일자.\n\n - ○ 재시험기간: 원료의약품이 정해진 조건에서 저장되고 있는 경우 기준 내 적합할 것으로 예상됨에\n따라 완제의약품 제조에 사용될 수 있는 기간.\n\n - ○ 사용기간: 정해진 조건에서 보관된다면, 원료의약품 뱃치가 그 날짜 이전에는 승인된 기준(Shelf\nlife specification)에 적합할 것으로 예상되고 그 이후에는 사용해서는 안 되는 날짜\n\n- ○ 가혹시험 및 분해경로의 확인과 같은 정보가 중요한 경우, 이 항에 기재하지 않고 제3부에 상세\n- - 12 -\n기재 한다.  또한, 이러한 정보는 완제의약품의 설계, 성능 또는 제조에 영향을 미칠 수 있으므로\n\n- 2.3.P.2.  개발경위에 기재할 수 있다.\n - ○ 아래 표와 같이 요약 기재할 수 있다.\n 시험종류\n\n시험조건\n\n용기형태/재질\n\n제조번호\n\n시험 주기\n\n시험 결과\n\n<!-- PAGE_18 -->\n##### 2.3.P 완제의약품(제품명, 제형)(Drug Product)(name, dosage form)\n\n<!-- PAGE_18 -->\n##### 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형)(Description and Composition of the\n\n<!-- PAGE_18 -->\n##### Drug Product)(name, dosage form)\n\n- 3.2.P.1에서 얻은 정보를 포함한다.\n",
        "original_sentence": "또한, 이러한 정보는 완제의약품의 설계, 성능 또는 제조에 영향을 미칠 수 있으므로\n\n- 2.3.P.2. "
      }
    },
    {
      "chunk_id": "chunk_293",
      "text": "개발경위에 기재할 수 있다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 292,
        "window_size": 3,
        "char_count": 16,
        "word_count": 4,
        "page_number": 12,
        "window_text": "- ○ 재시험기간: 원료의약품이 정해진 조건에서 저장되고 있는 경우 기준 내 적합할 것으로 예상됨에\n따라 완제의약품 제조에 사용될 수 있는 기간.\n\n - ○ 사용기간: 정해진 조건에서 보관된다면, 원료의약품 뱃치가 그 날짜 이전에는 승인된 기준(Shelf\nlife specification)에 적합할 것으로 예상되고 그 이후에는 사용해서는 안 되는 날짜\n\n- ○ 가혹시험 및 분해경로의 확인과 같은 정보가 중요한 경우, 이 항에 기재하지 않고 제3부에 상세\n- - 12 -\n기재 한다.  또한, 이러한 정보는 완제의약품의 설계, 성능 또는 제조에 영향을 미칠 수 있으므로\n\n- 2.3.P.2.  개발경위에 기재할 수 있다.\n - ○ 아래 표와 같이 요약 기재할 수 있다.\n 시험종류\n\n시험조건\n\n용기형태/재질\n\n제조번호\n\n시험 주기\n\n시험 결과\n\n<!-- PAGE_18 -->\n##### 2.3.P 완제의약품(제품명, 제형)(Drug Product)(name, dosage form)\n\n<!-- PAGE_18 -->\n##### 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형)(Description and Composition of the\n\n<!-- PAGE_18 -->\n##### Drug Product)(name, dosage form)\n\n- 3.2.P.1에서 얻은 정보를 포함한다.\n - 3.2.P.1에서 얻은 조성을 제공하여야 한다.\n",
        "original_sentence": "개발경위에 기재할 수 있다.\n"
      }
    },
    {
      "chunk_id": "chunk_294",
      "text": "- ○ 아래 표와 같이 요약 기재할 수 있다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 293,
        "window_size": 3,
        "char_count": 26,
        "word_count": 9,
        "page_number": 3,
        "window_text": "- ○ 사용기간: 정해진 조건에서 보관된다면, 원료의약품 뱃치가 그 날짜 이전에는 승인된 기준(Shelf\nlife specification)에 적합할 것으로 예상되고 그 이후에는 사용해서는 안 되는 날짜\n\n- ○ 가혹시험 및 분해경로의 확인과 같은 정보가 중요한 경우, 이 항에 기재하지 않고 제3부에 상세\n- - 12 -\n기재 한다.  또한, 이러한 정보는 완제의약품의 설계, 성능 또는 제조에 영향을 미칠 수 있으므로\n\n- 2.3.P.2.  개발경위에 기재할 수 있다.\n - ○ 아래 표와 같이 요약 기재할 수 있다.\n 시험종류\n\n시험조건\n\n용기형태/재질\n\n제조번호\n\n시험 주기\n\n시험 결과\n\n<!-- PAGE_18 -->\n##### 2.3.P 완제의약품(제품명, 제형)(Drug Product)(name, dosage form)\n\n<!-- PAGE_18 -->\n##### 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형)(Description and Composition of the\n\n<!-- PAGE_18 -->\n##### Drug Product)(name, dosage form)\n\n- 3.2.P.1에서 얻은 정보를 포함한다.\n - 3.2.P.1에서 얻은 조성을 제공하여야 한다.\n <!-- PAGE_18 -->\n##### 해 설\n\n- ○ 3.2.P.1 완제의약품의 개요와 조성에서 얻은 제형에 대한 정보(성상 등), 조성(성분, 용도,\n규격, 분량)을 요약하여 표 등으로 제공하고, 첨부용제 및 제제에 사용된 용기와 마개를 포\n\n함한다.\n\n",
        "original_sentence": "- ○ 아래 표와 같이 요약 기재할 수 있다.\n"
      }
    },
    {
      "chunk_id": "chunk_295",
      "text": "시험종류\n\n시험조건\n\n용기형태/재질\n\n제조번호\n\n시험 주기\n\n시험 결과\n\n<!-- PAGE_18 -->\n##### 2.3.P 완제의약품(제품명, 제형)(Drug Product)(name, dosage form)\n\n<!-- PAGE_18 -->\n##### 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형)(Description and Composition of the\n\n<!-- PAGE_18 -->\n##### Drug Product)(name, dosage form)\n\n- 3.2.P.1에서 얻은 정보를 포함한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 294,
        "window_size": 3,
        "char_count": 291,
        "word_count": 44,
        "page_number": 18,
        "window_text": "또한, 이러한 정보는 완제의약품의 설계, 성능 또는 제조에 영향을 미칠 수 있으므로\n\n- 2.3.P.2.  개발경위에 기재할 수 있다.\n - ○ 아래 표와 같이 요약 기재할 수 있다.\n 시험종류\n\n시험조건\n\n용기형태/재질\n\n제조번호\n\n시험 주기\n\n시험 결과\n\n<!-- PAGE_18 -->\n##### 2.3.P 완제의약품(제품명, 제형)(Drug Product)(name, dosage form)\n\n<!-- PAGE_18 -->\n##### 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형)(Description and Composition of the\n\n<!-- PAGE_18 -->\n##### Drug Product)(name, dosage form)\n\n- 3.2.P.1에서 얻은 정보를 포함한다.\n - 3.2.P.1에서 얻은 조성을 제공하여야 한다.\n <!-- PAGE_18 -->\n##### 해 설\n\n- ○ 3.2.P.1 완제의약품의 개요와 조성에서 얻은 제형에 대한 정보(성상 등), 조성(성분, 용도,\n규격, 분량)을 요약하여 표 등으로 제공하고, 첨부용제 및 제제에 사용된 용기와 마개를 포\n\n함한다.\n\n - ○ 필요시 대조약과의 조성 비교표를 기재할 수 있다(예 : 주사제).\n",
        "original_sentence": "시험종류\n\n시험조건\n\n용기형태/재질\n\n제조번호\n\n시험 주기\n\n시험 결과\n\n<!-- PAGE_18 -->\n##### 2.3.P 완제의약품(제품명, 제형)(Drug Product)(name, dosage form)\n\n<!-- PAGE_18 -->\n##### 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형)(Description and Composition of the\n\n<!-- PAGE_18 -->\n##### Drug Product)(name, dosage form)\n\n- 3.2.P.1에서 얻은 정보를 포함한다.\n"
      }
    },
    {
      "chunk_id": "chunk_296",
      "text": "- 3.2.P.1에서 얻은 조성을 제공하여야 한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 295,
        "window_size": 3,
        "char_count": 29,
        "word_count": 6,
        "page_number": 5,
        "window_text": "개발경위에 기재할 수 있다.\n - ○ 아래 표와 같이 요약 기재할 수 있다.\n 시험종류\n\n시험조건\n\n용기형태/재질\n\n제조번호\n\n시험 주기\n\n시험 결과\n\n<!-- PAGE_18 -->\n##### 2.3.P 완제의약품(제품명, 제형)(Drug Product)(name, dosage form)\n\n<!-- PAGE_18 -->\n##### 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형)(Description and Composition of the\n\n<!-- PAGE_18 -->\n##### Drug Product)(name, dosage form)\n\n- 3.2.P.1에서 얻은 정보를 포함한다.\n - 3.2.P.1에서 얻은 조성을 제공하여야 한다.\n <!-- PAGE_18 -->\n##### 해 설\n\n- ○ 3.2.P.1 완제의약품의 개요와 조성에서 얻은 제형에 대한 정보(성상 등), 조성(성분, 용도,\n규격, 분량)을 요약하여 표 등으로 제공하고, 첨부용제 및 제제에 사용된 용기와 마개를 포\n\n함한다.\n\n - ○ 필요시 대조약과의 조성 비교표를 기재할 수 있다(예 : 주사제).\n - ○ 조성 기재 시, 제조공정 중 제거되는 용매 및 공정보조제(processing aid)를 포함하여 완제의\n약품을 구성하는 성분, 분량, 규격 및 배합목적 등을 모두 기재한다.\n\n",
        "original_sentence": "- 3.2.P.1에서 얻은 조성을 제공하여야 한다.\n"
      }
    },
    {
      "chunk_id": "chunk_297",
      "text": "<!-- PAGE_18 -->\n##### 해 설\n\n- ○ 3.2.P.1 완제의약품의 개요와 조성에서 얻은 제형에 대한 정보(성상 등), 조성(성분, 용도,\n규격, 분량)을 요약하여 표 등으로 제공하고, 첨부용제 및 제제에 사용된 용기와 마개를 포\n\n함한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 296,
        "window_size": 3,
        "char_count": 145,
        "word_count": 33,
        "page_number": 18,
        "window_text": "- ○ 아래 표와 같이 요약 기재할 수 있다.\n 시험종류\n\n시험조건\n\n용기형태/재질\n\n제조번호\n\n시험 주기\n\n시험 결과\n\n<!-- PAGE_18 -->\n##### 2.3.P 완제의약품(제품명, 제형)(Drug Product)(name, dosage form)\n\n<!-- PAGE_18 -->\n##### 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형)(Description and Composition of the\n\n<!-- PAGE_18 -->\n##### Drug Product)(name, dosage form)\n\n- 3.2.P.1에서 얻은 정보를 포함한다.\n - 3.2.P.1에서 얻은 조성을 제공하여야 한다.\n <!-- PAGE_18 -->\n##### 해 설\n\n- ○ 3.2.P.1 완제의약품의 개요와 조성에서 얻은 제형에 대한 정보(성상 등), 조성(성분, 용도,\n규격, 분량)을 요약하여 표 등으로 제공하고, 첨부용제 및 제제에 사용된 용기와 마개를 포\n\n함한다.\n\n - ○ 필요시 대조약과의 조성 비교표를 기재할 수 있다(예 : 주사제).\n - ○ 조성 기재 시, 제조공정 중 제거되는 용매 및 공정보조제(processing aid)를 포함하여 완제의\n약품을 구성하는 성분, 분량, 규격 및 배합목적 등을 모두 기재한다.\n\n **[표 시작]**\n\n| 장기보존시험 | 25℃/60% RH |\n| --- | --- |\n\n**[표 끝]**\n\n- - 13 -\n- ○ 첨가제는 2.3.P.4 첨가제의 관리에 기재한다. ",
        "original_sentence": "<!-- PAGE_18 -->\n##### 해 설\n\n- ○ 3.2.P.1 완제의약품의 개요와 조성에서 얻은 제형에 대한 정보(성상 등), 조성(성분, 용도,\n규격, 분량)을 요약하여 표 등으로 제공하고, 첨부용제 및 제제에 사용된 용기와 마개를 포\n\n함한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_298",
      "text": "- ○ 필요시 대조약과의 조성 비교표를 기재할 수 있다(예 : 주사제).\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 297,
        "window_size": 3,
        "char_count": 41,
        "word_count": 11,
        "page_number": 5,
        "window_text": "시험종류\n\n시험조건\n\n용기형태/재질\n\n제조번호\n\n시험 주기\n\n시험 결과\n\n<!-- PAGE_18 -->\n##### 2.3.P 완제의약품(제품명, 제형)(Drug Product)(name, dosage form)\n\n<!-- PAGE_18 -->\n##### 2.3.P.1 완제의약품의 개요와 조성(제품명, 제형)(Description and Composition of the\n\n<!-- PAGE_18 -->\n##### Drug Product)(name, dosage form)\n\n- 3.2.P.1에서 얻은 정보를 포함한다.\n - 3.2.P.1에서 얻은 조성을 제공하여야 한다.\n <!-- PAGE_18 -->\n##### 해 설\n\n- ○ 3.2.P.1 완제의약품의 개요와 조성에서 얻은 제형에 대한 정보(성상 등), 조성(성분, 용도,\n규격, 분량)을 요약하여 표 등으로 제공하고, 첨부용제 및 제제에 사용된 용기와 마개를 포\n\n함한다.\n\n - ○ 필요시 대조약과의 조성 비교표를 기재할 수 있다(예 : 주사제).\n - ○ 조성 기재 시, 제조공정 중 제거되는 용매 및 공정보조제(processing aid)를 포함하여 완제의\n약품을 구성하는 성분, 분량, 규격 및 배합목적 등을 모두 기재한다.\n\n **[표 시작]**\n\n| 장기보존시험 | 25℃/60% RH |\n| --- | --- |\n\n**[표 끝]**\n\n- - 13 -\n- ○ 첨가제는 2.3.P.4 첨가제의 관리에 기재한다.  허가제출용 뱃치와 실생산 뱃치의 투입 원료량은\n- 2.3.P.3 제조에 기재한다. ",
        "original_sentence": "- ○ 필요시 대조약과의 조성 비교표를 기재할 수 있다(예 : 주사제).\n"
      }
    },
    {
      "chunk_id": "chunk_299",
      "text": "- ○ 조성 기재 시, 제조공정 중 제거되는 용매 및 공정보조제(processing aid)를 포함하여 완제의\n약품을 구성하는 성분, 분량, 규격 및 배합목적 등을 모두 기재한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 298,
        "window_size": 3,
        "char_count": 102,
        "word_count": 24,
        "page_number": 5,
        "window_text": "- 3.2.P.1에서 얻은 조성을 제공하여야 한다.\n <!-- PAGE_18 -->\n##### 해 설\n\n- ○ 3.2.P.1 완제의약품의 개요와 조성에서 얻은 제형에 대한 정보(성상 등), 조성(성분, 용도,\n규격, 분량)을 요약하여 표 등으로 제공하고, 첨부용제 및 제제에 사용된 용기와 마개를 포\n\n함한다.\n\n - ○ 필요시 대조약과의 조성 비교표를 기재할 수 있다(예 : 주사제).\n - ○ 조성 기재 시, 제조공정 중 제거되는 용매 및 공정보조제(processing aid)를 포함하여 완제의\n약품을 구성하는 성분, 분량, 규격 및 배합목적 등을 모두 기재한다.\n\n **[표 시작]**\n\n| 장기보존시험 | 25℃/60% RH |\n| --- | --- |\n\n**[표 끝]**\n\n- - 13 -\n- ○ 첨가제는 2.3.P.4 첨가제의 관리에 기재한다.  허가제출용 뱃치와 실생산 뱃치의 투입 원료량은\n- 2.3.P.3 제조에 기재한다.  여러 공정 단계를 거치는 방출제어 등의 완제의약품은 중요 중간체\n(예: tablet core 또는 bead) 별로 구분하여 아래 표와 같이 기재한다.\n\n",
        "original_sentence": "- ○ 조성 기재 시, 제조공정 중 제거되는 용매 및 공정보조제(processing aid)를 포함하여 완제의\n약품을 구성하는 성분, 분량, 규격 및 배합목적 등을 모두 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_300",
      "text": "**[표 시작]**\n\n| 장기보존시험 | 25℃/60% RH |\n| --- | --- |\n\n**[표 끝]**\n\n- - 13 -\n- ○ 첨가제는 2.3.P.4 첨가제의 관리에 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 299,
        "window_size": 3,
        "char_count": 103,
        "word_count": 26,
        "page_number": 5,
        "window_text": "<!-- PAGE_18 -->\n##### 해 설\n\n- ○ 3.2.P.1 완제의약품의 개요와 조성에서 얻은 제형에 대한 정보(성상 등), 조성(성분, 용도,\n규격, 분량)을 요약하여 표 등으로 제공하고, 첨부용제 및 제제에 사용된 용기와 마개를 포\n\n함한다.\n\n - ○ 필요시 대조약과의 조성 비교표를 기재할 수 있다(예 : 주사제).\n - ○ 조성 기재 시, 제조공정 중 제거되는 용매 및 공정보조제(processing aid)를 포함하여 완제의\n약품을 구성하는 성분, 분량, 규격 및 배합목적 등을 모두 기재한다.\n\n **[표 시작]**\n\n| 장기보존시험 | 25℃/60% RH |\n| --- | --- |\n\n**[표 끝]**\n\n- - 13 -\n- ○ 첨가제는 2.3.P.4 첨가제의 관리에 기재한다.  허가제출용 뱃치와 실생산 뱃치의 투입 원료량은\n- 2.3.P.3 제조에 기재한다.  여러 공정 단계를 거치는 방출제어 등의 완제의약품은 중요 중간체\n(예: tablet core 또는 bead) 별로 구분하여 아래 표와 같이 기재한다.\n\n * 제조 공정 중 제거됨\n\n- ○ 완제의약품 제조 과정에서 과량 투입 또는 과량 충전할 경우 그 근거를 기재한다.\n",
        "original_sentence": "**[표 시작]**\n\n| 장기보존시험 | 25℃/60% RH |\n| --- | --- |\n\n**[표 끝]**\n\n- - 13 -\n- ○ 첨가제는 2.3.P.4 첨가제의 관리에 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_301",
      "text": "허가제출용 뱃치와 실생산 뱃치의 투입 원료량은\n- 2.3.P.3 제조에 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 300,
        "window_size": 3,
        "char_count": 46,
        "word_count": 10,
        "page_number": 5,
        "window_text": "- ○ 필요시 대조약과의 조성 비교표를 기재할 수 있다(예 : 주사제).\n - ○ 조성 기재 시, 제조공정 중 제거되는 용매 및 공정보조제(processing aid)를 포함하여 완제의\n약품을 구성하는 성분, 분량, 규격 및 배합목적 등을 모두 기재한다.\n\n **[표 시작]**\n\n| 장기보존시험 | 25℃/60% RH |\n| --- | --- |\n\n**[표 끝]**\n\n- - 13 -\n- ○ 첨가제는 2.3.P.4 첨가제의 관리에 기재한다.  허가제출용 뱃치와 실생산 뱃치의 투입 원료량은\n- 2.3.P.3 제조에 기재한다.  여러 공정 단계를 거치는 방출제어 등의 완제의약품은 중요 중간체\n(예: tablet core 또는 bead) 별로 구분하여 아래 표와 같이 기재한다.\n\n * 제조 공정 중 제거됨\n\n- ○ 완제의약품 제조 과정에서 과량 투입 또는 과량 충전할 경우 그 근거를 기재한다.\n - ○ 사용되는 첨가제가 단일 성분이 아닐 경우(착색제, 착향제 등) 그 조성을 모두 기재한다. ",
        "original_sentence": "허가제출용 뱃치와 실생산 뱃치의 투입 원료량은\n- 2.3.P.3 제조에 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_302",
      "text": "여러 공정 단계를 거치는 방출제어 등의 완제의약품은 중요 중간체\n(예: tablet core 또는 bead) 별로 구분하여 아래 표와 같이 기재한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 301,
        "window_size": 3,
        "char_count": 85,
        "word_count": 20,
        "page_number": 26,
        "window_text": "- ○ 조성 기재 시, 제조공정 중 제거되는 용매 및 공정보조제(processing aid)를 포함하여 완제의\n약품을 구성하는 성분, 분량, 규격 및 배합목적 등을 모두 기재한다.\n\n **[표 시작]**\n\n| 장기보존시험 | 25℃/60% RH |\n| --- | --- |\n\n**[표 끝]**\n\n- - 13 -\n- ○ 첨가제는 2.3.P.4 첨가제의 관리에 기재한다.  허가제출용 뱃치와 실생산 뱃치의 투입 원료량은\n- 2.3.P.3 제조에 기재한다.  여러 공정 단계를 거치는 방출제어 등의 완제의약품은 중요 중간체\n(예: tablet core 또는 bead) 별로 구분하여 아래 표와 같이 기재한다.\n\n * 제조 공정 중 제거됨\n\n- ○ 완제의약품 제조 과정에서 과량 투입 또는 과량 충전할 경우 그 근거를 기재한다.\n - ○ 사용되는 첨가제가 단일 성분이 아닐 경우(착색제, 착향제 등) 그 조성을 모두 기재한다.  단,\n- ○ 제조공정 중 사용되는 용매에 대한 정보도 간략히 기술한다.\n",
        "original_sentence": "여러 공정 단계를 거치는 방출제어 등의 완제의약품은 중요 중간체\n(예: tablet core 또는 bead) 별로 구분하여 아래 표와 같이 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_303",
      "text": "* 제조 공정 중 제거됨\n\n- ○ 완제의약품 제조 과정에서 과량 투입 또는 과량 충전할 경우 그 근거를 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 302,
        "window_size": 3,
        "char_count": 64,
        "word_count": 19,
        "page_number": 5,
        "window_text": "**[표 시작]**\n\n| 장기보존시험 | 25℃/60% RH |\n| --- | --- |\n\n**[표 끝]**\n\n- - 13 -\n- ○ 첨가제는 2.3.P.4 첨가제의 관리에 기재한다.  허가제출용 뱃치와 실생산 뱃치의 투입 원료량은\n- 2.3.P.3 제조에 기재한다.  여러 공정 단계를 거치는 방출제어 등의 완제의약품은 중요 중간체\n(예: tablet core 또는 bead) 별로 구분하여 아래 표와 같이 기재한다.\n\n * 제조 공정 중 제거됨\n\n- ○ 완제의약품 제조 과정에서 과량 투입 또는 과량 충전할 경우 그 근거를 기재한다.\n - ○ 사용되는 첨가제가 단일 성분이 아닐 경우(착색제, 착향제 등) 그 조성을 모두 기재한다.  단,\n- ○ 제조공정 중 사용되는 용매에 대한 정보도 간략히 기술한다.\n - ○ 제조 공정 중 사용되는 용매(결합용수, 코팅용매 등)에 대해서도 기술한다.\n",
        "original_sentence": "* 제조 공정 중 제거됨\n\n- ○ 완제의약품 제조 과정에서 과량 투입 또는 과량 충전할 경우 그 근거를 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_304",
      "text": "- ○ 사용되는 첨가제가 단일 성분이 아닐 경우(착색제, 착향제 등) 그 조성을 모두 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 303,
        "window_size": 3,
        "char_count": 54,
        "word_count": 14,
        "page_number": 3,
        "window_text": "허가제출용 뱃치와 실생산 뱃치의 투입 원료량은\n- 2.3.P.3 제조에 기재한다.  여러 공정 단계를 거치는 방출제어 등의 완제의약품은 중요 중간체\n(예: tablet core 또는 bead) 별로 구분하여 아래 표와 같이 기재한다.\n\n * 제조 공정 중 제거됨\n\n- ○ 완제의약품 제조 과정에서 과량 투입 또는 과량 충전할 경우 그 근거를 기재한다.\n - ○ 사용되는 첨가제가 단일 성분이 아닐 경우(착색제, 착향제 등) 그 조성을 모두 기재한다.  단,\n- ○ 제조공정 중 사용되는 용매에 대한 정보도 간략히 기술한다.\n - ○ 제조 공정 중 사용되는 용매(결합용수, 코팅용매 등)에 대해서도 기술한다.\n - ○ 첨가제 사용량의 적절성에 대해 추가로 기재할 수 있다.\n",
        "original_sentence": "- ○ 사용되는 첨가제가 단일 성분이 아닐 경우(착색제, 착향제 등) 그 조성을 모두 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_305",
      "text": "단,\n- ○ 제조공정 중 사용되는 용매에 대한 정보도 간략히 기술한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 304,
        "window_size": 3,
        "char_count": 40,
        "word_count": 11,
        "page_number": 5,
        "window_text": "여러 공정 단계를 거치는 방출제어 등의 완제의약품은 중요 중간체\n(예: tablet core 또는 bead) 별로 구분하여 아래 표와 같이 기재한다.\n\n * 제조 공정 중 제거됨\n\n- ○ 완제의약품 제조 과정에서 과량 투입 또는 과량 충전할 경우 그 근거를 기재한다.\n - ○ 사용되는 첨가제가 단일 성분이 아닐 경우(착색제, 착향제 등) 그 조성을 모두 기재한다.  단,\n- ○ 제조공정 중 사용되는 용매에 대한 정보도 간략히 기술한다.\n - ○ 제조 공정 중 사용되는 용매(결합용수, 코팅용매 등)에 대해서도 기술한다.\n - ○ 첨가제 사용량의 적절성에 대해 추가로 기재할 수 있다.\n - ○ 대조약의 첨가제 정보가 확인되는 경우(예: 주사제 등)는 이에 대해 추가 기술할 수 있다.\n",
        "original_sentence": "단,\n- ○ 제조공정 중 사용되는 용매에 대한 정보도 간략히 기술한다.\n"
      }
    },
    {
      "chunk_id": "chunk_306",
      "text": "- ○ 제조 공정 중 사용되는 용매(결합용수, 코팅용매 등)에 대해서도 기술한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 305,
        "window_size": 3,
        "char_count": 46,
        "word_count": 11,
        "page_number": 5,
        "window_text": "* 제조 공정 중 제거됨\n\n- ○ 완제의약품 제조 과정에서 과량 투입 또는 과량 충전할 경우 그 근거를 기재한다.\n - ○ 사용되는 첨가제가 단일 성분이 아닐 경우(착색제, 착향제 등) 그 조성을 모두 기재한다.  단,\n- ○ 제조공정 중 사용되는 용매에 대한 정보도 간략히 기술한다.\n - ○ 제조 공정 중 사용되는 용매(결합용수, 코팅용매 등)에 대해서도 기술한다.\n - ○ 첨가제 사용량의 적절성에 대해 추가로 기재할 수 있다.\n - ○ 대조약의 첨가제 정보가 확인되는 경우(예: 주사제 등)는 이에 대해 추가 기술할 수 있다.\n <속방성 제제>\n\n포비돈\n\nNF\n\n결합제\n\n- 7.20\nK 값 기재\n\n크로스포비돈\n\nNF\n\n붕해제\n\n- 7.20\ntype 기재\n\n스테아르산마그네슘\n\nNF\n\n활택제\n\n- 1.20\nFD&C Blue #2\n\n별규\n\n착색제\n\n- 0.80\n정제수\n\nUSP\n\n결합용수*\n\n- -\n총 질량\n\n- - 14 -\n* 제조 공정 중 제거됨.\n\n",
        "original_sentence": "- ○ 제조 공정 중 사용되는 용매(결합용수, 코팅용매 등)에 대해서도 기술한다.\n"
      }
    },
    {
      "chunk_id": "chunk_307",
      "text": "- ○ 첨가제 사용량의 적절성에 대해 추가로 기재할 수 있다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 306,
        "window_size": 3,
        "char_count": 35,
        "word_count": 10,
        "page_number": 5,
        "window_text": "- ○ 사용되는 첨가제가 단일 성분이 아닐 경우(착색제, 착향제 등) 그 조성을 모두 기재한다.  단,\n- ○ 제조공정 중 사용되는 용매에 대한 정보도 간략히 기술한다.\n - ○ 제조 공정 중 사용되는 용매(결합용수, 코팅용매 등)에 대해서도 기술한다.\n - ○ 첨가제 사용량의 적절성에 대해 추가로 기재할 수 있다.\n - ○ 대조약의 첨가제 정보가 확인되는 경우(예: 주사제 등)는 이에 대해 추가 기술할 수 있다.\n <속방성 제제>\n\n포비돈\n\nNF\n\n결합제\n\n- 7.20\nK 값 기재\n\n크로스포비돈\n\nNF\n\n붕해제\n\n- 7.20\ntype 기재\n\n스테아르산마그네슘\n\nNF\n\n활택제\n\n- 1.20\nFD&C Blue #2\n\n별규\n\n착색제\n\n- 0.80\n정제수\n\nUSP\n\n결합용수*\n\n- -\n총 질량\n\n- - 14 -\n* 제조 공정 중 제거됨.\n\n <서방성제제>\n\n1: 히프로멜로오스와 PEG 400의 혼합물\n\n2: 제조 공정 중 제거됨\n\n<대조약과의 특징 비교표 - 서방캡슐>\n\n성분\n\n규격\n\n배합목적\n\n질량 (mg)\n\n비고\n\n방출제어(Controlled Released, CR) 펠렛\n\n대조약\n\n신청품목\n\n검토의견\n\n제형\n\n캡슐\n\n캡슐\n\n제제학적 동등성\n\n제제설계\n\n용출시험 결과 속방층(주성\n\n분 함량 25%) 및 서방층(주\n\n주성분 25%를 함유하는 속방\n\n펠렛 및 주성분 75%를 함유하\n\n생체 내 유사한 약물방출 설계\n\n- - 15 -\n<!-- PAGE_21 -->\n##### 2.3.P.2 개발경위(제품명, 제형)(Pharmaceutical Development)(name, dosage form)\n\n- 3.2.P.2.에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n",
        "original_sentence": "- ○ 첨가제 사용량의 적절성에 대해 추가로 기재할 수 있다.\n"
      }
    },
    {
      "chunk_id": "chunk_308",
      "text": "- ○ 대조약의 첨가제 정보가 확인되는 경우(예: 주사제 등)는 이에 대해 추가 기술할 수 있다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 307,
        "window_size": 3,
        "char_count": 55,
        "word_count": 15,
        "page_number": 3,
        "window_text": "단,\n- ○ 제조공정 중 사용되는 용매에 대한 정보도 간략히 기술한다.\n - ○ 제조 공정 중 사용되는 용매(결합용수, 코팅용매 등)에 대해서도 기술한다.\n - ○ 첨가제 사용량의 적절성에 대해 추가로 기재할 수 있다.\n - ○ 대조약의 첨가제 정보가 확인되는 경우(예: 주사제 등)는 이에 대해 추가 기술할 수 있다.\n <속방성 제제>\n\n포비돈\n\nNF\n\n결합제\n\n- 7.20\nK 값 기재\n\n크로스포비돈\n\nNF\n\n붕해제\n\n- 7.20\ntype 기재\n\n스테아르산마그네슘\n\nNF\n\n활택제\n\n- 1.20\nFD&C Blue #2\n\n별규\n\n착색제\n\n- 0.80\n정제수\n\nUSP\n\n결합용수*\n\n- -\n총 질량\n\n- - 14 -\n* 제조 공정 중 제거됨.\n\n <서방성제제>\n\n1: 히프로멜로오스와 PEG 400의 혼합물\n\n2: 제조 공정 중 제거됨\n\n<대조약과의 특징 비교표 - 서방캡슐>\n\n성분\n\n규격\n\n배합목적\n\n질량 (mg)\n\n비고\n\n방출제어(Controlled Released, CR) 펠렛\n\n대조약\n\n신청품목\n\n검토의견\n\n제형\n\n캡슐\n\n캡슐\n\n제제학적 동등성\n\n제제설계\n\n용출시험 결과 속방층(주성\n\n분 함량 25%) 및 서방층(주\n\n주성분 25%를 함유하는 속방\n\n펠렛 및 주성분 75%를 함유하\n\n생체 내 유사한 약물방출 설계\n\n- - 15 -\n<!-- PAGE_21 -->\n##### 2.3.P.2 개발경위(제품명, 제형)(Pharmaceutical Development)(name, dosage form)\n\n- 3.2.P.2.에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n 필요에 따라 임상시험에서 사용된 제형의 조성에 대한 도표 요약과 용출 프로파일을 제공하여야\n\n한다.\n\n",
        "original_sentence": "- ○ 대조약의 첨가제 정보가 확인되는 경우(예: 주사제 등)는 이에 대해 추가 기술할 수 있다.\n"
      }
    },
    {
      "chunk_id": "chunk_309",
      "text": "<속방성 제제>\n\n포비돈\n\nNF\n\n결합제\n\n- 7.20\nK 값 기재\n\n크로스포비돈\n\nNF\n\n붕해제\n\n- 7.20\ntype 기재\n\n스테아르산마그네슘\n\nNF\n\n활택제\n\n- 1.20\nFD&C Blue #2\n\n별규\n\n착색제\n\n- 0.80\n정제수\n\nUSP\n\n결합용수*\n\n- -\n총 질량\n\n- - 14 -\n* 제조 공정 중 제거됨.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 308,
        "window_size": 3,
        "char_count": 181,
        "word_count": 45,
        "page_number": 5,
        "window_text": "- ○ 제조 공정 중 사용되는 용매(결합용수, 코팅용매 등)에 대해서도 기술한다.\n - ○ 첨가제 사용량의 적절성에 대해 추가로 기재할 수 있다.\n - ○ 대조약의 첨가제 정보가 확인되는 경우(예: 주사제 등)는 이에 대해 추가 기술할 수 있다.\n <속방성 제제>\n\n포비돈\n\nNF\n\n결합제\n\n- 7.20\nK 값 기재\n\n크로스포비돈\n\nNF\n\n붕해제\n\n- 7.20\ntype 기재\n\n스테아르산마그네슘\n\nNF\n\n활택제\n\n- 1.20\nFD&C Blue #2\n\n별규\n\n착색제\n\n- 0.80\n정제수\n\nUSP\n\n결합용수*\n\n- -\n총 질량\n\n- - 14 -\n* 제조 공정 중 제거됨.\n\n <서방성제제>\n\n1: 히프로멜로오스와 PEG 400의 혼합물\n\n2: 제조 공정 중 제거됨\n\n<대조약과의 특징 비교표 - 서방캡슐>\n\n성분\n\n규격\n\n배합목적\n\n질량 (mg)\n\n비고\n\n방출제어(Controlled Released, CR) 펠렛\n\n대조약\n\n신청품목\n\n검토의견\n\n제형\n\n캡슐\n\n캡슐\n\n제제학적 동등성\n\n제제설계\n\n용출시험 결과 속방층(주성\n\n분 함량 25%) 및 서방층(주\n\n주성분 25%를 함유하는 속방\n\n펠렛 및 주성분 75%를 함유하\n\n생체 내 유사한 약물방출 설계\n\n- - 15 -\n<!-- PAGE_21 -->\n##### 2.3.P.2 개발경위(제품명, 제형)(Pharmaceutical Development)(name, dosage form)\n\n- 3.2.P.2.에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n 필요에 따라 임상시험에서 사용된 제형의 조성에 대한 도표 요약과 용출 프로파일을 제공하여야\n\n한다.\n\n - ○ 3.2.P.2. ",
        "original_sentence": "<속방성 제제>\n\n포비돈\n\nNF\n\n결합제\n\n- 7.20\nK 값 기재\n\n크로스포비돈\n\nNF\n\n붕해제\n\n- 7.20\ntype 기재\n\n스테아르산마그네슘\n\nNF\n\n활택제\n\n- 1.20\nFD&C Blue #2\n\n별규\n\n착색제\n\n- 0.80\n정제수\n\nUSP\n\n결합용수*\n\n- -\n총 질량\n\n- - 14 -\n* 제조 공정 중 제거됨.\n\n"
      }
    },
    {
      "chunk_id": "chunk_310",
      "text": "<서방성제제>\n\n1: 히프로멜로오스와 PEG 400의 혼합물\n\n2: 제조 공정 중 제거됨\n\n<대조약과의 특징 비교표 - 서방캡슐>\n\n성분\n\n규격\n\n배합목적\n\n질량 (mg)\n\n비고\n\n방출제어(Controlled Released, CR) 펠렛\n\n대조약\n\n신청품목\n\n검토의견\n\n제형\n\n캡슐\n\n캡슐\n\n제제학적 동등성\n\n제제설계\n\n용출시험 결과 속방층(주성\n\n분 함량 25%) 및 서방층(주\n\n주성분 25%를 함유하는 속방\n\n펠렛 및 주성분 75%를 함유하\n\n생체 내 유사한 약물방출 설계\n\n- - 15 -\n<!-- PAGE_21 -->\n##### 2.3.P.2 개발경위(제품명, 제형)(Pharmaceutical Development)(name, dosage form)\n\n- 3.2.P.2.에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 309,
        "window_size": 3,
        "char_count": 413,
        "word_count": 80,
        "page_number": 21,
        "window_text": "- ○ 첨가제 사용량의 적절성에 대해 추가로 기재할 수 있다.\n - ○ 대조약의 첨가제 정보가 확인되는 경우(예: 주사제 등)는 이에 대해 추가 기술할 수 있다.\n <속방성 제제>\n\n포비돈\n\nNF\n\n결합제\n\n- 7.20\nK 값 기재\n\n크로스포비돈\n\nNF\n\n붕해제\n\n- 7.20\ntype 기재\n\n스테아르산마그네슘\n\nNF\n\n활택제\n\n- 1.20\nFD&C Blue #2\n\n별규\n\n착색제\n\n- 0.80\n정제수\n\nUSP\n\n결합용수*\n\n- -\n총 질량\n\n- - 14 -\n* 제조 공정 중 제거됨.\n\n <서방성제제>\n\n1: 히프로멜로오스와 PEG 400의 혼합물\n\n2: 제조 공정 중 제거됨\n\n<대조약과의 특징 비교표 - 서방캡슐>\n\n성분\n\n규격\n\n배합목적\n\n질량 (mg)\n\n비고\n\n방출제어(Controlled Released, CR) 펠렛\n\n대조약\n\n신청품목\n\n검토의견\n\n제형\n\n캡슐\n\n캡슐\n\n제제학적 동등성\n\n제제설계\n\n용출시험 결과 속방층(주성\n\n분 함량 25%) 및 서방층(주\n\n주성분 25%를 함유하는 속방\n\n펠렛 및 주성분 75%를 함유하\n\n생체 내 유사한 약물방출 설계\n\n- - 15 -\n<!-- PAGE_21 -->\n##### 2.3.P.2 개발경위(제품명, 제형)(Pharmaceutical Development)(name, dosage form)\n\n- 3.2.P.2.에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n 필요에 따라 임상시험에서 사용된 제형의 조성에 대한 도표 요약과 용출 프로파일을 제공하여야\n\n한다.\n\n - ○ 3.2.P.2.  개발경위에서 얻은 정보와 자료에 대한 고찰을 요약하여 기재하되, 개발계획을 수\n- ○ 필요 시 대조약(제품명)에 대한 정보를 기재할 수 있다.\n",
        "original_sentence": "<서방성제제>\n\n1: 히프로멜로오스와 PEG 400의 혼합물\n\n2: 제조 공정 중 제거됨\n\n<대조약과의 특징 비교표 - 서방캡슐>\n\n성분\n\n규격\n\n배합목적\n\n질량 (mg)\n\n비고\n\n방출제어(Controlled Released, CR) 펠렛\n\n대조약\n\n신청품목\n\n검토의견\n\n제형\n\n캡슐\n\n캡슐\n\n제제학적 동등성\n\n제제설계\n\n용출시험 결과 속방층(주성\n\n분 함량 25%) 및 서방층(주\n\n주성분 25%를 함유하는 속방\n\n펠렛 및 주성분 75%를 함유하\n\n생체 내 유사한 약물방출 설계\n\n- - 15 -\n<!-- PAGE_21 -->\n##### 2.3.P.2 개발경위(제품명, 제형)(Pharmaceutical Development)(name, dosage form)\n\n- 3.2.P.2.에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n"
      }
    },
    {
      "chunk_id": "chunk_311",
      "text": "필요에 따라 임상시험에서 사용된 제형의 조성에 대한 도표 요약과 용출 프로파일을 제공하여야\n\n한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 310,
        "window_size": 3,
        "char_count": 57,
        "word_count": 13,
        "page_number": 21,
        "window_text": "- ○ 대조약의 첨가제 정보가 확인되는 경우(예: 주사제 등)는 이에 대해 추가 기술할 수 있다.\n <속방성 제제>\n\n포비돈\n\nNF\n\n결합제\n\n- 7.20\nK 값 기재\n\n크로스포비돈\n\nNF\n\n붕해제\n\n- 7.20\ntype 기재\n\n스테아르산마그네슘\n\nNF\n\n활택제\n\n- 1.20\nFD&C Blue #2\n\n별규\n\n착색제\n\n- 0.80\n정제수\n\nUSP\n\n결합용수*\n\n- -\n총 질량\n\n- - 14 -\n* 제조 공정 중 제거됨.\n\n <서방성제제>\n\n1: 히프로멜로오스와 PEG 400의 혼합물\n\n2: 제조 공정 중 제거됨\n\n<대조약과의 특징 비교표 - 서방캡슐>\n\n성분\n\n규격\n\n배합목적\n\n질량 (mg)\n\n비고\n\n방출제어(Controlled Released, CR) 펠렛\n\n대조약\n\n신청품목\n\n검토의견\n\n제형\n\n캡슐\n\n캡슐\n\n제제학적 동등성\n\n제제설계\n\n용출시험 결과 속방층(주성\n\n분 함량 25%) 및 서방층(주\n\n주성분 25%를 함유하는 속방\n\n펠렛 및 주성분 75%를 함유하\n\n생체 내 유사한 약물방출 설계\n\n- - 15 -\n<!-- PAGE_21 -->\n##### 2.3.P.2 개발경위(제품명, 제형)(Pharmaceutical Development)(name, dosage form)\n\n- 3.2.P.2.에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n 필요에 따라 임상시험에서 사용된 제형의 조성에 대한 도표 요약과 용출 프로파일을 제공하여야\n\n한다.\n\n - ○ 3.2.P.2.  개발경위에서 얻은 정보와 자료에 대한 고찰을 요약하여 기재하되, 개발계획을 수\n- ○ 필요 시 대조약(제품명)에 대한 정보를 기재할 수 있다.\n - ○ 제품의 개발, 생산에 영향을 미치는 원료의약품의 특징, 첨가제의 선정 사유 등에 대해\n- ○ 제조방법 개발과정에 대해 기재한다.\n",
        "original_sentence": "필요에 따라 임상시험에서 사용된 제형의 조성에 대한 도표 요약과 용출 프로파일을 제공하여야\n\n한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_312",
      "text": "- ○ 3.2.P.2. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 311,
        "window_size": 3,
        "char_count": 13,
        "word_count": 3,
        "page_number": 5,
        "window_text": "<속방성 제제>\n\n포비돈\n\nNF\n\n결합제\n\n- 7.20\nK 값 기재\n\n크로스포비돈\n\nNF\n\n붕해제\n\n- 7.20\ntype 기재\n\n스테아르산마그네슘\n\nNF\n\n활택제\n\n- 1.20\nFD&C Blue #2\n\n별규\n\n착색제\n\n- 0.80\n정제수\n\nUSP\n\n결합용수*\n\n- -\n총 질량\n\n- - 14 -\n* 제조 공정 중 제거됨.\n\n <서방성제제>\n\n1: 히프로멜로오스와 PEG 400의 혼합물\n\n2: 제조 공정 중 제거됨\n\n<대조약과의 특징 비교표 - 서방캡슐>\n\n성분\n\n규격\n\n배합목적\n\n질량 (mg)\n\n비고\n\n방출제어(Controlled Released, CR) 펠렛\n\n대조약\n\n신청품목\n\n검토의견\n\n제형\n\n캡슐\n\n캡슐\n\n제제학적 동등성\n\n제제설계\n\n용출시험 결과 속방층(주성\n\n분 함량 25%) 및 서방층(주\n\n주성분 25%를 함유하는 속방\n\n펠렛 및 주성분 75%를 함유하\n\n생체 내 유사한 약물방출 설계\n\n- - 15 -\n<!-- PAGE_21 -->\n##### 2.3.P.2 개발경위(제품명, 제형)(Pharmaceutical Development)(name, dosage form)\n\n- 3.2.P.2.에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n 필요에 따라 임상시험에서 사용된 제형의 조성에 대한 도표 요약과 용출 프로파일을 제공하여야\n\n한다.\n\n - ○ 3.2.P.2.  개발경위에서 얻은 정보와 자료에 대한 고찰을 요약하여 기재하되, 개발계획을 수\n- ○ 필요 시 대조약(제품명)에 대한 정보를 기재할 수 있다.\n - ○ 제품의 개발, 생산에 영향을 미치는 원료의약품의 특징, 첨가제의 선정 사유 등에 대해\n- ○ 제조방법 개발과정에 대해 기재한다.\n - ○ 필요 시 대조약과의 이화학적동등성시험 결과, 생물학적동등성시험 결과 등에 대해 요약하여\n- ○ 필요 시, 대조약의 제제 또는 제법 특허를 회피한 경우 해당 정보를 기재할 수 있다.\n",
        "original_sentence": "- ○ 3.2.P.2. "
      }
    },
    {
      "chunk_id": "chunk_313",
      "text": "개발경위에서 얻은 정보와 자료에 대한 고찰을 요약하여 기재하되, 개발계획을 수\n- ○ 필요 시 대조약(제품명)에 대한 정보를 기재할 수 있다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 312,
        "window_size": 3,
        "char_count": 80,
        "word_count": 20,
        "page_number": 5,
        "window_text": "<서방성제제>\n\n1: 히프로멜로오스와 PEG 400의 혼합물\n\n2: 제조 공정 중 제거됨\n\n<대조약과의 특징 비교표 - 서방캡슐>\n\n성분\n\n규격\n\n배합목적\n\n질량 (mg)\n\n비고\n\n방출제어(Controlled Released, CR) 펠렛\n\n대조약\n\n신청품목\n\n검토의견\n\n제형\n\n캡슐\n\n캡슐\n\n제제학적 동등성\n\n제제설계\n\n용출시험 결과 속방층(주성\n\n분 함량 25%) 및 서방층(주\n\n주성분 25%를 함유하는 속방\n\n펠렛 및 주성분 75%를 함유하\n\n생체 내 유사한 약물방출 설계\n\n- - 15 -\n<!-- PAGE_21 -->\n##### 2.3.P.2 개발경위(제품명, 제형)(Pharmaceutical Development)(name, dosage form)\n\n- 3.2.P.2.에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n 필요에 따라 임상시험에서 사용된 제형의 조성에 대한 도표 요약과 용출 프로파일을 제공하여야\n\n한다.\n\n - ○ 3.2.P.2.  개발경위에서 얻은 정보와 자료에 대한 고찰을 요약하여 기재하되, 개발계획을 수\n- ○ 필요 시 대조약(제품명)에 대한 정보를 기재할 수 있다.\n - ○ 제품의 개발, 생산에 영향을 미치는 원료의약품의 특징, 첨가제의 선정 사유 등에 대해\n- ○ 제조방법 개발과정에 대해 기재한다.\n - ○ 필요 시 대조약과의 이화학적동등성시험 결과, 생물학적동등성시험 결과 등에 대해 요약하여\n- ○ 필요 시, 대조약의 제제 또는 제법 특허를 회피한 경우 해당 정보를 기재할 수 있다.\n - ○ 2.3.P.2.1. ",
        "original_sentence": "개발경위에서 얻은 정보와 자료에 대한 고찰을 요약하여 기재하되, 개발계획을 수\n- ○ 필요 시 대조약(제품명)에 대한 정보를 기재할 수 있다.\n"
      }
    },
    {
      "chunk_id": "chunk_314",
      "text": "- ○ 제품의 개발, 생산에 영향을 미치는 원료의약품의 특징, 첨가제의 선정 사유 등에 대해\n- ○ 제조방법 개발과정에 대해 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 313,
        "window_size": 3,
        "char_count": 76,
        "word_count": 20,
        "page_number": 5,
        "window_text": "필요에 따라 임상시험에서 사용된 제형의 조성에 대한 도표 요약과 용출 프로파일을 제공하여야\n\n한다.\n\n - ○ 3.2.P.2.  개발경위에서 얻은 정보와 자료에 대한 고찰을 요약하여 기재하되, 개발계획을 수\n- ○ 필요 시 대조약(제품명)에 대한 정보를 기재할 수 있다.\n - ○ 제품의 개발, 생산에 영향을 미치는 원료의약품의 특징, 첨가제의 선정 사유 등에 대해\n- ○ 제조방법 개발과정에 대해 기재한다.\n - ○ 필요 시 대조약과의 이화학적동등성시험 결과, 생물학적동등성시험 결과 등에 대해 요약하여\n- ○ 필요 시, 대조약의 제제 또는 제법 특허를 회피한 경우 해당 정보를 기재할 수 있다.\n - ○ 2.3.P.2.1.  완제의약품의 조성에는 제조방법 초기 연구 및 스케일업, 그 근거 등에 대해\n기재한다.\n\n",
        "original_sentence": "- ○ 제품의 개발, 생산에 영향을 미치는 원료의약품의 특징, 첨가제의 선정 사유 등에 대해\n- ○ 제조방법 개발과정에 대해 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_315",
      "text": "- ○ 필요 시 대조약과의 이화학적동등성시험 결과, 생물학적동등성시험 결과 등에 대해 요약하여\n- ○ 필요 시, 대조약의 제제 또는 제법 특허를 회피한 경우 해당 정보를 기재할 수 있다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 314,
        "window_size": 3,
        "char_count": 105,
        "word_count": 28,
        "page_number": 3,
        "window_text": "- ○ 3.2.P.2.  개발경위에서 얻은 정보와 자료에 대한 고찰을 요약하여 기재하되, 개발계획을 수\n- ○ 필요 시 대조약(제품명)에 대한 정보를 기재할 수 있다.\n - ○ 제품의 개발, 생산에 영향을 미치는 원료의약품의 특징, 첨가제의 선정 사유 등에 대해\n- ○ 제조방법 개발과정에 대해 기재한다.\n - ○ 필요 시 대조약과의 이화학적동등성시험 결과, 생물학적동등성시험 결과 등에 대해 요약하여\n- ○ 필요 시, 대조약의 제제 또는 제법 특허를 회피한 경우 해당 정보를 기재할 수 있다.\n - ○ 2.3.P.2.1.  완제의약품의 조성에는 제조방법 초기 연구 및 스케일업, 그 근거 등에 대해\n기재한다.\n\n - ○ 2.3.P.2.1.1. ",
        "original_sentence": "- ○ 필요 시 대조약과의 이화학적동등성시험 결과, 생물학적동등성시험 결과 등에 대해 요약하여\n- ○ 필요 시, 대조약의 제제 또는 제법 특허를 회피한 경우 해당 정보를 기재할 수 있다.\n"
      }
    },
    {
      "chunk_id": "chunk_316",
      "text": "- ○ 2.3.P.2.1. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 315,
        "window_size": 3,
        "char_count": 15,
        "word_count": 3,
        "page_number": 5,
        "window_text": "개발경위에서 얻은 정보와 자료에 대한 고찰을 요약하여 기재하되, 개발계획을 수\n- ○ 필요 시 대조약(제품명)에 대한 정보를 기재할 수 있다.\n - ○ 제품의 개발, 생산에 영향을 미치는 원료의약품의 특징, 첨가제의 선정 사유 등에 대해\n- ○ 제조방법 개발과정에 대해 기재한다.\n - ○ 필요 시 대조약과의 이화학적동등성시험 결과, 생물학적동등성시험 결과 등에 대해 요약하여\n- ○ 필요 시, 대조약의 제제 또는 제법 특허를 회피한 경우 해당 정보를 기재할 수 있다.\n - ○ 2.3.P.2.1.  완제의약품의 조성에는 제조방법 초기 연구 및 스케일업, 그 근거 등에 대해\n기재한다.\n\n - ○ 2.3.P.2.1.1.  원료의약품에는 완제의약품의 안정성, 제조, 또는 생물약제학적으로 영향을\n미치는 원료의약품의 특성 또는 물리화학적 성질을 기재하고, 그 근거로 수행한 시험결과를\n\n요약한다 (예: 원료의약품 입자도와 완제의약품 용출패턴과의 관계 등).\n\n",
        "original_sentence": "- ○ 2.3.P.2.1. "
      }
    },
    {
      "chunk_id": "chunk_317",
      "text": "완제의약품의 조성에는 제조방법 초기 연구 및 스케일업, 그 근거 등에 대해\n기재한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 316,
        "window_size": 3,
        "char_count": 49,
        "word_count": 12,
        "page_number": 13,
        "window_text": "- ○ 제품의 개발, 생산에 영향을 미치는 원료의약품의 특징, 첨가제의 선정 사유 등에 대해\n- ○ 제조방법 개발과정에 대해 기재한다.\n - ○ 필요 시 대조약과의 이화학적동등성시험 결과, 생물학적동등성시험 결과 등에 대해 요약하여\n- ○ 필요 시, 대조약의 제제 또는 제법 특허를 회피한 경우 해당 정보를 기재할 수 있다.\n - ○ 2.3.P.2.1.  완제의약품의 조성에는 제조방법 초기 연구 및 스케일업, 그 근거 등에 대해\n기재한다.\n\n - ○ 2.3.P.2.1.1.  원료의약품에는 완제의약품의 안정성, 제조, 또는 생물약제학적으로 영향을\n미치는 원료의약품의 특성 또는 물리화학적 성질을 기재하고, 그 근거로 수행한 시험결과를\n\n요약한다 (예: 원료의약품 입자도와 완제의약품 용출패턴과의 관계 등).\n\n 원료의약품의 안정성시험 결과는 완제의약품의 설계, 성능 및 제조에 영향을 줄 수 있으므로\n\n**[표 시작]**\n\n| 해 설 | 예 시 | Lot #9A | 25 ± 2℃ | 적으로 영향을 미치므로 제조공정 중 중요단계로 확인되었다. ",
        "original_sentence": "완제의약품의 조성에는 제조방법 초기 연구 및 스케일업, 그 근거 등에 대해\n기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_318",
      "text": "- ○ 2.3.P.2.1.1. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 317,
        "window_size": 3,
        "char_count": 17,
        "word_count": 3,
        "page_number": 5,
        "window_text": "- ○ 필요 시 대조약과의 이화학적동등성시험 결과, 생물학적동등성시험 결과 등에 대해 요약하여\n- ○ 필요 시, 대조약의 제제 또는 제법 특허를 회피한 경우 해당 정보를 기재할 수 있다.\n - ○ 2.3.P.2.1.  완제의약품의 조성에는 제조방법 초기 연구 및 스케일업, 그 근거 등에 대해\n기재한다.\n\n - ○ 2.3.P.2.1.1.  원료의약품에는 완제의약품의 안정성, 제조, 또는 생물약제학적으로 영향을\n미치는 원료의약품의 특성 또는 물리화학적 성질을 기재하고, 그 근거로 수행한 시험결과를\n\n요약한다 (예: 원료의약품 입자도와 완제의약품 용출패턴과의 관계 등).\n\n 원료의약품의 안정성시험 결과는 완제의약품의 설계, 성능 및 제조에 영향을 줄 수 있으므로\n\n**[표 시작]**\n\n| 해 설 | 예 시 | Lot #9A | 25 ± 2℃ | 적으로 영향을 미치므로 제조공정 중 중요단계로 확인되었다.  | 검출기 | UV (파장 272 nm) | 산출량 | 47.04kg(98%) | 48kg(100%) | 96% | 시험조건 | 설정값 | 성분 함량 75%)으로 설계 | 는 서방 펠렛 혼합물로 구성하 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 성상 | 주성분 함량 | Impurity A | 적합 | Impurity E |\n| 펠렛이 충진되어 있다. ",
        "original_sentence": "- ○ 2.3.P.2.1.1. "
      }
    },
    {
      "chunk_id": "chunk_319",
      "text": "원료의약품에는 완제의약품의 안정성, 제조, 또는 생물약제학적으로 영향을\n미치는 원료의약품의 특성 또는 물리화학적 성질을 기재하고, 그 근거로 수행한 시험결과를\n\n요약한다 (예: 원료의약품 입자도와 완제의약품 용출패턴과의 관계 등).\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 318,
        "window_size": 3,
        "char_count": 131,
        "word_count": 26,
        "page_number": 56,
        "window_text": "- ○ 2.3.P.2.1.  완제의약품의 조성에는 제조방법 초기 연구 및 스케일업, 그 근거 등에 대해\n기재한다.\n\n - ○ 2.3.P.2.1.1.  원료의약품에는 완제의약품의 안정성, 제조, 또는 생물약제학적으로 영향을\n미치는 원료의약품의 특성 또는 물리화학적 성질을 기재하고, 그 근거로 수행한 시험결과를\n\n요약한다 (예: 원료의약품 입자도와 완제의약품 용출패턴과의 관계 등).\n\n 원료의약품의 안정성시험 결과는 완제의약품의 설계, 성능 및 제조에 영향을 줄 수 있으므로\n\n**[표 시작]**\n\n| 해 설 | 예 시 | Lot #9A | 25 ± 2℃ | 적으로 영향을 미치므로 제조공정 중 중요단계로 확인되었다.  | 검출기 | UV (파장 272 nm) | 산출량 | 47.04kg(98%) | 48kg(100%) | 96% | 시험조건 | 설정값 | 성분 함량 75%)으로 설계 | 는 서방 펠렛 혼합물로 구성하 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 성상 | 주성분 함량 | Impurity A | 적합 | Impurity E |\n| 펠렛이 충진되어 있다.  | <서방성 제제> |\n| 또는 서술 형태의 요약자료로 제출한다. ",
        "original_sentence": "원료의약품에는 완제의약품의 안정성, 제조, 또는 생물약제학적으로 영향을\n미치는 원료의약품의 특성 또는 물리화학적 성질을 기재하고, 그 근거로 수행한 시험결과를\n\n요약한다 (예: 원료의약품 입자도와 완제의약품 용출패턴과의 관계 등).\n\n"
      }
    },
    {
      "chunk_id": "chunk_320",
      "text": "원료의약품의 안정성시험 결과는 완제의약품의 설계, 성능 및 제조에 영향을 줄 수 있으므로\n\n**[표 시작]**\n\n| 해 설 | 예 시 | Lot #9A | 25 ± 2℃ | 적으로 영향을 미치므로 제조공정 중 중요단계로 확인되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 319,
        "window_size": 3,
        "char_count": 130,
        "word_count": 35,
        "page_number": 21,
        "window_text": "완제의약품의 조성에는 제조방법 초기 연구 및 스케일업, 그 근거 등에 대해\n기재한다.\n\n - ○ 2.3.P.2.1.1.  원료의약품에는 완제의약품의 안정성, 제조, 또는 생물약제학적으로 영향을\n미치는 원료의약품의 특성 또는 물리화학적 성질을 기재하고, 그 근거로 수행한 시험결과를\n\n요약한다 (예: 원료의약품 입자도와 완제의약품 용출패턴과의 관계 등).\n\n 원료의약품의 안정성시험 결과는 완제의약품의 설계, 성능 및 제조에 영향을 줄 수 있으므로\n\n**[표 시작]**\n\n| 해 설 | 예 시 | Lot #9A | 25 ± 2℃ | 적으로 영향을 미치므로 제조공정 중 중요단계로 확인되었다.  | 검출기 | UV (파장 272 nm) | 산출량 | 47.04kg(98%) | 48kg(100%) | 96% | 시험조건 | 설정값 | 성분 함량 75%)으로 설계 | 는 서방 펠렛 혼합물로 구성하 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 성상 | 주성분 함량 | Impurity A | 적합 | Impurity E |\n| 펠렛이 충진되어 있다.  | <서방성 제제> |\n| 또는 서술 형태의 요약자료로 제출한다.  | 주입량 | 10 ㎕ | 건조한다. ",
        "original_sentence": "원료의약품의 안정성시험 결과는 완제의약품의 설계, 성능 및 제조에 영향을 줄 수 있으므로\n\n**[표 시작]**\n\n| 해 설 | 예 시 | Lot #9A | 25 ± 2℃ | 적으로 영향을 미치므로 제조공정 중 중요단계로 확인되었다. "
      }
    },
    {
      "chunk_id": "chunk_321",
      "text": "| 검출기 | UV (파장 272 nm) | 산출량 | 47.04kg(98%) | 48kg(100%) | 96% | 시험조건 | 설정값 | 성분 함량 75%)으로 설계 | 는 서방 펠렛 혼합물로 구성하 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 성상 | 주성분 함량 | Impurity A | 적합 | Impurity E |\n| 펠렛이 충진되어 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 320,
        "window_size": 3,
        "char_count": 269,
        "word_count": 80,
        "page_number": 5,
        "window_text": "- ○ 2.3.P.2.1.1.  원료의약품에는 완제의약품의 안정성, 제조, 또는 생물약제학적으로 영향을\n미치는 원료의약품의 특성 또는 물리화학적 성질을 기재하고, 그 근거로 수행한 시험결과를\n\n요약한다 (예: 원료의약품 입자도와 완제의약품 용출패턴과의 관계 등).\n\n 원료의약품의 안정성시험 결과는 완제의약품의 설계, 성능 및 제조에 영향을 줄 수 있으므로\n\n**[표 시작]**\n\n| 해 설 | 예 시 | Lot #9A | 25 ± 2℃ | 적으로 영향을 미치므로 제조공정 중 중요단계로 확인되었다.  | 검출기 | UV (파장 272 nm) | 산출량 | 47.04kg(98%) | 48kg(100%) | 96% | 시험조건 | 설정값 | 성분 함량 75%)으로 설계 | 는 서방 펠렛 혼합물로 구성하 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 성상 | 주성분 함량 | Impurity A | 적합 | Impurity E |\n| 펠렛이 충진되어 있다.  | <서방성 제제> |\n| 또는 서술 형태의 요약자료로 제출한다.  | 주입량 | 10 ㎕ | 건조한다.  | 된 제형을 나타냄 | 흰색의 과립 | 여 개발 | 평균질량 △~△mg, | M-1234 |\n| 0, 3, 6, 9, 12 개월 | 60 정 병포장 | Lot #10A | 모두의 100% 질량확인 기능이 있는 캡슐 충진 기계에서 수행될 것이다. ",
        "original_sentence": "| 검출기 | UV (파장 272 nm) | 산출량 | 47.04kg(98%) | 48kg(100%) | 96% | 시험조건 | 설정값 | 성분 함량 75%)으로 설계 | 는 서방 펠렛 혼합물로 구성하 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 성상 | 주성분 함량 | Impurity A | 적합 | Impurity E |\n| 펠렛이 충진되어 있다. "
      }
    },
    {
      "chunk_id": "chunk_322",
      "text": "| <서방성 제제> |\n| 또는 서술 형태의 요약자료로 제출한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 321,
        "window_size": 3,
        "char_count": 37,
        "word_count": 10,
        "page_number": 13,
        "window_text": "원료의약품에는 완제의약품의 안정성, 제조, 또는 생물약제학적으로 영향을\n미치는 원료의약품의 특성 또는 물리화학적 성질을 기재하고, 그 근거로 수행한 시험결과를\n\n요약한다 (예: 원료의약품 입자도와 완제의약품 용출패턴과의 관계 등).\n\n 원료의약품의 안정성시험 결과는 완제의약품의 설계, 성능 및 제조에 영향을 줄 수 있으므로\n\n**[표 시작]**\n\n| 해 설 | 예 시 | Lot #9A | 25 ± 2℃ | 적으로 영향을 미치므로 제조공정 중 중요단계로 확인되었다.  | 검출기 | UV (파장 272 nm) | 산출량 | 47.04kg(98%) | 48kg(100%) | 96% | 시험조건 | 설정값 | 성분 함량 75%)으로 설계 | 는 서방 펠렛 혼합물로 구성하 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 성상 | 주성분 함량 | Impurity A | 적합 | Impurity E |\n| 펠렛이 충진되어 있다.  | <서방성 제제> |\n| 또는 서술 형태의 요약자료로 제출한다.  | 주입량 | 10 ㎕ | 건조한다.  | 된 제형을 나타냄 | 흰색의 과립 | 여 개발 | 평균질량 △~△mg, | M-1234 |\n| 0, 3, 6, 9, 12 개월 | 60 정 병포장 | Lot #10A | 모두의 100% 질량확인 기능이 있는 캡슐 충진 기계에서 수행될 것이다.  캡슐충진공정 공 | 제조를 위해 이용될 수 있는 공정변수를 선택하기 위해 이용되어, 유사성 인자 >50 (즉 | 시점 | 제조번호 P034 시험 결과 | 설정 기준 | 근거 | 시험액 | 함량 | (%) | 99.1% | (%) | (%) |\n| 1. ",
        "original_sentence": "| <서방성 제제> |\n| 또는 서술 형태의 요약자료로 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_323",
      "text": "| 주입량 | 10 ㎕ | 건조한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 322,
        "window_size": 3,
        "char_count": 21,
        "word_count": 7,
        "page_number": 5,
        "window_text": "원료의약품의 안정성시험 결과는 완제의약품의 설계, 성능 및 제조에 영향을 줄 수 있으므로\n\n**[표 시작]**\n\n| 해 설 | 예 시 | Lot #9A | 25 ± 2℃ | 적으로 영향을 미치므로 제조공정 중 중요단계로 확인되었다.  | 검출기 | UV (파장 272 nm) | 산출량 | 47.04kg(98%) | 48kg(100%) | 96% | 시험조건 | 설정값 | 성분 함량 75%)으로 설계 | 는 서방 펠렛 혼합물로 구성하 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 성상 | 주성분 함량 | Impurity A | 적합 | Impurity E |\n| 펠렛이 충진되어 있다.  | <서방성 제제> |\n| 또는 서술 형태의 요약자료로 제출한다.  | 주입량 | 10 ㎕ | 건조한다.  | 된 제형을 나타냄 | 흰색의 과립 | 여 개발 | 평균질량 △~△mg, | M-1234 |\n| 0, 3, 6, 9, 12 개월 | 60 정 병포장 | Lot #10A | 모두의 100% 질량확인 기능이 있는 캡슐 충진 기계에서 수행될 것이다.  캡슐충진공정 공 | 제조를 위해 이용될 수 있는 공정변수를 선택하기 위해 이용되어, 유사성 인자 >50 (즉 | 시점 | 제조번호 P034 시험 결과 | 설정 기준 | 근거 | 시험액 | 함량 | (%) | 99.1% | (%) | (%) |\n| 1.  HPLC: 크로마토그램의 주피크의 유지시 | <속방성 제제> | 분포-플레이트 면적 비율에 근거하여 | 대조약 허가사항에 따르면 캡슐을 |\n| 30분 | 27-31%, 평균 29% | 25-35% | 25% 가량의 주성분 속방이 필요하며, 이보다 더 |\n| 이미 사용되는 에틸셀룰로오스의 등급인 20 mPa.S 점도를 갖는 것을 사용하였다. ",
        "original_sentence": "| 주입량 | 10 ㎕ | 건조한다. "
      }
    },
    {
      "chunk_id": "chunk_324",
      "text": "| 된 제형을 나타냄 | 흰색의 과립 | 여 개발 | 평균질량 △~△mg, | M-1234 |\n| 0, 3, 6, 9, 12 개월 | 60 정 병포장 | Lot #10A | 모두의 100% 질량확인 기능이 있는 캡슐 충진 기계에서 수행될 것이다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 323,
        "window_size": 3,
        "char_count": 138,
        "word_count": 41,
        "page_number": 5,
        "window_text": "| 검출기 | UV (파장 272 nm) | 산출량 | 47.04kg(98%) | 48kg(100%) | 96% | 시험조건 | 설정값 | 성분 함량 75%)으로 설계 | 는 서방 펠렛 혼합물로 구성하 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 성상 | 주성분 함량 | Impurity A | 적합 | Impurity E |\n| 펠렛이 충진되어 있다.  | <서방성 제제> |\n| 또는 서술 형태의 요약자료로 제출한다.  | 주입량 | 10 ㎕ | 건조한다.  | 된 제형을 나타냄 | 흰색의 과립 | 여 개발 | 평균질량 △~△mg, | M-1234 |\n| 0, 3, 6, 9, 12 개월 | 60 정 병포장 | Lot #10A | 모두의 100% 질량확인 기능이 있는 캡슐 충진 기계에서 수행될 것이다.  캡슐충진공정 공 | 제조를 위해 이용될 수 있는 공정변수를 선택하기 위해 이용되어, 유사성 인자 >50 (즉 | 시점 | 제조번호 P034 시험 결과 | 설정 기준 | 근거 | 시험액 | 함량 | (%) | 99.1% | (%) | (%) |\n| 1.  HPLC: 크로마토그램의 주피크의 유지시 | <속방성 제제> | 분포-플레이트 면적 비율에 근거하여 | 대조약 허가사항에 따르면 캡슐을 |\n| 30분 | 27-31%, 평균 29% | 25-35% | 25% 가량의 주성분 속방이 필요하며, 이보다 더 |\n| 이미 사용되는 에틸셀룰로오스의 등급인 20 mPa.S 점도를 갖는 것을 사용하였다.  | 펠렛에서 구형백당-주성분 층화 공정 및 서방 펠렛에서 기능성 서방 코팅 공정에 채택하 | 명칭 | 배합목적 | 등급 | 로트 번호* | 공정서 규격 여부 | 속방 펠렛* (항산화제 무첨가) | 80 | 2 | 17 | 삼키기 어려운 환자들이 캡슐을 |\n| 가혹 조건 | 함량 시험 | 유연물질 시험 |\n**많은 주성분이 속방될 수 있으므로 기준 설정**\n| 충진물 | 펠렛으로 충진 | 속방과 서방 펠렛으로 충진 | 속방 펠렛* (+아스코르브산 5.0 mg) | 87 | 2 | 10 | 열어 스푼에 펠렛을 섞어 복용할 |\n| 있는 방출 프로파일을 유지하는 제품을 만들어내는 것이었다. ",
        "original_sentence": "| 된 제형을 나타냄 | 흰색의 과립 | 여 개발 | 평균질량 △~△mg, | M-1234 |\n| 0, 3, 6, 9, 12 개월 | 60 정 병포장 | Lot #10A | 모두의 100% 질량확인 기능이 있는 캡슐 충진 기계에서 수행될 것이다. "
      }
    },
    {
      "chunk_id": "chunk_325",
      "text": "캡슐충진공정 공 | 제조를 위해 이용될 수 있는 공정변수를 선택하기 위해 이용되어, 유사성 인자 >50 (즉 | 시점 | 제조번호 P034 시험 결과 | 설정 기준 | 근거 | 시험액 | 함량 | (%) | 99.1% | (%) | (%) |\n| 1. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 324,
        "window_size": 3,
        "char_count": 141,
        "word_count": 43,
        "page_number": 3,
        "window_text": "| <서방성 제제> |\n| 또는 서술 형태의 요약자료로 제출한다.  | 주입량 | 10 ㎕ | 건조한다.  | 된 제형을 나타냄 | 흰색의 과립 | 여 개발 | 평균질량 △~△mg, | M-1234 |\n| 0, 3, 6, 9, 12 개월 | 60 정 병포장 | Lot #10A | 모두의 100% 질량확인 기능이 있는 캡슐 충진 기계에서 수행될 것이다.  캡슐충진공정 공 | 제조를 위해 이용될 수 있는 공정변수를 선택하기 위해 이용되어, 유사성 인자 >50 (즉 | 시점 | 제조번호 P034 시험 결과 | 설정 기준 | 근거 | 시험액 | 함량 | (%) | 99.1% | (%) | (%) |\n| 1.  HPLC: 크로마토그램의 주피크의 유지시 | <속방성 제제> | 분포-플레이트 면적 비율에 근거하여 | 대조약 허가사항에 따르면 캡슐을 |\n| 30분 | 27-31%, 평균 29% | 25-35% | 25% 가량의 주성분 속방이 필요하며, 이보다 더 |\n| 이미 사용되는 에틸셀룰로오스의 등급인 20 mPa.S 점도를 갖는 것을 사용하였다.  | 펠렛에서 구형백당-주성분 층화 공정 및 서방 펠렛에서 기능성 서방 코팅 공정에 채택하 | 명칭 | 배합목적 | 등급 | 로트 번호* | 공정서 규격 여부 | 속방 펠렛* (항산화제 무첨가) | 80 | 2 | 17 | 삼키기 어려운 환자들이 캡슐을 |\n| 가혹 조건 | 함량 시험 | 유연물질 시험 |\n**많은 주성분이 속방될 수 있으므로 기준 설정**\n| 충진물 | 펠렛으로 충진 | 속방과 서방 펠렛으로 충진 | 속방 펠렛* (+아스코르브산 5.0 mg) | 87 | 2 | 10 | 열어 스푼에 펠렛을 섞어 복용할 |\n| 있는 방출 프로파일을 유지하는 제품을 만들어내는 것이었다.  실험설계는 몇 가지 공정 | <10% / 35% / 65%이고, 코팅 효율성이 95%를 초과하는 완제의약품을 제조하게 하였 | % 함량 | 피크순도 | 관찰된 분해산물 | 피크 순도 | 높은 분무 속도에 따라, 분무 방울 크 |\n| 시험항목 | 기준 | 시험방법 | 수 있도록 하는데, 동 제품에서도 |\n| 500정 병포장 | 198병 | 200병 | 변수를 극도로 하여 시험하는 것으로 설정되었고, 이 공정변수의 극도값은 다른 제품에 | 다. ",
        "original_sentence": "캡슐충진공정 공 | 제조를 위해 이용될 수 있는 공정변수를 선택하기 위해 이용되어, 유사성 인자 >50 (즉 | 시점 | 제조번호 P034 시험 결과 | 설정 기준 | 근거 | 시험액 | 함량 | (%) | 99.1% | (%) | (%) |\n| 1. "
      }
    },
    {
      "chunk_id": "chunk_326",
      "text": "HPLC: 크로마토그램의 주피크의 유지시 | <속방성 제제> | 분포-플레이트 면적 비율에 근거하여 | 대조약 허가사항에 따르면 캡슐을 |\n| 30분 | 27-31%, 평균 29% | 25-35% | 25% 가량의 주성분 속방이 필요하며, 이보다 더 |\n| 이미 사용되는 에틸셀룰로오스의 등급인 20 mPa.S 점도를 갖는 것을 사용하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 325,
        "window_size": 3,
        "char_count": 191,
        "word_count": 46,
        "page_number": 3,
        "window_text": "| 주입량 | 10 ㎕ | 건조한다.  | 된 제형을 나타냄 | 흰색의 과립 | 여 개발 | 평균질량 △~△mg, | M-1234 |\n| 0, 3, 6, 9, 12 개월 | 60 정 병포장 | Lot #10A | 모두의 100% 질량확인 기능이 있는 캡슐 충진 기계에서 수행될 것이다.  캡슐충진공정 공 | 제조를 위해 이용될 수 있는 공정변수를 선택하기 위해 이용되어, 유사성 인자 >50 (즉 | 시점 | 제조번호 P034 시험 결과 | 설정 기준 | 근거 | 시험액 | 함량 | (%) | 99.1% | (%) | (%) |\n| 1.  HPLC: 크로마토그램의 주피크의 유지시 | <속방성 제제> | 분포-플레이트 면적 비율에 근거하여 | 대조약 허가사항에 따르면 캡슐을 |\n| 30분 | 27-31%, 평균 29% | 25-35% | 25% 가량의 주성분 속방이 필요하며, 이보다 더 |\n| 이미 사용되는 에틸셀룰로오스의 등급인 20 mPa.S 점도를 갖는 것을 사용하였다.  | 펠렛에서 구형백당-주성분 층화 공정 및 서방 펠렛에서 기능성 서방 코팅 공정에 채택하 | 명칭 | 배합목적 | 등급 | 로트 번호* | 공정서 규격 여부 | 속방 펠렛* (항산화제 무첨가) | 80 | 2 | 17 | 삼키기 어려운 환자들이 캡슐을 |\n| 가혹 조건 | 함량 시험 | 유연물질 시험 |\n**많은 주성분이 속방될 수 있으므로 기준 설정**\n| 충진물 | 펠렛으로 충진 | 속방과 서방 펠렛으로 충진 | 속방 펠렛* (+아스코르브산 5.0 mg) | 87 | 2 | 10 | 열어 스푼에 펠렛을 섞어 복용할 |\n| 있는 방출 프로파일을 유지하는 제품을 만들어내는 것이었다.  실험설계는 몇 가지 공정 | <10% / 35% / 65%이고, 코팅 효율성이 95%를 초과하는 완제의약품을 제조하게 하였 | % 함량 | 피크순도 | 관찰된 분해산물 | 피크 순도 | 높은 분무 속도에 따라, 분무 방울 크 |\n| 시험항목 | 기준 | 시험방법 | 수 있도록 하는데, 동 제품에서도 |\n| 500정 병포장 | 198병 | 200병 | 변수를 극도로 하여 시험하는 것으로 설정되었고, 이 공정변수의 극도값은 다른 제품에 | 다.  실험설계 시험의 결과를 통해 분무 방울 크기 30 μm가 서방 막의 최적 코팅을 위 | 속방 펠렛* (+아스코르브산 10.0 mg) | 89 | 2 | 10 | 기 중앙값을 30μm로 유지하기 위해 |\n\n**[표 끝]**\n\n- - 16 -\n기재한다 (예: 가혹시험에서 확인된 유연물질, 분해경로에 대한 정보 등).\n\n",
        "original_sentence": "HPLC: 크로마토그램의 주피크의 유지시 | <속방성 제제> | 분포-플레이트 면적 비율에 근거하여 | 대조약 허가사항에 따르면 캡슐을 |\n| 30분 | 27-31%, 평균 29% | 25-35% | 25% 가량의 주성분 속방이 필요하며, 이보다 더 |\n| 이미 사용되는 에틸셀룰로오스의 등급인 20 mPa.S 점도를 갖는 것을 사용하였다. "
      }
    },
    {
      "chunk_id": "chunk_327",
      "text": "| 펠렛에서 구형백당-주성분 층화 공정 및 서방 펠렛에서 기능성 서방 코팅 공정에 채택하 | 명칭 | 배합목적 | 등급 | 로트 번호* | 공정서 규격 여부 | 속방 펠렛* (항산화제 무첨가) | 80 | 2 | 17 | 삼키기 어려운 환자들이 캡슐을 |\n| 가혹 조건 | 함량 시험 | 유연물질 시험 |\n**많은 주성분이 속방될 수 있으므로 기준 설정**\n| 충진물 | 펠렛으로 충진 | 속방과 서방 펠렛으로 충진 | 속방 펠렛* (+아스코르브산 5.0 mg) | 87 | 2 | 10 | 열어 스푼에 펠렛을 섞어 복용할 |\n| 있는 방출 프로파일을 유지하는 제품을 만들어내는 것이었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 326,
        "window_size": 3,
        "char_count": 330,
        "word_count": 97,
        "page_number": 5,
        "window_text": "| 된 제형을 나타냄 | 흰색의 과립 | 여 개발 | 평균질량 △~△mg, | M-1234 |\n| 0, 3, 6, 9, 12 개월 | 60 정 병포장 | Lot #10A | 모두의 100% 질량확인 기능이 있는 캡슐 충진 기계에서 수행될 것이다.  캡슐충진공정 공 | 제조를 위해 이용될 수 있는 공정변수를 선택하기 위해 이용되어, 유사성 인자 >50 (즉 | 시점 | 제조번호 P034 시험 결과 | 설정 기준 | 근거 | 시험액 | 함량 | (%) | 99.1% | (%) | (%) |\n| 1.  HPLC: 크로마토그램의 주피크의 유지시 | <속방성 제제> | 분포-플레이트 면적 비율에 근거하여 | 대조약 허가사항에 따르면 캡슐을 |\n| 30분 | 27-31%, 평균 29% | 25-35% | 25% 가량의 주성분 속방이 필요하며, 이보다 더 |\n| 이미 사용되는 에틸셀룰로오스의 등급인 20 mPa.S 점도를 갖는 것을 사용하였다.  | 펠렛에서 구형백당-주성분 층화 공정 및 서방 펠렛에서 기능성 서방 코팅 공정에 채택하 | 명칭 | 배합목적 | 등급 | 로트 번호* | 공정서 규격 여부 | 속방 펠렛* (항산화제 무첨가) | 80 | 2 | 17 | 삼키기 어려운 환자들이 캡슐을 |\n| 가혹 조건 | 함량 시험 | 유연물질 시험 |\n**많은 주성분이 속방될 수 있으므로 기준 설정**\n| 충진물 | 펠렛으로 충진 | 속방과 서방 펠렛으로 충진 | 속방 펠렛* (+아스코르브산 5.0 mg) | 87 | 2 | 10 | 열어 스푼에 펠렛을 섞어 복용할 |\n| 있는 방출 프로파일을 유지하는 제품을 만들어내는 것이었다.  실험설계는 몇 가지 공정 | <10% / 35% / 65%이고, 코팅 효율성이 95%를 초과하는 완제의약품을 제조하게 하였 | % 함량 | 피크순도 | 관찰된 분해산물 | 피크 순도 | 높은 분무 속도에 따라, 분무 방울 크 |\n| 시험항목 | 기준 | 시험방법 | 수 있도록 하는데, 동 제품에서도 |\n| 500정 병포장 | 198병 | 200병 | 변수를 극도로 하여 시험하는 것으로 설정되었고, 이 공정변수의 극도값은 다른 제품에 | 다.  실험설계 시험의 결과를 통해 분무 방울 크기 30 μm가 서방 막의 최적 코팅을 위 | 속방 펠렛* (+아스코르브산 10.0 mg) | 89 | 2 | 10 | 기 중앙값을 30μm로 유지하기 위해 |\n\n**[표 끝]**\n\n- - 16 -\n기재한다 (예: 가혹시험에서 확인된 유연물질, 분해경로에 대한 정보 등).\n\n - ○ 2.3.P.2.1.2 첨가제에는 첨가제와 원료의약품 간 배합적합성에 대해 기재한다. ",
        "original_sentence": "| 펠렛에서 구형백당-주성분 층화 공정 및 서방 펠렛에서 기능성 서방 코팅 공정에 채택하 | 명칭 | 배합목적 | 등급 | 로트 번호* | 공정서 규격 여부 | 속방 펠렛* (항산화제 무첨가) | 80 | 2 | 17 | 삼키기 어려운 환자들이 캡슐을 |\n| 가혹 조건 | 함량 시험 | 유연물질 시험 |\n**많은 주성분이 속방될 수 있으므로 기준 설정**\n| 충진물 | 펠렛으로 충진 | 속방과 서방 펠렛으로 충진 | 속방 펠렛* (+아스코르브산 5.0 mg) | 87 | 2 | 10 | 열어 스푼에 펠렛을 섞어 복용할 |\n| 있는 방출 프로파일을 유지하는 제품을 만들어내는 것이었다. "
      }
    },
    {
      "chunk_id": "chunk_328",
      "text": "실험설계는 몇 가지 공정 | <10% / 35% / 65%이고, 코팅 효율성이 95%를 초과하는 완제의약품을 제조하게 하였 | % 함량 | 피크순도 | 관찰된 분해산물 | 피크 순도 | 높은 분무 속도에 따라, 분무 방울 크 |\n| 시험항목 | 기준 | 시험방법 | 수 있도록 하는데, 동 제품에서도 |\n| 500정 병포장 | 198병 | 200병 | 변수를 극도로 하여 시험하는 것으로 설정되었고, 이 공정변수의 극도값은 다른 제품에 | 다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 327,
        "window_size": 3,
        "char_count": 249,
        "word_count": 71,
        "page_number": 3,
        "window_text": "캡슐충진공정 공 | 제조를 위해 이용될 수 있는 공정변수를 선택하기 위해 이용되어, 유사성 인자 >50 (즉 | 시점 | 제조번호 P034 시험 결과 | 설정 기준 | 근거 | 시험액 | 함량 | (%) | 99.1% | (%) | (%) |\n| 1.  HPLC: 크로마토그램의 주피크의 유지시 | <속방성 제제> | 분포-플레이트 면적 비율에 근거하여 | 대조약 허가사항에 따르면 캡슐을 |\n| 30분 | 27-31%, 평균 29% | 25-35% | 25% 가량의 주성분 속방이 필요하며, 이보다 더 |\n| 이미 사용되는 에틸셀룰로오스의 등급인 20 mPa.S 점도를 갖는 것을 사용하였다.  | 펠렛에서 구형백당-주성분 층화 공정 및 서방 펠렛에서 기능성 서방 코팅 공정에 채택하 | 명칭 | 배합목적 | 등급 | 로트 번호* | 공정서 규격 여부 | 속방 펠렛* (항산화제 무첨가) | 80 | 2 | 17 | 삼키기 어려운 환자들이 캡슐을 |\n| 가혹 조건 | 함량 시험 | 유연물질 시험 |\n**많은 주성분이 속방될 수 있으므로 기준 설정**\n| 충진물 | 펠렛으로 충진 | 속방과 서방 펠렛으로 충진 | 속방 펠렛* (+아스코르브산 5.0 mg) | 87 | 2 | 10 | 열어 스푼에 펠렛을 섞어 복용할 |\n| 있는 방출 프로파일을 유지하는 제품을 만들어내는 것이었다.  실험설계는 몇 가지 공정 | <10% / 35% / 65%이고, 코팅 효율성이 95%를 초과하는 완제의약품을 제조하게 하였 | % 함량 | 피크순도 | 관찰된 분해산물 | 피크 순도 | 높은 분무 속도에 따라, 분무 방울 크 |\n| 시험항목 | 기준 | 시험방법 | 수 있도록 하는데, 동 제품에서도 |\n| 500정 병포장 | 198병 | 200병 | 변수를 극도로 하여 시험하는 것으로 설정되었고, 이 공정변수의 극도값은 다른 제품에 | 다.  실험설계 시험의 결과를 통해 분무 방울 크기 30 μm가 서방 막의 최적 코팅을 위 | 속방 펠렛* (+아스코르브산 10.0 mg) | 89 | 2 | 10 | 기 중앙값을 30μm로 유지하기 위해 |\n\n**[표 끝]**\n\n- - 16 -\n기재한다 (예: 가혹시험에서 확인된 유연물질, 분해경로에 대한 정보 등).\n\n - ○ 2.3.P.2.1.2 첨가제에는 첨가제와 원료의약품 간 배합적합성에 대해 기재한다.  의약품 개발\n과정에서 첨가제와 원료의약품의 배합적합성을 평가하여야 하나, 일부 기존 자료로 대체할\n\n수도 있다. ",
        "original_sentence": "실험설계는 몇 가지 공정 | <10% / 35% / 65%이고, 코팅 효율성이 95%를 초과하는 완제의약품을 제조하게 하였 | % 함량 | 피크순도 | 관찰된 분해산물 | 피크 순도 | 높은 분무 속도에 따라, 분무 방울 크 |\n| 시험항목 | 기준 | 시험방법 | 수 있도록 하는데, 동 제품에서도 |\n| 500정 병포장 | 198병 | 200병 | 변수를 극도로 하여 시험하는 것으로 설정되었고, 이 공정변수의 극도값은 다른 제품에 | 다. "
      }
    },
    {
      "chunk_id": "chunk_329",
      "text": "실험설계 시험의 결과를 통해 분무 방울 크기 30 μm가 서방 막의 최적 코팅을 위 | 속방 펠렛* (+아스코르브산 10.0 mg) | 89 | 2 | 10 | 기 중앙값을 30μm로 유지하기 위해 |\n\n**[표 끝]**\n\n- - 16 -\n기재한다 (예: 가혹시험에서 확인된 유연물질, 분해경로에 대한 정보 등).\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 328,
        "window_size": 3,
        "char_count": 177,
        "word_count": 48,
        "page_number": 18,
        "window_text": "HPLC: 크로마토그램의 주피크의 유지시 | <속방성 제제> | 분포-플레이트 면적 비율에 근거하여 | 대조약 허가사항에 따르면 캡슐을 |\n| 30분 | 27-31%, 평균 29% | 25-35% | 25% 가량의 주성분 속방이 필요하며, 이보다 더 |\n| 이미 사용되는 에틸셀룰로오스의 등급인 20 mPa.S 점도를 갖는 것을 사용하였다.  | 펠렛에서 구형백당-주성분 층화 공정 및 서방 펠렛에서 기능성 서방 코팅 공정에 채택하 | 명칭 | 배합목적 | 등급 | 로트 번호* | 공정서 규격 여부 | 속방 펠렛* (항산화제 무첨가) | 80 | 2 | 17 | 삼키기 어려운 환자들이 캡슐을 |\n| 가혹 조건 | 함량 시험 | 유연물질 시험 |\n**많은 주성분이 속방될 수 있으므로 기준 설정**\n| 충진물 | 펠렛으로 충진 | 속방과 서방 펠렛으로 충진 | 속방 펠렛* (+아스코르브산 5.0 mg) | 87 | 2 | 10 | 열어 스푼에 펠렛을 섞어 복용할 |\n| 있는 방출 프로파일을 유지하는 제품을 만들어내는 것이었다.  실험설계는 몇 가지 공정 | <10% / 35% / 65%이고, 코팅 효율성이 95%를 초과하는 완제의약품을 제조하게 하였 | % 함량 | 피크순도 | 관찰된 분해산물 | 피크 순도 | 높은 분무 속도에 따라, 분무 방울 크 |\n| 시험항목 | 기준 | 시험방법 | 수 있도록 하는데, 동 제품에서도 |\n| 500정 병포장 | 198병 | 200병 | 변수를 극도로 하여 시험하는 것으로 설정되었고, 이 공정변수의 극도값은 다른 제품에 | 다.  실험설계 시험의 결과를 통해 분무 방울 크기 30 μm가 서방 막의 최적 코팅을 위 | 속방 펠렛* (+아스코르브산 10.0 mg) | 89 | 2 | 10 | 기 중앙값을 30μm로 유지하기 위해 |\n\n**[표 끝]**\n\n- - 16 -\n기재한다 (예: 가혹시험에서 확인된 유연물질, 분해경로에 대한 정보 등).\n\n - ○ 2.3.P.2.1.2 첨가제에는 첨가제와 원료의약품 간 배합적합성에 대해 기재한다.  의약품 개발\n과정에서 첨가제와 원료의약품의 배합적합성을 평가하여야 하나, 일부 기존 자료로 대체할\n\n수도 있다.  제네릭의약품의 경우, 안정성 문제가 없는 것으로 알려진 첨가제의 종류, 분량이\n\n대조약과 동일하다면 배합적합성 평가 자료 대신 경험적 자료가 허용될 수 있지만 이런\n\n첨가제의 적합성은 통상적으로 원료의약품과 각 첨가제 간 상호작용을 평가하기 위해\n\n“binary mixture\"를 가지고 시험하거나, 원료의약품과 모든 첨가제를 혼합한 것과 이\n\n시험 조건은 가속시험조건(40 ℃ / 75% RH), 장기보존조건(25 ℃ / 60% RH) 또는 완제\n\n의약품 제조공정을 반영한 조건(예: 수분 10∼20% 첨가 / 50 ℃ RH) 등을 고려할 수 있\n\n으며, 시험기간은 통상 4 주 이상 관찰하나 시험목적에 따라 과학적인 타당성을 가지고\n\n시험 항목은 일반적으로 함량 및 유연물질에 대해서는 반드시 설정하며, 원료의약품의\n\n- ○ 2.3.P.2.2 완제의약품에는 완제의약품의 특성, 이러한 특성을 확보하기 위한 방법, 개발과정\n- ○ 2.3.P.2.3 제조 공정 개발에는 3.2.P.3. ",
        "original_sentence": "실험설계 시험의 결과를 통해 분무 방울 크기 30 μm가 서방 막의 최적 코팅을 위 | 속방 펠렛* (+아스코르브산 10.0 mg) | 89 | 2 | 10 | 기 중앙값을 30μm로 유지하기 위해 |\n\n**[표 끝]**\n\n- - 16 -\n기재한다 (예: 가혹시험에서 확인된 유연물질, 분해경로에 대한 정보 등).\n\n"
      }
    },
    {
      "chunk_id": "chunk_330",
      "text": "- ○ 2.3.P.2.1.2 첨가제에는 첨가제와 원료의약품 간 배합적합성에 대해 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 329,
        "window_size": 3,
        "char_count": 51,
        "word_count": 10,
        "page_number": 5,
        "window_text": "| 펠렛에서 구형백당-주성분 층화 공정 및 서방 펠렛에서 기능성 서방 코팅 공정에 채택하 | 명칭 | 배합목적 | 등급 | 로트 번호* | 공정서 규격 여부 | 속방 펠렛* (항산화제 무첨가) | 80 | 2 | 17 | 삼키기 어려운 환자들이 캡슐을 |\n| 가혹 조건 | 함량 시험 | 유연물질 시험 |\n**많은 주성분이 속방될 수 있으므로 기준 설정**\n| 충진물 | 펠렛으로 충진 | 속방과 서방 펠렛으로 충진 | 속방 펠렛* (+아스코르브산 5.0 mg) | 87 | 2 | 10 | 열어 스푼에 펠렛을 섞어 복용할 |\n| 있는 방출 프로파일을 유지하는 제품을 만들어내는 것이었다.  실험설계는 몇 가지 공정 | <10% / 35% / 65%이고, 코팅 효율성이 95%를 초과하는 완제의약품을 제조하게 하였 | % 함량 | 피크순도 | 관찰된 분해산물 | 피크 순도 | 높은 분무 속도에 따라, 분무 방울 크 |\n| 시험항목 | 기준 | 시험방법 | 수 있도록 하는데, 동 제품에서도 |\n| 500정 병포장 | 198병 | 200병 | 변수를 극도로 하여 시험하는 것으로 설정되었고, 이 공정변수의 극도값은 다른 제품에 | 다.  실험설계 시험의 결과를 통해 분무 방울 크기 30 μm가 서방 막의 최적 코팅을 위 | 속방 펠렛* (+아스코르브산 10.0 mg) | 89 | 2 | 10 | 기 중앙값을 30μm로 유지하기 위해 |\n\n**[표 끝]**\n\n- - 16 -\n기재한다 (예: 가혹시험에서 확인된 유연물질, 분해경로에 대한 정보 등).\n\n - ○ 2.3.P.2.1.2 첨가제에는 첨가제와 원료의약품 간 배합적합성에 대해 기재한다.  의약품 개발\n과정에서 첨가제와 원료의약품의 배합적합성을 평가하여야 하나, 일부 기존 자료로 대체할\n\n수도 있다.  제네릭의약품의 경우, 안정성 문제가 없는 것으로 알려진 첨가제의 종류, 분량이\n\n대조약과 동일하다면 배합적합성 평가 자료 대신 경험적 자료가 허용될 수 있지만 이런\n\n첨가제의 적합성은 통상적으로 원료의약품과 각 첨가제 간 상호작용을 평가하기 위해\n\n“binary mixture\"를 가지고 시험하거나, 원료의약품과 모든 첨가제를 혼합한 것과 이\n\n시험 조건은 가속시험조건(40 ℃ / 75% RH), 장기보존조건(25 ℃ / 60% RH) 또는 완제\n\n의약품 제조공정을 반영한 조건(예: 수분 10∼20% 첨가 / 50 ℃ RH) 등을 고려할 수 있\n\n으며, 시험기간은 통상 4 주 이상 관찰하나 시험목적에 따라 과학적인 타당성을 가지고\n\n시험 항목은 일반적으로 함량 및 유연물질에 대해서는 반드시 설정하며, 원료의약품의\n\n- ○ 2.3.P.2.2 완제의약품에는 완제의약품의 특성, 이러한 특성을 확보하기 위한 방법, 개발과정\n- ○ 2.3.P.2.3 제조 공정 개발에는 3.2.P.3.  제조에 기술된 제조공정이 선택된 이유, 제조공정이\n- ○ 2.3.P.2.4 용기 및 포장에는 완제의약품의 용기 및 포장을 선정한 이유 등을 기재한다.\n",
        "original_sentence": "- ○ 2.3.P.2.1.2 첨가제에는 첨가제와 원료의약품 간 배합적합성에 대해 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_331",
      "text": "의약품 개발\n과정에서 첨가제와 원료의약품의 배합적합성을 평가하여야 하나, 일부 기존 자료로 대체할\n\n수도 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 330,
        "window_size": 3,
        "char_count": 63,
        "word_count": 14,
        "page_number": 14,
        "window_text": "실험설계는 몇 가지 공정 | <10% / 35% / 65%이고, 코팅 효율성이 95%를 초과하는 완제의약품을 제조하게 하였 | % 함량 | 피크순도 | 관찰된 분해산물 | 피크 순도 | 높은 분무 속도에 따라, 분무 방울 크 |\n| 시험항목 | 기준 | 시험방법 | 수 있도록 하는데, 동 제품에서도 |\n| 500정 병포장 | 198병 | 200병 | 변수를 극도로 하여 시험하는 것으로 설정되었고, 이 공정변수의 극도값은 다른 제품에 | 다.  실험설계 시험의 결과를 통해 분무 방울 크기 30 μm가 서방 막의 최적 코팅을 위 | 속방 펠렛* (+아스코르브산 10.0 mg) | 89 | 2 | 10 | 기 중앙값을 30μm로 유지하기 위해 |\n\n**[표 끝]**\n\n- - 16 -\n기재한다 (예: 가혹시험에서 확인된 유연물질, 분해경로에 대한 정보 등).\n\n - ○ 2.3.P.2.1.2 첨가제에는 첨가제와 원료의약품 간 배합적합성에 대해 기재한다.  의약품 개발\n과정에서 첨가제와 원료의약품의 배합적합성을 평가하여야 하나, 일부 기존 자료로 대체할\n\n수도 있다.  제네릭의약품의 경우, 안정성 문제가 없는 것으로 알려진 첨가제의 종류, 분량이\n\n대조약과 동일하다면 배합적합성 평가 자료 대신 경험적 자료가 허용될 수 있지만 이런\n\n첨가제의 적합성은 통상적으로 원료의약품과 각 첨가제 간 상호작용을 평가하기 위해\n\n“binary mixture\"를 가지고 시험하거나, 원료의약품과 모든 첨가제를 혼합한 것과 이\n\n시험 조건은 가속시험조건(40 ℃ / 75% RH), 장기보존조건(25 ℃ / 60% RH) 또는 완제\n\n의약품 제조공정을 반영한 조건(예: 수분 10∼20% 첨가 / 50 ℃ RH) 등을 고려할 수 있\n\n으며, 시험기간은 통상 4 주 이상 관찰하나 시험목적에 따라 과학적인 타당성을 가지고\n\n시험 항목은 일반적으로 함량 및 유연물질에 대해서는 반드시 설정하며, 원료의약품의\n\n- ○ 2.3.P.2.2 완제의약품에는 완제의약품의 특성, 이러한 특성을 확보하기 위한 방법, 개발과정\n- ○ 2.3.P.2.3 제조 공정 개발에는 3.2.P.3.  제조에 기술된 제조공정이 선택된 이유, 제조공정이\n- ○ 2.3.P.2.4 용기 및 포장에는 완제의약품의 용기 및 포장을 선정한 이유 등을 기재한다.\n - - 속방성 제제 및 서방성 제제의 개발경위 기재: Appendix 참조\n<!-- PAGE_22 -->\n##### 2.3.P.3 제조(제품명, 제형)(Manufacturing)(name, dosage form)\n\n- 3.2.P.3에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n",
        "original_sentence": "의약품 개발\n과정에서 첨가제와 원료의약품의 배합적합성을 평가하여야 하나, 일부 기존 자료로 대체할\n\n수도 있다. "
      }
    },
    {
      "chunk_id": "chunk_332",
      "text": "제네릭의약품의 경우, 안정성 문제가 없는 것으로 알려진 첨가제의 종류, 분량이\n\n대조약과 동일하다면 배합적합성 평가 자료 대신 경험적 자료가 허용될 수 있지만 이런\n\n첨가제의 적합성은 통상적으로 원료의약품과 각 첨가제 간 상호작용을 평가하기 위해\n\n“binary mixture\"를 가지고 시험하거나, 원료의약품과 모든 첨가제를 혼합한 것과 이\n\n시험 조건은 가속시험조건(40 ℃ / 75% RH), 장기보존조건(25 ℃ / 60% RH) 또는 완제\n\n의약품 제조공정을 반영한 조건(예: 수분 10∼20% 첨가 / 50 ℃ RH) 등을 고려할 수 있\n\n으며, 시험기간은 통상 4 주 이상 관찰하나 시험목적에 따라 과학적인 타당성을 가지고\n\n시험 항목은 일반적으로 함량 및 유연물질에 대해서는 반드시 설정하며, 원료의약품의\n\n- ○ 2.3.P.2.2 완제의약품에는 완제의약품의 특성, 이러한 특성을 확보하기 위한 방법, 개발과정\n- ○ 2.3.P.2.3 제조 공정 개발에는 3.2.P.3. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 331,
        "window_size": 3,
        "char_count": 496,
        "word_count": 112,
        "page_number": 3,
        "window_text": "실험설계 시험의 결과를 통해 분무 방울 크기 30 μm가 서방 막의 최적 코팅을 위 | 속방 펠렛* (+아스코르브산 10.0 mg) | 89 | 2 | 10 | 기 중앙값을 30μm로 유지하기 위해 |\n\n**[표 끝]**\n\n- - 16 -\n기재한다 (예: 가혹시험에서 확인된 유연물질, 분해경로에 대한 정보 등).\n\n - ○ 2.3.P.2.1.2 첨가제에는 첨가제와 원료의약품 간 배합적합성에 대해 기재한다.  의약품 개발\n과정에서 첨가제와 원료의약품의 배합적합성을 평가하여야 하나, 일부 기존 자료로 대체할\n\n수도 있다.  제네릭의약품의 경우, 안정성 문제가 없는 것으로 알려진 첨가제의 종류, 분량이\n\n대조약과 동일하다면 배합적합성 평가 자료 대신 경험적 자료가 허용될 수 있지만 이런\n\n첨가제의 적합성은 통상적으로 원료의약품과 각 첨가제 간 상호작용을 평가하기 위해\n\n“binary mixture\"를 가지고 시험하거나, 원료의약품과 모든 첨가제를 혼합한 것과 이\n\n시험 조건은 가속시험조건(40 ℃ / 75% RH), 장기보존조건(25 ℃ / 60% RH) 또는 완제\n\n의약품 제조공정을 반영한 조건(예: 수분 10∼20% 첨가 / 50 ℃ RH) 등을 고려할 수 있\n\n으며, 시험기간은 통상 4 주 이상 관찰하나 시험목적에 따라 과학적인 타당성을 가지고\n\n시험 항목은 일반적으로 함량 및 유연물질에 대해서는 반드시 설정하며, 원료의약품의\n\n- ○ 2.3.P.2.2 완제의약품에는 완제의약품의 특성, 이러한 특성을 확보하기 위한 방법, 개발과정\n- ○ 2.3.P.2.3 제조 공정 개발에는 3.2.P.3.  제조에 기술된 제조공정이 선택된 이유, 제조공정이\n- ○ 2.3.P.2.4 용기 및 포장에는 완제의약품의 용기 및 포장을 선정한 이유 등을 기재한다.\n - - 속방성 제제 및 서방성 제제의 개발경위 기재: Appendix 참조\n<!-- PAGE_22 -->\n##### 2.3.P.3 제조(제품명, 제형)(Manufacturing)(name, dosage form)\n\n- 3.2.P.3에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n ・제조자(제조원)에 대한 정보\n\n・적절한 품질을 일정하게 제조하기 위한 제조공정 및 그 공정 관리에 대한 간단한 설명\n\n- 3.2.P.3.3에 기재된 제조공정 도식\n- 3.2.P.3.5에 기재된 공정 밸리데이션 및 평가에 대한 간단한 설명\n- - 17 -\n- ○ 제조원에 대한 정보, 제조공정, 제조장비, 공정관리방법 등을 요약 기재한다.\n",
        "original_sentence": "제네릭의약품의 경우, 안정성 문제가 없는 것으로 알려진 첨가제의 종류, 분량이\n\n대조약과 동일하다면 배합적합성 평가 자료 대신 경험적 자료가 허용될 수 있지만 이런\n\n첨가제의 적합성은 통상적으로 원료의약품과 각 첨가제 간 상호작용을 평가하기 위해\n\n“binary mixture\"를 가지고 시험하거나, 원료의약품과 모든 첨가제를 혼합한 것과 이\n\n시험 조건은 가속시험조건(40 ℃ / 75% RH), 장기보존조건(25 ℃ / 60% RH) 또는 완제\n\n의약품 제조공정을 반영한 조건(예: 수분 10∼20% 첨가 / 50 ℃ RH) 등을 고려할 수 있\n\n으며, 시험기간은 통상 4 주 이상 관찰하나 시험목적에 따라 과학적인 타당성을 가지고\n\n시험 항목은 일반적으로 함량 및 유연물질에 대해서는 반드시 설정하며, 원료의약품의\n\n- ○ 2.3.P.2.2 완제의약품에는 완제의약품의 특성, 이러한 특성을 확보하기 위한 방법, 개발과정\n- ○ 2.3.P.2.3 제조 공정 개발에는 3.2.P.3. "
      }
    },
    {
      "chunk_id": "chunk_333",
      "text": "제조에 기술된 제조공정이 선택된 이유, 제조공정이\n- ○ 2.3.P.2.4 용기 및 포장에는 완제의약품의 용기 및 포장을 선정한 이유 등을 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 332,
        "window_size": 3,
        "char_count": 84,
        "word_count": 20,
        "page_number": 3,
        "window_text": "- ○ 2.3.P.2.1.2 첨가제에는 첨가제와 원료의약품 간 배합적합성에 대해 기재한다.  의약품 개발\n과정에서 첨가제와 원료의약품의 배합적합성을 평가하여야 하나, 일부 기존 자료로 대체할\n\n수도 있다.  제네릭의약품의 경우, 안정성 문제가 없는 것으로 알려진 첨가제의 종류, 분량이\n\n대조약과 동일하다면 배합적합성 평가 자료 대신 경험적 자료가 허용될 수 있지만 이런\n\n첨가제의 적합성은 통상적으로 원료의약품과 각 첨가제 간 상호작용을 평가하기 위해\n\n“binary mixture\"를 가지고 시험하거나, 원료의약품과 모든 첨가제를 혼합한 것과 이\n\n시험 조건은 가속시험조건(40 ℃ / 75% RH), 장기보존조건(25 ℃ / 60% RH) 또는 완제\n\n의약품 제조공정을 반영한 조건(예: 수분 10∼20% 첨가 / 50 ℃ RH) 등을 고려할 수 있\n\n으며, 시험기간은 통상 4 주 이상 관찰하나 시험목적에 따라 과학적인 타당성을 가지고\n\n시험 항목은 일반적으로 함량 및 유연물질에 대해서는 반드시 설정하며, 원료의약품의\n\n- ○ 2.3.P.2.2 완제의약품에는 완제의약품의 특성, 이러한 특성을 확보하기 위한 방법, 개발과정\n- ○ 2.3.P.2.3 제조 공정 개발에는 3.2.P.3.  제조에 기술된 제조공정이 선택된 이유, 제조공정이\n- ○ 2.3.P.2.4 용기 및 포장에는 완제의약품의 용기 및 포장을 선정한 이유 등을 기재한다.\n - - 속방성 제제 및 서방성 제제의 개발경위 기재: Appendix 참조\n<!-- PAGE_22 -->\n##### 2.3.P.3 제조(제품명, 제형)(Manufacturing)(name, dosage form)\n\n- 3.2.P.3에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n ・제조자(제조원)에 대한 정보\n\n・적절한 품질을 일정하게 제조하기 위한 제조공정 및 그 공정 관리에 대한 간단한 설명\n\n- 3.2.P.3.3에 기재된 제조공정 도식\n- 3.2.P.3.5에 기재된 공정 밸리데이션 및 평가에 대한 간단한 설명\n- - 17 -\n- ○ 제조원에 대한 정보, 제조공정, 제조장비, 공정관리방법 등을 요약 기재한다.\n - ○ 제조원에 대한 정보는 각 단위공정에 대한 제조 및 품질관리 범위에 대한 내용을 기재한다.\n",
        "original_sentence": "제조에 기술된 제조공정이 선택된 이유, 제조공정이\n- ○ 2.3.P.2.4 용기 및 포장에는 완제의약품의 용기 및 포장을 선정한 이유 등을 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_334",
      "text": "- - 속방성 제제 및 서방성 제제의 개발경위 기재: Appendix 참조\n<!-- PAGE_22 -->\n##### 2.3.P.3 제조(제품명, 제형)(Manufacturing)(name, dosage form)\n\n- 3.2.P.3에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 333,
        "window_size": 3,
        "char_count": 160,
        "word_count": 29,
        "page_number": 22,
        "window_text": "의약품 개발\n과정에서 첨가제와 원료의약품의 배합적합성을 평가하여야 하나, 일부 기존 자료로 대체할\n\n수도 있다.  제네릭의약품의 경우, 안정성 문제가 없는 것으로 알려진 첨가제의 종류, 분량이\n\n대조약과 동일하다면 배합적합성 평가 자료 대신 경험적 자료가 허용될 수 있지만 이런\n\n첨가제의 적합성은 통상적으로 원료의약품과 각 첨가제 간 상호작용을 평가하기 위해\n\n“binary mixture\"를 가지고 시험하거나, 원료의약품과 모든 첨가제를 혼합한 것과 이\n\n시험 조건은 가속시험조건(40 ℃ / 75% RH), 장기보존조건(25 ℃ / 60% RH) 또는 완제\n\n의약품 제조공정을 반영한 조건(예: 수분 10∼20% 첨가 / 50 ℃ RH) 등을 고려할 수 있\n\n으며, 시험기간은 통상 4 주 이상 관찰하나 시험목적에 따라 과학적인 타당성을 가지고\n\n시험 항목은 일반적으로 함량 및 유연물질에 대해서는 반드시 설정하며, 원료의약품의\n\n- ○ 2.3.P.2.2 완제의약품에는 완제의약품의 특성, 이러한 특성을 확보하기 위한 방법, 개발과정\n- ○ 2.3.P.2.3 제조 공정 개발에는 3.2.P.3.  제조에 기술된 제조공정이 선택된 이유, 제조공정이\n- ○ 2.3.P.2.4 용기 및 포장에는 완제의약품의 용기 및 포장을 선정한 이유 등을 기재한다.\n - - 속방성 제제 및 서방성 제제의 개발경위 기재: Appendix 참조\n<!-- PAGE_22 -->\n##### 2.3.P.3 제조(제품명, 제형)(Manufacturing)(name, dosage form)\n\n- 3.2.P.3에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n ・제조자(제조원)에 대한 정보\n\n・적절한 품질을 일정하게 제조하기 위한 제조공정 및 그 공정 관리에 대한 간단한 설명\n\n- 3.2.P.3.3에 기재된 제조공정 도식\n- 3.2.P.3.5에 기재된 공정 밸리데이션 및 평가에 대한 간단한 설명\n- - 17 -\n- ○ 제조원에 대한 정보, 제조공정, 제조장비, 공정관리방법 등을 요약 기재한다.\n - ○ 제조원에 대한 정보는 각 단위공정에 대한 제조 및 품질관리 범위에 대한 내용을 기재한다.\n (제조자, 제조의뢰자, 일부공정제조자 등)\n\n. ",
        "original_sentence": "- - 속방성 제제 및 서방성 제제의 개발경위 기재: Appendix 참조\n<!-- PAGE_22 -->\n##### 2.3.P.3 제조(제품명, 제형)(Manufacturing)(name, dosage form)\n\n- 3.2.P.3에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n"
      }
    },
    {
      "chunk_id": "chunk_335",
      "text": "・제조자(제조원)에 대한 정보\n\n・적절한 품질을 일정하게 제조하기 위한 제조공정 및 그 공정 관리에 대한 간단한 설명\n\n- 3.2.P.3.3에 기재된 제조공정 도식\n- 3.2.P.3.5에 기재된 공정 밸리데이션 및 평가에 대한 간단한 설명\n- - 17 -\n- ○ 제조원에 대한 정보, 제조공정, 제조장비, 공정관리방법 등을 요약 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 334,
        "window_size": 3,
        "char_count": 190,
        "word_count": 46,
        "page_number": 22,
        "window_text": "제네릭의약품의 경우, 안정성 문제가 없는 것으로 알려진 첨가제의 종류, 분량이\n\n대조약과 동일하다면 배합적합성 평가 자료 대신 경험적 자료가 허용될 수 있지만 이런\n\n첨가제의 적합성은 통상적으로 원료의약품과 각 첨가제 간 상호작용을 평가하기 위해\n\n“binary mixture\"를 가지고 시험하거나, 원료의약품과 모든 첨가제를 혼합한 것과 이\n\n시험 조건은 가속시험조건(40 ℃ / 75% RH), 장기보존조건(25 ℃ / 60% RH) 또는 완제\n\n의약품 제조공정을 반영한 조건(예: 수분 10∼20% 첨가 / 50 ℃ RH) 등을 고려할 수 있\n\n으며, 시험기간은 통상 4 주 이상 관찰하나 시험목적에 따라 과학적인 타당성을 가지고\n\n시험 항목은 일반적으로 함량 및 유연물질에 대해서는 반드시 설정하며, 원료의약품의\n\n- ○ 2.3.P.2.2 완제의약품에는 완제의약품의 특성, 이러한 특성을 확보하기 위한 방법, 개발과정\n- ○ 2.3.P.2.3 제조 공정 개발에는 3.2.P.3.  제조에 기술된 제조공정이 선택된 이유, 제조공정이\n- ○ 2.3.P.2.4 용기 및 포장에는 완제의약품의 용기 및 포장을 선정한 이유 등을 기재한다.\n - - 속방성 제제 및 서방성 제제의 개발경위 기재: Appendix 참조\n<!-- PAGE_22 -->\n##### 2.3.P.3 제조(제품명, 제형)(Manufacturing)(name, dosage form)\n\n- 3.2.P.3에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n ・제조자(제조원)에 대한 정보\n\n・적절한 품질을 일정하게 제조하기 위한 제조공정 및 그 공정 관리에 대한 간단한 설명\n\n- 3.2.P.3.3에 기재된 제조공정 도식\n- 3.2.P.3.5에 기재된 공정 밸리데이션 및 평가에 대한 간단한 설명\n- - 17 -\n- ○ 제조원에 대한 정보, 제조공정, 제조장비, 공정관리방법 등을 요약 기재한다.\n - ○ 제조원에 대한 정보는 각 단위공정에 대한 제조 및 품질관리 범위에 대한 내용을 기재한다.\n (제조자, 제조의뢰자, 일부공정제조자 등)\n\n.  위수탁관계가 있는 경우 이를 기재한다.\n\n",
        "original_sentence": "・제조자(제조원)에 대한 정보\n\n・적절한 품질을 일정하게 제조하기 위한 제조공정 및 그 공정 관리에 대한 간단한 설명\n\n- 3.2.P.3.3에 기재된 제조공정 도식\n- 3.2.P.3.5에 기재된 공정 밸리데이션 및 평가에 대한 간단한 설명\n- - 17 -\n- ○ 제조원에 대한 정보, 제조공정, 제조장비, 공정관리방법 등을 요약 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_336",
      "text": "- ○ 제조원에 대한 정보는 각 단위공정에 대한 제조 및 품질관리 범위에 대한 내용을 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 335,
        "window_size": 3,
        "char_count": 54,
        "word_count": 15,
        "page_number": 5,
        "window_text": "제조에 기술된 제조공정이 선택된 이유, 제조공정이\n- ○ 2.3.P.2.4 용기 및 포장에는 완제의약품의 용기 및 포장을 선정한 이유 등을 기재한다.\n - - 속방성 제제 및 서방성 제제의 개발경위 기재: Appendix 참조\n<!-- PAGE_22 -->\n##### 2.3.P.3 제조(제품명, 제형)(Manufacturing)(name, dosage form)\n\n- 3.2.P.3에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n ・제조자(제조원)에 대한 정보\n\n・적절한 품질을 일정하게 제조하기 위한 제조공정 및 그 공정 관리에 대한 간단한 설명\n\n- 3.2.P.3.3에 기재된 제조공정 도식\n- 3.2.P.3.5에 기재된 공정 밸리데이션 및 평가에 대한 간단한 설명\n- - 17 -\n- ○ 제조원에 대한 정보, 제조공정, 제조장비, 공정관리방법 등을 요약 기재한다.\n - ○ 제조원에 대한 정보는 각 단위공정에 대한 제조 및 품질관리 범위에 대한 내용을 기재한다.\n (제조자, 제조의뢰자, 일부공정제조자 등)\n\n.  위수탁관계가 있는 경우 이를 기재한다.\n\n - ○ 허가신청용 뱃치와 실생산 뱃치 간에 뱃치사이즈, 제조장비, 작동원리 등이 다를 경우 그\n- ○ 제조공정은 공정조건과 중요 공정변수를 포함한 도식으로 나타낸다.\n",
        "original_sentence": "- ○ 제조원에 대한 정보는 각 단위공정에 대한 제조 및 품질관리 범위에 대한 내용을 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_337",
      "text": "(제조자, 제조의뢰자, 일부공정제조자 등)\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 336,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 23,
        "window_text": "- - 속방성 제제 및 서방성 제제의 개발경위 기재: Appendix 참조\n<!-- PAGE_22 -->\n##### 2.3.P.3 제조(제품명, 제형)(Manufacturing)(name, dosage form)\n\n- 3.2.P.3에서 얻은 정보와 자료에 대한 고찰을 제공하여야 한다.\n ・제조자(제조원)에 대한 정보\n\n・적절한 품질을 일정하게 제조하기 위한 제조공정 및 그 공정 관리에 대한 간단한 설명\n\n- 3.2.P.3.3에 기재된 제조공정 도식\n- 3.2.P.3.5에 기재된 공정 밸리데이션 및 평가에 대한 간단한 설명\n- - 17 -\n- ○ 제조원에 대한 정보, 제조공정, 제조장비, 공정관리방법 등을 요약 기재한다.\n - ○ 제조원에 대한 정보는 각 단위공정에 대한 제조 및 품질관리 범위에 대한 내용을 기재한다.\n (제조자, 제조의뢰자, 일부공정제조자 등)\n\n.  위수탁관계가 있는 경우 이를 기재한다.\n\n - ○ 허가신청용 뱃치와 실생산 뱃치 간에 뱃치사이즈, 제조장비, 작동원리 등이 다를 경우 그\n- ○ 제조공정은 공정조건과 중요 공정변수를 포함한 도식으로 나타낸다.\n - ○ 제조방법은 아래 서식으로 기재하거나, 서식의 항목을 포함한 다른 기술방식(예시 참조)을\n공정 번호\n\n공정 명칭\n\n원료․시약․용매 등\n\n공정 과정\n\n비고\n\n**[표 시작]**\n\n**(중요장비, 혼합속도**\n| 참조한다. ",
        "original_sentence": "(제조자, 제조의뢰자, 일부공정제조자 등)\n\n. "
      }
    },
    {
      "chunk_id": "chunk_338",
      "text": "위수탁관계가 있는 경우 이를 기재한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 337,
        "window_size": 3,
        "char_count": 23,
        "word_count": 5,
        "page_number": 3,
        "window_text": "・제조자(제조원)에 대한 정보\n\n・적절한 품질을 일정하게 제조하기 위한 제조공정 및 그 공정 관리에 대한 간단한 설명\n\n- 3.2.P.3.3에 기재된 제조공정 도식\n- 3.2.P.3.5에 기재된 공정 밸리데이션 및 평가에 대한 간단한 설명\n- - 17 -\n- ○ 제조원에 대한 정보, 제조공정, 제조장비, 공정관리방법 등을 요약 기재한다.\n - ○ 제조원에 대한 정보는 각 단위공정에 대한 제조 및 품질관리 범위에 대한 내용을 기재한다.\n (제조자, 제조의뢰자, 일부공정제조자 등)\n\n.  위수탁관계가 있는 경우 이를 기재한다.\n\n - ○ 허가신청용 뱃치와 실생산 뱃치 간에 뱃치사이즈, 제조장비, 작동원리 등이 다를 경우 그\n- ○ 제조공정은 공정조건과 중요 공정변수를 포함한 도식으로 나타낸다.\n - ○ 제조방법은 아래 서식으로 기재하거나, 서식의 항목을 포함한 다른 기술방식(예시 참조)을\n공정 번호\n\n공정 명칭\n\n원료․시약․용매 등\n\n공정 과정\n\n비고\n\n**[표 시작]**\n\n**(중요장비, 혼합속도**\n| 참조한다.  | 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 순도시험 | 허용기준 | 설정근거 | 허가제출용 의약품 | 공정2의 결합액 | 농도가 낮으면 낮은 점도의 코팅 현탁을 형성하여 분무 | Inc. ",
        "original_sentence": "위수탁관계가 있는 경우 이를 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_339",
      "text": "- ○ 허가신청용 뱃치와 실생산 뱃치 간에 뱃치사이즈, 제조장비, 작동원리 등이 다를 경우 그\n- ○ 제조공정은 공정조건과 중요 공정변수를 포함한 도식으로 나타낸다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 338,
        "window_size": 3,
        "char_count": 93,
        "word_count": 23,
        "page_number": 3,
        "window_text": "- ○ 제조원에 대한 정보는 각 단위공정에 대한 제조 및 품질관리 범위에 대한 내용을 기재한다.\n (제조자, 제조의뢰자, 일부공정제조자 등)\n\n.  위수탁관계가 있는 경우 이를 기재한다.\n\n - ○ 허가신청용 뱃치와 실생산 뱃치 간에 뱃치사이즈, 제조장비, 작동원리 등이 다를 경우 그\n- ○ 제조공정은 공정조건과 중요 공정변수를 포함한 도식으로 나타낸다.\n - ○ 제조방법은 아래 서식으로 기재하거나, 서식의 항목을 포함한 다른 기술방식(예시 참조)을\n공정 번호\n\n공정 명칭\n\n원료․시약․용매 등\n\n공정 과정\n\n비고\n\n**[표 시작]**\n\n**(중요장비, 혼합속도**\n| 참조한다.  | 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 순도시험 | 허용기준 | 설정근거 | 허가제출용 의약품 | 공정2의 결합액 | 농도가 낮으면 낮은 점도의 코팅 현탁을 형성하여 분무 | Inc.  | NF | CRC | Bottle.Co | 대조약 |\n| 도 움 주 신  분 | 이동상 | 이동상 A: K2HPO4 3.2 g 과 KH2PO4 0.85 g을 물에 녹여 1000 mL로 한다. ",
        "original_sentence": "- ○ 허가신청용 뱃치와 실생산 뱃치 간에 뱃치사이즈, 제조장비, 작동원리 등이 다를 경우 그\n- ○ 제조공정은 공정조건과 중요 공정변수를 포함한 도식으로 나타낸다.\n"
      }
    },
    {
      "chunk_id": "chunk_340",
      "text": "- ○ 제조방법은 아래 서식으로 기재하거나, 서식의 항목을 포함한 다른 기술방식(예시 참조)을\n공정 번호\n\n공정 명칭\n\n원료․시약․용매 등\n\n공정 과정\n\n비고\n\n**[표 시작]**\n\n**(중요장비, 혼합속도**\n| 참조한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 339,
        "window_size": 3,
        "char_count": 126,
        "word_count": 27,
        "page_number": 5,
        "window_text": "(제조자, 제조의뢰자, 일부공정제조자 등)\n\n.  위수탁관계가 있는 경우 이를 기재한다.\n\n - ○ 허가신청용 뱃치와 실생산 뱃치 간에 뱃치사이즈, 제조장비, 작동원리 등이 다를 경우 그\n- ○ 제조공정은 공정조건과 중요 공정변수를 포함한 도식으로 나타낸다.\n - ○ 제조방법은 아래 서식으로 기재하거나, 서식의 항목을 포함한 다른 기술방식(예시 참조)을\n공정 번호\n\n공정 명칭\n\n원료․시약․용매 등\n\n공정 과정\n\n비고\n\n**[표 시작]**\n\n**(중요장비, 혼합속도**\n| 참조한다.  | 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 순도시험 | 허용기준 | 설정근거 | 허가제출용 의약품 | 공정2의 결합액 | 농도가 낮으면 낮은 점도의 코팅 현탁을 형성하여 분무 | Inc.  | NF | CRC | Bottle.Co | 대조약 |\n| 도 움 주 신  분 | 이동상 | 이동상 A: K2HPO4 3.2 g 과 KH2PO4 0.85 g을 물에 녹여 1000 mL로 한다.  | 참고) | 식품의약품안전평가원 의약품심사조정과, | 를 피해야 함 |\n| 4 | 제립 | 30 분 | r2=0.996 | 25-35% | 평균 0.14% | 91-110% | 노즐의 기압이 증가되었음3 | 평균: 88% |\n| 공정3의 혼합물 | 속도에 영향을 미칠 수 있고, 농도가 높으면 너무 점도 | (제조번호) | (제조번호) |\n| RC3 | 0.5% 이하 | 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 | 주성분 피크 순도(PDA)>0.99 | 이동상 B: 아세토니트릴 | 0.035% | 0.1% |\n| 코팅액 농도 | 15 % w/v | 최종 제제에 |\n| <원료의약품 입자도(D90)에 따른 용출양상 (USP apparatus 2, 50 rpm, pH 4.5)> | 아세토니트릴:완충액 = 30:70 | 순환계약품과, 종양약품과, 소화계약품과, | RSD=1.5% | RSD 5.7% | 가 높은 현탁을 형성하여 최대 기압을 사용하지 않으면 | RSD=2.9% | 범위: 85-90% |\n| 5 | 건조 | 기준 | 0.05-2.5% | 첨가제/등급 | 주성분 ...  함량(%) | 4 시간 | 0.05-1.0% | 40-60% | 0.05-1.0% | Inc. ",
        "original_sentence": "- ○ 제조방법은 아래 서식으로 기재하거나, 서식의 항목을 포함한 다른 기술방식(예시 참조)을\n공정 번호\n\n공정 명칭\n\n원료․시약․용매 등\n\n공정 과정\n\n비고\n\n**[표 시작]**\n\n**(중요장비, 혼합속도**\n| 참조한다. "
      }
    },
    {
      "chunk_id": "chunk_341",
      "text": "| 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 순도시험 | 허용기준 | 설정근거 | 허가제출용 의약품 | 공정2의 결합액 | 농도가 낮으면 낮은 점도의 코팅 현탁을 형성하여 분무 | Inc. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 340,
        "window_size": 3,
        "char_count": 122,
        "word_count": 35,
        "page_number": 5,
        "window_text": "위수탁관계가 있는 경우 이를 기재한다.\n\n - ○ 허가신청용 뱃치와 실생산 뱃치 간에 뱃치사이즈, 제조장비, 작동원리 등이 다를 경우 그\n- ○ 제조공정은 공정조건과 중요 공정변수를 포함한 도식으로 나타낸다.\n - ○ 제조방법은 아래 서식으로 기재하거나, 서식의 항목을 포함한 다른 기술방식(예시 참조)을\n공정 번호\n\n공정 명칭\n\n원료․시약․용매 등\n\n공정 과정\n\n비고\n\n**[표 시작]**\n\n**(중요장비, 혼합속도**\n| 참조한다.  | 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 순도시험 | 허용기준 | 설정근거 | 허가제출용 의약품 | 공정2의 결합액 | 농도가 낮으면 낮은 점도의 코팅 현탁을 형성하여 분무 | Inc.  | NF | CRC | Bottle.Co | 대조약 |\n| 도 움 주 신  분 | 이동상 | 이동상 A: K2HPO4 3.2 g 과 KH2PO4 0.85 g을 물에 녹여 1000 mL로 한다.  | 참고) | 식품의약품안전평가원 의약품심사조정과, | 를 피해야 함 |\n| 4 | 제립 | 30 분 | r2=0.996 | 25-35% | 평균 0.14% | 91-110% | 노즐의 기압이 증가되었음3 | 평균: 88% |\n| 공정3의 혼합물 | 속도에 영향을 미칠 수 있고, 농도가 높으면 너무 점도 | (제조번호) | (제조번호) |\n| RC3 | 0.5% 이하 | 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 | 주성분 피크 순도(PDA)>0.99 | 이동상 B: 아세토니트릴 | 0.035% | 0.1% |\n| 코팅액 농도 | 15 % w/v | 최종 제제에 |\n| <원료의약품 입자도(D90)에 따른 용출양상 (USP apparatus 2, 50 rpm, pH 4.5)> | 아세토니트릴:완충액 = 30:70 | 순환계약품과, 종양약품과, 소화계약품과, | RSD=1.5% | RSD 5.7% | 가 높은 현탁을 형성하여 최대 기압을 사용하지 않으면 | RSD=2.9% | 범위: 85-90% |\n| 5 | 건조 | 기준 | 0.05-2.5% | 첨가제/등급 | 주성분 ...  함량(%) | 4 시간 | 0.05-1.0% | 40-60% | 0.05-1.0% | Inc.  | NF | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% |\n| 공정단계들로 1) 약물 층화(속방 펠렛 제조), 2) 서방코팅(서방 펠렛 제조), 3) 캡슐충진 | 컬럼 | Symtrex C18, 5 μm, 250 mm × 4.6 mm | 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 |\n| 완충액: 물 1000 mL에 KH2PO4 6.8g을 녹이고 트리에틸아민으로 pH를 7.4 ± 0.05로 | 사용여부(Y/N) |\n| 동등한 제네릭의약품을 설계할 때 유사하게 하였다. ",
        "original_sentence": "| 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 순도시험 | 허용기준 | 설정근거 | 허가제출용 의약품 | 공정2의 결합액 | 농도가 낮으면 낮은 점도의 코팅 현탁을 형성하여 분무 | Inc. "
      }
    },
    {
      "chunk_id": "chunk_342",
      "text": "| NF | CRC | Bottle.Co | 대조약 |\n| 도 움 주 신  분 | 이동상 | 이동상 A: K2HPO4 3.2 g 과 KH2PO4 0.85 g을 물에 녹여 1000 mL로 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 341,
        "window_size": 3,
        "char_count": 108,
        "word_count": 32,
        "page_number": 3,
        "window_text": "- ○ 허가신청용 뱃치와 실생산 뱃치 간에 뱃치사이즈, 제조장비, 작동원리 등이 다를 경우 그\n- ○ 제조공정은 공정조건과 중요 공정변수를 포함한 도식으로 나타낸다.\n - ○ 제조방법은 아래 서식으로 기재하거나, 서식의 항목을 포함한 다른 기술방식(예시 참조)을\n공정 번호\n\n공정 명칭\n\n원료․시약․용매 등\n\n공정 과정\n\n비고\n\n**[표 시작]**\n\n**(중요장비, 혼합속도**\n| 참조한다.  | 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 순도시험 | 허용기준 | 설정근거 | 허가제출용 의약품 | 공정2의 결합액 | 농도가 낮으면 낮은 점도의 코팅 현탁을 형성하여 분무 | Inc.  | NF | CRC | Bottle.Co | 대조약 |\n| 도 움 주 신  분 | 이동상 | 이동상 A: K2HPO4 3.2 g 과 KH2PO4 0.85 g을 물에 녹여 1000 mL로 한다.  | 참고) | 식품의약품안전평가원 의약품심사조정과, | 를 피해야 함 |\n| 4 | 제립 | 30 분 | r2=0.996 | 25-35% | 평균 0.14% | 91-110% | 노즐의 기압이 증가되었음3 | 평균: 88% |\n| 공정3의 혼합물 | 속도에 영향을 미칠 수 있고, 농도가 높으면 너무 점도 | (제조번호) | (제조번호) |\n| RC3 | 0.5% 이하 | 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 | 주성분 피크 순도(PDA)>0.99 | 이동상 B: 아세토니트릴 | 0.035% | 0.1% |\n| 코팅액 농도 | 15 % w/v | 최종 제제에 |\n| <원료의약품 입자도(D90)에 따른 용출양상 (USP apparatus 2, 50 rpm, pH 4.5)> | 아세토니트릴:완충액 = 30:70 | 순환계약품과, 종양약품과, 소화계약품과, | RSD=1.5% | RSD 5.7% | 가 높은 현탁을 형성하여 최대 기압을 사용하지 않으면 | RSD=2.9% | 범위: 85-90% |\n| 5 | 건조 | 기준 | 0.05-2.5% | 첨가제/등급 | 주성분 ...  함량(%) | 4 시간 | 0.05-1.0% | 40-60% | 0.05-1.0% | Inc.  | NF | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% |\n| 공정단계들로 1) 약물 층화(속방 펠렛 제조), 2) 서방코팅(서방 펠렛 제조), 3) 캡슐충진 | 컬럼 | Symtrex C18, 5 μm, 250 mm × 4.6 mm | 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 |\n| 완충액: 물 1000 mL에 KH2PO4 6.8g을 녹이고 트리에틸아민으로 pH를 7.4 ± 0.05로 | 사용여부(Y/N) |\n| 동등한 제네릭의약품을 설계할 때 유사하게 하였다.  | 분무하기 어려움 | 서방 층 |\n| 6 | 정립 | 기타 분해생성물 | 유속 | 1.5 mL/분 | UV (단파장/ 장파장), 7일 | 98% | >0.99 | r2=0.99 | 8 시간 | r2=0.99 | 65-85% | r2=0.99 | r2=0.99 | r2=0.99 | r2=0.99 |\n| (속방 및 서방 펠렛 충진)을 확인하였다. ",
        "original_sentence": "| NF | CRC | Bottle.Co | 대조약 |\n| 도 움 주 신  분 | 이동상 | 이동상 A: K2HPO4 3.2 g 과 KH2PO4 0.85 g을 물에 녹여 1000 mL로 한다. "
      }
    },
    {
      "chunk_id": "chunk_343",
      "text": "| 참고) | 식품의약품안전평가원 의약품심사조정과, | 를 피해야 함 |\n| 4 | 제립 | 30 분 | r2=0.996 | 25-35% | 평균 0.14% | 91-110% | 노즐의 기압이 증가되었음3 | 평균: 88% |\n| 공정3의 혼합물 | 속도에 영향을 미칠 수 있고, 농도가 높으면 너무 점도 | (제조번호) | (제조번호) |\n| RC3 | 0.5% 이하 | 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 | 주성분 피크 순도(PDA)>0.99 | 이동상 B: 아세토니트릴 | 0.035% | 0.1% |\n| 코팅액 농도 | 15 % w/v | 최종 제제에 |\n| <원료의약품 입자도(D90)에 따른 용출양상 (USP apparatus 2, 50 rpm, pH 4.5)> | 아세토니트릴:완충액 = 30:70 | 순환계약품과, 종양약품과, 소화계약품과, | RSD=1.5% | RSD 5.7% | 가 높은 현탁을 형성하여 최대 기압을 사용하지 않으면 | RSD=2.9% | 범위: 85-90% |\n| 5 | 건조 | 기준 | 0.05-2.5% | 첨가제/등급 | 주성분 ...  함량(%) | 4 시간 | 0.05-1.0% | 40-60% | 0.05-1.0% | Inc. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 342,
        "window_size": 3,
        "char_count": 617,
        "word_count": 157,
        "page_number": 23,
        "window_text": "- ○ 제조방법은 아래 서식으로 기재하거나, 서식의 항목을 포함한 다른 기술방식(예시 참조)을\n공정 번호\n\n공정 명칭\n\n원료․시약․용매 등\n\n공정 과정\n\n비고\n\n**[표 시작]**\n\n**(중요장비, 혼합속도**\n| 참조한다.  | 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 순도시험 | 허용기준 | 설정근거 | 허가제출용 의약품 | 공정2의 결합액 | 농도가 낮으면 낮은 점도의 코팅 현탁을 형성하여 분무 | Inc.  | NF | CRC | Bottle.Co | 대조약 |\n| 도 움 주 신  분 | 이동상 | 이동상 A: K2HPO4 3.2 g 과 KH2PO4 0.85 g을 물에 녹여 1000 mL로 한다.  | 참고) | 식품의약품안전평가원 의약품심사조정과, | 를 피해야 함 |\n| 4 | 제립 | 30 분 | r2=0.996 | 25-35% | 평균 0.14% | 91-110% | 노즐의 기압이 증가되었음3 | 평균: 88% |\n| 공정3의 혼합물 | 속도에 영향을 미칠 수 있고, 농도가 높으면 너무 점도 | (제조번호) | (제조번호) |\n| RC3 | 0.5% 이하 | 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 | 주성분 피크 순도(PDA)>0.99 | 이동상 B: 아세토니트릴 | 0.035% | 0.1% |\n| 코팅액 농도 | 15 % w/v | 최종 제제에 |\n| <원료의약품 입자도(D90)에 따른 용출양상 (USP apparatus 2, 50 rpm, pH 4.5)> | 아세토니트릴:완충액 = 30:70 | 순환계약품과, 종양약품과, 소화계약품과, | RSD=1.5% | RSD 5.7% | 가 높은 현탁을 형성하여 최대 기압을 사용하지 않으면 | RSD=2.9% | 범위: 85-90% |\n| 5 | 건조 | 기준 | 0.05-2.5% | 첨가제/등급 | 주성분 ...  함량(%) | 4 시간 | 0.05-1.0% | 40-60% | 0.05-1.0% | Inc.  | NF | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% |\n| 공정단계들로 1) 약물 층화(속방 펠렛 제조), 2) 서방코팅(서방 펠렛 제조), 3) 캡슐충진 | 컬럼 | Symtrex C18, 5 μm, 250 mm × 4.6 mm | 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 |\n| 완충액: 물 1000 mL에 KH2PO4 6.8g을 녹이고 트리에틸아민으로 pH를 7.4 ± 0.05로 | 사용여부(Y/N) |\n| 동등한 제네릭의약품을 설계할 때 유사하게 하였다.  | 분무하기 어려움 | 서방 층 |\n| 6 | 정립 | 기타 분해생성물 | 유속 | 1.5 mL/분 | UV (단파장/ 장파장), 7일 | 98% | >0.99 | r2=0.99 | 8 시간 | r2=0.99 | 65-85% | r2=0.99 | r2=0.99 | r2=0.99 | r2=0.99 |\n| (속방 및 서방 펠렛 충진)을 확인하였다.  | 제조번호 | 보존조건 | 시험일정 | 용기/포장 | 포장재질 | 조절한 액 | 약효동등성과 | Release Inc. ",
        "original_sentence": "| 참고) | 식품의약품안전평가원 의약품심사조정과, | 를 피해야 함 |\n| 4 | 제립 | 30 분 | r2=0.996 | 25-35% | 평균 0.14% | 91-110% | 노즐의 기압이 증가되었음3 | 평균: 88% |\n| 공정3의 혼합물 | 속도에 영향을 미칠 수 있고, 농도가 높으면 너무 점도 | (제조번호) | (제조번호) |\n| RC3 | 0.5% 이하 | 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 | 주성분 피크 순도(PDA)>0.99 | 이동상 B: 아세토니트릴 | 0.035% | 0.1% |\n| 코팅액 농도 | 15 % w/v | 최종 제제에 |\n| <원료의약품 입자도(D90)에 따른 용출양상 (USP apparatus 2, 50 rpm, pH 4.5)> | 아세토니트릴:완충액 = 30:70 | 순환계약품과, 종양약품과, 소화계약품과, | RSD=1.5% | RSD 5.7% | 가 높은 현탁을 형성하여 최대 기압을 사용하지 않으면 | RSD=2.9% | 범위: 85-90% |\n| 5 | 건조 | 기준 | 0.05-2.5% | 첨가제/등급 | 주성분 ...  함량(%) | 4 시간 | 0.05-1.0% | 40-60% | 0.05-1.0% | Inc. "
      }
    },
    {
      "chunk_id": "chunk_344",
      "text": "| NF | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% |\n| 공정단계들로 1) 약물 층화(속방 펠렛 제조), 2) 서방코팅(서방 펠렛 제조), 3) 캡슐충진 | 컬럼 | Symtrex C18, 5 μm, 250 mm × 4.6 mm | 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 |\n| 완충액: 물 1000 mL에 KH2PO4 6.8g을 녹이고 트리에틸아민으로 pH를 7.4 ± 0.05로 | 사용여부(Y/N) |\n| 동등한 제네릭의약품을 설계할 때 유사하게 하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 343,
        "window_size": 3,
        "char_count": 285,
        "word_count": 69,
        "page_number": 5,
        "window_text": "| 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 순도시험 | 허용기준 | 설정근거 | 허가제출용 의약품 | 공정2의 결합액 | 농도가 낮으면 낮은 점도의 코팅 현탁을 형성하여 분무 | Inc.  | NF | CRC | Bottle.Co | 대조약 |\n| 도 움 주 신  분 | 이동상 | 이동상 A: K2HPO4 3.2 g 과 KH2PO4 0.85 g을 물에 녹여 1000 mL로 한다.  | 참고) | 식품의약품안전평가원 의약품심사조정과, | 를 피해야 함 |\n| 4 | 제립 | 30 분 | r2=0.996 | 25-35% | 평균 0.14% | 91-110% | 노즐의 기압이 증가되었음3 | 평균: 88% |\n| 공정3의 혼합물 | 속도에 영향을 미칠 수 있고, 농도가 높으면 너무 점도 | (제조번호) | (제조번호) |\n| RC3 | 0.5% 이하 | 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 | 주성분 피크 순도(PDA)>0.99 | 이동상 B: 아세토니트릴 | 0.035% | 0.1% |\n| 코팅액 농도 | 15 % w/v | 최종 제제에 |\n| <원료의약품 입자도(D90)에 따른 용출양상 (USP apparatus 2, 50 rpm, pH 4.5)> | 아세토니트릴:완충액 = 30:70 | 순환계약품과, 종양약품과, 소화계약품과, | RSD=1.5% | RSD 5.7% | 가 높은 현탁을 형성하여 최대 기압을 사용하지 않으면 | RSD=2.9% | 범위: 85-90% |\n| 5 | 건조 | 기준 | 0.05-2.5% | 첨가제/등급 | 주성분 ...  함량(%) | 4 시간 | 0.05-1.0% | 40-60% | 0.05-1.0% | Inc.  | NF | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% |\n| 공정단계들로 1) 약물 층화(속방 펠렛 제조), 2) 서방코팅(서방 펠렛 제조), 3) 캡슐충진 | 컬럼 | Symtrex C18, 5 μm, 250 mm × 4.6 mm | 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 |\n| 완충액: 물 1000 mL에 KH2PO4 6.8g을 녹이고 트리에틸아민으로 pH를 7.4 ± 0.05로 | 사용여부(Y/N) |\n| 동등한 제네릭의약품을 설계할 때 유사하게 하였다.  | 분무하기 어려움 | 서방 층 |\n| 6 | 정립 | 기타 분해생성물 | 유속 | 1.5 mL/분 | UV (단파장/ 장파장), 7일 | 98% | >0.99 | r2=0.99 | 8 시간 | r2=0.99 | 65-85% | r2=0.99 | r2=0.99 | r2=0.99 | r2=0.99 |\n| (속방 및 서방 펠렛 충진)을 확인하였다.  | 제조번호 | 보존조건 | 시험일정 | 용기/포장 | 포장재질 | 조절한 액 | 약효동등성과 | Release Inc.  | 별규** | 시험 결과 |\n| 주입 기체 온도 | 55 ~ 62 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨. ",
        "original_sentence": "| NF | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% |\n| 공정단계들로 1) 약물 층화(속방 펠렛 제조), 2) 서방코팅(서방 펠렛 제조), 3) 캡슐충진 | 컬럼 | Symtrex C18, 5 μm, 250 mm × 4.6 mm | 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 |\n| 완충액: 물 1000 mL에 KH2PO4 6.8g을 녹이고 트리에틸아민으로 pH를 7.4 ± 0.05로 | 사용여부(Y/N) |\n| 동등한 제네릭의약품을 설계할 때 유사하게 하였다. "
      }
    },
    {
      "chunk_id": "chunk_345",
      "text": "| 분무하기 어려움 | 서방 층 |\n| 6 | 정립 | 기타 분해생성물 | 유속 | 1.5 mL/분 | UV (단파장/ 장파장), 7일 | 98% | >0.99 | r2=0.99 | 8 시간 | r2=0.99 | 65-85% | r2=0.99 | r2=0.99 | r2=0.99 | r2=0.99 |\n| (속방 및 서방 펠렛 충진)을 확인하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 344,
        "window_size": 3,
        "char_count": 194,
        "word_count": 53,
        "page_number": 5,
        "window_text": "| NF | CRC | Bottle.Co | 대조약 |\n| 도 움 주 신  분 | 이동상 | 이동상 A: K2HPO4 3.2 g 과 KH2PO4 0.85 g을 물에 녹여 1000 mL로 한다.  | 참고) | 식품의약품안전평가원 의약품심사조정과, | 를 피해야 함 |\n| 4 | 제립 | 30 분 | r2=0.996 | 25-35% | 평균 0.14% | 91-110% | 노즐의 기압이 증가되었음3 | 평균: 88% |\n| 공정3의 혼합물 | 속도에 영향을 미칠 수 있고, 농도가 높으면 너무 점도 | (제조번호) | (제조번호) |\n| RC3 | 0.5% 이하 | 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 | 주성분 피크 순도(PDA)>0.99 | 이동상 B: 아세토니트릴 | 0.035% | 0.1% |\n| 코팅액 농도 | 15 % w/v | 최종 제제에 |\n| <원료의약품 입자도(D90)에 따른 용출양상 (USP apparatus 2, 50 rpm, pH 4.5)> | 아세토니트릴:완충액 = 30:70 | 순환계약품과, 종양약품과, 소화계약품과, | RSD=1.5% | RSD 5.7% | 가 높은 현탁을 형성하여 최대 기압을 사용하지 않으면 | RSD=2.9% | 범위: 85-90% |\n| 5 | 건조 | 기준 | 0.05-2.5% | 첨가제/등급 | 주성분 ...  함량(%) | 4 시간 | 0.05-1.0% | 40-60% | 0.05-1.0% | Inc.  | NF | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% |\n| 공정단계들로 1) 약물 층화(속방 펠렛 제조), 2) 서방코팅(서방 펠렛 제조), 3) 캡슐충진 | 컬럼 | Symtrex C18, 5 μm, 250 mm × 4.6 mm | 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 |\n| 완충액: 물 1000 mL에 KH2PO4 6.8g을 녹이고 트리에틸아민으로 pH를 7.4 ± 0.05로 | 사용여부(Y/N) |\n| 동등한 제네릭의약품을 설계할 때 유사하게 하였다.  | 분무하기 어려움 | 서방 층 |\n| 6 | 정립 | 기타 분해생성물 | 유속 | 1.5 mL/분 | UV (단파장/ 장파장), 7일 | 98% | >0.99 | r2=0.99 | 8 시간 | r2=0.99 | 65-85% | r2=0.99 | r2=0.99 | r2=0.99 | r2=0.99 |\n| (속방 및 서방 펠렛 충진)을 확인하였다.  | 제조번호 | 보존조건 | 시험일정 | 용기/포장 | 포장재질 | 조절한 액 | 약효동등성과 | Release Inc.  | 별규** | 시험 결과 |\n| 주입 기체 온도 | 55 ~ 62 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨.  | 후 분쇄한다. ",
        "original_sentence": "| 분무하기 어려움 | 서방 층 |\n| 6 | 정립 | 기타 분해생성물 | 유속 | 1.5 mL/분 | UV (단파장/ 장파장), 7일 | 98% | >0.99 | r2=0.99 | 8 시간 | r2=0.99 | 65-85% | r2=0.99 | r2=0.99 | r2=0.99 | r2=0.99 |\n| (속방 및 서방 펠렛 충진)을 확인하였다. "
      }
    },
    {
      "chunk_id": "chunk_346",
      "text": "| 제조번호 | 보존조건 | 시험일정 | 용기/포장 | 포장재질 | 조절한 액 | 약효동등성과 | Release Inc. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 345,
        "window_size": 3,
        "char_count": 68,
        "word_count": 18,
        "page_number": 18,
        "window_text": "| 참고) | 식품의약품안전평가원 의약품심사조정과, | 를 피해야 함 |\n| 4 | 제립 | 30 분 | r2=0.996 | 25-35% | 평균 0.14% | 91-110% | 노즐의 기압이 증가되었음3 | 평균: 88% |\n| 공정3의 혼합물 | 속도에 영향을 미칠 수 있고, 농도가 높으면 너무 점도 | (제조번호) | (제조번호) |\n| RC3 | 0.5% 이하 | 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 | 주성분 피크 순도(PDA)>0.99 | 이동상 B: 아세토니트릴 | 0.035% | 0.1% |\n| 코팅액 농도 | 15 % w/v | 최종 제제에 |\n| <원료의약품 입자도(D90)에 따른 용출양상 (USP apparatus 2, 50 rpm, pH 4.5)> | 아세토니트릴:완충액 = 30:70 | 순환계약품과, 종양약품과, 소화계약품과, | RSD=1.5% | RSD 5.7% | 가 높은 현탁을 형성하여 최대 기압을 사용하지 않으면 | RSD=2.9% | 범위: 85-90% |\n| 5 | 건조 | 기준 | 0.05-2.5% | 첨가제/등급 | 주성분 ...  함량(%) | 4 시간 | 0.05-1.0% | 40-60% | 0.05-1.0% | Inc.  | NF | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% |\n| 공정단계들로 1) 약물 층화(속방 펠렛 제조), 2) 서방코팅(서방 펠렛 제조), 3) 캡슐충진 | 컬럼 | Symtrex C18, 5 μm, 250 mm × 4.6 mm | 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 |\n| 완충액: 물 1000 mL에 KH2PO4 6.8g을 녹이고 트리에틸아민으로 pH를 7.4 ± 0.05로 | 사용여부(Y/N) |\n| 동등한 제네릭의약품을 설계할 때 유사하게 하였다.  | 분무하기 어려움 | 서방 층 |\n| 6 | 정립 | 기타 분해생성물 | 유속 | 1.5 mL/분 | UV (단파장/ 장파장), 7일 | 98% | >0.99 | r2=0.99 | 8 시간 | r2=0.99 | 65-85% | r2=0.99 | r2=0.99 | r2=0.99 | r2=0.99 |\n| (속방 및 서방 펠렛 충진)을 확인하였다.  | 제조번호 | 보존조건 | 시험일정 | 용기/포장 | 포장재질 | 조절한 액 | 약효동등성과 | Release Inc.  | 별규** | 시험 결과 |\n| 주입 기체 온도 | 55 ~ 62 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨.  | 후 분쇄한다.  | 공정단계 | 제조번호 #9A | 목표량 | 최소 생산 수율 (limit) | 첨가제 없음(대조군) | 91 | N/A | 공정변수 | 사유 |\n| 7 | 활택 | 효율성에 어느 정도의 효과를 가지는 것으로 보였는데, 최대의 효과는 분무속도 및 약 | Heat seal | S Liner |\n| 총 분해생성물 | 건열, 105 ℃, 14 시간 | 70% | >0.99 | 시간 (분) | 0.0 | 30.0 | 37.0 | (제조번호 P034) |\n| Lot #9A | 40 ± 2℃ | 관리방법 등에 관한 자료. ",
        "original_sentence": "| 제조번호 | 보존조건 | 시험일정 | 용기/포장 | 포장재질 | 조절한 액 | 약효동등성과 | Release Inc. "
      }
    },
    {
      "chunk_id": "chunk_347",
      "text": "| 별규** | 시험 결과 |\n| 주입 기체 온도 | 55 ~ 62 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 346,
        "window_size": 3,
        "char_count": 72,
        "word_count": 21,
        "page_number": 5,
        "window_text": "| NF | 0.05-1.0% | 0.05-1.0% | 0.05-1.0% |\n| 공정단계들로 1) 약물 층화(속방 펠렛 제조), 2) 서방코팅(서방 펠렛 제조), 3) 캡슐충진 | 컬럼 | Symtrex C18, 5 μm, 250 mm × 4.6 mm | 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 |\n| 완충액: 물 1000 mL에 KH2PO4 6.8g을 녹이고 트리에틸아민으로 pH를 7.4 ± 0.05로 | 사용여부(Y/N) |\n| 동등한 제네릭의약품을 설계할 때 유사하게 하였다.  | 분무하기 어려움 | 서방 층 |\n| 6 | 정립 | 기타 분해생성물 | 유속 | 1.5 mL/분 | UV (단파장/ 장파장), 7일 | 98% | >0.99 | r2=0.99 | 8 시간 | r2=0.99 | 65-85% | r2=0.99 | r2=0.99 | r2=0.99 | r2=0.99 |\n| (속방 및 서방 펠렛 충진)을 확인하였다.  | 제조번호 | 보존조건 | 시험일정 | 용기/포장 | 포장재질 | 조절한 액 | 약효동등성과 | Release Inc.  | 별규** | 시험 결과 |\n| 주입 기체 온도 | 55 ~ 62 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨.  | 후 분쇄한다.  | 공정단계 | 제조번호 #9A | 목표량 | 최소 생산 수율 (limit) | 첨가제 없음(대조군) | 91 | N/A | 공정변수 | 사유 |\n| 7 | 활택 | 효율성에 어느 정도의 효과를 가지는 것으로 보였는데, 최대의 효과는 분무속도 및 약 | Heat seal | S Liner |\n| 총 분해생성물 | 건열, 105 ℃, 14 시간 | 70% | >0.99 | 시간 (분) | 0.0 | 30.0 | 37.0 | (제조번호 P034) |\n| Lot #9A | 40 ± 2℃ | 관리방법 등에 관한 자료.  | <용출시험결과(USP Apparatus 1, 100rpm, 37℃, pH 6.8)> | 12 시간 | 0.5% 이하 | 1.0% 이하 | M-1232 | 0.3% | 85% 이상 |\n| 발 | 행 | 처 | 구형 백당 | 90 | Y | 90~110 | 540~660 | 분포-플레이트 면적 비율2에 근거하 | 식품의약품안전평가원 의약품심사부 의약품규격과 |\n| 물미세화 압력을 공정에서 변경했을 때 관찰되었다. ",
        "original_sentence": "| 별규** | 시험 결과 |\n| 주입 기체 온도 | 55 ~ 62 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨. "
      }
    },
    {
      "chunk_id": "chunk_348",
      "text": "| 후 분쇄한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 347,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 13,
        "window_text": "| 분무하기 어려움 | 서방 층 |\n| 6 | 정립 | 기타 분해생성물 | 유속 | 1.5 mL/분 | UV (단파장/ 장파장), 7일 | 98% | >0.99 | r2=0.99 | 8 시간 | r2=0.99 | 65-85% | r2=0.99 | r2=0.99 | r2=0.99 | r2=0.99 |\n| (속방 및 서방 펠렛 충진)을 확인하였다.  | 제조번호 | 보존조건 | 시험일정 | 용기/포장 | 포장재질 | 조절한 액 | 약효동등성과 | Release Inc.  | 별규** | 시험 결과 |\n| 주입 기체 온도 | 55 ~ 62 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨.  | 후 분쇄한다.  | 공정단계 | 제조번호 #9A | 목표량 | 최소 생산 수율 (limit) | 첨가제 없음(대조군) | 91 | N/A | 공정변수 | 사유 |\n| 7 | 활택 | 효율성에 어느 정도의 효과를 가지는 것으로 보였는데, 최대의 효과는 분무속도 및 약 | Heat seal | S Liner |\n| 총 분해생성물 | 건열, 105 ℃, 14 시간 | 70% | >0.99 | 시간 (분) | 0.0 | 30.0 | 37.0 | (제조번호 P034) |\n| Lot #9A | 40 ± 2℃ | 관리방법 등에 관한 자료.  | <용출시험결과(USP Apparatus 1, 100rpm, 37℃, pH 6.8)> | 12 시간 | 0.5% 이하 | 1.0% 이하 | M-1232 | 0.3% | 85% 이상 |\n| 발 | 행 | 처 | 구형 백당 | 90 | Y | 90~110 | 540~660 | 분포-플레이트 면적 비율2에 근거하 | 식품의약품안전평가원 의약품심사부 의약품규격과 |\n| 물미세화 압력을 공정에서 변경했을 때 관찰되었다.  Curing과 관련하여 관찰된 용출 프 | 농도구배 | 이동상 A (%) | 80 | 20 | 20 |\n| 체에 남은 분율 | 상부 불투명한 청녹색과 하부 불투명한 노 | 타정기에서 | 0.1 % 이하 | 중요공정 |\n| 0, 3, 6 개월 | 60 정 병포장 | Lot #10A | 산출량 | 45.629kg(98%) | 46.56kg(100%) | 96% | 이동상 B (%) | 20 | 80 | 80 | 여 선형 스케일업 |\n| 정하므로, 결정형 I 형을 유지하는 것이 품질 유지에 중요하다. ",
        "original_sentence": "| 후 분쇄한다. "
      }
    },
    {
      "chunk_id": "chunk_349",
      "text": "| 공정단계 | 제조번호 #9A | 목표량 | 최소 생산 수율 (limit) | 첨가제 없음(대조군) | 91 | N/A | 공정변수 | 사유 |\n| 7 | 활택 | 효율성에 어느 정도의 효과를 가지는 것으로 보였는데, 최대의 효과는 분무속도 및 약 | Heat seal | S Liner |\n| 총 분해생성물 | 건열, 105 ℃, 14 시간 | 70% | >0.99 | 시간 (분) | 0.0 | 30.0 | 37.0 | (제조번호 P034) |\n| Lot #9A | 40 ± 2℃ | 관리방법 등에 관한 자료. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 348,
        "window_size": 3,
        "char_count": 289,
        "word_count": 86,
        "page_number": 18,
        "window_text": "| 제조번호 | 보존조건 | 시험일정 | 용기/포장 | 포장재질 | 조절한 액 | 약효동등성과 | Release Inc.  | 별규** | 시험 결과 |\n| 주입 기체 온도 | 55 ~ 62 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨.  | 후 분쇄한다.  | 공정단계 | 제조번호 #9A | 목표량 | 최소 생산 수율 (limit) | 첨가제 없음(대조군) | 91 | N/A | 공정변수 | 사유 |\n| 7 | 활택 | 효율성에 어느 정도의 효과를 가지는 것으로 보였는데, 최대의 효과는 분무속도 및 약 | Heat seal | S Liner |\n| 총 분해생성물 | 건열, 105 ℃, 14 시간 | 70% | >0.99 | 시간 (분) | 0.0 | 30.0 | 37.0 | (제조번호 P034) |\n| Lot #9A | 40 ± 2℃ | 관리방법 등에 관한 자료.  | <용출시험결과(USP Apparatus 1, 100rpm, 37℃, pH 6.8)> | 12 시간 | 0.5% 이하 | 1.0% 이하 | M-1232 | 0.3% | 85% 이상 |\n| 발 | 행 | 처 | 구형 백당 | 90 | Y | 90~110 | 540~660 | 분포-플레이트 면적 비율2에 근거하 | 식품의약품안전평가원 의약품심사부 의약품규격과 |\n| 물미세화 압력을 공정에서 변경했을 때 관찰되었다.  Curing과 관련하여 관찰된 용출 프 | 농도구배 | 이동상 A (%) | 80 | 20 | 20 |\n| 체에 남은 분율 | 상부 불투명한 청녹색과 하부 불투명한 노 | 타정기에서 | 0.1 % 이하 | 중요공정 |\n| 0, 3, 6 개월 | 60 정 병포장 | Lot #10A | 산출량 | 45.629kg(98%) | 46.56kg(100%) | 96% | 이동상 B (%) | 20 | 80 | 80 | 여 선형 스케일업 |\n| 정하므로, 결정형 I 형을 유지하는 것이 품질 유지에 중요하다.  I 형은 안정하고 과립 | 에틸셀룰로오스 | 92 | Y | <에틸셀룰로오스 점도에 따른 주성분 ...  코팅펠렛의 용출 양상> |\n| 8 | 타정 | 공정7의 반제품 | “LOQ 미만”으로 기재하고, “불검출”인 경우 검출한계(LOD)를 함께 기재한다. ",
        "original_sentence": "| 공정단계 | 제조번호 #9A | 목표량 | 최소 생산 수율 (limit) | 첨가제 없음(대조군) | 91 | N/A | 공정변수 | 사유 |\n| 7 | 활택 | 효율성에 어느 정도의 효과를 가지는 것으로 보였는데, 최대의 효과는 분무속도 및 약 | Heat seal | S Liner |\n| 총 분해생성물 | 건열, 105 ℃, 14 시간 | 70% | >0.99 | 시간 (분) | 0.0 | 30.0 | 37.0 | (제조번호 P034) |\n| Lot #9A | 40 ± 2℃ | 관리방법 등에 관한 자료. "
      }
    },
    {
      "chunk_id": "chunk_350",
      "text": "| <용출시험결과(USP Apparatus 1, 100rpm, 37℃, pH 6.8)> | 12 시간 | 0.5% 이하 | 1.0% 이하 | M-1232 | 0.3% | 85% 이상 |\n| 발 | 행 | 처 | 구형 백당 | 90 | Y | 90~110 | 540~660 | 분포-플레이트 면적 비율2에 근거하 | 식품의약품안전평가원 의약품심사부 의약품규격과 |\n| 물미세화 압력을 공정에서 변경했을 때 관찰되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 349,
        "window_size": 3,
        "char_count": 233,
        "word_count": 59,
        "page_number": 5,
        "window_text": "| 별규** | 시험 결과 |\n| 주입 기체 온도 | 55 ~ 62 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨.  | 후 분쇄한다.  | 공정단계 | 제조번호 #9A | 목표량 | 최소 생산 수율 (limit) | 첨가제 없음(대조군) | 91 | N/A | 공정변수 | 사유 |\n| 7 | 활택 | 효율성에 어느 정도의 효과를 가지는 것으로 보였는데, 최대의 효과는 분무속도 및 약 | Heat seal | S Liner |\n| 총 분해생성물 | 건열, 105 ℃, 14 시간 | 70% | >0.99 | 시간 (분) | 0.0 | 30.0 | 37.0 | (제조번호 P034) |\n| Lot #9A | 40 ± 2℃ | 관리방법 등에 관한 자료.  | <용출시험결과(USP Apparatus 1, 100rpm, 37℃, pH 6.8)> | 12 시간 | 0.5% 이하 | 1.0% 이하 | M-1232 | 0.3% | 85% 이상 |\n| 발 | 행 | 처 | 구형 백당 | 90 | Y | 90~110 | 540~660 | 분포-플레이트 면적 비율2에 근거하 | 식품의약품안전평가원 의약품심사부 의약품규격과 |\n| 물미세화 압력을 공정에서 변경했을 때 관찰되었다.  Curing과 관련하여 관찰된 용출 프 | 농도구배 | 이동상 A (%) | 80 | 20 | 20 |\n| 체에 남은 분율 | 상부 불투명한 청녹색과 하부 불투명한 노 | 타정기에서 | 0.1 % 이하 | 중요공정 |\n| 0, 3, 6 개월 | 60 정 병포장 | Lot #10A | 산출량 | 45.629kg(98%) | 46.56kg(100%) | 96% | 이동상 B (%) | 20 | 80 | 80 | 여 선형 스케일업 |\n| 정하므로, 결정형 I 형을 유지하는 것이 품질 유지에 중요하다.  I 형은 안정하고 과립 | 에틸셀룰로오스 | 92 | Y | <에틸셀룰로오스 점도에 따른 주성분 ...  코팅펠렛의 용출 양상> |\n| 8 | 타정 | 공정7의 반제품 | “LOQ 미만”으로 기재하고, “불검출”인 경우 검출한계(LOD)를 함께 기재한다.  | 로파일 유사성 인자(f2 > 50)는 실험설계에서 조사된 코팅 조건들의 범위 하에서 서방 | 란색의 경질 1호 캡슐. ",
        "original_sentence": "| <용출시험결과(USP Apparatus 1, 100rpm, 37℃, pH 6.8)> | 12 시간 | 0.5% 이하 | 1.0% 이하 | M-1232 | 0.3% | 85% 이상 |\n| 발 | 행 | 처 | 구형 백당 | 90 | Y | 90~110 | 540~660 | 분포-플레이트 면적 비율2에 근거하 | 식품의약품안전평가원 의약품심사부 의약품규격과 |\n| 물미세화 압력을 공정에서 변경했을 때 관찰되었다. "
      }
    },
    {
      "chunk_id": "chunk_351",
      "text": "Curing과 관련하여 관찰된 용출 프 | 농도구배 | 이동상 A (%) | 80 | 20 | 20 |\n| 체에 남은 분율 | 상부 불투명한 청녹색과 하부 불투명한 노 | 타정기에서 | 0.1 % 이하 | 중요공정 |\n| 0, 3, 6 개월 | 60 정 병포장 | Lot #10A | 산출량 | 45.629kg(98%) | 46.56kg(100%) | 96% | 이동상 B (%) | 20 | 80 | 80 | 여 선형 스케일업 |\n| 정하므로, 결정형 I 형을 유지하는 것이 품질 유지에 중요하다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 350,
        "window_size": 3,
        "char_count": 280,
        "word_count": 83,
        "page_number": 3,
        "window_text": "| 후 분쇄한다.  | 공정단계 | 제조번호 #9A | 목표량 | 최소 생산 수율 (limit) | 첨가제 없음(대조군) | 91 | N/A | 공정변수 | 사유 |\n| 7 | 활택 | 효율성에 어느 정도의 효과를 가지는 것으로 보였는데, 최대의 효과는 분무속도 및 약 | Heat seal | S Liner |\n| 총 분해생성물 | 건열, 105 ℃, 14 시간 | 70% | >0.99 | 시간 (분) | 0.0 | 30.0 | 37.0 | (제조번호 P034) |\n| Lot #9A | 40 ± 2℃ | 관리방법 등에 관한 자료.  | <용출시험결과(USP Apparatus 1, 100rpm, 37℃, pH 6.8)> | 12 시간 | 0.5% 이하 | 1.0% 이하 | M-1232 | 0.3% | 85% 이상 |\n| 발 | 행 | 처 | 구형 백당 | 90 | Y | 90~110 | 540~660 | 분포-플레이트 면적 비율2에 근거하 | 식품의약품안전평가원 의약품심사부 의약품규격과 |\n| 물미세화 압력을 공정에서 변경했을 때 관찰되었다.  Curing과 관련하여 관찰된 용출 프 | 농도구배 | 이동상 A (%) | 80 | 20 | 20 |\n| 체에 남은 분율 | 상부 불투명한 청녹색과 하부 불투명한 노 | 타정기에서 | 0.1 % 이하 | 중요공정 |\n| 0, 3, 6 개월 | 60 정 병포장 | Lot #10A | 산출량 | 45.629kg(98%) | 46.56kg(100%) | 96% | 이동상 B (%) | 20 | 80 | 80 | 여 선형 스케일업 |\n| 정하므로, 결정형 I 형을 유지하는 것이 품질 유지에 중요하다.  I 형은 안정하고 과립 | 에틸셀룰로오스 | 92 | Y | <에틸셀룰로오스 점도에 따른 주성분 ...  코팅펠렛의 용출 양상> |\n| 8 | 타정 | 공정7의 반제품 | “LOQ 미만”으로 기재하고, “불검출”인 경우 검출한계(LOD)를 함께 기재한다.  | 로파일 유사성 인자(f2 > 50)는 실험설계에서 조사된 코팅 조건들의 범위 하에서 서방 | 란색의 경질 1호 캡슐.  상‧하부 각각 흰색으로 | 75 ± 5% RH | 본압: □~□mm, | 육안 검사 | 적합 | (중요장비, 타정조건 |\n| Lot #11A | 온도 | 40 ℃ | 미결정셀룰로오스 | 90 | N |\n| 경질 젤라틴 캡슐에 충진된다. ",
        "original_sentence": "Curing과 관련하여 관찰된 용출 프 | 농도구배 | 이동상 A (%) | 80 | 20 | 20 |\n| 체에 남은 분율 | 상부 불투명한 청녹색과 하부 불투명한 노 | 타정기에서 | 0.1 % 이하 | 중요공정 |\n| 0, 3, 6 개월 | 60 정 병포장 | Lot #10A | 산출량 | 45.629kg(98%) | 46.56kg(100%) | 96% | 이동상 B (%) | 20 | 80 | 80 | 여 선형 스케일업 |\n| 정하므로, 결정형 I 형을 유지하는 것이 품질 유지에 중요하다. "
      }
    },
    {
      "chunk_id": "chunk_352",
      "text": "I 형은 안정하고 과립 | 에틸셀룰로오스 | 92 | Y | <에틸셀룰로오스 점도에 따른 주성분 ...  코팅펠렛의 용출 양상> |\n| 8 | 타정 | 공정7의 반제품 | “LOQ 미만”으로 기재하고, “불검출”인 경우 검출한계(LOD)를 함께 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 351,
        "window_size": 3,
        "char_count": 143,
        "word_count": 36,
        "page_number": 5,
        "window_text": "| 공정단계 | 제조번호 #9A | 목표량 | 최소 생산 수율 (limit) | 첨가제 없음(대조군) | 91 | N/A | 공정변수 | 사유 |\n| 7 | 활택 | 효율성에 어느 정도의 효과를 가지는 것으로 보였는데, 최대의 효과는 분무속도 및 약 | Heat seal | S Liner |\n| 총 분해생성물 | 건열, 105 ℃, 14 시간 | 70% | >0.99 | 시간 (분) | 0.0 | 30.0 | 37.0 | (제조번호 P034) |\n| Lot #9A | 40 ± 2℃ | 관리방법 등에 관한 자료.  | <용출시험결과(USP Apparatus 1, 100rpm, 37℃, pH 6.8)> | 12 시간 | 0.5% 이하 | 1.0% 이하 | M-1232 | 0.3% | 85% 이상 |\n| 발 | 행 | 처 | 구형 백당 | 90 | Y | 90~110 | 540~660 | 분포-플레이트 면적 비율2에 근거하 | 식품의약품안전평가원 의약품심사부 의약품규격과 |\n| 물미세화 압력을 공정에서 변경했을 때 관찰되었다.  Curing과 관련하여 관찰된 용출 프 | 농도구배 | 이동상 A (%) | 80 | 20 | 20 |\n| 체에 남은 분율 | 상부 불투명한 청녹색과 하부 불투명한 노 | 타정기에서 | 0.1 % 이하 | 중요공정 |\n| 0, 3, 6 개월 | 60 정 병포장 | Lot #10A | 산출량 | 45.629kg(98%) | 46.56kg(100%) | 96% | 이동상 B (%) | 20 | 80 | 80 | 여 선형 스케일업 |\n| 정하므로, 결정형 I 형을 유지하는 것이 품질 유지에 중요하다.  I 형은 안정하고 과립 | 에틸셀룰로오스 | 92 | Y | <에틸셀룰로오스 점도에 따른 주성분 ...  코팅펠렛의 용출 양상> |\n| 8 | 타정 | 공정7의 반제품 | “LOQ 미만”으로 기재하고, “불검출”인 경우 검출한계(LOD)를 함께 기재한다.  | 로파일 유사성 인자(f2 > 50)는 실험설계에서 조사된 코팅 조건들의 범위 하에서 서방 | 란색의 경질 1호 캡슐.  상‧하부 각각 흰색으로 | 75 ± 5% RH | 본압: □~□mm, | 육안 검사 | 적합 | (중요장비, 타정조건 |\n| Lot #11A | 온도 | 40 ℃ | 미결정셀룰로오스 | 90 | N |\n| 경질 젤라틴 캡슐에 충진된다.  캡슐충진 공정변수들은 기기 제조사의 권장사항과 유사 제 | 에서 중요 단계로 확인되었다. ",
        "original_sentence": "I 형은 안정하고 과립 | 에틸셀룰로오스 | 92 | Y | <에틸셀룰로오스 점도에 따른 주성분 ...  코팅펠렛의 용출 양상> |\n| 8 | 타정 | 공정7의 반제품 | “LOQ 미만”으로 기재하고, “불검출”인 경우 검출한계(LOD)를 함께 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_353",
      "text": "| 로파일 유사성 인자(f2 > 50)는 실험설계에서 조사된 코팅 조건들의 범위 하에서 서방 | 란색의 경질 1호 캡슐. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 352,
        "window_size": 3,
        "char_count": 68,
        "word_count": 18,
        "page_number": 5,
        "window_text": "| <용출시험결과(USP Apparatus 1, 100rpm, 37℃, pH 6.8)> | 12 시간 | 0.5% 이하 | 1.0% 이하 | M-1232 | 0.3% | 85% 이상 |\n| 발 | 행 | 처 | 구형 백당 | 90 | Y | 90~110 | 540~660 | 분포-플레이트 면적 비율2에 근거하 | 식품의약품안전평가원 의약품심사부 의약품규격과 |\n| 물미세화 압력을 공정에서 변경했을 때 관찰되었다.  Curing과 관련하여 관찰된 용출 프 | 농도구배 | 이동상 A (%) | 80 | 20 | 20 |\n| 체에 남은 분율 | 상부 불투명한 청녹색과 하부 불투명한 노 | 타정기에서 | 0.1 % 이하 | 중요공정 |\n| 0, 3, 6 개월 | 60 정 병포장 | Lot #10A | 산출량 | 45.629kg(98%) | 46.56kg(100%) | 96% | 이동상 B (%) | 20 | 80 | 80 | 여 선형 스케일업 |\n| 정하므로, 결정형 I 형을 유지하는 것이 품질 유지에 중요하다.  I 형은 안정하고 과립 | 에틸셀룰로오스 | 92 | Y | <에틸셀룰로오스 점도에 따른 주성분 ...  코팅펠렛의 용출 양상> |\n| 8 | 타정 | 공정7의 반제품 | “LOQ 미만”으로 기재하고, “불검출”인 경우 검출한계(LOD)를 함께 기재한다.  | 로파일 유사성 인자(f2 > 50)는 실험설계에서 조사된 코팅 조건들의 범위 하에서 서방 | 란색의 경질 1호 캡슐.  상‧하부 각각 흰색으로 | 75 ± 5% RH | 본압: □~□mm, | 육안 검사 | 적합 | (중요장비, 타정조건 |\n| Lot #11A | 온도 | 40 ℃ | 미결정셀룰로오스 | 90 | N |\n| 경질 젤라틴 캡슐에 충진된다.  캡슐충진 공정변수들은 기기 제조사의 권장사항과 유사 제 | 에서 중요 단계로 확인되었다.  | “MK”와 “32”가 각인되어 있다. ",
        "original_sentence": "| 로파일 유사성 인자(f2 > 50)는 실험설계에서 조사된 코팅 조건들의 범위 하에서 서방 | 란색의 경질 1호 캡슐. "
      }
    },
    {
      "chunk_id": "chunk_354",
      "text": "상‧하부 각각 흰색으로 | 75 ± 5% RH | 본압: □~□mm, | 육안 검사 | 적합 | (중요장비, 타정조건 |\n| Lot #11A | 온도 | 40 ℃ | 미결정셀룰로오스 | 90 | N |\n| 경질 젤라틴 캡슐에 충진된다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 353,
        "window_size": 3,
        "char_count": 132,
        "word_count": 40,
        "page_number": 23,
        "window_text": "Curing과 관련하여 관찰된 용출 프 | 농도구배 | 이동상 A (%) | 80 | 20 | 20 |\n| 체에 남은 분율 | 상부 불투명한 청녹색과 하부 불투명한 노 | 타정기에서 | 0.1 % 이하 | 중요공정 |\n| 0, 3, 6 개월 | 60 정 병포장 | Lot #10A | 산출량 | 45.629kg(98%) | 46.56kg(100%) | 96% | 이동상 B (%) | 20 | 80 | 80 | 여 선형 스케일업 |\n| 정하므로, 결정형 I 형을 유지하는 것이 품질 유지에 중요하다.  I 형은 안정하고 과립 | 에틸셀룰로오스 | 92 | Y | <에틸셀룰로오스 점도에 따른 주성분 ...  코팅펠렛의 용출 양상> |\n| 8 | 타정 | 공정7의 반제품 | “LOQ 미만”으로 기재하고, “불검출”인 경우 검출한계(LOD)를 함께 기재한다.  | 로파일 유사성 인자(f2 > 50)는 실험설계에서 조사된 코팅 조건들의 범위 하에서 서방 | 란색의 경질 1호 캡슐.  상‧하부 각각 흰색으로 | 75 ± 5% RH | 본압: □~□mm, | 육안 검사 | 적합 | (중요장비, 타정조건 |\n| Lot #11A | 온도 | 40 ℃ | 미결정셀룰로오스 | 90 | N |\n| 경질 젤라틴 캡슐에 충진된다.  캡슐충진 공정변수들은 기기 제조사의 권장사항과 유사 제 | 에서 중요 단계로 확인되었다.  | “MK”와 “32”가 각인되어 있다.  | 예압: □~□mm, | 등) |\n\n**[표 끝]**\n\n- - 18 -\n* 최종제품이 동물유래성분을 함유하거나 제조과정 중 동물유래성분이 사용된 경우 「의약품의\n\n품목허가‧신고‧심사 규정」제14조(제조방법)에 따라 필요한 사항을 기재한다.\n\n",
        "original_sentence": "상‧하부 각각 흰색으로 | 75 ± 5% RH | 본압: □~□mm, | 육안 검사 | 적합 | (중요장비, 타정조건 |\n| Lot #11A | 온도 | 40 ℃ | 미결정셀룰로오스 | 90 | N |\n| 경질 젤라틴 캡슐에 충진된다. "
      }
    },
    {
      "chunk_id": "chunk_355",
      "text": "캡슐충진 공정변수들은 기기 제조사의 권장사항과 유사 제 | 에서 중요 단계로 확인되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 354,
        "window_size": 3,
        "char_count": 50,
        "word_count": 12,
        "page_number": 2,
        "window_text": "I 형은 안정하고 과립 | 에틸셀룰로오스 | 92 | Y | <에틸셀룰로오스 점도에 따른 주성분 ...  코팅펠렛의 용출 양상> |\n| 8 | 타정 | 공정7의 반제품 | “LOQ 미만”으로 기재하고, “불검출”인 경우 검출한계(LOD)를 함께 기재한다.  | 로파일 유사성 인자(f2 > 50)는 실험설계에서 조사된 코팅 조건들의 범위 하에서 서방 | 란색의 경질 1호 캡슐.  상‧하부 각각 흰색으로 | 75 ± 5% RH | 본압: □~□mm, | 육안 검사 | 적합 | (중요장비, 타정조건 |\n| Lot #11A | 온도 | 40 ℃ | 미결정셀룰로오스 | 90 | N |\n| 경질 젤라틴 캡슐에 충진된다.  캡슐충진 공정변수들은 기기 제조사의 권장사항과 유사 제 | 에서 중요 단계로 확인되었다.  | “MK”와 “32”가 각인되어 있다.  | 예압: □~□mm, | 등) |\n\n**[표 끝]**\n\n- - 18 -\n* 최종제품이 동물유래성분을 함유하거나 제조과정 중 동물유래성분이 사용된 경우 「의약품의\n\n품목허가‧신고‧심사 규정」제14조(제조방법)에 따라 필요한 사항을 기재한다.\n\n - ○ 제조자(제조원)에 대한 정보 : 회사명 및 주소 기재\n**[표 시작]**\n\n**2 스케일업 동안 동일한 기체 속도를 유지한다.",
        "original_sentence": "캡슐충진 공정변수들은 기기 제조사의 권장사항과 유사 제 | 에서 중요 단계로 확인되었다. "
      }
    },
    {
      "chunk_id": "chunk_356",
      "text": "| “MK”와 “32”가 각인되어 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 355,
        "window_size": 3,
        "char_count": 23,
        "word_count": 5,
        "page_number": 5,
        "window_text": "| 로파일 유사성 인자(f2 > 50)는 실험설계에서 조사된 코팅 조건들의 범위 하에서 서방 | 란색의 경질 1호 캡슐.  상‧하부 각각 흰색으로 | 75 ± 5% RH | 본압: □~□mm, | 육안 검사 | 적합 | (중요장비, 타정조건 |\n| Lot #11A | 온도 | 40 ℃ | 미결정셀룰로오스 | 90 | N |\n| 경질 젤라틴 캡슐에 충진된다.  캡슐충진 공정변수들은 기기 제조사의 권장사항과 유사 제 | 에서 중요 단계로 확인되었다.  | “MK”와 “32”가 각인되어 있다.  | 예압: □~□mm, | 등) |\n\n**[표 끝]**\n\n- - 18 -\n* 최종제품이 동물유래성분을 함유하거나 제조과정 중 동물유래성분이 사용된 경우 「의약품의\n\n품목허가‧신고‧심사 규정」제14조(제조방법)에 따라 필요한 사항을 기재한다.\n\n - ○ 제조자(제조원)에 대한 정보 : 회사명 및 주소 기재\n**[표 시작]**\n\n**2 스케일업 동안 동일한 기체 속도를 유지한다. **\n**자료는 2.3.P.2.2 완제의약품에 기재한다.",
        "original_sentence": "| “MK”와 “32”가 각인되어 있다. "
      }
    },
    {
      "chunk_id": "chunk_357",
      "text": "| 예압: □~□mm, | 등) |\n\n**[표 끝]**\n\n- - 18 -\n* 최종제품이 동물유래성분을 함유하거나 제조과정 중 동물유래성분이 사용된 경우 「의약품의\n\n품목허가‧신고‧심사 규정」제14조(제조방법)에 따라 필요한 사항을 기재한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 356,
        "window_size": 3,
        "char_count": 136,
        "word_count": 28,
        "page_number": 3,
        "window_text": "상‧하부 각각 흰색으로 | 75 ± 5% RH | 본압: □~□mm, | 육안 검사 | 적합 | (중요장비, 타정조건 |\n| Lot #11A | 온도 | 40 ℃ | 미결정셀룰로오스 | 90 | N |\n| 경질 젤라틴 캡슐에 충진된다.  캡슐충진 공정변수들은 기기 제조사의 권장사항과 유사 제 | 에서 중요 단계로 확인되었다.  | “MK”와 “32”가 각인되어 있다.  | 예압: □~□mm, | 등) |\n\n**[표 끝]**\n\n- - 18 -\n* 최종제품이 동물유래성분을 함유하거나 제조과정 중 동물유래성분이 사용된 경우 「의약품의\n\n품목허가‧신고‧심사 규정」제14조(제조방법)에 따라 필요한 사항을 기재한다.\n\n - ○ 제조자(제조원)에 대한 정보 : 회사명 및 주소 기재\n**[표 시작]**\n\n**2 스케일업 동안 동일한 기체 속도를 유지한다. **\n**자료는 2.3.P.2.2 완제의약품에 기재한다. **\n**▪ 용해도 및 pH에 따른 용해도**\n**2.3.P.2.1.2 첨가제**\n| ▪ 첨가제 | 첨가제 선정 | 적으로 유사함 | 캡슐 충진공정 |\n**2.3.P.2.4 용기 및 포장**\n**제품의 생물학적 동등성/생체이용률 최적화**\n**2.3.P.2.2 완제의약품**\n**▪ 입자도**\n**2.3.P.2.1.2 첨가제**\n| 최종 제제의 최적화 | 특이성 |\n**2.3.P.2.2 완제의약품**\n| 단위 공정명 | 장비명 |\n**▪ 대조약(RLD)의 정보 검토**\n**▪ 제제 조성 최적화**\n| 완제의약품 품질과 관련된 제조공정 | 직선성 | 10 - 150%, r2 = 0.99 |\n| 정밀성 | RSD 0.18% |\n| > 0.99로 계산되어 주성분 피크가 균일함을 확인하였다. ",
        "original_sentence": "| 예압: □~□mm, | 등) |\n\n**[표 끝]**\n\n- - 18 -\n* 최종제품이 동물유래성분을 함유하거나 제조과정 중 동물유래성분이 사용된 경우 「의약품의\n\n품목허가‧신고‧심사 규정」제14조(제조방법)에 따라 필요한 사항을 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_358",
      "text": "- ○ 제조자(제조원)에 대한 정보 : 회사명 및 주소 기재\n**[표 시작]**\n\n**2 스케일업 동안 동일한 기체 속도를 유지한다.",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 357,
        "window_size": 3,
        "char_count": 74,
        "word_count": 19,
        "page_number": 5,
        "window_text": "캡슐충진 공정변수들은 기기 제조사의 권장사항과 유사 제 | 에서 중요 단계로 확인되었다.  | “MK”와 “32”가 각인되어 있다.  | 예압: □~□mm, | 등) |\n\n**[표 끝]**\n\n- - 18 -\n* 최종제품이 동물유래성분을 함유하거나 제조과정 중 동물유래성분이 사용된 경우 「의약품의\n\n품목허가‧신고‧심사 규정」제14조(제조방법)에 따라 필요한 사항을 기재한다.\n\n - ○ 제조자(제조원)에 대한 정보 : 회사명 및 주소 기재\n**[표 시작]**\n\n**2 스케일업 동안 동일한 기체 속도를 유지한다. **\n**자료는 2.3.P.2.2 완제의약품에 기재한다. **\n**▪ 용해도 및 pH에 따른 용해도**\n**2.3.P.2.1.2 첨가제**\n| ▪ 첨가제 | 첨가제 선정 | 적으로 유사함 | 캡슐 충진공정 |\n**2.3.P.2.4 용기 및 포장**\n**제품의 생물학적 동등성/생체이용률 최적화**\n**2.3.P.2.2 완제의약품**\n**▪ 입자도**\n**2.3.P.2.1.2 첨가제**\n| 최종 제제의 최적화 | 특이성 |\n**2.3.P.2.2 완제의약품**\n| 단위 공정명 | 장비명 |\n**▪ 대조약(RLD)의 정보 검토**\n**▪ 제제 조성 최적화**\n| 완제의약품 품질과 관련된 제조공정 | 직선성 | 10 - 150%, r2 = 0.99 |\n| 정밀성 | RSD 0.18% |\n| > 0.99로 계산되어 주성분 피크가 균일함을 확인하였다.  | 실험실내 정밀성* | RSD 0.5% |\n**회사명**\n| 주소 | 함량균일성 |\n**회사명**\n\n**[표 끝]**\n\n주소\n\n- ○ 제조공정 요약\n- - 제조공정은 다음과 같다.\n",
        "original_sentence": "- ○ 제조자(제조원)에 대한 정보 : 회사명 및 주소 기재\n**[표 시작]**\n\n**2 스케일업 동안 동일한 기체 속도를 유지한다."
      }
    },
    {
      "chunk_id": "chunk_359",
      "text": "**\n**자료는 2.3.P.2.2 완제의약품에 기재한다.",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 358,
        "window_size": 3,
        "char_count": 31,
        "word_count": 5,
        "page_number": 5,
        "window_text": "| “MK”와 “32”가 각인되어 있다.  | 예압: □~□mm, | 등) |\n\n**[표 끝]**\n\n- - 18 -\n* 최종제품이 동물유래성분을 함유하거나 제조과정 중 동물유래성분이 사용된 경우 「의약품의\n\n품목허가‧신고‧심사 규정」제14조(제조방법)에 따라 필요한 사항을 기재한다.\n\n - ○ 제조자(제조원)에 대한 정보 : 회사명 및 주소 기재\n**[표 시작]**\n\n**2 스케일업 동안 동일한 기체 속도를 유지한다. **\n**자료는 2.3.P.2.2 완제의약품에 기재한다. **\n**▪ 용해도 및 pH에 따른 용해도**\n**2.3.P.2.1.2 첨가제**\n| ▪ 첨가제 | 첨가제 선정 | 적으로 유사함 | 캡슐 충진공정 |\n**2.3.P.2.4 용기 및 포장**\n**제품의 생물학적 동등성/생체이용률 최적화**\n**2.3.P.2.2 완제의약품**\n**▪ 입자도**\n**2.3.P.2.1.2 첨가제**\n| 최종 제제의 최적화 | 특이성 |\n**2.3.P.2.2 완제의약품**\n| 단위 공정명 | 장비명 |\n**▪ 대조약(RLD)의 정보 검토**\n**▪ 제제 조성 최적화**\n| 완제의약품 품질과 관련된 제조공정 | 직선성 | 10 - 150%, r2 = 0.99 |\n| 정밀성 | RSD 0.18% |\n| > 0.99로 계산되어 주성분 피크가 균일함을 확인하였다.  | 실험실내 정밀성* | RSD 0.5% |\n**회사명**\n| 주소 | 함량균일성 |\n**회사명**\n\n**[표 끝]**\n\n주소\n\n- ○ 제조공정 요약\n- - 제조공정은 다음과 같다.\n - 1. ",
        "original_sentence": "**\n**자료는 2.3.P.2.2 완제의약품에 기재한다."
      }
    },
    {
      "chunk_id": "chunk_360",
      "text": "**\n**▪ 용해도 및 pH에 따른 용해도**\n**2.3.P.2.1.2 첨가제**\n| ▪ 첨가제 | 첨가제 선정 | 적으로 유사함 | 캡슐 충진공정 |\n**2.3.P.2.4 용기 및 포장**\n**제품의 생물학적 동등성/생체이용률 최적화**\n**2.3.P.2.2 완제의약품**\n**▪ 입자도**\n**2.3.P.2.1.2 첨가제**\n| 최종 제제의 최적화 | 특이성 |\n**2.3.P.2.2 완제의약품**\n| 단위 공정명 | 장비명 |\n**▪ 대조약(RLD)의 정보 검토**\n**▪ 제제 조성 최적화**\n| 완제의약품 품질과 관련된 제조공정 | 직선성 | 10 - 150%, r2 = 0.99 |\n| 정밀성 | RSD 0.18% |\n| > 0.99로 계산되어 주성분 피크가 균일함을 확인하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 359,
        "window_size": 3,
        "char_count": 387,
        "word_count": 88,
        "page_number": 5,
        "window_text": "| 예압: □~□mm, | 등) |\n\n**[표 끝]**\n\n- - 18 -\n* 최종제품이 동물유래성분을 함유하거나 제조과정 중 동물유래성분이 사용된 경우 「의약품의\n\n품목허가‧신고‧심사 규정」제14조(제조방법)에 따라 필요한 사항을 기재한다.\n\n - ○ 제조자(제조원)에 대한 정보 : 회사명 및 주소 기재\n**[표 시작]**\n\n**2 스케일업 동안 동일한 기체 속도를 유지한다. **\n**자료는 2.3.P.2.2 완제의약품에 기재한다. **\n**▪ 용해도 및 pH에 따른 용해도**\n**2.3.P.2.1.2 첨가제**\n| ▪ 첨가제 | 첨가제 선정 | 적으로 유사함 | 캡슐 충진공정 |\n**2.3.P.2.4 용기 및 포장**\n**제품의 생물학적 동등성/생체이용률 최적화**\n**2.3.P.2.2 완제의약품**\n**▪ 입자도**\n**2.3.P.2.1.2 첨가제**\n| 최종 제제의 최적화 | 특이성 |\n**2.3.P.2.2 완제의약품**\n| 단위 공정명 | 장비명 |\n**▪ 대조약(RLD)의 정보 검토**\n**▪ 제제 조성 최적화**\n| 완제의약품 품질과 관련된 제조공정 | 직선성 | 10 - 150%, r2 = 0.99 |\n| 정밀성 | RSD 0.18% |\n| > 0.99로 계산되어 주성분 피크가 균일함을 확인하였다.  | 실험실내 정밀성* | RSD 0.5% |\n**회사명**\n| 주소 | 함량균일성 |\n**회사명**\n\n**[표 끝]**\n\n주소\n\n- ○ 제조공정 요약\n- - 제조공정은 다음과 같다.\n - 1.  <혼합> 유당수화물, 포비돈, 미결정셀룰로오스를 high shear mixer에서 혼합한다.\n",
        "original_sentence": "**\n**▪ 용해도 및 pH에 따른 용해도**\n**2.3.P.2.1.2 첨가제**\n| ▪ 첨가제 | 첨가제 선정 | 적으로 유사함 | 캡슐 충진공정 |\n**2.3.P.2.4 용기 및 포장**\n**제품의 생물학적 동등성/생체이용률 최적화**\n**2.3.P.2.2 완제의약품**\n**▪ 입자도**\n**2.3.P.2.1.2 첨가제**\n| 최종 제제의 최적화 | 특이성 |\n**2.3.P.2.2 완제의약품**\n| 단위 공정명 | 장비명 |\n**▪ 대조약(RLD)의 정보 검토**\n**▪ 제제 조성 최적화**\n| 완제의약품 품질과 관련된 제조공정 | 직선성 | 10 - 150%, r2 = 0.99 |\n| 정밀성 | RSD 0.18% |\n| > 0.99로 계산되어 주성분 피크가 균일함을 확인하였다. "
      }
    },
    {
      "chunk_id": "chunk_361",
      "text": "| 실험실내 정밀성* | RSD 0.5% |\n**회사명**\n| 주소 | 함량균일성 |\n**회사명**\n\n**[표 끝]**\n\n주소\n\n- ○ 제조공정 요약\n- - 제조공정은 다음과 같다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 360,
        "window_size": 3,
        "char_count": 102,
        "word_count": 26,
        "page_number": 14,
        "window_text": "- ○ 제조자(제조원)에 대한 정보 : 회사명 및 주소 기재\n**[표 시작]**\n\n**2 스케일업 동안 동일한 기체 속도를 유지한다. **\n**자료는 2.3.P.2.2 완제의약품에 기재한다. **\n**▪ 용해도 및 pH에 따른 용해도**\n**2.3.P.2.1.2 첨가제**\n| ▪ 첨가제 | 첨가제 선정 | 적으로 유사함 | 캡슐 충진공정 |\n**2.3.P.2.4 용기 및 포장**\n**제품의 생물학적 동등성/생체이용률 최적화**\n**2.3.P.2.2 완제의약품**\n**▪ 입자도**\n**2.3.P.2.1.2 첨가제**\n| 최종 제제의 최적화 | 특이성 |\n**2.3.P.2.2 완제의약품**\n| 단위 공정명 | 장비명 |\n**▪ 대조약(RLD)의 정보 검토**\n**▪ 제제 조성 최적화**\n| 완제의약품 품질과 관련된 제조공정 | 직선성 | 10 - 150%, r2 = 0.99 |\n| 정밀성 | RSD 0.18% |\n| > 0.99로 계산되어 주성분 피크가 균일함을 확인하였다.  | 실험실내 정밀성* | RSD 0.5% |\n**회사명**\n| 주소 | 함량균일성 |\n**회사명**\n\n**[표 끝]**\n\n주소\n\n- ○ 제조공정 요약\n- - 제조공정은 다음과 같다.\n - 1.  <혼합> 유당수화물, 포비돈, 미결정셀룰로오스를 high shear mixer에서 혼합한다.\n - 2. ",
        "original_sentence": "| 실험실내 정밀성* | RSD 0.5% |\n**회사명**\n| 주소 | 함량균일성 |\n**회사명**\n\n**[표 끝]**\n\n주소\n\n- ○ 제조공정 요약\n- - 제조공정은 다음과 같다.\n"
      }
    },
    {
      "chunk_id": "chunk_362",
      "text": "- 1. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 361,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 5,
        "window_text": "**\n**자료는 2.3.P.2.2 완제의약품에 기재한다. **\n**▪ 용해도 및 pH에 따른 용해도**\n**2.3.P.2.1.2 첨가제**\n| ▪ 첨가제 | 첨가제 선정 | 적으로 유사함 | 캡슐 충진공정 |\n**2.3.P.2.4 용기 및 포장**\n**제품의 생물학적 동등성/생체이용률 최적화**\n**2.3.P.2.2 완제의약품**\n**▪ 입자도**\n**2.3.P.2.1.2 첨가제**\n| 최종 제제의 최적화 | 특이성 |\n**2.3.P.2.2 완제의약품**\n| 단위 공정명 | 장비명 |\n**▪ 대조약(RLD)의 정보 검토**\n**▪ 제제 조성 최적화**\n| 완제의약품 품질과 관련된 제조공정 | 직선성 | 10 - 150%, r2 = 0.99 |\n| 정밀성 | RSD 0.18% |\n| > 0.99로 계산되어 주성분 피크가 균일함을 확인하였다.  | 실험실내 정밀성* | RSD 0.5% |\n**회사명**\n| 주소 | 함량균일성 |\n**회사명**\n\n**[표 끝]**\n\n주소\n\n- ○ 제조공정 요약\n- - 제조공정은 다음과 같다.\n - 1.  <혼합> 유당수화물, 포비돈, 미결정셀룰로오스를 high shear mixer에서 혼합한다.\n - 2.  <습식과립> 주성분을 별도로 정제수와 섞는다.\n",
        "original_sentence": "- 1. "
      }
    },
    {
      "chunk_id": "chunk_363",
      "text": "<혼합> 유당수화물, 포비돈, 미결정셀룰로오스를 high shear mixer에서 혼합한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 362,
        "window_size": 3,
        "char_count": 52,
        "word_count": 8,
        "page_number": 19,
        "window_text": "**\n**▪ 용해도 및 pH에 따른 용해도**\n**2.3.P.2.1.2 첨가제**\n| ▪ 첨가제 | 첨가제 선정 | 적으로 유사함 | 캡슐 충진공정 |\n**2.3.P.2.4 용기 및 포장**\n**제품의 생물학적 동등성/생체이용률 최적화**\n**2.3.P.2.2 완제의약품**\n**▪ 입자도**\n**2.3.P.2.1.2 첨가제**\n| 최종 제제의 최적화 | 특이성 |\n**2.3.P.2.2 완제의약품**\n| 단위 공정명 | 장비명 |\n**▪ 대조약(RLD)의 정보 검토**\n**▪ 제제 조성 최적화**\n| 완제의약품 품질과 관련된 제조공정 | 직선성 | 10 - 150%, r2 = 0.99 |\n| 정밀성 | RSD 0.18% |\n| > 0.99로 계산되어 주성분 피크가 균일함을 확인하였다.  | 실험실내 정밀성* | RSD 0.5% |\n**회사명**\n| 주소 | 함량균일성 |\n**회사명**\n\n**[표 끝]**\n\n주소\n\n- ○ 제조공정 요약\n- - 제조공정은 다음과 같다.\n - 1.  <혼합> 유당수화물, 포비돈, 미결정셀룰로오스를 high shear mixer에서 혼합한다.\n - 2.  <습식과립> 주성분을 별도로 정제수와 섞는다.\n - 3. ",
        "original_sentence": "<혼합> 유당수화물, 포비돈, 미결정셀룰로오스를 high shear mixer에서 혼합한다.\n"
      }
    },
    {
      "chunk_id": "chunk_364",
      "text": "- 2. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 363,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 5,
        "window_text": "| 실험실내 정밀성* | RSD 0.5% |\n**회사명**\n| 주소 | 함량균일성 |\n**회사명**\n\n**[표 끝]**\n\n주소\n\n- ○ 제조공정 요약\n- - 제조공정은 다음과 같다.\n - 1.  <혼합> 유당수화물, 포비돈, 미결정셀룰로오스를 high shear mixer에서 혼합한다.\n - 2.  <습식과립> 주성분을 별도로 정제수와 섞는다.\n - 3.  <습식체과> 주성분 현탁액을 공정 1의 혼합물에 분사하고 impeller에서 빠른 속도로 혼합\n- 4. ",
        "original_sentence": "- 2. "
      }
    },
    {
      "chunk_id": "chunk_365",
      "text": "<습식과립> 주성분을 별도로 정제수와 섞는다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 364,
        "window_size": 3,
        "char_count": 26,
        "word_count": 5,
        "page_number": 19,
        "window_text": "- 1.  <혼합> 유당수화물, 포비돈, 미결정셀룰로오스를 high shear mixer에서 혼합한다.\n - 2.  <습식과립> 주성분을 별도로 정제수와 섞는다.\n - 3.  <습식체과> 주성분 현탁액을 공정 1의 혼합물에 분사하고 impeller에서 빠른 속도로 혼합\n- 4.  <습식체과> 분쇄를 계속하여 종말점에 다다른 후(약 5분 후) 균질한 혼합물을 얻는다.\n",
        "original_sentence": "<습식과립> 주성분을 별도로 정제수와 섞는다.\n"
      }
    },
    {
      "chunk_id": "chunk_366",
      "text": "- 3. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 365,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 5,
        "window_text": "<혼합> 유당수화물, 포비돈, 미결정셀룰로오스를 high shear mixer에서 혼합한다.\n - 2.  <습식과립> 주성분을 별도로 정제수와 섞는다.\n - 3.  <습식체과> 주성분 현탁액을 공정 1의 혼합물에 분사하고 impeller에서 빠른 속도로 혼합\n- 4.  <습식체과> 분쇄를 계속하여 종말점에 다다른 후(약 5분 후) 균질한 혼합물을 얻는다.\n - 5. ",
        "original_sentence": "- 3. "
      }
    },
    {
      "chunk_id": "chunk_367",
      "text": "<습식체과> 주성분 현탁액을 공정 1의 혼합물에 분사하고 impeller에서 빠른 속도로 혼합\n- 4. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 366,
        "window_size": 3,
        "char_count": 58,
        "word_count": 13,
        "page_number": 5,
        "window_text": "- 2.  <습식과립> 주성분을 별도로 정제수와 섞는다.\n - 3.  <습식체과> 주성분 현탁액을 공정 1의 혼합물에 분사하고 impeller에서 빠른 속도로 혼합\n- 4.  <습식체과> 분쇄를 계속하여 종말점에 다다른 후(약 5분 후) 균질한 혼합물을 얻는다.\n - 5.  <습식체과> 습체를 6 mesh(3.3 mm) 체에 통과시켜 큰 덩어리를 제거하여 건조가 균일\n하게 될 수 있도록 한다.\n\n",
        "original_sentence": "<습식체과> 주성분 현탁액을 공정 1의 혼합물에 분사하고 impeller에서 빠른 속도로 혼합\n- 4. "
      }
    },
    {
      "chunk_id": "chunk_368",
      "text": "<습식체과> 분쇄를 계속하여 종말점에 다다른 후(약 5분 후) 균질한 혼합물을 얻는다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 367,
        "window_size": 3,
        "char_count": 49,
        "word_count": 11,
        "page_number": 23,
        "window_text": "<습식과립> 주성분을 별도로 정제수와 섞는다.\n - 3.  <습식체과> 주성분 현탁액을 공정 1의 혼합물에 분사하고 impeller에서 빠른 속도로 혼합\n- 4.  <습식체과> 분쇄를 계속하여 종말점에 다다른 후(약 5분 후) 균질한 혼합물을 얻는다.\n - 5.  <습식체과> 습체를 6 mesh(3.3 mm) 체에 통과시켜 큰 덩어리를 제거하여 건조가 균일\n하게 될 수 있도록 한다.\n\n 속도: □~□rpm으로\n\n- - 19 -\n- 6. ",
        "original_sentence": "<습식체과> 분쇄를 계속하여 종말점에 다다른 후(약 5분 후) 균질한 혼합물을 얻는다.\n"
      }
    },
    {
      "chunk_id": "chunk_369",
      "text": "- 5. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 368,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 5,
        "window_text": "- 3.  <습식체과> 주성분 현탁액을 공정 1의 혼합물에 분사하고 impeller에서 빠른 속도로 혼합\n- 4.  <습식체과> 분쇄를 계속하여 종말점에 다다른 후(약 5분 후) 균질한 혼합물을 얻는다.\n - 5.  <습식체과> 습체를 6 mesh(3.3 mm) 체에 통과시켜 큰 덩어리를 제거하여 건조가 균일\n하게 될 수 있도록 한다.\n\n 속도: □~□rpm으로\n\n- - 19 -\n- 6.  <건조> 과립물을 60±5°C (LOD 0.5 % 이하가 될 때까지) 온도에서 fluid bed dryer로\n- 7. ",
        "original_sentence": "- 5. "
      }
    },
    {
      "chunk_id": "chunk_370",
      "text": "<습식체과> 습체를 6 mesh(3.3 mm) 체에 통과시켜 큰 덩어리를 제거하여 건조가 균일\n하게 될 수 있도록 한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 369,
        "window_size": 3,
        "char_count": 69,
        "word_count": 17,
        "page_number": 23,
        "window_text": "<습식체과> 주성분 현탁액을 공정 1의 혼합물에 분사하고 impeller에서 빠른 속도로 혼합\n- 4.  <습식체과> 분쇄를 계속하여 종말점에 다다른 후(약 5분 후) 균질한 혼합물을 얻는다.\n - 5.  <습식체과> 습체를 6 mesh(3.3 mm) 체에 통과시켜 큰 덩어리를 제거하여 건조가 균일\n하게 될 수 있도록 한다.\n\n 속도: □~□rpm으로\n\n- - 19 -\n- 6.  <건조> 과립물을 60±5°C (LOD 0.5 % 이하가 될 때까지) 온도에서 fluid bed dryer로\n- 7.  <분쇄> 건조된 과립을 impact mill(날 장착)에서 12 mesh (1.1 mm) 체를 통과시킨다.\n",
        "original_sentence": "<습식체과> 습체를 6 mesh(3.3 mm) 체에 통과시켜 큰 덩어리를 제거하여 건조가 균일\n하게 될 수 있도록 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_371",
      "text": "속도: □~□rpm으로\n\n- - 19 -\n- 6. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 370,
        "window_size": 3,
        "char_count": 28,
        "word_count": 8,
        "page_number": 5,
        "window_text": "<습식체과> 분쇄를 계속하여 종말점에 다다른 후(약 5분 후) 균질한 혼합물을 얻는다.\n - 5.  <습식체과> 습체를 6 mesh(3.3 mm) 체에 통과시켜 큰 덩어리를 제거하여 건조가 균일\n하게 될 수 있도록 한다.\n\n 속도: □~□rpm으로\n\n- - 19 -\n- 6.  <건조> 과립물을 60±5°C (LOD 0.5 % 이하가 될 때까지) 온도에서 fluid bed dryer로\n- 7.  <분쇄> 건조된 과립을 impact mill(날 장착)에서 12 mesh (1.1 mm) 체를 통과시킨다.\n - 8. ",
        "original_sentence": "속도: □~□rpm으로\n\n- - 19 -\n- 6. "
      }
    },
    {
      "chunk_id": "chunk_372",
      "text": "<건조> 과립물을 60±5°C (LOD 0.5 % 이하가 될 때까지) 온도에서 fluid bed dryer로\n- 7. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 371,
        "window_size": 3,
        "char_count": 66,
        "word_count": 15,
        "page_number": 3,
        "window_text": "- 5.  <습식체과> 습체를 6 mesh(3.3 mm) 체에 통과시켜 큰 덩어리를 제거하여 건조가 균일\n하게 될 수 있도록 한다.\n\n 속도: □~□rpm으로\n\n- - 19 -\n- 6.  <건조> 과립물을 60±5°C (LOD 0.5 % 이하가 될 때까지) 온도에서 fluid bed dryer로\n- 7.  <분쇄> 건조된 과립을 impact mill(날 장착)에서 12 mesh (1.1 mm) 체를 통과시킨다.\n - 8.  <최종혼합> 분쇄된 과립을 bin-blender에서 크로스포비돈을 넣어 5 분간 혼합하고,\n- 9. ",
        "original_sentence": "<건조> 과립물을 60±5°C (LOD 0.5 % 이하가 될 때까지) 온도에서 fluid bed dryer로\n- 7. "
      }
    },
    {
      "chunk_id": "chunk_373",
      "text": "<분쇄> 건조된 과립을 impact mill(날 장착)에서 12 mesh (1.1 mm) 체를 통과시킨다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 372,
        "window_size": 3,
        "char_count": 60,
        "word_count": 12,
        "page_number": 5,
        "window_text": "<습식체과> 습체를 6 mesh(3.3 mm) 체에 통과시켜 큰 덩어리를 제거하여 건조가 균일\n하게 될 수 있도록 한다.\n\n 속도: □~□rpm으로\n\n- - 19 -\n- 6.  <건조> 과립물을 60±5°C (LOD 0.5 % 이하가 될 때까지) 온도에서 fluid bed dryer로\n- 7.  <분쇄> 건조된 과립을 impact mill(날 장착)에서 12 mesh (1.1 mm) 체를 통과시킨다.\n - 8.  <최종혼합> 분쇄된 과립을 bin-blender에서 크로스포비돈을 넣어 5 분간 혼합하고,\n- 9.  <타정 및 포장> 혼합물을 타정 후 포장한다.\n",
        "original_sentence": "<분쇄> 건조된 과립을 impact mill(날 장착)에서 12 mesh (1.1 mm) 체를 통과시킨다.\n"
      }
    },
    {
      "chunk_id": "chunk_374",
      "text": "- 8. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 373,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 5,
        "window_text": "속도: □~□rpm으로\n\n- - 19 -\n- 6.  <건조> 과립물을 60±5°C (LOD 0.5 % 이하가 될 때까지) 온도에서 fluid bed dryer로\n- 7.  <분쇄> 건조된 과립을 impact mill(날 장착)에서 12 mesh (1.1 mm) 체를 통과시킨다.\n - 8.  <최종혼합> 분쇄된 과립을 bin-blender에서 크로스포비돈을 넣어 5 분간 혼합하고,\n- 9.  <타정 및 포장> 혼합물을 타정 후 포장한다.\n - - 제조공정을 도식으로 표현하면 다음과 같다.\n",
        "original_sentence": "- 8. "
      }
    },
    {
      "chunk_id": "chunk_375",
      "text": "<최종혼합> 분쇄된 과립을 bin-blender에서 크로스포비돈을 넣어 5 분간 혼합하고,\n- 9. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 374,
        "window_size": 3,
        "char_count": 56,
        "word_count": 11,
        "page_number": 5,
        "window_text": "<건조> 과립물을 60±5°C (LOD 0.5 % 이하가 될 때까지) 온도에서 fluid bed dryer로\n- 7.  <분쇄> 건조된 과립을 impact mill(날 장착)에서 12 mesh (1.1 mm) 체를 통과시킨다.\n - 8.  <최종혼합> 분쇄된 과립을 bin-blender에서 크로스포비돈을 넣어 5 분간 혼합하고,\n- 9.  <타정 및 포장> 혼합물을 타정 후 포장한다.\n - - 제조공정을 도식으로 표현하면 다음과 같다.\n - ○ 허가제출용 뱃치에 관한 사항(요약)\n- - 제조량 및 목표량\n혼합(건조 후)\n\n최종혼합\n\n- - 20 -\n- - 뱃치조성(실생산 뱃치와 비교)\n**[표 시작]**\n\n| 성분명, 규격 | 허가제출용 뱃치 |\n| --- | --- |\n| 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 |\n**첨가제 선택과 관련한 추가 상세 정보는 3.2.P.2.1.2 첨가제를 참조한다.",
        "original_sentence": "<최종혼합> 분쇄된 과립을 bin-blender에서 크로스포비돈을 넣어 5 분간 혼합하고,\n- 9. "
      }
    },
    {
      "chunk_id": "chunk_376",
      "text": "<타정 및 포장> 혼합물을 타정 후 포장한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 375,
        "window_size": 3,
        "char_count": 26,
        "word_count": 7,
        "page_number": 13,
        "window_text": "<분쇄> 건조된 과립을 impact mill(날 장착)에서 12 mesh (1.1 mm) 체를 통과시킨다.\n - 8.  <최종혼합> 분쇄된 과립을 bin-blender에서 크로스포비돈을 넣어 5 분간 혼합하고,\n- 9.  <타정 및 포장> 혼합물을 타정 후 포장한다.\n - - 제조공정을 도식으로 표현하면 다음과 같다.\n - ○ 허가제출용 뱃치에 관한 사항(요약)\n- - 제조량 및 목표량\n혼합(건조 후)\n\n최종혼합\n\n- - 20 -\n- - 뱃치조성(실생산 뱃치와 비교)\n**[표 시작]**\n\n| 성분명, 규격 | 허가제출용 뱃치 |\n| --- | --- |\n| 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 |\n**첨가제 선택과 관련한 추가 상세 정보는 3.2.P.2.1.2 첨가제를 참조한다. **\n| 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 | 유연물질 A(3%) |\n**순도시험**\n| UV (단파장/ 장파장), 7 일 | 98% | >0.99 | NA |\n| 건열, 105 ℃, 14 시간 | 70% | >0.99 | 유연물질 A(23%) |\n**1. ",
        "original_sentence": "<타정 및 포장> 혼합물을 타정 후 포장한다.\n"
      }
    },
    {
      "chunk_id": "chunk_377",
      "text": "- - 제조공정을 도식으로 표현하면 다음과 같다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 376,
        "window_size": 3,
        "char_count": 28,
        "word_count": 7,
        "page_number": 5,
        "window_text": "- 8.  <최종혼합> 분쇄된 과립을 bin-blender에서 크로스포비돈을 넣어 5 분간 혼합하고,\n- 9.  <타정 및 포장> 혼합물을 타정 후 포장한다.\n - - 제조공정을 도식으로 표현하면 다음과 같다.\n - ○ 허가제출용 뱃치에 관한 사항(요약)\n- - 제조량 및 목표량\n혼합(건조 후)\n\n최종혼합\n\n- - 20 -\n- - 뱃치조성(실생산 뱃치와 비교)\n**[표 시작]**\n\n| 성분명, 규격 | 허가제출용 뱃치 |\n| --- | --- |\n| 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 |\n**첨가제 선택과 관련한 추가 상세 정보는 3.2.P.2.1.2 첨가제를 참조한다. **\n| 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 | 유연물질 A(3%) |\n**순도시험**\n| UV (단파장/ 장파장), 7 일 | 98% | >0.99 | NA |\n| 건열, 105 ℃, 14 시간 | 70% | >0.99 | 유연물질 A(23%) |\n**1.  대조약과 약제학적으로 동일하도록 캡슐제형으로 한다.",
        "original_sentence": "- - 제조공정을 도식으로 표현하면 다음과 같다.\n"
      }
    },
    {
      "chunk_id": "chunk_378",
      "text": "- ○ 허가제출용 뱃치에 관한 사항(요약)\n- - 제조량 및 목표량\n혼합(건조 후)\n\n최종혼합\n\n- - 20 -\n- - 뱃치조성(실생산 뱃치와 비교)\n**[표 시작]**\n\n| 성분명, 규격 | 허가제출용 뱃치 |\n| --- | --- |\n| 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 |\n**첨가제 선택과 관련한 추가 상세 정보는 3.2.P.2.1.2 첨가제를 참조한다.",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 377,
        "window_size": 3,
        "char_count": 217,
        "word_count": 58,
        "page_number": 2,
        "window_text": "<최종혼합> 분쇄된 과립을 bin-blender에서 크로스포비돈을 넣어 5 분간 혼합하고,\n- 9.  <타정 및 포장> 혼합물을 타정 후 포장한다.\n - - 제조공정을 도식으로 표현하면 다음과 같다.\n - ○ 허가제출용 뱃치에 관한 사항(요약)\n- - 제조량 및 목표량\n혼합(건조 후)\n\n최종혼합\n\n- - 20 -\n- - 뱃치조성(실생산 뱃치와 비교)\n**[표 시작]**\n\n| 성분명, 규격 | 허가제출용 뱃치 |\n| --- | --- |\n| 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 |\n**첨가제 선택과 관련한 추가 상세 정보는 3.2.P.2.1.2 첨가제를 참조한다. **\n| 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 | 유연물질 A(3%) |\n**순도시험**\n| UV (단파장/ 장파장), 7 일 | 98% | >0.99 | NA |\n| 건열, 105 ℃, 14 시간 | 70% | >0.99 | 유연물질 A(23%) |\n**1.  대조약과 약제학적으로 동일하도록 캡슐제형으로 한다. **\n| 정확성 | 98 - 101%, 표시량의 50%, 100%, 150% 포함 |\n| 정제수 | 9.6 L | 96 L |\n| 총 질량 | 48 kg | 480 kg |\n**직선성, 특이성 및 시스템적합성이 검증된 방법이다.",
        "original_sentence": "- ○ 허가제출용 뱃치에 관한 사항(요약)\n- - 제조량 및 목표량\n혼합(건조 후)\n\n최종혼합\n\n- - 20 -\n- - 뱃치조성(실생산 뱃치와 비교)\n**[표 시작]**\n\n| 성분명, 규격 | 허가제출용 뱃치 |\n| --- | --- |\n| 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 |\n**첨가제 선택과 관련한 추가 상세 정보는 3.2.P.2.1.2 첨가제를 참조한다."
      }
    },
    {
      "chunk_id": "chunk_379",
      "text": "**\n| 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 | 유연물질 A(3%) |\n**순도시험**\n| UV (단파장/ 장파장), 7 일 | 98% | >0.99 | NA |\n| 건열, 105 ℃, 14 시간 | 70% | >0.99 | 유연물질 A(23%) |\n**1. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 378,
        "window_size": 3,
        "char_count": 161,
        "word_count": 45,
        "page_number": 5,
        "window_text": "<타정 및 포장> 혼합물을 타정 후 포장한다.\n - - 제조공정을 도식으로 표현하면 다음과 같다.\n - ○ 허가제출용 뱃치에 관한 사항(요약)\n- - 제조량 및 목표량\n혼합(건조 후)\n\n최종혼합\n\n- - 20 -\n- - 뱃치조성(실생산 뱃치와 비교)\n**[표 시작]**\n\n| 성분명, 규격 | 허가제출용 뱃치 |\n| --- | --- |\n| 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 |\n**첨가제 선택과 관련한 추가 상세 정보는 3.2.P.2.1.2 첨가제를 참조한다. **\n| 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 | 유연물질 A(3%) |\n**순도시험**\n| UV (단파장/ 장파장), 7 일 | 98% | >0.99 | NA |\n| 건열, 105 ℃, 14 시간 | 70% | >0.99 | 유연물질 A(23%) |\n**1.  대조약과 약제학적으로 동일하도록 캡슐제형으로 한다. **\n| 정확성 | 98 - 101%, 표시량의 50%, 100%, 150% 포함 |\n| 정제수 | 9.6 L | 96 L |\n| 총 질량 | 48 kg | 480 kg |\n**직선성, 특이성 및 시스템적합성이 검증된 방법이다. **\n**▪ 목표 제품 설계 방법**\n**2.3.P.2.4 용기 및 포장**\n| 구형백당, 25-30 mesh* | Sugar Inc. ",
        "original_sentence": "**\n| 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 | 유연물질 A(3%) |\n**순도시험**\n| UV (단파장/ 장파장), 7 일 | 98% | >0.99 | NA |\n| 건열, 105 ℃, 14 시간 | 70% | >0.99 | 유연물질 A(23%) |\n**1. "
      }
    },
    {
      "chunk_id": "chunk_380",
      "text": "대조약과 약제학적으로 동일하도록 캡슐제형으로 한다.",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 379,
        "window_size": 3,
        "char_count": 28,
        "word_count": 5,
        "page_number": 13,
        "window_text": "- - 제조공정을 도식으로 표현하면 다음과 같다.\n - ○ 허가제출용 뱃치에 관한 사항(요약)\n- - 제조량 및 목표량\n혼합(건조 후)\n\n최종혼합\n\n- - 20 -\n- - 뱃치조성(실생산 뱃치와 비교)\n**[표 시작]**\n\n| 성분명, 규격 | 허가제출용 뱃치 |\n| --- | --- |\n| 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 |\n**첨가제 선택과 관련한 추가 상세 정보는 3.2.P.2.1.2 첨가제를 참조한다. **\n| 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 | 유연물질 A(3%) |\n**순도시험**\n| UV (단파장/ 장파장), 7 일 | 98% | >0.99 | NA |\n| 건열, 105 ℃, 14 시간 | 70% | >0.99 | 유연물질 A(23%) |\n**1.  대조약과 약제학적으로 동일하도록 캡슐제형으로 한다. **\n| 정확성 | 98 - 101%, 표시량의 50%, 100%, 150% 포함 |\n| 정제수 | 9.6 L | 96 L |\n| 총 질량 | 48 kg | 480 kg |\n**직선성, 특이성 및 시스템적합성이 검증된 방법이다. **\n**▪ 목표 제품 설계 방법**\n**2.3.P.2.4 용기 및 포장**\n| 구형백당, 25-30 mesh* | Sugar Inc.  | NF |\n| √ 완제의약품에서의 원료의약품 입자도 | 3.2.P.5.4 뱃치 분석을 참고한다. ",
        "original_sentence": "대조약과 약제학적으로 동일하도록 캡슐제형으로 한다."
      }
    },
    {
      "chunk_id": "chunk_381",
      "text": "**\n| 정확성 | 98 - 101%, 표시량의 50%, 100%, 150% 포함 |\n| 정제수 | 9.6 L | 96 L |\n| 총 질량 | 48 kg | 480 kg |\n**직선성, 특이성 및 시스템적합성이 검증된 방법이다.",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 380,
        "window_size": 3,
        "char_count": 127,
        "word_count": 38,
        "page_number": 5,
        "window_text": "- ○ 허가제출용 뱃치에 관한 사항(요약)\n- - 제조량 및 목표량\n혼합(건조 후)\n\n최종혼합\n\n- - 20 -\n- - 뱃치조성(실생산 뱃치와 비교)\n**[표 시작]**\n\n| 성분명, 규격 | 허가제출용 뱃치 |\n| --- | --- |\n| 3% H2O2, 60 ℃, 2 시간 | 20% | >0.99 |\n**첨가제 선택과 관련한 추가 상세 정보는 3.2.P.2.1.2 첨가제를 참조한다. **\n| 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 | 유연물질 A(3%) |\n**순도시험**\n| UV (단파장/ 장파장), 7 일 | 98% | >0.99 | NA |\n| 건열, 105 ℃, 14 시간 | 70% | >0.99 | 유연물질 A(23%) |\n**1.  대조약과 약제학적으로 동일하도록 캡슐제형으로 한다. **\n| 정확성 | 98 - 101%, 표시량의 50%, 100%, 150% 포함 |\n| 정제수 | 9.6 L | 96 L |\n| 총 질량 | 48 kg | 480 kg |\n**직선성, 특이성 및 시스템적합성이 검증된 방법이다. **\n**▪ 목표 제품 설계 방법**\n**2.3.P.2.4 용기 및 포장**\n| 구형백당, 25-30 mesh* | Sugar Inc.  | NF |\n| √ 완제의약품에서의 원료의약품 입자도 | 3.2.P.5.4 뱃치 분석을 참고한다.  |\n| 뚜껑 (60 mL 용) | 28 mm CR cap white HDPE Outer Shell clear PP |\n| 시트르산트리에틸 | Plasticizer |\n| √ 완제의약품에서의 원료의약품 결정다형 | 균일성과 용출 시험에서도 HPLC 법이 사용되었다. ",
        "original_sentence": "**\n| 정확성 | 98 - 101%, 표시량의 50%, 100%, 150% 포함 |\n| 정제수 | 9.6 L | 96 L |\n| 총 질량 | 48 kg | 480 kg |\n**직선성, 특이성 및 시스템적합성이 검증된 방법이다."
      }
    },
    {
      "chunk_id": "chunk_382",
      "text": "**\n**▪ 목표 제품 설계 방법**\n**2.3.P.2.4 용기 및 포장**\n| 구형백당, 25-30 mesh* | Sugar Inc. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 381,
        "window_size": 3,
        "char_count": 76,
        "word_count": 17,
        "page_number": 5,
        "window_text": "**\n| 습도(90% RH), 25 ℃, 7 일 | 95% | >0.99 | 유연물질 A(3%) |\n**순도시험**\n| UV (단파장/ 장파장), 7 일 | 98% | >0.99 | NA |\n| 건열, 105 ℃, 14 시간 | 70% | >0.99 | 유연물질 A(23%) |\n**1.  대조약과 약제학적으로 동일하도록 캡슐제형으로 한다. **\n| 정확성 | 98 - 101%, 표시량의 50%, 100%, 150% 포함 |\n| 정제수 | 9.6 L | 96 L |\n| 총 질량 | 48 kg | 480 kg |\n**직선성, 특이성 및 시스템적합성이 검증된 방법이다. **\n**▪ 목표 제품 설계 방법**\n**2.3.P.2.4 용기 및 포장**\n| 구형백당, 25-30 mesh* | Sugar Inc.  | NF |\n| √ 완제의약품에서의 원료의약품 입자도 | 3.2.P.5.4 뱃치 분석을 참고한다.  |\n| 뚜껑 (60 mL 용) | 28 mm CR cap white HDPE Outer Shell clear PP |\n| 시트르산트리에틸 | Plasticizer |\n| √ 완제의약품에서의 원료의약품 결정다형 | 균일성과 용출 시험에서도 HPLC 법이 사용되었다.  | 강제 분해시험(가혹 조건에서 실시) 결과 요약 및 타당성입증자료를 제출한다. ",
        "original_sentence": "**\n**▪ 목표 제품 설계 방법**\n**2.3.P.2.4 용기 및 포장**\n| 구형백당, 25-30 mesh* | Sugar Inc. "
      }
    },
    {
      "chunk_id": "chunk_383",
      "text": "| NF |\n| √ 완제의약품에서의 원료의약품 입자도 | 3.2.P.5.4 뱃치 분석을 참고한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 382,
        "window_size": 3,
        "char_count": 55,
        "word_count": 13,
        "page_number": 5,
        "window_text": "대조약과 약제학적으로 동일하도록 캡슐제형으로 한다. **\n| 정확성 | 98 - 101%, 표시량의 50%, 100%, 150% 포함 |\n| 정제수 | 9.6 L | 96 L |\n| 총 질량 | 48 kg | 480 kg |\n**직선성, 특이성 및 시스템적합성이 검증된 방법이다. **\n**▪ 목표 제품 설계 방법**\n**2.3.P.2.4 용기 및 포장**\n| 구형백당, 25-30 mesh* | Sugar Inc.  | NF |\n| √ 완제의약품에서의 원료의약품 입자도 | 3.2.P.5.4 뱃치 분석을 참고한다.  |\n| 뚜껑 (60 mL 용) | 28 mm CR cap white HDPE Outer Shell clear PP |\n| 시트르산트리에틸 | Plasticizer |\n| √ 완제의약품에서의 원료의약품 결정다형 | 균일성과 용출 시험에서도 HPLC 법이 사용되었다.  | 강제 분해시험(가혹 조건에서 실시) 결과 요약 및 타당성입증자료를 제출한다.  |\n| 특이성 | 대한 정보를 요약하여 기재한다. ",
        "original_sentence": "| NF |\n| √ 완제의약품에서의 원료의약품 입자도 | 3.2.P.5.4 뱃치 분석을 참고한다. "
      }
    },
    {
      "chunk_id": "chunk_384",
      "text": "|\n| 뚜껑 (60 mL 용) | 28 mm CR cap white HDPE Outer Shell clear PP |\n| 시트르산트리에틸 | Plasticizer |\n| √ 완제의약품에서의 원료의약품 결정다형 | 균일성과 용출 시험에서도 HPLC 법이 사용되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 383,
        "window_size": 3,
        "char_count": 148,
        "word_count": 35,
        "page_number": 5,
        "window_text": "**\n| 정확성 | 98 - 101%, 표시량의 50%, 100%, 150% 포함 |\n| 정제수 | 9.6 L | 96 L |\n| 총 질량 | 48 kg | 480 kg |\n**직선성, 특이성 및 시스템적합성이 검증된 방법이다. **\n**▪ 목표 제품 설계 방법**\n**2.3.P.2.4 용기 및 포장**\n| 구형백당, 25-30 mesh* | Sugar Inc.  | NF |\n| √ 완제의약품에서의 원료의약품 입자도 | 3.2.P.5.4 뱃치 분석을 참고한다.  |\n| 뚜껑 (60 mL 용) | 28 mm CR cap white HDPE Outer Shell clear PP |\n| 시트르산트리에틸 | Plasticizer |\n| √ 완제의약품에서의 원료의약품 결정다형 | 균일성과 용출 시험에서도 HPLC 법이 사용되었다.  | 강제 분해시험(가혹 조건에서 실시) 결과 요약 및 타당성입증자료를 제출한다.  |\n| 특이성 | 대한 정보를 요약하여 기재한다.  |\n| 혼합 | 체에 남은 분율 | 1.0% 이하 | M-1231 | 0.1% |\n| √ 완제의약품에서의 붕해도 | 용출시험 | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP(HPLC) |\n| 부틸레이티드히드록시아니솔 | Antioxidant |\n| 코팅효율 | 98% | 98% | N/A |\n| [특정 분해생성물] | [허가제출용 뱃치의 결과] |\n**√ 완제의약품에서의 용출**\n| 습식체과 | 체에 남은 분율 | 1.0% 이하 | M-1233 | 0.1% | 이동상 | 직선성 |\n| 에틸셀룰로오스 | Control |\n**√ 완제의약품의 경도**\n| ▪ 결정형 | 시험항목 | 허용 기준 | 시험 방법 |\n**개월 동안 시험하였다. ",
        "original_sentence": "|\n| 뚜껑 (60 mL 용) | 28 mm CR cap white HDPE Outer Shell clear PP |\n| 시트르산트리에틸 | Plasticizer |\n| √ 완제의약품에서의 원료의약품 결정다형 | 균일성과 용출 시험에서도 HPLC 법이 사용되었다. "
      }
    },
    {
      "chunk_id": "chunk_385",
      "text": "| 강제 분해시험(가혹 조건에서 실시) 결과 요약 및 타당성입증자료를 제출한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 384,
        "window_size": 3,
        "char_count": 45,
        "word_count": 10,
        "page_number": 13,
        "window_text": "**\n**▪ 목표 제품 설계 방법**\n**2.3.P.2.4 용기 및 포장**\n| 구형백당, 25-30 mesh* | Sugar Inc.  | NF |\n| √ 완제의약품에서의 원료의약품 입자도 | 3.2.P.5.4 뱃치 분석을 참고한다.  |\n| 뚜껑 (60 mL 용) | 28 mm CR cap white HDPE Outer Shell clear PP |\n| 시트르산트리에틸 | Plasticizer |\n| √ 완제의약품에서의 원료의약품 결정다형 | 균일성과 용출 시험에서도 HPLC 법이 사용되었다.  | 강제 분해시험(가혹 조건에서 실시) 결과 요약 및 타당성입증자료를 제출한다.  |\n| 특이성 | 대한 정보를 요약하여 기재한다.  |\n| 혼합 | 체에 남은 분율 | 1.0% 이하 | M-1231 | 0.1% |\n| √ 완제의약품에서의 붕해도 | 용출시험 | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP(HPLC) |\n| 부틸레이티드히드록시아니솔 | Antioxidant |\n| 코팅효율 | 98% | 98% | N/A |\n| [특정 분해생성물] | [허가제출용 뱃치의 결과] |\n**√ 완제의약품에서의 용출**\n| 습식체과 | 체에 남은 분율 | 1.0% 이하 | M-1233 | 0.1% | 이동상 | 직선성 |\n| 에틸셀룰로오스 | Control |\n**√ 완제의약품의 경도**\n| ▪ 결정형 | 시험항목 | 허용 기준 | 시험 방법 |\n**개월 동안 시험하였다.  향후 연간 모니터링할 예정이다.",
        "original_sentence": "| 강제 분해시험(가혹 조건에서 실시) 결과 요약 및 타당성입증자료를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_386",
      "text": "|\n| 특이성 | 대한 정보를 요약하여 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 385,
        "window_size": 3,
        "char_count": 28,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| NF |\n| √ 완제의약품에서의 원료의약품 입자도 | 3.2.P.5.4 뱃치 분석을 참고한다.  |\n| 뚜껑 (60 mL 용) | 28 mm CR cap white HDPE Outer Shell clear PP |\n| 시트르산트리에틸 | Plasticizer |\n| √ 완제의약품에서의 원료의약품 결정다형 | 균일성과 용출 시험에서도 HPLC 법이 사용되었다.  | 강제 분해시험(가혹 조건에서 실시) 결과 요약 및 타당성입증자료를 제출한다.  |\n| 특이성 | 대한 정보를 요약하여 기재한다.  |\n| 혼합 | 체에 남은 분율 | 1.0% 이하 | M-1231 | 0.1% |\n| √ 완제의약품에서의 붕해도 | 용출시험 | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP(HPLC) |\n| 부틸레이티드히드록시아니솔 | Antioxidant |\n| 코팅효율 | 98% | 98% | N/A |\n| [특정 분해생성물] | [허가제출용 뱃치의 결과] |\n**√ 완제의약품에서의 용출**\n| 습식체과 | 체에 남은 분율 | 1.0% 이하 | M-1233 | 0.1% | 이동상 | 직선성 |\n| 에틸셀룰로오스 | Control |\n**√ 완제의약품의 경도**\n| ▪ 결정형 | 시험항목 | 허용 기준 | 시험 방법 |\n**개월 동안 시험하였다.  향후 연간 모니터링할 예정이다. **\n| 건조 | 건조감량 | 칼럼 | Symtrex C8, 5 ㎛, 150mm X 4.6mm | 기재한다. ",
        "original_sentence": "|\n| 특이성 | 대한 정보를 요약하여 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_387",
      "text": "|\n| 혼합 | 체에 남은 분율 | 1.0% 이하 | M-1231 | 0.1% |\n| √ 완제의약품에서의 붕해도 | 용출시험 | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP(HPLC) |\n| 부틸레이티드히드록시아니솔 | Antioxidant |\n| 코팅효율 | 98% | 98% | N/A |\n| [특정 분해생성물] | [허가제출용 뱃치의 결과] |\n**√ 완제의약품에서의 용출**\n| 습식체과 | 체에 남은 분율 | 1.0% 이하 | M-1233 | 0.1% | 이동상 | 직선성 |\n| 에틸셀룰로오스 | Control |\n**√ 완제의약품의 경도**\n| ▪ 결정형 | 시험항목 | 허용 기준 | 시험 방법 |\n**개월 동안 시험하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 386,
        "window_size": 3,
        "char_count": 372,
        "word_count": 99,
        "page_number": 3,
        "window_text": "|\n| 뚜껑 (60 mL 용) | 28 mm CR cap white HDPE Outer Shell clear PP |\n| 시트르산트리에틸 | Plasticizer |\n| √ 완제의약품에서의 원료의약품 결정다형 | 균일성과 용출 시험에서도 HPLC 법이 사용되었다.  | 강제 분해시험(가혹 조건에서 실시) 결과 요약 및 타당성입증자료를 제출한다.  |\n| 특이성 | 대한 정보를 요약하여 기재한다.  |\n| 혼합 | 체에 남은 분율 | 1.0% 이하 | M-1231 | 0.1% |\n| √ 완제의약품에서의 붕해도 | 용출시험 | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP(HPLC) |\n| 부틸레이티드히드록시아니솔 | Antioxidant |\n| 코팅효율 | 98% | 98% | N/A |\n| [특정 분해생성물] | [허가제출용 뱃치의 결과] |\n**√ 완제의약품에서의 용출**\n| 습식체과 | 체에 남은 분율 | 1.0% 이하 | M-1233 | 0.1% | 이동상 | 직선성 |\n| 에틸셀룰로오스 | Control |\n**√ 완제의약품의 경도**\n| ▪ 결정형 | 시험항목 | 허용 기준 | 시험 방법 |\n**개월 동안 시험하였다.  향후 연간 모니터링할 예정이다. **\n| 건조 | 건조감량 | 칼럼 | Symtrex C8, 5 ㎛, 150mm X 4.6mm | 기재한다.  |\n| 정제수 | In-House | USP | 유동화 기체 부피 | 사실과 기허가 사항에 근거한 것이다. ",
        "original_sentence": "|\n| 혼합 | 체에 남은 분율 | 1.0% 이하 | M-1231 | 0.1% |\n| √ 완제의약품에서의 붕해도 | 용출시험 | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP(HPLC) |\n| 부틸레이티드히드록시아니솔 | Antioxidant |\n| 코팅효율 | 98% | 98% | N/A |\n| [특정 분해생성물] | [허가제출용 뱃치의 결과] |\n**√ 완제의약품에서의 용출**\n| 습식체과 | 체에 남은 분율 | 1.0% 이하 | M-1233 | 0.1% | 이동상 | 직선성 |\n| 에틸셀룰로오스 | Control |\n**√ 완제의약품의 경도**\n| ▪ 결정형 | 시험항목 | 허용 기준 | 시험 방법 |\n**개월 동안 시험하였다. "
      }
    },
    {
      "chunk_id": "chunk_388",
      "text": "향후 연간 모니터링할 예정이다.",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 387,
        "window_size": 3,
        "char_count": 17,
        "word_count": 4,
        "page_number": 3,
        "window_text": "| 강제 분해시험(가혹 조건에서 실시) 결과 요약 및 타당성입증자료를 제출한다.  |\n| 특이성 | 대한 정보를 요약하여 기재한다.  |\n| 혼합 | 체에 남은 분율 | 1.0% 이하 | M-1231 | 0.1% |\n| √ 완제의약품에서의 붕해도 | 용출시험 | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP(HPLC) |\n| 부틸레이티드히드록시아니솔 | Antioxidant |\n| 코팅효율 | 98% | 98% | N/A |\n| [특정 분해생성물] | [허가제출용 뱃치의 결과] |\n**√ 완제의약품에서의 용출**\n| 습식체과 | 체에 남은 분율 | 1.0% 이하 | M-1233 | 0.1% | 이동상 | 직선성 |\n| 에틸셀룰로오스 | Control |\n**√ 완제의약품의 경도**\n| ▪ 결정형 | 시험항목 | 허용 기준 | 시험 방법 |\n**개월 동안 시험하였다.  향후 연간 모니터링할 예정이다. **\n| 건조 | 건조감량 | 칼럼 | Symtrex C8, 5 ㎛, 150mm X 4.6mm | 기재한다.  |\n| 정제수 | In-House | USP | 유동화 기체 부피 | 사실과 기허가 사항에 근거한 것이다.  |\n| 실험실 | 내 | 사용하는 용출 용매와 다르게 사용한 경우 이를 작성한다. ",
        "original_sentence": "향후 연간 모니터링할 예정이다."
      }
    },
    {
      "chunk_id": "chunk_389",
      "text": "**\n| 건조 | 건조감량 | 칼럼 | Symtrex C8, 5 ㎛, 150mm X 4.6mm | 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 388,
        "window_size": 3,
        "char_count": 61,
        "word_count": 17,
        "page_number": 5,
        "window_text": "|\n| 특이성 | 대한 정보를 요약하여 기재한다.  |\n| 혼합 | 체에 남은 분율 | 1.0% 이하 | M-1231 | 0.1% |\n| √ 완제의약품에서의 붕해도 | 용출시험 | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP(HPLC) |\n| 부틸레이티드히드록시아니솔 | Antioxidant |\n| 코팅효율 | 98% | 98% | N/A |\n| [특정 분해생성물] | [허가제출용 뱃치의 결과] |\n**√ 완제의약품에서의 용출**\n| 습식체과 | 체에 남은 분율 | 1.0% 이하 | M-1233 | 0.1% | 이동상 | 직선성 |\n| 에틸셀룰로오스 | Control |\n**√ 완제의약품의 경도**\n| ▪ 결정형 | 시험항목 | 허용 기준 | 시험 방법 |\n**개월 동안 시험하였다.  향후 연간 모니터링할 예정이다. **\n| 건조 | 건조감량 | 칼럼 | Symtrex C8, 5 ㎛, 150mm X 4.6mm | 기재한다.  |\n| 정제수 | In-House | USP | 유동화 기체 부피 | 사실과 기허가 사항에 근거한 것이다.  |\n| 실험실 | 내 | 사용하는 용출 용매와 다르게 사용한 경우 이를 작성한다.  |\n\n**[표 끝]**\n\n주성분, USP\n\n- 0.4 kg\n- 4.0 kg\n- 0.83\n유당, NF\n\n- 32.00 kg\n- 320.00 kg\n- 66.67\n미결정셀룰로오스, NF\n\n- 12.32 kg\n- 123.20 kg\n- 25.67\n포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n크로스포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n스테아르산마그네슘, NF\n\n- 0.24 kg\n- 2.4 kg\n- 0.50\nFD&C Blue #2\n\n- 0.160 kg\n- 1.60 kg\n- 0.33\n- - 제조공정 중 품질검사 항목\n타정\n\n분쇄\n\n체에 남은 분율\n\n- 1.0% 이하\nM-1233\n\n- 0.2%\n- - 21 -\n- - 실생산 뱃치와 허가제출용 뱃치 간의 장비 및 작동원리 비교\n<!-- PAGE_27 -->\n##### 2.3.P.4 첨가제의 관리(제품명, 제형)(Control of Excipients)(name, dosage form)\n\n- 3.2.P.4에 기재된 첨가제의 품질에 관한 간략한 요약을 포함하여야 한다.\n",
        "original_sentence": "**\n| 건조 | 건조감량 | 칼럼 | Symtrex C8, 5 ㎛, 150mm X 4.6mm | 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_390",
      "text": "|\n| 정제수 | In-House | USP | 유동화 기체 부피 | 사실과 기허가 사항에 근거한 것이다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 389,
        "window_size": 3,
        "char_count": 60,
        "word_count": 17,
        "page_number": 2,
        "window_text": "|\n| 혼합 | 체에 남은 분율 | 1.0% 이하 | M-1231 | 0.1% |\n| √ 완제의약품에서의 붕해도 | 용출시험 | 표시량의 80% (Q) 이상 / 30 분, USP<711> | USP(HPLC) |\n| 부틸레이티드히드록시아니솔 | Antioxidant |\n| 코팅효율 | 98% | 98% | N/A |\n| [특정 분해생성물] | [허가제출용 뱃치의 결과] |\n**√ 완제의약품에서의 용출**\n| 습식체과 | 체에 남은 분율 | 1.0% 이하 | M-1233 | 0.1% | 이동상 | 직선성 |\n| 에틸셀룰로오스 | Control |\n**√ 완제의약품의 경도**\n| ▪ 결정형 | 시험항목 | 허용 기준 | 시험 방법 |\n**개월 동안 시험하였다.  향후 연간 모니터링할 예정이다. **\n| 건조 | 건조감량 | 칼럼 | Symtrex C8, 5 ㎛, 150mm X 4.6mm | 기재한다.  |\n| 정제수 | In-House | USP | 유동화 기체 부피 | 사실과 기허가 사항에 근거한 것이다.  |\n| 실험실 | 내 | 사용하는 용출 용매와 다르게 사용한 경우 이를 작성한다.  |\n\n**[표 끝]**\n\n주성분, USP\n\n- 0.4 kg\n- 4.0 kg\n- 0.83\n유당, NF\n\n- 32.00 kg\n- 320.00 kg\n- 66.67\n미결정셀룰로오스, NF\n\n- 12.32 kg\n- 123.20 kg\n- 25.67\n포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n크로스포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n스테아르산마그네슘, NF\n\n- 0.24 kg\n- 2.4 kg\n- 0.50\nFD&C Blue #2\n\n- 0.160 kg\n- 1.60 kg\n- 0.33\n- - 제조공정 중 품질검사 항목\n타정\n\n분쇄\n\n체에 남은 분율\n\n- 1.0% 이하\nM-1233\n\n- 0.2%\n- - 21 -\n- - 실생산 뱃치와 허가제출용 뱃치 간의 장비 및 작동원리 비교\n<!-- PAGE_27 -->\n##### 2.3.P.4 첨가제의 관리(제품명, 제형)(Control of Excipients)(name, dosage form)\n\n- 3.2.P.4에 기재된 첨가제의 품질에 관한 간략한 요약을 포함하여야 한다.\n <!-- PAGE_27 -->\n##### 해 설\n\n**[표 시작]**\n\n| 분석 시간 | 15 분 | 자세한 내용은 3.2.P.5.3 시험방법 밸리데이션을 참고한다. ",
        "original_sentence": "|\n| 정제수 | In-House | USP | 유동화 기체 부피 | 사실과 기허가 사항에 근거한 것이다. "
      }
    },
    {
      "chunk_id": "chunk_391",
      "text": "|\n| 실험실 | 내 | 사용하는 용출 용매와 다르게 사용한 경우 이를 작성한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 390,
        "window_size": 3,
        "char_count": 46,
        "word_count": 14,
        "page_number": 3,
        "window_text": "향후 연간 모니터링할 예정이다. **\n| 건조 | 건조감량 | 칼럼 | Symtrex C8, 5 ㎛, 150mm X 4.6mm | 기재한다.  |\n| 정제수 | In-House | USP | 유동화 기체 부피 | 사실과 기허가 사항에 근거한 것이다.  |\n| 실험실 | 내 | 사용하는 용출 용매와 다르게 사용한 경우 이를 작성한다.  |\n\n**[표 끝]**\n\n주성분, USP\n\n- 0.4 kg\n- 4.0 kg\n- 0.83\n유당, NF\n\n- 32.00 kg\n- 320.00 kg\n- 66.67\n미결정셀룰로오스, NF\n\n- 12.32 kg\n- 123.20 kg\n- 25.67\n포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n크로스포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n스테아르산마그네슘, NF\n\n- 0.24 kg\n- 2.4 kg\n- 0.50\nFD&C Blue #2\n\n- 0.160 kg\n- 1.60 kg\n- 0.33\n- - 제조공정 중 품질검사 항목\n타정\n\n분쇄\n\n체에 남은 분율\n\n- 1.0% 이하\nM-1233\n\n- 0.2%\n- - 21 -\n- - 실생산 뱃치와 허가제출용 뱃치 간의 장비 및 작동원리 비교\n<!-- PAGE_27 -->\n##### 2.3.P.4 첨가제의 관리(제품명, 제형)(Control of Excipients)(name, dosage form)\n\n- 3.2.P.4에 기재된 첨가제의 품질에 관한 간략한 요약을 포함하여야 한다.\n <!-- PAGE_27 -->\n##### 해 설\n\n**[표 시작]**\n\n| 분석 시간 | 15 분 | 자세한 내용은 3.2.P.5.3 시험방법 밸리데이션을 참고한다.  |\n| --- | --- | --- |\n| 최종혼합 | 분무 속도(mL/분) | 25~30 | 150~180 |\n| 유지 시간 | 약 8 분 | 에서 관리한다. ",
        "original_sentence": "|\n| 실험실 | 내 | 사용하는 용출 용매와 다르게 사용한 경우 이를 작성한다. "
      }
    },
    {
      "chunk_id": "chunk_392",
      "text": "|\n\n**[표 끝]**\n\n주성분, USP\n\n- 0.4 kg\n- 4.0 kg\n- 0.83\n유당, NF\n\n- 32.00 kg\n- 320.00 kg\n- 66.67\n미결정셀룰로오스, NF\n\n- 12.32 kg\n- 123.20 kg\n- 25.67\n포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n크로스포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n스테아르산마그네슘, NF\n\n- 0.24 kg\n- 2.4 kg\n- 0.50\nFD&C Blue #2\n\n- 0.160 kg\n- 1.60 kg\n- 0.33\n- - 제조공정 중 품질검사 항목\n타정\n\n분쇄\n\n체에 남은 분율\n\n- 1.0% 이하\nM-1233\n\n- 0.2%\n- - 21 -\n- - 실생산 뱃치와 허가제출용 뱃치 간의 장비 및 작동원리 비교\n<!-- PAGE_27 -->\n##### 2.3.P.4 첨가제의 관리(제품명, 제형)(Control of Excipients)(name, dosage form)\n\n- 3.2.P.4에 기재된 첨가제의 품질에 관한 간략한 요약을 포함하여야 한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 391,
        "window_size": 3,
        "char_count": 537,
        "word_count": 128,
        "page_number": 27,
        "window_text": "**\n| 건조 | 건조감량 | 칼럼 | Symtrex C8, 5 ㎛, 150mm X 4.6mm | 기재한다.  |\n| 정제수 | In-House | USP | 유동화 기체 부피 | 사실과 기허가 사항에 근거한 것이다.  |\n| 실험실 | 내 | 사용하는 용출 용매와 다르게 사용한 경우 이를 작성한다.  |\n\n**[표 끝]**\n\n주성분, USP\n\n- 0.4 kg\n- 4.0 kg\n- 0.83\n유당, NF\n\n- 32.00 kg\n- 320.00 kg\n- 66.67\n미결정셀룰로오스, NF\n\n- 12.32 kg\n- 123.20 kg\n- 25.67\n포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n크로스포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n스테아르산마그네슘, NF\n\n- 0.24 kg\n- 2.4 kg\n- 0.50\nFD&C Blue #2\n\n- 0.160 kg\n- 1.60 kg\n- 0.33\n- - 제조공정 중 품질검사 항목\n타정\n\n분쇄\n\n체에 남은 분율\n\n- 1.0% 이하\nM-1233\n\n- 0.2%\n- - 21 -\n- - 실생산 뱃치와 허가제출용 뱃치 간의 장비 및 작동원리 비교\n<!-- PAGE_27 -->\n##### 2.3.P.4 첨가제의 관리(제품명, 제형)(Control of Excipients)(name, dosage form)\n\n- 3.2.P.4에 기재된 첨가제의 품질에 관한 간략한 요약을 포함하여야 한다.\n <!-- PAGE_27 -->\n##### 해 설\n\n**[표 시작]**\n\n| 분석 시간 | 15 분 | 자세한 내용은 3.2.P.5.3 시험방법 밸리데이션을 참고한다.  |\n| --- | --- | --- |\n| 최종혼합 | 분무 속도(mL/분) | 25~30 | 150~180 |\n| 유지 시간 | 약 8 분 | 에서 관리한다.  | 중 미생물관련 특성에 대하여 별도로 기재한다. ",
        "original_sentence": "|\n\n**[표 끝]**\n\n주성분, USP\n\n- 0.4 kg\n- 4.0 kg\n- 0.83\n유당, NF\n\n- 32.00 kg\n- 320.00 kg\n- 66.67\n미결정셀룰로오스, NF\n\n- 12.32 kg\n- 123.20 kg\n- 25.67\n포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n크로스포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n스테아르산마그네슘, NF\n\n- 0.24 kg\n- 2.4 kg\n- 0.50\nFD&C Blue #2\n\n- 0.160 kg\n- 1.60 kg\n- 0.33\n- - 제조공정 중 품질검사 항목\n타정\n\n분쇄\n\n체에 남은 분율\n\n- 1.0% 이하\nM-1233\n\n- 0.2%\n- - 21 -\n- - 실생산 뱃치와 허가제출용 뱃치 간의 장비 및 작동원리 비교\n<!-- PAGE_27 -->\n##### 2.3.P.4 첨가제의 관리(제품명, 제형)(Control of Excipients)(name, dosage form)\n\n- 3.2.P.4에 기재된 첨가제의 품질에 관한 간략한 요약을 포함하여야 한다.\n"
      }
    },
    {
      "chunk_id": "chunk_393",
      "text": "<!-- PAGE_27 -->\n##### 해 설\n\n**[표 시작]**\n\n| 분석 시간 | 15 분 | 자세한 내용은 3.2.P.5.3 시험방법 밸리데이션을 참고한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 392,
        "window_size": 3,
        "char_count": 93,
        "word_count": 21,
        "page_number": 27,
        "window_text": "|\n| 정제수 | In-House | USP | 유동화 기체 부피 | 사실과 기허가 사항에 근거한 것이다.  |\n| 실험실 | 내 | 사용하는 용출 용매와 다르게 사용한 경우 이를 작성한다.  |\n\n**[표 끝]**\n\n주성분, USP\n\n- 0.4 kg\n- 4.0 kg\n- 0.83\n유당, NF\n\n- 32.00 kg\n- 320.00 kg\n- 66.67\n미결정셀룰로오스, NF\n\n- 12.32 kg\n- 123.20 kg\n- 25.67\n포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n크로스포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n스테아르산마그네슘, NF\n\n- 0.24 kg\n- 2.4 kg\n- 0.50\nFD&C Blue #2\n\n- 0.160 kg\n- 1.60 kg\n- 0.33\n- - 제조공정 중 품질검사 항목\n타정\n\n분쇄\n\n체에 남은 분율\n\n- 1.0% 이하\nM-1233\n\n- 0.2%\n- - 21 -\n- - 실생산 뱃치와 허가제출용 뱃치 간의 장비 및 작동원리 비교\n<!-- PAGE_27 -->\n##### 2.3.P.4 첨가제의 관리(제품명, 제형)(Control of Excipients)(name, dosage form)\n\n- 3.2.P.4에 기재된 첨가제의 품질에 관한 간략한 요약을 포함하여야 한다.\n <!-- PAGE_27 -->\n##### 해 설\n\n**[표 시작]**\n\n| 분석 시간 | 15 분 | 자세한 내용은 3.2.P.5.3 시험방법 밸리데이션을 참고한다.  |\n| --- | --- | --- |\n| 최종혼합 | 분무 속도(mL/분) | 25~30 | 150~180 |\n| 유지 시간 | 약 8 분 | 에서 관리한다.  | 중 미생물관련 특성에 대하여 별도로 기재한다.  |\n**2.3.P.2.1 완제의약품 조성**\n| 확인시험 | 표준액 및 시험액 | 주성분 0.1 mg/mL을 포함하는 표준액과 시험액을 조제한다. ",
        "original_sentence": "<!-- PAGE_27 -->\n##### 해 설\n\n**[표 시작]**\n\n| 분석 시간 | 15 분 | 자세한 내용은 3.2.P.5.3 시험방법 밸리데이션을 참고한다. "
      }
    },
    {
      "chunk_id": "chunk_394",
      "text": "|\n| --- | --- | --- |\n| 최종혼합 | 분무 속도(mL/분) | 25~30 | 150~180 |\n| 유지 시간 | 약 8 분 | 에서 관리한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 393,
        "window_size": 3,
        "char_count": 90,
        "word_count": 28,
        "page_number": 5,
        "window_text": "|\n| 실험실 | 내 | 사용하는 용출 용매와 다르게 사용한 경우 이를 작성한다.  |\n\n**[표 끝]**\n\n주성분, USP\n\n- 0.4 kg\n- 4.0 kg\n- 0.83\n유당, NF\n\n- 32.00 kg\n- 320.00 kg\n- 66.67\n미결정셀룰로오스, NF\n\n- 12.32 kg\n- 123.20 kg\n- 25.67\n포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n크로스포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n스테아르산마그네슘, NF\n\n- 0.24 kg\n- 2.4 kg\n- 0.50\nFD&C Blue #2\n\n- 0.160 kg\n- 1.60 kg\n- 0.33\n- - 제조공정 중 품질검사 항목\n타정\n\n분쇄\n\n체에 남은 분율\n\n- 1.0% 이하\nM-1233\n\n- 0.2%\n- - 21 -\n- - 실생산 뱃치와 허가제출용 뱃치 간의 장비 및 작동원리 비교\n<!-- PAGE_27 -->\n##### 2.3.P.4 첨가제의 관리(제품명, 제형)(Control of Excipients)(name, dosage form)\n\n- 3.2.P.4에 기재된 첨가제의 품질에 관한 간략한 요약을 포함하여야 한다.\n <!-- PAGE_27 -->\n##### 해 설\n\n**[표 시작]**\n\n| 분석 시간 | 15 분 | 자세한 내용은 3.2.P.5.3 시험방법 밸리데이션을 참고한다.  |\n| --- | --- | --- |\n| 최종혼합 | 분무 속도(mL/분) | 25~30 | 150~180 |\n| 유지 시간 | 약 8 분 | 에서 관리한다.  | 중 미생물관련 특성에 대하여 별도로 기재한다.  |\n**2.3.P.2.1 완제의약품 조성**\n| 확인시험 | 표준액 및 시험액 | 주성분 0.1 mg/mL을 포함하는 표준액과 시험액을 조제한다.  | 2.3.P.2 개발경위 |\n**점도 관리를 포함한 규격을 설정하였다.",
        "original_sentence": "|\n| --- | --- | --- |\n| 최종혼합 | 분무 속도(mL/분) | 25~30 | 150~180 |\n| 유지 시간 | 약 8 분 | 에서 관리한다. "
      }
    },
    {
      "chunk_id": "chunk_395",
      "text": "| 중 미생물관련 특성에 대하여 별도로 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 394,
        "window_size": 3,
        "char_count": 28,
        "word_count": 7,
        "page_number": 13,
        "window_text": "|\n\n**[표 끝]**\n\n주성분, USP\n\n- 0.4 kg\n- 4.0 kg\n- 0.83\n유당, NF\n\n- 32.00 kg\n- 320.00 kg\n- 66.67\n미결정셀룰로오스, NF\n\n- 12.32 kg\n- 123.20 kg\n- 25.67\n포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n크로스포비돈, NF\n\n- 1.44 kg\n- 14.40 kg\n- 3.00\n스테아르산마그네슘, NF\n\n- 0.24 kg\n- 2.4 kg\n- 0.50\nFD&C Blue #2\n\n- 0.160 kg\n- 1.60 kg\n- 0.33\n- - 제조공정 중 품질검사 항목\n타정\n\n분쇄\n\n체에 남은 분율\n\n- 1.0% 이하\nM-1233\n\n- 0.2%\n- - 21 -\n- - 실생산 뱃치와 허가제출용 뱃치 간의 장비 및 작동원리 비교\n<!-- PAGE_27 -->\n##### 2.3.P.4 첨가제의 관리(제품명, 제형)(Control of Excipients)(name, dosage form)\n\n- 3.2.P.4에 기재된 첨가제의 품질에 관한 간략한 요약을 포함하여야 한다.\n <!-- PAGE_27 -->\n##### 해 설\n\n**[표 시작]**\n\n| 분석 시간 | 15 분 | 자세한 내용은 3.2.P.5.3 시험방법 밸리데이션을 참고한다.  |\n| --- | --- | --- |\n| 최종혼합 | 분무 속도(mL/분) | 25~30 | 150~180 |\n| 유지 시간 | 약 8 분 | 에서 관리한다.  | 중 미생물관련 특성에 대하여 별도로 기재한다.  |\n**2.3.P.2.1 완제의약품 조성**\n| 확인시험 | 표준액 및 시험액 | 주성분 0.1 mg/mL을 포함하는 표준액과 시험액을 조제한다.  | 2.3.P.2 개발경위 |\n**점도 관리를 포함한 규격을 설정하였다. **\n**2.3.P.2.1.1 원료의약품**\n| ▪ 안정성 | 2.3.P.2.1 완제의약품 조성 | 시험의 분석방법 밸리데이션을 위해 기재함. ",
        "original_sentence": "| 중 미생물관련 특성에 대하여 별도로 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_396",
      "text": "|\n**2.3.P.2.1 완제의약품 조성**\n| 확인시험 | 표준액 및 시험액 | 주성분 0.1 mg/mL을 포함하는 표준액과 시험액을 조제한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 395,
        "window_size": 3,
        "char_count": 82,
        "word_count": 18,
        "page_number": 5,
        "window_text": "<!-- PAGE_27 -->\n##### 해 설\n\n**[표 시작]**\n\n| 분석 시간 | 15 분 | 자세한 내용은 3.2.P.5.3 시험방법 밸리데이션을 참고한다.  |\n| --- | --- | --- |\n| 최종혼합 | 분무 속도(mL/분) | 25~30 | 150~180 |\n| 유지 시간 | 약 8 분 | 에서 관리한다.  | 중 미생물관련 특성에 대하여 별도로 기재한다.  |\n**2.3.P.2.1 완제의약품 조성**\n| 확인시험 | 표준액 및 시험액 | 주성분 0.1 mg/mL을 포함하는 표준액과 시험액을 조제한다.  | 2.3.P.2 개발경위 |\n**점도 관리를 포함한 규격을 설정하였다. **\n**2.3.P.2.1.1 원료의약품**\n| ▪ 안정성 | 2.3.P.2.1 완제의약품 조성 | 시험의 분석방법 밸리데이션을 위해 기재함.  (2.3.S.4 원료의약품의 품질관리 참조) |\n| 스케일업 | 약물미세화 기압(bar) | 1.5 | 2.5 |\n| 미처리 | 99% | >0.99 | NA | >0.99 |\n| 2.3.P.2.1.1 원료의약품 | 유연물질 A | [화학 구조] |\n| 에톡시함량 (N-Type) | 48.0 ~ 49.5 % | 48.8 % | 실험설계 시험의 결과는 아래에 요약하였다. ",
        "original_sentence": "|\n**2.3.P.2.1 완제의약품 조성**\n| 확인시험 | 표준액 및 시험액 | 주성분 0.1 mg/mL을 포함하는 표준액과 시험액을 조제한다. "
      }
    },
    {
      "chunk_id": "chunk_397",
      "text": "| 2.3.P.2 개발경위 |\n**점도 관리를 포함한 규격을 설정하였다.",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 396,
        "window_size": 3,
        "char_count": 40,
        "word_count": 9,
        "page_number": 5,
        "window_text": "|\n| --- | --- | --- |\n| 최종혼합 | 분무 속도(mL/분) | 25~30 | 150~180 |\n| 유지 시간 | 약 8 분 | 에서 관리한다.  | 중 미생물관련 특성에 대하여 별도로 기재한다.  |\n**2.3.P.2.1 완제의약품 조성**\n| 확인시험 | 표준액 및 시험액 | 주성분 0.1 mg/mL을 포함하는 표준액과 시험액을 조제한다.  | 2.3.P.2 개발경위 |\n**점도 관리를 포함한 규격을 설정하였다. **\n**2.3.P.2.1.1 원료의약품**\n| ▪ 안정성 | 2.3.P.2.1 완제의약품 조성 | 시험의 분석방법 밸리데이션을 위해 기재함.  (2.3.S.4 원료의약품의 품질관리 참조) |\n| 스케일업 | 약물미세화 기압(bar) | 1.5 | 2.5 |\n| 미처리 | 99% | >0.99 | NA | >0.99 |\n| 2.3.P.2.1.1 원료의약품 | 유연물질 A | [화학 구조] |\n| 에톡시함량 (N-Type) | 48.0 ~ 49.5 % | 48.8 % | 실험설계 시험의 결과는 아래에 요약하였다.  |\n**1 뱃치크기는 사전 경험 뿐 아니라 기기 제조원의 권장사항에 따른다.",
        "original_sentence": "| 2.3.P.2 개발경위 |\n**점도 관리를 포함한 규격을 설정하였다."
      }
    },
    {
      "chunk_id": "chunk_398",
      "text": "**\n**2.3.P.2.1.1 원료의약품**\n| ▪ 안정성 | 2.3.P.2.1 완제의약품 조성 | 시험의 분석방법 밸리데이션을 위해 기재함. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 397,
        "window_size": 3,
        "char_count": 80,
        "word_count": 16,
        "page_number": 5,
        "window_text": "| 중 미생물관련 특성에 대하여 별도로 기재한다.  |\n**2.3.P.2.1 완제의약품 조성**\n| 확인시험 | 표준액 및 시험액 | 주성분 0.1 mg/mL을 포함하는 표준액과 시험액을 조제한다.  | 2.3.P.2 개발경위 |\n**점도 관리를 포함한 규격을 설정하였다. **\n**2.3.P.2.1.1 원료의약품**\n| ▪ 안정성 | 2.3.P.2.1 완제의약품 조성 | 시험의 분석방법 밸리데이션을 위해 기재함.  (2.3.S.4 원료의약품의 품질관리 참조) |\n| 스케일업 | 약물미세화 기압(bar) | 1.5 | 2.5 |\n| 미처리 | 99% | >0.99 | NA | >0.99 |\n| 2.3.P.2.1.1 원료의약품 | 유연물질 A | [화학 구조] |\n| 에톡시함량 (N-Type) | 48.0 ~ 49.5 % | 48.8 % | 실험설계 시험의 결과는 아래에 요약하였다.  |\n**1 뱃치크기는 사전 경험 뿐 아니라 기기 제조원의 권장사항에 따른다. **\n**용출시험**\n| 점도 | 18.0 ~ 22.0 mPa.s | 20.1 mPa.s |\n| 제형설계와 관련한 상세한 정보는 3.2.P.2.2.1 제제 개발을 참조한다. ",
        "original_sentence": "**\n**2.3.P.2.1.1 원료의약품**\n| ▪ 안정성 | 2.3.P.2.1 완제의약품 조성 | 시험의 분석방법 밸리데이션을 위해 기재함. "
      }
    },
    {
      "chunk_id": "chunk_399",
      "text": "(2.3.S.4 원료의약품의 품질관리 참조) |\n| 스케일업 | 약물미세화 기압(bar) | 1.5 | 2.5 |\n| 미처리 | 99% | >0.99 | NA | >0.99 |\n| 2.3.P.2.1.1 원료의약품 | 유연물질 A | [화학 구조] |\n| 에톡시함량 (N-Type) | 48.0 ~ 49.5 % | 48.8 % | 실험설계 시험의 결과는 아래에 요약하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 398,
        "window_size": 3,
        "char_count": 208,
        "word_count": 53,
        "page_number": 5,
        "window_text": "|\n**2.3.P.2.1 완제의약품 조성**\n| 확인시험 | 표준액 및 시험액 | 주성분 0.1 mg/mL을 포함하는 표준액과 시험액을 조제한다.  | 2.3.P.2 개발경위 |\n**점도 관리를 포함한 규격을 설정하였다. **\n**2.3.P.2.1.1 원료의약품**\n| ▪ 안정성 | 2.3.P.2.1 완제의약품 조성 | 시험의 분석방법 밸리데이션을 위해 기재함.  (2.3.S.4 원료의약품의 품질관리 참조) |\n| 스케일업 | 약물미세화 기압(bar) | 1.5 | 2.5 |\n| 미처리 | 99% | >0.99 | NA | >0.99 |\n| 2.3.P.2.1.1 원료의약품 | 유연물질 A | [화학 구조] |\n| 에톡시함량 (N-Type) | 48.0 ~ 49.5 % | 48.8 % | 실험설계 시험의 결과는 아래에 요약하였다.  |\n**1 뱃치크기는 사전 경험 뿐 아니라 기기 제조원의 권장사항에 따른다. **\n**용출시험**\n| 점도 | 18.0 ~ 22.0 mPa.s | 20.1 mPa.s |\n| 제형설계와 관련한 상세한 정보는 3.2.P.2.2.1 제제 개발을 참조한다.  | 미처리 | 99% | >0.99 | NA |\n| 타정 | 3 실험실 규모 시험 결과 노즐압이 증가하면 원하는 펠렛 특징이 나오지 않을 수 있다. ",
        "original_sentence": "(2.3.S.4 원료의약품의 품질관리 참조) |\n| 스케일업 | 약물미세화 기압(bar) | 1.5 | 2.5 |\n| 미처리 | 99% | >0.99 | NA | >0.99 |\n| 2.3.P.2.1.1 원료의약품 | 유연물질 A | [화학 구조] |\n| 에톡시함량 (N-Type) | 48.0 ~ 49.5 % | 48.8 % | 실험설계 시험의 결과는 아래에 요약하였다. "
      }
    },
    {
      "chunk_id": "chunk_400",
      "text": "|\n**1 뱃치크기는 사전 경험 뿐 아니라 기기 제조원의 권장사항에 따른다.",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 399,
        "window_size": 3,
        "char_count": 42,
        "word_count": 11,
        "page_number": 2,
        "window_text": "| 2.3.P.2 개발경위 |\n**점도 관리를 포함한 규격을 설정하였다. **\n**2.3.P.2.1.1 원료의약품**\n| ▪ 안정성 | 2.3.P.2.1 완제의약품 조성 | 시험의 분석방법 밸리데이션을 위해 기재함.  (2.3.S.4 원료의약품의 품질관리 참조) |\n| 스케일업 | 약물미세화 기압(bar) | 1.5 | 2.5 |\n| 미처리 | 99% | >0.99 | NA | >0.99 |\n| 2.3.P.2.1.1 원료의약품 | 유연물질 A | [화학 구조] |\n| 에톡시함량 (N-Type) | 48.0 ~ 49.5 % | 48.8 % | 실험설계 시험의 결과는 아래에 요약하였다.  |\n**1 뱃치크기는 사전 경험 뿐 아니라 기기 제조원의 권장사항에 따른다. **\n**용출시험**\n| 점도 | 18.0 ~ 22.0 mPa.s | 20.1 mPa.s |\n| 제형설계와 관련한 상세한 정보는 3.2.P.2.2.1 제제 개발을 참조한다.  | 미처리 | 99% | >0.99 | NA |\n| 타정 | 3 실험실 규모 시험 결과 노즐압이 증가하면 원하는 펠렛 특징이 나오지 않을 수 있다.  |\n| 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유연물질 A(12%) |\n| 함량균일성 | 시험 | USP<905> | 자사 시험방법 #125c (HPLC) | 99.1-101.3% |\n| 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 유연물질 A(65%) |\n**물질은 기준에 적합하였다. ",
        "original_sentence": "|\n**1 뱃치크기는 사전 경험 뿐 아니라 기기 제조원의 권장사항에 따른다."
      }
    },
    {
      "chunk_id": "chunk_401",
      "text": "**\n**용출시험**\n| 점도 | 18.0 ~ 22.0 mPa.s | 20.1 mPa.s |\n| 제형설계와 관련한 상세한 정보는 3.2.P.2.2.1 제제 개발을 참조한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 400,
        "window_size": 3,
        "char_count": 97,
        "word_count": 22,
        "page_number": 5,
        "window_text": "**\n**2.3.P.2.1.1 원료의약품**\n| ▪ 안정성 | 2.3.P.2.1 완제의약품 조성 | 시험의 분석방법 밸리데이션을 위해 기재함.  (2.3.S.4 원료의약품의 품질관리 참조) |\n| 스케일업 | 약물미세화 기압(bar) | 1.5 | 2.5 |\n| 미처리 | 99% | >0.99 | NA | >0.99 |\n| 2.3.P.2.1.1 원료의약품 | 유연물질 A | [화학 구조] |\n| 에톡시함량 (N-Type) | 48.0 ~ 49.5 % | 48.8 % | 실험설계 시험의 결과는 아래에 요약하였다.  |\n**1 뱃치크기는 사전 경험 뿐 아니라 기기 제조원의 권장사항에 따른다. **\n**용출시험**\n| 점도 | 18.0 ~ 22.0 mPa.s | 20.1 mPa.s |\n| 제형설계와 관련한 상세한 정보는 3.2.P.2.2.1 제제 개발을 참조한다.  | 미처리 | 99% | >0.99 | NA |\n| 타정 | 3 실험실 규모 시험 결과 노즐압이 증가하면 원하는 펠렛 특징이 나오지 않을 수 있다.  |\n| 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유연물질 A(12%) |\n| 함량균일성 | 시험 | USP<905> | 자사 시험방법 #125c (HPLC) | 99.1-101.3% |\n| 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 유연물질 A(65%) |\n**물질은 기준에 적합하였다.  추가적인 내용은 3.2.P.5.6 기준 설정근거를 참고한다.",
        "original_sentence": "**\n**용출시험**\n| 점도 | 18.0 ~ 22.0 mPa.s | 20.1 mPa.s |\n| 제형설계와 관련한 상세한 정보는 3.2.P.2.2.1 제제 개발을 참조한다. "
      }
    },
    {
      "chunk_id": "chunk_402",
      "text": "| 미처리 | 99% | >0.99 | NA |\n| 타정 | 3 실험실 규모 시험 결과 노즐압이 증가하면 원하는 펠렛 특징이 나오지 않을 수 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 401,
        "window_size": 3,
        "char_count": 83,
        "word_count": 26,
        "page_number": 18,
        "window_text": "(2.3.S.4 원료의약품의 품질관리 참조) |\n| 스케일업 | 약물미세화 기압(bar) | 1.5 | 2.5 |\n| 미처리 | 99% | >0.99 | NA | >0.99 |\n| 2.3.P.2.1.1 원료의약품 | 유연물질 A | [화학 구조] |\n| 에톡시함량 (N-Type) | 48.0 ~ 49.5 % | 48.8 % | 실험설계 시험의 결과는 아래에 요약하였다.  |\n**1 뱃치크기는 사전 경험 뿐 아니라 기기 제조원의 권장사항에 따른다. **\n**용출시험**\n| 점도 | 18.0 ~ 22.0 mPa.s | 20.1 mPa.s |\n| 제형설계와 관련한 상세한 정보는 3.2.P.2.2.1 제제 개발을 참조한다.  | 미처리 | 99% | >0.99 | NA |\n| 타정 | 3 실험실 규모 시험 결과 노즐압이 증가하면 원하는 펠렛 특징이 나오지 않을 수 있다.  |\n| 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유연물질 A(12%) |\n| 함량균일성 | 시험 | USP<905> | 자사 시험방법 #125c (HPLC) | 99.1-101.3% |\n| 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 유연물질 A(65%) |\n**물질은 기준에 적합하였다.  추가적인 내용은 3.2.P.5.6 기준 설정근거를 참고한다. **\n| 함량 | 95.0-105.0% | 자사 시험방법 #125b (HPLC) | 101.2% | 첨가제 종류 및 등급 선정은 기사용례와  대조약 분석을 바탕으로 하였다. ",
        "original_sentence": "| 미처리 | 99% | >0.99 | NA |\n| 타정 | 3 실험실 규모 시험 결과 노즐압이 증가하면 원하는 펠렛 특징이 나오지 않을 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_403",
      "text": "|\n| 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유연물질 A(12%) |\n| 함량균일성 | 시험 | USP<905> | 자사 시험방법 #125c (HPLC) | 99.1-101.3% |\n| 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 유연물질 A(65%) |\n**물질은 기준에 적합하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 402,
        "window_size": 3,
        "char_count": 192,
        "word_count": 50,
        "page_number": 5,
        "window_text": "|\n**1 뱃치크기는 사전 경험 뿐 아니라 기기 제조원의 권장사항에 따른다. **\n**용출시험**\n| 점도 | 18.0 ~ 22.0 mPa.s | 20.1 mPa.s |\n| 제형설계와 관련한 상세한 정보는 3.2.P.2.2.1 제제 개발을 참조한다.  | 미처리 | 99% | >0.99 | NA |\n| 타정 | 3 실험실 규모 시험 결과 노즐압이 증가하면 원하는 펠렛 특징이 나오지 않을 수 있다.  |\n| 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유연물질 A(12%) |\n| 함량균일성 | 시험 | USP<905> | 자사 시험방법 #125c (HPLC) | 99.1-101.3% |\n| 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 유연물질 A(65%) |\n**물질은 기준에 적합하였다.  추가적인 내용은 3.2.P.5.6 기준 설정근거를 참고한다. **\n| 함량 | 95.0-105.0% | 자사 시험방법 #125b (HPLC) | 101.2% | 첨가제 종류 및 등급 선정은 기사용례와  대조약 분석을 바탕으로 하였다.  |\n| 수분 | 3.5% 이하 | 칼피셔법 (USP<921> 1a법) | 2.9% |\n\n**[표 끝]**\n\n- - 22 -\n- ○ 첨가제의 용도, 규격 등에 대해 도표로 요약, 기재한다.\n",
        "original_sentence": "|\n| 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유연물질 A(12%) |\n| 함량균일성 | 시험 | USP<905> | 자사 시험방법 #125c (HPLC) | 99.1-101.3% |\n| 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 유연물질 A(65%) |\n**물질은 기준에 적합하였다. "
      }
    },
    {
      "chunk_id": "chunk_404",
      "text": "추가적인 내용은 3.2.P.5.6 기준 설정근거를 참고한다.",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 403,
        "window_size": 3,
        "char_count": 33,
        "word_count": 6,
        "page_number": 5,
        "window_text": "**\n**용출시험**\n| 점도 | 18.0 ~ 22.0 mPa.s | 20.1 mPa.s |\n| 제형설계와 관련한 상세한 정보는 3.2.P.2.2.1 제제 개발을 참조한다.  | 미처리 | 99% | >0.99 | NA |\n| 타정 | 3 실험실 규모 시험 결과 노즐압이 증가하면 원하는 펠렛 특징이 나오지 않을 수 있다.  |\n| 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유연물질 A(12%) |\n| 함량균일성 | 시험 | USP<905> | 자사 시험방법 #125c (HPLC) | 99.1-101.3% |\n| 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 유연물질 A(65%) |\n**물질은 기준에 적합하였다.  추가적인 내용은 3.2.P.5.6 기준 설정근거를 참고한다. **\n| 함량 | 95.0-105.0% | 자사 시험방법 #125b (HPLC) | 101.2% | 첨가제 종류 및 등급 선정은 기사용례와  대조약 분석을 바탕으로 하였다.  |\n| 수분 | 3.5% 이하 | 칼피셔법 (USP<921> 1a법) | 2.9% |\n\n**[표 끝]**\n\n- - 22 -\n- ○ 첨가제의 용도, 규격 등에 대해 도표로 요약, 기재한다.\n - ○ 공정서 규격 첨가제인 경우에는 등급을 포함하여 아래 표와 같이 기재한다.\n",
        "original_sentence": "추가적인 내용은 3.2.P.5.6 기준 설정근거를 참고한다."
      }
    },
    {
      "chunk_id": "chunk_405",
      "text": "**\n| 함량 | 95.0-105.0% | 자사 시험방법 #125b (HPLC) | 101.2% | 첨가제 종류 및 등급 선정은 기사용례와  대조약 분석을 바탕으로 하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 404,
        "window_size": 3,
        "char_count": 97,
        "word_count": 23,
        "page_number": 5,
        "window_text": "| 미처리 | 99% | >0.99 | NA |\n| 타정 | 3 실험실 규모 시험 결과 노즐압이 증가하면 원하는 펠렛 특징이 나오지 않을 수 있다.  |\n| 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유연물질 A(12%) |\n| 함량균일성 | 시험 | USP<905> | 자사 시험방법 #125c (HPLC) | 99.1-101.3% |\n| 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 유연물질 A(65%) |\n**물질은 기준에 적합하였다.  추가적인 내용은 3.2.P.5.6 기준 설정근거를 참고한다. **\n| 함량 | 95.0-105.0% | 자사 시험방법 #125b (HPLC) | 101.2% | 첨가제 종류 및 등급 선정은 기사용례와  대조약 분석을 바탕으로 하였다.  |\n| 수분 | 3.5% 이하 | 칼피셔법 (USP<921> 1a법) | 2.9% |\n\n**[표 끝]**\n\n- - 22 -\n- ○ 첨가제의 용도, 규격 등에 대해 도표로 요약, 기재한다.\n - ○ 공정서 규격 첨가제인 경우에는 등급을 포함하여 아래 표와 같이 기재한다.\n * 허가제출용 뱃치의 생산에 사용된 첨가제의 로트 번호\n\n공정서 규격 이외 추가로 설정된 항목이 있다면 아래 표와 같이 기재하고 이에 대한 근거\n\n- ○ 공정서에 수재되지 않은 첨가제의 경우는 해당 첨가제에 대한 기준을 표로 요약하고 필요한\n- ○ 동물유래성분 첨가제의 경우, 원산국, 전염성해면상뇌증(BSE/TSE) 증명서의 발행처를 기재\n- ○ 기 사용례가 없는 새로운 첨가제는 제조사, 특성, 품질관리, 안전성 입증자료 등을 포함한\n- 2.3.P.4. ",
        "original_sentence": "**\n| 함량 | 95.0-105.0% | 자사 시험방법 #125b (HPLC) | 101.2% | 첨가제 종류 및 등급 선정은 기사용례와  대조약 분석을 바탕으로 하였다. "
      }
    },
    {
      "chunk_id": "chunk_406",
      "text": "|\n| 수분 | 3.5% 이하 | 칼피셔법 (USP<921> 1a법) | 2.9% |\n\n**[표 끝]**\n\n- - 22 -\n- ○ 첨가제의 용도, 규격 등에 대해 도표로 요약, 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 405,
        "window_size": 3,
        "char_count": 105,
        "word_count": 29,
        "page_number": 3,
        "window_text": "|\n| 0.1 N HCl, 70 ℃, 14 시간 | 85% | >0.99 | 유연물질 A(12%) |\n| 함량균일성 | 시험 | USP<905> | 자사 시험방법 #125c (HPLC) | 99.1-101.3% |\n| 0.1 N NaOH, 70 ℃, 30 분 | 30% | >0.99 | 유연물질 A(65%) |\n**물질은 기준에 적합하였다.  추가적인 내용은 3.2.P.5.6 기준 설정근거를 참고한다. **\n| 함량 | 95.0-105.0% | 자사 시험방법 #125b (HPLC) | 101.2% | 첨가제 종류 및 등급 선정은 기사용례와  대조약 분석을 바탕으로 하였다.  |\n| 수분 | 3.5% 이하 | 칼피셔법 (USP<921> 1a법) | 2.9% |\n\n**[표 끝]**\n\n- - 22 -\n- ○ 첨가제의 용도, 규격 등에 대해 도표로 요약, 기재한다.\n - ○ 공정서 규격 첨가제인 경우에는 등급을 포함하여 아래 표와 같이 기재한다.\n * 허가제출용 뱃치의 생산에 사용된 첨가제의 로트 번호\n\n공정서 규격 이외 추가로 설정된 항목이 있다면 아래 표와 같이 기재하고 이에 대한 근거\n\n- ○ 공정서에 수재되지 않은 첨가제의 경우는 해당 첨가제에 대한 기준을 표로 요약하고 필요한\n- ○ 동물유래성분 첨가제의 경우, 원산국, 전염성해면상뇌증(BSE/TSE) 증명서의 발행처를 기재\n- ○ 기 사용례가 없는 새로운 첨가제는 제조사, 특성, 품질관리, 안전성 입증자료 등을 포함한\n- 2.3.P.4.  첨가제의 관리 (서방성 제제 예시)\n공정서에 수재된 첨가제들을 아래 표에 정리하였다. ",
        "original_sentence": "|\n| 수분 | 3.5% 이하 | 칼피셔법 (USP<921> 1a법) | 2.9% |\n\n**[표 끝]**\n\n- - 22 -\n- ○ 첨가제의 용도, 규격 등에 대해 도표로 요약, 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_407",
      "text": "- ○ 공정서 규격 첨가제인 경우에는 등급을 포함하여 아래 표와 같이 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 406,
        "window_size": 3,
        "char_count": 45,
        "word_count": 12,
        "page_number": 3,
        "window_text": "추가적인 내용은 3.2.P.5.6 기준 설정근거를 참고한다. **\n| 함량 | 95.0-105.0% | 자사 시험방법 #125b (HPLC) | 101.2% | 첨가제 종류 및 등급 선정은 기사용례와  대조약 분석을 바탕으로 하였다.  |\n| 수분 | 3.5% 이하 | 칼피셔법 (USP<921> 1a법) | 2.9% |\n\n**[표 끝]**\n\n- - 22 -\n- ○ 첨가제의 용도, 규격 등에 대해 도표로 요약, 기재한다.\n - ○ 공정서 규격 첨가제인 경우에는 등급을 포함하여 아래 표와 같이 기재한다.\n * 허가제출용 뱃치의 생산에 사용된 첨가제의 로트 번호\n\n공정서 규격 이외 추가로 설정된 항목이 있다면 아래 표와 같이 기재하고 이에 대한 근거\n\n- ○ 공정서에 수재되지 않은 첨가제의 경우는 해당 첨가제에 대한 기준을 표로 요약하고 필요한\n- ○ 동물유래성분 첨가제의 경우, 원산국, 전염성해면상뇌증(BSE/TSE) 증명서의 발행처를 기재\n- ○ 기 사용례가 없는 새로운 첨가제는 제조사, 특성, 품질관리, 안전성 입증자료 등을 포함한\n- 2.3.P.4.  첨가제의 관리 (서방성 제제 예시)\n공정서에 수재된 첨가제들을 아래 표에 정리하였다.  첨가제들의 관리는 해당 공정서에 따른다.\n\n",
        "original_sentence": "- ○ 공정서 규격 첨가제인 경우에는 등급을 포함하여 아래 표와 같이 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_408",
      "text": "* 허가제출용 뱃치의 생산에 사용된 첨가제의 로트 번호\n\n공정서 규격 이외 추가로 설정된 항목이 있다면 아래 표와 같이 기재하고 이에 대한 근거\n\n- ○ 공정서에 수재되지 않은 첨가제의 경우는 해당 첨가제에 대한 기준을 표로 요약하고 필요한\n- ○ 동물유래성분 첨가제의 경우, 원산국, 전염성해면상뇌증(BSE/TSE) 증명서의 발행처를 기재\n- ○ 기 사용례가 없는 새로운 첨가제는 제조사, 특성, 품질관리, 안전성 입증자료 등을 포함한\n- 2.3.P.4. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 407,
        "window_size": 3,
        "char_count": 256,
        "word_count": 62,
        "page_number": 3,
        "window_text": "**\n| 함량 | 95.0-105.0% | 자사 시험방법 #125b (HPLC) | 101.2% | 첨가제 종류 및 등급 선정은 기사용례와  대조약 분석을 바탕으로 하였다.  |\n| 수분 | 3.5% 이하 | 칼피셔법 (USP<921> 1a법) | 2.9% |\n\n**[표 끝]**\n\n- - 22 -\n- ○ 첨가제의 용도, 규격 등에 대해 도표로 요약, 기재한다.\n - ○ 공정서 규격 첨가제인 경우에는 등급을 포함하여 아래 표와 같이 기재한다.\n * 허가제출용 뱃치의 생산에 사용된 첨가제의 로트 번호\n\n공정서 규격 이외 추가로 설정된 항목이 있다면 아래 표와 같이 기재하고 이에 대한 근거\n\n- ○ 공정서에 수재되지 않은 첨가제의 경우는 해당 첨가제에 대한 기준을 표로 요약하고 필요한\n- ○ 동물유래성분 첨가제의 경우, 원산국, 전염성해면상뇌증(BSE/TSE) 증명서의 발행처를 기재\n- ○ 기 사용례가 없는 새로운 첨가제는 제조사, 특성, 품질관리, 안전성 입증자료 등을 포함한\n- 2.3.P.4.  첨가제의 관리 (서방성 제제 예시)\n공정서에 수재된 첨가제들을 아래 표에 정리하였다.  첨가제들의 관리는 해당 공정서에 따른다.\n\n * 구형백당의 입자 크기는 25~30 mesh로, 완제의약품의 약물방출이 일정하고 재현성 있도록\n\n서방펠렛이 일정한 표면적을 갖게 한다.\n\n",
        "original_sentence": "* 허가제출용 뱃치의 생산에 사용된 첨가제의 로트 번호\n\n공정서 규격 이외 추가로 설정된 항목이 있다면 아래 표와 같이 기재하고 이에 대한 근거\n\n- ○ 공정서에 수재되지 않은 첨가제의 경우는 해당 첨가제에 대한 기준을 표로 요약하고 필요한\n- ○ 동물유래성분 첨가제의 경우, 원산국, 전염성해면상뇌증(BSE/TSE) 증명서의 발행처를 기재\n- ○ 기 사용례가 없는 새로운 첨가제는 제조사, 특성, 품질관리, 안전성 입증자료 등을 포함한\n- 2.3.P.4. "
      }
    },
    {
      "chunk_id": "chunk_409",
      "text": "첨가제의 관리 (서방성 제제 예시)\n공정서에 수재된 첨가제들을 아래 표에 정리하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 408,
        "window_size": 3,
        "char_count": 48,
        "word_count": 11,
        "page_number": 26,
        "window_text": "|\n| 수분 | 3.5% 이하 | 칼피셔법 (USP<921> 1a법) | 2.9% |\n\n**[표 끝]**\n\n- - 22 -\n- ○ 첨가제의 용도, 규격 등에 대해 도표로 요약, 기재한다.\n - ○ 공정서 규격 첨가제인 경우에는 등급을 포함하여 아래 표와 같이 기재한다.\n * 허가제출용 뱃치의 생산에 사용된 첨가제의 로트 번호\n\n공정서 규격 이외 추가로 설정된 항목이 있다면 아래 표와 같이 기재하고 이에 대한 근거\n\n- ○ 공정서에 수재되지 않은 첨가제의 경우는 해당 첨가제에 대한 기준을 표로 요약하고 필요한\n- ○ 동물유래성분 첨가제의 경우, 원산국, 전염성해면상뇌증(BSE/TSE) 증명서의 발행처를 기재\n- ○ 기 사용례가 없는 새로운 첨가제는 제조사, 특성, 품질관리, 안전성 입증자료 등을 포함한\n- 2.3.P.4.  첨가제의 관리 (서방성 제제 예시)\n공정서에 수재된 첨가제들을 아래 표에 정리하였다.  첨가제들의 관리는 해당 공정서에 따른다.\n\n * 구형백당의 입자 크기는 25~30 mesh로, 완제의약품의 약물방출이 일정하고 재현성 있도록\n\n서방펠렛이 일정한 표면적을 갖게 한다.\n\n - - 23 -\n** 에틸셀룰로오스는 완제의약품의 방출속도 조절에 중요한 기능을 한다. ",
        "original_sentence": "첨가제의 관리 (서방성 제제 예시)\n공정서에 수재된 첨가제들을 아래 표에 정리하였다. "
      }
    },
    {
      "chunk_id": "chunk_410",
      "text": "첨가제들의 관리는 해당 공정서에 따른다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 409,
        "window_size": 3,
        "char_count": 24,
        "word_count": 5,
        "page_number": 26,
        "window_text": "- ○ 공정서 규격 첨가제인 경우에는 등급을 포함하여 아래 표와 같이 기재한다.\n * 허가제출용 뱃치의 생산에 사용된 첨가제의 로트 번호\n\n공정서 규격 이외 추가로 설정된 항목이 있다면 아래 표와 같이 기재하고 이에 대한 근거\n\n- ○ 공정서에 수재되지 않은 첨가제의 경우는 해당 첨가제에 대한 기준을 표로 요약하고 필요한\n- ○ 동물유래성분 첨가제의 경우, 원산국, 전염성해면상뇌증(BSE/TSE) 증명서의 발행처를 기재\n- ○ 기 사용례가 없는 새로운 첨가제는 제조사, 특성, 품질관리, 안전성 입증자료 등을 포함한\n- 2.3.P.4.  첨가제의 관리 (서방성 제제 예시)\n공정서에 수재된 첨가제들을 아래 표에 정리하였다.  첨가제들의 관리는 해당 공정서에 따른다.\n\n * 구형백당의 입자 크기는 25~30 mesh로, 완제의약품의 약물방출이 일정하고 재현성 있도록\n\n서방펠렛이 일정한 표면적을 갖게 한다.\n\n - - 23 -\n** 에틸셀룰로오스는 완제의약품의 방출속도 조절에 중요한 기능을 한다.  개발 과정 중 에틸셀\n\n룰로오스의 등급에 따라 점도가 다르며, 점도는 서방코팅층을 통한 방출속도에 유의하게\n\n영향을 미치는 것으로 나타났다(2.3.P.2.2 완제의약품 참조). ",
        "original_sentence": "첨가제들의 관리는 해당 공정서에 따른다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_411",
      "text": "* 구형백당의 입자 크기는 25~30 mesh로, 완제의약품의 약물방출이 일정하고 재현성 있도록\n\n서방펠렛이 일정한 표면적을 갖게 한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 410,
        "window_size": 3,
        "char_count": 78,
        "word_count": 16,
        "page_number": 3,
        "window_text": "* 허가제출용 뱃치의 생산에 사용된 첨가제의 로트 번호\n\n공정서 규격 이외 추가로 설정된 항목이 있다면 아래 표와 같이 기재하고 이에 대한 근거\n\n- ○ 공정서에 수재되지 않은 첨가제의 경우는 해당 첨가제에 대한 기준을 표로 요약하고 필요한\n- ○ 동물유래성분 첨가제의 경우, 원산국, 전염성해면상뇌증(BSE/TSE) 증명서의 발행처를 기재\n- ○ 기 사용례가 없는 새로운 첨가제는 제조사, 특성, 품질관리, 안전성 입증자료 등을 포함한\n- 2.3.P.4.  첨가제의 관리 (서방성 제제 예시)\n공정서에 수재된 첨가제들을 아래 표에 정리하였다.  첨가제들의 관리는 해당 공정서에 따른다.\n\n * 구형백당의 입자 크기는 25~30 mesh로, 완제의약품의 약물방출이 일정하고 재현성 있도록\n\n서방펠렛이 일정한 표면적을 갖게 한다.\n\n - - 23 -\n** 에틸셀룰로오스는 완제의약품의 방출속도 조절에 중요한 기능을 한다.  개발 과정 중 에틸셀\n\n룰로오스의 등급에 따라 점도가 다르며, 점도는 서방코팅층을 통한 방출속도에 유의하게\n\n영향을 미치는 것으로 나타났다(2.3.P.2.2 완제의약품 참조).  방출 양상이 일관성 있도록,\n\n<!-- PAGE_29 -->\n##### 2.3.P.5 완제의약품의 관리(제품명, 제형)(Control of Drug Product)(name, dosage\n\n<!-- PAGE_29 -->\n##### form)\n\n기준의 설정근거에 대한 간단한 요약, 시험방법과 밸리데이션 및 불순물의 특징에 대한 요약을\n\n제공하여야 한다.\n\n",
        "original_sentence": "* 구형백당의 입자 크기는 25~30 mesh로, 완제의약품의 약물방출이 일정하고 재현성 있도록\n\n서방펠렛이 일정한 표면적을 갖게 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_412",
      "text": "- - 23 -\n** 에틸셀룰로오스는 완제의약품의 방출속도 조절에 중요한 기능을 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 411,
        "window_size": 3,
        "char_count": 49,
        "word_count": 12,
        "page_number": 5,
        "window_text": "첨가제의 관리 (서방성 제제 예시)\n공정서에 수재된 첨가제들을 아래 표에 정리하였다.  첨가제들의 관리는 해당 공정서에 따른다.\n\n * 구형백당의 입자 크기는 25~30 mesh로, 완제의약품의 약물방출이 일정하고 재현성 있도록\n\n서방펠렛이 일정한 표면적을 갖게 한다.\n\n - - 23 -\n** 에틸셀룰로오스는 완제의약품의 방출속도 조절에 중요한 기능을 한다.  개발 과정 중 에틸셀\n\n룰로오스의 등급에 따라 점도가 다르며, 점도는 서방코팅층을 통한 방출속도에 유의하게\n\n영향을 미치는 것으로 나타났다(2.3.P.2.2 완제의약품 참조).  방출 양상이 일관성 있도록,\n\n<!-- PAGE_29 -->\n##### 2.3.P.5 완제의약품의 관리(제품명, 제형)(Control of Drug Product)(name, dosage\n\n<!-- PAGE_29 -->\n##### form)\n\n기준의 설정근거에 대한 간단한 요약, 시험방법과 밸리데이션 및 불순물의 특징에 대한 요약을\n\n제공하여야 한다.\n\n - 3.2.P.5.1에서 얻은 기준을 제공하여야 한다.\n",
        "original_sentence": "- - 23 -\n** 에틸셀룰로오스는 완제의약품의 방출속도 조절에 중요한 기능을 한다. "
      }
    },
    {
      "chunk_id": "chunk_413",
      "text": "개발 과정 중 에틸셀\n\n룰로오스의 등급에 따라 점도가 다르며, 점도는 서방코팅층을 통한 방출속도에 유의하게\n\n영향을 미치는 것으로 나타났다(2.3.P.2.2 완제의약품 참조). ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 412,
        "window_size": 3,
        "char_count": 99,
        "word_count": 20,
        "page_number": 28,
        "window_text": "첨가제들의 관리는 해당 공정서에 따른다.\n\n * 구형백당의 입자 크기는 25~30 mesh로, 완제의약품의 약물방출이 일정하고 재현성 있도록\n\n서방펠렛이 일정한 표면적을 갖게 한다.\n\n - - 23 -\n** 에틸셀룰로오스는 완제의약품의 방출속도 조절에 중요한 기능을 한다.  개발 과정 중 에틸셀\n\n룰로오스의 등급에 따라 점도가 다르며, 점도는 서방코팅층을 통한 방출속도에 유의하게\n\n영향을 미치는 것으로 나타났다(2.3.P.2.2 완제의약품 참조).  방출 양상이 일관성 있도록,\n\n<!-- PAGE_29 -->\n##### 2.3.P.5 완제의약품의 관리(제품명, 제형)(Control of Drug Product)(name, dosage\n\n<!-- PAGE_29 -->\n##### form)\n\n기준의 설정근거에 대한 간단한 요약, 시험방법과 밸리데이션 및 불순물의 특징에 대한 요약을\n\n제공하여야 한다.\n\n - 3.2.P.5.1에서 얻은 기준을 제공하여야 한다.\n - 3.2.P.5.4에서 제공된 뱃치 분석의 도표요약을 필요시 그래프와 함께 포함하여야 한다.\n",
        "original_sentence": "개발 과정 중 에틸셀\n\n룰로오스의 등급에 따라 점도가 다르며, 점도는 서방코팅층을 통한 방출속도에 유의하게\n\n영향을 미치는 것으로 나타났다(2.3.P.2.2 완제의약품 참조). "
      }
    },
    {
      "chunk_id": "chunk_414",
      "text": "방출 양상이 일관성 있도록,\n\n<!-- PAGE_29 -->\n##### 2.3.P.5 완제의약품의 관리(제품명, 제형)(Control of Drug Product)(name, dosage\n\n<!-- PAGE_29 -->\n##### form)\n\n기준의 설정근거에 대한 간단한 요약, 시험방법과 밸리데이션 및 불순물의 특징에 대한 요약을\n\n제공하여야 한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 413,
        "window_size": 3,
        "char_count": 199,
        "word_count": 35,
        "page_number": 29,
        "window_text": "* 구형백당의 입자 크기는 25~30 mesh로, 완제의약품의 약물방출이 일정하고 재현성 있도록\n\n서방펠렛이 일정한 표면적을 갖게 한다.\n\n - - 23 -\n** 에틸셀룰로오스는 완제의약품의 방출속도 조절에 중요한 기능을 한다.  개발 과정 중 에틸셀\n\n룰로오스의 등급에 따라 점도가 다르며, 점도는 서방코팅층을 통한 방출속도에 유의하게\n\n영향을 미치는 것으로 나타났다(2.3.P.2.2 완제의약품 참조).  방출 양상이 일관성 있도록,\n\n<!-- PAGE_29 -->\n##### 2.3.P.5 완제의약품의 관리(제품명, 제형)(Control of Drug Product)(name, dosage\n\n<!-- PAGE_29 -->\n##### form)\n\n기준의 설정근거에 대한 간단한 요약, 시험방법과 밸리데이션 및 불순물의 특징에 대한 요약을\n\n제공하여야 한다.\n\n - 3.2.P.5.1에서 얻은 기준을 제공하여야 한다.\n - 3.2.P.5.4에서 제공된 뱃치 분석의 도표요약을 필요시 그래프와 함께 포함하여야 한다.\n - ○ 제품의 규격 및 시험방법, 기준설정 근거 및 시험방법 밸리데이션에 대해 기재한다.\n",
        "original_sentence": "방출 양상이 일관성 있도록,\n\n<!-- PAGE_29 -->\n##### 2.3.P.5 완제의약품의 관리(제품명, 제형)(Control of Drug Product)(name, dosage\n\n<!-- PAGE_29 -->\n##### form)\n\n기준의 설정근거에 대한 간단한 요약, 시험방법과 밸리데이션 및 불순물의 특징에 대한 요약을\n\n제공하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_415",
      "text": "- 3.2.P.5.1에서 얻은 기준을 제공하여야 한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 414,
        "window_size": 3,
        "char_count": 31,
        "word_count": 6,
        "page_number": 5,
        "window_text": "- - 23 -\n** 에틸셀룰로오스는 완제의약품의 방출속도 조절에 중요한 기능을 한다.  개발 과정 중 에틸셀\n\n룰로오스의 등급에 따라 점도가 다르며, 점도는 서방코팅층을 통한 방출속도에 유의하게\n\n영향을 미치는 것으로 나타났다(2.3.P.2.2 완제의약품 참조).  방출 양상이 일관성 있도록,\n\n<!-- PAGE_29 -->\n##### 2.3.P.5 완제의약품의 관리(제품명, 제형)(Control of Drug Product)(name, dosage\n\n<!-- PAGE_29 -->\n##### form)\n\n기준의 설정근거에 대한 간단한 요약, 시험방법과 밸리데이션 및 불순물의 특징에 대한 요약을\n\n제공하여야 한다.\n\n - 3.2.P.5.1에서 얻은 기준을 제공하여야 한다.\n - 3.2.P.5.4에서 제공된 뱃치 분석의 도표요약을 필요시 그래프와 함께 포함하여야 한다.\n - ○ 제품의 규격 및 시험방법, 기준설정 근거 및 시험방법 밸리데이션에 대해 기재한다.\n - ○ 완제의약품의 기준 및 시험방법은 중요 특성을 포함하도록 하여 표로 작성한다.\n",
        "original_sentence": "- 3.2.P.5.1에서 얻은 기준을 제공하여야 한다.\n"
      }
    },
    {
      "chunk_id": "chunk_416",
      "text": "- 3.2.P.5.4에서 제공된 뱃치 분석의 도표요약을 필요시 그래프와 함께 포함하여야 한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 415,
        "window_size": 3,
        "char_count": 53,
        "word_count": 11,
        "page_number": 5,
        "window_text": "개발 과정 중 에틸셀\n\n룰로오스의 등급에 따라 점도가 다르며, 점도는 서방코팅층을 통한 방출속도에 유의하게\n\n영향을 미치는 것으로 나타났다(2.3.P.2.2 완제의약품 참조).  방출 양상이 일관성 있도록,\n\n<!-- PAGE_29 -->\n##### 2.3.P.5 완제의약품의 관리(제품명, 제형)(Control of Drug Product)(name, dosage\n\n<!-- PAGE_29 -->\n##### form)\n\n기준의 설정근거에 대한 간단한 요약, 시험방법과 밸리데이션 및 불순물의 특징에 대한 요약을\n\n제공하여야 한다.\n\n - 3.2.P.5.1에서 얻은 기준을 제공하여야 한다.\n - 3.2.P.5.4에서 제공된 뱃치 분석의 도표요약을 필요시 그래프와 함께 포함하여야 한다.\n - ○ 제품의 규격 및 시험방법, 기준설정 근거 및 시험방법 밸리데이션에 대해 기재한다.\n - ○ 완제의약품의 기준 및 시험방법은 중요 특성을 포함하도록 하여 표로 작성한다.\n - - 완제의약품에 적용하는 시험항목은 다음과 같다.\n",
        "original_sentence": "- 3.2.P.5.4에서 제공된 뱃치 분석의 도표요약을 필요시 그래프와 함께 포함하여야 한다.\n"
      }
    },
    {
      "chunk_id": "chunk_417",
      "text": "- ○ 제품의 규격 및 시험방법, 기준설정 근거 및 시험방법 밸리데이션에 대해 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 416,
        "window_size": 3,
        "char_count": 50,
        "word_count": 13,
        "page_number": 3,
        "window_text": "방출 양상이 일관성 있도록,\n\n<!-- PAGE_29 -->\n##### 2.3.P.5 완제의약품의 관리(제품명, 제형)(Control of Drug Product)(name, dosage\n\n<!-- PAGE_29 -->\n##### form)\n\n기준의 설정근거에 대한 간단한 요약, 시험방법과 밸리데이션 및 불순물의 특징에 대한 요약을\n\n제공하여야 한다.\n\n - 3.2.P.5.1에서 얻은 기준을 제공하여야 한다.\n - 3.2.P.5.4에서 제공된 뱃치 분석의 도표요약을 필요시 그래프와 함께 포함하여야 한다.\n - ○ 제품의 규격 및 시험방법, 기준설정 근거 및 시험방법 밸리데이션에 대해 기재한다.\n - ○ 완제의약품의 기준 및 시험방법은 중요 특성을 포함하도록 하여 표로 작성한다.\n - - 완제의약품에 적용하는 시험항목은 다음과 같다.\n . ",
        "original_sentence": "- ○ 제품의 규격 및 시험방법, 기준설정 근거 및 시험방법 밸리데이션에 대해 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_418",
      "text": "- ○ 완제의약품의 기준 및 시험방법은 중요 특성을 포함하도록 하여 표로 작성한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 417,
        "window_size": 3,
        "char_count": 47,
        "word_count": 12,
        "page_number": 5,
        "window_text": "- 3.2.P.5.1에서 얻은 기준을 제공하여야 한다.\n - 3.2.P.5.4에서 제공된 뱃치 분석의 도표요약을 필요시 그래프와 함께 포함하여야 한다.\n - ○ 제품의 규격 및 시험방법, 기준설정 근거 및 시험방법 밸리데이션에 대해 기재한다.\n - ○ 완제의약품의 기준 및 시험방법은 중요 특성을 포함하도록 하여 표로 작성한다.\n - - 완제의약품에 적용하는 시험항목은 다음과 같다.\n .  성상\n\n. ",
        "original_sentence": "- ○ 완제의약품의 기준 및 시험방법은 중요 특성을 포함하도록 하여 표로 작성한다.\n"
      }
    },
    {
      "chunk_id": "chunk_419",
      "text": "- - 완제의약품에 적용하는 시험항목은 다음과 같다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 418,
        "window_size": 3,
        "char_count": 30,
        "word_count": 7,
        "page_number": 5,
        "window_text": "- 3.2.P.5.4에서 제공된 뱃치 분석의 도표요약을 필요시 그래프와 함께 포함하여야 한다.\n - ○ 제품의 규격 및 시험방법, 기준설정 근거 및 시험방법 밸리데이션에 대해 기재한다.\n - ○ 완제의약품의 기준 및 시험방법은 중요 특성을 포함하도록 하여 표로 작성한다.\n - - 완제의약품에 적용하는 시험항목은 다음과 같다.\n .  성상\n\n.  확인시험\n\n. ",
        "original_sentence": "- - 완제의약품에 적용하는 시험항목은 다음과 같다.\n"
      }
    },
    {
      "chunk_id": "chunk_420",
      "text": ". ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 419,
        "window_size": 3,
        "char_count": 2,
        "word_count": 1,
        "page_number": 1,
        "window_text": "- ○ 제품의 규격 및 시험방법, 기준설정 근거 및 시험방법 밸리데이션에 대해 기재한다.\n - ○ 완제의약품의 기준 및 시험방법은 중요 특성을 포함하도록 하여 표로 작성한다.\n - - 완제의약품에 적용하는 시험항목은 다음과 같다.\n .  성상\n\n.  확인시험\n\n.  함량시험\n\n. ",
        "original_sentence": ". "
      }
    },
    {
      "chunk_id": "chunk_421",
      "text": "성상\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 420,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 14,
        "window_text": "- ○ 완제의약품의 기준 및 시험방법은 중요 특성을 포함하도록 하여 표로 작성한다.\n - - 완제의약품에 적용하는 시험항목은 다음과 같다.\n .  성상\n\n.  확인시험\n\n.  함량시험\n\n.  분해 산물\n\n. ",
        "original_sentence": "성상\n\n. "
      }
    },
    {
      "chunk_id": "chunk_422",
      "text": "확인시험\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 421,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 14,
        "window_text": "- - 완제의약품에 적용하는 시험항목은 다음과 같다.\n .  성상\n\n.  확인시험\n\n.  함량시험\n\n.  분해 산물\n\n.  제제학적시험(「의약품의 품목허가‧신고‧심사 규정」[별표13])\n\n- ○ 뱃치 결과는 다음을 고려하여 기재한다.\n",
        "original_sentence": "확인시험\n\n. "
      }
    },
    {
      "chunk_id": "chunk_423",
      "text": "함량시험\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 422,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 14,
        "window_text": ".  성상\n\n.  확인시험\n\n.  함량시험\n\n.  분해 산물\n\n.  제제학적시험(「의약품의 품목허가‧신고‧심사 규정」[별표13])\n\n- ○ 뱃치 결과는 다음을 고려하여 기재한다.\n - - 모든 용량(strengths)에 대한 시험 결과를 표로 작성한다.\n",
        "original_sentence": "함량시험\n\n. "
      }
    },
    {
      "chunk_id": "chunk_424",
      "text": "분해 산물\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 423,
        "window_size": 3,
        "char_count": 9,
        "word_count": 3,
        "page_number": 1,
        "window_text": "성상\n\n.  확인시험\n\n.  함량시험\n\n.  분해 산물\n\n.  제제학적시험(「의약품의 품목허가‧신고‧심사 규정」[별표13])\n\n- ○ 뱃치 결과는 다음을 고려하여 기재한다.\n - - 모든 용량(strengths)에 대한 시험 결과를 표로 작성한다.\n - - 정량적인 시험 결과는 “기준에 적합” 또는 “적합”이 아닌 수치로 기재한다.\n",
        "original_sentence": "분해 산물\n\n. "
      }
    },
    {
      "chunk_id": "chunk_425",
      "text": "제제학적시험(「의약품의 품목허가‧신고‧심사 규정」[별표13])\n\n- ○ 뱃치 결과는 다음을 고려하여 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 424,
        "window_size": 3,
        "char_count": 62,
        "word_count": 10,
        "page_number": 5,
        "window_text": "확인시험\n\n.  함량시험\n\n.  분해 산물\n\n.  제제학적시험(「의약품의 품목허가‧신고‧심사 규정」[별표13])\n\n- ○ 뱃치 결과는 다음을 고려하여 기재한다.\n - - 모든 용량(strengths)에 대한 시험 결과를 표로 작성한다.\n - - 정량적인 시험 결과는 “기준에 적합” 또는 “적합”이 아닌 수치로 기재한다.\n - - 순도시험(정량시험)의 경우, 정량한계 이상은 결과 값을 기재하고 정량한계 미만에서는\n- ○ 기준 및 시험방법 설정 근거는 다음과 같이 기재한다.\n",
        "original_sentence": "제제학적시험(「의약품의 품목허가‧신고‧심사 규정」[별표13])\n\n- ○ 뱃치 결과는 다음을 고려하여 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_426",
      "text": "- - 모든 용량(strengths)에 대한 시험 결과를 표로 작성한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 425,
        "window_size": 3,
        "char_count": 41,
        "word_count": 9,
        "page_number": 5,
        "window_text": "함량시험\n\n.  분해 산물\n\n.  제제학적시험(「의약품의 품목허가‧신고‧심사 규정」[별표13])\n\n- ○ 뱃치 결과는 다음을 고려하여 기재한다.\n - - 모든 용량(strengths)에 대한 시험 결과를 표로 작성한다.\n - - 정량적인 시험 결과는 “기준에 적합” 또는 “적합”이 아닌 수치로 기재한다.\n - - 순도시험(정량시험)의 경우, 정량한계 이상은 결과 값을 기재하고 정량한계 미만에서는\n- ○ 기준 및 시험방법 설정 근거는 다음과 같이 기재한다.\n - - 24 -\n- - 공정서에 수재되지 않은 시험방법은 중요 변수 및 시스템적합성시험 기준을 포함하여 표\n- - 기준 설정근거로 대조약을 사용한 경우, 대조약 분석결과를 기재한다.\n",
        "original_sentence": "- - 모든 용량(strengths)에 대한 시험 결과를 표로 작성한다.\n"
      }
    },
    {
      "chunk_id": "chunk_427",
      "text": "- - 정량적인 시험 결과는 “기준에 적합” 또는 “적합”이 아닌 수치로 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 426,
        "window_size": 3,
        "char_count": 47,
        "word_count": 12,
        "page_number": 3,
        "window_text": "분해 산물\n\n.  제제학적시험(「의약품의 품목허가‧신고‧심사 규정」[별표13])\n\n- ○ 뱃치 결과는 다음을 고려하여 기재한다.\n - - 모든 용량(strengths)에 대한 시험 결과를 표로 작성한다.\n - - 정량적인 시험 결과는 “기준에 적합” 또는 “적합”이 아닌 수치로 기재한다.\n - - 순도시험(정량시험)의 경우, 정량한계 이상은 결과 값을 기재하고 정량한계 미만에서는\n- ○ 기준 및 시험방법 설정 근거는 다음과 같이 기재한다.\n - - 24 -\n- - 공정서에 수재되지 않은 시험방법은 중요 변수 및 시스템적합성시험 기준을 포함하여 표\n- - 기준 설정근거로 대조약을 사용한 경우, 대조약 분석결과를 기재한다.\n - - 시험방법 밸리데이션을 수행한 경우 아래와 같이 요약표를 기재한다.\n",
        "original_sentence": "- - 정량적인 시험 결과는 “기준에 적합” 또는 “적합”이 아닌 수치로 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_428",
      "text": "- - 순도시험(정량시험)의 경우, 정량한계 이상은 결과 값을 기재하고 정량한계 미만에서는\n- ○ 기준 및 시험방법 설정 근거는 다음과 같이 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 427,
        "window_size": 3,
        "char_count": 85,
        "word_count": 21,
        "page_number": 3,
        "window_text": "제제학적시험(「의약품의 품목허가‧신고‧심사 규정」[별표13])\n\n- ○ 뱃치 결과는 다음을 고려하여 기재한다.\n - - 모든 용량(strengths)에 대한 시험 결과를 표로 작성한다.\n - - 정량적인 시험 결과는 “기준에 적합” 또는 “적합”이 아닌 수치로 기재한다.\n - - 순도시험(정량시험)의 경우, 정량한계 이상은 결과 값을 기재하고 정량한계 미만에서는\n- ○ 기준 및 시험방법 설정 근거는 다음과 같이 기재한다.\n - - 24 -\n- - 공정서에 수재되지 않은 시험방법은 중요 변수 및 시스템적합성시험 기준을 포함하여 표\n- - 기준 설정근거로 대조약을 사용한 경우, 대조약 분석결과를 기재한다.\n - - 시험방법 밸리데이션을 수행한 경우 아래와 같이 요약표를 기재한다.\n - - 유연물질은 원료의약품의 분해생성물, 용기/마개와 반응하여 생성된 유연물질로 분류할 수\n있다. ",
        "original_sentence": "- - 순도시험(정량시험)의 경우, 정량한계 이상은 결과 값을 기재하고 정량한계 미만에서는\n- ○ 기준 및 시험방법 설정 근거는 다음과 같이 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_429",
      "text": "- - 24 -\n- - 공정서에 수재되지 않은 시험방법은 중요 변수 및 시스템적합성시험 기준을 포함하여 표\n- - 기준 설정근거로 대조약을 사용한 경우, 대조약 분석결과를 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 428,
        "window_size": 3,
        "char_count": 102,
        "word_count": 27,
        "page_number": 5,
        "window_text": "- - 모든 용량(strengths)에 대한 시험 결과를 표로 작성한다.\n - - 정량적인 시험 결과는 “기준에 적합” 또는 “적합”이 아닌 수치로 기재한다.\n - - 순도시험(정량시험)의 경우, 정량한계 이상은 결과 값을 기재하고 정량한계 미만에서는\n- ○ 기준 및 시험방법 설정 근거는 다음과 같이 기재한다.\n - - 24 -\n- - 공정서에 수재되지 않은 시험방법은 중요 변수 및 시스템적합성시험 기준을 포함하여 표\n- - 기준 설정근거로 대조약을 사용한 경우, 대조약 분석결과를 기재한다.\n - - 시험방법 밸리데이션을 수행한 경우 아래와 같이 요약표를 기재한다.\n - - 유연물질은 원료의약품의 분해생성물, 용기/마개와 반응하여 생성된 유연물질로 분류할 수\n있다.  2.3.S.3. ",
        "original_sentence": "- - 24 -\n- - 공정서에 수재되지 않은 시험방법은 중요 변수 및 시스템적합성시험 기준을 포함하여 표\n- - 기준 설정근거로 대조약을 사용한 경우, 대조약 분석결과를 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_430",
      "text": "- - 시험방법 밸리데이션을 수행한 경우 아래와 같이 요약표를 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 429,
        "window_size": 3,
        "char_count": 41,
        "word_count": 10,
        "page_number": 3,
        "window_text": "- - 정량적인 시험 결과는 “기준에 적합” 또는 “적합”이 아닌 수치로 기재한다.\n - - 순도시험(정량시험)의 경우, 정량한계 이상은 결과 값을 기재하고 정량한계 미만에서는\n- ○ 기준 및 시험방법 설정 근거는 다음과 같이 기재한다.\n - - 24 -\n- - 공정서에 수재되지 않은 시험방법은 중요 변수 및 시스템적합성시험 기준을 포함하여 표\n- - 기준 설정근거로 대조약을 사용한 경우, 대조약 분석결과를 기재한다.\n - - 시험방법 밸리데이션을 수행한 경우 아래와 같이 요약표를 기재한다.\n - - 유연물질은 원료의약품의 분해생성물, 용기/마개와 반응하여 생성된 유연물질로 분류할 수\n있다.  2.3.S.3.  특성 또는 2.3.S.4. ",
        "original_sentence": "- - 시험방법 밸리데이션을 수행한 경우 아래와 같이 요약표를 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_431",
      "text": "- - 유연물질은 원료의약품의 분해생성물, 용기/마개와 반응하여 생성된 유연물질로 분류할 수\n있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 430,
        "window_size": 3,
        "char_count": 56,
        "word_count": 12,
        "page_number": 5,
        "window_text": "- - 순도시험(정량시험)의 경우, 정량한계 이상은 결과 값을 기재하고 정량한계 미만에서는\n- ○ 기준 및 시험방법 설정 근거는 다음과 같이 기재한다.\n - - 24 -\n- - 공정서에 수재되지 않은 시험방법은 중요 변수 및 시스템적합성시험 기준을 포함하여 표\n- - 기준 설정근거로 대조약을 사용한 경우, 대조약 분석결과를 기재한다.\n - - 시험방법 밸리데이션을 수행한 경우 아래와 같이 요약표를 기재한다.\n - - 유연물질은 원료의약품의 분해생성물, 용기/마개와 반응하여 생성된 유연물질로 분류할 수\n있다.  2.3.S.3.  특성 또는 2.3.S.4.  원료의약품의 품질관리에서 확인된 유연물질은 구조 기재를\n\n- - 일반적으로 유연물질이 완제의약품에서 발생한 분해생성물이 아니라면 완제의약품에서 관리\n또는 규명할 필요는 없다. ",
        "original_sentence": "- - 유연물질은 원료의약품의 분해생성물, 용기/마개와 반응하여 생성된 유연물질로 분류할 수\n있다. "
      }
    },
    {
      "chunk_id": "chunk_432",
      "text": "2.3.S.3. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 431,
        "window_size": 3,
        "char_count": 9,
        "word_count": 1,
        "page_number": 4,
        "window_text": "- - 24 -\n- - 공정서에 수재되지 않은 시험방법은 중요 변수 및 시스템적합성시험 기준을 포함하여 표\n- - 기준 설정근거로 대조약을 사용한 경우, 대조약 분석결과를 기재한다.\n - - 시험방법 밸리데이션을 수행한 경우 아래와 같이 요약표를 기재한다.\n - - 유연물질은 원료의약품의 분해생성물, 용기/마개와 반응하여 생성된 유연물질로 분류할 수\n있다.  2.3.S.3.  특성 또는 2.3.S.4.  원료의약품의 품질관리에서 확인된 유연물질은 구조 기재를\n\n- - 일반적으로 유연물질이 완제의약품에서 발생한 분해생성물이 아니라면 완제의약품에서 관리\n또는 규명할 필요는 없다.  신청자가 원료의약품의 합성 중간체 또는 공정 불순물을 완제\n\n의약품에 규격 설정하는 경우(예: 크로마토그램에 검출되거나 마커로 사용 등), 원료의약품\n\n- ○ 순도시험의 경우, 특정 유연물질에 대해 표준품을 이용하여 정량하거나, 유연물질의 상대반\n주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 간에 방해가 없음 (첨부된 크로마토그램\n\n- - 25 -\n응계수(RRF)를 기재한다.\n\n",
        "original_sentence": "2.3.S.3. "
      }
    },
    {
      "chunk_id": "chunk_433",
      "text": "특성 또는 2.3.S.4. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 432,
        "window_size": 3,
        "char_count": 15,
        "word_count": 3,
        "page_number": 5,
        "window_text": "- - 시험방법 밸리데이션을 수행한 경우 아래와 같이 요약표를 기재한다.\n - - 유연물질은 원료의약품의 분해생성물, 용기/마개와 반응하여 생성된 유연물질로 분류할 수\n있다.  2.3.S.3.  특성 또는 2.3.S.4.  원료의약품의 품질관리에서 확인된 유연물질은 구조 기재를\n\n- - 일반적으로 유연물질이 완제의약품에서 발생한 분해생성물이 아니라면 완제의약품에서 관리\n또는 규명할 필요는 없다.  신청자가 원료의약품의 합성 중간체 또는 공정 불순물을 완제\n\n의약품에 규격 설정하는 경우(예: 크로마토그램에 검출되거나 마커로 사용 등), 원료의약품\n\n- ○ 순도시험의 경우, 특정 유연물질에 대해 표준품을 이용하여 정량하거나, 유연물질의 상대반\n주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 간에 방해가 없음 (첨부된 크로마토그램\n\n- - 25 -\n응계수(RRF)를 기재한다.\n\n - ○ 분해생성물의 기준은 다음과 같이 설정할 수 있다.\n",
        "original_sentence": "특성 또는 2.3.S.4. "
      }
    },
    {
      "chunk_id": "chunk_434",
      "text": "원료의약품의 품질관리에서 확인된 유연물질은 구조 기재를\n\n- - 일반적으로 유연물질이 완제의약품에서 발생한 분해생성물이 아니라면 완제의약품에서 관리\n또는 규명할 필요는 없다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 433,
        "window_size": 3,
        "char_count": 98,
        "word_count": 20,
        "page_number": 3,
        "window_text": "- - 유연물질은 원료의약품의 분해생성물, 용기/마개와 반응하여 생성된 유연물질로 분류할 수\n있다.  2.3.S.3.  특성 또는 2.3.S.4.  원료의약품의 품질관리에서 확인된 유연물질은 구조 기재를\n\n- - 일반적으로 유연물질이 완제의약품에서 발생한 분해생성물이 아니라면 완제의약품에서 관리\n또는 규명할 필요는 없다.  신청자가 원료의약품의 합성 중간체 또는 공정 불순물을 완제\n\n의약품에 규격 설정하는 경우(예: 크로마토그램에 검출되거나 마커로 사용 등), 원료의약품\n\n- ○ 순도시험의 경우, 특정 유연물질에 대해 표준품을 이용하여 정량하거나, 유연물질의 상대반\n주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 간에 방해가 없음 (첨부된 크로마토그램\n\n- - 25 -\n응계수(RRF)를 기재한다.\n\n - ○ 분해생성물의 기준은 다음과 같이 설정할 수 있다.\n 1) 공정서 규격(기타 유연물질의 설정 근거는 공정서 규격에 근거할 수 없다.)\n\n",
        "original_sentence": "원료의약품의 품질관리에서 확인된 유연물질은 구조 기재를\n\n- - 일반적으로 유연물질이 완제의약품에서 발생한 분해생성물이 아니라면 완제의약품에서 관리\n또는 규명할 필요는 없다. "
      }
    },
    {
      "chunk_id": "chunk_435",
      "text": "신청자가 원료의약품의 합성 중간체 또는 공정 불순물을 완제\n\n의약품에 규격 설정하는 경우(예: 크로마토그램에 검출되거나 마커로 사용 등), 원료의약품\n\n- ○ 순도시험의 경우, 특정 유연물질에 대해 표준품을 이용하여 정량하거나, 유연물질의 상대반\n주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 간에 방해가 없음 (첨부된 크로마토그램\n\n- - 25 -\n응계수(RRF)를 기재한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 434,
        "window_size": 3,
        "char_count": 218,
        "word_count": 48,
        "page_number": 16,
        "window_text": "2.3.S.3.  특성 또는 2.3.S.4.  원료의약품의 품질관리에서 확인된 유연물질은 구조 기재를\n\n- - 일반적으로 유연물질이 완제의약품에서 발생한 분해생성물이 아니라면 완제의약품에서 관리\n또는 규명할 필요는 없다.  신청자가 원료의약품의 합성 중간체 또는 공정 불순물을 완제\n\n의약품에 규격 설정하는 경우(예: 크로마토그램에 검출되거나 마커로 사용 등), 원료의약품\n\n- ○ 순도시험의 경우, 특정 유연물질에 대해 표준품을 이용하여 정량하거나, 유연물질의 상대반\n주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 간에 방해가 없음 (첨부된 크로마토그램\n\n- - 25 -\n응계수(RRF)를 기재한다.\n\n - ○ 분해생성물의 기준은 다음과 같이 설정할 수 있다.\n 1) 공정서 규격(기타 유연물질의 설정 근거는 공정서 규격에 근거할 수 없다.)\n\n 2) 「의약품의 품목허가·신고·심사 규정」(식약처고시)에 따라 아래와 같이 기준을 설정한다.\n\n",
        "original_sentence": "신청자가 원료의약품의 합성 중간체 또는 공정 불순물을 완제\n\n의약품에 규격 설정하는 경우(예: 크로마토그램에 검출되거나 마커로 사용 등), 원료의약품\n\n- ○ 순도시험의 경우, 특정 유연물질에 대해 표준품을 이용하여 정량하거나, 유연물질의 상대반\n주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 간에 방해가 없음 (첨부된 크로마토그램\n\n- - 25 -\n응계수(RRF)를 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_436",
      "text": "- ○ 분해생성물의 기준은 다음과 같이 설정할 수 있다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 435,
        "window_size": 3,
        "char_count": 32,
        "word_count": 9,
        "page_number": 3,
        "window_text": "특성 또는 2.3.S.4.  원료의약품의 품질관리에서 확인된 유연물질은 구조 기재를\n\n- - 일반적으로 유연물질이 완제의약품에서 발생한 분해생성물이 아니라면 완제의약품에서 관리\n또는 규명할 필요는 없다.  신청자가 원료의약품의 합성 중간체 또는 공정 불순물을 완제\n\n의약품에 규격 설정하는 경우(예: 크로마토그램에 검출되거나 마커로 사용 등), 원료의약품\n\n- ○ 순도시험의 경우, 특정 유연물질에 대해 표준품을 이용하여 정량하거나, 유연물질의 상대반\n주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 간에 방해가 없음 (첨부된 크로마토그램\n\n- - 25 -\n응계수(RRF)를 기재한다.\n\n - ○ 분해생성물의 기준은 다음과 같이 설정할 수 있다.\n 1) 공정서 규격(기타 유연물질의 설정 근거는 공정서 규격에 근거할 수 없다.)\n\n 2) 「의약품의 품목허가·신고·심사 규정」(식약처고시)에 따라 아래와 같이 기준을 설정한다.\n\n - - 보고수준(RT; reporting threshold), 구조규명 수준(IT; identification threshold), 안전성\n- - 기타 유연물질은 구조규명 수준과 동등 또는 그 이하로 설정\n- - 특정 유연물질은 안전성입증 수준과 동등 또는 그 이하로 설정하거나 입증\n- ○ 불순물의 안전성은 아래와 같이 입증한다.\n",
        "original_sentence": "- ○ 분해생성물의 기준은 다음과 같이 설정할 수 있다.\n"
      }
    },
    {
      "chunk_id": "chunk_437",
      "text": "1) 공정서 규격(기타 유연물질의 설정 근거는 공정서 규격에 근거할 수 없다.)\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 436,
        "window_size": 3,
        "char_count": 46,
        "word_count": 11,
        "page_number": 31,
        "window_text": "원료의약품의 품질관리에서 확인된 유연물질은 구조 기재를\n\n- - 일반적으로 유연물질이 완제의약품에서 발생한 분해생성물이 아니라면 완제의약품에서 관리\n또는 규명할 필요는 없다.  신청자가 원료의약품의 합성 중간체 또는 공정 불순물을 완제\n\n의약품에 규격 설정하는 경우(예: 크로마토그램에 검출되거나 마커로 사용 등), 원료의약품\n\n- ○ 순도시험의 경우, 특정 유연물질에 대해 표준품을 이용하여 정량하거나, 유연물질의 상대반\n주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 간에 방해가 없음 (첨부된 크로마토그램\n\n- - 25 -\n응계수(RRF)를 기재한다.\n\n - ○ 분해생성물의 기준은 다음과 같이 설정할 수 있다.\n 1) 공정서 규격(기타 유연물질의 설정 근거는 공정서 규격에 근거할 수 없다.)\n\n 2) 「의약품의 품목허가·신고·심사 규정」(식약처고시)에 따라 아래와 같이 기준을 설정한다.\n\n - - 보고수준(RT; reporting threshold), 구조규명 수준(IT; identification threshold), 안전성\n- - 기타 유연물질은 구조규명 수준과 동등 또는 그 이하로 설정\n- - 특정 유연물질은 안전성입증 수준과 동등 또는 그 이하로 설정하거나 입증\n- ○ 불순물의 안전성은 아래와 같이 입증한다.\n 1) 독성시험자료: 반복투여독성시험자료, 유전독성시험자료(복귀돌연변이시험, 체외염색체이상\n\n2) 주요 대사산물 여부\n\n3) 공정서 또는 기타 과학적 문헌\n\n4) 기허가 완제의약품에서 확인된 유연물질 수준(일반적으로 사용기간 만료 시점 또는 만료\n\n- ○ 완제의약품의 가혹시험 결과 및 분석 방법을 피크 순도를 포함하여 요약, 기재한다.\n",
        "original_sentence": "1) 공정서 규격(기타 유연물질의 설정 근거는 공정서 규격에 근거할 수 없다.)\n\n"
      }
    },
    {
      "chunk_id": "chunk_438",
      "text": "2) 「의약품의 품목허가·신고·심사 규정」(식약처고시)에 따라 아래와 같이 기준을 설정한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 437,
        "window_size": 3,
        "char_count": 53,
        "word_count": 9,
        "page_number": 3,
        "window_text": "신청자가 원료의약품의 합성 중간체 또는 공정 불순물을 완제\n\n의약품에 규격 설정하는 경우(예: 크로마토그램에 검출되거나 마커로 사용 등), 원료의약품\n\n- ○ 순도시험의 경우, 특정 유연물질에 대해 표준품을 이용하여 정량하거나, 유연물질의 상대반\n주성분을 제외한 첨가제만을 포함한 검체와 특정 유연물질 간에 방해가 없음 (첨부된 크로마토그램\n\n- - 25 -\n응계수(RRF)를 기재한다.\n\n - ○ 분해생성물의 기준은 다음과 같이 설정할 수 있다.\n 1) 공정서 규격(기타 유연물질의 설정 근거는 공정서 규격에 근거할 수 없다.)\n\n 2) 「의약품의 품목허가·신고·심사 규정」(식약처고시)에 따라 아래와 같이 기준을 설정한다.\n\n - - 보고수준(RT; reporting threshold), 구조규명 수준(IT; identification threshold), 안전성\n- - 기타 유연물질은 구조규명 수준과 동등 또는 그 이하로 설정\n- - 특정 유연물질은 안전성입증 수준과 동등 또는 그 이하로 설정하거나 입증\n- ○ 불순물의 안전성은 아래와 같이 입증한다.\n 1) 독성시험자료: 반복투여독성시험자료, 유전독성시험자료(복귀돌연변이시험, 체외염색체이상\n\n2) 주요 대사산물 여부\n\n3) 공정서 또는 기타 과학적 문헌\n\n4) 기허가 완제의약품에서 확인된 유연물질 수준(일반적으로 사용기간 만료 시점 또는 만료\n\n- ○ 완제의약품의 가혹시험 결과 및 분석 방법을 피크 순도를 포함하여 요약, 기재한다.\n - - 가혹시험은 주성분이 10 ~ 30 % 분해되는 것을 목표로 한다. ",
        "original_sentence": "2) 「의약품의 품목허가·신고·심사 규정」(식약처고시)에 따라 아래와 같이 기준을 설정한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_439",
      "text": "- - 보고수준(RT; reporting threshold), 구조규명 수준(IT; identification threshold), 안전성\n- - 기타 유연물질은 구조규명 수준과 동등 또는 그 이하로 설정\n- - 특정 유연물질은 안전성입증 수준과 동등 또는 그 이하로 설정하거나 입증\n- ○ 불순물의 안전성은 아래와 같이 입증한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 438,
        "window_size": 3,
        "char_count": 186,
        "word_count": 40,
        "page_number": 5,
        "window_text": "- ○ 분해생성물의 기준은 다음과 같이 설정할 수 있다.\n 1) 공정서 규격(기타 유연물질의 설정 근거는 공정서 규격에 근거할 수 없다.)\n\n 2) 「의약품의 품목허가·신고·심사 규정」(식약처고시)에 따라 아래와 같이 기준을 설정한다.\n\n - - 보고수준(RT; reporting threshold), 구조규명 수준(IT; identification threshold), 안전성\n- - 기타 유연물질은 구조규명 수준과 동등 또는 그 이하로 설정\n- - 특정 유연물질은 안전성입증 수준과 동등 또는 그 이하로 설정하거나 입증\n- ○ 불순물의 안전성은 아래와 같이 입증한다.\n 1) 독성시험자료: 반복투여독성시험자료, 유전독성시험자료(복귀돌연변이시험, 체외염색체이상\n\n2) 주요 대사산물 여부\n\n3) 공정서 또는 기타 과학적 문헌\n\n4) 기허가 완제의약품에서 확인된 유연물질 수준(일반적으로 사용기간 만료 시점 또는 만료\n\n- ○ 완제의약품의 가혹시험 결과 및 분석 방법을 피크 순도를 포함하여 요약, 기재한다.\n - - 가혹시험은 주성분이 10 ~ 30 % 분해되는 것을 목표로 한다.  매우 안정한 주성분의 경우,\n- ○ 용출시험은 다음과 같은 양식으로 기재한다.\n",
        "original_sentence": "- - 보고수준(RT; reporting threshold), 구조규명 수준(IT; identification threshold), 안전성\n- - 기타 유연물질은 구조규명 수준과 동등 또는 그 이하로 설정\n- - 특정 유연물질은 안전성입증 수준과 동등 또는 그 이하로 설정하거나 입증\n- ○ 불순물의 안전성은 아래와 같이 입증한다.\n"
      }
    },
    {
      "chunk_id": "chunk_440",
      "text": "1) 독성시험자료: 반복투여독성시험자료, 유전독성시험자료(복귀돌연변이시험, 체외염색체이상\n\n2) 주요 대사산물 여부\n\n3) 공정서 또는 기타 과학적 문헌\n\n4) 기허가 완제의약품에서 확인된 유연물질 수준(일반적으로 사용기간 만료 시점 또는 만료\n\n- ○ 완제의약품의 가혹시험 결과 및 분석 방법을 피크 순도를 포함하여 요약, 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 439,
        "window_size": 3,
        "char_count": 188,
        "word_count": 39,
        "page_number": 31,
        "window_text": "1) 공정서 규격(기타 유연물질의 설정 근거는 공정서 규격에 근거할 수 없다.)\n\n 2) 「의약품의 품목허가·신고·심사 규정」(식약처고시)에 따라 아래와 같이 기준을 설정한다.\n\n - - 보고수준(RT; reporting threshold), 구조규명 수준(IT; identification threshold), 안전성\n- - 기타 유연물질은 구조규명 수준과 동등 또는 그 이하로 설정\n- - 특정 유연물질은 안전성입증 수준과 동등 또는 그 이하로 설정하거나 입증\n- ○ 불순물의 안전성은 아래와 같이 입증한다.\n 1) 독성시험자료: 반복투여독성시험자료, 유전독성시험자료(복귀돌연변이시험, 체외염색체이상\n\n2) 주요 대사산물 여부\n\n3) 공정서 또는 기타 과학적 문헌\n\n4) 기허가 완제의약품에서 확인된 유연물질 수준(일반적으로 사용기간 만료 시점 또는 만료\n\n- ○ 완제의약품의 가혹시험 결과 및 분석 방법을 피크 순도를 포함하여 요약, 기재한다.\n - - 가혹시험은 주성분이 10 ~ 30 % 분해되는 것을 목표로 한다.  매우 안정한 주성분의 경우,\n- ○ 용출시험은 다음과 같은 양식으로 기재한다.\n - - 26 -\n- - 공정서에 수재된 시험방법이 아닌 경우, 용출시험 분석 방법을 상세 기술하고, 용출규격설정\n1) 속방성 제제의 기준 및 시험방법 기재\n\n. ",
        "original_sentence": "1) 독성시험자료: 반복투여독성시험자료, 유전독성시험자료(복귀돌연변이시험, 체외염색체이상\n\n2) 주요 대사산물 여부\n\n3) 공정서 또는 기타 과학적 문헌\n\n4) 기허가 완제의약품에서 확인된 유연물질 수준(일반적으로 사용기간 만료 시점 또는 만료\n\n- ○ 완제의약품의 가혹시험 결과 및 분석 방법을 피크 순도를 포함하여 요약, 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_441",
      "text": "- - 가혹시험은 주성분이 10 ~ 30 % 분해되는 것을 목표로 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 440,
        "window_size": 3,
        "char_count": 41,
        "word_count": 12,
        "page_number": 3,
        "window_text": "2) 「의약품의 품목허가·신고·심사 규정」(식약처고시)에 따라 아래와 같이 기준을 설정한다.\n\n - - 보고수준(RT; reporting threshold), 구조규명 수준(IT; identification threshold), 안전성\n- - 기타 유연물질은 구조규명 수준과 동등 또는 그 이하로 설정\n- - 특정 유연물질은 안전성입증 수준과 동등 또는 그 이하로 설정하거나 입증\n- ○ 불순물의 안전성은 아래와 같이 입증한다.\n 1) 독성시험자료: 반복투여독성시험자료, 유전독성시험자료(복귀돌연변이시험, 체외염색체이상\n\n2) 주요 대사산물 여부\n\n3) 공정서 또는 기타 과학적 문헌\n\n4) 기허가 완제의약품에서 확인된 유연물질 수준(일반적으로 사용기간 만료 시점 또는 만료\n\n- ○ 완제의약품의 가혹시험 결과 및 분석 방법을 피크 순도를 포함하여 요약, 기재한다.\n - - 가혹시험은 주성분이 10 ~ 30 % 분해되는 것을 목표로 한다.  매우 안정한 주성분의 경우,\n- ○ 용출시험은 다음과 같은 양식으로 기재한다.\n - - 26 -\n- - 공정서에 수재된 시험방법이 아닌 경우, 용출시험 분석 방법을 상세 기술하고, 용출규격설정\n1) 속방성 제제의 기준 및 시험방법 기재\n\n.  본 제품은 USP 의약품각조를 참고하여 작성한 자사 기준에 따른다. ",
        "original_sentence": "- - 가혹시험은 주성분이 10 ~ 30 % 분해되는 것을 목표로 한다. "
      }
    },
    {
      "chunk_id": "chunk_442",
      "text": "매우 안정한 주성분의 경우,\n- ○ 용출시험은 다음과 같은 양식으로 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 441,
        "window_size": 3,
        "char_count": 44,
        "word_count": 11,
        "page_number": 5,
        "window_text": "- - 보고수준(RT; reporting threshold), 구조규명 수준(IT; identification threshold), 안전성\n- - 기타 유연물질은 구조규명 수준과 동등 또는 그 이하로 설정\n- - 특정 유연물질은 안전성입증 수준과 동등 또는 그 이하로 설정하거나 입증\n- ○ 불순물의 안전성은 아래와 같이 입증한다.\n 1) 독성시험자료: 반복투여독성시험자료, 유전독성시험자료(복귀돌연변이시험, 체외염색체이상\n\n2) 주요 대사산물 여부\n\n3) 공정서 또는 기타 과학적 문헌\n\n4) 기허가 완제의약품에서 확인된 유연물질 수준(일반적으로 사용기간 만료 시점 또는 만료\n\n- ○ 완제의약품의 가혹시험 결과 및 분석 방법을 피크 순도를 포함하여 요약, 기재한다.\n - - 가혹시험은 주성분이 10 ~ 30 % 분해되는 것을 목표로 한다.  매우 안정한 주성분의 경우,\n- ○ 용출시험은 다음과 같은 양식으로 기재한다.\n - - 26 -\n- - 공정서에 수재된 시험방법이 아닌 경우, 용출시험 분석 방법을 상세 기술하고, 용출규격설정\n1) 속방성 제제의 기준 및 시험방법 기재\n\n.  본 제품은 USP 의약품각조를 참고하여 작성한 자사 기준에 따른다.  USP 의약품각조에서\n\n. ",
        "original_sentence": "매우 안정한 주성분의 경우,\n- ○ 용출시험은 다음과 같은 양식으로 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_443",
      "text": "- - 26 -\n- - 공정서에 수재된 시험방법이 아닌 경우, 용출시험 분석 방법을 상세 기술하고, 용출규격설정\n1) 속방성 제제의 기준 및 시험방법 기재\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 442,
        "window_size": 3,
        "char_count": 90,
        "word_count": 25,
        "page_number": 3,
        "window_text": "1) 독성시험자료: 반복투여독성시험자료, 유전독성시험자료(복귀돌연변이시험, 체외염색체이상\n\n2) 주요 대사산물 여부\n\n3) 공정서 또는 기타 과학적 문헌\n\n4) 기허가 완제의약품에서 확인된 유연물질 수준(일반적으로 사용기간 만료 시점 또는 만료\n\n- ○ 완제의약품의 가혹시험 결과 및 분석 방법을 피크 순도를 포함하여 요약, 기재한다.\n - - 가혹시험은 주성분이 10 ~ 30 % 분해되는 것을 목표로 한다.  매우 안정한 주성분의 경우,\n- ○ 용출시험은 다음과 같은 양식으로 기재한다.\n - - 26 -\n- - 공정서에 수재된 시험방법이 아닌 경우, 용출시험 분석 방법을 상세 기술하고, 용출규격설정\n1) 속방성 제제의 기준 및 시험방법 기재\n\n.  본 제품은 USP 의약품각조를 참고하여 작성한 자사 기준에 따른다.  USP 의약품각조에서\n\n.  개발단계에서 완제의약품이 수분에 민감성을 보이지 않았고, 건조 공정의 종료 시점 결정을\n\n위해 건조감량을 측정하므로 기준 및 시험방법에는 수분 시험은 포함하지 않는다.\n\n",
        "original_sentence": "- - 26 -\n- - 공정서에 수재된 시험방법이 아닌 경우, 용출시험 분석 방법을 상세 기술하고, 용출규격설정\n1) 속방성 제제의 기준 및 시험방법 기재\n\n. "
      }
    },
    {
      "chunk_id": "chunk_444",
      "text": "본 제품은 USP 의약품각조를 참고하여 작성한 자사 기준에 따른다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 443,
        "window_size": 3,
        "char_count": 38,
        "word_count": 9,
        "page_number": 14,
        "window_text": "- - 가혹시험은 주성분이 10 ~ 30 % 분해되는 것을 목표로 한다.  매우 안정한 주성분의 경우,\n- ○ 용출시험은 다음과 같은 양식으로 기재한다.\n - - 26 -\n- - 공정서에 수재된 시험방법이 아닌 경우, 용출시험 분석 방법을 상세 기술하고, 용출규격설정\n1) 속방성 제제의 기준 및 시험방법 기재\n\n.  본 제품은 USP 의약품각조를 참고하여 작성한 자사 기준에 따른다.  USP 의약품각조에서\n\n.  개발단계에서 완제의약품이 수분에 민감성을 보이지 않았고, 건조 공정의 종료 시점 결정을\n\n위해 건조감량을 측정하므로 기준 및 시험방법에는 수분 시험은 포함하지 않는다.\n\n - - 27 -\n- ○ 기준 및 시험방법 설정 요약\n. ",
        "original_sentence": "본 제품은 USP 의약품각조를 참고하여 작성한 자사 기준에 따른다. "
      }
    },
    {
      "chunk_id": "chunk_445",
      "text": "USP 의약품각조에서\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 444,
        "window_size": 3,
        "char_count": 15,
        "word_count": 3,
        "page_number": 14,
        "window_text": "매우 안정한 주성분의 경우,\n- ○ 용출시험은 다음과 같은 양식으로 기재한다.\n - - 26 -\n- - 공정서에 수재된 시험방법이 아닌 경우, 용출시험 분석 방법을 상세 기술하고, 용출규격설정\n1) 속방성 제제의 기준 및 시험방법 기재\n\n.  본 제품은 USP 의약품각조를 참고하여 작성한 자사 기준에 따른다.  USP 의약품각조에서\n\n.  개발단계에서 완제의약품이 수분에 민감성을 보이지 않았고, 건조 공정의 종료 시점 결정을\n\n위해 건조감량을 측정하므로 기준 및 시험방법에는 수분 시험은 포함하지 않는다.\n\n - - 27 -\n- ○ 기준 및 시험방법 설정 요약\n.  성상: 정제의 색상, 형태, 일반적 외형에 대해 육안 시험한다.\n\n",
        "original_sentence": "USP 의약품각조에서\n\n. "
      }
    },
    {
      "chunk_id": "chunk_446",
      "text": "개발단계에서 완제의약품이 수분에 민감성을 보이지 않았고, 건조 공정의 종료 시점 결정을\n\n위해 건조감량을 측정하므로 기준 및 시험방법에는 수분 시험은 포함하지 않는다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 445,
        "window_size": 3,
        "char_count": 95,
        "word_count": 21,
        "page_number": 3,
        "window_text": "- - 26 -\n- - 공정서에 수재된 시험방법이 아닌 경우, 용출시험 분석 방법을 상세 기술하고, 용출규격설정\n1) 속방성 제제의 기준 및 시험방법 기재\n\n.  본 제품은 USP 의약품각조를 참고하여 작성한 자사 기준에 따른다.  USP 의약품각조에서\n\n.  개발단계에서 완제의약품이 수분에 민감성을 보이지 않았고, 건조 공정의 종료 시점 결정을\n\n위해 건조감량을 측정하므로 기준 및 시험방법에는 수분 시험은 포함하지 않는다.\n\n - - 27 -\n- ○ 기준 및 시험방법 설정 요약\n.  성상: 정제의 색상, 형태, 일반적 외형에 대해 육안 시험한다.\n\n . ",
        "original_sentence": "개발단계에서 완제의약품이 수분에 민감성을 보이지 않았고, 건조 공정의 종료 시점 결정을\n\n위해 건조감량을 측정하므로 기준 및 시험방법에는 수분 시험은 포함하지 않는다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_447",
      "text": "- - 27 -\n- ○ 기준 및 시험방법 설정 요약\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 446,
        "window_size": 3,
        "char_count": 31,
        "word_count": 12,
        "page_number": 5,
        "window_text": "본 제품은 USP 의약품각조를 참고하여 작성한 자사 기준에 따른다.  USP 의약품각조에서\n\n.  개발단계에서 완제의약품이 수분에 민감성을 보이지 않았고, 건조 공정의 종료 시점 결정을\n\n위해 건조감량을 측정하므로 기준 및 시험방법에는 수분 시험은 포함하지 않는다.\n\n - - 27 -\n- ○ 기준 및 시험방법 설정 요약\n.  성상: 정제의 색상, 형태, 일반적 외형에 대해 육안 시험한다.\n\n .  확인시험: USP 의약품각조의 함량시험법에 따라 시험한다.\n\n",
        "original_sentence": "- - 27 -\n- ○ 기준 및 시험방법 설정 요약\n. "
      }
    },
    {
      "chunk_id": "chunk_448",
      "text": "성상: 정제의 색상, 형태, 일반적 외형에 대해 육안 시험한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 447,
        "window_size": 3,
        "char_count": 37,
        "word_count": 9,
        "page_number": 13,
        "window_text": "USP 의약품각조에서\n\n.  개발단계에서 완제의약품이 수분에 민감성을 보이지 않았고, 건조 공정의 종료 시점 결정을\n\n위해 건조감량을 측정하므로 기준 및 시험방법에는 수분 시험은 포함하지 않는다.\n\n - - 27 -\n- ○ 기준 및 시험방법 설정 요약\n.  성상: 정제의 색상, 형태, 일반적 외형에 대해 육안 시험한다.\n\n .  확인시험: USP 의약품각조의 함량시험법에 따라 시험한다.\n\n . ",
        "original_sentence": "성상: 정제의 색상, 형태, 일반적 외형에 대해 육안 시험한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_449",
      "text": ". ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 448,
        "window_size": 3,
        "char_count": 2,
        "word_count": 1,
        "page_number": 1,
        "window_text": "개발단계에서 완제의약품이 수분에 민감성을 보이지 않았고, 건조 공정의 종료 시점 결정을\n\n위해 건조감량을 측정하므로 기준 및 시험방법에는 수분 시험은 포함하지 않는다.\n\n - - 27 -\n- ○ 기준 및 시험방법 설정 요약\n.  성상: 정제의 색상, 형태, 일반적 외형에 대해 육안 시험한다.\n\n .  확인시험: USP 의약품각조의 함량시험법에 따라 시험한다.\n\n .  함량시험: USP 의약품각조에 따라 기준은 90.0 - 110.0%로 설정하고, 의약품각조의 시험\n\n법을 사용하였다. ",
        "original_sentence": ". "
      }
    },
    {
      "chunk_id": "chunk_450",
      "text": "확인시험: USP 의약품각조의 함량시험법에 따라 시험한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 449,
        "window_size": 3,
        "char_count": 34,
        "word_count": 6,
        "page_number": 13,
        "window_text": "- - 27 -\n- ○ 기준 및 시험방법 설정 요약\n.  성상: 정제의 색상, 형태, 일반적 외형에 대해 육안 시험한다.\n\n .  확인시험: USP 의약품각조의 함량시험법에 따라 시험한다.\n\n .  함량시험: USP 의약품각조에 따라 기준은 90.0 - 110.0%로 설정하고, 의약품각조의 시험\n\n법을 사용하였다.  위약에 의한 간섭효과는 없었다. ",
        "original_sentence": "확인시험: USP 의약품각조의 함량시험법에 따라 시험한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_451",
      "text": ". ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 450,
        "window_size": 3,
        "char_count": 2,
        "word_count": 1,
        "page_number": 1,
        "window_text": "성상: 정제의 색상, 형태, 일반적 외형에 대해 육안 시험한다.\n\n .  확인시험: USP 의약품각조의 함량시험법에 따라 시험한다.\n\n .  함량시험: USP 의약품각조에 따라 기준은 90.0 - 110.0%로 설정하고, 의약품각조의 시험\n\n법을 사용하였다.  위약에 의한 간섭효과는 없었다.  시험검체와 위약, 대조약의 크로마토그램은\n\n- 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다. ",
        "original_sentence": ". "
      }
    },
    {
      "chunk_id": "chunk_452",
      "text": "함량시험: USP 의약품각조에 따라 기준은 90.0 - 110.0%로 설정하고, 의약품각조의 시험\n\n법을 사용하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 451,
        "window_size": 3,
        "char_count": 66,
        "word_count": 13,
        "page_number": 5,
        "window_text": ".  확인시험: USP 의약품각조의 함량시험법에 따라 시험한다.\n\n .  함량시험: USP 의약품각조에 따라 기준은 90.0 - 110.0%로 설정하고, 의약품각조의 시험\n\n법을 사용하였다.  위약에 의한 간섭효과는 없었다.  시험검체와 위약, 대조약의 크로마토그램은\n\n- 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.  가혹시험은 유연물질 항 다음에 기재\n. ",
        "original_sentence": "함량시험: USP 의약품각조에 따라 기준은 90.0 - 110.0%로 설정하고, 의약품각조의 시험\n\n법을 사용하였다. "
      }
    },
    {
      "chunk_id": "chunk_453",
      "text": "위약에 의한 간섭효과는 없었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 452,
        "window_size": 3,
        "char_count": 18,
        "word_count": 4,
        "page_number": 33,
        "window_text": "확인시험: USP 의약품각조의 함량시험법에 따라 시험한다.\n\n .  함량시험: USP 의약품각조에 따라 기준은 90.0 - 110.0%로 설정하고, 의약품각조의 시험\n\n법을 사용하였다.  위약에 의한 간섭효과는 없었다.  시험검체와 위약, 대조약의 크로마토그램은\n\n- 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.  가혹시험은 유연물질 항 다음에 기재\n.  함량균일성 시험: USP 일반시험법 <905> 함량균일성시험의 허용기준을 적용하였다.\n\n",
        "original_sentence": "위약에 의한 간섭효과는 없었다. "
      }
    },
    {
      "chunk_id": "chunk_454",
      "text": "시험검체와 위약, 대조약의 크로마토그램은\n\n- 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 453,
        "window_size": 3,
        "char_count": 65,
        "word_count": 11,
        "page_number": 5,
        "window_text": ".  함량시험: USP 의약품각조에 따라 기준은 90.0 - 110.0%로 설정하고, 의약품각조의 시험\n\n법을 사용하였다.  위약에 의한 간섭효과는 없었다.  시험검체와 위약, 대조약의 크로마토그램은\n\n- 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.  가혹시험은 유연물질 항 다음에 기재\n.  함량균일성 시험: USP 일반시험법 <905> 함량균일성시험의 허용기준을 적용하였다.\n\n . ",
        "original_sentence": "시험검체와 위약, 대조약의 크로마토그램은\n\n- 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다. "
      }
    },
    {
      "chunk_id": "chunk_455",
      "text": "가혹시험은 유연물질 항 다음에 기재\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 454,
        "window_size": 3,
        "char_count": 22,
        "word_count": 6,
        "page_number": 15,
        "window_text": "함량시험: USP 의약품각조에 따라 기준은 90.0 - 110.0%로 설정하고, 의약품각조의 시험\n\n법을 사용하였다.  위약에 의한 간섭효과는 없었다.  시험검체와 위약, 대조약의 크로마토그램은\n\n- 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.  가혹시험은 유연물질 항 다음에 기재\n.  함량균일성 시험: USP 일반시험법 <905> 함량균일성시험의 허용기준을 적용하였다.\n\n .  순도(분해산물): 주성분에서 2개의 주요 분해산물이 확인되었다.\n\n",
        "original_sentence": "가혹시험은 유연물질 항 다음에 기재\n. "
      }
    },
    {
      "chunk_id": "chunk_456",
      "text": "함량균일성 시험: USP 일반시험법 <905> 함량균일성시험의 허용기준을 적용하였다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 455,
        "window_size": 3,
        "char_count": 49,
        "word_count": 8,
        "page_number": 14,
        "window_text": "위약에 의한 간섭효과는 없었다.  시험검체와 위약, 대조약의 크로마토그램은\n\n- 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.  가혹시험은 유연물질 항 다음에 기재\n.  함량균일성 시험: USP 일반시험법 <905> 함량균일성시험의 허용기준을 적용하였다.\n\n .  순도(분해산물): 주성분에서 2개의 주요 분해산물이 확인되었다.\n\n 이 품목에 대한 USP 의약품각조의 기준은 다음과 같다.\n\n",
        "original_sentence": "함량균일성 시험: USP 일반시험법 <905> 함량균일성시험의 허용기준을 적용하였다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_457",
      "text": ". ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 456,
        "window_size": 3,
        "char_count": 2,
        "word_count": 1,
        "page_number": 1,
        "window_text": "시험검체와 위약, 대조약의 크로마토그램은\n\n- 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.  가혹시험은 유연물질 항 다음에 기재\n.  함량균일성 시험: USP 일반시험법 <905> 함량균일성시험의 허용기준을 적용하였다.\n\n .  순도(분해산물): 주성분에서 2개의 주요 분해산물이 확인되었다.\n\n 이 품목에 대한 USP 의약품각조의 기준은 다음과 같다.\n\n 유연물질 시험방법은, 공정 불순물 검출이 가능한 자사 시험방법(#41)이며, 정확성, 정밀성,\n\n함량 시험방법과 유연물질 시험방법이 특이적이고 안정적임을 증명하기 위해 가혹시험을\n\n실시하였다. ",
        "original_sentence": ". "
      }
    },
    {
      "chunk_id": "chunk_458",
      "text": "순도(분해산물): 주성분에서 2개의 주요 분해산물이 확인되었다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 457,
        "window_size": 3,
        "char_count": 37,
        "word_count": 6,
        "page_number": 3,
        "window_text": "가혹시험은 유연물질 항 다음에 기재\n.  함량균일성 시험: USP 일반시험법 <905> 함량균일성시험의 허용기준을 적용하였다.\n\n .  순도(분해산물): 주성분에서 2개의 주요 분해산물이 확인되었다.\n\n 이 품목에 대한 USP 의약품각조의 기준은 다음과 같다.\n\n 유연물질 시험방법은, 공정 불순물 검출이 가능한 자사 시험방법(#41)이며, 정확성, 정밀성,\n\n함량 시험방법과 유연물질 시험방법이 특이적이고 안정적임을 증명하기 위해 가혹시험을\n\n실시하였다.  산, 염기, 산화제, 열, 빛 조건에 노출시킨 후, HPLC(PDA, Peak purity analysi\n\ns)로 분석하였다. ",
        "original_sentence": "순도(분해산물): 주성분에서 2개의 주요 분해산물이 확인되었다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_459",
      "text": "이 품목에 대한 USP 의약품각조의 기준은 다음과 같다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 458,
        "window_size": 3,
        "char_count": 33,
        "word_count": 8,
        "page_number": 33,
        "window_text": "함량균일성 시험: USP 일반시험법 <905> 함량균일성시험의 허용기준을 적용하였다.\n\n .  순도(분해산물): 주성분에서 2개의 주요 분해산물이 확인되었다.\n\n 이 품목에 대한 USP 의약품각조의 기준은 다음과 같다.\n\n 유연물질 시험방법은, 공정 불순물 검출이 가능한 자사 시험방법(#41)이며, 정확성, 정밀성,\n\n함량 시험방법과 유연물질 시험방법이 특이적이고 안정적임을 증명하기 위해 가혹시험을\n\n실시하였다.  산, 염기, 산화제, 열, 빛 조건에 노출시킨 후, HPLC(PDA, Peak purity analysi\n\ns)로 분석하였다.  분해산물 피크들은 관련 피크들에서 완전히 분리되었다. ",
        "original_sentence": "이 품목에 대한 USP 의약품각조의 기준은 다음과 같다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_460",
      "text": "유연물질 시험방법은, 공정 불순물 검출이 가능한 자사 시험방법(#41)이며, 정확성, 정밀성,\n\n함량 시험방법과 유연물질 시험방법이 특이적이고 안정적임을 증명하기 위해 가혹시험을\n\n실시하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 459,
        "window_size": 3,
        "char_count": 108,
        "word_count": 20,
        "page_number": 3,
        "window_text": ".  순도(분해산물): 주성분에서 2개의 주요 분해산물이 확인되었다.\n\n 이 품목에 대한 USP 의약품각조의 기준은 다음과 같다.\n\n 유연물질 시험방법은, 공정 불순물 검출이 가능한 자사 시험방법(#41)이며, 정확성, 정밀성,\n\n함량 시험방법과 유연물질 시험방법이 특이적이고 안정적임을 증명하기 위해 가혹시험을\n\n실시하였다.  산, 염기, 산화제, 열, 빛 조건에 노출시킨 후, HPLC(PDA, Peak purity analysi\n\ns)로 분석하였다.  분해산물 피크들은 관련 피크들에서 완전히 분리되었다.  주성분 피크의 피크\n\n순도는 > 0.99로 관찰되었다. ",
        "original_sentence": "유연물질 시험방법은, 공정 불순물 검출이 가능한 자사 시험방법(#41)이며, 정확성, 정밀성,\n\n함량 시험방법과 유연물질 시험방법이 특이적이고 안정적임을 증명하기 위해 가혹시험을\n\n실시하였다. "
      }
    },
    {
      "chunk_id": "chunk_461",
      "text": "산, 염기, 산화제, 열, 빛 조건에 노출시킨 후, HPLC(PDA, Peak purity analysi\n\ns)로 분석하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 460,
        "window_size": 3,
        "char_count": 71,
        "word_count": 14,
        "page_number": 30,
        "window_text": "순도(분해산물): 주성분에서 2개의 주요 분해산물이 확인되었다.\n\n 이 품목에 대한 USP 의약품각조의 기준은 다음과 같다.\n\n 유연물질 시험방법은, 공정 불순물 검출이 가능한 자사 시험방법(#41)이며, 정확성, 정밀성,\n\n함량 시험방법과 유연물질 시험방법이 특이적이고 안정적임을 증명하기 위해 가혹시험을\n\n실시하였다.  산, 염기, 산화제, 열, 빛 조건에 노출시킨 후, HPLC(PDA, Peak purity analysi\n\ns)로 분석하였다.  분해산물 피크들은 관련 피크들에서 완전히 분리되었다.  주성분 피크의 피크\n\n순도는 > 0.99로 관찰되었다.  Peak purity angle은 peak purity threshold보다 작고, 간섭은\n\n- - 28 -\n없었다. ",
        "original_sentence": "산, 염기, 산화제, 열, 빛 조건에 노출시킨 후, HPLC(PDA, Peak purity analysi\n\ns)로 분석하였다. "
      }
    },
    {
      "chunk_id": "chunk_462",
      "text": "분해산물 피크들은 관련 피크들에서 완전히 분리되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 461,
        "window_size": 3,
        "char_count": 30,
        "word_count": 6,
        "page_number": 33,
        "window_text": "이 품목에 대한 USP 의약품각조의 기준은 다음과 같다.\n\n 유연물질 시험방법은, 공정 불순물 검출이 가능한 자사 시험방법(#41)이며, 정확성, 정밀성,\n\n함량 시험방법과 유연물질 시험방법이 특이적이고 안정적임을 증명하기 위해 가혹시험을\n\n실시하였다.  산, 염기, 산화제, 열, 빛 조건에 노출시킨 후, HPLC(PDA, Peak purity analysi\n\ns)로 분석하였다.  분해산물 피크들은 관련 피크들에서 완전히 분리되었다.  주성분 피크의 피크\n\n순도는 > 0.99로 관찰되었다.  Peak purity angle은 peak purity threshold보다 작고, 간섭은\n\n- - 28 -\n없었다.  주성분 피크나 유연물질 RC2와 RC3 피크에 대한 분해산물 피크의 간섭은 없었다.\n\n",
        "original_sentence": "분해산물 피크들은 관련 피크들에서 완전히 분리되었다. "
      }
    },
    {
      "chunk_id": "chunk_463",
      "text": "주성분 피크의 피크\n\n순도는 > 0.99로 관찰되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 462,
        "window_size": 3,
        "char_count": 31,
        "word_count": 7,
        "page_number": 19,
        "window_text": "유연물질 시험방법은, 공정 불순물 검출이 가능한 자사 시험방법(#41)이며, 정확성, 정밀성,\n\n함량 시험방법과 유연물질 시험방법이 특이적이고 안정적임을 증명하기 위해 가혹시험을\n\n실시하였다.  산, 염기, 산화제, 열, 빛 조건에 노출시킨 후, HPLC(PDA, Peak purity analysi\n\ns)로 분석하였다.  분해산물 피크들은 관련 피크들에서 완전히 분리되었다.  주성분 피크의 피크\n\n순도는 > 0.99로 관찰되었다.  Peak purity angle은 peak purity threshold보다 작고, 간섭은\n\n- - 28 -\n없었다.  주성분 피크나 유연물질 RC2와 RC3 피크에 대한 분해산물 피크의 간섭은 없었다.\n\n . ",
        "original_sentence": "주성분 피크의 피크\n\n순도는 > 0.99로 관찰되었다. "
      }
    },
    {
      "chunk_id": "chunk_464",
      "text": "Peak purity angle은 peak purity threshold보다 작고, 간섭은\n\n- - 28 -\n없었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 463,
        "window_size": 3,
        "char_count": 66,
        "word_count": 13,
        "page_number": 31,
        "window_text": "산, 염기, 산화제, 열, 빛 조건에 노출시킨 후, HPLC(PDA, Peak purity analysi\n\ns)로 분석하였다.  분해산물 피크들은 관련 피크들에서 완전히 분리되었다.  주성분 피크의 피크\n\n순도는 > 0.99로 관찰되었다.  Peak purity angle은 peak purity threshold보다 작고, 간섭은\n\n- - 28 -\n없었다.  주성분 피크나 유연물질 RC2와 RC3 피크에 대한 분해산물 피크의 간섭은 없었다.\n\n .  용출: 용출시험법은 USP 의약품각조의 시험방법을 따랐으며, 시험 조건과 기준은 다음과\n\n2) 서방성 제제의 기준 및 시험방법 기재\n\n**[표 시작]**\n\n**아님을 확인하였다. ",
        "original_sentence": "Peak purity angle은 peak purity threshold보다 작고, 간섭은\n\n- - 28 -\n없었다. "
      }
    },
    {
      "chunk_id": "chunk_465",
      "text": "주성분 피크나 유연물질 RC2와 RC3 피크에 대한 분해산물 피크의 간섭은 없었다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 464,
        "window_size": 3,
        "char_count": 48,
        "word_count": 11,
        "page_number": 5,
        "window_text": "분해산물 피크들은 관련 피크들에서 완전히 분리되었다.  주성분 피크의 피크\n\n순도는 > 0.99로 관찰되었다.  Peak purity angle은 peak purity threshold보다 작고, 간섭은\n\n- - 28 -\n없었다.  주성분 피크나 유연물질 RC2와 RC3 피크에 대한 분해산물 피크의 간섭은 없었다.\n\n .  용출: 용출시험법은 USP 의약품각조의 시험방법을 따랐으며, 시험 조건과 기준은 다음과\n\n2) 서방성 제제의 기준 및 시험방법 기재\n\n**[표 시작]**\n\n**아님을 확인하였다.  분석법 밸리데이션과 가혹시험에 관련해서 아래 표에 요약하였다.",
        "original_sentence": "주성분 피크나 유연물질 RC2와 RC3 피크에 대한 분해산물 피크의 간섭은 없었다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_466",
      "text": ". ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 465,
        "window_size": 3,
        "char_count": 2,
        "word_count": 1,
        "page_number": 1,
        "window_text": "주성분 피크의 피크\n\n순도는 > 0.99로 관찰되었다.  Peak purity angle은 peak purity threshold보다 작고, 간섭은\n\n- - 28 -\n없었다.  주성분 피크나 유연물질 RC2와 RC3 피크에 대한 분해산물 피크의 간섭은 없었다.\n\n .  용출: 용출시험법은 USP 의약품각조의 시험방법을 따랐으며, 시험 조건과 기준은 다음과\n\n2) 서방성 제제의 기준 및 시험방법 기재\n\n**[표 시작]**\n\n**아님을 확인하였다.  분석법 밸리데이션과 가혹시험에 관련해서 아래 표에 요약하였다. **\n**제조공정개발 시 최종 완제의약품의 품질 보증을 위해 다음 특성을 규정하였다.",
        "original_sentence": ". "
      }
    },
    {
      "chunk_id": "chunk_467",
      "text": "용출: 용출시험법은 USP 의약품각조의 시험방법을 따랐으며, 시험 조건과 기준은 다음과\n\n2) 서방성 제제의 기준 및 시험방법 기재\n\n**[표 시작]**\n\n**아님을 확인하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 466,
        "window_size": 3,
        "char_count": 100,
        "word_count": 21,
        "page_number": 14,
        "window_text": "Peak purity angle은 peak purity threshold보다 작고, 간섭은\n\n- - 28 -\n없었다.  주성분 피크나 유연물질 RC2와 RC3 피크에 대한 분해산물 피크의 간섭은 없었다.\n\n .  용출: 용출시험법은 USP 의약품각조의 시험방법을 따랐으며, 시험 조건과 기준은 다음과\n\n2) 서방성 제제의 기준 및 시험방법 기재\n\n**[표 시작]**\n\n**아님을 확인하였다.  분석법 밸리데이션과 가혹시험에 관련해서 아래 표에 요약하였다. **\n**제조공정개발 시 최종 완제의약품의 품질 보증을 위해 다음 특성을 규정하였다. **\n**시아니솔(안정화제)을 10% w/ 부틸레이티드히드록시아니솔 수용액 상태로 분무한다.",
        "original_sentence": "용출: 용출시험법은 USP 의약품각조의 시험방법을 따랐으며, 시험 조건과 기준은 다음과\n\n2) 서방성 제제의 기준 및 시험방법 기재\n\n**[표 시작]**\n\n**아님을 확인하였다. "
      }
    },
    {
      "chunk_id": "chunk_468",
      "text": "분석법 밸리데이션과 가혹시험에 관련해서 아래 표에 요약하였다.",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 467,
        "window_size": 3,
        "char_count": 34,
        "word_count": 7,
        "page_number": 3,
        "window_text": "주성분 피크나 유연물질 RC2와 RC3 피크에 대한 분해산물 피크의 간섭은 없었다.\n\n .  용출: 용출시험법은 USP 의약품각조의 시험방법을 따랐으며, 시험 조건과 기준은 다음과\n\n2) 서방성 제제의 기준 및 시험방법 기재\n\n**[표 시작]**\n\n**아님을 확인하였다.  분석법 밸리데이션과 가혹시험에 관련해서 아래 표에 요약하였다. **\n**제조공정개발 시 최종 완제의약품의 품질 보증을 위해 다음 특성을 규정하였다. **\n**시아니솔(안정화제)을 10% w/ 부틸레이티드히드록시아니솔 수용액 상태로 분무한다. **\n| 유량 | 1.5 mL/분 |\n| 중요공정변수 | (m3/시간) |\n**성상**\n\n**[표 끝]**\n\n- - 29 -\n- ○ 기준 및 시험방법 설정 요약\n. ",
        "original_sentence": "분석법 밸리데이션과 가혹시험에 관련해서 아래 표에 요약하였다."
      }
    },
    {
      "chunk_id": "chunk_469",
      "text": "**\n**제조공정개발 시 최종 완제의약품의 품질 보증을 위해 다음 특성을 규정하였다.",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 468,
        "window_size": 3,
        "char_count": 47,
        "word_count": 11,
        "page_number": 26,
        "window_text": ".  용출: 용출시험법은 USP 의약품각조의 시험방법을 따랐으며, 시험 조건과 기준은 다음과\n\n2) 서방성 제제의 기준 및 시험방법 기재\n\n**[표 시작]**\n\n**아님을 확인하였다.  분석법 밸리데이션과 가혹시험에 관련해서 아래 표에 요약하였다. **\n**제조공정개발 시 최종 완제의약품의 품질 보증을 위해 다음 특성을 규정하였다. **\n**시아니솔(안정화제)을 10% w/ 부틸레이티드히드록시아니솔 수용액 상태로 분무한다. **\n| 유량 | 1.5 mL/분 |\n| 중요공정변수 | (m3/시간) |\n**성상**\n\n**[표 끝]**\n\n- - 29 -\n- ○ 기준 및 시험방법 설정 요약\n.  성상: 캡슐의 낱알표시, 색상과 형태에 대해 육안으로 검사한다. ",
        "original_sentence": "**\n**제조공정개발 시 최종 완제의약품의 품질 보증을 위해 다음 특성을 규정하였다."
      }
    },
    {
      "chunk_id": "chunk_470",
      "text": "**\n**시아니솔(안정화제)을 10% w/ 부틸레이티드히드록시아니솔 수용액 상태로 분무한다.",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 469,
        "window_size": 3,
        "char_count": 51,
        "word_count": 8,
        "page_number": 3,
        "window_text": "용출: 용출시험법은 USP 의약품각조의 시험방법을 따랐으며, 시험 조건과 기준은 다음과\n\n2) 서방성 제제의 기준 및 시험방법 기재\n\n**[표 시작]**\n\n**아님을 확인하였다.  분석법 밸리데이션과 가혹시험에 관련해서 아래 표에 요약하였다. **\n**제조공정개발 시 최종 완제의약품의 품질 보증을 위해 다음 특성을 규정하였다. **\n**시아니솔(안정화제)을 10% w/ 부틸레이티드히드록시아니솔 수용액 상태로 분무한다. **\n| 유량 | 1.5 mL/분 |\n| 중요공정변수 | (m3/시간) |\n**성상**\n\n**[표 끝]**\n\n- - 29 -\n- ○ 기준 및 시험방법 설정 요약\n.  성상: 캡슐의 낱알표시, 색상과 형태에 대해 육안으로 검사한다.  이 때 캡슐 표면의 색상\n\n. ",
        "original_sentence": "**\n**시아니솔(안정화제)을 10% w/ 부틸레이티드히드록시아니솔 수용액 상태로 분무한다."
      }
    },
    {
      "chunk_id": "chunk_471",
      "text": "**\n| 유량 | 1.5 mL/분 |\n| 중요공정변수 | (m3/시간) |\n**성상**\n\n**[표 끝]**\n\n- - 29 -\n- ○ 기준 및 시험방법 설정 요약\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 470,
        "window_size": 3,
        "char_count": 92,
        "word_count": 27,
        "page_number": 5,
        "window_text": "분석법 밸리데이션과 가혹시험에 관련해서 아래 표에 요약하였다. **\n**제조공정개발 시 최종 완제의약품의 품질 보증을 위해 다음 특성을 규정하였다. **\n**시아니솔(안정화제)을 10% w/ 부틸레이티드히드록시아니솔 수용액 상태로 분무한다. **\n| 유량 | 1.5 mL/분 |\n| 중요공정변수 | (m3/시간) |\n**성상**\n\n**[표 끝]**\n\n- - 29 -\n- ○ 기준 및 시험방법 설정 요약\n.  성상: 캡슐의 낱알표시, 색상과 형태에 대해 육안으로 검사한다.  이 때 캡슐 표면의 색상\n\n.  확인시험: 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.\n\n",
        "original_sentence": "**\n| 유량 | 1.5 mL/분 |\n| 중요공정변수 | (m3/시간) |\n**성상**\n\n**[표 끝]**\n\n- - 29 -\n- ○ 기준 및 시험방법 설정 요약\n. "
      }
    },
    {
      "chunk_id": "chunk_472",
      "text": "성상: 캡슐의 낱알표시, 색상과 형태에 대해 육안으로 검사한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 471,
        "window_size": 3,
        "char_count": 36,
        "word_count": 8,
        "page_number": 13,
        "window_text": "**\n**제조공정개발 시 최종 완제의약품의 품질 보증을 위해 다음 특성을 규정하였다. **\n**시아니솔(안정화제)을 10% w/ 부틸레이티드히드록시아니솔 수용액 상태로 분무한다. **\n| 유량 | 1.5 mL/분 |\n| 중요공정변수 | (m3/시간) |\n**성상**\n\n**[표 끝]**\n\n- - 29 -\n- ○ 기준 및 시험방법 설정 요약\n.  성상: 캡슐의 낱알표시, 색상과 형태에 대해 육안으로 검사한다.  이 때 캡슐 표면의 색상\n\n.  확인시험: 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.\n\n HPLC: 주성분 피크의 유지시간은 표준품과 같다.\n\n",
        "original_sentence": "성상: 캡슐의 낱알표시, 색상과 형태에 대해 육안으로 검사한다. "
      }
    },
    {
      "chunk_id": "chunk_473",
      "text": "이 때 캡슐 표면의 색상\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 472,
        "window_size": 3,
        "char_count": 17,
        "word_count": 6,
        "page_number": 3,
        "window_text": "**\n**시아니솔(안정화제)을 10% w/ 부틸레이티드히드록시아니솔 수용액 상태로 분무한다. **\n| 유량 | 1.5 mL/분 |\n| 중요공정변수 | (m3/시간) |\n**성상**\n\n**[표 끝]**\n\n- - 29 -\n- ○ 기준 및 시험방법 설정 요약\n.  성상: 캡슐의 낱알표시, 색상과 형태에 대해 육안으로 검사한다.  이 때 캡슐 표면의 색상\n\n.  확인시험: 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.\n\n HPLC: 주성분 피크의 유지시간은 표준품과 같다.\n\n UV: 표준품과 같은 파장에서 흡수극대를 나타낸다.\n\n",
        "original_sentence": "이 때 캡슐 표면의 색상\n\n. "
      }
    },
    {
      "chunk_id": "chunk_474",
      "text": "확인시험: 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 473,
        "window_size": 3,
        "char_count": 54,
        "word_count": 9,
        "page_number": 2,
        "window_text": "**\n| 유량 | 1.5 mL/분 |\n| 중요공정변수 | (m3/시간) |\n**성상**\n\n**[표 끝]**\n\n- - 29 -\n- ○ 기준 및 시험방법 설정 요약\n.  성상: 캡슐의 낱알표시, 색상과 형태에 대해 육안으로 검사한다.  이 때 캡슐 표면의 색상\n\n.  확인시험: 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.\n\n HPLC: 주성분 피크의 유지시간은 표준품과 같다.\n\n UV: 표준품과 같은 파장에서 흡수극대를 나타낸다.\n\n . ",
        "original_sentence": "확인시험: 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_475",
      "text": "HPLC: 주성분 피크의 유지시간은 표준품과 같다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 474,
        "window_size": 3,
        "char_count": 30,
        "word_count": 6,
        "page_number": 35,
        "window_text": "성상: 캡슐의 낱알표시, 색상과 형태에 대해 육안으로 검사한다.  이 때 캡슐 표면의 색상\n\n.  확인시험: 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.\n\n HPLC: 주성분 피크의 유지시간은 표준품과 같다.\n\n UV: 표준품과 같은 파장에서 흡수극대를 나타낸다.\n\n .  함량시험: 함량 기준은 95.0 - 105.0%이며, 분석 조건은 다음 표와 같다. ",
        "original_sentence": "HPLC: 주성분 피크의 유지시간은 표준품과 같다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_476",
      "text": "UV: 표준품과 같은 파장에서 흡수극대를 나타낸다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 475,
        "window_size": 3,
        "char_count": 30,
        "word_count": 6,
        "page_number": 35,
        "window_text": "이 때 캡슐 표면의 색상\n\n.  확인시험: 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.\n\n HPLC: 주성분 피크의 유지시간은 표준품과 같다.\n\n UV: 표준품과 같은 파장에서 흡수극대를 나타낸다.\n\n .  함량시험: 함량 기준은 95.0 - 105.0%이며, 분석 조건은 다음 표와 같다.  이 시험과 관련\n\n하여 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다. ",
        "original_sentence": "UV: 표준품과 같은 파장에서 흡수극대를 나타낸다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_477",
      "text": ". ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 476,
        "window_size": 3,
        "char_count": 2,
        "word_count": 1,
        "page_number": 1,
        "window_text": "확인시험: 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.\n\n HPLC: 주성분 피크의 유지시간은 표준품과 같다.\n\n UV: 표준품과 같은 파장에서 흡수극대를 나타낸다.\n\n .  함량시험: 함량 기준은 95.0 - 105.0%이며, 분석 조건은 다음 표와 같다.  이 시험과 관련\n\n하여 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.  대조약의 함량\n\n캡슐 내부에는 흰색 또는 미황색의 구형의\n\n온도\n\n40°C\n\n검출기\n\n272 nm UV detector\n\n- - 30 -\nHPLC 분석법에 대해 정확성, 정밀성, 특이성과 직선성을 평가하기 위한 밸리데이션을 실시\n\n하였다. ",
        "original_sentence": ". "
      }
    },
    {
      "chunk_id": "chunk_478",
      "text": "함량시험: 함량 기준은 95.0 - 105.0%이며, 분석 조건은 다음 표와 같다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 477,
        "window_size": 3,
        "char_count": 47,
        "word_count": 11,
        "page_number": 3,
        "window_text": "HPLC: 주성분 피크의 유지시간은 표준품과 같다.\n\n UV: 표준품과 같은 파장에서 흡수극대를 나타낸다.\n\n .  함량시험: 함량 기준은 95.0 - 105.0%이며, 분석 조건은 다음 표와 같다.  이 시험과 관련\n\n하여 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.  대조약의 함량\n\n캡슐 내부에는 흰색 또는 미황색의 구형의\n\n온도\n\n40°C\n\n검출기\n\n272 nm UV detector\n\n- - 30 -\nHPLC 분석법에 대해 정확성, 정밀성, 특이성과 직선성을 평가하기 위한 밸리데이션을 실시\n\n하였다.  특이성과 안정성을 검증하기 위해 제품은 여러 가지 가혹 조건에서 PDA 검출기가\n\n장착된 HPLC 기기로 분석이 진행되었다. ",
        "original_sentence": "함량시험: 함량 기준은 95.0 - 105.0%이며, 분석 조건은 다음 표와 같다. "
      }
    },
    {
      "chunk_id": "chunk_479",
      "text": "이 시험과 관련\n\n하여 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 478,
        "window_size": 3,
        "char_count": 60,
        "word_count": 12,
        "page_number": 2,
        "window_text": "UV: 표준품과 같은 파장에서 흡수극대를 나타낸다.\n\n .  함량시험: 함량 기준은 95.0 - 105.0%이며, 분석 조건은 다음 표와 같다.  이 시험과 관련\n\n하여 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.  대조약의 함량\n\n캡슐 내부에는 흰색 또는 미황색의 구형의\n\n온도\n\n40°C\n\n검출기\n\n272 nm UV detector\n\n- - 30 -\nHPLC 분석법에 대해 정확성, 정밀성, 특이성과 직선성을 평가하기 위한 밸리데이션을 실시\n\n하였다.  특이성과 안정성을 검증하기 위해 제품은 여러 가지 가혹 조건에서 PDA 검출기가\n\n장착된 HPLC 기기로 분석이 진행되었다.  모든 분해산물 피크는 주성분 피크로부터 분리되\n\n었고, 피크 순도는 > 0.99로 계산되어 주성분 피크가 완전히 분리됨을 확인하였다. ",
        "original_sentence": "이 시험과 관련\n\n하여 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다. "
      }
    },
    {
      "chunk_id": "chunk_480",
      "text": "대조약의 함량\n\n캡슐 내부에는 흰색 또는 미황색의 구형의\n\n온도\n\n40°C\n\n검출기\n\n272 nm UV detector\n\n- - 30 -\nHPLC 분석법에 대해 정확성, 정밀성, 특이성과 직선성을 평가하기 위한 밸리데이션을 실시\n\n하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 479,
        "window_size": 3,
        "char_count": 134,
        "word_count": 31,
        "page_number": 5,
        "window_text": ".  함량시험: 함량 기준은 95.0 - 105.0%이며, 분석 조건은 다음 표와 같다.  이 시험과 관련\n\n하여 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.  대조약의 함량\n\n캡슐 내부에는 흰색 또는 미황색의 구형의\n\n온도\n\n40°C\n\n검출기\n\n272 nm UV detector\n\n- - 30 -\nHPLC 분석법에 대해 정확성, 정밀성, 특이성과 직선성을 평가하기 위한 밸리데이션을 실시\n\n하였다.  특이성과 안정성을 검증하기 위해 제품은 여러 가지 가혹 조건에서 PDA 검출기가\n\n장착된 HPLC 기기로 분석이 진행되었다.  모든 분해산물 피크는 주성분 피크로부터 분리되\n\n었고, 피크 순도는 > 0.99로 계산되어 주성분 피크가 완전히 분리됨을 확인하였다.  분석방법\n\n밸리데이션과 가혹시험에 대해 아래에 요약되어 있다. ",
        "original_sentence": "대조약의 함량\n\n캡슐 내부에는 흰색 또는 미황색의 구형의\n\n온도\n\n40°C\n\n검출기\n\n272 nm UV detector\n\n- - 30 -\nHPLC 분석법에 대해 정확성, 정밀성, 특이성과 직선성을 평가하기 위한 밸리데이션을 실시\n\n하였다. "
      }
    },
    {
      "chunk_id": "chunk_481",
      "text": "특이성과 안정성을 검증하기 위해 제품은 여러 가지 가혹 조건에서 PDA 검출기가\n\n장착된 HPLC 기기로 분석이 진행되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 480,
        "window_size": 3,
        "char_count": 70,
        "word_count": 16,
        "page_number": 3,
        "window_text": "함량시험: 함량 기준은 95.0 - 105.0%이며, 분석 조건은 다음 표와 같다.  이 시험과 관련\n\n하여 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.  대조약의 함량\n\n캡슐 내부에는 흰색 또는 미황색의 구형의\n\n온도\n\n40°C\n\n검출기\n\n272 nm UV detector\n\n- - 30 -\nHPLC 분석법에 대해 정확성, 정밀성, 특이성과 직선성을 평가하기 위한 밸리데이션을 실시\n\n하였다.  특이성과 안정성을 검증하기 위해 제품은 여러 가지 가혹 조건에서 PDA 검출기가\n\n장착된 HPLC 기기로 분석이 진행되었다.  모든 분해산물 피크는 주성분 피크로부터 분리되\n\n었고, 피크 순도는 > 0.99로 계산되어 주성분 피크가 완전히 분리됨을 확인하였다.  분석방법\n\n밸리데이션과 가혹시험에 대해 아래에 요약되어 있다.  자세한 사항은 3.2.P.5.3 시험방법 밸\n\n리데이션을 참고한다.\n\n",
        "original_sentence": "특이성과 안정성을 검증하기 위해 제품은 여러 가지 가혹 조건에서 PDA 검출기가\n\n장착된 HPLC 기기로 분석이 진행되었다. "
      }
    },
    {
      "chunk_id": "chunk_482",
      "text": "모든 분해산물 피크는 주성분 피크로부터 분리되\n\n었고, 피크 순도는 > 0.99로 계산되어 주성분 피크가 완전히 분리됨을 확인하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 481,
        "window_size": 3,
        "char_count": 75,
        "word_count": 17,
        "page_number": 19,
        "window_text": "이 시험과 관련\n\n하여 자세한 사항은 3.2.P.5.2 시험방법과 3.2.P.5.4 뱃치 분석을 참고한다.  대조약의 함량\n\n캡슐 내부에는 흰색 또는 미황색의 구형의\n\n온도\n\n40°C\n\n검출기\n\n272 nm UV detector\n\n- - 30 -\nHPLC 분석법에 대해 정확성, 정밀성, 특이성과 직선성을 평가하기 위한 밸리데이션을 실시\n\n하였다.  특이성과 안정성을 검증하기 위해 제품은 여러 가지 가혹 조건에서 PDA 검출기가\n\n장착된 HPLC 기기로 분석이 진행되었다.  모든 분해산물 피크는 주성분 피크로부터 분리되\n\n었고, 피크 순도는 > 0.99로 계산되어 주성분 피크가 완전히 분리됨을 확인하였다.  분석방법\n\n밸리데이션과 가혹시험에 대해 아래에 요약되어 있다.  자세한 사항은 3.2.P.5.3 시험방법 밸\n\n리데이션을 참고한다.\n\n * 2명의 시험자가 서로 다른 기구로 시험\n\n. ",
        "original_sentence": "모든 분해산물 피크는 주성분 피크로부터 분리되\n\n었고, 피크 순도는 > 0.99로 계산되어 주성분 피크가 완전히 분리됨을 확인하였다. "
      }
    },
    {
      "chunk_id": "chunk_483",
      "text": "분석방법\n\n밸리데이션과 가혹시험에 대해 아래에 요약되어 있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 482,
        "window_size": 3,
        "char_count": 35,
        "word_count": 7,
        "page_number": 3,
        "window_text": "대조약의 함량\n\n캡슐 내부에는 흰색 또는 미황색의 구형의\n\n온도\n\n40°C\n\n검출기\n\n272 nm UV detector\n\n- - 30 -\nHPLC 분석법에 대해 정확성, 정밀성, 특이성과 직선성을 평가하기 위한 밸리데이션을 실시\n\n하였다.  특이성과 안정성을 검증하기 위해 제품은 여러 가지 가혹 조건에서 PDA 검출기가\n\n장착된 HPLC 기기로 분석이 진행되었다.  모든 분해산물 피크는 주성분 피크로부터 분리되\n\n었고, 피크 순도는 > 0.99로 계산되어 주성분 피크가 완전히 분리됨을 확인하였다.  분석방법\n\n밸리데이션과 가혹시험에 대해 아래에 요약되어 있다.  자세한 사항은 3.2.P.5.3 시험방법 밸\n\n리데이션을 참고한다.\n\n * 2명의 시험자가 서로 다른 기구로 시험\n\n.  함량균일성 시험: USP 일반시험법 <905>에 따라 시험한다.\n\n",
        "original_sentence": "분석방법\n\n밸리데이션과 가혹시험에 대해 아래에 요약되어 있다. "
      }
    },
    {
      "chunk_id": "chunk_484",
      "text": "자세한 사항은 3.2.P.5.3 시험방법 밸\n\n리데이션을 참고한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 483,
        "window_size": 3,
        "char_count": 39,
        "word_count": 7,
        "page_number": 2,
        "window_text": "특이성과 안정성을 검증하기 위해 제품은 여러 가지 가혹 조건에서 PDA 검출기가\n\n장착된 HPLC 기기로 분석이 진행되었다.  모든 분해산물 피크는 주성분 피크로부터 분리되\n\n었고, 피크 순도는 > 0.99로 계산되어 주성분 피크가 완전히 분리됨을 확인하였다.  분석방법\n\n밸리데이션과 가혹시험에 대해 아래에 요약되어 있다.  자세한 사항은 3.2.P.5.3 시험방법 밸\n\n리데이션을 참고한다.\n\n * 2명의 시험자가 서로 다른 기구로 시험\n\n.  함량균일성 시험: USP 일반시험법 <905>에 따라 시험한다.\n\n 주입량\n\n20 ㎕\n\n**[표 시작]**\n\n| 시스템 적합성 | 주성분 피크로 계산한 칼럼 효율은 이론단수 5000 이상, 대칭계수는 2.0 이하이다. ",
        "original_sentence": "자세한 사항은 3.2.P.5.3 시험방법 밸\n\n리데이션을 참고한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_485",
      "text": "* 2명의 시험자가 서로 다른 기구로 시험\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 484,
        "window_size": 3,
        "char_count": 27,
        "word_count": 8,
        "page_number": 5,
        "window_text": "모든 분해산물 피크는 주성분 피크로부터 분리되\n\n었고, 피크 순도는 > 0.99로 계산되어 주성분 피크가 완전히 분리됨을 확인하였다.  분석방법\n\n밸리데이션과 가혹시험에 대해 아래에 요약되어 있다.  자세한 사항은 3.2.P.5.3 시험방법 밸\n\n리데이션을 참고한다.\n\n * 2명의 시험자가 서로 다른 기구로 시험\n\n.  함량균일성 시험: USP 일반시험법 <905>에 따라 시험한다.\n\n 주입량\n\n20 ㎕\n\n**[표 시작]**\n\n| 시스템 적합성 | 주성분 피크로 계산한 칼럼 효율은 이론단수 5000 이상, 대칭계수는 2.0 이하이다.  표준 |\n| --- | --- |\n| 뚜껑 (325 mL 용) | 45 mm PP white CT Fine Ribbed Closures | Bottle.Co |\n\n**[표 끝]**\n\n- - 31 -\n. ",
        "original_sentence": "* 2명의 시험자가 서로 다른 기구로 시험\n\n. "
      }
    },
    {
      "chunk_id": "chunk_486",
      "text": "함량균일성 시험: USP 일반시험법 <905>에 따라 시험한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 485,
        "window_size": 3,
        "char_count": 37,
        "word_count": 7,
        "page_number": 13,
        "window_text": "분석방법\n\n밸리데이션과 가혹시험에 대해 아래에 요약되어 있다.  자세한 사항은 3.2.P.5.3 시험방법 밸\n\n리데이션을 참고한다.\n\n * 2명의 시험자가 서로 다른 기구로 시험\n\n.  함량균일성 시험: USP 일반시험법 <905>에 따라 시험한다.\n\n 주입량\n\n20 ㎕\n\n**[표 시작]**\n\n| 시스템 적합성 | 주성분 피크로 계산한 칼럼 효율은 이론단수 5000 이상, 대칭계수는 2.0 이하이다.  표준 |\n| --- | --- |\n| 뚜껑 (325 mL 용) | 45 mm PP white CT Fine Ribbed Closures | Bottle.Co |\n\n**[표 끝]**\n\n- - 31 -\n.  순도(분해산물): 주성분의 기지 분해산물에 대해 아래 표에 요약하였다. ",
        "original_sentence": "함량균일성 시험: USP 일반시험법 <905>에 따라 시험한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_487",
      "text": "주입량\n\n20 ㎕\n\n**[표 시작]**\n\n| 시스템 적합성 | 주성분 피크로 계산한 칼럼 효율은 이론단수 5000 이상, 대칭계수는 2.0 이하이다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 486,
        "window_size": 3,
        "char_count": 84,
        "word_count": 20,
        "page_number": 5,
        "window_text": "자세한 사항은 3.2.P.5.3 시험방법 밸\n\n리데이션을 참고한다.\n\n * 2명의 시험자가 서로 다른 기구로 시험\n\n.  함량균일성 시험: USP 일반시험법 <905>에 따라 시험한다.\n\n 주입량\n\n20 ㎕\n\n**[표 시작]**\n\n| 시스템 적합성 | 주성분 피크로 계산한 칼럼 효율은 이론단수 5000 이상, 대칭계수는 2.0 이하이다.  표준 |\n| --- | --- |\n| 뚜껑 (325 mL 용) | 45 mm PP white CT Fine Ribbed Closures | Bottle.Co |\n\n**[표 끝]**\n\n- - 31 -\n.  순도(분해산물): 주성분의 기지 분해산물에 대해 아래 표에 요약하였다.  유연물질 B, C, D,\n\nF (2.3.S.4 원료의약품 품질관리 참고)는 완제의약품에서는 관찰되지 않았으므로, 원료의약품\n\n최종 제품의 분해산물 기준에 대한 근거는 다음 표에 제시하였다. ",
        "original_sentence": "주입량\n\n20 ㎕\n\n**[표 시작]**\n\n| 시스템 적합성 | 주성분 피크로 계산한 칼럼 효율은 이론단수 5000 이상, 대칭계수는 2.0 이하이다. "
      }
    },
    {
      "chunk_id": "chunk_488",
      "text": "표준 |\n| --- | --- |\n| 뚜껑 (325 mL 용) | 45 mm PP white CT Fine Ribbed Closures | Bottle.Co |\n\n**[표 끝]**\n\n- - 31 -\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 487,
        "window_size": 3,
        "char_count": 113,
        "word_count": 31,
        "page_number": 5,
        "window_text": "* 2명의 시험자가 서로 다른 기구로 시험\n\n.  함량균일성 시험: USP 일반시험법 <905>에 따라 시험한다.\n\n 주입량\n\n20 ㎕\n\n**[표 시작]**\n\n| 시스템 적합성 | 주성분 피크로 계산한 칼럼 효율은 이론단수 5000 이상, 대칭계수는 2.0 이하이다.  표준 |\n| --- | --- |\n| 뚜껑 (325 mL 용) | 45 mm PP white CT Fine Ribbed Closures | Bottle.Co |\n\n**[표 끝]**\n\n- - 31 -\n.  순도(분해산물): 주성분의 기지 분해산물에 대해 아래 표에 요약하였다.  유연물질 B, C, D,\n\nF (2.3.S.4 원료의약품 품질관리 참고)는 완제의약품에서는 관찰되지 않았으므로, 원료의약품\n\n최종 제품의 분해산물 기준에 대한 근거는 다음 표에 제시하였다.  제시된 기준은 「의약품의\n\n품목허가‧신고‧심사 규정」(식약처고시)에 근거하여 설정하였다. ",
        "original_sentence": "표준 |\n| --- | --- |\n| 뚜껑 (325 mL 용) | 45 mm PP white CT Fine Ribbed Closures | Bottle.Co |\n\n**[표 끝]**\n\n- - 31 -\n. "
      }
    },
    {
      "chunk_id": "chunk_489",
      "text": "순도(분해산물): 주성분의 기지 분해산물에 대해 아래 표에 요약하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 488,
        "window_size": 3,
        "char_count": 40,
        "word_count": 8,
        "page_number": 19,
        "window_text": "함량균일성 시험: USP 일반시험법 <905>에 따라 시험한다.\n\n 주입량\n\n20 ㎕\n\n**[표 시작]**\n\n| 시스템 적합성 | 주성분 피크로 계산한 칼럼 효율은 이론단수 5000 이상, 대칭계수는 2.0 이하이다.  표준 |\n| --- | --- |\n| 뚜껑 (325 mL 용) | 45 mm PP white CT Fine Ribbed Closures | Bottle.Co |\n\n**[표 끝]**\n\n- - 31 -\n.  순도(분해산물): 주성분의 기지 분해산물에 대해 아래 표에 요약하였다.  유연물질 B, C, D,\n\nF (2.3.S.4 원료의약품 품질관리 참고)는 완제의약품에서는 관찰되지 않았으므로, 원료의약품\n\n최종 제품의 분해산물 기준에 대한 근거는 다음 표에 제시하였다.  제시된 기준은 「의약품의\n\n품목허가‧신고‧심사 규정」(식약처고시)에 근거하여 설정하였다.  제조번호 P034 시험결과 유연\n\n2) 동 품목의 일일최대복용량은 64 mg이므로 미지 유연물질의 기준은 구조규명 수준(IT)인\n\n유연물질(분해산물)은 다음 HPLC 조건으로 시험한다. ",
        "original_sentence": "순도(분해산물): 주성분의 기지 분해산물에 대해 아래 표에 요약하였다. "
      }
    },
    {
      "chunk_id": "chunk_490",
      "text": "유연물질 B, C, D,\n\nF (2.3.S.4 원료의약품 품질관리 참고)는 완제의약품에서는 관찰되지 않았으므로, 원료의약품\n\n최종 제품의 분해산물 기준에 대한 근거는 다음 표에 제시하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 489,
        "window_size": 3,
        "char_count": 106,
        "word_count": 22,
        "page_number": 5,
        "window_text": "주입량\n\n20 ㎕\n\n**[표 시작]**\n\n| 시스템 적합성 | 주성분 피크로 계산한 칼럼 효율은 이론단수 5000 이상, 대칭계수는 2.0 이하이다.  표준 |\n| --- | --- |\n| 뚜껑 (325 mL 용) | 45 mm PP white CT Fine Ribbed Closures | Bottle.Co |\n\n**[표 끝]**\n\n- - 31 -\n.  순도(분해산물): 주성분의 기지 분해산물에 대해 아래 표에 요약하였다.  유연물질 B, C, D,\n\nF (2.3.S.4 원료의약품 품질관리 참고)는 완제의약품에서는 관찰되지 않았으므로, 원료의약품\n\n최종 제품의 분해산물 기준에 대한 근거는 다음 표에 제시하였다.  제시된 기준은 「의약품의\n\n품목허가‧신고‧심사 규정」(식약처고시)에 근거하여 설정하였다.  제조번호 P034 시험결과 유연\n\n2) 동 품목의 일일최대복용량은 64 mg이므로 미지 유연물질의 기준은 구조규명 수준(IT)인\n\n유연물질(분해산물)은 다음 HPLC 조건으로 시험한다.  자세한 사항은 3.2.P.5.2 시험방법과\n\n- - 32 -\n* 유연물질 B, C, D, F는 완제의약품에서 유연물질에서는 제외한다.\n\n",
        "original_sentence": "유연물질 B, C, D,\n\nF (2.3.S.4 원료의약품 품질관리 참고)는 완제의약품에서는 관찰되지 않았으므로, 원료의약품\n\n최종 제품의 분해산물 기준에 대한 근거는 다음 표에 제시하였다. "
      }
    },
    {
      "chunk_id": "chunk_491",
      "text": "제시된 기준은 「의약품의\n\n품목허가‧신고‧심사 규정」(식약처고시)에 근거하여 설정하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 490,
        "window_size": 3,
        "char_count": 50,
        "word_count": 7,
        "page_number": 26,
        "window_text": "표준 |\n| --- | --- |\n| 뚜껑 (325 mL 용) | 45 mm PP white CT Fine Ribbed Closures | Bottle.Co |\n\n**[표 끝]**\n\n- - 31 -\n.  순도(분해산물): 주성분의 기지 분해산물에 대해 아래 표에 요약하였다.  유연물질 B, C, D,\n\nF (2.3.S.4 원료의약품 품질관리 참고)는 완제의약품에서는 관찰되지 않았으므로, 원료의약품\n\n최종 제품의 분해산물 기준에 대한 근거는 다음 표에 제시하였다.  제시된 기준은 「의약품의\n\n품목허가‧신고‧심사 규정」(식약처고시)에 근거하여 설정하였다.  제조번호 P034 시험결과 유연\n\n2) 동 품목의 일일최대복용량은 64 mg이므로 미지 유연물질의 기준은 구조규명 수준(IT)인\n\n유연물질(분해산물)은 다음 HPLC 조건으로 시험한다.  자세한 사항은 3.2.P.5.2 시험방법과\n\n- - 32 -\n* 유연물질 B, C, D, F는 완제의약품에서 유연물질에서는 제외한다.\n\n 유연물질 분석법에 대하여 정확성, 정밀성, 특이성과 직선성에 대한 밸리데이션을 실시하였다.\n\n",
        "original_sentence": "제시된 기준은 「의약품의\n\n품목허가‧신고‧심사 규정」(식약처고시)에 근거하여 설정하였다. "
      }
    },
    {
      "chunk_id": "chunk_492",
      "text": "제조번호 P034 시험결과 유연\n\n2) 동 품목의 일일최대복용량은 64 mg이므로 미지 유연물질의 기준은 구조규명 수준(IT)인\n\n유연물질(분해산물)은 다음 HPLC 조건으로 시험한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 491,
        "window_size": 3,
        "char_count": 104,
        "word_count": 20,
        "page_number": 3,
        "window_text": "순도(분해산물): 주성분의 기지 분해산물에 대해 아래 표에 요약하였다.  유연물질 B, C, D,\n\nF (2.3.S.4 원료의약품 품질관리 참고)는 완제의약품에서는 관찰되지 않았으므로, 원료의약품\n\n최종 제품의 분해산물 기준에 대한 근거는 다음 표에 제시하였다.  제시된 기준은 「의약품의\n\n품목허가‧신고‧심사 규정」(식약처고시)에 근거하여 설정하였다.  제조번호 P034 시험결과 유연\n\n2) 동 품목의 일일최대복용량은 64 mg이므로 미지 유연물질의 기준은 구조규명 수준(IT)인\n\n유연물질(분해산물)은 다음 HPLC 조건으로 시험한다.  자세한 사항은 3.2.P.5.2 시험방법과\n\n- - 32 -\n* 유연물질 B, C, D, F는 완제의약품에서 유연물질에서는 제외한다.\n\n 유연물질 분석법에 대하여 정확성, 정밀성, 특이성과 직선성에 대한 밸리데이션을 실시하였다.\n\n 특이성과 안정성을 검증하기 위해 여러 가지 가혹 조건에서 PDA 검출기가 장착된 HPLC\n\n기기로 분석이 진행되었다. ",
        "original_sentence": "제조번호 P034 시험결과 유연\n\n2) 동 품목의 일일최대복용량은 64 mg이므로 미지 유연물질의 기준은 구조규명 수준(IT)인\n\n유연물질(분해산물)은 다음 HPLC 조건으로 시험한다. "
      }
    },
    {
      "chunk_id": "chunk_493",
      "text": "자세한 사항은 3.2.P.5.2 시험방법과\n\n- - 32 -\n* 유연물질 B, C, D, F는 완제의약품에서 유연물질에서는 제외한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 492,
        "window_size": 3,
        "char_count": 76,
        "word_count": 17,
        "page_number": 2,
        "window_text": "유연물질 B, C, D,\n\nF (2.3.S.4 원료의약품 품질관리 참고)는 완제의약품에서는 관찰되지 않았으므로, 원료의약품\n\n최종 제품의 분해산물 기준에 대한 근거는 다음 표에 제시하였다.  제시된 기준은 「의약품의\n\n품목허가‧신고‧심사 규정」(식약처고시)에 근거하여 설정하였다.  제조번호 P034 시험결과 유연\n\n2) 동 품목의 일일최대복용량은 64 mg이므로 미지 유연물질의 기준은 구조규명 수준(IT)인\n\n유연물질(분해산물)은 다음 HPLC 조건으로 시험한다.  자세한 사항은 3.2.P.5.2 시험방법과\n\n- - 32 -\n* 유연물질 B, C, D, F는 완제의약품에서 유연물질에서는 제외한다.\n\n 유연물질 분석법에 대하여 정확성, 정밀성, 특이성과 직선성에 대한 밸리데이션을 실시하였다.\n\n 특이성과 안정성을 검증하기 위해 여러 가지 가혹 조건에서 PDA 검출기가 장착된 HPLC\n\n기기로 분석이 진행되었다.  모든 분해산물 피크는 주성분 피크로부터 분리되었고, 피크 순도는\n\n유연물질 A는 열, 염기 및 산 조건에서 생성되는 1차 분해산물이다. ",
        "original_sentence": "자세한 사항은 3.2.P.5.2 시험방법과\n\n- - 32 -\n* 유연물질 B, C, D, F는 완제의약품에서 유연물질에서는 제외한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_494",
      "text": "유연물질 분석법에 대하여 정확성, 정밀성, 특이성과 직선성에 대한 밸리데이션을 실시하였다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 493,
        "window_size": 3,
        "char_count": 52,
        "word_count": 10,
        "page_number": 38,
        "window_text": "제시된 기준은 「의약품의\n\n품목허가‧신고‧심사 규정」(식약처고시)에 근거하여 설정하였다.  제조번호 P034 시험결과 유연\n\n2) 동 품목의 일일최대복용량은 64 mg이므로 미지 유연물질의 기준은 구조규명 수준(IT)인\n\n유연물질(분해산물)은 다음 HPLC 조건으로 시험한다.  자세한 사항은 3.2.P.5.2 시험방법과\n\n- - 32 -\n* 유연물질 B, C, D, F는 완제의약품에서 유연물질에서는 제외한다.\n\n 유연물질 분석법에 대하여 정확성, 정밀성, 특이성과 직선성에 대한 밸리데이션을 실시하였다.\n\n 특이성과 안정성을 검증하기 위해 여러 가지 가혹 조건에서 PDA 검출기가 장착된 HPLC\n\n기기로 분석이 진행되었다.  모든 분해산물 피크는 주성분 피크로부터 분리되었고, 피크 순도는\n\n유연물질 A는 열, 염기 및 산 조건에서 생성되는 1차 분해산물이다.  예상한 바와 같이 유연\n\n물질 B, C, D, F는 가혹시험 조건에서 변화가 없었으므로 이 유연물질들이 제품의 분해산물이\n\n정밀성\n\nRSD 6.7%\n\nRSD 4.5%\n\nRSD 6.8%\n\nRSD 5.2%\n\nRSD 3.2%\n\nRSD 4.5%\n\n정밀성2\n\nRSD 8.2%\n\nRSD 9.2%\n\nRSD 10.4%\n\nRSD 9.6%\n\nRSD 8.2%\n\nRSD 9.8%\n\n정확성3\n\n95-104%\n\n80-97%\n\n88-105%\n\n92-112%\n\n80-101%\n\n82-115%\n\n- - 33 -\n1 유연물질 B, C, D, F는 제품 유연물질 계산에 포함되지 않으나, 원료의약품 HPLC(분해산물)\n\n2 2명의 시험자가 서로 다른 기구로 시험함\n\n. ",
        "original_sentence": "유연물질 분석법에 대하여 정확성, 정밀성, 특이성과 직선성에 대한 밸리데이션을 실시하였다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_495",
      "text": "특이성과 안정성을 검증하기 위해 여러 가지 가혹 조건에서 PDA 검출기가 장착된 HPLC\n\n기기로 분석이 진행되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 494,
        "window_size": 3,
        "char_count": 66,
        "word_count": 15,
        "page_number": 38,
        "window_text": "제조번호 P034 시험결과 유연\n\n2) 동 품목의 일일최대복용량은 64 mg이므로 미지 유연물질의 기준은 구조규명 수준(IT)인\n\n유연물질(분해산물)은 다음 HPLC 조건으로 시험한다.  자세한 사항은 3.2.P.5.2 시험방법과\n\n- - 32 -\n* 유연물질 B, C, D, F는 완제의약품에서 유연물질에서는 제외한다.\n\n 유연물질 분석법에 대하여 정확성, 정밀성, 특이성과 직선성에 대한 밸리데이션을 실시하였다.\n\n 특이성과 안정성을 검증하기 위해 여러 가지 가혹 조건에서 PDA 검출기가 장착된 HPLC\n\n기기로 분석이 진행되었다.  모든 분해산물 피크는 주성분 피크로부터 분리되었고, 피크 순도는\n\n유연물질 A는 열, 염기 및 산 조건에서 생성되는 1차 분해산물이다.  예상한 바와 같이 유연\n\n물질 B, C, D, F는 가혹시험 조건에서 변화가 없었으므로 이 유연물질들이 제품의 분해산물이\n\n정밀성\n\nRSD 6.7%\n\nRSD 4.5%\n\nRSD 6.8%\n\nRSD 5.2%\n\nRSD 3.2%\n\nRSD 4.5%\n\n정밀성2\n\nRSD 8.2%\n\nRSD 9.2%\n\nRSD 10.4%\n\nRSD 9.6%\n\nRSD 8.2%\n\nRSD 9.8%\n\n정확성3\n\n95-104%\n\n80-97%\n\n88-105%\n\n92-112%\n\n80-101%\n\n82-115%\n\n- - 33 -\n1 유연물질 B, C, D, F는 제품 유연물질 계산에 포함되지 않으나, 원료의약품 HPLC(분해산물)\n\n2 2명의 시험자가 서로 다른 기구로 시험함\n\n.  용출: 「경구용의약품의 용출규격 설정 가이드라인」에 따라 예비시험 및 본시험을 수행하여\n\n용출 기준은 4 개의 시점에 대해 설정하였으며, 평균 용출률의 ± 10% 범위로 설정하였다.\n\n",
        "original_sentence": "특이성과 안정성을 검증하기 위해 여러 가지 가혹 조건에서 PDA 검출기가 장착된 HPLC\n\n기기로 분석이 진행되었다. "
      }
    },
    {
      "chunk_id": "chunk_496",
      "text": "모든 분해산물 피크는 주성분 피크로부터 분리되었고, 피크 순도는\n\n유연물질 A는 열, 염기 및 산 조건에서 생성되는 1차 분해산물이다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 495,
        "window_size": 3,
        "char_count": 76,
        "word_count": 18,
        "page_number": 15,
        "window_text": "자세한 사항은 3.2.P.5.2 시험방법과\n\n- - 32 -\n* 유연물질 B, C, D, F는 완제의약품에서 유연물질에서는 제외한다.\n\n 유연물질 분석법에 대하여 정확성, 정밀성, 특이성과 직선성에 대한 밸리데이션을 실시하였다.\n\n 특이성과 안정성을 검증하기 위해 여러 가지 가혹 조건에서 PDA 검출기가 장착된 HPLC\n\n기기로 분석이 진행되었다.  모든 분해산물 피크는 주성분 피크로부터 분리되었고, 피크 순도는\n\n유연물질 A는 열, 염기 및 산 조건에서 생성되는 1차 분해산물이다.  예상한 바와 같이 유연\n\n물질 B, C, D, F는 가혹시험 조건에서 변화가 없었으므로 이 유연물질들이 제품의 분해산물이\n\n정밀성\n\nRSD 6.7%\n\nRSD 4.5%\n\nRSD 6.8%\n\nRSD 5.2%\n\nRSD 3.2%\n\nRSD 4.5%\n\n정밀성2\n\nRSD 8.2%\n\nRSD 9.2%\n\nRSD 10.4%\n\nRSD 9.6%\n\nRSD 8.2%\n\nRSD 9.8%\n\n정확성3\n\n95-104%\n\n80-97%\n\n88-105%\n\n92-112%\n\n80-101%\n\n82-115%\n\n- - 33 -\n1 유연물질 B, C, D, F는 제품 유연물질 계산에 포함되지 않으나, 원료의약품 HPLC(분해산물)\n\n2 2명의 시험자가 서로 다른 기구로 시험함\n\n.  용출: 「경구용의약품의 용출규격 설정 가이드라인」에 따라 예비시험 및 본시험을 수행하여\n\n용출 기준은 4 개의 시점에 대해 설정하였으며, 평균 용출률의 ± 10% 범위로 설정하였다.\n\n LOQ\n\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\nLOD\n\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- - 34 -\n4 시간, 8 시간 시점의 기준은 개발 뱃치의 용출 평균 값보다 엄격한 기준을 적용하였다.\n\n",
        "original_sentence": "모든 분해산물 피크는 주성분 피크로부터 분리되었고, 피크 순도는\n\n유연물질 A는 열, 염기 및 산 조건에서 생성되는 1차 분해산물이다. "
      }
    },
    {
      "chunk_id": "chunk_497",
      "text": "예상한 바와 같이 유연\n\n물질 B, C, D, F는 가혹시험 조건에서 변화가 없었으므로 이 유연물질들이 제품의 분해산물이\n\n정밀성\n\nRSD 6.7%\n\nRSD 4.5%\n\nRSD 6.8%\n\nRSD 5.2%\n\nRSD 3.2%\n\nRSD 4.5%\n\n정밀성2\n\nRSD 8.2%\n\nRSD 9.2%\n\nRSD 10.4%\n\nRSD 9.6%\n\nRSD 8.2%\n\nRSD 9.8%\n\n정확성3\n\n95-104%\n\n80-97%\n\n88-105%\n\n92-112%\n\n80-101%\n\n82-115%\n\n- - 33 -\n1 유연물질 B, C, D, F는 제품 유연물질 계산에 포함되지 않으나, 원료의약품 HPLC(분해산물)\n\n2 2명의 시험자가 서로 다른 기구로 시험함\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 496,
        "window_size": 3,
        "char_count": 356,
        "word_count": 75,
        "page_number": 3,
        "window_text": "유연물질 분석법에 대하여 정확성, 정밀성, 특이성과 직선성에 대한 밸리데이션을 실시하였다.\n\n 특이성과 안정성을 검증하기 위해 여러 가지 가혹 조건에서 PDA 검출기가 장착된 HPLC\n\n기기로 분석이 진행되었다.  모든 분해산물 피크는 주성분 피크로부터 분리되었고, 피크 순도는\n\n유연물질 A는 열, 염기 및 산 조건에서 생성되는 1차 분해산물이다.  예상한 바와 같이 유연\n\n물질 B, C, D, F는 가혹시험 조건에서 변화가 없었으므로 이 유연물질들이 제품의 분해산물이\n\n정밀성\n\nRSD 6.7%\n\nRSD 4.5%\n\nRSD 6.8%\n\nRSD 5.2%\n\nRSD 3.2%\n\nRSD 4.5%\n\n정밀성2\n\nRSD 8.2%\n\nRSD 9.2%\n\nRSD 10.4%\n\nRSD 9.6%\n\nRSD 8.2%\n\nRSD 9.8%\n\n정확성3\n\n95-104%\n\n80-97%\n\n88-105%\n\n92-112%\n\n80-101%\n\n82-115%\n\n- - 33 -\n1 유연물질 B, C, D, F는 제품 유연물질 계산에 포함되지 않으나, 원료의약품 HPLC(분해산물)\n\n2 2명의 시험자가 서로 다른 기구로 시험함\n\n.  용출: 「경구용의약품의 용출규격 설정 가이드라인」에 따라 예비시험 및 본시험을 수행하여\n\n용출 기준은 4 개의 시점에 대해 설정하였으며, 평균 용출률의 ± 10% 범위로 설정하였다.\n\n LOQ\n\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\nLOD\n\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- - 34 -\n4 시간, 8 시간 시점의 기준은 개발 뱃치의 용출 평균 값보다 엄격한 기준을 적용하였다.\n\n . ",
        "original_sentence": "예상한 바와 같이 유연\n\n물질 B, C, D, F는 가혹시험 조건에서 변화가 없었으므로 이 유연물질들이 제품의 분해산물이\n\n정밀성\n\nRSD 6.7%\n\nRSD 4.5%\n\nRSD 6.8%\n\nRSD 5.2%\n\nRSD 3.2%\n\nRSD 4.5%\n\n정밀성2\n\nRSD 8.2%\n\nRSD 9.2%\n\nRSD 10.4%\n\nRSD 9.6%\n\nRSD 8.2%\n\nRSD 9.8%\n\n정확성3\n\n95-104%\n\n80-97%\n\n88-105%\n\n92-112%\n\n80-101%\n\n82-115%\n\n- - 33 -\n1 유연물질 B, C, D, F는 제품 유연물질 계산에 포함되지 않으나, 원료의약품 HPLC(분해산물)\n\n2 2명의 시험자가 서로 다른 기구로 시험함\n\n. "
      }
    },
    {
      "chunk_id": "chunk_498",
      "text": "용출: 「경구용의약품의 용출규격 설정 가이드라인」에 따라 예비시험 및 본시험을 수행하여\n\n용출 기준은 4 개의 시점에 대해 설정하였으며, 평균 용출률의 ± 10% 범위로 설정하였다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 497,
        "window_size": 3,
        "char_count": 103,
        "word_count": 23,
        "page_number": 3,
        "window_text": "특이성과 안정성을 검증하기 위해 여러 가지 가혹 조건에서 PDA 검출기가 장착된 HPLC\n\n기기로 분석이 진행되었다.  모든 분해산물 피크는 주성분 피크로부터 분리되었고, 피크 순도는\n\n유연물질 A는 열, 염기 및 산 조건에서 생성되는 1차 분해산물이다.  예상한 바와 같이 유연\n\n물질 B, C, D, F는 가혹시험 조건에서 변화가 없었으므로 이 유연물질들이 제품의 분해산물이\n\n정밀성\n\nRSD 6.7%\n\nRSD 4.5%\n\nRSD 6.8%\n\nRSD 5.2%\n\nRSD 3.2%\n\nRSD 4.5%\n\n정밀성2\n\nRSD 8.2%\n\nRSD 9.2%\n\nRSD 10.4%\n\nRSD 9.6%\n\nRSD 8.2%\n\nRSD 9.8%\n\n정확성3\n\n95-104%\n\n80-97%\n\n88-105%\n\n92-112%\n\n80-101%\n\n82-115%\n\n- - 33 -\n1 유연물질 B, C, D, F는 제품 유연물질 계산에 포함되지 않으나, 원료의약품 HPLC(분해산물)\n\n2 2명의 시험자가 서로 다른 기구로 시험함\n\n.  용출: 「경구용의약품의 용출규격 설정 가이드라인」에 따라 예비시험 및 본시험을 수행하여\n\n용출 기준은 4 개의 시점에 대해 설정하였으며, 평균 용출률의 ± 10% 범위로 설정하였다.\n\n LOQ\n\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\nLOD\n\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- - 34 -\n4 시간, 8 시간 시점의 기준은 개발 뱃치의 용출 평균 값보다 엄격한 기준을 적용하였다.\n\n .  수분: 주성분이 가수분해될 수 있으므로 완제의약품의 수분함량 조절이 필요하다. ",
        "original_sentence": "용출: 「경구용의약품의 용출규격 설정 가이드라인」에 따라 예비시험 및 본시험을 수행하여\n\n용출 기준은 4 개의 시점에 대해 설정하였으며, 평균 용출률의 ± 10% 범위로 설정하였다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_499",
      "text": "LOQ\n\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\nLOD\n\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- - 34 -\n4 시간, 8 시간 시점의 기준은 개발 뱃치의 용출 평균 값보다 엄격한 기준을 적용하였다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 498,
        "window_size": 3,
        "char_count": 167,
        "word_count": 44,
        "page_number": 5,
        "window_text": "모든 분해산물 피크는 주성분 피크로부터 분리되었고, 피크 순도는\n\n유연물질 A는 열, 염기 및 산 조건에서 생성되는 1차 분해산물이다.  예상한 바와 같이 유연\n\n물질 B, C, D, F는 가혹시험 조건에서 변화가 없었으므로 이 유연물질들이 제품의 분해산물이\n\n정밀성\n\nRSD 6.7%\n\nRSD 4.5%\n\nRSD 6.8%\n\nRSD 5.2%\n\nRSD 3.2%\n\nRSD 4.5%\n\n정밀성2\n\nRSD 8.2%\n\nRSD 9.2%\n\nRSD 10.4%\n\nRSD 9.6%\n\nRSD 8.2%\n\nRSD 9.8%\n\n정확성3\n\n95-104%\n\n80-97%\n\n88-105%\n\n92-112%\n\n80-101%\n\n82-115%\n\n- - 33 -\n1 유연물질 B, C, D, F는 제품 유연물질 계산에 포함되지 않으나, 원료의약품 HPLC(분해산물)\n\n2 2명의 시험자가 서로 다른 기구로 시험함\n\n.  용출: 「경구용의약품의 용출규격 설정 가이드라인」에 따라 예비시험 및 본시험을 수행하여\n\n용출 기준은 4 개의 시점에 대해 설정하였으며, 평균 용출률의 ± 10% 범위로 설정하였다.\n\n LOQ\n\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\nLOD\n\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- - 34 -\n4 시간, 8 시간 시점의 기준은 개발 뱃치의 용출 평균 값보다 엄격한 기준을 적용하였다.\n\n .  수분: 주성분이 가수분해될 수 있으므로 완제의약품의 수분함량 조절이 필요하다.  수분 기\n\n준(3.5% 이하)은 각 성분의 수분기준 상한(2.8%), 시험 결과(2.9%)와 안정성시험 결과(3.\n\n",
        "original_sentence": "LOQ\n\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\nLOD\n\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- - 34 -\n4 시간, 8 시간 시점의 기준은 개발 뱃치의 용출 평균 값보다 엄격한 기준을 적용하였다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_500",
      "text": ". ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 499,
        "window_size": 3,
        "char_count": 2,
        "word_count": 1,
        "page_number": 1,
        "window_text": "예상한 바와 같이 유연\n\n물질 B, C, D, F는 가혹시험 조건에서 변화가 없었으므로 이 유연물질들이 제품의 분해산물이\n\n정밀성\n\nRSD 6.7%\n\nRSD 4.5%\n\nRSD 6.8%\n\nRSD 5.2%\n\nRSD 3.2%\n\nRSD 4.5%\n\n정밀성2\n\nRSD 8.2%\n\nRSD 9.2%\n\nRSD 10.4%\n\nRSD 9.6%\n\nRSD 8.2%\n\nRSD 9.8%\n\n정확성3\n\n95-104%\n\n80-97%\n\n88-105%\n\n92-112%\n\n80-101%\n\n82-115%\n\n- - 33 -\n1 유연물질 B, C, D, F는 제품 유연물질 계산에 포함되지 않으나, 원료의약품 HPLC(분해산물)\n\n2 2명의 시험자가 서로 다른 기구로 시험함\n\n.  용출: 「경구용의약품의 용출규격 설정 가이드라인」에 따라 예비시험 및 본시험을 수행하여\n\n용출 기준은 4 개의 시점에 대해 설정하였으며, 평균 용출률의 ± 10% 범위로 설정하였다.\n\n LOQ\n\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\nLOD\n\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- - 34 -\n4 시간, 8 시간 시점의 기준은 개발 뱃치의 용출 평균 값보다 엄격한 기준을 적용하였다.\n\n .  수분: 주성분이 가수분해될 수 있으므로 완제의약품의 수분함량 조절이 필요하다.  수분 기\n\n준(3.5% 이하)은 각 성분의 수분기준 상한(2.8%), 시험 결과(2.9%)와 안정성시험 결과(3.\n\n 3) 무균 제제\n\n. ",
        "original_sentence": ". "
      }
    },
    {
      "chunk_id": "chunk_501",
      "text": "수분: 주성분이 가수분해될 수 있으므로 완제의약품의 수분함량 조절이 필요하다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 500,
        "window_size": 3,
        "char_count": 44,
        "word_count": 9,
        "page_number": 3,
        "window_text": "용출: 「경구용의약품의 용출규격 설정 가이드라인」에 따라 예비시험 및 본시험을 수행하여\n\n용출 기준은 4 개의 시점에 대해 설정하였으며, 평균 용출률의 ± 10% 범위로 설정하였다.\n\n LOQ\n\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\nLOD\n\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- - 34 -\n4 시간, 8 시간 시점의 기준은 개발 뱃치의 용출 평균 값보다 엄격한 기준을 적용하였다.\n\n .  수분: 주성분이 가수분해될 수 있으므로 완제의약품의 수분함량 조절이 필요하다.  수분 기\n\n준(3.5% 이하)은 각 성분의 수분기준 상한(2.8%), 시험 결과(2.9%)와 안정성시험 결과(3.\n\n 3) 무균 제제\n\n.  미생물관련 기준 및 시험방법, 결과 요약\n\n<!-- PAGE_40 -->\n##### 2.3.P.6 표준품 또는 표준물질(제품명, 제형)(Reference Standards or Materials)(name,\n\n<!-- PAGE_40 -->\n##### dosage form)\n\n- 3.2.P.6에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n",
        "original_sentence": "수분: 주성분이 가수분해될 수 있으므로 완제의약품의 수분함량 조절이 필요하다. "
      }
    },
    {
      "chunk_id": "chunk_502",
      "text": "수분 기\n\n준(3.5% 이하)은 각 성분의 수분기준 상한(2.8%), 시험 결과(2.9%)와 안정성시험 결과(3.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 501,
        "window_size": 3,
        "char_count": 65,
        "word_count": 12,
        "page_number": 3,
        "window_text": "LOQ\n\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\n- 0.05%\nLOD\n\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- 0.02%\n- - 34 -\n4 시간, 8 시간 시점의 기준은 개발 뱃치의 용출 평균 값보다 엄격한 기준을 적용하였다.\n\n .  수분: 주성분이 가수분해될 수 있으므로 완제의약품의 수분함량 조절이 필요하다.  수분 기\n\n준(3.5% 이하)은 각 성분의 수분기준 상한(2.8%), 시험 결과(2.9%)와 안정성시험 결과(3.\n\n 3) 무균 제제\n\n.  미생물관련 기준 및 시험방법, 결과 요약\n\n<!-- PAGE_40 -->\n##### 2.3.P.6 표준품 또는 표준물질(제품명, 제형)(Reference Standards or Materials)(name,\n\n<!-- PAGE_40 -->\n##### dosage form)\n\n- 3.2.P.6에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n - ○ 3.2.P.6 표준품 및 표준물질에 설명된 완제의약품 시험에 필요한 표준품 또는 표준물질에\n- ○ 원료의약품과 동일한 표준품을 사용하는 경우, 2.3.S.5 표준품 또는 표준물질을 참고한다.\n",
        "original_sentence": "수분 기\n\n준(3.5% 이하)은 각 성분의 수분기준 상한(2.8%), 시험 결과(2.9%)와 안정성시험 결과(3.\n\n"
      }
    },
    {
      "chunk_id": "chunk_503",
      "text": "3) 무균 제제\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 502,
        "window_size": 3,
        "char_count": 12,
        "word_count": 4,
        "page_number": 23,
        "window_text": ".  수분: 주성분이 가수분해될 수 있으므로 완제의약품의 수분함량 조절이 필요하다.  수분 기\n\n준(3.5% 이하)은 각 성분의 수분기준 상한(2.8%), 시험 결과(2.9%)와 안정성시험 결과(3.\n\n 3) 무균 제제\n\n.  미생물관련 기준 및 시험방법, 결과 요약\n\n<!-- PAGE_40 -->\n##### 2.3.P.6 표준품 또는 표준물질(제품명, 제형)(Reference Standards or Materials)(name,\n\n<!-- PAGE_40 -->\n##### dosage form)\n\n- 3.2.P.6에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n - ○ 3.2.P.6 표준품 및 표준물질에 설명된 완제의약품 시험에 필요한 표준품 또는 표준물질에\n- ○ 원료의약품과 동일한 표준품을 사용하는 경우, 2.3.S.5 표준품 또는 표준물질을 참고한다.\n - ○ 표준품은 로트 번호와 시험성적서 발행처 및 주소 등 품질을 입증할 수 있는 정보를 기재\n한다. ",
        "original_sentence": "3) 무균 제제\n\n. "
      }
    },
    {
      "chunk_id": "chunk_504",
      "text": "미생물관련 기준 및 시험방법, 결과 요약\n\n<!-- PAGE_40 -->\n##### 2.3.P.6 표준품 또는 표준물질(제품명, 제형)(Reference Standards or Materials)(name,\n\n<!-- PAGE_40 -->\n##### dosage form)\n\n- 3.2.P.6에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 503,
        "window_size": 3,
        "char_count": 191,
        "word_count": 31,
        "page_number": 40,
        "window_text": "수분: 주성분이 가수분해될 수 있으므로 완제의약품의 수분함량 조절이 필요하다.  수분 기\n\n준(3.5% 이하)은 각 성분의 수분기준 상한(2.8%), 시험 결과(2.9%)와 안정성시험 결과(3.\n\n 3) 무균 제제\n\n.  미생물관련 기준 및 시험방법, 결과 요약\n\n<!-- PAGE_40 -->\n##### 2.3.P.6 표준품 또는 표준물질(제품명, 제형)(Reference Standards or Materials)(name,\n\n<!-- PAGE_40 -->\n##### dosage form)\n\n- 3.2.P.6에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n - ○ 3.2.P.6 표준품 및 표준물질에 설명된 완제의약품 시험에 필요한 표준품 또는 표준물질에\n- ○ 원료의약품과 동일한 표준품을 사용하는 경우, 2.3.S.5 표준품 또는 표준물질을 참고한다.\n - ○ 표준품은 로트 번호와 시험성적서 발행처 및 주소 등 품질을 입증할 수 있는 정보를 기재\n한다.  단, 공정서 표준품에 대하여 정보가 제공되는 경우 그 품질을 알 수 있는 정보를\n\n- ○ 순도시험에서 표준품을 사용하는 경우, 해당 표준품에 대한 내용도 기재한다.\n",
        "original_sentence": "미생물관련 기준 및 시험방법, 결과 요약\n\n<!-- PAGE_40 -->\n##### 2.3.P.6 표준품 또는 표준물질(제품명, 제형)(Reference Standards or Materials)(name,\n\n<!-- PAGE_40 -->\n##### dosage form)\n\n- 3.2.P.6에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n"
      }
    },
    {
      "chunk_id": "chunk_505",
      "text": "- ○ 3.2.P.6 표준품 및 표준물질에 설명된 완제의약품 시험에 필요한 표준품 또는 표준물질에\n- ○ 원료의약품과 동일한 표준품을 사용하는 경우, 2.3.S.5 표준품 또는 표준물질을 참고한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 504,
        "window_size": 3,
        "char_count": 111,
        "word_count": 25,
        "page_number": 5,
        "window_text": "수분 기\n\n준(3.5% 이하)은 각 성분의 수분기준 상한(2.8%), 시험 결과(2.9%)와 안정성시험 결과(3.\n\n 3) 무균 제제\n\n.  미생물관련 기준 및 시험방법, 결과 요약\n\n<!-- PAGE_40 -->\n##### 2.3.P.6 표준품 또는 표준물질(제품명, 제형)(Reference Standards or Materials)(name,\n\n<!-- PAGE_40 -->\n##### dosage form)\n\n- 3.2.P.6에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n - ○ 3.2.P.6 표준품 및 표준물질에 설명된 완제의약품 시험에 필요한 표준품 또는 표준물질에\n- ○ 원료의약품과 동일한 표준품을 사용하는 경우, 2.3.S.5 표준품 또는 표준물질을 참고한다.\n - ○ 표준품은 로트 번호와 시험성적서 발행처 및 주소 등 품질을 입증할 수 있는 정보를 기재\n한다.  단, 공정서 표준품에 대하여 정보가 제공되는 경우 그 품질을 알 수 있는 정보를\n\n- ○ 순도시험에서 표준품을 사용하는 경우, 해당 표준품에 대한 내용도 기재한다.\n - - 35 -\n<!-- PAGE_41 -->\n##### 2.3.P.7 용기 및 포장(제품명, 제형)(Container Closure System)(name, dosage form)\n\n- 3.2.P.7에 있는 정보의 간단한 설명과 고찰을 포함한다.\n",
        "original_sentence": "- ○ 3.2.P.6 표준품 및 표준물질에 설명된 완제의약품 시험에 필요한 표준품 또는 표준물질에\n- ○ 원료의약품과 동일한 표준품을 사용하는 경우, 2.3.S.5 표준품 또는 표준물질을 참고한다.\n"
      }
    },
    {
      "chunk_id": "chunk_506",
      "text": "- ○ 표준품은 로트 번호와 시험성적서 발행처 및 주소 등 품질을 입증할 수 있는 정보를 기재\n한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 505,
        "window_size": 3,
        "char_count": 57,
        "word_count": 17,
        "page_number": 5,
        "window_text": "3) 무균 제제\n\n.  미생물관련 기준 및 시험방법, 결과 요약\n\n<!-- PAGE_40 -->\n##### 2.3.P.6 표준품 또는 표준물질(제품명, 제형)(Reference Standards or Materials)(name,\n\n<!-- PAGE_40 -->\n##### dosage form)\n\n- 3.2.P.6에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n - ○ 3.2.P.6 표준품 및 표준물질에 설명된 완제의약품 시험에 필요한 표준품 또는 표준물질에\n- ○ 원료의약품과 동일한 표준품을 사용하는 경우, 2.3.S.5 표준품 또는 표준물질을 참고한다.\n - ○ 표준품은 로트 번호와 시험성적서 발행처 및 주소 등 품질을 입증할 수 있는 정보를 기재\n한다.  단, 공정서 표준품에 대하여 정보가 제공되는 경우 그 품질을 알 수 있는 정보를\n\n- ○ 순도시험에서 표준품을 사용하는 경우, 해당 표준품에 대한 내용도 기재한다.\n - - 35 -\n<!-- PAGE_41 -->\n##### 2.3.P.7 용기 및 포장(제품명, 제형)(Container Closure System)(name, dosage form)\n\n- 3.2.P.7에 있는 정보의 간단한 설명과 고찰을 포함한다.\n - ○ 3.2.P.7 용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n",
        "original_sentence": "- ○ 표준품은 로트 번호와 시험성적서 발행처 및 주소 등 품질을 입증할 수 있는 정보를 기재\n한다. "
      }
    },
    {
      "chunk_id": "chunk_507",
      "text": "단, 공정서 표준품에 대하여 정보가 제공되는 경우 그 품질을 알 수 있는 정보를\n\n- ○ 순도시험에서 표준품을 사용하는 경우, 해당 표준품에 대한 내용도 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 506,
        "window_size": 3,
        "char_count": 92,
        "word_count": 24,
        "page_number": 5,
        "window_text": "미생물관련 기준 및 시험방법, 결과 요약\n\n<!-- PAGE_40 -->\n##### 2.3.P.6 표준품 또는 표준물질(제품명, 제형)(Reference Standards or Materials)(name,\n\n<!-- PAGE_40 -->\n##### dosage form)\n\n- 3.2.P.6에서 얻은 정보(필요시 도표로 표시)를 포함한다.\n - ○ 3.2.P.6 표준품 및 표준물질에 설명된 완제의약품 시험에 필요한 표준품 또는 표준물질에\n- ○ 원료의약품과 동일한 표준품을 사용하는 경우, 2.3.S.5 표준품 또는 표준물질을 참고한다.\n - ○ 표준품은 로트 번호와 시험성적서 발행처 및 주소 등 품질을 입증할 수 있는 정보를 기재\n한다.  단, 공정서 표준품에 대하여 정보가 제공되는 경우 그 품질을 알 수 있는 정보를\n\n- ○ 순도시험에서 표준품을 사용하는 경우, 해당 표준품에 대한 내용도 기재한다.\n - - 35 -\n<!-- PAGE_41 -->\n##### 2.3.P.7 용기 및 포장(제품명, 제형)(Container Closure System)(name, dosage form)\n\n- 3.2.P.7에 있는 정보의 간단한 설명과 고찰을 포함한다.\n - ○ 3.2.P.7 용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n - ○ 용기 및 포장에 대해 요약하여 표로 기재한다.\n",
        "original_sentence": "단, 공정서 표준품에 대하여 정보가 제공되는 경우 그 품질을 알 수 있는 정보를\n\n- ○ 순도시험에서 표준품을 사용하는 경우, 해당 표준품에 대한 내용도 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_508",
      "text": "- - 35 -\n<!-- PAGE_41 -->\n##### 2.3.P.7 용기 및 포장(제품명, 제형)(Container Closure System)(name, dosage form)\n\n- 3.2.P.7에 있는 정보의 간단한 설명과 고찰을 포함한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 507,
        "window_size": 3,
        "char_count": 139,
        "word_count": 25,
        "page_number": 41,
        "window_text": "- ○ 3.2.P.6 표준품 및 표준물질에 설명된 완제의약품 시험에 필요한 표준품 또는 표준물질에\n- ○ 원료의약품과 동일한 표준품을 사용하는 경우, 2.3.S.5 표준품 또는 표준물질을 참고한다.\n - ○ 표준품은 로트 번호와 시험성적서 발행처 및 주소 등 품질을 입증할 수 있는 정보를 기재\n한다.  단, 공정서 표준품에 대하여 정보가 제공되는 경우 그 품질을 알 수 있는 정보를\n\n- ○ 순도시험에서 표준품을 사용하는 경우, 해당 표준품에 대한 내용도 기재한다.\n - - 35 -\n<!-- PAGE_41 -->\n##### 2.3.P.7 용기 및 포장(제품명, 제형)(Container Closure System)(name, dosage form)\n\n- 3.2.P.7에 있는 정보의 간단한 설명과 고찰을 포함한다.\n - ○ 3.2.P.7 용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n - ○ 용기 및 포장에 대해 요약하여 표로 기재한다.\n - ○ 사용된 용기 및 포장의 안전성 입증을 위해 공정서 수재 시험방법 등으로 시험할 수 있다.\n",
        "original_sentence": "- - 35 -\n<!-- PAGE_41 -->\n##### 2.3.P.7 용기 및 포장(제품명, 제형)(Container Closure System)(name, dosage form)\n\n- 3.2.P.7에 있는 정보의 간단한 설명과 고찰을 포함한다.\n"
      }
    },
    {
      "chunk_id": "chunk_509",
      "text": "- ○ 3.2.P.7 용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 508,
        "window_size": 3,
        "char_count": 57,
        "word_count": 15,
        "page_number": 3,
        "window_text": "- ○ 표준품은 로트 번호와 시험성적서 발행처 및 주소 등 품질을 입증할 수 있는 정보를 기재\n한다.  단, 공정서 표준품에 대하여 정보가 제공되는 경우 그 품질을 알 수 있는 정보를\n\n- ○ 순도시험에서 표준품을 사용하는 경우, 해당 표준품에 대한 내용도 기재한다.\n - - 35 -\n<!-- PAGE_41 -->\n##### 2.3.P.7 용기 및 포장(제품명, 제형)(Container Closure System)(name, dosage form)\n\n- 3.2.P.7에 있는 정보의 간단한 설명과 고찰을 포함한다.\n - ○ 3.2.P.7 용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n - ○ 용기 및 포장에 대해 요약하여 표로 기재한다.\n - ○ 사용된 용기 및 포장의 안전성 입증을 위해 공정서 수재 시험방법 등으로 시험할 수 있다.\n 또한 동일한 포장 형태를 사용하는 기허가 의약품을 근거로 갈음할 수 있으며 시험성적서를\n\n- ○ 포장 용기에 대해 다음과 같이 기재할 수 있다.\n",
        "original_sentence": "- ○ 3.2.P.7 용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_510",
      "text": "- ○ 용기 및 포장에 대해 요약하여 표로 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 509,
        "window_size": 3,
        "char_count": 30,
        "word_count": 9,
        "page_number": 5,
        "window_text": "단, 공정서 표준품에 대하여 정보가 제공되는 경우 그 품질을 알 수 있는 정보를\n\n- ○ 순도시험에서 표준품을 사용하는 경우, 해당 표준품에 대한 내용도 기재한다.\n - - 35 -\n<!-- PAGE_41 -->\n##### 2.3.P.7 용기 및 포장(제품명, 제형)(Container Closure System)(name, dosage form)\n\n- 3.2.P.7에 있는 정보의 간단한 설명과 고찰을 포함한다.\n - ○ 3.2.P.7 용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n - ○ 용기 및 포장에 대해 요약하여 표로 기재한다.\n - ○ 사용된 용기 및 포장의 안전성 입증을 위해 공정서 수재 시험방법 등으로 시험할 수 있다.\n 또한 동일한 포장 형태를 사용하는 기허가 의약품을 근거로 갈음할 수 있으며 시험성적서를\n\n- ○ 포장 용기에 대해 다음과 같이 기재할 수 있다.\n - - XXX 정 2 mg은 HDPE (흰색, 원형) 병포장으로 시판될 것이다.\n",
        "original_sentence": "- ○ 용기 및 포장에 대해 요약하여 표로 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_511",
      "text": "- ○ 사용된 용기 및 포장의 안전성 입증을 위해 공정서 수재 시험방법 등으로 시험할 수 있다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 510,
        "window_size": 3,
        "char_count": 54,
        "word_count": 16,
        "page_number": 5,
        "window_text": "- - 35 -\n<!-- PAGE_41 -->\n##### 2.3.P.7 용기 및 포장(제품명, 제형)(Container Closure System)(name, dosage form)\n\n- 3.2.P.7에 있는 정보의 간단한 설명과 고찰을 포함한다.\n - ○ 3.2.P.7 용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n - ○ 용기 및 포장에 대해 요약하여 표로 기재한다.\n - ○ 사용된 용기 및 포장의 안전성 입증을 위해 공정서 수재 시험방법 등으로 시험할 수 있다.\n 또한 동일한 포장 형태를 사용하는 기허가 의약품을 근거로 갈음할 수 있으며 시험성적서를\n\n- ○ 포장 용기에 대해 다음과 같이 기재할 수 있다.\n - - XXX 정 2 mg은 HDPE (흰색, 원형) 병포장으로 시판될 것이다.\n . ",
        "original_sentence": "- ○ 사용된 용기 및 포장의 안전성 입증을 위해 공정서 수재 시험방법 등으로 시험할 수 있다.\n"
      }
    },
    {
      "chunk_id": "chunk_512",
      "text": "또한 동일한 포장 형태를 사용하는 기허가 의약품을 근거로 갈음할 수 있으며 시험성적서를\n\n- ○ 포장 용기에 대해 다음과 같이 기재할 수 있다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 511,
        "window_size": 3,
        "char_count": 81,
        "word_count": 22,
        "page_number": 41,
        "window_text": "- ○ 3.2.P.7 용기 및 포장에 기재된 일차 포장재 및 이차 포장재에 대하여 요약하여 기재한다.\n - ○ 용기 및 포장에 대해 요약하여 표로 기재한다.\n - ○ 사용된 용기 및 포장의 안전성 입증을 위해 공정서 수재 시험방법 등으로 시험할 수 있다.\n 또한 동일한 포장 형태를 사용하는 기허가 의약품을 근거로 갈음할 수 있으며 시험성적서를\n\n- ○ 포장 용기에 대해 다음과 같이 기재할 수 있다.\n - - XXX 정 2 mg은 HDPE (흰색, 원형) 병포장으로 시판될 것이다.\n .  60 mL (60, 100 정) 28mm 지름, Al induction 씰로 된 PP CRC\n\n. ",
        "original_sentence": "또한 동일한 포장 형태를 사용하는 기허가 의약품을 근거로 갈음할 수 있으며 시험성적서를\n\n- ○ 포장 용기에 대해 다음과 같이 기재할 수 있다.\n"
      }
    },
    {
      "chunk_id": "chunk_513",
      "text": "- - XXX 정 2 mg은 HDPE (흰색, 원형) 병포장으로 시판될 것이다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 512,
        "window_size": 3,
        "char_count": 45,
        "word_count": 12,
        "page_number": 3,
        "window_text": "- ○ 용기 및 포장에 대해 요약하여 표로 기재한다.\n - ○ 사용된 용기 및 포장의 안전성 입증을 위해 공정서 수재 시험방법 등으로 시험할 수 있다.\n 또한 동일한 포장 형태를 사용하는 기허가 의약품을 근거로 갈음할 수 있으며 시험성적서를\n\n- ○ 포장 용기에 대해 다음과 같이 기재할 수 있다.\n - - XXX 정 2 mg은 HDPE (흰색, 원형) 병포장으로 시판될 것이다.\n .  60 mL (60, 100 정) 28mm 지름, Al induction 씰로 된 PP CRC\n\n.  325 mL (500 정) 45mm 지름, Al induction 씰로 된 PP CRC\n\n- - 용기 시스템에 대한 요약은 다음과 같다.\n",
        "original_sentence": "- - XXX 정 2 mg은 HDPE (흰색, 원형) 병포장으로 시판될 것이다.\n"
      }
    },
    {
      "chunk_id": "chunk_514",
      "text": ". ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 513,
        "window_size": 3,
        "char_count": 2,
        "word_count": 1,
        "page_number": 1,
        "window_text": "- ○ 사용된 용기 및 포장의 안전성 입증을 위해 공정서 수재 시험방법 등으로 시험할 수 있다.\n 또한 동일한 포장 형태를 사용하는 기허가 의약품을 근거로 갈음할 수 있으며 시험성적서를\n\n- ○ 포장 용기에 대해 다음과 같이 기재할 수 있다.\n - - XXX 정 2 mg은 HDPE (흰색, 원형) 병포장으로 시판될 것이다.\n .  60 mL (60, 100 정) 28mm 지름, Al induction 씰로 된 PP CRC\n\n.  325 mL (500 정) 45mm 지름, Al induction 씰로 된 PP CRC\n\n- - 용기 시스템에 대한 요약은 다음과 같다.\n **[표 시작]**\n\n| Closure liner | PE faced Al inner seal | Pulp.inc |\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 사용된 용기 포장은 USP <661> 플라스틱용기시험법과 USP <671> 용기성능시험법에\n적합하다. ",
        "original_sentence": ". "
      }
    },
    {
      "chunk_id": "chunk_515",
      "text": "60 mL (60, 100 정) 28mm 지름, Al induction 씰로 된 PP CRC\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 514,
        "window_size": 3,
        "char_count": 55,
        "word_count": 14,
        "page_number": 5,
        "window_text": "또한 동일한 포장 형태를 사용하는 기허가 의약품을 근거로 갈음할 수 있으며 시험성적서를\n\n- ○ 포장 용기에 대해 다음과 같이 기재할 수 있다.\n - - XXX 정 2 mg은 HDPE (흰색, 원형) 병포장으로 시판될 것이다.\n .  60 mL (60, 100 정) 28mm 지름, Al induction 씰로 된 PP CRC\n\n.  325 mL (500 정) 45mm 지름, Al induction 씰로 된 PP CRC\n\n- - 용기 시스템에 대한 요약은 다음과 같다.\n **[표 시작]**\n\n| Closure liner | PE faced Al inner seal | Pulp.inc |\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 사용된 용기 포장은 USP <661> 플라스틱용기시험법과 USP <671> 용기성능시험법에\n적합하다.  자세한 사항은 3.2.P.2.4. ",
        "original_sentence": "60 mL (60, 100 정) 28mm 지름, Al induction 씰로 된 PP CRC\n\n. "
      }
    },
    {
      "chunk_id": "chunk_516",
      "text": "325 mL (500 정) 45mm 지름, Al induction 씰로 된 PP CRC\n\n- - 용기 시스템에 대한 요약은 다음과 같다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 515,
        "window_size": 3,
        "char_count": 77,
        "word_count": 20,
        "page_number": 5,
        "window_text": "- - XXX 정 2 mg은 HDPE (흰색, 원형) 병포장으로 시판될 것이다.\n .  60 mL (60, 100 정) 28mm 지름, Al induction 씰로 된 PP CRC\n\n.  325 mL (500 정) 45mm 지름, Al induction 씰로 된 PP CRC\n\n- - 용기 시스템에 대한 요약은 다음과 같다.\n **[표 시작]**\n\n| Closure liner | PE faced Al inner seal | Pulp.inc |\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 사용된 용기 포장은 USP <661> 플라스틱용기시험법과 USP <671> 용기성능시험법에\n적합하다.  자세한 사항은 3.2.P.2.4.  용기 및 포장을 참조한다.\n\n",
        "original_sentence": "325 mL (500 정) 45mm 지름, Al induction 씰로 된 PP CRC\n\n- - 용기 시스템에 대한 요약은 다음과 같다.\n"
      }
    },
    {
      "chunk_id": "chunk_517",
      "text": "**[표 시작]**\n\n| Closure liner | PE faced Al inner seal | Pulp.inc |\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 사용된 용기 포장은 USP <661> 플라스틱용기시험법과 USP <671> 용기성능시험법에\n적합하다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 516,
        "window_size": 3,
        "char_count": 159,
        "word_count": 35,
        "page_number": 30,
        "window_text": ".  60 mL (60, 100 정) 28mm 지름, Al induction 씰로 된 PP CRC\n\n.  325 mL (500 정) 45mm 지름, Al induction 씰로 된 PP CRC\n\n- - 용기 시스템에 대한 요약은 다음과 같다.\n **[표 시작]**\n\n| Closure liner | PE faced Al inner seal | Pulp.inc |\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 사용된 용기 포장은 USP <661> 플라스틱용기시험법과 USP <671> 용기성능시험법에\n적합하다.  자세한 사항은 3.2.P.2.4.  용기 및 포장을 참조한다.\n\n - - 36 -\n<!-- PAGE_42 -->\n##### 2.3.P.8 안정성(제품명, 제형)(Stability)(name, dosage form)\n\n수행된 시험(조건, 뱃치, 시험방법)의 요약 그리고, 안정성시험 및 데이터 해석에 대한 결과 및\n\n결론의 간략한 고찰을 포함하여야 한다. ",
        "original_sentence": "**[표 시작]**\n\n| Closure liner | PE faced Al inner seal | Pulp.inc |\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 사용된 용기 포장은 USP <661> 플라스틱용기시험법과 USP <671> 용기성능시험법에\n적합하다. "
      }
    },
    {
      "chunk_id": "chunk_518",
      "text": "자세한 사항은 3.2.P.2.4. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 517,
        "window_size": 3,
        "char_count": 19,
        "word_count": 3,
        "page_number": 2,
        "window_text": "60 mL (60, 100 정) 28mm 지름, Al induction 씰로 된 PP CRC\n\n.  325 mL (500 정) 45mm 지름, Al induction 씰로 된 PP CRC\n\n- - 용기 시스템에 대한 요약은 다음과 같다.\n **[표 시작]**\n\n| Closure liner | PE faced Al inner seal | Pulp.inc |\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 사용된 용기 포장은 USP <661> 플라스틱용기시험법과 USP <671> 용기성능시험법에\n적합하다.  자세한 사항은 3.2.P.2.4.  용기 및 포장을 참조한다.\n\n - - 36 -\n<!-- PAGE_42 -->\n##### 2.3.P.8 안정성(제품명, 제형)(Stability)(name, dosage form)\n\n수행된 시험(조건, 뱃치, 시험방법)의 요약 그리고, 안정성시험 및 데이터 해석에 대한 결과 및\n\n결론의 간략한 고찰을 포함하여야 한다.  보관조건, 유효기간, 필요시 사용시 보관조건 및 사용\n\n시 유효기간에 관한 결론을 제시하여야 한다.\n\n",
        "original_sentence": "자세한 사항은 3.2.P.2.4. "
      }
    },
    {
      "chunk_id": "chunk_519",
      "text": "용기 및 포장을 참조한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 518,
        "window_size": 3,
        "char_count": 16,
        "word_count": 4,
        "page_number": 13,
        "window_text": "325 mL (500 정) 45mm 지름, Al induction 씰로 된 PP CRC\n\n- - 용기 시스템에 대한 요약은 다음과 같다.\n **[표 시작]**\n\n| Closure liner | PE faced Al inner seal | Pulp.inc |\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 사용된 용기 포장은 USP <661> 플라스틱용기시험법과 USP <671> 용기성능시험법에\n적합하다.  자세한 사항은 3.2.P.2.4.  용기 및 포장을 참조한다.\n\n - - 36 -\n<!-- PAGE_42 -->\n##### 2.3.P.8 안정성(제품명, 제형)(Stability)(name, dosage form)\n\n수행된 시험(조건, 뱃치, 시험방법)의 요약 그리고, 안정성시험 및 데이터 해석에 대한 결과 및\n\n결론의 간략한 고찰을 포함하여야 한다.  보관조건, 유효기간, 필요시 사용시 보관조건 및 사용\n\n시 유효기간에 관한 결론을 제시하여야 한다.\n\n - 3.2.P.8.3에 기재된 안정성시험 결과가 필요시 그래프와 함께 요약표를 포함하여야 한다.\n",
        "original_sentence": "용기 및 포장을 참조한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_520",
      "text": "- - 36 -\n<!-- PAGE_42 -->\n##### 2.3.P.8 안정성(제품명, 제형)(Stability)(name, dosage form)\n\n수행된 시험(조건, 뱃치, 시험방법)의 요약 그리고, 안정성시험 및 데이터 해석에 대한 결과 및\n\n결론의 간략한 고찰을 포함하여야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 519,
        "window_size": 3,
        "char_count": 161,
        "word_count": 31,
        "page_number": 42,
        "window_text": "**[표 시작]**\n\n| Closure liner | PE faced Al inner seal | Pulp.inc |\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 사용된 용기 포장은 USP <661> 플라스틱용기시험법과 USP <671> 용기성능시험법에\n적합하다.  자세한 사항은 3.2.P.2.4.  용기 및 포장을 참조한다.\n\n - - 36 -\n<!-- PAGE_42 -->\n##### 2.3.P.8 안정성(제품명, 제형)(Stability)(name, dosage form)\n\n수행된 시험(조건, 뱃치, 시험방법)의 요약 그리고, 안정성시험 및 데이터 해석에 대한 결과 및\n\n결론의 간략한 고찰을 포함하여야 한다.  보관조건, 유효기간, 필요시 사용시 보관조건 및 사용\n\n시 유효기간에 관한 결론을 제시하여야 한다.\n\n - 3.2.P.8.3에 기재된 안정성시험 결과가 필요시 그래프와 함께 요약표를 포함하여야 한다.\n - 3.2.P.8.2에 기재된 승인 후의 안정성시험 계획을 제공하여야 한다.\n",
        "original_sentence": "- - 36 -\n<!-- PAGE_42 -->\n##### 2.3.P.8 안정성(제품명, 제형)(Stability)(name, dosage form)\n\n수행된 시험(조건, 뱃치, 시험방법)의 요약 그리고, 안정성시험 및 데이터 해석에 대한 결과 및\n\n결론의 간략한 고찰을 포함하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_521",
      "text": "보관조건, 유효기간, 필요시 사용시 보관조건 및 사용\n\n시 유효기간에 관한 결론을 제시하여야 한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 520,
        "window_size": 3,
        "char_count": 57,
        "word_count": 13,
        "page_number": 1,
        "window_text": "자세한 사항은 3.2.P.2.4.  용기 및 포장을 참조한다.\n\n - - 36 -\n<!-- PAGE_42 -->\n##### 2.3.P.8 안정성(제품명, 제형)(Stability)(name, dosage form)\n\n수행된 시험(조건, 뱃치, 시험방법)의 요약 그리고, 안정성시험 및 데이터 해석에 대한 결과 및\n\n결론의 간략한 고찰을 포함하여야 한다.  보관조건, 유효기간, 필요시 사용시 보관조건 및 사용\n\n시 유효기간에 관한 결론을 제시하여야 한다.\n\n - 3.2.P.8.3에 기재된 안정성시험 결과가 필요시 그래프와 함께 요약표를 포함하여야 한다.\n - 3.2.P.8.2에 기재된 승인 후의 안정성시험 계획을 제공하여야 한다.\n - ○ 안정성시험에 적용된 기준 및 시험방법을 기재한다.\n",
        "original_sentence": "보관조건, 유효기간, 필요시 사용시 보관조건 및 사용\n\n시 유효기간에 관한 결론을 제시하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_522",
      "text": "- 3.2.P.8.3에 기재된 안정성시험 결과가 필요시 그래프와 함께 요약표를 포함하여야 한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 521,
        "window_size": 3,
        "char_count": 54,
        "word_count": 11,
        "page_number": 5,
        "window_text": "용기 및 포장을 참조한다.\n\n - - 36 -\n<!-- PAGE_42 -->\n##### 2.3.P.8 안정성(제품명, 제형)(Stability)(name, dosage form)\n\n수행된 시험(조건, 뱃치, 시험방법)의 요약 그리고, 안정성시험 및 데이터 해석에 대한 결과 및\n\n결론의 간략한 고찰을 포함하여야 한다.  보관조건, 유효기간, 필요시 사용시 보관조건 및 사용\n\n시 유효기간에 관한 결론을 제시하여야 한다.\n\n - 3.2.P.8.3에 기재된 안정성시험 결과가 필요시 그래프와 함께 요약표를 포함하여야 한다.\n - 3.2.P.8.2에 기재된 승인 후의 안정성시험 계획을 제공하여야 한다.\n - ○ 안정성시험에 적용된 기준 및 시험방법을 기재한다.\n - - 완제의약품의 기준 및 시험방법과 안정성시험의 기준 및 시험방법이 상이할 경우, 이를\n- ○ 용기 및 포장 형태에 대해 명확히 기재한다.\n",
        "original_sentence": "- 3.2.P.8.3에 기재된 안정성시험 결과가 필요시 그래프와 함께 요약표를 포함하여야 한다.\n"
      }
    },
    {
      "chunk_id": "chunk_523",
      "text": "- 3.2.P.8.2에 기재된 승인 후의 안정성시험 계획을 제공하여야 한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 522,
        "window_size": 3,
        "char_count": 43,
        "word_count": 9,
        "page_number": 5,
        "window_text": "- - 36 -\n<!-- PAGE_42 -->\n##### 2.3.P.8 안정성(제품명, 제형)(Stability)(name, dosage form)\n\n수행된 시험(조건, 뱃치, 시험방법)의 요약 그리고, 안정성시험 및 데이터 해석에 대한 결과 및\n\n결론의 간략한 고찰을 포함하여야 한다.  보관조건, 유효기간, 필요시 사용시 보관조건 및 사용\n\n시 유효기간에 관한 결론을 제시하여야 한다.\n\n - 3.2.P.8.3에 기재된 안정성시험 결과가 필요시 그래프와 함께 요약표를 포함하여야 한다.\n - 3.2.P.8.2에 기재된 승인 후의 안정성시험 계획을 제공하여야 한다.\n - ○ 안정성시험에 적용된 기준 및 시험방법을 기재한다.\n - - 완제의약품의 기준 및 시험방법과 안정성시험의 기준 및 시험방법이 상이할 경우, 이를\n- ○ 용기 및 포장 형태에 대해 명확히 기재한다.\n - ○ 안정성시험(장기보존시험, 가속시험) 기준 및 결과를 표로 나타낸다.\n",
        "original_sentence": "- 3.2.P.8.2에 기재된 승인 후의 안정성시험 계획을 제공하여야 한다.\n"
      }
    },
    {
      "chunk_id": "chunk_524",
      "text": "- ○ 안정성시험에 적용된 기준 및 시험방법을 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 523,
        "window_size": 3,
        "char_count": 32,
        "word_count": 8,
        "page_number": 5,
        "window_text": "보관조건, 유효기간, 필요시 사용시 보관조건 및 사용\n\n시 유효기간에 관한 결론을 제시하여야 한다.\n\n - 3.2.P.8.3에 기재된 안정성시험 결과가 필요시 그래프와 함께 요약표를 포함하여야 한다.\n - 3.2.P.8.2에 기재된 승인 후의 안정성시험 계획을 제공하여야 한다.\n - ○ 안정성시험에 적용된 기준 및 시험방법을 기재한다.\n - - 완제의약품의 기준 및 시험방법과 안정성시험의 기준 및 시험방법이 상이할 경우, 이를\n- ○ 용기 및 포장 형태에 대해 명확히 기재한다.\n - ○ 안정성시험(장기보존시험, 가속시험) 기준 및 결과를 표로 나타낸다.\n - ○ 보관 검체를 재시험하는 경우, 해당 사항을 표시한다 (예: 용출기준 변경이 있는 경우).\n",
        "original_sentence": "- ○ 안정성시험에 적용된 기준 및 시험방법을 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_525",
      "text": "- - 완제의약품의 기준 및 시험방법과 안정성시험의 기준 및 시험방법이 상이할 경우, 이를\n- ○ 용기 및 포장 형태에 대해 명확히 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 524,
        "window_size": 3,
        "char_count": 80,
        "word_count": 22,
        "page_number": 3,
        "window_text": "- 3.2.P.8.3에 기재된 안정성시험 결과가 필요시 그래프와 함께 요약표를 포함하여야 한다.\n - 3.2.P.8.2에 기재된 승인 후의 안정성시험 계획을 제공하여야 한다.\n - ○ 안정성시험에 적용된 기준 및 시험방법을 기재한다.\n - - 완제의약품의 기준 및 시험방법과 안정성시험의 기준 및 시험방법이 상이할 경우, 이를\n- ○ 용기 및 포장 형태에 대해 명확히 기재한다.\n - ○ 안정성시험(장기보존시험, 가속시험) 기준 및 결과를 표로 나타낸다.\n - ○ 보관 검체를 재시험하는 경우, 해당 사항을 표시한다 (예: 용출기준 변경이 있는 경우).\n - ○ 필요한 경우, 쓸 때 조제하는 제제 또는 완제의약품 복용 시와 동일한 조건과 같은 특수\n연구를 실시하고, 안정성시험 결과 및 시험방법을 기재한다. ",
        "original_sentence": "- - 완제의약품의 기준 및 시험방법과 안정성시험의 기준 및 시험방법이 상이할 경우, 이를\n- ○ 용기 및 포장 형태에 대해 명확히 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_526",
      "text": "- ○ 안정성시험(장기보존시험, 가속시험) 기준 및 결과를 표로 나타낸다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 525,
        "window_size": 3,
        "char_count": 42,
        "word_count": 9,
        "page_number": 5,
        "window_text": "- 3.2.P.8.2에 기재된 승인 후의 안정성시험 계획을 제공하여야 한다.\n - ○ 안정성시험에 적용된 기준 및 시험방법을 기재한다.\n - - 완제의약품의 기준 및 시험방법과 안정성시험의 기준 및 시험방법이 상이할 경우, 이를\n- ○ 용기 및 포장 형태에 대해 명확히 기재한다.\n - ○ 안정성시험(장기보존시험, 가속시험) 기준 및 결과를 표로 나타낸다.\n - ○ 보관 검체를 재시험하는 경우, 해당 사항을 표시한다 (예: 용출기준 변경이 있는 경우).\n - ○ 필요한 경우, 쓸 때 조제하는 제제 또는 완제의약품 복용 시와 동일한 조건과 같은 특수\n연구를 실시하고, 안정성시험 결과 및 시험방법을 기재한다.  사이클링 연구 수행 결과(동결\n\n- ○ 안정성시험 결과를 바탕으로 보관조건 및 사용기한 설정에 대해 기술한다.\n",
        "original_sentence": "- ○ 안정성시험(장기보존시험, 가속시험) 기준 및 결과를 표로 나타낸다.\n"
      }
    },
    {
      "chunk_id": "chunk_527",
      "text": "- ○ 보관 검체를 재시험하는 경우, 해당 사항을 표시한다 (예: 용출기준 변경이 있는 경우).\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 526,
        "window_size": 3,
        "char_count": 54,
        "word_count": 14,
        "page_number": 2,
        "window_text": "- ○ 안정성시험에 적용된 기준 및 시험방법을 기재한다.\n - - 완제의약품의 기준 및 시험방법과 안정성시험의 기준 및 시험방법이 상이할 경우, 이를\n- ○ 용기 및 포장 형태에 대해 명확히 기재한다.\n - ○ 안정성시험(장기보존시험, 가속시험) 기준 및 결과를 표로 나타낸다.\n - ○ 보관 검체를 재시험하는 경우, 해당 사항을 표시한다 (예: 용출기준 변경이 있는 경우).\n - ○ 필요한 경우, 쓸 때 조제하는 제제 또는 완제의약품 복용 시와 동일한 조건과 같은 특수\n연구를 실시하고, 안정성시험 결과 및 시험방법을 기재한다.  사이클링 연구 수행 결과(동결\n\n- ○ 안정성시험 결과를 바탕으로 보관조건 및 사용기한 설정에 대해 기술한다.\n - ○ 시판 후 안정성시험 계획서와 이행서약을 기재한다.\n",
        "original_sentence": "- ○ 보관 검체를 재시험하는 경우, 해당 사항을 표시한다 (예: 용출기준 변경이 있는 경우).\n"
      }
    },
    {
      "chunk_id": "chunk_528",
      "text": "- ○ 필요한 경우, 쓸 때 조제하는 제제 또는 완제의약품 복용 시와 동일한 조건과 같은 특수\n연구를 실시하고, 안정성시험 결과 및 시험방법을 기재한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 527,
        "window_size": 3,
        "char_count": 86,
        "word_count": 23,
        "page_number": 5,
        "window_text": "- - 완제의약품의 기준 및 시험방법과 안정성시험의 기준 및 시험방법이 상이할 경우, 이를\n- ○ 용기 및 포장 형태에 대해 명확히 기재한다.\n - ○ 안정성시험(장기보존시험, 가속시험) 기준 및 결과를 표로 나타낸다.\n - ○ 보관 검체를 재시험하는 경우, 해당 사항을 표시한다 (예: 용출기준 변경이 있는 경우).\n - ○ 필요한 경우, 쓸 때 조제하는 제제 또는 완제의약품 복용 시와 동일한 조건과 같은 특수\n연구를 실시하고, 안정성시험 결과 및 시험방법을 기재한다.  사이클링 연구 수행 결과(동결\n\n- ○ 안정성시험 결과를 바탕으로 보관조건 및 사용기한 설정에 대해 기술한다.\n - ○ 시판 후 안정성시험 계획서와 이행서약을 기재한다.\n - - 안정성시험 계획서는 다음 사항에 대해 기재한다.\n",
        "original_sentence": "- ○ 필요한 경우, 쓸 때 조제하는 제제 또는 완제의약품 복용 시와 동일한 조건과 같은 특수\n연구를 실시하고, 안정성시험 결과 및 시험방법을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_529",
      "text": "사이클링 연구 수행 결과(동결\n\n- ○ 안정성시험 결과를 바탕으로 보관조건 및 사용기한 설정에 대해 기술한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 528,
        "window_size": 3,
        "char_count": 62,
        "word_count": 15,
        "page_number": 3,
        "window_text": "- ○ 안정성시험(장기보존시험, 가속시험) 기준 및 결과를 표로 나타낸다.\n - ○ 보관 검체를 재시험하는 경우, 해당 사항을 표시한다 (예: 용출기준 변경이 있는 경우).\n - ○ 필요한 경우, 쓸 때 조제하는 제제 또는 완제의약품 복용 시와 동일한 조건과 같은 특수\n연구를 실시하고, 안정성시험 결과 및 시험방법을 기재한다.  사이클링 연구 수행 결과(동결\n\n- ○ 안정성시험 결과를 바탕으로 보관조건 및 사용기한 설정에 대해 기술한다.\n - ○ 시판 후 안정성시험 계획서와 이행서약을 기재한다.\n - - 안정성시험 계획서는 다음 사항에 대해 기재한다.\n 1) 검체 보존조건\n\n2) 안정성시험용 검체 정보 (제조번호, 포장형태 등)\n\n3) 시험주기\n\n4) 시험항목과 시험 일정\n\n- - 안정성시험 이행서약은 다음 사항에 대해 기재한다.\n",
        "original_sentence": "사이클링 연구 수행 결과(동결\n\n- ○ 안정성시험 결과를 바탕으로 보관조건 및 사용기한 설정에 대해 기술한다.\n"
      }
    },
    {
      "chunk_id": "chunk_530",
      "text": "- ○ 시판 후 안정성시험 계획서와 이행서약을 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 529,
        "window_size": 3,
        "char_count": 32,
        "word_count": 8,
        "page_number": 3,
        "window_text": "- ○ 보관 검체를 재시험하는 경우, 해당 사항을 표시한다 (예: 용출기준 변경이 있는 경우).\n - ○ 필요한 경우, 쓸 때 조제하는 제제 또는 완제의약품 복용 시와 동일한 조건과 같은 특수\n연구를 실시하고, 안정성시험 결과 및 시험방법을 기재한다.  사이클링 연구 수행 결과(동결\n\n- ○ 안정성시험 결과를 바탕으로 보관조건 및 사용기한 설정에 대해 기술한다.\n - ○ 시판 후 안정성시험 계획서와 이행서약을 기재한다.\n - - 안정성시험 계획서는 다음 사항에 대해 기재한다.\n 1) 검체 보존조건\n\n2) 안정성시험용 검체 정보 (제조번호, 포장형태 등)\n\n3) 시험주기\n\n4) 시험항목과 시험 일정\n\n- - 안정성시험 이행서약은 다음 사항에 대해 기재한다.\n 1) 안정성시험을 실시할 제조단위\n\n2) 연 단위로 안정성 계획에 추가될 제조단위\n\n3) 연간보고서의 안정성시험 결과 및 시판된 완제의약품의 변화 및 이상이 발견될 경우\n\n- - 37 -\n1) 비무균제제(정제)\n\n- - 안정성시험 항목\n. ",
        "original_sentence": "- ○ 시판 후 안정성시험 계획서와 이행서약을 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_531",
      "text": "- - 안정성시험 계획서는 다음 사항에 대해 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 530,
        "window_size": 3,
        "char_count": 31,
        "word_count": 8,
        "page_number": 2,
        "window_text": "- ○ 필요한 경우, 쓸 때 조제하는 제제 또는 완제의약품 복용 시와 동일한 조건과 같은 특수\n연구를 실시하고, 안정성시험 결과 및 시험방법을 기재한다.  사이클링 연구 수행 결과(동결\n\n- ○ 안정성시험 결과를 바탕으로 보관조건 및 사용기한 설정에 대해 기술한다.\n - ○ 시판 후 안정성시험 계획서와 이행서약을 기재한다.\n - - 안정성시험 계획서는 다음 사항에 대해 기재한다.\n 1) 검체 보존조건\n\n2) 안정성시험용 검체 정보 (제조번호, 포장형태 등)\n\n3) 시험주기\n\n4) 시험항목과 시험 일정\n\n- - 안정성시험 이행서약은 다음 사항에 대해 기재한다.\n 1) 안정성시험을 실시할 제조단위\n\n2) 연 단위로 안정성 계획에 추가될 제조단위\n\n3) 연간보고서의 안정성시험 결과 및 시판된 완제의약품의 변화 및 이상이 발견될 경우\n\n- - 37 -\n1) 비무균제제(정제)\n\n- - 안정성시험 항목\n.  기준 및 시험방법에 설정된 모든 시험 항목을 설정하였다. ",
        "original_sentence": "- - 안정성시험 계획서는 다음 사항에 대해 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_532",
      "text": "1) 검체 보존조건\n\n2) 안정성시험용 검체 정보 (제조번호, 포장형태 등)\n\n3) 시험주기\n\n4) 시험항목과 시험 일정\n\n- - 안정성시험 이행서약은 다음 사항에 대해 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 531,
        "window_size": 3,
        "char_count": 101,
        "word_count": 24,
        "page_number": 5,
        "window_text": "사이클링 연구 수행 결과(동결\n\n- ○ 안정성시험 결과를 바탕으로 보관조건 및 사용기한 설정에 대해 기술한다.\n - ○ 시판 후 안정성시험 계획서와 이행서약을 기재한다.\n - - 안정성시험 계획서는 다음 사항에 대해 기재한다.\n 1) 검체 보존조건\n\n2) 안정성시험용 검체 정보 (제조번호, 포장형태 등)\n\n3) 시험주기\n\n4) 시험항목과 시험 일정\n\n- - 안정성시험 이행서약은 다음 사항에 대해 기재한다.\n 1) 안정성시험을 실시할 제조단위\n\n2) 연 단위로 안정성 계획에 추가될 제조단위\n\n3) 연간보고서의 안정성시험 결과 및 시판된 완제의약품의 변화 및 이상이 발견될 경우\n\n- - 37 -\n1) 비무균제제(정제)\n\n- - 안정성시험 항목\n.  기준 및 시험방법에 설정된 모든 시험 항목을 설정하였다.  단, 경시 변화가 없을 것으로\n\n- - 안정성시험결과 요약\n. ",
        "original_sentence": "1) 검체 보존조건\n\n2) 안정성시험용 검체 정보 (제조번호, 포장형태 등)\n\n3) 시험주기\n\n4) 시험항목과 시험 일정\n\n- - 안정성시험 이행서약은 다음 사항에 대해 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_533",
      "text": "1) 안정성시험을 실시할 제조단위\n\n2) 연 단위로 안정성 계획에 추가될 제조단위\n\n3) 연간보고서의 안정성시험 결과 및 시판된 완제의약품의 변화 및 이상이 발견될 경우\n\n- - 37 -\n1) 비무균제제(정제)\n\n- - 안정성시험 항목\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 532,
        "window_size": 3,
        "char_count": 134,
        "word_count": 34,
        "page_number": 5,
        "window_text": "- ○ 시판 후 안정성시험 계획서와 이행서약을 기재한다.\n - - 안정성시험 계획서는 다음 사항에 대해 기재한다.\n 1) 검체 보존조건\n\n2) 안정성시험용 검체 정보 (제조번호, 포장형태 등)\n\n3) 시험주기\n\n4) 시험항목과 시험 일정\n\n- - 안정성시험 이행서약은 다음 사항에 대해 기재한다.\n 1) 안정성시험을 실시할 제조단위\n\n2) 연 단위로 안정성 계획에 추가될 제조단위\n\n3) 연간보고서의 안정성시험 결과 및 시판된 완제의약품의 변화 및 이상이 발견될 경우\n\n- - 37 -\n1) 비무균제제(정제)\n\n- - 안정성시험 항목\n.  기준 및 시험방법에 설정된 모든 시험 항목을 설정하였다.  단, 경시 변화가 없을 것으로\n\n- - 안정성시험결과 요약\n.  60 정, 500 정 병포장에 대해 가속시험(40 ℃, 75% RH)을 0, 3, 6 개월에 실시하였고,\n\n장기보존시험(25 ℃, 60% RH)을 0, 3, 6, 9, 12 개월에 실시하였다. ",
        "original_sentence": "1) 안정성시험을 실시할 제조단위\n\n2) 연 단위로 안정성 계획에 추가될 제조단위\n\n3) 연간보고서의 안정성시험 결과 및 시판된 완제의약품의 변화 및 이상이 발견될 경우\n\n- - 37 -\n1) 비무균제제(정제)\n\n- - 안정성시험 항목\n. "
      }
    },
    {
      "chunk_id": "chunk_534",
      "text": "기준 및 시험방법에 설정된 모든 시험 항목을 설정하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 533,
        "window_size": 3,
        "char_count": 32,
        "word_count": 8,
        "page_number": 26,
        "window_text": "- - 안정성시험 계획서는 다음 사항에 대해 기재한다.\n 1) 검체 보존조건\n\n2) 안정성시험용 검체 정보 (제조번호, 포장형태 등)\n\n3) 시험주기\n\n4) 시험항목과 시험 일정\n\n- - 안정성시험 이행서약은 다음 사항에 대해 기재한다.\n 1) 안정성시험을 실시할 제조단위\n\n2) 연 단위로 안정성 계획에 추가될 제조단위\n\n3) 연간보고서의 안정성시험 결과 및 시판된 완제의약품의 변화 및 이상이 발견될 경우\n\n- - 37 -\n1) 비무균제제(정제)\n\n- - 안정성시험 항목\n.  기준 및 시험방법에 설정된 모든 시험 항목을 설정하였다.  단, 경시 변화가 없을 것으로\n\n- - 안정성시험결과 요약\n.  60 정, 500 정 병포장에 대해 가속시험(40 ℃, 75% RH)을 0, 3, 6 개월에 실시하였고,\n\n장기보존시험(25 ℃, 60% RH)을 0, 3, 6, 9, 12 개월에 실시하였다.  (100 정 포장은 브래\n\n켓팅 방법으로 갈음하며, 3.2.P.8. ",
        "original_sentence": "기준 및 시험방법에 설정된 모든 시험 항목을 설정하였다. "
      }
    },
    {
      "chunk_id": "chunk_535",
      "text": "단, 경시 변화가 없을 것으로\n\n- - 안정성시험결과 요약\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 534,
        "window_size": 3,
        "char_count": 35,
        "word_count": 10,
        "page_number": 5,
        "window_text": "1) 검체 보존조건\n\n2) 안정성시험용 검체 정보 (제조번호, 포장형태 등)\n\n3) 시험주기\n\n4) 시험항목과 시험 일정\n\n- - 안정성시험 이행서약은 다음 사항에 대해 기재한다.\n 1) 안정성시험을 실시할 제조단위\n\n2) 연 단위로 안정성 계획에 추가될 제조단위\n\n3) 연간보고서의 안정성시험 결과 및 시판된 완제의약품의 변화 및 이상이 발견될 경우\n\n- - 37 -\n1) 비무균제제(정제)\n\n- - 안정성시험 항목\n.  기준 및 시험방법에 설정된 모든 시험 항목을 설정하였다.  단, 경시 변화가 없을 것으로\n\n- - 안정성시험결과 요약\n.  60 정, 500 정 병포장에 대해 가속시험(40 ℃, 75% RH)을 0, 3, 6 개월에 실시하였고,\n\n장기보존시험(25 ℃, 60% RH)을 0, 3, 6, 9, 12 개월에 실시하였다.  (100 정 포장은 브래\n\n켓팅 방법으로 갈음하며, 3.2.P.8.  안정성을 참조한다.) ",
        "original_sentence": "단, 경시 변화가 없을 것으로\n\n- - 안정성시험결과 요약\n. "
      }
    },
    {
      "chunk_id": "chunk_536",
      "text": "60 정, 500 정 병포장에 대해 가속시험(40 ℃, 75% RH)을 0, 3, 6 개월에 실시하였고,\n\n장기보존시험(25 ℃, 60% RH)을 0, 3, 6, 9, 12 개월에 실시하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 535,
        "window_size": 3,
        "char_count": 108,
        "word_count": 26,
        "page_number": 18,
        "window_text": "1) 안정성시험을 실시할 제조단위\n\n2) 연 단위로 안정성 계획에 추가될 제조단위\n\n3) 연간보고서의 안정성시험 결과 및 시판된 완제의약품의 변화 및 이상이 발견될 경우\n\n- - 37 -\n1) 비무균제제(정제)\n\n- - 안정성시험 항목\n.  기준 및 시험방법에 설정된 모든 시험 항목을 설정하였다.  단, 경시 변화가 없을 것으로\n\n- - 안정성시험결과 요약\n.  60 정, 500 정 병포장에 대해 가속시험(40 ℃, 75% RH)을 0, 3, 6 개월에 실시하였고,\n\n장기보존시험(25 ℃, 60% RH)을 0, 3, 6, 9, 12 개월에 실시하였다.  (100 정 포장은 브래\n\n켓팅 방법으로 갈음하며, 3.2.P.8.  안정성을 참조한다.)  안정성시험 결과는 다음 표와 같다.\n\n",
        "original_sentence": "60 정, 500 정 병포장에 대해 가속시험(40 ℃, 75% RH)을 0, 3, 6 개월에 실시하였고,\n\n장기보존시험(25 ℃, 60% RH)을 0, 3, 6, 9, 12 개월에 실시하였다. "
      }
    },
    {
      "chunk_id": "chunk_537",
      "text": "(100 정 포장은 브래\n\n켓팅 방법으로 갈음하며, 3.2.P.8. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 536,
        "window_size": 3,
        "char_count": 38,
        "word_count": 8,
        "page_number": 5,
        "window_text": "기준 및 시험방법에 설정된 모든 시험 항목을 설정하였다.  단, 경시 변화가 없을 것으로\n\n- - 안정성시험결과 요약\n.  60 정, 500 정 병포장에 대해 가속시험(40 ℃, 75% RH)을 0, 3, 6 개월에 실시하였고,\n\n장기보존시험(25 ℃, 60% RH)을 0, 3, 6, 9, 12 개월에 실시하였다.  (100 정 포장은 브래\n\n켓팅 방법으로 갈음하며, 3.2.P.8.  안정성을 참조한다.)  안정성시험 결과는 다음 표와 같다.\n\n 가속시험 결과 모든 시험항목에 대해 기준에 적합하였다. ",
        "original_sentence": "(100 정 포장은 브래\n\n켓팅 방법으로 갈음하며, 3.2.P.8. "
      }
    },
    {
      "chunk_id": "chunk_538",
      "text": "안정성을 참조한다.) ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 537,
        "window_size": 3,
        "char_count": 12,
        "word_count": 2,
        "page_number": 13,
        "window_text": "단, 경시 변화가 없을 것으로\n\n- - 안정성시험결과 요약\n.  60 정, 500 정 병포장에 대해 가속시험(40 ℃, 75% RH)을 0, 3, 6 개월에 실시하였고,\n\n장기보존시험(25 ℃, 60% RH)을 0, 3, 6, 9, 12 개월에 실시하였다.  (100 정 포장은 브래\n\n켓팅 방법으로 갈음하며, 3.2.P.8.  안정성을 참조한다.)  안정성시험 결과는 다음 표와 같다.\n\n 가속시험 결과 모든 시험항목에 대해 기준에 적합하였다.  가속시험 결과와 장기보존시험\n\n결과를 비교했을 때, 가속시험에서만 유연물질 증가 경향이 있었다. ",
        "original_sentence": "안정성을 참조한다.) "
      }
    },
    {
      "chunk_id": "chunk_539",
      "text": "안정성시험 결과는 다음 표와 같다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 538,
        "window_size": 3,
        "char_count": 21,
        "word_count": 5,
        "page_number": 18,
        "window_text": "60 정, 500 정 병포장에 대해 가속시험(40 ℃, 75% RH)을 0, 3, 6 개월에 실시하였고,\n\n장기보존시험(25 ℃, 60% RH)을 0, 3, 6, 9, 12 개월에 실시하였다.  (100 정 포장은 브래\n\n켓팅 방법으로 갈음하며, 3.2.P.8.  안정성을 참조한다.)  안정성시험 결과는 다음 표와 같다.\n\n 가속시험 결과 모든 시험항목에 대해 기준에 적합하였다.  가속시험 결과와 장기보존시험\n\n결과를 비교했을 때, 가속시험에서만 유연물질 증가 경향이 있었다.  허가 신청한 사용기간\n\n(제조일로부터 24 개월)은 타당하며, 추후 장기보존시험을 계속하여 신청한 사용기간에 대해\n\n- - 안정성시험 계획\n- - 38 -\n- - 안정성 시험 결과 요약\n- - 허가 후 안정성시험\n. ",
        "original_sentence": "안정성시험 결과는 다음 표와 같다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_540",
      "text": "가속시험 결과 모든 시험항목에 대해 기준에 적합하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 539,
        "window_size": 3,
        "char_count": 31,
        "word_count": 7,
        "page_number": 14,
        "window_text": "(100 정 포장은 브래\n\n켓팅 방법으로 갈음하며, 3.2.P.8.  안정성을 참조한다.)  안정성시험 결과는 다음 표와 같다.\n\n 가속시험 결과 모든 시험항목에 대해 기준에 적합하였다.  가속시험 결과와 장기보존시험\n\n결과를 비교했을 때, 가속시험에서만 유연물질 증가 경향이 있었다.  허가 신청한 사용기간\n\n(제조일로부터 24 개월)은 타당하며, 추후 장기보존시험을 계속하여 신청한 사용기간에 대해\n\n- - 안정성시험 계획\n- - 38 -\n- - 안정성 시험 결과 요약\n- - 허가 후 안정성시험\n.  3 개 뱃치의 최소, 최대 포장 단위에 대해 장기보존시험을 실시하였으며, 0, 3, 6, 9, 12\n\n. ",
        "original_sentence": "가속시험 결과 모든 시험항목에 대해 기준에 적합하였다. "
      }
    },
    {
      "chunk_id": "chunk_541",
      "text": "가속시험 결과와 장기보존시험\n\n결과를 비교했을 때, 가속시험에서만 유연물질 증가 경향이 있었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 540,
        "window_size": 3,
        "char_count": 54,
        "word_count": 11,
        "page_number": 3,
        "window_text": "안정성을 참조한다.)  안정성시험 결과는 다음 표와 같다.\n\n 가속시험 결과 모든 시험항목에 대해 기준에 적합하였다.  가속시험 결과와 장기보존시험\n\n결과를 비교했을 때, 가속시험에서만 유연물질 증가 경향이 있었다.  허가 신청한 사용기간\n\n(제조일로부터 24 개월)은 타당하며, 추후 장기보존시험을 계속하여 신청한 사용기간에 대해\n\n- - 안정성시험 계획\n- - 38 -\n- - 안정성 시험 결과 요약\n- - 허가 후 안정성시험\n.  3 개 뱃치의 최소, 최대 포장 단위에 대해 장기보존시험을 실시하였으며, 0, 3, 6, 9, 12\n\n.  매년 1 개 이상 제조단위를 가지고 장기보존시험을 수행할 것이다.\n\n",
        "original_sentence": "가속시험 결과와 장기보존시험\n\n결과를 비교했을 때, 가속시험에서만 유연물질 증가 경향이 있었다. "
      }
    },
    {
      "chunk_id": "chunk_542",
      "text": "허가 신청한 사용기간\n\n(제조일로부터 24 개월)은 타당하며, 추후 장기보존시험을 계속하여 신청한 사용기간에 대해\n\n- - 안정성시험 계획\n- - 38 -\n- - 안정성 시험 결과 요약\n- - 허가 후 안정성시험\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 541,
        "window_size": 3,
        "char_count": 121,
        "word_count": 33,
        "page_number": 5,
        "window_text": "안정성시험 결과는 다음 표와 같다.\n\n 가속시험 결과 모든 시험항목에 대해 기준에 적합하였다.  가속시험 결과와 장기보존시험\n\n결과를 비교했을 때, 가속시험에서만 유연물질 증가 경향이 있었다.  허가 신청한 사용기간\n\n(제조일로부터 24 개월)은 타당하며, 추후 장기보존시험을 계속하여 신청한 사용기간에 대해\n\n- - 안정성시험 계획\n- - 38 -\n- - 안정성 시험 결과 요약\n- - 허가 후 안정성시험\n.  3 개 뱃치의 최소, 최대 포장 단위에 대해 장기보존시험을 실시하였으며, 0, 3, 6, 9, 12\n\n.  매년 1 개 이상 제조단위를 가지고 장기보존시험을 수행할 것이다.\n\n . ",
        "original_sentence": "허가 신청한 사용기간\n\n(제조일로부터 24 개월)은 타당하며, 추후 장기보존시험을 계속하여 신청한 사용기간에 대해\n\n- - 안정성시험 계획\n- - 38 -\n- - 안정성 시험 결과 요약\n- - 허가 후 안정성시험\n. "
      }
    },
    {
      "chunk_id": "chunk_543",
      "text": "3 개 뱃치의 최소, 최대 포장 단위에 대해 장기보존시험을 실시하였으며, 0, 3, 6, 9, 12\n\n. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 542,
        "window_size": 3,
        "char_count": 59,
        "word_count": 16,
        "page_number": 18,
        "window_text": "가속시험 결과 모든 시험항목에 대해 기준에 적합하였다.  가속시험 결과와 장기보존시험\n\n결과를 비교했을 때, 가속시험에서만 유연물질 증가 경향이 있었다.  허가 신청한 사용기간\n\n(제조일로부터 24 개월)은 타당하며, 추후 장기보존시험을 계속하여 신청한 사용기간에 대해\n\n- - 안정성시험 계획\n- - 38 -\n- - 안정성 시험 결과 요약\n- - 허가 후 안정성시험\n.  3 개 뱃치의 최소, 최대 포장 단위에 대해 장기보존시험을 실시하였으며, 0, 3, 6, 9, 12\n\n.  매년 1 개 이상 제조단위를 가지고 장기보존시험을 수행할 것이다.\n\n .  사용기간은 3 개 이상 제조단위의 장기보존시험 결과에 따라 연장될 수 있을 것이다.\n\n",
        "original_sentence": "3 개 뱃치의 최소, 최대 포장 단위에 대해 장기보존시험을 실시하였으며, 0, 3, 6, 9, 12\n\n. "
      }
    },
    {
      "chunk_id": "chunk_544",
      "text": "매년 1 개 이상 제조단위를 가지고 장기보존시험을 수행할 것이다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 543,
        "window_size": 3,
        "char_count": 38,
        "word_count": 9,
        "page_number": 3,
        "window_text": "가속시험 결과와 장기보존시험\n\n결과를 비교했을 때, 가속시험에서만 유연물질 증가 경향이 있었다.  허가 신청한 사용기간\n\n(제조일로부터 24 개월)은 타당하며, 추후 장기보존시험을 계속하여 신청한 사용기간에 대해\n\n- - 안정성시험 계획\n- - 38 -\n- - 안정성 시험 결과 요약\n- - 허가 후 안정성시험\n.  3 개 뱃치의 최소, 최대 포장 단위에 대해 장기보존시험을 실시하였으며, 0, 3, 6, 9, 12\n\n.  매년 1 개 이상 제조단위를 가지고 장기보존시험을 수행할 것이다.\n\n .  사용기간은 3 개 이상 제조단위의 장기보존시험 결과에 따라 연장될 수 있을 것이다.\n\n . ",
        "original_sentence": "매년 1 개 이상 제조단위를 가지고 장기보존시험을 수행할 것이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_545",
      "text": ". ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 544,
        "window_size": 3,
        "char_count": 2,
        "word_count": 1,
        "page_number": 1,
        "window_text": "허가 신청한 사용기간\n\n(제조일로부터 24 개월)은 타당하며, 추후 장기보존시험을 계속하여 신청한 사용기간에 대해\n\n- - 안정성시험 계획\n- - 38 -\n- - 안정성 시험 결과 요약\n- - 허가 후 안정성시험\n.  3 개 뱃치의 최소, 최대 포장 단위에 대해 장기보존시험을 실시하였으며, 0, 3, 6, 9, 12\n\n.  매년 1 개 이상 제조단위를 가지고 장기보존시험을 수행할 것이다.\n\n .  사용기간은 3 개 이상 제조단위의 장기보존시험 결과에 따라 연장될 수 있을 것이다.\n\n .  허가 후 안정성시험에서 부적합이 될 경우, 해당 뱃치를 회수할 것이다.\n\n",
        "original_sentence": ". "
      }
    },
    {
      "chunk_id": "chunk_546",
      "text": "사용기간은 3 개 이상 제조단위의 장기보존시험 결과에 따라 연장될 수 있을 것이다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 545,
        "window_size": 3,
        "char_count": 48,
        "word_count": 12,
        "page_number": 3,
        "window_text": "3 개 뱃치의 최소, 최대 포장 단위에 대해 장기보존시험을 실시하였으며, 0, 3, 6, 9, 12\n\n.  매년 1 개 이상 제조단위를 가지고 장기보존시험을 수행할 것이다.\n\n .  사용기간은 3 개 이상 제조단위의 장기보존시험 결과에 따라 연장될 수 있을 것이다.\n\n .  허가 후 안정성시험에서 부적합이 될 경우, 해당 뱃치를 회수할 것이다.\n\n - - 39 -\n2) 무균제제\n\n- ○ 무균제제의 경우 안정성시험 조건‧시험항목 등에 대해 비무균제제와 다르지 않으나, 시험항목\n- 2.3.P.8.1 안정성 요약 및 결론\n- - 무균시험 등과 관련된 안정성시험에 대해 요약하여 기재한다.\n",
        "original_sentence": "사용기간은 3 개 이상 제조단위의 장기보존시험 결과에 따라 연장될 수 있을 것이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_547",
      "text": ". ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 546,
        "window_size": 3,
        "char_count": 2,
        "word_count": 1,
        "page_number": 1,
        "window_text": "매년 1 개 이상 제조단위를 가지고 장기보존시험을 수행할 것이다.\n\n .  사용기간은 3 개 이상 제조단위의 장기보존시험 결과에 따라 연장될 수 있을 것이다.\n\n .  허가 후 안정성시험에서 부적합이 될 경우, 해당 뱃치를 회수할 것이다.\n\n - - 39 -\n2) 무균제제\n\n- ○ 무균제제의 경우 안정성시험 조건‧시험항목 등에 대해 비무균제제와 다르지 않으나, 시험항목\n- 2.3.P.8.1 안정성 요약 및 결론\n- - 무균시험 등과 관련된 안정성시험에 대해 요약하여 기재한다.\n - 2.3.P.8.2 허가 후 안정성시험 계획과 이행서약\n- - 허가 후 수행할 안정성시험 항목 중 무균시험 등 다음 사항을 포함하여 기재한다.\n",
        "original_sentence": ". "
      }
    },
    {
      "chunk_id": "chunk_548",
      "text": "허가 후 안정성시험에서 부적합이 될 경우, 해당 뱃치를 회수할 것이다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 547,
        "window_size": 3,
        "char_count": 41,
        "word_count": 10,
        "page_number": 3,
        "window_text": ".  사용기간은 3 개 이상 제조단위의 장기보존시험 결과에 따라 연장될 수 있을 것이다.\n\n .  허가 후 안정성시험에서 부적합이 될 경우, 해당 뱃치를 회수할 것이다.\n\n - - 39 -\n2) 무균제제\n\n- ○ 무균제제의 경우 안정성시험 조건‧시험항목 등에 대해 비무균제제와 다르지 않으나, 시험항목\n- 2.3.P.8.1 안정성 요약 및 결론\n- - 무균시험 등과 관련된 안정성시험에 대해 요약하여 기재한다.\n - 2.3.P.8.2 허가 후 안정성시험 계획과 이행서약\n- - 허가 후 수행할 안정성시험 항목 중 무균시험 등 다음 사항을 포함하여 기재한다.\n - - 안정성시험 시점\n- 2.3.P.8.3 안정성자료\n안정성자료에서는 용기/마개 완전성, 무균, 엔도톡신 등을 포함해 시험 결과를 요약 기재한다.\n\n",
        "original_sentence": "허가 후 안정성시험에서 부적합이 될 경우, 해당 뱃치를 회수할 것이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_549",
      "text": "- - 39 -\n2) 무균제제\n\n- ○ 무균제제의 경우 안정성시험 조건‧시험항목 등에 대해 비무균제제와 다르지 않으나, 시험항목\n- 2.3.P.8.1 안정성 요약 및 결론\n- - 무균시험 등과 관련된 안정성시험에 대해 요약하여 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 548,
        "window_size": 3,
        "char_count": 133,
        "word_count": 33,
        "page_number": 5,
        "window_text": "사용기간은 3 개 이상 제조단위의 장기보존시험 결과에 따라 연장될 수 있을 것이다.\n\n .  허가 후 안정성시험에서 부적합이 될 경우, 해당 뱃치를 회수할 것이다.\n\n - - 39 -\n2) 무균제제\n\n- ○ 무균제제의 경우 안정성시험 조건‧시험항목 등에 대해 비무균제제와 다르지 않으나, 시험항목\n- 2.3.P.8.1 안정성 요약 및 결론\n- - 무균시험 등과 관련된 안정성시험에 대해 요약하여 기재한다.\n - 2.3.P.8.2 허가 후 안정성시험 계획과 이행서약\n- - 허가 후 수행할 안정성시험 항목 중 무균시험 등 다음 사항을 포함하여 기재한다.\n - - 안정성시험 시점\n- 2.3.P.8.3 안정성자료\n안정성자료에서는 용기/마개 완전성, 무균, 엔도톡신 등을 포함해 시험 결과를 요약 기재한다.\n\n - - 40 -\n<!-- PAGE_46 -->\n##### 2.3.A 부록(Appendices)\n\n<!-- PAGE_46 -->\n##### 2.3.A.1 시설과 설비(Facilities and Equipment)\n\n- 3.2.A.1에 기재된 시설에 관한 내용의 요약이 포함되어야 한다.\n",
        "original_sentence": "- - 39 -\n2) 무균제제\n\n- ○ 무균제제의 경우 안정성시험 조건‧시험항목 등에 대해 비무균제제와 다르지 않으나, 시험항목\n- 2.3.P.8.1 안정성 요약 및 결론\n- - 무균시험 등과 관련된 안정성시험에 대해 요약하여 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_550",
      "text": "- 2.3.P.8.2 허가 후 안정성시험 계획과 이행서약\n- - 허가 후 수행할 안정성시험 항목 중 무균시험 등 다음 사항을 포함하여 기재한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 549,
        "window_size": 3,
        "char_count": 81,
        "word_count": 21,
        "page_number": 3,
        "window_text": ".  허가 후 안정성시험에서 부적합이 될 경우, 해당 뱃치를 회수할 것이다.\n\n - - 39 -\n2) 무균제제\n\n- ○ 무균제제의 경우 안정성시험 조건‧시험항목 등에 대해 비무균제제와 다르지 않으나, 시험항목\n- 2.3.P.8.1 안정성 요약 및 결론\n- - 무균시험 등과 관련된 안정성시험에 대해 요약하여 기재한다.\n - 2.3.P.8.2 허가 후 안정성시험 계획과 이행서약\n- - 허가 후 수행할 안정성시험 항목 중 무균시험 등 다음 사항을 포함하여 기재한다.\n - - 안정성시험 시점\n- 2.3.P.8.3 안정성자료\n안정성자료에서는 용기/마개 완전성, 무균, 엔도톡신 등을 포함해 시험 결과를 요약 기재한다.\n\n - - 40 -\n<!-- PAGE_46 -->\n##### 2.3.A 부록(Appendices)\n\n<!-- PAGE_46 -->\n##### 2.3.A.1 시설과 설비(Facilities and Equipment)\n\n- 3.2.A.1에 기재된 시설에 관한 내용의 요약이 포함되어야 한다.\n <!-- PAGE_46 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가(Adventitious Agents Safety Evaluation)\n\n생산 시 내인성 및 외래성 물질을 관리하기 위하여 실행된 방법에 대한 고찰이 포함되어야 한다.\n\n",
        "original_sentence": "- 2.3.P.8.2 허가 후 안정성시험 계획과 이행서약\n- - 허가 후 수행할 안정성시험 항목 중 무균시험 등 다음 사항을 포함하여 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_551",
      "text": "- - 안정성시험 시점\n- 2.3.P.8.3 안정성자료\n안정성자료에서는 용기/마개 완전성, 무균, 엔도톡신 등을 포함해 시험 결과를 요약 기재한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 550,
        "window_size": 3,
        "char_count": 84,
        "word_count": 18,
        "page_number": 5,
        "window_text": "허가 후 안정성시험에서 부적합이 될 경우, 해당 뱃치를 회수할 것이다.\n\n - - 39 -\n2) 무균제제\n\n- ○ 무균제제의 경우 안정성시험 조건‧시험항목 등에 대해 비무균제제와 다르지 않으나, 시험항목\n- 2.3.P.8.1 안정성 요약 및 결론\n- - 무균시험 등과 관련된 안정성시험에 대해 요약하여 기재한다.\n - 2.3.P.8.2 허가 후 안정성시험 계획과 이행서약\n- - 허가 후 수행할 안정성시험 항목 중 무균시험 등 다음 사항을 포함하여 기재한다.\n - - 안정성시험 시점\n- 2.3.P.8.3 안정성자료\n안정성자료에서는 용기/마개 완전성, 무균, 엔도톡신 등을 포함해 시험 결과를 요약 기재한다.\n\n - - 40 -\n<!-- PAGE_46 -->\n##### 2.3.A 부록(Appendices)\n\n<!-- PAGE_46 -->\n##### 2.3.A.1 시설과 설비(Facilities and Equipment)\n\n- 3.2.A.1에 기재된 시설에 관한 내용의 요약이 포함되어야 한다.\n <!-- PAGE_46 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가(Adventitious Agents Safety Evaluation)\n\n생산 시 내인성 및 외래성 물질을 관리하기 위하여 실행된 방법에 대한 고찰이 포함되어야 한다.\n\n - 3.2.A.2의 바이러스 제거 감소인수(reduction factor)에 대한 도표로 된 요약을 제공한다.\n",
        "original_sentence": "- - 안정성시험 시점\n- 2.3.P.8.3 안정성자료\n안정성자료에서는 용기/마개 완전성, 무균, 엔도톡신 등을 포함해 시험 결과를 요약 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_552",
      "text": "- - 40 -\n<!-- PAGE_46 -->\n##### 2.3.A 부록(Appendices)\n\n<!-- PAGE_46 -->\n##### 2.3.A.1 시설과 설비(Facilities and Equipment)\n\n- 3.2.A.1에 기재된 시설에 관한 내용의 요약이 포함되어야 한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 551,
        "window_size": 3,
        "char_count": 159,
        "word_count": 28,
        "page_number": 46,
        "window_text": "- - 39 -\n2) 무균제제\n\n- ○ 무균제제의 경우 안정성시험 조건‧시험항목 등에 대해 비무균제제와 다르지 않으나, 시험항목\n- 2.3.P.8.1 안정성 요약 및 결론\n- - 무균시험 등과 관련된 안정성시험에 대해 요약하여 기재한다.\n - 2.3.P.8.2 허가 후 안정성시험 계획과 이행서약\n- - 허가 후 수행할 안정성시험 항목 중 무균시험 등 다음 사항을 포함하여 기재한다.\n - - 안정성시험 시점\n- 2.3.P.8.3 안정성자료\n안정성자료에서는 용기/마개 완전성, 무균, 엔도톡신 등을 포함해 시험 결과를 요약 기재한다.\n\n - - 40 -\n<!-- PAGE_46 -->\n##### 2.3.A 부록(Appendices)\n\n<!-- PAGE_46 -->\n##### 2.3.A.1 시설과 설비(Facilities and Equipment)\n\n- 3.2.A.1에 기재된 시설에 관한 내용의 요약이 포함되어야 한다.\n <!-- PAGE_46 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가(Adventitious Agents Safety Evaluation)\n\n생산 시 내인성 및 외래성 물질을 관리하기 위하여 실행된 방법에 대한 고찰이 포함되어야 한다.\n\n - 3.2.A.2의 바이러스 제거 감소인수(reduction factor)에 대한 도표로 된 요약을 제공한다.\n <!-- PAGE_46 -->\n##### 2.3.A.3 첨가제(Excipients)\n\n<!-- PAGE_46 -->\n##### 2.3.R. ",
        "original_sentence": "- - 40 -\n<!-- PAGE_46 -->\n##### 2.3.A 부록(Appendices)\n\n<!-- PAGE_46 -->\n##### 2.3.A.1 시설과 설비(Facilities and Equipment)\n\n- 3.2.A.1에 기재된 시설에 관한 내용의 요약이 포함되어야 한다.\n"
      }
    },
    {
      "chunk_id": "chunk_553",
      "text": "<!-- PAGE_46 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가(Adventitious Agents Safety Evaluation)\n\n생산 시 내인성 및 외래성 물질을 관리하기 위하여 실행된 방법에 대한 고찰이 포함되어야 한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 552,
        "window_size": 3,
        "char_count": 143,
        "word_count": 27,
        "page_number": 46,
        "window_text": "- 2.3.P.8.2 허가 후 안정성시험 계획과 이행서약\n- - 허가 후 수행할 안정성시험 항목 중 무균시험 등 다음 사항을 포함하여 기재한다.\n - - 안정성시험 시점\n- 2.3.P.8.3 안정성자료\n안정성자료에서는 용기/마개 완전성, 무균, 엔도톡신 등을 포함해 시험 결과를 요약 기재한다.\n\n - - 40 -\n<!-- PAGE_46 -->\n##### 2.3.A 부록(Appendices)\n\n<!-- PAGE_46 -->\n##### 2.3.A.1 시설과 설비(Facilities and Equipment)\n\n- 3.2.A.1에 기재된 시설에 관한 내용의 요약이 포함되어야 한다.\n <!-- PAGE_46 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가(Adventitious Agents Safety Evaluation)\n\n생산 시 내인성 및 외래성 물질을 관리하기 위하여 실행된 방법에 대한 고찰이 포함되어야 한다.\n\n - 3.2.A.2의 바이러스 제거 감소인수(reduction factor)에 대한 도표로 된 요약을 제공한다.\n <!-- PAGE_46 -->\n##### 2.3.A.3 첨가제(Excipients)\n\n<!-- PAGE_46 -->\n##### 2.3.R.  지역별 정보(Regional Information)\n\n필요에 따라 3.2.R에 기재된 지역별 요구 사항에 대하여 간략하게 기재한다.\n\n",
        "original_sentence": "<!-- PAGE_46 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가(Adventitious Agents Safety Evaluation)\n\n생산 시 내인성 및 외래성 물질을 관리하기 위하여 실행된 방법에 대한 고찰이 포함되어야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_554",
      "text": "- 3.2.A.2의 바이러스 제거 감소인수(reduction factor)에 대한 도표로 된 요약을 제공한다.\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 553,
        "window_size": 3,
        "char_count": 62,
        "word_count": 11,
        "page_number": 3,
        "window_text": "- - 안정성시험 시점\n- 2.3.P.8.3 안정성자료\n안정성자료에서는 용기/마개 완전성, 무균, 엔도톡신 등을 포함해 시험 결과를 요약 기재한다.\n\n - - 40 -\n<!-- PAGE_46 -->\n##### 2.3.A 부록(Appendices)\n\n<!-- PAGE_46 -->\n##### 2.3.A.1 시설과 설비(Facilities and Equipment)\n\n- 3.2.A.1에 기재된 시설에 관한 내용의 요약이 포함되어야 한다.\n <!-- PAGE_46 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가(Adventitious Agents Safety Evaluation)\n\n생산 시 내인성 및 외래성 물질을 관리하기 위하여 실행된 방법에 대한 고찰이 포함되어야 한다.\n\n - 3.2.A.2의 바이러스 제거 감소인수(reduction factor)에 대한 도표로 된 요약을 제공한다.\n <!-- PAGE_46 -->\n##### 2.3.A.3 첨가제(Excipients)\n\n<!-- PAGE_46 -->\n##### 2.3.R.  지역별 정보(Regional Information)\n\n필요에 따라 3.2.R에 기재된 지역별 요구 사항에 대하여 간략하게 기재한다.\n\n - - 41 -\nAppendix. ",
        "original_sentence": "- 3.2.A.2의 바이러스 제거 감소인수(reduction factor)에 대한 도표로 된 요약을 제공한다.\n"
      }
    },
    {
      "chunk_id": "chunk_555",
      "text": "<!-- PAGE_46 -->\n##### 2.3.A.3 첨가제(Excipients)\n\n<!-- PAGE_46 -->\n##### 2.3.R. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 554,
        "window_size": 3,
        "char_count": 78,
        "word_count": 11,
        "page_number": 46,
        "window_text": "- - 40 -\n<!-- PAGE_46 -->\n##### 2.3.A 부록(Appendices)\n\n<!-- PAGE_46 -->\n##### 2.3.A.1 시설과 설비(Facilities and Equipment)\n\n- 3.2.A.1에 기재된 시설에 관한 내용의 요약이 포함되어야 한다.\n <!-- PAGE_46 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가(Adventitious Agents Safety Evaluation)\n\n생산 시 내인성 및 외래성 물질을 관리하기 위하여 실행된 방법에 대한 고찰이 포함되어야 한다.\n\n - 3.2.A.2의 바이러스 제거 감소인수(reduction factor)에 대한 도표로 된 요약을 제공한다.\n <!-- PAGE_46 -->\n##### 2.3.A.3 첨가제(Excipients)\n\n<!-- PAGE_46 -->\n##### 2.3.R.  지역별 정보(Regional Information)\n\n필요에 따라 3.2.R에 기재된 지역별 요구 사항에 대하여 간략하게 기재한다.\n\n - - 41 -\nAppendix.  속방성 및 서방성 제제의 개발경위 기재 예시 (FDA)\n\n완제의약품 개발에 영향을 미칠 것으로 판단되는 원료의약품에 대한 성질을 간단하게\n\n기재하였으며, 원료의약품에 대한 기본적인 정보를 포함한 기타 구체적인 사항은 3.2.S\n\n완제의약품 개발에 영향을 줄 것으로 판단되는 항목은 용해도, pH에 따른 용해도, 입자도,\n\n- 2.3.S.1에 요약된 사항을 참고한다. ",
        "original_sentence": "<!-- PAGE_46 -->\n##### 2.3.A.3 첨가제(Excipients)\n\n<!-- PAGE_46 -->\n##### 2.3.R. "
      }
    },
    {
      "chunk_id": "chunk_556",
      "text": "지역별 정보(Regional Information)\n\n필요에 따라 3.2.R에 기재된 지역별 요구 사항에 대하여 간략하게 기재한다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 555,
        "window_size": 3,
        "char_count": 75,
        "word_count": 13,
        "page_number": 5,
        "window_text": "<!-- PAGE_46 -->\n##### 2.3.A.2 외래성 물질에 대한 안전성 평가(Adventitious Agents Safety Evaluation)\n\n생산 시 내인성 및 외래성 물질을 관리하기 위하여 실행된 방법에 대한 고찰이 포함되어야 한다.\n\n - 3.2.A.2의 바이러스 제거 감소인수(reduction factor)에 대한 도표로 된 요약을 제공한다.\n <!-- PAGE_46 -->\n##### 2.3.A.3 첨가제(Excipients)\n\n<!-- PAGE_46 -->\n##### 2.3.R.  지역별 정보(Regional Information)\n\n필요에 따라 3.2.R에 기재된 지역별 요구 사항에 대하여 간략하게 기재한다.\n\n - - 41 -\nAppendix.  속방성 및 서방성 제제의 개발경위 기재 예시 (FDA)\n\n완제의약품 개발에 영향을 미칠 것으로 판단되는 원료의약품에 대한 성질을 간단하게\n\n기재하였으며, 원료의약품에 대한 기본적인 정보를 포함한 기타 구체적인 사항은 3.2.S\n\n완제의약품 개발에 영향을 줄 것으로 판단되는 항목은 용해도, pH에 따른 용해도, 입자도,\n\n- 2.3.S.1에 요약된 사항을 참고한다.  원료의약품은 생물학약제학적 분류체계(BCS)에\n따라 낮은 용해성 약물로 분류된다. ",
        "original_sentence": "지역별 정보(Regional Information)\n\n필요에 따라 3.2.R에 기재된 지역별 요구 사항에 대하여 간략하게 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_557",
      "text": "- - 41 -\nAppendix. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 556,
        "window_size": 3,
        "char_count": 19,
        "word_count": 5,
        "page_number": 5,
        "window_text": "- 3.2.A.2의 바이러스 제거 감소인수(reduction factor)에 대한 도표로 된 요약을 제공한다.\n <!-- PAGE_46 -->\n##### 2.3.A.3 첨가제(Excipients)\n\n<!-- PAGE_46 -->\n##### 2.3.R.  지역별 정보(Regional Information)\n\n필요에 따라 3.2.R에 기재된 지역별 요구 사항에 대하여 간략하게 기재한다.\n\n - - 41 -\nAppendix.  속방성 및 서방성 제제의 개발경위 기재 예시 (FDA)\n\n완제의약품 개발에 영향을 미칠 것으로 판단되는 원료의약품에 대한 성질을 간단하게\n\n기재하였으며, 원료의약품에 대한 기본적인 정보를 포함한 기타 구체적인 사항은 3.2.S\n\n완제의약품 개발에 영향을 줄 것으로 판단되는 항목은 용해도, pH에 따른 용해도, 입자도,\n\n- 2.3.S.1에 요약된 사항을 참고한다.  원료의약품은 생물학약제학적 분류체계(BCS)에\n따라 낮은 용해성 약물로 분류된다.  pH에 따라 용해도는 달라지며, pH가 낮을 때\n\n원료의약품의 용해도가 낮으므로 제제에서의 입자도가 중요하다. ",
        "original_sentence": "- - 41 -\nAppendix. "
      }
    },
    {
      "chunk_id": "chunk_558",
      "text": "속방성 및 서방성 제제의 개발경위 기재 예시 (FDA)\n\n완제의약품 개발에 영향을 미칠 것으로 판단되는 원료의약품에 대한 성질을 간단하게\n\n기재하였으며, 원료의약품에 대한 기본적인 정보를 포함한 기타 구체적인 사항은 3.2.S\n\n완제의약품 개발에 영향을 줄 것으로 판단되는 항목은 용해도, pH에 따른 용해도, 입자도,\n\n- 2.3.S.1에 요약된 사항을 참고한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 557,
        "window_size": 3,
        "char_count": 205,
        "word_count": 45,
        "page_number": 19,
        "window_text": "<!-- PAGE_46 -->\n##### 2.3.A.3 첨가제(Excipients)\n\n<!-- PAGE_46 -->\n##### 2.3.R.  지역별 정보(Regional Information)\n\n필요에 따라 3.2.R에 기재된 지역별 요구 사항에 대하여 간략하게 기재한다.\n\n - - 41 -\nAppendix.  속방성 및 서방성 제제의 개발경위 기재 예시 (FDA)\n\n완제의약품 개발에 영향을 미칠 것으로 판단되는 원료의약품에 대한 성질을 간단하게\n\n기재하였으며, 원료의약품에 대한 기본적인 정보를 포함한 기타 구체적인 사항은 3.2.S\n\n완제의약품 개발에 영향을 줄 것으로 판단되는 항목은 용해도, pH에 따른 용해도, 입자도,\n\n- 2.3.S.1에 요약된 사항을 참고한다.  원료의약품은 생물학약제학적 분류체계(BCS)에\n따라 낮은 용해성 약물로 분류된다.  pH에 따라 용해도는 달라지며, pH가 낮을 때\n\n원료의약품의 용해도가 낮으므로 제제에서의 입자도가 중요하다.  아래 그림은 입자\n\n도가 용출에 중요한 영향을 미침을 보여준다. ",
        "original_sentence": "속방성 및 서방성 제제의 개발경위 기재 예시 (FDA)\n\n완제의약품 개발에 영향을 미칠 것으로 판단되는 원료의약품에 대한 성질을 간단하게\n\n기재하였으며, 원료의약품에 대한 기본적인 정보를 포함한 기타 구체적인 사항은 3.2.S\n\n완제의약품 개발에 영향을 줄 것으로 판단되는 항목은 용해도, pH에 따른 용해도, 입자도,\n\n- 2.3.S.1에 요약된 사항을 참고한다. "
      }
    },
    {
      "chunk_id": "chunk_559",
      "text": "원료의약품은 생물학약제학적 분류체계(BCS)에\n따라 낮은 용해성 약물로 분류된다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 558,
        "window_size": 3,
        "char_count": 46,
        "word_count": 8,
        "page_number": 30,
        "window_text": "지역별 정보(Regional Information)\n\n필요에 따라 3.2.R에 기재된 지역별 요구 사항에 대하여 간략하게 기재한다.\n\n - - 41 -\nAppendix.  속방성 및 서방성 제제의 개발경위 기재 예시 (FDA)\n\n완제의약품 개발에 영향을 미칠 것으로 판단되는 원료의약품에 대한 성질을 간단하게\n\n기재하였으며, 원료의약품에 대한 기본적인 정보를 포함한 기타 구체적인 사항은 3.2.S\n\n완제의약품 개발에 영향을 줄 것으로 판단되는 항목은 용해도, pH에 따른 용해도, 입자도,\n\n- 2.3.S.1에 요약된 사항을 참고한다.  원료의약품은 생물학약제학적 분류체계(BCS)에\n따라 낮은 용해성 약물로 분류된다.  pH에 따라 용해도는 달라지며, pH가 낮을 때\n\n원료의약품의 용해도가 낮으므로 제제에서의 입자도가 중요하다.  아래 그림은 입자\n\n도가 용출에 중요한 영향을 미침을 보여준다.  원료의약품이 적절한 입자도(30 um)를\n\n- 2.3.S.1 일반정보에 결정형에 대해 상세히 기술하였다. ",
        "original_sentence": "원료의약품은 생물학약제학적 분류체계(BCS)에\n따라 낮은 용해성 약물로 분류된다. "
      }
    },
    {
      "chunk_id": "chunk_560",
      "text": "pH에 따라 용해도는 달라지며, pH가 낮을 때\n\n원료의약품의 용해도가 낮으므로 제제에서의 입자도가 중요하다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 559,
        "window_size": 3,
        "char_count": 62,
        "word_count": 13,
        "page_number": 56,
        "window_text": "- - 41 -\nAppendix.  속방성 및 서방성 제제의 개발경위 기재 예시 (FDA)\n\n완제의약품 개발에 영향을 미칠 것으로 판단되는 원료의약품에 대한 성질을 간단하게\n\n기재하였으며, 원료의약품에 대한 기본적인 정보를 포함한 기타 구체적인 사항은 3.2.S\n\n완제의약품 개발에 영향을 줄 것으로 판단되는 항목은 용해도, pH에 따른 용해도, 입자도,\n\n- 2.3.S.1에 요약된 사항을 참고한다.  원료의약품은 생물학약제학적 분류체계(BCS)에\n따라 낮은 용해성 약물로 분류된다.  pH에 따라 용해도는 달라지며, pH가 낮을 때\n\n원료의약품의 용해도가 낮으므로 제제에서의 입자도가 중요하다.  아래 그림은 입자\n\n도가 용출에 중요한 영향을 미침을 보여준다.  원료의약품이 적절한 입자도(30 um)를\n\n- 2.3.S.1 일반정보에 결정형에 대해 상세히 기술하였다.  결정형 II 형은 I 형보다 불안\n물에서의 용해도가 낮으며, 외부 압력에 대한 영향을 적게 받아 제조공정에 미치는\n\n- - 42 -\n√ 문헌연구: 이 약은 가혹조건(열, 빛, 습도)에 대한 문헌 보고서가 있으며, 빛에 대한\n\n√ 자체 안정성 연구: 결정형 I 및 II에 대해서 평가가 이루어졌으며, 가속 시험에서 II\n\n대조약에서 유당수화물, 스테아르산마그네슘, 미결정셀룰로오스를 사용하는 것으로 파악\n\n되므로, 위 첨가제는 원료의약품과 배합 가능하다고 판단된다. ",
        "original_sentence": "pH에 따라 용해도는 달라지며, pH가 낮을 때\n\n원료의약품의 용해도가 낮으므로 제제에서의 입자도가 중요하다. "
      }
    },
    {
      "chunk_id": "chunk_561",
      "text": "아래 그림은 입자\n\n도가 용출에 중요한 영향을 미침을 보여준다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 560,
        "window_size": 3,
        "char_count": 36,
        "word_count": 9,
        "page_number": 44,
        "window_text": "속방성 및 서방성 제제의 개발경위 기재 예시 (FDA)\n\n완제의약품 개발에 영향을 미칠 것으로 판단되는 원료의약품에 대한 성질을 간단하게\n\n기재하였으며, 원료의약품에 대한 기본적인 정보를 포함한 기타 구체적인 사항은 3.2.S\n\n완제의약품 개발에 영향을 줄 것으로 판단되는 항목은 용해도, pH에 따른 용해도, 입자도,\n\n- 2.3.S.1에 요약된 사항을 참고한다.  원료의약품은 생물학약제학적 분류체계(BCS)에\n따라 낮은 용해성 약물로 분류된다.  pH에 따라 용해도는 달라지며, pH가 낮을 때\n\n원료의약품의 용해도가 낮으므로 제제에서의 입자도가 중요하다.  아래 그림은 입자\n\n도가 용출에 중요한 영향을 미침을 보여준다.  원료의약품이 적절한 입자도(30 um)를\n\n- 2.3.S.1 일반정보에 결정형에 대해 상세히 기술하였다.  결정형 II 형은 I 형보다 불안\n물에서의 용해도가 낮으며, 외부 압력에 대한 영향을 적게 받아 제조공정에 미치는\n\n- - 42 -\n√ 문헌연구: 이 약은 가혹조건(열, 빛, 습도)에 대한 문헌 보고서가 있으며, 빛에 대한\n\n√ 자체 안정성 연구: 결정형 I 및 II에 대해서 평가가 이루어졌으며, 가속 시험에서 II\n\n대조약에서 유당수화물, 스테아르산마그네슘, 미결정셀룰로오스를 사용하는 것으로 파악\n\n되므로, 위 첨가제는 원료의약품과 배합 가능하다고 판단된다.  또한 배합적합성시험 결과,\n\n√ 완제의약품 개발 시 속방성 제제의 특성을 같이 고려하여 용출, 함량, 붕해, 안정성,\n\n√ 특히 USP 각조에 따르면 대조약은 pH 4.5 완충액에서 30 분 안에 즉시 용출된다고\n\n- - 43 -\n본 공정에 사용되는 방식인 습식과립법을 기준으로 각 첨가제에 대해 추천되는 등급\n\n(입자도 포함)을 사용하였으며, 유당수화물은 ... , 미결정셀룰로오스는 평균입도 ... ,\n\n제제 조성을 최적화하기 위해, 각 제제 조성에 대한 함량균일성시험 및 30 분간의\n\n광안정성시험 결과를 참조하여 차광이 되는 1차 포장 용기를 선택하였으며, 이 용기는\n\n미국약전 <661> “Containers-plastics\"에 따른 용기이다. ",
        "original_sentence": "아래 그림은 입자\n\n도가 용출에 중요한 영향을 미침을 보여준다. "
      }
    },
    {
      "chunk_id": "chunk_562",
      "text": "원료의약품이 적절한 입자도(30 um)를\n\n- 2.3.S.1 일반정보에 결정형에 대해 상세히 기술하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 561,
        "window_size": 3,
        "char_count": 59,
        "word_count": 11,
        "page_number": 3,
        "window_text": "원료의약품은 생물학약제학적 분류체계(BCS)에\n따라 낮은 용해성 약물로 분류된다.  pH에 따라 용해도는 달라지며, pH가 낮을 때\n\n원료의약품의 용해도가 낮으므로 제제에서의 입자도가 중요하다.  아래 그림은 입자\n\n도가 용출에 중요한 영향을 미침을 보여준다.  원료의약품이 적절한 입자도(30 um)를\n\n- 2.3.S.1 일반정보에 결정형에 대해 상세히 기술하였다.  결정형 II 형은 I 형보다 불안\n물에서의 용해도가 낮으며, 외부 압력에 대한 영향을 적게 받아 제조공정에 미치는\n\n- - 42 -\n√ 문헌연구: 이 약은 가혹조건(열, 빛, 습도)에 대한 문헌 보고서가 있으며, 빛에 대한\n\n√ 자체 안정성 연구: 결정형 I 및 II에 대해서 평가가 이루어졌으며, 가속 시험에서 II\n\n대조약에서 유당수화물, 스테아르산마그네슘, 미결정셀룰로오스를 사용하는 것으로 파악\n\n되므로, 위 첨가제는 원료의약품과 배합 가능하다고 판단된다.  또한 배합적합성시험 결과,\n\n√ 완제의약품 개발 시 속방성 제제의 특성을 같이 고려하여 용출, 함량, 붕해, 안정성,\n\n√ 특히 USP 각조에 따르면 대조약은 pH 4.5 완충액에서 30 분 안에 즉시 용출된다고\n\n- - 43 -\n본 공정에 사용되는 방식인 습식과립법을 기준으로 각 첨가제에 대해 추천되는 등급\n\n(입자도 포함)을 사용하였으며, 유당수화물은 ... , 미결정셀룰로오스는 평균입도 ... ,\n\n제제 조성을 최적화하기 위해, 각 제제 조성에 대한 함량균일성시험 및 30 분간의\n\n광안정성시험 결과를 참조하여 차광이 되는 1차 포장 용기를 선택하였으며, 이 용기는\n\n미국약전 <661> “Containers-plastics\"에 따른 용기이다.  이 용기를 다시 차광성이 있는\n\n- - 44 -\n주성분 ... 의 용량 용해도(dose solubility volume)는 0.68 mL이다 (2.3.S.1 일반정보\n\n다형과 같은 모든 고체 상태 특성들은 제조가능성 및 개발 상황과는 관계가 없을 것이다.\n\n",
        "original_sentence": "원료의약품이 적절한 입자도(30 um)를\n\n- 2.3.S.1 일반정보에 결정형에 대해 상세히 기술하였다. "
      }
    },
    {
      "chunk_id": "chunk_563",
      "text": "결정형 II 형은 I 형보다 불안\n물에서의 용해도가 낮으며, 외부 압력에 대한 영향을 적게 받아 제조공정에 미치는\n\n- - 42 -\n√ 문헌연구: 이 약은 가혹조건(열, 빛, 습도)에 대한 문헌 보고서가 있으며, 빛에 대한\n\n√ 자체 안정성 연구: 결정형 I 및 II에 대해서 평가가 이루어졌으며, 가속 시험에서 II\n\n대조약에서 유당수화물, 스테아르산마그네슘, 미결정셀룰로오스를 사용하는 것으로 파악\n\n되므로, 위 첨가제는 원료의약품과 배합 가능하다고 판단된다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 562,
        "window_size": 3,
        "char_count": 260,
        "word_count": 62,
        "page_number": 9,
        "window_text": "pH에 따라 용해도는 달라지며, pH가 낮을 때\n\n원료의약품의 용해도가 낮으므로 제제에서의 입자도가 중요하다.  아래 그림은 입자\n\n도가 용출에 중요한 영향을 미침을 보여준다.  원료의약품이 적절한 입자도(30 um)를\n\n- 2.3.S.1 일반정보에 결정형에 대해 상세히 기술하였다.  결정형 II 형은 I 형보다 불안\n물에서의 용해도가 낮으며, 외부 압력에 대한 영향을 적게 받아 제조공정에 미치는\n\n- - 42 -\n√ 문헌연구: 이 약은 가혹조건(열, 빛, 습도)에 대한 문헌 보고서가 있으며, 빛에 대한\n\n√ 자체 안정성 연구: 결정형 I 및 II에 대해서 평가가 이루어졌으며, 가속 시험에서 II\n\n대조약에서 유당수화물, 스테아르산마그네슘, 미결정셀룰로오스를 사용하는 것으로 파악\n\n되므로, 위 첨가제는 원료의약품과 배합 가능하다고 판단된다.  또한 배합적합성시험 결과,\n\n√ 완제의약품 개발 시 속방성 제제의 특성을 같이 고려하여 용출, 함량, 붕해, 안정성,\n\n√ 특히 USP 각조에 따르면 대조약은 pH 4.5 완충액에서 30 분 안에 즉시 용출된다고\n\n- - 43 -\n본 공정에 사용되는 방식인 습식과립법을 기준으로 각 첨가제에 대해 추천되는 등급\n\n(입자도 포함)을 사용하였으며, 유당수화물은 ... , 미결정셀룰로오스는 평균입도 ... ,\n\n제제 조성을 최적화하기 위해, 각 제제 조성에 대한 함량균일성시험 및 30 분간의\n\n광안정성시험 결과를 참조하여 차광이 되는 1차 포장 용기를 선택하였으며, 이 용기는\n\n미국약전 <661> “Containers-plastics\"에 따른 용기이다.  이 용기를 다시 차광성이 있는\n\n- - 44 -\n주성분 ... 의 용량 용해도(dose solubility volume)는 0.68 mL이다 (2.3.S.1 일반정보\n\n다형과 같은 모든 고체 상태 특성들은 제조가능성 및 개발 상황과는 관계가 없을 것이다.\n\n 초기 제제 조성 단계에 주성분 ... 와 첨가제들 간 배합 부적합성에 대해 알기 위해\n\n다수의 첨가제들에 대하여 배합적합성시험을 수행하였다. ",
        "original_sentence": "결정형 II 형은 I 형보다 불안\n물에서의 용해도가 낮으며, 외부 압력에 대한 영향을 적게 받아 제조공정에 미치는\n\n- - 42 -\n√ 문헌연구: 이 약은 가혹조건(열, 빛, 습도)에 대한 문헌 보고서가 있으며, 빛에 대한\n\n√ 자체 안정성 연구: 결정형 I 및 II에 대해서 평가가 이루어졌으며, 가속 시험에서 II\n\n대조약에서 유당수화물, 스테아르산마그네슘, 미결정셀룰로오스를 사용하는 것으로 파악\n\n되므로, 위 첨가제는 원료의약품과 배합 가능하다고 판단된다. "
      }
    },
    {
      "chunk_id": "chunk_564",
      "text": "또한 배합적합성시험 결과,\n\n√ 완제의약품 개발 시 속방성 제제의 특성을 같이 고려하여 용출, 함량, 붕해, 안정성,\n\n√ 특히 USP 각조에 따르면 대조약은 pH 4.5 완충액에서 30 분 안에 즉시 용출된다고\n\n- - 43 -\n본 공정에 사용되는 방식인 습식과립법을 기준으로 각 첨가제에 대해 추천되는 등급\n\n(입자도 포함)을 사용하였으며, 유당수화물은 ... , 미결정셀룰로오스는 평균입도 ... ,\n\n제제 조성을 최적화하기 위해, 각 제제 조성에 대한 함량균일성시험 및 30 분간의\n\n광안정성시험 결과를 참조하여 차광이 되는 1차 포장 용기를 선택하였으며, 이 용기는\n\n미국약전 <661> “Containers-plastics\"에 따른 용기이다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 563,
        "window_size": 3,
        "char_count": 366,
        "word_count": 83,
        "page_number": 3,
        "window_text": "아래 그림은 입자\n\n도가 용출에 중요한 영향을 미침을 보여준다.  원료의약품이 적절한 입자도(30 um)를\n\n- 2.3.S.1 일반정보에 결정형에 대해 상세히 기술하였다.  결정형 II 형은 I 형보다 불안\n물에서의 용해도가 낮으며, 외부 압력에 대한 영향을 적게 받아 제조공정에 미치는\n\n- - 42 -\n√ 문헌연구: 이 약은 가혹조건(열, 빛, 습도)에 대한 문헌 보고서가 있으며, 빛에 대한\n\n√ 자체 안정성 연구: 결정형 I 및 II에 대해서 평가가 이루어졌으며, 가속 시험에서 II\n\n대조약에서 유당수화물, 스테아르산마그네슘, 미결정셀룰로오스를 사용하는 것으로 파악\n\n되므로, 위 첨가제는 원료의약품과 배합 가능하다고 판단된다.  또한 배합적합성시험 결과,\n\n√ 완제의약품 개발 시 속방성 제제의 특성을 같이 고려하여 용출, 함량, 붕해, 안정성,\n\n√ 특히 USP 각조에 따르면 대조약은 pH 4.5 완충액에서 30 분 안에 즉시 용출된다고\n\n- - 43 -\n본 공정에 사용되는 방식인 습식과립법을 기준으로 각 첨가제에 대해 추천되는 등급\n\n(입자도 포함)을 사용하였으며, 유당수화물은 ... , 미결정셀룰로오스는 평균입도 ... ,\n\n제제 조성을 최적화하기 위해, 각 제제 조성에 대한 함량균일성시험 및 30 분간의\n\n광안정성시험 결과를 참조하여 차광이 되는 1차 포장 용기를 선택하였으며, 이 용기는\n\n미국약전 <661> “Containers-plastics\"에 따른 용기이다.  이 용기를 다시 차광성이 있는\n\n- - 44 -\n주성분 ... 의 용량 용해도(dose solubility volume)는 0.68 mL이다 (2.3.S.1 일반정보\n\n다형과 같은 모든 고체 상태 특성들은 제조가능성 및 개발 상황과는 관계가 없을 것이다.\n\n 초기 제제 조성 단계에 주성분 ... 와 첨가제들 간 배합 부적합성에 대해 알기 위해\n\n다수의 첨가제들에 대하여 배합적합성시험을 수행하였다.  주성분 ... 와 첨가제들로\n\n이루어진 구형 백당의 수분 코팅이 이루어지는 제조공정과 유사하게 하기 위하여 물을\n\n10 % 추가하여 주성분-첨가제 혼합물 200 mg을 밀폐된 바이알에 넣고 50 ℃에 3 주간\n\n방치하였다. ",
        "original_sentence": "또한 배합적합성시험 결과,\n\n√ 완제의약품 개발 시 속방성 제제의 특성을 같이 고려하여 용출, 함량, 붕해, 안정성,\n\n√ 특히 USP 각조에 따르면 대조약은 pH 4.5 완충액에서 30 분 안에 즉시 용출된다고\n\n- - 43 -\n본 공정에 사용되는 방식인 습식과립법을 기준으로 각 첨가제에 대해 추천되는 등급\n\n(입자도 포함)을 사용하였으며, 유당수화물은 ... , 미결정셀룰로오스는 평균입도 ... ,\n\n제제 조성을 최적화하기 위해, 각 제제 조성에 대한 함량균일성시험 및 30 분간의\n\n광안정성시험 결과를 참조하여 차광이 되는 1차 포장 용기를 선택하였으며, 이 용기는\n\n미국약전 <661> “Containers-plastics\"에 따른 용기이다. "
      }
    },
    {
      "chunk_id": "chunk_565",
      "text": "이 용기를 다시 차광성이 있는\n\n- - 44 -\n주성분 ... 의 용량 용해도(dose solubility volume)는 0.68 mL이다 (2.3.S.1 일반정보\n\n다형과 같은 모든 고체 상태 특성들은 제조가능성 및 개발 상황과는 관계가 없을 것이다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 564,
        "window_size": 3,
        "char_count": 144,
        "word_count": 33,
        "page_number": 3,
        "window_text": "원료의약품이 적절한 입자도(30 um)를\n\n- 2.3.S.1 일반정보에 결정형에 대해 상세히 기술하였다.  결정형 II 형은 I 형보다 불안\n물에서의 용해도가 낮으며, 외부 압력에 대한 영향을 적게 받아 제조공정에 미치는\n\n- - 42 -\n√ 문헌연구: 이 약은 가혹조건(열, 빛, 습도)에 대한 문헌 보고서가 있으며, 빛에 대한\n\n√ 자체 안정성 연구: 결정형 I 및 II에 대해서 평가가 이루어졌으며, 가속 시험에서 II\n\n대조약에서 유당수화물, 스테아르산마그네슘, 미결정셀룰로오스를 사용하는 것으로 파악\n\n되므로, 위 첨가제는 원료의약품과 배합 가능하다고 판단된다.  또한 배합적합성시험 결과,\n\n√ 완제의약품 개발 시 속방성 제제의 특성을 같이 고려하여 용출, 함량, 붕해, 안정성,\n\n√ 특히 USP 각조에 따르면 대조약은 pH 4.5 완충액에서 30 분 안에 즉시 용출된다고\n\n- - 43 -\n본 공정에 사용되는 방식인 습식과립법을 기준으로 각 첨가제에 대해 추천되는 등급\n\n(입자도 포함)을 사용하였으며, 유당수화물은 ... , 미결정셀룰로오스는 평균입도 ... ,\n\n제제 조성을 최적화하기 위해, 각 제제 조성에 대한 함량균일성시험 및 30 분간의\n\n광안정성시험 결과를 참조하여 차광이 되는 1차 포장 용기를 선택하였으며, 이 용기는\n\n미국약전 <661> “Containers-plastics\"에 따른 용기이다.  이 용기를 다시 차광성이 있는\n\n- - 44 -\n주성분 ... 의 용량 용해도(dose solubility volume)는 0.68 mL이다 (2.3.S.1 일반정보\n\n다형과 같은 모든 고체 상태 특성들은 제조가능성 및 개발 상황과는 관계가 없을 것이다.\n\n 초기 제제 조성 단계에 주성분 ... 와 첨가제들 간 배합 부적합성에 대해 알기 위해\n\n다수의 첨가제들에 대하여 배합적합성시험을 수행하였다.  주성분 ... 와 첨가제들로\n\n이루어진 구형 백당의 수분 코팅이 이루어지는 제조공정과 유사하게 하기 위하여 물을\n\n10 % 추가하여 주성분-첨가제 혼합물 200 mg을 밀폐된 바이알에 넣고 50 ℃에 3 주간\n\n방치하였다.  다양한 폴리머, 충진제, 희석제, 가소제들에 대한 3 주간의 예비 배합적합성\n\n시험 결과, 유당이 배합 부적합성을 보였다. ",
        "original_sentence": "이 용기를 다시 차광성이 있는\n\n- - 44 -\n주성분 ... 의 용량 용해도(dose solubility volume)는 0.68 mL이다 (2.3.S.1 일반정보\n\n다형과 같은 모든 고체 상태 특성들은 제조가능성 및 개발 상황과는 관계가 없을 것이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_566",
      "text": "초기 제제 조성 단계에 주성분 ... 와 첨가제들 간 배합 부적합성에 대해 알기 위해\n\n다수의 첨가제들에 대하여 배합적합성시험을 수행하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 565,
        "window_size": 3,
        "char_count": 79,
        "word_count": 19,
        "page_number": 14,
        "window_text": "결정형 II 형은 I 형보다 불안\n물에서의 용해도가 낮으며, 외부 압력에 대한 영향을 적게 받아 제조공정에 미치는\n\n- - 42 -\n√ 문헌연구: 이 약은 가혹조건(열, 빛, 습도)에 대한 문헌 보고서가 있으며, 빛에 대한\n\n√ 자체 안정성 연구: 결정형 I 및 II에 대해서 평가가 이루어졌으며, 가속 시험에서 II\n\n대조약에서 유당수화물, 스테아르산마그네슘, 미결정셀룰로오스를 사용하는 것으로 파악\n\n되므로, 위 첨가제는 원료의약품과 배합 가능하다고 판단된다.  또한 배합적합성시험 결과,\n\n√ 완제의약품 개발 시 속방성 제제의 특성을 같이 고려하여 용출, 함량, 붕해, 안정성,\n\n√ 특히 USP 각조에 따르면 대조약은 pH 4.5 완충액에서 30 분 안에 즉시 용출된다고\n\n- - 43 -\n본 공정에 사용되는 방식인 습식과립법을 기준으로 각 첨가제에 대해 추천되는 등급\n\n(입자도 포함)을 사용하였으며, 유당수화물은 ... , 미결정셀룰로오스는 평균입도 ... ,\n\n제제 조성을 최적화하기 위해, 각 제제 조성에 대한 함량균일성시험 및 30 분간의\n\n광안정성시험 결과를 참조하여 차광이 되는 1차 포장 용기를 선택하였으며, 이 용기는\n\n미국약전 <661> “Containers-plastics\"에 따른 용기이다.  이 용기를 다시 차광성이 있는\n\n- - 44 -\n주성분 ... 의 용량 용해도(dose solubility volume)는 0.68 mL이다 (2.3.S.1 일반정보\n\n다형과 같은 모든 고체 상태 특성들은 제조가능성 및 개발 상황과는 관계가 없을 것이다.\n\n 초기 제제 조성 단계에 주성분 ... 와 첨가제들 간 배합 부적합성에 대해 알기 위해\n\n다수의 첨가제들에 대하여 배합적합성시험을 수행하였다.  주성분 ... 와 첨가제들로\n\n이루어진 구형 백당의 수분 코팅이 이루어지는 제조공정과 유사하게 하기 위하여 물을\n\n10 % 추가하여 주성분-첨가제 혼합물 200 mg을 밀폐된 바이알에 넣고 50 ℃에 3 주간\n\n방치하였다.  다양한 폴리머, 충진제, 희석제, 가소제들에 대한 3 주간의 예비 배합적합성\n\n시험 결과, 유당이 배합 부적합성을 보였다.  이는 주성분 ... 의 구조 중 1차 아민과\n\n유당의 glycosidic hydroxyl 간의 반응(Maillard 반응)에 의한 것이었다. ",
        "original_sentence": "초기 제제 조성 단계에 주성분 ... 와 첨가제들 간 배합 부적합성에 대해 알기 위해\n\n다수의 첨가제들에 대하여 배합적합성시험을 수행하였다. "
      }
    },
    {
      "chunk_id": "chunk_567",
      "text": "주성분 ... 와 첨가제들로\n\n이루어진 구형 백당의 수분 코팅이 이루어지는 제조공정과 유사하게 하기 위하여 물을\n\n10 % 추가하여 주성분-첨가제 혼합물 200 mg을 밀폐된 바이알에 넣고 50 ℃에 3 주간\n\n방치하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 566,
        "window_size": 3,
        "char_count": 125,
        "word_count": 30,
        "page_number": 3,
        "window_text": "또한 배합적합성시험 결과,\n\n√ 완제의약품 개발 시 속방성 제제의 특성을 같이 고려하여 용출, 함량, 붕해, 안정성,\n\n√ 특히 USP 각조에 따르면 대조약은 pH 4.5 완충액에서 30 분 안에 즉시 용출된다고\n\n- - 43 -\n본 공정에 사용되는 방식인 습식과립법을 기준으로 각 첨가제에 대해 추천되는 등급\n\n(입자도 포함)을 사용하였으며, 유당수화물은 ... , 미결정셀룰로오스는 평균입도 ... ,\n\n제제 조성을 최적화하기 위해, 각 제제 조성에 대한 함량균일성시험 및 30 분간의\n\n광안정성시험 결과를 참조하여 차광이 되는 1차 포장 용기를 선택하였으며, 이 용기는\n\n미국약전 <661> “Containers-plastics\"에 따른 용기이다.  이 용기를 다시 차광성이 있는\n\n- - 44 -\n주성분 ... 의 용량 용해도(dose solubility volume)는 0.68 mL이다 (2.3.S.1 일반정보\n\n다형과 같은 모든 고체 상태 특성들은 제조가능성 및 개발 상황과는 관계가 없을 것이다.\n\n 초기 제제 조성 단계에 주성분 ... 와 첨가제들 간 배합 부적합성에 대해 알기 위해\n\n다수의 첨가제들에 대하여 배합적합성시험을 수행하였다.  주성분 ... 와 첨가제들로\n\n이루어진 구형 백당의 수분 코팅이 이루어지는 제조공정과 유사하게 하기 위하여 물을\n\n10 % 추가하여 주성분-첨가제 혼합물 200 mg을 밀폐된 바이알에 넣고 50 ℃에 3 주간\n\n방치하였다.  다양한 폴리머, 충진제, 희석제, 가소제들에 대한 3 주간의 예비 배합적합성\n\n시험 결과, 유당이 배합 부적합성을 보였다.  이는 주성분 ... 의 구조 중 1차 아민과\n\n유당의 glycosidic hydroxyl 간의 반응(Maillard 반응)에 의한 것이었다.  따라서 최종\n\n제제에서 선택된 모든 첨가제들을 포함하여 일반적으로 사용되는 첨가제들과 주성분\n\n... 는 배합적합성이 있는 것으로 결론지었다 (2.3.P.1 완제의약품의 개요와 조성 참조).\n\n",
        "original_sentence": "주성분 ... 와 첨가제들로\n\n이루어진 구형 백당의 수분 코팅이 이루어지는 제조공정과 유사하게 하기 위하여 물을\n\n10 % 추가하여 주성분-첨가제 혼합물 200 mg을 밀폐된 바이알에 넣고 50 ℃에 3 주간\n\n방치하였다. "
      }
    },
    {
      "chunk_id": "chunk_568",
      "text": "다양한 폴리머, 충진제, 희석제, 가소제들에 대한 3 주간의 예비 배합적합성\n\n시험 결과, 유당이 배합 부적합성을 보였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 567,
        "window_size": 3,
        "char_count": 69,
        "word_count": 16,
        "page_number": 14,
        "window_text": "이 용기를 다시 차광성이 있는\n\n- - 44 -\n주성분 ... 의 용량 용해도(dose solubility volume)는 0.68 mL이다 (2.3.S.1 일반정보\n\n다형과 같은 모든 고체 상태 특성들은 제조가능성 및 개발 상황과는 관계가 없을 것이다.\n\n 초기 제제 조성 단계에 주성분 ... 와 첨가제들 간 배합 부적합성에 대해 알기 위해\n\n다수의 첨가제들에 대하여 배합적합성시험을 수행하였다.  주성분 ... 와 첨가제들로\n\n이루어진 구형 백당의 수분 코팅이 이루어지는 제조공정과 유사하게 하기 위하여 물을\n\n10 % 추가하여 주성분-첨가제 혼합물 200 mg을 밀폐된 바이알에 넣고 50 ℃에 3 주간\n\n방치하였다.  다양한 폴리머, 충진제, 희석제, 가소제들에 대한 3 주간의 예비 배합적합성\n\n시험 결과, 유당이 배합 부적합성을 보였다.  이는 주성분 ... 의 구조 중 1차 아민과\n\n유당의 glycosidic hydroxyl 간의 반응(Maillard 반응)에 의한 것이었다.  따라서 최종\n\n제제에서 선택된 모든 첨가제들을 포함하여 일반적으로 사용되는 첨가제들과 주성분\n\n... 는 배합적합성이 있는 것으로 결론지었다 (2.3.P.1 완제의약품의 개요와 조성 참조).\n\n 그러나 유당 또는 glycosidic hydroxyl 또는 알데히드기를 갖는 다른 첨가제들은\n\nMaillard 반응 가능하므로 사용을 피해야 한다. ",
        "original_sentence": "다양한 폴리머, 충진제, 희석제, 가소제들에 대한 3 주간의 예비 배합적합성\n\n시험 결과, 유당이 배합 부적합성을 보였다. "
      }
    },
    {
      "chunk_id": "chunk_569",
      "text": "이는 주성분 ... 의 구조 중 1차 아민과\n\n유당의 glycosidic hydroxyl 간의 반응(Maillard 반응)에 의한 것이었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 568,
        "window_size": 3,
        "char_count": 79,
        "word_count": 16,
        "page_number": 3,
        "window_text": "초기 제제 조성 단계에 주성분 ... 와 첨가제들 간 배합 부적합성에 대해 알기 위해\n\n다수의 첨가제들에 대하여 배합적합성시험을 수행하였다.  주성분 ... 와 첨가제들로\n\n이루어진 구형 백당의 수분 코팅이 이루어지는 제조공정과 유사하게 하기 위하여 물을\n\n10 % 추가하여 주성분-첨가제 혼합물 200 mg을 밀폐된 바이알에 넣고 50 ℃에 3 주간\n\n방치하였다.  다양한 폴리머, 충진제, 희석제, 가소제들에 대한 3 주간의 예비 배합적합성\n\n시험 결과, 유당이 배합 부적합성을 보였다.  이는 주성분 ... 의 구조 중 1차 아민과\n\n유당의 glycosidic hydroxyl 간의 반응(Maillard 반응)에 의한 것이었다.  따라서 최종\n\n제제에서 선택된 모든 첨가제들을 포함하여 일반적으로 사용되는 첨가제들과 주성분\n\n... 는 배합적합성이 있는 것으로 결론지었다 (2.3.P.1 완제의약품의 개요와 조성 참조).\n\n 그러나 유당 또는 glycosidic hydroxyl 또는 알데히드기를 갖는 다른 첨가제들은\n\nMaillard 반응 가능하므로 사용을 피해야 한다.  상세한 사항은 3.2.P.2.1.2 첨가제를\n\n- - 45 -\n대조약과 유사하게 하기 위하여 대조약의 특성에 근거하여 제네릭의약품이 다음 네 가지\n\n- 2. ",
        "original_sentence": "이는 주성분 ... 의 구조 중 1차 아민과\n\n유당의 glycosidic hydroxyl 간의 반응(Maillard 반응)에 의한 것이었다. "
      }
    },
    {
      "chunk_id": "chunk_570",
      "text": "따라서 최종\n\n제제에서 선택된 모든 첨가제들을 포함하여 일반적으로 사용되는 첨가제들과 주성분\n\n... 는 배합적합성이 있는 것으로 결론지었다 (2.3.P.1 완제의약품의 개요와 조성 참조).\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 569,
        "window_size": 3,
        "char_count": 108,
        "word_count": 22,
        "page_number": 62,
        "window_text": "주성분 ... 와 첨가제들로\n\n이루어진 구형 백당의 수분 코팅이 이루어지는 제조공정과 유사하게 하기 위하여 물을\n\n10 % 추가하여 주성분-첨가제 혼합물 200 mg을 밀폐된 바이알에 넣고 50 ℃에 3 주간\n\n방치하였다.  다양한 폴리머, 충진제, 희석제, 가소제들에 대한 3 주간의 예비 배합적합성\n\n시험 결과, 유당이 배합 부적합성을 보였다.  이는 주성분 ... 의 구조 중 1차 아민과\n\n유당의 glycosidic hydroxyl 간의 반응(Maillard 반응)에 의한 것이었다.  따라서 최종\n\n제제에서 선택된 모든 첨가제들을 포함하여 일반적으로 사용되는 첨가제들과 주성분\n\n... 는 배합적합성이 있는 것으로 결론지었다 (2.3.P.1 완제의약품의 개요와 조성 참조).\n\n 그러나 유당 또는 glycosidic hydroxyl 또는 알데히드기를 갖는 다른 첨가제들은\n\nMaillard 반응 가능하므로 사용을 피해야 한다.  상세한 사항은 3.2.P.2.1.2 첨가제를\n\n- - 45 -\n대조약과 유사하게 하기 위하여 대조약의 특성에 근거하여 제네릭의약품이 다음 네 가지\n\n- 2.  캡슐은 코팅 펠렛으로 충진한다. ",
        "original_sentence": "따라서 최종\n\n제제에서 선택된 모든 첨가제들을 포함하여 일반적으로 사용되는 첨가제들과 주성분\n\n... 는 배합적합성이 있는 것으로 결론지었다 (2.3.P.1 완제의약품의 개요와 조성 참조).\n\n"
      }
    },
    {
      "chunk_id": "chunk_571",
      "text": "그러나 유당 또는 glycosidic hydroxyl 또는 알데히드기를 갖는 다른 첨가제들은\n\nMaillard 반응 가능하므로 사용을 피해야 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 570,
        "window_size": 3,
        "char_count": 83,
        "word_count": 16,
        "page_number": 50,
        "window_text": "다양한 폴리머, 충진제, 희석제, 가소제들에 대한 3 주간의 예비 배합적합성\n\n시험 결과, 유당이 배합 부적합성을 보였다.  이는 주성분 ... 의 구조 중 1차 아민과\n\n유당의 glycosidic hydroxyl 간의 반응(Maillard 반응)에 의한 것이었다.  따라서 최종\n\n제제에서 선택된 모든 첨가제들을 포함하여 일반적으로 사용되는 첨가제들과 주성분\n\n... 는 배합적합성이 있는 것으로 결론지었다 (2.3.P.1 완제의약품의 개요와 조성 참조).\n\n 그러나 유당 또는 glycosidic hydroxyl 또는 알데히드기를 갖는 다른 첨가제들은\n\nMaillard 반응 가능하므로 사용을 피해야 한다.  상세한 사항은 3.2.P.2.1.2 첨가제를\n\n- - 45 -\n대조약과 유사하게 하기 위하여 대조약의 특성에 근거하여 제네릭의약품이 다음 네 가지\n\n- 2.  캡슐은 코팅 펠렛으로 충진한다.  이는 대조약의 분석 및 허가사항에 근거한 것으로,\n캡슐을 삼키는데 어려움이 있는 환자들을 위하여 캡슐을 열고 스푼에 펠렛을 섞어서\n\n- 3. ",
        "original_sentence": "그러나 유당 또는 glycosidic hydroxyl 또는 알데히드기를 갖는 다른 첨가제들은\n\nMaillard 반응 가능하므로 사용을 피해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_572",
      "text": "상세한 사항은 3.2.P.2.1.2 첨가제를\n\n- - 45 -\n대조약과 유사하게 하기 위하여 대조약의 특성에 근거하여 제네릭의약품이 다음 네 가지\n\n- 2. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 571,
        "window_size": 3,
        "char_count": 88,
        "word_count": 21,
        "page_number": 2,
        "window_text": "이는 주성분 ... 의 구조 중 1차 아민과\n\n유당의 glycosidic hydroxyl 간의 반응(Maillard 반응)에 의한 것이었다.  따라서 최종\n\n제제에서 선택된 모든 첨가제들을 포함하여 일반적으로 사용되는 첨가제들과 주성분\n\n... 는 배합적합성이 있는 것으로 결론지었다 (2.3.P.1 완제의약품의 개요와 조성 참조).\n\n 그러나 유당 또는 glycosidic hydroxyl 또는 알데히드기를 갖는 다른 첨가제들은\n\nMaillard 반응 가능하므로 사용을 피해야 한다.  상세한 사항은 3.2.P.2.1.2 첨가제를\n\n- - 45 -\n대조약과 유사하게 하기 위하여 대조약의 특성에 근거하여 제네릭의약품이 다음 네 가지\n\n- 2.  캡슐은 코팅 펠렛으로 충진한다.  이는 대조약의 분석 및 허가사항에 근거한 것으로,\n캡슐을 삼키는데 어려움이 있는 환자들을 위하여 캡슐을 열고 스푼에 펠렛을 섞어서\n\n- 3.  코팅 펠렛의 크기는 1.0 mm 이하로 한다. ",
        "original_sentence": "상세한 사항은 3.2.P.2.1.2 첨가제를\n\n- - 45 -\n대조약과 유사하게 하기 위하여 대조약의 특성에 근거하여 제네릭의약품이 다음 네 가지\n\n- 2. "
      }
    },
    {
      "chunk_id": "chunk_573",
      "text": "캡슐은 코팅 펠렛으로 충진한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 572,
        "window_size": 3,
        "char_count": 18,
        "word_count": 4,
        "page_number": 13,
        "window_text": "따라서 최종\n\n제제에서 선택된 모든 첨가제들을 포함하여 일반적으로 사용되는 첨가제들과 주성분\n\n... 는 배합적합성이 있는 것으로 결론지었다 (2.3.P.1 완제의약품의 개요와 조성 참조).\n\n 그러나 유당 또는 glycosidic hydroxyl 또는 알데히드기를 갖는 다른 첨가제들은\n\nMaillard 반응 가능하므로 사용을 피해야 한다.  상세한 사항은 3.2.P.2.1.2 첨가제를\n\n- - 45 -\n대조약과 유사하게 하기 위하여 대조약의 특성에 근거하여 제네릭의약품이 다음 네 가지\n\n- 2.  캡슐은 코팅 펠렛으로 충진한다.  이는 대조약의 분석 및 허가사항에 근거한 것으로,\n캡슐을 삼키는데 어려움이 있는 환자들을 위하여 캡슐을 열고 스푼에 펠렛을 섞어서\n\n- 3.  코팅 펠렛의 크기는 1.0 mm 이하로 한다.  이는 대조약이 1.0 mm 이하 크기의 코팅\n펠렛을 함유하고 있다는 것에 따른 것이다. ",
        "original_sentence": "캡슐은 코팅 펠렛으로 충진한다. "
      }
    },
    {
      "chunk_id": "chunk_574",
      "text": "이는 대조약의 분석 및 허가사항에 근거한 것으로,\n캡슐을 삼키는데 어려움이 있는 환자들을 위하여 캡슐을 열고 스푼에 펠렛을 섞어서\n\n- 3. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 573,
        "window_size": 3,
        "char_count": 79,
        "word_count": 20,
        "page_number": 2,
        "window_text": "그러나 유당 또는 glycosidic hydroxyl 또는 알데히드기를 갖는 다른 첨가제들은\n\nMaillard 반응 가능하므로 사용을 피해야 한다.  상세한 사항은 3.2.P.2.1.2 첨가제를\n\n- - 45 -\n대조약과 유사하게 하기 위하여 대조약의 특성에 근거하여 제네릭의약품이 다음 네 가지\n\n- 2.  캡슐은 코팅 펠렛으로 충진한다.  이는 대조약의 분석 및 허가사항에 근거한 것으로,\n캡슐을 삼키는데 어려움이 있는 환자들을 위하여 캡슐을 열고 스푼에 펠렛을 섞어서\n\n- 3.  코팅 펠렛의 크기는 1.0 mm 이하로 한다.  이는 대조약이 1.0 mm 이하 크기의 코팅\n펠렛을 함유하고 있다는 것에 따른 것이다.  이러한 펠렛 크기는 유문 괄약근(pyloric\n\nsphincter)을 통과할 수 있을 만큼 작아서 식전 및 식후 상태 모두에서 비슷한 위 체류\n\n시간을 나타내도록 한다. ",
        "original_sentence": "이는 대조약의 분석 및 허가사항에 근거한 것으로,\n캡슐을 삼키는데 어려움이 있는 환자들을 위하여 캡슐을 열고 스푼에 펠렛을 섞어서\n\n- 3. "
      }
    },
    {
      "chunk_id": "chunk_575",
      "text": "코팅 펠렛의 크기는 1.0 mm 이하로 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 574,
        "window_size": 3,
        "char_count": 26,
        "word_count": 7,
        "page_number": 3,
        "window_text": "상세한 사항은 3.2.P.2.1.2 첨가제를\n\n- - 45 -\n대조약과 유사하게 하기 위하여 대조약의 특성에 근거하여 제네릭의약품이 다음 네 가지\n\n- 2.  캡슐은 코팅 펠렛으로 충진한다.  이는 대조약의 분석 및 허가사항에 근거한 것으로,\n캡슐을 삼키는데 어려움이 있는 환자들을 위하여 캡슐을 열고 스푼에 펠렛을 섞어서\n\n- 3.  코팅 펠렛의 크기는 1.0 mm 이하로 한다.  이는 대조약이 1.0 mm 이하 크기의 코팅\n펠렛을 함유하고 있다는 것에 따른 것이다.  이러한 펠렛 크기는 유문 괄약근(pyloric\n\nsphincter)을 통과할 수 있을 만큼 작아서 식전 및 식후 상태 모두에서 비슷한 위 체류\n\n시간을 나타내도록 한다.  식후 및 식전 생물학적동등성시험이 모두 요구되므로, 식전 및\n\n식후 상태에서 생물학적으로 동등한 서방성 제제를 성공적으로 개발하기 위하여 제품\n\n- 4. ",
        "original_sentence": "코팅 펠렛의 크기는 1.0 mm 이하로 한다. "
      }
    },
    {
      "chunk_id": "chunk_576",
      "text": "이는 대조약이 1.0 mm 이하 크기의 코팅\n펠렛을 함유하고 있다는 것에 따른 것이다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 575,
        "window_size": 3,
        "char_count": 49,
        "word_count": 13,
        "page_number": 3,
        "window_text": "캡슐은 코팅 펠렛으로 충진한다.  이는 대조약의 분석 및 허가사항에 근거한 것으로,\n캡슐을 삼키는데 어려움이 있는 환자들을 위하여 캡슐을 열고 스푼에 펠렛을 섞어서\n\n- 3.  코팅 펠렛의 크기는 1.0 mm 이하로 한다.  이는 대조약이 1.0 mm 이하 크기의 코팅\n펠렛을 함유하고 있다는 것에 따른 것이다.  이러한 펠렛 크기는 유문 괄약근(pyloric\n\nsphincter)을 통과할 수 있을 만큼 작아서 식전 및 식후 상태 모두에서 비슷한 위 체류\n\n시간을 나타내도록 한다.  식후 및 식전 생물학적동등성시험이 모두 요구되므로, 식전 및\n\n식후 상태에서 생물학적으로 동등한 서방성 제제를 성공적으로 개발하기 위하여 제품\n\n- 4.  아래 그림에 묘사한 대로, 용출시험 결과 대조약이 속방층(주성분 ... 함량 25%)과 서\n방층(주성분 함량 75%)으로 이루어졌음을 나타냈다. ",
        "original_sentence": "이는 대조약이 1.0 mm 이하 크기의 코팅\n펠렛을 함유하고 있다는 것에 따른 것이다. "
      }
    },
    {
      "chunk_id": "chunk_577",
      "text": "이러한 펠렛 크기는 유문 괄약근(pyloric\n\nsphincter)을 통과할 수 있을 만큼 작아서 식전 및 식후 상태 모두에서 비슷한 위 체류\n\n시간을 나타내도록 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 576,
        "window_size": 3,
        "char_count": 95,
        "word_count": 22,
        "page_number": 3,
        "window_text": "이는 대조약의 분석 및 허가사항에 근거한 것으로,\n캡슐을 삼키는데 어려움이 있는 환자들을 위하여 캡슐을 열고 스푼에 펠렛을 섞어서\n\n- 3.  코팅 펠렛의 크기는 1.0 mm 이하로 한다.  이는 대조약이 1.0 mm 이하 크기의 코팅\n펠렛을 함유하고 있다는 것에 따른 것이다.  이러한 펠렛 크기는 유문 괄약근(pyloric\n\nsphincter)을 통과할 수 있을 만큼 작아서 식전 및 식후 상태 모두에서 비슷한 위 체류\n\n시간을 나타내도록 한다.  식후 및 식전 생물학적동등성시험이 모두 요구되므로, 식전 및\n\n식후 상태에서 생물학적으로 동등한 서방성 제제를 성공적으로 개발하기 위하여 제품\n\n- 4.  아래 그림에 묘사한 대로, 용출시험 결과 대조약이 속방층(주성분 ... 함량 25%)과 서\n방층(주성분 함량 75%)으로 이루어졌음을 나타냈다.  따라서, 대조약과 생물학적으로\n\n- - 46 -\n대조약이 속방 및 서방 펠렛으로 구성되었다는 점에 근거하여 제네릭의약품도 속방 및\n\n서방 펠렛들은 속도를 조절하는 막(에틸셀룰로오스(소수성 폴리머, 기허가례에 근거하여\n\n선정) 및 시트르산트리에틸(가소제)로 구성)을 코팅하여 약물 방출을 조절하였다. ",
        "original_sentence": "이러한 펠렛 크기는 유문 괄약근(pyloric\n\nsphincter)을 통과할 수 있을 만큼 작아서 식전 및 식후 상태 모두에서 비슷한 위 체류\n\n시간을 나타내도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_578",
      "text": "식후 및 식전 생물학적동등성시험이 모두 요구되므로, 식전 및\n\n식후 상태에서 생물학적으로 동등한 서방성 제제를 성공적으로 개발하기 위하여 제품\n\n- 4. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 577,
        "window_size": 3,
        "char_count": 86,
        "word_count": 20,
        "page_number": 3,
        "window_text": "코팅 펠렛의 크기는 1.0 mm 이하로 한다.  이는 대조약이 1.0 mm 이하 크기의 코팅\n펠렛을 함유하고 있다는 것에 따른 것이다.  이러한 펠렛 크기는 유문 괄약근(pyloric\n\nsphincter)을 통과할 수 있을 만큼 작아서 식전 및 식후 상태 모두에서 비슷한 위 체류\n\n시간을 나타내도록 한다.  식후 및 식전 생물학적동등성시험이 모두 요구되므로, 식전 및\n\n식후 상태에서 생물학적으로 동등한 서방성 제제를 성공적으로 개발하기 위하여 제품\n\n- 4.  아래 그림에 묘사한 대로, 용출시험 결과 대조약이 속방층(주성분 ... 함량 25%)과 서\n방층(주성분 함량 75%)으로 이루어졌음을 나타냈다.  따라서, 대조약과 생물학적으로\n\n- - 46 -\n대조약이 속방 및 서방 펠렛으로 구성되었다는 점에 근거하여 제네릭의약품도 속방 및\n\n서방 펠렛들은 속도를 조절하는 막(에틸셀룰로오스(소수성 폴리머, 기허가례에 근거하여\n\n선정) 및 시트르산트리에틸(가소제)로 구성)을 코팅하여 약물 방출을 조절하였다.  이러한\n\n시스템에서 수용성 주성분 ... 의 소수성 막 통과가 감소함으로써 약물방출이 약화되고,\n\n이는 pH 비의존적으로 이루어진다. ",
        "original_sentence": "식후 및 식전 생물학적동등성시험이 모두 요구되므로, 식전 및\n\n식후 상태에서 생물학적으로 동등한 서방성 제제를 성공적으로 개발하기 위하여 제품\n\n- 4. "
      }
    },
    {
      "chunk_id": "chunk_579",
      "text": "아래 그림에 묘사한 대로, 용출시험 결과 대조약이 속방층(주성분 ... 함량 25%)과 서\n방층(주성분 함량 75%)으로 이루어졌음을 나타냈다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 578,
        "window_size": 3,
        "char_count": 81,
        "word_count": 17,
        "page_number": 3,
        "window_text": "이는 대조약이 1.0 mm 이하 크기의 코팅\n펠렛을 함유하고 있다는 것에 따른 것이다.  이러한 펠렛 크기는 유문 괄약근(pyloric\n\nsphincter)을 통과할 수 있을 만큼 작아서 식전 및 식후 상태 모두에서 비슷한 위 체류\n\n시간을 나타내도록 한다.  식후 및 식전 생물학적동등성시험이 모두 요구되므로, 식전 및\n\n식후 상태에서 생물학적으로 동등한 서방성 제제를 성공적으로 개발하기 위하여 제품\n\n- 4.  아래 그림에 묘사한 대로, 용출시험 결과 대조약이 속방층(주성분 ... 함량 25%)과 서\n방층(주성분 함량 75%)으로 이루어졌음을 나타냈다.  따라서, 대조약과 생물학적으로\n\n- - 46 -\n대조약이 속방 및 서방 펠렛으로 구성되었다는 점에 근거하여 제네릭의약품도 속방 및\n\n서방 펠렛들은 속도를 조절하는 막(에틸셀룰로오스(소수성 폴리머, 기허가례에 근거하여\n\n선정) 및 시트르산트리에틸(가소제)로 구성)을 코팅하여 약물 방출을 조절하였다.  이러한\n\n시스템에서 수용성 주성분 ... 의 소수성 막 통과가 감소함으로써 약물방출이 약화되고,\n\n이는 pH 비의존적으로 이루어진다.  제형 설계와 관련한 상세 정보는 3.2.P.2.2.1 제제\n\n개발 과정 중, 폴리머의 점도 및 속도 조절 막의 두께가 완제의약품의 용출 양상을 변경할\n\n제품 개발 중 두 가지 펠렛 제제 형태들이 평가되었다. ",
        "original_sentence": "아래 그림에 묘사한 대로, 용출시험 결과 대조약이 속방층(주성분 ... 함량 25%)과 서\n방층(주성분 함량 75%)으로 이루어졌음을 나타냈다. "
      }
    },
    {
      "chunk_id": "chunk_580",
      "text": "따라서, 대조약과 생물학적으로\n\n- - 46 -\n대조약이 속방 및 서방 펠렛으로 구성되었다는 점에 근거하여 제네릭의약품도 속방 및\n\n서방 펠렛들은 속도를 조절하는 막(에틸셀룰로오스(소수성 폴리머, 기허가례에 근거하여\n\n선정) 및 시트르산트리에틸(가소제)로 구성)을 코팅하여 약물 방출을 조절하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 579,
        "window_size": 3,
        "char_count": 167,
        "word_count": 34,
        "page_number": 3,
        "window_text": "이러한 펠렛 크기는 유문 괄약근(pyloric\n\nsphincter)을 통과할 수 있을 만큼 작아서 식전 및 식후 상태 모두에서 비슷한 위 체류\n\n시간을 나타내도록 한다.  식후 및 식전 생물학적동등성시험이 모두 요구되므로, 식전 및\n\n식후 상태에서 생물학적으로 동등한 서방성 제제를 성공적으로 개발하기 위하여 제품\n\n- 4.  아래 그림에 묘사한 대로, 용출시험 결과 대조약이 속방층(주성분 ... 함량 25%)과 서\n방층(주성분 함량 75%)으로 이루어졌음을 나타냈다.  따라서, 대조약과 생물학적으로\n\n- - 46 -\n대조약이 속방 및 서방 펠렛으로 구성되었다는 점에 근거하여 제네릭의약품도 속방 및\n\n서방 펠렛들은 속도를 조절하는 막(에틸셀룰로오스(소수성 폴리머, 기허가례에 근거하여\n\n선정) 및 시트르산트리에틸(가소제)로 구성)을 코팅하여 약물 방출을 조절하였다.  이러한\n\n시스템에서 수용성 주성분 ... 의 소수성 막 통과가 감소함으로써 약물방출이 약화되고,\n\n이는 pH 비의존적으로 이루어진다.  제형 설계와 관련한 상세 정보는 3.2.P.2.2.1 제제\n\n개발 과정 중, 폴리머의 점도 및 속도 조절 막의 두께가 완제의약품의 용출 양상을 변경할\n\n제품 개발 중 두 가지 펠렛 제제 형태들이 평가되었다.  첫 번째 형태(I 형)는 캡슐에 두\n\n가지 펠렛(속방 펠렛 및 서방 펠렛) 혼합물이 충진된 형태이고, 두 번째 형태(II 형)는\n\n속방층 및 서방층으로 이루어진 한 가지 다층 펠렛이다. ",
        "original_sentence": "따라서, 대조약과 생물학적으로\n\n- - 46 -\n대조약이 속방 및 서방 펠렛으로 구성되었다는 점에 근거하여 제네릭의약품도 속방 및\n\n서방 펠렛들은 속도를 조절하는 막(에틸셀룰로오스(소수성 폴리머, 기허가례에 근거하여\n\n선정) 및 시트르산트리에틸(가소제)로 구성)을 코팅하여 약물 방출을 조절하였다. "
      }
    },
    {
      "chunk_id": "chunk_581",
      "text": "이러한\n\n시스템에서 수용성 주성분 ... 의 소수성 막 통과가 감소함으로써 약물방출이 약화되고,\n\n이는 pH 비의존적으로 이루어진다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 580,
        "window_size": 3,
        "char_count": 75,
        "word_count": 16,
        "page_number": 3,
        "window_text": "식후 및 식전 생물학적동등성시험이 모두 요구되므로, 식전 및\n\n식후 상태에서 생물학적으로 동등한 서방성 제제를 성공적으로 개발하기 위하여 제품\n\n- 4.  아래 그림에 묘사한 대로, 용출시험 결과 대조약이 속방층(주성분 ... 함량 25%)과 서\n방층(주성분 함량 75%)으로 이루어졌음을 나타냈다.  따라서, 대조약과 생물학적으로\n\n- - 46 -\n대조약이 속방 및 서방 펠렛으로 구성되었다는 점에 근거하여 제네릭의약품도 속방 및\n\n서방 펠렛들은 속도를 조절하는 막(에틸셀룰로오스(소수성 폴리머, 기허가례에 근거하여\n\n선정) 및 시트르산트리에틸(가소제)로 구성)을 코팅하여 약물 방출을 조절하였다.  이러한\n\n시스템에서 수용성 주성분 ... 의 소수성 막 통과가 감소함으로써 약물방출이 약화되고,\n\n이는 pH 비의존적으로 이루어진다.  제형 설계와 관련한 상세 정보는 3.2.P.2.2.1 제제\n\n개발 과정 중, 폴리머의 점도 및 속도 조절 막의 두께가 완제의약품의 용출 양상을 변경할\n\n제품 개발 중 두 가지 펠렛 제제 형태들이 평가되었다.  첫 번째 형태(I 형)는 캡슐에 두\n\n가지 펠렛(속방 펠렛 및 서방 펠렛) 혼합물이 충진된 형태이고, 두 번째 형태(II 형)는\n\n속방층 및 서방층으로 이루어진 한 가지 다층 펠렛이다.  결국은 속방 및 서방 펠렛 혼합\n\n물인 I 형으로 결정되었다. ",
        "original_sentence": "이러한\n\n시스템에서 수용성 주성분 ... 의 소수성 막 통과가 감소함으로써 약물방출이 약화되고,\n\n이는 pH 비의존적으로 이루어진다. "
      }
    },
    {
      "chunk_id": "chunk_582",
      "text": "제형 설계와 관련한 상세 정보는 3.2.P.2.2.1 제제\n\n개발 과정 중, 폴리머의 점도 및 속도 조절 막의 두께가 완제의약품의 용출 양상을 변경할\n\n제품 개발 중 두 가지 펠렛 제제 형태들이 평가되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 581,
        "window_size": 3,
        "char_count": 116,
        "word_count": 30,
        "page_number": 5,
        "window_text": "아래 그림에 묘사한 대로, 용출시험 결과 대조약이 속방층(주성분 ... 함량 25%)과 서\n방층(주성분 함량 75%)으로 이루어졌음을 나타냈다.  따라서, 대조약과 생물학적으로\n\n- - 46 -\n대조약이 속방 및 서방 펠렛으로 구성되었다는 점에 근거하여 제네릭의약품도 속방 및\n\n서방 펠렛들은 속도를 조절하는 막(에틸셀룰로오스(소수성 폴리머, 기허가례에 근거하여\n\n선정) 및 시트르산트리에틸(가소제)로 구성)을 코팅하여 약물 방출을 조절하였다.  이러한\n\n시스템에서 수용성 주성분 ... 의 소수성 막 통과가 감소함으로써 약물방출이 약화되고,\n\n이는 pH 비의존적으로 이루어진다.  제형 설계와 관련한 상세 정보는 3.2.P.2.2.1 제제\n\n개발 과정 중, 폴리머의 점도 및 속도 조절 막의 두께가 완제의약품의 용출 양상을 변경할\n\n제품 개발 중 두 가지 펠렛 제제 형태들이 평가되었다.  첫 번째 형태(I 형)는 캡슐에 두\n\n가지 펠렛(속방 펠렛 및 서방 펠렛) 혼합물이 충진된 형태이고, 두 번째 형태(II 형)는\n\n속방층 및 서방층으로 이루어진 한 가지 다층 펠렛이다.  결국은 속방 및 서방 펠렛 혼합\n\n물인 I 형으로 결정되었다.  이 결정은 속방 및 서방 펠렛을 각각 개발하는 것이 훨씬 쉽다는\n\n- - 47 -\n주성분 ... 가 구형 백당에 부착할 수 있도록 돕는 결합제로 Clear coating 732(히프로\n\n(소수성 폴리머)와 시트르산트리에틸(가소제)를 선택하였다. ",
        "original_sentence": "제형 설계와 관련한 상세 정보는 3.2.P.2.2.1 제제\n\n개발 과정 중, 폴리머의 점도 및 속도 조절 막의 두께가 완제의약품의 용출 양상을 변경할\n\n제품 개발 중 두 가지 펠렛 제제 형태들이 평가되었다. "
      }
    },
    {
      "chunk_id": "chunk_583",
      "text": "첫 번째 형태(I 형)는 캡슐에 두\n\n가지 펠렛(속방 펠렛 및 서방 펠렛) 혼합물이 충진된 형태이고, 두 번째 형태(II 형)는\n\n속방층 및 서방층으로 이루어진 한 가지 다층 펠렛이다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 582,
        "window_size": 3,
        "char_count": 104,
        "word_count": 27,
        "page_number": 3,
        "window_text": "따라서, 대조약과 생물학적으로\n\n- - 46 -\n대조약이 속방 및 서방 펠렛으로 구성되었다는 점에 근거하여 제네릭의약품도 속방 및\n\n서방 펠렛들은 속도를 조절하는 막(에틸셀룰로오스(소수성 폴리머, 기허가례에 근거하여\n\n선정) 및 시트르산트리에틸(가소제)로 구성)을 코팅하여 약물 방출을 조절하였다.  이러한\n\n시스템에서 수용성 주성분 ... 의 소수성 막 통과가 감소함으로써 약물방출이 약화되고,\n\n이는 pH 비의존적으로 이루어진다.  제형 설계와 관련한 상세 정보는 3.2.P.2.2.1 제제\n\n개발 과정 중, 폴리머의 점도 및 속도 조절 막의 두께가 완제의약품의 용출 양상을 변경할\n\n제품 개발 중 두 가지 펠렛 제제 형태들이 평가되었다.  첫 번째 형태(I 형)는 캡슐에 두\n\n가지 펠렛(속방 펠렛 및 서방 펠렛) 혼합물이 충진된 형태이고, 두 번째 형태(II 형)는\n\n속방층 및 서방층으로 이루어진 한 가지 다층 펠렛이다.  결국은 속방 및 서방 펠렛 혼합\n\n물인 I 형으로 결정되었다.  이 결정은 속방 및 서방 펠렛을 각각 개발하는 것이 훨씬 쉽다는\n\n- - 47 -\n주성분 ... 가 구형 백당에 부착할 수 있도록 돕는 결합제로 Clear coating 732(히프로\n\n(소수성 폴리머)와 시트르산트리에틸(가소제)를 선택하였다.  이는 기허가 유사 품목에서\n\n이들 첨가제들을 사용했던 경험과 주성분 ... 와 이 첨가제들의 배합적합성(2.3.P.2.1.2\n\n에틸셀룰로오스: 주성분 ... 의 방출을 약화시키는 소수성 폴리머인 에틸셀룰로오스는 다른\n\n점도를 갖는 여러 등급의 제품이 상용화 되어있다. ",
        "original_sentence": "첫 번째 형태(I 형)는 캡슐에 두\n\n가지 펠렛(속방 펠렛 및 서방 펠렛) 혼합물이 충진된 형태이고, 두 번째 형태(II 형)는\n\n속방층 및 서방층으로 이루어진 한 가지 다층 펠렛이다. "
      }
    },
    {
      "chunk_id": "chunk_584",
      "text": "결국은 속방 및 서방 펠렛 혼합\n\n물인 I 형으로 결정되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 583,
        "window_size": 3,
        "char_count": 35,
        "word_count": 10,
        "page_number": 21,
        "window_text": "이러한\n\n시스템에서 수용성 주성분 ... 의 소수성 막 통과가 감소함으로써 약물방출이 약화되고,\n\n이는 pH 비의존적으로 이루어진다.  제형 설계와 관련한 상세 정보는 3.2.P.2.2.1 제제\n\n개발 과정 중, 폴리머의 점도 및 속도 조절 막의 두께가 완제의약품의 용출 양상을 변경할\n\n제품 개발 중 두 가지 펠렛 제제 형태들이 평가되었다.  첫 번째 형태(I 형)는 캡슐에 두\n\n가지 펠렛(속방 펠렛 및 서방 펠렛) 혼합물이 충진된 형태이고, 두 번째 형태(II 형)는\n\n속방층 및 서방층으로 이루어진 한 가지 다층 펠렛이다.  결국은 속방 및 서방 펠렛 혼합\n\n물인 I 형으로 결정되었다.  이 결정은 속방 및 서방 펠렛을 각각 개발하는 것이 훨씬 쉽다는\n\n- - 47 -\n주성분 ... 가 구형 백당에 부착할 수 있도록 돕는 결합제로 Clear coating 732(히프로\n\n(소수성 폴리머)와 시트르산트리에틸(가소제)를 선택하였다.  이는 기허가 유사 품목에서\n\n이들 첨가제들을 사용했던 경험과 주성분 ... 와 이 첨가제들의 배합적합성(2.3.P.2.1.2\n\n에틸셀룰로오스: 주성분 ... 의 방출을 약화시키는 소수성 폴리머인 에틸셀룰로오스는 다른\n\n점도를 갖는 여러 등급의 제품이 상용화 되어있다.  이 첨가제는 제품 활성과 관련된 주요\n\n- - 48 -\n위 결과는 에틸셀룰로오스의 점도가 제품의 활성에 유의한 영향을 미친다는 것을 나타\n\n낸다. ",
        "original_sentence": "결국은 속방 및 서방 펠렛 혼합\n\n물인 I 형으로 결정되었다. "
      }
    },
    {
      "chunk_id": "chunk_585",
      "text": "이 결정은 속방 및 서방 펠렛을 각각 개발하는 것이 훨씬 쉽다는\n\n- - 47 -\n주성분 ... 가 구형 백당에 부착할 수 있도록 돕는 결합제로 Clear coating 732(히프로\n\n(소수성 폴리머)와 시트르산트리에틸(가소제)를 선택하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 584,
        "window_size": 3,
        "char_count": 137,
        "word_count": 32,
        "page_number": 3,
        "window_text": "제형 설계와 관련한 상세 정보는 3.2.P.2.2.1 제제\n\n개발 과정 중, 폴리머의 점도 및 속도 조절 막의 두께가 완제의약품의 용출 양상을 변경할\n\n제품 개발 중 두 가지 펠렛 제제 형태들이 평가되었다.  첫 번째 형태(I 형)는 캡슐에 두\n\n가지 펠렛(속방 펠렛 및 서방 펠렛) 혼합물이 충진된 형태이고, 두 번째 형태(II 형)는\n\n속방층 및 서방층으로 이루어진 한 가지 다층 펠렛이다.  결국은 속방 및 서방 펠렛 혼합\n\n물인 I 형으로 결정되었다.  이 결정은 속방 및 서방 펠렛을 각각 개발하는 것이 훨씬 쉽다는\n\n- - 47 -\n주성분 ... 가 구형 백당에 부착할 수 있도록 돕는 결합제로 Clear coating 732(히프로\n\n(소수성 폴리머)와 시트르산트리에틸(가소제)를 선택하였다.  이는 기허가 유사 품목에서\n\n이들 첨가제들을 사용했던 경험과 주성분 ... 와 이 첨가제들의 배합적합성(2.3.P.2.1.2\n\n에틸셀룰로오스: 주성분 ... 의 방출을 약화시키는 소수성 폴리머인 에틸셀룰로오스는 다른\n\n점도를 갖는 여러 등급의 제품이 상용화 되어있다.  이 첨가제는 제품 활성과 관련된 주요\n\n- - 48 -\n위 결과는 에틸셀룰로오스의 점도가 제품의 활성에 유의한 영향을 미친다는 것을 나타\n\n낸다.  따라서, 개발 및 제조 중 첨가제 점도 등급을 엄격히 관리하였다. ",
        "original_sentence": "이 결정은 속방 및 서방 펠렛을 각각 개발하는 것이 훨씬 쉽다는\n\n- - 47 -\n주성분 ... 가 구형 백당에 부착할 수 있도록 돕는 결합제로 Clear coating 732(히프로\n\n(소수성 폴리머)와 시트르산트리에틸(가소제)를 선택하였다. "
      }
    },
    {
      "chunk_id": "chunk_586",
      "text": "이는 기허가 유사 품목에서\n\n이들 첨가제들을 사용했던 경험과 주성분 ... 와 이 첨가제들의 배합적합성(2.3.P.2.1.2\n\n에틸셀룰로오스: 주성분 ... 의 방출을 약화시키는 소수성 폴리머인 에틸셀룰로오스는 다른\n\n점도를 갖는 여러 등급의 제품이 상용화 되어있다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 585,
        "window_size": 3,
        "char_count": 150,
        "word_count": 31,
        "page_number": 3,
        "window_text": "첫 번째 형태(I 형)는 캡슐에 두\n\n가지 펠렛(속방 펠렛 및 서방 펠렛) 혼합물이 충진된 형태이고, 두 번째 형태(II 형)는\n\n속방층 및 서방층으로 이루어진 한 가지 다층 펠렛이다.  결국은 속방 및 서방 펠렛 혼합\n\n물인 I 형으로 결정되었다.  이 결정은 속방 및 서방 펠렛을 각각 개발하는 것이 훨씬 쉽다는\n\n- - 47 -\n주성분 ... 가 구형 백당에 부착할 수 있도록 돕는 결합제로 Clear coating 732(히프로\n\n(소수성 폴리머)와 시트르산트리에틸(가소제)를 선택하였다.  이는 기허가 유사 품목에서\n\n이들 첨가제들을 사용했던 경험과 주성분 ... 와 이 첨가제들의 배합적합성(2.3.P.2.1.2\n\n에틸셀룰로오스: 주성분 ... 의 방출을 약화시키는 소수성 폴리머인 에틸셀룰로오스는 다른\n\n점도를 갖는 여러 등급의 제품이 상용화 되어있다.  이 첨가제는 제품 활성과 관련된 주요\n\n- - 48 -\n위 결과는 에틸셀룰로오스의 점도가 제품의 활성에 유의한 영향을 미친다는 것을 나타\n\n낸다.  따라서, 개발 및 제조 중 첨가제 점도 등급을 엄격히 관리하였다.  기허가 품목에\n\n구형 백당 : 제품 개발 중, 25 ~ 30 mesh의 입자 분포를 갖는 구형 백당을 선택하였다.\n\n",
        "original_sentence": "이는 기허가 유사 품목에서\n\n이들 첨가제들을 사용했던 경험과 주성분 ... 와 이 첨가제들의 배합적합성(2.3.P.2.1.2\n\n에틸셀룰로오스: 주성분 ... 의 방출을 약화시키는 소수성 폴리머인 에틸셀룰로오스는 다른\n\n점도를 갖는 여러 등급의 제품이 상용화 되어있다. "
      }
    },
    {
      "chunk_id": "chunk_587",
      "text": "이 첨가제는 제품 활성과 관련된 주요\n\n- - 48 -\n위 결과는 에틸셀룰로오스의 점도가 제품의 활성에 유의한 영향을 미친다는 것을 나타\n\n낸다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 586,
        "window_size": 3,
        "char_count": 82,
        "word_count": 22,
        "page_number": 3,
        "window_text": "결국은 속방 및 서방 펠렛 혼합\n\n물인 I 형으로 결정되었다.  이 결정은 속방 및 서방 펠렛을 각각 개발하는 것이 훨씬 쉽다는\n\n- - 47 -\n주성분 ... 가 구형 백당에 부착할 수 있도록 돕는 결합제로 Clear coating 732(히프로\n\n(소수성 폴리머)와 시트르산트리에틸(가소제)를 선택하였다.  이는 기허가 유사 품목에서\n\n이들 첨가제들을 사용했던 경험과 주성분 ... 와 이 첨가제들의 배합적합성(2.3.P.2.1.2\n\n에틸셀룰로오스: 주성분 ... 의 방출을 약화시키는 소수성 폴리머인 에틸셀룰로오스는 다른\n\n점도를 갖는 여러 등급의 제품이 상용화 되어있다.  이 첨가제는 제품 활성과 관련된 주요\n\n- - 48 -\n위 결과는 에틸셀룰로오스의 점도가 제품의 활성에 유의한 영향을 미친다는 것을 나타\n\n낸다.  따라서, 개발 및 제조 중 첨가제 점도 등급을 엄격히 관리하였다.  기허가 품목에\n\n구형 백당 : 제품 개발 중, 25 ~ 30 mesh의 입자 분포를 갖는 구형 백당을 선택하였다.\n\n 구형 백당의 입자 분포를 제한하는 것은 코팅 표면을 일정하게 하기 위함이다. ",
        "original_sentence": "이 첨가제는 제품 활성과 관련된 주요\n\n- - 48 -\n위 결과는 에틸셀룰로오스의 점도가 제품의 활성에 유의한 영향을 미친다는 것을 나타\n\n낸다. "
      }
    },
    {
      "chunk_id": "chunk_588",
      "text": "따라서, 개발 및 제조 중 첨가제 점도 등급을 엄격히 관리하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 587,
        "window_size": 3,
        "char_count": 37,
        "word_count": 10,
        "page_number": 28,
        "window_text": "이 결정은 속방 및 서방 펠렛을 각각 개발하는 것이 훨씬 쉽다는\n\n- - 47 -\n주성분 ... 가 구형 백당에 부착할 수 있도록 돕는 결합제로 Clear coating 732(히프로\n\n(소수성 폴리머)와 시트르산트리에틸(가소제)를 선택하였다.  이는 기허가 유사 품목에서\n\n이들 첨가제들을 사용했던 경험과 주성분 ... 와 이 첨가제들의 배합적합성(2.3.P.2.1.2\n\n에틸셀룰로오스: 주성분 ... 의 방출을 약화시키는 소수성 폴리머인 에틸셀룰로오스는 다른\n\n점도를 갖는 여러 등급의 제품이 상용화 되어있다.  이 첨가제는 제품 활성과 관련된 주요\n\n- - 48 -\n위 결과는 에틸셀룰로오스의 점도가 제품의 활성에 유의한 영향을 미친다는 것을 나타\n\n낸다.  따라서, 개발 및 제조 중 첨가제 점도 등급을 엄격히 관리하였다.  기허가 품목에\n\n구형 백당 : 제품 개발 중, 25 ~ 30 mesh의 입자 분포를 갖는 구형 백당을 선택하였다.\n\n 구형 백당의 입자 분포를 제한하는 것은 코팅 표면을 일정하게 하기 위함이다.  일정한\n\n표면의 구형 백당은 적용되는 코팅 수준에 따라 두께가 일정한 막으로 된 서방형 펠렛\n\n제조를 가능하게 한다. ",
        "original_sentence": "따라서, 개발 및 제조 중 첨가제 점도 등급을 엄격히 관리하였다. "
      }
    },
    {
      "chunk_id": "chunk_589",
      "text": "기허가 품목에\n\n구형 백당 : 제품 개발 중, 25 ~ 30 mesh의 입자 분포를 갖는 구형 백당을 선택하였다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 588,
        "window_size": 3,
        "char_count": 65,
        "word_count": 18,
        "page_number": 5,
        "window_text": "이는 기허가 유사 품목에서\n\n이들 첨가제들을 사용했던 경험과 주성분 ... 와 이 첨가제들의 배합적합성(2.3.P.2.1.2\n\n에틸셀룰로오스: 주성분 ... 의 방출을 약화시키는 소수성 폴리머인 에틸셀룰로오스는 다른\n\n점도를 갖는 여러 등급의 제품이 상용화 되어있다.  이 첨가제는 제품 활성과 관련된 주요\n\n- - 48 -\n위 결과는 에틸셀룰로오스의 점도가 제품의 활성에 유의한 영향을 미친다는 것을 나타\n\n낸다.  따라서, 개발 및 제조 중 첨가제 점도 등급을 엄격히 관리하였다.  기허가 품목에\n\n구형 백당 : 제품 개발 중, 25 ~ 30 mesh의 입자 분포를 갖는 구형 백당을 선택하였다.\n\n 구형 백당의 입자 분포를 제한하는 것은 코팅 표면을 일정하게 하기 위함이다.  일정한\n\n표면의 구형 백당은 적용되는 코팅 수준에 따라 두께가 일정한 막으로 된 서방형 펠렛\n\n제조를 가능하게 한다.  이는 일정하고 재현성 있는 약물 용출 양상을 보장하는 중요한\n\n요소이다. ",
        "original_sentence": "기허가 품목에\n\n구형 백당 : 제품 개발 중, 25 ~ 30 mesh의 입자 분포를 갖는 구형 백당을 선택하였다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_590",
      "text": "구형 백당의 입자 분포를 제한하는 것은 코팅 표면을 일정하게 하기 위함이다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 589,
        "window_size": 3,
        "char_count": 43,
        "word_count": 11,
        "page_number": 3,
        "window_text": "이 첨가제는 제품 활성과 관련된 주요\n\n- - 48 -\n위 결과는 에틸셀룰로오스의 점도가 제품의 활성에 유의한 영향을 미친다는 것을 나타\n\n낸다.  따라서, 개발 및 제조 중 첨가제 점도 등급을 엄격히 관리하였다.  기허가 품목에\n\n구형 백당 : 제품 개발 중, 25 ~ 30 mesh의 입자 분포를 갖는 구형 백당을 선택하였다.\n\n 구형 백당의 입자 분포를 제한하는 것은 코팅 표면을 일정하게 하기 위함이다.  일정한\n\n표면의 구형 백당은 적용되는 코팅 수준에 따라 두께가 일정한 막으로 된 서방형 펠렛\n\n제조를 가능하게 한다.  이는 일정하고 재현성 있는 약물 용출 양상을 보장하는 중요한\n\n요소이다.  추가적으로, 입자 크기를 25 ~ 30 mesh로 제한하는 것은 코팅 펠렛이 1.0\n\nmm 이하가 되도록 하고, 이는 주성분 ... 흡수에 대한 음식물의 영향을 최소화하는 중요한\n\n개발 초기 단계에 2.3.P.1 완제의약품의 개요와 조성에 기재된 최종 제제와 정성적으로\n\n비슷한 여러 가지 실험실 규모의 연구 제제에 대한 시험을 가속 시험조건(40 ℃/75%\n\n였으므로 다른 항산화제들을 함유하는 실험실 제제들을 가속 조건(40 ℃/75% RH, 4\n\n솔이 항산화 효과를 나타냈으나, 부틸레이티드히드록시아니솔의 효과가 훨씬 우수했으므로\n\n가수분해산물인 Impurity A는 활성 대사체로, 안전성 문제에 영향이 없으므로 제품\n\n- - 49 -\n* 괄호에 기재된 것을 제외하고 2.3.P.1 완제의약품의 개요와 조성에 기재된 제제와 정성\n\n용출에 미치는 방출 조절막 두께의 효과를 연구하기 위한 일련의 시험들을 수행하였다.\n\n",
        "original_sentence": "구형 백당의 입자 분포를 제한하는 것은 코팅 표면을 일정하게 하기 위함이다. "
      }
    },
    {
      "chunk_id": "chunk_591",
      "text": "일정한\n\n표면의 구형 백당은 적용되는 코팅 수준에 따라 두께가 일정한 막으로 된 서방형 펠렛\n\n제조를 가능하게 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 590,
        "window_size": 3,
        "char_count": 66,
        "word_count": 17,
        "page_number": 27,
        "window_text": "따라서, 개발 및 제조 중 첨가제 점도 등급을 엄격히 관리하였다.  기허가 품목에\n\n구형 백당 : 제품 개발 중, 25 ~ 30 mesh의 입자 분포를 갖는 구형 백당을 선택하였다.\n\n 구형 백당의 입자 분포를 제한하는 것은 코팅 표면을 일정하게 하기 위함이다.  일정한\n\n표면의 구형 백당은 적용되는 코팅 수준에 따라 두께가 일정한 막으로 된 서방형 펠렛\n\n제조를 가능하게 한다.  이는 일정하고 재현성 있는 약물 용출 양상을 보장하는 중요한\n\n요소이다.  추가적으로, 입자 크기를 25 ~ 30 mesh로 제한하는 것은 코팅 펠렛이 1.0\n\nmm 이하가 되도록 하고, 이는 주성분 ... 흡수에 대한 음식물의 영향을 최소화하는 중요한\n\n개발 초기 단계에 2.3.P.1 완제의약품의 개요와 조성에 기재된 최종 제제와 정성적으로\n\n비슷한 여러 가지 실험실 규모의 연구 제제에 대한 시험을 가속 시험조건(40 ℃/75%\n\n였으므로 다른 항산화제들을 함유하는 실험실 제제들을 가속 조건(40 ℃/75% RH, 4\n\n솔이 항산화 효과를 나타냈으나, 부틸레이티드히드록시아니솔의 효과가 훨씬 우수했으므로\n\n가수분해산물인 Impurity A는 활성 대사체로, 안전성 문제에 영향이 없으므로 제품\n\n- - 49 -\n* 괄호에 기재된 것을 제외하고 2.3.P.1 완제의약품의 개요와 조성에 기재된 제제와 정성\n\n용출에 미치는 방출 조절막 두께의 효과를 연구하기 위한 일련의 시험들을 수행하였다.\n\n 다양한 pH에서 주성분 ... 의 용해도가 유사하고 방출 조절막이 확산으로 제어된다는\n\n사실에 따라 연구용 제제에서 용출이 pH 비의존적이라는 것을 알아냈다. ",
        "original_sentence": "일정한\n\n표면의 구형 백당은 적용되는 코팅 수준에 따라 두께가 일정한 막으로 된 서방형 펠렛\n\n제조를 가능하게 한다. "
      }
    },
    {
      "chunk_id": "chunk_592",
      "text": "이는 일정하고 재현성 있는 약물 용출 양상을 보장하는 중요한\n\n요소이다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 591,
        "window_size": 3,
        "char_count": 41,
        "word_count": 10,
        "page_number": 3,
        "window_text": "기허가 품목에\n\n구형 백당 : 제품 개발 중, 25 ~ 30 mesh의 입자 분포를 갖는 구형 백당을 선택하였다.\n\n 구형 백당의 입자 분포를 제한하는 것은 코팅 표면을 일정하게 하기 위함이다.  일정한\n\n표면의 구형 백당은 적용되는 코팅 수준에 따라 두께가 일정한 막으로 된 서방형 펠렛\n\n제조를 가능하게 한다.  이는 일정하고 재현성 있는 약물 용출 양상을 보장하는 중요한\n\n요소이다.  추가적으로, 입자 크기를 25 ~ 30 mesh로 제한하는 것은 코팅 펠렛이 1.0\n\nmm 이하가 되도록 하고, 이는 주성분 ... 흡수에 대한 음식물의 영향을 최소화하는 중요한\n\n개발 초기 단계에 2.3.P.1 완제의약품의 개요와 조성에 기재된 최종 제제와 정성적으로\n\n비슷한 여러 가지 실험실 규모의 연구 제제에 대한 시험을 가속 시험조건(40 ℃/75%\n\n였으므로 다른 항산화제들을 함유하는 실험실 제제들을 가속 조건(40 ℃/75% RH, 4\n\n솔이 항산화 효과를 나타냈으나, 부틸레이티드히드록시아니솔의 효과가 훨씬 우수했으므로\n\n가수분해산물인 Impurity A는 활성 대사체로, 안전성 문제에 영향이 없으므로 제품\n\n- - 49 -\n* 괄호에 기재된 것을 제외하고 2.3.P.1 완제의약품의 개요와 조성에 기재된 제제와 정성\n\n용출에 미치는 방출 조절막 두께의 효과를 연구하기 위한 일련의 시험들을 수행하였다.\n\n 다양한 pH에서 주성분 ... 의 용해도가 유사하고 방출 조절막이 확산으로 제어된다는\n\n사실에 따라 연구용 제제에서 용출이 pH 비의존적이라는 것을 알아냈다.  이는 pH에\n\n따른 대조약의 관찰된 용출 양상과 일치하였다. ",
        "original_sentence": "이는 일정하고 재현성 있는 약물 용출 양상을 보장하는 중요한\n\n요소이다. "
      }
    },
    {
      "chunk_id": "chunk_593",
      "text": "추가적으로, 입자 크기를 25 ~ 30 mesh로 제한하는 것은 코팅 펠렛이 1.0\n\nmm 이하가 되도록 하고, 이는 주성분 ... 흡수에 대한 음식물의 영향을 최소화하는 중요한\n\n개발 초기 단계에 2.3.P.1 완제의약품의 개요와 조성에 기재된 최종 제제와 정성적으로\n\n비슷한 여러 가지 실험실 규모의 연구 제제에 대한 시험을 가속 시험조건(40 ℃/75%\n\n였으므로 다른 항산화제들을 함유하는 실험실 제제들을 가속 조건(40 ℃/75% RH, 4\n\n솔이 항산화 효과를 나타냈으나, 부틸레이티드히드록시아니솔의 효과가 훨씬 우수했으므로\n\n가수분해산물인 Impurity A는 활성 대사체로, 안전성 문제에 영향이 없으므로 제품\n\n- - 49 -\n* 괄호에 기재된 것을 제외하고 2.3.P.1 완제의약품의 개요와 조성에 기재된 제제와 정성\n\n용출에 미치는 방출 조절막 두께의 효과를 연구하기 위한 일련의 시험들을 수행하였다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 592,
        "window_size": 3,
        "char_count": 461,
        "word_count": 104,
        "page_number": 3,
        "window_text": "구형 백당의 입자 분포를 제한하는 것은 코팅 표면을 일정하게 하기 위함이다.  일정한\n\n표면의 구형 백당은 적용되는 코팅 수준에 따라 두께가 일정한 막으로 된 서방형 펠렛\n\n제조를 가능하게 한다.  이는 일정하고 재현성 있는 약물 용출 양상을 보장하는 중요한\n\n요소이다.  추가적으로, 입자 크기를 25 ~ 30 mesh로 제한하는 것은 코팅 펠렛이 1.0\n\nmm 이하가 되도록 하고, 이는 주성분 ... 흡수에 대한 음식물의 영향을 최소화하는 중요한\n\n개발 초기 단계에 2.3.P.1 완제의약품의 개요와 조성에 기재된 최종 제제와 정성적으로\n\n비슷한 여러 가지 실험실 규모의 연구 제제에 대한 시험을 가속 시험조건(40 ℃/75%\n\n였으므로 다른 항산화제들을 함유하는 실험실 제제들을 가속 조건(40 ℃/75% RH, 4\n\n솔이 항산화 효과를 나타냈으나, 부틸레이티드히드록시아니솔의 효과가 훨씬 우수했으므로\n\n가수분해산물인 Impurity A는 활성 대사체로, 안전성 문제에 영향이 없으므로 제품\n\n- - 49 -\n* 괄호에 기재된 것을 제외하고 2.3.P.1 완제의약품의 개요와 조성에 기재된 제제와 정성\n\n용출에 미치는 방출 조절막 두께의 효과를 연구하기 위한 일련의 시험들을 수행하였다.\n\n 다양한 pH에서 주성분 ... 의 용해도가 유사하고 방출 조절막이 확산으로 제어된다는\n\n사실에 따라 연구용 제제에서 용출이 pH 비의존적이라는 것을 알아냈다.  이는 pH에\n\n따른 대조약의 관찰된 용출 양상과 일치하였다.  따라서 서방 코팅(6%, 11%, 16%)의\n\n세 가지 연구용 제제를 설계하여 pH 6.8에서 대조약 용출 양상과 비교하였다. ",
        "original_sentence": "추가적으로, 입자 크기를 25 ~ 30 mesh로 제한하는 것은 코팅 펠렛이 1.0\n\nmm 이하가 되도록 하고, 이는 주성분 ... 흡수에 대한 음식물의 영향을 최소화하는 중요한\n\n개발 초기 단계에 2.3.P.1 완제의약품의 개요와 조성에 기재된 최종 제제와 정성적으로\n\n비슷한 여러 가지 실험실 규모의 연구 제제에 대한 시험을 가속 시험조건(40 ℃/75%\n\n였으므로 다른 항산화제들을 함유하는 실험실 제제들을 가속 조건(40 ℃/75% RH, 4\n\n솔이 항산화 효과를 나타냈으나, 부틸레이티드히드록시아니솔의 효과가 훨씬 우수했으므로\n\n가수분해산물인 Impurity A는 활성 대사체로, 안전성 문제에 영향이 없으므로 제품\n\n- - 49 -\n* 괄호에 기재된 것을 제외하고 2.3.P.1 완제의약품의 개요와 조성에 기재된 제제와 정성\n\n용출에 미치는 방출 조절막 두께의 효과를 연구하기 위한 일련의 시험들을 수행하였다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_594",
      "text": "다양한 pH에서 주성분 ... 의 용해도가 유사하고 방출 조절막이 확산으로 제어된다는\n\n사실에 따라 연구용 제제에서 용출이 pH 비의존적이라는 것을 알아냈다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 593,
        "window_size": 3,
        "char_count": 89,
        "word_count": 20,
        "page_number": 3,
        "window_text": "일정한\n\n표면의 구형 백당은 적용되는 코팅 수준에 따라 두께가 일정한 막으로 된 서방형 펠렛\n\n제조를 가능하게 한다.  이는 일정하고 재현성 있는 약물 용출 양상을 보장하는 중요한\n\n요소이다.  추가적으로, 입자 크기를 25 ~ 30 mesh로 제한하는 것은 코팅 펠렛이 1.0\n\nmm 이하가 되도록 하고, 이는 주성분 ... 흡수에 대한 음식물의 영향을 최소화하는 중요한\n\n개발 초기 단계에 2.3.P.1 완제의약품의 개요와 조성에 기재된 최종 제제와 정성적으로\n\n비슷한 여러 가지 실험실 규모의 연구 제제에 대한 시험을 가속 시험조건(40 ℃/75%\n\n였으므로 다른 항산화제들을 함유하는 실험실 제제들을 가속 조건(40 ℃/75% RH, 4\n\n솔이 항산화 효과를 나타냈으나, 부틸레이티드히드록시아니솔의 효과가 훨씬 우수했으므로\n\n가수분해산물인 Impurity A는 활성 대사체로, 안전성 문제에 영향이 없으므로 제품\n\n- - 49 -\n* 괄호에 기재된 것을 제외하고 2.3.P.1 완제의약품의 개요와 조성에 기재된 제제와 정성\n\n용출에 미치는 방출 조절막 두께의 효과를 연구하기 위한 일련의 시험들을 수행하였다.\n\n 다양한 pH에서 주성분 ... 의 용해도가 유사하고 방출 조절막이 확산으로 제어된다는\n\n사실에 따라 연구용 제제에서 용출이 pH 비의존적이라는 것을 알아냈다.  이는 pH에\n\n따른 대조약의 관찰된 용출 양상과 일치하였다.  따라서 서방 코팅(6%, 11%, 16%)의\n\n세 가지 연구용 제제를 설계하여 pH 6.8에서 대조약 용출 양상과 비교하였다.  이 시험\n\n- 2.3.P.2.3 제조공정개발\n- - 50 -\n코팅 공정\n\n완제의약품을 제조하기 위하여, bottom spray coating(Wurster coating) 공정을 속방\n\n- 1. ",
        "original_sentence": "다양한 pH에서 주성분 ... 의 용해도가 유사하고 방출 조절막이 확산으로 제어된다는\n\n사실에 따라 연구용 제제에서 용출이 pH 비의존적이라는 것을 알아냈다. "
      }
    },
    {
      "chunk_id": "chunk_595",
      "text": "이는 pH에\n\n따른 대조약의 관찰된 용출 양상과 일치하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 594,
        "window_size": 3,
        "char_count": 34,
        "word_count": 8,
        "page_number": 3,
        "window_text": "이는 일정하고 재현성 있는 약물 용출 양상을 보장하는 중요한\n\n요소이다.  추가적으로, 입자 크기를 25 ~ 30 mesh로 제한하는 것은 코팅 펠렛이 1.0\n\nmm 이하가 되도록 하고, 이는 주성분 ... 흡수에 대한 음식물의 영향을 최소화하는 중요한\n\n개발 초기 단계에 2.3.P.1 완제의약품의 개요와 조성에 기재된 최종 제제와 정성적으로\n\n비슷한 여러 가지 실험실 규모의 연구 제제에 대한 시험을 가속 시험조건(40 ℃/75%\n\n였으므로 다른 항산화제들을 함유하는 실험실 제제들을 가속 조건(40 ℃/75% RH, 4\n\n솔이 항산화 효과를 나타냈으나, 부틸레이티드히드록시아니솔의 효과가 훨씬 우수했으므로\n\n가수분해산물인 Impurity A는 활성 대사체로, 안전성 문제에 영향이 없으므로 제품\n\n- - 49 -\n* 괄호에 기재된 것을 제외하고 2.3.P.1 완제의약품의 개요와 조성에 기재된 제제와 정성\n\n용출에 미치는 방출 조절막 두께의 효과를 연구하기 위한 일련의 시험들을 수행하였다.\n\n 다양한 pH에서 주성분 ... 의 용해도가 유사하고 방출 조절막이 확산으로 제어된다는\n\n사실에 따라 연구용 제제에서 용출이 pH 비의존적이라는 것을 알아냈다.  이는 pH에\n\n따른 대조약의 관찰된 용출 양상과 일치하였다.  따라서 서방 코팅(6%, 11%, 16%)의\n\n세 가지 연구용 제제를 설계하여 pH 6.8에서 대조약 용출 양상과 비교하였다.  이 시험\n\n- 2.3.P.2.3 제조공정개발\n- - 50 -\n코팅 공정\n\n완제의약품을 제조하기 위하여, bottom spray coating(Wurster coating) 공정을 속방\n\n- 1.  Wuster 공정은 매우 일정한 코팅을 가능하게 한다. ",
        "original_sentence": "이는 pH에\n\n따른 대조약의 관찰된 용출 양상과 일치하였다. "
      }
    },
    {
      "chunk_id": "chunk_596",
      "text": "따라서 서방 코팅(6%, 11%, 16%)의\n\n세 가지 연구용 제제를 설계하여 pH 6.8에서 대조약 용출 양상과 비교하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 595,
        "window_size": 3,
        "char_count": 71,
        "word_count": 16,
        "page_number": 5,
        "window_text": "추가적으로, 입자 크기를 25 ~ 30 mesh로 제한하는 것은 코팅 펠렛이 1.0\n\nmm 이하가 되도록 하고, 이는 주성분 ... 흡수에 대한 음식물의 영향을 최소화하는 중요한\n\n개발 초기 단계에 2.3.P.1 완제의약품의 개요와 조성에 기재된 최종 제제와 정성적으로\n\n비슷한 여러 가지 실험실 규모의 연구 제제에 대한 시험을 가속 시험조건(40 ℃/75%\n\n였으므로 다른 항산화제들을 함유하는 실험실 제제들을 가속 조건(40 ℃/75% RH, 4\n\n솔이 항산화 효과를 나타냈으나, 부틸레이티드히드록시아니솔의 효과가 훨씬 우수했으므로\n\n가수분해산물인 Impurity A는 활성 대사체로, 안전성 문제에 영향이 없으므로 제품\n\n- - 49 -\n* 괄호에 기재된 것을 제외하고 2.3.P.1 완제의약품의 개요와 조성에 기재된 제제와 정성\n\n용출에 미치는 방출 조절막 두께의 효과를 연구하기 위한 일련의 시험들을 수행하였다.\n\n 다양한 pH에서 주성분 ... 의 용해도가 유사하고 방출 조절막이 확산으로 제어된다는\n\n사실에 따라 연구용 제제에서 용출이 pH 비의존적이라는 것을 알아냈다.  이는 pH에\n\n따른 대조약의 관찰된 용출 양상과 일치하였다.  따라서 서방 코팅(6%, 11%, 16%)의\n\n세 가지 연구용 제제를 설계하여 pH 6.8에서 대조약 용출 양상과 비교하였다.  이 시험\n\n- 2.3.P.2.3 제조공정개발\n- - 50 -\n코팅 공정\n\n완제의약품을 제조하기 위하여, bottom spray coating(Wurster coating) 공정을 속방\n\n- 1.  Wuster 공정은 매우 일정한 코팅을 가능하게 한다.  공정 설계 관점에서, 이는 함량\n- 2. ",
        "original_sentence": "따라서 서방 코팅(6%, 11%, 16%)의\n\n세 가지 연구용 제제를 설계하여 pH 6.8에서 대조약 용출 양상과 비교하였다. "
      }
    },
    {
      "chunk_id": "chunk_597",
      "text": "이 시험\n\n- 2.3.P.2.3 제조공정개발\n- - 50 -\n코팅 공정\n\n완제의약품을 제조하기 위하여, bottom spray coating(Wurster coating) 공정을 속방\n\n- 1. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 596,
        "window_size": 3,
        "char_count": 109,
        "word_count": 22,
        "page_number": 3,
        "window_text": "다양한 pH에서 주성분 ... 의 용해도가 유사하고 방출 조절막이 확산으로 제어된다는\n\n사실에 따라 연구용 제제에서 용출이 pH 비의존적이라는 것을 알아냈다.  이는 pH에\n\n따른 대조약의 관찰된 용출 양상과 일치하였다.  따라서 서방 코팅(6%, 11%, 16%)의\n\n세 가지 연구용 제제를 설계하여 pH 6.8에서 대조약 용출 양상과 비교하였다.  이 시험\n\n- 2.3.P.2.3 제조공정개발\n- - 50 -\n코팅 공정\n\n완제의약품을 제조하기 위하여, bottom spray coating(Wurster coating) 공정을 속방\n\n- 1.  Wuster 공정은 매우 일정한 코팅을 가능하게 한다.  공정 설계 관점에서, 이는 함량\n- 2.  Wurster 코팅 공정 구현 및 유사한 기능성 서방 코팅 기전에 대한 제조 관련 사전\n다른 제품의 충진 공정에 이용한 사전 지식에 기초하여 dosing disk와 질량 분급을\n\n이용한 캡슐 충진 공정을 선택하였다. ",
        "original_sentence": "이 시험\n\n- 2.3.P.2.3 제조공정개발\n- - 50 -\n코팅 공정\n\n완제의약품을 제조하기 위하여, bottom spray coating(Wurster coating) 공정을 속방\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_598",
      "text": "Wuster 공정은 매우 일정한 코팅을 가능하게 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 597,
        "window_size": 3,
        "char_count": 31,
        "word_count": 7,
        "page_number": 13,
        "window_text": "이는 pH에\n\n따른 대조약의 관찰된 용출 양상과 일치하였다.  따라서 서방 코팅(6%, 11%, 16%)의\n\n세 가지 연구용 제제를 설계하여 pH 6.8에서 대조약 용출 양상과 비교하였다.  이 시험\n\n- 2.3.P.2.3 제조공정개발\n- - 50 -\n코팅 공정\n\n완제의약품을 제조하기 위하여, bottom spray coating(Wurster coating) 공정을 속방\n\n- 1.  Wuster 공정은 매우 일정한 코팅을 가능하게 한다.  공정 설계 관점에서, 이는 함량\n- 2.  Wurster 코팅 공정 구현 및 유사한 기능성 서방 코팅 기전에 대한 제조 관련 사전\n다른 제품의 충진 공정에 이용한 사전 지식에 기초하여 dosing disk와 질량 분급을\n\n이용한 캡슐 충진 공정을 선택하였다.  하나의 캡슐에 충진된 두 가지 펠렛으로 제형을\n\n설계한 사실이 캡슐 충진 공정의 활용을 필요하게 한다. ",
        "original_sentence": "Wuster 공정은 매우 일정한 코팅을 가능하게 한다. "
      }
    },
    {
      "chunk_id": "chunk_599",
      "text": "공정 설계 관점에서, 이는 함량\n- 2. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 598,
        "window_size": 3,
        "char_count": 23,
        "word_count": 7,
        "page_number": 3,
        "window_text": "따라서 서방 코팅(6%, 11%, 16%)의\n\n세 가지 연구용 제제를 설계하여 pH 6.8에서 대조약 용출 양상과 비교하였다.  이 시험\n\n- 2.3.P.2.3 제조공정개발\n- - 50 -\n코팅 공정\n\n완제의약품을 제조하기 위하여, bottom spray coating(Wurster coating) 공정을 속방\n\n- 1.  Wuster 공정은 매우 일정한 코팅을 가능하게 한다.  공정 설계 관점에서, 이는 함량\n- 2.  Wurster 코팅 공정 구현 및 유사한 기능성 서방 코팅 기전에 대한 제조 관련 사전\n다른 제품의 충진 공정에 이용한 사전 지식에 기초하여 dosing disk와 질량 분급을\n\n이용한 캡슐 충진 공정을 선택하였다.  하나의 캡슐에 충진된 두 가지 펠렛으로 제형을\n\n설계한 사실이 캡슐 충진 공정의 활용을 필요하게 한다.  제조공정과 관련한 추가 상세\n\n완제의약품 품질 특성들과 관련 있는 공정 단계들에 대한 매트릭스를 구성하였다. ",
        "original_sentence": "공정 설계 관점에서, 이는 함량\n- 2. "
      }
    },
    {
      "chunk_id": "chunk_600",
      "text": "Wurster 코팅 공정 구현 및 유사한 기능성 서방 코팅 기전에 대한 제조 관련 사전\n다른 제품의 충진 공정에 이용한 사전 지식에 기초하여 dosing disk와 질량 분급을\n\n이용한 캡슐 충진 공정을 선택하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 599,
        "window_size": 3,
        "char_count": 121,
        "word_count": 31,
        "page_number": 26,
        "window_text": "이 시험\n\n- 2.3.P.2.3 제조공정개발\n- - 50 -\n코팅 공정\n\n완제의약품을 제조하기 위하여, bottom spray coating(Wurster coating) 공정을 속방\n\n- 1.  Wuster 공정은 매우 일정한 코팅을 가능하게 한다.  공정 설계 관점에서, 이는 함량\n- 2.  Wurster 코팅 공정 구현 및 유사한 기능성 서방 코팅 기전에 대한 제조 관련 사전\n다른 제품의 충진 공정에 이용한 사전 지식에 기초하여 dosing disk와 질량 분급을\n\n이용한 캡슐 충진 공정을 선택하였다.  하나의 캡슐에 충진된 두 가지 펠렛으로 제형을\n\n설계한 사실이 캡슐 충진 공정의 활용을 필요하게 한다.  제조공정과 관련한 추가 상세\n\n완제의약품 품질 특성들과 관련 있는 공정 단계들에 대한 매트릭스를 구성하였다.  약물\n\n품질에 높은 영향력을 갖는 공정단계가 확인된다. ",
        "original_sentence": "Wurster 코팅 공정 구현 및 유사한 기능성 서방 코팅 기전에 대한 제조 관련 사전\n다른 제품의 충진 공정에 이용한 사전 지식에 기초하여 dosing disk와 질량 분급을\n\n이용한 캡슐 충진 공정을 선택하였다. "
      }
    },
    {
      "chunk_id": "chunk_601",
      "text": "하나의 캡슐에 충진된 두 가지 펠렛으로 제형을\n\n설계한 사실이 캡슐 충진 공정의 활용을 필요하게 한다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 600,
        "window_size": 3,
        "char_count": 58,
        "word_count": 15,
        "page_number": 3,
        "window_text": "Wuster 공정은 매우 일정한 코팅을 가능하게 한다.  공정 설계 관점에서, 이는 함량\n- 2.  Wurster 코팅 공정 구현 및 유사한 기능성 서방 코팅 기전에 대한 제조 관련 사전\n다른 제품의 충진 공정에 이용한 사전 지식에 기초하여 dosing disk와 질량 분급을\n\n이용한 캡슐 충진 공정을 선택하였다.  하나의 캡슐에 충진된 두 가지 펠렛으로 제형을\n\n설계한 사실이 캡슐 충진 공정의 활용을 필요하게 한다.  제조공정과 관련한 추가 상세\n\n완제의약품 품질 특성들과 관련 있는 공정 단계들에 대한 매트릭스를 구성하였다.  약물\n\n품질에 높은 영향력을 갖는 공정단계가 확인된다.  공정단계가 성공적으로 진행되었음을\n\n요약하면, 대조약과 유사한 용출 양상을 구현하도록 속방 및 서방 펠렛을 혼합하여\n\n캡슐화하는 것으로 제품이 설계되었다. ",
        "original_sentence": "하나의 캡슐에 충진된 두 가지 펠렛으로 제형을\n\n설계한 사실이 캡슐 충진 공정의 활용을 필요하게 한다. "
      }
    },
    {
      "chunk_id": "chunk_602",
      "text": "제조공정과 관련한 추가 상세\n\n완제의약품 품질 특성들과 관련 있는 공정 단계들에 대한 매트릭스를 구성하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 601,
        "window_size": 3,
        "char_count": 61,
        "word_count": 14,
        "page_number": 26,
        "window_text": "공정 설계 관점에서, 이는 함량\n- 2.  Wurster 코팅 공정 구현 및 유사한 기능성 서방 코팅 기전에 대한 제조 관련 사전\n다른 제품의 충진 공정에 이용한 사전 지식에 기초하여 dosing disk와 질량 분급을\n\n이용한 캡슐 충진 공정을 선택하였다.  하나의 캡슐에 충진된 두 가지 펠렛으로 제형을\n\n설계한 사실이 캡슐 충진 공정의 활용을 필요하게 한다.  제조공정과 관련한 추가 상세\n\n완제의약품 품질 특성들과 관련 있는 공정 단계들에 대한 매트릭스를 구성하였다.  약물\n\n품질에 높은 영향력을 갖는 공정단계가 확인된다.  공정단계가 성공적으로 진행되었음을\n\n요약하면, 대조약과 유사한 용출 양상을 구현하도록 속방 및 서방 펠렛을 혼합하여\n\n캡슐화하는 것으로 제품이 설계되었다.  적절한 약물 방출 프로파일에 근거하여 중요\n\n약물층화 공정: 약물층화 공정은 완제품의 함량균일성 뿐만 아니라 코팅 효율성에 직접\n\n- - 51 -\n약물층화 공정에 대한 중요공정변수 및 최적 세팅은 동일한 크기 분포 및 다공성을 갖는\n\n구형 백당에 약물을 코팅하는 유사한 제품에서의 사전 지식에 근거하여 확인하였다.\n\n",
        "original_sentence": "제조공정과 관련한 추가 상세\n\n완제의약품 품질 특성들과 관련 있는 공정 단계들에 대한 매트릭스를 구성하였다. "
      }
    },
    {
      "chunk_id": "chunk_603",
      "text": "약물\n\n품질에 높은 영향력을 갖는 공정단계가 확인된다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 602,
        "window_size": 3,
        "char_count": 31,
        "word_count": 7,
        "page_number": 25,
        "window_text": "Wurster 코팅 공정 구현 및 유사한 기능성 서방 코팅 기전에 대한 제조 관련 사전\n다른 제품의 충진 공정에 이용한 사전 지식에 기초하여 dosing disk와 질량 분급을\n\n이용한 캡슐 충진 공정을 선택하였다.  하나의 캡슐에 충진된 두 가지 펠렛으로 제형을\n\n설계한 사실이 캡슐 충진 공정의 활용을 필요하게 한다.  제조공정과 관련한 추가 상세\n\n완제의약품 품질 특성들과 관련 있는 공정 단계들에 대한 매트릭스를 구성하였다.  약물\n\n품질에 높은 영향력을 갖는 공정단계가 확인된다.  공정단계가 성공적으로 진행되었음을\n\n요약하면, 대조약과 유사한 용출 양상을 구현하도록 속방 및 서방 펠렛을 혼합하여\n\n캡슐화하는 것으로 제품이 설계되었다.  적절한 약물 방출 프로파일에 근거하여 중요\n\n약물층화 공정: 약물층화 공정은 완제품의 함량균일성 뿐만 아니라 코팅 효율성에 직접\n\n- - 51 -\n약물층화 공정에 대한 중요공정변수 및 최적 세팅은 동일한 크기 분포 및 다공성을 갖는\n\n구형 백당에 약물을 코팅하는 유사한 제품에서의 사전 지식에 근거하여 확인하였다.\n\n 그리고, 7” Wurster에서 확인된 중요공정변수에 대하여 실험실 규모 시험(3 kg 뱃치)을\n\n수행하였다. ",
        "original_sentence": "약물\n\n품질에 높은 영향력을 갖는 공정단계가 확인된다. "
      }
    },
    {
      "chunk_id": "chunk_604",
      "text": "공정단계가 성공적으로 진행되었음을\n\n요약하면, 대조약과 유사한 용출 양상을 구현하도록 속방 및 서방 펠렛을 혼합하여\n\n캡슐화하는 것으로 제품이 설계되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 603,
        "window_size": 3,
        "char_count": 87,
        "word_count": 18,
        "page_number": 20,
        "window_text": "하나의 캡슐에 충진된 두 가지 펠렛으로 제형을\n\n설계한 사실이 캡슐 충진 공정의 활용을 필요하게 한다.  제조공정과 관련한 추가 상세\n\n완제의약품 품질 특성들과 관련 있는 공정 단계들에 대한 매트릭스를 구성하였다.  약물\n\n품질에 높은 영향력을 갖는 공정단계가 확인된다.  공정단계가 성공적으로 진행되었음을\n\n요약하면, 대조약과 유사한 용출 양상을 구현하도록 속방 및 서방 펠렛을 혼합하여\n\n캡슐화하는 것으로 제품이 설계되었다.  적절한 약물 방출 프로파일에 근거하여 중요\n\n약물층화 공정: 약물층화 공정은 완제품의 함량균일성 뿐만 아니라 코팅 효율성에 직접\n\n- - 51 -\n약물층화 공정에 대한 중요공정변수 및 최적 세팅은 동일한 크기 분포 및 다공성을 갖는\n\n구형 백당에 약물을 코팅하는 유사한 제품에서의 사전 지식에 근거하여 확인하였다.\n\n 그리고, 7” Wurster에서 확인된 중요공정변수에 대하여 실험실 규모 시험(3 kg 뱃치)을\n\n수행하였다.  약물층화 공정에 대한 중요공정변수는 약물층화액의 분무속도, Bed 온도,\n\n약물미립화 압력, 그리고 유동층 기체 부피인 것으로 확인되었다. ",
        "original_sentence": "공정단계가 성공적으로 진행되었음을\n\n요약하면, 대조약과 유사한 용출 양상을 구현하도록 속방 및 서방 펠렛을 혼합하여\n\n캡슐화하는 것으로 제품이 설계되었다. "
      }
    },
    {
      "chunk_id": "chunk_605",
      "text": "적절한 약물 방출 프로파일에 근거하여 중요\n\n약물층화 공정: 약물층화 공정은 완제품의 함량균일성 뿐만 아니라 코팅 효율성에 직접\n\n- - 51 -\n약물층화 공정에 대한 중요공정변수 및 최적 세팅은 동일한 크기 분포 및 다공성을 갖는\n\n구형 백당에 약물을 코팅하는 유사한 제품에서의 사전 지식에 근거하여 확인하였다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 604,
        "window_size": 3,
        "char_count": 177,
        "word_count": 44,
        "page_number": 14,
        "window_text": "제조공정과 관련한 추가 상세\n\n완제의약품 품질 특성들과 관련 있는 공정 단계들에 대한 매트릭스를 구성하였다.  약물\n\n품질에 높은 영향력을 갖는 공정단계가 확인된다.  공정단계가 성공적으로 진행되었음을\n\n요약하면, 대조약과 유사한 용출 양상을 구현하도록 속방 및 서방 펠렛을 혼합하여\n\n캡슐화하는 것으로 제품이 설계되었다.  적절한 약물 방출 프로파일에 근거하여 중요\n\n약물층화 공정: 약물층화 공정은 완제품의 함량균일성 뿐만 아니라 코팅 효율성에 직접\n\n- - 51 -\n약물층화 공정에 대한 중요공정변수 및 최적 세팅은 동일한 크기 분포 및 다공성을 갖는\n\n구형 백당에 약물을 코팅하는 유사한 제품에서의 사전 지식에 근거하여 확인하였다.\n\n 그리고, 7” Wurster에서 확인된 중요공정변수에 대하여 실험실 규모 시험(3 kg 뱃치)을\n\n수행하였다.  약물층화 공정에 대한 중요공정변수는 약물층화액의 분무속도, Bed 온도,\n\n약물미립화 압력, 그리고 유동층 기체 부피인 것으로 확인되었다.  가장 중요하게 이\n\n시험들은 분무 방울 크기를 20 μm로 하는 것이 구형 백당에 약물을 입히는 공정에\n\n요약하면, 최적화된 공정에서, 함량 98~101 %를 나타내는 펠렛으로 코팅 효율성이\n\n* 약물층화 공정에서, 주성분 ... , clear coating 732(결합제), 그리고 부틸레이티드히드록\n\n서방코팅 공정 : 제네릭의약품의 기능에 따라, 기능성 코팅 공정이 완제의약품 제조공정\n\n**[표 시작]**\n\n| 주입 기체 온도 | 45 ~ 55 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨. ",
        "original_sentence": "적절한 약물 방출 프로파일에 근거하여 중요\n\n약물층화 공정: 약물층화 공정은 완제품의 함량균일성 뿐만 아니라 코팅 효율성에 직접\n\n- - 51 -\n약물층화 공정에 대한 중요공정변수 및 최적 세팅은 동일한 크기 분포 및 다공성을 갖는\n\n구형 백당에 약물을 코팅하는 유사한 제품에서의 사전 지식에 근거하여 확인하였다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_606",
      "text": "그리고, 7” Wurster에서 확인된 중요공정변수에 대하여 실험실 규모 시험(3 kg 뱃치)을\n\n수행하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 605,
        "window_size": 3,
        "char_count": 62,
        "word_count": 12,
        "page_number": 23,
        "window_text": "약물\n\n품질에 높은 영향력을 갖는 공정단계가 확인된다.  공정단계가 성공적으로 진행되었음을\n\n요약하면, 대조약과 유사한 용출 양상을 구현하도록 속방 및 서방 펠렛을 혼합하여\n\n캡슐화하는 것으로 제품이 설계되었다.  적절한 약물 방출 프로파일에 근거하여 중요\n\n약물층화 공정: 약물층화 공정은 완제품의 함량균일성 뿐만 아니라 코팅 효율성에 직접\n\n- - 51 -\n약물층화 공정에 대한 중요공정변수 및 최적 세팅은 동일한 크기 분포 및 다공성을 갖는\n\n구형 백당에 약물을 코팅하는 유사한 제품에서의 사전 지식에 근거하여 확인하였다.\n\n 그리고, 7” Wurster에서 확인된 중요공정변수에 대하여 실험실 규모 시험(3 kg 뱃치)을\n\n수행하였다.  약물층화 공정에 대한 중요공정변수는 약물층화액의 분무속도, Bed 온도,\n\n약물미립화 압력, 그리고 유동층 기체 부피인 것으로 확인되었다.  가장 중요하게 이\n\n시험들은 분무 방울 크기를 20 μm로 하는 것이 구형 백당에 약물을 입히는 공정에\n\n요약하면, 최적화된 공정에서, 함량 98~101 %를 나타내는 펠렛으로 코팅 효율성이\n\n* 약물층화 공정에서, 주성분 ... , clear coating 732(결합제), 그리고 부틸레이티드히드록\n\n서방코팅 공정 : 제네릭의약품의 기능에 따라, 기능성 코팅 공정이 완제의약품 제조공정\n\n**[표 시작]**\n\n| 주입 기체 온도 | 45 ~ 55 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨.  |\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 52 -\n서방코팅 공정에 대한 중요공정변수들은 통계적 실험설계(DOE)를 이용하여 확인하였다.\n\n",
        "original_sentence": "그리고, 7” Wurster에서 확인된 중요공정변수에 대하여 실험실 규모 시험(3 kg 뱃치)을\n\n수행하였다. "
      }
    },
    {
      "chunk_id": "chunk_607",
      "text": "약물층화 공정에 대한 중요공정변수는 약물층화액의 분무속도, Bed 온도,\n\n약물미립화 압력, 그리고 유동층 기체 부피인 것으로 확인되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 606,
        "window_size": 3,
        "char_count": 78,
        "word_count": 16,
        "page_number": 20,
        "window_text": "공정단계가 성공적으로 진행되었음을\n\n요약하면, 대조약과 유사한 용출 양상을 구현하도록 속방 및 서방 펠렛을 혼합하여\n\n캡슐화하는 것으로 제품이 설계되었다.  적절한 약물 방출 프로파일에 근거하여 중요\n\n약물층화 공정: 약물층화 공정은 완제품의 함량균일성 뿐만 아니라 코팅 효율성에 직접\n\n- - 51 -\n약물층화 공정에 대한 중요공정변수 및 최적 세팅은 동일한 크기 분포 및 다공성을 갖는\n\n구형 백당에 약물을 코팅하는 유사한 제품에서의 사전 지식에 근거하여 확인하였다.\n\n 그리고, 7” Wurster에서 확인된 중요공정변수에 대하여 실험실 규모 시험(3 kg 뱃치)을\n\n수행하였다.  약물층화 공정에 대한 중요공정변수는 약물층화액의 분무속도, Bed 온도,\n\n약물미립화 압력, 그리고 유동층 기체 부피인 것으로 확인되었다.  가장 중요하게 이\n\n시험들은 분무 방울 크기를 20 μm로 하는 것이 구형 백당에 약물을 입히는 공정에\n\n요약하면, 최적화된 공정에서, 함량 98~101 %를 나타내는 펠렛으로 코팅 효율성이\n\n* 약물층화 공정에서, 주성분 ... , clear coating 732(결합제), 그리고 부틸레이티드히드록\n\n서방코팅 공정 : 제네릭의약품의 기능에 따라, 기능성 코팅 공정이 완제의약품 제조공정\n\n**[표 시작]**\n\n| 주입 기체 온도 | 45 ~ 55 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨.  |\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 52 -\n서방코팅 공정에 대한 중요공정변수들은 통계적 실험설계(DOE)를 이용하여 확인하였다.\n\n 통계적 실험설계의 1차 목적은 공정변수의 영향을 결정하여 코팅효율성을 최대화하는\n\n것이었고, 2차 목적은 최적화된 공정을 통해 완전히 바로잡힌, 즉 사용기간 동안 일관성\n\n공정변수 결과 범위는 코팅 두께 및 코팅 막 완전성 변경에 따라 서방 코팅된 완제의\n\n약품의 약물방출 프로파일에 대한 예측되는 영향을 나타냈다. ",
        "original_sentence": "약물층화 공정에 대한 중요공정변수는 약물층화액의 분무속도, Bed 온도,\n\n약물미립화 압력, 그리고 유동층 기체 부피인 것으로 확인되었다. "
      }
    },
    {
      "chunk_id": "chunk_608",
      "text": "가장 중요하게 이\n\n시험들은 분무 방울 크기를 20 μm로 하는 것이 구형 백당에 약물을 입히는 공정에\n\n요약하면, 최적화된 공정에서, 함량 98~101 %를 나타내는 펠렛으로 코팅 효율성이\n\n* 약물층화 공정에서, 주성분 ... , clear coating 732(결합제), 그리고 부틸레이티드히드록\n\n서방코팅 공정 : 제네릭의약품의 기능에 따라, 기능성 코팅 공정이 완제의약품 제조공정\n\n**[표 시작]**\n\n| 주입 기체 온도 | 45 ~ 55 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 607,
        "window_size": 3,
        "char_count": 286,
        "word_count": 65,
        "page_number": 3,
        "window_text": "적절한 약물 방출 프로파일에 근거하여 중요\n\n약물층화 공정: 약물층화 공정은 완제품의 함량균일성 뿐만 아니라 코팅 효율성에 직접\n\n- - 51 -\n약물층화 공정에 대한 중요공정변수 및 최적 세팅은 동일한 크기 분포 및 다공성을 갖는\n\n구형 백당에 약물을 코팅하는 유사한 제품에서의 사전 지식에 근거하여 확인하였다.\n\n 그리고, 7” Wurster에서 확인된 중요공정변수에 대하여 실험실 규모 시험(3 kg 뱃치)을\n\n수행하였다.  약물층화 공정에 대한 중요공정변수는 약물층화액의 분무속도, Bed 온도,\n\n약물미립화 압력, 그리고 유동층 기체 부피인 것으로 확인되었다.  가장 중요하게 이\n\n시험들은 분무 방울 크기를 20 μm로 하는 것이 구형 백당에 약물을 입히는 공정에\n\n요약하면, 최적화된 공정에서, 함량 98~101 %를 나타내는 펠렛으로 코팅 효율성이\n\n* 약물층화 공정에서, 주성분 ... , clear coating 732(결합제), 그리고 부틸레이티드히드록\n\n서방코팅 공정 : 제네릭의약품의 기능에 따라, 기능성 코팅 공정이 완제의약품 제조공정\n\n**[표 시작]**\n\n| 주입 기체 온도 | 45 ~ 55 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨.  |\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 52 -\n서방코팅 공정에 대한 중요공정변수들은 통계적 실험설계(DOE)를 이용하여 확인하였다.\n\n 통계적 실험설계의 1차 목적은 공정변수의 영향을 결정하여 코팅효율성을 최대화하는\n\n것이었고, 2차 목적은 최적화된 공정을 통해 완전히 바로잡힌, 즉 사용기간 동안 일관성\n\n공정변수 결과 범위는 코팅 두께 및 코팅 막 완전성 변경에 따라 서방 코팅된 완제의\n\n약품의 약물방출 프로파일에 대한 예측되는 영향을 나타냈다.  모든 공정변수들은 코팅\n\n코팅이 완전히 연합된다는 것을 나타냈고 추가 curing 단계의 필요성이 없어졌다.\n\n",
        "original_sentence": "가장 중요하게 이\n\n시험들은 분무 방울 크기를 20 μm로 하는 것이 구형 백당에 약물을 입히는 공정에\n\n요약하면, 최적화된 공정에서, 함량 98~101 %를 나타내는 펠렛으로 코팅 효율성이\n\n* 약물층화 공정에서, 주성분 ... , clear coating 732(결합제), 그리고 부틸레이티드히드록\n\n서방코팅 공정 : 제네릭의약품의 기능에 따라, 기능성 코팅 공정이 완제의약품 제조공정\n\n**[표 시작]**\n\n| 주입 기체 온도 | 45 ~ 55 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨. "
      }
    },
    {
      "chunk_id": "chunk_609",
      "text": "|\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 52 -\n서방코팅 공정에 대한 중요공정변수들은 통계적 실험설계(DOE)를 이용하여 확인하였다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 608,
        "window_size": 3,
        "char_count": 92,
        "word_count": 22,
        "page_number": 5,
        "window_text": "그리고, 7” Wurster에서 확인된 중요공정변수에 대하여 실험실 규모 시험(3 kg 뱃치)을\n\n수행하였다.  약물층화 공정에 대한 중요공정변수는 약물층화액의 분무속도, Bed 온도,\n\n약물미립화 압력, 그리고 유동층 기체 부피인 것으로 확인되었다.  가장 중요하게 이\n\n시험들은 분무 방울 크기를 20 μm로 하는 것이 구형 백당에 약물을 입히는 공정에\n\n요약하면, 최적화된 공정에서, 함량 98~101 %를 나타내는 펠렛으로 코팅 효율성이\n\n* 약물층화 공정에서, 주성분 ... , clear coating 732(결합제), 그리고 부틸레이티드히드록\n\n서방코팅 공정 : 제네릭의약품의 기능에 따라, 기능성 코팅 공정이 완제의약품 제조공정\n\n**[표 시작]**\n\n| 주입 기체 온도 | 45 ~ 55 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨.  |\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 52 -\n서방코팅 공정에 대한 중요공정변수들은 통계적 실험설계(DOE)를 이용하여 확인하였다.\n\n 통계적 실험설계의 1차 목적은 공정변수의 영향을 결정하여 코팅효율성을 최대화하는\n\n것이었고, 2차 목적은 최적화된 공정을 통해 완전히 바로잡힌, 즉 사용기간 동안 일관성\n\n공정변수 결과 범위는 코팅 두께 및 코팅 막 완전성 변경에 따라 서방 코팅된 완제의\n\n약품의 약물방출 프로파일에 대한 예측되는 영향을 나타냈다.  모든 공정변수들은 코팅\n\n코팅이 완전히 연합된다는 것을 나타냈고 추가 curing 단계의 필요성이 없어졌다.\n\n - - 53 -\n실험설계 시험의 결과들은 최적 조건을 이용한 3kg 실험실 규모의 서방코팅 뱃치의\n\n시 조제된 것 vs. ",
        "original_sentence": "|\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 52 -\n서방코팅 공정에 대한 중요공정변수들은 통계적 실험설계(DOE)를 이용하여 확인하였다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_610",
      "text": "통계적 실험설계의 1차 목적은 공정변수의 영향을 결정하여 코팅효율성을 최대화하는\n\n것이었고, 2차 목적은 최적화된 공정을 통해 완전히 바로잡힌, 즉 사용기간 동안 일관성\n\n공정변수 결과 범위는 코팅 두께 및 코팅 막 완전성 변경에 따라 서방 코팅된 완제의\n\n약품의 약물방출 프로파일에 대한 예측되는 영향을 나타냈다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 609,
        "window_size": 3,
        "char_count": 177,
        "word_count": 42,
        "page_number": 3,
        "window_text": "약물층화 공정에 대한 중요공정변수는 약물층화액의 분무속도, Bed 온도,\n\n약물미립화 압력, 그리고 유동층 기체 부피인 것으로 확인되었다.  가장 중요하게 이\n\n시험들은 분무 방울 크기를 20 μm로 하는 것이 구형 백당에 약물을 입히는 공정에\n\n요약하면, 최적화된 공정에서, 함량 98~101 %를 나타내는 펠렛으로 코팅 효율성이\n\n* 약물층화 공정에서, 주성분 ... , clear coating 732(결합제), 그리고 부틸레이티드히드록\n\n서방코팅 공정 : 제네릭의약품의 기능에 따라, 기능성 코팅 공정이 완제의약품 제조공정\n\n**[표 시작]**\n\n| 주입 기체 온도 | 45 ~ 55 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨.  |\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 52 -\n서방코팅 공정에 대한 중요공정변수들은 통계적 실험설계(DOE)를 이용하여 확인하였다.\n\n 통계적 실험설계의 1차 목적은 공정변수의 영향을 결정하여 코팅효율성을 최대화하는\n\n것이었고, 2차 목적은 최적화된 공정을 통해 완전히 바로잡힌, 즉 사용기간 동안 일관성\n\n공정변수 결과 범위는 코팅 두께 및 코팅 막 완전성 변경에 따라 서방 코팅된 완제의\n\n약품의 약물방출 프로파일에 대한 예측되는 영향을 나타냈다.  모든 공정변수들은 코팅\n\n코팅이 완전히 연합된다는 것을 나타냈고 추가 curing 단계의 필요성이 없어졌다.\n\n - - 53 -\n실험설계 시험의 결과들은 최적 조건을 이용한 3kg 실험실 규모의 서방코팅 뱃치의\n\n시 조제된 것 vs.  60℃에 18시간 보관한 것), 1시간/4시간/8시간의 약물방출이 각각\n\n실험설계 구성, 실험실 규모의 결과, 최적 공정변수 선택사유, 그리고 최적화된 3kg 규\n\n캡슐충진: 속방 및 서방 펠렛들은 자동캡슐 충진기에서 두 개의 독립된 feeder를 이용하여\n\n- - 54 -\n품을 충진할 때 자동캡슐충진기 작동 조건을 참고하였다. ",
        "original_sentence": "통계적 실험설계의 1차 목적은 공정변수의 영향을 결정하여 코팅효율성을 최대화하는\n\n것이었고, 2차 목적은 최적화된 공정을 통해 완전히 바로잡힌, 즉 사용기간 동안 일관성\n\n공정변수 결과 범위는 코팅 두께 및 코팅 막 완전성 변경에 따라 서방 코팅된 완제의\n\n약품의 약물방출 프로파일에 대한 예측되는 영향을 나타냈다. "
      }
    },
    {
      "chunk_id": "chunk_611",
      "text": "모든 공정변수들은 코팅\n\n코팅이 완전히 연합된다는 것을 나타냈고 추가 curing 단계의 필요성이 없어졌다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 610,
        "window_size": 3,
        "char_count": 62,
        "word_count": 13,
        "page_number": 3,
        "window_text": "가장 중요하게 이\n\n시험들은 분무 방울 크기를 20 μm로 하는 것이 구형 백당에 약물을 입히는 공정에\n\n요약하면, 최적화된 공정에서, 함량 98~101 %를 나타내는 펠렛으로 코팅 효율성이\n\n* 약물층화 공정에서, 주성분 ... , clear coating 732(결합제), 그리고 부틸레이티드히드록\n\n서방코팅 공정 : 제네릭의약품의 기능에 따라, 기능성 코팅 공정이 완제의약품 제조공정\n\n**[표 시작]**\n\n| 주입 기체 온도 | 45 ~ 55 ℃ | Wurster의 건조/습도 기록지를 이용하여 계산됨.  |\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 52 -\n서방코팅 공정에 대한 중요공정변수들은 통계적 실험설계(DOE)를 이용하여 확인하였다.\n\n 통계적 실험설계의 1차 목적은 공정변수의 영향을 결정하여 코팅효율성을 최대화하는\n\n것이었고, 2차 목적은 최적화된 공정을 통해 완전히 바로잡힌, 즉 사용기간 동안 일관성\n\n공정변수 결과 범위는 코팅 두께 및 코팅 막 완전성 변경에 따라 서방 코팅된 완제의\n\n약품의 약물방출 프로파일에 대한 예측되는 영향을 나타냈다.  모든 공정변수들은 코팅\n\n코팅이 완전히 연합된다는 것을 나타냈고 추가 curing 단계의 필요성이 없어졌다.\n\n - - 53 -\n실험설계 시험의 결과들은 최적 조건을 이용한 3kg 실험실 규모의 서방코팅 뱃치의\n\n시 조제된 것 vs.  60℃에 18시간 보관한 것), 1시간/4시간/8시간의 약물방출이 각각\n\n실험설계 구성, 실험실 규모의 결과, 최적 공정변수 선택사유, 그리고 최적화된 3kg 규\n\n캡슐충진: 속방 및 서방 펠렛들은 자동캡슐 충진기에서 두 개의 독립된 feeder를 이용하여\n\n- - 54 -\n품을 충진할 때 자동캡슐충진기 작동 조건을 참고하였다.  공정 검사는 속방 및 서방 펠렛\n\nWurster에서 스케일업이 서방캡슐 제품을 포함한 다른 제품들에서 성공적으로 이루어\n\n졌다. ",
        "original_sentence": "모든 공정변수들은 코팅\n\n코팅이 완전히 연합된다는 것을 나타냈고 추가 curing 단계의 필요성이 없어졌다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_612",
      "text": "- - 53 -\n실험설계 시험의 결과들은 최적 조건을 이용한 3kg 실험실 규모의 서방코팅 뱃치의\n\n시 조제된 것 vs. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 611,
        "window_size": 3,
        "char_count": 68,
        "word_count": 19,
        "page_number": 3,
        "window_text": "|\n| --- | --- | --- |\n\n**[표 끝]**\n\n- - 52 -\n서방코팅 공정에 대한 중요공정변수들은 통계적 실험설계(DOE)를 이용하여 확인하였다.\n\n 통계적 실험설계의 1차 목적은 공정변수의 영향을 결정하여 코팅효율성을 최대화하는\n\n것이었고, 2차 목적은 최적화된 공정을 통해 완전히 바로잡힌, 즉 사용기간 동안 일관성\n\n공정변수 결과 범위는 코팅 두께 및 코팅 막 완전성 변경에 따라 서방 코팅된 완제의\n\n약품의 약물방출 프로파일에 대한 예측되는 영향을 나타냈다.  모든 공정변수들은 코팅\n\n코팅이 완전히 연합된다는 것을 나타냈고 추가 curing 단계의 필요성이 없어졌다.\n\n - - 53 -\n실험설계 시험의 결과들은 최적 조건을 이용한 3kg 실험실 규모의 서방코팅 뱃치의\n\n시 조제된 것 vs.  60℃에 18시간 보관한 것), 1시간/4시간/8시간의 약물방출이 각각\n\n실험설계 구성, 실험실 규모의 결과, 최적 공정변수 선택사유, 그리고 최적화된 3kg 규\n\n캡슐충진: 속방 및 서방 펠렛들은 자동캡슐 충진기에서 두 개의 독립된 feeder를 이용하여\n\n- - 54 -\n품을 충진할 때 자동캡슐충진기 작동 조건을 참고하였다.  공정 검사는 속방 및 서방 펠렛\n\nWurster에서 스케일업이 서방캡슐 제품을 포함한 다른 제품들에서 성공적으로 이루어\n\n졌다.  추가적으로, 실험실 규모 뱃치들에서의 실험설계에 근거하여 구형 백당에 부착하는\n\n주성분 ...  및 서방층의 코팅과 관련한 중요공정변수들에 대한 허용범위가 결정되었다.\n\n",
        "original_sentence": "- - 53 -\n실험설계 시험의 결과들은 최적 조건을 이용한 3kg 실험실 규모의 서방코팅 뱃치의\n\n시 조제된 것 vs. "
      }
    },
    {
      "chunk_id": "chunk_613",
      "text": "60℃에 18시간 보관한 것), 1시간/4시간/8시간의 약물방출이 각각\n\n실험설계 구성, 실험실 규모의 결과, 최적 공정변수 선택사유, 그리고 최적화된 3kg 규\n\n캡슐충진: 속방 및 서방 펠렛들은 자동캡슐 충진기에서 두 개의 독립된 feeder를 이용하여\n\n- - 54 -\n품을 충진할 때 자동캡슐충진기 작동 조건을 참고하였다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 612,
        "window_size": 3,
        "char_count": 185,
        "word_count": 42,
        "page_number": 3,
        "window_text": "통계적 실험설계의 1차 목적은 공정변수의 영향을 결정하여 코팅효율성을 최대화하는\n\n것이었고, 2차 목적은 최적화된 공정을 통해 완전히 바로잡힌, 즉 사용기간 동안 일관성\n\n공정변수 결과 범위는 코팅 두께 및 코팅 막 완전성 변경에 따라 서방 코팅된 완제의\n\n약품의 약물방출 프로파일에 대한 예측되는 영향을 나타냈다.  모든 공정변수들은 코팅\n\n코팅이 완전히 연합된다는 것을 나타냈고 추가 curing 단계의 필요성이 없어졌다.\n\n - - 53 -\n실험설계 시험의 결과들은 최적 조건을 이용한 3kg 실험실 규모의 서방코팅 뱃치의\n\n시 조제된 것 vs.  60℃에 18시간 보관한 것), 1시간/4시간/8시간의 약물방출이 각각\n\n실험설계 구성, 실험실 규모의 결과, 최적 공정변수 선택사유, 그리고 최적화된 3kg 규\n\n캡슐충진: 속방 및 서방 펠렛들은 자동캡슐 충진기에서 두 개의 독립된 feeder를 이용하여\n\n- - 54 -\n품을 충진할 때 자동캡슐충진기 작동 조건을 참고하였다.  공정 검사는 속방 및 서방 펠렛\n\nWurster에서 스케일업이 서방캡슐 제품을 포함한 다른 제품들에서 성공적으로 이루어\n\n졌다.  추가적으로, 실험실 규모 뱃치들에서의 실험설계에 근거하여 구형 백당에 부착하는\n\n주성분 ...  및 서방층의 코팅과 관련한 중요공정변수들에 대한 허용범위가 결정되었다.\n\n 업 하는데 성공적으로 이용되었다. ",
        "original_sentence": "60℃에 18시간 보관한 것), 1시간/4시간/8시간의 약물방출이 각각\n\n실험설계 구성, 실험실 규모의 결과, 최적 공정변수 선택사유, 그리고 최적화된 3kg 규\n\n캡슐충진: 속방 및 서방 펠렛들은 자동캡슐 충진기에서 두 개의 독립된 feeder를 이용하여\n\n- - 54 -\n품을 충진할 때 자동캡슐충진기 작동 조건을 참고하였다. "
      }
    },
    {
      "chunk_id": "chunk_614",
      "text": "공정 검사는 속방 및 서방 펠렛\n\nWurster에서 스케일업이 서방캡슐 제품을 포함한 다른 제품들에서 성공적으로 이루어\n\n졌다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 613,
        "window_size": 3,
        "char_count": 72,
        "word_count": 16,
        "page_number": 3,
        "window_text": "모든 공정변수들은 코팅\n\n코팅이 완전히 연합된다는 것을 나타냈고 추가 curing 단계의 필요성이 없어졌다.\n\n - - 53 -\n실험설계 시험의 결과들은 최적 조건을 이용한 3kg 실험실 규모의 서방코팅 뱃치의\n\n시 조제된 것 vs.  60℃에 18시간 보관한 것), 1시간/4시간/8시간의 약물방출이 각각\n\n실험설계 구성, 실험실 규모의 결과, 최적 공정변수 선택사유, 그리고 최적화된 3kg 규\n\n캡슐충진: 속방 및 서방 펠렛들은 자동캡슐 충진기에서 두 개의 독립된 feeder를 이용하여\n\n- - 54 -\n품을 충진할 때 자동캡슐충진기 작동 조건을 참고하였다.  공정 검사는 속방 및 서방 펠렛\n\nWurster에서 스케일업이 서방캡슐 제품을 포함한 다른 제품들에서 성공적으로 이루어\n\n졌다.  추가적으로, 실험실 규모 뱃치들에서의 실험설계에 근거하여 구형 백당에 부착하는\n\n주성분 ...  및 서방층의 코팅과 관련한 중요공정변수들에 대한 허용범위가 결정되었다.\n\n 업 하는데 성공적으로 이용되었다.  성공적으로 스케일업하는데 이용되었던 공정변수의\n\n주입 기체 온도(℃)\n\n55~62\n\n55~62\n\n스케일 독립 변수\n\n- - 55 -\n주성분 ... 의 가수분해 가능성 때문에 용기 및 포장은 완제의약품을 수분으로부터 보호\n\nBed 온도(℃)\n\n37~43\n\n37~43\n\n스케일 독립 변수\n\n- - 56 -",
        "original_sentence": "공정 검사는 속방 및 서방 펠렛\n\nWurster에서 스케일업이 서방캡슐 제품을 포함한 다른 제품들에서 성공적으로 이루어\n\n졌다. "
      }
    },
    {
      "chunk_id": "chunk_615",
      "text": "추가적으로, 실험실 규모 뱃치들에서의 실험설계에 근거하여 구형 백당에 부착하는\n\n주성분 ...  및 서방층의 코팅과 관련한 중요공정변수들에 대한 허용범위가 결정되었다.\n\n",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 614,
        "window_size": 3,
        "char_count": 95,
        "word_count": 19,
        "page_number": 19,
        "window_text": "- - 53 -\n실험설계 시험의 결과들은 최적 조건을 이용한 3kg 실험실 규모의 서방코팅 뱃치의\n\n시 조제된 것 vs.  60℃에 18시간 보관한 것), 1시간/4시간/8시간의 약물방출이 각각\n\n실험설계 구성, 실험실 규모의 결과, 최적 공정변수 선택사유, 그리고 최적화된 3kg 규\n\n캡슐충진: 속방 및 서방 펠렛들은 자동캡슐 충진기에서 두 개의 독립된 feeder를 이용하여\n\n- - 54 -\n품을 충진할 때 자동캡슐충진기 작동 조건을 참고하였다.  공정 검사는 속방 및 서방 펠렛\n\nWurster에서 스케일업이 서방캡슐 제품을 포함한 다른 제품들에서 성공적으로 이루어\n\n졌다.  추가적으로, 실험실 규모 뱃치들에서의 실험설계에 근거하여 구형 백당에 부착하는\n\n주성분 ...  및 서방층의 코팅과 관련한 중요공정변수들에 대한 허용범위가 결정되었다.\n\n 업 하는데 성공적으로 이용되었다.  성공적으로 스케일업하는데 이용되었던 공정변수의\n\n주입 기체 온도(℃)\n\n55~62\n\n55~62\n\n스케일 독립 변수\n\n- - 55 -\n주성분 ... 의 가수분해 가능성 때문에 용기 및 포장은 완제의약품을 수분으로부터 보호\n\nBed 온도(℃)\n\n37~43\n\n37~43\n\n스케일 독립 변수\n\n- - 56 -",
        "original_sentence": "추가적으로, 실험실 규모 뱃치들에서의 실험설계에 근거하여 구형 백당에 부착하는\n\n주성분 ...  및 서방층의 코팅과 관련한 중요공정변수들에 대한 허용범위가 결정되었다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_616",
      "text": "업 하는데 성공적으로 이용되었다. ",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 615,
        "window_size": 3,
        "char_count": 19,
        "word_count": 4,
        "page_number": 3,
        "window_text": "60℃에 18시간 보관한 것), 1시간/4시간/8시간의 약물방출이 각각\n\n실험설계 구성, 실험실 규모의 결과, 최적 공정변수 선택사유, 그리고 최적화된 3kg 규\n\n캡슐충진: 속방 및 서방 펠렛들은 자동캡슐 충진기에서 두 개의 독립된 feeder를 이용하여\n\n- - 54 -\n품을 충진할 때 자동캡슐충진기 작동 조건을 참고하였다.  공정 검사는 속방 및 서방 펠렛\n\nWurster에서 스케일업이 서방캡슐 제품을 포함한 다른 제품들에서 성공적으로 이루어\n\n졌다.  추가적으로, 실험실 규모 뱃치들에서의 실험설계에 근거하여 구형 백당에 부착하는\n\n주성분 ...  및 서방층의 코팅과 관련한 중요공정변수들에 대한 허용범위가 결정되었다.\n\n 업 하는데 성공적으로 이용되었다.  성공적으로 스케일업하는데 이용되었던 공정변수의\n\n주입 기체 온도(℃)\n\n55~62\n\n55~62\n\n스케일 독립 변수\n\n- - 55 -\n주성분 ... 의 가수분해 가능성 때문에 용기 및 포장은 완제의약품을 수분으로부터 보호\n\nBed 온도(℃)\n\n37~43\n\n37~43\n\n스케일 독립 변수\n\n- - 56 -",
        "original_sentence": "업 하는데 성공적으로 이용되었다. "
      }
    },
    {
      "chunk_id": "chunk_617",
      "text": "성공적으로 스케일업하는데 이용되었던 공정변수의\n\n주입 기체 온도(℃)\n\n55~62\n\n55~62\n\n스케일 독립 변수\n\n- - 55 -\n주성분 ... 의 가수분해 가능성 때문에 용기 및 포장은 완제의약품을 수분으로부터 보호\n\nBed 온도(℃)\n\n37~43\n\n37~43\n\n스케일 독립 변수\n\n- - 56 -",
      "metadata": {
        "source": "21_제네릭의약품의+국제공통기술문서+품질요약자료+작성+가이드라인[민원인안내서].pdf",
        "chunk_index": 616,
        "window_size": 3,
        "char_count": 168,
        "word_count": 39,
        "page_number": 3,
        "window_text": "공정 검사는 속방 및 서방 펠렛\n\nWurster에서 스케일업이 서방캡슐 제품을 포함한 다른 제품들에서 성공적으로 이루어\n\n졌다.  추가적으로, 실험실 규모 뱃치들에서의 실험설계에 근거하여 구형 백당에 부착하는\n\n주성분 ...  및 서방층의 코팅과 관련한 중요공정변수들에 대한 허용범위가 결정되었다.\n\n 업 하는데 성공적으로 이용되었다.  성공적으로 스케일업하는데 이용되었던 공정변수의\n\n주입 기체 온도(℃)\n\n55~62\n\n55~62\n\n스케일 독립 변수\n\n- - 55 -\n주성분 ... 의 가수분해 가능성 때문에 용기 및 포장은 완제의약품을 수분으로부터 보호\n\nBed 온도(℃)\n\n37~43\n\n37~43\n\n스케일 독립 변수\n\n- - 56 -",
        "original_sentence": "성공적으로 스케일업하는데 이용되었던 공정변수의\n\n주입 기체 온도(℃)\n\n55~62\n\n55~62\n\n스케일 독립 변수\n\n- - 55 -\n주성분 ... 의 가수분해 가능성 때문에 용기 및 포장은 완제의약품을 수분으로부터 보호\n\nBed 온도(℃)\n\n37~43\n\n37~43\n\n스케일 독립 변수\n\n- - 56 -"
      }
    }
  ],
  "chunking_analysis": {
    "total_chunks": 617,
    "avg_chunk_length": 97.257698541329,
    "min_chunk_length": 2,
    "max_chunk_length": 617,
    "total_characters": 60008,
    "total_words": 14480,
    "window_size": 3
  },
  "statistics": {
    "total_text_blocks": 2798,
    "heading_count": 85,
    "paragraph_count": 513,
    "list_item_count": 316,
    "table_cell_count": 1884,
    "tables_detected": 19,
    "chunks_generated": 617
  }
}